{"meta":{"query_hash":"8b323155c888","filters":{"venue":"International Journal of Gynecological Cancer"},"cohort_total":914,"direct_labels_cover":3,"predictions_cover":914,"exported":914,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8b323155c888","api":"https://metacan.xera.ac/api/v1/cohort?venue=International+Journal+of+Gynecological+Cancer"},"results":[{"id":"W1964816236","doi":"10.1097/igc.0000000000000299","title":"Quality of Life and Patient-Reported Outcomes in Endometrial Cancer Clinical Trials","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Endometrial cancer; Clinical trial; Lymphadenectomy; Genitourinary system; Intensive care medicine; Cancer; Oncology; Physical therapy; Internal medicine","score_opus":0.21974399694420113,"score_gpt":0.5039026198972081,"score_spread":0.284158622953007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964816236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010295,0.0017066811,0.000067939,0.004448503,0.0029137963,0.00027021483,0.00004139743,0.000006500604,0.0004420097],"genre_scores_gemma":[0.99491954,0.0020177772,0.00032086083,0.001927648,0.00073198276,0.00002725008,0.000002572043,0.000008201456,0.0000441403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947516,0.0008503631,0.003131247,0.0002144282,0.0008826664,0.00016971765],"domain_scores_gemma":[0.9893667,0.0073097385,0.002147562,0.0001063974,0.0007824297,0.000287181],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041782754,0.0001562366,0.001748296,0.00033898035,0.000015627462,0.000016504802,0.00017728911,0.0001780232,0.0015620477],"category_scores_gemma":[0.051222812,0.000092704286,0.0005209536,0.00024721285,0.00013612317,0.0000962813,0.000075350734,0.00036175584,0.0000014009236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006467718,0.0007289927,0.81416273,0.000013254663,0.0009531284,0.00003480717,0.000028814955,0.000018544302,0.00029725913,0.0001349917,0.00014026031,0.17701949],"study_design_scores_gemma":[0.02329113,0.0015450293,0.97046655,0.000073162126,0.00013580215,0.000010686489,0.000034741326,0.00001676947,0.00027871507,0.0007403657,0.0033136522,0.00009341408],"about_ca_topic_score_codex":0.00045428242,"about_ca_topic_score_gemma":0.00015798562,"teacher_disagreement_score":0.17692609,"about_ca_system_score_codex":0.00023298753,"about_ca_system_score_gemma":0.0003242758,"threshold_uncertainty_score":0.99935067},"labels":[],"label_agreement":null},{"id":"W1966261847","doi":"10.1097/igc.0000000000000262","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Small Cell Carcinoma of the Cervix","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cervix; Adenocarcinoma; Incidence (geometry); Stage (stratigraphy); Cervical cancer; Cancer; Carcinoma; Metastasis; Oncology; Epidemiology; Uterine cervix; Basal cell; Gynecology; Pathology; Internal medicine","score_opus":0.09253205530852371,"score_gpt":0.42877125213557055,"score_spread":0.33623919682704684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966261847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014771224,0.9875851,0.000020852938,0.0045119366,0.0034500328,0.0020596492,0.0002687463,0.000011373148,0.00061518006],"genre_scores_gemma":[0.0045056264,0.9898104,0.00037806804,0.0023420325,0.0009821336,0.00048003977,0.0000136679355,0.000056458954,0.0014315438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99545085,0.0004896685,0.0021278192,0.00043398948,0.0010156386,0.0004820155],"domain_scores_gemma":[0.99077797,0.0030792896,0.0032293512,0.00038925963,0.0022702469,0.0002539059],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074121996,0.00049857824,0.0030123245,0.0002557403,0.000057683785,0.000026613408,0.0017339408,0.00011127404,0.0018707048],"category_scores_gemma":[0.0044709817,0.00026089043,0.0021186024,0.00028699503,0.00033370077,0.000046865192,0.0004184541,0.0012165577,0.000009436026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004933777,0.00072644633,0.0021729805,0.069413535,0.0012087317,0.001351325,0.000012440883,0.00001975519,0.00003621752,0.00016748141,0.04079273,0.883605],"study_design_scores_gemma":[0.0014236183,0.0011975558,0.0006716169,0.027369952,0.0016369523,0.0013306031,0.000008058426,0.0000063279795,0.00010348649,0.00012871063,0.9658923,0.00023080593],"about_ca_topic_score_codex":0.00004472672,"about_ca_topic_score_gemma":0.00012138494,"teacher_disagreement_score":0.92509955,"about_ca_system_score_codex":0.0009935122,"about_ca_system_score_gemma":0.0018133682,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W1967147743","doi":"10.1097/igc.0b013e31829a5527","title":"Risk Factors for Ovarian Cancers With and Without Microsatellite Instability","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Microsatellite instability; Oncology; Ovarian cancer; Gynecology; Internal medicine; Microsatellite; Cancer; Genetics; Gene","score_opus":0.023801167257815867,"score_gpt":0.311596328579462,"score_spread":0.2877951613216461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967147743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384344,0.00063656684,0.00031887577,0.0039825006,0.00046676505,0.00044410359,0.00007399697,0.000008177055,0.00022555485],"genre_scores_gemma":[0.9944023,0.0012150357,0.0033136029,0.0006279038,0.00024314139,0.00009316585,0.0000053818367,0.00001087241,0.00008862641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904245,0.000027296872,0.0003196048,0.00018059621,0.00027292478,0.00015715271],"domain_scores_gemma":[0.9983982,0.0002696366,0.00032865256,0.00007602685,0.0007519007,0.00017559524],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014406128,0.00013555658,0.0003151304,0.00006666837,0.000047698817,0.0000554047,0.00010318093,0.00006970666,0.0009857438],"category_scores_gemma":[0.00019456142,0.00007534785,0.00010769456,0.00004879349,0.00011749744,0.0001518188,0.000022127339,0.00016984207,0.0000019086413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006634382,0.00017391566,0.9694263,0.000011784324,0.0006978197,0.000012258029,0.00015525731,0.000066543376,0.00022256133,0.00009127588,0.00038744407,0.02809141],"study_design_scores_gemma":[0.0037256605,0.0012632441,0.98331463,0.000073042866,0.00019795036,0.00004992591,0.00011481222,0.000061862534,0.00096510863,0.00048465157,0.009656066,0.00009301868],"about_ca_topic_score_codex":0.0009599978,"about_ca_topic_score_gemma":0.0002801589,"teacher_disagreement_score":0.027998392,"about_ca_system_score_codex":0.00066596403,"about_ca_system_score_gemma":0.000279295,"threshold_uncertainty_score":0.99992746},"labels":[],"label_agreement":null},{"id":"W1969023321","doi":"10.1097/igc.0b013e3182798188","title":"BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Immunohistochemistry; Tissue microarray; Serous fluid; Medicine; Staining; Pathology; Serous carcinoma; Ovarian carcinoma; Carcinoma; Ovarian cancer; Cancer; Internal medicine","score_opus":0.025554933832673286,"score_gpt":0.3614962488458423,"score_spread":0.33594131501316904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969023321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906433,0.0027925004,0.000021215932,0.0044056145,0.0010452394,0.0001816271,0.00001068083,0.000009044962,0.0008907794],"genre_scores_gemma":[0.99677277,0.0003480615,0.0005862482,0.0013207872,0.0007978184,0.00006634567,0.000005751172,0.000012554693,0.000089639834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985755,0.000039361432,0.00049652305,0.00013343207,0.0004816629,0.0002735041],"domain_scores_gemma":[0.9989819,0.00020399544,0.00028578777,0.000082516315,0.00022749558,0.00021833454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026457058,0.00013481332,0.00033378723,0.0001735112,0.000019798514,0.000020237401,0.00018708824,0.000099642435,0.0024260024],"category_scores_gemma":[0.00038630544,0.000096800395,0.00013933382,0.00009697849,0.000059883754,0.00014752151,0.000070737064,0.0003325499,0.000027493503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060810737,0.0010103234,0.9802439,0.000013195355,0.00024468315,0.00092728774,0.00026536535,0.000010005688,0.000987635,0.00025304843,0.00050630316,0.014930139],"study_design_scores_gemma":[0.0031673186,0.00074971933,0.98166776,0.0001278055,0.000076478864,0.0007420215,0.00007022131,0.000013043233,0.0013614243,0.00011090815,0.011814773,0.00009850549],"about_ca_topic_score_codex":0.000089258996,"about_ca_topic_score_gemma":0.000009129201,"teacher_disagreement_score":0.014831633,"about_ca_system_score_codex":0.0013095441,"about_ca_system_score_gemma":0.00031891282,"threshold_uncertainty_score":0.9984859},"labels":[],"label_agreement":null},{"id":"W1970115049","doi":"10.1097/igc.0b013e31821bb700","title":"Clinical Trials and Treatment of the Elderly Diagnosed With Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Medicine; Ovarian cancer; Clinical trial; Cancer; Oncology; Internal medicine","score_opus":0.27931149285886586,"score_gpt":0.4963706761450325,"score_spread":0.21705918328616663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970115049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032697383,0.9915637,0.000007773472,0.0013140102,0.0023286233,0.001003484,0.00020150878,0.000005324056,0.00030583917],"genre_scores_gemma":[0.0048361407,0.9926596,0.00026027122,0.00019949998,0.0014680914,0.00028763583,0.0000060656766,0.000027530908,0.00025511856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963592,0.0006242671,0.002026533,0.00031415705,0.00049348705,0.00018231114],"domain_scores_gemma":[0.99366283,0.002317496,0.0029873636,0.00023027406,0.0005938123,0.00020821023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009301409,0.00036709453,0.0033644678,0.00013539984,0.000036050857,0.000028732862,0.0003317454,0.00032992248,0.0019393788],"category_scores_gemma":[0.00062200247,0.00014512912,0.0013907552,0.00013088973,0.00024257111,0.00005442329,0.00005699521,0.0003749751,0.0000023955276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004942954,0.001154043,0.020669784,0.00024108005,0.006511574,0.00032359286,0.000050033475,0.0000010231724,1.398151e-7,0.00015867842,0.0005532944,0.96984243],"study_design_scores_gemma":[0.005484613,0.0052517364,0.039797504,0.008255453,0.007531582,0.00025691453,0.000012850141,5.724071e-7,0.0000044163617,0.000049458453,0.9332026,0.00015225717],"about_ca_topic_score_codex":0.00029975455,"about_ca_topic_score_gemma":0.00029712744,"teacher_disagreement_score":0.9696902,"about_ca_system_score_codex":0.0007963738,"about_ca_system_score_gemma":0.0017436186,"threshold_uncertainty_score":0.998973},"labels":[],"label_agreement":null},{"id":"W1972040966","doi":"10.1111/j.1048-891x.2004.014319.x","title":"Female adnexal tumor of probable wolffian origin: a clinicopathological case report and a possible new treatment","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mesonephric duct; Debulking; Adnexal mass; Exploratory laparotomy; Asymptomatic; Surgery; Laparotomy; Cancer; Internal medicine; Ovarian cancer","score_opus":0.06598386324225584,"score_gpt":0.3881708864426696,"score_spread":0.32218702320041376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972040966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490434,0.0006089423,0.00008267009,0.0030147887,0.00048352082,0.00020915177,0.000014993156,0.000011017111,0.00067060394],"genre_scores_gemma":[0.9916412,0.00027946723,0.006299079,0.00032192396,0.000393813,0.000014585871,0.0000043303166,0.000008540292,0.0010370361],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986324,0.000023728335,0.0006561959,0.00020035775,0.00032270022,0.00016464888],"domain_scores_gemma":[0.99874705,0.00006911219,0.000489665,0.00010092364,0.0003415855,0.00025166446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016985506,0.00015112283,0.00045955225,0.00010016944,0.00003138381,0.000022558392,0.00009146015,0.000076404656,0.0005059019],"category_scores_gemma":[0.00023531905,0.000089361,0.00018590824,0.00007740044,0.00009341055,0.00009736034,0.000051213985,0.00014584669,0.0000038768812],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014506249,0.0018939838,0.3970708,0.000016353033,0.00048489356,0.58324945,0.0002135283,0.00013150684,0.0006385059,0.0003865593,0.00015798036,0.014305792],"study_design_scores_gemma":[0.016880725,0.0130395,0.3382397,0.0003011724,0.00045284367,0.6145551,0.0001803762,0.0000136518875,0.0037456513,0.0016762333,0.010701518,0.00021352318],"about_ca_topic_score_codex":0.00023672948,"about_ca_topic_score_gemma":0.00017306792,"teacher_disagreement_score":0.05883112,"about_ca_system_score_codex":0.0004564607,"about_ca_system_score_gemma":0.0006482888,"threshold_uncertainty_score":0.55392706},"labels":[],"label_agreement":null},{"id":"W1974929173","doi":"10.1046/j.1525-1438.2000.99509.x","title":"New cytotoxics and non-cytotoxics in epithelial ovarian cancer","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Topotecan; Medicine; Ovarian cancer; Gemcitabine; Paclitaxel; Epirubicin; Matrix metalloproteinase inhibitor; Oncology; Pharmacology; Cancer research; Cancer; Chemotherapy; Internal medicine; Matrix metalloproteinase; Breast cancer","score_opus":0.017505400216172314,"score_gpt":0.323875507917991,"score_spread":0.3063701077018187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974929173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765439,0.0015037319,0.00008823287,0.018584749,0.0009446308,0.00021743738,0.000043766126,0.0000080250975,0.0020655468],"genre_scores_gemma":[0.9831544,0.010346445,0.0015883209,0.0025794883,0.0012773938,0.00003269188,0.0000025375912,0.000013799965,0.0010049206],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861264,0.00002941693,0.000496233,0.0002000733,0.00045496604,0.0002066706],"domain_scores_gemma":[0.9991454,0.00013827052,0.00018481168,0.000082912054,0.00020381424,0.00024481828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017810303,0.00015721637,0.00038655603,0.00013729016,0.00002636689,0.000042848285,0.00017231925,0.0001305392,0.013030257],"category_scores_gemma":[0.000072912284,0.000112282636,0.00012810451,0.00012191937,0.000052927848,0.00013402854,0.00003139333,0.0003173608,0.00001495701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017986197,0.0006328177,0.41660735,0.000014533463,0.00056733214,0.0015996192,0.00029441324,0.000619408,0.0013287768,0.00026036322,0.0040356154,0.5722412],"study_design_scores_gemma":[0.007440857,0.0006936897,0.949898,0.0002795094,0.00011064128,0.00021578153,0.000024354613,0.00014626549,0.0017720897,0.0007400832,0.038531803,0.00014689795],"about_ca_topic_score_codex":0.00059187127,"about_ca_topic_score_gemma":0.00048440424,"teacher_disagreement_score":0.57209426,"about_ca_system_score_codex":0.0006866376,"about_ca_system_score_gemma":0.0005564941,"threshold_uncertainty_score":0.98787194},"labels":[],"label_agreement":null},{"id":"W1975273801","doi":"10.1046/j.1525-1438.2000.010003247.x","title":"Acceptance of voluntary HIV testing and the prevalence of HIV infection in women with cervical neoplasia in Toronto","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Cervical cancer; Population; Human immunodeficiency virus (HIV); Gynecology; Obstetrics; Cancer; Internal medicine; Family medicine","score_opus":0.016039149622362695,"score_gpt":0.3279197557412324,"score_spread":0.3118806061188697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975273801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945446,0.0008018681,0.00003920462,0.0013508464,0.000031930464,0.00013679813,0.000013998658,0.000002073844,0.0030786677],"genre_scores_gemma":[0.9962534,0.0023507406,0.0002951676,0.000109601744,0.00007233057,0.000022890532,4.6089508e-7,0.0000036439599,0.00089177984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988293,0.000099463876,0.00047498406,0.0000909587,0.0003751649,0.00013011762],"domain_scores_gemma":[0.998917,0.0004497714,0.00018763765,0.000054670323,0.00032748232,0.00006347527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047307648,0.0000655507,0.00024317444,0.00008001598,0.000012113229,0.000008013837,0.00015197562,0.000043645112,0.0072790934],"category_scores_gemma":[0.0006946387,0.00003731394,0.00004987105,0.00012638721,0.00019325562,0.00019280595,0.000031020925,0.00025335705,0.0000011425623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044974596,0.00030163125,0.91971195,0.00008909747,0.000074672695,0.000048734775,0.00037595988,0.00021424034,0.00027377025,0.00006167243,0.00024168899,0.07410913],"study_design_scores_gemma":[0.0033539447,0.0015515256,0.9923383,0.0006478283,0.000014992219,0.00008952424,0.00012827199,0.0012467096,0.00009630099,0.00018533533,0.00031189257,0.000035389567],"about_ca_topic_score_codex":0.0012727809,"about_ca_topic_score_gemma":0.0027758388,"teacher_disagreement_score":0.07407374,"about_ca_system_score_codex":0.0004927636,"about_ca_system_score_gemma":0.00012870095,"threshold_uncertainty_score":0.9936284},"labels":[],"label_agreement":null},{"id":"W1976881718","doi":"10.1097/igc.0b013e31826e22e4","title":"The MBD4 Glu346Lys Polymorphism Is Associated With the Risk of Cervical Cancer in a Chinese Population","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Genotype; Odds ratio; Cervical cancer; Medicine; Confidence interval; Oncology; Population; Internal medicine; Genetics; Cancer; Gene; Biology","score_opus":0.00842471056690292,"score_gpt":0.28348234253500104,"score_spread":0.2750576319680981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976881718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946281,0.0019348601,0.000091756265,0.0025191396,0.0005921904,0.00008714581,0.000043014756,0.0000022375111,0.00010158238],"genre_scores_gemma":[0.9980932,0.0007114856,0.000048803515,0.00055589684,0.0003872076,0.000020623185,0.0000051360157,0.000008855299,0.00016878884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988453,0.00016284293,0.0003179777,0.00009633875,0.00040005808,0.00017751592],"domain_scores_gemma":[0.99881136,0.00017575746,0.00054553594,0.00009980363,0.00031416427,0.0000533791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062294095,0.00010429537,0.00015404355,0.00003454395,0.00005284283,0.000017184868,0.00039758897,0.00011211844,0.00022993599],"category_scores_gemma":[0.0004862072,0.000047254805,0.00012315369,0.00009733272,0.000076017044,0.000013458955,0.000083148516,0.00021075501,7.78056e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052373344,0.00017460788,0.97206974,0.0000014862792,0.0004939115,0.0000064877136,0.00014454463,0.000868178,0.018970327,0.00012518004,0.00049703056,0.0061247484],"study_design_scores_gemma":[0.0007437777,0.00020755231,0.9916459,0.000021975888,0.000042269294,0.000013274406,0.00004031332,0.00016362565,0.005440643,0.00033301223,0.0012701156,0.00007757603],"about_ca_topic_score_codex":0.00024865379,"about_ca_topic_score_gemma":0.001552594,"teacher_disagreement_score":0.0195761,"about_ca_system_score_codex":0.0001362556,"about_ca_system_score_gemma":0.00007790435,"threshold_uncertainty_score":0.2517638},"labels":[],"label_agreement":null},{"id":"W1977234423","doi":"10.1111/j.1525-1438.2007.00888.x","title":"Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Uterine perforation; Perforation; Brachytherapy; Radiology; Radiation therapy; Cervix; Cervical cancer; Surgery; Nuclear medicine; Cancer; Internal medicine","score_opus":0.05179711895044871,"score_gpt":0.4407508705725151,"score_spread":0.3889537516220664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977234423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962972,0.00041666368,0.0016388658,0.00073685904,0.0004425407,0.00037015267,0.000013375028,0.0000022187164,0.00008213659],"genre_scores_gemma":[0.9955387,0.00005269102,0.0039788117,0.0001590794,0.00024768626,0.0000110760975,0.000001985143,0.000005290844,0.0000046871933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985086,0.000052346808,0.0008437123,0.00011801855,0.00037813655,0.0000992303],"domain_scores_gemma":[0.9978594,0.00068498927,0.0006640362,0.000053609037,0.00068070047,0.0000572616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006661653,0.00008658074,0.0004550473,0.00013928411,0.000021907521,0.0000059949302,0.00011634826,0.0000712112,0.000051936266],"category_scores_gemma":[0.000181469,0.000046614507,0.00014499943,0.00022213292,0.00012681122,0.00006559425,0.000031778247,0.00027498868,2.4691957e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004888724,0.00060037075,0.92688435,0.00003028963,0.00025486015,0.000013863042,0.00010902134,0.00008830867,0.00061955996,0.00010342574,0.0000046791347,0.066402525],"study_design_scores_gemma":[0.0076057827,0.0040555615,0.9813899,0.00012442922,0.000062347404,0.000027178847,0.00015095818,0.00041523163,0.0057786773,0.00027704606,0.00006815527,0.000044765824],"about_ca_topic_score_codex":0.000072564886,"about_ca_topic_score_gemma":0.0003375437,"teacher_disagreement_score":0.06635776,"about_ca_system_score_codex":0.00013321478,"about_ca_system_score_gemma":0.00013512239,"threshold_uncertainty_score":0.19008844},"labels":[],"label_agreement":null},{"id":"W1977303438","doi":"10.1097/igc.0b013e3182954ddf","title":"Simple Vaginal Trachelectomy in Early-Stage Low-Risk Cervical Cancer","year":2013,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Trachelectomy; Cervical cancer; Stage (stratigraphy); Obstetrics; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.06281722875244919,"score_gpt":0.4049725861570149,"score_spread":0.3421553574045657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977303438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021222565,0.9745118,0.000024014706,0.00044263562,0.0019319634,0.00080059434,0.00031356842,0.000021557928,0.0007313251],"genre_scores_gemma":[0.015241891,0.98064166,0.00016950277,0.00049924426,0.0021687085,0.000373537,0.000042688767,0.0000552281,0.00080754457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956871,0.00028930674,0.0017689884,0.0004772878,0.0012495215,0.0005277589],"domain_scores_gemma":[0.9960717,0.00090751296,0.0015129586,0.00019686543,0.00086790236,0.0004430499],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041919478,0.00056102296,0.002612245,0.0006878407,0.000043026706,0.00009705167,0.00077583885,0.0005876695,0.017608428],"category_scores_gemma":[0.0006834646,0.0003462648,0.0011821378,0.0006335308,0.00012930985,0.00023730053,0.00014974178,0.0019341973,0.00010830251],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047980077,0.00081969105,0.032210443,0.0011451464,0.0017074004,0.0012537997,0.000033026776,0.000026079635,0.0000024527822,0.00003581749,0.0006913511,0.961595],"study_design_scores_gemma":[0.005256449,0.0010090502,0.03455723,0.0048860065,0.0015160848,0.00016461326,0.000012792653,0.000013864368,0.000018729219,0.0002524758,0.95189023,0.00042249472],"about_ca_topic_score_codex":0.001800207,"about_ca_topic_score_gemma":0.00043940227,"teacher_disagreement_score":0.9611725,"about_ca_system_score_codex":0.0026676191,"about_ca_system_score_gemma":0.0012240341,"threshold_uncertainty_score":0.9998989},"labels":[],"label_agreement":null},{"id":"W1979055263","doi":"10.1097/igc.0000000000000230","title":"Early-Stage Endometrioid Ovarian Carcinoma","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Univariate analysis; Multivariate analysis; Oncology; Population; Adjuvant therapy; Adjuvant; Cancer; Gynecology; Surgery","score_opus":0.02579384745949379,"score_gpt":0.3204834208071613,"score_spread":0.2946895733476675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979055263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950125,0.0006063151,0.000593875,0.0094614,0.002101327,0.000126895,0.000020871646,0.000013440578,0.0075746253],"genre_scores_gemma":[0.9942724,0.0003822462,0.0011416252,0.0021047473,0.0012967793,0.000018892346,0.0000032304017,0.000011530208,0.00076852244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985897,0.00005192174,0.00042927937,0.00016007303,0.000592184,0.00017687467],"domain_scores_gemma":[0.9984382,0.00036051124,0.00031537007,0.00011165585,0.00057454844,0.00019971623],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030081018,0.00012632579,0.00034020207,0.00020733848,0.000031900683,0.000043448996,0.00022770301,0.00008690984,0.0046815756],"category_scores_gemma":[0.00054236443,0.000084857085,0.00024081262,0.00012515941,0.000055001812,0.00010033136,0.00004722475,0.00024243101,0.000034611203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077290257,0.0006826208,0.89525545,0.000012170016,0.0006805661,0.0008597862,0.00009156767,0.000089163645,0.0005123162,0.0042412407,0.0026651006,0.09413711],"study_design_scores_gemma":[0.0042407606,0.0012132453,0.8695388,0.00004913373,0.000101907106,0.00013275495,0.000014332999,0.000055899178,0.0013626876,0.0003139721,0.12289328,0.00008324478],"about_ca_topic_score_codex":0.00012598292,"about_ca_topic_score_gemma":0.00001913949,"teacher_disagreement_score":0.12022818,"about_ca_system_score_codex":0.00049538154,"about_ca_system_score_gemma":0.00017073602,"threshold_uncertainty_score":0.9962283},"labels":[],"label_agreement":null},{"id":"W1979262512","doi":"10.1111/igc.0b013e3181e6f321","title":"Patient Outcome Study of Concurrent Chemoradiation, External Beam Radiotherapy, and High-Dose Rate Brachytherapy in Locally Advanced Carcinoma of the Cervix","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Brachytherapy; External beam radiotherapy; Regimen; Radiation therapy; Cervical cancer; Adverse effect; Cervix; Surgery; Urology; Cancer; Internal medicine","score_opus":0.019308541397423502,"score_gpt":0.32667769092830284,"score_spread":0.30736914953087935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979262512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549997,0.0011094356,0.000030442961,0.0010439052,0.0018368643,0.0004324548,0.000020742771,0.0000026981243,0.000023481973],"genre_scores_gemma":[0.9987369,0.00032951013,0.00017239875,0.0005039323,0.00020044432,0.000024707519,0.000001141566,0.000009294917,0.000021662316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816203,0.000086588814,0.00088489,0.00015695438,0.0005805788,0.00012896696],"domain_scores_gemma":[0.9981414,0.00029947405,0.0007689688,0.000118423166,0.00057402137,0.000097731216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027814205,0.00014091034,0.00050791615,0.00014675928,0.00002086476,0.000010566663,0.00023831127,0.00007454924,0.0005631336],"category_scores_gemma":[0.00029973272,0.00008037786,0.00013558417,0.00019594943,0.00010926722,0.000088962865,0.000055730612,0.00036456704,2.715195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021945722,0.0016672895,0.89114636,0.00001566216,0.00020175517,0.000052051735,0.00034230645,0.00029232827,0.014874553,0.000063178704,0.000008838101,0.089141116],"study_design_scores_gemma":[0.016296344,0.0030194179,0.9735177,0.000062376144,0.000054994824,0.000034305154,0.00012147109,0.000064746026,0.0064463755,0.00014122782,0.00016960099,0.00007140976],"about_ca_topic_score_codex":0.00027578798,"about_ca_topic_score_gemma":0.00029879116,"teacher_disagreement_score":0.08906971,"about_ca_system_score_codex":0.00023679073,"about_ca_system_score_gemma":0.0001490648,"threshold_uncertainty_score":0.6165918},"labels":[],"label_agreement":null},{"id":"W1979909956","doi":"10.1046/j.1525-1438.2001.11(suppl.1)sup1068.x","title":"Impact of new non-cytotoxics in the treatment of ovarian cancer","year":2001,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Carboplatin; Oncology; Ovarian carcinoma; Clinical trial; Paclitaxel; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.11746670883883477,"score_gpt":0.4685798291412507,"score_spread":0.3511131203024159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979909956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01025546,0.9864369,0.000013572847,0.0009320577,0.00089761906,0.0007363085,0.00020119819,0.0000023411167,0.0005245542],"genre_scores_gemma":[0.017524492,0.9807341,0.00014724192,0.00009844102,0.0011349444,0.000118742275,0.000017564716,0.000020847807,0.0002035976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744385,0.000105045365,0.0013336663,0.00021279069,0.000689744,0.00021488272],"domain_scores_gemma":[0.9970688,0.0005523555,0.0015939546,0.00021248379,0.00043126364,0.0001410935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022642492,0.0003466738,0.002049773,0.00032307254,0.000013768112,0.000018161563,0.00045915946,0.00025432897,0.0030584554],"category_scores_gemma":[0.00009068722,0.00015974288,0.0016008453,0.0003489358,0.00007656682,0.000056941677,0.000025308975,0.00030870442,0.0000032613082],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032956182,0.0025876535,0.022778135,0.0002776794,0.003651154,0.00068849744,0.0002253399,0.00009313545,0.0000014458544,0.000035341924,0.0016849623,0.9676471],"study_design_scores_gemma":[0.00577591,0.006763219,0.13208629,0.008979254,0.002942082,0.00044150077,0.000028925626,0.000006566019,0.000013458814,0.000109799985,0.8426454,0.00020759045],"about_ca_topic_score_codex":0.0019633404,"about_ca_topic_score_gemma":0.00033827126,"teacher_disagreement_score":0.96743953,"about_ca_system_score_codex":0.0030629684,"about_ca_system_score_gemma":0.002864018,"threshold_uncertainty_score":0.99785286},"labels":[],"label_agreement":null},{"id":"W1980747736","doi":"10.1111/j.1525-1438.2006.00305.x","title":"Primary malignant mesodermal ovarian sarcomas","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Stage (stratigraphy); Adjuvant chemotherapy; Surgery; Disease; Adjuvant; Oncology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.01619722178816822,"score_gpt":0.29752697941472117,"score_spread":0.28132975762655293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980747736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92215294,0.005311691,0.0005599008,0.04241262,0.0031027836,0.00027102797,0.00005288464,0.00003258233,0.026103599],"genre_scores_gemma":[0.9920082,0.00053284207,0.0020461492,0.0030178695,0.0015841444,0.000020225536,0.000013136738,0.000011813073,0.00076558394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985039,0.000034150275,0.000504426,0.00015628102,0.00061603193,0.00018516507],"domain_scores_gemma":[0.9988587,0.00013635526,0.0003038835,0.000088651774,0.0004977969,0.000114628776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018038998,0.0001317661,0.00032855073,0.00011747353,0.000033073055,0.000037667112,0.00019186022,0.00008784434,0.0030690124],"category_scores_gemma":[0.000053919623,0.000086440654,0.00024294121,0.00007442542,0.00006117057,0.000110599234,0.00004776379,0.00019941057,0.000020010753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017259457,0.0031754947,0.81062984,0.000032735185,0.001460933,0.0082273055,0.00005954437,0.0005012925,0.0049311253,0.010134121,0.045239884,0.113881774],"study_design_scores_gemma":[0.003463373,0.00049136375,0.9049864,0.000100982936,0.00015057718,0.00063683203,0.000009458923,0.000024852206,0.0018316454,0.0013384233,0.08686634,0.00009976],"about_ca_topic_score_codex":0.00012553895,"about_ca_topic_score_gemma":0.000036035,"teacher_disagreement_score":0.11378202,"about_ca_system_score_codex":0.00075137324,"about_ca_system_score_gemma":0.00031141998,"threshold_uncertainty_score":0.9978423},"labels":[],"label_agreement":null},{"id":"W1981671145","doi":"10.1111/j.1525-1438.2007.01082.x","title":"Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University","funders":"","keywords":"Medicine; Stage (stratigraphy); Adjuvant therapy; Endometrial cancer; Surgery; Prospective cohort study; Carcinoma; Cancer; Internal medicine","score_opus":0.0296965691835992,"score_gpt":0.35377312250825377,"score_spread":0.32407655332465457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981671145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833397,0.012459487,0.00010353241,0.0026703442,0.000616827,0.00028167473,0.00012572965,0.000009925955,0.00039277674],"genre_scores_gemma":[0.9908306,0.0038668865,0.000667218,0.0030132944,0.00081174687,0.000021884534,0.0000072739595,0.000019698096,0.00076137186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984052,0.00003594345,0.000520998,0.00026111057,0.00049224787,0.00028449405],"domain_scores_gemma":[0.9984787,0.00044595322,0.00024578028,0.00008569408,0.00043530678,0.00030855805],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003690085,0.00020371005,0.00046016715,0.00016390071,0.000049021026,0.000042194173,0.00013842982,0.00013174943,0.0014723013],"category_scores_gemma":[0.00005721056,0.00013274157,0.00017550749,0.00009905631,0.000109096414,0.0001311966,0.00008550891,0.00025516748,0.0000015937335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019820658,0.00041642267,0.91119474,0.000087553795,0.0002612014,0.0032553296,0.00020789399,0.0000020230325,0.000740214,0.000044418975,0.00041536504,0.06355419],"study_design_scores_gemma":[0.01374394,0.0034963978,0.9348867,0.00004245991,0.000077713805,0.0003083184,0.000116584146,0.000030049145,0.002801487,0.00016572101,0.04416982,0.0001608019],"about_ca_topic_score_codex":0.0000943171,"about_ca_topic_score_gemma":0.000021369451,"teacher_disagreement_score":0.063393384,"about_ca_system_score_codex":0.00023890822,"about_ca_system_score_gemma":0.00010098731,"threshold_uncertainty_score":0.9994405},"labels":[],"label_agreement":null},{"id":"W1981858001","doi":"10.1111/j.1525-1438.2007.01108.x","title":"Future opportunities of the Gynecological Cancer Intergroup","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Cancer Research Institute","keywords":"Medicine; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.07982529874400798,"score_gpt":0.3351600051317568,"score_spread":0.2553347063877488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981858001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94433177,0.003800792,0.000021110005,0.04493234,0.0046299207,0.000181356,0.000049640545,0.000010272881,0.0020428023],"genre_scores_gemma":[0.9799449,0.013617681,0.00022034053,0.0037550493,0.001557691,0.00004784726,0.000002461196,0.000010787153,0.0008432681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982418,0.00007150141,0.0006209956,0.00015994316,0.00072196854,0.00018378628],"domain_scores_gemma":[0.99801755,0.00023153686,0.0005858987,0.00013978842,0.00088486494,0.00014036558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017120947,0.00016480772,0.00045454793,0.000093885435,0.0000684266,0.000012243081,0.0004263812,0.00014267699,0.006430919],"category_scores_gemma":[0.00019974008,0.00008477978,0.00042406685,0.00011038072,0.0002787271,0.00010366054,0.00011657953,0.00036417795,0.000003588063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012168722,0.0018418088,0.85795176,0.00003382507,0.0019806286,0.0018127224,0.00049701775,0.00022061069,0.0007590712,0.0027076346,0.037916858,0.09306117],"study_design_scores_gemma":[0.0022950228,0.0007821772,0.8868641,0.00017352783,0.00017987755,0.00054115814,0.00021114998,0.000016887374,0.001761839,0.00026067876,0.106809765,0.000103812505],"about_ca_topic_score_codex":0.000077896795,"about_ca_topic_score_gemma":0.000080122634,"teacher_disagreement_score":0.09295736,"about_ca_system_score_codex":0.0006125806,"about_ca_system_score_gemma":0.00060461654,"threshold_uncertainty_score":0.99447733},"labels":[],"label_agreement":null},{"id":"W1983367203","doi":"10.1097/igc.0b013e31821bb446","title":"The Global Impact of the Gynecologic Cancer InterGroup in Enhancing Clinical Trials in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Gynecologic oncology; Gynecologic cancer; Clinical trial; Ovarian cancer; Cervical cancer; Oncology; Cancer; Epithelial ovarian cancer; Gynecology; Cervix; Internal medicine; Family medicine","score_opus":0.18222419082206012,"score_gpt":0.5015021597815861,"score_spread":0.319277968959526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983367203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239225,0.0041030613,0.000031125794,0.007332107,0.0046602264,0.0005048005,0.00007529465,0.0000046825185,0.00089646043],"genre_scores_gemma":[0.9895696,0.008575673,0.00012019958,0.0009024403,0.0006079015,0.00015686771,8.310623e-7,0.000010466503,0.000056007928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99553764,0.0008826125,0.0024055988,0.0002613631,0.0005750703,0.00033772824],"domain_scores_gemma":[0.9950678,0.002354633,0.0016642867,0.00020467733,0.00056035205,0.00014827863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043740585,0.00022217711,0.0010674789,0.00011184185,0.00004543829,0.000029874192,0.0006846771,0.00021611164,0.0032800224],"category_scores_gemma":[0.004473541,0.00009873518,0.00097200944,0.00034498572,0.00023417146,0.0001206837,0.00015865892,0.00063258316,0.000002607067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020108966,0.0008878667,0.9417061,0.000007194165,0.0009600707,0.00017280334,0.00017111687,0.00024118435,0.00011549513,0.00043643883,0.00062367617,0.05266713],"study_design_scores_gemma":[0.004777627,0.0008469882,0.99054325,0.00048029618,0.00017580355,0.00003369571,0.00009535735,0.00005787696,0.0005107542,0.0015784121,0.0008011111,0.000098811994],"about_ca_topic_score_codex":0.0051625995,"about_ca_topic_score_gemma":0.024339912,"teacher_disagreement_score":0.052568316,"about_ca_system_score_codex":0.003398886,"about_ca_system_score_gemma":0.0015601335,"threshold_uncertainty_score":0.99763113},"labels":[],"label_agreement":null},{"id":"W1985988693","doi":"10.1097/igc.0b013e318291e5ef","title":"Performance Status and Symptom Scores of Women With Gynecologic Cancer at the End of Life","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Cancer Care Ontario; McMaster University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Cervical cancer; Odds ratio; Confidence interval; Gynecologic cancer; Performance status; Logistic regression; Gynecologic oncology; Cancer; Palliative care; Ovarian cancer; Internal medicine","score_opus":0.013957417701928486,"score_gpt":0.27318208645787756,"score_spread":0.2592246687559491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985988693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933611,0.0029418855,0.0000046334885,0.0022400878,0.0005667306,0.0001844235,0.000028919712,0.00000456879,0.00066760666],"genre_scores_gemma":[0.99377805,0.004581211,0.00003785965,0.0010376404,0.0001905879,0.000073125026,0.0000015535677,0.000008715866,0.00029124183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851435,0.00004556429,0.0004621037,0.00012796838,0.00060343486,0.00024657155],"domain_scores_gemma":[0.99770975,0.00042620447,0.00056501245,0.00009865208,0.0010050193,0.0001953847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025439513,0.0001261396,0.00040525946,0.00008873792,0.000036564838,0.000014811592,0.00021400076,0.00007471022,0.009257431],"category_scores_gemma":[0.00023721601,0.000063235,0.00007266452,0.00011012078,0.00042436665,0.00013166903,0.00009783383,0.00021820341,0.0000024365922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014250572,0.00010344471,0.95959336,0.000060626408,0.00044922094,0.000010657427,0.0008093979,0.00026439296,0.0017030954,0.000051305375,0.00048797746,0.035041463],"study_design_scores_gemma":[0.001486098,0.0014716795,0.9902678,0.00013639775,0.00006303807,0.000033175333,0.0005759266,0.00006447075,0.0014564587,0.00006776634,0.004297522,0.000079673955],"about_ca_topic_score_codex":0.0010484132,"about_ca_topic_score_gemma":0.0014913917,"teacher_disagreement_score":0.034961786,"about_ca_system_score_codex":0.00067737134,"about_ca_system_score_gemma":0.00048948644,"threshold_uncertainty_score":0.99164826},"labels":[],"label_agreement":null},{"id":"W1986328766","doi":"10.1111/j.1525-1438.2006.00759.x","title":"Clinical applications of immunohistochemistry in gynecological malignancies","year":2006,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Immunohistochemistry; Oncology; Internal medicine; Gynecology","score_opus":0.1040445174378144,"score_gpt":0.5094492657981338,"score_spread":0.40540474836031937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986328766","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005567089,0.9888064,0.000090150315,0.0002802089,0.0006928615,0.0006184889,0.000107417116,0.000010351517,0.008837394],"genre_scores_gemma":[0.0040480965,0.9929388,0.00039814945,0.00016755945,0.0013196369,0.00022767855,0.00005500972,0.00002478497,0.00082023855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995303,0.0001942017,0.0028020309,0.00035428716,0.0010333883,0.0003131181],"domain_scores_gemma":[0.9949293,0.0016491943,0.001443478,0.00024519188,0.001534463,0.00019836829],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010920963,0.00030795828,0.0025391802,0.00039182347,0.000024868765,0.000023827664,0.0009416314,0.00073231984,0.0072901607],"category_scores_gemma":[0.0012182813,0.00020537029,0.0014273553,0.00040530422,0.00042524294,0.00006067459,0.00023409126,0.001672746,0.000018327859],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021273163,0.0010447488,0.0040093767,0.001993853,0.00040573254,0.00026749558,0.0000046887344,0.0000047463236,0.000007381674,0.00015293188,0.0021200716,0.98977625],"study_design_scores_gemma":[0.0014329775,0.00051597453,0.022417769,0.0017765786,0.00044013426,0.0002183027,0.000011813403,0.0000030931246,0.0000076144124,0.00029421755,0.97268295,0.0001985842],"about_ca_topic_score_codex":0.000050321858,"about_ca_topic_score_gemma":0.00002431195,"teacher_disagreement_score":0.98957765,"about_ca_system_score_codex":0.0012262373,"about_ca_system_score_gemma":0.0018729648,"threshold_uncertainty_score":0.9936173},"labels":[],"label_agreement":null},{"id":"W1987105544","doi":"10.1097/igc.0000000000000084","title":"A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; Bill and Melinda Gates Foundation","keywords":"Medicine; Papanicolaou stain; Colposcopy; Papanicolaou Test; Cervical intraepithelial neoplasia; Gynecology; Cervical cancer; Obstetrics; Dysplasia; Confidence interval; Pap test; Cervical cancer screening; Cancer; Internal medicine","score_opus":0.0840263649788136,"score_gpt":0.40864608880056336,"score_spread":0.32461972382174975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987105544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287814,0.0015386028,0.0032311662,0.0010736885,0.0004044234,0.00050083414,0.000014326848,0.000009811976,0.00034901936],"genre_scores_gemma":[0.99846196,0.000105167484,0.0005039845,0.00018351276,0.0006249379,0.00010052156,0.0000011217692,0.000011042421,0.000007771572],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980447,0.0000972242,0.00046000027,0.00015129204,0.001100227,0.0001464977],"domain_scores_gemma":[0.9921422,0.0015820859,0.0004667723,0.00006972944,0.005653822,0.00008541554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011669052,0.00010493464,0.00029574786,0.00011189993,0.00007069239,0.000021186132,0.00014325256,0.00009026203,0.00037316993],"category_scores_gemma":[0.0046425443,0.00006011308,0.00007637909,0.0002099505,0.00018756228,0.00008745515,0.000045167726,0.00028397192,2.6537901e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027741233,0.00025013727,0.18312995,0.00014828154,0.00034410952,0.00000249865,0.00015842413,0.0015756048,0.046011433,0.00004658947,0.000022030097,0.76553684],"study_design_scores_gemma":[0.0043256814,0.0030924403,0.89118546,0.00014142584,0.00044380222,0.00006241748,0.00016344743,0.09016008,0.009886057,0.00020901978,0.0002565736,0.00007360151],"about_ca_topic_score_codex":0.00046588475,"about_ca_topic_score_gemma":0.0009226268,"teacher_disagreement_score":0.76546323,"about_ca_system_score_codex":0.00042246922,"about_ca_system_score_gemma":0.00041014163,"threshold_uncertainty_score":0.5557894},"labels":[],"label_agreement":null},{"id":"W1987450118","doi":"10.1097/igc.0b013e31825b7de8","title":"Uterine Sarcoma and Aromatase Inhibitors","year":2012,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Manitoba; CancerCare Manitoba; Health Sciences Centre","funders":"","keywords":"Medicine; Endometrial stromal sarcoma; Leiomyosarcoma; Sarcoma; Endometrial cancer; Uterine sarcoma; Oncology; Retrospective cohort study; Cancer; Internal medicine; Aromatase; Gynecology; Breast cancer; Surgery; Pathology","score_opus":0.07816873241412257,"score_gpt":0.4167080544526327,"score_spread":0.3385393220385101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987450118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033109041,0.993711,0.0000044634344,0.0005211458,0.0018256891,0.00020066723,0.00012062073,0.000009427108,0.0002960801],"genre_scores_gemma":[0.0039922795,0.9931203,0.0004389949,0.00021344674,0.0017564503,0.000025437774,0.000041130887,0.000021843349,0.00039009823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985055,0.000051116876,0.0007060901,0.00015596402,0.00040239407,0.00017898099],"domain_scores_gemma":[0.9986406,0.00015943327,0.00065213034,0.000096244235,0.00020672345,0.00024486397],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015826045,0.00025678467,0.0011258671,0.00020197347,0.000021227585,0.000033747165,0.0001879635,0.00018496532,0.0016423505],"category_scores_gemma":[0.00008899198,0.00014747113,0.00040153333,0.00006525322,0.00006737882,0.000107250584,0.00015570746,0.0003667387,0.00002395441],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006933266,0.00029422392,0.0013243753,0.0007268915,0.0011200791,0.001542369,0.000008411892,5.997589e-8,0.0000015647622,0.00004740903,0.00090428797,0.993961],"study_design_scores_gemma":[0.0009132759,0.00042536837,0.0029927797,0.0025650386,0.0010541633,0.004070473,0.000002229373,5.110801e-7,0.0000028748739,0.00002956033,0.98782164,0.00012208518],"about_ca_topic_score_codex":0.000011200247,"about_ca_topic_score_gemma":0.000003477246,"teacher_disagreement_score":0.9938389,"about_ca_system_score_codex":0.0003549534,"about_ca_system_score_gemma":0.00017543607,"threshold_uncertainty_score":0.99927026},"labels":[],"label_agreement":null},{"id":"W1987593512","doi":"10.1111/j.1525-1438.2006.00594.x","title":"Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Hazard ratio; Chemotherapy; Proportional hazards model; Neoadjuvant therapy; Internal medicine; Oncology; Stage (stratigraphy); Surgery; Cancer; Confidence interval; Breast cancer","score_opus":0.01255594879096513,"score_gpt":0.28171305097797655,"score_spread":0.26915710218701144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987593512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957059,0.00079531345,0.000021725054,0.0026398532,0.00021432224,0.00033395353,0.00003922865,0.0000064451924,0.0002432722],"genre_scores_gemma":[0.9983171,0.00054852036,0.00043455002,0.0003213364,0.0002184873,0.000082292485,0.00000738579,0.00001584623,0.000054445067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842954,0.00004658425,0.00061795977,0.0002306053,0.00047652543,0.00019877],"domain_scores_gemma":[0.9985416,0.00024181207,0.00048197436,0.00006667674,0.00057060306,0.000097346456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014672769,0.00017775994,0.0005117711,0.00015840503,0.000020487392,0.00002730057,0.00013157823,0.00006892382,0.00055223366],"category_scores_gemma":[0.000059921673,0.0001118291,0.00010641409,0.00016319808,0.00012438188,0.00010426955,0.000026998372,0.00019974713,5.458016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021957888,0.0013936838,0.97948784,0.00002175963,0.00027381277,0.00067391427,0.00005823036,0.000140342,0.0004596901,0.00008250698,0.00013077733,0.015081647],"study_design_scores_gemma":[0.009650681,0.0015929856,0.98304015,0.000627174,0.000119138764,0.000087132394,0.00001542714,0.00007986286,0.0036872155,0.00009539834,0.0008888836,0.000115940515],"about_ca_topic_score_codex":0.0014211348,"about_ca_topic_score_gemma":0.0005113457,"teacher_disagreement_score":0.0149657065,"about_ca_system_score_codex":0.0005358619,"about_ca_system_score_gemma":0.00021011173,"threshold_uncertainty_score":0.6046571},"labels":[],"label_agreement":null},{"id":"W1988131927","doi":"10.1097/igc.0000000000000239","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital Tract","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial stromal sarcoma; Female circumcision; Uterus; Gynecology; Sarcoma; Pathology; Internal medicine","score_opus":0.08216341843228388,"score_gpt":0.4233598417205688,"score_spread":0.3411964232882849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988131927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00280953,0.9881909,0.000019109546,0.003003887,0.0037575678,0.0014629879,0.00040400936,0.000010321443,0.00034170455],"genre_scores_gemma":[0.01191782,0.98412174,0.0003769147,0.0013316099,0.0010308513,0.00034184524,0.000029942092,0.00004168846,0.0008075601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967209,0.00023218914,0.0017843883,0.00032229925,0.0006433938,0.00029684437],"domain_scores_gemma":[0.99472815,0.0011754484,0.0026299488,0.00026732535,0.0010322904,0.00016683972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004957841,0.00044564722,0.0026640855,0.00015378375,0.000054770684,0.000024658799,0.0008465009,0.00032008934,0.0025957283],"category_scores_gemma":[0.0013237558,0.00022359093,0.0021384044,0.00015801734,0.00019216858,0.000044953773,0.00019166266,0.0005944008,0.000009046592],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023499144,0.00087065983,0.001971429,0.0118731,0.003510555,0.0003608545,0.000019744695,0.0000033328765,0.000007497053,0.00011505918,0.008715577,0.9723172],"study_design_scores_gemma":[0.001748795,0.0010991642,0.00378691,0.029590173,0.003385346,0.0010754047,0.000006676489,0.0000051646966,0.000009422894,0.00004865044,0.9590337,0.00021055785],"about_ca_topic_score_codex":0.000030877738,"about_ca_topic_score_gemma":0.00004566246,"teacher_disagreement_score":0.97210664,"about_ca_system_score_codex":0.00081582903,"about_ca_system_score_gemma":0.000866314,"threshold_uncertainty_score":0.99831605},"labels":[],"label_agreement":null},{"id":"W1989346822","doi":"10.1111/j.1525-1438.2006.00361.x","title":"Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ascus (bryozoa); Colposcopy; Medicine; Cervical intraepithelial neoplasia; Gynecology; Biopsy; Gold standard (test); Human papillomavirus; Cervical cancer; Obstetrics; Internal medicine; Cancer; Biology","score_opus":0.03442660273634538,"score_gpt":0.37048022224681454,"score_spread":0.33605361951046914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989346822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954112,0.00047269065,0.00007117754,0.0010813547,0.00037483187,0.00018141187,0.000012553097,0.0000052406112,0.002389517],"genre_scores_gemma":[0.9987609,0.00009330072,0.00017218766,0.00020976311,0.0006953775,0.000014112459,0.0000011162781,0.0000082686665,0.000044988385],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980301,0.00008896756,0.00082862756,0.00012234399,0.00075106305,0.00017889774],"domain_scores_gemma":[0.9969899,0.0011539628,0.0005076359,0.00008835278,0.0011956716,0.00006448208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005382573,0.00010320208,0.0003592537,0.00016949816,0.000035692923,0.000017314285,0.0003279579,0.000107424086,0.0013983595],"category_scores_gemma":[0.0016167895,0.00006216026,0.0001543417,0.0002580781,0.00020598134,0.0000937064,0.00008459118,0.0004924907,0.0000014464321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022870298,0.0009023135,0.25216007,0.00009712062,0.0001710014,0.00011836475,0.00012273838,0.0003981774,0.5429467,0.00055566913,0.00016704181,0.20007378],"study_design_scores_gemma":[0.0017572173,0.0010970334,0.95766956,0.00008935409,0.00003735257,0.000054728636,0.00006637084,0.00023639109,0.03713385,0.0012756031,0.0005247266,0.000057805206],"about_ca_topic_score_codex":0.0014997021,"about_ca_topic_score_gemma":0.0012040082,"teacher_disagreement_score":0.7055095,"about_ca_system_score_codex":0.00030648377,"about_ca_system_score_gemma":0.0002578806,"threshold_uncertainty_score":0.9995145},"labels":[],"label_agreement":null},{"id":"W1990506590","doi":"10.1046/j.1525-1438.2001.01020.x","title":"A unique BRCA1 mutation identified in Mongolia","year":2001,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; McMaster University","funders":"","keywords":"Medicine; Genetic counseling; Genetic testing; Mutation; Dna testing; Genetics; Gene; Gene mutation; Offspring; Exon; Buccal swab; Bioinformatics; Internal medicine; Biology; Pregnancy","score_opus":0.019250524394638528,"score_gpt":0.33516168690141923,"score_spread":0.3159111625067807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990506590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927795,0.0007027764,0.002075154,0.001987474,0.001266588,0.00007632546,0.0000085551765,0.0000037456743,0.0010999101],"genre_scores_gemma":[0.9964068,0.001023712,0.0006419833,0.0008270059,0.0005516456,0.000024404651,0.000012507899,0.000009216887,0.00050275296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989936,0.000065488486,0.00039181922,0.00015275179,0.00026631635,0.00013004533],"domain_scores_gemma":[0.99907535,0.000040953655,0.00024531467,0.00008340718,0.00050371775,0.00005127314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027256165,0.00008925538,0.00012215899,0.00012919775,0.00001946875,0.000033118482,0.00035565265,0.00012113538,0.00051446224],"category_scores_gemma":[0.00034034165,0.000077885066,0.000092132526,0.00011683538,0.000055361008,0.000015281492,0.00006085179,0.00015047971,0.0000067586134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027777934,0.0010609779,0.35036784,0.000018018241,0.0009799569,0.0021366868,0.00071021006,0.053062163,0.3842241,0.0014680871,0.027022839,0.17617133],"study_design_scores_gemma":[0.0049154204,0.00079763966,0.7464127,0.00009551389,0.00004699813,0.001032319,0.00038175462,0.00061605376,0.08687166,0.0059038014,0.15244536,0.00048077074],"about_ca_topic_score_codex":0.000046275753,"about_ca_topic_score_gemma":0.00051564036,"teacher_disagreement_score":0.39604485,"about_ca_system_score_codex":0.0003073197,"about_ca_system_score_gemma":0.00024627076,"threshold_uncertainty_score":0.5633001},"labels":[],"label_agreement":null},{"id":"W1991152196","doi":"10.1111/igc.0b013e318199009c","title":"The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; BC Cancer Agency; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Fallopian tube; Tubal ligation; Pelvic inflammatory disease; Serous carcinoma; Ovarian carcinoma; Salpingectomy; Gynecology; Endometriosis; Hysterectomy; Ovarian cancer; Oncology; Pregnancy; Ectopic pregnancy; Internal medicine; Cancer; Pathology; Population; Family planning","score_opus":0.04235860833698081,"score_gpt":0.35590021485305035,"score_spread":0.31354160651606955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991152196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018335991,0.9906965,0.0000065912914,0.0037902426,0.0019958531,0.0004776893,0.00014561627,0.0000095964115,0.001044346],"genre_scores_gemma":[0.0076039727,0.98915344,0.00024028291,0.0008523646,0.001368323,0.000055647975,0.000056375917,0.00002787409,0.0006417359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969944,0.00014801335,0.0013342102,0.0002728817,0.0009785836,0.00027193408],"domain_scores_gemma":[0.99643975,0.00088518916,0.0014676064,0.0002433153,0.00077478733,0.0001893317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000349926,0.00036386235,0.0017421661,0.00018476318,0.000066205044,0.000055784,0.00054607,0.00028449454,0.000647345],"category_scores_gemma":[0.00020800374,0.00018724341,0.0008819193,0.00020665354,0.00013621637,0.000074329146,0.000096351425,0.0007030243,0.000016196795],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015132896,0.0005525374,0.0018313193,0.00057373726,0.0019186111,0.0009822646,0.000023259301,0.0000149552625,0.0000018685815,0.00044995296,0.004890673,0.9886095],"study_design_scores_gemma":[0.0015607624,0.001022034,0.041319635,0.004464882,0.0017237482,0.0005916508,0.000006772906,0.0000016680452,0.0000061119385,0.00013739709,0.9489984,0.00016694835],"about_ca_topic_score_codex":0.000108879416,"about_ca_topic_score_gemma":0.00009547555,"teacher_disagreement_score":0.98844254,"about_ca_system_score_codex":0.0018100311,"about_ca_system_score_gemma":0.0014326419,"threshold_uncertainty_score":0.7635565},"labels":[],"label_agreement":null},{"id":"W1991654042","doi":"10.1046/j.1525-1438.2002.01067.x","title":"Postoperative chemotherapy in advanced ovarian granulosa cell tumors","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Univariate analysis; Stage (stratigraphy); Chemotherapy; Hysterectomy; Radiation therapy; Surgery; Retrospective cohort study; Population; Disease; Internal medicine; Multivariate analysis","score_opus":0.020721134848475244,"score_gpt":0.3043143164714355,"score_spread":0.2835931816229602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991654042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579582,0.0020962448,0.000036903013,0.033891007,0.0007702827,0.00020251842,0.000013522262,0.000008805012,0.005022488],"genre_scores_gemma":[0.9912415,0.002377668,0.00091042224,0.0047066887,0.00026754264,0.000029482202,0.0000019566858,0.000010956073,0.00045376417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998793,0.000037819565,0.00044013813,0.00016419114,0.0003977115,0.00016712546],"domain_scores_gemma":[0.9991248,0.00010312904,0.00023006264,0.00007568,0.00034841217,0.0001179146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001215285,0.0001332642,0.00033355813,0.00014881756,0.000021470667,0.000023299652,0.0001670081,0.00007156761,0.0069835573],"category_scores_gemma":[0.000082780716,0.0000917591,0.00015511212,0.00012128722,0.00004656638,0.00012742075,0.000019633582,0.00026341726,0.000022422406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028197228,0.00633656,0.66251135,0.000026378426,0.00073124067,0.006601582,0.0015535756,0.0011360548,0.005021937,0.0010917372,0.007919707,0.30425018],"study_design_scores_gemma":[0.015606657,0.0021732207,0.9458051,0.0002943772,0.000055461234,0.0002710041,0.00014397434,0.00027671302,0.006680863,0.00041524845,0.028081207,0.00019617836],"about_ca_topic_score_codex":0.000036546873,"about_ca_topic_score_gemma":0.00004179497,"teacher_disagreement_score":0.304054,"about_ca_system_score_codex":0.0006677096,"about_ca_system_score_gemma":0.00008739284,"threshold_uncertainty_score":0.9939242},"labels":[],"label_agreement":null},{"id":"W1993286491","doi":"10.1097/igc.0000000000000282","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Ovarian cancer; Gynecologic cancer; Gynecology; Gynecologic oncology; Oncology; Statement (logic); Consensus conference; Obstetrics and gynaecology; Internal medicine; Cancer; Pregnancy","score_opus":0.04385770882175851,"score_gpt":0.388409190163566,"score_spread":0.3445514813418075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993286491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017825211,0.9810968,0.00045848117,0.009325595,0.0053330553,0.002387249,0.0009397557,0.000027503427,0.00025328537],"genre_scores_gemma":[0.00392737,0.9856043,0.0016597871,0.0042605055,0.002926841,0.0009444569,0.00017343252,0.000094957584,0.00040834278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99346167,0.00037066708,0.0036731944,0.0007545233,0.0011336682,0.0006063027],"domain_scores_gemma":[0.9891637,0.0014392505,0.0047818436,0.00042909224,0.003760906,0.00042520338],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013168833,0.00085453875,0.0053281924,0.0004724352,0.00008077012,0.00005861604,0.0009989258,0.0005479079,0.0060345875],"category_scores_gemma":[0.0024275344,0.00054678466,0.0026195915,0.00033613265,0.00027554447,0.00008470699,0.00021368996,0.00089457165,0.000017935492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080321636,0.0017366734,0.0003360245,0.028258868,0.006207922,0.0018812597,0.000019116016,0.00007076956,0.0000103794455,0.000900148,0.028800901,0.9309747],"study_design_scores_gemma":[0.004813262,0.0025040107,0.001293717,0.121826604,0.006293225,0.0013229656,0.000013904089,0.000056318462,0.00002444249,0.00025938769,0.8610065,0.0005856558],"about_ca_topic_score_codex":0.00013495222,"about_ca_topic_score_gemma":0.00009722748,"teacher_disagreement_score":0.93038905,"about_ca_system_score_codex":0.0019079825,"about_ca_system_score_gemma":0.0028073536,"threshold_uncertainty_score":0.99969834},"labels":[],"label_agreement":null},{"id":"W1994498878","doi":"10.1111/j.1525-1438.2003.13356.x","title":"Systemic treatment policies in ovarian cancer: the next 10 years","year":2003,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Carboplatin; Randomized controlled trial; Ovarian cancer; Paclitaxel; Front line; Intensive care medicine; Oncology; Cancer; Internal medicine; Chemotherapy","score_opus":0.12375707875798199,"score_gpt":0.420059247060314,"score_spread":0.296302168302332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994498878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011299645,0.9926375,0.0000017249216,0.0024692754,0.0023258345,0.00067831855,0.000105563544,0.0000065485724,0.0006452456],"genre_scores_gemma":[0.0042823395,0.9923187,0.000044247743,0.00060309406,0.0011870558,0.0004703956,0.0000127517005,0.00003152229,0.0010498993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754864,0.00021223916,0.001098205,0.00027247678,0.0005844696,0.00028394468],"domain_scores_gemma":[0.99785244,0.0005141988,0.0009687383,0.00020641684,0.00031304747,0.00014513767],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029117818,0.00036358743,0.0016358512,0.00029782995,0.000034527002,0.00008500262,0.00043205777,0.0002694934,0.004034913],"category_scores_gemma":[0.00011347396,0.0001835285,0.00082894124,0.0002461118,0.00008816722,0.00007647878,0.00004850756,0.00044637755,0.000040475938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009672204,0.0005074289,0.0023038862,0.00031193782,0.0021840793,0.001226451,0.00009771114,0.000042056872,6.3919776e-7,0.0002615916,0.0023843828,0.9905831],"study_design_scores_gemma":[0.0018968675,0.0005634388,0.0052194567,0.0075995396,0.001394599,0.0009559156,0.00004057101,0.00000149487,0.0000016359068,0.000035779485,0.98213035,0.00016036692],"about_ca_topic_score_codex":0.000611152,"about_ca_topic_score_gemma":0.00028814655,"teacher_disagreement_score":0.9904227,"about_ca_system_score_codex":0.005519687,"about_ca_system_score_gemma":0.0019358121,"threshold_uncertainty_score":0.9982979},"labels":[],"label_agreement":null},{"id":"W1994720359","doi":"10.1097/igc.0000000000000297","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Cervix; Disease; Uterine cervix; Cancer; Gynecology; Epidemiology; Endometrial cancer; Adenocarcinoma; Cervical cancer; Carcinoma; Clear-cell adenocarcinoma; Oncology; Presentation (obstetrics); Pathology; Internal medicine; Obstetrics","score_opus":0.06629811062027573,"score_gpt":0.4045082341917866,"score_spread":0.33821012357151087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994720359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032466594,0.9888987,0.0000139979375,0.0024223647,0.0033521922,0.001319793,0.0003814683,0.000008010652,0.00035680708],"genre_scores_gemma":[0.013998633,0.9814792,0.00020323852,0.002360127,0.00094274443,0.0002511396,0.000016665552,0.000037207345,0.000711013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967982,0.00024713462,0.0016646045,0.00035649686,0.0006469933,0.00028658178],"domain_scores_gemma":[0.99430555,0.00175218,0.002404523,0.00023827598,0.0010888085,0.00021065839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000557635,0.00042935082,0.0027501038,0.00018080905,0.000051941937,0.000022479688,0.00068798463,0.0003189462,0.0018644527],"category_scores_gemma":[0.0012569632,0.00021713051,0.0013479658,0.00026446482,0.00023351831,0.000036991943,0.00027404373,0.0006046641,0.0000039878732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007147336,0.00038392912,0.0021452939,0.025643643,0.0011451389,0.00010297912,0.000011967699,0.0000021603191,0.0000079505735,0.000088776054,0.00474257,0.9650109],"study_design_scores_gemma":[0.0032904933,0.0020002802,0.003652357,0.01815353,0.0030186754,0.00033073622,0.000005298957,0.0000047953763,0.0000318569,0.00011948731,0.96917087,0.00022164872],"about_ca_topic_score_codex":0.00008316648,"about_ca_topic_score_gemma":0.000053133583,"teacher_disagreement_score":0.9647892,"about_ca_system_score_codex":0.00078733126,"about_ca_system_score_gemma":0.0006659512,"threshold_uncertainty_score":0.999048},"labels":[],"label_agreement":null},{"id":"W1997954755","doi":"10.1111/igc.0b013e3181a1bfbc","title":"Prognostic Factors in Early-Stage Leiomyosarcoma of the Uterus","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines; Université de Sherbrooke","funders":"","keywords":"Medicine; Stage (stratigraphy); Leiomyosarcoma; Clinical significance; Metastasis; Oncology; Gynecology; Internal medicine; Cancer; Radiology","score_opus":0.030237871308435273,"score_gpt":0.3344333597863756,"score_spread":0.30419548847794037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997954755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568594,0.00013156015,0.000012543306,0.0029901979,0.00049305713,0.000116561205,0.000011138893,0.000003231945,0.0005557492],"genre_scores_gemma":[0.9990234,0.0000644871,0.00014035031,0.00039127667,0.00010159073,0.0000024993901,0.0000010172456,0.0000033227425,0.0002720941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990788,0.000027539558,0.00034811936,0.00007346285,0.0003683478,0.00010371135],"domain_scores_gemma":[0.9993723,0.00009788493,0.00024968604,0.00006418791,0.00016333425,0.00005258143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007831166,0.00007992546,0.00021061934,0.00008730482,0.000011780133,0.000009956251,0.00021191445,0.00004821541,0.000414647],"category_scores_gemma":[0.00017584856,0.000040502986,0.00014739695,0.00008760941,0.000041142554,0.00006591136,0.000034124198,0.00017446271,0.0000010865658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018815746,0.00041623475,0.9922932,0.0000030113606,0.00009825309,0.0003168406,0.00008959386,0.000029473324,0.0009556511,0.00022443739,0.00005586963,0.00532927],"study_design_scores_gemma":[0.0013811091,0.0007411857,0.99341613,0.000087869106,0.000029684228,0.000051409734,0.00001590479,0.000015852725,0.0022139745,0.00026951949,0.0017411769,0.00003617362],"about_ca_topic_score_codex":0.00006232941,"about_ca_topic_score_gemma":0.000035915666,"teacher_disagreement_score":0.0052930964,"about_ca_system_score_codex":0.00017510839,"about_ca_system_score_gemma":0.00008717023,"threshold_uncertainty_score":0.45400935},"labels":[],"label_agreement":null},{"id":"W1998939264","doi":"10.1097/igc.0b013e3182028d09","title":"Summary of Gynecologic Pathology Papers With Significant Clinical Implications From the Last United States and Canadian Academy of Pathology, Boston, March 2009","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pathology; General surgery; Pathology; Family medicine","score_opus":0.07339199764521417,"score_gpt":0.40077837324148363,"score_spread":0.3273863755962695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998939264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04453684,0.9207176,0.0000069061753,0.028822051,0.00076936506,0.0010259842,0.0037942056,0.000008606333,0.00031841977],"genre_scores_gemma":[0.022464346,0.9737722,0.00046132336,0.0025032824,0.00037201104,0.00011455633,0.0002557261,0.000024654388,0.000031861273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997001,0.00042865047,0.0015451265,0.00037972696,0.00035995743,0.00028554795],"domain_scores_gemma":[0.9927128,0.004345784,0.0017573467,0.00020627948,0.00065205566,0.00032576488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008264885,0.00032220522,0.0017359719,0.0003209396,0.000059780024,0.000017842405,0.0005902235,0.0006785392,0.0007725728],"category_scores_gemma":[0.0006827278,0.00016280159,0.00042291483,0.0002547869,0.00088016526,0.000041682095,0.000107620406,0.0014507762,0.0000025565055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003017935,0.0007360491,0.12054703,0.00024669318,0.0025848926,0.0010100615,0.000055157343,0.000013163526,0.000015457794,0.0006633633,0.0056723277,0.868154],"study_design_scores_gemma":[0.0011164072,0.0010587869,0.3152015,0.0012999305,0.001470901,0.00040134965,0.00003725872,0.0000013114812,0.0000038190965,0.00023319693,0.6790453,0.00013020173],"about_ca_topic_score_codex":0.0021543961,"about_ca_topic_score_gemma":0.008958578,"teacher_disagreement_score":0.8680238,"about_ca_system_score_codex":0.0003895585,"about_ca_system_score_gemma":0.0017485418,"threshold_uncertainty_score":0.84591305},"labels":[],"label_agreement":null},{"id":"W2000194562","doi":"10.1046/j.1525-1438.2000.010003207.x","title":"A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Ifosfamide; Cisplatin; Chemotherapy; Nausea; Cervix; Mitomycin C; Vomiting; Carcinoma; Toxicity; Internal medicine; Cervical cancer; Oncology; Surgery; Progressive disease; Gastroenterology; Cancer","score_opus":0.032798229826645674,"score_gpt":0.35677445957958204,"score_spread":0.3239762297529364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000194562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993995,0.0013539045,0.0000017744653,0.002391047,0.0007457907,0.00024279639,0.000034638906,0.0000016398523,0.0012333763],"genre_scores_gemma":[0.9982431,0.00087546976,0.000088872286,0.00027020212,0.00030429196,0.0000124070575,0.0000015304832,0.0000045373313,0.00019960784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984731,0.00007494247,0.0006968293,0.00011112158,0.0005346176,0.00010941057],"domain_scores_gemma":[0.998917,0.0002822542,0.0003666965,0.00007910467,0.0002759824,0.000078975194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023816522,0.00009686012,0.00040885698,0.00012150565,0.000018668346,0.000004665418,0.00019528835,0.00007403053,0.00262966],"category_scores_gemma":[0.00040198982,0.000053266685,0.00019303933,0.0002052275,0.00010004289,0.000053565847,0.000055070723,0.00021811099,7.234609e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16119139,0.0085640345,0.15362655,0.0000560624,0.00049232505,0.0002007338,0.00040291235,0.0000632797,0.002288681,0.00017102709,0.00057877175,0.67236423],"study_design_scores_gemma":[0.2621029,0.019694678,0.70350593,0.00046063142,0.0002547936,0.000112719674,0.000065096574,0.00010533495,0.006788778,0.0013722669,0.0054074083,0.00012949365],"about_ca_topic_score_codex":0.00014755577,"about_ca_topic_score_gemma":0.000077595905,"teacher_disagreement_score":0.6722347,"about_ca_system_score_codex":0.00019858613,"about_ca_system_score_gemma":0.00016304129,"threshold_uncertainty_score":0.9982821},"labels":[],"label_agreement":null},{"id":"W2001771665","doi":"10.1111/j.1525-1438.2007.01171.x","title":"Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"Ministry of Fisheries, New Zealand","keywords":"Serous fluid; Serous carcinoma; Phenotype; Cancer research; Biology; Ovarian carcinoma; Ovarian cancer; Ovary; Cell culture; Genotype; Pathology; Cancer; Medicine; Gene; Genetics","score_opus":0.026658766446911442,"score_gpt":0.2954835696897994,"score_spread":0.26882480324288793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001771665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902075,0.0034483594,0.00028279374,0.004469863,0.0009752573,0.00022691506,0.00004659629,0.000012326188,0.00033040257],"genre_scores_gemma":[0.9936495,0.0029619618,0.0009198874,0.0012473814,0.0010150922,0.00003201084,0.000045068595,0.0000148438185,0.00011428196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845725,0.000063234285,0.00056882686,0.00027589465,0.00043595865,0.00019881933],"domain_scores_gemma":[0.9986664,0.00019428156,0.00034764656,0.00010588464,0.0004993563,0.00018639803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011859338,0.00019451618,0.00044336906,0.00014817693,0.00007235734,0.000030311927,0.0001626193,0.00013305462,0.0013454995],"category_scores_gemma":[0.00028282532,0.00013988624,0.000121977944,0.00012900357,0.0001102425,0.00015621528,0.00006076154,0.00035803003,0.000007397223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001001267,0.00058971584,0.97684765,0.000012296156,0.00039674167,0.0041590747,0.00043723595,0.00007092546,0.00036098022,0.00014493884,0.00032303535,0.015656147],"study_design_scores_gemma":[0.005280939,0.0006515913,0.9913122,0.00018951687,0.00012797989,0.0006703831,0.000043665885,0.000032064345,0.00044360905,0.0003981725,0.0007180384,0.00013180908],"about_ca_topic_score_codex":0.0006918776,"about_ca_topic_score_gemma":0.0016574052,"teacher_disagreement_score":0.015524338,"about_ca_system_score_codex":0.0007735669,"about_ca_system_score_gemma":0.00031690407,"threshold_uncertainty_score":0.9995674},"labels":[],"label_agreement":null},{"id":"W2002710053","doi":"10.1097/igc.0b013e3182070f17","title":"Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":619,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Clinical trial; Response Evaluation Criteria in Solid Tumors; Cancer; Gynecologic cancer; Disease; Oncology; Ovarian cancer; Consistency (knowledge bases); Internal medicine; Medical physics; Phases of clinical research; Artificial intelligence","score_opus":0.2990942419300802,"score_gpt":0.4831261344702777,"score_spread":0.18403189254019747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002710053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584372,0.0069338446,0.00025680626,0.030822339,0.0018466881,0.0010408543,0.0003200846,0.000012135823,0.00033001913],"genre_scores_gemma":[0.98296005,0.010957275,0.002159865,0.0023657796,0.00061892736,0.00080711645,0.00001132809,0.000017887678,0.000101802114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662614,0.0008024593,0.0015345067,0.0003749243,0.00039891517,0.00026306362],"domain_scores_gemma":[0.992751,0.005214386,0.0011079127,0.00012100628,0.00056466705,0.0002410474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045152544,0.00023502213,0.00085056905,0.00014141781,0.00012391503,0.00006991594,0.00024101864,0.00026196905,0.0013009964],"category_scores_gemma":[0.00515878,0.00012868138,0.0002564709,0.00014386565,0.00035489362,0.000154506,0.00012423503,0.00053933606,0.0000012749844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01950826,0.0016103982,0.70652163,0.00002966938,0.0010636703,0.00034952382,0.00044902615,0.000010063589,0.0010850411,0.001340053,0.008351944,0.25968072],"study_design_scores_gemma":[0.010987529,0.0031844184,0.97040683,0.00069131365,0.00045316402,0.00014604384,0.0002702904,0.00018352417,0.00055733696,0.0035900637,0.009312978,0.00021652489],"about_ca_topic_score_codex":0.00050959195,"about_ca_topic_score_gemma":0.0012542815,"teacher_disagreement_score":0.2638852,"about_ca_system_score_codex":0.0005879047,"about_ca_system_score_gemma":0.00050773844,"threshold_uncertainty_score":0.999612},"labels":[],"label_agreement":null},{"id":"W2003519987","doi":"10.1097/igc.0b013e31820fa24a","title":"Complementary and Alternative Medicine Use Among Women Receiving Chemotherapy for Ovarian Cancer in 2 Patient Populations","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Oncology; Alternative medicine; Gynecology; Family medicine; Traditional medicine; Cancer; Internal medicine; Pathology","score_opus":0.14477014420534612,"score_gpt":0.39521550796196864,"score_spread":0.2504453637566225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003519987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922599,0.00037645997,0.00071769353,0.004592118,0.0013857014,0.00038809876,0.00007208802,0.0000064781716,0.00020145596],"genre_scores_gemma":[0.9942683,0.001080257,0.0021011974,0.0016710467,0.00068286766,0.000106993444,0.000009118092,0.000011173074,0.00006901972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854076,0.000051931132,0.0006397424,0.00018627929,0.00036677677,0.00021450239],"domain_scores_gemma":[0.9985551,0.00033079652,0.00041156102,0.0000588659,0.00051513454,0.00012851621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002991062,0.00015323091,0.00041676083,0.00024163909,0.000055461514,0.000009932031,0.00014707397,0.000020079708,0.004258025],"category_scores_gemma":[0.00027468306,0.00010432464,0.00006769381,0.00009235538,0.00018892155,0.00021484548,0.00006909251,0.00019994251,2.1971323e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012917593,0.00024049511,0.94206595,0.0000134287675,0.00056665245,0.00013624007,0.0068254042,0.000069851216,0.00019307324,0.0004999538,0.0006052371,0.047491968],"study_design_scores_gemma":[0.005733489,0.0018607752,0.981732,0.00035834874,0.00006181217,0.000032433967,0.001939203,0.00033913372,0.00014397407,0.0024321536,0.0052585998,0.00010807181],"about_ca_topic_score_codex":0.002001456,"about_ca_topic_score_gemma":0.0011417954,"teacher_disagreement_score":0.047383897,"about_ca_system_score_codex":0.000529114,"about_ca_system_score_gemma":0.000050756065,"threshold_uncertainty_score":0.99665225},"labels":[],"label_agreement":null},{"id":"W2004872089","doi":"10.1097/igc.0000000000000403","title":"Feelings of Women With Strong Family Histories Who Subsequent to Their Breast Cancer Diagnosis Tested BRCA Positive","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"BC Cancer Agency; Health Research Board","keywords":"Medicine; Regret; BRCA mutation; Anger; Feeling; Genetic counseling; Breast cancer; Qualitative research; Family medicine; Family history; Genetic testing; Coping (psychology); Narrative; Clinical psychology; Gynecology; Cancer; Social psychology; Psychology; Internal medicine","score_opus":0.02338657802612077,"score_gpt":0.2981197066408456,"score_spread":0.2747331286147248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004872089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232554,0.001673837,0.00062131387,0.0036807938,0.0008784029,0.00013110324,0.00040908504,0.000004460197,0.00027546796],"genre_scores_gemma":[0.9967294,0.0005210796,0.00061796705,0.0012235099,0.0005545238,0.00019514513,0.0000097164475,0.00001761755,0.00013103931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986518,0.000060417184,0.00038883052,0.00021344076,0.00045200938,0.00023349466],"domain_scores_gemma":[0.9968378,0.00006639019,0.00039665223,0.00011320169,0.0023666683,0.00021930633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028049352,0.00016153415,0.0002707647,0.00009474942,0.00002997206,0.000028651932,0.00044217304,0.00010268502,0.00018316355],"category_scores_gemma":[0.00020552125,0.00011479667,0.000076735225,0.00012839565,0.00013666862,0.000019987305,0.00010821147,0.00014072681,0.0000010841804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01179406,0.0011008125,0.64744246,0.00003452695,0.0041412935,0.00015990734,0.007442239,0.047673736,0.1383301,0.00058593345,0.041702244,0.09959266],"study_design_scores_gemma":[0.0042577907,0.004572058,0.79628253,0.00032530652,0.0001245403,0.00022050468,0.00332658,0.000057469475,0.10187997,0.00030576123,0.08799594,0.0006515543],"about_ca_topic_score_codex":0.00020871517,"about_ca_topic_score_gemma":0.00028767114,"teacher_disagreement_score":0.14884004,"about_ca_system_score_codex":0.0022109128,"about_ca_system_score_gemma":0.001085373,"threshold_uncertainty_score":0.57814604},"labels":[],"label_agreement":null},{"id":"W2005113853","doi":"10.1111/j.1525-1438.2006.00465.x","title":"Irregularly shaped inclusion cysts display increased expression of Ki67, Fas, Fas ligand, and procaspase-3 but relatively little active caspase-3","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fas ligand; Apoptosis; Carcinogenesis; Cancer research; Fas receptor; Cell; Pathology; Caspase 3; Caspase; Cell biology; Programmed cell death; Biology; Medicine; Internal medicine; Cancer; Biochemistry","score_opus":0.014441140371477949,"score_gpt":0.2935255677960767,"score_spread":0.27908442742459877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005113853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935243,0.0017193584,0.0002489823,0.003128278,0.0003368786,0.00029057203,0.00013964203,0.0000107351325,0.0006012387],"genre_scores_gemma":[0.9975662,0.0004643196,0.0009984678,0.00031318387,0.00038458794,0.00004127291,0.000025751977,0.000015305983,0.00019086998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816155,0.00008341754,0.0006056375,0.00024439066,0.00072805973,0.00017693189],"domain_scores_gemma":[0.9978208,0.00046825726,0.0006617328,0.00009772098,0.0007878769,0.00016363672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022842154,0.0001952491,0.00047086467,0.00016796832,0.00011047245,0.000026076668,0.0001684459,0.00015920734,0.00041407117],"category_scores_gemma":[0.00031976873,0.00012828954,0.0001728082,0.0001103266,0.00013800057,0.00022496501,0.00022428758,0.00027961284,0.0000026928722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008230976,0.005042608,0.46339834,0.00012958134,0.0012599734,0.0029060622,0.0012507812,0.00014922902,0.47181433,0.002487565,0.0025518402,0.040778738],"study_design_scores_gemma":[0.006301797,0.0012581113,0.8670411,0.000742936,0.00025037336,0.00019808783,0.0001143699,0.00015460845,0.12042221,0.0016588598,0.0016937221,0.0001638352],"about_ca_topic_score_codex":0.0005195873,"about_ca_topic_score_gemma":0.00013084893,"teacher_disagreement_score":0.40364277,"about_ca_system_score_codex":0.0005598889,"about_ca_system_score_gemma":0.00026300608,"threshold_uncertainty_score":0.52314955},"labels":[],"label_agreement":null},{"id":"W2007089900","doi":"10.1111/j.1525-1438.2007.01109.x","title":"Addressing unanswered questions in ovarian cancer trial methodology: follow-up of the 2004 Baden–Baden Gynecologic Cancer Intergroup meeting","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Gynecologic cancer; Ovarian cancer; Cancer; Gynecology; Oncology; Internal medicine","score_opus":0.19537251337842815,"score_gpt":0.41808144920652285,"score_spread":0.2227089358280947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007089900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96348214,0.007385582,0.00018164839,0.018994888,0.0083146915,0.000692259,0.00008874554,0.00001639575,0.0008436272],"genre_scores_gemma":[0.9896573,0.005174694,0.0015560964,0.001547604,0.001200332,0.0003027147,0.000004045299,0.000024841165,0.0005324162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966064,0.00051460596,0.0013041703,0.00036148282,0.0008296838,0.000383656],"domain_scores_gemma":[0.9962319,0.0012648372,0.0012142451,0.00021533846,0.0009075411,0.00016610348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089499104,0.00028639205,0.0009189239,0.00029118636,0.00012897966,0.000027281098,0.00061197195,0.0002982047,0.004421998],"category_scores_gemma":[0.0021404265,0.00017712943,0.0005431503,0.00039812725,0.00031584798,0.00018499632,0.00016446732,0.000751164,0.0000027412393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026562355,0.0024264255,0.9072057,0.0000709339,0.002951206,0.0012338483,0.0018717091,0.005624269,0.0069886837,0.000625201,0.009283325,0.035156343],"study_design_scores_gemma":[0.062461987,0.0013042368,0.92056966,0.0017881517,0.0006296271,0.0002842764,0.0002906029,0.00013755473,0.006319804,0.0009663846,0.00493753,0.00031020353],"about_ca_topic_score_codex":0.0024935848,"about_ca_topic_score_gemma":0.0030579255,"teacher_disagreement_score":0.03589963,"about_ca_system_score_codex":0.0021167588,"about_ca_system_score_gemma":0.0014994085,"threshold_uncertainty_score":0.9964881},"labels":[],"label_agreement":null},{"id":"W2007606931","doi":"10.1046/j.1525-1438.2003.13035.x","title":"Presence and quantification of macrophages in squamous cell carcinoma of the cervix","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Pathology; CD68; Cervix; Infiltration (HVAC); Lymph node; Staining; Lesion; Basal cell; Macrophage; Lymph; Carcinoma; Cancer; Immunohistochemistry; Internal medicine; Biology; In vitro","score_opus":0.01756184998698769,"score_gpt":0.26852978413830036,"score_spread":0.2509679341513127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007606931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924309,0.0029015641,0.00008035781,0.00032864706,0.0032525063,0.0000629282,0.000003986193,0.0000012439582,0.00093786576],"genre_scores_gemma":[0.9987131,0.00020061768,0.000022965354,0.00007474945,0.0000129814725,0.0000029828382,0.0000010450665,0.0000026468745,0.00096891396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991948,0.0001797916,0.00041083596,0.00007488764,0.000067762914,0.00007194138],"domain_scores_gemma":[0.9988549,0.00028619423,0.00047072294,0.00006527637,0.0003153247,0.000007596786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002326682,0.0000579061,0.00014356007,0.00008198263,0.000020890608,0.0000047648073,0.000199375,0.00008455148,0.0013780762],"category_scores_gemma":[0.0004304165,0.00003683273,0.00007043041,0.00006880044,0.00012428584,0.000078006975,0.000031305924,0.00019929455,0.0000031811987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039659807,0.00035020083,0.21458234,0.00001835585,0.00004092603,0.000004603061,0.00030130282,0.0003415727,0.7789848,0.0012689364,0.0013917892,0.002318589],"study_design_scores_gemma":[0.0009625475,0.00019353535,0.45525494,0.000021323063,0.00001357657,0.00004922025,0.00023719964,0.000011373058,0.53664976,0.00015328017,0.0064125275,0.000040714414],"about_ca_topic_score_codex":0.00008907312,"about_ca_topic_score_gemma":0.00003056318,"teacher_disagreement_score":0.24233502,"about_ca_system_score_codex":0.00005735343,"about_ca_system_score_gemma":0.00006134235,"threshold_uncertainty_score":0.9995348},"labels":[],"label_agreement":null},{"id":"W2009212934","doi":"10.1111/j.1525-1438.2005.00139.x","title":"Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thames Valley Children's Centre; Université de Montréal; Hôpital Notre-Dame; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Nausea; Neutropenia; Internal medicine; Adverse effect; Vomiting; Phases of clinical research; Surgery; Chemotherapy; Gastroenterology; Cisplatin","score_opus":0.05852447160272847,"score_gpt":0.4342813146540661,"score_spread":0.3757568430513376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009212934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404466,0.0009996474,0.0000027038498,0.0040821317,0.00029382957,0.0003569404,0.000019383242,0.0000039672755,0.00019675506],"genre_scores_gemma":[0.9977951,0.0005961394,0.00039411354,0.00070232386,0.00023080908,0.000021527816,0.0000026464145,0.000007041055,0.00025031302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988646,0.00005926598,0.0005381077,0.0001580461,0.0002457512,0.00013425013],"domain_scores_gemma":[0.9991869,0.00014712667,0.00025386567,0.00004785834,0.00025588824,0.000108398825],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018058292,0.00012323057,0.00041219353,0.00014973288,0.0000275311,0.000019411502,0.00015942981,0.00006769318,0.0009489735],"category_scores_gemma":[0.000066643974,0.000087044624,0.000028377113,0.00007767456,0.00007772358,0.00015473105,0.00021619088,0.00021400092,5.681222e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029922938,0.086125754,0.54534733,0.000069956295,0.0017256897,0.0023382274,0.0049344013,0.00013429575,0.14179528,0.000114624505,0.0010197386,0.18647175],"study_design_scores_gemma":[0.16639833,0.036523763,0.77923673,0.00021417245,0.00033878416,0.00044590054,0.0005600088,0.0020631063,0.0065975077,0.000054967313,0.007347157,0.00021958213],"about_ca_topic_score_codex":0.00023652271,"about_ca_topic_score_gemma":0.0008989255,"teacher_disagreement_score":0.23388939,"about_ca_system_score_codex":0.00018065679,"about_ca_system_score_gemma":0.00007573977,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W2009758919","doi":"10.1097/igc.0b013e318295906b","title":"Evolution in Fertility-Preserving Options for Early-Stage Cervical Cancer","year":2013,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Stage (stratigraphy); Cervical cancer; Fertility; Cancer; Fertility preservation; Gynecology; Cancer stage; Obstetrics; Oncology; Internal medicine; Population; Environmental health","score_opus":0.11863390725676984,"score_gpt":0.4342555850742964,"score_spread":0.3156216778175266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009758919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01991003,0.97465557,0.00027259326,0.0012389014,0.002450579,0.0010981683,0.00016383894,0.000013152199,0.00019717994],"genre_scores_gemma":[0.0195974,0.976622,0.0004864795,0.00016386346,0.0014105461,0.0006427686,0.000030552586,0.000021997063,0.0010244056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744827,0.00024328801,0.0012135938,0.0004197533,0.0003845029,0.00029059817],"domain_scores_gemma":[0.9969785,0.0006006996,0.0007821164,0.00022151828,0.001265019,0.00015212367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077694986,0.0002807601,0.0014005919,0.00030204712,0.000046877616,0.000028823673,0.00056865346,0.00056206604,0.0032841973],"category_scores_gemma":[0.0018751243,0.00018142432,0.0007523116,0.00017571171,0.0001552087,0.00018729518,0.0001522059,0.00096708135,0.000015718366],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043035722,0.0013874304,0.075581804,0.0042827697,0.00207405,0.00016544481,0.00008343538,0.000101868696,0.0000482236,0.0005254917,0.0018142152,0.90963167],"study_design_scores_gemma":[0.00089292467,0.00032762438,0.457635,0.002825826,0.00039440286,0.000041134426,0.000013532321,0.00004441876,0.0000043034597,0.0007810645,0.53686184,0.0001779398],"about_ca_topic_score_codex":0.0003012822,"about_ca_topic_score_gemma":0.00018430268,"teacher_disagreement_score":0.90945375,"about_ca_system_score_codex":0.0019454911,"about_ca_system_score_gemma":0.0008386061,"threshold_uncertainty_score":0.99762696},"labels":[],"label_agreement":null},{"id":"W2010261386","doi":"10.1111/j.1048-891x.2004.014304.x","title":"Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"National Science Council","keywords":"Immunostaining; Ovary; Gonadotropin-releasing hormone receptor; Immunohistochemistry; Western blot; Ovarian cancer; Endocrinology; Internal medicine; Messenger RNA; Blot; Receptor; Monoclonal antibody; Biology; Medicine; Antibody; Cancer; Hormone receptor; Breast cancer; Immunology; Gene","score_opus":0.020891714403831075,"score_gpt":0.3015512834694513,"score_spread":0.28065956906562023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010261386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921381,0.0030341803,0.00006875383,0.003600483,0.0006864779,0.00016513723,0.000025535861,0.000005733095,0.0002756051],"genre_scores_gemma":[0.9943179,0.004194373,0.00047006927,0.00050581986,0.00045468708,0.000018177996,0.0000034352738,0.000010020411,0.000025546025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987667,0.00003229552,0.0005118727,0.00015531151,0.00039127175,0.00014251396],"domain_scores_gemma":[0.9990531,0.000071960734,0.0003703432,0.000052028503,0.0003465933,0.00010596695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013453,0.00011821418,0.0003462013,0.00018449638,0.000031615713,0.000014767129,0.000104975334,0.00009534652,0.00022961969],"category_scores_gemma":[0.00011033283,0.0000902752,0.000107014785,0.00010617786,0.00006136398,0.00012570871,0.000032885237,0.00024422084,0.0000018678508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470949,0.001633135,0.0699528,0.000090359004,0.001271544,0.0008118895,0.00056491914,0.0021705523,0.75990784,0.0019641633,0.00014795618,0.15677534],"study_design_scores_gemma":[0.007831664,0.001533162,0.96628183,0.00032714833,0.00008282959,0.00011030269,0.00003298414,0.000014383917,0.021829844,0.00050712546,0.0013503848,0.00009835248],"about_ca_topic_score_codex":0.0005839743,"about_ca_topic_score_gemma":0.00015673671,"teacher_disagreement_score":0.89632905,"about_ca_system_score_codex":0.0023871202,"about_ca_system_score_gemma":0.00037548432,"threshold_uncertainty_score":0.6242236},"labels":[],"label_agreement":null},{"id":"W2012773522","doi":"10.1111/j.1525-1438.2005.00141.x","title":"Quality of life assessments in epithelial ovarian cancer patients during and after chemotherapy","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Quality of life (healthcare); Ovarian cancer; Internal medicine; Disease; Cancer; Oncology; Epithelial ovarian cancer; Progressive disease; Physical therapy","score_opus":0.024166087515949567,"score_gpt":0.3670684280130039,"score_spread":0.3429023404970543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012773522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995302,0.0006542876,0.000020866932,0.0028179504,0.00076120585,0.00010064564,0.00005160866,0.000003544852,0.00028784497],"genre_scores_gemma":[0.99621516,0.0010972187,0.0001592745,0.0018379255,0.0005604244,0.000021456615,0.0000017462365,0.000008223683,0.000098565055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856216,0.000056990983,0.00059316825,0.00012877783,0.0005295048,0.00012939463],"domain_scores_gemma":[0.99890935,0.00008820025,0.0003511962,0.000054878266,0.00048046254,0.00011591907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002467751,0.00010096903,0.00033821384,0.0001210392,0.000011452135,0.000013199265,0.0001240324,0.000086134365,0.0022133824],"category_scores_gemma":[0.00013641732,0.000075696815,0.00010598953,0.00007313851,0.000055819553,0.00013607617,0.00003988828,0.00022425395,8.758671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003286159,0.00035804132,0.95888287,0.000026288488,0.00015679766,0.000017109016,0.00026587714,0.000038268132,0.0013397456,0.00002195283,0.000036368976,0.035570513],"study_design_scores_gemma":[0.00508538,0.0001906015,0.9913333,0.00011213414,0.000015658246,0.000004070425,0.00004826814,0.00001812065,0.0009732353,0.000055303186,0.0020877603,0.0000761705],"about_ca_topic_score_codex":0.0004921731,"about_ca_topic_score_gemma":0.0027547183,"teacher_disagreement_score":0.035494342,"about_ca_system_score_codex":0.00044189856,"about_ca_system_score_gemma":0.00019032444,"threshold_uncertainty_score":0.9986987},"labels":[],"label_agreement":null},{"id":"W2013149435","doi":"10.1111/igc.0b013e3181ee1c01","title":"Current Academic Clinical Trials in Ovarian Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Clinical trial; Ovarian cancer; Gynecologic oncology; Cancer; Family medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.42165541544232316,"score_gpt":0.6135878610745493,"score_spread":0.19193244563222617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013149435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003854677,0.97708756,0.000018092267,0.004022306,0.017222553,0.00085879804,0.00019986185,0.000009331076,0.00019601359],"genre_scores_gemma":[0.00056104345,0.98957896,0.00018951931,0.0006503934,0.00847343,0.0003740594,0.000028269054,0.000039621842,0.0001046981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99216396,0.0011057688,0.004984532,0.000476131,0.0009298565,0.00033973117],"domain_scores_gemma":[0.99048716,0.0043144217,0.0039274674,0.00021224986,0.0006659058,0.00039276932],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0062294053,0.00045992952,0.0050941934,0.0005388216,0.00002485193,0.000048483977,0.00071845704,0.0010711966,0.0052563767],"category_scores_gemma":[0.005970054,0.000269114,0.0024586804,0.0002490638,0.00013484193,0.00011288872,0.00013453253,0.0045604813,0.000039302715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023008604,0.0007267795,0.014144724,0.0004757135,0.0012614365,0.0005959756,0.000012235607,0.0000025051509,5.4910595e-7,0.00017469598,0.004492125,0.97788316],"study_design_scores_gemma":[0.0033196723,0.00032645243,0.016488703,0.017328767,0.0023371459,0.00019928445,0.0000029494859,0.0000025684924,0.0000016953786,0.00018762947,0.9595802,0.00022495785],"about_ca_topic_score_codex":0.000054384265,"about_ca_topic_score_gemma":0.000116830364,"teacher_disagreement_score":0.9776582,"about_ca_system_score_codex":0.0017454509,"about_ca_system_score_gemma":0.0036047238,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W2015755764","doi":"10.1111/j.1525-1438.2007.01134.x","title":"Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"University of California, Santa Cruz","keywords":"Transcriptome; Gene; Biology; Serous fluid; Chromosome; Genetics; Ovarian cancer; Gene expression; Cancer","score_opus":0.018072066527151046,"score_gpt":0.30414007467772486,"score_spread":0.2860680081505738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015755764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123204,0.0025691332,0.0038705156,0.00057512824,0.0014033404,0.00008323195,0.00005536778,0.0000029073615,0.00020833092],"genre_scores_gemma":[0.9953956,0.0031955773,0.00049653143,0.00015326281,0.00051563676,0.000018659217,0.000010533403,0.000008547574,0.00020562297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987745,0.000039063078,0.0005643164,0.0001652689,0.0003015997,0.00015523662],"domain_scores_gemma":[0.9989094,0.000030476709,0.00038283676,0.00009428572,0.0005241897,0.000058823844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025523774,0.000109980145,0.0002038969,0.0001343565,0.00002471474,0.000023935887,0.00034464258,0.00013543546,0.0006074368],"category_scores_gemma":[0.000057255053,0.00009023357,0.000135757,0.00008956612,0.00012387829,0.000018481227,0.00003572166,0.00012721043,5.259586e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997365,0.000152285,0.029201701,0.000009386669,0.00017938661,0.000022319335,0.000076255834,0.00055849977,0.94191027,0.00017268055,0.00024003895,0.026977437],"study_design_scores_gemma":[0.0025595622,0.00032383652,0.46400517,0.0001055274,0.000054429893,0.000071423514,0.00023823467,0.000039521157,0.5174635,0.0006790996,0.014224194,0.0002354735],"about_ca_topic_score_codex":0.00012037849,"about_ca_topic_score_gemma":0.0007460916,"teacher_disagreement_score":0.4348035,"about_ca_system_score_codex":0.00010906081,"about_ca_system_score_gemma":0.00016216935,"threshold_uncertainty_score":0.6651007},"labels":[],"label_agreement":null},{"id":"W2017627183","doi":"10.1046/j.1525-1438.2001.011001024.x","title":"Cervical cancer in Canada: Changing patterns in incidence and mortality","year":2001,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Incidence (geometry); Cervix; Cohort effect; Cervical cancer; Cohort; Adenocarcinoma; Demography; Mortality rate; Cancer; Cohort study; Basal cell; Obstetrics; Gynecology; Internal medicine","score_opus":0.04662371854369464,"score_gpt":0.3848071584714861,"score_spread":0.3381834399277915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017627183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898868,0.0014579169,0.000030422194,0.007108624,0.0004962374,0.00011010746,0.000020718617,0.0000027373865,0.00088642235],"genre_scores_gemma":[0.9929468,0.004503471,0.000016654358,0.0020495781,0.0003984513,0.00002436,0.0000013991745,0.0000065325967,0.000052772863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998215,0.000052378364,0.00048049862,0.00017199772,0.0007763099,0.00030378927],"domain_scores_gemma":[0.9990399,0.00020386302,0.00012312653,0.000061736566,0.0003803708,0.00019103457],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000391049,0.00010386797,0.0003359451,0.0002480335,0.000016989701,0.000019154917,0.00021484501,0.00006780657,0.009086423],"category_scores_gemma":[0.0002640419,0.00007825669,0.000053529762,0.00025099367,0.0000448272,0.00011542369,0.000114863,0.00053368154,8.6088227e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039871832,0.00007482118,0.93289423,0.000019705334,0.00004366329,0.00205076,0.0000765734,0.00018517602,0.000056891004,0.000048408747,0.000046695357,0.06410438],"study_design_scores_gemma":[0.0015881226,0.00009389849,0.9958529,0.00011764284,0.000013092242,0.00012014779,0.00017427924,0.00083172286,0.000063338244,0.00017585672,0.0008885532,0.00008046763],"about_ca_topic_score_codex":0.5553577,"about_ca_topic_score_gemma":0.96170837,"teacher_disagreement_score":0.40635064,"about_ca_system_score_codex":0.0026125994,"about_ca_system_score_gemma":0.0014555724,"threshold_uncertainty_score":0.9918194},"labels":[],"label_agreement":null},{"id":"W2017958518","doi":"10.1097/igc.0000000000000289","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital","funders":"Cancer Research UK","keywords":"Medicine; Carboplatin; Serous carcinoma; Oncology; Ovary; Clear cell carcinoma; Internal medicine; Serous fluid; Stage (stratigraphy); Ovarian cancer; Irinotecan; PI3K/AKT/mTOR pathway; Paclitaxel; Cisplatin; Chemotherapy; Gynecologic oncology; BRCA mutation; Clinical trial; Gynecology; Cancer; Colorectal cancer","score_opus":0.06846054688510105,"score_gpt":0.4027854182400701,"score_spread":0.334324871354969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017958518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005377331,0.98688716,0.000015610754,0.005438702,0.0045107487,0.0015983758,0.0003461133,0.000008019852,0.00065753516],"genre_scores_gemma":[0.008466867,0.9855557,0.00031201527,0.0033612899,0.0012073223,0.0005220041,0.000019770618,0.000046197878,0.0005088521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964296,0.00027464342,0.0018850089,0.0003837017,0.0007206376,0.0003063801],"domain_scores_gemma":[0.99335504,0.0017521877,0.0030413577,0.00033549484,0.0013416824,0.00017421905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006800455,0.00045512285,0.0028316793,0.00016030075,0.00005453655,0.00002216624,0.000877339,0.0003601883,0.002537677],"category_scores_gemma":[0.00088139303,0.00023308359,0.0023007675,0.00020032052,0.00020039928,0.000035942066,0.00019432146,0.0006822294,0.000009483855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031751517,0.000841877,0.00232868,0.022388062,0.0020795434,0.00017430847,0.00001765062,0.000010150593,0.0000024617461,0.00020721655,0.06868966,0.9029429],"study_design_scores_gemma":[0.0018766297,0.0013079968,0.0031443387,0.035257343,0.0045563728,0.00022803097,0.0000060387815,0.00000508316,0.000025134146,0.00007623098,0.9533005,0.00021634312],"about_ca_topic_score_codex":0.00005275077,"about_ca_topic_score_gemma":0.000041716306,"teacher_disagreement_score":0.90272653,"about_ca_system_score_codex":0.0014980058,"about_ca_system_score_gemma":0.0016220062,"threshold_uncertainty_score":0.99837416},"labels":[],"label_agreement":null},{"id":"W2018704813","doi":"10.1097/igc.0b013e31821778c4","title":"Preoperative Bowel Preparation in Gynecologic Oncology","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Surgical site infection prevention","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; University of Alberta","funders":"","keywords":"Medicine; Gynecologic oncology; Laparotomy; Endometriosis; Subspecialty; General surgery; Laparoscopy; Internal medicine; Surgery; Family medicine","score_opus":0.06499096504423373,"score_gpt":0.3993182773436182,"score_spread":0.33432731229938445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018704813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695241,0.00020562092,0.00046065773,0.0012370682,0.0016574906,0.00024661378,0.0000029018245,0.00001829693,0.026647244],"genre_scores_gemma":[0.99664706,0.00036358988,0.0011947115,0.0010577104,0.0002703737,0.00004308058,0.000003507146,0.000006631476,0.000413344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984391,0.00018329622,0.00069107756,0.00016538362,0.00036201513,0.0001591544],"domain_scores_gemma":[0.9983687,0.0002935959,0.00042208168,0.000066514316,0.0007375985,0.00011154516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006068492,0.00011255287,0.0003185625,0.00023729922,0.000022368446,0.000012939728,0.00017502856,0.00019564504,0.02452978],"category_scores_gemma":[0.0009183378,0.00007986801,0.0001761803,0.00015009858,0.00008152196,0.00025596024,0.000050676652,0.00039398196,0.000042191128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057215937,0.0031597442,0.89405215,0.000012039319,0.00043816757,0.001821509,0.00120473,0.00037550234,0.0028918742,0.0018952205,0.00081936695,0.087608084],"study_design_scores_gemma":[0.0029353127,0.0028251417,0.97851574,0.00006016773,0.000054073134,0.00044224804,0.00011147543,0.00016834556,0.0025817952,0.0022444804,0.009959552,0.00010164904],"about_ca_topic_score_codex":0.000051384297,"about_ca_topic_score_gemma":0.00017237199,"teacher_disagreement_score":0.087506436,"about_ca_system_score_codex":0.0010230831,"about_ca_system_score_gemma":0.00026804217,"threshold_uncertainty_score":0.97636193},"labels":[],"label_agreement":null},{"id":"W2021334860","doi":"10.1111/igc.0b013e3181e0a353","title":"Ovarian Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Clinical trial; Gynecologic cancer; Cancer; End point; Cancer imaging; Medical physics; Gynaecological cancer; Oncology; Gynecology; Pathology; Internal medicine","score_opus":0.08208195182534754,"score_gpt":0.44220837634441995,"score_spread":0.3601264245190724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021334860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007975553,0.98628366,0.00001331523,0.0037200074,0.007686053,0.0003772368,0.00016800246,0.000014702723,0.001657255],"genre_scores_gemma":[0.00025911658,0.99274015,0.0005351562,0.00095188536,0.0044399276,0.000208322,0.000023235612,0.000041279367,0.00080090313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754083,0.00006978034,0.0010627764,0.00030076876,0.0007744519,0.00025141926],"domain_scores_gemma":[0.99704635,0.00036735798,0.0012491511,0.00019119393,0.0008648221,0.00028112103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026159076,0.00036809576,0.001822202,0.00029049168,0.0000368106,0.00006704867,0.00052447553,0.00053203484,0.012054594],"category_scores_gemma":[0.0002596519,0.00021804786,0.001176282,0.00015734923,0.00009249785,0.000089948604,0.000093742674,0.0012525499,0.000052781437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007386197,0.00040722286,0.0007348108,0.00044300727,0.002023246,0.0011764833,0.000011649327,0.0000018107492,9.980711e-7,0.0002548653,0.0051559834,0.98971605],"study_design_scores_gemma":[0.0012915732,0.00031021863,0.0017406268,0.006964989,0.002359101,0.0007109644,0.0000027948404,0.0000010694231,0.0000047097224,0.00009033092,0.9863311,0.00019250833],"about_ca_topic_score_codex":0.00006860661,"about_ca_topic_score_gemma":0.000071773306,"teacher_disagreement_score":0.98952353,"about_ca_system_score_codex":0.0013393842,"about_ca_system_score_gemma":0.0020174528,"threshold_uncertainty_score":0.9888485},"labels":[],"label_agreement":null},{"id":"W2021449942","doi":"10.1111/j.1525-1438.2007.01177.x","title":"cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"CREB; Ovarian cancer; Cell growth; Cancer research; Carcinogenesis; Ovarian tumor; Biology; Cell culture; Apoptosis; Internal medicine; Endocrinology; Medicine; Transcription factor; Cancer; Gene","score_opus":0.036331901931240376,"score_gpt":0.3021647604758049,"score_spread":0.26583285854456457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021449942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027,0.0004289005,0.000020465219,0.008303266,0.00025050945,0.00051188393,0.000056536053,0.000010722433,0.00014770377],"genre_scores_gemma":[0.9965452,0.00010870658,0.001055985,0.00078444264,0.00032239404,0.00011926628,0.000009873193,0.000017617871,0.0010365344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806464,0.00014828925,0.00066722155,0.00029673352,0.000587493,0.00023564497],"domain_scores_gemma":[0.9987487,0.00017158264,0.0004454975,0.00012134366,0.00034691475,0.00016595394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004535355,0.00019192926,0.00039015483,0.0002706647,0.00012281413,0.00004278715,0.00016191782,0.00010624532,0.0025471444],"category_scores_gemma":[0.00016470904,0.00014573273,0.000103244696,0.00011683244,0.00008649205,0.00018352567,0.000083612904,0.00025737472,0.0000070958436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005561333,0.0010286692,0.8020844,0.000035400597,0.00034904672,0.0035656814,0.0009420558,0.00006277388,0.18331753,0.00040483338,0.0017247942,0.00092349114],"study_design_scores_gemma":[0.006865912,0.0010845576,0.8546228,0.00020608559,0.00005288987,0.00034577496,0.000046871384,0.000033248707,0.1352383,0.00031975485,0.0010468784,0.00013694612],"about_ca_topic_score_codex":0.00010925027,"about_ca_topic_score_gemma":0.000068753856,"teacher_disagreement_score":0.05253839,"about_ca_system_score_codex":0.0013065601,"about_ca_system_score_gemma":0.00029924317,"threshold_uncertainty_score":0.9983647},"labels":[],"label_agreement":null},{"id":"W2023067558","doi":"10.1111/j.1525-1438.2007.00990.x","title":"Decreased dose density of standard chemotherapy does not compromise survival for ovarian cancer patients","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Carboplatin; Chemotherapy; Ovarian cancer; Taxane; Internal medicine; Debulking; Proportional hazards model; Survival analysis; Surgery; Oncology; Paclitaxel; Cancer; Cisplatin; Prospective cohort study; Breast cancer","score_opus":0.02723114690335802,"score_gpt":0.35085182466723447,"score_spread":0.32362067776387643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023067558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899919,0.00017452301,0.0012320671,0.0054916325,0.0022294624,0.0004189996,0.00029929698,0.000008148737,0.00015398563],"genre_scores_gemma":[0.99491405,0.0005699686,0.00219903,0.001498186,0.0006741427,0.000029548122,0.000013223268,0.00001509144,0.00008677854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821365,0.000028517585,0.00065379654,0.0001843594,0.00071164843,0.00020804154],"domain_scores_gemma":[0.99682945,0.00048311465,0.0005975627,0.0000915627,0.0017985577,0.00019973585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005077215,0.0001556053,0.000514623,0.00011267973,0.00003830899,0.000018386118,0.00018835317,0.00010660925,0.0014339708],"category_scores_gemma":[0.00028211495,0.000094529394,0.00029119375,0.00006969094,0.00008675325,0.00007662104,0.000027464219,0.00014959727,7.8318925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01828092,0.0020959522,0.88910145,0.000036607424,0.0013768834,0.000104696184,0.000117846146,0.000047878908,0.0023273327,0.0003201663,0.00093774404,0.08525252],"study_design_scores_gemma":[0.016085098,0.0014222373,0.93468475,0.00014521228,0.00019125488,0.0000070905944,0.000028519311,0.00002416592,0.039879866,0.00032355994,0.007099206,0.00010905666],"about_ca_topic_score_codex":0.00022271478,"about_ca_topic_score_gemma":0.00041999156,"teacher_disagreement_score":0.08514347,"about_ca_system_score_codex":0.00087201793,"about_ca_system_score_gemma":0.0003443095,"threshold_uncertainty_score":0.9994789},"labels":[],"label_agreement":null},{"id":"W2023127826","doi":"10.1097/igc.0b013e31820003de","title":"Prolonged Conservative Treatment of Endometrial Cancer Patients","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Gynecology; Cancer; Oncology; Obstetrics; Internal medicine","score_opus":0.03924475839516032,"score_gpt":0.3650491955518446,"score_spread":0.3258044371566843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023127826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99147844,0.00060831575,0.000008069359,0.002286806,0.0042360965,0.00034503703,0.00013493757,0.0000084014355,0.0008938702],"genre_scores_gemma":[0.9964599,0.0011419847,0.0004164642,0.0004479248,0.0011965325,0.000067775276,0.000011418693,0.000010640627,0.00024737383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982281,0.000048506754,0.00065808615,0.00016334608,0.000726751,0.00017525021],"domain_scores_gemma":[0.9967917,0.00056397356,0.0006541465,0.00008593613,0.0017184875,0.00018572253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001406224,0.00016414012,0.0005772187,0.00025930366,0.000027150038,0.000013949039,0.00020508387,0.00013331509,0.0048816525],"category_scores_gemma":[0.0010567118,0.00009763577,0.00033111437,0.00026286225,0.00014046539,0.00010159893,0.000031374075,0.00023328065,0.0000056760528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077780792,0.0031591526,0.87129617,0.000010816626,0.0014594381,0.000109510045,0.00013977774,0.000009334651,0.007205892,0.00013495516,0.0003052947,0.10839157],"study_design_scores_gemma":[0.027370673,0.007846974,0.9098818,0.00006624271,0.00037932134,0.000029049697,0.000024116282,0.00001040111,0.029986044,0.00032459872,0.02394809,0.00013272934],"about_ca_topic_score_codex":0.00024501572,"about_ca_topic_score_gemma":0.00017518741,"teacher_disagreement_score":0.10825884,"about_ca_system_score_codex":0.00047775634,"about_ca_system_score_gemma":0.00038563332,"threshold_uncertainty_score":0.996028},"labels":[],"label_agreement":null},{"id":"W2023587700","doi":"10.1097/igc.0000000000000264","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Serous carcinoma; Endometrial cancer; Oncology; Radiation therapy; Serous fluid; Internal medicine; Carcinoma; Chemotherapy; Ovarian cancer; Breast cancer; Taxane; Cancer; Uterine cancer","score_opus":0.10405645144585765,"score_gpt":0.46071433317287425,"score_spread":0.3566578817270166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023587700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028960872,0.9866224,0.00008068112,0.0037896219,0.0064207693,0.0017113755,0.0004973184,0.000031848267,0.0005563638],"genre_scores_gemma":[0.0009432929,0.9868939,0.0005619178,0.0056117526,0.0034181422,0.00093997526,0.0000999159,0.000068732945,0.001462405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954916,0.00025745283,0.0023036501,0.0005549859,0.0008944524,0.0004978091],"domain_scores_gemma":[0.9929323,0.0021728629,0.002403033,0.0002817509,0.0017961602,0.00041388563],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007565194,0.00067937735,0.004363596,0.00038767376,0.00006315489,0.000049740138,0.00087821507,0.0005069441,0.0065639107],"category_scores_gemma":[0.0023438472,0.00040610193,0.002295164,0.00035902526,0.00015463516,0.000065322354,0.00020778367,0.00085243373,0.00003810447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005838926,0.00039204818,0.00035730164,0.01845185,0.002502384,0.00059590593,0.0000057651955,0.000002303506,0.0000015399041,0.000069697075,0.015823798,0.9612135],"study_design_scores_gemma":[0.0036452676,0.0021577482,0.00046298653,0.029455185,0.0041489573,0.0008983068,0.0000034396721,0.0000051456946,0.000004413493,0.00012452753,0.95872784,0.00036620867],"about_ca_topic_score_codex":0.000068833695,"about_ca_topic_score_gemma":0.00005939285,"teacher_disagreement_score":0.9608473,"about_ca_system_score_codex":0.0022747635,"about_ca_system_score_gemma":0.0011738237,"threshold_uncertainty_score":0.99983907},"labels":[],"label_agreement":null},{"id":"W2025549254","doi":"10.1097/igc.0000000000000118","title":"The Search Continues","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Endometrial cancer; Oncology; Sirolimus; Cancer research; Internal medicine; Cancer","score_opus":0.013244292211861746,"score_gpt":0.32377309207950455,"score_spread":0.3105287998676428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025549254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842803,0.0021799726,0.002322703,0.004614406,0.0033054124,0.000057593454,0.000009400572,0.000005054528,0.00322514],"genre_scores_gemma":[0.9949252,0.00081638177,0.00023693017,0.0011043925,0.0019266177,0.000007643127,0.000002423979,0.000008018735,0.00097241014],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898964,0.00010402074,0.00026842568,0.000115373674,0.00036701126,0.00015553922],"domain_scores_gemma":[0.99878067,0.00019767729,0.00018438174,0.00010255932,0.00067093613,0.00006376766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064524624,0.00007932362,0.00010598156,0.00002476716,0.000067047826,0.00006022345,0.0006447935,0.00008347453,0.00020696176],"category_scores_gemma":[0.0007342537,0.000047525966,0.00012157219,0.000031237185,0.00013464416,0.0000051001684,0.00010192101,0.00017012157,0.000007792758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017353883,0.00023733832,0.078477964,0.000008678173,0.001145678,0.00005577284,0.000113971146,0.0037649316,0.4752482,0.004062559,0.1098974,0.32525215],"study_design_scores_gemma":[0.00080430164,0.0006794686,0.02776507,0.000022019012,0.00001562796,0.00005079861,0.000033696622,0.00012890158,0.06306057,0.00082397804,0.9064938,0.000121806006],"about_ca_topic_score_codex":0.000009382543,"about_ca_topic_score_gemma":0.000040518633,"teacher_disagreement_score":0.79659635,"about_ca_system_score_codex":0.00006563033,"about_ca_system_score_gemma":0.000112181806,"threshold_uncertainty_score":0.22660862},"labels":[],"label_agreement":null},{"id":"W2026559005","doi":"10.1111/j.1525-1438.2005.00266.x","title":"Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"MLH1; DNA methylation; Methylation; CpG site; Microsatellite instability; Bisulfite sequencing; Cancer research; DNA mismatch repair; Biology; Promoter; Molecular biology; Gene; Genetics; Gene expression; DNA repair; Microsatellite","score_opus":0.035215424585043315,"score_gpt":0.3274752509164357,"score_spread":0.29225982633139236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026559005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365443,0.0010693938,0.00064612564,0.0012516495,0.0019430945,0.00031542542,0.000028078017,0.000016820239,0.0010750105],"genre_scores_gemma":[0.9900814,0.00027309384,0.007924553,0.00038174645,0.0011361133,0.000021334374,0.0000062799436,0.00001820826,0.00015726066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729174,0.00013350003,0.0010874703,0.00023716556,0.0009916318,0.00025850817],"domain_scores_gemma":[0.9971374,0.00089376257,0.0006999299,0.00013924982,0.0010035981,0.00012601455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010131206,0.00017683819,0.00058007886,0.00074205035,0.000018988758,0.000019932799,0.0003160666,0.00019493712,0.0041909367],"category_scores_gemma":[0.0028879128,0.00013715096,0.00027327158,0.0005059163,0.00006595115,0.0001718989,0.00009147268,0.0004647637,0.0000056906033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003172328,0.0007533724,0.89557475,0.000069200825,0.00051919505,0.00019616212,0.000404619,0.002028936,0.067244455,0.0001784508,0.0004787676,0.029379753],"study_design_scores_gemma":[0.010843653,0.002452751,0.8628707,0.00039204344,0.0001955191,0.00025467423,0.00010559874,0.0008965066,0.106971584,0.0006518895,0.014076902,0.00028820796],"about_ca_topic_score_codex":0.00017126436,"about_ca_topic_score_gemma":0.00017451125,"teacher_disagreement_score":0.039727133,"about_ca_system_score_codex":0.0011373444,"about_ca_system_score_gemma":0.0004263203,"threshold_uncertainty_score":0.99671936},"labels":[],"label_agreement":null},{"id":"W2030526345","doi":"10.1111/igc.0b013e3181e730aa","title":"The Development of Priority Cervical Cancer Trials A Gynecologic Cancer InterGroup Report","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Clinical trial; Gynecologic cancer; Family medicine; Cancer; Gynecology; Internal medicine","score_opus":0.15137807097285721,"score_gpt":0.4751192524572989,"score_spread":0.3237411814844417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030526345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036754103,0.9804254,0.00005030272,0.0018550621,0.011983579,0.0011774043,0.00018146994,0.000022900382,0.0006284288],"genre_scores_gemma":[0.0026098276,0.9912397,0.0008780475,0.0003125928,0.0031404076,0.0007891507,0.000037254424,0.000048508697,0.0009444662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913784,0.000550437,0.0051877163,0.0005388204,0.0018294643,0.0005151374],"domain_scores_gemma":[0.9858732,0.004883619,0.0062141735,0.00036321027,0.0022575841,0.00040816775],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037098797,0.00065127097,0.0045912834,0.00038993574,0.00016362031,0.000087410146,0.0013365749,0.000879099,0.005702676],"category_scores_gemma":[0.0071376786,0.00031027253,0.0022163412,0.00051874894,0.00032404103,0.00011842069,0.00038565465,0.001990119,0.000014005299],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008675719,0.00059336127,0.001980541,0.000874207,0.004369672,0.0006005584,0.000057020905,0.0000019543106,0.000019134994,0.00006180325,0.0006852688,0.9898889],"study_design_scores_gemma":[0.00250953,0.0004680358,0.004562476,0.0048669414,0.0028069662,0.00043120096,0.000023740708,0.0000014779154,0.0001035773,0.00017783266,0.9837411,0.00030708715],"about_ca_topic_score_codex":0.00013566249,"about_ca_topic_score_gemma":0.0013741117,"teacher_disagreement_score":0.9895818,"about_ca_system_score_codex":0.0026693125,"about_ca_system_score_gemma":0.0060167448,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W2032904048","doi":"10.1111/j.1525-1438.2006.00357.x","title":"Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Biopsy; Radioresistance; Immunohistochemistry; Erythropoietin; Cervix; Pathology; Receptor; Oncology; Internal medicine; Radiation therapy; Cancer","score_opus":0.009761644269694957,"score_gpt":0.26605904651118495,"score_spread":0.25629740224149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032904048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404716,0.00041967927,0.00004239766,0.0029516642,0.0007733321,0.000157895,0.000079134334,0.000011221089,0.0015175111],"genre_scores_gemma":[0.9936254,0.00007406358,0.0046684477,0.0002911911,0.0007283545,0.000011473986,0.0000711518,0.000016780621,0.00051316025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998403,0.000046887453,0.0005168005,0.00021635977,0.00061726564,0.00019967645],"domain_scores_gemma":[0.9988628,0.00015214368,0.0003562008,0.000101891266,0.0004170786,0.00010990613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007815742,0.00018036377,0.00033304983,0.00012688944,0.000027928647,0.000023762392,0.00017971794,0.00010818107,0.0077213557],"category_scores_gemma":[0.00004403731,0.000110924106,0.00011478623,0.00008950703,0.000084337174,0.00009131206,0.00005969215,0.0002774767,0.000024428033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016188442,0.0021416873,0.9745081,0.000011570317,0.000030493458,0.00080430263,0.00007081092,0.00008609936,0.014443201,0.000010851331,0.0049842065,0.0012898255],"study_design_scores_gemma":[0.008744766,0.001159421,0.9621037,0.0001190893,0.000034082073,0.000030500298,0.000076281285,0.000008316405,0.018710693,0.00008305355,0.008795404,0.0001346568],"about_ca_topic_score_codex":0.00038025703,"about_ca_topic_score_gemma":0.00009331169,"teacher_disagreement_score":0.012404371,"about_ca_system_score_codex":0.0006357974,"about_ca_system_score_gemma":0.00010358848,"threshold_uncertainty_score":0.9931857},"labels":[],"label_agreement":null},{"id":"W2032975573","doi":"10.1097/igc.0000000000000293","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Small Cell Cancers","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovary; Ovarian cancer; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.05149414847052934,"score_gpt":0.38109535075887013,"score_spread":0.3296012022883408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032975573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030158603,0.9910866,0.0010712886,0.00068217015,0.005131947,0.00080478285,0.00038759987,0.000013190251,0.000520823],"genre_scores_gemma":[0.00046893005,0.9905197,0.0011707158,0.002986044,0.0029805985,0.0005540872,0.00013574617,0.0000706237,0.001113579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99658376,0.00028134437,0.0016749669,0.00059592613,0.00042206323,0.0004419674],"domain_scores_gemma":[0.99537116,0.00044392174,0.002356813,0.00030787,0.0012975691,0.00022267638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092418084,0.0005739973,0.0018958715,0.00013573519,0.00007584498,0.000061009858,0.0013676552,0.000677069,0.0008546587],"category_scores_gemma":[0.0010449648,0.00041087478,0.0015428618,0.000119143806,0.00014251379,0.0000054923235,0.00022214504,0.0005927244,0.000009317356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015667787,0.00012468427,0.000027437538,0.00932306,0.0012987512,0.0000376995,0.000008896229,0.00037418507,0.00012006245,0.000032493437,0.067618825,0.9208772],"study_design_scores_gemma":[0.00094934844,0.0005857873,0.000009021333,0.013022771,0.0010474797,0.000114975766,0.000006877076,0.00004347187,0.000070391645,0.00006613566,0.9836003,0.00048341075],"about_ca_topic_score_codex":0.000072494746,"about_ca_topic_score_gemma":0.00027281645,"teacher_disagreement_score":0.9203938,"about_ca_system_score_codex":0.0009765046,"about_ca_system_score_gemma":0.0021699504,"threshold_uncertainty_score":0.9998343},"labels":[],"label_agreement":null},{"id":"W2033703555","doi":"10.1111/igc.0b013e3181990127","title":"Ovarian Epithelial Dysplasia and Prophylactic Oophorectomy for Genetic Risk","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Dysplasia; Ovarian cancer; Gynecology; Oophorectomy; Retrospective cohort study; Ovary; Cohort; Internal medicine; Oncology; Gastroenterology; Cancer; Pathology; Hysterectomy","score_opus":0.016156019650142347,"score_gpt":0.3183983369512164,"score_spread":0.30224231730107404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033703555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833623,0.0016462471,0.0007355676,0.012501614,0.0010143452,0.00034552606,0.000050519055,0.000009074504,0.00033480028],"genre_scores_gemma":[0.98765045,0.001679174,0.008261298,0.0012857239,0.0009978788,0.000032202206,0.0000020341315,0.000007360221,0.00008387167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99902785,0.000028888691,0.00034891663,0.00015775155,0.00029344676,0.0001431539],"domain_scores_gemma":[0.9988337,0.00021115695,0.00031021473,0.000061877516,0.00044073188,0.00014227838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155133,0.000114914175,0.0002705244,0.00009133267,0.000042813255,0.000038758142,0.0001069967,0.00007623286,0.00044995133],"category_scores_gemma":[0.00031250992,0.00007478306,0.00014070417,0.000049621325,0.000043588407,0.00006319502,0.00001333802,0.00016930138,0.0000031653042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004214018,0.0012222738,0.23514913,0.00002409496,0.0009811338,0.00078028796,0.00015397795,0.00014757183,0.0020476698,0.0009501838,0.0016976998,0.75263196],"study_design_scores_gemma":[0.0053401543,0.003481048,0.971654,0.00005772061,0.00031924303,0.00035046975,0.000012843656,0.0001355882,0.0011880317,0.0034788337,0.013891993,0.00009005956],"about_ca_topic_score_codex":0.000020039854,"about_ca_topic_score_gemma":0.000011016229,"teacher_disagreement_score":0.7525419,"about_ca_system_score_codex":0.00028770036,"about_ca_system_score_gemma":0.00018441636,"threshold_uncertainty_score":0.49266517},"labels":[],"label_agreement":null},{"id":"W2034572897","doi":"10.1111/j.1525-1438.2007.01041.x","title":"Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Topotecan; Medicine; Regimen; Internal medicine; Gastroenterology; Chemotherapy; Ovarian cancer; Prospective cohort study; Surgery; Progressive disease; Cancer","score_opus":0.04654194982179452,"score_gpt":0.3886737131277309,"score_spread":0.3421317633059364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034572897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824114,0.0018977133,0.00009675984,0.00514048,0.0018826067,0.00045143435,0.00006665278,0.0000054717266,0.0022177263],"genre_scores_gemma":[0.99779403,0.0005941928,0.0005374177,0.00024913173,0.0006970255,0.000060616432,0.000004115202,0.00000982007,0.00005364341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974776,0.000075094016,0.000809359,0.00019650198,0.0012440985,0.00019734321],"domain_scores_gemma":[0.99725026,0.00024197667,0.0006061632,0.00008909662,0.0016962686,0.00011621343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014799604,0.00013696,0.00039605697,0.0002525841,0.00002141399,0.0000141237415,0.00016742997,0.00010656745,0.002713402],"category_scores_gemma":[0.0004944024,0.00009925083,0.00014759725,0.00018852412,0.00007059246,0.000097870994,0.000033948214,0.0002847342,0.0000023508323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067712143,0.0021112391,0.5772219,0.000027288708,0.0009968816,0.00044927065,0.00064576336,0.001061576,0.0065089418,0.0017053843,0.0005325769,0.40196797],"study_design_scores_gemma":[0.007284467,0.001304582,0.9797282,0.00039398368,0.00023975574,0.000029325814,0.00012418508,0.00016272678,0.007533367,0.0015677328,0.0015344061,0.00009723145],"about_ca_topic_score_codex":0.00047312584,"about_ca_topic_score_gemma":0.00219182,"teacher_disagreement_score":0.40250635,"about_ca_system_score_codex":0.0027775704,"about_ca_system_score_gemma":0.00079093105,"threshold_uncertainty_score":0.9981983},"labels":[],"label_agreement":null},{"id":"W2034930875","doi":"10.1111/j.1525-1438.2007.01030.x","title":"Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Lynch syndrome; Internal medicine; Cancer; Radiation therapy; Population; Disease; Germline mutation; Serous fluid; Germline; Serous carcinoma; Stage (stratigraphy); Gynecology; BRCA mutation; Carcinoma; Mutation; Ovarian cancer; DNA mismatch repair; Colorectal cancer; Gene; Genetics","score_opus":0.019066215872749804,"score_gpt":0.3309937737192156,"score_spread":0.3119275578464658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034930875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931518,0.0010661366,0.0001458393,0.00394908,0.0010323051,0.00029647193,0.000058731657,0.000015205878,0.00028443965],"genre_scores_gemma":[0.9960976,0.0011386172,0.0012933525,0.0003396247,0.0008203332,0.00011038137,0.0000044492126,0.000014567195,0.00018107993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851334,0.000036998514,0.00048172497,0.0002005689,0.0005091886,0.00025815656],"domain_scores_gemma":[0.9980299,0.0004559961,0.00039838668,0.00007307653,0.00077355275,0.00026911925],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044730736,0.0001621231,0.00041196018,0.00022012621,0.000071768685,0.000043273372,0.00009602694,0.00008088989,0.0010574035],"category_scores_gemma":[0.0003137933,0.00010410569,0.00007449283,0.00020235988,0.00018497252,0.00023503185,0.000035359877,0.00025772414,9.889868e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014444317,0.0008276509,0.7623561,0.0000289905,0.0020591996,0.032010134,0.0008168974,0.0003815234,0.00051686825,0.00025639214,0.00013094195,0.18617097],"study_design_scores_gemma":[0.01449057,0.003988646,0.96590763,0.00017179594,0.00027526394,0.0073132617,0.00070934417,0.000017159915,0.0010810016,0.00017055465,0.0056868894,0.00018790059],"about_ca_topic_score_codex":0.0001328158,"about_ca_topic_score_gemma":0.001637007,"teacher_disagreement_score":0.20355149,"about_ca_system_score_codex":0.0008516384,"about_ca_system_score_gemma":0.00029899078,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W2035458641","doi":"10.1111/igc.0b013e3181bf7fb8","title":"Symptom Control in Patients With Recurrent Ovarian Cancer","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Quality of life (healthcare); Refractory (planetary science); Chemotherapy; Cancer; Oncology; Intensive care medicine; Clinical trial; Gynecologic cancer; Internal medicine","score_opus":0.0300218634020791,"score_gpt":0.3639423750675774,"score_spread":0.3339205116654983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035458641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010158406,0.99364406,0.000014496357,0.0020625475,0.0018521098,0.00085021293,0.00020802181,0.000009154563,0.00034356068],"genre_scores_gemma":[0.010330614,0.9872129,0.000133887,0.0010799018,0.00090931763,0.00019184941,0.000039214352,0.000028363855,0.00007397076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729484,0.00011611196,0.0010793019,0.00033027917,0.00089782994,0.0002816071],"domain_scores_gemma":[0.9973883,0.0002864749,0.0011608765,0.00014627152,0.0008090819,0.00020901208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021073753,0.00039086692,0.0019159126,0.0003653811,0.000022187181,0.000046791785,0.00035671575,0.0002685917,0.001981215],"category_scores_gemma":[0.000111524365,0.00021783379,0.0005180749,0.00020745167,0.000053894677,0.000101271864,0.00003160121,0.0007219258,0.000010698312],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007372593,0.0013826578,0.044439074,0.00026866316,0.0017038053,0.00049785257,0.000012480177,0.000018505107,1.735862e-8,0.000060803326,0.0012488315,0.94963],"study_design_scores_gemma":[0.008620221,0.0018528261,0.21114156,0.016418656,0.0016391233,0.00004528034,0.0000018031631,0.0000025879076,1.3917551e-7,0.00003128619,0.7600236,0.00022290924],"about_ca_topic_score_codex":0.000051590938,"about_ca_topic_score_gemma":0.00009579725,"teacher_disagreement_score":0.94940716,"about_ca_system_score_codex":0.0030431782,"about_ca_system_score_gemma":0.001271618,"threshold_uncertainty_score":0.9989311},"labels":[],"label_agreement":null},{"id":"W2035973935","doi":"10.1097/igc.0b013e31821bb717","title":"Survivorship as an Element of Clinical Trials in Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Survivorship curve; Ovarian cancer; Oncology; Clinical trial; Cancer survivorship; Cancer; Internal medicine","score_opus":0.5089301195320578,"score_gpt":0.5964039336662992,"score_spread":0.08747381413424138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035973935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022853673,0.98908013,0.000018022418,0.0009916048,0.0053903335,0.00089376327,0.00021050186,0.0000064342257,0.0011238119],"genre_scores_gemma":[0.008812807,0.98746026,0.00036982173,0.0004938999,0.0023808484,0.00023967454,0.000032002208,0.000035444,0.00017524298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909175,0.0019360175,0.0056182817,0.0004318743,0.0008142003,0.00028210727],"domain_scores_gemma":[0.9903891,0.0030573634,0.0050259945,0.00025921484,0.000908363,0.0003599373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008496972,0.0004119981,0.0056313663,0.0004664063,0.000016509772,0.00002840674,0.00064773735,0.0005813936,0.013637803],"category_scores_gemma":[0.003935828,0.0002397005,0.0020463434,0.0002134019,0.00011843284,0.00012512502,0.00009825078,0.00097205455,0.000016677925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008818337,0.002257914,0.02521927,0.00068257464,0.0028474266,0.00069270603,0.00005191079,0.0000041630065,4.13854e-7,0.0011917681,0.0006760207,0.965494],"study_design_scores_gemma":[0.004815971,0.0023635714,0.031795803,0.012830617,0.003031131,0.00013502922,0.000023497889,0.000002387668,0.000011634194,0.0005973812,0.9441294,0.00026357893],"about_ca_topic_score_codex":0.001614506,"about_ca_topic_score_gemma":0.0012385695,"teacher_disagreement_score":0.9652304,"about_ca_system_score_codex":0.0010576635,"about_ca_system_score_gemma":0.0030752183,"threshold_uncertainty_score":0.98726386},"labels":[],"label_agreement":null},{"id":"W2036387697","doi":"10.1097/igc.0000000000000245","title":"Quality of Life Research in Endometrial Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Quality (philosophy); Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.23556425811756274,"score_gpt":0.4984798347598638,"score_spread":0.26291557664230103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036387697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985386,0.002041667,0.000065908906,0.0063645034,0.0018507456,0.00017421761,0.00002566347,0.000005133784,0.0040861242],"genre_scores_gemma":[0.9956889,0.0015973301,0.0002486684,0.0007511477,0.0015397877,0.000031060372,0.000002240835,0.000008006301,0.00013284938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996744,0.00038154516,0.0009891499,0.00017086587,0.0014784386,0.00023599443],"domain_scores_gemma":[0.9953237,0.0024413685,0.00045488452,0.00010209298,0.0014602984,0.00021762418],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002432107,0.000106243024,0.0006401074,0.00065483205,0.00002141956,0.000015112547,0.00034197522,0.00012636624,0.0032791055],"category_scores_gemma":[0.0065311575,0.00006993691,0.00024011881,0.00066525734,0.00014779158,0.0000920062,0.00008554348,0.0005072265,0.000007545163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011128797,0.0011774374,0.83124477,0.000055067674,0.0005175134,0.000072584466,0.00007176152,0.00018908702,0.0033979514,0.0017357552,0.00071623933,0.14969304],"study_design_scores_gemma":[0.017284948,0.0016703538,0.9617113,0.00020237331,0.000037021142,0.000011024594,0.000060098293,0.0000345525,0.0020980441,0.003252695,0.013535218,0.000102411606],"about_ca_topic_score_codex":0.0010673045,"about_ca_topic_score_gemma":0.0003109807,"teacher_disagreement_score":0.14959063,"about_ca_system_score_codex":0.0006889854,"about_ca_system_score_gemma":0.00047063493,"threshold_uncertainty_score":0.997632},"labels":[],"label_agreement":null},{"id":"W2038359952","doi":"10.1111/igc.0b013e3181a83e1a","title":"Kallikrein 4 Overexpression in Endometrial Carcinoma and Upregulation by Estrogen via Mitogen-Activated Protein Kinase Signal Pathway","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Endometrium; Endometrial cancer; Endometrial hyperplasia; Estrogen; Medicine; MAPK/ERK pathway; Cancer research; Western blot; Internal medicine; Kinase; Cancer; Biology; Cell biology","score_opus":0.016311260418390254,"score_gpt":0.2870266428705044,"score_spread":0.27071538245211413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038359952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954005,0.0018808165,0.00032456545,0.0016450942,0.00029618508,0.00031072574,0.000020587358,0.000014086272,0.000107422755],"genre_scores_gemma":[0.9983686,0.000070122434,0.00037049295,0.0003688278,0.00056629506,0.000012262651,0.000025554084,0.000009925959,0.00020792491],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982851,0.00008487014,0.0006145417,0.00021213616,0.00060142495,0.0002018836],"domain_scores_gemma":[0.9988327,0.00017724368,0.00041144722,0.00006934179,0.00033713895,0.00017210178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025577488,0.00016968328,0.000348718,0.00024544323,0.000041415187,0.00003985362,0.00014620708,0.0001629776,0.0007800858],"category_scores_gemma":[0.0003144414,0.00012973034,0.00013618248,0.00017685755,0.0000559604,0.00024839325,0.0000320739,0.00025412484,0.0000017392667],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032968016,0.0003978386,0.08201708,0.000008803044,0.000080933045,0.00018472361,0.00012053131,0.000112036476,0.8283141,0.0002674162,0.00037308852,0.08482662],"study_design_scores_gemma":[0.009452506,0.0017546281,0.52739096,0.00041415734,0.00003818558,0.00014002022,0.000028678845,0.0009794502,0.4545673,0.0020702712,0.0029363588,0.00022750137],"about_ca_topic_score_codex":0.000085534484,"about_ca_topic_score_gemma":0.0000073275223,"teacher_disagreement_score":0.44537386,"about_ca_system_score_codex":0.0003382686,"about_ca_system_score_gemma":0.00016132822,"threshold_uncertainty_score":0.85413927},"labels":[],"label_agreement":null},{"id":"W2038535093","doi":"10.1097/igc.0000000000000066","title":"Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Epithelial ovarian cancer; Adjuvant; Oncology; Chemotherapy; Interval (graph theory); Ovarian cancer; Cancer; Modality (human–computer interaction); Internal medicine","score_opus":0.012538050743310937,"score_gpt":0.3185599847289857,"score_spread":0.3060219339856748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038535093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96887416,0.0004764302,0.00014261196,0.028046047,0.0017365452,0.00015597229,0.000052940595,0.0000061425385,0.0005091819],"genre_scores_gemma":[0.99506617,0.00089778786,0.00050096377,0.0022892337,0.0010378882,0.000064005464,0.0000027399599,0.000015304831,0.0001259027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981173,0.000103945145,0.00078539725,0.00022831715,0.0005479577,0.00021708467],"domain_scores_gemma":[0.99865276,0.0002568738,0.00042599053,0.00012360037,0.00041045455,0.00013032883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043829324,0.00017647185,0.00061579316,0.00015720069,0.000014460844,0.000023808925,0.00023780209,0.00012802678,0.008329847],"category_scores_gemma":[0.00008331461,0.00009434198,0.0002927745,0.00009123864,0.00010460199,0.00011171011,0.000058087415,0.00029700136,0.000007516753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029699684,0.00078375114,0.91698885,0.000030571635,0.00042865385,0.00043716704,0.0001894765,0.00013682625,0.00034921835,0.00018353084,0.00021037624,0.077291586],"study_design_scores_gemma":[0.0063835448,0.0004561626,0.97715884,0.00047664143,0.00008399296,0.000072540985,0.000021688636,0.00018694632,0.0029335734,0.0010540768,0.011050023,0.000121992096],"about_ca_topic_score_codex":0.00048327225,"about_ca_topic_score_gemma":0.0003447882,"teacher_disagreement_score":0.0771696,"about_ca_system_score_codex":0.0006283018,"about_ca_system_score_gemma":0.00017712374,"threshold_uncertainty_score":0.99257666},"labels":[],"label_agreement":null},{"id":"W2039126411","doi":"10.1111/igc.0b013e3181a3cd38","title":"Molecular Genetic Analysis of a Cell Adhesion Molecule With Homology to L1CAM, Contactin 6, and Contactin 4 Candidate Chromosome 3p26pter Tumor Suppressor Genes in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Loss of heterozygosity; Locus (genetics); Molecular biology; Serous fluid; Biology; Candidate gene; Gene; Clear cell; Genetics; Cancer research; Carcinoma; Allele","score_opus":0.008363807865375692,"score_gpt":0.29313647189429387,"score_spread":0.28477266402891815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039126411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965967,0.0014525381,0.00055613223,0.0010392121,0.000083600324,0.00015245078,0.000046679066,0.0000016306572,0.00007105369],"genre_scores_gemma":[0.99754065,0.0005282069,0.0006557144,0.0010960109,0.00007886175,0.000021919523,0.00000932244,0.000008883041,0.00006041211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986393,0.00010676483,0.00041562621,0.00026342165,0.00032395712,0.00025097383],"domain_scores_gemma":[0.99899226,0.000050888077,0.0002787093,0.00011643752,0.00039805102,0.00016365809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016618814,0.0001502015,0.00038105543,0.00030573327,0.000023409486,0.000028050505,0.00031189172,0.00009420837,0.00020290406],"category_scores_gemma":[0.000101271144,0.0001116484,0.00011333607,0.00020860854,0.00005543724,0.000012182419,0.0000737042,0.0001646992,4.7834436e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001387387,0.0001332632,0.055520233,0.000005105285,0.00042714333,0.00051175035,0.00003770357,0.002902239,0.93734014,0.000015222746,0.00004064947,0.0016791481],"study_design_scores_gemma":[0.0018084369,0.0018808816,0.37346572,0.00003798453,0.00014899639,0.00006731375,0.00004291262,0.0003149364,0.6216619,0.000020490024,0.00038675696,0.00016369027],"about_ca_topic_score_codex":0.00046486818,"about_ca_topic_score_gemma":0.0012972164,"teacher_disagreement_score":0.31794548,"about_ca_system_score_codex":0.00009932062,"about_ca_system_score_gemma":0.00015620928,"threshold_uncertainty_score":0.45528895},"labels":[],"label_agreement":null},{"id":"W2042835441","doi":"10.1111/j.1525-1438.2005.00134.x","title":"Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa","funders":"","keywords":"Debulking; Medicine; Perioperative; Chemotherapy; Surgery; Ovarian cancer; Stage (stratigraphy); Proportional hazards model; Confidence interval; Oncology; Tumor Debulking; Internal medicine; Cancer","score_opus":0.017705690702063532,"score_gpt":0.3242937361125526,"score_spread":0.30658804541048906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042835441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97312635,0.003798626,0.000045473553,0.020869186,0.0004284314,0.0002756218,0.000027883187,0.0000043355726,0.0014240822],"genre_scores_gemma":[0.98169947,0.0100418655,0.0026547955,0.0049750786,0.0004180734,0.000064696695,0.0000019045161,0.000009206485,0.0001349236],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99871945,0.000034640394,0.0004619058,0.00014973918,0.00048563242,0.00014859939],"domain_scores_gemma":[0.9992193,0.00012623059,0.00033390528,0.000087363405,0.00017401515,0.000059195077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029806956,0.00012248484,0.0003145759,0.000092154754,0.000022776383,0.000018094603,0.00021162216,0.000036057452,0.0008301846],"category_scores_gemma":[0.000016095859,0.00007111175,0.0001077938,0.000086783,0.00006607541,0.00010536618,0.00003956187,0.00018944393,0.0000010940287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014554824,0.0011431426,0.13145453,0.00006651966,0.00086973666,0.00089011475,0.00050227734,0.0010196877,0.0008449169,0.0011380729,0.00030773468,0.8603078],"study_design_scores_gemma":[0.0058008838,0.00037311466,0.95276535,0.00041732483,0.00011073752,0.00008568564,0.0001567846,0.00006106289,0.0010519722,0.00014261667,0.038953472,0.0000809881],"about_ca_topic_score_codex":0.00006353115,"about_ca_topic_score_gemma":0.00011312916,"teacher_disagreement_score":0.8602268,"about_ca_system_score_codex":0.00052981044,"about_ca_system_score_gemma":0.00011681562,"threshold_uncertainty_score":0.90899396},"labels":[],"label_agreement":null},{"id":"W2044540736","doi":"10.1111/j.1525-1438.2006.00643.x","title":"Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Syncytiotrophoblast; Trophoblast; Partial Hydatidiform Mole; Matrix metalloproteinase; Cytokeratin; Placenta; Immunohistochemistry; Andrology; Mole; Medicine; Internal medicine; Endocrinology; Biology; Pregnancy; Fetus; Genetics","score_opus":0.011128800890921135,"score_gpt":0.2985063845688607,"score_spread":0.2873775836779396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044540736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688876,0.0005180952,0.00008469549,0.0012193816,0.00008863961,0.00017186666,0.000058963193,0.0000046952605,0.0009649049],"genre_scores_gemma":[0.99745893,0.00010633853,0.001980801,0.0002298963,0.00009354289,0.000016572749,0.000010781959,0.00000725259,0.00009586268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853814,0.00003165593,0.00048776457,0.00012615407,0.0006896174,0.00012668839],"domain_scores_gemma":[0.99871075,0.00021832317,0.00037112166,0.000050986622,0.0005592074,0.00008959633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001384448,0.000119915116,0.0003399852,0.00016072555,0.000022083766,0.000012540431,0.000113548296,0.00004282217,0.0010014708],"category_scores_gemma":[0.00020530562,0.00007647995,0.000065876295,0.00009115625,0.00012853526,0.00011631421,0.00005715901,0.00015066254,0.0000024866943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019540377,0.0024129406,0.83789396,0.00015858862,0.00069546246,0.00264529,0.0003383362,0.002699993,0.1295137,0.0011765059,0.0015281199,0.0013967365],"study_design_scores_gemma":[0.0067009344,0.0008887146,0.9601836,0.00043079242,0.00011718961,0.00024295943,0.0003015464,0.00028139347,0.02919526,0.00089215,0.00064938015,0.00011606828],"about_ca_topic_score_codex":0.00041101442,"about_ca_topic_score_gemma":0.00011050696,"teacher_disagreement_score":0.12228966,"about_ca_system_score_codex":0.0001822379,"about_ca_system_score_gemma":0.00021613232,"threshold_uncertainty_score":0.9999117},"labels":[],"label_agreement":null},{"id":"W2045706652","doi":"10.1097/igc.0b013e318269e29d","title":"Determinants of Lymph Node Count in Endometrial Cancer Surgical Staging","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Université de Montréal; The Society of Gynecologic Oncology of Canada","funders":"","keywords":"Medicine; Endometrial cancer; Lymphadenectomy; Stage (stratigraphy); Lymph node; Gynecologic oncology; Internal medicine; Cancer; Cancer staging; Oncology; Gynecology","score_opus":0.04713640022786155,"score_gpt":0.3836237032102238,"score_spread":0.3364873029823623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045706652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902452,0.0048154476,0.000013385075,0.0007299983,0.0030848866,0.00013830645,0.000060885355,0.000006176555,0.0009057058],"genre_scores_gemma":[0.9947398,0.0027826955,0.00022193704,0.0004212805,0.0016614982,0.000028170763,0.0000027585081,0.000011911593,0.00012997615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760324,0.00008216503,0.0008973562,0.00014038794,0.00094445416,0.00033239214],"domain_scores_gemma":[0.9978938,0.00071044406,0.00054492167,0.00008035487,0.00053131435,0.00023918331],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060429715,0.00015936917,0.000670677,0.0004250327,0.000018612705,0.000013145725,0.00025292597,0.00012789742,0.0034164137],"category_scores_gemma":[0.00074096676,0.00010552384,0.00026840722,0.00038134833,0.00008893764,0.00021043312,0.00007580113,0.0002587896,0.000006133561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033532316,0.0008052875,0.95662004,0.000023172537,0.00021776886,0.0003641518,0.00006565679,0.0000636455,0.00049886265,0.00006617104,0.000071463925,0.03785056],"study_design_scores_gemma":[0.014719121,0.00037064884,0.9737271,0.00028080083,0.00013452236,0.00017407609,0.00005403982,0.00004055306,0.0037645618,0.00007703864,0.006530723,0.00012680245],"about_ca_topic_score_codex":0.0003963917,"about_ca_topic_score_gemma":0.000040501945,"teacher_disagreement_score":0.037723754,"about_ca_system_score_codex":0.0010821823,"about_ca_system_score_gemma":0.0003090043,"threshold_uncertainty_score":0.9974946},"labels":[],"label_agreement":null},{"id":"W2046786820","doi":"10.1097/igc.0b013e3182791efc","title":"COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and Celecoxib","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute","keywords":"Medicine; Proportional hazards model; Hazard ratio; Confidence interval; Tissue microarray; Internal medicine; Immunohistochemistry; Oncology; CD34; Cervical cancer; Chemoradiotherapy; Survival analysis; Celecoxib; Cancer; Gastroenterology; Pathology","score_opus":0.007766519013412612,"score_gpt":0.2730011756083715,"score_spread":0.2652346565949589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046786820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794567,0.001000056,0.00005318016,0.0004305321,0.00027447127,0.00020325991,0.000006881327,0.0000067565725,0.00007922058],"genre_scores_gemma":[0.99830854,0.0004884159,0.00039251105,0.0004543864,0.0002872904,0.00002342565,0.000003199138,0.000013854451,0.00002837293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989524,0.000049160433,0.00024901767,0.00012663404,0.0004180928,0.00020472285],"domain_scores_gemma":[0.9990769,0.0001387495,0.00019648571,0.00004652059,0.00032573624,0.00021562625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001792194,0.0001411899,0.00035380494,0.00009202338,0.000023418273,0.000014356031,0.000069421374,0.00008897401,0.00034384165],"category_scores_gemma":[0.000054718577,0.00007716486,0.00002629142,0.00007166788,0.00009313449,0.00019586313,0.000020545558,0.00024468522,4.6848893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060694474,0.00028174714,0.9767769,0.00001978962,0.00009028156,0.000069115624,0.000109199056,0.000027512182,0.0017993454,0.000009526118,0.00003664686,0.014710513],"study_design_scores_gemma":[0.010729134,0.0012278804,0.9838568,0.00027258284,0.000033844295,0.00003124876,0.000026729747,0.000033057706,0.0030267623,0.0000047470244,0.0006481734,0.00010904162],"about_ca_topic_score_codex":0.000028953433,"about_ca_topic_score_gemma":0.00007225937,"teacher_disagreement_score":0.014601471,"about_ca_system_score_codex":0.00022870048,"about_ca_system_score_gemma":0.0000931838,"threshold_uncertainty_score":0.3764825},"labels":[],"label_agreement":null},{"id":"W2047187032","doi":"10.1111/igc.0b013e3181c7fccf","title":"Malignant Transformation Within Ovarian Dermoid Cysts: An Audit of Treatment Received and Patient Outcomes. An Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) Study","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Debulking; Radiation therapy; Stage (stratigraphy); Surgery; Chemotherapy; Disease; Radical surgery; Ovarian cancer; Cancer; Internal medicine","score_opus":0.04252812577289607,"score_gpt":0.36851969982256144,"score_spread":0.3259915740496654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047187032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898432,0.00017786476,0.000029129298,0.005947085,0.0028429665,0.0009778941,0.00007737209,0.000020085488,0.000084390515],"genre_scores_gemma":[0.9963883,0.00077047467,0.0014963703,0.0007378313,0.00026088176,0.00019328838,0.000021121368,0.000018172203,0.000113526934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997357,0.00021824281,0.0011791411,0.000449881,0.00049053767,0.000305178],"domain_scores_gemma":[0.99762315,0.0002878427,0.0008941997,0.00018690953,0.0004655992,0.0005422934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004234342,0.00036137216,0.00095285435,0.00022448291,0.00008263183,0.00006762934,0.00024472974,0.00031863424,0.0031678535],"category_scores_gemma":[0.00017261303,0.00021942491,0.00016653555,0.000102490805,0.00020208897,0.0003917236,0.0000617376,0.00047512772,0.000001747154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020427501,0.00616652,0.7837944,0.000013141687,0.0014385051,0.00076376303,0.0040571042,0.000106723004,0.002245521,0.00041702407,0.00024728666,0.19870725],"study_design_scores_gemma":[0.010773692,0.033661406,0.9493069,0.000041157702,0.00053651904,0.00031332675,0.0009298192,0.000110927496,0.00045992603,0.00046297308,0.0031871994,0.00021614673],"about_ca_topic_score_codex":0.0023195203,"about_ca_topic_score_gemma":0.0134265805,"teacher_disagreement_score":0.19849111,"about_ca_system_score_codex":0.0012809552,"about_ca_system_score_gemma":0.00050464866,"threshold_uncertainty_score":0.99774337},"labels":[],"label_agreement":null},{"id":"W2048036268","doi":"10.1097/igc.0b013e31829b7dca","title":"Original Study Is Routine Appendectomy at the Time of Primary Surgery for Mucinous Ovarian Neoplasms Beneficial?","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pseudomyxoma peritonei; Appendix; Mucinous carcinoma; Mucinous Tumor; Ovarian carcinoma; Ovarian cancer; Ovary; Adenocarcinoma; General surgery; Stage (stratigraphy); Metastasis; Surgery; Cancer; Internal medicine","score_opus":0.025170298592732194,"score_gpt":0.29515798106786134,"score_spread":0.26998768247512916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048036268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884857,0.0003179656,0.000043113865,0.00885112,0.0009332594,0.00056598993,0.0000516917,0.000009320782,0.00074182736],"genre_scores_gemma":[0.99460524,0.00007894956,0.00024126311,0.0027581677,0.0008273244,0.00005799748,0.000011023327,0.000012571584,0.0014074642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981434,0.000053538548,0.0007224315,0.00016405203,0.0006864239,0.00023019787],"domain_scores_gemma":[0.99742347,0.00079533085,0.00055627595,0.00010800785,0.0010139329,0.00010300453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005183228,0.00015386031,0.0005403132,0.00010366281,0.000083393184,0.000031972668,0.00029322936,0.00008415336,0.009598524],"category_scores_gemma":[0.00023059973,0.00008369962,0.00030569496,0.000099560035,0.00011267247,0.000118615564,0.00008824712,0.0002080068,0.000054598597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008713979,0.004680958,0.80187976,0.00016541594,0.0031628793,0.00067141536,0.0017778181,0.0002179057,0.032577217,0.00079513993,0.08864778,0.05670974],"study_design_scores_gemma":[0.0040322323,0.002873081,0.9538779,0.00017820449,0.00033195998,0.0006854024,0.000422474,0.0002645914,0.0076748477,0.0006411229,0.02877905,0.000239131],"about_ca_topic_score_codex":0.00025756148,"about_ca_topic_score_gemma":0.000038382834,"teacher_disagreement_score":0.15199816,"about_ca_system_score_codex":0.0003284304,"about_ca_system_score_gemma":0.00030897456,"threshold_uncertainty_score":0.99130684},"labels":[],"label_agreement":null},{"id":"W2049371477","doi":"10.1111/igc.0b013e3181a83301","title":"Brain Metastases in Epithelial Ovarian and Primary Peritoneal Carcinoma","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Radiosurgery; Craniotomy; Radiation therapy; Brain metastasis; Surgery; Carcinoma; Retrospective cohort study; Metastasis; Cancer; Internal medicine","score_opus":0.020634489177947496,"score_gpt":0.32224950639839234,"score_spread":0.3016150172204448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049371477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96468383,0.001562671,0.000067928966,0.032552067,0.00035962395,0.00011119625,0.000040335857,0.0000051593056,0.0006172109],"genre_scores_gemma":[0.99012524,0.00027470847,0.0024868282,0.0065944646,0.000405066,0.000004616397,0.000008488522,0.0000046781474,0.00009591081],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989143,0.000075734046,0.00037327313,0.00013304541,0.00036057062,0.00014307786],"domain_scores_gemma":[0.99926555,0.00021397331,0.0001591243,0.000054792796,0.0001794284,0.00012710043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035555405,0.000109299355,0.0003220634,0.00014689709,0.000020664758,0.000025684887,0.000105865925,0.000057704543,0.0006566745],"category_scores_gemma":[0.000244495,0.00007258637,0.00011650512,0.000066622684,0.000056689434,0.0000988777,0.000027105685,0.00021736347,0.0000020429632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053596324,0.0026569506,0.36398777,0.00002949216,0.00077703386,0.014469081,0.00042265595,0.00012809022,0.012932932,0.0042653973,0.0044077514,0.5905632],"study_design_scores_gemma":[0.00434075,0.0014352951,0.9820148,0.000049258466,0.00007216738,0.0008587645,0.00004360444,0.00003278923,0.0005741475,0.0009662727,0.009536635,0.00007554708],"about_ca_topic_score_codex":0.000056111614,"about_ca_topic_score_gemma":0.000031115487,"teacher_disagreement_score":0.618027,"about_ca_system_score_codex":0.000284041,"about_ca_system_score_gemma":0.00016436413,"threshold_uncertainty_score":0.71901256},"labels":[],"label_agreement":null},{"id":"W2049559177","doi":"10.1111/igc.0b013e3181d94f05","title":"Efficacy of Photodynamic Therapy in Vulvar Lichen Sclerosus Treatment Based on Immunohistochemical Analysis of CD34, CD44, Myelin Basic Protein, and Ki67 Antibodies","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genital Health and Disease","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Immunohistochemistry; Lichen sclerosus; CD34; Myelin basic protein; Antibody; Propolis; CD44; Dermatology; Pathology; Myelin; Immunology; Internal medicine; Stem cell; Traditional medicine","score_opus":0.020695225104430635,"score_gpt":0.3475116033555107,"score_spread":0.32681637825108006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049559177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977895,0.0006773922,0.000007783756,0.0008266211,0.00016619293,0.0003062704,0.000050659568,0.0000039467222,0.00017162196],"genre_scores_gemma":[0.9990064,0.00019533838,0.0003137402,0.00033404012,0.00007849895,0.000023100296,0.000014663979,0.00000671274,0.000027510676],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986209,0.000047304125,0.00061647897,0.00015296403,0.00042092917,0.00014137462],"domain_scores_gemma":[0.99855995,0.00032907084,0.00039052064,0.00011687088,0.00044320629,0.00016037893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021915318,0.00013188421,0.0005082065,0.00041925797,0.000016402242,0.0000067709916,0.00014258901,0.00010761498,0.0006688461],"category_scores_gemma":[0.00045948054,0.00008673077,0.0002512015,0.00021332563,0.00015002306,0.00003662356,0.000016878632,0.00024563223,8.583919e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020656249,0.0044868393,0.4004896,0.00006127531,0.0010085723,0.00017585536,0.00021956173,0.0009274963,0.5360824,0.0000787883,0.000031733045,0.035781637],"study_design_scores_gemma":[0.006881023,0.0023275102,0.9692591,0.000079110236,0.00024857724,0.0000066875696,0.000023972498,0.0014747757,0.019487549,0.0000570304,0.00007669103,0.00007797314],"about_ca_topic_score_codex":0.00022231063,"about_ca_topic_score_gemma":0.00012251425,"teacher_disagreement_score":0.5687695,"about_ca_system_score_codex":0.00022502133,"about_ca_system_score_gemma":0.00034697575,"threshold_uncertainty_score":0.7323396},"labels":[],"label_agreement":null},{"id":"W2053358503","doi":"10.1097/igc.0b013e31821bb8aa","title":"Clinical Trials in Recurrent Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Transplant Association","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Medicine; Ovarian cancer; Gynecologic cancer; Clinical trial; Consensus conference; Oncology; Gynecology; Epithelial ovarian cancer; Randomized controlled trial; Cancer; Internal medicine","score_opus":0.4619277207717376,"score_gpt":0.5798671776175781,"score_spread":0.1179394568458405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053358503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001284361,0.98580235,0.000015326923,0.0016781753,0.010381108,0.0007872008,0.00016947131,0.000009858305,0.0010280664],"genre_scores_gemma":[0.00043126728,0.9938451,0.00041902813,0.00066109607,0.003986211,0.00034861936,0.000022502567,0.00003645643,0.00024972289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927614,0.0013185162,0.0045472845,0.0004432095,0.00062887045,0.00030076565],"domain_scores_gemma":[0.99237674,0.0028290465,0.0035778796,0.00020984828,0.0006763085,0.00033017556],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005131267,0.00042732785,0.0051265983,0.0004866295,0.000020310428,0.000045645967,0.0005770733,0.00061751105,0.010954848],"category_scores_gemma":[0.0035359953,0.00024760957,0.0026041728,0.00022432898,0.00010411799,0.000094502444,0.000117716634,0.0013853667,0.00004260642],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044315468,0.0013203233,0.006750164,0.000509354,0.0028673697,0.0011595748,0.000021615882,0.0000011895778,4.1514493e-8,0.00030738235,0.005689683,0.98093015],"study_design_scores_gemma":[0.003168995,0.00084155716,0.013189427,0.01781348,0.0026381372,0.00018926263,0.000005257436,0.0000017153262,5.222561e-7,0.00019156375,0.96174634,0.00021372593],"about_ca_topic_score_codex":0.00014398989,"about_ca_topic_score_gemma":0.00019188806,"teacher_disagreement_score":0.9807164,"about_ca_system_score_codex":0.0020339277,"about_ca_system_score_gemma":0.002515606,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W2054139086","doi":"10.1111/igc.0b013e31819c54db","title":"Cardiac Arrest During Laparotomy With Argon Beam Coagulation of Metastatic Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Laparotomy; Ovarian cancer; Coagulation; Internal medicine; Oncology; Cancer; Radiology","score_opus":0.022258698417812074,"score_gpt":0.32643685038215126,"score_spread":0.30417815196433917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054139086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030095,0.0012560219,0.00009103288,0.006489122,0.00096827943,0.00029160627,0.000048554208,0.000009808969,0.0005446218],"genre_scores_gemma":[0.99673575,0.0010988944,0.00093368534,0.0004733291,0.0006004272,0.000044515025,0.000007163022,0.0000096084905,0.000096642645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984943,0.00003743101,0.0004959895,0.00016363747,0.000645243,0.00016335286],"domain_scores_gemma":[0.99840355,0.00011483057,0.000535829,0.00009882878,0.0007149538,0.00013202784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016002599,0.0001489179,0.0004863474,0.00013942299,0.00003247981,0.00002241498,0.00014080957,0.00005498868,0.0007667991],"category_scores_gemma":[0.00007311485,0.000094912066,0.00018780337,0.00013301242,0.00005800716,0.0001440194,0.000015572423,0.00018855724,0.000002322275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066342186,0.0027118106,0.89866126,0.000104162435,0.0054441243,0.0013844218,0.0004190792,0.01578675,0.014701393,0.0013712194,0.0014827037,0.05129883],"study_design_scores_gemma":[0.003966317,0.0011473058,0.9739926,0.00039751912,0.00045041696,0.000050210507,0.000039204002,0.00003318223,0.017395604,0.00021587875,0.0022037635,0.000107987624],"about_ca_topic_score_codex":0.00011799243,"about_ca_topic_score_gemma":0.000043137476,"teacher_disagreement_score":0.07533132,"about_ca_system_score_codex":0.00056789117,"about_ca_system_score_gemma":0.00030439947,"threshold_uncertainty_score":0.8395912},"labels":[],"label_agreement":null},{"id":"W2054415199","doi":"10.1111/j.1525-1438.2006.00535.x","title":"Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Medicine; Microsatellite instability; Adenomyosis; Carcinoma; Pathology; Metaplasia; Microsatellite; Endometriosis; Allele; Gene; Biology","score_opus":0.022179841527685356,"score_gpt":0.3056588457164371,"score_spread":0.2834790041887517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054415199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926266,0.0011933914,0.0010008485,0.00091189356,0.0020841702,0.00037342144,0.00003067154,0.000016306876,0.0017626979],"genre_scores_gemma":[0.99152035,0.00043039033,0.006767178,0.00039855298,0.00072240323,0.000028462986,0.000013330765,0.000015587362,0.00010374008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697685,0.00018053374,0.0013412547,0.00032216933,0.0008886742,0.0002905383],"domain_scores_gemma":[0.99601763,0.0018693157,0.0007606503,0.00014692229,0.0010913676,0.00011408798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012358895,0.00020823767,0.00060915324,0.00050932844,0.000031285304,0.000041461135,0.00031732526,0.00024466176,0.0010786703],"category_scores_gemma":[0.0031774912,0.00013703023,0.00020414981,0.00056756655,0.0002254136,0.00013141321,0.00007715578,0.00069349457,0.0000070722353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008274033,0.0007068193,0.96962684,0.000013948112,0.000077174045,0.0010524795,0.000045077682,0.0021695155,0.008675081,0.0001082845,0.0001507922,0.009099977],"study_design_scores_gemma":[0.009082467,0.003503947,0.97982854,0.000095547126,0.00008357147,0.00046462525,0.00003806964,0.00014583867,0.0022252875,0.0013284737,0.0030292107,0.00017440152],"about_ca_topic_score_codex":0.00020646118,"about_ca_topic_score_gemma":0.00016816282,"teacher_disagreement_score":0.010201742,"about_ca_system_score_codex":0.0011864222,"about_ca_system_score_gemma":0.0005859362,"threshold_uncertainty_score":0.9998345},"labels":[],"label_agreement":null},{"id":"W2055272681","doi":"10.1111/j.1525-1438.2003.13357.x","title":"Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Paclitaxel; Cisplatin; Regimen; Oncology; Cyclophosphamide; Chemotherapy; Internal medicine; Ovarian cancer; Randomized controlled trial; Cancer","score_opus":0.021486651551304473,"score_gpt":0.3305047550723723,"score_spread":0.30901810352106784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055272681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841762,0.0021034058,0.000073552415,0.0074436218,0.0038389412,0.000575061,0.00005574008,0.000006788379,0.0017266596],"genre_scores_gemma":[0.99626184,0.0017524633,0.00013126424,0.00096979394,0.00016372307,0.00010745045,0.0000056715517,0.000019507122,0.0005882791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741477,0.0002240298,0.0008853872,0.00025331342,0.000954476,0.00026801566],"domain_scores_gemma":[0.997406,0.00071611593,0.0009344358,0.00023892046,0.0005993653,0.000105180574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066372834,0.00022924948,0.0005308494,0.00011249307,0.00006994844,0.00003441093,0.00040421332,0.00013535914,0.0025646626],"category_scores_gemma":[0.00066987437,0.00012294204,0.000321351,0.0002834656,0.0001628435,0.00017131407,0.00006860309,0.0004660701,0.000002914616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010719824,0.00065319607,0.9730106,0.000022213288,0.0005349871,0.00018146467,0.0002821642,0.00035382912,0.0006430847,0.005654917,0.00036453197,0.017227024],"study_design_scores_gemma":[0.010873986,0.0004431976,0.98177105,0.00046068232,0.0001729895,0.0000541737,0.0001311501,0.000036485126,0.0025708866,0.0010205414,0.0023335882,0.00013124332],"about_ca_topic_score_codex":0.00022579319,"about_ca_topic_score_gemma":0.0010437103,"teacher_disagreement_score":0.01709578,"about_ca_system_score_codex":0.0009590904,"about_ca_system_score_gemma":0.00050091126,"threshold_uncertainty_score":0.9983471},"labels":[],"label_agreement":null},{"id":"W2055638608","doi":"10.1111/j.1525-1438.2005.15355.x","title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Gemcitabine; Ovarian cancer; Internal medicine; Oncology; Hazard ratio; Regimen; Chemotherapy; Cancer; Surgery; Confidence interval; Cisplatin","score_opus":0.02572366799496827,"score_gpt":0.3329184474933183,"score_spread":0.30719477949835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055638608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555634,0.0045048194,0.000026652204,0.038739074,0.000421489,0.0001907955,0.000011332809,0.0000059288714,0.00053646],"genre_scores_gemma":[0.988745,0.008562139,0.0007279498,0.0013687009,0.00042987886,0.000059084912,0.0000033939357,0.000008570531,0.000095293086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998987,0.000031501786,0.00033158864,0.00014480708,0.00037961148,0.00012549404],"domain_scores_gemma":[0.9991644,0.00010752395,0.00022407579,0.00005138185,0.00035887834,0.000093728006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016223501,0.000114034054,0.0002595942,0.0001402842,0.000018810302,0.00002590336,0.00008509457,0.000059507744,0.001173662],"category_scores_gemma":[0.000044420794,0.0000702587,0.000051646577,0.00009549799,0.00004792814,0.00012672367,0.000017851187,0.00020680879,0.0000014526543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018204417,0.0011442328,0.50130624,0.0000066505786,0.00037307973,0.00023999144,0.00023518347,0.0003446982,0.00026082897,0.00081956503,0.00046795126,0.49298117],"study_design_scores_gemma":[0.009794781,0.0013694006,0.9708331,0.00021232245,0.000046698955,0.00009928877,0.000026937158,0.00026412425,0.0006934869,0.00016934311,0.016400615,0.00008990498],"about_ca_topic_score_codex":0.00014979846,"about_ca_topic_score_gemma":0.00072487065,"teacher_disagreement_score":0.49289125,"about_ca_system_score_codex":0.00068599544,"about_ca_system_score_gemma":0.00019283016,"threshold_uncertainty_score":0.9997394},"labels":[],"label_agreement":null},{"id":"W2056472796","doi":"10.1097/igc.0b013e318257b936","title":"Effectiveness of Risk-Reducing Salpingo-Oophorectomy in Preventing Ovarian Cancer in a High-Risk French Canadian Population","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Ovarian cancer; Population; Gynecology; Incidence (geometry); Hysterectomy; Breast cancer; Oophorectomy; Fallopian tube; Genetic testing; Obstetrics; Cancer; Surgery; Internal medicine","score_opus":0.009857037179346424,"score_gpt":0.30092560099343685,"score_spread":0.2910685638140904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056472796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954591,0.0021586658,0.00019744693,0.00010454726,0.0017503444,0.00014831696,0.00010535529,0.0000018282158,0.00007439923],"genre_scores_gemma":[0.99785024,0.0007601502,0.00075318676,0.000039165378,0.0005058184,0.000049398986,0.000020639249,0.000013242532,0.000008166319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843705,0.00035272917,0.0005249353,0.0001778494,0.00024276305,0.00026465344],"domain_scores_gemma":[0.998752,0.00018793733,0.0005598027,0.0000924304,0.000305339,0.00010246714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012172296,0.00012402331,0.00023722016,0.00030130285,0.000033002787,0.000015256741,0.000281078,0.0001694738,0.00024740087],"category_scores_gemma":[0.0009589322,0.00011290167,0.00009544409,0.00020526398,0.000039705483,0.000028090315,0.00005700059,0.00029285628,7.603553e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012847202,0.00008958982,0.9388066,0.000013306074,0.000119801014,0.0000057557727,0.0001671758,0.028617015,0.006983581,0.000031557356,0.000034197717,0.025002932],"study_design_scores_gemma":[0.0011068404,0.000073996336,0.9873479,0.00017599782,0.000027630145,0.000009454217,0.00003686524,0.0001246945,0.010387962,0.0003199159,0.00026918706,0.00011957086],"about_ca_topic_score_codex":0.21813272,"about_ca_topic_score_gemma":0.17859545,"teacher_disagreement_score":0.048541266,"about_ca_system_score_codex":0.0012136133,"about_ca_system_score_gemma":0.0005009603,"threshold_uncertainty_score":0.83639306},"labels":[],"label_agreement":null},{"id":"W2056604268","doi":"10.1097/igc.0b013e31829e9fb4","title":"Multiple-Type Human Papillomavirus (HPV) Infections","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"Medicine; Odds ratio; Confidence interval; Human papillomavirus; Logistic regression; Papillomaviridae; Cervical cancer; Multivariate analysis; HPV infection; Internal medicine; Gynecology; Oncology; Obstetrics; Cancer","score_opus":0.05750984560366653,"score_gpt":0.4070935734274205,"score_spread":0.34958372782375396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056604268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655241,0.00070520403,0.00010277165,0.0064327386,0.001585037,0.00024244803,0.000007788401,0.000026512727,0.025373397],"genre_scores_gemma":[0.99522233,0.0004834358,0.00016161035,0.0018618051,0.0012074512,0.000028913106,0.0000052016353,0.000011143342,0.0010180809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847245,0.000044743923,0.00043939851,0.00013490314,0.00069496705,0.00021355755],"domain_scores_gemma":[0.9968417,0.0002777115,0.00016850738,0.00009326618,0.0023606734,0.00025809405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018574134,0.00010867309,0.00027487573,0.00017540576,0.000071293514,0.00006207741,0.00026092058,0.00010810901,0.09537839],"category_scores_gemma":[0.00086569844,0.00007348976,0.00019486173,0.00016011712,0.000112818896,0.00018202601,0.00008599677,0.0005097331,0.00017935768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073322357,0.0013104605,0.6436793,0.000030220755,0.00073886325,0.00033632442,0.0000953114,0.0001313102,0.019247144,0.00092288794,0.026755104,0.3060198],"study_design_scores_gemma":[0.0022034175,0.0011918779,0.95039314,0.000016798927,0.00003942883,0.00013051766,0.00003499078,0.000105035724,0.0010371656,0.0013856887,0.043368366,0.00009358121],"about_ca_topic_score_codex":0.00037042948,"about_ca_topic_score_gemma":0.00015262591,"teacher_disagreement_score":0.30671382,"about_ca_system_score_codex":0.00044227895,"about_ca_system_score_gemma":0.00017950241,"threshold_uncertainty_score":0.90544856},"labels":[],"label_agreement":null},{"id":"W2056906105","doi":"10.1111/j.1525-1438.2005.15229.x","title":"Steppe by steppe: gynecological oncology on the Mongolian plains","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Global Health and Surgery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gynecologic oncology; Gynecologic cancer; Developing country; Health care; Family medicine; Nursing; Cancer; Oncology; Internal medicine; Economic growth; Ovarian cancer","score_opus":0.033836697738942,"score_gpt":0.3781927048153932,"score_spread":0.3443560070764512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056906105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8133903,0.000760181,0.00004560558,0.17007716,0.0018954435,0.00023250042,0.00004771626,0.000021638349,0.01352943],"genre_scores_gemma":[0.94853354,0.001093374,0.00021093016,0.04771146,0.0013683438,0.000030052524,0.0000067419246,0.000010745559,0.0010348414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749583,0.00019780392,0.0007831208,0.00021052462,0.00085412466,0.00045857477],"domain_scores_gemma":[0.9964527,0.0019173523,0.0004632424,0.0001324816,0.00061753945,0.0004167136],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009294189,0.00018886133,0.000483141,0.00011300996,0.0001015755,0.0000314065,0.00046009696,0.00027555402,0.007147728],"category_scores_gemma":[0.0017713115,0.00010059659,0.00027357743,0.00012427119,0.0001773804,0.0000984254,0.000072485775,0.00087276543,0.0001422153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00471869,0.002669328,0.05291313,0.000014090158,0.0005516231,0.0013810454,0.00015874859,0.0003812073,0.00092875917,0.0058812397,0.6369859,0.29341623],"study_design_scores_gemma":[0.0021782361,0.0024702884,0.10214892,0.00006142483,0.00004822221,0.00037535137,0.00015853508,0.00018538153,0.000385119,0.00034072084,0.89151645,0.00013136485],"about_ca_topic_score_codex":0.000024120409,"about_ca_topic_score_gemma":0.00008254547,"teacher_disagreement_score":0.2932849,"about_ca_system_score_codex":0.0014011501,"about_ca_system_score_gemma":0.0005197048,"threshold_uncertainty_score":0.9937599},"labels":[],"label_agreement":null},{"id":"W2059363839","doi":"10.1111/igc.0b013e31819902ec","title":"Physical Activity in Ovarian Cancer Survivors","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging","keywords":"Medicine; Psychosocial; Cancer-related fatigue; Sleep (system call); Ovarian cancer; Oncology; Clinical psychology; Psychiatry; Cancer; Internal medicine","score_opus":0.02887588455443654,"score_gpt":0.3589964137399209,"score_spread":0.3301205291854844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059363839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783906,0.00040749472,0.000109964225,0.01660156,0.0019770593,0.000098848126,0.000016735508,0.000010629152,0.002387131],"genre_scores_gemma":[0.995768,0.00051224494,0.000042846346,0.0020747841,0.0013005756,0.000011594452,0.0000014402494,0.00000736395,0.00028115764],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99867123,0.000061149,0.00027172154,0.00016753214,0.00062275433,0.00020563738],"domain_scores_gemma":[0.9989452,0.0001463683,0.00022420808,0.00008388845,0.000456281,0.00014408753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021885948,0.0001350346,0.000382363,0.00016728384,0.000019346984,0.000025606962,0.00024724973,0.00010050651,0.001111901],"category_scores_gemma":[0.00016003771,0.00009863522,0.00022287831,0.000193912,0.00005017621,0.00016549845,0.000028650664,0.0004884146,0.0000050371514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045175347,0.0025982514,0.38931042,0.000021853204,0.00037048612,0.0016858293,0.001222267,0.00078654377,0.025853397,0.0013876922,0.0014650091,0.5707807],"study_design_scores_gemma":[0.0018236582,0.0005590409,0.9821562,0.00012465332,0.00004765824,0.00006337261,0.00008107762,0.00018798126,0.0042460295,0.0009656137,0.00960854,0.00013616678],"about_ca_topic_score_codex":0.0014568735,"about_ca_topic_score_gemma":0.005809532,"teacher_disagreement_score":0.5928458,"about_ca_system_score_codex":0.00068786344,"about_ca_system_score_gemma":0.00029278043,"threshold_uncertainty_score":0.9998012},"labels":[],"label_agreement":null},{"id":"W2059558094","doi":"10.1111/j.1525-1438.2007.01062.x","title":"Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Protein kinase B; Apoptosis; PI3K/AKT/mTOR pathway; Cancer research; LY294002; Medicine; Phosphatidylinositol; Kinase; Cell biology; Programmed cell death; Biology; Biochemistry","score_opus":0.007834131652606827,"score_gpt":0.2641237137673065,"score_spread":0.25628958211469965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059558094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98206854,0.00956439,0.0045488416,0.0015135814,0.0013955404,0.00019110093,0.000038597296,0.000003951477,0.0006754395],"genre_scores_gemma":[0.99577576,0.0011042918,0.0010149422,0.000556697,0.00052121456,0.000014751737,0.00001356209,0.000012215279,0.0009865945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985653,0.00005807847,0.0005362559,0.00021179403,0.00038940337,0.00023917107],"domain_scores_gemma":[0.9990399,0.00008240483,0.00041823662,0.00010522274,0.00027728223,0.00007697778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060241186,0.00014987368,0.00016826033,0.00005242842,0.00006912033,0.000041586944,0.00038001637,0.00016192335,0.00025563053],"category_scores_gemma":[0.000042204447,0.000098464254,0.00013271888,0.000084004576,0.000058978472,0.0000134092925,0.0000653057,0.00019175922,0.0000011613067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036568136,0.00017295478,0.0038839018,0.0000071681216,0.00007289626,0.000043910277,0.0001102464,0.0041694236,0.97424364,0.00021165518,0.0021693502,0.014549144],"study_design_scores_gemma":[0.0013041236,0.00016779703,0.043048974,0.000052747288,0.00001944688,0.0000071851505,0.0000909624,0.00018155819,0.90928656,0.00046338385,0.045194317,0.00018293157],"about_ca_topic_score_codex":0.0000699857,"about_ca_topic_score_gemma":0.0005706303,"teacher_disagreement_score":0.0649571,"about_ca_system_score_codex":0.0001813745,"about_ca_system_score_gemma":0.0001027983,"threshold_uncertainty_score":0.4015256},"labels":[],"label_agreement":null},{"id":"W2059799831","doi":"10.1111/j.1048-891x.2004.14419.x","title":"The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre; McGill University; Queen's University; University Health Network","funders":"National Cancer Institute; Novartis Pharma","keywords":"Letrozole; Medicine; PTEN; Oncology; Internal medicine; Endometrial cancer; Cancer; Clinical trial; Breast cancer; Gynecology; Tamoxifen; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.03680642088849099,"score_gpt":0.36053074864187623,"score_spread":0.3237243277533852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059799831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975681,0.00057874684,0.000028082874,0.00027008142,0.0010383613,0.00044068,0.00005745668,6.2474743e-7,0.000017902103],"genre_scores_gemma":[0.9987446,0.0010023033,0.000047348323,0.0000403812,0.00011578811,0.000033135897,0.0000030237434,0.000004384402,0.000009005751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816835,0.0003138694,0.0006957133,0.00015067104,0.00056161906,0.00010977177],"domain_scores_gemma":[0.9976387,0.00044012265,0.0012037784,0.00006049023,0.0006095844,0.00004733074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010157994,0.00011084276,0.0003634108,0.0000482653,0.000042976746,0.0000062521804,0.00024378924,0.000104881976,0.000016193273],"category_scores_gemma":[0.0017190778,0.000046097895,0.00008318674,0.00015836574,0.00023304924,0.000016218455,0.00006971769,0.00025206045,1.0866486e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044449285,0.0013498039,0.9068295,0.0000089702135,0.0011056367,0.0000064685773,0.000039828945,0.016281882,0.0031051142,0.000046829562,0.00009535809,0.026681345],"study_design_scores_gemma":[0.0136852,0.006012071,0.9772346,0.00012881235,0.000066464585,0.000003744057,0.000053641827,0.000030160652,0.0022605688,0.00002231117,0.0004160181,0.000086402884],"about_ca_topic_score_codex":0.0036338912,"about_ca_topic_score_gemma":0.05886884,"teacher_disagreement_score":0.070405126,"about_ca_system_score_codex":0.0002116093,"about_ca_system_score_gemma":0.0010693681,"threshold_uncertainty_score":0.95830435},"labels":[],"label_agreement":null},{"id":"W2060929072","doi":"10.1097/igc.0000000000000111","title":"Oncogenic Viral Prevalence in Invasive Vulvar CancerSpecimens From Human ImmunodeficiencyVirus-Positive and -Negative Women in Botswana","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Sarcoma; Virology; Virus; Population; Vulvar cancer; Polymerase chain reaction; Immunohistochemistry; Cancer; Oncovirus; Biopsy; Pathology; Immunology; Biology; Internal medicine; Gene","score_opus":0.021955602223736947,"score_gpt":0.35043524303975804,"score_spread":0.3284796408160211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060929072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916816,0.0014521541,0.000018062507,0.0014211879,0.00024843108,0.0001939193,0.00005207748,0.000004630308,0.0049279504],"genre_scores_gemma":[0.996567,0.0017814722,0.000092921306,0.0009885337,0.00035303982,0.000041499847,0.0000034614925,0.000009492901,0.00016257222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792135,0.00017826953,0.00058079767,0.0002711947,0.00069211336,0.0003562583],"domain_scores_gemma":[0.9980411,0.0009001034,0.00024101933,0.00009108901,0.00053974026,0.00018693892],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007000733,0.00014837568,0.0004604957,0.00026391345,0.000038740567,0.00003736627,0.0003176636,0.0001110511,0.0067703426],"category_scores_gemma":[0.0011609992,0.00011498422,0.000085230124,0.00017369573,0.00023524545,0.00018404212,0.00013703502,0.0006656314,0.000008719029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073125726,0.0012320678,0.85911304,0.00008561919,0.0005550884,0.001144478,0.0062238546,0.00049934664,0.035954453,0.0014160966,0.00038769882,0.086075686],"study_design_scores_gemma":[0.0043963175,0.0012589935,0.9850827,0.00015594916,0.000021513373,0.000020829233,0.00043054586,0.0001158613,0.0024554888,0.005577135,0.00035909793,0.00012556388],"about_ca_topic_score_codex":0.002359252,"about_ca_topic_score_gemma":0.0025173961,"teacher_disagreement_score":0.12596966,"about_ca_system_score_codex":0.0027376604,"about_ca_system_score_gemma":0.00043946414,"threshold_uncertainty_score":0.9941376},"labels":[],"label_agreement":null},{"id":"W2060978013","doi":"10.1046/j.1525-1438.2003.13320.x","title":"A comparison of the incidence, duration, and degree of the neurologic toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC)","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Carboplatin; Cisplatin; Paclitaxel; Toxicity; Incidence (geometry); Neurotoxicity; Cyclophosphamide; Chemotherapy; Internal medicine; Oncology","score_opus":0.04396429752159475,"score_gpt":0.3429296773506782,"score_spread":0.29896537982908344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060978013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925193,0.003028817,0.00007928759,0.0031270192,0.0005015028,0.00025591336,0.00003504898,0.000001436522,0.00045165198],"genre_scores_gemma":[0.9981193,0.00067662954,0.0006342861,0.00044220625,0.000052858853,0.000015878482,5.012718e-7,0.000004754656,0.000053584507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985804,0.00008364492,0.0007370037,0.0001093547,0.00039998683,0.00008958618],"domain_scores_gemma":[0.9974193,0.00080855377,0.0010202677,0.00009997407,0.0006076444,0.00004423554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030947648,0.00010176697,0.0003850725,0.00004934296,0.000043877364,0.0000088739935,0.0001612743,0.00006955383,0.00015061538],"category_scores_gemma":[0.0012897248,0.000050321556,0.00013729888,0.000094956806,0.0002820377,0.000055115215,0.000054764554,0.0001500925,7.270336e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034078833,0.00024370766,0.9891764,0.00003822156,0.00019753329,0.0000049700093,0.00025044018,0.00019082223,0.0017864933,0.0039176587,0.00031203666,0.0035409497],"study_design_scores_gemma":[0.0017520319,0.00090490823,0.9769965,0.00016693992,0.00014359583,0.00006401297,0.0001419453,0.000099383156,0.016722249,0.0022031344,0.00076024944,0.000045083965],"about_ca_topic_score_codex":0.00003745881,"about_ca_topic_score_gemma":0.000098820565,"teacher_disagreement_score":0.014935756,"about_ca_system_score_codex":0.0000798391,"about_ca_system_score_gemma":0.00018849496,"threshold_uncertainty_score":0.20520535},"labels":[],"label_agreement":null},{"id":"W2063071218","doi":"10.1097/igc.0b013e3182353371","title":"Surgical Outcome of Robotic Surgery in Morbidly Obese Patient With Endometrial Cancer Compared to Laparotomy","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Laparotomy; Perioperative; Endometrial cancer; Surgery; Body mass index; Robotic surgery; Dissection (medical); General surgery; Cancer; Internal medicine","score_opus":0.1094991228657959,"score_gpt":0.3638834592524824,"score_spread":0.2543843363866865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063071218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500823,0.00076104974,0.000039747498,0.0009439106,0.0017256975,0.00041959737,0.000031423642,0.000008980944,0.001061344],"genre_scores_gemma":[0.9978776,0.00034521538,0.0006480921,0.00055958465,0.00037677164,0.00010039222,0.0000038067446,0.00001422659,0.0000743259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972652,0.000098245204,0.0011467164,0.00021976596,0.0009922006,0.00027784528],"domain_scores_gemma":[0.99739504,0.0008218086,0.00055623037,0.00011086601,0.0008096607,0.00030638973],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034574384,0.00019641726,0.0009993471,0.00067783915,0.000016067748,0.000011945893,0.00025960454,0.000099906196,0.0046091843],"category_scores_gemma":[0.00067176356,0.00011896837,0.00030060552,0.0006788618,0.00008838349,0.00011195989,0.000075008866,0.00030143847,0.000007995804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015395122,0.0014027042,0.9649113,0.000026199607,0.00053946296,0.0025528078,0.00017728575,0.00067794137,0.00010585099,0.000057542868,0.00019895993,0.013954813],"study_design_scores_gemma":[0.012009043,0.0025031993,0.97834545,0.00045390992,0.0002012863,0.0002791507,0.00009621604,0.000022554439,0.0030244694,0.00011178725,0.0027377005,0.00021520272],"about_ca_topic_score_codex":0.0013093678,"about_ca_topic_score_gemma":0.0005007371,"teacher_disagreement_score":0.01373961,"about_ca_system_score_codex":0.00068802753,"about_ca_system_score_gemma":0.00030079304,"threshold_uncertainty_score":0.99630076},"labels":[],"label_agreement":null},{"id":"W2063176854","doi":"10.1111/j.1048-891x.2005.14405.x","title":"Pseudomyxoma peritonei: a case series and review of the literature","year":2005,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Pseudomyxoma peritonei; Gynecologic oncology; Medical record; Appendix; General surgery; Surgery","score_opus":0.03378707259185032,"score_gpt":0.3787547335887457,"score_spread":0.34496766099689535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063176854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009661557,0.9939438,3.9497937e-7,0.0031417522,0.0010383049,0.00035640047,0.00013207975,0.0000046681416,0.00041641464],"genre_scores_gemma":[0.0007133128,0.99605906,0.00019565376,0.0012903278,0.0011387443,0.0000265497,0.0000084249,0.000014803611,0.00055310916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980332,0.00015767771,0.000982973,0.00016294511,0.0005172668,0.0001459082],"domain_scores_gemma":[0.99772775,0.00024025486,0.0009905987,0.0001281012,0.00080940186,0.000103864724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036616746,0.00025654127,0.0014447991,0.00009590977,0.000044964083,0.000032707503,0.00033496926,0.00023032515,0.00086525537],"category_scores_gemma":[0.00045475355,0.000118801654,0.00074232084,0.00018394571,0.0002246841,0.000118169315,0.00013906657,0.0007222333,0.0000021698265],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014466122,0.00015250492,0.000050646482,0.04862755,0.0007191803,0.009939704,0.000065510416,1.7969653e-7,0.000009077739,0.0006251169,0.0027983594,0.93686754],"study_design_scores_gemma":[0.00020191538,0.00023339341,0.000057117275,0.16666973,0.0006731098,0.12751575,0.000012348858,1.6789353e-7,0.000005408322,0.00002944533,0.70451504,0.00008658933],"about_ca_topic_score_codex":0.000006670654,"about_ca_topic_score_gemma":0.000008429842,"teacher_disagreement_score":0.9367809,"about_ca_system_score_codex":0.00020868643,"about_ca_system_score_gemma":0.0004846566,"threshold_uncertainty_score":0.94739395},"labels":[],"label_agreement":null},{"id":"W2063972716","doi":"10.1111/j.1525-1438.2006.00648.x","title":"Abdominal radical trachelectomy: two new surgical techniques for the conservation of uterine arteries","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Trachelectomy; Internal iliac artery; Uterine artery; Anatomy; Common iliac artery; Artery; Radiology; Surgery; Aneurysm; Cervical cancer; Internal medicine; Pregnancy","score_opus":0.033282895897077065,"score_gpt":0.37167094855561567,"score_spread":0.3383880526585386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063972716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94946337,0.0027723575,0.008204176,0.036943365,0.001140465,0.0005477219,0.00007334937,0.00002656135,0.00082866504],"genre_scores_gemma":[0.991505,0.00040259573,0.004383611,0.00083188084,0.0022127568,0.000041968662,0.000010078443,0.000008929073,0.00060315797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986095,0.000033581287,0.0006150747,0.00011407198,0.00048444388,0.00014335763],"domain_scores_gemma":[0.9979352,0.0008852938,0.00038400883,0.000067046836,0.0006437807,0.000084689455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028743318,0.00011741551,0.00037131252,0.00009941472,0.000034725977,0.000023454657,0.00021428379,0.00007766777,0.0015208835],"category_scores_gemma":[0.0002921572,0.00006353285,0.00028895514,0.00013472683,0.00015622556,0.00009452104,0.000026774667,0.00017622783,0.0000010410333],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03494733,0.0021338828,0.12173515,0.00010031057,0.0016833672,0.00071926217,0.00008130205,0.000108876215,0.021721318,0.009309506,0.024925109,0.7825346],"study_design_scores_gemma":[0.020440377,0.0041990294,0.22122847,0.00017234255,0.00045344557,0.0010057968,0.00003386644,0.0002903133,0.067189656,0.009291274,0.6754882,0.00020727812],"about_ca_topic_score_codex":0.00031590185,"about_ca_topic_score_gemma":0.000086735694,"teacher_disagreement_score":0.7823273,"about_ca_system_score_codex":0.00022124365,"about_ca_system_score_gemma":0.00027182893,"threshold_uncertainty_score":0.99939185},"labels":[],"label_agreement":null},{"id":"W2064295135","doi":"10.1097/igc.0b013e3182158640","title":"Comparative Study of Grade 3/4 Toxicity Associated With Intraperitoneal Chemotherapy Administered After Primary Versus Interval Surgical Debulking in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Toxicity; Chemotherapy; Oncology; Intraperitoneal chemotherapy; Surgery; Internal medicine; Cancer","score_opus":0.09030698841717472,"score_gpt":0.365542067431809,"score_spread":0.2752350790146343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064295135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682635,0.00036355815,0.000008905609,0.0009641575,0.0007604414,0.0003702253,0.000029400278,0.0000073990645,0.00066953414],"genre_scores_gemma":[0.99877894,0.0002441673,0.00024506144,0.00034815195,0.00021713294,0.00012320041,0.0000044969847,0.000013702552,0.000025172318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980832,0.00013412202,0.0007042905,0.00023836143,0.000628518,0.00021154045],"domain_scores_gemma":[0.9984355,0.00029938272,0.0005444949,0.00009828564,0.0004893228,0.00013301626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002404571,0.00020562139,0.00076639396,0.00016613315,0.00002030328,0.000017483366,0.00022526033,0.00009952461,0.0018040633],"category_scores_gemma":[0.000046747093,0.00013558747,0.00015173545,0.000177142,0.000121538695,0.0001303656,0.00005042515,0.00035905564,7.774571e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040249977,0.011928058,0.92813116,0.0000137919515,0.0034322473,0.0034473564,0.005162222,0.000047896585,0.00021186587,0.000029682016,0.00007502554,0.0072707026],"study_design_scores_gemma":[0.02189223,0.0075017055,0.96734434,0.00035892817,0.00021462952,0.00005557414,0.0004990684,0.00002259672,0.0017848335,0.00002180832,0.00016849469,0.00013577046],"about_ca_topic_score_codex":0.00040444688,"about_ca_topic_score_gemma":0.0026464784,"teacher_disagreement_score":0.039213188,"about_ca_system_score_codex":0.0011324357,"about_ca_system_score_gemma":0.00033495278,"threshold_uncertainty_score":0.99910843},"labels":[],"label_agreement":null},{"id":"W2071288910","doi":"10.1097/igc.0b013e318272f2c9","title":"Aberrant Expression of Long Noncoding RNAs in Cervical Intraepithelial Neoplasia","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Cervical intraepithelial neoplasia; Transcriptome; Serial analysis of gene expression; Long non-coding RNA; Gene expression; Cervical cancer; Non-coding RNA; Cervix; Gene; Biology; Computational biology; Medicine; RNA; Cancer; Genetics","score_opus":0.018850549012694808,"score_gpt":0.329092424190702,"score_spread":0.3102418751780072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071288910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573846,0.0016408017,0.010109692,0.0004663277,0.0014290261,0.000101648555,0.000014035021,0.0000025166448,0.00049749936],"genre_scores_gemma":[0.9972869,0.0008732381,0.0006716103,0.0001985552,0.0008825886,0.00001072759,0.000006570021,0.000012586155,0.00005723045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984865,0.000110253015,0.00048100564,0.00013920518,0.00051692117,0.00026607455],"domain_scores_gemma":[0.9990676,0.00006250792,0.00028079926,0.00009702238,0.00035855058,0.00013349835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049518765,0.00011392879,0.0002099804,0.00013683978,0.00001873275,0.000014384236,0.00042384595,0.00020688363,0.00063264795],"category_scores_gemma":[0.00038623626,0.00008991203,0.00015057555,0.000088564535,0.000067112844,0.000018500476,0.00017935454,0.00031928177,0.0000035694893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000890867,0.00029533295,0.016673338,0.000010817629,0.00009062376,0.00007450132,0.000087525485,0.001195426,0.9607024,0.000096024814,0.00045660598,0.019426517],"study_design_scores_gemma":[0.001646318,0.0004309518,0.056844637,0.00011428977,0.000015269123,0.00014421971,0.000058895886,0.00008443091,0.9332954,0.00009590067,0.0071303016,0.00013935468],"about_ca_topic_score_codex":0.000028130571,"about_ca_topic_score_gemma":0.000076149336,"teacher_disagreement_score":0.040171303,"about_ca_system_score_codex":0.00016833592,"about_ca_system_score_gemma":0.00017088583,"threshold_uncertainty_score":0.69270515},"labels":[],"label_agreement":null},{"id":"W2073979968","doi":"10.1046/j.1525-1438.2002.01132.x","title":"Desmoplastic small round cell tumor presenting in the ovaries: Report of a case and review of the literature","year":2002,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Debulking; Desmoplastic small-round-cell tumor; Presentation (obstetrics); Differential diagnosis; Case presentation; Pathology; Ovary; Ovarian cancer; Chemotherapy; Radiology; Immunohistochemistry; Surgery; Cancer; Internal medicine","score_opus":0.0734291034084805,"score_gpt":0.3737588097872283,"score_spread":0.3003297063787478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073979968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00968397,0.9884024,0.0000013827056,0.0007375545,0.00034261312,0.0004939926,0.00003916478,0.0000010906159,0.00029780043],"genre_scores_gemma":[0.01735583,0.98173374,0.00013032884,0.0004666035,0.00016846284,0.000057263227,0.000005155398,0.000008708002,0.00007389304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978413,0.0002287497,0.001208733,0.0001490255,0.00046428764,0.000107896216],"domain_scores_gemma":[0.9958393,0.0015881344,0.0018644214,0.0001688574,0.0004962296,0.00004306749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006073612,0.00018370413,0.0010949891,0.00010258867,0.000022437634,0.000024652158,0.00029088507,0.00010106344,0.00022600286],"category_scores_gemma":[0.0015579052,0.00007479027,0.0005231796,0.00021532681,0.000094100855,0.000037325786,0.00008999872,0.0005174204,3.7176483e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015794125,0.004014537,0.045337345,0.102156445,0.0028611377,0.29062566,0.0007984119,0.000007832326,0.0000019363579,0.00023479866,0.004380844,0.5494231],"study_design_scores_gemma":[0.0012108893,0.00029531182,0.011688817,0.2197388,0.0036955008,0.18137033,0.0000711102,0.000005282058,0.000006556358,0.00008246147,0.5816705,0.00016442203],"about_ca_topic_score_codex":0.00002797818,"about_ca_topic_score_gemma":0.000022745504,"teacher_disagreement_score":0.5772897,"about_ca_system_score_codex":0.00019838139,"about_ca_system_score_gemma":0.00026930386,"threshold_uncertainty_score":0.30498585},"labels":[],"label_agreement":null},{"id":"W2074059416","doi":"10.1111/igc.0b013e3181dd0110","title":"Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Histology; Stage (stratigraphy); Ovarian cancer; Epithelial ovarian cancer; Gynecology; Oncology; Internal medicine; Cancer; Pathology","score_opus":0.03717033442550096,"score_gpt":0.35891985178083596,"score_spread":0.321749517355335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074059416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018870128,0.9733527,0.000045234014,0.0023980783,0.0031616369,0.0010974099,0.00039364674,0.00001528027,0.00066593284],"genre_scores_gemma":[0.027532268,0.9689789,0.00093090587,0.00042212993,0.0009674403,0.0006447609,0.000020302003,0.000055232875,0.0004480703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641246,0.00018020252,0.0016530827,0.0004633331,0.00084191747,0.00044898648],"domain_scores_gemma":[0.99544233,0.0009750298,0.0022196171,0.00027897593,0.0008186325,0.00026544122],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005298772,0.00049172743,0.0027093866,0.00050182774,0.000032753076,0.000028597082,0.0006215056,0.00055003,0.0031111152],"category_scores_gemma":[0.0004745036,0.000302735,0.0003972174,0.00033099623,0.0002532733,0.00011819571,0.00009954722,0.001488655,0.0000073576416],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021846143,0.0011964669,0.011286533,0.0011872199,0.001853794,0.002548192,0.00016223514,0.000058617286,0.0000086810005,0.00034779712,0.00028662762,0.9788792],"study_design_scores_gemma":[0.0057129296,0.0019856358,0.028759394,0.011289917,0.0010424271,0.00042563365,0.000026498223,0.00000646027,0.0000110722685,0.00014581162,0.95027447,0.0003197652],"about_ca_topic_score_codex":0.0004947337,"about_ca_topic_score_gemma":0.001394447,"teacher_disagreement_score":0.97855943,"about_ca_system_score_codex":0.0032896304,"about_ca_system_score_gemma":0.0029609678,"threshold_uncertainty_score":0.9999425},"labels":[],"label_agreement":null},{"id":"W2074124042","doi":"10.1097/igc.0b013e31828f38e1","title":"Vaginal Vault Dehiscence After Robotic Hysterectomy for Gynecologic Cancers","year":2013,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vaginal vault; Dehiscence; Hysterectomy; Gynecology; Vault (architecture); Gynecologic cancer; Obstetrics; General surgery; Surgery; Cancer; Ovarian cancer; Internal medicine","score_opus":0.09074630560471376,"score_gpt":0.4163451591275311,"score_spread":0.32559885352281737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074124042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044187924,0.99046534,0.00028991356,0.00070686976,0.005798497,0.0015701363,0.00014207257,0.000026328336,0.00055893534],"genre_scores_gemma":[0.0033120224,0.9881605,0.0018557672,0.0011298809,0.0024165923,0.0014829002,0.00004628047,0.000055380064,0.0015406759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964083,0.0001440523,0.0015247642,0.0004907367,0.00091965863,0.00051248923],"domain_scores_gemma":[0.9949191,0.0015183142,0.0014538144,0.00020518717,0.0015000988,0.000403474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003287905,0.00058099395,0.0026717605,0.0004620742,0.00005419458,0.000095452655,0.00075992243,0.0005124487,0.0076298383],"category_scores_gemma":[0.001020994,0.0003419675,0.0016215906,0.00032556002,0.00015241,0.00019392041,0.0001328446,0.0007965983,0.000095079085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072332466,0.00034729516,0.0006494726,0.0020343205,0.0024553556,0.00057405233,0.000015192764,0.000025167394,0.0000017038456,0.00003798291,0.0026643176,0.99047184],"study_design_scores_gemma":[0.0036948791,0.002132518,0.0013387697,0.0057476154,0.0031761338,0.0005142795,0.000012089261,0.000013243429,0.000006392452,0.00027055605,0.98269516,0.00039833575],"about_ca_topic_score_codex":0.000075787335,"about_ca_topic_score_gemma":0.00004760033,"teacher_disagreement_score":0.9900735,"about_ca_system_score_codex":0.0040083867,"about_ca_system_score_gemma":0.0017215089,"threshold_uncertainty_score":0.99990326},"labels":[],"label_agreement":null},{"id":"W2075577979","doi":"10.1111/igc.0b013e3181ae3f71","title":"A Case of Peutz-Jeghers Syndrome With Breast Cancer, Bilateral Sex Cord Tumor With Annular Tubules, and Adenoma Malignum Caused by STK11 Gene Mutation","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Peutz–Jeghers syndrome; Concomitant; Breast cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.013113463897232249,"score_gpt":0.28616561314337985,"score_spread":0.2730521492461476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075577979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518883,0.0012323731,0.0001177891,0.0025882297,0.00029517815,0.0002979945,0.00020459005,0.0000142734025,0.00006071415],"genre_scores_gemma":[0.99750626,0.00020694296,0.0009129208,0.0010317647,0.00015134772,0.000020351037,0.00001023145,0.00002099762,0.00013918518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981882,0.000058959627,0.00053667324,0.000278078,0.00068615883,0.0002519459],"domain_scores_gemma":[0.99800843,0.00010821066,0.00058051007,0.000108430366,0.0009554696,0.0002389735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017194243,0.00024448463,0.0005293067,0.00016900583,0.000043783653,0.00003694278,0.00018272533,0.00009195345,0.0008015931],"category_scores_gemma":[0.000042848897,0.00015646461,0.000079570535,0.0001696111,0.0002100372,0.00016409121,0.000029062816,0.00031852754,7.3916425e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02252707,0.0015465548,0.6936522,0.00015605862,0.00299038,0.17105106,0.0009031513,0.0033089595,0.057126097,0.000058931073,0.0023308205,0.044348735],"study_design_scores_gemma":[0.0065768356,0.011492098,0.78390086,0.00036080886,0.00040957556,0.1852552,0.00027676517,0.00027386984,0.010631586,0.0000884287,0.00039851555,0.0003354577],"about_ca_topic_score_codex":0.0004168704,"about_ca_topic_score_gemma":0.00027862005,"teacher_disagreement_score":0.090248674,"about_ca_system_score_codex":0.0005640194,"about_ca_system_score_gemma":0.0005122864,"threshold_uncertainty_score":0.8776882},"labels":[],"label_agreement":null},{"id":"W2076677684","doi":"10.1111/j.1525-1438.2006.00599.x","title":"Psychologic morbidities prior to loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Colposcopy; Cervical intraepithelial neoplasia; Anxiety; Depression (economics); Psychosocial; Hospital Anxiety and Depression Scale; Distress; Cervical cancer; Obstetrics; Gynecology; Cancer; Clinical psychology; Internal medicine; Psychiatry","score_opus":0.03233978136452263,"score_gpt":0.3864086841429708,"score_spread":0.35406890277844816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076677684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800025,0.0009889518,0.00007331472,0.015133936,0.00039510374,0.00036294566,0.00001830483,0.0000071507884,0.0030177613],"genre_scores_gemma":[0.99588126,0.0010801951,0.0002037777,0.0012560132,0.0012775209,0.000057307112,0.000005561558,0.000008666241,0.00022966907],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99772894,0.00010363496,0.00066614244,0.00019746626,0.0010293351,0.00027450174],"domain_scores_gemma":[0.99850464,0.0004520359,0.0001778803,0.000112301284,0.0006374281,0.00011573816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036649875,0.0001515005,0.00042999955,0.00021996906,0.00003196302,0.000033991837,0.00039569868,0.00013678205,0.0040105926],"category_scores_gemma":[0.0002293276,0.00007779462,0.00024009706,0.00027779484,0.00011641344,0.00006059521,0.000029754106,0.000333596,0.000011382208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03420281,0.013750274,0.40593997,0.000104414285,0.00047250217,0.0033011443,0.0014562116,0.0013630472,0.010158521,0.0038876012,0.013306033,0.5120575],"study_design_scores_gemma":[0.0038194293,0.005970804,0.963427,0.000037483143,0.00004135138,0.00031556515,0.00012373118,0.00006940658,0.0019030145,0.0015377088,0.022661684,0.00009283522],"about_ca_topic_score_codex":0.00015847529,"about_ca_topic_score_gemma":0.00041002067,"teacher_disagreement_score":0.557487,"about_ca_system_score_codex":0.00056063116,"about_ca_system_score_gemma":0.0002703314,"threshold_uncertainty_score":0.9968999},"labels":[],"label_agreement":null},{"id":"W2076787905","doi":"10.1111/j.1525-1438.2006.00514.x","title":"Immunohistochemical characterization of endocervical papillary serous carcinoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pathology; Serous fluid; Carcinoembryonic antigen; Adenosquamous carcinoma; Immunohistochemistry; Immunostaining; Malignancy; Cervix; Adenocarcinoma; Immunophenotyping; Clear cell; Cancer; Internal medicine; Antigen","score_opus":0.014717601376427887,"score_gpt":0.29386459573895596,"score_spread":0.27914699436252804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076787905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942733,0.0009435406,0.00013513427,0.0019503135,0.00095068716,0.00012097074,0.000041061074,0.00001050601,0.001574464],"genre_scores_gemma":[0.9975106,0.00030353223,0.00028555488,0.0005860368,0.0010103362,0.000011292529,0.0000467742,0.0000105310555,0.00023530818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99831724,0.000038301157,0.0007000622,0.0001349005,0.0006562326,0.00015328573],"domain_scores_gemma":[0.9983738,0.00014962755,0.00046342012,0.000082420716,0.00083352276,0.00009720936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012166057,0.00012805994,0.00041919455,0.00014980507,0.000020239879,0.000012142411,0.00021439837,0.000120515266,0.0021511307],"category_scores_gemma":[0.00015862203,0.00008886099,0.00026163866,0.00017211284,0.00008723983,0.00009737146,0.000052908556,0.00021587509,0.0000065728705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043496625,0.0015511309,0.3984042,0.00005434764,0.00050348905,0.00074028684,0.00004258026,0.000024358038,0.56121594,0.0006996232,0.00050134136,0.031913016],"study_design_scores_gemma":[0.0046936367,0.00092904863,0.92525405,0.000076874036,0.00015607967,0.00032637612,0.000010575316,0.000027161477,0.062128235,0.00055861386,0.005732585,0.000106745974],"about_ca_topic_score_codex":0.000115934774,"about_ca_topic_score_gemma":0.000005330418,"teacher_disagreement_score":0.52684987,"about_ca_system_score_codex":0.00044818534,"about_ca_system_score_gemma":0.00017118343,"threshold_uncertainty_score":0.99876106},"labels":[],"label_agreement":null},{"id":"W2079156417","doi":"10.1111/igc.0b013e3181a1a657","title":"Should Preoperative Pathology Be Used to Select Patients for Surgical Staging in Endometrial Cancer?","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University; Queen's University","funders":"","keywords":"Medicine; Endometrial cancer; General surgery; Neoplasm staging; Surgical pathology; Cancer; Radiology; Gynecology; Internal medicine","score_opus":0.08458920240462503,"score_gpt":0.4154589183115473,"score_spread":0.33086971590692227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079156417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98241085,0.00046284622,0.00013190997,0.014028043,0.001635625,0.000704456,0.00015012259,0.000012595294,0.00046356724],"genre_scores_gemma":[0.9934037,0.00031928922,0.0005420385,0.004326116,0.0010990318,0.00011696742,0.000020724687,0.000011307369,0.00016086995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978163,0.000100090016,0.00072777586,0.00027734763,0.00074308325,0.00033540523],"domain_scores_gemma":[0.99752545,0.0008688992,0.0002712672,0.00007060888,0.0010130086,0.00025076634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040579456,0.00019324028,0.0006562492,0.0005034356,0.000037534384,0.00003292667,0.00026723347,0.00014761202,0.0008309356],"category_scores_gemma":[0.0016255629,0.00013115292,0.00025871125,0.0004923915,0.00003646546,0.00013294008,0.000041008363,0.00034076208,0.000002547637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0318187,0.0030740518,0.78994,0.00001886842,0.00065669,0.001044202,0.00062528887,0.000998599,0.0014558323,0.0005085255,0.0032795148,0.16657974],"study_design_scores_gemma":[0.06420067,0.014086461,0.8830383,0.0002221524,0.0002123746,0.0000738906,0.00006963909,0.00007524604,0.006117254,0.0008334845,0.030724775,0.00034576986],"about_ca_topic_score_codex":0.000074402815,"about_ca_topic_score_gemma":0.00013854516,"teacher_disagreement_score":0.16623396,"about_ca_system_score_codex":0.001243543,"about_ca_system_score_gemma":0.00030025546,"threshold_uncertainty_score":0.9098162},"labels":[],"label_agreement":null},{"id":"W2079378852","doi":"10.1097/igc.0b013e318280f2b4","title":"Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling?","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Referral; Genetic counseling; Breast cancer; Ovarian cancer; Gynecology; Genetic testing; Cancer; Family medicine; Obstetrics; Internal medicine","score_opus":0.020920445488641044,"score_gpt":0.3240782787145502,"score_spread":0.30315783322590917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079378852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754206,0.0009798456,0.00049968105,0.02021646,0.0023968406,0.00023738961,0.00012385228,0.0000035635082,0.0001217527],"genre_scores_gemma":[0.9908317,0.002318372,0.0010976178,0.0033312377,0.001340578,0.00028033776,0.000003896542,0.000015228784,0.0007810344],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861795,0.000077097444,0.0005137026,0.00019378052,0.0004171917,0.00018025316],"domain_scores_gemma":[0.99789906,0.0001271794,0.00036237584,0.00016251318,0.0013511501,0.00009773168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020445348,0.0001358482,0.00019741541,0.00006965465,0.000048403665,0.00004847631,0.000707493,0.000119514094,0.005196647],"category_scores_gemma":[0.00029353332,0.00006221998,0.00014497784,0.0001172266,0.000117150084,0.000013047479,0.00011124017,0.00015196299,0.000009991086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027560561,0.0007607304,0.27134407,0.00003744243,0.0026948962,0.000067102104,0.0009717273,0.0207124,0.119822055,0.00014776809,0.22588891,0.35479683],"study_design_scores_gemma":[0.0019515302,0.0008735046,0.6727962,0.0001229355,0.00013999897,0.00018879693,0.0003457539,0.000130653,0.04485219,0.0007449766,0.27747488,0.00037859537],"about_ca_topic_score_codex":0.00031589434,"about_ca_topic_score_gemma":0.00061187934,"teacher_disagreement_score":0.4014521,"about_ca_system_score_codex":0.00021112621,"about_ca_system_score_gemma":0.00045378663,"threshold_uncertainty_score":0.99571276},"labels":[],"label_agreement":null},{"id":"W2080156752","doi":"10.1111/j.1525-1438.2005.00483.x","title":"A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"University of Pittsburgh","keywords":"Medicine; Concomitant; Ovarian cancer; Internal medicine; Adjuvant; Chemotherapy; Adverse effect; Monoclonal antibody; Immune system; Antibody; Oncology; Immunotherapy; Phases of clinical research; Cancer; Gastroenterology; Immunology","score_opus":0.07371906642979087,"score_gpt":0.4565962377889497,"score_spread":0.38287717135915883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080156752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845817,0.0017063472,0.00025992835,0.010625762,0.0015655219,0.0010183731,0.00012987414,0.000011458503,0.00010100157],"genre_scores_gemma":[0.99359477,0.0008426803,0.0014359257,0.0023601127,0.0012571933,0.00031758432,0.00001616444,0.000023546456,0.00015201935],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978562,0.00006596507,0.00082554255,0.00029637734,0.00070919207,0.00024674076],"domain_scores_gemma":[0.99788404,0.00018442812,0.0005054234,0.0001711769,0.001020949,0.00023401706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030537977,0.00021998146,0.00055496296,0.00022136112,0.00005283327,0.000035665853,0.00033223056,0.000051900464,0.0029729751],"category_scores_gemma":[0.00011725584,0.00015519101,0.000211935,0.0001352603,0.00004101855,0.00014223982,0.000053984153,0.00020003977,0.0000063896327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04094687,0.061373156,0.068161145,0.000055702312,0.0060319956,0.00053940236,0.0020264024,0.002253592,0.011177801,0.00065662485,0.0027056877,0.8040716],"study_design_scores_gemma":[0.07644964,0.13174337,0.67442006,0.0007142419,0.0014969675,0.00028487862,0.0005911387,0.0008307307,0.009254738,0.00034688573,0.10332809,0.0005392564],"about_ca_topic_score_codex":0.0005406723,"about_ca_topic_score_gemma":0.00082410395,"teacher_disagreement_score":0.80353236,"about_ca_system_score_codex":0.0010838202,"about_ca_system_score_gemma":0.0004887481,"threshold_uncertainty_score":0.99793845},"labels":[],"label_agreement":null},{"id":"W2080742177","doi":"10.1111/j.1525-1438.2007.01187.x","title":"Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carcinosarcoma; Malignancy; Stage (stratigraphy); Uterus; Endometrial cancer; Gynecology; Adenocarcinoma; Cancer; Müllerian mimicry; Sarcoma; Uterine cancer; Internal medicine; Oncology; Carcinoma; Pathology","score_opus":0.020167194811597122,"score_gpt":0.2731174184994557,"score_spread":0.2529502236878586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080742177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959028,0.00020221202,0.0000028798586,0.0028898749,0.0003493876,0.0002188828,0.000029394836,0.0000034912825,0.00040108664],"genre_scores_gemma":[0.9982654,0.0002391635,0.00027066213,0.000730365,0.00010022664,0.00008793715,0.0000012436719,0.000009279371,0.00029571334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865854,0.00007607255,0.0004423052,0.00013721806,0.0005030711,0.00018276971],"domain_scores_gemma":[0.99904543,0.0001467257,0.00035145995,0.00009692977,0.00025669768,0.00010274168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001223787,0.00013307184,0.00036037405,0.00009533762,0.000040989427,0.0000074672803,0.00024087667,0.000036663543,0.0013948132],"category_scores_gemma":[0.00010807947,0.00006514287,0.00010458271,0.00011783169,0.00015959171,0.00008084621,0.00011168212,0.00016827277,0.0000020361124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034841024,0.00053308316,0.98937,0.000009111315,0.00038212753,0.0030509357,0.00041791832,0.000067531466,0.00060509244,0.000022017295,0.00057634944,0.0014817667],"study_design_scores_gemma":[0.0036194625,0.0015950511,0.986333,0.00022735109,0.000029920828,0.0011594335,0.0001071874,0.000016865655,0.005366262,0.000030447784,0.0014443678,0.00007060843],"about_ca_topic_score_codex":0.00009884504,"about_ca_topic_score_gemma":0.0001597688,"teacher_disagreement_score":0.0047611697,"about_ca_system_score_codex":0.0008295478,"about_ca_system_score_gemma":0.00022706398,"threshold_uncertainty_score":0.99951804},"labels":[],"label_agreement":null},{"id":"W2082810850","doi":"10.1111/j.1525-1438.2006.00472.x","title":"A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Carboplatin; Ovarian cancer; Surgery; Stage (stratigraphy); Retrospective cohort study; Internal medicine; Oncology; Cancer; Cisplatin","score_opus":0.02393308602563269,"score_gpt":0.33291612833109313,"score_spread":0.3089830423054604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082810850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893527,0.0013751542,0.00020691204,0.006288112,0.0017511131,0.00018524424,0.000118653596,0.0000092490245,0.0007128723],"genre_scores_gemma":[0.9973993,0.00084499735,0.00066529773,0.0005628223,0.00033385036,0.00006058176,0.000022740043,0.000013358624,0.000097108124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797356,0.00005103076,0.0008300071,0.00024348895,0.00068998145,0.00021193927],"domain_scores_gemma":[0.9978065,0.00047819392,0.0007580497,0.00012522556,0.0007446673,0.00008737522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028011546,0.00017885983,0.00088065385,0.0005942615,0.00001964479,0.00001716122,0.00015978001,0.00011189691,0.0041958624],"category_scores_gemma":[0.0001936049,0.00013190559,0.0005348457,0.00047028836,0.00007374401,0.00009474648,0.000018125693,0.00022556144,0.0000014529257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005323487,0.0009618891,0.94256556,0.0000092900345,0.0030236004,0.0003314993,0.00007337581,0.014879247,0.00055554433,0.00018812681,0.0009143463,0.031174056],"study_design_scores_gemma":[0.009369658,0.00048206572,0.9846714,0.0001787295,0.00068386726,0.0000045867423,0.000035605495,0.0009192468,0.0019394231,0.00011417467,0.0014806696,0.000120586155],"about_ca_topic_score_codex":0.001179893,"about_ca_topic_score_gemma":0.0029694345,"teacher_disagreement_score":0.04210585,"about_ca_system_score_codex":0.0020358488,"about_ca_system_score_gemma":0.00056717696,"threshold_uncertainty_score":0.9967144},"labels":[],"label_agreement":null},{"id":"W2083747737","doi":"10.1111/j.1525-1438.2007.00812.x","title":"Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Institute for Clinical Evaluative Sciences; Western University","funders":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Gynecology; Oncology; Population; Obstetrics; Cancer; Internal medicine; Environmental health","score_opus":0.02326353999464376,"score_gpt":0.36800391909881436,"score_spread":0.3447403791041706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083747737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965264,0.0010156027,0.0000658996,0.001246993,0.0006951017,0.00032342345,0.000099975005,0.0000046324935,0.000021938442],"genre_scores_gemma":[0.9976289,0.0013648856,0.00025486827,0.00046044323,0.0002255703,0.000015844646,0.00000382119,0.000007863927,0.00003778603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983086,0.00009809463,0.00069884874,0.00018451404,0.0005611786,0.00014876618],"domain_scores_gemma":[0.9966011,0.002211381,0.0006299577,0.000056687975,0.0003480311,0.00015284214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008135728,0.00013927132,0.0005367763,0.00045167198,0.00003429231,0.000019973333,0.00009303499,0.000079633006,0.0003139517],"category_scores_gemma":[0.0027053743,0.000091822134,0.00006380184,0.000170634,0.00004036445,0.00015274296,0.00008613295,0.00028271903,1.262963e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041711186,0.00092216313,0.9388586,0.000016485803,0.00041089603,0.00023488014,0.00020232298,0.000026870852,0.000044444165,0.000032260657,0.0000023330645,0.055077597],"study_design_scores_gemma":[0.016967315,0.003178538,0.97870076,0.00007877027,0.0002191146,0.000013591879,0.00037458554,0.000016390864,0.00013485183,0.00007538669,0.00016253932,0.00007818516],"about_ca_topic_score_codex":0.005581447,"about_ca_topic_score_gemma":0.0029965965,"teacher_disagreement_score":0.05499941,"about_ca_system_score_codex":0.00031018123,"about_ca_system_score_gemma":0.000086490974,"threshold_uncertainty_score":0.8437515},"labels":[],"label_agreement":null},{"id":"W2084325911","doi":"10.1097/igc.0000000000000217","title":"Cervical Cancer Incidence in Ontario Women","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; Juravinski Cancer Centre; Cancer Care Ontario","funders":"Cancer Care Ontario","keywords":"Medicine; Incidence (geometry); Demography; Cancer registry; Cervical cancer; Confidence interval; Relative risk; Population; Adenocarcinoma; Cancer; Rate ratio; Basal cell; Standardized rate; Internal medicine; Environmental health","score_opus":0.037504215464203114,"score_gpt":0.37022545543838753,"score_spread":0.3327212399741844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084325911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798914,0.00034425326,0.00009552181,0.0075595244,0.0010101403,0.00010952221,0.0000040213836,0.000008465438,0.0109771425],"genre_scores_gemma":[0.99351394,0.0003655957,0.00016255291,0.004085703,0.00075988146,0.000053499785,0.000001428935,0.000009584738,0.001047806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978653,0.00007331248,0.00054472435,0.00019026677,0.0009914204,0.00033496774],"domain_scores_gemma":[0.9981927,0.00031441724,0.00017832112,0.00009676706,0.0009153808,0.00030237314],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006701753,0.00012395649,0.00041328112,0.00021143864,0.000024023771,0.000036983536,0.0004161424,0.0001274153,0.058714274],"category_scores_gemma":[0.00065454975,0.0000873621,0.00013623587,0.00015267328,0.00010018434,0.00014005361,0.00012068125,0.00086504215,0.00002336551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019061964,0.00031151265,0.88932747,0.000017775508,0.00012101753,0.00026564152,0.0004148035,0.00025633746,0.0003405715,0.0003950719,0.0007554061,0.10588817],"study_design_scores_gemma":[0.002437816,0.0006019116,0.9444194,0.000059034217,0.00001501121,0.00006154336,0.000047037876,0.00019551718,0.00014968117,0.0015322623,0.050386857,0.00009394232],"about_ca_topic_score_codex":0.01311331,"about_ca_topic_score_gemma":0.14340177,"teacher_disagreement_score":0.13028847,"about_ca_system_score_codex":0.00357114,"about_ca_system_score_gemma":0.0009924133,"threshold_uncertainty_score":0.99345845},"labels":[],"label_agreement":null},{"id":"W2086037490","doi":"10.1111/j.1048-891x.2004.14065.x","title":"Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Stage (stratigraphy); Ascites; Multivariate analysis; Univariate analysis; Internal medicine; Epithelial ovarian cancer; Disease; Oncology; Gynecology; Surgery; Cancer","score_opus":0.028714013377175718,"score_gpt":0.3555106594136239,"score_spread":0.3267966460364482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086037490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208087,0.0021794739,0.000054098924,0.0038272194,0.0011611644,0.00038170238,0.000058093916,0.000007419593,0.00024993808],"genre_scores_gemma":[0.9894148,0.007142337,0.0021811016,0.000342765,0.0007491668,0.000111982714,0.000004321448,0.000014983401,0.00003851109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972275,0.00012125329,0.0012343716,0.00029378373,0.0008839711,0.00023911452],"domain_scores_gemma":[0.99731547,0.00045181517,0.0008975309,0.00012956084,0.0010162408,0.00018937745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324793,0.0001979396,0.00085825863,0.00018703047,0.00002018007,0.000011549191,0.0002495275,0.00015576096,0.00063048815],"category_scores_gemma":[0.00024557728,0.00012788846,0.00019183088,0.00022096896,0.00032912873,0.00033264834,0.00006223483,0.0004310318,9.777734e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045067117,0.00391945,0.8801696,0.00014044899,0.0017543095,0.0010992268,0.0009329356,0.01657805,0.003244209,0.00022829497,0.00008810071,0.046778288],"study_design_scores_gemma":[0.012034805,0.0060608257,0.9758062,0.0016935444,0.00015814805,0.00015505166,0.00011737672,0.0000065984327,0.0032537247,0.00010660964,0.00048404417,0.0001230882],"about_ca_topic_score_codex":0.00016634229,"about_ca_topic_score_gemma":0.00007358856,"teacher_disagreement_score":0.09563661,"about_ca_system_score_codex":0.0024295182,"about_ca_system_score_gemma":0.0020151997,"threshold_uncertainty_score":0.6903403},"labels":[],"label_agreement":null},{"id":"W2087016156","doi":"10.1111/j.1525-1438.2006.00713.x","title":"Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Intraperitoneal chemotherapy; Epithelial ovarian cancer; Catheter; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.014201608342584682,"score_gpt":0.3331052177308427,"score_spread":0.318903609388258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087016156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8244774,0.0040787263,0.00046073398,0.16114548,0.0044173994,0.00084977667,0.0005734638,0.000026468919,0.003970598],"genre_scores_gemma":[0.9889052,0.0013013126,0.0025105905,0.003911632,0.0028478052,0.00019011048,0.000012045678,0.000021233314,0.00030005784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868727,0.000020852682,0.0004182414,0.0002213236,0.00036611967,0.00028621772],"domain_scores_gemma":[0.9979914,0.0001457106,0.00027081362,0.000080362675,0.0012806862,0.00023105119],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014000312,0.0001683006,0.0003755172,0.00018116669,0.00006940044,0.000043728232,0.00020351009,0.00011748214,0.0022457303],"category_scores_gemma":[0.00010053854,0.0001243591,0.00028351115,0.00009888007,0.000074662705,0.000108532964,0.000012073791,0.00019717599,0.0000037528885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014678345,0.004108523,0.29278743,0.00005933604,0.006484381,0.0024914534,0.001178425,0.0035153273,0.015387046,0.053587724,0.04579594,0.55992603],"study_design_scores_gemma":[0.022155777,0.0023742602,0.66266423,0.00025861055,0.00038300062,0.0002879394,0.000331446,0.00021006711,0.009666924,0.008909079,0.29236472,0.0003939334],"about_ca_topic_score_codex":0.044059835,"about_ca_topic_score_gemma":0.050112307,"teacher_disagreement_score":0.5595321,"about_ca_system_score_codex":0.0031515951,"about_ca_system_score_gemma":0.0013587371,"threshold_uncertainty_score":0.99866635},"labels":[],"label_agreement":null},{"id":"W2089662123","doi":"10.1046/j.1525-1438.2002.01152.x","title":"Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches","year":2002,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Carcinogenesis; Ovarian cancer; Epithelial ovarian cancer; Malignancy; Bioinformatics; Oncology; Cancer; Pathology; Internal medicine; Biology","score_opus":0.1385814274880016,"score_gpt":0.37229298023828117,"score_spread":0.23371155275027958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089662123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030685231,0.9671544,0.000001365795,0.00053257705,0.0006535456,0.0007898609,0.000030940133,0.00000415934,0.00014794662],"genre_scores_gemma":[0.20914477,0.7897847,0.0001289327,0.00005537303,0.0004088209,0.00040422892,0.0000078801195,0.000022370075,0.00004287354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977594,0.00014694424,0.0009924462,0.00033309497,0.0005254254,0.00024266278],"domain_scores_gemma":[0.9989251,0.00013918846,0.0005891665,0.00009733725,0.0001054528,0.00014378704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029178275,0.0003107311,0.0013416816,0.00042250764,0.000015999189,0.000027604989,0.00025387388,0.00027269518,0.0004109259],"category_scores_gemma":[0.00005064872,0.00020409717,0.0003189114,0.00016754318,0.00007807835,0.00010376637,0.000089506306,0.00047382724,0.0000052073065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014154661,0.0021881342,0.15848373,0.000774099,0.0007884275,0.0011760984,0.0002640673,0.000011423115,0.0000013300696,0.0000891803,0.000033572986,0.83604836],"study_design_scores_gemma":[0.01457951,0.003190795,0.6556508,0.038843192,0.0013095676,0.0015851445,0.00009928992,0.000032306067,0.00003790513,0.0002187346,0.28361735,0.0008354093],"about_ca_topic_score_codex":0.00011806304,"about_ca_topic_score_gemma":0.00006966536,"teacher_disagreement_score":0.835213,"about_ca_system_score_codex":0.0014547717,"about_ca_system_score_gemma":0.00029600787,"threshold_uncertainty_score":0.8322841},"labels":[],"label_agreement":null},{"id":"W2090287261","doi":"10.1097/igc.0b013e318231f140","title":"Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"ARID1A; Medicine; Clear cell; Somatic cell; Oncology; Cancer research; Ovarian cancer; Cancer; Internal medicine; Carcinoma; Mutation; Gene; Biology; Genetics","score_opus":0.019613344807380154,"score_gpt":0.27875808366566707,"score_spread":0.2591447388582869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090287261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769694,0.0010991219,0.0003041868,0.00012448168,0.00025428506,0.00009461044,0.000028686189,0.000001791996,0.0003958846],"genre_scores_gemma":[0.99792147,0.00094387634,0.0007099787,0.00020899149,0.000094573574,0.0000131201305,0.0000031652746,0.000007399776,0.000097428885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990029,0.00005753804,0.00041250204,0.00014674924,0.0002572343,0.0001231251],"domain_scores_gemma":[0.999151,0.000022791319,0.00040938976,0.00006696429,0.00028809338,0.000061798084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026586105,0.00009348802,0.00018006231,0.0000857857,0.000015337477,0.000008211434,0.00022234445,0.00012494762,0.0004678421],"category_scores_gemma":[0.0001963296,0.000072784496,0.0000943525,0.00006491898,0.000060591607,0.000008128614,0.00007463621,0.00014419743,6.405335e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017930082,0.0005939806,0.0524431,0.000032816355,0.0002427401,0.00008406509,0.00071384176,0.0009361951,0.93387824,0.000044520108,0.0007619193,0.008475566],"study_design_scores_gemma":[0.0040956615,0.0015044939,0.06208132,0.00029901305,0.00002910868,0.000027330725,0.00018222547,0.00026274836,0.92752534,0.0008731192,0.0028889973,0.00023062048],"about_ca_topic_score_codex":0.00036780996,"about_ca_topic_score_gemma":0.00013551059,"teacher_disagreement_score":0.00963822,"about_ca_system_score_codex":0.0001955078,"about_ca_system_score_gemma":0.00019888066,"threshold_uncertainty_score":0.5122543},"labels":[],"label_agreement":null},{"id":"W2090635330","doi":"10.1111/j.1525-1438.2005.00431.x","title":"Trial design for testing new therapies in ovarian cancer","year":2005,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.25186206854200555,"score_gpt":0.5056156728524875,"score_spread":0.253753604310482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090635330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041532803,0.99184734,0.001296887,0.0021833824,0.0026312713,0.0016023066,0.000064805994,0.000010121337,0.00032233453],"genre_scores_gemma":[0.0001748526,0.9816007,0.010676342,0.0005005948,0.0052027577,0.0005360709,0.000016866989,0.000034272904,0.0012575502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801064,0.00008880384,0.0010327124,0.00022954804,0.00041117988,0.00022709821],"domain_scores_gemma":[0.9969012,0.001350589,0.00094873086,0.00008506257,0.0005659682,0.00014843243],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003465813,0.00027294917,0.0012553333,0.00030908568,0.000034935547,0.000051697047,0.0003116952,0.00024932355,0.00119345],"category_scores_gemma":[0.0008073748,0.00016828722,0.0005307827,0.00019000152,0.000036321635,0.00011182617,0.000028689186,0.00040999017,0.000004164531],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034322236,0.00027188743,0.00010601533,0.00018338273,0.0015737924,0.00010697959,0.00006607026,0.00015960285,0.0000011074112,0.00006341129,0.002722897,0.9913126],"study_design_scores_gemma":[0.024953313,0.0012575195,0.0002862705,0.0053461897,0.0017457269,0.00010633979,0.000011434349,0.000017177666,0.0000012881544,0.00031924463,0.96578497,0.0001705209],"about_ca_topic_score_codex":0.0001519743,"about_ca_topic_score_gemma":0.00010591944,"teacher_disagreement_score":0.9911421,"about_ca_system_score_codex":0.002014921,"about_ca_system_score_gemma":0.0042042877,"threshold_uncertainty_score":0.9997196},"labels":[],"label_agreement":null},{"id":"W2090955775","doi":"10.1111/j.1525-1438.2006.00857.x","title":"Paraneoplastic syndrome in vaginal melanoma: a case report and review of the literature","year":2007,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Melanoma; Dermatology; Gynecology; Cancer research","score_opus":0.03918271924526861,"score_gpt":0.38387952793202446,"score_spread":0.34469680868675584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090955775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055469857,0.9924322,0.0000035134397,0.0006736767,0.0006497796,0.00042908365,0.000033694854,0.000002906211,0.00022818505],"genre_scores_gemma":[0.016661508,0.9823752,0.000044376575,0.00065656856,0.00006353897,0.000023135413,0.0000107833075,0.000010923959,0.00015393441],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977465,0.00013770556,0.0012752748,0.00020671761,0.00048373692,0.00015004717],"domain_scores_gemma":[0.99759495,0.000545023,0.0012973334,0.00014175841,0.000343605,0.00007731489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000420213,0.00023990506,0.0015267608,0.0001681321,0.00001989273,0.000012841651,0.0002364907,0.00024716216,0.00034229326],"category_scores_gemma":[0.0011055344,0.00011052491,0.00052925386,0.00026918537,0.000118380216,0.00004426439,0.00010583462,0.0008474561,0.0000014135652],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092380025,0.00037883743,0.0021247733,0.010780855,0.00053041655,0.65398717,0.00001223386,7.9693103e-7,1.01738415e-7,0.00003541548,0.0001661629,0.33189088],"study_design_scores_gemma":[0.0008074812,0.0005599327,0.011224394,0.09225175,0.00091722264,0.6621786,0.000002370826,7.2320233e-7,1.2936763e-7,0.00008761113,0.23187315,0.000096643664],"about_ca_topic_score_codex":0.000013653055,"about_ca_topic_score_gemma":0.0000110121355,"teacher_disagreement_score":0.33179423,"about_ca_system_score_codex":0.000200699,"about_ca_system_score_gemma":0.00032246916,"threshold_uncertainty_score":0.4507075},"labels":[],"label_agreement":null},{"id":"W2091145066","doi":"10.1111/j.1525-1438.2003.13363.x","title":"First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Medicine; Carboplatin; Epirubicin; Paclitaxel; TEC; Internal medicine; Regimen; Oncology; Ovarian cancer; Chemotherapy; Urology; Gastroenterology; Cancer; Cisplatin; Cyclophosphamide","score_opus":0.052322890997252625,"score_gpt":0.34923049353517804,"score_spread":0.2969076025379254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091145066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97362554,0.007072028,0.0002076246,0.012211124,0.0023086965,0.0006121885,0.0002982727,0.000026001822,0.003638518],"genre_scores_gemma":[0.98922735,0.0067376783,0.0022388354,0.00041901783,0.00065976166,0.00015416261,0.000015457774,0.000034359124,0.0005133994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972354,0.00011233944,0.00095835637,0.00037541217,0.00094843406,0.00037003853],"domain_scores_gemma":[0.99671304,0.0008470444,0.00091668015,0.00024838498,0.0009702229,0.00030464493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025863727,0.00037993226,0.0009047404,0.00021438698,0.0000725256,0.00003944833,0.00021197803,0.00017879238,0.006202935],"category_scores_gemma":[0.0003751715,0.00023554615,0.00037694187,0.00023327497,0.00016237887,0.00015209246,0.000027904485,0.00025103174,0.0000074525788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01844987,0.0075949896,0.8537511,0.00012702915,0.011086345,0.003263432,0.001198247,0.009120127,0.0009883373,0.0056951493,0.002497515,0.08622784],"study_design_scores_gemma":[0.067988664,0.03063297,0.773168,0.0012541323,0.0023335903,0.00032848012,0.0005167629,0.00026315227,0.015767882,0.0009345206,0.10603493,0.0007768702],"about_ca_topic_score_codex":0.00065671233,"about_ca_topic_score_gemma":0.0012803447,"teacher_disagreement_score":0.10353741,"about_ca_system_score_codex":0.0020264413,"about_ca_system_score_gemma":0.0008416323,"threshold_uncertainty_score":0.99470556},"labels":[],"label_agreement":null},{"id":"W2094698614","doi":"10.1097/igc.0000000000000257","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian and Primary Peritoneal Low-Grade Serous Carcinomas","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Serous fluid; Ovarian cancer; Clear cell; Serous ovarian cancer; Oncology; Clinical trial; Serous carcinoma; Ovary; Internal medicine; Cancer; Pathology; Carcinoma","score_opus":0.06329750467361535,"score_gpt":0.40411303949501637,"score_spread":0.34081553482140103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094698614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058977614,0.98457515,0.00003595373,0.008482007,0.0037378103,0.0018434793,0.00039740102,0.00002441536,0.00031400617],"genre_scores_gemma":[0.0014134018,0.98792666,0.00096165965,0.0057680532,0.0023407503,0.0010681921,0.00009829602,0.00006771717,0.00035526234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996123,0.00024819263,0.001848675,0.00063103455,0.0006976268,0.00045147265],"domain_scores_gemma":[0.9946582,0.0017280777,0.0019269788,0.00026254592,0.001029137,0.00039507955],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072512234,0.0006576464,0.0037319595,0.00026136043,0.00008674149,0.000078269615,0.00051860994,0.00050043693,0.0014130147],"category_scores_gemma":[0.0007179834,0.0004209416,0.0013119014,0.00016051212,0.00022510895,0.00007213002,0.000180661,0.000808911,0.000009143979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025992413,0.0005957221,0.0012847157,0.022576481,0.0031938616,0.000837839,0.000021797181,0.0000027350463,0.0000022178033,0.0002048305,0.018987285,0.95203257],"study_design_scores_gemma":[0.0028880888,0.0013602377,0.0043266183,0.045606673,0.0049003223,0.0014631549,0.0000066022953,0.000007809405,0.0000028106965,0.00008694498,0.9389559,0.00039481162],"about_ca_topic_score_codex":0.00007781298,"about_ca_topic_score_gemma":0.000083134764,"teacher_disagreement_score":0.9516378,"about_ca_system_score_codex":0.0024864494,"about_ca_system_score_gemma":0.0016249415,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W2094720797","doi":"10.1111/igc.0b013e3181a83db8","title":"Laparoscopic Versus Abdominal Hysterectomy for Endometrial Cancer","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Endometrial cancer; Perioperative; Hysterectomy; Lymphadenectomy; Population; Cancer; Surgery; Internal medicine","score_opus":0.07003015125483446,"score_gpt":0.4129654882504364,"score_spread":0.3429353369956019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094720797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96980333,0.0037721319,0.00039658594,0.012246373,0.0107994815,0.00053353043,0.00010688551,0.000025778605,0.0023159208],"genre_scores_gemma":[0.9911953,0.0010627514,0.0012555176,0.00208593,0.0039090733,0.00006571561,0.000008478103,0.0000102213835,0.00040696707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99825877,0.000036463287,0.0005824777,0.0001974407,0.00066579896,0.00025905098],"domain_scores_gemma":[0.99766874,0.0007723397,0.00039632246,0.00008082503,0.0008668772,0.00021490741],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023248917,0.00017216342,0.000561273,0.00026775655,0.000044657325,0.00004105995,0.0002876415,0.00012317648,0.0025418438],"category_scores_gemma":[0.001138097,0.00011466992,0.0004110068,0.00024219399,0.000050775154,0.00013414063,0.000024667643,0.00023636443,0.000008246075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11698849,0.0019702753,0.03217448,0.000044208482,0.0027746418,0.0005097555,0.000099441,0.00015060147,0.008588698,0.0010065574,0.0075544906,0.82813835],"study_design_scores_gemma":[0.27145466,0.036176946,0.39238825,0.0007136075,0.0022701018,0.000283008,0.00013435194,0.00017522792,0.03697964,0.0048824647,0.2537236,0.0008181489],"about_ca_topic_score_codex":0.000037837726,"about_ca_topic_score_gemma":0.000028200697,"teacher_disagreement_score":0.8273202,"about_ca_system_score_codex":0.00081050274,"about_ca_system_score_gemma":0.000313259,"threshold_uncertainty_score":0.99837},"labels":[],"label_agreement":null},{"id":"W2095420209","doi":"10.1111/j.1525-1438.2006.00274.x","title":"Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Northern Cancer Care and Research Society; Cancer Research Society","keywords":"Cell culture; Programmed cell death; Luteinizing hormone; DNA synthesis; Cell growth; Follicle-stimulating hormone; Biology; Immortalised cell line; Cell; Epithelium; Internal medicine; Hormone; Endocrinology; In vitro; Cell biology; Medicine; Apoptosis; Biochemistry; Genetics","score_opus":0.019403038388312185,"score_gpt":0.27699915445766043,"score_spread":0.25759611606934824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095420209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914438,0.00071578915,0.00007575421,0.00612542,0.0005132787,0.00020249945,0.000058011738,0.000010063895,0.0008553913],"genre_scores_gemma":[0.9975028,0.00063085504,0.00075439416,0.00032061816,0.00061454537,0.000031175452,0.000006143508,0.000012337961,0.00012712149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875474,0.000065353444,0.0004492373,0.0001979009,0.00037519974,0.00015754894],"domain_scores_gemma":[0.9991171,0.00023619854,0.00027898705,0.000071220544,0.00020316063,0.00009335297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015730932,0.0001392737,0.00032830736,0.000107890424,0.000036734073,0.00003644262,0.00011610208,0.00010787554,0.0011928438],"category_scores_gemma":[0.00008605816,0.000100894045,0.0000999938,0.00006161595,0.00004273106,0.00008069479,0.000031684092,0.00022931445,0.000005167334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022880586,0.0033358452,0.8919691,0.00004411949,0.00073611096,0.017810948,0.0002016034,0.002066481,0.05579057,0.0009484493,0.00066093414,0.02414779],"study_design_scores_gemma":[0.0024907626,0.0004491077,0.9820682,0.00015863446,0.00011902508,0.00031678955,0.00001795308,0.000110830035,0.010205481,0.001317439,0.0026340336,0.000111744695],"about_ca_topic_score_codex":0.0026566552,"about_ca_topic_score_gemma":0.0012973804,"teacher_disagreement_score":0.09009911,"about_ca_system_score_codex":0.0007824977,"about_ca_system_score_gemma":0.00012268839,"threshold_uncertainty_score":0.9997202},"labels":[],"label_agreement":null},{"id":"W2095435655","doi":"10.1111/j.1525-1438.2007.01059.x","title":"Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging: a clinicopathologic study of a case and a brief review of the literature","year":2007,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Medicine; Small-cell carcinoma; Hysterectomy; Endometrium; Carcinoma; Polycystic ovarian disease; Radiology; Pathology; Internal medicine; Polycystic ovary","score_opus":0.09770742552199997,"score_gpt":0.4280387803787119,"score_spread":0.33033135485671195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095435655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32482886,0.6732616,3.5672144e-7,0.00031547307,0.00040729126,0.0010517394,0.00008133774,0.0000018893501,0.000051455776],"genre_scores_gemma":[0.21004786,0.7892968,0.00004847086,0.00033558923,0.00010873421,0.00002512255,0.0000011790482,0.000015767446,0.00012045304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960383,0.0007181582,0.0017782606,0.00030828244,0.00091978547,0.00023716899],"domain_scores_gemma":[0.9938785,0.0018771884,0.00258989,0.0003450446,0.0011738105,0.00013558513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066741684,0.00030505544,0.002053506,0.00034482084,0.000035275963,0.000017809942,0.0007028627,0.000033947672,0.000083168474],"category_scores_gemma":[0.0043485817,0.00013900692,0.00053071725,0.00067394436,0.00036538567,0.000059577666,0.000629913,0.0012814745,1.15956276e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013103079,0.0056924,0.19937266,0.19740626,0.001442833,0.13314928,0.0003625901,0.000005114785,0.00015372627,0.00006644745,0.00094431825,0.46009406],"study_design_scores_gemma":[0.017048039,0.018769145,0.06611855,0.21740063,0.0069110603,0.23903567,0.0004921954,0.0000041500425,0.000997461,0.000114479844,0.4324553,0.0006533027],"about_ca_topic_score_codex":0.000036715588,"about_ca_topic_score_gemma":0.000025883004,"teacher_disagreement_score":0.45944077,"about_ca_system_score_codex":0.00011209482,"about_ca_system_score_gemma":0.00044621134,"threshold_uncertainty_score":0.56685376},"labels":[],"label_agreement":null},{"id":"W2103370990","doi":"10.1111/j.1525-1438.2005.00155.x","title":"The psychosocial impact of cervical cancer among affected women and their partners","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Family Support in Illness","field":"Social Sciences","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; University of Toronto; University Health Network","keywords":"Psychosocial; Medicine; Cervical cancer; Disease; Stage (stratigraphy); Cancer; Social support; Human sexuality; Clinical psychology; Gynecology; Family medicine; Psychiatry; Internal medicine; Psychotherapist; Psychology","score_opus":0.024816361529800074,"score_gpt":0.38848599063650713,"score_spread":0.3636696291067071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103370990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887208,0.0006969464,0.00001507956,0.0065017426,0.0013336928,0.000104444705,0.000029549825,0.000009685667,0.0025880714],"genre_scores_gemma":[0.99626136,0.0018641019,0.000026810143,0.0003261733,0.0012496142,0.000029540422,5.0146684e-7,0.000006920817,0.00023498441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837023,0.00021734108,0.0004138908,0.00011636807,0.000579797,0.00030236272],"domain_scores_gemma":[0.99783355,0.0008182825,0.00048111973,0.000058625887,0.00062610017,0.00018230235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009378312,0.00011348625,0.00024239538,0.00006119725,0.00020502922,0.000083556384,0.00059888064,0.00012897608,0.0022043365],"category_scores_gemma":[0.0006250892,0.00006156303,0.00018194382,0.00014484,0.0007081813,0.00025073107,0.00006241393,0.0002739216,0.0000017120803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005732565,0.00026418,0.7746299,0.0000043096306,0.0008437537,0.000018075923,0.019316062,0.0007233109,0.0004082271,0.0020705045,0.009411896,0.19173655],"study_design_scores_gemma":[0.0006587289,0.00016620179,0.9572401,0.000026182475,0.000011335663,0.0000034952245,0.0019546428,0.00007619967,0.000059046877,0.0019634233,0.03772987,0.00011079544],"about_ca_topic_score_codex":0.0012285553,"about_ca_topic_score_gemma":0.0058926307,"teacher_disagreement_score":0.19162576,"about_ca_system_score_codex":0.0010835837,"about_ca_system_score_gemma":0.00052420405,"threshold_uncertainty_score":0.9987078},"labels":[],"label_agreement":null},{"id":"W2103735143","doi":"10.1046/j.1525-1438.2000.00072.x","title":"Treatment of advanced ovarian carcinoma with carboplatin and paclitaxel in a patient with renal failure","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Carboplatin; Medicine; Dosing; Urology; Renal function; Creatinine; Paclitaxel; Hemodialysis; Ovarian cancer; Internal medicine; Oncology; Chemotherapy; Cancer; Cisplatin","score_opus":0.009315916772855449,"score_gpt":0.26247644818900007,"score_spread":0.25316053141614464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103735143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958136,0.00024949163,0.000017496617,0.003277347,0.000032389944,0.00020124389,0.000012892465,0.000004333281,0.00039118694],"genre_scores_gemma":[0.99665827,0.00016771087,0.0027919097,0.00020314677,0.00008730395,0.00001313333,0.000003672141,0.000010054291,0.00006479896],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990028,0.000030752588,0.00034427975,0.00013528678,0.00037470763,0.00011218215],"domain_scores_gemma":[0.999261,0.0000923694,0.00024077648,0.00006411823,0.00025312166,0.000088605026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004723419,0.00012038669,0.0003025919,0.00011240687,0.000012907036,0.000009352826,0.00005855497,0.000064911714,0.000828836],"category_scores_gemma":[0.00003088794,0.000070620925,0.000045471017,0.00010761759,0.000080482896,0.00009110851,0.0000056235435,0.00012923294,5.14548e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01634746,0.0016340703,0.38094118,0.000027305607,0.0006616203,0.0031691713,0.0037968268,0.0018683715,0.10790733,0.000095083386,0.000049761926,0.48350182],"study_design_scores_gemma":[0.013375978,0.010540116,0.917294,0.00026843863,0.00007710703,0.0016104567,0.00039610275,0.00012959895,0.05471549,0.000102741295,0.0013502041,0.00013974053],"about_ca_topic_score_codex":0.0001118418,"about_ca_topic_score_gemma":0.00046675248,"teacher_disagreement_score":0.5363528,"about_ca_system_score_codex":0.00046362137,"about_ca_system_score_gemma":0.00018935803,"threshold_uncertainty_score":0.90751725},"labels":[],"label_agreement":null},{"id":"W2105247845","doi":"10.1111/j.1525-1438.2007.00900.x","title":"Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre","funders":"European Society for Medical Oncology","keywords":"Medicine; Topotecan; Oncology; Internal medicine; Chemoradiotherapy; Chemotherapy; Cervical cancer; Cisplatin; Cochrane Library; Randomized controlled trial; Cancer; Surgery","score_opus":0.18695294605859605,"score_gpt":0.4805401244932437,"score_spread":0.29358717843464766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105247845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004974193,0.99096704,0.000096059586,0.0022108513,0.0026706646,0.003501521,0.00035933414,0.000018492421,0.0001710898],"genre_scores_gemma":[0.000012700683,0.9904274,0.0007430912,0.0049201814,0.0014523168,0.0012091185,0.00006339227,0.000056147906,0.0011156823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951053,0.00020870843,0.002584413,0.0004028106,0.0012938436,0.00040490727],"domain_scores_gemma":[0.99322784,0.0020860343,0.0024285438,0.00022250702,0.0016387346,0.00039635872],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010657638,0.0005586092,0.0053310967,0.00039630872,0.000049410923,0.0000485972,0.0007499858,0.00027644174,0.0056435377],"category_scores_gemma":[0.002073231,0.00027724198,0.003422849,0.0004850772,0.000080711216,0.00008630276,0.00007348633,0.0006469968,0.00002030291],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014912784,0.000589138,0.000007146476,0.42969662,0.007845482,0.0003138382,0.000012542014,5.114064e-7,1.04778714e-7,0.000029750532,0.0027004208,0.55731314],"study_design_scores_gemma":[0.0028822687,0.0020974327,0.000005833949,0.3607574,0.015677832,0.00064892933,0.0000117540785,0.0000034922616,0.0000010316799,0.000024665158,0.6176628,0.00022654684],"about_ca_topic_score_codex":0.000019771163,"about_ca_topic_score_gemma":0.00004133328,"teacher_disagreement_score":0.6149624,"about_ca_system_score_codex":0.0025262316,"about_ca_system_score_gemma":0.0013459419,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W2105536678","doi":"10.1046/j.1525-1438.2001.011002087.x","title":"Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?","year":2001,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Cervix; Regimen; Randomized controlled trial; Cervical cancer; Cancer; Chemotherapy; Oncology; Intensive care medicine; Modality (human–computer interaction); Internal medicine","score_opus":0.053829541955517826,"score_gpt":0.4278483628601952,"score_spread":0.37401882090467736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105536678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002363005,0.9902022,0.00061554956,0.0055237915,0.0017660676,0.0010883654,0.0004593811,0.0000079207575,0.00010043255],"genre_scores_gemma":[0.000806286,0.994505,0.0006092493,0.0017946061,0.0018152549,0.00013445257,0.00002027923,0.00003733334,0.00027752607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750704,0.000072540526,0.0010794092,0.0002967083,0.00079845847,0.000245832],"domain_scores_gemma":[0.996538,0.00082736404,0.0011413085,0.00014104083,0.0011047072,0.00024762077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019036216,0.00036653463,0.0021587266,0.00016480345,0.00004726929,0.000033749515,0.0004805112,0.0002787687,0.0025389995],"category_scores_gemma":[0.00018087172,0.00018677859,0.000974751,0.00025571464,0.00015693578,0.00006152402,0.000050263763,0.00045898886,7.3198964e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026568798,0.0001115013,0.00027199867,0.0013319623,0.0020263037,0.00003092373,0.00013168075,0.000006427711,0.0000022158688,0.000084983,0.0017965949,0.99154854],"study_design_scores_gemma":[0.008572563,0.0032662093,0.00032134584,0.0053185625,0.0010967324,0.00010457748,0.00004739643,0.0000041339154,0.000038421644,0.0001429028,0.9809134,0.00017372989],"about_ca_topic_score_codex":0.000062567815,"about_ca_topic_score_gemma":0.00007471181,"teacher_disagreement_score":0.9913748,"about_ca_system_score_codex":0.0012733977,"about_ca_system_score_gemma":0.00158594,"threshold_uncertainty_score":0.9983728},"labels":[],"label_agreement":null},{"id":"W2110103048","doi":"10.1097/igc.0b013e31821b2669","title":"Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Transplant Association","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Clinical trial; Targeted therapy; Dysfunctional family; Bioinformatics; Computational biology; Oncology; Internal medicine","score_opus":0.22499213156271886,"score_gpt":0.48894391317644026,"score_spread":0.2639517816137214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110103048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024326108,0.97300625,0.00001865029,0.00044563066,0.00066209526,0.0011960808,0.0002052732,0.0000036577023,0.00013626079],"genre_scores_gemma":[0.022837969,0.97493166,0.000598482,0.00040197367,0.00045787156,0.0006912125,0.000010001707,0.000028800821,0.000042058156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968359,0.0003723377,0.0019380128,0.00028691924,0.00035582166,0.0002110489],"domain_scores_gemma":[0.9959981,0.0010345685,0.0020837502,0.0001177667,0.00057686353,0.0001889621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018454064,0.0002767118,0.002796883,0.00023933257,0.000012157285,0.000018107958,0.00025225306,0.0003028151,0.0014571674],"category_scores_gemma":[0.00063536235,0.00014997885,0.00056103786,0.000113947164,0.00009742584,0.000054217395,0.00003879523,0.0003757098,6.926114e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020720568,0.0007992653,0.009319406,0.00037524366,0.0044523953,0.00012000236,0.00007887322,0.0000035612,0.0000042208544,0.00015888088,0.00016096937,0.98245513],"study_design_scores_gemma":[0.010735379,0.0046007256,0.0693815,0.006468584,0.0011992973,0.00007463909,0.000029063533,0.0000043171976,0.0000311169,0.0006866623,0.9065652,0.000223504],"about_ca_topic_score_codex":0.00008683509,"about_ca_topic_score_gemma":0.00004243372,"teacher_disagreement_score":0.9822316,"about_ca_system_score_codex":0.0006453607,"about_ca_system_score_gemma":0.0009982984,"threshold_uncertainty_score":0.99945563},"labels":[],"label_agreement":null},{"id":"W2112178893","doi":"10.1111/j.1525-1438.2006.00420.x","title":"Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Radiation therapy; Chemotherapy; Retrospective cohort study; Internal medicine; Oncology; Stage (stratigraphy); Paclitaxel; Radiology; Adjuvant; Urology; Cisplatin","score_opus":0.03562922212631931,"score_gpt":0.35521290532392763,"score_spread":0.3195836831976083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112178893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992381,0.004325458,0.00012017604,0.002197369,0.0002471351,0.00029610045,0.000023766506,0.0000058947644,0.0004031342],"genre_scores_gemma":[0.99575335,0.0018060813,0.0014442911,0.00037999603,0.00046317902,0.000027231838,0.0000075973485,0.000009998024,0.00010830134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985232,0.00007369758,0.000411836,0.00014904844,0.00072666554,0.00011560092],"domain_scores_gemma":[0.99849755,0.00014157173,0.00034679484,0.00007830104,0.0008549518,0.00008085056],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027719777,0.00014206374,0.00041283626,0.000109769244,0.0000205873,0.000013033217,0.00008461875,0.00006717223,0.0011546854],"category_scores_gemma":[0.0000349194,0.00007970179,0.00011526149,0.00010399352,0.000088045614,0.00007635304,0.0000112950465,0.00008042745,4.941907e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007314412,0.00141759,0.6667567,0.000023923343,0.0009971347,0.00017077292,0.00009818095,0.00034143298,0.006452228,0.000049468414,0.00007927018,0.3162989],"study_design_scores_gemma":[0.024714433,0.004240112,0.96201086,0.000047030386,0.00027423425,0.00021623763,0.000022274875,0.0004496983,0.005326103,0.00027184418,0.0023375917,0.000089608264],"about_ca_topic_score_codex":0.00065043493,"about_ca_topic_score_gemma":0.000112481306,"teacher_disagreement_score":0.31620932,"about_ca_system_score_codex":0.0009191205,"about_ca_system_score_gemma":0.00021895682,"threshold_uncertainty_score":0.9997584},"labels":[],"label_agreement":null},{"id":"W2120500774","doi":"10.1111/j.1525-1438.2003.13350.x","title":"Translational research in ovarian cancer: a must","year":2003,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"National Cancer Institute","keywords":"Ovarian cancer; Disease; Medicine; Cancer; Stage (stratigraphy); Translational research; Bioinformatics; Epithelial ovarian cancer; Oncology; Internal medicine; Pathology; Biology","score_opus":0.11510850599062485,"score_gpt":0.5107540994854702,"score_spread":0.3956455934948454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120500774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002870038,0.9965436,0.00042878973,0.00028770184,0.0015578098,0.00017934662,0.00006801452,0.000001549542,0.0006462253],"genre_scores_gemma":[0.0032126459,0.9948385,0.00032012566,0.00008232496,0.0011709807,0.000075784425,0.000028440832,0.000022645872,0.00024856036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980961,0.00020496914,0.00067784067,0.0002516919,0.0005169923,0.0002523891],"domain_scores_gemma":[0.9989766,0.00013392925,0.00023688587,0.00010672832,0.00045286035,0.000093016686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007482643,0.0001947963,0.0005362678,0.00030479176,0.000026282321,0.00003514996,0.0005841714,0.00036314974,0.0006214834],"category_scores_gemma":[0.00014650045,0.000151657,0.0003411722,0.00019486723,0.00006777867,0.000005043424,0.00006766951,0.00065192307,0.0000043367672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006848943,0.00015064517,0.0003440252,0.00039911547,0.0004739844,0.00016049287,0.000023418681,0.0012726199,0.00021421908,0.00017461997,0.0023288978,0.9943895],"study_design_scores_gemma":[0.00044448805,0.000114799215,0.00027824545,0.0011568551,0.000050511593,0.00010421314,0.000008282499,0.0000056842578,0.000057637375,0.00010104434,0.9975169,0.0001613467],"about_ca_topic_score_codex":0.000028661236,"about_ca_topic_score_gemma":0.00015633334,"teacher_disagreement_score":0.995188,"about_ca_system_score_codex":0.00021113426,"about_ca_system_score_gemma":0.0008322396,"threshold_uncertainty_score":0.6804808},"labels":[],"label_agreement":null},{"id":"W2121537891","doi":"10.1046/j.1525-1438.2002.01055.x","title":"Use of CA-125 and ultrasound in high-risk women","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ultrasound; Ovarian cancer; Gynecology; BRCA mutation; Stage (stratigraphy); Population; Obstetrics; Retrospective cohort study; Cancer; Radiology; Internal medicine","score_opus":0.03750988866655887,"score_gpt":0.2948254529117063,"score_spread":0.25731556424514745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121537891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563146,0.0011687559,0.000010136119,0.0024807432,0.00039527603,0.000078285964,0.00004672043,0.0000023958605,0.00018624838],"genre_scores_gemma":[0.98764783,0.010990808,0.0004353096,0.0005547485,0.00016552504,0.000014994416,0.0000012450265,0.0000050873987,0.00018442818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990642,0.00003746219,0.00037498595,0.0001041589,0.00030038194,0.000118813776],"domain_scores_gemma":[0.9987088,0.0006210045,0.00027860375,0.000055848992,0.00023616172,0.00009959763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014458432,0.00008084947,0.00028351697,0.00012130103,0.000011552378,0.000018299388,0.00007684249,0.000060242844,0.0049425387],"category_scores_gemma":[0.0005316702,0.000054658816,0.00006251247,0.00007779308,0.00006626517,0.000112430804,0.00002180493,0.00017414872,0.0000037738798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002100862,0.0006521214,0.94317687,0.0000074349928,0.00036010362,0.0003396046,0.0002606395,0.00017611585,0.00021254308,0.00016663794,0.0015054147,0.052932423],"study_design_scores_gemma":[0.00277762,0.0008069492,0.9860401,0.000088840185,0.00005513168,0.00011213106,0.000046522066,0.000058694124,0.00026770317,0.00035030986,0.009341686,0.00005432006],"about_ca_topic_score_codex":0.00032068777,"about_ca_topic_score_gemma":0.00014812849,"teacher_disagreement_score":0.052878104,"about_ca_system_score_codex":0.0005135603,"about_ca_system_score_gemma":0.00004487914,"threshold_uncertainty_score":0.9959671},"labels":[],"label_agreement":null},{"id":"W2130046715","doi":"10.1111/j.1048-891x.2004.14607.x","title":"A pilot study for a screening trial of cervical fluorescence spectroscopy","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Agence des Aires Marines Protégées","keywords":"Colposcopy; Medicine; Clinical trial; Pathology; Internal medicine; Cervical cancer; Cancer","score_opus":0.0592843344422957,"score_gpt":0.4123063120095339,"score_spread":0.3530219775672382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130046715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96224046,0.0001042587,0.030238334,0.005461751,0.00080861594,0.0006880291,0.000011644117,0.000029210803,0.00041769148],"genre_scores_gemma":[0.928997,0.00007359325,0.069804415,0.00037588977,0.000664662,0.0000407408,0.0000012111357,0.000010184175,0.00003231287],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99839646,0.000032069624,0.00061681174,0.00015547944,0.00061941193,0.00017978832],"domain_scores_gemma":[0.9984144,0.00026275334,0.0003178306,0.00009155914,0.00079126074,0.00012222811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000449367,0.000117193566,0.0004271487,0.00013887572,0.000028332666,0.000025756983,0.00028684642,0.000037704198,0.00021680542],"category_scores_gemma":[0.0010425741,0.00008096292,0.0001886197,0.00009446445,0.00011005241,0.000090646485,0.00004790308,0.00031612287,0.000001011813],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.524536,0.035518438,0.08717718,0.00009794864,0.0021748426,0.0010621862,0.0005072126,0.0003115946,0.31773642,0.009208866,0.0020211802,0.019648086],"study_design_scores_gemma":[0.29990768,0.28814757,0.19647333,0.0011081583,0.00086841517,0.0004064508,0.0004563193,0.00045599535,0.18995196,0.020153675,0.001514535,0.0005558932],"about_ca_topic_score_codex":0.00006714472,"about_ca_topic_score_gemma":0.000017991826,"teacher_disagreement_score":0.25262913,"about_ca_system_score_codex":0.00027264946,"about_ca_system_score_gemma":0.00023996053,"threshold_uncertainty_score":0.3301572},"labels":[],"label_agreement":null},{"id":"W2132677643","doi":"10.1097/igc.0b013e3182a26edb","title":"Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Clinical trial; Lymphadenectomy; Gynecologic cancer; Adjuvant therapy; Cancer; Gynecologic oncology; Oncology; Internal medicine; Gynecology; Ovarian cancer","score_opus":0.21222888073544244,"score_gpt":0.5031440030061403,"score_spread":0.2909151222706978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132677643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534156,0.012812518,0.00021332162,0.012873458,0.01668916,0.0009478002,0.00008802256,0.0000618306,0.002898318],"genre_scores_gemma":[0.9744696,0.009055666,0.0008494496,0.0056439415,0.008708619,0.0004433981,0.000011620528,0.00003695324,0.0007807582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934712,0.00085774175,0.0031964884,0.00050591264,0.0013922343,0.0005764219],"domain_scores_gemma":[0.9876609,0.0071678,0.002355754,0.00018788659,0.0020016083,0.0006260378],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038111242,0.00041215177,0.002033408,0.0005655258,0.00010373826,0.00015679668,0.00073639175,0.0004383081,0.034201402],"category_scores_gemma":[0.018006982,0.00025425066,0.0012893026,0.0005581894,0.00021601074,0.00040604803,0.0002313718,0.0011146452,0.00007640329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047485325,0.00110051,0.5759133,0.000034163393,0.0039330004,0.0005299023,0.0001009218,0.00043965149,0.0023770926,0.00008080354,0.013906689,0.39683542],"study_design_scores_gemma":[0.041625716,0.0053996667,0.86747974,0.001437463,0.0019185962,0.00021272992,0.00038862685,0.00044180112,0.0033642657,0.002080727,0.07484805,0.0008025893],"about_ca_topic_score_codex":0.00097358396,"about_ca_topic_score_gemma":0.000098827964,"teacher_disagreement_score":0.39603284,"about_ca_system_score_codex":0.0014021384,"about_ca_system_score_gemma":0.0006946086,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W2139414196","doi":"10.1111/igc.0b013e3181a1a116","title":"Clinical Management of Ovarian Small-Cell Carcinoma of the Hypercalcemic Type: A Proposal for Conservative Surgery in an Advanced Stage of Disease","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Debulking; Radiation therapy; Stage (stratigraphy); Asymptomatic; Radical surgery; Chemotherapy; Ovarian carcinoma; Carcinoma; Surgery; Disease; Survival rate; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.08716109737112428,"score_gpt":0.4048324794794749,"score_spread":0.31767138210835066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139414196","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5082766,0.48984966,0.000149651,0.00009326712,0.0007614193,0.0005367706,0.00027868408,0.000001122466,0.00005284953],"genre_scores_gemma":[0.20358033,0.7940569,0.0017882432,0.00009386484,0.00017743223,0.000031792886,0.000046025372,0.000016563461,0.00020885647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979072,0.00022247668,0.001293564,0.00020986606,0.00024721894,0.00011966917],"domain_scores_gemma":[0.9972878,0.00022163737,0.0015503576,0.00018732299,0.00068630517,0.000066578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586982,0.00016620068,0.00082708534,0.00006686313,0.000011084448,0.000004922621,0.0005495944,0.00019042769,0.000038353788],"category_scores_gemma":[0.00025986717,0.0001049389,0.0006518426,0.0000942706,0.00012531225,0.0000056601925,0.00009837285,0.00019791535,9.276529e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003619527,0.0016830934,0.016980631,0.0069155023,0.00086742005,0.00005137095,0.000029009063,0.0010233182,0.00079775957,0.00032040168,0.00039799817,0.96731395],"study_design_scores_gemma":[0.018397007,0.0120043075,0.17573398,0.048775975,0.0048103393,0.00007968426,0.0005302215,0.0008708101,0.0064552715,0.0025221843,0.72731566,0.0025045504],"about_ca_topic_score_codex":0.000009483112,"about_ca_topic_score_gemma":0.00003079651,"teacher_disagreement_score":0.9648094,"about_ca_system_score_codex":0.00009377472,"about_ca_system_score_gemma":0.0014128478,"threshold_uncertainty_score":0.42792845},"labels":[],"label_agreement":null},{"id":"W2151582838","doi":"10.1111/j.1525-1438.2006.00624.x","title":"Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre","funders":"Heart and Stroke Foundation of Canada","keywords":"Fibrin; Medicine; Angiostatin; Plasmin; Molecular biology; High-molecular-weight kininogen; Fibrinogen; Pathology; Internal medicine; Biochemistry; Enzyme; Immunology; Chemistry; Biology; Angiogenesis; Kininogen; Receptor","score_opus":0.03696955861540818,"score_gpt":0.3129673443828387,"score_spread":0.2759977857674305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151582838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363697,0.004201352,0.00025637142,0.0006981454,0.0005662807,0.00018008247,0.00021867258,0.0000042266006,0.00023788073],"genre_scores_gemma":[0.99714226,0.00036931352,0.0008482858,0.00020194697,0.0009131163,0.000024342467,0.000048751397,0.000018145864,0.00043381806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984705,0.000103028986,0.0005446827,0.00027613709,0.00040977687,0.00019589663],"domain_scores_gemma":[0.99774665,0.000034498273,0.0006971621,0.00014549107,0.0013103682,0.00006583358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021449143,0.00017920719,0.0003738124,0.00009602955,0.000059910915,0.00002724436,0.0005283039,0.00016993971,0.00038030886],"category_scores_gemma":[0.000088541856,0.000118812306,0.0002509501,0.0001334729,0.00017561372,0.000026256776,0.00010329721,0.000103585684,3.363478e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005380588,0.00034441095,0.11309043,0.000016219225,0.0005105772,0.000016968754,0.000040920102,0.0005177395,0.87950337,0.00016494138,0.003919311,0.0013370704],"study_design_scores_gemma":[0.0013451742,0.0008433918,0.3732358,0.00007744281,0.00008299523,0.00002451097,0.00004955474,0.00003698769,0.6142167,0.00030693915,0.009588933,0.00019161377],"about_ca_topic_score_codex":0.0020765632,"about_ca_topic_score_gemma":0.0016899608,"teacher_disagreement_score":0.26528668,"about_ca_system_score_codex":0.00012608303,"about_ca_system_score_gemma":0.00044742343,"threshold_uncertainty_score":0.48450252},"labels":[],"label_agreement":null},{"id":"W2156461867","doi":"10.1046/j.1525-1438.2000.00080.x","title":"Histologic study of patterns of cervical involvement in FIGO stage II endometrial carcinoma","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Lymphovascular invasion; Stage (stratigraphy); Histopathology; Endocervix; Carcinoma; Curettage; Cervical carcinoma; Metastasis; Cervix; Histology; Pathology; Cervical cancer; Radiology; Gynecology; Internal medicine; Cancer; Uterine cervix","score_opus":0.05029511609895469,"score_gpt":0.34188231822648724,"score_spread":0.29158720212753253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156461867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657387,0.00074909505,0.000006573987,0.00061930466,0.0006377296,0.00038409894,0.00007009785,0.0000049381943,0.0009543006],"genre_scores_gemma":[0.9983856,0.0005083282,0.000083207764,0.0003103322,0.00026893071,0.000028874281,0.0000068286204,0.000008609866,0.0003992578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971978,0.00013387723,0.0012285628,0.00020451941,0.0010363108,0.000198941],"domain_scores_gemma":[0.99826974,0.0004280335,0.00056007836,0.00012798338,0.00047787605,0.00013630057],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038220765,0.00016512786,0.0007911571,0.00046441707,0.000021613094,0.000006365763,0.00036764986,0.00011294206,0.018674439],"category_scores_gemma":[0.0003847515,0.00011055115,0.00025739937,0.00036688359,0.000059990194,0.000085159154,0.00009498336,0.00031133415,0.000002876766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006913055,0.0066491626,0.95684,0.000036773978,0.00045060646,0.0006216356,0.00041327512,0.00025204793,0.00042609757,0.00005697897,0.000050475333,0.0272899],"study_design_scores_gemma":[0.022731923,0.01158334,0.9609398,0.000099036726,0.0001442498,0.000024542616,0.0004036564,0.000017835486,0.0014617451,0.000108138534,0.0023839837,0.000101719],"about_ca_topic_score_codex":0.0012579461,"about_ca_topic_score_gemma":0.0005070144,"teacher_disagreement_score":0.027188182,"about_ca_system_score_codex":0.000675141,"about_ca_system_score_gemma":0.0001766771,"threshold_uncertainty_score":0.9822226},"labels":[],"label_agreement":null},{"id":"W2158644353","doi":"10.1111/j.1525-1438.2007.01025.x","title":"The risk of developing uterine sarcoma after tamoxifen use","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Tamoxifen; Uterine sarcoma; Gynecology; Sarcoma; Oncology; Obstetrics; Cancer; Internal medicine; Breast cancer; Pathology","score_opus":0.010222919206179588,"score_gpt":0.30473796692373567,"score_spread":0.2945150477175561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158644353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460703,0.0021300605,0.0019003074,0.00039747093,0.0007920423,0.00004718953,0.000010217919,0.0000017296345,0.000113946255],"genre_scores_gemma":[0.9947061,0.003451898,0.001049262,0.00024936363,0.000346697,0.000003046761,0.0000020996783,0.0000059699723,0.0001855593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991798,0.00005419343,0.00033511998,0.000081877006,0.00021683419,0.00013218189],"domain_scores_gemma":[0.998984,0.00018432205,0.00031988838,0.000070181,0.00039096817,0.000050686056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048756276,0.00007687594,0.00010266885,0.00003434092,0.000036705016,0.000021577183,0.00027702656,0.00010640734,0.000045080702],"category_scores_gemma":[0.00043919834,0.000043017313,0.00013337206,0.000040007646,0.00009145203,0.000007630842,0.00009532206,0.00016653666,0.0000015339215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006237361,0.00025430793,0.60259354,0.000012292655,0.002266918,0.00051501207,0.000109978275,0.00048434595,0.25948274,0.0006739664,0.0027224915,0.12464705],"study_design_scores_gemma":[0.00092665287,0.00059965794,0.758073,0.00003560424,0.00003905381,0.00013871549,0.000022599517,0.00001761065,0.14293273,0.0003506959,0.096738525,0.00012517736],"about_ca_topic_score_codex":0.000012866253,"about_ca_topic_score_gemma":0.00004600202,"teacher_disagreement_score":0.15547943,"about_ca_system_score_codex":0.000049425667,"about_ca_system_score_gemma":0.000075816235,"threshold_uncertainty_score":0.17541952},"labels":[],"label_agreement":null},{"id":"W2200047700","doi":"10.1097/igc.0b013e31821ce75d","title":"First-Line Therapy in Ovarian Cancer Trials","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Transplant Association","funders":"","keywords":"Medicine; Gynecologic cancer; Ovarian cancer; Clinical trial; Oncology; Randomized controlled trial; Gynecologic oncology; Schedule; Cancer; Epithelial ovarian cancer; Gynecology; Internal medicine; Family medicine","score_opus":0.28905253002962966,"score_gpt":0.4770028652430502,"score_spread":0.18795033521342053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200047700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015819549,0.9911509,0.0000221701,0.0029067392,0.0040854537,0.00084150454,0.0001642735,0.000009075524,0.0006616971],"genre_scores_gemma":[0.0012081705,0.9940759,0.00023800661,0.0008551149,0.002742075,0.00050615775,0.000019957504,0.00004230533,0.00031230165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627435,0.0003022616,0.0021976633,0.00035505407,0.0005836826,0.0002869639],"domain_scores_gemma":[0.9958217,0.0011075644,0.0020559835,0.00018878448,0.00061541237,0.00021054638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001210697,0.00043839548,0.0034647977,0.0004948821,0.000027769125,0.00004451765,0.0005247963,0.00044927746,0.01629802],"category_scores_gemma":[0.0007144177,0.00024629713,0.0014342292,0.00024078102,0.000070290575,0.000101584796,0.000070083996,0.0007761766,0.000026964144],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055587105,0.0009914623,0.0020181495,0.0003890542,0.0029704543,0.0010398331,0.000048066973,0.000012778557,3.2625508e-7,0.00023553275,0.0018571637,0.98988134],"study_design_scores_gemma":[0.0045473967,0.00095976883,0.005336882,0.011225612,0.0011032677,0.0001967859,0.0000036355843,0.0000015116149,0.0000072304583,0.0003102859,0.9760889,0.00021873217],"about_ca_topic_score_codex":0.0002901583,"about_ca_topic_score_gemma":0.00031119175,"teacher_disagreement_score":0.9896626,"about_ca_system_score_codex":0.001990358,"about_ca_system_score_gemma":0.0015675564,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W2218197966","doi":"10.1097/igc.0000000000000643","title":"Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Serous fluid; Stage (stratigraphy); Serous carcinoma; Adjuvant therapy; Lymphadenectomy; Retrospective cohort study; Cohort; Endometrial cancer; Uterine cancer; Oncology; Adjuvant; Cancer; Internal medicine; Surgery; Ovarian cancer","score_opus":0.05984569226569996,"score_gpt":0.38198805791529883,"score_spread":0.32214236564959886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218197966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903921,0.004167814,0.00013470076,0.004146898,0.00039251475,0.00026052308,0.0003016598,0.0000071239897,0.00019668361],"genre_scores_gemma":[0.9841295,0.012847459,0.00047113665,0.0010808802,0.0004213955,0.000043780765,0.0000036893393,0.000011761457,0.0009904272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988138,0.000028090519,0.00045854787,0.00015473696,0.00039897798,0.00014584664],"domain_scores_gemma":[0.99837285,0.00027772447,0.00042847046,0.00006570435,0.0007366489,0.000118597054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016410956,0.00012453795,0.00036385347,0.000089646084,0.000022503715,0.000014912459,0.00014741947,0.000083250336,0.0024830305],"category_scores_gemma":[0.00009757363,0.00006657355,0.00015704884,0.00008171968,0.000056974746,0.0001357657,0.000030250423,0.0000887678,0.0000014260335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012902311,0.00078359526,0.17981176,0.00007610507,0.000800249,0.000047864727,0.000161431,0.00004142202,0.13162519,0.0002551494,0.0005895627,0.6729053],"study_design_scores_gemma":[0.026055021,0.009277252,0.7585348,0.0003202613,0.00017157567,0.000036286467,0.00013942119,0.00011646452,0.1289459,0.0026317022,0.07354566,0.00022566177],"about_ca_topic_score_codex":0.00016189643,"about_ca_topic_score_gemma":0.000041583728,"teacher_disagreement_score":0.67267966,"about_ca_system_score_codex":0.00025759052,"about_ca_system_score_gemma":0.00017054952,"threshold_uncertainty_score":0.9984288},"labels":[],"label_agreement":null},{"id":"W2221484896","doi":"10.1097/igc.0000000000000147","title":"Symptom Burden and Outcomes of Patients With Platinum Resistant/Refractory Recurrent Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Chemotherapy; Internal medicine; Ovarian cancer; Refractory (planetary science); Clinical trial; Cancer; Physical therapy; Intensive care medicine","score_opus":0.013711501300392094,"score_gpt":0.2984781835728649,"score_spread":0.28476668227247276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221484896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156237,0.00072688796,0.000046127516,0.006046568,0.0008062466,0.00015968339,0.000081328086,0.000005938218,0.00056484394],"genre_scores_gemma":[0.9978178,0.00066817837,0.0005352504,0.00045027575,0.00039562996,0.000023449069,0.0000070415454,0.000011032006,0.00009132105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859875,0.000043932327,0.00045076682,0.00016353498,0.0006086308,0.00013439737],"domain_scores_gemma":[0.99816,0.00031819002,0.00053268997,0.000090350004,0.00076308456,0.00013570317],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015609647,0.00014228947,0.00043718683,0.00010674117,0.000027013064,0.000019157518,0.00013418411,0.00007201509,0.0011281883],"category_scores_gemma":[0.0002010503,0.000082096,0.00008581648,0.00005748727,0.00008845002,0.00009319998,0.000040872765,0.00017941704,0.0000012188602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014969801,0.0003877325,0.90750873,0.000019314211,0.00087466615,0.000027519689,0.00010240583,0.00004419617,0.000058414764,0.00036139393,0.00042853036,0.088690124],"study_design_scores_gemma":[0.005285551,0.0019906021,0.97514707,0.00024851374,0.00021471916,0.0000049485784,0.000019339279,0.000021172767,0.00009830791,0.00014821938,0.016733607,0.0000879574],"about_ca_topic_score_codex":0.00012640572,"about_ca_topic_score_gemma":0.00010590605,"teacher_disagreement_score":0.08860217,"about_ca_system_score_codex":0.00036258783,"about_ca_system_score_gemma":0.00016715201,"threshold_uncertainty_score":0.9997849},"labels":[],"label_agreement":null},{"id":"W2301426291","doi":"10.1097/igc.0000000000000587","title":"Advances and Concepts in Cervical Cancer Trials","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Clinical trial; Micrometastasis; Cervix; Cancer; Family medicine; Gynecology; Metastasis; Internal medicine","score_opus":0.1217383505144179,"score_gpt":0.46037405919775376,"score_spread":0.33863570868333587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301426291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423037,0.037436135,0.00005788613,0.013840481,0.0028451122,0.00025228626,0.000034781868,0.0000119157385,0.003217675],"genre_scores_gemma":[0.98536146,0.010991512,0.00036739453,0.0020035396,0.0010719899,0.000037613943,0.0000025720287,0.000007503959,0.00015638798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981305,0.00014863614,0.000743673,0.00016118668,0.00064577936,0.00017024491],"domain_scores_gemma":[0.9979817,0.00065826357,0.00038151295,0.000050206832,0.0006262086,0.00030208845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008436321,0.00012906815,0.0006874653,0.000181769,0.000013141254,0.000025689886,0.00016235659,0.00010608301,0.0017290062],"category_scores_gemma":[0.0023615991,0.00007815796,0.00014743017,0.0001824431,0.000098897886,0.000189232,0.0000569428,0.00026380186,0.0000049787395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064417985,0.0005437374,0.6021142,0.000029644223,0.00037854258,0.00077895063,0.00023366584,0.00018961009,0.00028729453,0.00032777636,0.0011581971,0.3875166],"study_design_scores_gemma":[0.049917553,0.003989924,0.7019547,0.00066240196,0.00045382793,0.00045210656,0.00063215283,0.00014440765,0.00239464,0.010059489,0.22892506,0.00041371735],"about_ca_topic_score_codex":0.00015331249,"about_ca_topic_score_gemma":0.0002299068,"teacher_disagreement_score":0.38710287,"about_ca_system_score_codex":0.0005814662,"about_ca_system_score_gemma":0.00034576285,"threshold_uncertainty_score":0.99918354},"labels":[],"label_agreement":null},{"id":"W2312885801","doi":"10.1111/igc.0b013e3181dc827e","title":"Phase 1 Study of Tirapazamine in Combination With Radiation and Weekly Cisplatin in Patients With Locally Advanced Cervical Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Tirapazamine; Regimen; Radiation therapy; Neutropenia; Cisplatin; Urology; Cervical cancer; Internal medicine; Cancer; Chemotherapy","score_opus":0.005977795837945369,"score_gpt":0.2817508789096234,"score_spread":0.275773083071678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312885801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984693,0.00031700818,0.00007825912,0.00022658924,0.0005988051,0.00025765895,0.000018773253,0.0000013691994,0.00003223273],"genre_scores_gemma":[0.99911314,0.0002854889,0.0002001307,0.00011369922,0.00021219987,0.00003275213,0.00001379093,0.000008515257,0.000020306155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898565,0.00004475149,0.00036255422,0.00016974007,0.00032456205,0.000112769354],"domain_scores_gemma":[0.9990527,0.0000361048,0.0003304532,0.000067715184,0.00045696602,0.00005608579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016671109,0.00010837916,0.00021886604,0.00012744557,0.000013426143,0.000012206938,0.00015674335,0.00008619295,0.000071892515],"category_scores_gemma":[0.00009542921,0.0000763934,0.000023992994,0.000106039006,0.00006468563,0.000024491112,0.000034324064,0.00021679996,9.833977e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006206375,0.0037088317,0.8227704,0.000008098992,0.000118637,0.000009012338,0.00020132211,0.0012655468,0.020435782,0.00003253591,0.00005107805,0.14519237],"study_design_scores_gemma":[0.025433669,0.0048503284,0.9659987,0.00003542566,0.000023142318,0.00000432874,0.00009315597,0.00009308135,0.001910302,0.0000236285,0.0014240909,0.00011016597],"about_ca_topic_score_codex":0.000114826966,"about_ca_topic_score_gemma":0.004520723,"teacher_disagreement_score":0.1450822,"about_ca_system_score_codex":0.000050777893,"about_ca_system_score_gemma":0.00013466582,"threshold_uncertainty_score":0.31152323},"labels":[],"label_agreement":null},{"id":"W2313548048","doi":"10.1097/igc.0000000000000281","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for High-Grade Undifferentiated Sarcomas of the Uterus","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Gynecologic cancer; Uterus; Cancer; Gynecology; Internal medicine; Ovarian cancer","score_opus":0.07680404686913483,"score_gpt":0.4166345169441851,"score_spread":0.33983047007505024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313548048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002084396,0.98740345,0.000042161395,0.0037002426,0.0048617558,0.0013929787,0.0003997059,0.000013938862,0.00010137694],"genre_scores_gemma":[0.0124528995,0.98393846,0.0003135445,0.0014687602,0.0007329066,0.0003073792,0.00005710502,0.000042293203,0.0006866812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965534,0.0002774588,0.0018559195,0.00033301732,0.0006747155,0.0003054553],"domain_scores_gemma":[0.99464405,0.0011500234,0.0029299268,0.0002912966,0.0008307996,0.0001538883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039435623,0.00047571727,0.0029198118,0.00018305665,0.00005213001,0.00002490559,0.0008885659,0.00033344154,0.0019474031],"category_scores_gemma":[0.000809809,0.0002322267,0.0017127674,0.00019186278,0.00019429157,0.000035148,0.00023850735,0.0005992255,0.0000056115823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025276185,0.0009583132,0.0015605413,0.016002702,0.007041292,0.00023300132,0.000011081275,0.0000032967707,0.000012834064,0.00066483906,0.015782423,0.9574769],"study_design_scores_gemma":[0.0024694165,0.0009803033,0.0041766856,0.04387458,0.005192636,0.0004367318,0.000002160613,0.000005676652,0.000023598626,0.0003067914,0.942293,0.0002384222],"about_ca_topic_score_codex":0.00007334958,"about_ca_topic_score_gemma":0.00008133504,"teacher_disagreement_score":0.9572385,"about_ca_system_score_codex":0.00093150657,"about_ca_system_score_gemma":0.0006753874,"threshold_uncertainty_score":0.99896497},"labels":[],"label_agreement":null},{"id":"W2314135891","doi":"10.1097/igc.0000000000000167","title":"Development of the Measure of Ovarian Symptoms and Treatment Concerns","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bloating; Nausea; Ovarian cancer; Prom; Sleep disorder; Patient-reported outcome; Flatulence; Physical therapy; Rating scale; Quality of life (healthcare); Internal medicine; Cancer; Insomnia; Psychiatry; Obstetrics","score_opus":0.03688508592569373,"score_gpt":0.32033568369517484,"score_spread":0.2834505977694811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314135891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937752,0.00057527935,0.00013128565,0.0036429728,0.00060245144,0.00013479122,0.000012005013,0.0000023715565,0.0011236466],"genre_scores_gemma":[0.9978385,0.0002475619,0.0013634501,0.00025895843,0.0001982674,0.000013117436,8.6280335e-7,0.000004733764,0.000074548276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998957,0.00003771641,0.00042974873,0.0000909265,0.0004059557,0.00007868954],"domain_scores_gemma":[0.9988609,0.00015113057,0.0004210278,0.00007784145,0.000420641,0.000068472946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018442901,0.00008974745,0.00029921372,0.000045355697,0.000023455514,0.000006485886,0.00012726337,0.00005229893,0.00038824914],"category_scores_gemma":[0.00012043986,0.00004486519,0.00012535659,0.00004654648,0.00008994713,0.000029841163,0.00003636985,0.000072264134,6.4190664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005946453,0.00092567585,0.53971416,0.000020547017,0.0019124576,0.000022509914,0.0007536781,0.0000712859,0.0029508655,0.002999475,0.00022523076,0.4498095],"study_design_scores_gemma":[0.0039924183,0.00088335335,0.94899416,0.000257243,0.00019994914,0.00004595142,0.000049762886,0.000031737367,0.01587217,0.0001629165,0.02945399,0.00005635729],"about_ca_topic_score_codex":0.000031411808,"about_ca_topic_score_gemma":0.00007789259,"teacher_disagreement_score":0.44975314,"about_ca_system_score_codex":0.0003678824,"about_ca_system_score_gemma":0.00032151895,"threshold_uncertainty_score":0.4251056},"labels":[],"label_agreement":null},{"id":"W2315022953","doi":"10.1111/igc.0b013e3181a844c8","title":"Annexin IV is Differentially Expressed in Clear Cell Carcinoma of the Ovary","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Serous fluid; Ovarian carcinoma; Molecular biology; Microarray; Ovary; Serous carcinoma; Gene; Biology; Gene expression profiling; Ovarian cancer; Immunohistochemistry; Clear cell carcinoma; Gene expression; Annexin; Cancer research; Carcinoma; Medicine; Pathology; Cancer; Genetics; Flow cytometry","score_opus":0.012751179205949257,"score_gpt":0.26976260062857504,"score_spread":0.2570114214226258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315022953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964218,0.0005935901,0.00007969179,0.0016767571,0.00034368967,0.00006146019,0.000022036653,9.445317e-7,0.00079999625],"genre_scores_gemma":[0.99780625,0.00018453525,0.00011856942,0.0013996013,0.00027110614,0.000002453259,0.0000018551345,0.0000041781304,0.00021142807],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992057,0.000049670653,0.00030055322,0.000109957,0.00022779602,0.00010633574],"domain_scores_gemma":[0.9994015,0.000016915745,0.00024002347,0.00009399139,0.0002119925,0.00003556769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001077041,0.00007986612,0.00012900202,0.00004065245,0.00001652312,0.000012432526,0.00046862673,0.00009544891,0.0003325501],"category_scores_gemma":[0.000072030074,0.000049976225,0.00015606586,0.000045769393,0.000045022043,0.0000061959063,0.0000740147,0.00013959438,7.7168755e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007443661,0.00046672756,0.051674645,0.0000048630927,0.00004294318,0.000034228637,0.00009120157,0.00025047298,0.9354028,0.00010900933,0.00327905,0.007899663],"study_design_scores_gemma":[0.0010449879,0.00069533125,0.5866352,0.000024959116,0.000008226287,0.00000928046,0.00003626021,0.00003724222,0.40473592,0.00054854667,0.006143947,0.000080100275],"about_ca_topic_score_codex":0.00001894258,"about_ca_topic_score_gemma":0.000022394346,"teacher_disagreement_score":0.53496057,"about_ca_system_score_codex":0.000032667394,"about_ca_system_score_gemma":0.00009272476,"threshold_uncertainty_score":0.36411902},"labels":[],"label_agreement":null},{"id":"W2315196206","doi":"10.1097/igc.0b013e3182157a44","title":"Characterizing the Learning Curve for Laparoscopic Radical Hysterectomy","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Laparoscopy; Radical Hysterectomy; Lymphadenectomy; Blood loss; Learning curve; Hysterectomy; Surgery; General surgery; Urology; Cervical cancer; Internal medicine; Cancer","score_opus":0.08612278204970249,"score_gpt":0.3612929736970512,"score_spread":0.27517019164734874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315196206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903185,0.0008064748,0.00041429064,0.00443327,0.0023039551,0.00026995348,0.000012098795,0.000016226219,0.0027118907],"genre_scores_gemma":[0.9955696,0.00034126278,0.0005156895,0.0020383496,0.0010655411,0.00005233587,0.0000043785417,0.000009676942,0.00040319108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889386,0.00006031339,0.00038949077,0.000117230215,0.0003703012,0.0001688066],"domain_scores_gemma":[0.998664,0.00044258358,0.0003063343,0.000056387173,0.0004187308,0.000111958965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030364684,0.00010371853,0.0002957619,0.00007908531,0.00006011692,0.000022942224,0.00025271095,0.00007345332,0.0022918277],"category_scores_gemma":[0.00072428276,0.00005371606,0.00023974651,0.00009127914,0.0000821706,0.00009179478,0.000041527903,0.00030979927,0.0000099433855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015342592,0.001850076,0.7454673,0.00008972162,0.00349644,0.00065812096,0.0016658466,0.000021908101,0.011581174,0.0023342485,0.0018304547,0.21566208],"study_design_scores_gemma":[0.014471504,0.0044672345,0.8033413,0.00027066827,0.00042969245,0.00033140264,0.00022799538,0.00007850014,0.01606945,0.0016966949,0.15840246,0.0002130666],"about_ca_topic_score_codex":0.000029521398,"about_ca_topic_score_gemma":0.000008068263,"teacher_disagreement_score":0.21544902,"about_ca_system_score_codex":0.00022867865,"about_ca_system_score_gemma":0.00011473708,"threshold_uncertainty_score":0.9986202},"labels":[],"label_agreement":null},{"id":"W2315811257","doi":"10.1097/igc.0000000000000401","title":"Quebec Trophoblastic Disease Registry","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Database","score_opus":0.04721004543072913,"score_gpt":0.3526228075841813,"score_spread":0.30541276215345214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315811257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97767794,0.001645077,0.00081540196,0.015186991,0.0025698121,0.000119074524,0.000047634567,0.000022394983,0.0019156523],"genre_scores_gemma":[0.9944911,0.00015584966,0.0008825314,0.001430831,0.001005693,0.000014500432,0.0000068406266,0.000010384417,0.0020022718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982602,0.00003824049,0.00041961396,0.00013836108,0.0009916871,0.0001518846],"domain_scores_gemma":[0.99691767,0.00024807677,0.00029816205,0.000087589106,0.0018937087,0.00055480894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014575013,0.000123646,0.00026341487,0.000115669296,0.000023163519,0.000031899544,0.0002256098,0.000043123233,0.00090627675],"category_scores_gemma":[0.003710455,0.00008572079,0.00017588622,0.00008620552,0.00015370481,0.00011496747,0.00006536841,0.00020179375,0.00004804202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029026728,0.0041559683,0.6210275,0.00015013153,0.0036372163,0.024629436,0.00065045856,0.010990587,0.00173963,0.012078814,0.25949043,0.03242307],"study_design_scores_gemma":[0.0033495768,0.00049336156,0.9637451,0.00016031122,0.0002381563,0.00016168802,0.00022740377,0.0001813717,0.000042370546,0.0024219763,0.028853029,0.00012564949],"about_ca_topic_score_codex":0.00009868598,"about_ca_topic_score_gemma":0.0000766833,"teacher_disagreement_score":0.34271756,"about_ca_system_score_codex":0.00065073755,"about_ca_system_score_gemma":0.001314396,"threshold_uncertainty_score":0.99230945},"labels":[],"label_agreement":null},{"id":"W2316030169","doi":"10.1097/igc.0000000000000442","title":"Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University Medical Centre; McMaster University; Mount Sinai Hospital; Ontario Clinical Oncology Group; University Health Network; University of Toronto","funders":"Abbott Diagnostics","keywords":"Medicine; Malignancy; Ovarian cancer; Stage (stratigraphy); Histology; Cancer; Serous fluid; Internal medicine; Gynecology; Oncology; Gastroenterology; Biology","score_opus":0.011277928443958108,"score_gpt":0.28021973130373035,"score_spread":0.26894180285977226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316030169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951369,0.0023718718,0.00032614285,0.0007433482,0.00041972694,0.00057500903,0.00019904265,0.0000018786192,0.0002260875],"genre_scores_gemma":[0.99629474,0.0029373073,0.00045653275,0.000061609106,0.000088427434,0.00013117351,0.0000010529023,0.000011459353,0.000017672199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975755,0.0004883113,0.0007886715,0.00017930345,0.00078681635,0.00018137414],"domain_scores_gemma":[0.9960913,0.00088105496,0.001599093,0.00018675035,0.0011336821,0.000108140324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001891115,0.00016629268,0.00084815535,0.0001327688,0.000021083002,0.0000072346834,0.0003011773,0.00010434512,0.00020808495],"category_scores_gemma":[0.0005386523,0.000076580975,0.00016913628,0.0002644714,0.00043940343,0.00007833944,0.00009295437,0.00029723614,1.4060784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006196047,0.0006065373,0.97479254,0.000078555764,0.0023364455,0.000045532648,0.0006561854,0.0012681731,0.00009844426,0.0006010436,0.000020697116,0.013299779],"study_design_scores_gemma":[0.014865835,0.0011629384,0.9769609,0.0012314103,0.0005121827,0.00004407815,0.00020152342,0.0001836876,0.0026652883,0.002026,0.00007286138,0.00007331765],"about_ca_topic_score_codex":0.0047756108,"about_ca_topic_score_gemma":0.00038180273,"teacher_disagreement_score":0.013226462,"about_ca_system_score_codex":0.00067734666,"about_ca_system_score_gemma":0.00075920497,"threshold_uncertainty_score":0.7219327},"labels":[],"label_agreement":null},{"id":"W2316231454","doi":"10.1097/igc.0000000000000611","title":"Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Vaginal vault; Brachytherapy; Endometrial cancer; Stage (stratigraphy); Radiation therapy; Serous fluid; Adjuvant radiotherapy; Chemotherapy; Radiology; Oncology; Gynecology; Cancer; Hysterectomy; Surgery; Internal medicine","score_opus":0.03716225048573947,"score_gpt":0.3564498356631,"score_spread":0.31928758517736056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316231454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786809,0.006241285,0.002243519,0.010214211,0.0013349442,0.0008985551,0.00021582333,0.000032194966,0.00013856168],"genre_scores_gemma":[0.9485612,0.034979157,0.0038874599,0.004864414,0.0024019445,0.00016028476,0.0000043197133,0.000057406945,0.005083842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978102,0.000073855816,0.0006046504,0.0003533363,0.0008021126,0.00035585303],"domain_scores_gemma":[0.9971474,0.0010776989,0.00056749687,0.00012704731,0.00077352644,0.00030684128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003119938,0.00030808506,0.0008318048,0.00025599476,0.00007005915,0.000054902943,0.00027291448,0.00015791508,0.0076875677],"category_scores_gemma":[0.00022777353,0.00012801711,0.00020833002,0.00025570244,0.00016711527,0.0002222707,0.000026666086,0.00022497677,0.000002458943],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27291042,0.0011297215,0.18559447,0.0000934027,0.0026805936,0.000693061,0.00025657474,0.000030121908,0.0127012525,0.000041268868,0.0013891277,0.52248],"study_design_scores_gemma":[0.30031106,0.070786074,0.1868721,0.0011792482,0.00090211286,0.0013888861,0.00030708485,0.00016921145,0.024825286,0.00034466528,0.41178012,0.001134174],"about_ca_topic_score_codex":0.00010239656,"about_ca_topic_score_gemma":0.00018111651,"teacher_disagreement_score":0.5213458,"about_ca_system_score_codex":0.0007745628,"about_ca_system_score_gemma":0.0006271999,"threshold_uncertainty_score":0.99321955},"labels":[],"label_agreement":null},{"id":"W2316725894","doi":"10.1097/igc.0000000000000317","title":"Further Insights Into Long-Term Trends in Relative Survival of Vulvar Cancer Patients","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Relative survival; Vulvar cancer; Stage (stratigraphy); Cancer; Oncology; Population; Squamous cell cancer; Epidemiology; Relative risk; Cancer registry; Survival rate; Internal medicine; Gynecology; Confidence interval","score_opus":0.028895151630388104,"score_gpt":0.3477503491912761,"score_spread":0.31885519756088804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316725894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310255,0.0012676686,0.00009061417,0.00156852,0.001794231,0.00010101858,0.000012594186,0.00000617538,0.0020566343],"genre_scores_gemma":[0.9976961,0.00089663983,0.00011335228,0.0004731608,0.0005173636,0.00002026309,0.000013077222,0.000012857118,0.0002571944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979855,0.00013024794,0.00072243396,0.00018973602,0.00079895544,0.00017312785],"domain_scores_gemma":[0.99799484,0.00038638932,0.0005408506,0.000085098356,0.0008420335,0.00015075941],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021539553,0.00016557565,0.00055659784,0.0004400641,0.00001865763,0.000010832858,0.0002587791,0.00013669577,0.0031001125],"category_scores_gemma":[0.00044584018,0.00010625732,0.00022485254,0.00037209803,0.00010128842,0.00017872632,0.000066323046,0.00031658183,0.0000060377374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016719911,0.0008995409,0.8663094,0.000014111663,0.00041874632,0.0000610437,0.00034149562,0.00006200851,0.00023502196,0.00023955436,0.000056301367,0.12969077],"study_design_scores_gemma":[0.008024886,0.0014848816,0.98721236,0.00019386239,0.00010378183,0.0000029891262,0.00001657663,0.000020133257,0.0007566966,0.00088402425,0.0011953297,0.00010445137],"about_ca_topic_score_codex":0.0002507691,"about_ca_topic_score_gemma":0.00089089177,"teacher_disagreement_score":0.12958631,"about_ca_system_score_codex":0.00071536045,"about_ca_system_score_gemma":0.00010931194,"threshold_uncertainty_score":0.9978112},"labels":[],"label_agreement":null},{"id":"W2316835022","doi":"10.1111/igc.0b013e3181df3cab","title":"Association Between the CDC6 G1321A Polymorphism and the Risk of Cervical Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Genotype; Odds ratio; Confidence interval; Cervical cancer; Medicine; Carcinogenesis; Oncology; Internal medicine; Logistic regression; Gastroenterology; Genetics; Cancer; Gene; Biology","score_opus":0.007837812895554006,"score_gpt":0.2733603068573901,"score_spread":0.2655224939618361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316835022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885388,0.0007504441,0.00016131284,0.008990925,0.0011760321,0.00008582563,0.00006031223,0.0000022601278,0.00023406376],"genre_scores_gemma":[0.99635637,0.001333359,0.00017065724,0.00065384124,0.0011941636,0.00001436403,0.0000026764992,0.0000064499527,0.00026809212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892557,0.00015018428,0.000323196,0.00010868196,0.00037951837,0.000112846785],"domain_scores_gemma":[0.9983976,0.00036182298,0.00064044306,0.000099941724,0.00045273552,0.000047497666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000933766,0.00008471091,0.00016749853,0.000024010953,0.000055227967,0.00002546814,0.0004543298,0.0001602969,0.00037034627],"category_scores_gemma":[0.0010166961,0.000041661704,0.00015509447,0.00003740078,0.00015835921,0.000006960628,0.00013625601,0.00036881794,0.0000011102838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073502155,0.00009478457,0.82055086,0.0000049332907,0.0021606593,0.0000069000707,0.00014068004,0.000119851895,0.14199072,0.0016695085,0.0036224863,0.028903568],"study_design_scores_gemma":[0.0028225111,0.00028337352,0.88549566,0.000016418582,0.0003363397,0.000029816823,0.000050871156,0.0001172185,0.07314679,0.005114567,0.03244532,0.00014109728],"about_ca_topic_score_codex":0.00015689424,"about_ca_topic_score_gemma":0.00034691935,"teacher_disagreement_score":0.06884393,"about_ca_system_score_codex":0.000049222086,"about_ca_system_score_gemma":0.000097098324,"threshold_uncertainty_score":0.40550318},"labels":[],"label_agreement":null},{"id":"W2317375977","doi":"10.1111/igc.0b013e3181f6bde3","title":"Intraperitoneal Chemotherapy","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Chemotherapy; Intraperitoneal chemotherapy; Peritoneal cavity; Gynecologic oncology; Oncology; Randomized controlled trial; Internal medicine; Intensive care medicine; Surgery; Cancer; Ovarian cancer","score_opus":0.05825613593496491,"score_gpt":0.43704614987625223,"score_spread":0.3787900139412873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317375977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018700324,0.99090767,0.000010930672,0.0029832986,0.0044662813,0.00029384627,0.000050544488,0.000011807465,0.0010886131],"genre_scores_gemma":[0.00021335097,0.9938966,0.0007510264,0.0011456559,0.0035836196,0.00007382966,0.000017907361,0.00003251014,0.00028552546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811983,0.000045407272,0.00084495574,0.00021897382,0.00058872066,0.00018210532],"domain_scores_gemma":[0.9979797,0.00028695614,0.00085163134,0.00014364033,0.0005417379,0.00019636344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019690613,0.00028715777,0.0015071988,0.00020528841,0.000023447461,0.000050591883,0.00039991594,0.00043677428,0.0064462414],"category_scores_gemma":[0.00014335674,0.00016824793,0.0009977687,0.00010418005,0.00008919322,0.00006226575,0.000044931952,0.0009900182,0.00003655005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008504066,0.00045347714,0.00023592079,0.00028027524,0.0013745788,0.0007822124,0.000011664474,3.156535e-7,0.000001552972,0.00011701041,0.0028633866,0.99379456],"study_design_scores_gemma":[0.0012451411,0.00047887804,0.00084135425,0.003357496,0.00093310606,0.0011146963,0.0000025759232,6.371109e-7,0.00000862991,0.000060995244,0.9918144,0.00014214485],"about_ca_topic_score_codex":0.0000096687945,"about_ca_topic_score_gemma":0.000010001838,"teacher_disagreement_score":0.9936524,"about_ca_system_score_codex":0.0007561609,"about_ca_system_score_gemma":0.0010267905,"threshold_uncertainty_score":0.994462},"labels":[],"label_agreement":null},{"id":"W2317611891","doi":"10.1097/igc.0b013e31826fd490","title":"Vaginal Vault Dehiscence and Increased Use of Vaginal Vault Brachytherapy","year":2012,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Vaginal vault; Brachytherapy; Vault (architecture); Dehiscence; Surgery; Vaginal Vault Prolapse; Incidence (geometry); Vagina; Radiation therapy","score_opus":0.13471346258820732,"score_gpt":0.4129411807607423,"score_spread":0.278227718172535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317611891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005322928,0.9918374,0.00005167663,0.00040967562,0.0015099453,0.0003961792,0.0001739274,0.000012101706,0.000286157],"genre_scores_gemma":[0.0175264,0.9789861,0.0010838965,0.00062429236,0.0014100975,0.00004286312,0.00003509773,0.000031977033,0.0002593194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682045,0.00021400047,0.001281212,0.000297585,0.0010655253,0.00032120617],"domain_scores_gemma":[0.99563026,0.0012725808,0.0014968879,0.00016453577,0.0010189493,0.00041675335],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041086785,0.00041856218,0.002027543,0.00041717177,0.00003805741,0.00004997194,0.00039551055,0.00035295513,0.0022308866],"category_scores_gemma":[0.0006032861,0.00025433308,0.00067391736,0.0002993067,0.0002073508,0.00028509856,0.00011360904,0.0007774572,0.000011354583],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096452545,0.000678314,0.009697868,0.000962413,0.00203236,0.00037384473,0.000024682293,0.0000012144619,0.000014011016,0.00012258983,0.00036232686,0.9847658],"study_design_scores_gemma":[0.0033938738,0.0012945669,0.016286733,0.004091743,0.0026519555,0.0012056227,0.000006078875,0.0000025350143,0.000023077144,0.00008216679,0.97070557,0.00025606828],"about_ca_topic_score_codex":0.0002130712,"about_ca_topic_score_gemma":0.000023622037,"teacher_disagreement_score":0.98450977,"about_ca_system_score_codex":0.0006970291,"about_ca_system_score_gemma":0.0006459504,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2317661516","doi":"10.1111/igc.0b013e3181996ac3","title":"Patterns of Care for Radiotherapy in Vulvar Cancer: A Gynecologic Cancer Intergroup Study","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Vulvar cancer; Radiation therapy; Concomitant; Chemotherapy; Gynecologic oncology; Gynecologic cancer; Cancer; Internal medicine; Oncology; Surgery; Gynecology; Ovarian cancer","score_opus":0.03039399555011237,"score_gpt":0.38649754783726314,"score_spread":0.3561035522871508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317661516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838281,0.009271032,0.0001634936,0.003814504,0.0017577333,0.00088864064,0.00014657181,0.000012217658,0.00011765132],"genre_scores_gemma":[0.9910044,0.0055387327,0.00032443428,0.0019456723,0.00082737656,0.0002284407,0.0000074327895,0.000014627384,0.000108871485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780846,0.00008311349,0.0009237393,0.00027467182,0.0006255522,0.00028443808],"domain_scores_gemma":[0.99771625,0.0004202329,0.0005972418,0.000116267634,0.0010010988,0.00014891924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026220107,0.00022730915,0.0008825071,0.0003583074,0.000030229858,0.000020298692,0.0004176052,0.00014016629,0.0023178947],"category_scores_gemma":[0.0003121745,0.00015262907,0.0003515127,0.00026045545,0.00003576647,0.00012190731,0.000035356603,0.0003090292,6.6444215e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006223282,0.0022116888,0.7922002,0.000050531795,0.0007503741,0.00024164678,0.00087076065,0.00047654336,0.0011838342,0.000060226153,0.000151795,0.1955791],"study_design_scores_gemma":[0.0185789,0.012095318,0.9624193,0.00037468752,0.00024751166,0.000021954087,0.0008653875,0.000038922448,0.0014144097,0.00025517895,0.0035049173,0.00018352912],"about_ca_topic_score_codex":0.00070667657,"about_ca_topic_score_gemma":0.0023163054,"teacher_disagreement_score":0.19539557,"about_ca_system_score_codex":0.0017424425,"about_ca_system_score_gemma":0.00033712504,"threshold_uncertainty_score":0.9985941},"labels":[],"label_agreement":null},{"id":"W2317977662","doi":"10.1097/igc.0000000000000400","title":"An Organizational Guideline for Gynecologic Oncology Services","year":2015,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Kingston Health Sciences Centre; Cancer Care Ontario; McMaster University; Mount Sinai Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Guideline; Multidisciplinary approach; Gynecologic oncology; MEDLINE; Gynecologic cancer; Best practice; Stakeholder; Health care; Family medicine; Nursing; Oncology; Cancer; Internal medicine; Pathology; Public relations","score_opus":0.20921983882994624,"score_gpt":0.5274094493809413,"score_spread":0.31818961055099504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317977662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014458246,0.9922057,0.0007435191,0.0015850258,0.0034088443,0.0006702224,0.00026328606,0.00003247538,0.00094634114],"genre_scores_gemma":[0.00031186064,0.9797438,0.010477185,0.004270346,0.004428755,0.00009602974,0.00045650333,0.00004488232,0.00017063256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961857,0.000165594,0.001931927,0.00037285298,0.0010210648,0.00032284396],"domain_scores_gemma":[0.9907446,0.00055300514,0.0020184137,0.00018294643,0.0060835737,0.00041744258],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014257553,0.00038000778,0.0020965615,0.00032553225,0.00005940099,0.00007041941,0.0010696033,0.0006813408,0.0026510027],"category_scores_gemma":[0.00097366766,0.00024862107,0.0006623427,0.00025349628,0.00009804577,0.0002550949,0.00012118946,0.0006159703,0.000027356293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004327461,0.00039547106,0.00036366237,0.000749924,0.0009213602,0.000515437,0.00003882981,0.00010129649,0.0000041150265,0.0003355861,0.020233681,0.97590786],"study_design_scores_gemma":[0.0014063711,0.0027249581,0.00008186905,0.0018021162,0.0012717644,0.0011879393,0.00008493762,0.00008600054,0.0000018199939,0.00083824544,0.9902761,0.00023785302],"about_ca_topic_score_codex":0.000024588388,"about_ca_topic_score_gemma":0.00006869153,"teacher_disagreement_score":0.97567004,"about_ca_system_score_codex":0.0025667127,"about_ca_system_score_gemma":0.004334947,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2318030806","doi":"10.1097/igc.0000000000000322","title":"Coping With Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Coping (psychology); Feeling; Gynecologic cancer; Family medicine; Vulvar cancer; Cervical cancer; Gynecologic oncology; Cancer; Stressor; Social support; Ovarian cancer; Gynecology; Clinical psychology; Oncology; Psychotherapist; Internal medicine; Psychology","score_opus":0.022514799785130074,"score_gpt":0.33134624057064904,"score_spread":0.30883144078551894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318030806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96032923,0.0014337328,0.0028159863,0.023785263,0.0037326294,0.00010171934,0.000013002836,0.000022318416,0.00776614],"genre_scores_gemma":[0.9897093,0.0005807541,0.00025859816,0.00745531,0.0014348101,0.000016394284,0.0000017560147,0.000010030259,0.000533028],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989101,0.000031879914,0.0002636198,0.00011205964,0.0005466019,0.0001356844],"domain_scores_gemma":[0.99860096,0.00014191945,0.00023056833,0.00006590001,0.0008341622,0.00012649276],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018308683,0.000095028154,0.00025124187,0.00008346284,0.00002492139,0.000025873078,0.00018593934,0.0000625775,0.0031254205],"category_scores_gemma":[0.0001328697,0.000058057973,0.0001096984,0.00008200398,0.00006503382,0.000086560685,0.00002766392,0.00024785165,0.000006123989],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043967306,0.00041342436,0.6704244,0.0000722484,0.0013581645,0.00062345556,0.00072049955,0.001342556,0.0032441819,0.0027808966,0.022081325,0.29254213],"study_design_scores_gemma":[0.0036975357,0.0014699384,0.26068842,0.00040363212,0.00018401806,0.0003839702,0.00012454098,0.00014015539,0.002348317,0.00043001957,0.7299179,0.0002115927],"about_ca_topic_score_codex":0.00021016116,"about_ca_topic_score_gemma":0.00095742155,"teacher_disagreement_score":0.7078365,"about_ca_system_score_codex":0.00030632457,"about_ca_system_score_gemma":0.00021110562,"threshold_uncertainty_score":0.99778587},"labels":[],"label_agreement":null},{"id":"W2318409487","doi":"10.1111/igc.0b013e3181e273a8","title":"Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Sorafenib; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Ovarian cancer; Adverse effect; Toxicity; Clinical endpoint; Chemotherapy; Phases of clinical research; Cancer; Clinical trial; Gastroenterology; Hepatocellular carcinoma","score_opus":0.01911840457621101,"score_gpt":0.32815200818142676,"score_spread":0.30903360360521576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318409487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97260666,0.00038599098,0.000034917568,0.023871932,0.0021597089,0.00024269897,0.000025716085,0.0000064377023,0.0006659472],"genre_scores_gemma":[0.99696934,0.00087995874,0.0007198929,0.00072936784,0.0005146298,0.00009783348,0.0000068380405,0.000011120965,0.00007099844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985823,0.000038994145,0.00049415743,0.00018659943,0.00050945836,0.00018850784],"domain_scores_gemma":[0.99888945,0.0001475949,0.00029110114,0.000081947466,0.00047875856,0.000111172754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030874342,0.00013831098,0.0003409514,0.00028451663,0.000016334347,0.000027892333,0.00017952682,0.00010892123,0.0024122454],"category_scores_gemma":[0.00016328164,0.00009027352,0.00008521457,0.0001915414,0.0000658128,0.00014273348,0.000029350262,0.0005903654,0.0000048736642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023543537,0.0021633056,0.87243485,0.000012129444,0.00020654657,0.0011747606,0.0001581506,0.00026438496,0.0015146077,0.0020209812,0.00032205225,0.11737387],"study_design_scores_gemma":[0.011077466,0.0009609927,0.9764825,0.00026227869,0.000050290848,0.00009820343,0.00002766565,0.00015081043,0.0010164807,0.0006453022,0.009120322,0.00010768913],"about_ca_topic_score_codex":0.00051152514,"about_ca_topic_score_gemma":0.0071736625,"teacher_disagreement_score":0.117266186,"about_ca_system_score_codex":0.00074362586,"about_ca_system_score_gemma":0.0005265714,"threshold_uncertainty_score":0.9984997},"labels":[],"label_agreement":null},{"id":"W2318589689","doi":"10.1097/igc.0000000000000305","title":"Association Between Cervical Screening and Prevention of Invasive Cervical Cancer in Ontario A Population-Based Case-Control Study","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cervical cancer; Conditional logistic regression; Logistic regression; Obstetrics; Odds ratio; Gynecology; Case-control study; Cancer; Population; Internal medicine; Environmental health","score_opus":0.04639240230017182,"score_gpt":0.36869772401996337,"score_spread":0.32230532171979154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318589689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953639,0.00013592954,0.0007468022,0.0028544597,0.00022980844,0.00039692837,0.00003289351,0.000006194812,0.00023308782],"genre_scores_gemma":[0.9987457,0.000027111659,0.0002605415,0.00038724282,0.00043157538,0.000038159345,0.0000063650195,0.000010367281,0.0000929668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746144,0.0002913058,0.0008099239,0.0002113871,0.0010112306,0.00021469826],"domain_scores_gemma":[0.99660856,0.0015451701,0.00051779824,0.00007834818,0.001074631,0.00017548406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011905009,0.00013559504,0.00057539187,0.00027399056,0.000039552884,0.000032938195,0.0001634575,0.0001701652,0.006066921],"category_scores_gemma":[0.0012581508,0.0001059209,0.00016389265,0.00015630598,0.0000340883,0.00013281433,0.000055280758,0.00065059325,9.3475234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010858371,0.0003237843,0.9425909,0.00002779028,0.0004411699,0.00017107556,0.00014974111,0.00078649016,0.000034194672,0.000017692408,0.000021220161,0.054350138],"study_design_scores_gemma":[0.00777252,0.001374087,0.98892677,0.00010446936,0.00027925815,0.000034166656,0.00008724072,0.00077980425,0.00005075757,0.0003939085,0.00010273292,0.00009428338],"about_ca_topic_score_codex":0.031803157,"about_ca_topic_score_gemma":0.31056497,"teacher_disagreement_score":0.2787618,"about_ca_system_score_codex":0.0016039944,"about_ca_system_score_gemma":0.0004950556,"threshold_uncertainty_score":0.9948417},"labels":[],"label_agreement":null},{"id":"W2320762279","doi":"10.1097/igc.0000000000000157","title":"Determining the Role of a National Objective Assessment of Surgical Skills in Gynecological Oncology An e-Delphi Methodology","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Hospital","funders":"","keywords":"Medicine; Delphi method; Cronbach's alpha; Delphi; Gynecologic oncology; Medical education; Medical physics; Family medicine; Oncology; Psychometrics; Clinical psychology","score_opus":0.07211445854218244,"score_gpt":0.4659712119763746,"score_spread":0.39385675343419213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320762279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269504,0.000059699694,0.00048289204,0.0013200678,0.00049249973,0.0001598193,0.000009919638,0.0000073610076,0.014772715],"genre_scores_gemma":[0.99472576,0.00008585147,0.004120517,0.000676784,0.00034293285,0.000016931397,0.0000064486767,0.000008184816,0.000016604548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967656,0.0008945915,0.0010855318,0.00019764567,0.00085743994,0.00019920283],"domain_scores_gemma":[0.98903275,0.008333056,0.0008549103,0.00008243296,0.0015708982,0.00012593933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002999566,0.0001396688,0.00070629636,0.00025404608,0.00003130259,0.000009422209,0.00035518385,0.00023827658,0.0016465375],"category_scores_gemma":[0.00330378,0.000083106206,0.00024896374,0.00019250328,0.00028905566,0.000114214636,0.000089055284,0.00056169083,0.0000011188002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010367766,0.0021489407,0.79925424,0.000007584633,0.00031305582,0.000099040364,0.00052902725,0.006113741,0.00072866876,0.015031628,0.000015688074,0.17472163],"study_design_scores_gemma":[0.0066728666,0.0025456967,0.96564555,0.00005113887,0.000047530728,0.00013394887,0.0003958269,0.0066838297,0.00040292955,0.0060344613,0.011289904,0.00009628764],"about_ca_topic_score_codex":0.000020624584,"about_ca_topic_score_gemma":0.00006621739,"teacher_disagreement_score":0.17462534,"about_ca_system_score_codex":0.00047033673,"about_ca_system_score_gemma":0.00049404363,"threshold_uncertainty_score":0.9992661},"labels":[],"label_agreement":null},{"id":"W2321032832","doi":"10.1097/igc.0b013e3182a57ff6","title":"The Effects of Anemia and Blood Transfusion on Patients With Stage III–IV Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Blood transfusion and management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Manitoba; Health Sciences Centre; CancerCare Manitoba; Research Manitoba","funders":"","keywords":"Medicine; Anemia; Perioperative; Ovarian cancer; Blood transfusion; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Chemotherapy; Hazard ratio; Proportional hazards model; Hemoglobin; Surgery; Cancer; Gastroenterology; Confidence interval","score_opus":0.005879385321447713,"score_gpt":0.25228104926728,"score_spread":0.2464016639458323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321032832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298453,0.00037355226,0.00006250547,0.004824635,0.0006252596,0.00046152514,0.000006342138,0.0000054233587,0.00065619836],"genre_scores_gemma":[0.9944852,0.003452306,0.00009782539,0.001335094,0.00010534732,0.00004029394,0.0000012808072,0.000007330874,0.00047533202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988985,0.00003523224,0.00028947092,0.000110559726,0.000548254,0.00011797504],"domain_scores_gemma":[0.99886173,0.00028304994,0.00019695102,0.00006817952,0.00048959395,0.000100480574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000112867565,0.00010133209,0.00020530094,0.00006720889,0.000049957252,0.000023050716,0.0001415557,0.000054060485,0.00099171],"category_scores_gemma":[0.00008013994,0.000048733928,0.00006569511,0.000057687797,0.000087627646,0.00007178432,0.000022621727,0.00021431457,0.0000015524878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069136727,0.0033575026,0.5984032,0.00030417676,0.0025354049,0.00031073956,0.00071419554,0.00013163313,0.012503776,0.0022558218,0.0040253354,0.36854452],"study_design_scores_gemma":[0.010096047,0.002518314,0.9788371,0.00030604433,0.00022632733,0.000007804611,0.00005002401,0.000017682012,0.0027784805,0.00008389518,0.005003963,0.000074355],"about_ca_topic_score_codex":0.00022274735,"about_ca_topic_score_gemma":0.00014884766,"teacher_disagreement_score":0.38043383,"about_ca_system_score_codex":0.000063061394,"about_ca_system_score_gemma":0.00006214132,"threshold_uncertainty_score":0.9999215},"labels":[],"label_agreement":null},{"id":"W2321686350","doi":"10.1111/igc.0b013e3181c03909","title":"Fasudil Inhibits Lysophosphatidic Acid-Induced Invasiveness of Human Ovarian Cancer Cells","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Fasudil; Lysophosphatidic acid; Ovarian cancer; Medicine; Cancer research; Focal adhesion; Cancer cell; Rho-associated protein kinase; Pharmacology; Cancer; Internal medicine; Cell biology; Phosphorylation; Biology; Receptor","score_opus":0.02467519673160868,"score_gpt":0.31654518404562765,"score_spread":0.291869987314019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321686350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955595,0.0018318006,0.000554845,0.0010721809,0.00057868514,0.00010325326,0.000021357844,0.000004244829,0.00027412156],"genre_scores_gemma":[0.99766576,0.00044393368,0.00026124154,0.0009771917,0.00055553403,0.000009103474,0.000009991929,0.000007845921,0.000069408445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987342,0.0000658403,0.00050147116,0.0001706434,0.00037847547,0.00014941354],"domain_scores_gemma":[0.9984636,0.000020066114,0.000563833,0.00009657057,0.0007598818,0.00009609712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024962254,0.00013316842,0.00023459215,0.00008762626,0.000046109275,0.000022067374,0.00035632343,0.0001570026,0.0005278207],"category_scores_gemma":[0.00013036227,0.00010816295,0.00017768785,0.00008622266,0.000050624596,0.000014592054,0.00005576944,0.00014040631,0.0000015114954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001775577,0.00012801222,0.0014149098,0.0000055189143,0.00011084466,0.000027695143,0.000027676118,0.00053304853,0.9829972,0.0003160916,0.00025588463,0.014005588],"study_design_scores_gemma":[0.0011021451,0.00054046744,0.019631768,0.00008540975,0.000024370207,0.0000144380865,0.00001704233,0.000015734695,0.9762639,0.0006305314,0.0015497622,0.00012444289],"about_ca_topic_score_codex":0.000032140157,"about_ca_topic_score_gemma":0.00003913937,"teacher_disagreement_score":0.018216858,"about_ca_system_score_codex":0.00009477111,"about_ca_system_score_gemma":0.00023791002,"threshold_uncertainty_score":0.5779267},"labels":[],"label_agreement":null},{"id":"W2322691303","doi":"10.1097/igc.0b013e31822925c0","title":"Identification and Quantification of Peritoneal Metastases in Patients With Ovarian Cancer With Multidetector Computed Tomography","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Radiology; Multidetector computed tomography; Stage (stratigraphy); Metastasis; Computed tomography; Retrospective cohort study; Cancer; Nuclear medicine; Surgery; Internal medicine","score_opus":0.027438616178764065,"score_gpt":0.28938462997752934,"score_spread":0.26194601379876525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322691303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800175,0.00044399744,0.00039558584,0.0005624407,0.00023855567,0.00025485613,0.00006636912,0.0000050562126,0.00003141127],"genre_scores_gemma":[0.99753624,0.00018221291,0.0020630076,0.00009347826,0.000055046105,0.000044142467,0.000010626955,0.000008393614,0.0000068231134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888074,0.000040822215,0.00042405957,0.00016553054,0.00039134486,0.000097515],"domain_scores_gemma":[0.9984284,0.00007463433,0.00049245375,0.000079843114,0.00084853586,0.00007610743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013680963,0.00010954546,0.0002846687,0.00022340122,0.000018633484,0.000015108548,0.000099864534,0.000045898832,0.00033347396],"category_scores_gemma":[0.000036470276,0.00006618117,0.00005375236,0.00016671569,0.00010914842,0.00014249903,0.000015935539,0.000115255076,3.9325622e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026918412,0.001090487,0.9784123,0.000019110745,0.0005456488,0.00004006687,0.00020350859,0.000077902165,0.00038321942,0.00013498773,0.000025338386,0.016375639],"study_design_scores_gemma":[0.0047987932,0.0012074804,0.98786706,0.00021199515,0.00017592443,0.000011291506,0.000046881592,0.00005816687,0.0054263105,0.000028148017,0.00009498188,0.000072955394],"about_ca_topic_score_codex":0.000402574,"about_ca_topic_score_gemma":0.00039672598,"teacher_disagreement_score":0.016302682,"about_ca_system_score_codex":0.0001656285,"about_ca_system_score_gemma":0.000119132834,"threshold_uncertainty_score":0.3651306},"labels":[],"label_agreement":null},{"id":"W2324113074","doi":"10.1097/igc.0000000000000639","title":"Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Royal Jubilee Hospital; University of British Columbia; University of Calgary; University of Alberta; BC Cancer Agency; Calgary Laboratory Services; Royal Alexandra Hospital","funders":"","keywords":"Medicine; BRCA mutation; Serous carcinoma; Fallopian tube; Ovarian cancer; Serous fluid; Gynecology; Ovarian carcinoma; Genetic testing; Breast cancer; Cancer; Oncology; Obstetrics; Internal medicine","score_opus":0.009978530736780355,"score_gpt":0.2639358044063036,"score_spread":0.25395727366952325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324113074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180114,0.0011621364,0.0000069856965,0.00526724,0.00082493643,0.00021025586,0.0006987698,0.0000049949776,0.000023512279],"genre_scores_gemma":[0.996975,0.002038878,0.00014489425,0.00034078298,0.00036864623,0.000043194566,0.0000032152066,0.000016561997,0.000068851106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807775,0.00009380636,0.0007506667,0.0002665413,0.0005489795,0.00026226288],"domain_scores_gemma":[0.9984054,0.0003619249,0.0005506495,0.000113918926,0.0003391778,0.00022894626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619936,0.00022045382,0.00072454277,0.00019958254,0.000030413003,0.000012213378,0.000185751,0.00014261922,0.0007922035],"category_scores_gemma":[0.00011804317,0.00013132925,0.00011181731,0.000087674875,0.0002369344,0.0001594134,0.00015113852,0.0002051116,8.394493e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00203916,0.00049135194,0.9647378,0.000037371356,0.00072220684,0.0007003521,0.00045069057,0.000030140845,0.0013237663,0.000084580824,0.00011221559,0.029270409],"study_design_scores_gemma":[0.01041096,0.0011270259,0.98516387,0.00025655766,0.00016061288,0.0006060967,0.00014489863,0.000025328483,0.0016763507,0.00022867465,0.00006985186,0.0001297753],"about_ca_topic_score_codex":0.005076351,"about_ca_topic_score_gemma":0.002371202,"teacher_disagreement_score":0.029140633,"about_ca_system_score_codex":0.0014691782,"about_ca_system_score_gemma":0.00027270522,"threshold_uncertainty_score":0.86740726},"labels":[],"label_agreement":null},{"id":"W2324134517","doi":"10.1111/igc.0b013e3181bf830d","title":"Other New Targets","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Clinical trial; Precision medicine; Ovarian cancer; Personalized medicine; Targeted therapy; Cancer; Intensive care medicine; Medical physics; Bioinformatics; Internal medicine; Pathology","score_opus":0.09738799521216375,"score_gpt":0.4397810619632007,"score_spread":0.342393066751037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324134517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067361834,0.9912738,0.000055503988,0.0033957816,0.0021759206,0.00026779732,0.00003911282,0.000011548571,0.002773774],"genre_scores_gemma":[0.000062358195,0.9914146,0.0008477214,0.0020508748,0.0036035408,0.000021059841,0.00001161047,0.000025446847,0.0019627574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806213,0.00005440017,0.00085111277,0.00021995764,0.0006220817,0.00019031703],"domain_scores_gemma":[0.9980969,0.00022881778,0.00090124295,0.00012749374,0.0003764566,0.00026908427],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016027098,0.00028885162,0.0015105548,0.00021691671,0.000018075032,0.00004301857,0.00036227016,0.00027518277,0.008527138],"category_scores_gemma":[0.00018393771,0.00016708253,0.0010172733,0.00010783301,0.000033741388,0.00006657602,0.000040000425,0.00049675984,0.000081597675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062605046,0.00033162834,0.00014129946,0.00016546027,0.0014851182,0.00090139144,0.0000090197145,0.0000023277391,1.2802425e-7,0.0002238777,0.0352215,0.96145564],"study_design_scores_gemma":[0.0011625867,0.00063028437,0.0007965653,0.006050427,0.0013663381,0.0005452451,0.0000016117676,4.1527164e-7,0.0000017703503,0.0003945419,0.9889081,0.00014211604],"about_ca_topic_score_codex":0.000031160413,"about_ca_topic_score_gemma":0.000013046888,"teacher_disagreement_score":0.96131355,"about_ca_system_score_codex":0.0012148413,"about_ca_system_score_gemma":0.0014749792,"threshold_uncertainty_score":0.9923792},"labels":[],"label_agreement":null},{"id":"W2324164945","doi":"10.1097/igc.0000000000000196","title":"DNA Damage Signaling and Apoptosis in Preinvasive Tubal Lesions of Ovarian Carcinoma","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Serous fluid; Immunohistochemistry; Medicine; Cancer research; Apoptosis; Ovarian cancer; Fallopian tube; DNA damage; Genome instability; Serous carcinoma; Malignancy; Tissue microarray; Cancer; Pathology; Oncology; Internal medicine; Biology; DNA; Genetics; Gynecology","score_opus":0.026236640482513455,"score_gpt":0.3063069944518052,"score_spread":0.28007035396929175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324164945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327064,0.00032190394,0.00012661623,0.0048871506,0.00038986866,0.00010950865,0.000014833388,0.0000031681602,0.00087628776],"genre_scores_gemma":[0.99788076,0.00029628037,0.0009486525,0.00054138585,0.00027571226,0.000014269736,0.0000025854206,0.00000683408,0.0000335302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989109,0.000061108956,0.00044182304,0.00013581238,0.00033015577,0.000120172],"domain_scores_gemma":[0.9987867,0.00041294133,0.00027785308,0.000067369,0.00034427567,0.00011088572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025789512,0.00009911431,0.00033477455,0.0001574595,0.000018958895,0.000014799523,0.00012377577,0.00007542124,0.0006575582],"category_scores_gemma":[0.0003590245,0.000069937494,0.00010844033,0.00007960338,0.00007095226,0.00007928782,0.00004810099,0.00017248689,0.0000012321389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006534503,0.000729462,0.95050174,0.00003553727,0.0003912818,0.00020208,0.0003111491,0.00032684364,0.0119410865,0.002472538,0.000359934,0.032074872],"study_design_scores_gemma":[0.003671072,0.0009751929,0.97188205,0.00026173066,0.000116114934,0.000054090262,0.00008727944,0.00014176735,0.021079188,0.000750456,0.00090570754,0.000075364755],"about_ca_topic_score_codex":0.00012324483,"about_ca_topic_score_gemma":0.00006397769,"teacher_disagreement_score":0.03199951,"about_ca_system_score_codex":0.00025449027,"about_ca_system_score_gemma":0.00015197045,"threshold_uncertainty_score":0.7199801},"labels":[],"label_agreement":null},{"id":"W2325063432","doi":"10.1097/igc.0b013e31823c244b","title":"Fooled by the Film","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Minimally Invasive Surgical Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Port (circuit theory); General surgery; Plain radiography; Radiology; Intensive care medicine; Medical physics; Radiography","score_opus":0.06979572615654618,"score_gpt":0.3433091103477596,"score_spread":0.27351338419121346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325063432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.930336,0.0013419545,0.0011957955,0.010918905,0.0011722926,0.00022543444,0.000025524743,0.00004165485,0.054742415],"genre_scores_gemma":[0.99285597,0.00052410393,0.0009925375,0.004395446,0.00031809293,0.000017301662,0.0000015643326,0.0000075274547,0.00088746473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988698,0.00005098157,0.0003819846,0.00009363476,0.00047656585,0.00012708601],"domain_scores_gemma":[0.9985906,0.00025816652,0.00026897152,0.0000844622,0.00069668505,0.00010111408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031606967,0.000089485606,0.00020913134,0.000053283722,0.000024642306,0.000013338759,0.00039863237,0.000084531224,0.013056864],"category_scores_gemma":[0.000678291,0.000044957724,0.00019565076,0.00006218505,0.00013427468,0.00007081666,0.000063204534,0.0003318788,0.000019879146],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064998004,0.002653518,0.24351569,0.000028246091,0.002732279,0.0038719557,0.001092534,0.0000109049015,0.03666089,0.011200298,0.53994167,0.15179223],"study_design_scores_gemma":[0.0038295507,0.0034393682,0.4303215,0.0002177151,0.00025898486,0.0018941951,0.0002548916,0.00006522213,0.07295833,0.009101926,0.4773484,0.00030990198],"about_ca_topic_score_codex":0.000022621041,"about_ca_topic_score_gemma":0.0000062292766,"teacher_disagreement_score":0.18680584,"about_ca_system_score_codex":0.0001517993,"about_ca_system_score_gemma":0.00009939738,"threshold_uncertainty_score":0.98784536},"labels":[],"label_agreement":null},{"id":"W2326966695","doi":"10.1111/igc.0b013e3181f5c688","title":"A Role for Adjuvant Radiation in Clinically Early Carcinoma of the Endometrium?","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrium; Adjuvant radiotherapy; Adjuvant; Carcinoma; Oncology; Gynecology; Internal medicine; Radiation therapy","score_opus":0.06283266613727893,"score_gpt":0.4130577838859779,"score_spread":0.35022511774869897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326966695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016355846,0.97853553,0.000014069434,0.00050215906,0.003019871,0.0009941265,0.00019527096,0.0000037027435,0.00037943182],"genre_scores_gemma":[0.07767855,0.9201986,0.00025700146,0.00025468157,0.0012735913,0.00014614382,0.000014729809,0.000021529846,0.00015516217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970064,0.00013527673,0.0017359499,0.00021347581,0.0007134928,0.00019536802],"domain_scores_gemma":[0.994854,0.0022689165,0.0018505277,0.00016061662,0.00074062904,0.00012532307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006710855,0.00022834308,0.0016767752,0.00044446462,0.00002014816,0.000018183197,0.00063199067,0.00042172908,0.00046428796],"category_scores_gemma":[0.0039356616,0.00011641987,0.0013910546,0.00046913244,0.00009857606,0.00006415344,0.000092655915,0.0008763884,0.0000032488338],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007051498,0.00040844572,0.015962733,0.00036574798,0.00039674318,0.000033643144,0.000021435193,0.0000019064323,0.000010775955,0.00006284462,0.00006500739,0.98196554],"study_design_scores_gemma":[0.007846833,0.002265048,0.10928987,0.0033162397,0.0013318657,0.000116589064,0.0000099942445,0.0000052610035,0.00004602463,0.00054177584,0.8750554,0.00017514729],"about_ca_topic_score_codex":0.00006653973,"about_ca_topic_score_gemma":0.000042988217,"teacher_disagreement_score":0.9817904,"about_ca_system_score_codex":0.0006568592,"about_ca_system_score_gemma":0.0009996272,"threshold_uncertainty_score":0.50836277},"labels":[],"label_agreement":null},{"id":"W2327056717","doi":"10.1097/igc.0b013e318212981d","title":"Relationship Between Body Mass Index and Robotic Surgery Outcomes of Women Diagnosed With Endometrial Cancer","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Body mass index; Prospective cohort study; Endometrial cancer; Laparotomy; Quality of life (healthcare); Cancer; Obesity; Surgery; Internal medicine; Gynecology","score_opus":0.09133267684388538,"score_gpt":0.3414701875294628,"score_spread":0.25013751068557744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327056717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709505,0.00068937417,0.00019844882,0.0007078007,0.0007856665,0.0001795641,0.00003164423,0.0000096552485,0.00030281334],"genre_scores_gemma":[0.9982954,0.0004541023,0.00034635363,0.00027537497,0.0004435302,0.000054599423,0.0000041166895,0.000013483542,0.000112989655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980834,0.000082194216,0.0006941248,0.00016989547,0.00072032504,0.0002500292],"domain_scores_gemma":[0.9952449,0.0032005506,0.0006363458,0.00008444232,0.00055630103,0.000277443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045984038,0.00016609379,0.00081369694,0.00045532844,0.00003097212,0.0000147211285,0.00016852278,0.00012187799,0.0019512095],"category_scores_gemma":[0.002141371,0.00009867737,0.00018219705,0.00034196317,0.00014463982,0.00015799326,0.000040168023,0.00028477318,0.0000019837682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029193286,0.0002576172,0.9892192,0.00002193997,0.001084578,0.000213508,0.00014064762,0.000019938127,0.00002931386,0.00009971347,0.000044387936,0.0059498507],"study_design_scores_gemma":[0.0062484094,0.0009800041,0.99097276,0.0000906874,0.00027446303,0.000021345713,0.00008052911,0.0000027414367,0.000257155,0.0007866611,0.00018201843,0.00010323717],"about_ca_topic_score_codex":0.00039763955,"about_ca_topic_score_gemma":0.000046438425,"teacher_disagreement_score":0.0058466136,"about_ca_system_score_codex":0.00070600386,"about_ca_system_score_gemma":0.00032803757,"threshold_uncertainty_score":0.99896115},"labels":[],"label_agreement":null},{"id":"W2327737584","doi":"10.1097/igc.0b013e318205759f","title":"MYBL2 (B-MYB) in Cervical Cancer: Putative Biomarker","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Cervical cancer; Cervical intraepithelial neoplasia; Cancer research; Medicine; Oncogene; Cancer; Pathology; Biology; HeLa; Cell cycle; Cell; Genetics","score_opus":0.06702362069151328,"score_gpt":0.3507116974092771,"score_spread":0.2836880767177638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327737584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981854,0.0026554195,0.0004755343,0.0045970655,0.0027937172,0.00024342652,0.000044771885,0.000022466564,0.007313553],"genre_scores_gemma":[0.9953947,0.0012280465,0.0010114253,0.0017580284,0.00034983197,0.000041709412,0.0000048363204,0.000020276915,0.00019114996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804986,0.000086718544,0.0006897933,0.00022946202,0.0006725466,0.00027164383],"domain_scores_gemma":[0.99835175,0.00014192119,0.0003970138,0.00010157923,0.0007958898,0.0002118637],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031865394,0.00017677985,0.000421217,0.0003246411,0.00002154242,0.000014998472,0.0003434021,0.00020148317,0.008052647],"category_scores_gemma":[0.00040456906,0.00013293691,0.0002474736,0.00024730037,0.00017968018,0.0001446631,0.000089837915,0.00059556565,0.000027087986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013163367,0.003394232,0.6697011,0.00007427673,0.003192578,0.011474464,0.0039256136,0.000664943,0.033344988,0.0023173667,0.009863353,0.2488837],"study_design_scores_gemma":[0.0049673445,0.0007941381,0.97178596,0.00029876927,0.00013612813,0.00050383783,0.00021142753,0.00036826538,0.007395782,0.0015181246,0.011795172,0.00022502987],"about_ca_topic_score_codex":0.00045129802,"about_ca_topic_score_gemma":0.00040814604,"teacher_disagreement_score":0.30208486,"about_ca_system_score_codex":0.0011515839,"about_ca_system_score_gemma":0.00057156396,"threshold_uncertainty_score":0.9928541},"labels":[],"label_agreement":null},{"id":"W2328113542","doi":"10.1111/igc.0b013e318199617b","title":"Intraoperative Consultation in Gynecologic Pathology","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Audit; Tertiary care; Terminology; General surgery; Medical physics; Surgery","score_opus":0.0324177409387333,"score_gpt":0.38077263234073616,"score_spread":0.3483548914020029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328113542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408324,0.00022675206,0.00018989525,0.008007529,0.0006085457,0.00010911233,0.000002281356,0.000012071937,0.006760582],"genre_scores_gemma":[0.99287975,0.00023150891,0.00057502737,0.005991625,0.00022369587,0.000004471794,0.000004229129,0.000003004552,0.00008667909],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988867,0.000077141834,0.0004901094,0.0001166875,0.00029394432,0.00013541599],"domain_scores_gemma":[0.9985221,0.0005481621,0.0002138522,0.00003662573,0.00059100974,0.000088239074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032859214,0.00008676255,0.00027560827,0.00017891666,0.000018257579,0.000016781347,0.000116433635,0.00011342406,0.0026082033],"category_scores_gemma":[0.00171456,0.000059304624,0.00009409253,0.00014319945,0.00005974484,0.00011070695,0.000012110636,0.00032094718,0.000011626041],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035117273,0.0014690532,0.22979811,0.000005078675,0.0001990719,0.007328286,0.0011088029,0.005389074,0.0045582196,0.0068289344,0.00036004197,0.7394436],"study_design_scores_gemma":[0.0071144924,0.0011112859,0.98203695,0.000047284528,0.000021693957,0.00025645344,0.0001963698,0.00066184177,0.00056081434,0.0024902618,0.005416909,0.00008562364],"about_ca_topic_score_codex":0.0000028219708,"about_ca_topic_score_gemma":0.000015290309,"teacher_disagreement_score":0.75223887,"about_ca_system_score_codex":0.0002651747,"about_ca_system_score_gemma":0.00012706176,"threshold_uncertainty_score":0.99830353},"labels":[],"label_agreement":null},{"id":"W2328501245","doi":"10.1097/igc.0b013e31826d1438","title":"Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Topotecan; Medicine; Lapatinib; Internal medicine; Oncology; Gefitinib; Epidermal growth factor receptor; Cancer; Chemotherapy; Pharmacology; Trastuzumab; Breast cancer","score_opus":0.09748817472018313,"score_gpt":0.41249245806051915,"score_spread":0.31500428334033603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328501245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123573,0.0010501365,0.00006202969,0.0051080333,0.0011139049,0.0004509138,0.00005672698,0.000012421386,0.00091010064],"genre_scores_gemma":[0.9962279,0.0004898885,0.0017096503,0.0005967229,0.0007301824,0.00015920427,0.0000067496703,0.000015617057,0.00006406879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997668,0.00012099915,0.0006951264,0.00019942674,0.0009028365,0.00041357736],"domain_scores_gemma":[0.9978028,0.00031900982,0.00036241018,0.000119086595,0.0010647732,0.00033192427],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006371661,0.00016584326,0.00053736963,0.0003315776,0.000025501078,0.00001805545,0.00039509247,0.00014082842,0.003429211],"category_scores_gemma":[0.00094683876,0.000106232554,0.000107352156,0.00041053724,0.000096796844,0.00013279676,0.00013191738,0.0005520354,0.000007146403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058042463,0.0008623593,0.9096294,0.00002890112,0.00020850784,0.00008030917,0.00048308333,0.00029024688,0.0040128506,0.00048275338,0.0007978747,0.07731944],"study_design_scores_gemma":[0.0034842272,0.003652209,0.97991264,0.00075988413,0.00003169602,0.00007195902,0.0003841128,0.000046841615,0.008323247,0.000054812055,0.0031080781,0.00017027122],"about_ca_topic_score_codex":0.00025810112,"about_ca_topic_score_gemma":0.00029315232,"teacher_disagreement_score":0.077149175,"about_ca_system_score_codex":0.0009866119,"about_ca_system_score_gemma":0.00044258506,"threshold_uncertainty_score":0.99748176},"labels":[],"label_agreement":null},{"id":"W2328637892","doi":"10.1111/igc.0b013e3181f66743","title":"Adjuvant Pelvic Radiation Therapy in Endometrial Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Radiation therapy; External beam radiotherapy; Hysterectomy; External beam radiation; Adjuvant therapy; Stage (stratigraphy); Lymphovascular invasion; Randomized controlled trial; Surgery; Cancer; Oncology; Radiology; Internal medicine; Brachytherapy; Metastasis","score_opus":0.08925565288216748,"score_gpt":0.43348674323384057,"score_spread":0.3442310903516731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328637892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029946354,0.98644936,0.0000043492473,0.00077480497,0.008357833,0.00071372656,0.00012983654,0.0000131939405,0.00056224974],"genre_scores_gemma":[0.0035487406,0.99026203,0.00008434057,0.0005595214,0.004973187,0.00022794178,0.000044737073,0.000038651662,0.00026087338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965262,0.00018641482,0.0015286377,0.00034118912,0.0010988468,0.00031871616],"domain_scores_gemma":[0.99644727,0.0011175938,0.0014016596,0.00015363733,0.00062928593,0.00025056346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053838524,0.00041128165,0.0023389403,0.0011332033,0.000028020784,0.000053632073,0.00056598085,0.00060875167,0.0073385355],"category_scores_gemma":[0.001237103,0.0002444313,0.0011148534,0.00074708974,0.00008167591,0.00014260305,0.00007060355,0.0015236947,0.00002911317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009678679,0.0005072269,0.0025192103,0.00021319088,0.0008458939,0.0005036507,0.000018362045,0.0000036922045,0.000006719187,0.000025088066,0.0002860072,0.9941031],"study_design_scores_gemma":[0.009105801,0.0010712108,0.0057256254,0.0026941102,0.00057201314,0.00017726725,0.000003974275,0.000001860744,0.000018247674,0.000108928754,0.98029464,0.00022632703],"about_ca_topic_score_codex":0.00019332087,"about_ca_topic_score_gemma":0.00013321004,"teacher_disagreement_score":0.99387676,"about_ca_system_score_codex":0.0018922717,"about_ca_system_score_gemma":0.0014836484,"threshold_uncertainty_score":0.9967619},"labels":[],"label_agreement":null},{"id":"W2329173882","doi":"10.1097/igc.0b013e318263f014","title":"Temporal Trends in the Relative Survival Among Women With Cervical Cancer in Canada","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Relative survival; Medicine; Cervical cancer; Population; Cancer; Internal medicine; Relative risk; Oncology; Survival analysis; Demography; Cancer registry; Gynecology; Confidence interval","score_opus":0.040087159829658776,"score_gpt":0.357988401746065,"score_spread":0.31790124191640623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329173882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981322,0.0007080848,0.000010855025,0.00955539,0.00061685,0.00010537999,0.000023535487,0.0000026423268,0.007655279],"genre_scores_gemma":[0.9974368,0.00018790318,0.000028586604,0.0013752423,0.0006860857,0.00007060947,0.0000031919246,0.000009505037,0.00020202652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752253,0.00016791146,0.00045875218,0.00013291827,0.0012684914,0.00044942013],"domain_scores_gemma":[0.99868375,0.0004345771,0.00017805779,0.000083624254,0.0003796586,0.0002403473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007765597,0.00013352146,0.00036429884,0.00021232059,0.000024817482,0.000021080326,0.0003685959,0.00007611625,0.017380437],"category_scores_gemma":[0.00016081329,0.000070129456,0.00006441583,0.0004345712,0.00010821435,0.00023937412,0.000055118333,0.000905661,0.0000016036636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018181265,0.00021227333,0.9583207,0.0000072771936,0.00011608406,0.00040361864,0.00066744006,0.0001457778,0.000006704022,0.00015176399,0.0004985461,0.03765171],"study_design_scores_gemma":[0.0023466216,0.0003189444,0.991737,0.00003954697,0.000017268574,0.00004295462,0.00089778245,0.000060945495,0.000014050735,0.000099617384,0.004334361,0.00009091142],"about_ca_topic_score_codex":0.37814146,"about_ca_topic_score_gemma":0.8998038,"teacher_disagreement_score":0.5216624,"about_ca_system_score_codex":0.004355911,"about_ca_system_score_gemma":0.0013757165,"threshold_uncertainty_score":0.9994662},"labels":[],"label_agreement":null},{"id":"W2329904653","doi":"10.1097/igc.0b013e31821bb8be","title":"Patient-Reported Outcomes","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"World Health Organization","keywords":"Medicine; Ovarian cancer; Clinical trial; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.11240224310641674,"score_gpt":0.41666635818909503,"score_spread":0.3042641150826783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329904653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002562194,0.9923713,0.000007152969,0.0006356421,0.0039037205,0.00035183845,0.000049792467,0.000013694344,0.0024106328],"genre_scores_gemma":[0.00080195104,0.9970049,0.000352361,0.000695664,0.00058157847,0.00009592324,0.000017749784,0.000028571067,0.0004213009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976534,0.00006581762,0.0012904704,0.00023617543,0.0005667342,0.00018737688],"domain_scores_gemma":[0.9968777,0.00030271662,0.0017098688,0.00017061336,0.0007364202,0.00020270732],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015326068,0.00031422416,0.0017938017,0.00025711628,0.000021832124,0.000029204091,0.00028369317,0.0002715224,0.0063649477],"category_scores_gemma":[0.00036014576,0.00017118605,0.0012782387,0.00010264643,0.000059014503,0.00007237485,0.00008516233,0.0004892513,0.00004877835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006790793,0.0006356888,0.0050472524,0.00026913747,0.004696111,0.0021628758,0.000021585516,3.640649e-7,5.129484e-8,0.00014862581,0.0034420267,0.98350835],"study_design_scores_gemma":[0.0010207503,0.0006372223,0.0070079826,0.004137426,0.0025641185,0.0009084383,0.000005109217,1.4150628e-7,0.0000015556058,0.0000938655,0.98347306,0.0001503442],"about_ca_topic_score_codex":0.000031611085,"about_ca_topic_score_gemma":0.000008082278,"teacher_disagreement_score":0.983358,"about_ca_system_score_codex":0.0009925514,"about_ca_system_score_gemma":0.0008685541,"threshold_uncertainty_score":0.9945434},"labels":[],"label_agreement":null},{"id":"W2329909960","doi":"10.1097/igc.0000000000000171","title":"Radical Surgery in Patients With Residual Disease After (Chemo)Radiation for Cervical Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Radical surgery; Surgery; Radical Hysterectomy; Radiation therapy; Hysterectomy; Hazard ratio; Biopsy; Confidence interval; Cancer; Internal medicine","score_opus":0.016590425778131964,"score_gpt":0.30188699461929525,"score_spread":0.2852965688411633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329909960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896767,0.00065687485,0.0001652409,0.008038383,0.0009886079,0.00030174584,0.00008691209,0.000009458453,0.00007604834],"genre_scores_gemma":[0.9949134,0.00022152934,0.00028111352,0.0029887154,0.0012912856,0.00017627768,0.00003752521,0.00001670172,0.000073447685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812585,0.00007081824,0.0005510955,0.00021869864,0.0007913034,0.00024225708],"domain_scores_gemma":[0.9979185,0.000791788,0.00028109347,0.0000830668,0.0006216064,0.000303974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029361292,0.00015950981,0.00045228374,0.00024013425,0.00002395677,0.0000263396,0.00014925233,0.00010289812,0.0015908483],"category_scores_gemma":[0.0010141165,0.00009955507,0.00018910982,0.00017680279,0.00007828701,0.00014732342,0.000029783721,0.00022329992,0.0000037924572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019211885,0.00073666364,0.9136363,0.000029165578,0.0002054608,0.0000620065,0.000015677204,0.000080212754,0.0000051207276,0.00005078914,0.0007824264,0.06518429],"study_design_scores_gemma":[0.009065831,0.00073593494,0.9801012,0.00017608824,0.00014851084,0.0000032891667,0.0000033543297,0.000050284238,0.00007686432,0.00035569555,0.009162665,0.00012024004],"about_ca_topic_score_codex":0.000053180116,"about_ca_topic_score_gemma":0.000090144305,"teacher_disagreement_score":0.06646494,"about_ca_system_score_codex":0.00072703644,"about_ca_system_score_gemma":0.00033106853,"threshold_uncertainty_score":0.9993218},"labels":[],"label_agreement":null},{"id":"W2330013527","doi":"10.1111/igc.0b013e3181e0ef81","title":"Evaluating Contemporary Radiotherapy Approaches in the Primary Treatment of Cervical Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Cervical cancer; Radiation therapy; Oncology; Primary treatment; Medical physics; Cancer; Internal medicine","score_opus":0.20142317652025027,"score_gpt":0.42788857054677865,"score_spread":0.22646539402652838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330013527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808115,0.005818999,0.000021822376,0.009724857,0.001129962,0.0003318144,0.000025207408,0.000005107866,0.0021307638],"genre_scores_gemma":[0.9947735,0.0014043606,0.0010859706,0.0014678668,0.0010680073,0.00009226831,0.0000068061286,0.000009414337,0.00009177452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816495,0.00012081105,0.00063333136,0.00015452862,0.0007779634,0.00014842987],"domain_scores_gemma":[0.9983765,0.00070096145,0.00040925853,0.00011471277,0.00031093572,0.00008766537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004938947,0.00014535082,0.0004916047,0.00015297579,0.000023710341,0.00001805447,0.0003055922,0.000115074,0.0016607784],"category_scores_gemma":[0.00020535242,0.00007213662,0.00026687744,0.0002009153,0.00012009339,0.000087669716,0.000020171714,0.00031109943,0.0000011978815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005323096,0.0032862043,0.5704554,0.000034174886,0.0009925438,0.0003285279,0.00084192835,0.00019294587,0.011830114,0.00037341603,0.00025336628,0.4060883],"study_design_scores_gemma":[0.013963187,0.004213596,0.96776074,0.00009455426,0.00014841695,0.00015692557,0.00016929238,0.00023189503,0.0023734842,0.0005174846,0.0102461865,0.00012421384],"about_ca_topic_score_codex":0.00033324645,"about_ca_topic_score_gemma":0.00017482844,"teacher_disagreement_score":0.40596408,"about_ca_system_score_codex":0.00050809263,"about_ca_system_score_gemma":0.0005110575,"threshold_uncertainty_score":0.99925184},"labels":[],"label_agreement":null},{"id":"W2331413035","doi":"10.1111/igc.0b013e3181bcc96d","title":"Oviductal Glycoprotein (OVGP1, MUC9): A Differentiation-Based Mucin Present in Serum of Women With Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Serous fluid; Medicine; Immunohistochemistry; Pathology; Mucinous cystadenocarcinoma; Clear cell; Cystadenocarcinoma; Antibody; Ovarian cancer; Polyclonal antibodies; Serous carcinoma; Ovary; Cancer; Internal medicine; Immunology","score_opus":0.012686015767089822,"score_gpt":0.30133244785299385,"score_spread":0.288646432085904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331413035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255163,0.00023477332,0.000081308564,0.015506786,0.0010010261,0.0003350548,0.00006603354,0.000007862254,0.00021553846],"genre_scores_gemma":[0.9974664,0.0001304497,0.00091217924,0.00057485537,0.0005894661,0.00021881805,0.000004992756,0.000015414,0.00008743742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981431,0.00004764559,0.0005807822,0.00021596695,0.000734677,0.00027784912],"domain_scores_gemma":[0.99827135,0.00020409809,0.0005189678,0.00013784032,0.00066149095,0.00020626612],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027938109,0.00017309976,0.00046567677,0.00023458141,0.000022814407,0.00002933086,0.00024080576,0.00012059864,0.006963865],"category_scores_gemma":[0.00016998338,0.00011052579,0.000117460855,0.0001722064,0.00009853789,0.0001189064,0.000037244285,0.00047399095,0.0000021682463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034535972,0.001981618,0.95355636,0.000046261757,0.00080222206,0.0005048027,0.00035815116,0.0011565002,0.005543116,0.0004442264,0.0002764477,0.031876676],"study_design_scores_gemma":[0.008151341,0.0012562549,0.97788906,0.00025764655,0.00008772275,0.00004371536,0.00006414573,0.00031491625,0.008446321,0.00025497138,0.0031113736,0.00012253573],"about_ca_topic_score_codex":0.0008515896,"about_ca_topic_score_gemma":0.0018586003,"teacher_disagreement_score":0.03175414,"about_ca_system_score_codex":0.0011025525,"about_ca_system_score_gemma":0.0009791575,"threshold_uncertainty_score":0.9939439},"labels":[],"label_agreement":null},{"id":"W2331564138","doi":"10.1097/igc.0b013e31828a0623","title":"Hemoglobin Level in Cervical Cancer","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Cervical cancer; Hemoglobin; Oncology; Cancer; Internal medicine","score_opus":0.06121036663394259,"score_gpt":0.3618763636395027,"score_spread":0.3006659970055601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331564138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729533,0.0017508436,0.000045280103,0.020902712,0.0016975941,0.00023276174,0.0000274187,0.000011173469,0.002378926],"genre_scores_gemma":[0.9921056,0.0011083378,0.0004829017,0.0045538195,0.00087119895,0.00008938019,0.0000036208046,0.000010835581,0.00077429425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827385,0.000034529563,0.0006020748,0.00017067786,0.00067698676,0.0002418755],"domain_scores_gemma":[0.99849826,0.00023644643,0.00023821442,0.00007524914,0.0007287623,0.0002230826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016011954,0.00014519099,0.00042282324,0.00022999155,0.000018104294,0.000034625013,0.00028842632,0.00012990928,0.023991408],"category_scores_gemma":[0.00035466295,0.000093031405,0.00020782313,0.0002623709,0.0000639346,0.00019020968,0.00007019519,0.0003728638,0.00007525843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012888749,0.0010878866,0.7802879,0.000022932738,0.00050823856,0.0006502704,0.00008083073,0.0001618941,0.003015968,0.00028685355,0.0051790453,0.20742927],"study_design_scores_gemma":[0.005990964,0.00050311617,0.9821046,0.00014060341,0.000055301454,0.00010293926,0.00004640192,0.0000717872,0.0015216004,0.0014593934,0.00788767,0.00011561599],"about_ca_topic_score_codex":0.0012640028,"about_ca_topic_score_gemma":0.00032051347,"teacher_disagreement_score":0.20731367,"about_ca_system_score_codex":0.00097186916,"about_ca_system_score_gemma":0.00026142955,"threshold_uncertainty_score":0.9769008},"labels":[],"label_agreement":null},{"id":"W2331727214","doi":"10.1097/igc.0000000000000235","title":"Pelvic Inflammation and the Pathogenesis of Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Odds ratio; Ovarian cancer; Confidence interval; Cancer; Cohort; Population; Internal medicine; Cohort study; Gynecology; Oncology","score_opus":0.016100145827477853,"score_gpt":0.30308465884688957,"score_spread":0.2869845130194117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331727214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600011,0.0019458784,0.00023844207,0.03575886,0.00084498,0.00016094728,0.000014487122,0.000004212939,0.0010310777],"genre_scores_gemma":[0.99471444,0.003296812,0.00038719483,0.00075037417,0.0007333548,0.000035723006,0.0000014113374,0.000005658493,0.00007500635],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898785,0.00007627629,0.00039035227,0.00009242951,0.0003706283,0.00008243673],"domain_scores_gemma":[0.99851644,0.00039961128,0.00040845832,0.000070778515,0.00054011197,0.000064615706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040675112,0.00008221353,0.00028661574,0.0000668364,0.000027208309,0.000018072436,0.00012104074,0.000054242675,0.00088606036],"category_scores_gemma":[0.00032107587,0.000042506606,0.00012620863,0.000058996317,0.00012648109,0.00006295967,0.000034021785,0.00011212921,0.0000015719467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036954079,0.0003858949,0.33997223,0.00006120912,0.0018763731,0.00009135207,0.00059233035,0.0008683484,0.0045686974,0.022044053,0.0011706458,0.6246734],"study_design_scores_gemma":[0.0077396403,0.00036054896,0.9731547,0.00015722537,0.00031732573,0.000073074916,0.00003854046,0.0005048566,0.0019072908,0.001825043,0.013857679,0.000064067324],"about_ca_topic_score_codex":0.0001283729,"about_ca_topic_score_gemma":0.0000707674,"teacher_disagreement_score":0.63318247,"about_ca_system_score_codex":0.00015815806,"about_ca_system_score_gemma":0.00012260844,"threshold_uncertainty_score":0.97017395},"labels":[],"label_agreement":null},{"id":"W2333131025","doi":"10.1097/igc.0000000000000249","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Sex Cord Stromal Tumors","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Stage (stratigraphy); Natural history; Ovarian cancer; Stromal cell; Oncology; Chemotherapy; Adjuvant; Disease; Internal medicine; Cancer","score_opus":0.08887842818525894,"score_gpt":0.4453858892253338,"score_spread":0.35650746104007486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333131025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011942393,0.98481196,0.00010949083,0.0068262117,0.004932431,0.0019911136,0.0004714511,0.000032658907,0.0007052436],"genre_scores_gemma":[0.0008009706,0.98796207,0.0010760337,0.0048410646,0.0029578703,0.0011375045,0.00010574314,0.00007829338,0.0010404561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521065,0.00028686065,0.0024330665,0.0006498218,0.0008876422,0.00053197396],"domain_scores_gemma":[0.99268425,0.00216864,0.0029584598,0.0003249843,0.0014484571,0.0004152009],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095466484,0.0007314733,0.0043557566,0.00031857064,0.00008027705,0.00007588294,0.00082927715,0.00049209484,0.006095153],"category_scores_gemma":[0.0014960478,0.00046188,0.002218158,0.00021711059,0.00018632784,0.000068667345,0.0001650391,0.0009301258,0.000033253255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034349813,0.0005705718,0.00063726987,0.009591509,0.0037933942,0.0008096613,0.0000076776405,0.000005470257,5.551845e-7,0.00044426363,0.03726326,0.94653285],"study_design_scores_gemma":[0.0025747977,0.0025462075,0.0010090743,0.057220552,0.0049719447,0.0009482192,0.0000076105857,0.000009606377,0.0000026559296,0.00012540114,0.93018425,0.0003996752],"about_ca_topic_score_codex":0.00007354831,"about_ca_topic_score_gemma":0.00010057596,"teacher_disagreement_score":0.9461332,"about_ca_system_score_codex":0.0028281412,"about_ca_system_score_gemma":0.0026517364,"threshold_uncertainty_score":0.9997833},"labels":[],"label_agreement":null},{"id":"W2334084990","doi":"10.1111/igc.0b013e3181c10513","title":"Pharmacogenomics of Taxane/Platinum Therapy in Ovarian Cancer","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Taxane; Carboplatin; Oncology; Ovarian cancer; Paclitaxel; Docetaxel; Cisplatin; Pharmacodynamics; Internal medicine; Pharmacogenetics; Single-nucleotide polymorphism; Pharmacology; Bioinformatics; Cancer; Pharmacokinetics; Chemotherapy; Breast cancer; Genotype; Gene; Genetics; Biology","score_opus":0.04206432992510058,"score_gpt":0.38148674620156986,"score_spread":0.3394224162764693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334084990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011230942,0.9868089,0.000076641045,0.00011322101,0.0011491376,0.00022829486,0.0001758651,0.0000014444055,0.00021554789],"genre_scores_gemma":[0.0046768,0.99346876,0.00023254269,0.00038903035,0.0009878714,0.00002922951,0.000050151903,0.000021219059,0.0001443957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998269,0.00011644337,0.00095810916,0.00022628141,0.00024508007,0.00018508793],"domain_scores_gemma":[0.9981695,0.00005923926,0.0012195734,0.00011629976,0.00036814046,0.00006723899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002745726,0.00025521676,0.0008530995,0.00016956453,0.000013433263,0.000017998986,0.00076134136,0.00038004984,0.0004522959],"category_scores_gemma":[0.000084195,0.00018724072,0.00051685737,0.00009511586,0.00005746756,0.0000064980336,0.00008658648,0.00038115875,0.0000015323346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015606971,0.00020375437,0.0002886528,0.00012001914,0.00059855747,0.00005154517,0.000013011273,0.00015578029,0.0053717266,0.00002468634,0.0009825727,0.9920336],"study_design_scores_gemma":[0.000988702,0.0003453249,0.00024812785,0.0009903957,0.00011392079,0.00007563498,0.0000049740256,0.000005046226,0.0012727913,0.000041168492,0.9956964,0.00021751199],"about_ca_topic_score_codex":0.00004225333,"about_ca_topic_score_gemma":0.00009877776,"teacher_disagreement_score":0.99471384,"about_ca_system_score_codex":0.00021692783,"about_ca_system_score_gemma":0.0007055718,"threshold_uncertainty_score":0.7635455},"labels":[],"label_agreement":null},{"id":"W2334325689","doi":"10.1097/igc.0000000000000411","title":"Outcome of Robotic Surgery for Endometrial Cancer as a Function of Patient Age","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Perioperative; Quality of life (healthcare); Stage (stratigraphy); Cancer; Prospective cohort study; Surgery; Gynecology; Internal medicine","score_opus":0.1236698486028077,"score_gpt":0.39082707913334713,"score_spread":0.2671572305305394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334325689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856604,0.0023671312,0.0005255233,0.0013918056,0.0063023567,0.00033640602,0.00006262281,0.000006996199,0.00044113744],"genre_scores_gemma":[0.9976146,0.00036519347,0.00037973435,0.0005881667,0.0008131041,0.00005376808,0.000009550501,0.000010818325,0.00016505594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976976,0.000056260193,0.0010608468,0.00013562388,0.0008912125,0.00015849162],"domain_scores_gemma":[0.99590933,0.0011935262,0.0009180397,0.00007627587,0.0017020539,0.00020075722],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044323498,0.00012995268,0.0007629705,0.00038536548,0.00001312663,0.000008766533,0.0001479298,0.00010539449,0.001127314],"category_scores_gemma":[0.0037226165,0.0000845778,0.0005062641,0.00029042363,0.00007722321,0.00009512267,0.00004150467,0.00014793553,0.0000025017346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044654626,0.0025183663,0.7279629,0.0001694899,0.0034052148,0.0003230838,0.00020482858,0.0025477225,0.0024438915,0.0007331734,0.0040207305,0.21101594],"study_design_scores_gemma":[0.06673628,0.031446725,0.8045161,0.0011569926,0.003437975,0.00024647938,0.00064002787,0.00014958663,0.024764813,0.0117195025,0.05446887,0.0007166754],"about_ca_topic_score_codex":0.00026277182,"about_ca_topic_score_gemma":0.000043587395,"teacher_disagreement_score":0.21029927,"about_ca_system_score_codex":0.0005722667,"about_ca_system_score_gemma":0.00044331787,"threshold_uncertainty_score":0.9997858},"labels":[],"label_agreement":null},{"id":"W2334330026","doi":"10.1111/igc.0b013e31819a1fbe","title":"Evaluation of Morbidity of Suction Drains After Retroperitoneal Lymphadenectomy in Gynecological Tumors","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Lymphadenectomy; Suction; General surgery; Radiology; Internal medicine; Cancer","score_opus":0.09775143574625696,"score_gpt":0.4257843559132346,"score_spread":0.32803292016697766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334330026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28486592,0.7119814,0.000006302854,0.00031027434,0.001221111,0.00061571103,0.00007719637,0.000008288752,0.0009137731],"genre_scores_gemma":[0.4076108,0.591429,0.00015922272,0.000098301345,0.0005739619,0.000055964436,0.000017292856,0.000013791825,0.00004169682],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946625,0.00053595135,0.0021035736,0.0003013198,0.0021248832,0.00027177396],"domain_scores_gemma":[0.9950004,0.0003892198,0.0018826319,0.00014983493,0.0024495786,0.00012829706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021017867,0.0003423749,0.0022248153,0.00051534333,0.000019511624,0.00001615995,0.00044379398,0.00049715285,0.0024518722],"category_scores_gemma":[0.001629416,0.00022356331,0.00083472824,0.00035088608,0.00024605723,0.00015403648,0.00008361936,0.0006621932,0.000005403748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069825264,0.0013560902,0.003361884,0.0013736193,0.0006814699,0.00082047813,0.00008000677,0.00014804659,0.00012840219,0.00016337581,0.00023164545,0.9909567],"study_design_scores_gemma":[0.011808183,0.009890314,0.572577,0.057984456,0.009724419,0.005215076,0.00021590822,0.0005118527,0.00096951664,0.0025122203,0.32708377,0.0015072947],"about_ca_topic_score_codex":0.00008129777,"about_ca_topic_score_gemma":0.000066931294,"teacher_disagreement_score":0.98944944,"about_ca_system_score_codex":0.0017215465,"about_ca_system_score_gemma":0.0017144234,"threshold_uncertainty_score":0.99846},"labels":[],"label_agreement":null},{"id":"W2334855903","doi":"10.1097/igc.0000000000000055","title":"The Significance of Combination Chemotherapy in Epithelial Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Debulking; Oncology; Internal medicine; Chemotherapy; Ovarian cancer; Population; Proportional hazards model; Combination chemotherapy; Cancer; Surgery; Cisplatin","score_opus":0.018265196115459733,"score_gpt":0.3240976720827991,"score_spread":0.30583247596733937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334855903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9456885,0.001041519,0.00028099105,0.04958513,0.0018738791,0.00027513658,0.000018193175,0.000005687623,0.0012309758],"genre_scores_gemma":[0.99476993,0.0030981784,0.00022503683,0.0012067215,0.00047649993,0.00006272794,0.0000014154641,0.000008421296,0.00015104262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986707,0.00007553962,0.0005162627,0.000119885866,0.0004802443,0.00013739073],"domain_scores_gemma":[0.99831855,0.0004964402,0.00045956887,0.00009144703,0.00056963036,0.000064371154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004965841,0.0000991338,0.00028831008,0.000086567125,0.000030984454,0.00002083454,0.0002370734,0.00006954456,0.00066444144],"category_scores_gemma":[0.00026571268,0.00005742989,0.00013575437,0.00011251945,0.00010269532,0.00006717276,0.000020126467,0.00019257989,0.0000022112738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002182156,0.0012981154,0.50811005,0.000020451158,0.00063165976,0.00006553327,0.00024101327,0.000502476,0.0037351174,0.010166143,0.0016497998,0.47139746],"study_design_scores_gemma":[0.0060004704,0.00070995797,0.9461872,0.00015166024,0.000049441187,0.000016089985,0.000032444717,0.00032728858,0.0064724004,0.00251625,0.03746536,0.00007146011],"about_ca_topic_score_codex":0.0002329451,"about_ca_topic_score_gemma":0.00024997993,"teacher_disagreement_score":0.47132602,"about_ca_system_score_codex":0.0004942474,"about_ca_system_score_gemma":0.00024057495,"threshold_uncertainty_score":0.7275168},"labels":[],"label_agreement":null},{"id":"W2337566264","doi":"10.1097/igc.0000000000000698","title":"BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada); BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of British Columbia; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Endometriosis; Ovarian cancer; Oncology; Gynecology; Cancer research; Internal medicine; Cancer","score_opus":0.016889652567051657,"score_gpt":0.30573388749183494,"score_spread":0.2888442349247833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337566264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225396,0.0037735272,0.0007982942,0.0019842035,0.00094599626,0.00006780468,0.000047239253,0.0000046434347,0.00012435191],"genre_scores_gemma":[0.98702025,0.011536066,0.00032742554,0.00047992737,0.0004298568,0.000023603321,0.000003177408,0.0000104372,0.00016922885],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874425,0.000093206196,0.0004267126,0.0002090686,0.00033897767,0.00018779904],"domain_scores_gemma":[0.99874693,0.00044163098,0.0002894794,0.000076869284,0.00034353227,0.0001015313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003514663,0.00012449635,0.00022700179,0.00016722192,0.000028267723,0.00002544464,0.00028578925,0.00018126014,0.0005220706],"category_scores_gemma":[0.003231688,0.00007659995,0.00011327735,0.00012938111,0.00006970336,0.0000152292005,0.00012103709,0.0001378608,0.0000015037034],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009608085,0.000218284,0.1140041,0.0000051249,0.00020560237,0.000039512193,0.000037889047,0.00015121429,0.75404024,0.000026631771,0.0019111884,0.12839939],"study_design_scores_gemma":[0.016147332,0.0012736629,0.5143009,0.00091345044,0.00008080164,0.00011525916,0.00009060655,0.00016523381,0.40140072,0.00092431495,0.063944995,0.0006427614],"about_ca_topic_score_codex":0.00003577373,"about_ca_topic_score_gemma":0.00013390403,"teacher_disagreement_score":0.40029675,"about_ca_system_score_codex":0.00024477844,"about_ca_system_score_gemma":0.00013672416,"threshold_uncertainty_score":0.5716307},"labels":[],"label_agreement":null},{"id":"W2344200071","doi":"10.1097/igc.0000000000000697","title":"Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal Immunity","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Medicine; Mesothelial Cell; Antigen; Immunology; Peritoneal cavity; Immunity; Pathology; Immune system; Anatomy","score_opus":0.019841760912464347,"score_gpt":0.328275109890655,"score_spread":0.30843334897819064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344200071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452544,0.00017180166,0.0005012373,0.012156465,0.0017913476,0.0002476886,0.0001624008,0.000021801952,0.00042180106],"genre_scores_gemma":[0.9948223,0.00015630672,0.00043972785,0.002140639,0.0015145862,0.000025107445,0.0000034038492,0.000015426422,0.00088246615],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981807,0.00006851461,0.00058634375,0.00022903769,0.0005840072,0.00035141426],"domain_scores_gemma":[0.9983028,0.00022442201,0.0002052981,0.00010886914,0.00072743825,0.00043115384],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034792954,0.00019059035,0.00042927495,0.00019054486,0.00017537313,0.00007445572,0.00030186266,0.000107621134,0.0013493778],"category_scores_gemma":[0.00033215087,0.00011472261,0.00016506796,0.0001248941,0.00014775389,0.00017254449,0.00018244582,0.000268506,0.000057698846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009882387,0.00030686634,0.02602562,0.000015136455,0.00034798935,0.00056328473,0.00034107792,0.00002804296,0.948462,0.00068255543,0.003088599,0.019150557],"study_design_scores_gemma":[0.005234785,0.0031369356,0.7562938,0.0006122802,0.00018426513,0.0010696447,0.00041347728,0.00003124944,0.11347572,0.0003287154,0.11872624,0.00049292395],"about_ca_topic_score_codex":0.00011540739,"about_ca_topic_score_gemma":0.00008056922,"teacher_disagreement_score":0.8349863,"about_ca_system_score_codex":0.00031413737,"about_ca_system_score_gemma":0.00012487522,"threshold_uncertainty_score":0.9995635},"labels":[],"label_agreement":null},{"id":"W2407112162","doi":"10.1097/igc.0000000000000541","title":"Pure Immature Teratoma of the Ovary in Adults","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Etoposide; Immature teratoma; Cystectomy; Fertility preservation; Stage (stratigraphy); Hysterectomy; Chemotherapy; Surgery; Oophorectomy; Gynecology; Fertility; Cancer; Internal medicine; Germ cell tumors; Population","score_opus":0.02475905282875507,"score_gpt":0.32274308205781277,"score_spread":0.2979840292290577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407112162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770029,0.0018402645,0.000003774389,0.018552452,0.0014526299,0.000121100195,0.000017450477,0.0000026619127,0.0010067202],"genre_scores_gemma":[0.9979448,0.00028893605,0.00018402416,0.0011063742,0.0003675537,0.00001207368,0.0000013695573,0.000004718122,0.00009017537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895227,0.00003811191,0.00035489706,0.000084530286,0.00048200483,0.00008815698],"domain_scores_gemma":[0.99893284,0.000083601255,0.0002694599,0.00008006953,0.00055174495,0.00008231543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016874622,0.0000757286,0.00022106644,0.00006976259,0.0000078430585,0.000008873328,0.00020988341,0.0000785903,0.00041413226],"category_scores_gemma":[0.00025396355,0.000038473805,0.00013815853,0.00010738836,0.000048055113,0.00006410616,0.00004917188,0.00023540342,0.0000023327977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031213823,0.0010309254,0.9557827,0.000023565413,0.00038236377,0.0010373233,0.00054644083,0.00026570412,0.00018910244,0.0005854469,0.011894012,0.02514105],"study_design_scores_gemma":[0.004517394,0.0005211874,0.98454154,0.0005234739,0.000040387044,0.00023603793,0.0001162902,0.000025328172,0.0014442278,0.00076010433,0.0072267465,0.00004727169],"about_ca_topic_score_codex":0.00004330258,"about_ca_topic_score_gemma":0.00009735661,"teacher_disagreement_score":0.028758865,"about_ca_system_score_codex":0.00042502253,"about_ca_system_score_gemma":0.00034322252,"threshold_uncertainty_score":0.45344576},"labels":[],"label_agreement":null},{"id":"W2411567469","doi":"10.1097/igc.0000000000000488","title":"Is a More Comprehensive Surgery Necessary in Patients With Uterine Serous Carcinoma?","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Medicine; Omentectomy; Stage (stratigraphy); Serous fluid; Endometrial cancer; Ovarian cancer; Radiology; Serous carcinoma; Lymphadenectomy; Sentinel lymph node; Lymph node; Cancer; Surgery; General surgery; Breast cancer; Hysterectomy; Internal medicine","score_opus":0.06489455593212966,"score_gpt":0.3485831189859651,"score_spread":0.28368856305383544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411567469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934619,0.00065958465,0.000012706576,0.004508524,0.0008588652,0.00014386217,0.00003631851,0.0000072971184,0.00031093956],"genre_scores_gemma":[0.99508834,0.00011243894,0.00021646896,0.0041020215,0.00033368787,0.000013227657,0.000015325908,0.000010582691,0.000107894055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834764,0.000042103533,0.00044809683,0.00015461972,0.0008302843,0.00017724866],"domain_scores_gemma":[0.997866,0.0002388716,0.00027775683,0.000077524695,0.0013024487,0.0002374459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001136578,0.00014156835,0.0004665951,0.00024065615,0.000012215024,0.000018049308,0.00015757271,0.00007422289,0.0008347694],"category_scores_gemma":[0.0001926738,0.0000850608,0.00012851301,0.00023947116,0.00006304019,0.00014707568,0.000057049674,0.00023349845,0.0000073859956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057536387,0.0006342885,0.9792805,0.000012931939,0.0002442617,0.0008573402,0.00010277836,0.0000600277,0.000007589712,0.0000044212875,0.001894023,0.011148213],"study_design_scores_gemma":[0.009467709,0.0012378519,0.98332846,0.00009568424,0.000049666272,0.00006261722,0.00007375281,0.000013023653,0.000111866764,0.00008376699,0.0053823497,0.00009324007],"about_ca_topic_score_codex":0.00019082449,"about_ca_topic_score_gemma":0.000028876586,"teacher_disagreement_score":0.011054974,"about_ca_system_score_codex":0.00065850664,"about_ca_system_score_gemma":0.00031140257,"threshold_uncertainty_score":0.914014},"labels":[],"label_agreement":null},{"id":"W2412169767","doi":"10.1136/00009577-201505001-00054","title":"UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Endometrial cancer; Cancer; Gynecologic cancer; Uterine sarcoma; Uterine cancer; Sarcoma; Gynecology; Oncology; Ovarian cancer; Internal medicine; Pathology","score_opus":0.07350475750504878,"score_gpt":0.38407118295865306,"score_spread":0.31056642545360424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412169767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615186,0.0005166376,0.00008207957,0.00082646747,0.002014607,0.00019544661,0.000055860593,0.000015711299,0.00014131184],"genre_scores_gemma":[0.9979438,0.0003411611,0.00032020282,0.0002271822,0.00082913716,0.000060973467,0.00002270052,0.000012499357,0.00024235032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984771,0.00005635674,0.0003528593,0.00016356375,0.0007781146,0.00017199678],"domain_scores_gemma":[0.99795085,0.00006519648,0.000552168,0.00008767132,0.0009866897,0.0003574444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000089100184,0.00016060416,0.00038602087,0.0001813268,0.000026878794,0.000050614657,0.00021476364,0.00007673343,0.0017174273],"category_scores_gemma":[0.00019338625,0.00008775122,0.0001276849,0.00010135172,0.00006910388,0.00015999717,0.00005793268,0.00022546912,0.0000044507037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067693777,0.0034818805,0.9518957,0.0000070168453,0.0013686322,0.005183394,0.00011594687,0.00003333451,0.0007676012,0.000081030375,0.00047209178,0.029824005],"study_design_scores_gemma":[0.016348345,0.005753877,0.9725849,0.00013810958,0.00071721745,0.00076390663,0.000052514166,0.000049189915,0.0015900893,0.00013005492,0.0017285619,0.00014322608],"about_ca_topic_score_codex":0.00022060167,"about_ca_topic_score_gemma":0.00031594574,"teacher_disagreement_score":0.02968078,"about_ca_system_score_codex":0.00065817544,"about_ca_system_score_gemma":0.0002699256,"threshold_uncertainty_score":0.99919516},"labels":[],"label_agreement":null},{"id":"W2412393832","doi":"10.1097/igc.0000000000000492","title":"Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Calgary Laboratory Services; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Cancer research; Missense mutation; Point mutation; Gene; Mutation; Pathology; Biology; Genetics","score_opus":0.05680496379844683,"score_gpt":0.3514368437438316,"score_spread":0.29463187994538476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412393832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845165,0.001969006,0.00015150645,0.0074546216,0.0016168308,0.00018622637,0.000036569385,0.000010449202,0.0040582903],"genre_scores_gemma":[0.9954983,0.00013682891,0.0018030307,0.0017328424,0.00056160486,0.000025834763,0.000012898215,0.000012198063,0.00021646242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807423,0.00009388398,0.00062799535,0.00017511628,0.000807132,0.00022162123],"domain_scores_gemma":[0.99818027,0.00035919575,0.0002919012,0.00009240883,0.0006469495,0.00042929407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039844486,0.00014624259,0.00040239972,0.0005901003,0.000023695433,0.000031719992,0.00024126915,0.00010439199,0.0021835282],"category_scores_gemma":[0.0014647098,0.000103532795,0.0001980732,0.00053441594,0.000076396944,0.00017274416,0.000056830144,0.00032183697,0.000030497731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010827177,0.0029763654,0.91176486,0.000020340673,0.0007023761,0.010546862,0.00067153265,0.0003727081,0.003354598,0.0015322727,0.0019446911,0.055286195],"study_design_scores_gemma":[0.040300626,0.0033592635,0.9271687,0.00014173584,0.00021042327,0.0009393064,0.00067845173,0.00007251015,0.0034832158,0.006459545,0.016893752,0.00029241855],"about_ca_topic_score_codex":0.0003863339,"about_ca_topic_score_gemma":0.0001078012,"teacher_disagreement_score":0.05499378,"about_ca_system_score_codex":0.0011671382,"about_ca_system_score_gemma":0.00051464123,"threshold_uncertainty_score":0.99872863},"labels":[],"label_agreement":null},{"id":"W2413833375","doi":"10.1097/igc.0000000000000754","title":"A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Genotyping; Incidence (geometry); Mole; Obstetrics; Gynecology; Internal medicine; Genotype; Genetics; Gene; Biology","score_opus":0.020411113158334895,"score_gpt":0.3397694356946676,"score_spread":0.31935832253633273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413833375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953577,0.00027009696,0.0019381003,0.0013190149,0.0004357806,0.00010348844,0.000042053583,0.0000026126256,0.0005311764],"genre_scores_gemma":[0.99770796,0.000068803005,0.0019160378,0.00017256007,0.00009781879,0.000003727035,3.97404e-7,0.0000060835923,0.000026614422],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986208,0.000044253582,0.00044356947,0.000092611364,0.0006940551,0.00010468373],"domain_scores_gemma":[0.9975464,0.00043520203,0.0005871431,0.000062621184,0.0013130073,0.00005563351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015502112,0.000084186795,0.0002375769,0.00007726614,0.000022606575,0.000003398541,0.0002165887,0.000039280265,0.00025463355],"category_scores_gemma":[0.001940751,0.000042192543,0.00016435997,0.0001060158,0.00021678349,0.00008498831,0.0001033437,0.0001057762,0.0000010014552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025590886,0.00053676043,0.26393828,0.000050608225,0.0014023222,0.00021451592,0.000319292,0.0016761651,0.7185718,0.0033889015,0.0002916688,0.007050603],"study_design_scores_gemma":[0.0024091846,0.00049497536,0.9124626,0.00080411095,0.00020616264,0.0002532005,0.00018034653,0.00028314322,0.08106834,0.001535072,0.00020924948,0.000093646086],"about_ca_topic_score_codex":0.000031107924,"about_ca_topic_score_gemma":0.000010013606,"teacher_disagreement_score":0.6485243,"about_ca_system_score_codex":0.00024760712,"about_ca_system_score_gemma":0.00044251585,"threshold_uncertainty_score":0.27880585},"labels":[],"label_agreement":null},{"id":"W2417035048","doi":"10.1097/igc.0000000000000751","title":"How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma?","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Germ cell tumors; Chemotherapy; Malignancy; Incidence (geometry); Immature teratoma; Teratoma; Adjuvant chemotherapy; Demographics; Adjuvant therapy; Internal medicine; Surgery; Cancer","score_opus":0.0076618218991625275,"score_gpt":0.25942238866336137,"score_spread":0.25176056676419883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417035048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663559,0.00031694694,0.000033685097,0.032751035,0.00030562602,0.0001476404,0.00004084246,0.0000065634786,0.000041746513],"genre_scores_gemma":[0.9975784,0.0000319138,0.00013458732,0.0020027976,0.00010248676,0.000012648919,0.0000037900988,0.000008860607,0.00012452422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898666,0.000037656573,0.00021746468,0.00011770131,0.0005026228,0.0001378638],"domain_scores_gemma":[0.9991477,0.00014525464,0.00020765535,0.00009081162,0.0003116918,0.0000968851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006867291,0.00011389097,0.00021104263,0.000075395285,0.000029687408,0.000056336718,0.00018750525,0.00005957684,0.00037224297],"category_scores_gemma":[0.000118425654,0.000043577405,0.00010835248,0.00007617888,0.000053998425,0.0002952368,0.000036579047,0.0001570323,0.0000038892194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095263013,0.0003984852,0.97890216,0.0000037976272,0.00037872852,0.0014978164,0.000024735733,0.0000023194825,0.000055435015,0.0001493265,0.0002554493,0.01737913],"study_design_scores_gemma":[0.004896004,0.00071833,0.9916773,0.00030999325,0.00008317833,0.0002281062,0.000014105987,0.000004653197,0.00009798064,0.00026156323,0.0016447873,0.00006401029],"about_ca_topic_score_codex":0.000011562561,"about_ca_topic_score_gemma":0.0000132272735,"teacher_disagreement_score":0.031222478,"about_ca_system_score_codex":0.00028700748,"about_ca_system_score_gemma":0.00008591663,"threshold_uncertainty_score":0.40757996},"labels":[],"label_agreement":null},{"id":"W2418350638","doi":"10.1097/igc.0000000000000740","title":"Gestational Trophoblastic Disease","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gestational trophoblastic disease; Disease registry; Pregnancy; Family medicine; Gynecologic oncology; Obstetrics; Disease; Gynecology; Gestation; Internal medicine","score_opus":0.022745419162718706,"score_gpt":0.33126015306117385,"score_spread":0.30851473389845513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418350638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95434135,0.00065304484,0.0040634824,0.03781087,0.0019064384,0.00012916584,0.00013988795,0.000022547953,0.000933206],"genre_scores_gemma":[0.99530333,0.00052674714,0.0011468424,0.0012704539,0.0007692433,0.000020452911,0.0000033646197,0.000010840596,0.00094870484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983104,0.000034158937,0.00043794804,0.00014734364,0.0009110816,0.00015910905],"domain_scores_gemma":[0.9970636,0.00075348874,0.00026937138,0.0000664427,0.0015357307,0.00031137958],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000109828085,0.00012104623,0.0002256614,0.0001503769,0.000032259373,0.000016751577,0.00018610676,0.00003529507,0.0047191684],"category_scores_gemma":[0.0026295632,0.000065000386,0.000198071,0.000071933915,0.00017093125,0.00013918291,0.00004950407,0.000103246304,0.000076111035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01683144,0.0025898654,0.7758804,0.00008051215,0.0029886721,0.0076664933,0.00014346767,0.0009006509,0.021850068,0.020614624,0.038936965,0.11151687],"study_design_scores_gemma":[0.002759066,0.00036067265,0.9795149,0.00021147465,0.00014265325,0.00009591005,0.00002162752,0.000028269027,0.00011496008,0.0048876344,0.011767732,0.00009508748],"about_ca_topic_score_codex":0.0000017360117,"about_ca_topic_score_gemma":0.0000018696178,"teacher_disagreement_score":0.20363455,"about_ca_system_score_codex":0.00037543342,"about_ca_system_score_gemma":0.00052148243,"threshold_uncertainty_score":0.99619067},"labels":[],"label_agreement":null},{"id":"W2422175811","doi":"10.1097/igc.0000000000000548","title":"Oncologists’ Perceptions of Recurrent Ovarian Cancer Patients’ Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Preference; Perception; Certainty; Family medicine; Gynecology; Affect (linguistics); Qualitative research; Psychology","score_opus":0.38603019837096436,"score_gpt":0.5242907844306114,"score_spread":0.13826058605964703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422175811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926708,0.00046843715,0.00072062016,0.0032923901,0.00081220345,0.0017073691,0.0002811072,0.000004969019,0.000042116404],"genre_scores_gemma":[0.99266404,0.00038585495,0.005076231,0.00030393773,0.000082432656,0.0014359526,0.00003132427,0.0000083244595,0.000011893022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822974,0.00025358205,0.00075672584,0.00022360697,0.0003234875,0.00021285733],"domain_scores_gemma":[0.99513113,0.0015756654,0.00072646234,0.00012445757,0.0023195674,0.00012269377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042660814,0.00012023074,0.00031153287,0.00021726973,0.00008465293,0.000022257458,0.00033417158,0.00013823775,0.000053927684],"category_scores_gemma":[0.0027242852,0.00009009259,0.000029969584,0.00009697693,0.00005323052,0.00036983372,0.00015126562,0.00020182483,2.9421423e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015177162,0.00044488005,0.91684556,0.00007682434,0.00002336331,3.357969e-7,0.014958526,0.00034711257,0.0000040113687,0.00018313245,0.0005151483,0.065083385],"study_design_scores_gemma":[0.0050770612,0.0023095754,0.97543555,0.0008531569,0.00002399868,1.6179591e-7,0.006275486,0.0019615474,0.0000039316706,0.0068054753,0.0011472853,0.000106792424],"about_ca_topic_score_codex":0.00046808802,"about_ca_topic_score_gemma":0.016642388,"teacher_disagreement_score":0.064976595,"about_ca_system_score_codex":0.0014760166,"about_ca_system_score_gemma":0.00085835106,"threshold_uncertainty_score":0.9286843},"labels":[],"label_agreement":null},{"id":"W2460872248","doi":"10.1097/igc.0000000000000747","title":"Cost-Efficiency of Robotic Surgery","year":2016,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Robotic surgery; General surgery; Surgery","score_opus":0.12292179449638994,"score_gpt":0.38455201390622457,"score_spread":0.2616302194098346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460872248","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02692449,0.0012797577,0.0017378507,0.95508057,0.0072742715,0.0003421663,0.00006623961,0.000028873548,0.0072657736],"genre_scores_gemma":[0.64246744,0.00078112434,0.00015487954,0.34520528,0.009134643,0.000014073872,0.000029183806,0.000029775705,0.002183586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733096,0.00008961312,0.001003919,0.00017815361,0.0011533758,0.00024398923],"domain_scores_gemma":[0.9944286,0.0028870257,0.0010796264,0.00010517386,0.0013906455,0.000108951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000455519,0.00018570358,0.00080430205,0.00034828816,0.000018828443,0.00001726564,0.00030335403,0.00044915106,0.011306344],"category_scores_gemma":[0.001486059,0.0001085666,0.00064664567,0.0001117671,0.00015930718,0.00007473089,0.000048339054,0.0009544015,0.000024371762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088968466,0.00031369214,0.032414243,0.00010585959,0.0014243929,0.0070641087,0.000055394095,0.0005324272,0.000107323765,0.00009898507,0.78414655,0.17284735],"study_design_scores_gemma":[0.0018616371,0.00021831616,0.014750675,0.00072147517,0.00015666119,0.0002468881,0.000008011695,0.000065138745,0.00013671145,0.00024285933,0.9814398,0.00015181571],"about_ca_topic_score_codex":0.0000058687338,"about_ca_topic_score_gemma":0.0000012178962,"teacher_disagreement_score":0.61554295,"about_ca_system_score_codex":0.00035994698,"about_ca_system_score_gemma":0.00048061417,"threshold_uncertainty_score":0.98959744},"labels":[],"label_agreement":null},{"id":"W2508425080","doi":"10.1097/igc.0000000000000764","title":"Hysterectomy for Uterine Cancer in the Elderly","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Uterine cancer; Perioperative; Odds ratio; Hysterectomy; Complication; Laparoscopy; Laparoscopic surgery; Confounding; Ileus; Logistic regression; Cancer; Surgery; Internal medicine","score_opus":0.051015719320649,"score_gpt":0.3991572375752952,"score_spread":0.3481415182546462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508425080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452214,0.0012533106,0.0005014923,0.049982097,0.0018371833,0.00032370506,0.00009501761,0.0000068986697,0.0007788806],"genre_scores_gemma":[0.9944574,0.0012065996,0.0002033767,0.0022299178,0.0011096474,0.00014375077,0.0000011379789,0.000006859481,0.0006412712],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988807,0.000042834425,0.00038482275,0.00011656959,0.00041411197,0.00016099926],"domain_scores_gemma":[0.99852234,0.0007299339,0.0002038399,0.00006678231,0.00040995024,0.00006716445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027604564,0.00009699011,0.00025774102,0.00011424193,0.000018309885,0.000018203024,0.00028892173,0.00005968787,0.0027796277],"category_scores_gemma":[0.00039388792,0.000038593498,0.00018663735,0.00011787039,0.000046054258,0.00009497798,0.000024040306,0.000113599446,0.0000050628355],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040105307,0.00051950704,0.10804796,0.000022695272,0.00045495306,0.0002933005,0.0000907028,0.000011770089,0.0041901157,0.00051158626,0.002234684,0.8796122],"study_design_scores_gemma":[0.02332406,0.005050006,0.6691471,0.00048366853,0.00016377706,0.00023090238,0.0000764854,0.000011678002,0.0032658493,0.0036612249,0.29440406,0.00018121116],"about_ca_topic_score_codex":0.000056627694,"about_ca_topic_score_gemma":0.00015388141,"teacher_disagreement_score":0.87943095,"about_ca_system_score_codex":0.00041860054,"about_ca_system_score_gemma":0.00013439936,"threshold_uncertainty_score":0.998132},"labels":[],"label_agreement":null},{"id":"W2516496845","doi":"10.1097/igc.0000000000000767","title":"European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Documentation; Quality management; Quality (philosophy); Multidisciplinary approach; Audit; Medical physics; Performance indicator; Operations management; Management system","score_opus":0.07202843200884235,"score_gpt":0.4079634512288954,"score_spread":0.33593501922005303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516496845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94018286,0.0016715202,0.0014548951,0.051390152,0.0030078064,0.00043891114,0.00028252715,0.000022406939,0.001548936],"genre_scores_gemma":[0.988114,0.0057920353,0.0024602346,0.0024899512,0.0007301157,0.000106903295,0.00000584822,0.000018487091,0.00028242858],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99787253,0.00016309238,0.0009926234,0.00024919194,0.00047008356,0.0002525065],"domain_scores_gemma":[0.9952016,0.0022927094,0.0012740914,0.00012618201,0.00092202617,0.00018342755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010970576,0.00017141021,0.00070531765,0.00014868833,0.00004201592,0.000010281671,0.00026638375,0.00014246079,0.0034883374],"category_scores_gemma":[0.00083878555,0.000095514384,0.0007111852,0.0001301133,0.00018708446,0.00012055534,0.00006678826,0.00016179644,0.0000045953025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013488104,0.0009701552,0.37977353,0.00004001552,0.0013723841,0.00008991717,0.0000901881,0.000028310693,0.002809917,0.0005487478,0.013016553,0.59991145],"study_design_scores_gemma":[0.0061353752,0.00099249,0.87166524,0.0002001189,0.000193463,0.000030500636,0.00005831951,0.0000034913048,0.00411757,0.00045621025,0.11601065,0.00013659324],"about_ca_topic_score_codex":0.000036548503,"about_ca_topic_score_gemma":0.00003986324,"teacher_disagreement_score":0.5997749,"about_ca_system_score_codex":0.0015190073,"about_ca_system_score_gemma":0.00090040517,"threshold_uncertainty_score":0.99742264},"labels":[],"label_agreement":null},{"id":"W2520365215","doi":"10.1097/igc.0000000000000761","title":"Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute of Cancer Research; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Epithelial–mesenchymal transition; Metformin; Oncology; Cancer research; Internal medicine; Cancer; Cadherin; Cell; Metastasis; Insulin","score_opus":0.009525383185721875,"score_gpt":0.25984433132700485,"score_spread":0.25031894814128297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520365215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541135,0.044322163,0.0000377438,0.00010368526,0.0007558189,0.00020086653,0.00042890353,0.0000020482642,0.000035317433],"genre_scores_gemma":[0.93248934,0.06641733,0.000108107335,0.00013083215,0.0007244626,0.000082676605,0.000010195115,0.000012784923,0.00002429913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998255,0.00012875044,0.0006618528,0.00025426951,0.00045067165,0.0002494369],"domain_scores_gemma":[0.9985577,0.00030514802,0.00046876352,0.000081554,0.00048682658,0.00009999773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000345998,0.00019161413,0.00046855828,0.00026147554,0.000016360162,0.000017771172,0.00027890137,0.00014131714,0.000832945],"category_scores_gemma":[0.0006302362,0.000117053714,0.00011139205,0.00019442354,0.00015049131,0.000051408962,0.000060249728,0.00012466781,3.6021908e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008355817,0.0010469103,0.60833454,0.00006128101,0.0003525058,0.000039173305,0.00012831065,0.0007770411,0.13471246,0.000030705367,0.00018957448,0.24597171],"study_design_scores_gemma":[0.03225477,0.0021720296,0.48626915,0.0005725838,0.00014195117,0.000007667199,0.0001064272,0.000018702322,0.46592355,0.0001922563,0.011830136,0.00051076844],"about_ca_topic_score_codex":0.0011384857,"about_ca_topic_score_gemma":0.0025744662,"teacher_disagreement_score":0.3312111,"about_ca_system_score_codex":0.0001715383,"about_ca_system_score_gemma":0.00029007642,"threshold_uncertainty_score":0.91201633},"labels":[],"label_agreement":null},{"id":"W2526061589","doi":"10.1136/ijgc-00009577-200303001-00066","title":"Human Kallikreins (HKS) as Novel Serum Biomarkers in Ovarian Cancer","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Kallikrein; Ovarian cancer; Cancer biomarkers; Oncology; Cancer; Internal medicine; Cancer research; Enzyme; Biochemistry","score_opus":0.019716495900939424,"score_gpt":0.3292309527982408,"score_spread":0.30951445689730134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526061589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925161,0.0021787141,0.00025282073,0.0012829422,0.0011595204,0.00009584388,0.00007129994,0.0000031128745,0.0024396686],"genre_scores_gemma":[0.9959769,0.0010759723,0.0003969406,0.0016719293,0.000510447,0.00002158081,0.000011412002,0.000012259145,0.00032254978],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988367,0.0000641438,0.00039713757,0.00020969943,0.0002917425,0.00020055476],"domain_scores_gemma":[0.9991081,0.00002054912,0.00022101634,0.00009733169,0.00040426737,0.00014874565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022912098,0.00013311743,0.00016018972,0.000106293744,0.000042653883,0.00003474968,0.00033096023,0.00014690576,0.0015318709],"category_scores_gemma":[0.00027760834,0.000115912444,0.00014870908,0.00007447894,0.000085433036,0.000010243193,0.000047158956,0.00013292472,0.0000037535372],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076853344,0.0015555888,0.32001036,0.000021213047,0.00095414143,0.00023484536,0.00007373261,0.0019213876,0.6601592,0.0031870278,0.0076250215,0.0034889672],"study_design_scores_gemma":[0.0103900535,0.001117407,0.7095718,0.00013512533,0.0000995228,0.00016269126,0.00023708623,0.000026136628,0.11188894,0.005490119,0.16024365,0.00063748716],"about_ca_topic_score_codex":0.000108325075,"about_ca_topic_score_gemma":0.00059892714,"teacher_disagreement_score":0.5482702,"about_ca_system_score_codex":0.0001527052,"about_ca_system_score_gemma":0.0003292588,"threshold_uncertainty_score":0.9993809},"labels":[],"label_agreement":null},{"id":"W2532858212","doi":"10.1097/igc.0000000000000609","title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":757,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"European Society for Medical Oncology; Fonds Wetenschappelijk Onderzoek; Vlaamse regering; Clovis Oncology; AstraZeneca","keywords":"Medicine; Endometrial cancer; Gynecology; Cancer; General surgery; Obstetrics; Internal medicine","score_opus":0.15376275156976282,"score_gpt":0.410199666340215,"score_spread":0.25643691477045216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532858212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524284,0.0018040567,0.00006784867,0.022905074,0.008341581,0.00029356245,0.000113903196,0.00003114467,0.014014459],"genre_scores_gemma":[0.99209905,0.00093630963,0.00044010428,0.0030295402,0.002516565,0.00003708283,0.000006645382,0.000014005368,0.0009206977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99752116,0.00009525046,0.00063448766,0.0002257649,0.0012600777,0.00026324915],"domain_scores_gemma":[0.99656177,0.0005893156,0.0004699507,0.00011110001,0.0017768438,0.0004910381],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038371896,0.00020256548,0.00056696305,0.0003172275,0.000031874195,0.000046374636,0.00032495684,0.00014850033,0.004537166],"category_scores_gemma":[0.002232055,0.000129781,0.0002743757,0.00029205286,0.00013682905,0.00007244087,0.000064389074,0.00044727846,0.000053698637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0847773,0.005489738,0.400425,0.00005443237,0.0064465036,0.008312832,0.0004674503,0.001753371,0.004045448,0.009471854,0.0645353,0.41422078],"study_design_scores_gemma":[0.15739654,0.030748768,0.42406884,0.001358537,0.001838373,0.0018305902,0.00080109254,0.00047316268,0.020796021,0.016523307,0.34275198,0.0014127676],"about_ca_topic_score_codex":0.00027043512,"about_ca_topic_score_gemma":0.00006238198,"teacher_disagreement_score":0.41280803,"about_ca_system_score_codex":0.0011421108,"about_ca_system_score_gemma":0.0009052571,"threshold_uncertainty_score":0.9963728},"labels":[],"label_agreement":null},{"id":"W2538173625","doi":"10.1097/igc.0000000000000836","title":"Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca España; Sanofi; PharmaMar; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Bevacizumab; Neutropenia; Gastrointestinal perforation; Surgery; Ovarian cancer; Adverse effect; Perforation; Carboplatin; Clinical endpoint; Internal medicine; Febrile neutropenia; Chemotherapy; Cancer; Peritonitis; Randomized controlled trial","score_opus":0.04761933129659347,"score_gpt":0.3667722720665962,"score_spread":0.3191529407700027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538173625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804784,0.002343268,0.000068457826,0.008086729,0.0006950744,0.00052295247,0.000047084162,0.000008295537,0.00018031542],"genre_scores_gemma":[0.9924691,0.0062951003,0.00018712993,0.00054098095,0.00038174374,0.00007380668,0.0000017478502,0.00001496368,0.00003544993],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998149,0.00009961705,0.00078534364,0.00024804188,0.0005123437,0.00020567856],"domain_scores_gemma":[0.9979471,0.00082984555,0.0005096125,0.00011363708,0.00044329083,0.0001565339],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036858264,0.00018381426,0.0005739948,0.00019844095,0.000030497431,0.000024317667,0.00019940858,0.0000867186,0.0016888657],"category_scores_gemma":[0.00033560058,0.000105212755,0.00012591004,0.00012409555,0.000093466464,0.00014749114,0.000050722505,0.0001832252,0.0000013123782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011051608,0.008107911,0.45705244,0.000005101114,0.00079835864,0.00079933373,0.0005775605,0.000043201737,0.002924977,0.00012477368,0.00010494419,0.5184098],"study_design_scores_gemma":[0.07796419,0.013611398,0.9022247,0.00054071314,0.00012633622,0.000048455,0.0001806528,0.000012037393,0.0018600054,0.00013362122,0.0031678504,0.00013000389],"about_ca_topic_score_codex":0.00038008965,"about_ca_topic_score_gemma":0.0004735507,"teacher_disagreement_score":0.5182798,"about_ca_system_score_codex":0.0009113002,"about_ca_system_score_gemma":0.0003023964,"threshold_uncertainty_score":0.9992237},"labels":[],"label_agreement":null},{"id":"W2555336854","doi":"10.1097/igc.0000000000000871","title":"Synchronous Ovarian and Appendiceal Mucinous Neoplasms in the Absence of Pseudomyxoma Peritonei","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"Calgary Laboratory Services","keywords":"Pseudomyxoma peritonei; Medicine; Appendix; Pathology; Mucin; PAX8; Immunohistochemistry; Concordance; Mucinous cystadenoma; Ovary; Internal medicine; Biology","score_opus":0.01425579091304168,"score_gpt":0.2938120571779009,"score_spread":0.2795562662648592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555336854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838794,0.00049622176,0.00009081303,0.013880301,0.00051605445,0.00011757944,0.00001617431,0.0000044161816,0.0009990333],"genre_scores_gemma":[0.9974279,0.00066342833,0.00032367668,0.0011268319,0.0003703387,0.0000084081075,6.507979e-7,0.0000053833933,0.0000733952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998685,0.000059249345,0.00047079378,0.00012508204,0.00048730435,0.00017254136],"domain_scores_gemma":[0.9988902,0.00042941578,0.00028233044,0.000073426505,0.00025138777,0.00007321496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037246794,0.0001070735,0.00029006484,0.00010221989,0.000029253448,0.000017280809,0.0002879379,0.00008069024,0.0007547436],"category_scores_gemma":[0.0002231285,0.00004893224,0.000095398835,0.00007945449,0.00024633456,0.00011673241,0.00004800108,0.0001944267,0.0000049954415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004016457,0.0014613121,0.6333104,0.000115311006,0.0005606252,0.0067829425,0.002450349,0.00003428881,0.12928435,0.015807737,0.0012153141,0.20496096],"study_design_scores_gemma":[0.0027877388,0.0014373347,0.98154914,0.00043279512,0.000040675608,0.0037138779,0.00040297463,0.000030437843,0.0030525322,0.0011282916,0.005308757,0.000115434195],"about_ca_topic_score_codex":0.000103380116,"about_ca_topic_score_gemma":0.00007413161,"teacher_disagreement_score":0.3482388,"about_ca_system_score_codex":0.00012104108,"about_ca_system_score_gemma":0.00014824174,"threshold_uncertainty_score":0.8263913},"labels":[],"label_agreement":null},{"id":"W2570142471","doi":"10.1097/igc.0000000000000907","title":"Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Western University; Institute for Clinical Evaluative Sciences","funders":"Schulich School of Medicine and Dentistry, Western University; Cancer Care Ontario; Ontario Ministry of Health and Long-Term Care; Schulich School of Medicine and Dentistry; Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute","keywords":"Medicine; Serous carcinoma; Odds ratio; Confidence interval; Logistic regression; Medical genetics; Gynecology; Ovarian cancer; Family medicine; Human genetics; Cancer; Demography; Internal medicine; Genetics","score_opus":0.027122887361327543,"score_gpt":0.3166035112877513,"score_spread":0.28948062392642376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570142471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616903,0.00052011077,0.00004123529,0.0020586771,0.00073537836,0.000136932,0.00004199981,5.0943663e-7,0.0002961181],"genre_scores_gemma":[0.99848753,0.00012044799,0.00085895346,0.00027316768,0.00015147595,0.000028697876,0.000010155427,0.0000059752642,0.00006357587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900544,0.00006373344,0.00039551838,0.00012251084,0.00029015268,0.00012267365],"domain_scores_gemma":[0.9986638,0.000093225484,0.00056297454,0.00016938802,0.00046403497,0.000046607907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033098253,0.000088753695,0.00016903426,0.0000786556,0.00007887488,0.00004556471,0.0007353364,0.00011233566,0.00007570275],"category_scores_gemma":[0.00054414856,0.00006435664,0.00010704393,0.000035353834,0.00012973741,0.000013773956,0.000056279732,0.0001462164,3.404528e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011781199,0.00011038066,0.98601454,0.0000066800403,0.00020976411,0.000092632676,0.0006628893,0.0023639456,0.004659819,0.00021027958,0.0005179956,0.00503327],"study_design_scores_gemma":[0.0011323264,0.00026819977,0.96085376,0.000033274122,0.000039232476,0.000020450492,0.000101644386,0.000027897126,0.031985655,0.00045261605,0.0050036972,0.000081237755],"about_ca_topic_score_codex":0.18799892,"about_ca_topic_score_gemma":0.89914364,"teacher_disagreement_score":0.7111447,"about_ca_system_score_codex":0.0006200615,"about_ca_system_score_gemma":0.0027488596,"threshold_uncertainty_score":0.81740826},"labels":[],"label_agreement":null},{"id":"W2583145397","doi":"10.1097/igc.0000000000000900","title":"Improved Outcome of High-Grade, Early 1-Stage Endometrioid Endometrial Carcinoma With Adjuvant Chemotherapy and Radiotherapy","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Radiation therapy; Endometrial cancer; Stage (stratigraphy); Lymphadenectomy; Carcinoma; Chemotherapy; Cancer; Internal medicine; Surgery; Oncology; Gynecology","score_opus":0.038542006488905454,"score_gpt":0.3460330891168387,"score_spread":0.3074910826279333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583145397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928951,0.0021286986,0.00028945014,0.002857447,0.0011877834,0.00032560882,0.00007818531,0.000008875942,0.00022880414],"genre_scores_gemma":[0.99386346,0.0022546048,0.0020117345,0.0005451105,0.0008780155,0.000018793811,0.0000029383407,0.000021190292,0.00040415884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979979,0.00004663532,0.0007108539,0.00023775602,0.00077743136,0.00022943965],"domain_scores_gemma":[0.9971676,0.00052901317,0.001181321,0.00022699554,0.00065860373,0.00023645468],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035003532,0.00022036023,0.0009010181,0.0004134017,0.00008163859,0.0000802398,0.00046481643,0.00011676002,0.0010299489],"category_scores_gemma":[0.0008941702,0.00012934899,0.0002502801,0.00016993619,0.0002757646,0.00022226326,0.00006426239,0.00031840746,8.626218e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013256557,0.0005595659,0.88299257,0.000028503639,0.0013333561,0.0003815806,0.00007134633,0.0000069426396,0.005674707,0.0001588267,0.000035362944,0.09550068],"study_design_scores_gemma":[0.03833938,0.0055919765,0.94375217,0.000059283837,0.00016041948,0.000114201335,0.000020139418,0.000020325817,0.009660499,0.00009770989,0.0020438007,0.00014008034],"about_ca_topic_score_codex":0.001105475,"about_ca_topic_score_gemma":0.000072009556,"teacher_disagreement_score":0.0953606,"about_ca_system_score_codex":0.00035741352,"about_ca_system_score_gemma":0.00015401474,"threshold_uncertainty_score":0.99988323},"labels":[],"label_agreement":null},{"id":"W2599032975","doi":"10.1097/igc.0000000000000934","title":"The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; University of British Columbia","funders":"","keywords":"Medicine; Gynecologic cancer; Clinical trial; Proxy (statistics); Citation; Impact factor; Gynecologic oncology; Cancer; Demography; Gerontology; Oncology; Statistics; Library science; Internal medicine; Ovarian cancer","score_opus":0.6701508049921997,"score_gpt":0.6895927536888642,"score_spread":0.01944194869666449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599032975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524609,0.0015978424,0.00030938114,0.022754123,0.018721264,0.0020371284,0.0013474929,0.000018325878,0.0007535384],"genre_scores_gemma":[0.9685294,0.017038468,0.0017455512,0.0011514213,0.010138354,0.0011585993,0.000024274852,0.000029479954,0.0001844516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929852,0.0012940433,0.003125368,0.0006871712,0.0011790327,0.00072919164],"domain_scores_gemma":[0.972432,0.017853959,0.003705651,0.00061171333,0.0049100886,0.00048658063],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.018173583,0.00037923388,0.0017441093,0.00012406944,0.00058548193,0.00030797345,0.0021410915,0.0005604783,0.0014627654],"category_scores_gemma":[0.030994562,0.00020230122,0.002346508,0.00011937695,0.0010018157,0.00033795947,0.00028828086,0.0009937289,0.0000048020183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014939094,0.0024847132,0.60850847,0.000015533024,0.00503595,0.00006317193,0.00001996539,0.0013593878,0.00001579903,0.0022357046,0.032858666,0.33246353],"study_design_scores_gemma":[0.011551868,0.012322861,0.92529255,0.000296457,0.00044391688,0.00002384371,0.000040968756,0.0012259184,0.000066883804,0.0074150893,0.04111306,0.00020657909],"about_ca_topic_score_codex":0.000710496,"about_ca_topic_score_gemma":0.0020307428,"teacher_disagreement_score":0.33225694,"about_ca_system_score_codex":0.0030157974,"about_ca_system_score_gemma":0.0018524496,"threshold_uncertainty_score":0.99945},"labels":[],"label_agreement":null},{"id":"W2608251600","doi":"10.1097/igc.0000000000000946","title":"A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; Women's College Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Surgery; Stage (stratigraphy); Oncology; Internal medicine; Cancer","score_opus":0.0554060840473489,"score_gpt":0.38358083397277015,"score_spread":0.3281747499254213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608251600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342984,0.00045620123,0.000011625033,0.0037572763,0.0015467673,0.0002278933,0.000039861345,0.0000074439117,0.00052307465],"genre_scores_gemma":[0.9981327,0.000939749,0.0003346445,0.0003054506,0.00015858268,0.000045720957,0.000010813618,0.000018075665,0.00005425851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998146,0.00004408547,0.0006961855,0.00020976471,0.00068861013,0.00021536287],"domain_scores_gemma":[0.9973482,0.0004892901,0.0011755095,0.00017434212,0.0006995243,0.000113135124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018958285,0.00019744634,0.0009887681,0.00015775838,0.000058140322,0.00004004421,0.00028197456,0.00009585885,0.00044065525],"category_scores_gemma":[0.00025015205,0.00012496856,0.00020027267,0.00006600763,0.00010123314,0.00019264144,0.000046457895,0.0002321051,9.876934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006951118,0.001659861,0.8981569,0.000016346774,0.000868553,0.00019733323,0.00009712581,0.00018866594,0.000093455856,0.00001610065,0.00009265001,0.09166189],"study_design_scores_gemma":[0.015292383,0.0011652552,0.9810386,0.00042643546,0.00013005153,0.0000052625687,0.000031513267,0.000028805782,0.0011025273,0.000012317698,0.0006428619,0.00012398834],"about_ca_topic_score_codex":0.00069729204,"about_ca_topic_score_gemma":0.0010447735,"teacher_disagreement_score":0.09153791,"about_ca_system_score_codex":0.0010270185,"about_ca_system_score_gemma":0.00038222614,"threshold_uncertainty_score":0.509607},"labels":[],"label_agreement":null},{"id":"W2614076649","doi":"10.1097/igc.0000000000000989","title":"Simple Vaginal Trachelectomy","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Trachelectomy; Pelvic exenteration; Stage (stratigraphy); Cervical cancer; Lymphovascular invasion; Surgery; Lymph node; Dissection (medical); Adenocarcinoma; Cancer; Internal medicine; Metastasis","score_opus":0.05167931698252111,"score_gpt":0.3989455529319204,"score_spread":0.3472662359493993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614076649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765254,0.0007831881,0.00014108473,0.010116097,0.0017491103,0.00010013891,0.000017861908,0.000011135994,0.010555986],"genre_scores_gemma":[0.9959173,0.00044161614,0.00033390362,0.0013407427,0.0013914974,0.000009269128,0.000002939771,0.0000072478774,0.0005554458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881476,0.000020550196,0.00033085057,0.000118078045,0.000559429,0.0001563281],"domain_scores_gemma":[0.9985118,0.00012847046,0.0004337699,0.00013083188,0.0006217067,0.00017344978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017750161,0.00010085268,0.00029652004,0.00009236439,0.00009509585,0.00008066949,0.00044186538,0.00007442211,0.0050883023],"category_scores_gemma":[0.00084571034,0.00006393914,0.00022014798,0.000039514915,0.000093476156,0.0001839819,0.00006461153,0.00025314282,0.00002312275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028637135,0.0007661875,0.7227471,0.0000129926,0.0010352433,0.0017780729,0.000037308455,0.000019822122,0.0025803351,0.0005753614,0.0034838605,0.2641],"study_design_scores_gemma":[0.0060359454,0.0009844934,0.9296754,0.000044965673,0.00013915292,0.00023262152,0.000013022359,0.000020256866,0.0033059327,0.0022426308,0.05721861,0.000086943044],"about_ca_topic_score_codex":0.00008143593,"about_ca_topic_score_gemma":0.00003250861,"teacher_disagreement_score":0.26401305,"about_ca_system_score_codex":0.00031912336,"about_ca_system_score_gemma":0.00017493541,"threshold_uncertainty_score":0.9958212},"labels":[],"label_agreement":null},{"id":"W2726082851","doi":"10.1097/igc.0000000000001062","title":"Resisting RECIST—Uniformity Versus Clinical Validity","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Clinical trial; Radiological weapon; Clinical endpoint; Context (archaeology); Medical physics; Internal medicine; Phases of clinical research; Radiology","score_opus":0.313133501353789,"score_gpt":0.5049708940150812,"score_spread":0.19183739266129224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726082851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546726,0.00031876154,0.00007884809,0.010368019,0.010328377,0.0001155331,0.000025439433,0.000014770353,0.024077646],"genre_scores_gemma":[0.9930982,0.001129307,0.0011034189,0.00068278005,0.0031678095,0.000006077887,0.0000032835865,0.000008035274,0.0008011094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981039,0.0001034472,0.0007173984,0.00018140116,0.00071417075,0.00017965207],"domain_scores_gemma":[0.9965119,0.0011390471,0.0009264994,0.00022248708,0.00094738085,0.00025271738],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011154095,0.00012185632,0.00045207192,0.00007732197,0.00024494904,0.000088027715,0.0005897534,0.00014653591,0.0022247022],"category_scores_gemma":[0.012032668,0.00007921958,0.00041588122,0.00004556398,0.00018070875,0.00020069865,0.00015939877,0.0005568165,0.000027671053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0137673225,0.0006861099,0.6696786,0.000010748335,0.00085451984,0.0011089542,0.000015782729,0.0000057354264,0.0000646941,0.00039478246,0.0028584658,0.31055427],"study_design_scores_gemma":[0.011578452,0.0018572665,0.93879366,0.00009517866,0.00021059049,0.00006993311,0.000018141842,0.000016322889,0.0003124478,0.0011958779,0.045752034,0.00010011428],"about_ca_topic_score_codex":0.00011070611,"about_ca_topic_score_gemma":0.00009507287,"teacher_disagreement_score":0.31045416,"about_ca_system_score_codex":0.000461869,"about_ca_system_score_gemma":0.00026193188,"threshold_uncertainty_score":0.9986874},"labels":[],"label_agreement":null},{"id":"W2736297642","doi":"10.1097/igc.0000000000001074","title":"Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Medicine; Hazard ratio; Stage (stratigraphy); Internal medicine; Proportional hazards model; Retrospective cohort study; Confidence interval; Confounding; Cohort; Cancer; Ovarian cancer; Population; Cohort study; Oncology; Environmental health","score_opus":0.01872574061172092,"score_gpt":0.31438678397740977,"score_spread":0.2956610433656888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736297642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925939,0.0004164184,0.000011467167,0.0047448785,0.0016268084,0.00027758465,0.000024803037,0.000003675509,0.00030047641],"genre_scores_gemma":[0.997015,0.0013876163,0.000036487738,0.0007592801,0.00059177313,0.00011579239,7.8365366e-7,0.0000098710525,0.00008338587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.00007407301,0.0003723543,0.0001704448,0.0004740177,0.00014136423],"domain_scores_gemma":[0.9983081,0.0008089906,0.00043211266,0.00013597382,0.00020772794,0.000107062486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003293517,0.00013018868,0.00034583235,0.00013039012,0.00007726106,0.000056977133,0.00026203366,0.00008052165,0.0005242617],"category_scores_gemma":[0.00092212704,0.000079354155,0.00008484095,0.00004138922,0.0000833406,0.00011609416,0.000113845585,0.00023912419,0.0000063612365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092172826,0.0003194951,0.84333146,0.000019265557,0.000362704,0.0002685456,0.00012098001,0.00011175661,0.0020926138,0.00006866849,0.00011116047,0.15227161],"study_design_scores_gemma":[0.0036506339,0.0016360485,0.98514134,0.0006459405,0.000087948225,0.000027474378,0.000010020377,0.00003420416,0.0076151663,0.00010450376,0.0009708065,0.00007588962],"about_ca_topic_score_codex":0.0008965176,"about_ca_topic_score_gemma":0.00073290383,"teacher_disagreement_score":0.15219572,"about_ca_system_score_codex":0.0006133155,"about_ca_system_score_gemma":0.000113571194,"threshold_uncertainty_score":0.57402974},"labels":[],"label_agreement":null},{"id":"W2756082032","doi":"10.1097/igc.0000000000001124","title":"Survival Benefit of Adjuvant Radiotherapy","year":2017,"lang":"fr","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Stage (stratigraphy); Internal medicine; Oncology; Radiation therapy; Multivariate analysis; Population; Univariate analysis; Gynecology","score_opus":0.04861966841275897,"score_gpt":0.39249215057113496,"score_spread":0.34387248215837596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756082032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7344556,0.11286221,0.0003158656,0.094871685,0.05036372,0.00027416268,0.00033735228,0.0000066363796,0.006512807],"genre_scores_gemma":[0.9263678,0.06381303,0.0008957288,0.00067159237,0.005235992,0.000011572595,0.0000028478653,0.000018646082,0.0029827591],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776876,0.000059501148,0.0008259686,0.0002038621,0.0008547155,0.00028721808],"domain_scores_gemma":[0.99624723,0.00042648552,0.0015963339,0.00028312954,0.0012066726,0.00024012188],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005226285,0.00020902074,0.00076054607,0.00010854229,0.000091250426,0.00008946394,0.0007899204,0.00017294071,0.011977364],"category_scores_gemma":[0.0005262989,0.00015269713,0.00047216102,0.000035843615,0.0003707246,0.0002566769,0.000099255696,0.0003410845,0.000017589398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001087259,0.0015661736,0.40270635,0.000048585218,0.0033456774,0.0014683299,0.000145556,0.00042696416,0.0005231246,0.0067995344,0.004329667,0.5775528],"study_design_scores_gemma":[0.0058556404,0.0016860667,0.87424284,0.0010412126,0.00038401448,0.00013837467,0.000045236487,0.0001331592,0.001540737,0.0010461825,0.11374741,0.00013911062],"about_ca_topic_score_codex":0.0005379543,"about_ca_topic_score_gemma":0.00021154684,"teacher_disagreement_score":0.5774137,"about_ca_system_score_codex":0.001174762,"about_ca_system_score_gemma":0.000498657,"threshold_uncertainty_score":0.9889258},"labels":[],"label_agreement":null},{"id":"W2756953462","doi":"10.1097/igc.0000000000001132","title":"National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Surgery; Ovarian cancer; Incidence (geometry); Splenectomy; Cancer; Internal medicine","score_opus":0.08102089862001093,"score_gpt":0.4154022105215397,"score_spread":0.33438131190152875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756953462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88626987,0.0027270871,0.00017505359,0.10122992,0.0045883753,0.0003982815,0.00017780981,0.000020187892,0.0044134343],"genre_scores_gemma":[0.9945502,0.001089771,0.00071005215,0.0014472964,0.0014662141,0.00020506285,0.000009803917,0.00001317143,0.00050841004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847126,0.000020126217,0.0005135682,0.00020080424,0.0005898672,0.00020438276],"domain_scores_gemma":[0.9978127,0.0003917138,0.00063585717,0.000097697615,0.0009526485,0.00010937296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042676862,0.00013656444,0.00039473962,0.00032009085,0.00009964064,0.0000980408,0.00027907063,0.000101043326,0.0017541329],"category_scores_gemma":[0.0012685463,0.00009775625,0.00029901494,0.00006069148,0.00007069422,0.00022238429,0.000043114327,0.00017437166,0.000001619548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018499714,0.0010090448,0.6907404,0.000034376866,0.00089499325,0.00043952384,0.00008723389,0.0002774127,0.00022058446,0.0018135768,0.021691833,0.280941],"study_design_scores_gemma":[0.0033206074,0.00018480625,0.9778434,0.00033201152,0.00007807156,0.00007817823,0.000012840429,0.000151914,0.0004326411,0.001671537,0.015788376,0.00010563498],"about_ca_topic_score_codex":0.0001699992,"about_ca_topic_score_gemma":0.0010188364,"teacher_disagreement_score":0.28710294,"about_ca_system_score_codex":0.0009877401,"about_ca_system_score_gemma":0.0009126171,"threshold_uncertainty_score":0.9991584},"labels":[],"label_agreement":null},{"id":"W2773127260","doi":"10.1097/igc.0000000000001149","title":"Ovarian Yolk Sac Tumors; Does Age Matter?","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Germ cell tumors; Endodermal sinus tumor; Carboplatin; Internal medicine; Regimen; Gynecology; Oncology; Cisplatin; Chemotherapy","score_opus":0.025737019870740695,"score_gpt":0.36172498854123014,"score_spread":0.33598796867048947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773127260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98427093,0.00035574078,0.000080442485,0.0095110545,0.0015306864,0.00009472217,0.00003809159,0.000009561295,0.0041087517],"genre_scores_gemma":[0.995918,0.00011802462,0.0006493953,0.0013968986,0.0006950982,0.000008246818,0.00000475384,0.00000842799,0.0012011699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904364,0.000018328541,0.00027941543,0.00011743654,0.0004110374,0.0001301474],"domain_scores_gemma":[0.998843,0.00006545283,0.00043839423,0.00015687461,0.00032032494,0.00017593658],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008695386,0.00010096594,0.00023731044,0.00005590631,0.00008717783,0.00011019841,0.0003470156,0.000052946772,0.005269477],"category_scores_gemma":[0.0004296275,0.000055222306,0.00020492538,0.000013501038,0.00009310955,0.00013694953,0.000081436636,0.00015356072,0.000057289024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042139072,0.00047138604,0.9659033,0.000008854164,0.0005713672,0.007964266,0.000027776516,0.000010249849,0.0005603569,0.00036501556,0.0016135204,0.022082545],"study_design_scores_gemma":[0.0019942413,0.00022227169,0.98963434,0.00011756243,0.00013708865,0.00026992246,0.000014809892,0.0000127651065,0.00025416128,0.0016593314,0.0056176875,0.00006580076],"about_ca_topic_score_codex":0.00007468936,"about_ca_topic_score_gemma":0.000022764072,"teacher_disagreement_score":0.023731086,"about_ca_system_score_codex":0.00020423267,"about_ca_system_score_gemma":0.00012585075,"threshold_uncertainty_score":0.99563986},"labels":[],"label_agreement":null},{"id":"W2793566573","doi":"10.1097/igc.0000000000001229","title":"Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Lymphadenectomy; Stage (stratigraphy); Oncology; Proportional hazards model; Univariate analysis; Hysterectomy; Lymph node; Lymphovascular invasion; Retrospective cohort study; Survival analysis; Multivariate analysis; Cancer; Radiology; Metastasis","score_opus":0.04717568821761944,"score_gpt":0.34251187006249406,"score_spread":0.29533618184487465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793566573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946675,0.0024462617,0.00009492204,0.0011429411,0.00082527014,0.00038854912,0.00008008279,0.0000035289245,0.00035098693],"genre_scores_gemma":[0.9966761,0.0018516649,0.00046842414,0.00040876112,0.0004786275,0.00006321311,0.0000031188383,0.000009328646,0.000040791794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972792,0.00022647051,0.0009111482,0.00021162625,0.0011452124,0.00022629813],"domain_scores_gemma":[0.996801,0.0014682971,0.0006983615,0.00014893568,0.0008006092,0.00008279879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009700949,0.0001641376,0.000632017,0.00048138972,0.000019610243,0.000014791925,0.00049320364,0.000099912235,0.0011495556],"category_scores_gemma":[0.0027616383,0.00009535663,0.00024627583,0.00093507965,0.00027814624,0.00013690435,0.00007004297,0.00021588521,0.000003120585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004148342,0.0010577438,0.976239,0.00005852746,0.00038608964,0.00034818024,0.00033950884,0.00037863286,0.0056320997,0.00023898127,0.000048893686,0.011123945],"study_design_scores_gemma":[0.010105704,0.0012244585,0.9675564,0.0004724478,0.00012378303,0.000031211162,0.00017910272,0.000041105108,0.019044273,0.0003137403,0.00080289645,0.00010484194],"about_ca_topic_score_codex":0.0026552028,"about_ca_topic_score_gemma":0.00056990684,"teacher_disagreement_score":0.013412173,"about_ca_system_score_codex":0.00054106617,"about_ca_system_score_gemma":0.00048604133,"threshold_uncertainty_score":0.99976355},"labels":[],"label_agreement":null},{"id":"W2795906974","doi":"10.1097/igc.0000000000001244","title":"Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; London Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Ovarian cancer; Cohort; Oncology; Cohort study; Cancer; Overall survival; Gynecology; Internal medicine; Obstetrics","score_opus":0.04396397100379561,"score_gpt":0.35094423362071553,"score_spread":0.3069802626169199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795906974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906885,0.00039847073,0.00013907797,0.00476865,0.0017125679,0.00013576463,0.00003694978,0.000010170552,0.002109867],"genre_scores_gemma":[0.9957911,0.00054763793,0.001553033,0.0010555357,0.00069689157,0.00006109792,0.0000016289929,0.000015220416,0.00027785325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983729,0.000037928705,0.0004959001,0.00018514175,0.0006835073,0.00022462093],"domain_scores_gemma":[0.99773335,0.00025238137,0.00053751003,0.00011613982,0.0011937765,0.00016685003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024812482,0.00015840483,0.00055503554,0.00012678663,0.000033228815,0.000018311479,0.00022418582,0.00007321715,0.005435734],"category_scores_gemma":[0.00017971019,0.000093557115,0.00009004123,0.00012650042,0.00017167957,0.00012955834,0.00004794137,0.00017699531,0.0000049810924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025934828,0.00056376157,0.9025561,0.000012960395,0.001963878,0.00057581504,0.00035714818,0.000112289934,0.00075137167,0.00032555358,0.00032571887,0.0898619],"study_design_scores_gemma":[0.00551822,0.0035322958,0.98266244,0.00019719343,0.00013663813,0.00009207116,0.0002455676,0.000011604927,0.0016614281,0.000116734656,0.0057172314,0.00010858948],"about_ca_topic_score_codex":0.00008484246,"about_ca_topic_score_gemma":0.00014887011,"teacher_disagreement_score":0.08975331,"about_ca_system_score_codex":0.00077513786,"about_ca_system_score_gemma":0.0004273485,"threshold_uncertainty_score":0.99547344},"labels":[],"label_agreement":null},{"id":"W2800112131","doi":"10.1097/igc.0000000000001288","title":"Changing Clinical Practice","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Population and Public Health; Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Workload; Knowledge translation; Cohesion (chemistry); Public relations; Family medicine; Management; Knowledge management; Political science","score_opus":0.7046344571015535,"score_gpt":0.7782160147021238,"score_spread":0.07358155760057028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800112131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7652998,0.000088942004,0.007443123,0.15868376,0.027997965,0.0003773526,0.000036382757,0.0000403901,0.040032305],"genre_scores_gemma":[0.8506005,0.00024386079,0.0059464895,0.13331996,0.00902483,0.000023349723,5.2850095e-7,0.000007806154,0.00083272404],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962185,0.00093586877,0.0014742733,0.00014657358,0.00081477576,0.0004100274],"domain_scores_gemma":[0.9874089,0.0069958386,0.0014537678,0.000092089016,0.003806455,0.0002429767],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0066556456,0.000079041296,0.00022288317,0.00020422132,0.0002890354,0.000018010098,0.0005903311,0.0001246012,0.010966105],"category_scores_gemma":[0.025477538,0.000056304878,0.00009083622,0.0002432149,0.00019687554,0.00043625827,0.00017247467,0.00064533815,0.000494464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015051555,0.00038802632,0.34851345,0.00003119092,0.00045443463,0.00032845137,0.015914228,0.000016382062,0.00041342241,0.013430829,0.33632335,0.28268108],"study_design_scores_gemma":[0.0010755757,0.00041313499,0.0906415,0.0000572559,0.000015046729,0.000028340008,0.0020719457,0.000042912,0.00003591492,0.00061321707,0.9049378,0.000067351415],"about_ca_topic_score_codex":0.000031733583,"about_ca_topic_score_gemma":0.00006742328,"teacher_disagreement_score":0.5686145,"about_ca_system_score_codex":0.00046164475,"about_ca_system_score_gemma":0.001135038,"threshold_uncertainty_score":0.989938},"labels":[],"label_agreement":null},{"id":"W2802955457","doi":"10.1097/igc.0000000000001266","title":"A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ureteral procedures and complications","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Medicine; Cervical cancer; General surgery; Medical physics; Surgery; Urology; Cancer; Internal medicine","score_opus":0.0376210652470438,"score_gpt":0.3904043807795871,"score_spread":0.35278331553254333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802955457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98237914,0.00055602443,0.0028326088,0.01340095,0.00039699773,0.000310721,0.000070297945,0.000009770582,0.000043472817],"genre_scores_gemma":[0.9923315,0.0002589328,0.003163612,0.0032221423,0.0007086966,0.00021529626,0.000022563236,0.000008785996,0.00006847931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988752,0.00003251327,0.000513971,0.00015154017,0.0003059714,0.00012081517],"domain_scores_gemma":[0.9978876,0.00048167552,0.00026205103,0.00006559265,0.0012099728,0.00009312095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018638521,0.000101980324,0.00028834693,0.00015211655,0.00005996502,0.000030568677,0.00010789926,0.00008869491,0.0015681994],"category_scores_gemma":[0.00072798034,0.000064991975,0.00013298482,0.00010381237,0.00008032981,0.000107212414,0.000021726264,0.000114073315,5.31095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019428539,0.0003728391,0.98573005,0.000109562585,0.00025328845,0.000013775876,0.000057824902,0.0009175482,0.00080881856,0.00051330455,0.0014492786,0.007830853],"study_design_scores_gemma":[0.0009878516,0.0007467673,0.98867065,0.000107778345,0.00011986828,0.000040321273,0.0000134849115,0.007325814,0.00015595186,0.00038096844,0.0013710634,0.000079456455],"about_ca_topic_score_codex":0.000081559694,"about_ca_topic_score_gemma":0.0006423215,"teacher_disagreement_score":0.010178807,"about_ca_system_score_codex":0.00018114163,"about_ca_system_score_gemma":0.000881626,"threshold_uncertainty_score":0.9993445},"labels":[],"label_agreement":null},{"id":"W2802973166","doi":"10.1097/igc.0000000000001260","title":"The Feasibility of Laparoscopic Surgery in Gynecologic Oncology for Obese and Morbidly Obese Patients","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto; Canada Research Chairs","funders":"","keywords":"Medicine; Morbidly obese; Gynecologic oncology; General surgery; Laparoscopic surgery; Internal medicine; Laparoscopy; Oncology; Obesity; Weight loss","score_opus":0.0821649365873252,"score_gpt":0.41405026968757724,"score_spread":0.33188533310025203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802973166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370635,0.0011687601,0.000011796207,0.0025572958,0.0017440199,0.0003463176,0.000026291473,0.0000038078786,0.0004353681],"genre_scores_gemma":[0.9970353,0.0015241418,0.00021946299,0.0007202455,0.0003755785,0.000044100994,0.0000036624285,0.0000057483326,0.00007171725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848247,0.000103709266,0.0006964339,0.00015908656,0.00036008618,0.00019824698],"domain_scores_gemma":[0.9950023,0.0031771774,0.00046137883,0.00008422845,0.0011641711,0.00011071888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073157356,0.000108894616,0.00049280666,0.00013506555,0.00004835018,0.000013578404,0.00019058798,0.00012136491,0.00036817696],"category_scores_gemma":[0.004497334,0.00005918355,0.00016801868,0.00016228035,0.00030498402,0.00007501541,0.00006888027,0.00017408411,0.0000018293983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004545484,0.0008932769,0.91651255,0.000024161054,0.00016765688,0.000039899503,0.000052202235,0.0000023423086,0.00013888856,0.000106689804,0.0005526476,0.076964185],"study_design_scores_gemma":[0.006126698,0.0036881552,0.98245573,0.00007833507,0.000058029353,0.000013312587,0.00004527278,0.00001796862,0.000531007,0.0030418641,0.0038864734,0.00005712904],"about_ca_topic_score_codex":0.000062636194,"about_ca_topic_score_gemma":0.0006168006,"teacher_disagreement_score":0.07690705,"about_ca_system_score_codex":0.00063913956,"about_ca_system_score_gemma":0.00032335415,"threshold_uncertainty_score":0.53840536},"labels":[],"label_agreement":null},{"id":"W2885119975","doi":"10.1097/igc.0000000000001343","title":"Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Lions Gate Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Presentation (obstetrics); Cancer; Oncology; Population; Protein expression; Internal medicine; Obstetrics; Gene; Genetics; Environmental health","score_opus":0.03634856272110681,"score_gpt":0.37480343244463504,"score_spread":0.33845486972352823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885119975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940476,0.0001307262,0.00024199541,0.002452714,0.0021626104,0.00077211246,0.000053492982,0.000031941192,0.00010682825],"genre_scores_gemma":[0.99467987,0.000009989645,0.002594566,0.0012747587,0.0011655637,0.00015289227,0.000010603434,0.000017703716,0.00009405384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975956,0.0001689254,0.00060385757,0.000297513,0.0011703189,0.00016379946],"domain_scores_gemma":[0.9975767,0.00081032305,0.00048239803,0.00014556569,0.00083343394,0.00015157001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032168886,0.00018774264,0.00040915352,0.00027766568,0.00006666314,0.000043355223,0.00020134007,0.00012524416,0.0037689477],"category_scores_gemma":[0.0017387827,0.00012591766,0.00017362843,0.00015221705,0.00006974386,0.00008816656,0.000046251338,0.000275932,0.0000040964824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049446803,0.0007044547,0.980571,0.000008185367,0.00021118303,0.00006150793,0.000110019646,0.0006840487,0.00724449,0.0000027698006,0.00047468705,0.004983013],"study_design_scores_gemma":[0.007494226,0.0031507197,0.97527397,0.00021141674,0.000109451,0.000002149426,0.0000702062,0.0019862235,0.010945398,0.00013274375,0.000491771,0.00013169939],"about_ca_topic_score_codex":0.0007438789,"about_ca_topic_score_gemma":0.00037976625,"teacher_disagreement_score":0.0052969647,"about_ca_system_score_codex":0.0006111919,"about_ca_system_score_gemma":0.00029944818,"threshold_uncertainty_score":0.9971417},"labels":[],"label_agreement":null},{"id":"W2886197649","doi":"10.1097/igc.0000000000001347","title":"Low-Risk Gestational Trophoblastic Neoplasia in Manitoba","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Gestational trophoblastic neoplasia; Methotrexate; Dactinomycin; Obstetrics; Gynecology; Internal medicine","score_opus":0.01785775449673799,"score_gpt":0.31375335960092837,"score_spread":0.2958956051041904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886197649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933303,0.0002009499,0.00069240946,0.0024101902,0.0017765838,0.00012638097,0.000051768387,0.000011840125,0.0013995639],"genre_scores_gemma":[0.9952148,0.00035772496,0.002013876,0.00090936874,0.0013279063,0.00001913681,0.000006068496,0.000012452456,0.0001386241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807864,0.0000640584,0.0006095149,0.00018120253,0.00085807004,0.0002085132],"domain_scores_gemma":[0.99708456,0.00064132974,0.0003893069,0.000067148125,0.0016619974,0.0001556864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020992271,0.00014693175,0.00030389946,0.00028505622,0.00004720173,0.000027314947,0.00021988769,0.00007027925,0.002523853],"category_scores_gemma":[0.0021626202,0.000109649685,0.00014405417,0.00017428058,0.00025302148,0.00012876681,0.00005931224,0.0003170875,0.00009769321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059423507,0.0017521946,0.94684327,0.000041347557,0.0009849119,0.0026247615,0.00047257886,0.0019499463,0.0025605548,0.0017377315,0.0075973347,0.027492993],"study_design_scores_gemma":[0.0028523232,0.0009854949,0.99023026,0.00017297846,0.000086401225,0.00018629564,0.00022697613,0.0003988672,0.00028442926,0.0023495648,0.0021208208,0.00010561237],"about_ca_topic_score_codex":0.000045556408,"about_ca_topic_score_gemma":0.0003468505,"teacher_disagreement_score":0.04338694,"about_ca_system_score_codex":0.0005563866,"about_ca_system_score_gemma":0.00043784568,"threshold_uncertainty_score":0.998388},"labels":[],"label_agreement":null},{"id":"W2895289546","doi":"10.1097/igc.0000000000001351","title":"Bevacizumab in Metastatic, Recurrent, or Persistent Cervical Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Cervical cancer; Oncology; Cancer; Internal medicine; Chemotherapy","score_opus":0.0868023314230248,"score_gpt":0.40661551677113994,"score_spread":0.31981318534811515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895289546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97712886,0.0031251707,0.000048005357,0.012916912,0.0038628876,0.00025873934,0.00006273343,0.00001486521,0.0025818471],"genre_scores_gemma":[0.99232996,0.0019809627,0.00069174415,0.0026563432,0.001580364,0.000047443908,0.0000047819076,0.000012676684,0.00069571804],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99793136,0.00007932728,0.0006842978,0.00022120705,0.00081233046,0.00027147465],"domain_scores_gemma":[0.99807394,0.0002982989,0.00031738667,0.00009110278,0.0009803667,0.00023888862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027057392,0.00017129519,0.0005050974,0.00028039105,0.000034806475,0.000030388019,0.00031385422,0.00008910163,0.02245898],"category_scores_gemma":[0.0006667858,0.000099352685,0.00032110076,0.00035613932,0.00014250944,0.00013313907,0.00008162184,0.0003471045,0.00003737148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051004883,0.004437764,0.3077677,0.00009633404,0.0039642286,0.0037699463,0.00078646035,0.00013041256,0.0010765096,0.00052893907,0.007220888,0.61921597],"study_design_scores_gemma":[0.040987793,0.01784116,0.7654017,0.0011003654,0.0011851548,0.0011397932,0.00062489597,0.0006891225,0.0032789381,0.0015430616,0.16558674,0.0006212631],"about_ca_topic_score_codex":0.00023936495,"about_ca_topic_score_gemma":0.0011263922,"teacher_disagreement_score":0.6185947,"about_ca_system_score_codex":0.0012439532,"about_ca_system_score_gemma":0.00047968607,"threshold_uncertainty_score":0.9784346},"labels":[],"label_agreement":null},{"id":"W2898411507","doi":"10.1097/igc.0000000000001367","title":"Outcome of First-Line Hysterectomy for Gestational Trophoblastic Neoplasia in Patients No Longer Wishing to Conceive and Considered With Isolated Lung Metastases","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Hysterectomy; Methotrexate; Gestational trophoblastic disease; Chemotherapy; Salvage therapy; Lung; Surgery; Metastasis; Choriocarcinoma; Radiology; Pregnancy; Internal medicine; Gestation; Cancer","score_opus":0.023075307440337693,"score_gpt":0.3347471994054304,"score_spread":0.3116718919650927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898411507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422085,0.00010277304,0.0027930718,0.0016694464,0.00045430966,0.00044732878,0.00024326204,0.000005399465,0.000063572304],"genre_scores_gemma":[0.9944838,0.00002076252,0.004591151,0.00061104,0.00017604831,0.000042066917,0.000016070344,0.000012271879,0.00004677819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984097,0.000034785964,0.00067135115,0.000184393,0.0005357048,0.00016408587],"domain_scores_gemma":[0.99396116,0.001216816,0.00040219276,0.000049001465,0.004230908,0.00013993018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014168154,0.00015092995,0.00044386135,0.00022054074,0.00003710035,0.00002326909,0.00010723312,0.000045538392,0.00034643494],"category_scores_gemma":[0.003235434,0.00010383956,0.00007218474,0.000120145356,0.00020265907,0.0001445505,0.0000459334,0.00012608092,0.0000027385167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011019558,0.0004455147,0.9842709,0.000087488654,0.0007086333,0.000090391426,0.00032334475,0.0010740923,0.00015514145,0.00013479106,0.0006736891,0.0010165032],"study_design_scores_gemma":[0.008425112,0.0046054376,0.9843028,0.00037811525,0.00020444125,0.000031963747,0.000114037684,0.0011105047,0.000099065364,0.0002470662,0.00036014285,0.00012131697],"about_ca_topic_score_codex":0.000021742622,"about_ca_topic_score_gemma":0.00015592719,"teacher_disagreement_score":0.004448528,"about_ca_system_score_codex":0.00027559642,"about_ca_system_score_gemma":0.00019875157,"threshold_uncertainty_score":0.4234454},"labels":[],"label_agreement":null},{"id":"W2909029412","doi":"10.1136/ijgc-2018-000040","title":"Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Epithelial ovarian cancer; Gynecology; Ovarian cancer; Demography; Cancer; Population; Oncology; Obstetrics; Internal medicine; Environmental health","score_opus":0.011652689490016653,"score_gpt":0.2713113292248358,"score_spread":0.2596586397348192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909029412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678946,0.00040260155,0.0000019727806,0.00096319575,0.0007021342,0.00053224317,0.0005581613,0.0000038590024,0.000046372155],"genre_scores_gemma":[0.9989128,0.00018915789,0.000055933775,0.0003938,0.00011446289,0.00019139679,0.000014006575,0.000016810718,0.00011160015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778116,0.00009534502,0.0007377108,0.00022620753,0.00094019424,0.00021940327],"domain_scores_gemma":[0.9977906,0.00034521997,0.0006788842,0.00011358627,0.0009309501,0.00014080715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026130184,0.00013162181,0.0006895547,0.00009023495,0.000020905118,0.00003607945,0.00021704254,0.00007410357,0.0037273024],"category_scores_gemma":[0.00015354583,0.00012681793,0.00008119281,0.00015479137,0.00003872025,0.000104987164,0.000028556226,0.0002121775,3.086711e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007169898,0.0017202396,0.99117714,0.00003180216,0.00084905676,0.00036538613,0.000111775975,0.001044049,0.000051802654,0.0000030018296,0.00025269567,0.0036760797],"study_design_scores_gemma":[0.0076085827,0.0024732165,0.9882688,0.00048365133,0.00012918517,0.0000102424365,0.00047246975,0.000020975956,0.00015535353,0.000010972597,0.00024481557,0.00012175493],"about_ca_topic_score_codex":0.92527765,"about_ca_topic_score_gemma":0.98039174,"teacher_disagreement_score":0.055114117,"about_ca_system_score_codex":0.0020464833,"about_ca_system_score_gemma":0.0018900232,"threshold_uncertainty_score":0.99718344},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2909128886","doi":"10.1136/ijgc-2018-000087","title":"TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Serous ovarian cancer; Ovarian cancer; DNA sequencing; Serous fluid; Oncology; Bioinformatics; Internal medicine; Computational biology; Cancer; Genetics; Gene; Biology","score_opus":0.24498401400662734,"score_gpt":0.4870466006560772,"score_spread":0.24206258664944985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909128886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995313,0.0006915966,0.000064458975,0.0030427307,0.0005839076,0.00020130667,0.00004292883,0.0000037252275,0.00005637463],"genre_scores_gemma":[0.9959376,0.0014752321,0.0017021403,0.0006686605,0.00016648228,0.0000139013555,0.000011443465,0.000006558013,0.000017973689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984637,0.000054398446,0.0008669867,0.00013479766,0.00036346377,0.00011666025],"domain_scores_gemma":[0.9984431,0.00051106024,0.00057008944,0.00007409956,0.0002909534,0.00011069029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026605508,0.00013172986,0.0005805899,0.00021151762,0.000020517542,0.000038814385,0.000077412464,0.00009832292,0.00035424123],"category_scores_gemma":[0.00019099053,0.00008047307,0.00013845996,0.00010565537,0.00006362181,0.00017551574,0.000027704127,0.00024524424,0.0000017444252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021814306,0.00035997372,0.96800035,0.000016601613,0.0006623636,0.000037095455,0.00027108256,0.0047275755,0.00040968138,0.00012647516,0.00010133472,0.025069293],"study_design_scores_gemma":[0.0037549047,0.0014783372,0.98448104,0.0001823136,0.00019414672,0.00003084274,0.0002284788,0.00907779,0.00033929962,0.00010681971,0.000048578946,0.000077458644],"about_ca_topic_score_codex":0.0008520985,"about_ca_topic_score_gemma":0.00041296036,"teacher_disagreement_score":0.024991835,"about_ca_system_score_codex":0.0005943284,"about_ca_system_score_gemma":0.00029509034,"threshold_uncertainty_score":0.38786933},"labels":[],"label_agreement":null},{"id":"W2909218349","doi":"10.1136/ijgc-2018-000030","title":"Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Stage (stratigraphy); Oncology; Radiation therapy; Proportional hazards model; Cancer; Chemotherapy; Serous fluid; Carcinosarcoma; Retrospective cohort study; Adjuvant therapy; Gynecology; Carcinoma","score_opus":0.044363637120202935,"score_gpt":0.3880524691110429,"score_spread":0.34368883199084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909218349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539864,0.0003553432,0.000005273244,0.00028938137,0.002142303,0.0010019828,0.00040845983,0.000009172173,0.0003894382],"genre_scores_gemma":[0.99806076,0.00087333756,0.000040577845,0.00010312495,0.0005745049,0.000078618,0.0000059006907,0.000018436787,0.0002447379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971707,0.0001335164,0.0010146273,0.0003189438,0.0010780283,0.0002842208],"domain_scores_gemma":[0.9975986,0.00056687347,0.0008987594,0.0001775998,0.00057350186,0.0001846948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036013202,0.0002778459,0.0011659652,0.0006290657,0.000021097327,0.000022953905,0.000287726,0.00012046574,0.006165708],"category_scores_gemma":[0.0005521613,0.00015694786,0.0006322431,0.0004621667,0.00005043673,0.00012268333,0.000064072636,0.00043896874,0.000023347702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015580959,0.0054853233,0.9564144,0.000005762555,0.0021747665,0.0003820573,0.00013854109,0.000601753,0.00010209483,0.0000336709,0.00001670659,0.019063946],"study_design_scores_gemma":[0.042626258,0.031053843,0.9254417,0.000091717695,0.00020374871,0.000009486744,0.000046186124,0.00001872733,0.00017809948,0.00010756147,0.00010270385,0.0001199774],"about_ca_topic_score_codex":0.010719161,"about_ca_topic_score_gemma":0.0017650903,"teacher_disagreement_score":0.030972732,"about_ca_system_score_codex":0.0049359165,"about_ca_system_score_gemma":0.00030405654,"threshold_uncertainty_score":0.99888396},"labels":[],"label_agreement":null},{"id":"W2910095889","doi":"10.1097/igc.0000000000000410","title":"Bulky Early-Stage Cervical Cancer (2-4 cm Lesions)","year":2015,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Trachelectomy; Medicine; Cervical cancer; Stage (stratigraphy); Neoadjuvant therapy; Chemotherapy; Surgery; Gynecology; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.15060104443749547,"score_gpt":0.4505455161857786,"score_spread":0.2999444717482831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910095889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000964896,0.9898542,0.000015706806,0.0014188804,0.0052246023,0.00053978764,0.00040195207,0.000031830357,0.0015481303],"genre_scores_gemma":[0.0010795416,0.9889134,0.00020271033,0.00076344,0.004113141,0.00017653173,0.000050769617,0.00006035835,0.0046401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955253,0.00014606879,0.00161011,0.0004478652,0.0018349044,0.00043577063],"domain_scores_gemma":[0.9951581,0.00065101346,0.0014215081,0.00024532486,0.0018014908,0.0007226128],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005422506,0.00055484,0.0028000604,0.00052275957,0.000054035878,0.00008207613,0.0009118799,0.00064406043,0.013595679],"category_scores_gemma":[0.0007738175,0.0003271406,0.0014627387,0.0005077971,0.00014617085,0.00015872523,0.00026713902,0.0013264217,0.00015933433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061699434,0.0005706036,0.0012971382,0.00089844904,0.0023976567,0.0016142178,0.000025298086,0.000009224613,9.799818e-7,0.0001574895,0.0046608457,0.9877511],"study_design_scores_gemma":[0.0030041062,0.0009250856,0.0017282156,0.0049929563,0.0020538224,0.00029399272,0.000011949182,0.0000021481446,0.0000041772346,0.00015650023,0.9865206,0.00030648606],"about_ca_topic_score_codex":0.0003543195,"about_ca_topic_score_gemma":0.000071685914,"teacher_disagreement_score":0.98744464,"about_ca_system_score_codex":0.0029897867,"about_ca_system_score_gemma":0.0023538147,"threshold_uncertainty_score":0.99991804},"labels":[],"label_agreement":null},{"id":"W2911587956","doi":"10.1136/ijgc-2018-000092","title":"Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Cancer Research UK","keywords":"Medicine; Debulking; Oncology; Internal medicine; Stage (stratigraphy); Serous fluid; Ovarian cancer; Biomarker; Serous carcinoma; Chemotherapy; Progression-free survival; Gynecologic oncology; Ovarian carcinoma; Cancer","score_opus":0.024587047046545067,"score_gpt":0.31904137099560215,"score_spread":0.2944543239490571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911587956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113255,0.00045101778,0.000018288252,0.08570577,0.0012633464,0.0009320057,0.00008513188,0.000030258921,0.00018866376],"genre_scores_gemma":[0.9880409,0.00022000153,0.0011150216,0.009234138,0.00021867127,0.00010069293,0.00002202308,0.000040785864,0.0010077608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966576,0.0004467542,0.0010375865,0.00056053,0.00086086144,0.00043665094],"domain_scores_gemma":[0.99724025,0.00092269044,0.00053855916,0.00033051157,0.00064479973,0.00032316498],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015575102,0.00034982606,0.00076070486,0.000582953,0.000040354123,0.0000641747,0.00047028466,0.00025185553,0.002587164],"category_scores_gemma":[0.001158569,0.00024941645,0.00025498716,0.0004454146,0.00008891519,0.00014231238,0.00007793462,0.00045919523,0.00011146564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32613802,0.003298909,0.5728917,0.000020380909,0.00062157004,0.0127715515,0.0009878259,0.0005834651,0.049229667,0.0001195044,0.0063702455,0.02696717],"study_design_scores_gemma":[0.021934045,0.0052353363,0.9493961,0.00034443525,0.0000618591,0.00073268445,0.000072041024,0.000069182206,0.0022550393,0.00018723785,0.019460386,0.00025167307],"about_ca_topic_score_codex":0.00029896703,"about_ca_topic_score_gemma":0.000074112235,"teacher_disagreement_score":0.3765044,"about_ca_system_score_codex":0.0025008665,"about_ca_system_score_gemma":0.00088446535,"threshold_uncertainty_score":0.9999958},"labels":[],"label_agreement":null},{"id":"W2913384654","doi":"10.1136/ijgc-2018-000099","title":"Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona; “la Caixa” Foundation","keywords":"Medicine; Peritoneal carcinomatosis; Cytoreductive surgery; Cisplatin; Hyperthermic intraperitoneal chemotherapy; Ovarian cancer; Oncology; Acute kidney injury; Chemotherapy; Internal medicine; Urology; Surgery; Cancer","score_opus":0.010464702742518485,"score_gpt":0.28055477052945227,"score_spread":0.2700900677869338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913384654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443513,0.00008038211,0.0003197681,0.002765877,0.0010300856,0.00049606006,0.00082635233,0.000015596077,0.00003074104],"genre_scores_gemma":[0.9967558,0.00021449967,0.0012025766,0.0011745754,0.0005147827,0.00003709424,0.000034224377,0.000036081125,0.000030395995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825907,0.00007768731,0.0006536576,0.00027050526,0.000527142,0.00021195742],"domain_scores_gemma":[0.99755126,0.00054999394,0.00072719244,0.00012141725,0.0008280898,0.0002220406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029137486,0.00023224426,0.00065153145,0.00025463288,0.000036224377,0.000026682284,0.00016276338,0.00022824596,0.0010707884],"category_scores_gemma":[0.0003791024,0.00017660056,0.0003358627,0.000116931296,0.00018510819,0.00018725039,0.000023692648,0.00034519436,0.0000012466983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009561902,0.00036674624,0.793132,0.00005271772,0.0015601788,0.000023436573,0.0008977973,0.000024641806,0.18772678,0.000010175881,0.00046753662,0.0061760936],"study_design_scores_gemma":[0.0027187613,0.0012122811,0.7013081,0.00016653056,0.00025371497,0.000056728302,0.00013171484,0.00069329824,0.292896,0.00013210047,0.00026249202,0.00016830262],"about_ca_topic_score_codex":0.0000788063,"about_ca_topic_score_gemma":0.0000038137648,"teacher_disagreement_score":0.105169214,"about_ca_system_score_codex":0.000509638,"about_ca_system_score_gemma":0.0006226503,"threshold_uncertainty_score":0.99984235},"labels":[],"label_agreement":null},{"id":"W2921263241","doi":"10.1136/ijgc-00009577-200303001-00065","title":"Human Kallikrein Gene 15 (KLK15) Expression","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Kallikrein; Gene; Gene expression; Computational biology; Genetics; Biochemistry; Enzyme","score_opus":0.03484108767788285,"score_gpt":0.34908738390010613,"score_spread":0.3142462962222233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921263241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988313,0.0025984233,0.00063183234,0.0019448763,0.0016630208,0.00011475005,0.000008041455,0.000022559132,0.004703501],"genre_scores_gemma":[0.9936593,0.00026536552,0.001610505,0.00158956,0.0008393606,0.000008020702,0.000006411432,0.000013716972,0.0020077277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839514,0.00006458099,0.00055480027,0.00016168333,0.0006341263,0.000189672],"domain_scores_gemma":[0.9986042,0.000121035024,0.00037184692,0.000097818134,0.00061881647,0.0001863334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031612933,0.00013821165,0.00030334943,0.00013251777,0.00007106642,0.00003470355,0.00021242986,0.00012352374,0.007789614],"category_scores_gemma":[0.0004332755,0.000097890756,0.00023540366,0.000083954445,0.0000721676,0.00014492735,0.000033873566,0.00024407543,0.000021163216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009415814,0.0018034283,0.56278366,0.000038276074,0.00094705005,0.0018613843,0.00052088336,0.00095307635,0.34782225,0.011470951,0.04113231,0.029725153],"study_design_scores_gemma":[0.0061664553,0.0011433305,0.69731236,0.00032706,0.00016956254,0.0008336666,0.00012427443,0.000102454724,0.11989062,0.0065638185,0.16700415,0.00036221134],"about_ca_topic_score_codex":0.000016507802,"about_ca_topic_score_gemma":0.00001477522,"teacher_disagreement_score":0.22793163,"about_ca_system_score_codex":0.00024873074,"about_ca_system_score_gemma":0.00018010016,"threshold_uncertainty_score":0.9931174},"labels":[],"label_agreement":null},{"id":"W2921529689","doi":"10.1136/ijgc-2019-000356","title":"Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations—2019 update","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":748,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Perioperative; General surgery; Gynecologic surgical procedures; Surgical oncology; Oncology; Internal medicine; Surgery; Laparoscopy","score_opus":0.04135568318817294,"score_gpt":0.3875678548566092,"score_spread":0.34621217166843626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921529689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96557075,0.0029866279,0.0012425504,0.02012908,0.0084028775,0.0007283955,0.00015068243,0.000026386546,0.00076267536],"genre_scores_gemma":[0.9581555,0.008499279,0.013116608,0.017141562,0.001110102,0.0003498977,0.000106950814,0.00003664188,0.0014834218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704987,0.0001608781,0.001480124,0.00041849105,0.0004942121,0.0003964524],"domain_scores_gemma":[0.9928509,0.0023470153,0.0007781801,0.00017824808,0.0036999125,0.00014575412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011121586,0.0002892796,0.0009841152,0.0003088068,0.000044807526,0.00005700991,0.00030158344,0.00036796235,0.0048131305],"category_scores_gemma":[0.0023140954,0.00021749389,0.00085927267,0.00022254838,0.0000830767,0.0005188151,0.00011299344,0.00057542336,0.00005058833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02537584,0.0015716354,0.2778876,0.0002914801,0.0023681906,0.00058668404,0.002220132,0.0039052747,0.02238186,0.000111220535,0.10951767,0.5537824],"study_design_scores_gemma":[0.012159985,0.0048962785,0.3047081,0.001818485,0.00030024897,0.0003039811,0.0038235937,0.000496045,0.019974563,0.00081727066,0.6495048,0.0011966869],"about_ca_topic_score_codex":0.00001320958,"about_ca_topic_score_gemma":0.00014109067,"teacher_disagreement_score":0.5525857,"about_ca_system_score_codex":0.0019769552,"about_ca_system_score_gemma":0.0012438152,"threshold_uncertainty_score":0.9960966},"labels":[],"label_agreement":null},{"id":"W2921629341","doi":"10.1136/ijgc-00009577-200303001-00038","title":"Tissue Human Kallikrein 11 (HK11) Evaluation","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Kallikrein; Biochemistry","score_opus":0.060739675116000216,"score_gpt":0.4132752336713656,"score_spread":0.3525355585553654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921629341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879233,0.0011808267,0.00035937107,0.00299521,0.0017427822,0.00019176907,0.0000059187796,0.000016146949,0.0055846367],"genre_scores_gemma":[0.9959302,0.0002654339,0.00079453003,0.0014396491,0.0006097204,0.000014366235,0.0000067228293,0.000010949615,0.0009284126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788606,0.00013298819,0.0005384806,0.00016709187,0.0010896927,0.00018569955],"domain_scores_gemma":[0.9977881,0.00014826751,0.00034174355,0.000102878286,0.0014512696,0.00016774044],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077475415,0.00012998385,0.000291294,0.00012911703,0.000056664205,0.000033749584,0.00023087638,0.00011312168,0.011220365],"category_scores_gemma":[0.0012022341,0.00009508683,0.00013485797,0.00011560639,0.00008226566,0.00014140639,0.000021642078,0.00027337138,0.000031779342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008640992,0.002163895,0.5061445,0.00005682351,0.0010337465,0.002182308,0.0006765726,0.0008430881,0.14560895,0.017419847,0.026772562,0.2962336],"study_design_scores_gemma":[0.0055755083,0.0013144936,0.67843026,0.00020298603,0.00028412367,0.0008815094,0.00019892005,0.00012659584,0.038351618,0.004158298,0.27016687,0.0003088398],"about_ca_topic_score_codex":0.000040819483,"about_ca_topic_score_gemma":0.00010358921,"teacher_disagreement_score":0.29592475,"about_ca_system_score_codex":0.0005013042,"about_ca_system_score_gemma":0.00034261236,"threshold_uncertainty_score":0.9896835},"labels":[],"label_agreement":null},{"id":"W2921795917","doi":"10.1136/ijgc-00009577-200303001-00404","title":"Multimodality and Interdisciplinary Approach of the Canadian Gynecologic Oncologist: Canmed 2000 Procures and Ensures His Competence","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Multimodality; Competence (human resources); Gynecology; Internal medicine; Medical physics; Oncology; General surgery; Obstetrics; Management; World Wide Web","score_opus":0.024165573573413805,"score_gpt":0.38157225455926164,"score_spread":0.3574066809858478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921795917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119915,0.0051230337,0.0001790581,0.0061552515,0.001326383,0.00032340313,0.000025105177,0.000006468276,0.005662162],"genre_scores_gemma":[0.9920013,0.0009528037,0.005117195,0.0015359404,0.00014616395,0.000017379718,0.0000010032884,0.00000609433,0.00022209974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987266,0.00018318614,0.00043088262,0.00017859208,0.00029274667,0.00018800276],"domain_scores_gemma":[0.9983773,0.00054691447,0.00039803045,0.00009481012,0.00041078305,0.00017211764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052532024,0.00013337939,0.00038808415,0.00009862336,0.00014781415,0.000013454569,0.00025612424,0.0001965764,0.0003587224],"category_scores_gemma":[0.0010660623,0.000073480136,0.00009564839,0.000089051864,0.00092324184,0.00007936015,0.00008145634,0.00045497378,2.827032e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007519291,0.0005595392,0.95955646,0.00005275277,0.00053168536,0.00024932416,0.0011714951,0.00058803137,0.00071606715,0.0039039582,0.0012185853,0.030700149],"study_design_scores_gemma":[0.0019656166,0.00084993924,0.9752466,0.000064345986,0.00007804013,0.0010106991,0.000328798,0.00020550385,0.0003915888,0.0029915366,0.016750317,0.00011703478],"about_ca_topic_score_codex":0.0011558217,"about_ca_topic_score_gemma":0.019989194,"teacher_disagreement_score":0.030583113,"about_ca_system_score_codex":0.00087157794,"about_ca_system_score_gemma":0.0011167733,"threshold_uncertainty_score":0.99789345},"labels":[],"label_agreement":null},{"id":"W2921843095","doi":"10.1136/ijgc-00009577-200303001-00029","title":"Prognostic Precision With Sentinel Node Localization (SNL) in Cancer of the Cervix, Stage 1B1","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Sentinel node; Stage (stratigraphy); Cervix; Node (physics); Oncology; Cancer; Gynecology; Internal medicine; Breast cancer","score_opus":0.018078548027772617,"score_gpt":0.3338803823247408,"score_spread":0.3158018342969682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921843095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98636115,0.0005598115,0.004324911,0.006845685,0.0007342967,0.00017659784,0.0000045698894,0.00000490398,0.0009880894],"genre_scores_gemma":[0.9967701,0.0004173394,0.0006118961,0.0017876233,0.00013182356,0.000011077988,0.0000013245276,0.000010270161,0.0002585628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985316,0.0001045188,0.00045244093,0.000118560216,0.0006592214,0.00013369371],"domain_scores_gemma":[0.99866813,0.00023498233,0.000424792,0.00007816599,0.00052091305,0.00007298261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043926435,0.00009402894,0.00024341568,0.000106691834,0.000026104934,0.000016261329,0.00021182757,0.000061785046,0.0008985152],"category_scores_gemma":[0.0016395244,0.000049224735,0.00008691963,0.00019769096,0.000107627886,0.000073382624,0.000034319568,0.00040757534,7.3854426e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025510704,0.00025219514,0.96857136,0.00002745665,0.000095468575,0.00008648188,0.000104873754,0.023626978,0.0010546932,0.00033808887,0.0004255249,0.005161755],"study_design_scores_gemma":[0.0037440166,0.00026405844,0.9576033,0.00099902,0.000103538245,0.00014108387,0.00009252294,0.013785472,0.0016131856,0.0003532676,0.021185402,0.0001151615],"about_ca_topic_score_codex":0.000086398286,"about_ca_topic_score_gemma":0.000059534184,"teacher_disagreement_score":0.020759877,"about_ca_system_score_codex":0.00024679565,"about_ca_system_score_gemma":0.0003220809,"threshold_uncertainty_score":0.9838112},"labels":[],"label_agreement":null},{"id":"W2922831530","doi":"10.1136/ijgc-2019-000332","title":"SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fondation du CHUM","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Sentinel node; Biopsy; Oncology; Cancer; Internal medicine; Breast cancer","score_opus":0.03584143467148106,"score_gpt":0.3656823325815666,"score_spread":0.3298408979100856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922831530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960784,0.00011032385,0.00001163188,0.0010155393,0.0016611486,0.00082754594,0.000026448075,0.000011295526,0.00025767015],"genre_scores_gemma":[0.9987058,0.00015651324,0.00011230663,0.0003395745,0.00045248537,0.00007359852,0.000009049651,0.000016671529,0.00013401688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724877,0.00015580583,0.0009771156,0.00034880673,0.0010573325,0.00021215391],"domain_scores_gemma":[0.9980256,0.00025491725,0.00055182143,0.0001518433,0.0008330241,0.00018277249],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004072593,0.00021219662,0.0006114483,0.0004437353,0.00002408928,0.000056175842,0.0003615236,0.00010419985,0.0023116707],"category_scores_gemma":[0.0002086239,0.00015396278,0.00012960382,0.00027207265,0.000047331494,0.00036816302,0.00015018145,0.0003662893,0.00000640315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037877045,0.0076393317,0.98072463,0.000017960348,0.0008329122,0.00026330785,0.0011041441,0.00027522029,0.0013673864,0.000013703467,0.0000112582975,0.003962431],"study_design_scores_gemma":[0.025258182,0.0020217597,0.97002566,0.000108145585,0.00019899906,0.000029568875,0.0012027507,0.0005437554,0.00033089763,0.000027070708,0.000119970435,0.00013322839],"about_ca_topic_score_codex":0.0017115519,"about_ca_topic_score_gemma":0.00030646994,"teacher_disagreement_score":0.021470478,"about_ca_system_score_codex":0.0004669981,"about_ca_system_score_gemma":0.00011657764,"threshold_uncertainty_score":0.99860036},"labels":[],"label_agreement":null},{"id":"W2934044410","doi":"10.1136/ijgc-2018-000091","title":"Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's Health Research Institute; University Health Network; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Pelvic exenteration; Radiology; Surgery","score_opus":0.01595441871343033,"score_gpt":0.30503293321579017,"score_spread":0.28907851450235983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934044410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956322,0.00024111377,0.000033915792,0.0015291388,0.0011719373,0.00050998386,0.000034768265,0.000008096869,0.0008388524],"genre_scores_gemma":[0.9982881,0.000072671195,0.0005572101,0.0008252435,0.000113480026,0.000021800608,0.000013638122,0.000008985105,0.000098883516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785686,0.00007856514,0.0007235518,0.0002471683,0.0008682271,0.00022566046],"domain_scores_gemma":[0.9980522,0.00031238122,0.00041211516,0.00011146211,0.00095251104,0.00015937445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027736317,0.00017088348,0.00051957613,0.00026630354,0.000019237632,0.000023306919,0.000243802,0.00001839072,0.0041748066],"category_scores_gemma":[0.0005913352,0.00010415019,0.0001614301,0.000268189,0.00005574642,0.00017646435,0.00008446258,0.00024968554,0.00001943429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004955074,0.0012092172,0.9600737,0.000023395847,0.00011147488,0.00030600972,0.000035944668,0.000062371946,0.00018112763,0.00004841787,0.00013966944,0.032853596],"study_design_scores_gemma":[0.0077901147,0.002363319,0.98734075,0.0002686996,0.000053830314,0.00005868526,0.00004837071,0.000049316666,0.0006276439,0.00010230287,0.0011900841,0.00010686761],"about_ca_topic_score_codex":0.000046306293,"about_ca_topic_score_gemma":0.00008132755,"teacher_disagreement_score":0.03274673,"about_ca_system_score_codex":0.00049519277,"about_ca_system_score_gemma":0.00019014478,"threshold_uncertainty_score":0.9967355},"labels":[],"label_agreement":null},{"id":"W2945267190","doi":"10.1136/ijgc-00009577-200409001-00310","title":"310 Activated Bone Morphogenetic Protein Receptor Signalling Enhances The Malignant Phenotype of Human Ovarian Cancer Cells","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bone morphogenetic protein; Phenotype; Ovarian cancer; Cancer research; Bone morphogenetic protein 2; Bone morphogenetic protein receptor; Receptor; Cancer; Oncology; Internal medicine; Gene; In vitro; Genetics; Biology","score_opus":0.031550509529929646,"score_gpt":0.33407123828293406,"score_spread":0.3025207287530044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945267190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090976,0.00131485,0.00013419152,0.0063519916,0.00071025256,0.0003772072,0.000029160916,0.0000087051085,0.00016389367],"genre_scores_gemma":[0.99687755,0.00061453594,0.0011089783,0.0007239378,0.0003372616,0.000058898127,0.0000045819697,0.000013277275,0.0002609863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983105,0.00007171412,0.0006397496,0.00015754659,0.00060079497,0.00021969932],"domain_scores_gemma":[0.9983016,0.00010538635,0.0006789418,0.0000872902,0.0006765683,0.0001501798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028503785,0.0001463852,0.00036289566,0.000090709065,0.000089372865,0.000016617636,0.00023096988,0.000104542654,0.0025322996],"category_scores_gemma":[0.00010707603,0.00008219753,0.00015350456,0.00012663454,0.00011331804,0.00007182239,0.000034855304,0.00035936444,0.00000961376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096282945,0.0005278888,0.0019732874,0.000027456725,0.00044325265,0.00013398944,0.00016268146,0.00046835688,0.987767,0.00020752157,0.00011708345,0.0072087003],"study_design_scores_gemma":[0.0038891009,0.001404002,0.03767868,0.0006054077,0.00013857461,0.000038938088,0.00006550741,0.000009641547,0.9533981,0.0010502429,0.0016069344,0.00011486241],"about_ca_topic_score_codex":0.0008148317,"about_ca_topic_score_gemma":0.00019218243,"teacher_disagreement_score":0.035705395,"about_ca_system_score_codex":0.0005236806,"about_ca_system_score_gemma":0.00056404667,"threshold_uncertainty_score":0.9983795},"labels":[],"label_agreement":null},{"id":"W2945989550","doi":"10.1136/ijgc-2019-000398","title":"FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cervical cancer; Hysterectomy; Stage (stratigraphy); Fertility; Cancer; Fertility preservation; Surgery; Chemotherapy; Gynecology; Internal medicine; Population","score_opus":0.04251947698444884,"score_gpt":0.3311115163148956,"score_spread":0.28859203933044675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945989550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982843,0.0037846896,0.000024107325,0.01029895,0.0007321719,0.0018523518,0.00034569725,0.000037631286,0.000081410915],"genre_scores_gemma":[0.99209493,0.0016157728,0.00007450774,0.0049941093,0.00026399287,0.0003909928,0.000027232161,0.00005867879,0.00047977112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952048,0.00039108182,0.0014896246,0.0009585128,0.0012256093,0.00073034514],"domain_scores_gemma":[0.9951504,0.0021680642,0.00070618105,0.00031987973,0.00096839014,0.0006870686],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096727634,0.00064416585,0.0020732023,0.00037584506,0.00008820652,0.00013343689,0.00036397204,0.0002904835,0.004327527],"category_scores_gemma":[0.0005010658,0.00042835274,0.00032928083,0.0005549221,0.0002233641,0.00041411677,0.00018452315,0.0007434109,0.0000055656405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035891548,0.0022992736,0.9435205,0.00011694877,0.0014371338,0.00033140052,0.00053961907,0.000060691855,0.0009878793,0.0000012374393,0.0009898033,0.013823963],"study_design_scores_gemma":[0.017086748,0.0014982735,0.97558504,0.000592661,0.00019956373,0.000016088085,0.00035201968,0.00035858032,0.0020319812,0.000020179763,0.0018209771,0.00043787324],"about_ca_topic_score_codex":0.015329047,"about_ca_topic_score_gemma":0.008136409,"teacher_disagreement_score":0.032064553,"about_ca_system_score_codex":0.0015021173,"about_ca_system_score_gemma":0.00061174337,"threshold_uncertainty_score":0.99981683},"labels":[],"label_agreement":null},{"id":"W2946071563","doi":"10.1136/ijgc-00009577-200409001-00385","title":"385 Ovarian Cancer (Eoc): Relapse Outcomes and A Predictive Survival Model","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Ovarian cancer; Internal medicine; Gynecology; Cancer","score_opus":0.033747950500730144,"score_gpt":0.34600672107734676,"score_spread":0.3122587705766166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946071563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9358579,0.0022233604,0.0018744171,0.055948507,0.0021540378,0.00026465798,0.00017606645,0.00002015714,0.0014809349],"genre_scores_gemma":[0.9920142,0.0031497793,0.0016903875,0.0022740366,0.00046939444,0.000063752275,0.000004722419,0.000014720863,0.0003189501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850994,0.00002625217,0.0004437759,0.00021827973,0.0006109346,0.00019079506],"domain_scores_gemma":[0.99870294,0.00013056227,0.0002851938,0.00009059048,0.0005698147,0.00022090653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019300266,0.00017417956,0.00043930364,0.00011906704,0.000046330464,0.000038684153,0.00016089706,0.000117083975,0.0007351821],"category_scores_gemma":[0.00020067253,0.000113083166,0.00019323852,0.00007351226,0.00010018755,0.00016702362,0.00006617873,0.00030007015,0.000004575267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025034042,0.0017898089,0.924078,0.000025973397,0.003653674,0.0015257768,0.0007623082,0.028807381,0.0003317595,0.006017149,0.0018028381,0.028701939],"study_design_scores_gemma":[0.009512871,0.0008511804,0.9805994,0.00022542101,0.00038232998,0.00014603705,0.000067497975,0.0006737486,0.00032159773,0.0049747657,0.0020946213,0.00015054921],"about_ca_topic_score_codex":0.0002562581,"about_ca_topic_score_gemma":0.00018610014,"teacher_disagreement_score":0.056521393,"about_ca_system_score_codex":0.000983116,"about_ca_system_score_gemma":0.0005274742,"threshold_uncertainty_score":0.8049728},"labels":[],"label_agreement":null},{"id":"W2946293380","doi":"10.1136/ijgc-00009577-200509001-00388","title":"000392: STAGE III ENDOMETRIAL CANCER - PREOPERATIVE PREDICTORS OF EXTRAUTERINE SPREAD AND INFLUENCE OF ADJUVANT THERAPY ON SURVIVAL","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Adjuvant therapy; Endometrial cancer; Stage (stratigraphy); Oncology; Adjuvant; Internal medicine; Gynecology; Cancer","score_opus":0.03877119583145396,"score_gpt":0.35740563316061097,"score_spread":0.318634437329157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946293380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398416,0.002616258,0.000033402455,0.0013659974,0.0010287508,0.00029049895,0.00021219085,0.000007146765,0.00046157042],"genre_scores_gemma":[0.9888682,0.0090652555,0.00018490973,0.00041508902,0.0011423839,0.000028757699,0.0000043554296,0.000010855039,0.00028021532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978423,0.00008626994,0.0008117425,0.00019593265,0.00089403265,0.00016970733],"domain_scores_gemma":[0.9974645,0.000673723,0.0006541774,0.00009542303,0.0009468809,0.00016529103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031509326,0.0001854241,0.0006931318,0.000279564,0.000022052187,0.000013235679,0.0002335277,0.00010403898,0.002461409],"category_scores_gemma":[0.00059712614,0.00011393878,0.00018775067,0.00023907283,0.00018573678,0.00018565847,0.000058583068,0.00025996333,0.0000011156269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04293025,0.0030165957,0.6551884,0.000077281715,0.0038663289,0.0002113231,0.0011256237,0.00731117,0.029265178,0.0006528316,0.00028347713,0.25607157],"study_design_scores_gemma":[0.02526479,0.0071093426,0.90509796,0.0003557861,0.00016512063,0.000027565886,0.00007882197,0.000059091708,0.05024675,0.00008928104,0.011336096,0.00016940809],"about_ca_topic_score_codex":0.00045263575,"about_ca_topic_score_gemma":0.00010049324,"teacher_disagreement_score":0.25590214,"about_ca_system_score_codex":0.00032956098,"about_ca_system_score_gemma":0.00024380375,"threshold_uncertainty_score":0.99845046},"labels":[],"label_agreement":null},{"id":"W2946322894","doi":"10.1136/ijgc-00009577-200509001-00089","title":"00089: PREVENTION AND TREATMENT OF CANCERS ARISING IN EXTRA-GONADAL ENDOMETRIOSIS – A SYSTEMATIC REVIEW OF THE LITERATURE","year":2005,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Endometriosis; Oncology; Gynecology","score_opus":0.06580948097938238,"score_gpt":0.4301273563657134,"score_spread":0.36431787538633104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946322894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059781043,0.9967944,0.0000020323012,0.00038372146,0.000265937,0.0017308232,0.00009988263,0.0000017308579,0.0001236345],"genre_scores_gemma":[0.0041748327,0.99499327,0.00015245454,0.000073881616,0.00019809243,0.00018889549,0.000012755371,0.000012384118,0.00019341195],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99662054,0.0004117918,0.0016627592,0.00018082136,0.00095836,0.00016574159],"domain_scores_gemma":[0.99472827,0.0024825686,0.0018740968,0.00016573591,0.00064120383,0.00010815235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006000722,0.00025504414,0.0026302768,0.00065003743,0.000016820532,0.000018347524,0.0002795883,0.00016555384,0.00027979832],"category_scores_gemma":[0.0048549147,0.00011738516,0.0010224187,0.00072479545,0.00008395183,0.00007508047,0.000052180625,0.00033298985,5.357149e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011342955,0.0006547687,0.00031724418,0.25762522,0.002339617,0.00017863487,0.00005808145,0.0000020974621,0.0000025944012,0.000022612618,0.00006864308,0.73861706],"study_design_scores_gemma":[0.0020769243,0.001411452,0.00043607346,0.8875211,0.00273402,0.0005753908,0.00001517291,0.000001658523,0.000017560133,0.00002018069,0.10508844,0.00010203695],"about_ca_topic_score_codex":0.000053267875,"about_ca_topic_score_gemma":0.000092730115,"teacher_disagreement_score":0.738515,"about_ca_system_score_codex":0.0027262482,"about_ca_system_score_gemma":0.0010583849,"threshold_uncertainty_score":0.71290445},"labels":[],"label_agreement":null},{"id":"W2946645287","doi":"10.1136/ijgc-2019-000310","title":"Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Trillium Health Centre; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Debulking; Ascites; Ovarian cancer; Serous fluid; Stage (stratigraphy); Lymph node; Cancer; Surgery; Internal medicine; Urology","score_opus":0.020713627029189784,"score_gpt":0.298504350260105,"score_spread":0.27779072323091525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946645287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932031,0.001478084,0.00019450221,0.003419783,0.0012438374,0.00026381438,0.00007715257,0.0000047231115,0.00011502195],"genre_scores_gemma":[0.99723405,0.0015482266,0.00034535083,0.00048756422,0.00017250045,0.000055900626,0.000020804207,0.00001033425,0.000125249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984994,0.000048400037,0.0005614675,0.00022543929,0.00051482563,0.0001504912],"domain_scores_gemma":[0.9984017,0.00029944303,0.0005695243,0.000089730376,0.00047201436,0.00016756292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015592185,0.00015060771,0.00048502063,0.00019923937,0.000016516242,0.000018763076,0.000104445025,0.00005842566,0.0011007406],"category_scores_gemma":[0.00019570271,0.00010144348,0.00011341668,0.00012573278,0.00009068125,0.00022563944,0.000044477812,0.0001697738,0.0000018264093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002638234,0.0005354424,0.97501373,0.000062960185,0.00030105872,0.0000985977,0.00007296754,0.00094279245,0.00022219014,0.00012453509,0.000110327885,0.019877149],"study_design_scores_gemma":[0.0037716138,0.0002490315,0.99420017,0.0006902397,0.00013514857,0.0000135889695,0.000043374705,0.0002931908,0.00009648271,0.00014677932,0.0002541628,0.00010623799],"about_ca_topic_score_codex":0.00013981208,"about_ca_topic_score_gemma":0.000048725273,"teacher_disagreement_score":0.019770911,"about_ca_system_score_codex":0.0008181566,"about_ca_system_score_gemma":0.00060249143,"threshold_uncertainty_score":0.99981236},"labels":[],"label_agreement":null},{"id":"W2947103550","doi":"10.1136/ijgc-00009577-200409001-00169","title":"169 Do Traditional Field Borders Based on Bony Landmarks Adequately Cover Pelvic Lymph Nodes in The Treatment of Advanced Cervix Cancer? A CT-Simulation Study","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cover (algebra); Lymph; Radiology; Cervix; Cancer; Pathology; Internal medicine","score_opus":0.054872092231261195,"score_gpt":0.3800972499286169,"score_spread":0.32522515769735566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947103550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901412,0.00093436486,0.000106871696,0.006662217,0.0006420316,0.00047122026,0.00008146888,0.0000069214757,0.0009536993],"genre_scores_gemma":[0.99650466,0.00074486487,0.00010106702,0.0021051785,0.00036529108,0.00012074148,0.0000159145,0.0000096084705,0.000032688607],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9979873,0.00010061836,0.00058356475,0.00020040997,0.00095299707,0.0001751179],"domain_scores_gemma":[0.99789596,0.0012236921,0.00035374053,0.00011067387,0.0003296123,0.000086320004],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002034354,0.00018644297,0.00042699577,0.00023586684,0.000039636918,0.00002423645,0.00022502594,0.000063626874,0.002053214],"category_scores_gemma":[0.00026148307,0.00010449402,0.00025057187,0.00027087083,0.00004691059,0.000095554,0.000009603423,0.00017834439,0.000004681373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016069952,0.016631825,0.37407833,0.000028255143,0.00084163056,0.0011542641,0.000828975,0.4423234,0.00014024565,0.00021631877,0.00007579628,0.147611],"study_design_scores_gemma":[0.039581083,0.010543947,0.94345677,0.00027156383,0.00026554058,0.000029221737,0.00044054128,0.00093436433,0.00067803473,0.001282853,0.0023467804,0.00016929347],"about_ca_topic_score_codex":0.00045757988,"about_ca_topic_score_gemma":0.00020963818,"teacher_disagreement_score":0.56937844,"about_ca_system_score_codex":0.0013926596,"about_ca_system_score_gemma":0.00038775656,"threshold_uncertainty_score":0.99885905},"labels":[],"label_agreement":null},{"id":"W2947277253","doi":"10.1136/ijgc-00009577-200610001-00111","title":"Epigenetic Loss of Brca1 is Common in Highgrade Serous Ovarian Carcinomas, But Not in Other Histopathologic Subtypes of Ovarian Carcinoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Ovarian carcinoma; Ovarian carcinomas; Epigenetics; Oncology; Serous carcinoma; Pathology; Carcinoma; Cancer research; Ovarian cancer; Internal medicine; Cancer; Gene; Biology; Genetics","score_opus":0.02348879262082419,"score_gpt":0.29522487750994497,"score_spread":0.27173608488912077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947277253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905015,0.002330676,0.000026623653,0.0053949733,0.00054881815,0.00022071281,0.00012991198,0.000004598962,0.00084217225],"genre_scores_gemma":[0.99799764,0.00027842014,0.0005189585,0.0007875986,0.00023548184,0.000024124594,0.0000067329847,0.000015712865,0.00013530882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977958,0.00011343737,0.0010899382,0.00023941121,0.00052965805,0.00023171857],"domain_scores_gemma":[0.99849594,0.00024069965,0.00068157545,0.00016395855,0.00034119902,0.00007663558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033853223,0.00018918284,0.0007249307,0.00035818506,0.0000140383945,0.000009841945,0.000293707,0.00017267854,0.0011067674],"category_scores_gemma":[0.00007829157,0.0001426024,0.00021377223,0.00020072408,0.00015274329,0.0000676898,0.00005365262,0.00028837976,0.0000022522784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000947957,0.0012754966,0.9889019,0.000034615707,0.000093510615,0.0017710887,0.00017812238,0.00040873908,0.002335333,0.0010227053,0.00017191992,0.0028585924],"study_design_scores_gemma":[0.0048010387,0.0008398968,0.97897255,0.00018242873,0.00008399213,0.00016592571,0.0000393915,0.000057691737,0.012832529,0.0010436665,0.00086593546,0.00011492631],"about_ca_topic_score_codex":0.0076382374,"about_ca_topic_score_gemma":0.002574957,"teacher_disagreement_score":0.010497196,"about_ca_system_score_codex":0.0009500338,"about_ca_system_score_gemma":0.00029018804,"threshold_uncertainty_score":0.99980634},"labels":[],"label_agreement":null},{"id":"W2953647067","doi":"10.1136/ijgc-2019-000287","title":"Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Survival analysis; Log-rank test; Internal medicine; Univariate analysis; Ovarian cancer; Carcinoma; Clear cell carcinoma; Clear cell; Oncology; Cancer; Multivariate analysis; Surgery; Confidence interval","score_opus":0.012837694296677648,"score_gpt":0.2875586852126202,"score_spread":0.27472099091594254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953647067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813086,0.00010295712,0.0000043860337,0.00062342035,0.00043342295,0.00016287457,0.000050078637,0.000001464144,0.00049054006],"genre_scores_gemma":[0.9994896,0.00014161444,0.00007132288,0.00018097094,0.000072741605,0.000004115963,0.000004482001,0.0000063737057,0.000028760021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999037,0.00003383974,0.00027595437,0.00012766379,0.00041913782,0.00010635013],"domain_scores_gemma":[0.99913067,0.00016012926,0.00025526926,0.00006873295,0.00030378142,0.00008144007],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000118166085,0.00009939775,0.00029057116,0.00011161881,0.000006278694,0.000010562921,0.00009560796,0.000048249265,0.001105232],"category_scores_gemma":[0.000032198317,0.00005615787,0.000070837326,0.000052755597,0.000019187706,0.000064923224,0.000023982675,0.00017348875,0.0000032801436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028367292,0.0007528971,0.9893562,0.00001410851,0.00011155209,0.00006939365,0.000053591277,0.00011594286,0.000014122049,0.00006013947,0.00003564263,0.0065796506],"study_design_scores_gemma":[0.0064532612,0.0054343226,0.98741317,0.00021100527,0.000032111104,0.000005938975,0.000024268422,0.000016394893,0.00020542611,0.000023299837,0.0001246137,0.000056204346],"about_ca_topic_score_codex":0.00015383781,"about_ca_topic_score_gemma":0.000032353393,"teacher_disagreement_score":0.006523446,"about_ca_system_score_codex":0.00033419783,"about_ca_system_score_gemma":0.00012637088,"threshold_uncertainty_score":0.9998079},"labels":[],"label_agreement":null},{"id":"W2963837190","doi":"10.1136/ijgc-2019-000387","title":"Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Indocyanine green; Medicine; Sentinel lymph node; TRACER; Lymph node; Lymph; Nuclear medicine; Endometrial cancer; Prospective cohort study; Stage (stratigraphy); Cancer; Pathology; Breast cancer; Internal medicine","score_opus":0.030720733837588485,"score_gpt":0.32583074046691907,"score_spread":0.29511000662933057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963837190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919575,0.0009703718,0.00030085488,0.0024446505,0.0010627032,0.003001465,0.00007400863,0.000017843107,0.00017064156],"genre_scores_gemma":[0.9967603,0.00025011424,0.00021989904,0.00053411856,0.00092559034,0.0006615126,0.0000072782636,0.000029342216,0.000611844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724513,0.0001023701,0.0008842486,0.00050065684,0.00091104273,0.00035652352],"domain_scores_gemma":[0.99758327,0.0005548266,0.0005003271,0.00011582148,0.000936645,0.00030911987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005923895,0.0003283115,0.001062737,0.00058017444,0.00006913823,0.00007393271,0.00018863885,0.00012875612,0.00062860135],"category_scores_gemma":[0.00032233744,0.00021442786,0.00016096163,0.000548579,0.00009182261,0.0002296109,0.00008858258,0.00034606436,0.0000031383393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13826552,0.0018930591,0.82943296,0.000065343585,0.0016370005,0.0001746481,0.00056642416,0.00053155445,0.0030252251,0.000016797747,0.00004442852,0.024347056],"study_design_scores_gemma":[0.19595829,0.00467139,0.7928494,0.00021838195,0.0004806565,0.00011070554,0.00046650818,0.00032827538,0.0033275525,0.00009841812,0.0012062947,0.0002840881],"about_ca_topic_score_codex":0.0022925627,"about_ca_topic_score_gemma":0.0019964767,"teacher_disagreement_score":0.057692774,"about_ca_system_score_codex":0.0012776642,"about_ca_system_score_gemma":0.00021848133,"threshold_uncertainty_score":0.8744114},"labels":[],"label_agreement":null},{"id":"W2964735075","doi":"10.1136/ijgc-00009577-200409001-00240","title":"240 Uterine Papillary Serous Carcinoma – The Mcgill Experience","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Carcinoma; Papillary carcinoma; Gynecology; General surgery; Pathology; Internal medicine","score_opus":0.053280013663873624,"score_gpt":0.4020626845124578,"score_spread":0.34878267084858416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964735075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96547115,0.0010513356,0.000120080615,0.027780551,0.0011792318,0.0001420645,0.00003830868,0.000012629842,0.0042046504],"genre_scores_gemma":[0.9908062,0.0010619675,0.00022268805,0.0065975464,0.0009300347,0.000022866661,0.00000177901,0.000009343884,0.00034753117],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831444,0.000034822682,0.00038567043,0.00014674135,0.0008977072,0.00022064122],"domain_scores_gemma":[0.99842966,0.00015443908,0.00015262845,0.00012388495,0.00095414685,0.00018527069],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022493933,0.000111730355,0.00023613591,0.00007583965,0.00008174538,0.000023732837,0.00047283547,0.000073764044,0.008952459],"category_scores_gemma":[0.0003553103,0.000060130606,0.00018525808,0.00013077339,0.00016832986,0.000113285845,0.00014020728,0.00044018382,0.000021712414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011773333,0.0025271212,0.21850911,0.0001608764,0.0013360297,0.014646968,0.0022191543,0.0028070123,0.021101361,0.00893719,0.0128836855,0.7030982],"study_design_scores_gemma":[0.0031558108,0.0010441609,0.8484837,0.00003261106,0.000033706958,0.0011438618,0.00018193893,0.000031285057,0.004069066,0.0016933059,0.14001657,0.000114002374],"about_ca_topic_score_codex":0.00017115343,"about_ca_topic_score_gemma":0.00007904936,"teacher_disagreement_score":0.70298415,"about_ca_system_score_codex":0.0006324281,"about_ca_system_score_gemma":0.0002426211,"threshold_uncertainty_score":0.9919535},"labels":[],"label_agreement":null},{"id":"W2965311325","doi":"10.1136/ijgc-00009577-200610001-00689","title":"Non-Endometrioid Type Endometrial Cancer: Prognostic Variables in Surgically Staged Patients","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Endometrial cancer; Medicine; Metastasis; Stage (stratigraphy); Internal medicine; Oncology; Cancer; Biology","score_opus":0.01930459219646889,"score_gpt":0.3152726893310588,"score_spread":0.2959680971345899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965311325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072856,0.0020376458,0.000032787804,0.0009645451,0.0036201274,0.0004340651,0.00006864127,0.000016091426,0.0020975329],"genre_scores_gemma":[0.99526083,0.0018350204,0.00040338724,0.0004835087,0.0015197484,0.000051890296,0.000034700206,0.000018768116,0.00039215197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970643,0.00008432698,0.0010203465,0.00027161947,0.0012027713,0.00035661418],"domain_scores_gemma":[0.99649316,0.0011648866,0.00054864684,0.00009684946,0.0015051056,0.0001913669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045920568,0.00022766167,0.00070204923,0.00083762244,0.000038818245,0.000054062733,0.0003495335,0.00017370678,0.004196198],"category_scores_gemma":[0.0023200682,0.0001554909,0.00026922568,0.0012587983,0.00007751497,0.00017887042,0.00008333782,0.00046139964,0.000016505443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056681703,0.0018180236,0.97431636,0.000020606112,0.0003450825,0.00055463164,0.000014355286,0.00037665234,0.00051357085,0.00009134325,0.0008701744,0.015411038],"study_design_scores_gemma":[0.024529252,0.002052523,0.9630074,0.0002096068,0.00016975841,0.000027140879,0.000011013951,0.000028635808,0.0007725679,0.000525505,0.008489262,0.0001773245],"about_ca_topic_score_codex":0.00089195534,"about_ca_topic_score_gemma":0.00022703226,"teacher_disagreement_score":0.018861081,"about_ca_system_score_codex":0.0012415396,"about_ca_system_score_gemma":0.0004833703,"threshold_uncertainty_score":0.9967141},"labels":[],"label_agreement":null},{"id":"W2965951732","doi":"10.1136/ijgc-00009577-200610001-00697","title":"Endometrial Biopsy Poor Predictor Of Papillary Serous Histololgy","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Serous fluid; Medicine; Biopsy; Internal medicine","score_opus":0.02127167859292118,"score_gpt":0.3093032968523005,"score_spread":0.28803161825937934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965951732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910184,0.0011366267,0.0001657662,0.0017151488,0.0016314994,0.00016307776,0.0001076066,0.000016169612,0.004045684],"genre_scores_gemma":[0.9971639,0.00013182315,0.0012387325,0.00033956429,0.000509663,0.000015263924,0.000025706635,0.000008783871,0.0005665547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982751,0.00005316619,0.000727784,0.0001487401,0.00062065537,0.00017457864],"domain_scores_gemma":[0.997888,0.0004550835,0.00057187077,0.00008101167,0.00088939193,0.000114640774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018524272,0.00013729399,0.0004542272,0.00026461176,0.000033346274,0.0000139961285,0.0002228379,0.00014778288,0.0049109655],"category_scores_gemma":[0.00068823365,0.00008850814,0.00031325934,0.00017817743,0.00014073044,0.00009387889,0.00005174321,0.00021645827,0.000013329707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019233571,0.0038873828,0.9448097,0.000033782922,0.0015509296,0.0037809927,0.000024915424,0.00023822344,0.017050717,0.0037051006,0.007441783,0.015553124],"study_design_scores_gemma":[0.006792342,0.0021352314,0.9744426,0.00006488313,0.00022093915,0.00040137835,0.000019138757,0.000026960804,0.0025788802,0.0019810677,0.01122709,0.00010948814],"about_ca_topic_score_codex":0.00009390526,"about_ca_topic_score_gemma":0.000017535738,"teacher_disagreement_score":0.02963291,"about_ca_system_score_codex":0.0003280819,"about_ca_system_score_gemma":0.00019408255,"threshold_uncertainty_score":0.9959987},"labels":[],"label_agreement":null},{"id":"W2966099035","doi":"10.1136/ijgc-00009577-200409001-00134","title":"134 Phase I Study of Patupilone Plus Carboplatin in Patients With Advanced Malignancies","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Oncology; Internal medicine; Urology; Chemotherapy; Cisplatin","score_opus":0.020496997130148475,"score_gpt":0.360257502046621,"score_spread":0.3397605049164725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966099035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800324,0.00026702505,0.000014727664,0.0005841834,0.0005292512,0.00037168912,0.00001842663,0.0000050430413,0.00020641802],"genre_scores_gemma":[0.99918556,0.000092236325,0.00024208557,0.00028353595,0.00011049695,0.000027499882,0.0000061677233,0.000007980632,0.000044408174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987338,0.00003106696,0.0004737138,0.00012681699,0.0004995475,0.00013503847],"domain_scores_gemma":[0.99880755,0.00008770631,0.00038335245,0.000058150592,0.0005862401,0.00007701164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009719219,0.000117559255,0.00039691746,0.00016876675,0.000014175256,0.000005626553,0.00013693163,0.00004892318,0.00056802033],"category_scores_gemma":[0.00007054276,0.00007582291,0.00006469536,0.0001346358,0.000056572986,0.00010207968,0.000029173496,0.00020189185,0.0000011918843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024064744,0.015906071,0.9288748,0.000016688915,0.0007801121,0.0009912348,0.0012761231,0.0068347533,0.0022260165,0.000047918336,0.00008111048,0.018900445],"study_design_scores_gemma":[0.076493755,0.018561361,0.9027166,0.00012867423,0.00014017716,0.00001819329,0.0002594188,0.000007746282,0.0012723207,0.00007831453,0.00023614166,0.000087290835],"about_ca_topic_score_codex":0.0001281545,"about_ca_topic_score_gemma":0.00033489199,"teacher_disagreement_score":0.052429013,"about_ca_system_score_codex":0.0007478632,"about_ca_system_score_gemma":0.000292015,"threshold_uncertainty_score":0.62194246},"labels":[],"label_agreement":null},{"id":"W2966259063","doi":"10.1136/ijgc-00009577-200409001-00324","title":"324 Atypical Glandular Cells: Still A Challenge","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine","score_opus":0.03568410334120097,"score_gpt":0.3363552867373443,"score_spread":0.3006711833961433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966259063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767117,0.0036629005,0.00012359479,0.017517066,0.0012110485,0.00010724485,0.000012423261,0.000012505482,0.0006415503],"genre_scores_gemma":[0.9939873,0.0024819404,0.0010179154,0.0016911,0.00074927974,0.000016427886,0.0000027998526,0.000008412534,0.000044825516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883854,0.00002107891,0.00034545895,0.00012792154,0.00051903183,0.00014796636],"domain_scores_gemma":[0.9990437,0.00012908326,0.00017595159,0.00007064087,0.00041499824,0.00016561752],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000118368844,0.00011022484,0.00027091923,0.0000865238,0.00001903339,0.000019796074,0.00017002567,0.0000949717,0.0017437306],"category_scores_gemma":[0.00015146466,0.00006882702,0.00022534662,0.000049714276,0.000053311553,0.00006597434,0.000040499046,0.00023249882,0.000042086664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00924684,0.021568056,0.5473137,0.000068959154,0.005670983,0.04364238,0.0010854325,0.0030052774,0.0061492836,0.022474235,0.0059014526,0.3338734],"study_design_scores_gemma":[0.012385031,0.0025509747,0.86368114,0.0003162908,0.00027782755,0.0009572353,0.00007768461,0.000029026109,0.0059093228,0.004908379,0.10870385,0.00020323027],"about_ca_topic_score_codex":0.000025970481,"about_ca_topic_score_gemma":0.000024779563,"teacher_disagreement_score":0.33367017,"about_ca_system_score_codex":0.00054630474,"about_ca_system_score_gemma":0.00016792835,"threshold_uncertainty_score":0.9991688},"labels":[],"label_agreement":null},{"id":"W2968064572","doi":"10.1136/ijgc-00009577-200610001-00698","title":"Laparoscopy Vs. Laparotomy For The Surgical Management Of Borderline Ovarian Tumors (Bot)","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Carboplatin; Paclitaxel; Medicine; Radiation therapy; Oncology; Internal medicine; Adjuvant; Gynecology; Radiology; Chemotherapy; Cisplatin","score_opus":0.022748811093208775,"score_gpt":0.34683763421991237,"score_spread":0.3240888231267036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968064572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958496,0.0037218095,0.0013188579,0.025693936,0.0027641475,0.0011700498,0.00012819842,0.000023535526,0.0066834805],"genre_scores_gemma":[0.99428254,0.00077502383,0.0019141801,0.0007317045,0.00121491,0.00010256295,0.000013029591,0.000010814783,0.0009552293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833727,0.000031967225,0.0006601642,0.00014175694,0.0006435873,0.00018524626],"domain_scores_gemma":[0.9980345,0.0006006947,0.0004069462,0.0000968519,0.00077807164,0.00008294968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033674922,0.00013214478,0.0004071035,0.00009723849,0.000043948276,0.000019501485,0.00031512653,0.00007018968,0.0015637416],"category_scores_gemma":[0.000107807224,0.00007043962,0.00033154403,0.0001835404,0.000102613674,0.000058403457,0.000055749017,0.00016966283,0.0000034289503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07605588,0.009877737,0.5763041,0.0006069265,0.012057315,0.005462442,0.000121841105,0.0049744006,0.0015874925,0.07484215,0.03920788,0.19890188],"study_design_scores_gemma":[0.026950832,0.0034240144,0.7025074,0.0004583791,0.0010292958,0.00034047558,0.00011288597,0.0003116696,0.007066896,0.0060971887,0.2514387,0.0002623061],"about_ca_topic_score_codex":0.00012945902,"about_ca_topic_score_gemma":0.000026480044,"teacher_disagreement_score":0.21223082,"about_ca_system_score_codex":0.00025577223,"about_ca_system_score_gemma":0.00009990494,"threshold_uncertainty_score":0.99934894},"labels":[],"label_agreement":null},{"id":"W2968073358","doi":"10.1136/ijgc-00009577-200409001-00242","title":"242 Sentinel Node Mapping With Isosulfan Blue Dye in Endometrial Cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Endometrial cancer; Hysteroscopy; Sentinel lymph node; Lymphadenectomy; Sentinel node; Laparotomy; Lymph node; Surgery; Radiology; Cancer; Breast cancer; Pathology; Internal medicine","score_opus":0.039374068512224615,"score_gpt":0.33787178279429425,"score_spread":0.2984977142820696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968073358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795724,0.0010952268,0.00038398654,0.0159831,0.001555076,0.00022530387,0.00003318514,0.000016510357,0.0011351714],"genre_scores_gemma":[0.99196154,0.0014930882,0.00078948884,0.00397569,0.0015348356,0.00005255129,0.0000068270765,0.000017531414,0.00016847163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977991,0.000043895063,0.00068455405,0.00024040697,0.0009263745,0.00030564744],"domain_scores_gemma":[0.9983947,0.000265552,0.0004199284,0.00009167707,0.0006128297,0.00021527431],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027329713,0.00020315115,0.0005629077,0.0005587835,0.000034708424,0.000039196908,0.00028515892,0.0001254654,0.0021548395],"category_scores_gemma":[0.0005105312,0.0001271399,0.00022008852,0.00065889326,0.00009120495,0.00017110752,0.000061504885,0.0004678427,0.000008774107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016660163,0.002435818,0.91220605,0.000059528804,0.0021977124,0.005167955,0.00042150775,0.010635431,0.004874392,0.0004413276,0.0006341116,0.044265993],"study_design_scores_gemma":[0.07495941,0.002427189,0.8862052,0.001198455,0.000337038,0.00061241625,0.00028687896,0.000052311327,0.007964843,0.00097470236,0.024522757,0.00045879083],"about_ca_topic_score_codex":0.00055905076,"about_ca_topic_score_gemma":0.0003768849,"teacher_disagreement_score":0.058299243,"about_ca_system_score_codex":0.0015906567,"about_ca_system_score_gemma":0.0005447145,"threshold_uncertainty_score":0.9987573},"labels":[],"label_agreement":null},{"id":"W2969124354","doi":"10.1136/00009577-201809002-00001","title":"17th Biennial Meeting of the International Gynecologic Cancer Society Kyoto, Japan September 14-16, 2018","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Gynecologic cancer; Gynecology; Cancer; Family medicine; Internal medicine; Ovarian cancer","score_opus":0.03149553926749486,"score_gpt":0.3360346258657554,"score_spread":0.3045390865982605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969124354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95172787,0.00093749,0.00006754829,0.021759113,0.010686874,0.00031929868,0.00010539181,0.00001832097,0.014378101],"genre_scores_gemma":[0.9877227,0.0010113902,0.0009890983,0.005134406,0.0032762105,0.00006056263,0.000004980426,0.000019158982,0.0017815187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974002,0.00007022432,0.00081947044,0.00028745545,0.0011390529,0.0002835715],"domain_scores_gemma":[0.9964267,0.00037020794,0.0009880153,0.00018675116,0.0018815531,0.00014679511],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005085295,0.0002239069,0.00046545215,0.000094691015,0.000105483334,0.000048379356,0.0007306134,0.00018712634,0.014347883],"category_scores_gemma":[0.00047266582,0.00012927636,0.000652968,0.00019533669,0.00040580123,0.00015657395,0.00024911543,0.00039233212,0.000028637392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059566123,0.0010850074,0.8024863,0.00002303855,0.0028351645,0.000050210016,0.00039185176,0.00019588572,0.0034646806,0.00044028249,0.1611165,0.027315404],"study_design_scores_gemma":[0.005217094,0.001200047,0.76395005,0.0005036988,0.00045668185,0.00013882933,0.00018233314,0.00027805558,0.013992558,0.0007898276,0.2130603,0.00023050334],"about_ca_topic_score_codex":0.00020431141,"about_ca_topic_score_gemma":0.0004628235,"teacher_disagreement_score":0.051943816,"about_ca_system_score_codex":0.0017172527,"about_ca_system_score_gemma":0.00064406486,"threshold_uncertainty_score":0.98655313},"labels":[],"label_agreement":null},{"id":"W2969328213","doi":"10.1136/ijgc-00009577-200409001-00177","title":"177 Conservative Management of Advanced or Recurrent Vulvar Carcinoma","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Vulvar Carcinoma; Conservative management; General surgery; Carcinoma; Vulvar cancer; Vulva; Gynecology; Oncology; Dermatology; Surgery; Internal medicine","score_opus":0.06535382660670842,"score_gpt":0.40956980770768403,"score_spread":0.3442159811009756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969328213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97939765,0.0015560918,0.00032999262,0.0074602244,0.0010687711,0.0002968812,0.00003236099,0.00000895401,0.009849067],"genre_scores_gemma":[0.99446464,0.0019707226,0.0020018807,0.00085171784,0.00025689384,0.000022524464,0.000003730389,0.000008280285,0.00041964327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982103,0.000031524472,0.0005372817,0.00014833568,0.00088836876,0.00018416956],"domain_scores_gemma":[0.99785054,0.00015582386,0.00028431913,0.000090391295,0.0014517147,0.00016718735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023496311,0.000111903166,0.00034894282,0.00012480968,0.000024155293,0.000011945994,0.00030506542,0.00006416735,0.008738961],"category_scores_gemma":[0.0002122081,0.00006974615,0.00017198808,0.00017460388,0.00013550532,0.00009331569,0.00010244085,0.00031572062,0.000009035215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04468555,0.0031862548,0.08729243,0.00053818565,0.002741612,0.006711121,0.00069220236,0.0016508155,0.0024876702,0.013765276,0.0030275285,0.8332214],"study_design_scores_gemma":[0.010149013,0.0035468906,0.96353525,0.00028996062,0.00012243347,0.00016840956,0.00043313796,0.000020762107,0.0046777106,0.0021304316,0.014796792,0.00012921388],"about_ca_topic_score_codex":0.0000419569,"about_ca_topic_score_gemma":0.00006225101,"teacher_disagreement_score":0.8762428,"about_ca_system_score_codex":0.00073882594,"about_ca_system_score_gemma":0.00040953647,"threshold_uncertainty_score":0.9921672},"labels":[],"label_agreement":null},{"id":"W2969375619","doi":"10.1136/ijgc-00009577-200409001-00468","title":"468 Phase I/II Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients (PTS) With Relapsed/Refractory Ovarian, Primary Fallopian, or Primary Peritoneal Cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Ovarian cancer; Fallopian tube; Internal medicine; Oncology; Gynecology; Urology; Cancer","score_opus":0.02566531339371038,"score_gpt":0.3233031724292442,"score_spread":0.29763785903553386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969375619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915707,0.0005592302,0.0000677945,0.004426825,0.0018543955,0.0007467068,0.00011140401,0.000013605204,0.0006493092],"genre_scores_gemma":[0.9945683,0.0016574397,0.0011510389,0.0013080118,0.00085309235,0.000135122,0.00006203461,0.00002804113,0.00023693462],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969775,0.00008071561,0.0011031232,0.0003314076,0.0012253865,0.00028188265],"domain_scores_gemma":[0.99756896,0.00021230291,0.0009349088,0.00016492709,0.00092129025,0.00019763144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030293508,0.00027447916,0.0007838083,0.00029420454,0.0000567736,0.000025912255,0.00025624773,0.00021971377,0.0013256588],"category_scores_gemma":[0.00017603721,0.00017482777,0.00022248067,0.00024358675,0.00013627103,0.0003681804,0.000080405276,0.00051983487,0.0000030959038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46827385,0.040002573,0.30355078,0.00014807543,0.0021212515,0.0015764538,0.00060801284,0.002157582,0.001080047,0.00021237704,0.0014117169,0.17885728],"study_design_scores_gemma":[0.23299265,0.02217642,0.7388538,0.00072096224,0.00025428517,0.000037501617,0.000023157598,0.000008989016,0.00035870142,0.000105256775,0.004269354,0.00019888734],"about_ca_topic_score_codex":0.00034634402,"about_ca_topic_score_gemma":0.00032582338,"teacher_disagreement_score":0.43530306,"about_ca_system_score_codex":0.0035506855,"about_ca_system_score_gemma":0.001883368,"threshold_uncertainty_score":0.99958724},"labels":[],"label_agreement":null},{"id":"W2969742353","doi":"10.1136/ijgc-00009577-200409001-00268","title":"268 Carboplatin and Paclitaxel for Advanced and Recurrent Cervical Carcinoma: BCCA Experience","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Cervical carcinoma; Oncology; Carcinoma; Urology; Cervical cancer; Internal medicine; Chemotherapy; Cisplatin; Cancer","score_opus":0.03558977188078134,"score_gpt":0.3616310608155147,"score_spread":0.3260412889347334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969742353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885725,0.0051779025,0.00023980039,0.0046224603,0.00086560484,0.00023592931,0.000032506618,0.000007931485,0.00024541075],"genre_scores_gemma":[0.9950055,0.0012007251,0.002311892,0.00094236864,0.00042398035,0.00005893515,0.00000392474,0.000008028085,0.00004465534],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99887985,0.000017831993,0.00038233097,0.00019282092,0.00035909732,0.00016809556],"domain_scores_gemma":[0.99884665,0.00028029265,0.0001931901,0.00005298716,0.0004014509,0.00022542982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011880892,0.00012929486,0.00032888283,0.000094226976,0.000044112963,0.000025295807,0.000106857835,0.00008150969,0.00020884474],"category_scores_gemma":[0.0005337142,0.000085618296,0.000108951164,0.00008494191,0.00010800948,0.00011394312,0.000055569206,0.00017281761,8.3309027e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018226001,0.0017385333,0.29126543,0.00018379948,0.000886696,0.0008718977,0.0018362656,0.00015722994,0.012468925,0.005030029,0.00020972152,0.66712546],"study_design_scores_gemma":[0.023501959,0.004940902,0.95328534,0.0002249802,0.00018071652,0.00043332338,0.0003888124,0.00004443986,0.0035692772,0.0053021717,0.007907807,0.00022025182],"about_ca_topic_score_codex":0.000052442163,"about_ca_topic_score_gemma":0.00003834862,"teacher_disagreement_score":0.6669052,"about_ca_system_score_codex":0.00035986534,"about_ca_system_score_gemma":0.00012463269,"threshold_uncertainty_score":0.34914127},"labels":[],"label_agreement":null},{"id":"W2969763526","doi":"10.1136/ijgc-00009577-200409001-00082","title":"082 Grade 3 Endometrioid Endometrial Cancer – Recurrence Risk in Comparison to Serous Papillary and Clear Cell Endometrial Cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Endometrial cancer; Clear cell; Oncology; Serous fluid; Cancer; Internal medicine; Gynecology; Carcinoma","score_opus":0.044506144003516046,"score_gpt":0.3637448836157148,"score_spread":0.31923873961219873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969763526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96601766,0.022445789,0.00016257382,0.0042995773,0.005634979,0.0007600507,0.0002893787,0.000026314721,0.00036367914],"genre_scores_gemma":[0.9611757,0.03358499,0.001123596,0.0013483618,0.0024715865,0.00015977246,0.00000882747,0.0000322138,0.0000949865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995718,0.00020341984,0.0014056115,0.0005521892,0.0015447916,0.00057599554],"domain_scores_gemma":[0.99590147,0.0016193779,0.0009093035,0.00017118236,0.0007550166,0.00064365746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008054543,0.00040290243,0.001258692,0.0016951094,0.00009298473,0.00009556655,0.0005306901,0.0002693614,0.0018265513],"category_scores_gemma":[0.0037110576,0.00029760422,0.00036966975,0.002101691,0.00014503523,0.0002565274,0.00020870366,0.001046171,0.000020624162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024378778,0.0026857185,0.75858706,0.00007488627,0.0011967336,0.0010651594,0.0005834728,0.005948329,0.0045030876,0.000087524655,0.0010261163,0.19986312],"study_design_scores_gemma":[0.13163489,0.013830923,0.7726019,0.0012168573,0.0011641982,0.00030914397,0.00042543677,0.000084957486,0.03301275,0.0017269341,0.042837884,0.0011541082],"about_ca_topic_score_codex":0.004770261,"about_ca_topic_score_gemma":0.0014615415,"teacher_disagreement_score":0.19870903,"about_ca_system_score_codex":0.0025197873,"about_ca_system_score_gemma":0.0006646127,"threshold_uncertainty_score":0.9999476},"labels":[],"label_agreement":null},{"id":"W2971037744","doi":"10.1136/ijgc-00009577-200610001-00582","title":"Intracavitary Medium Dose Rate Brachytherapy In Vain3: A 20 Year Retrospective Review","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of British Columbia; Memorial University of Newfoundland","funders":"","keywords":"Topotecan; Cervix; Cisplatin; Basal cell; Oncology; Medicine; Internal medicine; Chemotherapy; Cancer","score_opus":0.010099173138082887,"score_gpt":0.30274543944892246,"score_spread":0.29264626631083956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971037744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94232196,0.040256456,0.00069650164,0.012227976,0.0025669527,0.00029804866,0.00007790633,0.0000076056913,0.0015465914],"genre_scores_gemma":[0.95776623,0.035015557,0.00033794428,0.005195942,0.0012558585,0.000022705854,0.000023902832,0.000013215147,0.0003686286],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989515,0.00007467727,0.0003965893,0.0001697527,0.000252816,0.00015467813],"domain_scores_gemma":[0.9992104,0.00002640927,0.0002646275,0.0000862063,0.00036353964,0.000048821486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044697552,0.000114096896,0.00022161589,0.00005909888,0.0000166992,0.00001723683,0.00030510643,0.0001037756,0.0005888397],"category_scores_gemma":[0.000078590834,0.00008947749,0.00014028321,0.000077621386,0.00004471201,0.000009698832,0.000049685146,0.00020142466,0.0000036595256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024165695,0.0010783249,0.051897272,0.00007953793,0.0007302479,0.0006093131,0.00005511416,0.0008383951,0.86336476,0.0035329703,0.035129342,0.04026815],"study_design_scores_gemma":[0.007221919,0.0026071477,0.4032356,0.0008475397,0.00010860682,0.00022623499,0.000053227046,0.000053108095,0.071186416,0.019448603,0.49430835,0.0007032462],"about_ca_topic_score_codex":0.000049421982,"about_ca_topic_score_gemma":0.00039679222,"teacher_disagreement_score":0.79217833,"about_ca_system_score_codex":0.00017657844,"about_ca_system_score_gemma":0.00015920571,"threshold_uncertainty_score":0.64473814},"labels":[],"label_agreement":null},{"id":"W2973024847","doi":"10.1136/ijgc-2019-000724","title":"Impact of transversus abdominis plane blocks versus non-steroidal anti-inflammatory on post-operative opioid use in ERAS ovarian cancer surgery","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Opioid; Retrospective cohort study; Surgery; Confounding; Ovarian cancer; Analgesic; Anesthesia; Cancer; Internal medicine","score_opus":0.029358670839596916,"score_gpt":0.3322717531094104,"score_spread":0.30291308226981345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973024847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654466,0.00011637717,0.000014615008,0.0017400427,0.0009352849,0.00028969717,0.00003065957,0.0000057472425,0.00032291896],"genre_scores_gemma":[0.9978116,0.0005621993,0.00006526043,0.0009766095,0.00029512626,0.000013610889,0.000010765641,0.000013738409,0.00025105214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824315,0.00009597097,0.0006383185,0.0001914744,0.0006080451,0.00022304639],"domain_scores_gemma":[0.9977447,0.0011536938,0.00039569516,0.00011226487,0.00046902295,0.00012464261],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004096528,0.00019318123,0.0005884619,0.00033116687,0.000018125646,0.000027141774,0.00021568411,0.00013496146,0.0042172237],"category_scores_gemma":[0.00018074895,0.00013239917,0.00037073714,0.00010223836,0.000069191825,0.000176899,0.000021446582,0.0003596784,0.00001391051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016572768,0.00042115917,0.9688781,0.000025849773,0.0009581548,0.0010598501,0.00039525583,0.0042130593,0.003282596,0.000054716627,0.0012709196,0.0028675734],"study_design_scores_gemma":[0.0059912987,0.0017504138,0.9891473,0.000305185,0.00007582082,0.000033466702,0.00012175342,0.0001756984,0.00059928134,0.000006204225,0.0016555425,0.00013800041],"about_ca_topic_score_codex":0.000534341,"about_ca_topic_score_gemma":0.00022609375,"teacher_disagreement_score":0.020269237,"about_ca_system_score_codex":0.00065017934,"about_ca_system_score_gemma":0.00051945506,"threshold_uncertainty_score":0.9966931},"labels":[],"label_agreement":null},{"id":"W2973241778","doi":"10.1136/ijgc-2019-igcs.248","title":"248 Challenges and opportunities in the integration of pathology consultation into the IGCS project echo global telementoring program","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical education; Specialty; Telemedicine; Medical physics; Curriculum; Health care; Pathology; Psychology","score_opus":0.08996985667400342,"score_gpt":0.45360462576675814,"score_spread":0.3636347690927547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973241778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772602,0.0072649657,0.00019318506,0.012419425,0.00085379014,0.00042312322,0.000003264895,0.000005263056,0.0015768391],"genre_scores_gemma":[0.97323024,0.02386472,0.0015587839,0.0010090804,0.00024283605,0.000043911707,0.000002219423,0.0000026774528,0.00004553319],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99909085,0.00015065829,0.00033746014,0.00008532689,0.00025206382,0.00008362095],"domain_scores_gemma":[0.99870735,0.00057548605,0.00031860996,0.00005606247,0.00032600053,0.000016462758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006805609,0.00007124917,0.0001893945,0.000058487407,0.00002221723,0.000009170711,0.00017872496,0.00008043557,0.000068532565],"category_scores_gemma":[0.00036688327,0.00003334421,0.00004605357,0.000051830793,0.0002393418,0.00010090604,0.000022152473,0.00022693546,3.6776785e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067894865,0.00027047266,0.02846742,0.000019542756,0.00011821549,0.00013158473,0.006149324,0.000036950616,0.00044193023,0.007837365,0.00007229082,0.955776],"study_design_scores_gemma":[0.007880797,0.008725737,0.8375863,0.00045608796,0.00014104483,0.0019112444,0.039400592,0.00064208155,0.0005144493,0.013938841,0.08858472,0.00021811722],"about_ca_topic_score_codex":0.00001549061,"about_ca_topic_score_gemma":0.00012619038,"teacher_disagreement_score":0.9555578,"about_ca_system_score_codex":0.00019638737,"about_ca_system_score_gemma":0.00015077941,"threshold_uncertainty_score":0.13597375},"labels":[],"label_agreement":null},{"id":"W2973249208","doi":"10.1136/ijgc-2019-igcs.148","title":"148 Senticol III: international validation study of sentinel node biopsy in early cervical cancer. A gineco, engot and gcig study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada","funders":"","keywords":"Medicine; Stage (stratigraphy); Sentinel node; Biopsy; Quality of life (healthcare); Cervical cancer; Sentinel lymph node; Oncology; Randomized controlled trial; Cancer; Internal medicine; Breast cancer","score_opus":0.038909674614215024,"score_gpt":0.3881199388228276,"score_spread":0.34921026420861256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973249208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380285,0.00018218474,0.000019067238,0.0027252769,0.0012093384,0.0007690296,0.000019812102,0.000010254115,0.0012621896],"genre_scores_gemma":[0.99850744,0.00021956775,0.00005156405,0.00032202838,0.0005171231,0.00007127291,0.000005468675,0.000016975127,0.00028856428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967435,0.0001440111,0.0009873954,0.0003424002,0.0015265533,0.0002561422],"domain_scores_gemma":[0.99747086,0.00032666943,0.00042756132,0.00015220411,0.0014372854,0.00018545325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006650096,0.00019388039,0.0006105399,0.00047945094,0.00002807824,0.000068506364,0.0004465167,0.000116035975,0.008686476],"category_scores_gemma":[0.00030359876,0.00014778308,0.00013740612,0.0002947644,0.000073329786,0.00022718594,0.00025683542,0.00061592617,0.000009589069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026738069,0.003645678,0.982529,0.000033112377,0.00058829936,0.00025991874,0.0010278363,0.00031418464,0.0013051694,0.00003672042,0.000095372685,0.007490895],"study_design_scores_gemma":[0.013205578,0.0012969217,0.9823346,0.00006950153,0.000100968646,0.000053916512,0.0013382657,0.0008228461,0.0002470756,0.00006413925,0.0003322108,0.00013397308],"about_ca_topic_score_codex":0.0015624532,"about_ca_topic_score_gemma":0.00043649078,"teacher_disagreement_score":0.010531771,"about_ca_system_score_codex":0.00052664505,"about_ca_system_score_gemma":0.0002549023,"threshold_uncertainty_score":0.99221975},"labels":[],"label_agreement":null},{"id":"W2973302883","doi":"10.1136/ijgc-2019-igcs.376","title":"376 Dual mechanical and pharmacological thromboprophylaxis significantly decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Pulmonary embolism; Perioperative; Intermittent pneumatic compression; Surgery; Laparotomy; Hysterectomy; Low molecular weight heparin; Gynecologic oncology; Thrombosis; Deep vein","score_opus":0.0145141888286125,"score_gpt":0.30276537603305076,"score_spread":0.28825118720443826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973302883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946979,0.0012044192,0.00017387503,0.0010785004,0.0012361015,0.0010357194,0.00010476051,0.000018012473,0.0004506962],"genre_scores_gemma":[0.9936755,0.0028327177,0.0012587123,0.0014473855,0.00041594726,0.00021885634,0.0000062873387,0.000017529359,0.00012709935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978189,0.000113682625,0.00080141984,0.00033090194,0.0006265226,0.00030856987],"domain_scores_gemma":[0.99717706,0.0009931723,0.0006655263,0.00011656183,0.0008379232,0.00020973022],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062456256,0.00023380839,0.0009074384,0.00017056984,0.000045912384,0.00003125349,0.00026757037,0.00018931573,0.004305685],"category_scores_gemma":[0.00074902835,0.00015446513,0.00037879165,0.00010321114,0.00017913268,0.00014687712,0.00018810917,0.00030496984,0.0000109143875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012671739,0.010471502,0.7654335,0.0005722653,0.0077813356,0.0025005706,0.00036837836,0.00061906996,0.113623664,0.004764138,0.0070190043,0.07417485],"study_design_scores_gemma":[0.0037861338,0.0045826347,0.97279483,0.00016262132,0.0008645655,0.00015023885,0.00025522747,0.0004001337,0.009037048,0.0025502262,0.0051665506,0.0002497833],"about_ca_topic_score_codex":0.000031926655,"about_ca_topic_score_gemma":0.000012313679,"teacher_disagreement_score":0.20736136,"about_ca_system_score_codex":0.00020271883,"about_ca_system_score_gemma":0.00017052425,"threshold_uncertainty_score":0.9966045},"labels":[],"label_agreement":null},{"id":"W2973307751","doi":"10.1136/ijgc-2019-igcs.49","title":"49 Circulating cell-free tumour dna for surveillance of endometrial and ovarian carcinoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Endometrial cancer; Ovarian cancer; Internal medicine; Serous carcinoma; Oncology; Ovarian carcinoma; Minimal residual disease; Gastroenterology; Gynecology; Cancer; Pathology","score_opus":0.012417491501575248,"score_gpt":0.2674846180265895,"score_spread":0.2550671265250143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973307751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956339,0.0012290392,0.0005725181,0.00037731434,0.0013476061,0.0001349523,0.00014764153,0.0000010980245,0.0005559076],"genre_scores_gemma":[0.9978154,0.00038939994,0.0007412551,0.00020597217,0.0007679968,0.0000067435653,0.000011141153,0.0000087308335,0.00005338341],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991958,0.00002486042,0.0003449195,0.00014221025,0.0001759247,0.00011627619],"domain_scores_gemma":[0.9987172,0.00029089075,0.0003791236,0.000092985094,0.00046331476,0.00005646875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028288458,0.00008491487,0.00020199231,0.000060892566,0.000017538714,0.000020955918,0.0002996827,0.000084834435,0.00008921325],"category_scores_gemma":[0.0009357414,0.00007187466,0.00012667644,0.00003802784,0.00003816863,0.0000052383066,0.00012282055,0.00007100066,5.6106023e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011055706,0.0001165155,0.29956985,0.000032356387,0.00017410028,0.000014567844,0.00003316015,0.0011066858,0.6923393,0.00044793106,0.001459455,0.0036004987],"study_design_scores_gemma":[0.01651071,0.0034525685,0.6881492,0.00005527084,0.00007048966,0.00012377753,0.00012629142,0.00054043776,0.2533303,0.001970215,0.035214808,0.00045595816],"about_ca_topic_score_codex":0.000027603799,"about_ca_topic_score_gemma":0.00003873965,"teacher_disagreement_score":0.43900904,"about_ca_system_score_codex":0.000051355928,"about_ca_system_score_gemma":0.00014809577,"threshold_uncertainty_score":0.29309633},"labels":[],"label_agreement":null},{"id":"W2973599998","doi":"10.1136/ijgc-2019-igcs.119","title":"119 Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; PTEN; Gastroenterology; Retrospective cohort study; Biopsy; Carcinoma; Cancer; Oncology; Biology","score_opus":0.031129258652901295,"score_gpt":0.3176969059258206,"score_spread":0.28656764727291933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973599998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992296,0.003719041,0.000049011935,0.0015353105,0.0010036143,0.0004503417,0.000044291508,0.00001528711,0.000887112],"genre_scores_gemma":[0.9958274,0.0011865145,0.0018735173,0.000513625,0.00025942005,0.00005178927,0.0000072490197,0.000013594826,0.00026690366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811286,0.00008372988,0.00062272814,0.00025974665,0.0007024545,0.00021847013],"domain_scores_gemma":[0.9972049,0.00067357824,0.0006400914,0.00007753846,0.0012334196,0.00017047733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023036666,0.00020427986,0.0007123544,0.00027263895,0.000032845997,0.00002427879,0.00019453198,0.00015121665,0.0023888592],"category_scores_gemma":[0.00076395343,0.00011465394,0.0001547619,0.00035970443,0.00014334814,0.0001514328,0.00006368176,0.00033991746,0.0000044956305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012708861,0.00047812474,0.9427012,0.00006305449,0.0017514719,0.00044105816,0.00023683498,0.00033966705,0.02891026,0.00031503252,0.0000983692,0.0119560165],"study_design_scores_gemma":[0.034024138,0.018319216,0.90575725,0.001045246,0.0010364283,0.0010853161,0.00028431194,0.00019909302,0.03569551,0.0007432853,0.0013181577,0.0004920354],"about_ca_topic_score_codex":0.00021293927,"about_ca_topic_score_gemma":0.000054973618,"teacher_disagreement_score":0.036943987,"about_ca_system_score_codex":0.00081985083,"about_ca_system_score_gemma":0.0004849072,"threshold_uncertainty_score":0.9985231},"labels":[],"label_agreement":null},{"id":"W2973618456","doi":"10.1136/ijgc-2019-igcs.247","title":"247 Project echo: reaching best practices in gynecologic oncology through international videoconferencing with case management and didactics","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Global Health and Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Videoconferencing; Curriculum; Best practice; Specialty; Gynecologic oncology; Telemedicine; Medicine; Medical education; Echo (communications protocol); Health care; Computer science; Psychology; Oncology; Multimedia; Family medicine; Management; Political science; Pedagogy","score_opus":0.10306196043270943,"score_gpt":0.4413618740381708,"score_spread":0.33829991360546136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973618456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96208066,0.00049363123,0.0001467204,0.005897116,0.0016815207,0.00044192883,0.000007394441,0.000011581443,0.029239468],"genre_scores_gemma":[0.98811543,0.002553267,0.005805349,0.0028460838,0.0002469205,0.000028841736,0.0000049803134,0.000010033735,0.00038908704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818194,0.00013642498,0.00064376224,0.00026352977,0.0004814604,0.00029290907],"domain_scores_gemma":[0.99723023,0.0010415127,0.000997665,0.00009304086,0.0005158352,0.00012170821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008596017,0.00016377751,0.000435071,0.00026253017,0.00004034648,0.000055840443,0.00020023418,0.00015402793,0.0005764611],"category_scores_gemma":[0.0009125328,0.00010910589,0.00007373416,0.00013364365,0.00006775119,0.00043949025,0.000117458796,0.0006639193,0.00000997993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004168304,0.0011613743,0.83357793,0.00012604024,0.0006614864,0.037956156,0.0008041343,0.00021828456,0.0001500887,0.001709467,0.00056194287,0.11890481],"study_design_scores_gemma":[0.021093821,0.010654515,0.496734,0.0018722983,0.0005627386,0.07181113,0.014829077,0.0025224856,0.00017517383,0.00263863,0.37628168,0.0008244604],"about_ca_topic_score_codex":0.0005705287,"about_ca_topic_score_gemma":0.00083534734,"teacher_disagreement_score":0.37571976,"about_ca_system_score_codex":0.0011826317,"about_ca_system_score_gemma":0.0005130148,"threshold_uncertainty_score":0.63118446},"labels":[],"label_agreement":null},{"id":"W2973632359","doi":"10.1136/ijgc-2019-igcs.6","title":"6 Interpreting immune infiltrates and hormone biomarkers in young women with endometrial carcinoma (EC) through a moder lens (POST-TCGA) of molecular classification","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Internal medicine; Immune system; Cohort; Medicine; Immunohistochemistry; Estrogen; Context (archaeology); Oncology; Stromal cell; Endocrinology; Immunology; Biology","score_opus":0.019812903537582454,"score_gpt":0.2933445948046755,"score_spread":0.27353169126709304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973632359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941553,0.0019529355,0.00011094908,0.001207102,0.00033465447,0.0002971867,0.000022030881,0.0000059059844,0.0019139377],"genre_scores_gemma":[0.99827987,0.0006745926,0.0006080832,0.00027443314,0.00008920807,0.00003180834,0.00000686275,0.0000125267425,0.00002264183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830407,0.000076017175,0.00065873394,0.00020028182,0.0005565699,0.00020435549],"domain_scores_gemma":[0.99832,0.00041012792,0.0005061818,0.0000941248,0.00058844284,0.00008115825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033303723,0.00015507342,0.0005201251,0.00032784432,0.000014002582,0.000023215638,0.00017532974,0.00010628804,0.00043465785],"category_scores_gemma":[0.0005072028,0.000101578706,0.00010324948,0.000347035,0.000107937696,0.00024296336,0.00005819678,0.0002550107,0.0000019920878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02401139,0.00051944825,0.75513977,0.000043745567,0.001385911,0.00020309536,0.0007704541,0.00011804581,0.20709638,0.00030796742,0.0000106965945,0.010393124],"study_design_scores_gemma":[0.0156018445,0.005033453,0.96657026,0.0002221987,0.00010418709,0.00015676852,0.0010499848,0.00019213239,0.010526202,0.00030002958,0.000094739626,0.00014818409],"about_ca_topic_score_codex":0.0003358652,"about_ca_topic_score_gemma":0.000028891214,"teacher_disagreement_score":0.21143053,"about_ca_system_score_codex":0.0005855483,"about_ca_system_score_gemma":0.00018176986,"threshold_uncertainty_score":0.47591987},"labels":[],"label_agreement":null},{"id":"W2973731620","doi":"10.1136/ijgc-2019-igcs.1","title":"1 MILO/ENGOT-OV11: Phase-3 study of binimetinib versus physician’s choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; KRAS; Selumetinib; MEK inhibitor; Chemotherapy; Clinical endpoint; Internal medicine; Serous carcinoma; Progression-free survival; Ovarian cancer; Oncology; Gastroenterology; Serous fluid; Surgery; Randomized controlled trial; Cancer; MAPK/ERK pathway; Kinase; Colorectal cancer; Biology","score_opus":0.05509890882951412,"score_gpt":0.3621649320535733,"score_spread":0.3070660232240592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973731620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919788,0.00083908025,8.2025736e-7,0.0035548059,0.0023428455,0.000833623,0.000051795847,0.0000053389554,0.00039287758],"genre_scores_gemma":[0.9976259,0.0007570423,0.000092976334,0.00084789,0.00038043098,0.000054424552,0.000004749637,0.000018934712,0.00021768802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976494,0.0001305388,0.00083085365,0.00027450648,0.0008982707,0.0002164511],"domain_scores_gemma":[0.99796474,0.00055101275,0.0006835032,0.00023334935,0.00046831675,0.000099099816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022420757,0.00022248074,0.00072399975,0.00015719951,0.00002723938,0.000015115922,0.00046049524,0.00009272068,0.0011493596],"category_scores_gemma":[0.00014110422,0.00011897723,0.00038185838,0.0002615875,0.00008846593,0.00009118776,0.00009032271,0.00036399695,0.000002522429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04249487,0.035992347,0.8450006,0.00022246553,0.004567493,0.00036277002,0.0030731638,0.0007673196,0.005199135,0.000049083006,0.0014944088,0.060776304],"study_design_scores_gemma":[0.03950505,0.017638177,0.93260014,0.00057406374,0.00033359908,0.000038555863,0.0011986417,0.00010529221,0.0025577547,0.0000063241678,0.005275447,0.0001669261],"about_ca_topic_score_codex":0.0003253738,"about_ca_topic_score_gemma":0.0004901157,"teacher_disagreement_score":0.08759953,"about_ca_system_score_codex":0.0010256305,"about_ca_system_score_gemma":0.0005765542,"threshold_uncertainty_score":0.9997637},"labels":[],"label_agreement":null},{"id":"W2973874320","doi":"10.1136/ijgc-2019-igcs.239","title":"239 Gynecological cancers in haiti: epidemiological characteristics and diagnostic challenges","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Cervical cancer; Cancer; Gynecology; Epidemiology; Uterine cancer; Retrospective cohort study; Cancer registry; Vulvar cancer; Internal medicine; Obstetrics; Oncology","score_opus":0.055357873497382734,"score_gpt":0.3782502377900784,"score_spread":0.32289236429269563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973874320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694193,0.0059447973,0.00001729722,0.016953234,0.001211705,0.00031593244,0.000023450337,0.000014877961,0.006099379],"genre_scores_gemma":[0.96759593,0.028415019,0.0001462993,0.002964678,0.00063873216,0.000038457147,0.000005014956,0.000011613438,0.00018424912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767655,0.00018023925,0.0007645489,0.00032555434,0.00066540093,0.000387715],"domain_scores_gemma":[0.9948214,0.003770168,0.0002802087,0.00011363556,0.00063494564,0.00037958985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009554049,0.00019969845,0.00080116716,0.00020914777,0.000027292208,0.000031104075,0.00032935588,0.0002655554,0.016499601],"category_scores_gemma":[0.008075937,0.0001300785,0.0001825275,0.0001161524,0.00020547422,0.00012522942,0.00017414808,0.00088300393,0.000035139245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014540465,0.00024314027,0.8193126,0.00006588208,0.00016658474,0.0010467224,0.00009453374,0.000070954506,0.00018790436,0.0016948194,0.00054045627,0.17512237],"study_design_scores_gemma":[0.0025633643,0.0014898182,0.9794857,0.00009733005,0.00003171158,0.00019069153,0.00012941941,0.00026585325,0.00004028185,0.0012249355,0.01433691,0.00014401363],"about_ca_topic_score_codex":0.00006560943,"about_ca_topic_score_gemma":0.000153501,"teacher_disagreement_score":0.17497836,"about_ca_system_score_codex":0.0009145198,"about_ca_system_score_gemma":0.0004099697,"threshold_uncertainty_score":0.98439944},"labels":[],"label_agreement":null},{"id":"W2973970504","doi":"10.1136/ijgc-2019-igcs.232","title":"232 Surgical wait time might impact survival in selected patients with endometrial carcinoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Proportional hazards model; Endometrial cancer; Retrospective cohort study; Hazard ratio; Stage (stratigraphy); Carcinoma; Survival analysis; Surgery; Cancer; Biopsy; Internal medicine; Confidence interval","score_opus":0.012133920750626663,"score_gpt":0.2959329414382339,"score_spread":0.28379902068760726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973970504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954714,0.0003522714,0.000002554436,0.00055134203,0.001182315,0.000356603,0.000069557886,0.00001176654,0.0020021508],"genre_scores_gemma":[0.9984862,0.00008836632,0.000077079145,0.0001577101,0.00066604896,0.000011754942,0.00004211332,0.000017187704,0.00045352493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974928,0.00012225355,0.00062509,0.00024228205,0.0012011126,0.0003164877],"domain_scores_gemma":[0.99734116,0.0007795525,0.00035924226,0.000100467296,0.0011715156,0.00024806432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027818495,0.00021736276,0.0007206331,0.00047116494,0.000018031458,0.00003285312,0.0002768174,0.00014692829,0.0138890315],"category_scores_gemma":[0.00049860484,0.000120889,0.00026665037,0.0007546467,0.0000521131,0.00017073998,0.000056128014,0.00043474926,0.00008616248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016627064,0.0009978018,0.97578865,0.000006655877,0.0005102754,0.00065133,0.000020455645,0.00007618362,0.00014354466,0.000015196811,0.00020661754,0.004956237],"study_design_scores_gemma":[0.033881783,0.004450028,0.9590155,0.000070813185,0.00007395064,0.00007565291,0.000006083026,0.000025625159,0.0002254604,0.00003521388,0.0020010055,0.00013889649],"about_ca_topic_score_codex":0.0001519768,"about_ca_topic_score_gemma":0.000031822492,"teacher_disagreement_score":0.017254721,"about_ca_system_score_codex":0.0011921945,"about_ca_system_score_gemma":0.00040963932,"threshold_uncertainty_score":0.9870124},"labels":[],"label_agreement":null},{"id":"W2974031519","doi":"10.1136/ijgc-2019-igcs.315","title":"315 Is it safe to immediately initiate adjuvant intraperitoneal chemotherapy following bowel resection in patients with newly diagnosed advanced ovarian cancer?","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Surgery; Bowel obstruction; Chemotherapy; Ovarian cancer; Port (circuit theory); Bowel resection; Retrospective cohort study; Anastomosis; Carboplatin; Stage (stratigraphy); Cancer; Cisplatin; Internal medicine","score_opus":0.013576226305599185,"score_gpt":0.30667555822929843,"score_spread":0.29309933192369925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974031519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853483,0.00020834367,0.000053224016,0.010767168,0.0024455965,0.00053089124,0.000041982228,0.0000112281705,0.0005932891],"genre_scores_gemma":[0.9863772,0.0003802817,0.00068359374,0.011838719,0.000418924,0.00005953517,0.000012188846,0.000024772276,0.00020479191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766856,0.000049069113,0.00067482697,0.00030055016,0.00093590695,0.00037107652],"domain_scores_gemma":[0.9985242,0.00018962103,0.0003472074,0.000108366694,0.000607408,0.00022322568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023952033,0.00023568203,0.00054693053,0.00025561644,0.000043010743,0.000046260735,0.0002944801,0.00014472294,0.003437061],"category_scores_gemma":[0.00015199854,0.00016404482,0.00018099176,0.00025722003,0.000046755853,0.00032088056,0.000049759732,0.00046890718,0.000032149423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021609189,0.0010399771,0.904296,0.000048074766,0.0006860988,0.0011150286,0.0017725443,0.0013802571,0.0072620483,0.00011661809,0.0018961255,0.058778055],"study_design_scores_gemma":[0.015256872,0.003440193,0.97333974,0.00080599036,0.000050044313,0.000028629442,0.0002693184,0.000085228785,0.0025822632,0.00017663301,0.003705679,0.0002594363],"about_ca_topic_score_codex":0.00038159473,"about_ca_topic_score_gemma":0.00036444605,"teacher_disagreement_score":0.069043726,"about_ca_system_score_codex":0.00073211413,"about_ca_system_score_gemma":0.00032158158,"threshold_uncertainty_score":0.99747396},"labels":[],"label_agreement":null},{"id":"W2974072392","doi":"10.1136/ijgc-2019-igcs.314","title":"314 Patients with ovarian clear cell carcinoma are at high risk of secondary malignancy","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Clear cell carcinoma; Internal medicine; Cohort; Retrospective cohort study; Malignancy; Cancer; Carcinoma; Gastroenterology; Oncology","score_opus":0.006460709447811825,"score_gpt":0.23001274874425345,"score_spread":0.22355203929644163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974072392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950172,0.00049411145,0.000008648939,0.0011839847,0.0010157686,0.00023665083,0.00019614254,0.00000507482,0.00184242],"genre_scores_gemma":[0.9978958,0.00028067193,0.0005151829,0.0005767544,0.00021714554,0.00001143312,0.000014940864,0.000015925343,0.00047216262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850523,0.00004992986,0.0004554451,0.0001930191,0.0006365726,0.00015982201],"domain_scores_gemma":[0.9978206,0.00016685062,0.0008946899,0.00013760038,0.000848657,0.0001315624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011912983,0.0001488237,0.0004271001,0.000105222985,0.000026919754,0.000013062546,0.0001887308,0.00009291063,0.009464364],"category_scores_gemma":[0.000049098107,0.00009169836,0.00017637598,0.000073920884,0.000052113246,0.00009982466,0.00006692953,0.00025267806,0.000035829908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022254826,0.0008218688,0.9900907,0.00003085495,0.00044479533,0.00020522019,0.000051421204,0.00011725025,0.000060889037,0.00008030382,0.0012294711,0.0046417415],"study_design_scores_gemma":[0.0093154535,0.0030171226,0.98146874,0.00015691255,0.00022077655,0.000023396431,0.000032886295,0.000007358205,0.0018948762,0.00008473306,0.003679989,0.00009777595],"about_ca_topic_score_codex":0.0001515094,"about_ca_topic_score_gemma":0.000062159925,"teacher_disagreement_score":0.009428534,"about_ca_system_score_codex":0.0006450539,"about_ca_system_score_gemma":0.00021746667,"threshold_uncertainty_score":0.99144113},"labels":[],"label_agreement":null},{"id":"W2974264218","doi":"10.1136/ijgc-2019-igcs.293","title":"293 Molecular determinants of CDK4 inhibitor activity in low-grade serous ovarian cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University; University of British Columbia","funders":"","keywords":"Palbociclib; Cyclin-dependent kinase 6; CDKN2A; Cancer research; Medicine; Ovarian cancer; Oncology; Internal medicine; Breast cancer; Cancer; Cell cycle; Cyclin D1","score_opus":0.017429251695311496,"score_gpt":0.3436476119863559,"score_spread":0.3262183602910444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974264218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948823,0.0009468513,0.00016602047,0.0019586473,0.0015947132,0.00023478131,0.000032179203,0.000008650404,0.00017587512],"genre_scores_gemma":[0.9977771,0.0002961862,0.0006302984,0.00075977284,0.00034442017,0.000024551879,9.929112e-7,0.000019581468,0.00014707334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820435,0.00006634647,0.0005809392,0.00021157914,0.00069371745,0.00024304695],"domain_scores_gemma":[0.9983941,0.00016136064,0.0006249311,0.00013362533,0.00056764425,0.00011835052],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022989669,0.00017460162,0.0005744183,0.00021869279,0.000012001222,0.000012360096,0.0003121919,0.00014083352,0.0017746689],"category_scores_gemma":[0.00016485057,0.00013323329,0.00019411759,0.00017182884,0.00009744554,0.00023014331,0.00007679849,0.00042846362,0.0000070891556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037974925,0.0007799952,0.65557253,0.000098955024,0.00036680466,0.00093295774,0.0002141251,0.0027390958,0.23728004,0.000087698805,0.000036315218,0.09809397],"study_design_scores_gemma":[0.00607301,0.00068080344,0.8543004,0.00090880244,0.00004924821,0.00022509189,0.000068531575,0.00037096985,0.13490584,0.0005239338,0.0016991185,0.00019424313],"about_ca_topic_score_codex":0.00019930981,"about_ca_topic_score_gemma":0.0001829387,"teacher_disagreement_score":0.19872786,"about_ca_system_score_codex":0.00082442316,"about_ca_system_score_gemma":0.00041323132,"threshold_uncertainty_score":0.9991378},"labels":[],"label_agreement":null},{"id":"W2974328195","doi":"10.1136/ijgc-2019-igcs.246","title":"246 The international gynecologic cancer society global curriculum: partnerships building capacity and expertise in gynecologic oncology for the world’s poorest women","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Global Health and Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Curriculum; Medicine; Capacity building; Gynecologic cancer; Gynecologic oncology; Specialty; Medical education; Developing country; Family medicine; Oncology; Cancer; Internal medicine; Political science; Economic growth","score_opus":0.062126588318264085,"score_gpt":0.3897604650434113,"score_spread":0.3276338767251472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974328195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282568,0.0024101296,0.000092062335,0.062318884,0.0054244497,0.0006805808,0.000057433444,0.000016039601,0.000743625],"genre_scores_gemma":[0.97675467,0.002276149,0.00044929475,0.018950202,0.00086478057,0.00037096927,0.0000038149087,0.000010141241,0.00031997365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737346,0.00015675057,0.0008394876,0.00033188533,0.00066292303,0.0006355076],"domain_scores_gemma":[0.9958031,0.0024411464,0.0006082473,0.00014277433,0.0007480207,0.00025670827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019621504,0.00023897148,0.0005753,0.00009656528,0.0001350607,0.00007307948,0.00068460434,0.00023065276,0.002046736],"category_scores_gemma":[0.0015517995,0.00012427008,0.0003213298,0.00026347133,0.00028774593,0.00017498288,0.00018785946,0.00069250475,0.0000070998467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009331956,0.0004689821,0.9311593,0.000032558193,0.00045342525,0.00009361978,0.00033626694,0.00061333063,0.00018550566,0.002501655,0.014254232,0.048967883],"study_design_scores_gemma":[0.0041546687,0.0007981169,0.8231195,0.00011883673,0.00007534981,0.00021165822,0.0011318192,0.0055019394,0.000041312607,0.0019383733,0.1627037,0.00020473401],"about_ca_topic_score_codex":0.00021358207,"about_ca_topic_score_gemma":0.0022003942,"teacher_disagreement_score":0.14844947,"about_ca_system_score_codex":0.004476268,"about_ca_system_score_gemma":0.00078260334,"threshold_uncertainty_score":0.99934536},"labels":[],"label_agreement":null},{"id":"W2974669716","doi":"10.1136/ijgc-2019-igcs.3","title":"3 Translating endometrial molecular risk stratification to endometrioid ovarian carcinoma: a novel application of precision medicine","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"","keywords":"Endometrial cancer; Oncology; Internal medicine; Medicine; Carcinoma; Ovarian cancer; Ovarian carcinoma; Stage (stratigraphy); Biomarker; Cohort; Risk stratification; Cancer; Biology","score_opus":0.02519755294587055,"score_gpt":0.33477523806144827,"score_spread":0.3095776851155777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974669716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9405933,0.0010229725,0.048238676,0.006788248,0.0011337856,0.0009040851,0.000070039285,0.0000096850845,0.0012392241],"genre_scores_gemma":[0.9913772,0.00022904389,0.007528663,0.00025948184,0.0004955033,0.000054483604,0.000014561729,0.000013112502,0.000027992104],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99769694,0.000059076974,0.0008992667,0.0002582922,0.000939197,0.00014720444],"domain_scores_gemma":[0.997107,0.00068944687,0.0008279459,0.00018170236,0.0010297431,0.00016412113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066690665,0.00014979576,0.00051606464,0.000535413,0.000022290333,0.000015217203,0.00025744212,0.00010672271,0.0011877348],"category_scores_gemma":[0.0011142154,0.00010437551,0.00020911326,0.00044180104,0.000042474545,0.00009801935,0.000029666257,0.00023545441,0.0000133804015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041448865,0.0014560833,0.35712552,0.000049048325,0.0010491393,0.00006486691,0.00049001834,0.0045122597,0.23011751,0.0036369655,0.00017009568,0.3971836],"study_design_scores_gemma":[0.03151681,0.007962695,0.9014655,0.00044946617,0.000818748,0.00015696546,0.00020650991,0.0018623166,0.043877818,0.0012973222,0.010080164,0.0003056944],"about_ca_topic_score_codex":0.00025446806,"about_ca_topic_score_gemma":0.000016276563,"teacher_disagreement_score":0.54433995,"about_ca_system_score_codex":0.00047514017,"about_ca_system_score_gemma":0.00021631524,"threshold_uncertainty_score":0.99972534},"labels":[],"label_agreement":null},{"id":"W2974732176","doi":"10.1136/ijgc-2019-esgo.1167","title":"EP1125 Chemotherapy reduces par glycohydrolase (PARG) expression in high-grade serous ovarian cancer patients","year":2019,"lang":"fr","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ovarian cancer; Serous fluid; Immunohistochemistry; Chemotherapy; Cancer; Cancer research; Internal medicine; Medicine; Biology; Oncology","score_opus":0.01883457527051502,"score_gpt":0.3270956318515802,"score_spread":0.3082610565810652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974732176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321021,0.013944879,0.000066655906,0.026096886,0.026358716,0.00059240643,0.00024633805,0.00002071112,0.00057130924],"genre_scores_gemma":[0.96976614,0.017415345,0.00070449663,0.00575731,0.004184475,0.00009863389,0.000026647713,0.00005838257,0.0019885483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953482,0.00034023848,0.0015461328,0.0005307313,0.0015470897,0.0006875899],"domain_scores_gemma":[0.9963545,0.0005262822,0.0013748612,0.00023002895,0.0011238618,0.00039042678],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006540037,0.00045338937,0.00094801805,0.00043326814,0.000060513223,0.00008788485,0.0007843502,0.0005224442,0.030466251],"category_scores_gemma":[0.00025852007,0.00037182303,0.0003547987,0.00036692256,0.000241639,0.0006136523,0.00010589143,0.0011619483,0.00014522125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009679141,0.0054832357,0.7651662,0.00014727884,0.0013567132,0.0009710302,0.0012304813,0.008410317,0.08887216,0.00035895332,0.023145424,0.09517902],"study_design_scores_gemma":[0.03974796,0.00279454,0.7193162,0.0055911075,0.00017190515,0.0001356257,0.00016746945,0.0005759786,0.11921919,0.0022756488,0.109203115,0.00080128864],"about_ca_topic_score_codex":0.0005427608,"about_ca_topic_score_gemma":0.00012521073,"teacher_disagreement_score":0.09437773,"about_ca_system_score_codex":0.0035138582,"about_ca_system_score_gemma":0.0008626694,"threshold_uncertainty_score":0.9998734},"labels":[],"label_agreement":null},{"id":"W2974744095","doi":"10.1136/ijgc-2019-igcs.2","title":"2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Barts Health NHS Trust; Universitätsklinikum Heidelberg; Universiteit Leiden; Calgary Laboratory Services","keywords":"Medicine; Discontinuation; Internal medicine; Dysgeusia; Anemia; Adverse effect; Population; Placebo; Nausea; Oncology","score_opus":0.019188474624683326,"score_gpt":0.32760682534098606,"score_spread":0.30841835071630275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974744095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971109,0.0003751772,0.000018146995,0.00030121868,0.00034840594,0.0017560248,0.00005001377,0.0000026433042,0.000037450067],"genre_scores_gemma":[0.9994463,0.00012551431,0.00009212411,0.00012412942,0.000015115115,0.00016674043,0.000010148215,0.00000805257,0.000011908101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745286,0.00030424754,0.0012325472,0.00021427401,0.00064862584,0.00014745785],"domain_scores_gemma":[0.9974073,0.00050593837,0.0012228449,0.00012647908,0.0006559315,0.00008148285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039299717,0.00018150045,0.001662621,0.00071840064,0.0000096662825,0.000009464229,0.00012097001,0.00006509608,0.0002879948],"category_scores_gemma":[0.00021700698,0.00010150943,0.0002411534,0.00027726148,0.00009261183,0.00009985111,0.00003105826,0.00017375882,2.6300208e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3627101,0.00578037,0.62350464,0.000006078388,0.0018780006,0.00004587702,0.0012321824,0.00026346938,0.00006509476,0.000010680807,0.0000030777921,0.004500435],"study_design_scores_gemma":[0.47026935,0.006405837,0.52167076,0.00017445964,0.000409677,0.0000017321884,0.0005482061,0.00035722574,0.000074256706,0.00001581817,0.000008881946,0.00006378978],"about_ca_topic_score_codex":0.00013048592,"about_ca_topic_score_gemma":0.0003132675,"teacher_disagreement_score":0.10755927,"about_ca_system_score_codex":0.00061951985,"about_ca_system_score_gemma":0.000172702,"threshold_uncertainty_score":0.41394347},"labels":[],"label_agreement":null},{"id":"W2974833868","doi":"10.1136/ijgc-2019-igcs.233","title":"233 Clinical next-generation sequencing pipeline for brca mutations provides traceback to the families of deceased ovarian cancer patients","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sanger sequencing; Multiplex ligation-dependent probe amplification; Ovarian cancer; Olaparib; Copy-number variation; Multiplex; Germline; Cancer; Medicine; Oncology; Exon; Genetics; Computational biology; Biology; Mutation; Bioinformatics; Gene; Genome","score_opus":0.0638745798712036,"score_gpt":0.3509909308023965,"score_spread":0.2871163509311929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974833868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990199,0.00047975223,0.0039189113,0.0023412989,0.0023148623,0.00040285315,0.0002685888,0.0000017889997,0.00007290713],"genre_scores_gemma":[0.9941258,0.0008716896,0.0012466622,0.001997681,0.001488835,0.000056725996,0.000065041626,0.000010689024,0.00013691552],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988209,0.00005171515,0.0006016969,0.00017354969,0.00022827611,0.00012386868],"domain_scores_gemma":[0.99788254,0.0002489848,0.00042325695,0.00009983034,0.0012730868,0.000072298964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035089924,0.000099346966,0.00018816839,0.000047510443,0.00004022379,0.000040058105,0.00032806597,0.000098062614,0.00013569281],"category_scores_gemma":[0.0011665283,0.00006847068,0.00018186793,0.00005460654,0.000049209346,0.000013375372,0.000060115337,0.00009862838,0.0000025237155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027095221,0.0009349315,0.32507256,0.00005785385,0.00095394405,0.0000064461547,0.00045821097,0.09400126,0.33030456,0.0007274408,0.04351139,0.20126186],"study_design_scores_gemma":[0.015623561,0.007988382,0.3511875,0.0003106741,0.00051479647,0.000020408777,0.0008905731,0.025365455,0.1627458,0.0011104863,0.4331697,0.0010726843],"about_ca_topic_score_codex":0.00009369237,"about_ca_topic_score_gemma":0.00093005376,"teacher_disagreement_score":0.3896583,"about_ca_system_score_codex":0.00013925685,"about_ca_system_score_gemma":0.00049145834,"threshold_uncertainty_score":0.27921534},"labels":[],"label_agreement":null},{"id":"W2974918122","doi":"10.1136/ijgc-2019-igcs.231","title":"231 Risk factors for lymph nodes involvement in obese women with endometrial carcinomas","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Lymph node; Body mass index; Hazard ratio; Endometrial cancer; Quartile; Proportional hazards model; Internal medicine; Confidence interval; Odds ratio; Retrospective cohort study; Carcinoma; Gynecology; Gastroenterology; Urology; Cancer","score_opus":0.03249020287289897,"score_gpt":0.3145711755809616,"score_spread":0.28208097270806265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974918122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640226,0.0005804059,0.0000685108,0.0005350994,0.0014067824,0.00045861863,0.00007693685,0.000008259251,0.00046310553],"genre_scores_gemma":[0.99771196,0.00049576774,0.00042971884,0.0004724595,0.00054209604,0.00009282483,0.000009650204,0.000014197854,0.00023133321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981908,0.000054755743,0.0005399467,0.00021326155,0.00071158865,0.0002896556],"domain_scores_gemma":[0.99772567,0.00104904,0.00042409645,0.00009084819,0.00051637023,0.00019400397],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038781832,0.00017357797,0.00055050844,0.00040212265,0.000023491944,0.000029513014,0.00024415515,0.00009790784,0.0024835656],"category_scores_gemma":[0.0008092566,0.00009890149,0.00017761372,0.00029487646,0.000047228314,0.000134092,0.000047161182,0.00022427952,0.000008092449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011923905,0.00059794093,0.97651035,0.00002123354,0.0006550134,0.00009030675,0.00022847838,0.0002953543,0.00042196517,0.000066295215,0.000044294924,0.0091448445],"study_design_scores_gemma":[0.029846055,0.0039306935,0.9604508,0.000110777255,0.000107210944,0.00001960558,0.0004964374,0.000040690575,0.001410494,0.0006142519,0.002832161,0.0001408129],"about_ca_topic_score_codex":0.0003656723,"about_ca_topic_score_gemma":0.00007284898,"teacher_disagreement_score":0.017922148,"about_ca_system_score_codex":0.0019564189,"about_ca_system_score_gemma":0.00030591091,"threshold_uncertainty_score":0.9984283},"labels":[],"label_agreement":null},{"id":"W2979768168","doi":"10.1136/ijgc-2019-000413","title":"Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Réseau de cancérologie Rossy; Israel Cancer Research Fund","keywords":"Medicine; Laparotomy; Ovarian cancer; Gynecologic oncology; Debulking; Surgery; Chemotherapy; Robotic surgery; Stage (stratigraphy); Cancer; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer","score_opus":0.018935551979156667,"score_gpt":0.3095042097879975,"score_spread":0.2905686578088408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979768168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651773,0.0034898699,0.00014132755,0.027690645,0.002418161,0.00031463164,0.0000073101496,0.0000070600886,0.00075367163],"genre_scores_gemma":[0.9917821,0.0035980938,0.0012657361,0.002514153,0.00041612718,0.00007938117,0.000002347791,0.000013949998,0.0003280769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984303,0.00004278763,0.0005992684,0.00016648232,0.00061127415,0.00014987469],"domain_scores_gemma":[0.99848443,0.00025207,0.00057766313,0.00014661807,0.000458898,0.0000803192],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035882567,0.000141915,0.00042599984,0.00010028892,0.000023787014,0.000026202004,0.00022354351,0.00006638434,0.0044472427],"category_scores_gemma":[0.000023665069,0.00007865141,0.00027829446,0.0001334691,0.00007064423,0.000094794326,0.00006196115,0.00019602444,0.000012238504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014660592,0.00059863715,0.7720749,0.00009723024,0.002987071,0.00058779336,0.00032595574,0.0016397947,0.00030582416,0.00090963294,0.0011822863,0.21782485],"study_design_scores_gemma":[0.0024799777,0.0003217899,0.98733646,0.0008405712,0.0002606119,0.00004813557,0.00013998439,0.00014554086,0.00096980867,0.0007241139,0.0066215517,0.000111441135],"about_ca_topic_score_codex":0.00017571409,"about_ca_topic_score_gemma":0.000050304276,"teacher_disagreement_score":0.2177134,"about_ca_system_score_codex":0.00053312135,"about_ca_system_score_gemma":0.00023113038,"threshold_uncertainty_score":0.9964628},"labels":[],"label_agreement":null},{"id":"W2983987940","doi":"10.1136/ijgc-2019-esgo.1291","title":"EP1286 Single institution experience with neoadjuvant chemotherapy compared to primary debulking surgery in patients over 75 with high grade ovarian cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Chemotherapy; Internal medicine; Oncology; Stage (stratigraphy); Surgery; Retrospective cohort study; Cancer","score_opus":0.02192791675438917,"score_gpt":0.2889775793463173,"score_spread":0.26704966259192814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983987940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943172,0.00018689281,0.00009931793,0.003758376,0.0010080668,0.0004019317,0.00001696362,0.000010615865,0.00020065793],"genre_scores_gemma":[0.9945235,0.00018932484,0.00077801227,0.0041209883,0.00023026418,0.00008333999,0.00001160794,0.000016500735,0.000046452766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982493,0.000032694847,0.00045086996,0.00027562195,0.0007578203,0.00023372662],"domain_scores_gemma":[0.9987879,0.0001527942,0.00034819214,0.000118370466,0.00043863305,0.00015413311],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012130923,0.00018618457,0.0004984443,0.00020657259,0.00002841715,0.00004421294,0.00016014093,0.00006920778,0.0012613356],"category_scores_gemma":[0.000037502497,0.0001144047,0.00008260505,0.00021468497,0.000058718088,0.00023212415,0.00003061429,0.00019852813,0.000004853178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037128215,0.0012333342,0.97639257,0.000012870561,0.0002645769,0.00023034193,0.0002874019,0.0018008772,0.00034839,0.000049228125,0.0002621673,0.01540543],"study_design_scores_gemma":[0.0072587198,0.0011189093,0.9865826,0.0007890483,0.000041274176,0.000030176925,0.00003393015,0.000021644155,0.0010452173,0.00001682158,0.0029063518,0.00015533928],"about_ca_topic_score_codex":0.0005985365,"about_ca_topic_score_gemma":0.00036171803,"teacher_disagreement_score":0.015250091,"about_ca_system_score_codex":0.0019901358,"about_ca_system_score_gemma":0.00038868017,"threshold_uncertainty_score":0.9996517},"labels":[],"label_agreement":null},{"id":"W2984793218","doi":"10.1136/ijgc-2019-esgo.28","title":"Effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: an analysis from the phase 3 study ARIEL3","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Regimen; Oncology; Placebo; Progression-free survival; Population; BRCA mutation; Ovarian cancer; Chemotherapy; Cancer; Pathology","score_opus":0.020466524810887073,"score_gpt":0.35341917229194064,"score_spread":0.3329526474810536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984793218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967728,0.0000544698,0.00008805838,0.0009627446,0.00047696248,0.001380473,0.00016642862,0.0000065239565,0.000091515925],"genre_scores_gemma":[0.9993266,0.000005393373,0.00020030496,0.00021482841,0.00010578931,0.00007765145,0.000044289496,0.000014951451,0.000010190262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699223,0.00059851125,0.00082833855,0.00029294775,0.0010953164,0.00019265794],"domain_scores_gemma":[0.9950504,0.0028540457,0.0011079964,0.00039945787,0.0005062878,0.000081841674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087604934,0.00024705633,0.00079460297,0.00019696113,0.00004404179,0.000024451776,0.0004638944,0.00007330553,0.0004931696],"category_scores_gemma":[0.00055016635,0.000108938046,0.00036756112,0.00030652722,0.00012276074,0.000100102196,0.000051885294,0.00035614945,0.000001586108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04240315,0.0042537544,0.93816847,0.0000072812322,0.0021957997,0.00010856387,0.0011308986,0.0022489724,0.00031803868,0.000020730875,0.000051820247,0.009092542],"study_design_scores_gemma":[0.048877202,0.028100992,0.91456187,0.0006268544,0.0007489647,0.0000022763581,0.0003108775,0.002091943,0.0045077302,0.000024010904,0.000028553739,0.00011873004],"about_ca_topic_score_codex":0.00029303166,"about_ca_topic_score_gemma":0.00017174993,"teacher_disagreement_score":0.023847237,"about_ca_system_score_codex":0.00077741157,"about_ca_system_score_gemma":0.00020949237,"threshold_uncertainty_score":0.53998613},"labels":[],"label_agreement":null},{"id":"W2984886575","doi":"10.1136/ijgc-2019-000623","title":"Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Foundation Medicine; National Institute for Health and Care Research; Wellcome Trust; Clovis Oncology; University College London; Wellcome","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Poly ADP ribose polymerase; Polymerase; Cancer research; BRCA mutation; Olaparib; Oncology; Internal medicine; Pharmacology; Cancer; Gene; Genetics; Biology","score_opus":0.010216513708256455,"score_gpt":0.2947875185163555,"score_spread":0.28457100480809905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984886575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009484,0.00018680339,0.000027815735,0.007276462,0.0014792915,0.00047853508,0.0002242326,0.000010970145,0.00022102795],"genre_scores_gemma":[0.9959805,0.00042744388,0.00024350024,0.0027831034,0.00041713685,0.00001694127,0.000012154478,0.000026644137,0.000092591974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977779,0.00017627969,0.0005938946,0.00031080935,0.00090153015,0.0002396309],"domain_scores_gemma":[0.9980627,0.00023612032,0.0008258251,0.0002001335,0.0005217607,0.0001534684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026985593,0.00024225083,0.0005405204,0.0002100476,0.000054948716,0.000028987837,0.00025089947,0.00014859026,0.00089985825],"category_scores_gemma":[0.00007969937,0.00014981553,0.00011334394,0.00022603339,0.00021204221,0.00030752367,0.00004644789,0.00061999477,0.000004348846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054580905,0.002386562,0.86410576,0.00003041678,0.0008223455,0.00018247307,0.0004590999,0.001307533,0.039646246,0.0012947146,0.00034565647,0.034838315],"study_design_scores_gemma":[0.020810524,0.0023923086,0.90867186,0.00055003876,0.000047044217,0.000048467395,0.000044329634,0.00009098097,0.06602048,0.00024355236,0.00088105793,0.00019935652],"about_ca_topic_score_codex":0.0008139394,"about_ca_topic_score_gemma":0.0002186177,"teacher_disagreement_score":0.04456613,"about_ca_system_score_codex":0.00076623575,"about_ca_system_score_gemma":0.0004489305,"threshold_uncertainty_score":0.98528165},"labels":[],"label_agreement":null},{"id":"W2986040815","doi":"10.1136/ijgc-2019-esgo.146","title":"P84 Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Hazard ratio; Oncology; Radiation therapy; Adjuvant; Brachytherapy; Retrospective cohort study; Proportional hazards model; Stage (stratigraphy); External beam radiotherapy; Cohort; Adjuvant radiotherapy; Cancer; Confidence interval; Biology","score_opus":0.020731583177859624,"score_gpt":0.3604658984584617,"score_spread":0.3397343152806021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986040815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833368,0.0025059287,0.00035217736,0.0068317433,0.0052621774,0.0011667702,0.000081506514,0.000021740427,0.00044115895],"genre_scores_gemma":[0.9914391,0.00072220695,0.0026782672,0.0030050105,0.0007793279,0.00026326353,0.0000019690135,0.000026790409,0.0010840654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750596,0.0001207077,0.00076077133,0.00034722246,0.0009266308,0.0003386819],"domain_scores_gemma":[0.99664515,0.001613926,0.00034983654,0.00015140507,0.001019659,0.00022001946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001194362,0.00020331344,0.000586477,0.00052318245,0.000023980425,0.000026031561,0.0003893023,0.00018200108,0.005731655],"category_scores_gemma":[0.0032206606,0.00014993802,0.00036269642,0.00035660298,0.0000636004,0.000098142256,0.000066210414,0.0003621486,0.000016021237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.263929,0.0008965311,0.56761956,0.000058932637,0.00084469636,0.00036346028,0.0010574121,0.007365362,0.12066815,0.00006449558,0.007513808,0.029618558],"study_design_scores_gemma":[0.01595467,0.012838345,0.89414567,0.0004270881,0.00009906352,0.00020154999,0.00022990606,0.00105986,0.006031348,0.0003774874,0.06832991,0.0003050885],"about_ca_topic_score_codex":0.00012031552,"about_ca_topic_score_gemma":0.0000915568,"teacher_disagreement_score":0.3265261,"about_ca_system_score_codex":0.0023842133,"about_ca_system_score_gemma":0.0010903478,"threshold_uncertainty_score":0.99517727},"labels":[],"label_agreement":null},{"id":"W2986890944","doi":"10.1136/ijgc-2019-esgo.675","title":"EP618 The use of preoperative imaging in endometrial cancer: are ontario physicians following GOC guidelines?","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Endometrial cancer; Incidence (geometry); Population; Cancer registry; Radiology; Stage (stratigraphy); Hysterectomy; Comorbidity; Cancer; Internal medicine","score_opus":0.09458181301061142,"score_gpt":0.37670641956956863,"score_spread":0.2821246065589572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986890944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781985,0.0016766061,0.000042860585,0.0062542586,0.0034195594,0.000367216,0.000030385443,0.0000054582674,0.00038381328],"genre_scores_gemma":[0.9947624,0.0005190119,0.0004044616,0.0027401026,0.0007546994,0.000032713444,0.0000038114194,0.000011367333,0.000771426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978426,0.000089153276,0.0008442124,0.00019105888,0.00082788925,0.00020506134],"domain_scores_gemma":[0.99729663,0.0008744688,0.00067623524,0.000115322466,0.0009657937,0.00007154452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032855303,0.00016336878,0.0005971763,0.00024045503,0.000026710257,0.00003966563,0.0003104446,0.00006546451,0.0018885222],"category_scores_gemma":[0.0012839738,0.00009244499,0.00042014633,0.0003551802,0.000056457437,0.00028045283,0.00008303626,0.0003936814,0.000006162854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016118882,0.00029086412,0.96959364,0.000006302406,0.0005318261,0.00019495438,0.00024635502,0.0016934305,0.00083097094,0.000035660993,0.00065395335,0.024310146],"study_design_scores_gemma":[0.010038316,0.0004808398,0.97133464,0.0006034492,0.00020343791,0.00002692889,0.00019007047,0.00016757188,0.0011918534,0.00012127571,0.015515006,0.00012660673],"about_ca_topic_score_codex":0.012269658,"about_ca_topic_score_gemma":0.015169219,"teacher_disagreement_score":0.024183538,"about_ca_system_score_codex":0.0015247511,"about_ca_system_score_gemma":0.00048289518,"threshold_uncertainty_score":0.9990239},"labels":[],"label_agreement":null},{"id":"W2987054527","doi":"10.1136/ijgc-2019-esgo.219","title":"P158 Efficacy of a coriolus versicolor-based vaginal gel in repairing HPV-dependent cervical lesions (ASCUS/LSIL) in three patients groups according to the risk of HPV strains","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ascus (bryozoa); Colposcopy; Cytology; Medicine; Gynecology; HPV infection; Population; Cervical cancer; Dysplasia; Randomized controlled trial; Obstetrics; Internal medicine; Cancer; Biology; Pathology; Spore; Microbiology","score_opus":0.03588934689500833,"score_gpt":0.3455964613671219,"score_spread":0.3097071144721136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987054527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480534,0.00017535084,0.00018014462,0.0020112484,0.00066825026,0.0005271067,0.0000635782,0.000005712674,0.0015632646],"genre_scores_gemma":[0.99906105,0.00010889359,0.00018390873,0.00038629008,0.00020352904,0.000019148283,0.0000053688364,0.000012460392,0.000019378193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702334,0.00015695584,0.0009031128,0.0002537369,0.0013521449,0.0003107008],"domain_scores_gemma":[0.9972498,0.0010496615,0.00042291818,0.00019097717,0.0009070407,0.00017964421],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009925634,0.00015577697,0.0005545222,0.00041052714,0.000030146803,0.00001861834,0.0006276057,0.00012991951,0.005262186],"category_scores_gemma":[0.0014977714,0.00010054411,0.00028449643,0.00037886002,0.00009690647,0.000103584716,0.0002240926,0.00087481295,0.000009836453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004190712,0.0010032728,0.91805696,0.000043249016,0.00014677452,0.00006549312,0.00018434445,0.009177226,0.00025337932,0.00015585315,0.00005358519,0.06666916],"study_design_scores_gemma":[0.00797862,0.0017270502,0.9875128,0.00011639363,0.000053965803,0.0000067207397,0.0002465963,0.0015571954,0.00027451402,0.0001973988,0.00023160089,0.00009709926],"about_ca_topic_score_codex":0.0008403451,"about_ca_topic_score_gemma":0.0030365142,"teacher_disagreement_score":0.06945589,"about_ca_system_score_codex":0.0010999686,"about_ca_system_score_gemma":0.000513229,"threshold_uncertainty_score":0.99564713},"labels":[],"label_agreement":null},{"id":"W2987952658","doi":"10.1136/ijgc-2019-esgo.8","title":"Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Endometrial cancer; Oncology; Survival analysis; Hazard ratio; Immunohistochemistry; Proportional hazards model; Log-rank test; Cancer; Gastroenterology; Confidence interval","score_opus":0.02231413883171365,"score_gpt":0.3206133101735926,"score_spread":0.298299171341879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987952658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922756,0.0007890564,0.000051716943,0.0017787621,0.00416553,0.0006968335,0.00006494158,0.0000028525312,0.00017468655],"genre_scores_gemma":[0.99863,0.00064566755,0.00016398323,0.00021079571,0.00021246698,0.000043948145,0.0000019585086,0.000008994729,0.00008219173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725527,0.0002174061,0.0009882095,0.00019058317,0.0012007538,0.00014778893],"domain_scores_gemma":[0.9961798,0.0009581893,0.0016558695,0.00025309811,0.00090467965,0.000048325906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006025092,0.00012701582,0.00058787543,0.00033031558,0.000017325057,0.000009084932,0.0006536773,0.00013714013,0.0010931679],"category_scores_gemma":[0.004173236,0.000067337285,0.0005308796,0.0011827201,0.00016364461,0.00004734619,0.000106040476,0.00047071362,9.173388e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009761462,0.00030105552,0.9483541,0.000014121344,0.0014095566,0.000007660591,0.000071331255,0.012323435,0.018942052,0.00021461921,0.00006668972,0.008533893],"study_design_scores_gemma":[0.013211958,0.00073007256,0.97317946,0.0001316745,0.0010418557,0.0000049696514,0.00003273556,0.0007345145,0.010138827,0.0003211081,0.00040380642,0.00006903987],"about_ca_topic_score_codex":0.00035855238,"about_ca_topic_score_gemma":0.00041182744,"teacher_disagreement_score":0.024825316,"about_ca_system_score_codex":0.0006076159,"about_ca_system_score_gemma":0.0006020242,"threshold_uncertainty_score":0.99982},"labels":[],"label_agreement":null},{"id":"W2988004744","doi":"10.1136/ijgc-2019-esgo.179","title":"P116 ATHENA (GOG-3020/ENGOT-ov45; EudraCT 2017–004557–17; NCT03522246): a randomised, double-blind, placebo-controlled, phase 3 study of the poly(ADP-Ribose) polymerase (PARP) inhibitor rucaparib + the PD-1 inhibitor nivolumab following frontline platinum-based chemotherapy in ovarian cancer (OC)","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; PARP inhibitor; Internal medicine; Oncology; Chemotherapy; Placebo; BRCA mutation; Nivolumab; Ovarian cancer; Cancer; Immunotherapy; Poly ADP ribose polymerase; Pathology; Polymerase; Biology","score_opus":0.034188081077340865,"score_gpt":0.3591871224557714,"score_spread":0.3249990413784305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988004744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97155607,0.0030434805,0.00028903622,0.013789705,0.005350638,0.0049082655,0.00013226106,0.000034139604,0.00089640653],"genre_scores_gemma":[0.9902152,0.00025195495,0.00020561389,0.0044450187,0.003046266,0.0008365465,0.00001637386,0.00008195686,0.00090106117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99302137,0.0006329339,0.0025845103,0.00068535906,0.002401466,0.00067435694],"domain_scores_gemma":[0.9939472,0.0016478774,0.0024832394,0.0006743276,0.00094277225,0.00030459499],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002182107,0.0006777101,0.0019275717,0.0005071118,0.00020306672,0.00013055596,0.0012727237,0.00037665266,0.004069871],"category_scores_gemma":[0.00048621587,0.00038916199,0.0012689234,0.00059097057,0.00025880957,0.0004090125,0.00014087248,0.001561607,0.000015105787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85614115,0.010492175,0.05706483,0.00005847921,0.0047349585,0.0003634371,0.0032224024,0.0046020243,0.048618827,0.00007324419,0.007729698,0.006898755],"study_design_scores_gemma":[0.95799345,0.0028587196,0.010072175,0.00093215855,0.0006658036,0.00010636072,0.0012090078,0.0022551476,0.01815126,0.00009464092,0.0050660535,0.0005952195],"about_ca_topic_score_codex":0.0012379242,"about_ca_topic_score_gemma":0.00063732226,"teacher_disagreement_score":0.10185228,"about_ca_system_score_codex":0.0017973434,"about_ca_system_score_gemma":0.0017674341,"threshold_uncertainty_score":0.99985605},"labels":[],"label_agreement":null},{"id":"W2988847662","doi":"10.1136/ijgc-2019-esgo.16","title":"Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Université de Montréal; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Groin; Vulvar cancer; Surgery; Metastasis; Micrometastasis; Sentinel node; Radiology; Cancer; Internal medicine; Vulva; Breast cancer","score_opus":0.02092344724333174,"score_gpt":0.3238757724864513,"score_spread":0.30295232524311955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988847662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953346,0.00108195,0.000011524325,0.0018954123,0.0006682328,0.00031145936,0.00010348184,0.0000048553784,0.0005884373],"genre_scores_gemma":[0.9975684,0.000555033,0.00069572526,0.0008336015,0.0001366634,0.000016990964,0.000013466091,0.000014792899,0.00016527344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758464,0.00007350311,0.000979069,0.0002003233,0.00096619996,0.00019628825],"domain_scores_gemma":[0.9974671,0.0002868305,0.0009658979,0.00011235205,0.0010601768,0.000107648426],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025224313,0.00017662253,0.0007702582,0.00036151902,0.000013877191,0.000007801079,0.00026555953,0.000075534146,0.0012529895],"category_scores_gemma":[0.0002950768,0.00010803688,0.00018428365,0.0004148921,0.00008817479,0.00014428527,0.000056209712,0.00020169266,0.0000016279583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013755561,0.0018332087,0.9735928,0.00006201976,0.00094151497,0.00009296971,0.00021940935,0.0006952141,0.0015688557,0.000047767713,0.0001546388,0.0070360014],"study_design_scores_gemma":[0.04579707,0.002924493,0.94635326,0.0005653733,0.00014855912,0.000021543512,0.000041809133,0.00008233753,0.0025702976,0.00009188032,0.0012736643,0.00012971711],"about_ca_topic_score_codex":0.00057681423,"about_ca_topic_score_gemma":0.00011348413,"teacher_disagreement_score":0.03204151,"about_ca_system_score_codex":0.0006272176,"about_ca_system_score_gemma":0.00037798006,"threshold_uncertainty_score":0.99966},"labels":[],"label_agreement":null},{"id":"W2989596404","doi":"10.1136/ijgc-2019-000713","title":"Role of primary care enrolment in advanced cervical cancer diagnosis: a population-based case–control study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Ottawa","funders":"","keywords":"Medicine; Cervical cancer; Primary care; Gynecology; Oncology; Cancer; Family medicine; Internal medicine","score_opus":0.017888436590536662,"score_gpt":0.3539704943073124,"score_spread":0.33608205771677574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989596404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171144,0.004570617,0.000008636369,0.0011550701,0.00051339867,0.0008203859,0.00012491716,0.000008082258,0.0010874682],"genre_scores_gemma":[0.99797004,0.00023718266,0.0000961288,0.0010370512,0.00028728592,0.00031907603,0.000008916365,0.000015543535,0.000028796747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974046,0.0001394008,0.0008048869,0.00025169176,0.0011466494,0.0002527908],"domain_scores_gemma":[0.9974753,0.00057567947,0.00033862513,0.00014508524,0.0012902422,0.00017502278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035261567,0.00016425068,0.00065726304,0.00029348186,0.000022829416,0.000019241768,0.0002925539,0.00011510772,0.015443956],"category_scores_gemma":[0.00020911625,0.00012005163,0.00023287484,0.00020944467,0.000035992292,0.00011910869,0.00006607279,0.0004940538,0.0000055815826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032324712,0.00099861,0.8595087,0.00008496422,0.0002240286,0.00068903784,0.00022522334,0.004186297,0.00027007272,0.000017598833,0.000017225717,0.1305458],"study_design_scores_gemma":[0.011002084,0.0018850662,0.9847081,0.00014197016,0.00010153953,0.000054176857,0.000798625,0.00039333262,0.00023810954,0.000065422304,0.00049609964,0.000115523195],"about_ca_topic_score_codex":0.0014144521,"about_ca_topic_score_gemma":0.0029545978,"teacher_disagreement_score":0.13043028,"about_ca_system_score_codex":0.0019246562,"about_ca_system_score_gemma":0.0006288658,"threshold_uncertainty_score":0.98545605},"labels":[],"label_agreement":null},{"id":"W2989705447","doi":"10.1136/ijgc-2019-esgo.335","title":"EP274 Effect of a Coriolus versicolor-based vaginal gel in HPV infected women: normalizing HPV-dependent cervical lesions (ASCUS/LSIL) and high-risk HPV clearance","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Colposcopy; Ascus (bryozoa); Medicine; Cytology; Gynecology; Population; HPV infection; Cervical cancer; Cervix; Cervical intraepithelial neoplasia; Obstetrics; Urology; Internal medicine; Cancer; Biology; Pathology","score_opus":0.01405869652177609,"score_gpt":0.3189515401634204,"score_spread":0.3048928436416443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989705447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947149,0.00095371826,0.000092614544,0.0012389296,0.00075923343,0.00040162684,0.000048579284,0.000014617195,0.001775788],"genre_scores_gemma":[0.9980037,0.0008436186,0.00011112672,0.0005835849,0.00030237593,0.000039268114,0.000006541353,0.000018037677,0.00009170494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970063,0.0002947219,0.0007264906,0.00031316397,0.0012260628,0.00043328168],"domain_scores_gemma":[0.9969891,0.0013280676,0.00040759213,0.0001563959,0.0007888686,0.0003299838],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010517287,0.00022655222,0.0007863659,0.00038783337,0.000050839477,0.00004182556,0.00037964797,0.0002151487,0.017497694],"category_scores_gemma":[0.0008767012,0.00016137533,0.00020417786,0.000296711,0.00018702894,0.00017529438,0.00017947686,0.0010970127,0.000025292198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0147157805,0.00052594993,0.8507022,0.0001982248,0.00032909334,0.00033686904,0.00016012702,0.0017688936,0.0012140672,0.00014970277,0.0001701781,0.12972887],"study_design_scores_gemma":[0.0126276305,0.0052518738,0.97704965,0.00009081728,0.00008131668,0.00006493886,0.0000633023,0.0016890895,0.0013862745,0.0001483102,0.0013862165,0.0001605915],"about_ca_topic_score_codex":0.00064056,"about_ca_topic_score_gemma":0.000302278,"teacher_disagreement_score":0.12956828,"about_ca_system_score_codex":0.0012738005,"about_ca_system_score_gemma":0.00047993832,"threshold_uncertainty_score":0.98340046},"labels":[],"label_agreement":null},{"id":"W2989990330","doi":"10.1136/ijgc-2019-000832","title":"Low-grade serous ovarian carcinoma: an evolution toward targeted therapy","year":2019,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Serous fluid; Ovarian carcinoma; Serous carcinoma; Medicine; Cystadenocarcinoma; Oncology; Targeted therapy; Internal medicine; Ovarian cancer; Pathology; Cancer research; Cancer","score_opus":0.12250854995067831,"score_gpt":0.4058079041628934,"score_spread":0.2832993542122151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989990330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028249295,0.98980653,0.00007823991,0.0013963267,0.004693934,0.0007587602,0.00014873393,0.000023306357,0.0002692257],"genre_scores_gemma":[0.065729275,0.9305253,0.00031576236,0.0005912335,0.0023668758,0.000110344736,0.000104194856,0.000049141818,0.00020788703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970404,0.00020874453,0.0011032732,0.00042763032,0.00090722216,0.00031272098],"domain_scores_gemma":[0.9971621,0.0002655791,0.0011993027,0.00026218613,0.00082267687,0.00028816762],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031727395,0.00045151988,0.0018843734,0.00034580252,0.000040144267,0.000075463,0.0005654568,0.00047157446,0.002778081],"category_scores_gemma":[0.00012022531,0.00027949817,0.001049565,0.00019781121,0.00006896197,0.0001950662,0.00006667219,0.0007623326,0.000059862683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036157283,0.0017288136,0.0038647132,0.00080819067,0.0025915205,0.001231356,0.00006844409,0.000023641358,0.0000051752945,0.00032400244,0.0017949215,0.98719764],"study_design_scores_gemma":[0.004382107,0.0026812113,0.032863367,0.004168851,0.0016014822,0.00093848025,0.000024800773,0.000017296074,0.000018951469,0.00017302755,0.95275044,0.00037995385],"about_ca_topic_score_codex":0.000119377146,"about_ca_topic_score_gemma":0.00001863204,"teacher_disagreement_score":0.9868177,"about_ca_system_score_codex":0.0031218256,"about_ca_system_score_gemma":0.0019206505,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2991529219","doi":"10.1136/ijgc-2019-000793","title":"Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Human papilloma virus; Vulvar Carcinoma; Radiation therapy; Vulvar cancer; Basal cell; Oncology; Vulvar neoplasm; Papilloma; Carcinoma; Internal medicine; Vulva; Cancer research; Dermatology; Pathology; Cancer; Cervical cancer","score_opus":0.01966886052930533,"score_gpt":0.3549465451038967,"score_spread":0.3352776845745914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991529219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484813,0.000980469,0.000007499677,0.0025158,0.0003050878,0.00020709807,0.000020231568,0.0000032757753,0.001112407],"genre_scores_gemma":[0.9977192,0.0002709091,0.00010109282,0.0009181686,0.00018279886,0.0000079046795,0.0000016578339,0.000009152233,0.0007891171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983293,0.00013571227,0.0004462126,0.00013938536,0.00073502265,0.00021436383],"domain_scores_gemma":[0.99823636,0.0006032598,0.00023417456,0.00007239004,0.00067392504,0.00017991207],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006776713,0.00008836449,0.00033848948,0.00027150384,0.000014387431,0.000018512997,0.00015435558,0.00010440798,0.007309672],"category_scores_gemma":[0.0005305907,0.000067335735,0.000087316315,0.00014132497,0.000029147108,0.0000708384,0.000049953043,0.00031262042,0.000006327679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076541794,0.00025510555,0.8622158,0.000024080084,0.000048444115,0.000084568244,0.0003261571,0.00006531521,0.12177824,0.000031509313,0.00042320666,0.007093387],"study_design_scores_gemma":[0.0052856165,0.0028037718,0.97902125,0.00001630585,0.00001563306,0.00000950331,0.00010482181,0.000032421216,0.007835789,0.00008283756,0.0047235223,0.00006855591],"about_ca_topic_score_codex":0.00040239762,"about_ca_topic_score_gemma":0.0003337623,"teacher_disagreement_score":0.11680542,"about_ca_system_score_codex":0.0014973576,"about_ca_system_score_gemma":0.00026394578,"threshold_uncertainty_score":0.9935978},"labels":[],"label_agreement":null},{"id":"W2991608936","doi":"10.1136/ijgc-2019-esgo.29","title":"Patient-centred outcomes in the phase 3 study ARIEL3 of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: post hoc exploratory analyses by BRCA mutation status and patient age","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Context (archaeology); Oncology; Population; Adverse effect; Nausea; Placebo; Tolerability; Pathology","score_opus":0.03350772699812896,"score_gpt":0.33854867216716467,"score_spread":0.3050409451690357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991608936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733084,0.0004560242,0.000007853349,0.0005345313,0.0003798588,0.0010095886,0.00022007684,0.0000037831037,0.0000574342],"genre_scores_gemma":[0.9990436,0.00009417862,0.00008658706,0.0006182082,0.000022831728,0.000064179294,0.00005311346,0.000010655087,0.0000066583416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775183,0.0002474113,0.00077987765,0.0002384844,0.0007702223,0.00021218737],"domain_scores_gemma":[0.9980548,0.00035579415,0.00070668635,0.00012660533,0.00066958996,0.000086513624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115068055,0.00020054185,0.0005131109,0.00023681071,0.000023172815,0.000025500718,0.000105015904,0.000061635656,0.00015841918],"category_scores_gemma":[0.00013842514,0.00011250181,0.000085752465,0.00017399696,0.00009323974,0.0001800105,0.000026458194,0.00025032458,0.0000010647911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010833731,0.0070517384,0.9500087,0.0000082481665,0.00036348304,0.000418811,0.012829025,0.00019726774,0.0004005477,0.000020028576,0.000087792956,0.017780615],"study_design_scores_gemma":[0.03028152,0.018620737,0.93894356,0.00014088053,0.00007297828,0.0000122318,0.010936534,0.000042155632,0.000547369,0.000035947753,0.00023470163,0.00013136092],"about_ca_topic_score_codex":0.00025250032,"about_ca_topic_score_gemma":0.00032004362,"teacher_disagreement_score":0.019447789,"about_ca_system_score_codex":0.000953693,"about_ca_system_score_gemma":0.00021300273,"threshold_uncertainty_score":0.45876905},"labels":[],"label_agreement":null},{"id":"W2995202816","doi":"10.1136/ijgc-2019-esgo.18","title":"Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Sherbrooke","funders":"","keywords":"Incidence (geometry); Medicine; Adverse effect; Internal medicine; Ovarian cancer; Chemotherapy; Oncology; Cancer","score_opus":0.036556426443372654,"score_gpt":0.37193563605527485,"score_spread":0.3353792096119022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995202816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875526,0.0003078529,0.00012431722,0.0059844423,0.0039411816,0.0007353401,0.0003937422,0.0000068188347,0.0009537345],"genre_scores_gemma":[0.99685365,0.00072367734,0.00033020257,0.0010524044,0.0008615558,0.000033217173,0.00006619458,0.000013795366,0.00006531159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701595,0.00016585228,0.0011375574,0.00025808183,0.0012218264,0.00020072116],"domain_scores_gemma":[0.99678993,0.0007629939,0.0011451881,0.00021136459,0.0009924142,0.00009809589],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000622154,0.00017978878,0.00053227093,0.0001266312,0.000025402058,0.000025431807,0.00043134898,0.00012286099,0.0042644446],"category_scores_gemma":[0.00021189875,0.0001022531,0.00017123006,0.00018424512,0.00010914665,0.00014725685,0.00006141351,0.0006195646,0.0000044561657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11897018,0.0009237862,0.85523844,0.000007056038,0.0005578896,0.00003395774,0.00016128954,0.0005280919,0.00015764625,0.0001441365,0.00061270595,0.022664797],"study_design_scores_gemma":[0.1038459,0.0022616906,0.89087176,0.00059810287,0.00006372874,0.0000041828425,0.00002007496,0.000039228646,0.00014745268,0.00009297441,0.0019473716,0.00010753122],"about_ca_topic_score_codex":0.0002997759,"about_ca_topic_score_gemma":0.0005324557,"teacher_disagreement_score":0.0356333,"about_ca_system_score_codex":0.0013214329,"about_ca_system_score_gemma":0.0007538859,"threshold_uncertainty_score":0.9966458},"labels":[],"label_agreement":null},{"id":"W2997471184","doi":"10.1136/ijgc-2019-000838","title":"A comparison of disease recurrence between robotic versus laparotomy approach in patients with intermediate-risk endometrial cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Laparotomy; Radiation therapy; Surgery; Hysterectomy; Retrospective cohort study; Dissection (medical); Stage (stratigraphy); Brachytherapy; Adjuvant therapy; Population; Cancer; Internal medicine; Chemotherapy","score_opus":0.04581502412463464,"score_gpt":0.36352936173794187,"score_spread":0.31771433761330725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997471184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962366,0.0006828999,0.00006636041,0.00020878759,0.0018368162,0.0005746712,0.000112733615,0.000006169767,0.00027492305],"genre_scores_gemma":[0.99880457,0.0002702642,0.00028723516,0.00007255629,0.0004422931,0.000051975545,0.000032758304,0.000012032785,0.000026312571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758244,0.00010832944,0.00077696546,0.00023964247,0.0010685379,0.00022406886],"domain_scores_gemma":[0.997332,0.0007824669,0.0008384209,0.00011783836,0.0006864661,0.0002428069],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023248751,0.00018419066,0.0008221786,0.00039801985,0.00001545672,0.000016906022,0.0003410747,0.000091085705,0.001133735],"category_scores_gemma":[0.00071666704,0.000114860086,0.00019669186,0.00046580474,0.00009759952,0.00015151348,0.00007665519,0.00046485415,0.0000071145273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027862787,0.0012441912,0.94688386,0.000038045855,0.0006031473,0.00001353541,0.000061217885,0.0013091818,0.00000457035,0.00001319497,0.000048865648,0.021917406],"study_design_scores_gemma":[0.030393679,0.003776739,0.96466464,0.00026028536,0.0003161526,4.378748e-7,0.00003544225,0.000087180044,0.00008514123,0.000035498575,0.0002277259,0.000117093565],"about_ca_topic_score_codex":0.0001240747,"about_ca_topic_score_gemma":0.000029269186,"teacher_disagreement_score":0.021800313,"about_ca_system_score_codex":0.0007046697,"about_ca_system_score_gemma":0.0003312172,"threshold_uncertainty_score":0.99977934},"labels":[],"label_agreement":null},{"id":"W2997664396","doi":"10.1136/ijgc-2019-000928","title":"Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Micrometastasis; Lymphadenectomy; Cervical cancer; Sentinel lymph node; Lymph node; Lymph; Stage (stratigraphy); Sentinel node; Cancer; Adjuvant therapy; Radiology; Oncology; Metastasis; Surgery; Internal medicine; Breast cancer; Pathology","score_opus":0.03118253854524904,"score_gpt":0.3333785630452046,"score_spread":0.30219602449995553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997664396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780715,0.0016172485,0.000037949587,0.007230254,0.0025030524,0.00047496107,0.00008056614,0.000019140021,0.00022969674],"genre_scores_gemma":[0.99565184,0.00086584385,0.00025771276,0.001565709,0.0006566129,0.00014668393,0.000012902166,0.000022456996,0.0008202335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976341,0.00012303617,0.0007008661,0.0003285038,0.0008750562,0.0003384127],"domain_scores_gemma":[0.998168,0.00039563572,0.00038762786,0.00012522511,0.0005053232,0.00041818633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023258518,0.00024567428,0.0006623901,0.00030249107,0.000024897283,0.00006160736,0.00040825285,0.000098670665,0.0069444254],"category_scores_gemma":[0.00037274207,0.00013143457,0.00039270075,0.00030538015,0.00007563386,0.00018613647,0.00010610251,0.0003646883,0.00006907034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034986301,0.000968306,0.97238463,0.00010139513,0.0006203584,0.0015509608,0.000039283623,0.00014890164,0.0002126395,0.000039488357,0.00003817255,0.020397227],"study_design_scores_gemma":[0.007460735,0.0006304396,0.98993695,0.0004753473,0.0003099002,0.00003045537,0.000013366437,0.00009580578,0.00030779865,0.00024656308,0.0003218439,0.000170817],"about_ca_topic_score_codex":0.0003643804,"about_ca_topic_score_gemma":0.0002518421,"teacher_disagreement_score":0.02022641,"about_ca_system_score_codex":0.001215942,"about_ca_system_score_gemma":0.00043394548,"threshold_uncertainty_score":0.99396336},"labels":[],"label_agreement":null},{"id":"W2997786171","doi":"10.1136/ijgc-2019-esgo.133","title":"P71 Does mismatch repair (MMR) deficiency have prognostic significance in low-risk endometrioid endometrial cancers?","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Women's Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; Proportional hazards model; Retrospective cohort study; Cohort; Stage (stratigraphy); Immunohistochemistry; Population; Adjuvant therapy; Gynecology; Cancer; Biology","score_opus":0.015500989810884266,"score_gpt":0.30202933245355346,"score_spread":0.2865283426426692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997786171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671126,0.0022030545,0.00012604495,0.00082494156,0.0072338395,0.00090881245,0.00006980666,0.000038148522,0.0018840783],"genre_scores_gemma":[0.9942316,0.0019352031,0.0015784838,0.0005983526,0.00095991703,0.00009882939,0.0000045509464,0.000029753519,0.00056334765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598306,0.00019239208,0.0012428702,0.000494744,0.0015801985,0.0005067218],"domain_scores_gemma":[0.99516255,0.0022626398,0.0009469232,0.00024091531,0.0011340114,0.00025293758],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010553082,0.0003081539,0.0008082777,0.00081661646,0.00004085322,0.000054391312,0.0006309605,0.00025290903,0.0060674152],"category_scores_gemma":[0.0068727243,0.00020415371,0.0004746869,0.0006726005,0.00017564613,0.00018527465,0.00013245446,0.000977744,0.00004763598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031344404,0.0004745506,0.9760393,0.00006825212,0.00027426842,0.00045402153,0.00024046752,0.003347675,0.00598914,0.000035479454,0.0005543608,0.009388068],"study_design_scores_gemma":[0.015215154,0.0047039036,0.9507468,0.00083534926,0.00024221693,0.00026765914,0.00059605896,0.001030641,0.015889052,0.000898004,0.008996694,0.0005785052],"about_ca_topic_score_codex":0.0005051384,"about_ca_topic_score_gemma":0.0004261599,"teacher_disagreement_score":0.025292516,"about_ca_system_score_codex":0.0027400935,"about_ca_system_score_gemma":0.0012763406,"threshold_uncertainty_score":0.99484116},"labels":[],"label_agreement":null},{"id":"W2998080630","doi":"10.1136/ijgc-2019-esgo.9","title":"Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Internal medicine; Oncology; Neutropenia; Population; Clinical endpoint; Chemotherapy; Progression-free survival; Gastroenterology; Randomized controlled trial; Cancer","score_opus":0.013153484769935895,"score_gpt":0.3148937811599277,"score_spread":0.30174029638999184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998080630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259794,0.0009164026,0.00006890028,0.0029744133,0.0016659517,0.0013264841,0.00004226585,0.000025048816,0.00038261953],"genre_scores_gemma":[0.99071187,0.0010427404,0.0005267355,0.006653852,0.0004330258,0.00033206854,0.000008314868,0.000047499085,0.00024389707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970114,0.00012600725,0.00082043034,0.00040287717,0.0012691286,0.00037013282],"domain_scores_gemma":[0.9975268,0.00027855692,0.0006283683,0.00024300526,0.0011350471,0.00018818394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034817436,0.00032401472,0.0006975044,0.000311716,0.000030558924,0.0000519195,0.00041303877,0.00015448016,0.011416249],"category_scores_gemma":[0.000085548185,0.00021816163,0.00018382515,0.00030330743,0.000092258,0.0003791542,0.000043488893,0.00062664674,0.000021700595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020246187,0.002663505,0.92162037,0.0000087256,0.0006485759,0.000193665,0.0006268824,0.0007351092,0.00045404423,0.000025729341,0.00036486003,0.05241235],"study_design_scores_gemma":[0.052008715,0.0043299044,0.9370347,0.00026559093,0.000036905778,0.000010819588,0.00011632807,0.000021129155,0.00037027005,0.00016694922,0.0053834086,0.00025525055],"about_ca_topic_score_codex":0.00012776876,"about_ca_topic_score_gemma":0.00021934294,"teacher_disagreement_score":0.0521571,"about_ca_system_score_codex":0.0013109971,"about_ca_system_score_gemma":0.00048424792,"threshold_uncertainty_score":0.98948747},"labels":[],"label_agreement":null},{"id":"W3006699187","doi":"10.1136/ijgc-2019-esgo.1243","title":"EP1206 Timely access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Genetic counseling; Referral; Medicine; Family medicine; Nova scotia; Genetic testing; Cohort; Gynecology; Oncology; Internal medicine; Biology; Genetics","score_opus":0.017650724911279853,"score_gpt":0.3320263471757928,"score_spread":0.314375622264513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006699187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991484,0.00043686735,0.0031415056,0.0023373568,0.001873999,0.0003618957,0.000120711884,0.0000032917553,0.00024037583],"genre_scores_gemma":[0.9934433,0.00018624739,0.0027214882,0.002311379,0.00085468026,0.00010069363,0.0000055965916,0.000022374199,0.0003542489],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99869764,0.000035347668,0.00039862495,0.00027558656,0.0003261247,0.00026668215],"domain_scores_gemma":[0.99868196,0.00006921217,0.00025902467,0.000119277145,0.0007692295,0.00010127663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028175185,0.00014532058,0.00022249614,0.00013430405,0.000019642705,0.00007459106,0.00066007406,0.000117267366,0.0016026198],"category_scores_gemma":[0.00012505648,0.000113525886,0.00006640614,0.00013005611,0.000042306263,0.000020644658,0.00009366139,0.00014232761,0.000012603919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008055509,0.00034063,0.2929423,0.000046796722,0.0010220514,0.00006565056,0.00067092886,0.3228759,0.29184586,0.00007113202,0.004959593,0.07710367],"study_design_scores_gemma":[0.009232888,0.003445088,0.800148,0.0002756827,0.00006698593,0.00012019748,0.0003053925,0.00080501044,0.05892823,0.0008367634,0.12502499,0.0008107456],"about_ca_topic_score_codex":0.00011660115,"about_ca_topic_score_gemma":0.0018602702,"teacher_disagreement_score":0.5072057,"about_ca_system_score_codex":0.0006353013,"about_ca_system_score_gemma":0.00071435334,"threshold_uncertainty_score":0.9993101},"labels":[],"label_agreement":null},{"id":"W3006763233","doi":"10.1136/ijgc-2019-001034","title":"Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Endometrial cancer; Gynecology; Menopause; Obstetrics; Incidence (geometry); Genitourinary system; Vaginal cancer; Cervical cancer; Ovarian cancer; Cancer; Internal medicine","score_opus":0.07417214708398058,"score_gpt":0.3490829034919735,"score_spread":0.27491075640799295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006763233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317044,0.0004612172,0.00013151545,0.0054155034,0.00033264852,0.00029298317,0.00005775659,0.0000061649057,0.000131786],"genre_scores_gemma":[0.99311745,0.00013341584,0.0022263164,0.0037718392,0.00037115853,0.000053304128,0.0000034630068,0.000012216639,0.0003108569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871266,0.000036075016,0.0005027987,0.00014674442,0.00037497742,0.00022672894],"domain_scores_gemma":[0.99860996,0.00020009858,0.0003586264,0.00006603978,0.00041003767,0.0003552081],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011844837,0.00012833891,0.00040275935,0.00011139151,0.000011823738,0.000010140001,0.00016854754,0.00006790018,0.0016773613],"category_scores_gemma":[0.00022880449,0.000075947006,0.000028075396,0.00007321465,0.00005980219,0.00014286888,0.000035483336,0.00019079511,0.0000013957831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1703393,0.0025134378,0.7684932,0.0006760469,0.00208999,0.01029712,0.0021706899,0.00027320007,0.0061115595,0.00030172,0.005964129,0.030769622],"study_design_scores_gemma":[0.016870225,0.03248721,0.8624631,0.0001477107,0.00011827207,0.0005436459,0.000058289494,0.00025080948,0.00011081264,0.00005405868,0.08676937,0.00012647014],"about_ca_topic_score_codex":0.000111254696,"about_ca_topic_score_gemma":0.000024143652,"teacher_disagreement_score":0.15346907,"about_ca_system_score_codex":0.0016703093,"about_ca_system_score_gemma":0.001110662,"threshold_uncertainty_score":0.9992352},"labels":[],"label_agreement":null},{"id":"W3006776002","doi":"10.1136/ijgc-2019-esgo.256","title":"P1240 Outcome of different treatment modalities for gestational trophoblastic neoplasia in women at 40 years old or above: a multicenter retrospective study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Chemotherapy; Retrospective cohort study; Gestational trophoblastic neoplasia; Hysterectomy; Medical record; Referral; Pediatrics; Pregnancy; Gestational age; Obstetrics; Surgery; Gynecology","score_opus":0.028703259805105855,"score_gpt":0.34920525802603203,"score_spread":0.3205019982209262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006776002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726856,0.000068959496,0.000027523087,0.0006528598,0.00085109175,0.0008389517,0.00021368769,0.000006575699,0.000071789254],"genre_scores_gemma":[0.9970624,0.000091656155,0.00027865986,0.00022818989,0.00015795525,0.00023777636,0.000008207841,0.000016416076,0.0019187728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786544,0.000057865287,0.00081672973,0.00023454323,0.00079052965,0.00023489048],"domain_scores_gemma":[0.9976148,0.0009198206,0.00047197234,0.00008845688,0.0007832818,0.00012169285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014720978,0.00019700498,0.0006634159,0.00024316742,0.0000220147,0.000015561143,0.00016195327,0.000055011733,0.002062017],"category_scores_gemma":[0.00075006846,0.00012467658,0.0001952079,0.00008743752,0.000083747225,0.00008443334,0.000067077315,0.00013296965,0.000009314862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019603021,0.0026646547,0.9722774,0.000043064345,0.0010205235,0.00018288875,0.0019042937,0.0010836539,0.00042180848,0.00023056105,0.000064155065,0.0005039871],"study_design_scores_gemma":[0.0137374895,0.0059543615,0.9771706,0.0001070085,0.0001253193,0.00001621308,0.0018943904,0.0002601334,0.000052841104,0.0004454783,0.00012789703,0.00010825442],"about_ca_topic_score_codex":0.00004223161,"about_ca_topic_score_gemma":0.00018503414,"teacher_disagreement_score":0.0058655315,"about_ca_system_score_codex":0.0031491553,"about_ca_system_score_gemma":0.00019808236,"threshold_uncertainty_score":0.9988502},"labels":[],"label_agreement":null},{"id":"W3007153728","doi":"10.1136/ijgc-2019-esgo.26","title":"Patient-reported sexual frequency and vaginal functioning in patients with locally advanced cervical cancer following definitive radiochemotherapy and image-guided adaptive brachytherapy (EMBRACE study)","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Brachytherapy; Cervical cancer; Prospective cohort study; Radiation therapy; Gynecology; Cancer; Internal medicine","score_opus":0.01801561585449537,"score_gpt":0.302795448645682,"score_spread":0.2847798327911866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007153728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961959,0.0013394806,0.00008655908,0.000674506,0.0006327397,0.0007568233,0.00001568658,0.000013031764,0.00028524877],"genre_scores_gemma":[0.9971985,0.00024171581,0.0011994916,0.0010916007,0.00012379322,0.00006466082,0.0000066387147,0.00002293838,0.000050622177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781775,0.0001001307,0.0006314839,0.00038877045,0.0008117211,0.00025014952],"domain_scores_gemma":[0.9981921,0.000305004,0.00046932028,0.000091819194,0.0007577253,0.00018406069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019829733,0.00025027158,0.0005945128,0.00022833642,0.000047922902,0.000046088644,0.00010448812,0.00009752532,0.0006224506],"category_scores_gemma":[0.00015950736,0.00016748774,0.000083113824,0.00026782227,0.000080650476,0.00036082778,0.000045505716,0.00040628714,0.0000015853203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010337412,0.0009676815,0.92965597,0.000010616913,0.0011559438,0.00033830863,0.00037328433,0.00008324859,0.0003796714,0.000018204733,0.000010199318,0.056669485],"study_design_scores_gemma":[0.030384043,0.011217804,0.9568759,0.00020026509,0.00015751514,0.00004829701,0.0005754705,0.000041595344,0.00012583574,0.00013341072,0.0000534684,0.00018638802],"about_ca_topic_score_codex":0.00030630425,"about_ca_topic_score_gemma":0.00018905017,"teacher_disagreement_score":0.056483097,"about_ca_system_score_codex":0.00059896975,"about_ca_system_score_gemma":0.00025312367,"threshold_uncertainty_score":0.6829952},"labels":[],"label_agreement":null},{"id":"W3007192988","doi":"10.1136/ijgc-2019-esgo.1007","title":"EP961 Are there opportunities to improve the number of women able to start and tolerate treatment for ovarian cancer? European perspectives from the world ovarian cancer coalition‘s every woman study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Cancer; Demography; Ovarian cancer; Family medicine; Quality of life (healthcare); Gynecology; Internal medicine; Nursing","score_opus":0.05866873424555503,"score_gpt":0.34903754494733547,"score_spread":0.29036881070178044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007192988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433054,0.0009109352,0.000020845837,0.051708814,0.0009770053,0.001419194,0.0007814099,0.000008782071,0.0008676465],"genre_scores_gemma":[0.9896127,0.00082669227,0.00017510123,0.004634047,0.0009568076,0.00083533133,0.0000054442835,0.000025814077,0.002928057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827224,0.00017150654,0.0004965555,0.00031754424,0.00045873562,0.00028340964],"domain_scores_gemma":[0.9977478,0.00060243026,0.0004266197,0.00021940743,0.00077459036,0.00022915709],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045833687,0.00023133458,0.00051755784,0.0000759536,0.00010912743,0.00010149321,0.00030016125,0.00003708944,0.0048611383],"category_scores_gemma":[0.000082329236,0.00011717011,0.00015492468,0.00010078752,0.000069804744,0.000113837435,0.000095223564,0.00015656334,0.000007707558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005680414,0.0023818028,0.9198456,0.000026297761,0.0065523298,0.00029868502,0.017012741,0.00079876033,0.0004969774,0.0011610063,0.008262598,0.03748282],"study_design_scores_gemma":[0.0054195113,0.0020886147,0.9254495,0.0002915982,0.00032374467,0.000010680082,0.020186707,0.000022658494,0.00026543852,0.00021199185,0.04556666,0.00016288635],"about_ca_topic_score_codex":0.0033768218,"about_ca_topic_score_gemma":0.003993831,"teacher_disagreement_score":0.04707477,"about_ca_system_score_codex":0.002235595,"about_ca_system_score_gemma":0.00044373597,"threshold_uncertainty_score":0.99604857},"labels":[],"label_agreement":null},{"id":"W3007214813","doi":"10.1136/ijgc-2019-esgo.1282","title":"EP1276 Microinvasive tubal carcinomas: cases of poor outcome despite ‘very early’ diagnosis. A systematic review of the literature","year":2019,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Occult; Incidence (geometry); Data extraction; Breast cancer; Cancer; Gynecology; MEDLINE; Internal medicine; Pathology","score_opus":0.07673757741182304,"score_gpt":0.3880349631889383,"score_spread":0.3112973857771153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007214813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021070302,0.9918282,0.000001056768,0.0013437519,0.0019389067,0.0020444088,0.0006548352,0.0000041533517,0.000077630495],"genre_scores_gemma":[0.010699355,0.98678696,0.0000729691,0.001415846,0.0003845012,0.00032695296,0.000021802329,0.00003181907,0.00025980073],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995322,0.0004080138,0.00269356,0.00029741466,0.0010612885,0.00021770805],"domain_scores_gemma":[0.9912485,0.0021990475,0.0043189134,0.00039929154,0.0017027057,0.0001315605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676114,0.00044868942,0.004452407,0.00024213696,0.000024558556,0.000033670036,0.0008271912,0.00030467284,0.00067934947],"category_scores_gemma":[0.0025095514,0.00021263701,0.0027295158,0.00033787495,0.00012426819,0.000101268146,0.00018405939,0.0006681208,0.0000113131255],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000894634,0.0007304202,0.020740747,0.9467019,0.0054114815,0.0013555619,0.00007219324,0.0000016011527,0.0000013845195,0.00010436679,0.0027607516,0.022030162],"study_design_scores_gemma":[0.0009905074,0.00084520783,0.005718595,0.93457115,0.012285005,0.0017639097,0.000011234819,1.8602019e-7,0.000027195962,0.0000150119195,0.043575462,0.00019654993],"about_ca_topic_score_codex":0.000045540437,"about_ca_topic_score_gemma":0.000013598464,"teacher_disagreement_score":0.040814713,"about_ca_system_score_codex":0.0011313194,"about_ca_system_score_gemma":0.0011076942,"threshold_uncertainty_score":0.8671086},"labels":[],"label_agreement":null},{"id":"W3007250044","doi":"10.1136/ijgc-2019-esgo.897","title":"EP848 Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cisplatin; Ovarian cancer; Cell cycle; DUSP6; Cancer research; Chemotherapy; Cell growth; MAPK/ERK pathway; Transfection; Cell; Biology; Cancer; Molecular biology; Chemistry; Signal transduction; Cell culture; Phosphorylation; Cell biology; Biochemistry; Phosphatase","score_opus":0.010917051213299762,"score_gpt":0.3043301448208946,"score_spread":0.2934130936075948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007250044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503493,0.0030265325,0.00013090568,0.0007671746,0.0003656629,0.00013591858,0.0001723807,0.0000015540596,0.0003649476],"genre_scores_gemma":[0.9974831,0.0011069449,0.00022420996,0.00019043063,0.00031505548,0.000016448324,0.000009346407,0.000009765331,0.0006447162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986885,0.00007778689,0.0004142027,0.00016190403,0.00050051924,0.00015706645],"domain_scores_gemma":[0.998641,0.00009298949,0.00062983716,0.00012049896,0.00046319445,0.000052491396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025673702,0.00011257812,0.00021889005,0.000033666347,0.000032969514,0.000016458362,0.00044163756,0.00009050022,0.00094101485],"category_scores_gemma":[0.00012052855,0.000068573754,0.00016563211,0.000059831473,0.000103601364,0.000014146371,0.00007543945,0.00013325768,9.593455e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010305912,0.000113436916,0.007977792,0.000015024629,0.00032452744,0.0000023960838,0.000054328346,0.00032170265,0.9815143,0.000052244184,0.0010204784,0.007573182],"study_design_scores_gemma":[0.0014833823,0.00034572702,0.008335431,0.00019255928,0.000012170809,0.0000034089796,0.000042757005,0.000017483631,0.9780837,0.00026153223,0.011142721,0.00007909103],"about_ca_topic_score_codex":0.00016785691,"about_ca_topic_score_gemma":0.000115904586,"teacher_disagreement_score":0.010122242,"about_ca_system_score_codex":0.00008836532,"about_ca_system_score_gemma":0.00022132757,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W3007317409","doi":"10.1136/ijgc-2019-esgo.55","title":"P09 FIGO 2018 stage IB2 (≥2 to <4 cm) cervical cancer treated with neoadjuvant chemotherapy followed by fertility sparing surgery (CoNteSSa)/Neoadjuvant chemotherapy and conservative surgery in cervical cancer to preserve fertility (NeoCon-F)","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Chemotherapy; Hysterectomy; Cancer; Surgery; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer","score_opus":0.04226384902116824,"score_gpt":0.32610392454272236,"score_spread":0.2838400755215541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007317409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686736,0.0026307134,0.000057536236,0.02566752,0.0009286255,0.0013355884,0.00044636914,0.000042451953,0.00021758993],"genre_scores_gemma":[0.985851,0.0014828601,0.00015101115,0.010818281,0.00030615713,0.0003852822,0.000036202862,0.000060348724,0.0009088925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951497,0.00027351087,0.0014893442,0.0009331272,0.0013545479,0.0007998008],"domain_scores_gemma":[0.9949082,0.002109827,0.0006309724,0.0003476259,0.001130846,0.0008725091],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093512627,0.0006160846,0.0019967468,0.0004502104,0.000073752344,0.00011060455,0.00046124533,0.00033543847,0.007657545],"category_scores_gemma":[0.00065271836,0.00041745164,0.00043266529,0.00081232935,0.00016418502,0.0003509677,0.00016077171,0.0006871401,0.000016060414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03441527,0.0010819216,0.9328559,0.00010072099,0.001019301,0.00029259792,0.00023390162,0.00021299398,0.0036019841,0.0000051232364,0.0032917785,0.022888493],"study_design_scores_gemma":[0.0091248965,0.0011817848,0.9712375,0.00081338437,0.000109788394,0.000020991423,0.000083063824,0.00018858584,0.0091637205,0.000044052467,0.007567063,0.0004652147],"about_ca_topic_score_codex":0.009933824,"about_ca_topic_score_gemma":0.0057077967,"teacher_disagreement_score":0.038381543,"about_ca_system_score_codex":0.002221967,"about_ca_system_score_gemma":0.0008985632,"threshold_uncertainty_score":0.99982774},"labels":[],"label_agreement":null},{"id":"W3007328482","doi":"10.1136/ijgc-2019-esgo.950","title":"EP904 Clinical outcomes of post-operative intraperitoneal chemotherapy for patients with early stage high grade serous ovarian cancer treated at british columbia cancer agency","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Chemotherapy; Serous fluid; Oncology; Stage (stratigraphy); Retrospective cohort study; Internal medicine; Paclitaxel; Cancer; Cisplatin","score_opus":0.02086995546776464,"score_gpt":0.3410569255234656,"score_spread":0.32018697005570096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007328482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912782,0.00039857015,0.0000117277095,0.0037011579,0.0017633068,0.0010888794,0.0016858901,0.000013692413,0.000058588485],"genre_scores_gemma":[0.99195427,0.002339291,0.0006396103,0.0022077928,0.00040761527,0.0002512529,0.00006186789,0.000038363323,0.0020999406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975453,0.00007691385,0.0009641348,0.00038550494,0.0007292575,0.00029891482],"domain_scores_gemma":[0.996386,0.0004056804,0.0008493722,0.0001487145,0.0019928722,0.00021734159],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018328342,0.00022646242,0.00096267095,0.00006823848,0.00006621823,0.00008977709,0.00027406984,0.00019628252,0.011602536],"category_scores_gemma":[0.00010311605,0.0001849922,0.00038113765,0.000117453375,0.00014730406,0.00018557857,0.00004848232,0.0002808357,0.000003815869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003093405,0.001984684,0.96118236,0.000026684775,0.0032500278,0.000110758185,0.00014671635,0.00007084715,0.00010405661,0.00001915358,0.001105906,0.028905382],"study_design_scores_gemma":[0.01951383,0.0051881415,0.971213,0.00026174303,0.00032049156,0.0000132866135,0.000021508627,0.000015872758,0.00023578045,0.00003028553,0.0029870383,0.00019901911],"about_ca_topic_score_codex":0.028936125,"about_ca_topic_score_gemma":0.029431023,"teacher_disagreement_score":0.028706362,"about_ca_system_score_codex":0.0011278361,"about_ca_system_score_gemma":0.00055550004,"threshold_uncertainty_score":0.98930097},"labels":[],"label_agreement":null},{"id":"W3007354585","doi":"10.1136/ijgc-2019-esgo.182","title":"P119 An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Organoid; Ovarian cancer; Cancer; In vivo; Cancer research; Medicine; Internal medicine; Oncology; Pathology; Biology; Neuroscience","score_opus":0.031160801266148834,"score_gpt":0.34896937163930436,"score_spread":0.3178085703731555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007354585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896468,0.0013605863,0.00019400858,0.0057716984,0.002298481,0.00040844633,0.000105787054,0.000010635954,0.00020357895],"genre_scores_gemma":[0.9941087,0.000959025,0.0010621407,0.002952141,0.0007104724,0.000077203964,0.00001334889,0.000016130016,0.00010088746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998766,0.000020484156,0.000424639,0.00023385481,0.0003655665,0.00018942099],"domain_scores_gemma":[0.998626,0.0001646793,0.000304237,0.000103733444,0.0005973896,0.00020398191],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017467425,0.00016092915,0.00037511368,0.00010593707,0.000033765027,0.000052630417,0.00017795822,0.000112652604,0.00214589],"category_scores_gemma":[0.000091198526,0.00010650596,0.00015065045,0.000048086316,0.00005090626,0.00019980328,0.000051364306,0.0001894234,0.0000045123165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039605657,0.0013428358,0.7957385,0.00007802717,0.0020372684,0.00019699111,0.00059229357,0.0004315,0.004367517,0.0017259347,0.0024697904,0.18705878],"study_design_scores_gemma":[0.010949853,0.005180266,0.92604643,0.00034053795,0.0003755742,0.00029750552,0.00018689688,0.0005799261,0.013794951,0.001155967,0.04078944,0.00030267233],"about_ca_topic_score_codex":0.00015204151,"about_ca_topic_score_gemma":0.00033801442,"teacher_disagreement_score":0.1867561,"about_ca_system_score_codex":0.0006239996,"about_ca_system_score_gemma":0.0002445473,"threshold_uncertainty_score":0.9987663},"labels":[],"label_agreement":null},{"id":"W3007379615","doi":"10.1136/ijgc-2019-esgo.17","title":"Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the Phase III SOLO1 trial","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Medicine; Internal medicine; Ovarian cancer; Surgery; Placebo; Oncology; Chemotherapy; Cancer; Pathology","score_opus":0.027395970010690433,"score_gpt":0.3306703729266041,"score_spread":0.3032744029159137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007379615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942116,0.0006063987,0.00011676778,0.0033573227,0.0007538169,0.00085500546,0.000078553596,0.0000052795335,0.000015233203],"genre_scores_gemma":[0.9973311,0.00023154255,0.00019603736,0.0018299967,0.0001731335,0.00017795937,0.00001974097,0.00001912036,0.00002139741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976452,0.00022391495,0.0008720958,0.00026800408,0.0007076409,0.00028313312],"domain_scores_gemma":[0.9952608,0.0034703158,0.000735243,0.0001109232,0.00034100586,0.00008173667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008782255,0.00021261603,0.0006681601,0.00020508652,0.00003587622,0.000043240565,0.0001566302,0.00009139019,0.00041430624],"category_scores_gemma":[0.0006209636,0.00011233506,0.00014139018,0.00021653011,0.0001775865,0.00025425092,0.000023778566,0.00041927793,3.048102e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46707216,0.0019039453,0.47105914,0.000040401585,0.0005817301,0.0005130464,0.003127215,0.0008817867,0.0005574484,0.000012974468,0.001429921,0.052820224],"study_design_scores_gemma":[0.20714739,0.0019089656,0.7874956,0.0012276331,0.00007355322,0.000032601787,0.0007379949,0.0002680518,0.00049204525,0.00008019569,0.00031968503,0.00021626694],"about_ca_topic_score_codex":0.00017743286,"about_ca_topic_score_gemma":0.00023052396,"teacher_disagreement_score":0.31643647,"about_ca_system_score_codex":0.0005246912,"about_ca_system_score_gemma":0.0006683933,"threshold_uncertainty_score":0.45808908},"labels":[],"label_agreement":null},{"id":"W3007425265","doi":"10.1136/ijgc-2019-esgo.825","title":"EP774 Gallic acid exhibits lower cytotoxicity on normal ovarian cells than cisplatin-sensitive and cisplatin-resistant ovarian cancer cells","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Tannin, Tannase and Anticancer Activities","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cisplatin; Cytotoxicity; Ovarian cancer; Apoptosis; Cancer research; Cell culture; Viability assay; Cancer cell; Cancer; Chemistry; Molecular biology; Pharmacology; Biology; Medicine; Internal medicine; Chemotherapy; Biochemistry; In vitro; Genetics","score_opus":0.012969218790216466,"score_gpt":0.2612027456872922,"score_spread":0.24823352689707573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007425265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98928696,0.0007167421,0.000112556685,0.0015375257,0.005137972,0.0002448614,0.00036281877,0.000023758437,0.002576785],"genre_scores_gemma":[0.99552137,0.000661031,0.00012416774,0.0014138222,0.00042460344,0.000017654183,0.0000105541385,0.000024442392,0.0018023548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997944,0.00021120741,0.00066144246,0.00041452693,0.00028643303,0.0004823632],"domain_scores_gemma":[0.99797654,0.0005866582,0.00067059766,0.00016299592,0.000501819,0.00010138171],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031222554,0.00034850553,0.00061246275,0.0002038367,0.00014086792,0.00008107231,0.00042726702,0.00034865976,0.006407796],"category_scores_gemma":[0.00008429548,0.0002623307,0.00024417037,0.000114872695,0.00027169025,0.0003145853,0.00015205117,0.000819584,0.00013855376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038356353,0.0003448099,0.0055733714,0.000016542235,0.0008296551,0.0004241496,0.00038516038,0.00026498357,0.98208886,0.0011265078,0.0017930726,0.0033172476],"study_design_scores_gemma":[0.00403363,0.0016841238,0.13970359,0.00035048195,0.00012269693,0.00017460377,0.00033301994,0.00004591893,0.8434284,0.00028409375,0.009334137,0.0005053498],"about_ca_topic_score_codex":0.00023427275,"about_ca_topic_score_gemma":0.0002360676,"teacher_disagreement_score":0.1386605,"about_ca_system_score_codex":0.0003325129,"about_ca_system_score_gemma":0.000258858,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W3007560595","doi":"10.1136/ijgc-2019-esgo.231","title":"P171 Development of an ex-vivo patient-derived explant model for predicting drug responses in endometrial cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Carboplatin; Ex vivo; Explant culture; Apoptosis; Paclitaxel; Chemotherapy; Stromal cell; Cancer; Cancer research; Medicine; Biology; In vivo; Oncology; Pathology; Internal medicine; In vitro; Cisplatin","score_opus":0.05479260605629013,"score_gpt":0.3570089948614471,"score_spread":0.302216388805157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007560595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616104,0.00069475966,0.0002724208,0.0004953647,0.0015694392,0.0005156477,0.00014311036,0.000008625343,0.00013959142],"genre_scores_gemma":[0.9939963,0.00030175896,0.0046728156,0.00038029495,0.000346331,0.000103429426,0.0000114056165,0.000014362069,0.0001732513],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977463,0.00007119145,0.0009779521,0.00021935826,0.00075154466,0.0002336562],"domain_scores_gemma":[0.99747825,0.0009812951,0.00061977335,0.00008451827,0.0006791419,0.00015699788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047013402,0.00016134886,0.0005571223,0.0004215436,0.000026617707,0.00001632421,0.00025100005,0.000096947915,0.0011240969],"category_scores_gemma":[0.0010498358,0.00011119711,0.00018821195,0.00020164717,0.00003647623,0.00018949105,0.00006455015,0.00021105753,0.0000019258673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09361526,0.0033787575,0.40324026,0.00018266248,0.0018819013,0.0002129792,0.004652592,0.0128222555,0.16184519,0.00011535667,0.00028058345,0.3177722],"study_design_scores_gemma":[0.12208416,0.011085674,0.30529797,0.0025397593,0.00062725134,0.00018022086,0.0024658272,0.029414656,0.5133605,0.002028777,0.009786455,0.0011287369],"about_ca_topic_score_codex":0.000097967866,"about_ca_topic_score_gemma":0.000265684,"teacher_disagreement_score":0.35151532,"about_ca_system_score_codex":0.00082507805,"about_ca_system_score_gemma":0.00076648005,"threshold_uncertainty_score":0.999789},"labels":[],"label_agreement":null},{"id":"W3007626256","doi":"10.1136/ijgc-2019-esgo.816","title":"EP765 The effect of malformina1 on cisplatin-sensitive and cisplatin-resistant ovarian cancer cell lines","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cisplatin; Apoptosis; Cytotoxic T cell; Flow cytometry; Western blot; Ovarian cancer; Cancer research; Cell culture; Molecular biology; Biology; Cell growth; Cell; Cancer; Chemistry; Chemotherapy; In vitro; Biochemistry; Gene","score_opus":0.006901117323380675,"score_gpt":0.2760326212809836,"score_spread":0.26913150395760294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007626256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824036,0.0024366223,0.00004266346,0.00066261657,0.006698322,0.00017538933,0.000076708464,0.000001969375,0.0016653275],"genre_scores_gemma":[0.9917831,0.0024766675,0.00006922212,0.0005540363,0.004367821,0.000014561561,0.0000059906592,0.000010987296,0.00071762153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889857,0.00009521703,0.00035552704,0.00018054202,0.00032019627,0.00014996536],"domain_scores_gemma":[0.998812,0.00023927185,0.0004230035,0.00011408719,0.0003474112,0.00006422991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034970697,0.00015199042,0.0002825901,0.00003911373,0.000035663437,0.00002123277,0.00025994176,0.00012367687,0.00036686513],"category_scores_gemma":[0.00016507998,0.00008725706,0.00016031557,0.000041213854,0.00009798575,0.00001129087,0.00008705028,0.00017343252,0.000002563345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008059464,0.00014477536,0.028345589,0.00006665272,0.00067027454,0.0000086051805,0.00021133594,0.0021595762,0.8992548,0.000543262,0.010802939,0.049732734],"study_design_scores_gemma":[0.0066565224,0.0059201387,0.29342037,0.00023100065,0.00024121352,0.00008459006,0.00023885799,0.00021301003,0.42179745,0.00013942544,0.2706309,0.00042652563],"about_ca_topic_score_codex":0.00014721234,"about_ca_topic_score_gemma":0.00021883252,"teacher_disagreement_score":0.47745734,"about_ca_system_score_codex":0.000065266744,"about_ca_system_score_gemma":0.000110097295,"threshold_uncertainty_score":0.4016916},"labels":[],"label_agreement":null},{"id":"W3008056316","doi":"10.1136/ijgc-2019-esgo.224","title":"P163 Hormone replacement therapy use after premature surgical menopause and impact on subsequent health services","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Menopause; Hormone replacement therapy (female-to-male); Retrospective cohort study; Premature Menopause; Hysterectomy; Cohort; Surgical Menopause; Osteoporosis; Population; Gynecology; Pediatrics; Obstetrics; Surgery; Internal medicine","score_opus":0.02925329301647449,"score_gpt":0.3745022862903247,"score_spread":0.3452489932738502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008056316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851483,0.007117604,0.000001462095,0.006392302,0.00056637207,0.0005399616,0.000060289214,0.000011884598,0.0001618166],"genre_scores_gemma":[0.9817965,0.01190136,0.00013692376,0.005444363,0.0002828305,0.000021449967,0.000013327282,0.000016021835,0.00038721706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980698,0.00010349154,0.00056535006,0.00023095119,0.0007253799,0.0003050104],"domain_scores_gemma":[0.99831533,0.00023525988,0.00048304687,0.00015097177,0.000343507,0.00047186576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040562268,0.00021803856,0.0005052683,0.00013747773,0.00003661576,0.00007521793,0.00012759356,0.00011345448,0.0025692608],"category_scores_gemma":[0.000028973767,0.000114442395,0.000052165913,0.00006584539,0.00003321139,0.00021459631,0.000040546358,0.0003509944,0.000021891075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13409828,0.003493269,0.82337815,0.00023198688,0.0034636077,0.0033257888,0.0010089864,0.00020664532,0.0032023818,0.00020654257,0.0036237116,0.023760688],"study_design_scores_gemma":[0.014698714,0.027804906,0.93855464,0.00043239316,0.000047409678,0.000602377,0.000027446587,0.000036272577,0.00013328137,0.00009050722,0.017446,0.00012604549],"about_ca_topic_score_codex":0.00018131205,"about_ca_topic_score_gemma":0.000021020105,"teacher_disagreement_score":0.11939956,"about_ca_system_score_codex":0.0009196264,"about_ca_system_score_gemma":0.00029399153,"threshold_uncertainty_score":0.9983425},"labels":[],"label_agreement":null},{"id":"W3008557130","doi":"10.1136/ijgc-2019-esgo.208","title":"P147 Long-term survival in women with high-grade serous ovarian cancer: interplay between RB1 and BRCA1/2","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Children's & Women's Health Centre of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Serous fluid; Germline; Immunohistochemistry; Cancer; Oncology; Cancer research; Internal medicine; Gene; Biology; Genetics","score_opus":0.010458464796147501,"score_gpt":0.29077225782139593,"score_spread":0.28031379302524845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008557130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963925,0.0009173108,0.0001127444,0.0012335423,0.0010209806,0.00011882546,0.00009151809,0.0000027305728,0.0001098865],"genre_scores_gemma":[0.9959569,0.0023168542,0.00012634207,0.0006810139,0.000737157,0.000021479904,0.000013604188,0.000015486188,0.00013113736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998888,0.00004446374,0.00034446883,0.0002374066,0.00025293845,0.0002327109],"domain_scores_gemma":[0.9991779,0.00011255408,0.00025972797,0.00010127712,0.00022445522,0.00012414095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021369172,0.00015159685,0.00028653952,0.00008266783,0.000019212139,0.00006555709,0.0003483322,0.00013265216,0.00036818243],"category_scores_gemma":[0.00007211981,0.00011600391,0.000043756194,0.000059732174,0.00007111129,0.0000136714525,0.00014780404,0.0002176379,0.0000025375223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095457374,0.00009302288,0.9721902,0.000010690439,0.00032535565,0.00008916578,0.000087823035,0.0007062248,0.00846067,0.000081596954,0.00013093505,0.01686974],"study_design_scores_gemma":[0.0028333128,0.0010175892,0.9892187,0.00007570715,0.000023306871,0.000038899132,0.000048443526,0.000007833518,0.0024738293,0.00015439687,0.0039189123,0.0001890744],"about_ca_topic_score_codex":0.00025772257,"about_ca_topic_score_gemma":0.0011670793,"teacher_disagreement_score":0.017028494,"about_ca_system_score_codex":0.00029243692,"about_ca_system_score_gemma":0.00023677065,"threshold_uncertainty_score":0.4730502},"labels":[],"label_agreement":null},{"id":"W3008817870","doi":"10.1136/ijgc-2019-esgo.149","title":"P87 Mesenchymal splice isoform fibroblast growth factor receptor (FGFR2c) is an independent prognostic biomarker and further refines risk stratification within endometrial cancer molecular subtypes","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Proportional hazards model; Biomarker; Cohort; Internal medicine; Oncology; Cancer; splice; Cancer research; Biology; Medicine; Gene; Genetics","score_opus":0.022469288870031228,"score_gpt":0.3151096172281171,"score_spread":0.29264032835808584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008817870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660957,0.0007435409,0.00018976774,0.000949797,0.0007719299,0.0003387346,0.0002987898,0.000008103773,0.000089764115],"genre_scores_gemma":[0.9977101,0.00081367226,0.00052348844,0.00021794443,0.00044519792,0.000036019283,0.000037235077,0.00002800927,0.00018830254],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99774635,0.00018858524,0.0005594863,0.00043980882,0.0007813516,0.0002844388],"domain_scores_gemma":[0.9978862,0.00012956419,0.0005875814,0.00017675661,0.0010209267,0.00019898941],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042399197,0.00023877641,0.00027287845,0.00020086646,0.000051315958,0.000104435196,0.0005308578,0.00026949664,0.0019292023],"category_scores_gemma":[0.000816709,0.00017890886,0.00014324825,0.00015891694,0.00012500946,0.000064986096,0.00016486192,0.000358828,0.000017407801],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013942706,0.00016951704,0.22158454,0.000022880284,0.00045770663,0.000012215327,0.00016636505,0.00010735207,0.77135473,0.0000668078,0.00038922226,0.004274394],"study_design_scores_gemma":[0.0033613176,0.0028712985,0.6241781,0.00012781909,0.00006221727,0.000060287115,0.00020141999,0.00033774634,0.36547598,0.0003420973,0.0024968293,0.0004848814],"about_ca_topic_score_codex":0.00024271182,"about_ca_topic_score_gemma":0.00024281198,"teacher_disagreement_score":0.40587875,"about_ca_system_score_codex":0.0001559525,"about_ca_system_score_gemma":0.00029555126,"threshold_uncertainty_score":0.99898314},"labels":[],"label_agreement":null},{"id":"W3008908488","doi":"10.1136/ijgc-2019-esgo.1046","title":"EP1002 Secondary cytoreduction surgery for recurrent ovarian cancer – twelve radiological criteria for case selection: preliminary data","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Radiological weapon; Surgery; Radiology; Retrospective cohort study; Greater omentum","score_opus":0.1056103769625253,"score_gpt":0.40958475005376754,"score_spread":0.30397437309124226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008908488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445352,0.0053969,0.002172837,0.026860395,0.01766083,0.0017471384,0.0013637582,0.00003818441,0.0002247876],"genre_scores_gemma":[0.9876249,0.0015812764,0.0042000883,0.0011132666,0.0044592046,0.00045717228,0.00021361519,0.000024894995,0.00032561208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811506,0.00007422719,0.0007311563,0.00045429246,0.00034255386,0.00028272806],"domain_scores_gemma":[0.996851,0.0011478895,0.0005459035,0.00020396191,0.0010680897,0.00018314754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006654088,0.00021616717,0.0006126175,0.00016425249,0.00008460321,0.00005992584,0.00028162458,0.00018962527,0.006451656],"category_scores_gemma":[0.0005077411,0.00015401031,0.00036509737,0.00010129662,0.00006213383,0.00030058026,0.000086744505,0.00028590896,0.000006042306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029315807,0.0027722144,0.09808025,0.0003604224,0.0046039904,0.0021450312,0.00023778065,0.00042947056,0.0011727307,0.0006364492,0.31207332,0.54817253],"study_design_scores_gemma":[0.019644842,0.01576416,0.32307455,0.0010816877,0.002065307,0.020168073,0.00042125786,0.007329316,0.002366833,0.0016815278,0.6055241,0.0008783296],"about_ca_topic_score_codex":0.000059523594,"about_ca_topic_score_gemma":0.000049281865,"teacher_disagreement_score":0.5472942,"about_ca_system_score_codex":0.0009758936,"about_ca_system_score_gemma":0.00078487047,"threshold_uncertainty_score":0.9944566},"labels":[],"label_agreement":null},{"id":"W3008947683","doi":"10.1136/ijgc-2019-esgo.41","title":"Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"","keywords":"Oncology; Stage (stratigraphy); Cohort; Internal medicine; Medicine; Ovarian cancer; Carcinoma; Endometrial cancer; Ovarian carcinoma; Context (archaeology); Cancer; Gynecology; Biology","score_opus":0.01826137168898121,"score_gpt":0.32536187398099586,"score_spread":0.30710050229201463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008947683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.893986,0.0021508858,0.08204611,0.015004806,0.0016161985,0.0031472943,0.00022928833,0.0000199122,0.0017995394],"genre_scores_gemma":[0.9897881,0.0010217158,0.007847608,0.0002973219,0.0003046312,0.00015169258,0.000048598606,0.000013496133,0.00052684976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982275,0.00004516476,0.00069837866,0.0002453953,0.0006433371,0.00014025657],"domain_scores_gemma":[0.9976803,0.00034191806,0.00086482114,0.00020281109,0.0007634196,0.00014670203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003819236,0.00013945627,0.00036686336,0.00028862926,0.00002737497,0.000017943114,0.00024674222,0.00008463882,0.0008768849],"category_scores_gemma":[0.00026285675,0.00009890991,0.00019029732,0.0001960665,0.000043979064,0.00008802609,0.00003270772,0.00015168487,0.000004769721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032363662,0.0018872555,0.30002844,0.00030210125,0.0025204076,0.000108983535,0.00035246045,0.008647564,0.021920351,0.037732575,0.0030950513,0.62016845],"study_design_scores_gemma":[0.017353049,0.0040432136,0.9182545,0.00045949916,0.00096327986,0.00004084895,0.0002796861,0.0020270366,0.018195655,0.0053222193,0.03281481,0.0002462163],"about_ca_topic_score_codex":0.00033011838,"about_ca_topic_score_gemma":0.00005045039,"teacher_disagreement_score":0.6199222,"about_ca_system_score_codex":0.0006341471,"about_ca_system_score_gemma":0.00027098504,"threshold_uncertainty_score":0.9601275},"labels":[],"label_agreement":null},{"id":"W3014772184","doi":"10.1136/ijgc-2019-001127","title":"IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"National Cancer Institute","keywords":"Medicine; Indocyanine green; White light; Imaging technology; Radiology; Surgery; Optics","score_opus":0.019565086694757306,"score_gpt":0.34909899696264235,"score_spread":0.32953391026788503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014772184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026456958,0.9066011,0.0000060143298,0.06381926,0.000254634,0.002217852,0.00012479437,0.000035556313,0.00048386026],"genre_scores_gemma":[0.047904268,0.94985104,0.00053258514,0.00075208495,0.0001364866,0.0006673525,0.000021796543,0.000030272788,0.00010412628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967034,0.00033438468,0.0013201929,0.000506753,0.0006796467,0.0004556296],"domain_scores_gemma":[0.99614304,0.0016493109,0.0011270281,0.00032860314,0.0006123793,0.00013961567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051662885,0.00055740325,0.0024274462,0.0015051549,0.00016324599,0.00009853375,0.00085319806,0.00057703286,0.00022828527],"category_scores_gemma":[0.0026539885,0.00025409838,0.00034278675,0.0018329292,0.0016061069,0.0001010074,0.00026991213,0.0014952321,0.0000064676587],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013081118,0.0005783424,0.009161636,0.00026256609,0.0026653071,0.0026686217,0.00045421996,0.000014703941,0.000013420558,0.0018189845,0.0003681194,0.98068595],"study_design_scores_gemma":[0.012666389,0.0068221074,0.001214112,0.001914481,0.0010235277,0.0010763082,0.0006707758,0.000109061635,0.000118589756,0.0042646485,0.9698008,0.000319212],"about_ca_topic_score_codex":0.000046612284,"about_ca_topic_score_gemma":0.00011264041,"teacher_disagreement_score":0.98036677,"about_ca_system_score_codex":0.0016604842,"about_ca_system_score_gemma":0.0011108101,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W3015368557","doi":"10.1136/ijgc-2020-001288","title":"Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Poly ADP ribose polymerase; Adverse effect; Polymerase; PARP inhibitor; Internal medicine; Enzyme; Biochemistry","score_opus":0.0755815279870802,"score_gpt":0.41434140622800464,"score_spread":0.33875987824092446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015368557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000790659,0.989901,0.00003912198,0.0047352077,0.0029118154,0.0006074611,0.00041688062,0.000031382715,0.0005664572],"genre_scores_gemma":[0.0017197342,0.9909408,0.00032880504,0.0016469036,0.004404835,0.00012037753,0.00005879977,0.000054862252,0.0007248444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970564,0.00017791861,0.0012771927,0.00043019064,0.00076585537,0.00029244716],"domain_scores_gemma":[0.9972679,0.00035965507,0.0013178698,0.00016842672,0.00039979615,0.0004863423],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017311618,0.0005231576,0.0019455028,0.0003556592,0.000056220815,0.000024129735,0.00036604147,0.0003484201,0.0026551294],"category_scores_gemma":[0.00019890194,0.00034933753,0.0009412187,0.00020200615,0.00014086142,0.00016404134,0.00011355883,0.00064783375,0.00005811506],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071949884,0.0003858884,0.00021142424,0.00049436407,0.0026945272,0.002058841,0.00006606287,0.0000013977254,0.000014831576,0.000061603525,0.0021349683,0.9911566],"study_design_scores_gemma":[0.0036782487,0.0012561347,0.0003587513,0.0050608157,0.0015142304,0.001194411,0.000019888788,0.0000037657499,0.00005564893,0.00009093408,0.98648036,0.000286833],"about_ca_topic_score_codex":0.000030776744,"about_ca_topic_score_gemma":0.000009942429,"teacher_disagreement_score":0.99086976,"about_ca_system_score_codex":0.0023568457,"about_ca_system_score_gemma":0.00094005896,"threshold_uncertainty_score":0.9998959},"labels":[],"label_agreement":null},{"id":"W3022716418","doi":"10.1136/ijgc-00009577-200609000-00039","title":"To the Editor:","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Computational biology","score_opus":0.011902808108165647,"score_gpt":0.3175104469808236,"score_spread":0.30560763887265796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022716418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7729008,0.000910315,0.079194404,0.09412088,0.0071341917,0.00026568677,0.00016925232,0.00011985266,0.045184594],"genre_scores_gemma":[0.9789864,0.00008875396,0.007571725,0.0010716901,0.011201238,0.000060002287,0.0000024278797,0.000006830278,0.0010109578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993236,0.0000052242035,0.00024832776,0.00007420518,0.00025938512,0.00008927063],"domain_scores_gemma":[0.9992776,0.00010961656,0.00018099762,0.000076389675,0.0003179736,0.00003744389],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009521628,0.000058338443,0.00007988626,0.000024246832,0.000042546577,0.000030908475,0.00053789513,0.000047996964,0.0018198],"category_scores_gemma":[0.00008172289,0.000034475823,0.00007796905,0.000044566477,0.000029345185,0.0000493969,0.000063376785,0.0001829639,0.000015156611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002703808,0.00045250513,0.020938944,0.0000072157404,0.00015418863,0.00006617739,0.000062018524,0.0119539555,0.123907484,0.03254679,0.7383656,0.07127475],"study_design_scores_gemma":[0.00015731044,0.000025237428,0.0022095735,0.000013463618,0.0000072693597,0.000019424477,0.000013515384,0.00003870598,0.026748335,0.011518972,0.95918566,0.00006254965],"about_ca_topic_score_codex":0.00003099595,"about_ca_topic_score_gemma":0.00003476507,"teacher_disagreement_score":0.22082005,"about_ca_system_score_codex":0.00016775422,"about_ca_system_score_gemma":0.00003782557,"threshold_uncertainty_score":0.9990927},"labels":[],"label_agreement":null},{"id":"W3022965701","doi":"10.1136/ijgc-2020-001309","title":"Improving response to progestin treatment of low-grade endometrial cancer","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Progestin; Endometrial cancer; Oncology; Internal medicine; Endometrial hyperplasia; Cancer; Gynecology; Estrogen; Carcinoma","score_opus":0.10498779416094824,"score_gpt":0.43367593304985175,"score_spread":0.3286881388889035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022965701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038174149,0.98763067,0.00003147839,0.0034757773,0.0031774275,0.0013198872,0.00046419058,0.000020095027,0.00006305317],"genre_scores_gemma":[0.0035916981,0.9913995,0.00068593345,0.0004783641,0.003166442,0.00037879794,0.000019012132,0.000048143724,0.00023208658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99603707,0.00030494653,0.001723555,0.0004252076,0.0011826421,0.0003266063],"domain_scores_gemma":[0.9946954,0.0020491146,0.0016779976,0.0001730689,0.0008463813,0.0005580156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037524183,0.0004946576,0.003093717,0.00079715106,0.000031530402,0.000038442162,0.00053157547,0.00032353835,0.0016710708],"category_scores_gemma":[0.003424103,0.0002915605,0.0015158298,0.0008933177,0.00008134907,0.000073490824,0.00012308873,0.00041791837,0.000021869366],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009755631,0.0009933051,0.0003533076,0.0008658155,0.002549714,0.0012654772,0.000053412135,0.000009893691,0.00013733644,0.000006746911,0.00024647434,0.98376286],"study_design_scores_gemma":[0.007900091,0.0083343545,0.00056043075,0.0052145524,0.0023817648,0.00022929377,0.000011827248,0.0000030177353,0.0004156264,0.0000140713755,0.9746781,0.00025685065],"about_ca_topic_score_codex":0.00017556471,"about_ca_topic_score_gemma":0.000022398319,"teacher_disagreement_score":0.983506,"about_ca_system_score_codex":0.003781558,"about_ca_system_score_gemma":0.0019959316,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W3023007077","doi":"10.1136/ijgc-2019-001141","title":"Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Women's College Hospital; University of Toronto; Public Health Ontario","funders":"Peter Gilgan Foundation","keywords":"Medicine; BRCA mutation; Ovarian cancer; Occult; Fallopian tube cancer; Oophorectomy; Prophylactic Surgery; Fallopian tube; Serous fluid; Stage (stratigraphy); Gynecology; Cancer; Disease; Oncology; Obstetrics; Internal medicine; Surgery; Hysterectomy; Pathology","score_opus":0.01668208222240581,"score_gpt":0.3115769426127724,"score_spread":0.2948948603903666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023007077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396867,0.0026407659,0.00019613464,0.0023618145,0.0005001304,0.00016366174,0.00010001346,0.0000022537697,0.00006655656],"genre_scores_gemma":[0.99830455,0.0006246445,0.00015324938,0.0005634759,0.00017173162,0.00005458525,0.0000127552275,0.0000114178065,0.00010356747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988269,0.00008915527,0.00044815548,0.0001826288,0.00034211107,0.000111015404],"domain_scores_gemma":[0.9986899,0.00016096815,0.0005811314,0.00008080713,0.00041294255,0.0000742466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019678578,0.000120531695,0.00025317678,0.000043454347,0.000041654035,0.000016412283,0.00032187326,0.000101275626,0.00061042106],"category_scores_gemma":[0.00047446365,0.00008351348,0.00022694742,0.0000889461,0.00018934027,0.000017085084,0.00015607197,0.000116362135,7.533259e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022127116,0.00004890463,0.9596668,0.000014438789,0.0013317072,0.000024718607,0.00059313205,0.0013168162,0.026768584,0.0000069106427,0.00072217523,0.009284581],"study_design_scores_gemma":[0.0011874491,0.0002839327,0.91155446,0.000053931803,0.00015666403,0.00000919439,0.0000968897,0.00005269316,0.08589134,0.000048129255,0.0005609476,0.000104392435],"about_ca_topic_score_codex":0.00006542276,"about_ca_topic_score_gemma":0.00021321083,"teacher_disagreement_score":0.05912276,"about_ca_system_score_codex":0.00018954495,"about_ca_system_score_gemma":0.00022002067,"threshold_uncertainty_score":0.6683683},"labels":[],"label_agreement":null},{"id":"W3023729609","doi":"10.1136/ijgc-2019-000910","title":"Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Women's Health Research Institute; Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; Clinical significance; Gynecology; Cancer","score_opus":0.014460960575508218,"score_gpt":0.2660244535393415,"score_spread":0.2515634929638333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023729609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957015,0.0012924472,0.00014799573,0.001166923,0.00086891314,0.00053111225,0.00004639632,0.000021388976,0.00022334282],"genre_scores_gemma":[0.9960733,0.0006355833,0.001861126,0.0009859884,0.00037334862,0.00003736892,0.0000032341632,0.000017086124,0.000012951424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766344,0.000090512905,0.0006422756,0.00031785486,0.0010224234,0.00026351606],"domain_scores_gemma":[0.997492,0.00083758857,0.00051653443,0.00008051661,0.0007955938,0.00027777936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029878243,0.00019270288,0.00048456868,0.00028383176,0.000031892232,0.000030466093,0.00025757978,0.000107944266,0.0006689361],"category_scores_gemma":[0.0050068973,0.00013200099,0.00012830274,0.0005885971,0.0001684755,0.00011572175,0.0000725778,0.0005434318,0.0000034217476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053164484,0.00023309342,0.9825065,0.000032403535,0.00015970004,0.0001535189,0.00020149566,0.0009649424,0.00033554222,0.000007049482,0.0002965244,0.009792768],"study_design_scores_gemma":[0.009893881,0.0049875984,0.9825981,0.0001398658,0.00010930806,0.000020872805,0.00007485192,0.00017645032,0.00071815826,0.000042869968,0.0010699147,0.0001680848],"about_ca_topic_score_codex":0.00010004773,"about_ca_topic_score_gemma":0.00006990681,"teacher_disagreement_score":0.009624684,"about_ca_system_score_codex":0.0008437988,"about_ca_system_score_gemma":0.0005977985,"threshold_uncertainty_score":0.73243815},"labels":[],"label_agreement":null},{"id":"W3033636741","doi":"10.1136/ijgc-2020-001432","title":"Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Trachelectomy; Obstetrics; Cervical cancer; Fertility; Gynecology; Stage (stratigraphy); Wish; Cancer; Internal medicine; Population; Environmental health","score_opus":0.02222076511417046,"score_gpt":0.3223000966183914,"score_spread":0.3000793315042209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033636741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980473,0.001372731,0.00023840238,0.0167797,0.00019792984,0.00040042202,0.00019750261,0.000010098806,0.00033021625],"genre_scores_gemma":[0.9952794,0.00038027833,0.00019212901,0.0034428176,0.0005259591,0.00006519161,0.000002855458,0.00001646378,0.000094941824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754316,0.00011568833,0.00064050825,0.00026226393,0.0011155359,0.00032281847],"domain_scores_gemma":[0.99782723,0.00034936974,0.00036367204,0.00012034782,0.000845618,0.00049377006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023548238,0.0001964677,0.00067617133,0.00011768734,0.000033539884,0.00004187633,0.0004877273,0.00009602051,0.0039262534],"category_scores_gemma":[0.0006296146,0.00010784208,0.00015070426,0.00052288536,0.0000943056,0.00014903043,0.000107087544,0.00057752506,0.0000032448281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07405174,0.00033216216,0.8535992,0.00009544354,0.0009970564,0.00039641684,0.00378651,0.0025955895,0.00040012854,0.00003931542,0.0009673358,0.06273912],"study_design_scores_gemma":[0.009001544,0.0073392466,0.9644459,0.0001913215,0.00013792061,0.0000074366617,0.00049302785,0.000038888924,0.0032637883,0.00024640287,0.014694171,0.00014035856],"about_ca_topic_score_codex":0.0016507987,"about_ca_topic_score_gemma":0.0019991896,"teacher_disagreement_score":0.110846706,"about_ca_system_score_codex":0.001118076,"about_ca_system_score_gemma":0.00076949975,"threshold_uncertainty_score":0.9969843},"labels":[],"label_agreement":null},{"id":"W3035508928","doi":"10.1136/ijgc-2019-000983","title":"The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ovarian Cancer Canada","funders":"","keywords":"Medicine; Incidence (geometry); Quality of life (healthcare); Quarter (Canadian coin); Family medicine; Cancer; Gynecology; Demography; Internal medicine; Nursing","score_opus":0.2505835560051818,"score_gpt":0.4073779733004365,"score_spread":0.15679441729525473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035508928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87127244,0.009924197,0.000027866254,0.11702117,0.0009766285,0.00027913143,0.000046864152,0.0000066168773,0.000445097],"genre_scores_gemma":[0.9799466,0.016635064,0.00006571858,0.0026071225,0.00057647156,0.00005278043,0.0000010334512,0.0000074375384,0.0001077842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985446,0.00013226614,0.00053008,0.0001721392,0.00050344574,0.000117476295],"domain_scores_gemma":[0.99828506,0.0005621891,0.00037298008,0.000065496635,0.00046383744,0.00025044277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586877,0.00011174757,0.00037572414,0.000063772924,0.000056529043,0.000048291804,0.0001253463,0.000035639423,0.00022963637],"category_scores_gemma":[0.00037291893,0.000069250375,0.00007327397,0.00003995572,0.000085537766,0.0001063469,0.0001011111,0.0001575267,4.3546177e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006939633,0.0013536061,0.5612837,0.0002571996,0.0048635365,0.000352233,0.004967451,0.00005793891,0.0013396961,0.013301056,0.002505474,0.40277848],"study_design_scores_gemma":[0.002600117,0.0009886153,0.98479646,0.00011304354,0.00013011372,0.0000039379956,0.002708279,0.000013386965,0.0001474781,0.00018110084,0.00823605,0.00008138438],"about_ca_topic_score_codex":0.00023308895,"about_ca_topic_score_gemma":0.0017237648,"teacher_disagreement_score":0.4235128,"about_ca_system_score_codex":0.00018154856,"about_ca_system_score_gemma":0.00020863216,"threshold_uncertainty_score":0.28239483},"labels":[],"label_agreement":null},{"id":"W3036167750","doi":"10.1136/ijgc-2020-001205","title":"Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Gynecologic oncology; Pulmonary embolism; Body mass index; Laparotomy; Surgery; Internal medicine","score_opus":0.027924955640715263,"score_gpt":0.31591338064213753,"score_spread":0.28798842500142224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036167750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898834,0.0015354907,0.00050537393,0.006417748,0.00063423824,0.0006675429,0.00010850365,0.000020168663,0.00022752314],"genre_scores_gemma":[0.98876923,0.0041814377,0.002043233,0.004079951,0.000700236,0.00018058396,0.0000055323785,0.000014425105,0.000025354258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981271,0.00009460867,0.00071722415,0.00028349392,0.00053008273,0.00024750963],"domain_scores_gemma":[0.99768984,0.0006925328,0.00054643117,0.00006843636,0.00070961006,0.0002931343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000368603,0.00020162559,0.00079633336,0.00009280756,0.000049217997,0.000026460171,0.00023665931,0.00015133077,0.0023951132],"category_scores_gemma":[0.0014579286,0.00013415948,0.00034137716,0.00010281066,0.0001899627,0.0001215393,0.0002040706,0.0002831732,0.0000041426483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03129045,0.015220918,0.54179126,0.0011231673,0.015427172,0.008985376,0.0013375087,0.0010940921,0.11861327,0.007473756,0.030601598,0.22704145],"study_design_scores_gemma":[0.004961048,0.007175551,0.9553777,0.00015267139,0.0015378646,0.00021263797,0.0003133011,0.0012938315,0.011807473,0.0027220196,0.014123458,0.00032242812],"about_ca_topic_score_codex":0.000018991592,"about_ca_topic_score_gemma":0.000006615991,"teacher_disagreement_score":0.41358647,"about_ca_system_score_codex":0.00012834626,"about_ca_system_score_gemma":0.00013780309,"threshold_uncertainty_score":0.99851686},"labels":[],"label_agreement":null},{"id":"W3041327040","doi":"10.1136/ijgc-2020-001723","title":"Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Poly ADP ribose polymerase; Medicine; PARP inhibitor; Polymerase; Ovarian cancer; Homologous recombination; Cancer research; Gene; Cancer; Internal medicine; Genetics; Biology","score_opus":0.025651223492386497,"score_gpt":0.3256051834118799,"score_spread":0.29995395991949336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041327040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91003543,0.0096549345,0.0003632635,0.07767306,0.001254153,0.00026183948,0.0004423728,0.000014507589,0.00030041236],"genre_scores_gemma":[0.9831107,0.004968012,0.0008905326,0.00881243,0.0021080917,0.000022648079,0.000017048467,0.000020101343,0.000050418887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977211,0.00009930626,0.0009966352,0.0003070536,0.0006384568,0.00023746454],"domain_scores_gemma":[0.9980077,0.00042933054,0.0006559624,0.00010592391,0.00049424474,0.0003068241],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022800105,0.00020996532,0.00063079916,0.000121963974,0.000027722082,0.000025221821,0.00030308953,0.00015078994,0.004637027],"category_scores_gemma":[0.0005830306,0.00016259876,0.00015466216,0.00022984456,0.00020425043,0.00020061243,0.00009500716,0.0005332637,0.000006246033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057423137,0.001665008,0.54008967,0.000108728316,0.002312797,0.0025823305,0.0025251324,0.000730261,0.23894438,0.0009273922,0.029509144,0.12318202],"study_design_scores_gemma":[0.030995771,0.0015723235,0.8661112,0.0014060839,0.00019137959,0.0001362839,0.00026708693,0.0003954737,0.057813555,0.0007262715,0.039952602,0.00043195474],"about_ca_topic_score_codex":0.00044216448,"about_ca_topic_score_gemma":0.00010079255,"teacher_disagreement_score":0.32602155,"about_ca_system_score_codex":0.00045262297,"about_ca_system_score_gemma":0.0004437856,"threshold_uncertainty_score":0.99627286},"labels":[],"label_agreement":null},{"id":"W3044310338","doi":"10.1136/ijgc-2020-001584","title":"Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Laparotomy; Surgery; Chemotherapy; Ovarian cancer; Laparoscopy; Randomized controlled trial; Neoadjuvant therapy; Stage (stratigraphy); Cancer; Internal medicine; Breast cancer","score_opus":0.02612274058956314,"score_gpt":0.3254590829397936,"score_spread":0.29933634235023043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044310338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9060466,0.0016790186,0.00011160033,0.08997176,0.0015242342,0.00012187739,0.0000152548755,0.000014669144,0.0005149439],"genre_scores_gemma":[0.98209196,0.0019011779,0.000711864,0.013025564,0.0021296397,0.000027473843,0.000002916405,0.000010077825,0.00009930018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898213,0.000019780791,0.00032991436,0.00014640002,0.0004013739,0.00012038033],"domain_scores_gemma":[0.9991747,0.00003843096,0.00020697803,0.000054231637,0.00034984856,0.00017581318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006478991,0.000107280044,0.00028910182,0.000044945835,0.000015799478,0.000026911885,0.00012724481,0.000066464294,0.0050945333],"category_scores_gemma":[0.00008729423,0.00007182638,0.00016944189,0.00007168847,0.000045135184,0.00009704732,0.000021488993,0.00018981667,0.000026804168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008093798,0.001477113,0.7050716,0.00004834039,0.002132528,0.0026083207,0.00090838305,0.00030528114,0.008772194,0.000395306,0.030432316,0.2397548],"study_design_scores_gemma":[0.005992368,0.0015769425,0.8668391,0.00012570126,0.00012413869,0.00014245896,0.00004910603,0.000071285234,0.0057676723,0.00019165619,0.11900777,0.000111782654],"about_ca_topic_score_codex":0.000010455933,"about_ca_topic_score_gemma":0.000004492084,"teacher_disagreement_score":0.23964302,"about_ca_system_score_codex":0.00034992624,"about_ca_system_score_gemma":0.00016409678,"threshold_uncertainty_score":0.9958149},"labels":[],"label_agreement":null},{"id":"W3045017845","doi":"10.1136/ijgc-2020-001840","title":"Adjuvant treatment in early stage cervical cancer—does more equal better?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Adjuvant; Radical Hysterectomy; Gynecology; Malignancy; Cancer; Hysterectomy; Gynecologic cancer; Obstetrics; Oncology; General surgery; Internal medicine; Ovarian cancer; Surgery","score_opus":0.056796739434322625,"score_gpt":0.3667627509133354,"score_spread":0.30996601147901276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045017845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532652,0.0014621565,0.000062996376,0.04334135,0.0010607232,0.00024891432,0.00014828167,0.000019292018,0.00039112385],"genre_scores_gemma":[0.9883538,0.0016587933,0.00025426675,0.0077896044,0.0016305384,0.00006572013,0.000009421313,0.000016990569,0.00022088148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978647,0.00006894572,0.0007062305,0.00027537884,0.0007986232,0.00028612113],"domain_scores_gemma":[0.99858487,0.00026578113,0.00031698565,0.00008090434,0.00035278185,0.00039868214],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010950238,0.00022585978,0.0006542519,0.00015751463,0.000026249652,0.000036345897,0.00030062438,0.00013360799,0.005370628],"category_scores_gemma":[0.00026603608,0.00012593721,0.00030911644,0.00026172271,0.00007989151,0.00014747455,0.00007590091,0.0003572183,0.000018731847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050838226,0.0009132823,0.85825795,0.000029558882,0.0008047609,0.0030742604,0.00071129075,0.00028756703,0.0010805303,0.00011769445,0.00022417758,0.12941508],"study_design_scores_gemma":[0.013867464,0.0041709673,0.9528559,0.00014632281,0.00020709875,0.00003260542,0.00019725114,0.0002218446,0.0033061523,0.0002623542,0.024510646,0.00022140134],"about_ca_topic_score_codex":0.0010809022,"about_ca_topic_score_gemma":0.00044785134,"teacher_disagreement_score":0.12919368,"about_ca_system_score_codex":0.0012888747,"about_ca_system_score_gemma":0.00034087553,"threshold_uncertainty_score":0.9955386},"labels":[],"label_agreement":null},{"id":"W3047413216","doi":"10.1136/ijgc-2020-001838","title":"Management of low-grade serous ovarian neoplasm in the setting of fertility preservation","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Serous fluid; Infertility; Gynecology; Work-up; Fertility; Fertility preservation; General surgery; Biopsy; Internal medicine; Population; Pregnancy","score_opus":0.04379454189632725,"score_gpt":0.3358986830964269,"score_spread":0.29210414120009964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047413216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583775,0.00032580624,0.00016951778,0.03988046,0.0002326041,0.00022130365,0.000015934284,0.0000028606862,0.0007740356],"genre_scores_gemma":[0.99738044,0.00031203558,0.0008686917,0.0012839235,0.000117390315,0.00001867132,0.0000035146086,0.0000039860993,0.000011359092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986648,0.00006638426,0.0005467375,0.0001063338,0.0005264416,0.00008932348],"domain_scores_gemma":[0.9989937,0.0002049965,0.00039960066,0.00007464383,0.0002780728,0.000048964765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003150422,0.00007635874,0.00025107284,0.00004730893,0.00001121972,0.000009322299,0.00024395416,0.000045241413,0.00032985886],"category_scores_gemma":[0.0001332986,0.000045847708,0.00012141607,0.00015206465,0.00003332161,0.00008720609,0.000048026424,0.00016343441,9.625551e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016462074,0.0015545046,0.941485,0.00025453977,0.0009946288,0.0006434803,0.0015494731,0.0022783617,0.0005855277,0.0017091527,0.0006580297,0.046641093],"study_design_scores_gemma":[0.002265738,0.00042005995,0.99398,0.00023920523,0.000088750676,0.000013262503,0.00023838937,0.00037118705,0.0011273903,0.00040290892,0.0008169406,0.00003618406],"about_ca_topic_score_codex":0.0000702614,"about_ca_topic_score_gemma":0.000040661387,"teacher_disagreement_score":0.05249498,"about_ca_system_score_codex":0.00017013105,"about_ca_system_score_gemma":0.00007845157,"threshold_uncertainty_score":0.36117232},"labels":[],"label_agreement":null},{"id":"W3047578607","doi":"10.1136/ijgc-2020-001261","title":"BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Referral; Ovarian cancer; Gynecologic cancer; Gynecology; BRCA mutation; Serous ovarian cancer; Cancer genetics; Oncology; Serous fluid; Genetic testing; Internal medicine; Cancer; Family medicine","score_opus":0.08645963514611715,"score_gpt":0.330309988877199,"score_spread":0.24385035373108183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047578607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932649,0.0005960383,0.00047791435,0.0044619865,0.0004582869,0.00024140203,0.000068224406,0.00002343135,0.00040779606],"genre_scores_gemma":[0.9802103,0.00021588594,0.014554428,0.004034991,0.0007785156,0.00013306247,0.000017247456,0.00003281527,0.000022728515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978262,0.0001561285,0.00065521995,0.00043289916,0.00049645535,0.00043308947],"domain_scores_gemma":[0.99743766,0.00030120887,0.0007128277,0.00013376444,0.0011994593,0.00021507301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028725632,0.0002772704,0.00042541887,0.00010072017,0.00007973662,0.00007453048,0.0007159905,0.0002044686,0.00028591635],"category_scores_gemma":[0.00097334565,0.00020342441,0.000047069985,0.0004522891,0.00021334013,0.000023686645,0.00016574832,0.0004805683,0.000002495533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005774755,0.00061986194,0.5491048,0.000041568204,0.001108339,0.0013402896,0.00064356154,0.3258892,0.073206685,0.000039602095,0.0016434231,0.040587913],"study_design_scores_gemma":[0.009806483,0.00952848,0.95429003,0.00020616481,0.00011846942,0.00037372054,0.0008088773,0.0026032785,0.011755436,0.0003076608,0.009397471,0.0008039075],"about_ca_topic_score_codex":0.00019047804,"about_ca_topic_score_gemma":0.0009431271,"teacher_disagreement_score":0.40518525,"about_ca_system_score_codex":0.0011092712,"about_ca_system_score_gemma":0.0014049349,"threshold_uncertainty_score":0.82954067},"labels":[],"label_agreement":null},{"id":"W3048352886","doi":"10.1136/ijgc-2020-001837","title":"Uterine rupture: an unusual presentation of a uterine perivascular epithelioid cell tumor (PEComa)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Hemoperitoneum; Presentation (obstetrics); Abdominal pain; Perivascular Epithelioid Cell; Uterine bleeding; Nausea; Biopsy; Surgery; Radiology; Epithelioid cell; Pathology; Immunohistochemistry","score_opus":0.07001026399534344,"score_gpt":0.38997229011971724,"score_spread":0.3199620261243738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048352886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878139,0.00035330988,0.0010229793,0.009748144,0.00041155834,0.00021294765,0.00006107828,0.000018613013,0.0003574736],"genre_scores_gemma":[0.9936231,0.00025717774,0.0028648446,0.00205785,0.0010048213,0.000014463579,0.000011759074,0.000020084904,0.00014594535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99762875,0.00012932853,0.0006803879,0.00022082713,0.0011267717,0.00021396033],"domain_scores_gemma":[0.99786586,0.000144457,0.00043684832,0.00013537373,0.0010820583,0.00033541655],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002813627,0.00015408035,0.0004457322,0.0001499926,0.00002871276,0.000039421066,0.00053399085,0.000067703186,0.0055572568],"category_scores_gemma":[0.0004366857,0.000114460534,0.0002482005,0.00017582274,0.00012990429,0.00023012687,0.00017365295,0.00040494945,0.0000140321845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006305565,0.002466465,0.10773937,0.00034517652,0.0009679569,0.0023901088,0.0012155442,0.0019396155,0.8357219,0.0003951919,0.0037123347,0.036800753],"study_design_scores_gemma":[0.007908748,0.0077515817,0.8318372,0.00012908934,0.000110482826,0.00066143234,0.00031638588,0.0053399904,0.102541484,0.00024045017,0.042881466,0.00028171093],"about_ca_topic_score_codex":0.000049196136,"about_ca_topic_score_gemma":0.000014248568,"teacher_disagreement_score":0.73318046,"about_ca_system_score_codex":0.00019821675,"about_ca_system_score_gemma":0.00022932662,"threshold_uncertainty_score":0.9953518},"labels":[],"label_agreement":null},{"id":"W3048693593","doi":"10.1136/ijgc-2020-001403","title":"Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Dalhousie University; Vancouver General Hospital; University of Manitoba","funders":"Cancer Council Victoria; Public Health Agency; Cancer Society of New Zealand; Cancer Institute NSW; Cancer Research UK; Scottish Government; World Health Organization; Kreftforeningen; Kræftens Bekæmpelse; Partenariat Canadien Contre Le Cancer; National Cancer Registry Ireland","keywords":"Medicine; Clinical Practice; Ovarian cancer; Cancer; Gynecology; Family medicine; Oncology; Internal medicine","score_opus":0.4470309393113331,"score_gpt":0.5072405154513994,"score_spread":0.06020957614006628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048693593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588631,0.0041069384,0.0000859817,0.03513309,0.0012886764,0.00015564017,0.000107603904,0.0000037862005,0.00025523335],"genre_scores_gemma":[0.9769364,0.019354263,0.0018625109,0.0009625741,0.0008204055,0.00004164686,0.000006022854,0.000007822401,0.000008377555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976519,0.00007399203,0.0014218744,0.00020309401,0.0005428021,0.00010637252],"domain_scores_gemma":[0.99660873,0.00058442046,0.0009814809,0.00006241232,0.0016225432,0.00014043796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019143292,0.00013839577,0.0007562896,0.0001104839,0.000012152416,0.000015489264,0.00018975904,0.00007434372,0.0005280992],"category_scores_gemma":[0.0014895682,0.00009266803,0.00019240624,0.00008044804,0.000059857543,0.00021156955,0.00006451828,0.00019818035,5.5222097e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015352656,0.0006725799,0.8480066,0.000032986823,0.0008279119,0.00014465823,0.0013738039,0.00012957906,0.0000834763,0.00013357244,0.00008648875,0.14697304],"study_design_scores_gemma":[0.0054744557,0.002381148,0.97888106,0.000517488,0.00025953734,0.000020519534,0.0022319,0.00028098255,0.0012917841,0.000016332797,0.008561809,0.000082966166],"about_ca_topic_score_codex":0.0007224944,"about_ca_topic_score_gemma":0.00034014526,"teacher_disagreement_score":0.14689009,"about_ca_system_score_codex":0.00026714953,"about_ca_system_score_gemma":0.00029924756,"threshold_uncertainty_score":0.5782316},"labels":[],"label_agreement":null},{"id":"W3048741359","doi":"10.1136/ijgc-2020-001378","title":"Preoperative neutrophil-to-lymphocyte ratio predicts 30 day postoperative morbidity and survival after primary surgery for ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Neutrophil to lymphocyte ratio; Perioperative; Hazard ratio; Odds ratio; Receiver operating characteristic; Confidence interval; Ovarian cancer; Serous fluid; Lymphocyte; Surgery; Retrospective cohort study; Proportional hazards model; Internal medicine; Cancer","score_opus":0.03677182395618362,"score_gpt":0.31247153722021015,"score_spread":0.27569971326402654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048741359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96062845,0.0016376491,0.0013629916,0.033015497,0.0018852525,0.00079654326,0.0004268546,0.000025428852,0.00022133195],"genre_scores_gemma":[0.9808523,0.00070493476,0.00084707106,0.015494197,0.0016386354,0.00035513373,0.000018843166,0.00002454693,0.00006430304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796486,0.00016612871,0.0006512696,0.00033682145,0.00063195906,0.0002489737],"domain_scores_gemma":[0.9969876,0.0006414956,0.00030435328,0.00008422438,0.0014990133,0.0004833209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044545092,0.00023338998,0.0005695285,0.00011889216,0.00007256525,0.00008006415,0.00021276713,0.00013345979,0.0016696113],"category_scores_gemma":[0.0012605534,0.00017309588,0.00023406345,0.000120065786,0.00014081482,0.00026903691,0.00013716135,0.00024596884,0.0000060870493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023992116,0.00049912493,0.91233957,0.00020880095,0.00310456,0.0016504928,0.0020265935,0.00060546317,0.009904537,0.0002202907,0.017736966,0.02771149],"study_design_scores_gemma":[0.0030217536,0.00067496015,0.98292047,0.00020366647,0.00025142133,0.000034321878,0.000071218434,0.000578249,0.0027693217,0.000049538874,0.009199041,0.00022605946],"about_ca_topic_score_codex":0.000019552008,"about_ca_topic_score_gemma":0.000021113281,"teacher_disagreement_score":0.070580885,"about_ca_system_score_codex":0.0006575535,"about_ca_system_score_gemma":0.0010775983,"threshold_uncertainty_score":0.999243},"labels":[],"label_agreement":null},{"id":"W3048833574","doi":"10.1136/ijgc-00009577-200610001-00439","title":"Talking About Sexuality After A Cancer Diagnosis: Provider And Patient Perspectives","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Human sexuality; Medicine; Psychology; Sociology; Gender studies","score_opus":0.014747019737132175,"score_gpt":0.33581896961406504,"score_spread":0.3210719498769329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048833574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94296175,0.01564603,0.00013662159,0.040080383,0.00075350504,0.00012425092,0.000022131382,0.00000913475,0.0002661712],"genre_scores_gemma":[0.9946349,0.0018918855,0.0004372233,0.0018955687,0.0008732607,0.00014057351,0.0000018600092,0.000006919337,0.00011781237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987034,0.00004215919,0.0003891944,0.00015126231,0.00058811175,0.00012586395],"domain_scores_gemma":[0.99873245,0.00012855395,0.0002640118,0.000043466876,0.0007304462,0.00010106657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017839366,0.00009736954,0.00020775209,0.000084744854,0.00003451882,0.000038581737,0.00007201701,0.00013913853,0.0019163784],"category_scores_gemma":[0.00014267495,0.000060613216,0.00009315673,0.0000645271,0.00033021372,0.00010599642,0.000049132093,0.00031056404,9.807871e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001286367,0.0012024957,0.53261155,0.00007159623,0.0005263278,0.0005808938,0.0017251711,0.00008186466,0.00093433255,0.003086705,0.0049631395,0.45292956],"study_design_scores_gemma":[0.0010833328,0.00032141342,0.95060486,0.00023957893,0.00006744633,0.000081125625,0.00026932097,0.00012910255,0.00025456847,0.0026223047,0.044234943,0.00009200901],"about_ca_topic_score_codex":0.00026033062,"about_ca_topic_score_gemma":0.00017561251,"teacher_disagreement_score":0.45283753,"about_ca_system_score_codex":0.00032248246,"about_ca_system_score_gemma":0.00017076098,"threshold_uncertainty_score":0.998996},"labels":[],"label_agreement":null},{"id":"W3049105864","doi":"10.1136/ijgc-00009577-200610001-00592","title":"SCORING SYSTEMS AS NON-INVASIVE DIAGNOSTIC TOOLS FOR ENDOMETRIAL CANCER","year":2006,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Outcome (game theory); Uterine sarcoma; Medicine; Retrospective cohort study; Gynecology; Obstetrics; Sarcoma; Internal medicine; Pathology; Economics","score_opus":0.1157121415244537,"score_gpt":0.43537993397232483,"score_spread":0.31966779244787114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049105864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018405864,0.9851491,0.00011973692,0.00027417592,0.01006645,0.0014931235,0.00048519092,0.000013169698,0.0005585031],"genre_scores_gemma":[0.0054516573,0.98483235,0.00019740193,0.0001475295,0.007294519,0.0009297429,0.00009592096,0.00004596867,0.0010048846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729395,0.000064359556,0.0012876462,0.0003104681,0.00073661085,0.00030694992],"domain_scores_gemma":[0.9904451,0.0067377607,0.0014745668,0.00012695226,0.001022652,0.00019297606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026052122,0.00039519055,0.0020654825,0.000414112,0.000049652772,0.00016511434,0.0003574826,0.0003046125,0.0005536661],"category_scores_gemma":[0.005153243,0.0002457329,0.001154401,0.00017573117,0.000053251195,0.0001733649,0.00009359889,0.00042241046,0.000022722184],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038801928,0.00046808616,0.0010515519,0.0029346193,0.0046883053,0.0033109896,0.000009402392,0.00010380062,0.000004288823,0.00015334993,0.0047339806,0.9821536],"study_design_scores_gemma":[0.0038152742,0.0011913122,0.000618415,0.01513511,0.0026743636,0.000929853,0.0000060929447,0.000005084812,0.000011506135,0.00003992048,0.97534317,0.00022992441],"about_ca_topic_score_codex":0.00027347915,"about_ca_topic_score_gemma":0.00003846025,"teacher_disagreement_score":0.9819237,"about_ca_system_score_codex":0.001823825,"about_ca_system_score_gemma":0.0014686433,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W3081091874","doi":"10.1136/ijgc-2020-001702","title":"Appendectomy at the time of ovarian cancer staging increases infectious complications: a National Surgical Quality Improvement Program (NSQIP) propensity score-stratified analysis","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Appendicitis Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Propensity score matching; Ovarian cancer; General surgery; Oncology; Cancer; Internal medicine","score_opus":0.07947058393225871,"score_gpt":0.38307794811690415,"score_spread":0.30360736418464546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081091874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768369,0.00031377873,0.00026735794,0.02033355,0.00013043886,0.0007792242,0.00012124237,0.00003885899,0.0011786455],"genre_scores_gemma":[0.99516743,0.00038194872,0.00017765728,0.0036416522,0.00030929063,0.00019180536,0.000048973747,0.000010915834,0.00007033954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997254,0.00014403473,0.0009114649,0.0002692352,0.0012404247,0.00018080705],"domain_scores_gemma":[0.9969213,0.0004062592,0.0009402932,0.000119549506,0.0014296005,0.00018300094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006935552,0.00016397797,0.0005597279,0.00013813983,0.00008679971,0.000055142813,0.00033736174,0.00006790492,0.0032789097],"category_scores_gemma":[0.00048567232,0.000101426296,0.0003842649,0.00040190184,0.00018473352,0.000114587965,0.0002263226,0.00027001512,0.000008326926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016308998,0.0024686314,0.922403,0.0000736823,0.0075552943,0.00017944141,0.0002387501,0.003334002,0.0032370875,0.0022822348,0.005047326,0.05154966],"study_design_scores_gemma":[0.002727804,0.00076158316,0.98013216,0.00007536163,0.00074145925,0.000026673022,0.00005900442,0.0011403091,0.00096133695,0.00018529492,0.013044958,0.00014407812],"about_ca_topic_score_codex":0.00074036885,"about_ca_topic_score_gemma":0.00038168931,"teacher_disagreement_score":0.057729147,"about_ca_system_score_codex":0.00066953927,"about_ca_system_score_gemma":0.000341667,"threshold_uncertainty_score":0.9976322},"labels":[],"label_agreement":null},{"id":"W3081248220","doi":"10.1136/ijgc-00009577-200610001-00690","title":"Treatment of Stage iiic Endometrial Cancer With Adjuvant Radiotherapy and Chemotherapy","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Radiation therapy; Endometrial cancer; Stage (stratigraphy); Medicine; Chemotherapy; Oncology; Adjuvant; Cancer; Internal medicine; Adjuvant chemotherapy; Breast cancer; Biology","score_opus":0.024282155734664385,"score_gpt":0.33620192490088796,"score_spread":0.31191976916622355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081248220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98207045,0.012745216,0.00016075262,0.0035199567,0.0006136881,0.00026858228,0.00007670126,0.00000908111,0.0005355731],"genre_scores_gemma":[0.98107815,0.015486827,0.0009452928,0.0004305123,0.0012088239,0.000036159516,0.0000052979503,0.000015051034,0.0007938643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856496,0.00003561865,0.00048803003,0.00016878138,0.00057826226,0.00016431962],"domain_scores_gemma":[0.99863786,0.00028595413,0.0004514626,0.000073722,0.0004349092,0.00011607437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088619345,0.0001742853,0.0006135411,0.00023519594,0.000023773515,0.00001816555,0.00011246301,0.000080037324,0.0026765505],"category_scores_gemma":[0.000044581644,0.00009411639,0.00018123072,0.00021610958,0.00012701456,0.00007948547,0.000010391448,0.00009733937,5.9325663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024791805,0.002287921,0.65607923,0.000028124245,0.0024178347,0.00056470966,0.0001226927,0.0003118338,0.007533715,0.00030012312,0.00025461745,0.3053074],"study_design_scores_gemma":[0.07354628,0.015141331,0.8240507,0.00015312555,0.00039753036,0.00025577773,0.000055047363,0.00006805358,0.018050384,0.00024859485,0.067802355,0.00023078316],"about_ca_topic_score_codex":0.0008194474,"about_ca_topic_score_gemma":0.00014636901,"teacher_disagreement_score":0.3050766,"about_ca_system_score_codex":0.0007865614,"about_ca_system_score_gemma":0.00022669409,"threshold_uncertainty_score":0.99823517},"labels":[],"label_agreement":null},{"id":"W3083593114","doi":"10.1136/ijgc-2020-001694","title":"DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Tolerability; Epithelial ovarian cancer; Oncology; Internal medicine; Ovarian cancer; Randomized controlled trial; Maintenance therapy; Phases of clinical research; Gynecology; Clinical trial; Cancer; Chemotherapy; Adverse effect","score_opus":0.024050440850557023,"score_gpt":0.31408328392920226,"score_spread":0.29003284307864524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083593114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217613,0.00039932938,0.00013822553,0.022541247,0.00042753515,0.003802345,0.00044803525,0.000013658443,0.000053514326],"genre_scores_gemma":[0.99396425,0.00033615695,0.00034361376,0.004186796,0.00051443203,0.00042447445,0.000011692698,0.000029100598,0.0001894861],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99640965,0.0005731029,0.0013863908,0.00054019515,0.00071222946,0.00037841467],"domain_scores_gemma":[0.996511,0.0008224537,0.0010713422,0.00021918133,0.00096160715,0.0004144371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443278,0.00042609734,0.0014435895,0.00015191406,0.00009850945,0.000038570255,0.00023653997,0.0000944788,0.00044724124],"category_scores_gemma":[0.0009426373,0.00022936471,0.00024183592,0.0002126575,0.00045245947,0.00016611144,0.000085047315,0.00037978461,0.000001542212],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7318855,0.012248677,0.19072999,0.000038572343,0.0032811682,0.0006322927,0.031774234,0.0008842258,0.0032906646,0.000024533287,0.000904628,0.02430553],"study_design_scores_gemma":[0.67738813,0.03293845,0.27246097,0.0010797605,0.0005624734,0.00003204201,0.0010683823,0.00083206734,0.01141531,0.00003923086,0.0017725391,0.00041066154],"about_ca_topic_score_codex":0.00072989345,"about_ca_topic_score_gemma":0.0010293683,"teacher_disagreement_score":0.08173096,"about_ca_system_score_codex":0.0017437768,"about_ca_system_score_gemma":0.000536767,"threshold_uncertainty_score":0.93532217},"labels":[],"label_agreement":null},{"id":"W3091531293","doi":"10.1136/ijgc-2020-001849","title":"Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Serous fluid; Ovarian cancer; Serous ovarian cancer; Abdominal pain; Abdominal distension; Poly ADP ribose polymerase; Internal medicine; Oncology; Polymerase; Gastroenterology; Cancer; Gynecology; Pathology; Enzyme","score_opus":0.028620173436476336,"score_gpt":0.37068385931199804,"score_spread":0.3420636858755217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091531293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.865077,0.0036841899,0.00022318253,0.12904495,0.001215082,0.00032574,0.00031727884,0.00003560034,0.000076986995],"genre_scores_gemma":[0.97562,0.00047120085,0.0011436339,0.020232188,0.0022988482,0.00010810642,0.00002153268,0.000035846537,0.00006868522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970228,0.00017662394,0.00083657354,0.0003733127,0.0011751029,0.00041557068],"domain_scores_gemma":[0.9977485,0.0002846826,0.00067293947,0.000120457225,0.00057822606,0.000595218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039505254,0.00029475338,0.0006170459,0.00017046642,0.0000796166,0.00007937154,0.0003708334,0.00016977658,0.0032619608],"category_scores_gemma":[0.0004832542,0.00020048006,0.00019105955,0.00041914117,0.00024397868,0.00038318106,0.000086907814,0.0007439483,0.0000063177235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037213445,0.0020381694,0.61571324,0.00016913554,0.0030830204,0.014573834,0.006014463,0.0028189954,0.08566336,0.0008052651,0.038608547,0.19329855],"study_design_scores_gemma":[0.09032343,0.014952279,0.3911481,0.004307171,0.00064693054,0.0023752928,0.0035797376,0.0006611891,0.34829295,0.0016491818,0.13994513,0.0021186292],"about_ca_topic_score_codex":0.00034681056,"about_ca_topic_score_gemma":0.00028866227,"teacher_disagreement_score":0.26262957,"about_ca_system_score_codex":0.0008271647,"about_ca_system_score_gemma":0.00085581397,"threshold_uncertainty_score":0.9976492},"labels":[],"label_agreement":null},{"id":"W3091958610","doi":"10.1136/ijgc-2020-001816","title":"Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Blame; Cervical cancer; Invasive surgery; Uterine cancer; Gynecologic surgical procedures; General surgery; Gynecology; Surgery; Laparoscopy; Cancer; Internal medicine; Psychiatry","score_opus":0.05377912807909555,"score_gpt":0.33488856006033907,"score_spread":0.2811094319812435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091958610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8873198,0.00089455495,0.000019923848,0.1098141,0.0014119939,0.00024622184,0.00007527801,0.00001065596,0.0002074894],"genre_scores_gemma":[0.96252465,0.0010909927,0.00015248857,0.03417449,0.0018355462,0.0000995762,0.0000028059894,0.000018078097,0.00010135702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976177,0.000099186866,0.0007894152,0.0002810677,0.00091302616,0.000299561],"domain_scores_gemma":[0.997775,0.00089603773,0.00026481482,0.0001037374,0.00054389297,0.00041649185],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000261803,0.00021342665,0.0006265848,0.00017128311,0.0000259085,0.00005544731,0.00041451468,0.00011951795,0.007500043],"category_scores_gemma":[0.0009351766,0.00012608006,0.00034378236,0.00045688535,0.00007363721,0.00013087392,0.00016496748,0.0004546226,0.00004965567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009886288,0.0003436852,0.96216744,0.00004201562,0.00067721057,0.0021466136,0.0006972111,0.00007511266,0.0008457314,0.000040916842,0.0024838052,0.02059397],"study_design_scores_gemma":[0.0025746173,0.0009279244,0.97393113,0.000169483,0.00009697266,0.000039159262,0.00007498692,0.000016635018,0.0015773074,0.00013596038,0.020298306,0.00015749728],"about_ca_topic_score_codex":0.00040607882,"about_ca_topic_score_gemma":0.00065938925,"teacher_disagreement_score":0.07563961,"about_ca_system_score_codex":0.00058330613,"about_ca_system_score_gemma":0.00041378938,"threshold_uncertainty_score":0.99340725},"labels":[],"label_agreement":null},{"id":"W3093853414","doi":"10.1136/ijgc-2020-001927","title":"Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Toronto Metropolitan University; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Microsatellite instability; Lynch syndrome; Endometrial cancer; Immunohistochemistry; Medicine; Ovarian cancer; PMS2; DNA mismatch repair; Cancer; Oncology; Pathology; Internal medicine; Microsatellite; Biology; Colorectal cancer; Gene; Genetics","score_opus":0.025260322405729372,"score_gpt":0.30819683004062876,"score_spread":0.28293650763489936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093853414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992443,0.0023399496,0.00009845824,0.0056644618,0.0012128415,0.00024304856,0.000019344576,0.000013547056,0.00048393224],"genre_scores_gemma":[0.9948253,0.0005887724,0.0015276328,0.0024909147,0.00050773605,0.000024717177,0.0000014604451,0.000011870442,0.000021592183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981587,0.00007130523,0.00069299154,0.0002730072,0.00056068687,0.00024330706],"domain_scores_gemma":[0.99887145,0.00035159464,0.00029183796,0.00006846899,0.00022109288,0.00019553374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032362406,0.00015339795,0.00045584954,0.00023423036,0.000017070357,0.00002413257,0.00022765114,0.00007993917,0.000721471],"category_scores_gemma":[0.0016640372,0.000119598546,0.00012649229,0.00038275612,0.00011915107,0.00011142749,0.00009292721,0.00049950206,0.000004059568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004349632,0.00022361144,0.96823335,0.000055446846,0.000093723786,0.002371094,0.000876162,0.0029411903,0.008036183,0.00008274697,0.00062813045,0.012108751],"study_design_scores_gemma":[0.006383277,0.0017252133,0.98592055,0.00020745031,0.000037185677,0.00026160156,0.00018796197,0.0016229297,0.0008221106,0.00018757806,0.0024651866,0.00017896056],"about_ca_topic_score_codex":0.00036997322,"about_ca_topic_score_gemma":0.00081639836,"teacher_disagreement_score":0.017687216,"about_ca_system_score_codex":0.0012936039,"about_ca_system_score_gemma":0.00060429913,"threshold_uncertainty_score":0.7899601},"labels":[],"label_agreement":null},{"id":"W3095506561","doi":"10.1136/ijgc-2020-001652","title":"Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cervical cancer; Medicine; Cervix; Cancer; Clinical trial; Gynecology; Gynecologic cancer; Disease; Family medicine; Oncology; Internal medicine; Ovarian cancer","score_opus":0.2049080942355187,"score_gpt":0.4696778956837078,"score_spread":0.2647698014481891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095506561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007557708,0.95751435,0.0000017079587,0.03852607,0.000985847,0.001071123,0.00041558826,0.00001402975,0.00071553886],"genre_scores_gemma":[0.002944467,0.98820317,0.000041765452,0.0052959053,0.0026395174,0.0004856794,0.000021097976,0.000049318965,0.0003190842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951159,0.0003974678,0.0015812685,0.0006605018,0.001756545,0.00048834225],"domain_scores_gemma":[0.9947179,0.0015070185,0.0008797677,0.00016059144,0.00225067,0.00048402793],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087924546,0.00050573115,0.002720367,0.00024500303,0.00007555438,0.0001469819,0.0012139158,0.00038392557,0.008909213],"category_scores_gemma":[0.0016785472,0.0002630104,0.00050014845,0.0011288795,0.00031640555,0.00016472294,0.00057549373,0.0027298366,0.000046268735],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054486975,0.00028291717,0.011224258,0.004642337,0.0014194617,0.0007116626,0.000096012685,5.004515e-7,0.0000028321335,0.00015953367,0.004453932,0.9764617],"study_design_scores_gemma":[0.0019472117,0.0004476924,0.012455191,0.04101927,0.0019737014,0.00012880753,0.000028769413,0.000008913421,0.0000021008805,0.00017120718,0.9415573,0.00025983702],"about_ca_topic_score_codex":0.0012738486,"about_ca_topic_score_gemma":0.0006341302,"teacher_disagreement_score":0.97620183,"about_ca_system_score_codex":0.0013836161,"about_ca_system_score_gemma":0.001797167,"threshold_uncertainty_score":0.99998224},"labels":[],"label_agreement":null},{"id":"W3097413644","doi":"10.1136/ijgc-2020-001797","title":"Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cervical cancer; Brachytherapy; Endometrial cancer; Stage (stratigraphy); Radiation therapy; Hysterectomy; Surgery; Cancer; Internal medicine","score_opus":0.11024988246953749,"score_gpt":0.4179737505142262,"score_spread":0.3077238680446887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097413644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760656,0.007417493,0.0000655979,0.014956877,0.00055518886,0.00075316447,0.000027046051,0.000014100208,0.00014497712],"genre_scores_gemma":[0.98820263,0.006134844,0.00034549378,0.003321823,0.0017912753,0.00014360556,0.000003912921,0.000022997832,0.00003342187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967514,0.0002765703,0.0006966126,0.00038213385,0.0015357903,0.00035744547],"domain_scores_gemma":[0.9979505,0.00070712325,0.0002646539,0.00009379476,0.000588348,0.00039560298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007583066,0.00021844229,0.0007177669,0.00044379992,0.00006187317,0.0000797903,0.00033979674,0.000107589585,0.0019960648],"category_scores_gemma":[0.00040342493,0.0001321961,0.00013168114,0.00092538464,0.0001712538,0.00018678734,0.00009425406,0.0008010063,0.0000024069573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028817326,0.0023129857,0.8606628,0.000026618176,0.0011997807,0.0019243509,0.0012786868,0.00008043772,0.0014309819,0.00011777663,0.00018121571,0.101967014],"study_design_scores_gemma":[0.059967864,0.021504492,0.9073205,0.00019238087,0.00011921555,0.00010552199,0.00072483777,0.00014430641,0.00035928655,0.00024035675,0.00909613,0.00022509537],"about_ca_topic_score_codex":0.0006900571,"about_ca_topic_score_gemma":0.00080012943,"teacher_disagreement_score":0.10174192,"about_ca_system_score_codex":0.0008374532,"about_ca_system_score_gemma":0.00026225633,"threshold_uncertainty_score":0.99891627},"labels":[],"label_agreement":null},{"id":"W3098119439","doi":"10.1136/ijgc-2020-igcs.225","title":"262 Pre-operative wait times in high risk endometrial cancer: do surgical delays impact patient survival?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Entomological Society of Canada; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Hysterectomy; Carcinosarcoma; Retrospective cohort study; Serous fluid; Cancer; Internal medicine; Surgery; General surgery; Oncology; Carcinoma","score_opus":0.02887814219100694,"score_gpt":0.35927199733363296,"score_spread":0.33039385514262604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098119439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718935,0.003391611,0.000037885027,0.005536441,0.001997134,0.00039101276,0.00036660972,0.000018889994,0.0010710737],"genre_scores_gemma":[0.9908856,0.0056378352,0.0001792411,0.0009991422,0.0021425518,0.000059325575,0.00001884212,0.000020280555,0.000057146764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677265,0.00028173294,0.0010140507,0.00034881703,0.0012314626,0.00035129036],"domain_scores_gemma":[0.9968151,0.0011884104,0.00062859023,0.00009432871,0.00077307277,0.000500499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035791515,0.00029037817,0.00092998584,0.0002985786,0.00004827926,0.00006498756,0.00035925905,0.00018579798,0.016124574],"category_scores_gemma":[0.0017314721,0.00017646658,0.0005093817,0.0006522291,0.00009667411,0.00020714929,0.00013041943,0.0007683852,0.000024719038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03007196,0.0012597918,0.8182008,0.00001727841,0.0023349135,0.0029874232,0.0006134843,0.004929699,0.00022973363,0.00030836486,0.0014083773,0.13763815],"study_design_scores_gemma":[0.05247475,0.014862142,0.9031891,0.0002980012,0.0006051486,0.00019571712,0.00023672759,0.0006596854,0.002282708,0.0009543616,0.023676448,0.0005652069],"about_ca_topic_score_codex":0.0015507675,"about_ca_topic_score_gemma":0.00016730442,"teacher_disagreement_score":0.13707295,"about_ca_system_score_codex":0.0014420657,"about_ca_system_score_gemma":0.00051506027,"threshold_uncertainty_score":0.9847748},"labels":[],"label_agreement":null},{"id":"W3098481241","doi":"10.1136/ijgc-2020-igcs.287","title":"335 Low BRCA 1/2 germline mutation rate in a french canadian population","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"MUTYH; Medicine; Population; Oncology; Germline mutation; Lynch syndrome; BRCA mutation; MSH6; Serous carcinoma; Frameshift mutation; Ovarian cancer; Internal medicine; Cancer; Serous fluid; Cancer research; Mutation; Colorectal cancer; Biology; Genetics; DNA mismatch repair; Gene","score_opus":0.016185305304560665,"score_gpt":0.29924947451174705,"score_spread":0.28306416920718636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098481241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735535,0.00053444866,0.0006830955,0.010102802,0.00089093123,0.000096427015,0.0000474372,0.0000035927349,0.0002859183],"genre_scores_gemma":[0.9940174,0.0002137626,0.0005192533,0.0042150756,0.000882943,0.000014838242,0.000071067836,0.0000103441025,0.000055264798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998968,0.000075201264,0.00040993153,0.00017797304,0.00021531155,0.00015355067],"domain_scores_gemma":[0.9990926,0.000034289522,0.00023519904,0.000058908103,0.0004258972,0.00015312037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021230476,0.000099963516,0.00013877843,0.00011634149,0.000026891652,0.00003309207,0.00029799071,0.0001269017,0.00062031235],"category_scores_gemma":[0.00060130656,0.000090739566,0.00008218965,0.00013354761,0.000032072516,0.00001655098,0.000038095197,0.00017283253,0.000007864638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001034581,0.00037791178,0.44554335,0.00004514758,0.0007866451,0.0011740931,0.001158158,0.20774469,0.11149509,0.0003847396,0.031175667,0.19907993],"study_design_scores_gemma":[0.0018220478,0.00043899653,0.9560016,0.00003826308,0.000021855752,0.000050970622,0.00007042724,0.0021300982,0.008792319,0.0005619909,0.029830743,0.00024072839],"about_ca_topic_score_codex":0.0050954185,"about_ca_topic_score_gemma":0.050859984,"teacher_disagreement_score":0.51045823,"about_ca_system_score_codex":0.00048384655,"about_ca_system_score_gemma":0.0005553698,"threshold_uncertainty_score":0.96645933},"labels":[],"label_agreement":null},{"id":"W3098572759","doi":"10.1136/ijgc-2020-igcs.4","title":"4 Refining pathologic interpretation of endometrial carcinomas: lessons learned from a nationwide study in a new era of molecular classification","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; McGill University; Sunnybrook Health Science Centre; Centre for Advancing Health Outcomes; Jewish General Hospital; University Health Network; Health Sciences Centre; McMaster University; Université de Montréal; University of Saskatchewan; Vancouver General Hospital; Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Immunohistochemistry; Context (archaeology); Medicine; MLH1; Oncology; Internal medicine; Stage (stratigraphy); Pathology; Carcinoma; DNA mismatch repair; Cancer; Biology; Colorectal cancer","score_opus":0.09646630015805031,"score_gpt":0.3826161744200102,"score_spread":0.2861498742619599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098572759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701536,0.00090989715,0.025200823,0.003099985,0.0003071759,0.00017954563,0.00004129934,0.0000032921616,0.00010432713],"genre_scores_gemma":[0.9979061,0.00030882415,0.0012521899,0.00026453033,0.00020284802,0.000014646984,0.000027543634,0.0000122754045,0.000011033322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979805,0.00027931147,0.00074834336,0.00027078908,0.00059163343,0.0001294259],"domain_scores_gemma":[0.9983008,0.00014946431,0.00068274443,0.000117780335,0.00065643835,0.00009279144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042613028,0.00012097697,0.00031635573,0.00017600213,0.0000125787,0.000018202974,0.000493852,0.00015763807,0.00018032745],"category_scores_gemma":[0.003141648,0.00010842643,0.00016730271,0.00027730543,0.0000539,0.000015788262,0.00014778752,0.00036730216,0.0000011318193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002398514,0.00025911635,0.008943133,0.000005512395,0.00024920303,0.000090538735,0.00040572687,0.005960259,0.93283665,0.00011034161,0.00005254954,0.048688453],"study_design_scores_gemma":[0.014906898,0.0079712765,0.16561778,0.0002109019,0.00017712385,0.000025781055,0.0015725489,0.0050915508,0.801232,0.0016915918,0.0010681478,0.00043443686],"about_ca_topic_score_codex":0.00023086407,"about_ca_topic_score_gemma":0.0002334924,"teacher_disagreement_score":0.15667464,"about_ca_system_score_codex":0.00011721303,"about_ca_system_score_gemma":0.0005475445,"threshold_uncertainty_score":0.44215015},"labels":[],"label_agreement":null},{"id":"W3098742625","doi":"10.1136/ijgc-2020-igcs.263","title":"306 Outcomes after the regionalization of care for high risk endometrial cancers: a population-based study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Entomological Society of Canada; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Carcinosarcoma; Retrospective cohort study; Serous fluid; Stage (stratigraphy); Internal medicine; Cohort; Proportional hazards model; Population; Oncology; Cancer; Gynecology; Carcinoma; Environmental health","score_opus":0.03914533360251822,"score_gpt":0.35266445823692516,"score_spread":0.31351912463440695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098742625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820204,0.0010566479,0.0009577422,0.00736014,0.0012614818,0.00087036646,0.00024400484,0.000010309189,0.0000373012],"genre_scores_gemma":[0.99593663,0.0001032832,0.0004805327,0.0022559343,0.0010120898,0.00014933255,0.000028315366,0.000012233869,0.000021635578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981043,0.00010776696,0.0006671828,0.00017169285,0.00082422234,0.00012483676],"domain_scores_gemma":[0.9966563,0.0012262445,0.0006992603,0.00008696524,0.0012148892,0.00011635111],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002051144,0.00014090382,0.00051116163,0.00014130192,0.000050037714,0.00002076895,0.00025074903,0.00007065713,0.0011309977],"category_scores_gemma":[0.0025737844,0.0000759391,0.0003556184,0.00030658953,0.000037609774,0.00007497275,0.000033466564,0.00017727938,0.0000013263754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013653828,0.00032170385,0.9718,0.000029831275,0.00082581595,0.000033375745,0.00030692984,0.0015824061,0.000012194647,0.00007697809,0.00012726325,0.011229639],"study_design_scores_gemma":[0.0161811,0.0038915486,0.9766332,0.000052723808,0.0006221916,0.0000027002905,0.00035107543,0.00008761874,0.00016704937,0.00030282812,0.0016195724,0.00008840894],"about_ca_topic_score_codex":0.00066517247,"about_ca_topic_score_gemma":0.00034462885,"teacher_disagreement_score":0.011141229,"about_ca_system_score_codex":0.0006013441,"about_ca_system_score_gemma":0.00029863665,"threshold_uncertainty_score":0.9997821},"labels":[],"label_agreement":null},{"id":"W3098999550","doi":"10.1136/ijgc-2020-igcs.281","title":"327 Venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Incidence (geometry); Ovarian cancer; Chemotherapy; Univariate analysis; Retrospective cohort study; Proportional hazards model; Stage (stratigraphy); Multivariate analysis; Cancer; Oncology","score_opus":0.033376243383823695,"score_gpt":0.3357510797904709,"score_spread":0.3023748364066472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098999550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9258662,0.001114583,0.00022913452,0.06993776,0.0018714549,0.0004933285,0.00007032855,0.000012880986,0.00040434056],"genre_scores_gemma":[0.98488194,0.0016647696,0.00096171576,0.01118952,0.0011590985,0.000086042455,0.000008426575,0.000018853418,0.000029666004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864644,0.000026328547,0.00050002633,0.00020654047,0.00041715428,0.00020351486],"domain_scores_gemma":[0.9987339,0.00015693775,0.00032826842,0.00006090872,0.0005484986,0.00017148939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013313653,0.00014441571,0.00050135824,0.00008105747,0.000026782933,0.000029459372,0.00020626714,0.000096614756,0.001497896],"category_scores_gemma":[0.00024876307,0.00010444748,0.00019389871,0.000106474974,0.000033196397,0.000106386986,0.000030133768,0.00022202497,0.0000040941422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00275069,0.0018872098,0.6496746,0.00003483956,0.0009452652,0.00017445319,0.00080166425,0.00046776587,0.00024685654,0.00027550603,0.0064811,0.33626008],"study_design_scores_gemma":[0.011179256,0.001820372,0.9638063,0.00020323442,0.000093593146,0.00000729264,0.00003033288,0.00014570785,0.0005466633,0.00034223727,0.021711929,0.000113116446],"about_ca_topic_score_codex":0.000085094405,"about_ca_topic_score_gemma":0.00006085993,"teacher_disagreement_score":0.33614695,"about_ca_system_score_codex":0.0007731238,"about_ca_system_score_gemma":0.00029579262,"threshold_uncertainty_score":0.99941486},"labels":[],"label_agreement":null},{"id":"W3099179122","doi":"10.1136/ijgc-2020-igcs.394","title":"454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Université Laval; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Medicine; Lymphadenectomy; Endometrial cancer; Ovarian cancer; Lymph node; Ovarian carcinoma; Carcinoma; Retrospective cohort study; Oncology; General surgery; Internal medicine; Radiology; Cancer","score_opus":0.027959555970759078,"score_gpt":0.3217667415991104,"score_spread":0.29380718562835134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099179122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991863,0.00014342698,0.0000054510815,0.0057025133,0.0006040351,0.0013282155,0.00008074223,0.000011538493,0.00026105926],"genre_scores_gemma":[0.9984885,0.000034501183,0.00007041545,0.0007596287,0.00036842827,0.00022377733,0.000009221341,0.000020054369,0.00002551262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970657,0.0001405755,0.0006754427,0.00043215908,0.0014584039,0.00022770962],"domain_scores_gemma":[0.9983388,0.00016062795,0.0004123297,0.00012535758,0.00066817424,0.0002946808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024595286,0.00023742222,0.0005313421,0.0004642062,0.000025080913,0.000075186945,0.0003732465,0.000051717405,0.0007661426],"category_scores_gemma":[0.0005205764,0.00016088662,0.00011720765,0.00043704844,0.00005480266,0.00021103496,0.000096518714,0.0003886565,0.000007312631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00952744,0.013052614,0.9668134,0.000005062638,0.0006622756,0.0056998814,0.0011710718,0.00016989945,0.0000015526222,0.00004790491,0.00004740592,0.0028014912],"study_design_scores_gemma":[0.030539032,0.010774419,0.9575058,0.00010484523,0.00010545275,0.0000034703053,0.00052844465,0.00003228429,0.0000121401,0.000020060728,0.00023160662,0.00014241306],"about_ca_topic_score_codex":0.0001913423,"about_ca_topic_score_gemma":0.00026398338,"teacher_disagreement_score":0.021011591,"about_ca_system_score_codex":0.0020480137,"about_ca_system_score_gemma":0.00035284407,"threshold_uncertainty_score":0.83887243},"labels":[],"label_agreement":null},{"id":"W3099232962","doi":"10.1136/ijgc-2020-igcs.6","title":"6 Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Saskatchewan; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Dalhousie University; McGill University; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Cancer; Radiation therapy; Dissection (medical); Lymph node; Internal medicine; Oncology; Surgery","score_opus":0.028677350325695315,"score_gpt":0.3379426788967647,"score_spread":0.3092653285710694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099232962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98240864,0.0017043294,0.000062572115,0.0110325795,0.00061805197,0.00042231,0.00002843637,0.000010510827,0.003712582],"genre_scores_gemma":[0.9948411,0.002004492,0.000943454,0.0019096984,0.0001932068,0.00007031793,0.000008998696,0.000013805543,0.000014905646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982792,0.00015903355,0.00046530165,0.00024940952,0.0006832092,0.0001638205],"domain_scores_gemma":[0.99815625,0.0005094208,0.0004515272,0.00005701075,0.00070301467,0.00012279494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026216518,0.0001342993,0.00031684994,0.0002463538,0.000016289563,0.000034970297,0.00016616864,0.00011551006,0.00017367561],"category_scores_gemma":[0.0028679913,0.00010632512,0.00004999958,0.00047130344,0.000054139087,0.00012748854,0.000049202827,0.00038371843,6.402845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021831894,0.001133877,0.69566226,0.00012606014,0.002629422,0.00437828,0.006960239,0.009855603,0.038953904,0.0005987764,0.0005970083,0.21727265],"study_design_scores_gemma":[0.0083503565,0.001399896,0.9846199,0.00037831417,0.00023673533,0.000031901083,0.0008718342,0.0004886112,0.0014044382,0.000037605474,0.002008237,0.00017217099],"about_ca_topic_score_codex":0.0002454309,"about_ca_topic_score_gemma":0.00067358196,"teacher_disagreement_score":0.28895763,"about_ca_system_score_codex":0.0019555506,"about_ca_system_score_gemma":0.0003053032,"threshold_uncertainty_score":0.5113697},"labels":[],"label_agreement":null},{"id":"W3099479634","doi":"10.1136/ijgc-2020-igcs.48","title":"49 2D ICRU-based vs 3D image-guided planning in high dose rate brachytherapy for cervical cancer – a study on efficacy and treatment-related toxicities","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cervical cancer; Brachytherapy; Retrospective cohort study; Cancer; Internal medicine; Radiation treatment planning; Oncology; Urology; Radiation therapy","score_opus":0.07767306323443031,"score_gpt":0.39004120486713395,"score_spread":0.31236814163270366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099479634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98009366,0.0008625829,0.000046599143,0.017257722,0.0006210064,0.0008722591,0.00008563774,0.000024408144,0.00013613261],"genre_scores_gemma":[0.99293685,0.0003019779,0.00024028037,0.005572224,0.000635356,0.00019724302,0.00001531159,0.000024378063,0.00007636496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980817,0.00014054921,0.00072630343,0.00033099853,0.00045605085,0.00026439183],"domain_scores_gemma":[0.99781823,0.0011415514,0.00034876802,0.00007579011,0.00035351777,0.0002621482],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002238655,0.00026652822,0.00072592334,0.00021705907,0.000054065335,0.000054761367,0.00018194669,0.00012501016,0.0010876294],"category_scores_gemma":[0.00050688046,0.00017176398,0.0001818133,0.00024786443,0.0000780759,0.00010964672,0.00003064665,0.00029798946,0.0000048231514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12924996,0.009860263,0.7302276,0.00009563674,0.004778977,0.0034962771,0.0028708496,0.009313069,0.011196649,0.0001307659,0.00087287504,0.09790709],"study_design_scores_gemma":[0.08190474,0.021519827,0.89040023,0.00025724902,0.00034828566,0.000023401368,0.00022073946,0.00059834844,0.0026092085,0.00018239909,0.0016853908,0.0002502103],"about_ca_topic_score_codex":0.00022515438,"about_ca_topic_score_gemma":0.00007806782,"teacher_disagreement_score":0.16017261,"about_ca_system_score_codex":0.0008049391,"about_ca_system_score_gemma":0.00027280423,"threshold_uncertainty_score":0.99982554},"labels":[],"label_agreement":null},{"id":"W3099629322","doi":"10.1136/ijgc-2020-igcs.7","title":"7 Sentinel lymph node biopsy versus lymphadenectomy for intermediate and high grade endometrial cancer staging (SENTOR trial): a prospective multicenter cohort study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre; Trillium Health Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Endometrial cancer; Sentinel lymph node; Prospective cohort study; Radiology; Biopsy; Lymph node; Surgery; Cancer; Internal medicine; Breast cancer","score_opus":0.04949678157042836,"score_gpt":0.3649122253469383,"score_spread":0.31541544377650993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099629322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98675543,0.0007111437,0.00017621218,0.0052036988,0.0051210527,0.001788323,0.00013998215,0.0000300594,0.00007411729],"genre_scores_gemma":[0.993111,0.00063337974,0.00032747653,0.0012897375,0.004016414,0.000520974,0.00001357771,0.00002885682,0.000058588572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731433,0.00010402223,0.0008587696,0.0004552697,0.0009416965,0.00032591596],"domain_scores_gemma":[0.9970126,0.0010183916,0.0006298253,0.000092589195,0.00084333756,0.00040325368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000350242,0.00028871335,0.0008600629,0.0002646629,0.00007080706,0.000091605616,0.00029484945,0.000110923,0.00074158324],"category_scores_gemma":[0.0022016023,0.00019916201,0.00033412033,0.00033848465,0.00010392691,0.00018743257,0.0001462676,0.00024241801,0.000004001987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17946178,0.001350013,0.8095496,0.00003050003,0.0031437161,0.00029047165,0.00022034618,0.000025808811,0.00048866053,0.000023094839,0.00008951625,0.0053264354],"study_design_scores_gemma":[0.29198807,0.0022623409,0.7031686,0.00007178088,0.0009108565,0.000014331201,0.00022807177,0.00018684375,0.0005230036,0.000053665997,0.00041213547,0.00018034893],"about_ca_topic_score_codex":0.00027776114,"about_ca_topic_score_gemma":0.000013603106,"teacher_disagreement_score":0.112526275,"about_ca_system_score_codex":0.0010820952,"about_ca_system_score_gemma":0.00027361294,"threshold_uncertainty_score":0.81215906},"labels":[],"label_agreement":null},{"id":"W3099778542","doi":"10.1136/ijgc-2020-igcs.5","title":"5 Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; Juravinski Cancer Centre; Sinai Health System; Princess Margaret Cancer Centre; Toronto Metropolitan University; University Health Network; University of Toronto","funders":"","keywords":"Endometrial cancer; Medicine; Internal medicine; Oncology; Cancer; Uterine cancer; MLH1; Adjuvant therapy; Gastroenterology; DNA mismatch repair","score_opus":0.24793430903422115,"score_gpt":0.44190385154508044,"score_spread":0.1939695425108593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099778542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874691,0.0015205005,0.001176236,0.006305806,0.0017883232,0.00095372467,0.000021559123,0.000016372027,0.0007484179],"genre_scores_gemma":[0.9967043,0.0009020963,0.0005448795,0.0009319549,0.0008062159,0.000082538034,7.9734696e-7,0.000013071399,0.000014160511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969003,0.00022374478,0.0013212261,0.00029930277,0.0010521758,0.00020323278],"domain_scores_gemma":[0.9963257,0.0017890884,0.0008466011,0.0001311873,0.0007956596,0.00011179279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010610775,0.0001575272,0.0006048172,0.00018214907,0.00003920111,0.00002041793,0.0004712039,0.000121787736,0.0008558126],"category_scores_gemma":[0.0053343414,0.00009647168,0.00035101877,0.00086808647,0.0002074082,0.00011089817,0.00013017192,0.00066466647,0.0000022770575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040719346,0.0009861868,0.98702097,0.000018222094,0.0004677899,0.000085675274,0.0018813283,0.0006271518,0.0015545477,0.0002680061,0.00078005844,0.002238115],"study_design_scores_gemma":[0.010413225,0.0063884645,0.97556907,0.000101096,0.00023708421,0.000048589256,0.002803599,0.00019672884,0.0016241277,0.0015423546,0.00092478323,0.00015085681],"about_ca_topic_score_codex":0.00012426768,"about_ca_topic_score_gemma":0.00016400302,"teacher_disagreement_score":0.0114518935,"about_ca_system_score_codex":0.0012680418,"about_ca_system_score_gemma":0.0006312658,"threshold_uncertainty_score":0.9370548},"labels":[],"label_agreement":null},{"id":"W3099824724","doi":"10.1136/ijgc-2020-001991","title":"Efficacy of pre-operative pharmacologic thromboprophylaxis on incidence of venous thromboembolism following major gynecologic and gynecologic oncology surgery: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Occupational Cancer Research Centre","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Medicine; Gynecologic oncology; Venous thromboembolism; Incidence (geometry); Meta-analysis; Gynecologic cancer; Oncology; Surgery; Internal medicine; Cancer; Thrombosis; Ovarian cancer","score_opus":0.0876702949193393,"score_gpt":0.4349096519962064,"score_spread":0.3472393570768671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099824724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005346235,0.98816586,0.000022846418,0.0017123983,0.000568605,0.0038416903,0.00014369762,0.00002075325,0.00017791495],"genre_scores_gemma":[0.096567586,0.89985156,0.00026139387,0.0025870008,0.000105688494,0.000531035,0.000022410082,0.000035708093,0.000037626716],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99257565,0.0013841596,0.003721997,0.0007639487,0.0011511293,0.0004031313],"domain_scores_gemma":[0.98488754,0.007945754,0.0055844327,0.00034623838,0.0009221654,0.00031384238],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002329966,0.0007988389,0.021586062,0.00084289286,0.00008701968,0.000043095806,0.0007942123,0.00051405956,0.0021604234],"category_scores_gemma":[0.005507738,0.00045884744,0.0046682656,0.0008936336,0.00037807084,0.00015504115,0.0004748251,0.0009591239,0.0000067313017],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029475897,0.0049353517,0.00013814257,0.28925335,0.6602979,0.0024921624,0.00039960758,0.000056309622,0.000015214054,0.00027778684,0.0012299176,0.040609516],"study_design_scores_gemma":[0.0011033741,0.005851974,0.0039006716,0.019106803,0.9605172,0.00022612669,0.00006698343,0.000011387253,0.000016217684,0.00010949656,0.008581395,0.0005083658],"about_ca_topic_score_codex":0.00005815004,"about_ca_topic_score_gemma":0.000032028773,"teacher_disagreement_score":0.30021933,"about_ca_system_score_codex":0.00077873614,"about_ca_system_score_gemma":0.00089861907,"threshold_uncertainty_score":0.9997863},"labels":[],"label_agreement":null},{"id":"W3099978515","doi":"10.1136/ijgc-2020-igcs.246","title":"286 Barriers and opportunities for optimizing pathology mentoring in the project ECHO tumor board program of the IGC:A pilot examination of adequacy of pathology case presentations","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Presentation (obstetrics); Medicine; Curriculum; Attendance; Medical education; TUTOR; Pathology; Medical physics; Radiology; Psychology","score_opus":0.1218558182626412,"score_gpt":0.4346024382820864,"score_spread":0.3127466200194452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099978515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088717,0.00067860127,0.0011648366,0.00590606,0.0004129723,0.0006201546,0.000032987602,0.0000035411285,0.00029370765],"genre_scores_gemma":[0.9935061,0.000717869,0.0045989505,0.0008943621,0.00016599885,0.00009174601,0.0000017124263,0.000005445465,0.00001785192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988298,0.00023842268,0.0005242001,0.00009710789,0.00020977065,0.00010070217],"domain_scores_gemma":[0.99806315,0.00082814,0.00063423166,0.00005791362,0.00037792607,0.00003861667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058326666,0.00007665923,0.00029354013,0.00009247426,0.000035903216,0.0000042258357,0.00019984717,0.00005758256,0.00005626535],"category_scores_gemma":[0.0011491834,0.000042705495,0.00008631726,0.000087120774,0.00038183056,0.00009024078,0.000038139628,0.0002093195,1.3771158e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015624501,0.004628584,0.29333135,0.0011294225,0.002170914,0.016044829,0.071396895,0.007986031,0.059474785,0.015117871,0.0015323365,0.51156247],"study_design_scores_gemma":[0.046070483,0.07467136,0.64273584,0.0012592245,0.0016657161,0.031093292,0.11809877,0.013186947,0.04117687,0.0047324123,0.024433421,0.00087568094],"about_ca_topic_score_codex":0.000010011227,"about_ca_topic_score_gemma":0.000024374249,"teacher_disagreement_score":0.5106868,"about_ca_system_score_codex":0.00006207026,"about_ca_system_score_gemma":0.00022233075,"threshold_uncertainty_score":0.17414795},"labels":[],"label_agreement":null},{"id":"W3100331039","doi":"10.1136/ijgc-2020-igcs.200","title":"234 Addressing variation in preoperative workup of high-grade endometrial carcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carcinosarcoma; Stage (stratigraphy); Radiology; Serous fluid; Pathological; Debulking; Retrospective cohort study; Carcinoma; Cohort; Cancer; Internal medicine; Oncology; Ovarian cancer","score_opus":0.08376450979262559,"score_gpt":0.356233080358292,"score_spread":0.2724685705656664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100331039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920673,0.0010505398,0.00037158214,0.00757427,0.00109236,0.00020905423,0.000033008986,0.0000066470384,0.00045578968],"genre_scores_gemma":[0.99618393,0.0002634564,0.0010695381,0.0012069476,0.0012203667,0.000014099603,0.0000061015553,0.000008295753,0.00002727659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981821,0.00010678591,0.00071611704,0.0001655536,0.0006854058,0.0001440045],"domain_scores_gemma":[0.9982258,0.000558832,0.00047153016,0.000049518578,0.0005350994,0.00015923397],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022006426,0.00012288144,0.00052073156,0.0002514551,0.000016800837,0.000019939203,0.00021003652,0.000104599094,0.0020429979],"category_scores_gemma":[0.0019246916,0.00008423757,0.00017983073,0.00049830886,0.000054806766,0.00015187328,0.000056111723,0.00031863785,0.0000041529483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02285591,0.0019659742,0.89375466,0.000086761596,0.001388573,0.0013309992,0.0015554944,0.002217548,0.02104781,0.001291408,0.0006342861,0.051870573],"study_design_scores_gemma":[0.015788374,0.002121108,0.9723784,0.00015510715,0.00013586885,0.000026786536,0.000074655145,0.00016435455,0.008000133,0.0005415705,0.0005143697,0.00009930351],"about_ca_topic_score_codex":0.0001933497,"about_ca_topic_score_gemma":0.000027840688,"teacher_disagreement_score":0.078623705,"about_ca_system_score_codex":0.0004571744,"about_ca_system_score_gemma":0.0002558145,"threshold_uncertainty_score":0.99886924},"labels":[],"label_agreement":null},{"id":"W3100488932","doi":"10.1136/ijgc-2020-001893","title":"FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Medicine; Stage (stratigraphy); Gynecology; Oncology; Adenocarcinoma; Internal medicine; Cancer","score_opus":0.06971726341461665,"score_gpt":0.377827949961027,"score_spread":0.30811068654641033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100488932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900631,0.00034330934,0.00004724986,0.0066488273,0.0012662215,0.00046249814,0.00019614535,0.00002276793,0.00094993494],"genre_scores_gemma":[0.9960581,0.00025354227,0.00028187415,0.002710851,0.00048332862,0.000037356895,0.000042477255,0.000016288779,0.00011620206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703425,0.00008913492,0.0010215433,0.00026509754,0.0013653416,0.00022462099],"domain_scores_gemma":[0.99744177,0.00054135825,0.0006562763,0.00011861352,0.0008140609,0.00042791106],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001840836,0.00022452243,0.0006289563,0.00019657759,0.00003195943,0.000043530807,0.00066205254,0.000113182585,0.005603661],"category_scores_gemma":[0.0017553188,0.0001479936,0.00025834056,0.0002545237,0.00009550491,0.0003619212,0.00014488639,0.0003289833,0.000012640017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042564254,0.002760686,0.9754469,0.000028288634,0.0023999421,0.000409115,0.00047744348,0.00006133975,0.00054118683,0.000039877472,0.0014694356,0.012109364],"study_design_scores_gemma":[0.015274271,0.009195951,0.9637107,0.00005557446,0.0003101313,0.000043001008,0.0010337294,0.00017237997,0.0007322811,0.000047193593,0.00924663,0.00017815933],"about_ca_topic_score_codex":0.00015199292,"about_ca_topic_score_gemma":0.00005908143,"teacher_disagreement_score":0.011931204,"about_ca_system_score_codex":0.00044748312,"about_ca_system_score_gemma":0.00029004697,"threshold_uncertainty_score":0.99530536},"labels":[],"label_agreement":null},{"id":"W3100904250","doi":"10.1136/ijgc-2020-igcs.40","title":"40 Integrated model of patient factors, resectability score and surgical complexity index to predict surgical outcome in debulking surgery for advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Medicine; Surgery; Ovarian cancer; Cancer; Internal medicine","score_opus":0.12257249512661651,"score_gpt":0.36861874435782177,"score_spread":0.24604624923120527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100904250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507434,0.0005488252,0.0005436684,0.012407776,0.000466331,0.00054283446,0.00036231527,0.00001192997,0.00004196332],"genre_scores_gemma":[0.9979603,0.00032789007,0.0007241566,0.0006466013,0.00019554308,0.00010302967,0.000020529838,0.000015178138,0.000006747757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755764,0.00009949388,0.0011305739,0.00034244376,0.00060909986,0.00026076974],"domain_scores_gemma":[0.99712074,0.0011872408,0.00044231743,0.00009354521,0.0007808395,0.00037531706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041692922,0.00021741724,0.00091027067,0.00017029405,0.000032246815,0.000022978988,0.00017512073,0.00014014351,0.00048071923],"category_scores_gemma":[0.0010850064,0.00014678731,0.0002864204,0.00021472941,0.00012415322,0.0001229173,0.000102072,0.00035376791,2.6025174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00812211,0.00054150535,0.9658466,0.00006189646,0.00025877438,0.00023908474,0.00027634777,0.0061955377,0.000116152594,0.00020041417,0.00017380543,0.017967783],"study_design_scores_gemma":[0.0072663263,0.001369788,0.9734597,0.00048039458,0.000107259104,0.00004282705,0.00014741435,0.0122633325,0.0012017676,0.0004692565,0.00296764,0.00022427454],"about_ca_topic_score_codex":0.0003381121,"about_ca_topic_score_gemma":0.00031582903,"teacher_disagreement_score":0.01774351,"about_ca_system_score_codex":0.00079113996,"about_ca_system_score_gemma":0.0005042957,"threshold_uncertainty_score":0.59858125},"labels":[],"label_agreement":null},{"id":"W3100944217","doi":"10.1136/ijgc-2020-igcs.88","title":"97 Practicing knowledge translation: building awareness and assessing barriers and facilitators to provincial implementation of the proactive molecular risk classifier for endometrial cancer (ProMisE)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Women's Health Research Institute","funders":"","keywords":"Focus group; Thematic analysis; Psychology; Knowledge translation; Medical education; Computer science; Medicine; Knowledge management; Qualitative research; Sociology","score_opus":0.21098755489678056,"score_gpt":0.5310677374330005,"score_spread":0.32008018253621995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100944217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732822,0.0003175993,0.012706369,0.012111899,0.0005299977,0.00084501103,0.00008686862,0.0000077468585,0.000112271075],"genre_scores_gemma":[0.99641347,0.0001445631,0.0027884794,0.00015528407,0.00037514712,0.00011061295,3.4582135e-7,0.000006612381,0.000005508354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983275,0.00035317833,0.0003810011,0.00017257434,0.00060265476,0.00016311233],"domain_scores_gemma":[0.99717855,0.0013315666,0.00042993503,0.0000322645,0.0008574102,0.00017026831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013267315,0.00008205415,0.00018901461,0.00011276434,0.00024414287,0.00011717314,0.00029019266,0.00007978933,0.00012576279],"category_scores_gemma":[0.0056846635,0.000061453204,0.00008572191,0.00026347736,0.00018250731,0.00036676324,0.00007531852,0.00023459633,8.577599e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011512255,0.000057135407,0.21934547,0.000052523472,0.0004750319,0.000010829169,0.020107921,0.00044450117,0.032957617,0.0022595203,0.00026149096,0.7228767],"study_design_scores_gemma":[0.019549575,0.0037495813,0.51719725,0.0007523992,0.0011214393,0.00002156835,0.112490796,0.0051114634,0.23043513,0.014576354,0.09349977,0.001494689],"about_ca_topic_score_codex":0.0009521954,"about_ca_topic_score_gemma":0.0010874418,"teacher_disagreement_score":0.721382,"about_ca_system_score_codex":0.00040230987,"about_ca_system_score_gemma":0.0011720721,"threshold_uncertainty_score":0.68054837},"labels":[],"label_agreement":null},{"id":"W3101493270","doi":"10.1136/ijgc-2020-igcs.235","title":"273 Project echo: 2-years experience in Belarus","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Videoconferencing; Medicine; Session (web analytics); Curriculum; Mentorship; Medical education; General partnership; Competence (human resources); Echo (communications protocol); Alliance; Family medicine; Medical physics; Psychology; Telecommunications; Computer science; Political science","score_opus":0.22414058052562716,"score_gpt":0.453145224466401,"score_spread":0.22900464394077383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101493270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885515,0.0008065689,0.00012246275,0.008062335,0.00055345456,0.000116791925,0.0000061228625,0.000011271078,0.001769481],"genre_scores_gemma":[0.9894384,0.00044730544,0.000955828,0.008512314,0.0005862341,0.0000126505065,0.0000012405341,0.0000056308345,0.000040379608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985787,0.000032388856,0.00043098078,0.00015083616,0.0006420142,0.00016505187],"domain_scores_gemma":[0.99919266,0.00008274434,0.00020416504,0.000047775346,0.00033562732,0.00013701906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017106696,0.00008900141,0.000257196,0.00009227063,0.000013621329,0.00002670619,0.00031796316,0.00007643068,0.0011359089],"category_scores_gemma":[0.0008124256,0.00006759764,0.00012240322,0.00020422734,0.000059096736,0.0001905276,0.0000668199,0.0003688947,0.000011151099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003454577,0.0002424277,0.88682586,0.000017425124,0.00019638053,0.0065795253,0.0036465202,0.000756527,0.008111131,0.00030683907,0.007432871,0.08242993],"study_design_scores_gemma":[0.0036952638,0.00168796,0.9238213,0.00028672212,0.00004115252,0.0004543706,0.0015173369,0.00052197237,0.0016130263,0.00025607794,0.065901116,0.0002037472],"about_ca_topic_score_codex":0.00013691724,"about_ca_topic_score_gemma":0.00005041831,"teacher_disagreement_score":0.08222619,"about_ca_system_score_codex":0.00033616982,"about_ca_system_score_gemma":0.0002977367,"threshold_uncertainty_score":0.9997772},"labels":[],"label_agreement":null},{"id":"W3101563407","doi":"10.1136/ijgc-2020-igcs.320","title":"370 The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Cytoreductive surgery; Chemotherapy; Ovarian cancer; Oncology; Retrospective cohort study; Stage (stratigraphy); Surgery; Serous fluid; Neoadjuvant therapy; Internal medicine; Cancer; Breast cancer","score_opus":0.03406802900001799,"score_gpt":0.32576368770970804,"score_spread":0.29169565870969005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101563407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488738,0.0019242412,0.000021664611,0.047730792,0.00085967884,0.00016352131,0.00021607726,0.000004022921,0.00020615982],"genre_scores_gemma":[0.9910191,0.006008717,0.00023921908,0.0019788775,0.000711326,0.000015110264,0.0000043686655,0.000011824968,0.0000114539025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986359,0.000059468366,0.0004887363,0.00016712432,0.00052518345,0.00012357144],"domain_scores_gemma":[0.9978821,0.00078619045,0.00059838674,0.000084568615,0.000505113,0.00014359226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017284998,0.00013627988,0.0005378853,0.000057471316,0.000022198077,0.000011683547,0.00015572843,0.00006796978,0.0013379401],"category_scores_gemma":[0.0003462328,0.000075576034,0.00020204175,0.00009975858,0.00013343323,0.00007335646,0.00003259987,0.00020748109,0.0000010606207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010608622,0.0009394608,0.8499605,0.000036174726,0.0033614365,0.00021132265,0.001079905,0.00043620018,0.009460072,0.0008063058,0.0033152662,0.11978475],"study_design_scores_gemma":[0.0036756026,0.0010411888,0.97385335,0.0002824347,0.00014352094,0.000009287587,0.0002565129,0.000027313614,0.01823832,0.00028758062,0.0021053886,0.000079473495],"about_ca_topic_score_codex":0.00041575625,"about_ca_topic_score_gemma":0.000052649793,"teacher_disagreement_score":0.123892896,"about_ca_system_score_codex":0.00023307337,"about_ca_system_score_gemma":0.00034594582,"threshold_uncertainty_score":0.99957496},"labels":[],"label_agreement":null},{"id":"W3102241214","doi":"10.1136/ijgc-2020-igcs.20","title":"20 Long-term survival outcomes of intravenous vs intraperitoneal chemotherapy in the treatment of advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Internal medicine; Serous fluid; Proportional hazards model; Stage (stratigraphy); Oncology; Retrospective cohort study; Surgery; Cancer; Gastroenterology","score_opus":0.03785718218444149,"score_gpt":0.35207448689682785,"score_spread":0.31421730471238635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102241214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94839907,0.0019311607,0.00003740581,0.04827284,0.0007737018,0.0003256507,0.00007646861,0.0000045139186,0.00017916708],"genre_scores_gemma":[0.98669535,0.010167436,0.0002587056,0.0022920272,0.00048391146,0.000060792107,0.0000067938436,0.000012123928,0.000022838669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828553,0.00007160099,0.00071197894,0.00017549154,0.00058657856,0.00016883702],"domain_scores_gemma":[0.9986045,0.00032526918,0.0005064785,0.00010857375,0.00034847794,0.000106732055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001322735,0.0001800326,0.0007365495,0.00008337433,0.000016740127,0.000013153853,0.00029545944,0.00008417942,0.0015776918],"category_scores_gemma":[0.00006708133,0.00009932938,0.00029178557,0.00014929823,0.0001065162,0.00006919375,0.000016230919,0.00016203262,0.0000011751123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003139028,0.0028049978,0.8470259,0.000027437301,0.0013376646,0.0004546849,0.0018761854,0.0003750374,0.0011856128,0.00018268586,0.00007945451,0.14151134],"study_design_scores_gemma":[0.008558178,0.0044053434,0.98043865,0.00009732883,0.00016930744,0.000026260352,0.00014433487,0.000019028801,0.0036824723,0.000049988477,0.0023245262,0.000084571686],"about_ca_topic_score_codex":0.00018243614,"about_ca_topic_score_gemma":0.000333277,"teacher_disagreement_score":0.14142677,"about_ca_system_score_codex":0.0004962028,"about_ca_system_score_gemma":0.00029901596,"threshold_uncertainty_score":0.999335},"labels":[],"label_agreement":null},{"id":"W3102299777","doi":"10.1136/ijgc-2020-002122","title":"MEK inhibition for low-grade serous ovarian cancer: are we there yet?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Serous fluid; Serous ovarian cancer; Ovarian cancer; Oncology; Disease; Cancer; Internal medicine; Gynecology","score_opus":0.07077248093687619,"score_gpt":0.3541726584955367,"score_spread":0.28340017755866054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102299777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.586086,0.0063053826,0.0010212597,0.4027032,0.0024792347,0.00059656147,0.00035516117,0.000036842994,0.00041637587],"genre_scores_gemma":[0.9810363,0.005958782,0.00082140986,0.009944013,0.0019487282,0.00014699319,0.000013218752,0.00002046488,0.000110093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985827,0.00003440688,0.00047730186,0.00022428056,0.00048687772,0.00019438616],"domain_scores_gemma":[0.9982969,0.00022651882,0.0004934122,0.0000677673,0.0006690259,0.00024633837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011627523,0.00016623421,0.00041329244,0.00006547871,0.00004797496,0.000045933528,0.00016707063,0.00011609221,0.0026555602],"category_scores_gemma":[0.0002033839,0.00011502482,0.0002916975,0.00010366238,0.000048473783,0.00012607992,0.000037906415,0.00024701803,0.000009395572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011859828,0.0048181703,0.39180174,0.00058205053,0.008007932,0.006299888,0.0019989018,0.0053430623,0.008682281,0.0055777184,0.2276268,0.32740164],"study_design_scores_gemma":[0.030697212,0.0056640473,0.54688513,0.002497111,0.0012681235,0.00037437945,0.00070571015,0.0013424102,0.021842757,0.0046343417,0.3834046,0.0006841416],"about_ca_topic_score_codex":0.0000528128,"about_ca_topic_score_gemma":0.00009755586,"teacher_disagreement_score":0.39495033,"about_ca_system_score_codex":0.0006676601,"about_ca_system_score_gemma":0.00031058802,"threshold_uncertainty_score":0.99825615},"labels":[],"label_agreement":null},{"id":"W3102390828","doi":"10.1136/ijgc-2020-igcs.1","title":"1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Javelin; Avelumab; Ovarian cancer; Oncology; Medicine; Chemotherapy; Internal medicine; Biomarker; Cancer; Immunotherapy; Biology; Nivolumab","score_opus":0.0672957544888583,"score_gpt":0.3820117891237232,"score_spread":0.31471603463486486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102390828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95619744,0.00049751025,0.00013657368,0.04192642,0.00030090386,0.000799663,0.00007582315,0.000008485477,0.00005718989],"genre_scores_gemma":[0.9930378,0.0013062344,0.0006514257,0.0044409707,0.00032836653,0.00014698933,0.000040445033,0.000022346363,0.000025392685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982651,0.00010829783,0.0005495332,0.000316081,0.00056396745,0.00019701074],"domain_scores_gemma":[0.99872977,0.000376625,0.00041329305,0.0000972419,0.00024161616,0.00014144351],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014845218,0.00024851874,0.00059830886,0.00012908413,0.000049730083,0.00006832187,0.00017940089,0.0000981389,0.0013668401],"category_scores_gemma":[0.00009862836,0.000119732504,0.00013450104,0.0003079793,0.000077408724,0.00017405223,0.000018141342,0.00021301971,0.0000010056963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19548029,0.003664144,0.6638776,0.0000043256,0.0022743854,0.00047767322,0.0010689868,0.00008477761,0.00009659546,0.000019587234,0.00022177205,0.13272986],"study_design_scores_gemma":[0.2635332,0.008010595,0.7252169,0.00020861294,0.00023456647,0.000005786344,0.0001305123,0.0003524648,0.00030512147,0.000046610203,0.0018205318,0.00013505001],"about_ca_topic_score_codex":0.0018296705,"about_ca_topic_score_gemma":0.001291336,"teacher_disagreement_score":0.13259481,"about_ca_system_score_codex":0.0010046771,"about_ca_system_score_gemma":0.00045018047,"threshold_uncertainty_score":0.99954605},"labels":[],"label_agreement":null},{"id":"W3102925784","doi":"10.1136/ijgc-2020-igcs.17","title":"17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McGill University","funders":"","keywords":"Medicine; Population; Adverse effect; Placebo; Clinical endpoint; Internal medicine; Oncology; Randomized controlled trial; Pathology","score_opus":0.04570199330148044,"score_gpt":0.34951643181102754,"score_spread":0.3038144385095471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102925784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97035956,0.00027344894,0.00004545912,0.026918337,0.00093880645,0.00047945356,0.000017370885,0.0000086401105,0.0009589475],"genre_scores_gemma":[0.98586524,0.00040786713,0.00016258814,0.01317391,0.0003236065,0.000030807274,0.000006106872,0.000009503963,0.00002035931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975852,0.00016588194,0.0010487319,0.0001970129,0.00081758783,0.00018563318],"domain_scores_gemma":[0.99832207,0.0005369482,0.0005934483,0.00008491888,0.0003469549,0.00011566795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045864654,0.00014763985,0.0004483501,0.00013790555,0.000030410674,0.000034644858,0.00024138081,0.00010828785,0.000668517],"category_scores_gemma":[0.0014471669,0.00009151591,0.00013038202,0.00018555172,0.00008064343,0.0001729533,0.000055508768,0.00056839833,0.0000022642637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037486523,0.00074091676,0.91286504,0.000007713116,0.00021219887,0.0002741452,0.0015535572,0.0001475944,0.00012145649,0.00006846685,0.0018888075,0.044633586],"study_design_scores_gemma":[0.051682837,0.0017112219,0.93247604,0.000097271084,0.000029236528,0.000027936332,0.00016445755,0.000051997235,0.000064723514,0.00018074788,0.013406676,0.00010682886],"about_ca_topic_score_codex":0.000030260582,"about_ca_topic_score_gemma":0.000054638676,"teacher_disagreement_score":0.04452676,"about_ca_system_score_codex":0.00048347787,"about_ca_system_score_gemma":0.00017855664,"threshold_uncertainty_score":0.73197925},"labels":[],"label_agreement":null},{"id":"W3103484839","doi":"10.1136/ijgc-2020-igcs.28","title":"28 Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in the combined PORTEC-1,-2 and -3 endometrial cancer trials","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Endometrial cancer; Lynch syndrome; Medicine; MLH1; MSH2; Population; Internal medicine; Oncology; PMS2; Gastroenterology; Cancer; Urology; DNA mismatch repair","score_opus":0.07595434010128699,"score_gpt":0.3549393646963157,"score_spread":0.2789850245950287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103484839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777551,0.011631868,0.0000110842975,0.009355658,0.00047576186,0.0006504755,0.000039129427,0.000007725571,0.00007318969],"genre_scores_gemma":[0.99109006,0.0072242008,0.00039162475,0.0010205666,0.00018428778,0.00006590964,9.182883e-7,0.000007851911,0.000014610409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978273,0.00020097668,0.0009021274,0.00023493837,0.00067994517,0.0001547226],"domain_scores_gemma":[0.9975268,0.0013290237,0.0006148328,0.00006518995,0.00032467218,0.00013944988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013886845,0.00014722516,0.00067260617,0.00015110054,0.000026335627,0.000026228552,0.0002217694,0.000109187495,0.0005060873],"category_scores_gemma":[0.003254101,0.000087967084,0.00012210662,0.0002517428,0.00025450755,0.00008222333,0.000085659936,0.0003207681,2.4107004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027767872,0.00024562172,0.98076224,0.0002280935,0.00025101594,0.0003547366,0.0008783245,0.000027754779,0.0031716896,0.000084729414,0.0005538781,0.010665116],"study_design_scores_gemma":[0.005379723,0.0033669241,0.98782575,0.00026872256,0.0002622668,0.000505258,0.00018615137,0.00017463448,0.0008860242,0.00027573833,0.0007548464,0.000113941984],"about_ca_topic_score_codex":0.000061050705,"about_ca_topic_score_gemma":0.00003150816,"teacher_disagreement_score":0.0133349225,"about_ca_system_score_codex":0.00012247414,"about_ca_system_score_gemma":0.00022866299,"threshold_uncertainty_score":0.55413014},"labels":[],"label_agreement":null},{"id":"W3103813253","doi":"10.1136/ijgc-2020-igcs.366","title":"421 Prevalence of cachexia in treatment-naïve patients with gynaecological cancer: a systematic review","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CINAHL; Cachexia; Cochrane Library; Cervical cancer; Cancer; MEDLINE; Gynaecological cancer; Cancer cachexia; Meta-analysis; Population; Quality of life (healthcare); Systematic review; Psychological intervention; Internal medicine; Intensive care medicine","score_opus":0.018528454080830706,"score_gpt":0.3270104976709971,"score_spread":0.3084820435901664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103813253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016447253,0.99663377,0.000009537408,0.00010016953,0.0005569171,0.0008075239,0.00016569857,0.0000026522089,0.00007898982],"genre_scores_gemma":[0.0043035946,0.9948392,0.000080300226,0.00026154838,0.00023527752,0.00013861585,0.000039593848,0.000018772424,0.00008311161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979199,0.00023192087,0.0010278601,0.0002819724,0.00038779396,0.00015051855],"domain_scores_gemma":[0.9976671,0.00010664446,0.0015267633,0.00014064297,0.0004746769,0.00008421234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015469082,0.0002919339,0.001615812,0.000081509235,0.000014541919,0.000013112583,0.00052088517,0.000263335,0.00056824984],"category_scores_gemma":[0.00048836175,0.00015836419,0.00043790066,0.00012837761,0.00006986306,0.000009192788,0.00008362432,0.00025491705,0.0000031405764],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006234806,0.00088721624,0.011013975,0.40608177,0.0043035294,0.00029273648,0.00004357133,0.000043513464,0.000020584583,0.000044728386,0.0011840285,0.57546085],"study_design_scores_gemma":[0.0034153082,0.008238876,0.012304573,0.30522558,0.007393488,0.00019165213,0.000016120579,0.0000051191414,0.00003309074,0.0000305825,0.66225183,0.00089380087],"about_ca_topic_score_codex":0.0000130481185,"about_ca_topic_score_gemma":0.000041897583,"teacher_disagreement_score":0.6610678,"about_ca_system_score_codex":0.0004219856,"about_ca_system_score_gemma":0.00044337046,"threshold_uncertainty_score":0.64579046},"labels":[],"label_agreement":null},{"id":"W3104847006","doi":"10.1136/ijgc-2020-igcs.11","title":"11 Oncologic outcomes and role of adjuvant therapy in endometrial cancer patients with low volume metastasis in the sentinel lymph nodes: an international multi-institutional study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Oncology; Metastasis; Stage (stratigraphy); Radiation therapy; Adjuvant therapy; Lymphovascular invasion; Cancer; Gastroenterology; Urology","score_opus":0.046458993023498374,"score_gpt":0.3512879785825601,"score_spread":0.30482898555906174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104847006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953942,0.0005728164,0.000021165366,0.0028449306,0.00047768798,0.00050740194,0.00011064733,0.00000605998,0.000065096996],"genre_scores_gemma":[0.9969355,0.0006151608,0.00026219958,0.001776166,0.0002849485,0.00008962393,0.000018408715,0.000009354475,0.000008640516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997461,0.0001970066,0.000773781,0.0002700012,0.0011150666,0.0001831448],"domain_scores_gemma":[0.9982901,0.0004064106,0.0004717437,0.000079796744,0.00061719306,0.00013474948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004277598,0.00021233685,0.00065761124,0.00032737077,0.00003191352,0.000037105336,0.00045794537,0.00007716057,0.00082572893],"category_scores_gemma":[0.0007613951,0.00010484233,0.00014888367,0.00043439431,0.00012630929,0.00028009308,0.00007577249,0.00027521132,0.000001236431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005131187,0.005118116,0.9612964,0.000006305004,0.00058236,0.00018734053,0.000563404,0.0004871424,0.00009489696,0.000025857773,0.0000056379317,0.026501369],"study_design_scores_gemma":[0.036217205,0.0016921633,0.9606002,0.000049886294,0.0000958953,0.000010244089,0.0005696981,0.0002993456,0.00006159728,0.000027065455,0.00027331107,0.000103371174],"about_ca_topic_score_codex":0.00068962807,"about_ca_topic_score_gemma":0.000338536,"teacher_disagreement_score":0.031086018,"about_ca_system_score_codex":0.00045236133,"about_ca_system_score_gemma":0.00027632565,"threshold_uncertainty_score":0.90411526},"labels":[],"label_agreement":null},{"id":"W3105065440","doi":"10.1136/ijgc-2020-igcs.292","title":"340 Performance characteristics of screening strategies to identify Lynch syndrome in women with non-serous and non-mucinous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Juravinski Cancer Centre; Trillium Health Centre; University Health Network; Toronto Metropolitan University; Health Sciences Centre; Princess Margaret Cancer Centre; Mount Sinai Hospital; McMaster University; Sunnybrook Health Science Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Lynch syndrome; Microsatellite instability; MLH1; MSH2; MSH6; Medicine; PMS2; Oncology; Serous fluid; Endometrial cancer; Internal medicine; Family history; Ovarian cancer; Cancer; Population; Gynecology; Germline mutation; Colorectal cancer; Biology; Mutation; Genetics; DNA mismatch repair; Microsatellite","score_opus":0.023448248199516842,"score_gpt":0.31238430159075237,"score_spread":0.2889360533912355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105065440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949196,0.00018371358,0.0007316225,0.0032599934,0.00045790192,0.00024698648,0.000029244116,0.0000067386723,0.0001641887],"genre_scores_gemma":[0.9958952,0.00052877323,0.001542241,0.0016887351,0.0002517417,0.000051699666,0.0000014576588,0.000017939296,0.000022224382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823856,0.000025494413,0.00060904206,0.00022697366,0.0006382229,0.00026167373],"domain_scores_gemma":[0.99854374,0.00011327167,0.00039115147,0.00007732646,0.0006105157,0.0002640165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022077259,0.00017918095,0.0005527223,0.00016579333,0.000024992689,0.00004695196,0.0002919848,0.000103625396,0.00069156836],"category_scores_gemma":[0.000153959,0.00013181649,0.000047003065,0.00023423758,0.00009962418,0.00017741759,0.00010522141,0.00040657067,0.0000021811227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009023825,0.00020807625,0.89704686,0.00021863326,0.0005758539,0.001162394,0.0032201852,0.0041584712,0.021481203,0.000010095111,0.00015596848,0.062738426],"study_design_scores_gemma":[0.0021625946,0.0034288054,0.9912077,0.0004732163,0.000045677494,0.00022296036,0.00042800483,0.0005021044,0.0011065862,0.000014711141,0.0002648529,0.0001427405],"about_ca_topic_score_codex":0.0001249163,"about_ca_topic_score_gemma":0.00007371093,"teacher_disagreement_score":0.09416088,"about_ca_system_score_codex":0.00041507787,"about_ca_system_score_gemma":0.00046462315,"threshold_uncertainty_score":0.75721884},"labels":[],"label_agreement":null},{"id":"W3105158144","doi":"10.1136/ijgc-2020-igcs.226","title":"263 Discordant mismatch repair protein expression in synchronous endometrial and ovarian cancers","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; Juravinski Cancer Centre; Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"MSH6; MSH2; Lynch syndrome; PMS2; MLH1; Endometrial cancer; Immunohistochemistry; Medicine; Oncology; Concordance; Ovarian cancer; Internal medicine; Endometrium; Germline mutation; Cancer; Gynecology; Biology; Mutation; DNA mismatch repair; Genetics","score_opus":0.02940242640058891,"score_gpt":0.31186227026493707,"score_spread":0.28245984386434814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105158144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788506,0.0016591154,0.00032737004,0.008142965,0.0011498152,0.0003938858,0.00001694992,0.000020513142,0.00040432907],"genre_scores_gemma":[0.99278915,0.00054062845,0.0042655687,0.0013657387,0.0009200583,0.000046558624,0.000001876322,0.000014248711,0.000056150402],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982006,0.00008197318,0.0006124858,0.00025347556,0.0006459824,0.00020548764],"domain_scores_gemma":[0.9988423,0.00021892434,0.00032165003,0.00007371673,0.00028544862,0.00025797472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026275753,0.00015721777,0.0004270711,0.00015515191,0.000024855188,0.000027804323,0.0002269302,0.000098293836,0.0014822545],"category_scores_gemma":[0.0015648186,0.00011147936,0.0001525276,0.0001939859,0.00010584147,0.00010528887,0.00011730812,0.0004665694,0.0000031554537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026375571,0.00075137056,0.34824187,0.0002922944,0.0009127457,0.005958116,0.0020294376,0.0025715118,0.54166996,0.0001697633,0.005928567,0.065098755],"study_design_scores_gemma":[0.03472467,0.012852897,0.76740766,0.002046794,0.00027814027,0.0011204628,0.0010440776,0.003243752,0.12636891,0.0012093475,0.048717823,0.0009854708],"about_ca_topic_score_codex":0.00011547548,"about_ca_topic_score_gemma":0.00007394333,"teacher_disagreement_score":0.41916576,"about_ca_system_score_codex":0.00090827164,"about_ca_system_score_gemma":0.00053891353,"threshold_uncertainty_score":0.99943054},"labels":[],"label_agreement":null},{"id":"W3105684072","doi":"10.1136/ijgc-2020-igcs.3","title":"3 Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Internal medicine; Medicine; Oncology; Ovarian cancer; BRCA mutation; Placebo; Nausea; Clinical endpoint; Cancer; Clinical trial; Pathology","score_opus":0.05720377875601789,"score_gpt":0.3614086970169437,"score_spread":0.3042049182609258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105684072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128675,0.00005190086,0.00008224489,0.007307947,0.00029993124,0.0006891554,0.00020252744,0.000011166679,0.000068370646],"genre_scores_gemma":[0.9978473,0.000008697073,0.00021132588,0.0016590406,0.00016068398,0.000030699506,0.00005248697,0.000017365754,0.0000124028265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977327,0.00021138597,0.00068288477,0.00022198498,0.000995054,0.00015601779],"domain_scores_gemma":[0.99661255,0.0010983951,0.00088953297,0.0001040502,0.0011694279,0.00012605236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019016332,0.00018481821,0.00049638475,0.00008606412,0.00005134756,0.000027160308,0.00023574138,0.00007835039,0.0010802064],"category_scores_gemma":[0.0008484642,0.000087821354,0.00008443415,0.00027081708,0.0001342456,0.000120280274,0.000040444585,0.00048300845,0.0000016934923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025302341,0.004681445,0.956738,0.000002591371,0.0010663565,0.00031034346,0.004232712,0.00035070477,0.00008836766,0.000009312284,0.00029021243,0.0069276225],"study_design_scores_gemma":[0.040752556,0.009864109,0.9472759,0.00030676657,0.00017092004,0.0000065387962,0.0010333841,0.00011387847,0.0002338409,0.000018741273,0.00011235258,0.000111010144],"about_ca_topic_score_codex":0.00011457884,"about_ca_topic_score_gemma":0.00037179276,"teacher_disagreement_score":0.015450216,"about_ca_system_score_codex":0.0004247692,"about_ca_system_score_gemma":0.00034626984,"threshold_uncertainty_score":0.9998329},"labels":[],"label_agreement":null},{"id":"W3105691884","doi":"10.1136/ijgc-2020-igcs.22","title":"22 COVID-19: A review of the impact of the pandemic on ovarian cancer patient advocacy organizations from around the world","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Medicine; Pandemic; Ovarian cancer; Work (physics); Cancer; Coronavirus disease 2019 (COVID-19); Family medicine; Nursing; Internal medicine; Disease","score_opus":0.11870777929739897,"score_gpt":0.4887429075120903,"score_spread":0.37003512821469137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105691884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009700776,0.9469207,0.000020210418,0.048290614,0.0016374777,0.0012610446,0.0006980172,0.000008260922,0.00019361617],"genre_scores_gemma":[0.021964494,0.94997054,0.00001268995,0.026855541,0.0009896109,0.000052717693,0.000017994213,0.000027864504,0.00010857023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960782,0.00061549153,0.0016335455,0.00024424627,0.0012144442,0.00021409572],"domain_scores_gemma":[0.99195135,0.0027610497,0.0032318097,0.00040519328,0.0013278406,0.0003227643],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005092036,0.00033423008,0.0016030521,0.0001337524,0.00011055055,0.000023317647,0.0012071868,0.00018260117,0.0061306944],"category_scores_gemma":[0.010918934,0.00012314689,0.0013550407,0.0009860251,0.00020903796,0.0000508952,0.00025479597,0.0013393613,0.0000048045213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005550907,0.00069793535,0.03030671,0.012677157,0.004773196,0.0001115385,0.00071694277,0.00048417324,0.0000122453575,0.0003094291,0.07082051,0.8785351],"study_design_scores_gemma":[0.0006679145,0.00038512726,0.02618134,0.053299353,0.0013773046,0.00008840261,0.000025929548,0.0000078416715,0.000002887745,0.00022262729,0.9176124,0.00012887358],"about_ca_topic_score_codex":0.002357351,"about_ca_topic_score_gemma":0.0009193944,"teacher_disagreement_score":0.8784062,"about_ca_system_score_codex":0.0039389436,"about_ca_system_score_gemma":0.017697487,"threshold_uncertainty_score":0.9998848},"labels":[],"label_agreement":null},{"id":"W3106214715","doi":"10.1136/ijgc-2020-igcs.29","title":"29 Comprehensive molecular assessment of mismatch repair deficiency in lynch-associated ovarian cancers using next-generation sequencing (NGS) panel","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"MSH6; Lynch syndrome; PMS2; MSH2; MLH1; Germline mutation; Endometrial cancer; Biology; Cancer research; Genetics; Ovarian cancer; Germline; Oncology; Mutation; Medicine; Cancer; DNA mismatch repair; Colorectal cancer; Gene","score_opus":0.2057987381319273,"score_gpt":0.37459708372364175,"score_spread":0.16879834559171444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106214715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940836,0.0006814568,0.0017263211,0.0018531259,0.0010089193,0.00024896764,0.000020299633,0.000016180886,0.0003611671],"genre_scores_gemma":[0.99002516,0.00018048567,0.007227914,0.0022761268,0.00024853353,0.000011240786,0.000008036423,0.000016068021,0.0000064515116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975243,0.00014926922,0.0009010776,0.0002574635,0.00093795214,0.0002299289],"domain_scores_gemma":[0.9975782,0.00017093463,0.00071887934,0.000087399276,0.0012826992,0.0001619091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002921602,0.00017722302,0.0005296178,0.0001568846,0.00003098905,0.00002447461,0.0002638228,0.0001585859,0.0006514698],"category_scores_gemma":[0.0006587439,0.00015049097,0.00023355315,0.00032181627,0.00009654321,0.00012693535,0.00007817292,0.0004614491,7.4139257e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034405745,0.00018218465,0.09450276,0.00006307649,0.00037625272,0.0008539091,0.00068442104,0.11521737,0.7855614,0.00010726549,0.00024764438,0.0018596728],"study_design_scores_gemma":[0.0077757384,0.003653502,0.5654553,0.00086659874,0.00044726007,0.00035238013,0.0013987441,0.37005383,0.048450455,0.0004106698,0.0005241007,0.00061139814],"about_ca_topic_score_codex":0.0005013017,"about_ca_topic_score_gemma":0.0001824571,"teacher_disagreement_score":0.7371109,"about_ca_system_score_codex":0.0037475962,"about_ca_system_score_gemma":0.0017616167,"threshold_uncertainty_score":0.9799833},"labels":[],"label_agreement":null},{"id":"W3110686803","doi":"10.1136/ijgc-2020-esgo.72","title":"386 Patient-reported outcomes (PROS) in the garnet trial in patients (PTS) with advanced or recurrent mismatch repair deficient/microsatelite instability-high (DMMR/MSI-H) endometrial cancer (EC) treated with dostarlimab","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Eisai; GlaxoSmithKline; AstraZeneca; Pfizer","keywords":"Tolerability; Medicine; Discontinuation; Adverse effect; Nausea; Internal medicine; Oncology; Regimen; Endometrial cancer; Cancer","score_opus":0.034115411449986484,"score_gpt":0.3137642473573286,"score_spread":0.27964883590734213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110686803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927436,0.00047230482,0.000009082829,0.0029764771,0.0014519261,0.0020920946,0.00011526708,0.000032253487,0.00010695978],"genre_scores_gemma":[0.9963072,0.00028072562,0.0005709962,0.002204792,0.00024353479,0.00030179595,0.000038345806,0.000032870765,0.000019734485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951906,0.00031412422,0.0015960388,0.0005857438,0.0018409853,0.00047249158],"domain_scores_gemma":[0.9963987,0.0008080166,0.001101601,0.00024448286,0.0012203718,0.00022681337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005360178,0.00041685978,0.0009974986,0.00032511092,0.000051559506,0.000065611406,0.00050261326,0.00018662537,0.0011228148],"category_scores_gemma":[0.0023656057,0.00020571267,0.00024758847,0.0009927427,0.00020569029,0.00019553723,0.00010440748,0.0009168818,0.0000024783858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2818351,0.0018076112,0.6957069,0.000028480565,0.00038238603,0.0005583414,0.0009955445,0.0011118855,0.00011800669,0.0000044033277,0.00020961309,0.017241733],"study_design_scores_gemma":[0.15099788,0.02743821,0.81508553,0.00045085378,0.00023301457,0.000059335303,0.00050841336,0.0000753326,0.000727706,0.000022206466,0.004025957,0.00037557795],"about_ca_topic_score_codex":0.00042138214,"about_ca_topic_score_gemma":0.0016611654,"teacher_disagreement_score":0.13083723,"about_ca_system_score_codex":0.0015924792,"about_ca_system_score_gemma":0.00090345426,"threshold_uncertainty_score":0.9997903},"labels":[],"label_agreement":null},{"id":"W3110924137","doi":"10.1136/ijgc-2020-esgo.21","title":"288 Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in high-risk HPV+ patients: results of different studies","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Clinical endpoint; Clearance; Internal medicine; Prospective cohort study; Randomized controlled trial; Gynecology; Urology","score_opus":0.07980968766881297,"score_gpt":0.38500872032072553,"score_spread":0.30519903265191256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110924137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358827,0.0008617678,0.00009090548,0.0040751062,0.0007169761,0.00026356766,0.00015235436,0.000006101205,0.0002449319],"genre_scores_gemma":[0.99782556,0.0009353477,0.00028311615,0.00062662293,0.00028583748,0.000011099486,0.000011821431,0.00000747337,0.000013106028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973766,0.000121338744,0.000987847,0.00021481463,0.0010918952,0.00020748079],"domain_scores_gemma":[0.9959005,0.0010005921,0.0006870562,0.00008809254,0.00212015,0.00020362616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003098165,0.00015121518,0.0006805663,0.00019868232,0.000021285805,0.000008469332,0.00033981822,0.00008869932,0.00085158023],"category_scores_gemma":[0.0044421046,0.000100443576,0.00023209964,0.00020653722,0.00020492016,0.00006112042,0.00011655472,0.0005262997,0.000002043826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046792854,0.00460068,0.80114704,0.0002241587,0.0011691614,0.00028047335,0.0011315221,0.0032486555,0.00068674854,0.00009891379,0.0018300117,0.13878979],"study_design_scores_gemma":[0.026460318,0.0049391664,0.9647057,0.00012838932,0.00011278962,0.0000016856894,0.00015476032,0.0010093405,0.0018739116,0.000059468748,0.000466806,0.000087679815],"about_ca_topic_score_codex":0.00017768369,"about_ca_topic_score_gemma":0.00015826419,"teacher_disagreement_score":0.16355865,"about_ca_system_score_codex":0.0007271923,"about_ca_system_score_gemma":0.00029530606,"threshold_uncertainty_score":0.9324206},"labels":[],"label_agreement":null},{"id":"W3110945690","doi":"10.1136/ijgc-2020-esgo.147","title":"518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ignyta; Clovis Oncology; Amgen; Pfizer; PharmaMar; Mersana Therapeutics; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; Cervical cancer; Durvalumab; Ovarian cancer; Tolerability; Cancer; Adverse effect; Clinical endpoint; Immunotherapy; Nivolumab; Clinical trial","score_opus":0.029914152296946425,"score_gpt":0.31827349044143205,"score_spread":0.2883593381444856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110945690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943289,0.0018937456,0.0000868674,0.0023442295,0.00056979334,0.0005682093,0.00013108988,0.0000058868513,0.00007128474],"genre_scores_gemma":[0.99616206,0.002031635,0.00048690315,0.0009245823,0.00033280565,0.0000101201895,0.000015818647,0.000013969426,0.000022094559],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978563,0.000110460445,0.00091680145,0.00023629876,0.00068763737,0.00019251046],"domain_scores_gemma":[0.9981402,0.000591082,0.00057646015,0.000068713365,0.00043134717,0.00019215509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038338956,0.00018280471,0.0006839504,0.0001917967,0.000032857904,0.000037518883,0.00015917013,0.00008548215,0.00075877085],"category_scores_gemma":[0.00065847713,0.00012431988,0.00012526599,0.00029531468,0.00022439683,0.0001583772,0.0000574855,0.00030000723,4.963874e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90751755,0.00186053,0.018448802,0.0000714094,0.0011569206,0.00017751854,0.00061507715,0.00020360325,0.0012888671,0.000033683773,0.00016285756,0.06846318],"study_design_scores_gemma":[0.80736655,0.01835875,0.15489267,0.0003416224,0.00033885348,0.000045530025,0.0001726628,0.00025247023,0.0013683789,0.000033040065,0.016554905,0.00027454575],"about_ca_topic_score_codex":0.00022302826,"about_ca_topic_score_gemma":0.000047720194,"teacher_disagreement_score":0.13644387,"about_ca_system_score_codex":0.0006425216,"about_ca_system_score_gemma":0.0005653057,"threshold_uncertainty_score":0.8308009},"labels":[],"label_agreement":null},{"id":"W3110977585","doi":"10.1136/ijgc-2020-esgo.103","title":"197 Can D-dimers and fibrinogen aid in the diagnosis of ovarian cancer?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Russian Science Foundation","keywords":"Fibrinogen; Biomarker; Medicine; Internal medicine; Ovarian cancer; Malignancy; Gastroenterology; Prospective cohort study; Oncology; Logistic regression; Debulking; Cancer; Biology","score_opus":0.05399880983272408,"score_gpt":0.3389683208829947,"score_spread":0.28496951105027063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110977585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86923045,0.003254908,0.000006937658,0.1265249,0.00033982308,0.00017133431,0.00006474662,0.0000032470234,0.0004036383],"genre_scores_gemma":[0.98602533,0.006057991,0.00020101781,0.0071961177,0.00043874828,0.000061447565,0.0000025015484,0.0000064554824,0.000010415593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988421,0.000057785233,0.0004074503,0.00013971877,0.0004286757,0.000124249],"domain_scores_gemma":[0.99901515,0.00031485024,0.00027117843,0.000059434573,0.00021937801,0.00012002328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016795573,0.00010511843,0.0003155785,0.00006730945,0.000018608614,0.000018792261,0.00021249345,0.00005923987,0.0011260117],"category_scores_gemma":[0.00020816171,0.00006180315,0.00011963614,0.00013289649,0.00007987394,0.00005639434,0.0000432597,0.00021121681,0.0000010584815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004940739,0.00026653017,0.944655,0.000022878332,0.00047325224,0.00047679368,0.00086865027,0.00021758994,0.00023554884,0.0004030571,0.0026471417,0.04923951],"study_design_scores_gemma":[0.0035328981,0.0009759758,0.97151023,0.00017899416,0.00018052649,0.00006748642,0.00025395953,0.00005547343,0.0023117438,0.00019407766,0.020657271,0.00008136324],"about_ca_topic_score_codex":0.00068535237,"about_ca_topic_score_gemma":0.00036598393,"teacher_disagreement_score":0.119328775,"about_ca_system_score_codex":0.00022955102,"about_ca_system_score_gemma":0.00022854285,"threshold_uncertainty_score":0.9997871},"labels":[],"label_agreement":null},{"id":"W3111234139","doi":"10.1136/ijgc-2020-esgo.54","title":"71 Omitting lymphadenectomy in obese endometrial cancer patients undergoing sentinel lymph node mapping: when more is less","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Lymphadenectomy; Lymph node; Carcinoma; Internal medicine; Cancer; Biopsy; Surgery; Oncology; Gastroenterology; Breast cancer","score_opus":0.06178735913724094,"score_gpt":0.3345606316279136,"score_spread":0.2727732724906727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111234139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971592,0.0018157476,0.00008916398,0.023763297,0.0016450108,0.0002333808,0.000054370383,0.000022327366,0.0007847047],"genre_scores_gemma":[0.9827065,0.001436386,0.00042581145,0.013065285,0.002161432,0.00004114585,0.000013422229,0.000026144819,0.00012390962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688596,0.000092669594,0.0010483899,0.00036716135,0.0012298679,0.0003759588],"domain_scores_gemma":[0.997318,0.00075063616,0.0006718677,0.00008820614,0.0007997726,0.00037151258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024349394,0.00026977915,0.0007422134,0.0004134628,0.000045444423,0.00006577217,0.00044157595,0.00017699083,0.0028891077],"category_scores_gemma":[0.0022683612,0.00019804713,0.00037891837,0.0006104531,0.00007228069,0.00023908465,0.00018040878,0.00037150137,0.00001570331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024568338,0.0006066104,0.96975696,0.00006130356,0.0006737187,0.00041380175,0.00055038783,0.00019558928,0.00047206567,0.000019240584,0.0006772092,0.024116276],"study_design_scores_gemma":[0.041062318,0.00037545324,0.9509119,0.00058022304,0.00019032948,0.000030502579,0.00035540495,0.0004388539,0.0014831276,0.00024376258,0.004042338,0.00028581588],"about_ca_topic_score_codex":0.00030047554,"about_ca_topic_score_gemma":0.000025448608,"teacher_disagreement_score":0.03860548,"about_ca_system_score_codex":0.0015118541,"about_ca_system_score_gemma":0.0005398451,"threshold_uncertainty_score":0.9980224},"labels":[],"label_agreement":null},{"id":"W3111363049","doi":"10.1136/ijgc-2020-esgo.53","title":"70 The added value of sentinel node mapping in endometrial cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Lymph node; Hazard ratio; Sentinel lymph node; Proportional hazards model; Retrospective cohort study; Oncology; Internal medicine; Adjuvant therapy; Dissection (medical); Stage (stratigraphy); Cancer; Surgery; Radiology; Breast cancer; Confidence interval","score_opus":0.06981008991331393,"score_gpt":0.3550536435064308,"score_spread":0.28524355359311687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111363049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94625765,0.0026522395,0.00013139754,0.04793591,0.0014510053,0.00021942159,0.000041350984,0.000008244664,0.0013027934],"genre_scores_gemma":[0.9899003,0.00164191,0.00021551627,0.0065101106,0.0016407515,0.000025342943,0.0000030357305,0.0000093032795,0.000053752126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980186,0.00009342063,0.0007585966,0.00015696627,0.00079175533,0.00018064764],"domain_scores_gemma":[0.99808085,0.0007086153,0.0005025363,0.00006794922,0.00049172,0.00014833914],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031840385,0.00013136069,0.00050031336,0.00019980961,0.000021655324,0.000016683265,0.00036302605,0.0000857208,0.0031298483],"category_scores_gemma":[0.0018429898,0.000073488714,0.00029288215,0.0005949226,0.00008406186,0.00008216969,0.0000913318,0.00038632908,0.0000058567907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007374849,0.0008367641,0.9224283,0.00007299275,0.0017532952,0.0006725373,0.00065244525,0.00203074,0.013505239,0.0005818651,0.0029490835,0.047141872],"study_design_scores_gemma":[0.025395405,0.000821882,0.9365418,0.0003800493,0.0002963289,0.00006417519,0.0002924266,0.00075885264,0.008038436,0.0005827137,0.026623243,0.00020468989],"about_ca_topic_score_codex":0.00022622125,"about_ca_topic_score_gemma":0.000018795692,"teacher_disagreement_score":0.046937183,"about_ca_system_score_codex":0.0003532001,"about_ca_system_score_gemma":0.0002781014,"threshold_uncertainty_score":0.99778146},"labels":[],"label_agreement":null},{"id":"W3111542420","doi":"10.1136/ijgc-2020-esgo.19","title":"285 Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel in HPV+ women older than 40 years: sub-analysis of paloma clinical trial","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Colposcopy; Gynecology; Randomized controlled trial; Population; Clinical trial; Clinical endpoint; Atypia; Cervical cancer; Obstetrics; Internal medicine; Cancer","score_opus":0.13769260901487676,"score_gpt":0.4474923052513086,"score_spread":0.3097996962364319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111542420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995735,0.00035652853,0.00026194274,0.002401112,0.0006676966,0.0003267857,0.00005803534,0.0000067972323,0.00018610322],"genre_scores_gemma":[0.997694,0.000277751,0.00022101754,0.0011233184,0.0006249431,0.000020365289,0.000011198822,0.000010650562,0.000016737458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654466,0.00021081758,0.0014155584,0.00028052312,0.0012607817,0.0002876551],"domain_scores_gemma":[0.99649686,0.0012401328,0.0006804733,0.0001268957,0.0010766513,0.00037900367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010621625,0.0001482815,0.0010836856,0.00045043515,0.000014256289,0.000017492837,0.0004893707,0.00017731207,0.0075167506],"category_scores_gemma":[0.0026767678,0.000113412236,0.0007287646,0.00068722916,0.00023562413,0.00006809318,0.00012249568,0.0006817663,0.0000050690282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26380908,0.005663783,0.60824156,0.00009209226,0.005659152,0.0009720677,0.001182286,0.0032742328,0.00090618845,0.000054580054,0.0006970585,0.10944788],"study_design_scores_gemma":[0.06336127,0.004559418,0.92589384,0.000038052076,0.0004972818,0.0000030465521,0.00013151109,0.004137692,0.00029789394,0.000014964327,0.00096698594,0.00009801415],"about_ca_topic_score_codex":0.00010608919,"about_ca_topic_score_gemma":0.00013766866,"teacher_disagreement_score":0.3176523,"about_ca_system_score_codex":0.000674793,"about_ca_system_score_gemma":0.00085190445,"threshold_uncertainty_score":0.9933905},"labels":[],"label_agreement":null},{"id":"W3111966079","doi":"10.1136/ijgc-2020-esgo.96","title":"468 Racial disparities in patients with covid-19 infection and gynecologic malignancy","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute; Columbia College","funders":"","keywords":"Medicine; Logistic regression; Internal medicine; Coronavirus disease 2019 (COVID-19); Malignancy; Cohort; Retrospective cohort study; Gynecologic oncology","score_opus":0.05648536155868109,"score_gpt":0.3844695633815201,"score_spread":0.327984201822839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111966079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94798684,0.0002914912,0.00024494837,0.050733514,0.00039628686,0.00021564105,0.000018107077,0.000014717152,0.00009845603],"genre_scores_gemma":[0.96715426,0.00053134654,0.000130445,0.031798042,0.00034477876,0.000010578758,0.000006185544,0.0000071051536,0.000017259403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987333,0.00006435344,0.00040550876,0.00015983319,0.00045892474,0.00017812719],"domain_scores_gemma":[0.9984708,0.0003807972,0.00027068547,0.000038751856,0.00041396814,0.0004250394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019190264,0.00011869933,0.00032202838,0.00014245979,0.000041688272,0.000030765073,0.000095748735,0.00011135854,0.000813303],"category_scores_gemma":[0.0030644774,0.0000787215,0.000061012575,0.00013416712,0.00008896467,0.00017589971,0.000050205665,0.00035734678,0.0000030244273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024450514,0.00020621857,0.9874072,0.000063946805,0.00006546179,0.0002631086,0.00026019453,0.00015344656,0.000017928684,0.00017015023,0.0005345694,0.00841271],"study_design_scores_gemma":[0.0047283657,0.002425494,0.9839219,0.00006795743,0.000033829747,0.000024133242,0.00002194212,0.000037524158,0.000016142216,0.00030408104,0.008331302,0.000087325076],"about_ca_topic_score_codex":0.00030703502,"about_ca_topic_score_gemma":0.0005457008,"teacher_disagreement_score":0.019167423,"about_ca_system_score_codex":0.0007161406,"about_ca_system_score_gemma":0.0006807944,"threshold_uncertainty_score":0.8905097},"labels":[],"label_agreement":null},{"id":"W3112113494","doi":"10.1136/ijgc-2020-esgo.55","title":"72 Sentinel lymph node mapping: the answer to the surgical staging dilemma in elderly patients with endometrial cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Lymphadenectomy; Sentinel lymph node; Perioperative; Stage (stratigraphy); Lymph node; Cancer; Carcinoma; Cohort; Surgery; Internal medicine; Oncology; Breast cancer","score_opus":0.04813981538364897,"score_gpt":0.31189880475855114,"score_spread":0.26375898937490216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112113494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9234153,0.00057275477,0.00010153054,0.07385087,0.0011521031,0.0003658616,0.00005052722,0.000011007212,0.00048002868],"genre_scores_gemma":[0.9876451,0.0002708539,0.0001016991,0.009715121,0.0020770424,0.00007329433,0.000006913688,0.000015469928,0.000094512456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747014,0.00012212098,0.00061860716,0.00024920824,0.0012138586,0.00032607894],"domain_scores_gemma":[0.9978638,0.000732664,0.00031938872,0.00010684448,0.00071351905,0.00026375894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034957987,0.00019658005,0.0004428875,0.00017930895,0.00007337796,0.00007370131,0.0005139867,0.000074293086,0.0019179223],"category_scores_gemma":[0.0008597925,0.00008500745,0.00020464318,0.0008209961,0.00008072523,0.00011726027,0.00013561483,0.0004407764,0.000014533502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006480414,0.00036946594,0.9546328,0.000009434038,0.0005342654,0.00041314095,0.00027329242,0.0010697766,0.000038740243,0.000056741887,0.0010693858,0.03505253],"study_design_scores_gemma":[0.015984587,0.00057725137,0.9208986,0.00012076642,0.00010657832,0.000021785916,0.0001071752,0.00007666561,0.00007165437,0.000030844683,0.061874513,0.00012954965],"about_ca_topic_score_codex":0.00026117396,"about_ca_topic_score_gemma":0.000041616735,"teacher_disagreement_score":0.06422978,"about_ca_system_score_codex":0.00053498516,"about_ca_system_score_gemma":0.00025814824,"threshold_uncertainty_score":0.99899447},"labels":[],"label_agreement":null},{"id":"W3112132685","doi":"10.1136/ijgc-2020-esgo.180","title":"256 Differences in immune-related adverse events between vulvovaginal vs. cutaneous melanoma: a retrospective cohort study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Melanoma; Dermatology; Internal medicine; Retrospective cohort study; Cohort","score_opus":0.024203209545164577,"score_gpt":0.3092863526856376,"score_spread":0.285083143140473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112132685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174964,0.0004223857,0.000019908563,0.0060484596,0.0008081188,0.00044492,0.000026196181,0.000016431808,0.00046390676],"genre_scores_gemma":[0.9983507,0.00037529637,0.000051618557,0.0007027556,0.00036810918,0.000020488398,0.0000057912207,0.000011818332,0.000113435075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976407,0.00012072198,0.0009167582,0.00025244782,0.0008684537,0.00020086674],"domain_scores_gemma":[0.99867374,0.00016903541,0.0005230745,0.00008050333,0.00041001692,0.00014363372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000371682,0.00018158357,0.00067609036,0.0001524302,0.000035064513,0.000013015512,0.0003799555,0.000120082295,0.0025615525],"category_scores_gemma":[0.00036226117,0.00012875951,0.00024129965,0.00025498995,0.00009049069,0.00011903847,0.00007219986,0.0005996094,0.000011965561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047720405,0.00046388476,0.9878457,0.000005116688,0.0014905287,0.0014090441,0.00052638457,0.000014416303,0.00048438486,0.00000946381,0.000107200685,0.002871831],"study_design_scores_gemma":[0.0056794235,0.0037048266,0.9890985,0.00009686093,0.00016587698,0.00017785949,0.00028460144,0.000045366454,0.00010232258,0.00012472305,0.0003886256,0.00013100923],"about_ca_topic_score_codex":0.00020072787,"about_ca_topic_score_gemma":0.000061716615,"teacher_disagreement_score":0.0066010146,"about_ca_system_score_codex":0.0009143637,"about_ca_system_score_gemma":0.00022732481,"threshold_uncertainty_score":0.99835026},"labels":[],"label_agreement":null},{"id":"W3112428377","doi":"10.1136/ijgc-2020-esgo.151","title":"557 Peritoneal cancer index (PCI) as a predictor of completeness of cytoreduction at primary and interval debulking surgery in advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Debulking; Conventional PCI; Hyperthermic intraperitoneal chemotherapy; Ovarian cancer; Surgery; Oncology; Cancer; Internal medicine; Cytoreductive surgery; Myocardial infarction","score_opus":0.041210008967156826,"score_gpt":0.32598918462867055,"score_spread":0.28477917566151373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112428377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148125,0.0050434424,0.000052407344,0.011677857,0.0012663786,0.00022980415,0.00012814111,0.00000777943,0.00011296137],"genre_scores_gemma":[0.9932219,0.0046324087,0.00021855303,0.001178338,0.0006150597,0.00007973874,0.00001027994,0.000017033808,0.00002671399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979423,0.000069256195,0.0009174746,0.0002584189,0.00062350737,0.00018902036],"domain_scores_gemma":[0.9980012,0.0003288975,0.0007972782,0.00007402031,0.000611415,0.00018714675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020293586,0.00018248503,0.00080486474,0.00018131234,0.00002555896,0.000013082566,0.00016218676,0.000116783536,0.0015037677],"category_scores_gemma":[0.0002451944,0.00014076801,0.00021089117,0.00017982625,0.00015982025,0.00017397794,0.00011563612,0.0002591547,5.807679e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054652705,0.00042174303,0.92766476,0.00016445878,0.00061674934,0.00024446065,0.00054741336,0.0009892493,0.008294412,0.0000593463,0.0003921824,0.055139937],"study_design_scores_gemma":[0.0043174126,0.0006697351,0.98619133,0.0009733227,0.000152466,0.000114140916,0.00011989336,0.0003500908,0.0045856927,0.00006164699,0.002338153,0.00012613539],"about_ca_topic_score_codex":0.0009783187,"about_ca_topic_score_gemma":0.0004348143,"teacher_disagreement_score":0.058526535,"about_ca_system_score_codex":0.0011878274,"about_ca_system_score_gemma":0.0006980635,"threshold_uncertainty_score":0.999409},"labels":[],"label_agreement":null},{"id":"W3112945290","doi":"10.1136/ijgc-2020-esgo.71","title":"385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Endometrial cancer; Oncology; Cohort; Regimen; Tolerability; Cancer; Population; Immunohistochemistry; Surgery; Adverse effect","score_opus":0.024748779868440863,"score_gpt":0.29889504878012374,"score_spread":0.27414626891168287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112945290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531066,0.00073348003,0.00005749228,0.0015226541,0.00074348686,0.00053870614,0.0010612551,0.000003339657,0.000028908109],"genre_scores_gemma":[0.9967222,0.002219398,0.00020027757,0.0004193947,0.0003587016,0.000027434671,0.00002845248,0.000010722393,0.000013424934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982407,0.00011631229,0.00063608587,0.00034773274,0.00048309416,0.00017606305],"domain_scores_gemma":[0.9981804,0.00043935594,0.00065108633,0.0001329798,0.0004935738,0.000102605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032157142,0.00016906239,0.00034288882,0.000048042613,0.000042060165,0.000029527546,0.0003472076,0.00007061047,0.00009625836],"category_scores_gemma":[0.0018188746,0.00009124509,0.00009024214,0.0001700089,0.000096186246,0.000012628067,0.0002149715,0.0002112324,3.4800448e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34752238,0.004365658,0.52419937,0.000037298698,0.0011549402,0.00023991839,0.0019390703,0.012478269,0.013177318,0.00002122761,0.0025288067,0.09233575],"study_design_scores_gemma":[0.033013016,0.019013507,0.909689,0.00018845568,0.0001573351,0.000008761346,0.0007760359,0.00042837186,0.010211912,0.000011178725,0.026118029,0.00038439938],"about_ca_topic_score_codex":0.00026795335,"about_ca_topic_score_gemma":0.0022957765,"teacher_disagreement_score":0.38548964,"about_ca_system_score_codex":0.00019013578,"about_ca_system_score_gemma":0.00041496378,"threshold_uncertainty_score":0.3720867},"labels":[],"label_agreement":null},{"id":"W3114984412","doi":"10.1136/ijgc-2020-001946","title":"Risk of second malignancy in patients with ovarian clear cell carcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Clear cell carcinoma; Ovarian carcinoma; Carcinoma; Malignancy; Oncology; Ovarian cancer; Internal medicine; Radiation therapy; Incidence (geometry); Cancer","score_opus":0.01358094029146053,"score_gpt":0.24746597567322795,"score_spread":0.23388503538176741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114984412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574596,0.00023429438,0.000033752327,0.001213042,0.00028485927,0.00013676309,0.00007979668,0.000003434082,0.0022680764],"genre_scores_gemma":[0.9967515,0.00008603348,0.0006285102,0.0022653814,0.00019003269,0.0000031683187,0.000007165876,0.000009687509,0.000058537247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987454,0.000050734132,0.00049163896,0.00013842026,0.00044638908,0.0001274375],"domain_scores_gemma":[0.9987367,0.0001036711,0.00047422101,0.000061012448,0.00047890499,0.00014549466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000118853204,0.00010418836,0.0003408377,0.00009422421,0.000012416481,0.000008470304,0.00020578063,0.000070983195,0.0063075307],"category_scores_gemma":[0.00013726814,0.00007067769,0.00011296151,0.00010328791,0.00005587684,0.00012517592,0.00003837002,0.000356053,0.0000042504057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049278466,0.0002443944,0.9863511,0.00003052147,0.0001226184,0.0001786852,0.00025249587,0.00015855447,0.00036601129,0.0000145420745,0.00075825787,0.0065950216],"study_design_scores_gemma":[0.007743005,0.0024382249,0.9843922,0.0000406119,0.000051607323,0.000006322883,0.000057493497,0.000060652044,0.0014287615,0.00002468159,0.0036791347,0.000077272045],"about_ca_topic_score_codex":0.00004016408,"about_ca_topic_score_gemma":0.00004878864,"teacher_disagreement_score":0.0065177493,"about_ca_system_score_codex":0.00022692143,"about_ca_system_score_gemma":0.00029453434,"threshold_uncertainty_score":0.99460083},"labels":[],"label_agreement":null},{"id":"W3116313627","doi":"10.1136/ijgc-2020-esgo.213","title":"589 Early stage, low grade endometrial adenocarcinoma in reproductive aged women. an evaluation of patient perspectives of diagnosis, treatment decision making, management, fertility and survivorship: a qualitative study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Survivorship curve; Fertility; Fertility preservation; Cohort; Family medicine; Medicine; Gynecology; Cohort study; Qualitative research; Retrospective cohort study; Gerontology; Demography; Population; Cancer; Internal medicine; Sociology","score_opus":0.10504731603277341,"score_gpt":0.43046024994216503,"score_spread":0.32541293390939163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116313627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996146,0.0019380187,0.000020655772,0.00032403762,0.0002800776,0.0011619751,0.0000714909,0.0000050934163,0.000052655487],"genre_scores_gemma":[0.9988849,0.00043361363,0.0002800111,0.000054749074,0.00012088659,0.00020767881,0.0000035131447,0.000009262773,0.0000053938006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961984,0.0009153699,0.0009129585,0.0004058036,0.0014050236,0.0001624019],"domain_scores_gemma":[0.9968666,0.0010178939,0.00075391645,0.00013133531,0.0010778254,0.00015244717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014581977,0.00018113312,0.00067692937,0.00039372634,0.000024114352,0.000018244747,0.00016830611,0.00006241299,0.0006936616],"category_scores_gemma":[0.00292275,0.00012431525,0.00014520639,0.0005122078,0.00011839705,0.00020490575,0.000079138415,0.00017872878,4.4521315e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028961696,0.0076129106,0.7849326,0.000036835165,0.001543073,0.00016759051,0.11567533,0.00021920602,0.00009508257,0.000049035574,0.0000036810018,0.060702957],"study_design_scores_gemma":[0.01575083,0.01626915,0.8957221,0.00010524406,0.00027079415,0.000002080882,0.07008141,0.000030121313,0.000784934,0.0008899616,0.000006428428,0.00008694212],"about_ca_topic_score_codex":0.00047138953,"about_ca_topic_score_gemma":0.00030037758,"teacher_disagreement_score":0.1107895,"about_ca_system_score_codex":0.0014773849,"about_ca_system_score_gemma":0.00013145336,"threshold_uncertainty_score":0.7595108},"labels":[],"label_agreement":null},{"id":"W3116720339","doi":"10.1136/ijgc-2020-esgo.229","title":"599 Circulating tumour cells in breast and ovarian cancer: size-based isolation and ex vivo expansion","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Ovarian cancer; Cancer research; Circulating tumor cell; Intravasation; Metastasis; Population; Ex vivo; Breast cancer; Biology; Cancer; Cancer cell; Immunology; Medicine; In vivo; Internal medicine","score_opus":0.022826020674859053,"score_gpt":0.29641004577317814,"score_spread":0.2735840250983191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116720339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548778,0.0009558289,0.00019825998,0.04329113,0.00035477913,0.0001576765,0.000041102612,0.000008219226,0.00011520054],"genre_scores_gemma":[0.9938394,0.0009952309,0.00080535567,0.0038519232,0.000469239,0.000015956783,0.0000019414704,0.000010034546,0.000010954225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888796,0.000045136425,0.00040096164,0.00020217165,0.00033250108,0.00013129652],"domain_scores_gemma":[0.99904215,0.00026463956,0.00023068955,0.000037858168,0.00023829924,0.00018637137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014491276,0.00012568152,0.0003009123,0.00007300821,0.000029092407,0.000042038373,0.00007269232,0.00007805215,0.0010614863],"category_scores_gemma":[0.00012640044,0.00009432422,0.00006805028,0.000095036565,0.00004357002,0.00012089598,0.000034970646,0.0002124725,0.0000012055815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012918818,0.0003753583,0.8786811,0.00006159925,0.0002492017,0.0009790873,0.0004363874,0.00289322,0.058680702,0.000104040766,0.0005594581,0.055687957],"study_design_scores_gemma":[0.0053893696,0.00044992872,0.9828739,0.00033397612,0.00009435315,0.000108724744,0.00008051044,0.0068290215,0.0028401546,0.00009088609,0.0007948789,0.000114261034],"about_ca_topic_score_codex":0.00022489816,"about_ca_topic_score_gemma":0.00008199594,"teacher_disagreement_score":0.10419283,"about_ca_system_score_codex":0.00035464866,"about_ca_system_score_gemma":0.0002186154,"threshold_uncertainty_score":0.9998517},"labels":[],"label_agreement":null},{"id":"W3119279423","doi":"10.1136/ijgc-2020-esgo.223","title":"596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Nintedanib; Medicine; Internal medicine; Chemotherapy; Topotecan; Clinical endpoint; Oncology; Progression-free survival; Ovarian cancer; Phases of clinical research; Gastroenterology; Urology; Cancer; Clinical trial","score_opus":0.03735796590788373,"score_gpt":0.32496898208309755,"score_spread":0.2876110161752138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119279423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476016,0.00022593867,0.000014879053,0.00325246,0.00036904358,0.001190833,0.000056488476,0.000003604229,0.0001266158],"genre_scores_gemma":[0.9983029,0.00008455073,0.00019202048,0.0011975969,0.00013113294,0.000052689862,0.0000030853678,0.000013719532,0.000022322009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978998,0.0001150833,0.00080665,0.00020319645,0.0008290276,0.00014627058],"domain_scores_gemma":[0.99801505,0.00031641606,0.0006529368,0.00012828123,0.0007253221,0.0001619763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019627402,0.00016564367,0.0006694639,0.00017767132,0.000025180256,0.000009285407,0.00034317427,0.00004811556,0.0013274481],"category_scores_gemma":[0.00026923622,0.00008458337,0.00017741074,0.00042954195,0.000050743165,0.000053477626,0.00008663172,0.0002542316,0.000001020145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21509731,0.023187269,0.7364605,0.00004090761,0.00093496713,0.00015428502,0.0031137194,0.00043473835,0.00052601006,0.0000070367732,0.0016882378,0.018355016],"study_design_scores_gemma":[0.18124072,0.033503264,0.7810154,0.00016209779,0.00017190639,0.000004631522,0.00037034886,0.00006176717,0.0022323972,0.000003316357,0.0011439335,0.00009019431],"about_ca_topic_score_codex":0.0000863213,"about_ca_topic_score_gemma":0.000069119036,"teacher_disagreement_score":0.044554915,"about_ca_system_score_codex":0.0003875416,"about_ca_system_score_gemma":0.00027067552,"threshold_uncertainty_score":0.99958545},"labels":[],"label_agreement":null},{"id":"W3120292946","doi":"10.1136/ijgc-2020-esgo.218","title":"594 Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute; Centre for Global Health Research","funders":"","keywords":"Medicine; Perioperative; Pandemic; Coronavirus disease 2019 (COVID-19); Radiation therapy; Cancer; Elective surgery; General surgery; Surgery; Internal medicine; Disease","score_opus":0.2122118667215521,"score_gpt":0.4650149120712619,"score_spread":0.25280304534970977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120292946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86178374,0.00054656185,0.00002151561,0.13133729,0.0044438597,0.00064298115,0.00097000937,0.000032830107,0.00022119503],"genre_scores_gemma":[0.95712036,0.0020969773,0.000017304601,0.03796677,0.0025992978,0.00008051828,0.000020518528,0.0000220951,0.00007618057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485505,0.0005988746,0.0016603494,0.00052097935,0.0019077931,0.00045692804],"domain_scores_gemma":[0.9881632,0.007956285,0.0015852686,0.0002944683,0.0014429227,0.0005578691],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013268713,0.00038012298,0.0010182003,0.00013397506,0.00017639974,0.00007375182,0.001377044,0.00032048946,0.01226657],"category_scores_gemma":[0.016061438,0.00017584272,0.0009773113,0.0003915509,0.00034560994,0.0001559198,0.00035891373,0.0014673182,0.000013169402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007982011,0.0010090908,0.9346276,0.000009984582,0.0014255816,0.000408894,0.000757626,0.0036424014,0.0003285414,0.000021448477,0.027501542,0.022285312],"study_design_scores_gemma":[0.0046049533,0.0018331034,0.9803192,0.00010066792,0.00022706026,0.000036780995,0.00025490962,0.00025981537,0.000070149545,0.00014658562,0.011957703,0.00018906384],"about_ca_topic_score_codex":0.003877425,"about_ca_topic_score_gemma":0.0019203911,"teacher_disagreement_score":0.095336586,"about_ca_system_score_codex":0.0030908233,"about_ca_system_score_gemma":0.0037702532,"threshold_uncertainty_score":0.9922267},"labels":[],"label_agreement":null},{"id":"W3125810708","doi":"10.1136/ijgc-2020-002133","title":"Factors impacting length of stay and survival in patients with advanced gynecologic malignancies and malignant bowel obstruction","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Bowel obstruction; Gynecologic oncology; Malignancy; Retrospective cohort study; Surgery; Radiation therapy; Internal medicine","score_opus":0.024506216592016468,"score_gpt":0.29415663463276065,"score_spread":0.2696504180407442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125810708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839735,0.00032593324,0.000013764343,0.00059268397,0.00043116737,0.00008111049,0.000026693224,0.00000414337,0.00012718228],"genre_scores_gemma":[0.99865633,0.0002917405,0.0008048432,0.00012436703,0.000058740934,0.0000027701233,0.000005863501,0.000005994308,0.000049325005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989304,0.00004977197,0.0003897236,0.00013954175,0.00035236287,0.00013821601],"domain_scores_gemma":[0.99831074,0.0003946072,0.00030866545,0.000041865675,0.00085126836,0.00009286455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014309771,0.00011559609,0.00032615068,0.000094642775,0.000031494987,0.00001471888,0.00006127577,0.00006663845,0.0002821277],"category_scores_gemma":[0.0009135994,0.000068037276,0.000051623723,0.00008994176,0.00010177649,0.00014196527,0.0000512748,0.00022268234,1.6015838e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066537777,0.00021171452,0.98927814,0.000022281354,0.000091414026,0.00014338501,0.00015847379,0.000059140988,0.0034563493,0.00009871453,0.0000072711837,0.0058077145],"study_design_scores_gemma":[0.0018657984,0.0013116492,0.99247867,0.00020297976,0.00003826583,0.00008947732,0.00056694984,0.000018725206,0.003075679,0.00015971765,0.00011446012,0.000077647324],"about_ca_topic_score_codex":0.00003329798,"about_ca_topic_score_gemma":0.00010197779,"teacher_disagreement_score":0.005730067,"about_ca_system_score_codex":0.00014922985,"about_ca_system_score_gemma":0.00013506899,"threshold_uncertainty_score":0.30891004},"labels":[],"label_agreement":null},{"id":"W3130912400","doi":"10.1136/ijgc-2021-002422","title":"The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries","year":2021,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Cancer Care South East","funders":"","keywords":"Medicine; Cervical cancer; Low and middle income countries; Global health; Portfolio; Clinical trial; Disease; Burden of disease; Cancer; Family medicine; Developing country; Economic growth; Nursing; Public health; Internal medicine","score_opus":0.22892064126654948,"score_gpt":0.532260257937271,"score_spread":0.30333961667072157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130912400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045279516,0.9726237,0.000005203989,0.017022895,0.0031058975,0.0014264142,0.00010416837,0.000014349942,0.0011693997],"genre_scores_gemma":[0.013897897,0.97695446,0.000060786017,0.00095805654,0.0051648663,0.0015632532,0.000012588414,0.00007159279,0.0013165054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9888302,0.0021400368,0.0021433546,0.00093065563,0.00411611,0.001839609],"domain_scores_gemma":[0.9811428,0.010336195,0.000515434,0.00046372076,0.006662248,0.0008795651],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00926727,0.0005521344,0.002600106,0.0010551168,0.0005121769,0.0005844085,0.0019545134,0.00081909884,0.010237149],"category_scores_gemma":[0.003541612,0.00032210932,0.00064424763,0.0020314518,0.0010547711,0.00017986543,0.0019906329,0.00595198,0.000047115966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020056,0.00038519944,0.009761799,0.0058148494,0.00140528,0.00265576,0.00023501318,0.0001161638,0.000001082144,0.001148369,0.0084987525,0.96797216],"study_design_scores_gemma":[0.0014716282,0.0009787523,0.021629874,0.03161617,0.000191373,0.00020076636,0.00021606914,0.000023929153,0.000004222264,0.0006715745,0.94263566,0.00036000856],"about_ca_topic_score_codex":0.0010931895,"about_ca_topic_score_gemma":0.0109666865,"teacher_disagreement_score":0.96761215,"about_ca_system_score_codex":0.006212226,"about_ca_system_score_gemma":0.0052345768,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W3132563712","doi":"10.1136/ijgc-2020-002256","title":"p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification","year":2021,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Medicine; Serous fluid; Oncology; Internal medicine; Cancer; Cancer research","score_opus":0.1511165782892949,"score_gpt":0.42366775335391765,"score_spread":0.2725511750646228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132563712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001357054,0.98919284,0.00013911148,0.0027777918,0.0045687496,0.0010626292,0.00024479086,0.0000063732205,0.0006506766],"genre_scores_gemma":[0.068561316,0.9282333,0.000057996156,0.00067935523,0.0020688502,0.00028223245,0.000054570355,0.000030047926,0.0000322823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945797,0.00080813956,0.0018996722,0.00038682672,0.0019705687,0.00035513905],"domain_scores_gemma":[0.9900121,0.0052789305,0.003385785,0.00029055978,0.0008931666,0.00013942232],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012751705,0.00043210978,0.0022646168,0.00071211933,0.000080369646,0.000094231225,0.0011612123,0.00038119795,0.0015481676],"category_scores_gemma":[0.005302105,0.00020823667,0.0013293098,0.0024720747,0.00027254497,0.00011158456,0.00013462384,0.0016678814,0.000002846625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013552511,0.00046835022,0.0007576159,0.00053979876,0.0038300569,0.0014720355,0.00017387667,0.00014741422,0.000026410347,0.001260862,0.0007134571,0.9892549],"study_design_scores_gemma":[0.031376123,0.0033496511,0.002425396,0.03742088,0.010587804,0.0013921838,0.0018965667,0.00003341128,0.00017848152,0.0017794608,0.90857196,0.0009880634],"about_ca_topic_score_codex":0.00046832315,"about_ca_topic_score_gemma":0.00019772149,"teacher_disagreement_score":0.9882668,"about_ca_system_score_codex":0.005427471,"about_ca_system_score_gemma":0.0031984146,"threshold_uncertainty_score":0.99936455},"labels":[],"label_agreement":null},{"id":"W3135001208","doi":"10.1136/ijgc-2020-001785","title":"Cervical conization and lymph node assessment for early stage low-risk cervical cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Sentinel lymph node; Stage (stratigraphy); Cervical conization; Adenosquamous carcinoma; Lymph node; Biopsy; Lymphadenectomy; Gynecologic oncology; Surgery; Adenocarcinoma; Cancer; Radiology; Cervical intraepithelial neoplasia; Internal medicine; Breast cancer","score_opus":0.028451717163571266,"score_gpt":0.363726091307798,"score_spread":0.33527437414422673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135001208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802251,0.0020563663,0.0034030878,0.011019919,0.0018883161,0.00025736514,0.0003263484,0.000018592908,0.00080493995],"genre_scores_gemma":[0.9881143,0.0035910658,0.0029313993,0.0030926303,0.0014536871,0.00008324255,0.0000321879,0.000020221984,0.00068126735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980266,0.00009236132,0.0006162558,0.0002888508,0.0007284136,0.00024749382],"domain_scores_gemma":[0.9967249,0.0006073786,0.00041038595,0.000098460034,0.0018662051,0.00029265348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025513495,0.00018400661,0.0005017149,0.00011507694,0.00007699113,0.00008760883,0.00017197663,0.0001713662,0.004527944],"category_scores_gemma":[0.0006734242,0.00013110739,0.00024837165,0.00020169346,0.00008964213,0.00016572571,0.000097117205,0.00029999975,0.0000036094928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021863026,0.0008867912,0.94179016,0.000097869444,0.0012652465,0.00047120854,0.00008554257,0.00045610787,0.0011650141,0.0009814673,0.0003993672,0.05021494],"study_design_scores_gemma":[0.010997965,0.0005973184,0.9739902,0.00017732903,0.00038779096,0.000087365785,0.00008042709,0.00084989006,0.0020172212,0.0010589019,0.009584728,0.00017086863],"about_ca_topic_score_codex":0.00024404524,"about_ca_topic_score_gemma":0.00007519546,"teacher_disagreement_score":0.050044067,"about_ca_system_score_codex":0.00082275894,"about_ca_system_score_gemma":0.00065725524,"threshold_uncertainty_score":0.99638206},"labels":[],"label_agreement":null},{"id":"W3135169920","doi":"10.1136/ijgc-2020-002315","title":"Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Toronto; University Health Network; Université Laval; University of Manitoba; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; National Institutes of Health; Intuitive Surgical; CancerCare Manitoba Foundation; Pfizer; Stryker; Sanofi; AstraZeneca; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Dissection (medical); Medical physics; Delphi method; Sentinel node; Vulvar cancer; Surgical oncology; General surgery; Breast cancer; Surgery; Cancer; Internal medicine","score_opus":0.04358499093167858,"score_gpt":0.36600450176836574,"score_spread":0.3224195108366872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135169920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870325,0.0016621328,0.0018013892,0.004512646,0.0024716393,0.00039305293,0.00026885446,0.000009804063,0.00017724339],"genre_scores_gemma":[0.98229045,0.0019391675,0.012767458,0.0007238857,0.0013365195,0.0004098703,0.00016716211,0.000021051303,0.00034445163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974503,0.00006189879,0.0011812113,0.0002649685,0.0007851214,0.00025647986],"domain_scores_gemma":[0.9935551,0.0032114366,0.00074762764,0.000074567775,0.0022555427,0.00015569951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005119825,0.00019004152,0.0007834598,0.00021778727,0.000065791995,0.00003209498,0.00016512125,0.00013307235,0.0014352788],"category_scores_gemma":[0.0013995821,0.00013829925,0.0006161601,0.00028085412,0.000053339973,0.00010621338,0.000055674765,0.0001399961,8.1151154e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025229959,0.005638747,0.73815155,0.0005660685,0.007117185,0.00063422014,0.00016011675,0.00012756581,0.082216494,0.0005374259,0.008049667,0.13157102],"study_design_scores_gemma":[0.064928606,0.0011276855,0.671328,0.001193381,0.0012905676,0.00043871236,0.00029794133,0.00018737098,0.14516771,0.0007441432,0.11258189,0.00071395474],"about_ca_topic_score_codex":0.000018969022,"about_ca_topic_score_gemma":0.000028487331,"teacher_disagreement_score":0.13085707,"about_ca_system_score_codex":0.0010725266,"about_ca_system_score_gemma":0.0027049193,"threshold_uncertainty_score":0.99947757},"labels":[],"label_agreement":null},{"id":"W3142780458","doi":"10.1097/igc.0000000000001216","title":"The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; European SocieTy for Radiotherapy and Oncology","keywords":"Medicine; Cervical cancer; Radiation oncology; Gynecologic oncology; Clinical Oncology; Gynaecological cancer; Oncology; Internal medicine; Radiation therapy; General surgery; Gynecology; Cancer","score_opus":0.06616388887206559,"score_gpt":0.38610355171556915,"score_spread":0.31993966284350356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142780458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273153,0.008349872,0.011321283,0.042852625,0.0030826484,0.0027483783,0.0006087747,0.00003251025,0.0036885838],"genre_scores_gemma":[0.9432635,0.016905013,0.031384747,0.0063101077,0.0017166191,0.00009592425,0.000020110743,0.000049157035,0.0002548636],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973068,0.000319624,0.0011874619,0.00030433535,0.00057210133,0.00030963836],"domain_scores_gemma":[0.99362093,0.0016813178,0.0013374233,0.00018196664,0.0030548894,0.00012346235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023985312,0.00024300024,0.00068612327,0.000033458666,0.00018528702,0.00001678912,0.0006187146,0.00012686664,0.00027761402],"category_scores_gemma":[0.00020758873,0.000112780595,0.0008763908,0.00016697026,0.0011368819,0.00006226893,0.00021665404,0.00028730964,6.2727054e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009824048,0.0022964792,0.07351057,0.00028908128,0.011151595,0.00004367992,0.0012861422,0.00014636586,0.0010602296,0.00041492618,0.033615146,0.86636174],"study_design_scores_gemma":[0.023111645,0.012836021,0.7615074,0.00018637908,0.0011627618,0.00003085347,0.000965649,0.0003892361,0.00038608693,0.00028549245,0.1989363,0.0002021783],"about_ca_topic_score_codex":0.000019230612,"about_ca_topic_score_gemma":0.00003136481,"teacher_disagreement_score":0.86615956,"about_ca_system_score_codex":0.0005831399,"about_ca_system_score_gemma":0.00020434898,"threshold_uncertainty_score":0.45990592},"labels":[],"label_agreement":null},{"id":"W3154751361","doi":"10.1136/ijgc-2021-002484","title":"Assessment of anastomotic perfusion using indocyanine green fluorescence angiography following bowel resection for gynecologic malignancies: an instructional surgical video","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Indocyanine green; Anastomosis; Perfusion; Bowel resection; Angiography; Radiology; Resection; Surgery","score_opus":0.03778399451916821,"score_gpt":0.3701307345170367,"score_spread":0.3323467399978685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154751361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942458,0.00094424904,0.0007341439,0.0015730581,0.002046907,0.00025267567,0.00005601346,0.000011061413,0.00013603637],"genre_scores_gemma":[0.9806289,0.00047201675,0.017854165,0.00022701586,0.0007018301,0.000035475674,0.00003116599,0.000014425709,0.000034982728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977699,0.000113783215,0.0007557011,0.00030871594,0.00082305144,0.00022883664],"domain_scores_gemma":[0.99718344,0.0004107495,0.0005356677,0.00012966736,0.0015663332,0.00017412985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047360687,0.0001775261,0.0005047453,0.0002910758,0.00009542892,0.00003791491,0.00018845874,0.0001523939,0.0009845027],"category_scores_gemma":[0.00027694012,0.00013508566,0.0007598846,0.0003094387,0.00008918939,0.0002608246,0.000071340524,0.00023580181,3.7772008e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016836585,0.0025722622,0.92235726,0.00008425249,0.0018622013,0.002458909,0.00008987738,0.0025976847,0.022642951,0.0014368127,0.00015676311,0.042057395],"study_design_scores_gemma":[0.006633733,0.0036427013,0.977741,0.00041443505,0.0005156193,0.0009565332,0.00016668683,0.0027527662,0.004956188,0.00064674893,0.0013997097,0.00017390218],"about_ca_topic_score_codex":0.00008916517,"about_ca_topic_score_gemma":0.000112347465,"teacher_disagreement_score":0.05538374,"about_ca_system_score_codex":0.00084383896,"about_ca_system_score_gemma":0.00078192307,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W3157009966","doi":"10.1136/ijgc-2021-002666","title":"Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymphadenectomy for vulvar cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Lymphedema; Lymphadenectomy; Lymphatic system; Gynecologic cancer; Complication; Vulvar cancer; Surgery; Incidence (geometry); Cancer; Vulva; Internal medicine; Pathology; Ovarian cancer; Breast cancer","score_opus":0.019708000452790867,"score_gpt":0.33410094866195494,"score_spread":0.3143929482091641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157009966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94891816,0.0059018224,0.00051195326,0.037130743,0.0058593387,0.0005220453,0.00008516908,0.000018207267,0.0010525608],"genre_scores_gemma":[0.9787639,0.00050465565,0.0011533189,0.013020671,0.0025832378,0.0002452168,0.0000070701703,0.000022310101,0.0036996633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792236,0.00009563808,0.0007201149,0.00025045534,0.00075783976,0.00025357198],"domain_scores_gemma":[0.9973528,0.0006936619,0.00038864458,0.00015472418,0.0011347538,0.00027542352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036619094,0.00018036854,0.00047836307,0.000096967335,0.00010695201,0.00007940415,0.00032453373,0.000097994176,0.0070361923],"category_scores_gemma":[0.00093685254,0.000107100044,0.00055534596,0.00018481495,0.000050669056,0.0001539576,0.00007318075,0.00002293908,0.000052333693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00466778,0.0038825904,0.46077964,0.00048179168,0.017582344,0.004344653,0.0025343993,0.0015315666,0.046487294,0.0009806432,0.1603706,0.2963567],"study_design_scores_gemma":[0.046285808,0.0026469638,0.5184737,0.0070824716,0.0066631734,0.01257192,0.0020257884,0.0031120374,0.13466953,0.010501139,0.25398633,0.0019811548],"about_ca_topic_score_codex":0.000028349274,"about_ca_topic_score_gemma":0.000024409368,"teacher_disagreement_score":0.29437557,"about_ca_system_score_codex":0.0010473692,"about_ca_system_score_gemma":0.0014818396,"threshold_uncertainty_score":0.9938715},"labels":[],"label_agreement":null},{"id":"W3161283469","doi":"10.1136/ijgc-2021-002476","title":"Continuing medical education during COVID-19: virtual training for gynecologic oncology management in Rwanda","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"Merck","keywords":"Medicine; Gynecologic oncology; Landlocked country; Incidence (geometry); Coronavirus disease 2019 (COVID-19); Gynecologic cancer; Population; Family medicine; Cancer; Internal medicine; Gynecology; Ovarian cancer; Environmental health","score_opus":0.08882130369841984,"score_gpt":0.47807532754738497,"score_spread":0.3892540238489651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161283469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8974996,0.00082951,0.0012144299,0.096147396,0.0028421471,0.00034223348,0.000011561779,0.000018682389,0.0010944416],"genre_scores_gemma":[0.96270674,0.0016966336,0.001411862,0.03255861,0.00094076263,0.00008360143,0.000014249439,0.00001147237,0.00057606795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774474,0.0001358346,0.0008312507,0.000252721,0.00071182626,0.0003236236],"domain_scores_gemma":[0.99679756,0.0013279414,0.0003913251,0.00008589107,0.00076599215,0.0006313165],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010944242,0.00013855903,0.0004924385,0.00031031485,0.00006379712,0.00003068591,0.00025060296,0.00024725022,0.0037039204],"category_scores_gemma":[0.013126154,0.00011272401,0.00019561617,0.00017556672,0.00008054192,0.00011379282,0.00009596471,0.00050039124,0.0000032084001],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038802128,0.0018150173,0.049473427,0.00027005209,0.000545075,0.008417051,0.0023240726,0.0006400905,0.0009774951,0.0054912576,0.0038050045,0.92236125],"study_design_scores_gemma":[0.018552704,0.0022352156,0.5982003,0.0008296502,0.00018412873,0.0025236479,0.005212333,0.00043773907,0.00046522633,0.0037250135,0.3673216,0.00031241227],"about_ca_topic_score_codex":0.00003934458,"about_ca_topic_score_gemma":0.0007462741,"teacher_disagreement_score":0.9220488,"about_ca_system_score_codex":0.0029845794,"about_ca_system_score_gemma":0.006666013,"threshold_uncertainty_score":0.99896526},"labels":[],"label_agreement":null},{"id":"W3168769114","doi":"10.1136/ijgc-2020-002367","title":"Management of Wolffian adnexal tumors","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Mesonephric duct; Past medical history; Adnexal mass; Quadrant (abdomen); Gynecology; Adnexal Diseases; Medical history; General surgery; Radiology; Surgery; Internal medicine; Laparoscopy","score_opus":0.03351712860077428,"score_gpt":0.35351648969901284,"score_spread":0.31999936109823857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168769114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97380316,0.0026859099,0.00015413239,0.0058471877,0.0016366588,0.00009617894,0.0000250215,0.0000082287725,0.015743533],"genre_scores_gemma":[0.9945264,0.0014106358,0.001667992,0.0008320544,0.0003646859,0.0000070958017,0.000005596655,0.000006141086,0.0011794396],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99863046,0.000030855306,0.0004704063,0.000114559094,0.0006345023,0.00011918795],"domain_scores_gemma":[0.9986392,0.000113242146,0.00026762963,0.00007308048,0.0007812233,0.00012557094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012935796,0.00008619861,0.00031692546,0.00009319818,0.000013806863,0.000010663822,0.00016596707,0.0000517626,0.0065075215],"category_scores_gemma":[0.00014513891,0.000058482685,0.00023655729,0.0001973577,0.000048432838,0.000057058718,0.00007254855,0.00015616285,0.000008811529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065630144,0.004483722,0.2851975,0.0002486449,0.0077008726,0.03266037,0.0001693752,0.00032612067,0.0056718457,0.009440183,0.0032644845,0.6442739],"study_design_scores_gemma":[0.011349632,0.0014816932,0.9221904,0.00072178507,0.00047817008,0.0007491829,0.00033459632,0.000017108734,0.022427227,0.0024711126,0.03761187,0.00016720346],"about_ca_topic_score_codex":0.000012822972,"about_ca_topic_score_gemma":0.000007014957,"teacher_disagreement_score":0.6441067,"about_ca_system_score_codex":0.00028179676,"about_ca_system_score_gemma":0.00016798486,"threshold_uncertainty_score":0.9944007},"labels":[],"label_agreement":null},{"id":"W3170209696","doi":"10.1136/ijgc-2020-002240","title":"Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"National Cancer Institute; Takeda Oncology; Janssen Research and Development; EMD Serono; Genentech; Shire; Astellas Pharma; Eisai; University College London; Syndax Pharmaceuticals; Mersana Therapeutics; National Institute for Health and Care Research; Clovis Oncology; U.S. Department of Defense; National Comprehensive Cancer Network; Ovarian Cancer Research Fund; Gateway Foundation; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Amgen; American Association for Cancer Research; National Ovarian Cancer Coalition; National Institutes of Health; Regeneron Pharmaceuticals; Ipsen; Array BioPharma; Ludwig Institute for Cancer Research; Memorial Sloan-Kettering Cancer Center; PharmaMar; Yale University; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; NuCana; Incyte; Pfizer; Ovarian Cancer Research Fund Alliance; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Medicine; Internal medicine; Progression-free survival; Population; Oncology; Placebo; Randomized controlled trial; Confidence interval; PARP inhibitor; Gastroenterology; Surgery; Chemotherapy; Poly ADP ribose polymerase; Pathology; Polymerase","score_opus":0.035228706060634864,"score_gpt":0.3851610700811711,"score_spread":0.34993236402053624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170209696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643179,0.0062893573,0.00041627168,0.025437495,0.0014270528,0.0019656143,0.00003757601,0.0000040144882,0.000104673905],"genre_scores_gemma":[0.9937606,0.0037030103,0.00035383023,0.0012351086,0.0004990573,0.00038737044,0.0000057208067,0.000007826522,0.0000475008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99819756,0.00039696938,0.00066716335,0.00017946181,0.00041697858,0.00014188098],"domain_scores_gemma":[0.9936031,0.0053283926,0.0004921167,0.00014636976,0.00037246005,0.00005755421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000991204,0.00015386549,0.00062681385,0.00006985356,0.000063747146,0.000036513484,0.0002103149,0.00007323529,0.00009682264],"category_scores_gemma":[0.002199664,0.00006668288,0.00022824731,0.00007482223,0.00029748946,0.000049988448,0.0000414247,0.00024460827,1.1277712e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8659853,0.0017672796,0.00037907518,0.000034454697,0.0006232174,0.00015453383,0.001880208,0.000005068556,0.00059683126,0.0025427719,0.00053701404,0.12549426],"study_design_scores_gemma":[0.9657434,0.00882454,0.0129975425,0.00073357817,0.00023748558,0.00016646633,0.00028139944,0.00010772829,0.0023150898,0.0026405693,0.005858679,0.00009348225],"about_ca_topic_score_codex":0.000016949058,"about_ca_topic_score_gemma":0.000040345607,"teacher_disagreement_score":0.12540077,"about_ca_system_score_codex":0.000268314,"about_ca_system_score_gemma":0.00025520395,"threshold_uncertainty_score":0.27192488},"labels":[],"label_agreement":null},{"id":"W3182504797","doi":"10.1136/ijgc-2021-002841","title":"Enhanced recovery after surgery in gynecologic oncology: time to address barriers to implementation in low- and middle-income countries","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Gynecologic oncology; Gynecologic cancer; Citation; General surgery; Oncology; Internal medicine; Cancer; Library science","score_opus":0.016260919533769014,"score_gpt":0.3314598302806849,"score_spread":0.31519891074691586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182504797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98767835,0.0006009919,0.000079976075,0.009333675,0.001582373,0.00031200846,0.00005142504,0.000011067248,0.00035012644],"genre_scores_gemma":[0.9868129,0.0008200287,0.0006264572,0.010911332,0.00026213247,0.00017279995,0.00000932812,0.000016630971,0.0003684265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974346,0.00022213889,0.0010882441,0.00035532142,0.00052004156,0.0003796325],"domain_scores_gemma":[0.99662167,0.001846501,0.0003109635,0.00011480682,0.00069198536,0.00041407984],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009996613,0.00020335539,0.00074986095,0.00068543636,0.000024866296,0.00005450982,0.00016192632,0.00019676492,0.011996168],"category_scores_gemma":[0.0031831013,0.00017555962,0.00016491536,0.00041405726,0.000058807484,0.00031153788,0.00015877669,0.0003859944,0.000058911264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013571298,0.0005523661,0.91299105,0.0002173918,0.00048648161,0.013348135,0.0011972387,0.0016184733,0.010493628,0.000018890833,0.0020071822,0.04349784],"study_design_scores_gemma":[0.0019845038,0.0008107771,0.972881,0.0016883314,0.00003631614,0.00021494235,0.00033593122,0.000014314741,0.016123919,0.00017556563,0.0054568676,0.0002774982],"about_ca_topic_score_codex":0.000030463087,"about_ca_topic_score_gemma":0.0014169825,"teacher_disagreement_score":0.059889957,"about_ca_system_score_codex":0.0018426684,"about_ca_system_score_gemma":0.0012872898,"threshold_uncertainty_score":0.988907},"labels":[],"label_agreement":null},{"id":"W3183967008","doi":"10.1136/ijgc-2021-002601","title":"Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Medicine; Cervical cancer; Proportional hazards model; Hazard ratio; Radiation therapy; Internal medicine; Stage (stratigraphy); Cancer; Oncology; Chemoradiotherapy; Survival analysis; Gynecology; Confidence interval","score_opus":0.04565743820447126,"score_gpt":0.3935156590547687,"score_spread":0.34785822085029744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183967008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940326,0.001068444,0.00005283205,0.001997636,0.00085184636,0.00022148041,0.000063698644,0.000011311215,0.0017001147],"genre_scores_gemma":[0.99718434,0.0010008023,0.00012182356,0.0006735709,0.0004709901,0.000042852327,0.000056610384,0.000017576114,0.00043141373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750775,0.00008224817,0.0006079404,0.0002565643,0.0012608416,0.0002846599],"domain_scores_gemma":[0.99743545,0.00019791028,0.00031655197,0.0001168352,0.0017597203,0.00017354476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026031866,0.00016091787,0.00045918798,0.00020338784,0.000060823197,0.00006192138,0.00024947175,0.00013346678,0.0225741],"category_scores_gemma":[0.0004267521,0.00010670076,0.000115498005,0.00037454296,0.00009037775,0.00023732349,0.0000773208,0.0005569715,0.0000078362955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03840206,0.0037739158,0.8059732,0.00007576818,0.0005246766,0.0006989046,0.0003727557,0.00071316375,0.0033088503,0.00020915887,0.00043355348,0.14551401],"study_design_scores_gemma":[0.030234247,0.0024054109,0.95855993,0.000068747286,0.00007581195,0.00001429972,0.000094214854,0.0003988907,0.0025583038,0.000036760284,0.0053906124,0.00016277729],"about_ca_topic_score_codex":0.00044652342,"about_ca_topic_score_gemma":0.0027104223,"teacher_disagreement_score":0.15258674,"about_ca_system_score_codex":0.0015834342,"about_ca_system_score_gemma":0.00094468077,"threshold_uncertainty_score":0.9783194},"labels":[],"label_agreement":null},{"id":"W3184735255","doi":"10.1136/ijgc-2021-002752","title":"High laparoscopic bilateral ovarian transposition to the upper abdomen prior to pelvic radiotherapy","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Abdomen; Radiology; Surgery","score_opus":0.020305666211566174,"score_gpt":0.3309747790629615,"score_spread":0.31066911285139537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184735255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88318735,0.00061444216,0.0011151269,0.11219261,0.0023697393,0.00023908427,0.00004330749,0.0000107185615,0.00022759156],"genre_scores_gemma":[0.9675861,0.00042522355,0.0040215235,0.025593666,0.0013771361,0.000045215376,0.000009383037,0.000012320124,0.00092945376],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998507,0.00007465552,0.0004147607,0.00018720193,0.00061970524,0.00019663366],"domain_scores_gemma":[0.9987562,0.00018457683,0.000113060276,0.000109654145,0.00058757816,0.00024896913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017763386,0.00013117795,0.00034631745,0.0001332323,0.000056045617,0.00005754147,0.0002480653,0.00006698302,0.005941963],"category_scores_gemma":[0.00017642585,0.00007336826,0.00020369967,0.00031568157,0.000024284804,0.00007748346,0.000032024815,0.0002186001,0.000038354552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029754013,0.0041536647,0.16238008,0.00008260852,0.006639102,0.005883144,0.0032900132,0.00559251,0.10749752,0.0042906892,0.014514651,0.655922],"study_design_scores_gemma":[0.007469778,0.001998055,0.9234624,0.00015449456,0.00015841295,0.000273483,0.000052152096,0.0000134447155,0.010386993,0.0006664078,0.055222187,0.00014221262],"about_ca_topic_score_codex":0.000079737096,"about_ca_topic_score_gemma":0.00008071853,"teacher_disagreement_score":0.7610823,"about_ca_system_score_codex":0.00066093146,"about_ca_system_score_gemma":0.00021582487,"threshold_uncertainty_score":0.99496675},"labels":[],"label_agreement":null},{"id":"W3194982821","doi":"10.1136/ijgc-2021-002910","title":"Correspondence on \"ESGO/ISUOG/IOTA/ESGE consensus statement on pre-operative diagnosis of ovarian tumors\" by Timmerman et al","year":2021,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Ultrasonography; Statement (logic); Consensus conference; Gynecology; Ovarian carcinoma; General surgery; Ovarian cancer; Surgery; Internal medicine; Cancer; Law","score_opus":0.03985683519524161,"score_gpt":0.38220260456899674,"score_spread":0.34234576937375516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194982821","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16579157,0.0012694502,0.000011606985,0.8265754,0.0030839604,0.00055207283,0.0014574712,0.000010431291,0.0012480195],"genre_scores_gemma":[0.28468412,0.002976025,0.0002273778,0.7082392,0.0012609108,0.00023199616,0.0002639172,0.000049324943,0.0020671645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542016,0.00041914315,0.0013167305,0.0005685566,0.0019133952,0.00036200281],"domain_scores_gemma":[0.9943397,0.0021202727,0.0014404262,0.0002786962,0.0016302295,0.00019068556],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045018247,0.0004926329,0.0011409007,0.0002853774,0.000051769224,0.000079857105,0.00044433272,0.00035979896,0.010388952],"category_scores_gemma":[0.0007084427,0.00034866497,0.0005019044,0.00014176576,0.00018808487,0.000056220535,0.00010737549,0.001917036,0.00003518564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019412491,0.0015906483,0.007807749,0.000038593676,0.0020565179,0.010517829,0.00017282393,0.00031517973,0.00016093945,0.00012243852,0.9722966,0.00297943],"study_design_scores_gemma":[0.0051261233,0.006507073,0.0428723,0.002725159,0.00039378056,0.00023702644,0.00006293877,0.000036310343,0.003837987,0.000065721826,0.9377546,0.00038102805],"about_ca_topic_score_codex":0.00017677915,"about_ca_topic_score_gemma":0.000051053077,"teacher_disagreement_score":0.11889254,"about_ca_system_score_codex":0.0021125406,"about_ca_system_score_gemma":0.0013275075,"threshold_uncertainty_score":0.9998965},"labels":[],"label_agreement":null},{"id":"W3196951793","doi":"10.1136/ijgc-2021-002840","title":"Surgical technique for sentinel lymph node sampling in endometrial cancer using the articulated HOOK monopolar instrument","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Sentinel lymph node; Lymphadenectomy; Endometrial cancer; Lymph node; Hook; Sampling (signal processing); Lymph; Sentinel node; Cancer; Surgery; General surgery; Internal medicine; Pathology; Breast cancer; Telecommunications","score_opus":0.0863926144736647,"score_gpt":0.3936659107485605,"score_spread":0.3072732962748958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196951793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865755,0.0029642673,0.0020027251,0.006165935,0.0016847834,0.00040320112,0.000049013517,0.000009925037,0.00014465384],"genre_scores_gemma":[0.9936446,0.0012792457,0.0024694633,0.0010589482,0.0013022426,0.00014251843,0.000010585341,0.00001550162,0.000076903074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980049,0.0001047734,0.0007594451,0.00022334793,0.00062872935,0.000278801],"domain_scores_gemma":[0.99770236,0.0008244445,0.00035264232,0.000099943885,0.0008834265,0.00013717906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005001278,0.00016627289,0.0004905276,0.00022581262,0.00006213865,0.000050537503,0.00021420713,0.00014448068,0.0012716271],"category_scores_gemma":[0.0010298473,0.00010004145,0.00036055298,0.0005009586,0.00006809356,0.000098058576,0.00009224883,0.0003160673,0.0000012131925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011490053,0.002222116,0.84841037,0.000080420505,0.0025043304,0.0028097357,0.00012364502,0.007645157,0.08097753,0.00060640206,0.00013378925,0.042996433],"study_design_scores_gemma":[0.09813692,0.0009785666,0.6617472,0.0018890003,0.0016071346,0.003365705,0.00045932716,0.0046878816,0.18457824,0.004783486,0.03682312,0.0009433842],"about_ca_topic_score_codex":0.00019841548,"about_ca_topic_score_gemma":0.00002539839,"teacher_disagreement_score":0.18666315,"about_ca_system_score_codex":0.001355092,"about_ca_system_score_gemma":0.000612573,"threshold_uncertainty_score":0.99964136},"labels":[],"label_agreement":null},{"id":"W3200393034","doi":"10.1136/ijgc-2021-002771","title":"High-grade endometrial carcinoma limited to the endometrium or a polyp: is adjuvant treatment necessary?","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Carcinoma; Carcinosarcoma; Hysterectomy; Clear cell carcinoma; Endometrial cancer; Endometrium; Stage (stratigraphy); Adenocarcinoma; Surgery; Internal medicine; Cancer","score_opus":0.06372522664066063,"score_gpt":0.3549222331774995,"score_spread":0.2911970065368389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200393034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274164,0.0062826183,0.00015180843,0.05888066,0.0059289243,0.00048352673,0.00027193138,0.00002268499,0.0005614792],"genre_scores_gemma":[0.98018014,0.0026232325,0.0009074664,0.010366764,0.003417974,0.000084479376,0.000022523318,0.000021050351,0.0023763408],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970408,0.00015583918,0.0008329429,0.0003442576,0.0012588731,0.0003672833],"domain_scores_gemma":[0.9960532,0.0016529226,0.0003911321,0.00023670618,0.0012336387,0.00043238662],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027063108,0.00027991895,0.00080352416,0.0005079331,0.00008871327,0.000092855036,0.0004450405,0.00013986339,0.011001702],"category_scores_gemma":[0.0028483267,0.00013383826,0.0005630089,0.0014225929,0.00006585608,0.00011660976,0.00014363427,0.00032652417,0.00005940004],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058311183,0.009788361,0.13909528,0.000055485776,0.010981608,0.025166065,0.0011954166,0.00049737614,0.019574286,0.0007462845,0.03364381,0.70094484],"study_design_scores_gemma":[0.056530982,0.014925043,0.49839452,0.00019430413,0.001426106,0.002063443,0.00050196145,0.0000401444,0.0852785,0.00040146318,0.3397761,0.0004674367],"about_ca_topic_score_codex":0.00042769575,"about_ca_topic_score_gemma":0.0002298277,"teacher_disagreement_score":0.7004774,"about_ca_system_score_codex":0.0015132211,"about_ca_system_score_gemma":0.0008301739,"threshold_uncertainty_score":0.9899024},"labels":[],"label_agreement":null},{"id":"W3201333387","doi":"10.1136/ijgc-2021-002973","title":"ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Institute for Health and Care Research; Cancer Research UK; European Society for Medical Oncology; Royal Marsden NHS Foundation Trust; AstraZeneca","keywords":"Olaparib; ARID1A; Medicine; Clear cell carcinoma; Cancer research; Endometrial cancer; Oncology; Serous fluid; Carcinosarcoma; Carcinoma; Internal medicine; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Polymerase","score_opus":0.016548853655433866,"score_gpt":0.2995015857474742,"score_spread":0.28295273209204036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201333387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957469,0.000427373,0.0003794179,0.0016686463,0.0010822181,0.0002275787,0.000029459601,0.0000073886767,0.00043101923],"genre_scores_gemma":[0.9957673,0.001044243,0.0009631841,0.0010093317,0.0006469075,0.00006796742,0.000043838947,0.000019778177,0.00043743092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978837,0.00016132898,0.0006799749,0.00039937874,0.00056919176,0.00030645268],"domain_scores_gemma":[0.99817073,0.00017139083,0.00040738817,0.00015633288,0.0009787044,0.00011544118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004248505,0.00022977246,0.00041638876,0.000107998625,0.000039793427,0.00006415967,0.0003884655,0.00025714844,0.000679973],"category_scores_gemma":[0.00064647355,0.00014911633,0.00011466136,0.00023148605,0.00016042824,0.000030768202,0.00010943838,0.00045544276,0.0000038566673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2511336,0.0062077353,0.5336977,0.00016857688,0.0018277252,0.0107161505,0.0006382229,0.11008502,0.03529384,0.0006437725,0.009066995,0.04052065],"study_design_scores_gemma":[0.3641754,0.04153394,0.4028406,0.00211663,0.0003373079,0.0027984446,0.001426902,0.004691771,0.060431857,0.0013301265,0.11514176,0.0031752598],"about_ca_topic_score_codex":0.00021577024,"about_ca_topic_score_gemma":0.0085547725,"teacher_disagreement_score":0.13085711,"about_ca_system_score_codex":0.000789359,"about_ca_system_score_gemma":0.0016069079,"threshold_uncertainty_score":0.74452275},"labels":[],"label_agreement":null},{"id":"W3204360130","doi":"10.1136/ijgc-2021-002933","title":"ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research; Clovis Oncology; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.028380843124332988,"score_gpt":0.37404610184741677,"score_spread":0.3456652587230838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204360130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96850216,0.0022221624,0.005194073,0.019959731,0.0012133097,0.0022106855,0.000046333447,0.000028705224,0.00062283466],"genre_scores_gemma":[0.98451376,0.0029923194,0.0033341988,0.006760126,0.00058611715,0.0011408787,0.000035739664,0.00006538178,0.0005714903],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99553055,0.000512786,0.0015732319,0.00065997953,0.0012134716,0.00051000103],"domain_scores_gemma":[0.9968169,0.0008800075,0.0008646021,0.00026823636,0.0008439559,0.0003263405],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014823017,0.0005137799,0.0017647451,0.0005250311,0.00008648438,0.00011489827,0.00031875473,0.00025390318,0.0022519266],"category_scores_gemma":[0.0005405405,0.00036709008,0.0004786818,0.0004644273,0.00018558018,0.00027846248,0.00003630528,0.00057626737,0.0000061935884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9292773,0.005587657,0.0046203476,0.000020725414,0.00186727,0.0013734996,0.0034179064,0.0048240214,0.008056595,0.0008906093,0.00033452502,0.039729565],"study_design_scores_gemma":[0.970534,0.005463549,0.00249875,0.0009510367,0.00024136223,0.0001754208,0.0003320869,0.0058076065,0.006751525,0.0030375004,0.003741344,0.00046579482],"about_ca_topic_score_codex":0.0014511604,"about_ca_topic_score_gemma":0.000984413,"teacher_disagreement_score":0.041256744,"about_ca_system_score_codex":0.003331222,"about_ca_system_score_gemma":0.0019116577,"threshold_uncertainty_score":0.9998781},"labels":[],"label_agreement":null},{"id":"W3204978188","doi":"10.1136/ijgc-2021-esgo.124","title":"189 Laparoscopic repair of obturator nerve injury at the time of pelvic lymphadenectomy","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Pelvic and Acetabular Injuries","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"","keywords":"Obturator nerve; Medicine; Lumbar plexus; Surgery; External iliac vein; Endometrial cancer; Neurovascular bundle; Dissection (medical); Lymphadenectomy; Femoral nerve; Groin; Lymph node; Lumbar; Cancer; Vein","score_opus":0.013684010576935282,"score_gpt":0.31673580238005344,"score_spread":0.30305179180311814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204978188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989586,0.004588085,0.000009641243,0.003779709,0.0007750363,0.00006867033,0.000050503695,0.0000083054965,0.0011340512],"genre_scores_gemma":[0.9942328,0.0005213479,0.00023373947,0.0012365609,0.00036807987,0.0000047250287,0.0000067249734,0.0000076274036,0.0033884377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840355,0.00008801635,0.0006305583,0.00012174115,0.0006321044,0.00012402162],"domain_scores_gemma":[0.9977608,0.00028310038,0.0005545353,0.00014168955,0.0011844866,0.00007542247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027490588,0.00010423843,0.0004452455,0.00006525726,0.00003066287,0.000009279136,0.00022433659,0.00009121061,0.006736958],"category_scores_gemma":[0.00068916014,0.000060135328,0.00034970735,0.00012805703,0.00021247925,0.00007885268,0.00013895189,0.00017617764,0.000015546597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003899138,0.0013690649,0.53196365,0.00017436843,0.0033281264,0.0015686823,0.000689391,0.00014764415,0.3758472,0.0013234275,0.0710664,0.008622921],"study_design_scores_gemma":[0.004011819,0.0011318588,0.58621556,0.0004721907,0.00042427453,0.0007067739,0.0002786707,0.00009761825,0.34885192,0.0005754265,0.057055257,0.00017864254],"about_ca_topic_score_codex":0.000019495401,"about_ca_topic_score_gemma":0.00002006446,"teacher_disagreement_score":0.05425191,"about_ca_system_score_codex":0.0002353373,"about_ca_system_score_gemma":0.00049532996,"threshold_uncertainty_score":0.994171},"labels":[],"label_agreement":null},{"id":"W3205218264","doi":"10.1136/ijgc-2021-esgo.171","title":"595 Implementation of collaborative translational research (TransPORTEC) findings in an international endometrial cancer clinical trials program (RAINBO)","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clinical trial; Biobank; Translational science; Translational research; Medicine; Medical education; Medical physics; Family medicine; Oncology; Internal medicine; Pathology; Bioinformatics","score_opus":0.20163532276953386,"score_gpt":0.5738976185236626,"score_spread":0.3722622957541287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205218264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210846,0.0013407492,0.00022108984,0.0024389075,0.002694981,0.00034326024,0.0006770994,0.000002844519,0.0001725844],"genre_scores_gemma":[0.98733085,0.008548055,0.0016440029,0.00024586282,0.0018876416,0.00009553479,0.00020620985,0.000012886154,0.000028964381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996372,0.00068496447,0.0016088438,0.00031612316,0.0008018326,0.0002162669],"domain_scores_gemma":[0.9948843,0.0009493702,0.00060386676,0.000111052046,0.0033268025,0.00012459012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004201553,0.00013272297,0.00045768404,0.00026548665,0.000036503832,0.000069356814,0.0004966482,0.00021283246,0.0016200965],"category_scores_gemma":[0.0030130146,0.00011718785,0.00028485377,0.00033091396,0.00016785246,0.000038732047,0.00007308947,0.00035585553,7.757155e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032414333,0.0013686253,0.6815936,0.000010653826,0.00087260373,0.00014077415,0.00031464483,0.001567462,0.0899545,0.0009599824,0.0015193835,0.21845634],"study_design_scores_gemma":[0.014079361,0.0029033972,0.77006984,0.00010221797,0.0001075466,0.000028886705,0.0011690481,0.0001470144,0.12435687,0.0012458276,0.08545259,0.00033742507],"about_ca_topic_score_codex":0.00011186689,"about_ca_topic_score_gemma":0.002520277,"teacher_disagreement_score":0.21811892,"about_ca_system_score_codex":0.00018290943,"about_ca_system_score_gemma":0.0018533104,"threshold_uncertainty_score":0.99929255},"labels":[],"label_agreement":null},{"id":"W3205316473","doi":"10.1136/ijgc-2021-esgo.616","title":"231 Molecular subclassification of vulvar squamous cell carcinoma: prognostic significance and reproducibility","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Vulvar Carcinoma; Immunohistochemistry; Medicine; Vulvar intraepithelial neoplasia; Vulva; Oncology; Vulvar cancer; Internal medicine; Vulvar neoplasm; Pathology","score_opus":0.039658129173794666,"score_gpt":0.3463613307430684,"score_spread":0.3067032015692737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205316473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869106,0.0049184645,0.00035619267,0.004356366,0.00046656717,0.00019246091,0.000019858846,0.0000062071267,0.0027732875],"genre_scores_gemma":[0.9982728,0.00030864956,0.0005278646,0.00038962334,0.0002493631,0.000016868822,0.0000071176596,0.000008930525,0.00021881152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980196,0.00012024752,0.00055900717,0.00039755658,0.0007422286,0.00016140706],"domain_scores_gemma":[0.99612993,0.00042508545,0.0002881894,0.00027722865,0.002710652,0.0001689297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071535417,0.000103064405,0.00033540546,0.00008420855,0.000024504383,0.00002278105,0.00018834407,0.00009245669,0.0024691217],"category_scores_gemma":[0.003610752,0.000079173835,0.00013890487,0.00017848943,0.00016504778,0.00007425918,0.00009059596,0.00034772247,0.0000024346189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001605934,0.0013672651,0.76112443,0.0002695548,0.00012080512,0.0012699561,0.0001511358,0.00009900623,0.20064224,0.00053917646,0.00074855925,0.03206192],"study_design_scores_gemma":[0.0016414761,0.000596963,0.86699814,0.000016755863,0.00008269663,0.0001249394,0.0000759089,0.00008949235,0.12832373,0.00079500914,0.0011793694,0.000075501484],"about_ca_topic_score_codex":0.000058665366,"about_ca_topic_score_gemma":0.000027371354,"teacher_disagreement_score":0.105873704,"about_ca_system_score_codex":0.00027041038,"about_ca_system_score_gemma":0.0006679563,"threshold_uncertainty_score":0.99844277},"labels":[],"label_agreement":null},{"id":"W3205660495","doi":"10.1136/ijgc-2021-esgo.58","title":"694 Cervical cancer application (CER-CAP): a new App for estimation of the lymph nodal risk invasion in patients with early-stage cervical cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Medicine; Micrometastasis; Cervical cancer; Stage (stratigraphy); Sentinel lymph node; Oncology; Lymph node; Internal medicine; Logistic regression; Sentinel node; Nomogram; Gynecologic oncology; Proportional hazards model; Multivariate analysis; Cancer; Breast cancer","score_opus":0.020003558157669077,"score_gpt":0.31016635650180135,"score_spread":0.2901627983441323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205660495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990028,0.00091046625,0.0022646233,0.004771065,0.000934979,0.000667715,0.00026923144,0.00001183224,0.00014209187],"genre_scores_gemma":[0.9961485,0.00057763996,0.0011513669,0.0010289791,0.00055461476,0.00018505464,0.00003424318,0.000024219056,0.00029537015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973718,0.00010543525,0.0008229189,0.00033480674,0.0010976425,0.00026742768],"domain_scores_gemma":[0.99704564,0.0004173468,0.00084222323,0.00019008412,0.001293014,0.00021167053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022317865,0.0002249275,0.0005651423,0.00015156511,0.00006314966,0.00003237027,0.00036534615,0.0001958944,0.0016097937],"category_scores_gemma":[0.00055481103,0.00013233867,0.00029156386,0.0005262929,0.00009463589,0.00018074598,0.00011758237,0.00037348943,0.0000030450406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047970084,0.0008959711,0.8864494,0.00006097787,0.00041847117,0.000016181928,0.000105343664,0.0060760775,0.00017991223,0.00015228231,0.000184045,0.10066434],"study_design_scores_gemma":[0.013952048,0.0005855847,0.97894126,0.00033581743,0.00030372618,0.0000071973054,0.000028223336,0.0011399222,0.002164143,0.00063229946,0.0017630953,0.0001466711],"about_ca_topic_score_codex":0.0027360332,"about_ca_topic_score_gemma":0.0020433944,"teacher_disagreement_score":0.10051767,"about_ca_system_score_codex":0.0012443361,"about_ca_system_score_gemma":0.0010198315,"threshold_uncertainty_score":0.99930286},"labels":[],"label_agreement":null},{"id":"W3206125898","doi":"10.1136/ijgc-2021-esgo.131","title":"272 Dostarlimab in advanced/recurrent mismatch repair deficient/microsatellite instability high or proficient/stable endometrial cancer: the GARNET study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Microsatellite instability; Endometrial cancer; Medicine; Internal medicine; Regimen; Discontinuation; Oncology; Cohort; Cancer; DNA mismatch repair; Biology; Colorectal cancer; Microsatellite","score_opus":0.0420416897781298,"score_gpt":0.36080014882368067,"score_spread":0.3187584590455509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206125898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981651,0.006829084,0.000026016029,0.0031590955,0.006974571,0.0009695688,0.00011755072,0.000027683694,0.00024543586],"genre_scores_gemma":[0.9952982,0.0020091585,0.0006784122,0.0009375389,0.0005236278,0.0001839603,0.000014485208,0.000022480102,0.0003321294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995878,0.0003573679,0.0012755737,0.0005336103,0.0014829588,0.00047251856],"domain_scores_gemma":[0.9960447,0.0009596569,0.00059231394,0.00032301288,0.0018986091,0.00018169318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001217146,0.00029197702,0.0007191528,0.0002371857,0.00008938783,0.000082870654,0.00056965015,0.00018651897,0.0043942104],"category_scores_gemma":[0.0027598194,0.00017127636,0.0003248648,0.0008623827,0.00019010744,0.000141361,0.00029235985,0.0011167101,0.000007300354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018941406,0.006911793,0.8787934,0.00009058915,0.00086942624,0.0021694563,0.0018466132,0.006082974,0.007823618,0.000082733095,0.0014697746,0.074918196],"study_design_scores_gemma":[0.019406326,0.005976453,0.89755917,0.0006018971,0.00036230378,0.0004378845,0.003447607,0.00033259057,0.014612676,0.0003667373,0.056379166,0.0005171941],"about_ca_topic_score_codex":0.00036422192,"about_ca_topic_score_gemma":0.0031060458,"teacher_disagreement_score":0.074401006,"about_ca_system_score_codex":0.0024246285,"about_ca_system_score_gemma":0.0018456036,"threshold_uncertainty_score":0.9965159},"labels":[],"label_agreement":null},{"id":"W3206338191","doi":"10.1136/ijgc-2021-esgo.360","title":"225 Avelumab alone in platinum-resistant/refractory ovarian cancer: selected biomarker analyses from the JAVELIN Ovarian 200 trial","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Avelumab; Medicine; Ovarian cancer; Internal medicine; Hazard ratio; Oncology; Progression-free survival; Biomarker; Bevacizumab; Cancer; Immunotherapy; Confidence interval; Chemotherapy; Pembrolizumab; Biology","score_opus":0.07675292072476093,"score_gpt":0.38714916161761215,"score_spread":0.3103962408928512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206338191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94704276,0.009098883,0.00014622226,0.03811356,0.0037419354,0.00041157648,0.00038122653,0.000019421765,0.0010443978],"genre_scores_gemma":[0.9912934,0.0032154138,0.0008305954,0.0023431494,0.0017857036,0.00009608663,0.00007404146,0.00002264517,0.00033901454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970184,0.00029365445,0.0010507647,0.00038476064,0.0009373835,0.0003150549],"domain_scores_gemma":[0.9964361,0.0012417817,0.0006276868,0.0002249848,0.0012820889,0.00018736279],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038742452,0.00026392305,0.00071293674,0.0001675624,0.000091410264,0.00010646963,0.00037173915,0.00021474624,0.0137797985],"category_scores_gemma":[0.0011064773,0.00016484907,0.00029568697,0.0005345841,0.00010709456,0.00015035679,0.0000902489,0.0005870101,0.000011670116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16451955,0.010332072,0.4954319,0.000037945018,0.017955301,0.018673277,0.0010833878,0.0011905207,0.052253112,0.00085758534,0.049190484,0.18847486],"study_design_scores_gemma":[0.055580374,0.0006596927,0.9216266,0.00034020844,0.0005218832,0.00007320727,0.00015214231,0.00018598557,0.0022756674,0.0003701227,0.018011387,0.0002026878],"about_ca_topic_score_codex":0.0030413095,"about_ca_topic_score_gemma":0.0053480975,"teacher_disagreement_score":0.42619473,"about_ca_system_score_codex":0.0015144155,"about_ca_system_score_gemma":0.0018310074,"threshold_uncertainty_score":0.98712176},"labels":[],"label_agreement":null},{"id":"W3206448916","doi":"10.1136/ijgc-2021-esgo.156","title":"482 Tertiary lymphoid structures as markers of anti-tumor immunity with independent prognostic value in the PORTEC-3 trial of high-risk endometrial cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Germinal center; Immunohistochemistry; Endometrial cancer; Medicine; Oncology; Cancer; Internal medicine; Pathology; Cancer research; Biology; Antibody; B cell; Immunology","score_opus":0.01618138655093317,"score_gpt":0.3054717830177106,"score_spread":0.28929039646677746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206448916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938964,0.0022020463,0.000035978926,0.0014336775,0.0017395575,0.00045000404,0.000086938846,0.000003966775,0.00015138632],"genre_scores_gemma":[0.99599963,0.0025426839,0.00019630433,0.00071239803,0.00046714194,0.000035890065,0.000008977042,0.000011634354,0.000025321717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704176,0.00037710494,0.0009836731,0.00017990504,0.0012295044,0.00018806197],"domain_scores_gemma":[0.9967873,0.0009863613,0.0011896769,0.00017120599,0.0008012607,0.00006419415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001012763,0.00017472544,0.00059407623,0.0002596716,0.00003573704,0.00002511667,0.00044449492,0.00011301337,0.0018198849],"category_scores_gemma":[0.0013236625,0.0000967898,0.000291624,0.00038954636,0.00023123677,0.000103262435,0.000063220454,0.00048710778,3.329992e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3103224,0.002071252,0.61975116,0.00007194187,0.0036435954,0.0018966768,0.0004398777,0.0010816068,0.021633917,0.00023756402,0.00033681397,0.038513202],"study_design_scores_gemma":[0.06824198,0.0034212964,0.9091936,0.00032125815,0.00034874355,0.0007730667,0.00047153997,0.000018558892,0.016071176,0.0005194791,0.0004923339,0.00012701054],"about_ca_topic_score_codex":0.0037138732,"about_ca_topic_score_gemma":0.00044877315,"teacher_disagreement_score":0.28944242,"about_ca_system_score_codex":0.00041681126,"about_ca_system_score_gemma":0.0015168284,"threshold_uncertainty_score":0.9990926},"labels":[],"label_agreement":null},{"id":"W3206631507","doi":"10.1136/ijgc-2021-esgo.113","title":"83 Time course of adverse events during dostarlimab treatment in patients with recurrent or advanced endometrial cancer in the garnet trial","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Discontinuation; Medicine; Adverse effect; Internal medicine; Nausea; Endometrial cancer; Regimen; Cohort; Population; Oncology; Diarrhea; Cancer; Gastroenterology","score_opus":0.02143238114503353,"score_gpt":0.33461269149926737,"score_spread":0.3131803103542338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206631507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959293,0.00061415846,0.0000017723893,0.0008097195,0.0017296742,0.0007053313,0.00010930396,0.0000032240507,0.00009754371],"genre_scores_gemma":[0.99827087,0.0008127822,0.00018572765,0.00014322987,0.0003259114,0.00010941799,0.000012634582,0.000012107907,0.00012732789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976793,0.0001845829,0.0007536275,0.00022271629,0.0009297289,0.00023007534],"domain_scores_gemma":[0.9980376,0.000533301,0.0005237015,0.00012792715,0.000695829,0.00008164377],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026183217,0.00018880064,0.0005531969,0.00019763394,0.000018493676,0.0000056807744,0.00025938707,0.00009400996,0.0032850772],"category_scores_gemma":[0.0006614138,0.000097707525,0.00017039671,0.00036782684,0.00006522664,0.00009052612,0.000051259583,0.00031177627,0.0000019715144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32516992,0.0049491012,0.63179237,0.000025081841,0.00063068775,0.0007096677,0.0005821284,0.0031414893,0.00094944256,0.0000031191423,0.00006511221,0.031981856],"study_design_scores_gemma":[0.12294669,0.0064814864,0.8674264,0.00031989833,0.000109517525,0.000029532306,0.0001537289,0.000024839002,0.0017834275,0.000020002071,0.0005900159,0.00011447418],"about_ca_topic_score_codex":0.00005651006,"about_ca_topic_score_gemma":0.00092055905,"teacher_disagreement_score":0.235634,"about_ca_system_score_codex":0.0016047374,"about_ca_system_score_gemma":0.0010682265,"threshold_uncertainty_score":0.99762607},"labels":[],"label_agreement":null},{"id":"W3206779595","doi":"10.1136/ijgc-2021-esgo.135","title":"382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Oncology; MSH6; Carcinoma; Endometrial cancer; Gynecology; Cancer; Colorectal cancer","score_opus":0.05376381640885287,"score_gpt":0.3478871577556323,"score_spread":0.2941233413467794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206779595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874908,0.0012676662,0.0012894035,0.0020316564,0.0014961546,0.0001677085,0.0005251885,0.00001090212,0.0057205213],"genre_scores_gemma":[0.9951636,0.0009907089,0.0023524424,0.00045955976,0.00085272855,0.00000592793,0.000112318645,0.000015214657,0.000047494465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732643,0.0003887565,0.00092551956,0.00025982506,0.0009025786,0.00019690754],"domain_scores_gemma":[0.99553186,0.0010892099,0.0011700916,0.00013893441,0.0019074818,0.00016239556],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052399695,0.00015678654,0.0004755307,0.0003224465,0.000041604544,0.000034972636,0.00023900987,0.000086023174,0.0011420349],"category_scores_gemma":[0.0035566927,0.000117497875,0.00033409116,0.0005205413,0.00006495524,0.00013122469,0.00009674327,0.00036782632,0.0000067885694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026690446,0.004271025,0.578429,0.000053227795,0.00667682,0.012635747,0.00217131,0.0005240251,0.15571237,0.0012116453,0.0003703392,0.21125406],"study_design_scores_gemma":[0.026742404,0.00077086204,0.9366993,0.0002072455,0.0005942919,0.000048474587,0.00061151176,0.00028399847,0.0320383,0.00039974108,0.0014521626,0.00015175428],"about_ca_topic_score_codex":0.00009135981,"about_ca_topic_score_gemma":0.00004369875,"teacher_disagreement_score":0.35827026,"about_ca_system_score_codex":0.00053028855,"about_ca_system_score_gemma":0.00043014475,"threshold_uncertainty_score":0.99977106},"labels":[],"label_agreement":null},{"id":"W3207087887","doi":"10.1136/ijgc-2021-esgo.11","title":"132 Survival outcomes in cervical cancer: what factors affect recurrence?","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of the Fraser Valley; University of British Columbia","funders":"","keywords":"Medicine; Stage (stratigraphy); Retrospective cohort study; Proportional hazards model; Cervical cancer; Internal medicine; Lymphovascular invasion; Oncology; Brachytherapy; Nedaplatin; Cohort; Radiation therapy; Cancer; Chemotherapy; Surgery; Cisplatin; Metastasis","score_opus":0.06301507117829232,"score_gpt":0.3862788944075459,"score_spread":0.3232638232292536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207087887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97302574,0.006209024,0.000020543253,0.0126758,0.0071949633,0.00013433537,0.000043046166,0.000012766071,0.00068378693],"genre_scores_gemma":[0.9873409,0.009851598,0.00013266606,0.0015939648,0.00063080434,0.000027544882,0.000015354613,0.000013009468,0.0003941573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976118,0.00014953424,0.00067920657,0.00026873755,0.0009999297,0.00029076726],"domain_scores_gemma":[0.99758416,0.00094143744,0.0003004432,0.00011154531,0.0008059966,0.00025643862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027037,0.00021364393,0.00078610185,0.00021512264,0.000030429741,0.00008992156,0.0002956079,0.00016458287,0.008311976],"category_scores_gemma":[0.0011570371,0.00013633617,0.00040863542,0.00038748406,0.00007114933,0.00034066298,0.000106893116,0.0005235542,0.000011585804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071105285,0.00082125515,0.9445889,0.000018097262,0.0005439811,0.0014028482,0.00009205306,0.00005975657,0.00027694876,0.00013581023,0.00017004707,0.051179253],"study_design_scores_gemma":[0.005294908,0.000509309,0.98543197,0.0003143848,0.00011813591,0.00006397849,0.00031204458,0.000012957576,0.0022402501,0.00054247264,0.0050081974,0.00015138931],"about_ca_topic_score_codex":0.000251898,"about_ca_topic_score_gemma":0.001041645,"teacher_disagreement_score":0.051027864,"about_ca_system_score_codex":0.001078738,"about_ca_system_score_gemma":0.0005576834,"threshold_uncertainty_score":0.99259454},"labels":[],"label_agreement":null},{"id":"W3207550038","doi":"10.1136/ijgc-2021-esgo.484","title":"846 Cancer-induced accelerated immunoaging in women suffering from ovarian cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Socioeconomic status; Medicine; Ovarian cancer; Cancer; Oncology; Internal medicine; Population; Environmental health","score_opus":0.050946680115362776,"score_gpt":0.3572223587196444,"score_spread":0.3062756786042816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207550038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786868,0.006013204,0.00002854864,0.011298497,0.0034231616,0.00011250404,0.00005552982,0.000016728778,0.00036502926],"genre_scores_gemma":[0.9875922,0.0064347265,0.00017394913,0.004499246,0.0009569233,0.000080166836,0.00000905699,0.000020417692,0.00023331119],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797773,0.00009119796,0.0007490459,0.0002648708,0.00057709345,0.00034005364],"domain_scores_gemma":[0.9983625,0.0001986795,0.00038992643,0.00012483,0.00078232534,0.00014173577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031832332,0.00019225913,0.00050995784,0.00018501868,0.00004618267,0.00008577284,0.00032647295,0.00015826958,0.01582821],"category_scores_gemma":[0.00019754123,0.00015385218,0.00018952275,0.0003347905,0.000050543455,0.00021597993,0.000088329216,0.00057168014,0.000004061373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007652288,0.0004959605,0.19134231,0.000021974945,0.0021198494,0.002408841,0.0011439602,0.00037446208,0.5439261,0.000028366958,0.0007462226,0.24973968],"study_design_scores_gemma":[0.008144159,0.00023305544,0.9266432,0.0007614108,0.00006887961,0.000099402554,0.0005035276,0.00020282531,0.043181863,0.0002079945,0.019702163,0.00025154708],"about_ca_topic_score_codex":0.0038797178,"about_ca_topic_score_gemma":0.001398851,"teacher_disagreement_score":0.7353009,"about_ca_system_score_codex":0.0028067369,"about_ca_system_score_gemma":0.0012374901,"threshold_uncertainty_score":0.9850715},"labels":[],"label_agreement":null},{"id":"W3207579801","doi":"10.1136/ijgc-2021-esgo.137","title":"397 Molecular profiling of NSMP high-risk endometrial cancers of the PORTEC-3 trial – prognostic refinement and druggable targets","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"KRAS; Endometrial cancer; Microsatellite instability; Internal medicine; Immunohistochemistry; Oncology; Medicine; Hazard ratio; Proportional hazards model; Cancer research; Cancer; Biology; Colorectal cancer; Gene; Genetics; Allele; Confidence interval","score_opus":0.010052641984795798,"score_gpt":0.2710167967117309,"score_spread":0.2609641547269351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207579801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919928,0.0046053673,0.00040684492,0.00050367066,0.002000751,0.00019597265,0.00015435745,0.0000010189852,0.00013922488],"genre_scores_gemma":[0.9944725,0.0035258143,0.0012206999,0.000216289,0.0004841548,0.000017813945,0.000013170361,0.000008305213,0.00004123843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987102,0.00007869863,0.00055089983,0.00016830648,0.0003650176,0.00012688982],"domain_scores_gemma":[0.99811006,0.00017298978,0.0007434901,0.00012212602,0.00079334894,0.00005800692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003159293,0.000103884224,0.00025476998,0.00005002172,0.000029089591,0.000016368553,0.00027305767,0.00009479134,0.00013161516],"category_scores_gemma":[0.0024099397,0.00007322496,0.00017881145,0.00009988011,0.000107953914,0.0000048963275,0.00019510998,0.00014313615,1.2960389e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017272558,0.0008474721,0.11432506,0.00006724284,0.0021645443,0.00016356805,0.00008833202,0.019544026,0.81918925,0.002135737,0.0021661,0.022036102],"study_design_scores_gemma":[0.023467138,0.0020102982,0.023991564,0.00008761966,0.00025352993,0.000039956074,0.00009250905,0.000075215125,0.9371054,0.001182739,0.01149519,0.00019882839],"about_ca_topic_score_codex":0.00015754302,"about_ca_topic_score_gemma":0.00011835404,"teacher_disagreement_score":0.11791616,"about_ca_system_score_codex":0.00010342473,"about_ca_system_score_gemma":0.000729088,"threshold_uncertainty_score":0.29860273},"labels":[],"label_agreement":null},{"id":"W3207768373","doi":"10.1136/ijgc-2021-esgo.189","title":"749 Tumor cell dissemination is independent from endometrial carcinoma molecular subtypes","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Carcinoma; Cytokeratin; Medicine; Oncology; Internal medicine; Bone marrow; Cancer research; Pathology; Cancer; Immunohistochemistry","score_opus":0.01720198512405045,"score_gpt":0.31841306656346696,"score_spread":0.3012110814394165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207768373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855511,0.005187853,0.0005573999,0.004188713,0.0025559764,0.00008899917,0.00012022047,0.0000068006366,0.0017429363],"genre_scores_gemma":[0.99409354,0.00074571575,0.0010921287,0.002438011,0.0010041135,0.000008585519,0.000024762066,0.000012528934,0.00058060966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998176,0.000060325212,0.0004903525,0.00021407787,0.00090138434,0.00015786038],"domain_scores_gemma":[0.9979197,0.00030457086,0.00036200532,0.000108870125,0.0011344167,0.00017044994],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019868239,0.00013036218,0.00035918906,0.00015423178,0.000025052532,0.00005190424,0.00020111138,0.00011225162,0.012032975],"category_scores_gemma":[0.0005417507,0.00010082734,0.00032185926,0.00016694295,0.000039513878,0.000095290605,0.000080057835,0.0004140824,0.000017460934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033706515,0.0018527223,0.19143465,0.000046078203,0.001339695,0.015652858,0.00049531145,0.00010733135,0.67677325,0.00025599988,0.016850766,0.091820695],"study_design_scores_gemma":[0.005931001,0.0005357303,0.20450823,0.00011703017,0.0004192093,0.00032384976,0.00024489075,0.000047777852,0.7362269,0.0006130947,0.05083105,0.00020122835],"about_ca_topic_score_codex":0.00010274599,"about_ca_topic_score_gemma":0.000033557775,"teacher_disagreement_score":0.09161946,"about_ca_system_score_codex":0.00047170036,"about_ca_system_score_gemma":0.00044901384,"threshold_uncertainty_score":0.98887014},"labels":[],"label_agreement":null},{"id":"W3208377964","doi":"10.1136/ijgc-2021-igcs.46","title":"SF002/#332 Sentinel lymph node mapping for cervical cancer: a practical illustration of using icg during a laparotomy","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Indocyanine green; Medicine; Cervical cancer; Sentinel lymph node; Laparotomy; Biopsy; Sentinel node; Radical Hysterectomy; Laparoscopy; Surgery; Lymph node; Stage (stratigraphy); Radiology; Cancer; General surgery; Breast cancer; Pathology; Internal medicine","score_opus":0.09813973248596566,"score_gpt":0.3959698665893973,"score_spread":0.2978301341034316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208377964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802364,0.00081971096,0.0018781532,0.007323232,0.0012553509,0.00023643131,0.00006586688,0.0000120597,0.0003855579],"genre_scores_gemma":[0.990572,0.0005471885,0.0060270224,0.0010296379,0.0015010199,0.000060198345,0.000013401558,0.00001708324,0.00023244554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784136,0.00007238739,0.0008392543,0.00024083113,0.00074810226,0.00025804964],"domain_scores_gemma":[0.99683857,0.00043324413,0.00063199253,0.00009701736,0.0018058867,0.00019329436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023507544,0.00016919346,0.00057059596,0.00017367644,0.00005968003,0.00003620391,0.00014754567,0.00016021985,0.0018961877],"category_scores_gemma":[0.0010130685,0.00012880488,0.00039312697,0.0002710782,0.00007506567,0.00018601144,0.000082439576,0.0002514765,0.0000018298225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008313429,0.0026582181,0.8452792,0.0005643797,0.0035873873,0.0019786437,0.00022258268,0.0020161513,0.12242206,0.0009144556,0.0004071036,0.01163636],"study_design_scores_gemma":[0.023248572,0.0003054515,0.91609997,0.0010661419,0.000911992,0.0019315582,0.00032430122,0.0029648077,0.046793494,0.00087107066,0.005128027,0.0003546081],"about_ca_topic_score_codex":0.00009470604,"about_ca_topic_score_gemma":0.000018616705,"teacher_disagreement_score":0.075628564,"about_ca_system_score_codex":0.00087122066,"about_ca_system_score_gemma":0.0008997104,"threshold_uncertainty_score":0.9990162},"labels":[],"label_agreement":null},{"id":"W3208404450","doi":"10.1136/ijgc-2021-igcs.228","title":"EPV158/#447 The IGCS project echo virtual tumor board: review of a pathologist’s experience from the first 2 years","year":2021,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Telepathology; Radiology; General surgery; Pathology; Medical physics; Telemedicine","score_opus":0.06902187781253834,"score_gpt":0.47574873783030003,"score_spread":0.4067268600177617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208404450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025758514,0.99168414,0.00010474903,0.0033433966,0.0035713068,0.0006380615,0.000121931895,0.000008394849,0.00027040634],"genre_scores_gemma":[0.00013503207,0.98592436,0.000573596,0.010902264,0.0020522696,0.00017398183,0.00001923423,0.00002165932,0.00019761888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996961,0.00042875714,0.0013116229,0.00029608913,0.0007962164,0.00020634441],"domain_scores_gemma":[0.9938839,0.003185072,0.0019010988,0.00033546024,0.00063295837,0.00006148335],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077999994,0.00029710273,0.0018390627,0.00006797847,0.00007532555,0.000022686405,0.0013199191,0.00025455916,0.0027581435],"category_scores_gemma":[0.0028808857,0.00012777503,0.0010162948,0.0002469383,0.0006775807,0.000078338126,0.00018371217,0.0012272901,0.000008242801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017047784,0.00032641215,0.0007075312,0.0013634985,0.0012975634,0.0023764994,0.0003894088,0.000005996005,0.0000012656259,0.0001736202,0.031275257,0.96191245],"study_design_scores_gemma":[0.00046885753,0.00045597096,0.00084530097,0.036646783,0.0006016104,0.0010601609,0.0001335289,0.0000014086158,0.000001899754,0.000042564443,0.95961034,0.00013157696],"about_ca_topic_score_codex":0.000038300866,"about_ca_topic_score_gemma":0.000036623824,"teacher_disagreement_score":0.9617809,"about_ca_system_score_codex":0.00062018156,"about_ca_system_score_gemma":0.0013999165,"threshold_uncertainty_score":0.99815345},"labels":[],"label_agreement":null},{"id":"W3208471746","doi":"10.1136/ijgc-2021-igcs.25","title":"OP008/#194 P53ABN molecular subtype encompasses a morphologically diverse subset of endometrial cancers and identifies therapeutic opportunities to improve outcomes","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université Laval; Dalhousie University; University of Toronto; McMaster University; McGill University; University of British Columbia","funders":"","keywords":"Endometrial cancer; Serous fluid; Internal medicine; Medicine; Oncology; Stage (stratigraphy); Chemotherapy; Serous carcinoma; Disease; Targeted therapy; Clear cell; Adjuvant therapy; Carcinoma; Cancer; Biology; Ovarian cancer","score_opus":0.07407512748475455,"score_gpt":0.36243307320743595,"score_spread":0.2883579457226814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208471746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779166,0.003985908,0.00014387447,0.005163065,0.0019977796,0.00020322636,0.00014838255,0.000011309322,0.00055477594],"genre_scores_gemma":[0.99129635,0.003606688,0.0006020437,0.00384667,0.00024914512,0.000026905982,0.000010311856,0.000011131301,0.0003507579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979206,0.00010374701,0.0006743331,0.0002453339,0.0008370875,0.00021893224],"domain_scores_gemma":[0.9971803,0.0007112707,0.0004199998,0.00012207897,0.0013023409,0.00026400771],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002494517,0.00019527406,0.0007248071,0.0002924203,0.000037679227,0.00005006353,0.0002615542,0.000112319736,0.0023219583],"category_scores_gemma":[0.0014590978,0.00012932676,0.00031063572,0.0002368053,0.00016097286,0.00012604988,0.00016689337,0.0002279133,0.000003603944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013204394,0.0020870443,0.5466586,0.0001627111,0.008771213,0.012875898,0.00047164215,0.00042227452,0.2108276,0.0030133766,0.0013974862,0.20010778],"study_design_scores_gemma":[0.017749548,0.0050766575,0.86970836,0.0002474353,0.0011156574,0.0004760114,0.0013336368,0.000012129828,0.08907607,0.004660356,0.010086785,0.00045734728],"about_ca_topic_score_codex":0.00021992836,"about_ca_topic_score_gemma":0.00010999865,"teacher_disagreement_score":0.32304978,"about_ca_system_score_codex":0.00045020843,"about_ca_system_score_gemma":0.00056814903,"threshold_uncertainty_score":0.99859005},"labels":[],"label_agreement":null},{"id":"W3208507772","doi":"10.1136/ijgc-2021-igcs.47","title":"SF003/#661 Total pelvic exenteration and perineal reconstruction for recurrent cervical cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Pelvic exenteration; Medicine; Surgery; Rectum; Vagina; Cervix; Cervical cancer; Radiation therapy; Cancer; Internal medicine","score_opus":0.03651167683243884,"score_gpt":0.3586648240579861,"score_spread":0.3221531472255473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208507772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791915,0.0045649647,0.00034304452,0.010513975,0.0046106717,0.00020660785,0.00008941669,0.000011872275,0.00046796637],"genre_scores_gemma":[0.99193704,0.002917548,0.00148234,0.0009232926,0.002046321,0.00007623841,0.00002445629,0.000011121885,0.0005816455],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986529,0.00004623222,0.00048189075,0.00021641362,0.0004149001,0.00018768125],"domain_scores_gemma":[0.99807185,0.00022604543,0.00024681288,0.000057331024,0.0011932336,0.0002047285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016028076,0.00013400616,0.00036082827,0.00010337426,0.000053924177,0.000055552537,0.00007846496,0.00010549203,0.0030714604],"category_scores_gemma":[0.0004970072,0.00009659746,0.00021946499,0.00012290964,0.000057786558,0.00015023552,0.000048893344,0.00021850922,0.000002372114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006488529,0.0007516059,0.13897365,0.00009890713,0.0010729395,0.00030349605,0.00015053106,0.00009615307,0.0050234203,0.0004695215,0.0010259469,0.8455453],"study_design_scores_gemma":[0.024017876,0.0049823085,0.91198283,0.00069222716,0.0008252846,0.0038179315,0.00036479093,0.0013764825,0.013997107,0.0026114602,0.034890063,0.00044161826],"about_ca_topic_score_codex":0.000031571424,"about_ca_topic_score_gemma":0.00012914801,"teacher_disagreement_score":0.8451037,"about_ca_system_score_codex":0.0006006868,"about_ca_system_score_gemma":0.00031736557,"threshold_uncertainty_score":0.99783987},"labels":[],"label_agreement":null},{"id":"W3208543017","doi":"10.1136/ijgc-2021-igcs.325","title":"EPV254/#148 Septuagenarians and octogenarians undergoing gynecologic oncology laparotomy: is there a role for routine postoperative cardiac biomarker monitoring?","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Biomarker; Univariate analysis; Coronary artery disease; Diabetes mellitus; Cohort; Myocardial infarction; Cardiology; Surgery; Multivariate analysis","score_opus":0.035441977445594845,"score_gpt":0.357580116492907,"score_spread":0.32213813904731214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208543017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94402736,0.00736596,0.0002860778,0.038978443,0.0026734686,0.00048440378,0.00008714914,0.000026893777,0.0060702357],"genre_scores_gemma":[0.9869815,0.002934982,0.0020675159,0.004175374,0.0009636186,0.00008294196,0.000012660814,0.00002445288,0.002756935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979891,0.00024671445,0.00063844206,0.00032812537,0.0004723932,0.00032518615],"domain_scores_gemma":[0.99475783,0.002890819,0.00032697502,0.00012625907,0.001644434,0.00025367588],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006099213,0.00023852638,0.0010320505,0.00011655598,0.00011063364,0.00007770606,0.0001860714,0.0002966604,0.0014415674],"category_scores_gemma":[0.002104331,0.0001675198,0.00073971023,0.00013944088,0.00013471539,0.00013568458,0.00009849313,0.00034224198,0.0000074269833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003004301,0.0009415072,0.89441156,0.0000637521,0.00546151,0.00508578,0.001747278,0.000101897924,0.014492865,0.003469491,0.004007258,0.06721279],"study_design_scores_gemma":[0.005882113,0.0020579111,0.52086383,0.00015681049,0.0006167625,0.0010877991,0.0025389825,0.000101459285,0.0056825164,0.00056480424,0.46011528,0.00033171498],"about_ca_topic_score_codex":0.00002431142,"about_ca_topic_score_gemma":0.00003177484,"teacher_disagreement_score":0.456108,"about_ca_system_score_codex":0.00063483504,"about_ca_system_score_gemma":0.0008703235,"threshold_uncertainty_score":0.99947125},"labels":[],"label_agreement":null},{"id":"W3208560765","doi":"10.1136/ijgc-2021-igcs.31","title":"OP014/#480 Targeted molecular testing in endometrial carcinoma: validation of a restricted testing protocol","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Jewish General Hospital; McMaster University; McGill University; Dalhousie University; Hamilton Health Sciences; Université Laval","keywords":"Cohort; Medicine; Oncology; Population; Endometrial cancer; Internal medicine; Stage (stratigraphy); DNA mismatch repair; Lymphovascular invasion; Adjuvant therapy; Immunohistochemistry; Cancer; Biology; Colorectal cancer","score_opus":0.07085003329389446,"score_gpt":0.36552741431514596,"score_spread":0.2946773810212515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208560765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932,0.00016473894,0.00020785377,0.00050895545,0.00076582073,0.003948148,0.00001300304,0.000011754328,0.0011797213],"genre_scores_gemma":[0.9836316,0.000006112849,0.014208223,0.00018755229,0.00035026332,0.0015695044,0.0000052548785,0.000015010239,0.000026471458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974649,0.00016682043,0.0010142493,0.00022331788,0.000916986,0.0002137343],"domain_scores_gemma":[0.9946006,0.0012807888,0.00075084163,0.00011225349,0.003144475,0.0001110228],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0004173789,0.00015025825,0.0004559737,0.00038586473,0.0000200477,0.000025574547,0.00025056858,0.00014923651,0.0007674375],"category_scores_gemma":[0.023801526,0.00012345062,0.00014265097,0.0010481288,0.00006805527,0.00008900662,0.000112889196,0.0004555821,0.0000014566001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011584698,0.0004148548,0.5117845,0.00004992021,0.0001239856,0.0015380204,0.000048237755,0.0028956232,0.4699912,0.000021798716,0.00010292964,0.011870496],"study_design_scores_gemma":[0.007457993,0.0015254369,0.57461816,0.0003418172,0.000068128385,0.00037130123,0.000049685546,0.0006382689,0.41382435,0.00048465325,0.00047568354,0.00014454128],"about_ca_topic_score_codex":0.00009922054,"about_ca_topic_score_gemma":0.000015216284,"teacher_disagreement_score":0.06283367,"about_ca_system_score_codex":0.0007355181,"about_ca_system_score_gemma":0.0013094129,"threshold_uncertainty_score":0.98442143},"labels":[],"label_agreement":null},{"id":"W3208698931","doi":"10.1136/ijgc-2021-igcs.196","title":"EPV126/#448 Undifferentiated and dedifferentiated carcinoma of the endometrium: clinicopathologic features and implications for prognostication and management","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Carboplatin; Stage (stratigraphy); Chemotherapy; Radiology; Surgery; Oncology; Internal medicine; Cisplatin","score_opus":0.043970909178268916,"score_gpt":0.3563483338242189,"score_spread":0.31237742464595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208698931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872949,0.0048882267,0.00020206725,0.006677355,0.00037745218,0.000353632,0.00006660929,0.000004542875,0.00013523069],"genre_scores_gemma":[0.9936364,0.0048381803,0.00081414386,0.00042613418,0.00009696609,0.00004884645,0.000014903299,0.0000053201775,0.000119104305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910945,0.000053522817,0.00036363417,0.00016488275,0.0001960697,0.000112467],"domain_scores_gemma":[0.99839133,0.00055479485,0.0002890882,0.00007522046,0.0005954323,0.0000941307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000139715,0.000094831164,0.0002689829,0.00010971273,0.00005001369,0.00002591072,0.00009680199,0.0000730344,0.00007685838],"category_scores_gemma":[0.0008185162,0.000053971595,0.00009268466,0.00018502872,0.00011440977,0.000041153413,0.00011298239,0.00011674732,1.0621464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006206916,0.0003866776,0.93489957,0.00009334273,0.00048855506,0.000024137342,0.000038608225,0.0000010285701,0.0034054124,0.0020295696,0.00013384433,0.057878587],"study_design_scores_gemma":[0.0041500367,0.00043409193,0.98877776,0.000078938894,0.0004182007,0.00021081365,0.0000390928,0.000008537559,0.0027693133,0.00275703,0.00030672157,0.000049451777],"about_ca_topic_score_codex":0.000007492643,"about_ca_topic_score_gemma":0.000017560616,"teacher_disagreement_score":0.057829134,"about_ca_system_score_codex":0.00008217555,"about_ca_system_score_gemma":0.00006156161,"threshold_uncertainty_score":0.22008978},"labels":[],"label_agreement":null},{"id":"W3208723168","doi":"10.1136/ijgc-2021-igcs.58","title":"SF014/#370 Laparoscopic repair of obturator nerve injury at the time of pelvic lymphadenectomy","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Pelvic and Acetabular Injuries","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Obturator nerve; Medicine; Lumbar plexus; Surgery; External iliac vein; Endometrial cancer; Lymphadenectomy; Dissection (medical); Pelvis; Neurovascular bundle; Lymph node; Lumbar; Cancer; Vein","score_opus":0.013703913801083493,"score_gpt":0.31670444650712243,"score_spread":0.30300053270603894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208723168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888346,0.0048330743,0.000011070966,0.004181755,0.00083782396,0.00007639868,0.00005621166,0.000009434771,0.001159623],"genre_scores_gemma":[0.993739,0.0005677648,0.0002526278,0.001324205,0.00040594823,0.0000054440316,0.000007940721,0.000008690537,0.0036883892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826777,0.000097735814,0.0006805379,0.00013504298,0.00068170286,0.00013720362],"domain_scores_gemma":[0.99759024,0.00030984663,0.00059947773,0.00015601168,0.0012608859,0.00008350551],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030232678,0.000115896735,0.00048336692,0.0000721851,0.00003392338,0.000010448687,0.0002453634,0.00010267521,0.006848044],"category_scores_gemma":[0.0008904968,0.000067371395,0.0003776408,0.00013932494,0.00022743699,0.00008552778,0.00015204263,0.0001978377,0.000017874901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038934518,0.001392577,0.5786303,0.00018429758,0.0034367638,0.0016044115,0.00060113106,0.00016053478,0.33343706,0.0012688632,0.0658431,0.009547486],"study_design_scores_gemma":[0.0040679816,0.0011460329,0.6102085,0.00048264736,0.0004440554,0.00069292594,0.00023357381,0.00010461357,0.32430938,0.000593787,0.057528894,0.00018759927],"about_ca_topic_score_codex":0.000018422395,"about_ca_topic_score_gemma":0.000019328763,"teacher_disagreement_score":0.031578194,"about_ca_system_score_codex":0.0002558197,"about_ca_system_score_gemma":0.00051631144,"threshold_uncertainty_score":0.99405986},"labels":[],"label_agreement":null},{"id":"W3208867838","doi":"10.1136/ijgc-2021-igcs.16","title":"O016/#233 Clinical and molecular characteristics of ariel3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC)","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Oncology; Placebo; PARP inhibitor; Clinical trial; Randomized controlled trial; Pathology; Biology; Genetics; Poly ADP ribose polymerase; Alternative medicine","score_opus":0.04660154904484661,"score_gpt":0.36745396807519604,"score_spread":0.32085241903034944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208867838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838443,0.0009454919,0.0033298675,0.00794374,0.002189397,0.00026914864,0.0014119531,0.000008084996,0.00005801745],"genre_scores_gemma":[0.9862158,0.0049908427,0.0040742364,0.0031297691,0.0011424691,0.00009907239,0.00015405723,0.000021946971,0.00017181262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976976,0.000078388024,0.0011081266,0.00032552224,0.0005748654,0.00021552638],"domain_scores_gemma":[0.996174,0.0005489684,0.00084949244,0.00013833889,0.0020792345,0.00020998725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018538492,0.00021113582,0.0007392368,0.00008208974,0.000045133922,0.000032980748,0.00017826211,0.0002005378,0.002166409],"category_scores_gemma":[0.0004781268,0.00016338499,0.00031787166,0.00007688392,0.00023537953,0.000104777726,0.000055553624,0.0002508122,0.0000017859124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065593286,0.0026954068,0.86530143,0.000048412865,0.0033391935,0.0003919788,0.00023888881,0.00011729404,0.023103597,0.004311588,0.002317183,0.09157569],"study_design_scores_gemma":[0.013541228,0.0011850913,0.9573428,0.00039868327,0.00027007688,0.000031991898,0.000036067348,0.000112181566,0.012741323,0.005532156,0.008628382,0.00018003755],"about_ca_topic_score_codex":0.00013889628,"about_ca_topic_score_gemma":0.00008075342,"teacher_disagreement_score":0.09204134,"about_ca_system_score_codex":0.0006017276,"about_ca_system_score_gemma":0.0005740075,"threshold_uncertainty_score":0.99874574},"labels":[],"label_agreement":null},{"id":"W3208922566","doi":"10.1136/ijgc-2021-002988","title":"Placenta increta mimicking placental site trophoblastic tumor","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Toronto General Hospital","funders":"","keywords":"Medicine; Placental site trophoblastic tumor; Gynecologic oncology; Obstetrics; Gynecology; Placenta; General surgery; Pregnancy; Surgery; Fetus","score_opus":0.017492431317243953,"score_gpt":0.3208531050418927,"score_spread":0.30336067372464876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208922566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901006,0.0013845621,0.00027108993,0.0045503024,0.0019986257,0.00008883681,0.00008112357,0.000016189497,0.0015086739],"genre_scores_gemma":[0.993961,0.0003643024,0.0018248726,0.0025845992,0.00076876563,0.000009394688,0.000019346891,0.0000150750175,0.00045268843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980353,0.000065204746,0.00054825266,0.00020499987,0.00092997355,0.00021626998],"domain_scores_gemma":[0.99731505,0.0005629365,0.00033729064,0.00008095139,0.0014904018,0.00021336797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013415603,0.00016050276,0.00037434854,0.00012416381,0.00005498463,0.000046021352,0.00017986212,0.00005003035,0.004605425],"category_scores_gemma":[0.0019000428,0.0001233601,0.00024916916,0.0001344184,0.00011343394,0.00012013362,0.00013791618,0.00031906855,0.000056124194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009089567,0.0028481504,0.8182489,0.00015796233,0.00408834,0.040984076,0.0006442377,0.0035776787,0.08256244,0.0017716903,0.028242217,0.007784704],"study_design_scores_gemma":[0.006415553,0.000651965,0.96671826,0.00046939292,0.00041480473,0.0030996143,0.00059889135,0.0005342669,0.0034566505,0.0005339259,0.016861217,0.00024543685],"about_ca_topic_score_codex":0.000010038015,"about_ca_topic_score_gemma":0.000023200002,"teacher_disagreement_score":0.14846934,"about_ca_system_score_codex":0.00057245744,"about_ca_system_score_gemma":0.000645415,"threshold_uncertainty_score":0.9963045},"labels":[],"label_agreement":null},{"id":"W3209066466","doi":"10.1136/ijgc-2021-igcs.1","title":"O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Vinorelbine; Cervical cancer; Population; Adenocarcinoma; Chemotherapy; Oncology; Cancer; Cisplatin","score_opus":0.04412350336334246,"score_gpt":0.4121404875033292,"score_spread":0.36801698413998674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209066466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830687,0.001140191,0.00005075385,0.0123765925,0.0015033325,0.00038257326,0.000252553,0.0000082608085,0.0012170342],"genre_scores_gemma":[0.9960916,0.00060051365,0.0011306166,0.0013487826,0.00053108815,0.000037538146,0.000064868625,0.000018946186,0.00017603989],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99677604,0.00018766726,0.001538681,0.0003036076,0.0009445524,0.00024942672],"domain_scores_gemma":[0.9964317,0.0008125081,0.0009029168,0.00020086668,0.0013439076,0.00030808343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042194346,0.00021987011,0.0008335264,0.00025430936,0.000026681842,0.00002088813,0.000306054,0.00014513798,0.0016210484],"category_scores_gemma":[0.0022096995,0.00016454727,0.000355332,0.0003662282,0.00017676014,0.0001487518,0.00007064631,0.0004640933,0.0000036066583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48340616,0.055549357,0.22812022,0.0007406749,0.008329988,0.0060485117,0.005487861,0.00068358635,0.032368828,0.0021222555,0.018034108,0.15910845],"study_design_scores_gemma":[0.51971054,0.014120464,0.40429,0.001043712,0.001068267,0.000341856,0.00055861496,0.0005510823,0.020146085,0.0015238915,0.036182273,0.00046322568],"about_ca_topic_score_codex":0.00020083207,"about_ca_topic_score_gemma":0.00020740379,"teacher_disagreement_score":0.17616978,"about_ca_system_score_codex":0.00068799424,"about_ca_system_score_gemma":0.0018513873,"threshold_uncertainty_score":0.9992916},"labels":[],"label_agreement":null},{"id":"W3209071745","doi":"10.1136/ijgc-2021-igcs.219","title":"EPV149/#132 Performance characteristics of brief family history questionnaire to screen for lynch syndrome in women with newly diagnosed ovarian cancers","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Juravinski Cancer Centre; McMaster University; Toronto Metropolitan University; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Lynch syndrome; Medicine; Family history; Ovarian cancer; Triage; Cohort; Internal medicine; Oncology; Population; Gynecology; Genetic testing; Prospective cohort study; Cancer; DNA mismatch repair; Psychiatry","score_opus":0.021691073188026953,"score_gpt":0.27901626733504015,"score_spread":0.2573251941470132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209071745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940048,0.00087674253,0.0007097364,0.0020196438,0.0017069762,0.00031989522,0.00006643449,0.000008866349,0.0002869432],"genre_scores_gemma":[0.99252456,0.0005416507,0.0032501954,0.0029675993,0.00028261225,0.00013955688,0.000007625894,0.000022466533,0.00026373405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803835,0.000050098548,0.0007000047,0.0002508863,0.00066984585,0.00029079762],"domain_scores_gemma":[0.9973492,0.00023761316,0.00043658112,0.00013756331,0.0016124421,0.00022661328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033607063,0.00017886174,0.0005731676,0.00021116673,0.000021536232,0.000014122344,0.00029411694,0.00012962049,0.000823627],"category_scores_gemma":[0.0007917502,0.00014398566,0.00009686244,0.00019201529,0.000116316085,0.00010893677,0.00005956704,0.00030846376,0.000001921304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023152621,0.0011226429,0.72322816,0.00037267437,0.0012857604,0.0036074976,0.0022113281,0.00668092,0.018653385,0.00025443375,0.006381269,0.2130493],"study_design_scores_gemma":[0.0037808863,0.0030754234,0.976867,0.0007973092,0.00005385965,0.00027618642,0.00011875518,0.00016274588,0.0007401239,0.000040554933,0.013920476,0.0001666691],"about_ca_topic_score_codex":0.00022712343,"about_ca_topic_score_gemma":0.00031824582,"teacher_disagreement_score":0.25363883,"about_ca_system_score_codex":0.005353334,"about_ca_system_score_gemma":0.0023511858,"threshold_uncertainty_score":0.99846494},"labels":[],"label_agreement":null},{"id":"W3209159424","doi":"10.1136/ijgc-2021-igcs.2","title":"O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Università degli Studi di Torino; Università di Bologna; Università degli Studi di Parma","keywords":"Pembrolizumab; Lenvatinib; Medicine; Internal medicine; Oncology; Tolerability; Regimen; Adverse effect; Cancer; Immunotherapy","score_opus":0.02673610835872959,"score_gpt":0.35229353432134514,"score_spread":0.32555742596261555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209159424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441254,0.001168118,0.00063131884,0.0002489997,0.0016229878,0.0014465419,0.00035964532,0.000014673925,0.00009517058],"genre_scores_gemma":[0.9972826,0.0002390608,0.0015970876,0.00019580644,0.00020561475,0.00029519448,0.00005148844,0.0000264745,0.000106652806],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995375,0.00026218308,0.0018772644,0.0004245104,0.0017603814,0.00030065523],"domain_scores_gemma":[0.99023265,0.0021521498,0.002019664,0.0002549631,0.0051605524,0.00018002451],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077988394,0.00029542326,0.0021814671,0.00069714343,0.00004749609,0.000018681128,0.00037195484,0.00012640364,0.0022861348],"category_scores_gemma":[0.003957667,0.00019907755,0.0010058309,0.0010763991,0.00021504267,0.000102669605,0.000104068844,0.0002992849,3.4235353e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6381677,0.009637542,0.2803728,0.00014636414,0.020920636,0.0001979215,0.0014256355,0.03515457,0.004691062,0.00005196157,0.0002788153,0.008955046],"study_design_scores_gemma":[0.7040696,0.01255805,0.25620395,0.00032592175,0.008793882,0.00001970357,0.0010733497,0.0022063737,0.013745983,0.00007682076,0.000533962,0.00039235404],"about_ca_topic_score_codex":0.00014450603,"about_ca_topic_score_gemma":0.00044410318,"teacher_disagreement_score":0.06590198,"about_ca_system_score_codex":0.0009894966,"about_ca_system_score_gemma":0.0010163483,"threshold_uncertainty_score":0.99862593},"labels":[],"label_agreement":null},{"id":"W3209160294","doi":"10.1136/ijgc-2021-igcs.341","title":"EPV270/#88 Optimizing the screening and management of preoperative anemia prior to gynecologic oncology surgery (OPRA): a quality improvement initiative","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Anemia; Gynecologic oncology; Referral; Perioperative; Blood management; Surgery; Blood transfusion; Internal medicine","score_opus":0.0779413114170938,"score_gpt":0.3912346664483054,"score_spread":0.3132933550312116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209160294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96066207,0.0009841387,0.0022947919,0.03216182,0.0008402931,0.00055916765,0.00001990035,0.0000093977,0.0024684076],"genre_scores_gemma":[0.979231,0.004733803,0.00764624,0.0079419585,0.00019296247,0.0001049012,0.0000051138845,0.00000969924,0.00013432768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978364,0.00021363529,0.0008705946,0.0002557748,0.0005930384,0.00023052873],"domain_scores_gemma":[0.9967343,0.001266525,0.0006361822,0.00013119617,0.0010890501,0.00014270455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011990587,0.00016239578,0.0006947987,0.00012314576,0.00008771159,0.00004161058,0.00022246946,0.000087831984,0.0009416638],"category_scores_gemma":[0.0007005611,0.00010260692,0.0002054057,0.0001707971,0.00012415531,0.000112821326,0.00038814475,0.00028083252,0.0000023385187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026294258,0.0053926785,0.07716801,0.0005409222,0.008099941,0.0047520986,0.004152723,0.004387078,0.0050186557,0.0070736404,0.014682363,0.86610246],"study_design_scores_gemma":[0.002797823,0.0019663225,0.96852165,0.0005548623,0.0004982983,0.00011198493,0.0053153303,0.000069332316,0.0056192176,0.00037551788,0.0139582865,0.00021139707],"about_ca_topic_score_codex":0.000048765094,"about_ca_topic_score_gemma":0.000097070646,"teacher_disagreement_score":0.8913536,"about_ca_system_score_codex":0.0004628139,"about_ca_system_score_gemma":0.00027861056,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W3209199157","doi":"10.1136/ijgc-2021-igcs.48","title":"SF004/#153 The use of lighted ureteral catheters in difficult minimally invasive gynecologic oncologic surgery","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ureteral procedures and complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto","keywords":"Medicine; Surgery; Ureter; Gynecologic oncology; Laparoscopy; Dissection (medical); Robotic surgery; Invasive surgery; General surgery; Complication","score_opus":0.10496899978552117,"score_gpt":0.3330399716608976,"score_spread":0.22807097187537645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209199157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750868,0.00074985856,0.00002491557,0.023140028,0.0005967597,0.00017065235,0.000030714647,0.000009356649,0.00019089265],"genre_scores_gemma":[0.99094826,0.0011012818,0.00078981306,0.0065615242,0.00023525029,0.00003600029,0.000019057981,0.000009252418,0.00029957172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980126,0.00016588469,0.0008883546,0.00021064335,0.0005002897,0.0002222303],"domain_scores_gemma":[0.99468553,0.0027467373,0.0006314243,0.00015679437,0.0016719463,0.000107561194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026584265,0.00016002574,0.00051436754,0.00016366053,0.00004402082,0.000047880992,0.00034303675,0.00015659684,0.001079046],"category_scores_gemma":[0.0038624243,0.00009189584,0.00038613137,0.00032654044,0.00016507157,0.0001543589,0.000120460216,0.00045914444,0.0000050734957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029745807,0.0036671641,0.84154683,0.00009518041,0.0014925959,0.004196078,0.00091060426,0.0033984696,0.074765556,0.000881592,0.049809918,0.016261432],"study_design_scores_gemma":[0.001143963,0.0006297813,0.9766148,0.0002040565,0.000114083865,0.0006224648,0.00013441824,0.0001555905,0.003781153,0.00046655996,0.015987972,0.000145185],"about_ca_topic_score_codex":0.000036251542,"about_ca_topic_score_gemma":0.0003242548,"teacher_disagreement_score":0.13506794,"about_ca_system_score_codex":0.00040463303,"about_ca_system_score_gemma":0.00089555606,"threshold_uncertainty_score":0.9998341},"labels":[],"label_agreement":null},{"id":"W3209258800","doi":"10.1136/ijgc-2021-igcs.27","title":"OP010/#223 Extrapelvic recurrence risk in women who underwent minimally-invasive versus open laparotomy for intermediate-risk endometrial cancer; a multi-center review","year":2021,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Endometrial cancer; Laparotomy; Surgery; Retrospective cohort study; Single Center; Stage (stratigraphy); Proportional hazards model; Cancer; Internal medicine","score_opus":0.14970212656433543,"score_gpt":0.458189315280252,"score_spread":0.3084871887159165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209258800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014672435,0.9840302,0.000036667192,0.00062015024,0.0074821957,0.004154506,0.0020430048,0.000012894252,0.00015315],"genre_scores_gemma":[0.00051309715,0.99125296,0.0006800902,0.0009828904,0.0018999357,0.004178636,0.0001635157,0.00006599887,0.0002628515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936324,0.0008266672,0.0027798186,0.00087948825,0.0011646039,0.0007170526],"domain_scores_gemma":[0.988428,0.0055121966,0.003683518,0.0003328823,0.0014958401,0.0005475941],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016766072,0.0007645961,0.0048848223,0.00076692906,0.0000783385,0.00016846202,0.0018257708,0.0004826056,0.0041458],"category_scores_gemma":[0.011843485,0.000514613,0.0017671041,0.0010621146,0.0001561509,0.0002859342,0.00063442194,0.0016245521,0.000018492694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005921271,0.0023352131,0.0016729289,0.0054033855,0.0046496466,0.0006727052,0.00007366964,0.0000037138598,3.8722575e-7,0.000010893303,0.0029350435,0.97632116],"study_design_scores_gemma":[0.04883047,0.0030621076,0.0010166026,0.08445216,0.003057294,0.00008051684,0.00006270544,0.0000046827845,0.0000059067447,0.00005335569,0.8588481,0.00052612263],"about_ca_topic_score_codex":0.00032120198,"about_ca_topic_score_gemma":0.00087427726,"teacher_disagreement_score":0.97579503,"about_ca_system_score_codex":0.006312945,"about_ca_system_score_gemma":0.0037691025,"threshold_uncertainty_score":0.9997305},"labels":[],"label_agreement":null},{"id":"W3209301031","doi":"10.1136/ijgc-2021-igcs.11","title":"O011/#287 Prognostic significance of ‘p53 signature’ (fields of dysplasia) and in situ margin status in organ-confined HPV-independent p53 abnormal vulvar squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Immunohistochemistry; Vulvar Carcinoma; Vulva; Vulvar cancer; Medicine; Oncology; Retrospective cohort study; Dysplasia; Pathology; Internal medicine","score_opus":0.020657105345237483,"score_gpt":0.3071955152635505,"score_spread":0.28653840991831303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209301031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898213,0.0035414519,0.00007048656,0.0013403837,0.0003745227,0.0002923075,0.00004130198,0.000003876382,0.0045143515],"genre_scores_gemma":[0.9983539,0.00068498316,0.0002443107,0.00032002715,0.00017760854,0.000021438997,0.000010162438,0.00001359513,0.00017400467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725324,0.00015065624,0.00092730136,0.00027556135,0.0010303493,0.0003628906],"domain_scores_gemma":[0.9970953,0.0008812603,0.0003687431,0.0001212403,0.0013113297,0.0002221557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048459024,0.0001747841,0.00063530734,0.0003209437,0.000016235655,0.000020894577,0.0002716234,0.0002382981,0.006368349],"category_scores_gemma":[0.0011046376,0.00014130253,0.0001290625,0.0003466147,0.00015068929,0.000109068475,0.00014312509,0.0009221297,0.0000017227333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004596039,0.0014002386,0.9190362,0.0003590164,0.00009441694,0.0037736755,0.0004987609,0.0006546211,0.054735076,0.00015646222,0.000202444,0.014493051],"study_design_scores_gemma":[0.0058027143,0.0010727716,0.93292725,0.0000685394,0.000046041976,0.00011174039,0.00032119383,0.00014897856,0.058880657,0.00025423802,0.00024302544,0.00012286258],"about_ca_topic_score_codex":0.00039065964,"about_ca_topic_score_gemma":0.0029173472,"teacher_disagreement_score":0.014370188,"about_ca_system_score_codex":0.0004610515,"about_ca_system_score_gemma":0.0011668083,"threshold_uncertainty_score":0.99454},"labels":[],"label_agreement":null},{"id":"W3209371553","doi":"10.1136/ijgc-2021-igcs.183","title":"EPV113/#323 Prognostic factors and oncologic outcomes for patients treated with adjuvant chemotherapy and vaginal vault brachytherapy for stage I endometrial serous carcinomas","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Brachytherapy; Vaginal vault; Serous fluid; Endometrial cancer; Carcinosarcoma; Hysterectomy; Proportional hazards model; Chemotherapy; Oncology; Univariate analysis; Internal medicine; Progression-free survival; Serous carcinoma; Cancer; Surgery; Ovarian cancer; Carcinoma; Radiation therapy; Multivariate analysis","score_opus":0.03668323045797917,"score_gpt":0.3394322201003172,"score_spread":0.30274898964233804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209371553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948132,0.00126755,0.00028176987,0.0018354212,0.0005574973,0.00087119173,0.00031988326,0.000013594837,0.000039868846],"genre_scores_gemma":[0.9955562,0.00088770164,0.001679755,0.0010582583,0.00031468287,0.00012771352,0.00006984271,0.000020962803,0.00028488645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848914,0.000049878035,0.00047036662,0.00028939795,0.0004554896,0.00024572047],"domain_scores_gemma":[0.9962676,0.001827481,0.0003809209,0.000067327914,0.0012479431,0.00020868843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015871142,0.00023934661,0.00072036753,0.00016579009,0.000070421345,0.00005606237,0.000107486434,0.00012355208,0.00029444846],"category_scores_gemma":[0.0011304833,0.00013126244,0.0001945074,0.00016736705,0.0000927128,0.000119753095,0.000028643315,0.00016377853,2.3438501e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008334458,0.0008917062,0.95561886,0.000038031103,0.0011010197,0.0001225157,0.00007028923,0.0000055393825,0.000170151,0.000050812632,0.00006464714,0.033531945],"study_design_scores_gemma":[0.04158511,0.0106101455,0.9410974,0.000058550104,0.00032533894,0.000055633573,0.000074925316,0.0000215573,0.0012138884,0.0001889606,0.004616576,0.00015195126],"about_ca_topic_score_codex":0.000050395396,"about_ca_topic_score_gemma":0.00007277681,"teacher_disagreement_score":0.033379994,"about_ca_system_score_codex":0.0003755555,"about_ca_system_score_gemma":0.00023106473,"threshold_uncertainty_score":0.53527266},"labels":[],"label_agreement":null},{"id":"W3209488401","doi":"10.1136/ijgc-2021-igcs.130","title":"EPV062/#354 Comparison of outcomes between abdominal, minimally invasive and combined vaginal- laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian cervical cancer collaborative) study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Alberta; Université de Montréal; Sunnybrook Health Science Centre; Alberta Health; Jewish General Hospital; Juravinski Cancer Centre; Trillium Health Centre; University of Manitoba; University of Calgary; Vancouver General Hospital; University of Toronto; Dalhousie University; Hamilton Health Sciences; Hôtel-Dieu de Québec; McMaster University","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Hysterectomy; Retrospective cohort study; Radical Hysterectomy; Surgery; Lymph node; Cancer; Laparoscopy; Gynecology; Internal medicine","score_opus":0.03047576265532807,"score_gpt":0.3525769129695174,"score_spread":0.3221011503141893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209488401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918962,0.0013979224,0.000003648934,0.004538015,0.00065285654,0.0007265205,0.00052168063,0.000008516683,0.00025464795],"genre_scores_gemma":[0.99801844,0.0003085711,0.00028571876,0.0008505983,0.00019113373,0.00011211107,0.000037568116,0.00002542428,0.00017040501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964769,0.0002670291,0.0011907016,0.0004419669,0.0012099753,0.0004134315],"domain_scores_gemma":[0.9954486,0.00088304834,0.00073335675,0.00016708607,0.0022379823,0.00052992377],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024236769,0.00035832776,0.0015978558,0.00042382051,0.00007061935,0.00007280951,0.00036206818,0.00018276053,0.0022867953],"category_scores_gemma":[0.00045843903,0.0002458565,0.0001522155,0.000692134,0.00018588192,0.0002083377,0.00013633941,0.000572859,0.0000032175517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039721914,0.002330073,0.984819,0.00008488845,0.001741863,0.00043098407,0.000543578,0.000048406542,0.000055191682,0.000020793515,0.00010595812,0.005847048],"study_design_scores_gemma":[0.026362343,0.004479692,0.96554154,0.00040043215,0.0004919261,0.0000036791978,0.000827441,0.000011364747,0.0008810995,0.000039709328,0.0007333011,0.00022744155],"about_ca_topic_score_codex":0.012261442,"about_ca_topic_score_gemma":0.14372298,"teacher_disagreement_score":0.13146153,"about_ca_system_score_codex":0.0014855121,"about_ca_system_score_gemma":0.0020225507,"threshold_uncertainty_score":0.99999934},"labels":[],"label_agreement":null},{"id":"W3209504444","doi":"10.1136/ijgc-2021-igcs.32","title":"OP015/#492 Further stratification of no specific molecular profile (NSMP/P53WT) endometrial carcinomas to refine prognosis and identify therapeutic opportunities","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Saskatchewan; McMaster University; Health Sciences Centre; Juravinski Cancer Centre; Centre for Advancing Health Outcomes; Sunnybrook Health Science Centre; Jewish General Hospital; Hamilton Health Sciences; Dalhousie University; McGill University; Vancouver General Hospital; Royal Jubilee Hospital; University of Calgary; Hôtel-Dieu de Québec; University of British Columbia","funders":"","keywords":"Internal medicine; Oncology; Medicine; Cohort; Immunohistochemistry; Endometrial cancer; Population; Risk stratification; Stage (stratigraphy); Molecular biomarkers; Cancer; Biology","score_opus":0.09592336468357765,"score_gpt":0.3625091111186488,"score_spread":0.26658574643507116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209504444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810148,0.0063582347,0.00022774778,0.008152074,0.0012904509,0.0003518977,0.000078148194,0.000010467201,0.0025161903],"genre_scores_gemma":[0.9946538,0.001980388,0.0012979498,0.00082964567,0.0005818819,0.000052133542,0.00002472669,0.00001434346,0.0005651159],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980149,0.00010765579,0.0006913126,0.00022936997,0.0007890526,0.00016767811],"domain_scores_gemma":[0.9971737,0.0003063138,0.0003833152,0.00011884447,0.0018151132,0.00020266081],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029732133,0.0001559143,0.00046906795,0.00027491842,0.000026930195,0.00005092626,0.00018327044,0.00010038004,0.005076823],"category_scores_gemma":[0.0005654438,0.00011118624,0.00019744446,0.00032015375,0.00008441907,0.0001115517,0.00007109542,0.00019848927,0.000010614771],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010395153,0.003014612,0.15288468,0.00019930597,0.0036707479,0.002812775,0.000567962,0.000063012696,0.37586835,0.0041303225,0.0016962143,0.44469687],"study_design_scores_gemma":[0.014213484,0.0050834245,0.77815855,0.000423287,0.0006528843,0.0004131105,0.00071044493,0.000025666255,0.16477183,0.0018339105,0.033314556,0.0003988761],"about_ca_topic_score_codex":0.000029088453,"about_ca_topic_score_gemma":0.000012860937,"teacher_disagreement_score":0.6252739,"about_ca_system_score_codex":0.00027077153,"about_ca_system_score_gemma":0.0003094582,"threshold_uncertainty_score":0.9958327},"labels":[],"label_agreement":null},{"id":"W3209512858","doi":"10.1136/ijgc-2021-igcs.191","title":"EPV121/#419 Baseline clinical outcomes of lynch syndrome patients undergoing annual surveillance versus risk-reducing surgery in a prospective cohort study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lynch syndrome; Prospective cohort study; Endometrial cancer; Cohort; Surgery; Colorectal cancer; Relative risk; Cancer; Internal medicine; Confidence interval; DNA mismatch repair","score_opus":0.035244345825150084,"score_gpt":0.3694672767715489,"score_spread":0.3342229309463988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209512858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280643,0.00034881762,0.000035930265,0.00044447675,0.0056801047,0.00043612428,0.00009883869,0.000010238203,0.0001390245],"genre_scores_gemma":[0.9983703,0.00067808555,0.00041800854,0.00016543287,0.00024115862,0.00003237524,0.000011368041,0.000019378498,0.00006392691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583155,0.00058366836,0.001678234,0.00040116388,0.0012409306,0.00026443307],"domain_scores_gemma":[0.98961556,0.0063772313,0.0010956214,0.00018711321,0.0025663637,0.00015809646],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022403381,0.00021462086,0.0011353439,0.00023694814,0.000031791795,0.000019189152,0.00026048318,0.00015845543,0.001057792],"category_scores_gemma":[0.01910685,0.00016644644,0.00040387124,0.00032887084,0.00012481249,0.000120726465,0.00016493553,0.0006907976,0.0000040914506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023223187,0.0024682488,0.9876361,0.000014235636,0.0013300133,0.00082081393,0.00014038957,0.0007995932,0.000010282858,0.0000024522815,0.00030658883,0.004148957],"study_design_scores_gemma":[0.0067392457,0.0020929545,0.99013054,0.00013239254,0.00013239606,0.000057151155,0.0003210102,0.00006261804,0.00007719248,0.000038922106,0.000065522596,0.00015006054],"about_ca_topic_score_codex":0.00017015518,"about_ca_topic_score_gemma":0.0015547044,"teacher_disagreement_score":0.016866513,"about_ca_system_score_codex":0.0010851992,"about_ca_system_score_gemma":0.0011990739,"threshold_uncertainty_score":0.9998554},"labels":[],"label_agreement":null},{"id":"W3209590302","doi":"10.1136/ijgc-2021-igcs.57","title":"SF013/#236 Robotic approach for a total hysterectomy bilateral salpingo-oophorectomy and suction curettage of a 20-week size uterus with gestational trophoblastic neoplasia","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Hysterectomy; Gestational trophoblastic disease; Curettage; Methotrexate; Surgery; Uterus; Gestational sac; Endometrial cancer; Pregnancy; Gestation; Internal medicine; Cancer","score_opus":0.019078460581728865,"score_gpt":0.2895214966341884,"score_spread":0.27044303605245956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209590302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852209,0.00069203984,0.010877907,0.0018602753,0.000638027,0.00034032174,0.00011893426,0.000013861103,0.00023769778],"genre_scores_gemma":[0.97511125,0.00013539319,0.023523882,0.00028189286,0.00040095707,0.00007787189,0.00003867064,0.000021625361,0.0004084661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998039,0.00006662953,0.00062752934,0.00029511936,0.0007484427,0.00022329134],"domain_scores_gemma":[0.9960582,0.0010842219,0.00047619327,0.00007833182,0.0021313268,0.00017172916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014168107,0.00021738939,0.0005491581,0.00015036622,0.00005723936,0.0000460534,0.00011499635,0.00008342781,0.00034575022],"category_scores_gemma":[0.0010656918,0.00015585293,0.0001871026,0.00017436115,0.00020997498,0.00019061174,0.00005593154,0.00023663853,0.0000012751511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06841722,0.014066344,0.4484379,0.0034453636,0.01958216,0.006405484,0.0040101972,0.30103493,0.09787883,0.006248248,0.007154137,0.02331918],"study_design_scores_gemma":[0.012122424,0.0039349445,0.9676724,0.00055878813,0.00082228973,0.003703769,0.00048019015,0.0071710013,0.0013399996,0.0012377675,0.0006004734,0.00035596607],"about_ca_topic_score_codex":0.000012508249,"about_ca_topic_score_gemma":0.000012047085,"teacher_disagreement_score":0.5192345,"about_ca_system_score_codex":0.00024985176,"about_ca_system_score_gemma":0.0005737939,"threshold_uncertainty_score":0.6355498},"labels":[],"label_agreement":null},{"id":"W3209713335","doi":"10.1136/ijgc-2021-igcs.329","title":"EPV258/#285 Improving the rates of same day discharge in robotic surgery patients – a gynecologic oncology quality improvement project","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Foley catheter; Psychological intervention; Perioperative; Quality management; Gynecologic oncology; Emergency medicine; Foley; Emergency department; Fast track; Robotic surgery; Surgery; Catheter; Operations management; Nursing","score_opus":0.05687492476919718,"score_gpt":0.38606760683782176,"score_spread":0.32919268206862456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209713335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776764,0.00070344115,0.000061421495,0.008749162,0.0016683461,0.0003163994,0.000015033495,0.0000069117195,0.0007116608],"genre_scores_gemma":[0.9960993,0.00069628167,0.000193175,0.0023092104,0.00025575087,0.000042986503,0.000014679848,0.000010278837,0.00037833926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967909,0.0005881191,0.0013140314,0.00023789874,0.0007774589,0.00029162577],"domain_scores_gemma":[0.99152035,0.0062648654,0.0008649718,0.00015103287,0.0010984532,0.00010032869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002065929,0.00017946506,0.0011487281,0.00017200399,0.000038369835,0.000028421136,0.00026077736,0.00016756551,0.00083818194],"category_scores_gemma":[0.007120176,0.00009991684,0.0007137993,0.00024685918,0.00014941551,0.00011932508,0.0001321734,0.00046959208,0.0000033454676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068601465,0.0013771793,0.9235589,0.000052710995,0.00041562505,0.000745032,0.00021653128,0.00012826294,0.0025070927,0.0006339534,0.00036190645,0.06931681],"study_design_scores_gemma":[0.0021367427,0.0007704065,0.98653966,0.00008499921,0.00010602495,0.00008260956,0.00038053349,0.000052929616,0.0015666944,0.00013285536,0.008017725,0.00012883467],"about_ca_topic_score_codex":0.00019555511,"about_ca_topic_score_gemma":0.00023460737,"teacher_disagreement_score":0.06918798,"about_ca_system_score_codex":0.0007523869,"about_ca_system_score_gemma":0.0010767238,"threshold_uncertainty_score":0.9177504},"labels":[],"label_agreement":null},{"id":"W3209815357","doi":"10.1136/ijgc-2021-igcs.317","title":"EPV246/#242 The gender imbalance in gynecologic oncology authorship and editorial boards","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Gender disparity; Workforce; Representation (politics); Gender diversity; Editorial board; Gynecologic oncology; Publishing; Diversity (politics); Gender gap; Family medicine; Oncology; Demography; Library science; Political science; Management; Corporate governance; Demographic economics; Sociology","score_opus":0.059884527878261595,"score_gpt":0.40620085651479965,"score_spread":0.34631632863653805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209815357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82804745,0.002074022,0.000055179127,0.06374755,0.08123012,0.00011529515,0.0000134627235,0.000013241629,0.024703661],"genre_scores_gemma":[0.9779063,0.002314686,0.00014096494,0.003522207,0.015647188,0.000005717306,0.0000012298115,0.0000028359216,0.00045889305],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977276,0.00052539253,0.00030578472,0.00014257185,0.0010735642,0.00022512503],"domain_scores_gemma":[0.9974687,0.0012705517,0.00022597783,0.000053986358,0.0008572403,0.00012352316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027409804,0.00007846044,0.00022118412,0.0000628357,0.00014825474,0.00009314605,0.0006506386,0.00023595686,0.0020138535],"category_scores_gemma":[0.0038712844,0.000052191386,0.000082570536,0.00016469505,0.00045138737,0.00016223079,0.00015378486,0.0005916097,0.0000055566506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008352156,0.00085181405,0.5509709,0.000015377898,0.00046561877,0.0038956434,0.02543571,0.00033287448,0.00051666854,0.052353486,0.2888397,0.07548701],"study_design_scores_gemma":[0.0012462345,0.00019641561,0.23549853,0.000023756742,0.000035820878,0.000035057128,0.0075220815,0.000009356182,0.000036203037,0.019930981,0.7353663,0.00009928117],"about_ca_topic_score_codex":0.00019986209,"about_ca_topic_score_gemma":0.0025337378,"teacher_disagreement_score":0.4465266,"about_ca_system_score_codex":0.00064437964,"about_ca_system_score_gemma":0.0008990865,"threshold_uncertainty_score":0.99889845},"labels":[],"label_agreement":null},{"id":"W3209837240","doi":"10.1136/ijgc-2021-igcs.22","title":"OP005/#352 Safety of vaginal hysterectomy for cervical cancer: a multicenter cohort study on behalf of the 4C (Canadian cervical cancer collaborative) working group","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Trillium Health Centre; Juravinski Cancer Centre; University of Manitoba; University of Calgary; Vancouver General Hospital; Alberta Health; Jewish General Hospital; Université Laval; McGill University; Hôtel-Dieu de Québec; Dalhousie University; Hamilton Health Sciences; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Cervical cancer; Retrospective cohort study; Hysterectomy; Radical Hysterectomy; Stage (stratigraphy); Cancer; Surgery; Laparoscopy; Cohort; Proportional hazards model; Urology; Gynecology; Internal medicine","score_opus":0.03562238707283386,"score_gpt":0.35104471824629524,"score_spread":0.31542233117346136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209837240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820435,0.0019636005,0.000055553304,0.009485668,0.00336341,0.0012784827,0.00059520133,0.000008307694,0.0012062443],"genre_scores_gemma":[0.9959301,0.00060021324,0.00026131948,0.0018654779,0.00083979126,0.00026965208,0.000015704167,0.000025537383,0.00019224513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966058,0.0002532473,0.0011338659,0.00038463948,0.0012497336,0.0003727228],"domain_scores_gemma":[0.9954461,0.00082725234,0.0007908736,0.00022332891,0.0023730902,0.00033937034],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004593115,0.00028021738,0.0009557593,0.00021979523,0.00010183903,0.000039729566,0.0005396682,0.00017716478,0.0034621628],"category_scores_gemma":[0.00056395686,0.0001742622,0.00048373386,0.0006182439,0.00015883477,0.000096076226,0.00012959054,0.0004949336,0.000001816471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005569409,0.0019528196,0.9742048,0.00005758875,0.002416391,0.00016979747,0.00028956012,0.00022920992,0.00067963946,0.00026680925,0.0002669866,0.013896991],"study_design_scores_gemma":[0.011918454,0.0016498447,0.97138727,0.0006610757,0.0007550001,0.000024080276,0.00043700417,0.00006721729,0.0024851693,0.00011171801,0.01033374,0.00016942825],"about_ca_topic_score_codex":0.0072945897,"about_ca_topic_score_gemma":0.046079412,"teacher_disagreement_score":0.03878482,"about_ca_system_score_codex":0.001846189,"about_ca_system_score_gemma":0.0014380706,"threshold_uncertainty_score":0.9993159},"labels":[],"label_agreement":null},{"id":"W3210022855","doi":"10.1136/ijgc-2021-igcs.252","title":"EPV181/#221 Carboplatin-based hyperthermic intraperitoneal chemotherapy for managing advanced primary and recurrent ovarian carcinoma – a single-center experience","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Hyperthermic intraperitoneal chemotherapy; Single Center; Perioperative; Regimen; Surgery; Retrospective cohort study; Internal medicine; Cisplatin; Oncology; Chemotherapy; Cancer; Ovarian cancer; Cytoreductive surgery","score_opus":0.025294125327218912,"score_gpt":0.30249894503584396,"score_spread":0.27720481970862504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210022855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848997,0.0016919199,0.0004901562,0.010604953,0.0013382075,0.00023707967,0.000032294673,0.00001498123,0.00069070345],"genre_scores_gemma":[0.98811847,0.00030543824,0.004461566,0.00633644,0.00058678904,0.00005210658,0.00001737922,0.000018511446,0.00010330949],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854136,0.00003948133,0.0004882954,0.00026011403,0.00041583026,0.00025494272],"domain_scores_gemma":[0.9986071,0.00022090446,0.00026303733,0.00008830097,0.000667876,0.000152783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012890834,0.00018133888,0.00040543886,0.00008590818,0.00006804768,0.00005606564,0.00016853055,0.000094446164,0.00049243827],"category_scores_gemma":[0.00014361665,0.00013904249,0.00018610762,0.0000882542,0.00013318619,0.00012310357,0.00004296761,0.00022860704,8.6600886e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008237682,0.001808395,0.07074285,0.00023793807,0.0004766764,0.0023771126,0.0012580474,0.00011867987,0.40288427,0.00076863344,0.00041215212,0.5106776],"study_design_scores_gemma":[0.042768434,0.00815731,0.64745927,0.0023531243,0.0003892682,0.0067971754,0.0021200753,0.0052555366,0.17657942,0.0014351055,0.10530117,0.0013841346],"about_ca_topic_score_codex":0.000010304062,"about_ca_topic_score_gemma":0.000019636482,"teacher_disagreement_score":0.5767164,"about_ca_system_score_codex":0.00035151272,"about_ca_system_score_gemma":0.00029160434,"threshold_uncertainty_score":0.5669988},"labels":[],"label_agreement":null},{"id":"W3210173250","doi":"10.1136/ijgc-2021-igcs.309","title":"EPV238/#131 Impact of lymphadenectomy and intraoperative tumor rupture on survival in early stage mucinous ovarian cancers","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Stage (stratigraphy); Retrospective cohort study; Hazard ratio; Ovarian cancer; Proportional hazards model; Cohort; Internal medicine; Oncology; Surgery; Radiology; Cancer; Confidence interval","score_opus":0.024347158000868986,"score_gpt":0.34816864620338994,"score_spread":0.32382148820252094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210173250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939097,0.001232099,0.000012435058,0.0028611552,0.00070499995,0.00014206755,0.000118644246,0.0000042630086,0.0010146431],"genre_scores_gemma":[0.9973361,0.0012223546,0.00022204164,0.0007217556,0.00032758625,0.000018404977,0.0000058637224,0.000011743107,0.000134183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849623,0.000097710676,0.00049234927,0.00022389184,0.00050088303,0.00018892933],"domain_scores_gemma":[0.998418,0.00032400803,0.00031294255,0.000095822186,0.00068521773,0.00016405447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019993751,0.00017200099,0.000535946,0.00015594861,0.000021806494,0.00003544232,0.000125924,0.00008784995,0.0020104356],"category_scores_gemma":[0.00029727456,0.00011353057,0.00020355705,0.00016284216,0.00008053395,0.00010788449,0.000043435324,0.00028453552,0.0000018486162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020479816,0.0009505244,0.9731948,0.000020247562,0.0013697097,0.0062376135,0.0006460326,0.0019211569,0.001468661,0.0009999404,0.00026533083,0.010878012],"study_design_scores_gemma":[0.0056671016,0.0020304052,0.987325,0.00026197507,0.000074703494,0.00019568624,0.00015110332,0.000061552964,0.0032363168,0.00011947453,0.00077131396,0.00010535748],"about_ca_topic_score_codex":0.0014582311,"about_ca_topic_score_gemma":0.00078964914,"teacher_disagreement_score":0.01413022,"about_ca_system_score_codex":0.001934226,"about_ca_system_score_gemma":0.0013165061,"threshold_uncertainty_score":0.99890184},"labels":[],"label_agreement":null},{"id":"W3210637992","doi":"10.1136/ijgc-2021-igcs.131","title":"EPV063/#357 The impact of surgical approach in cases with no residual disease on hysterectomy specimen: a 4C (Canadian cervical cancer collaborative) working group study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; University of Alberta; Trillium Health Centre; Juravinski Cancer Centre; University of Manitoba; Sunnybrook Health Science Centre; Jewish General Hospital; University of Calgary; Vancouver General Hospital; Health Sciences Centre; McMaster University; Dalhousie University; Hamilton Health Sciences; McGill University; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Cervical cancer; Hysterectomy; Retrospective cohort study; Surgery; Stage (stratigraphy); Cohort; Radical Hysterectomy; Population; Cancer; Urology; Internal medicine","score_opus":0.04442782749170586,"score_gpt":0.36166729279339965,"score_spread":0.3172394653016938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210637992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922019,0.0016496468,0.0000022230265,0.002573981,0.0004794516,0.00048128085,0.00013157529,0.0000058027367,0.0024741131],"genre_scores_gemma":[0.99785,0.0005239953,0.00008423649,0.0004045948,0.00087233,0.000090833266,0.000019715993,0.000017084252,0.00013720032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973809,0.0003352483,0.00063414103,0.00031976035,0.0010116202,0.00031830498],"domain_scores_gemma":[0.99713206,0.0009066999,0.00034231797,0.00016801922,0.0010066573,0.00044422978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003450124,0.00024394006,0.00064667314,0.00026682735,0.000060865492,0.00006391198,0.00030504528,0.00007685875,0.0037114928],"category_scores_gemma":[0.0003236143,0.00012200954,0.00024581188,0.00076622126,0.00012785179,0.000093745984,0.00006574043,0.0005125393,0.0000045245497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016963562,0.0035927463,0.95694596,0.000014898002,0.0014874561,0.0149828065,0.00018705125,0.0012972467,0.00003079926,0.0001142571,0.0005368226,0.0038464228],"study_design_scores_gemma":[0.0112300655,0.004061899,0.98169136,0.00030860124,0.00020864485,0.00025405604,0.00046262724,0.00004090669,0.000059153837,0.000051714513,0.0014770072,0.00015395258],"about_ca_topic_score_codex":0.009581654,"about_ca_topic_score_gemma":0.02159837,"teacher_disagreement_score":0.02474544,"about_ca_system_score_codex":0.0017956183,"about_ca_system_score_gemma":0.0018069873,"threshold_uncertainty_score":0.99719924},"labels":[],"label_agreement":null},{"id":"W3210639163","doi":"10.1136/ijgc-2021-esgo.641","title":"58 KEYNOTE-826: Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Medicine; Bevacizumab; Chemotherapy; Carboplatin; Internal medicine; Placebo; Oncology; Cervical cancer; Clinical endpoint; Surgery; Cancer; Randomized controlled trial; Cisplatin; Immunotherapy; Pathology","score_opus":0.073051747860394,"score_gpt":0.3840308324736213,"score_spread":0.3109790846132273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210639163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88976306,0.02033373,0.002274475,0.06967904,0.014256888,0.001503961,0.00040799842,0.00007886227,0.0017020201],"genre_scores_gemma":[0.9431252,0.02573657,0.004032227,0.016404731,0.003408719,0.0003619553,0.000074005606,0.00010594398,0.0067506577],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714357,0.00010642106,0.00092042895,0.0004239506,0.0009511862,0.0004544195],"domain_scores_gemma":[0.9965678,0.000789667,0.0006436463,0.00020472717,0.0015300342,0.00026413202],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040403684,0.00034979064,0.0008465811,0.00017337393,0.00010547775,0.00010118324,0.000483304,0.00020171455,0.017528158],"category_scores_gemma":[0.00045977396,0.00024355575,0.0010094426,0.0002760523,0.00018041805,0.00018164581,0.00005681274,0.0004791258,0.0000073945107],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63829494,0.0015328979,0.0019574976,0.000257644,0.01270394,0.0010506576,0.0011961306,0.0008193261,0.00904879,0.00021780591,0.038406853,0.2945135],"study_design_scores_gemma":[0.25895086,0.009573622,0.02533214,0.0010609931,0.0015803553,0.0016154448,0.0015794609,0.00466615,0.012006219,0.0003365869,0.68218833,0.0011098757],"about_ca_topic_score_codex":0.00009282938,"about_ca_topic_score_gemma":0.00040311198,"teacher_disagreement_score":0.6437815,"about_ca_system_score_codex":0.002864881,"about_ca_system_score_gemma":0.0025530837,"threshold_uncertainty_score":0.99319154},"labels":[],"label_agreement":null},{"id":"W3210668763","doi":"10.1136/ijgc-2021-igcs.343","title":"EPV272/#115 Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: a pilot project","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Hair loss; Scalp; Carboplatin; Quality of life (healthcare); Regimen; Chemotherapy; Paclitaxel; Visual analogue scale; Internal medicine; Cancer; Surgery; Oncology; Dermatology","score_opus":0.03666467923590057,"score_gpt":0.3542730720142976,"score_spread":0.31760839277839703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210668763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921446,0.00033506943,0.00020088404,0.0046750456,0.0006110669,0.0004754488,0.000019437497,0.00001575311,0.0015227214],"genre_scores_gemma":[0.9930572,0.00040637766,0.001976643,0.003827829,0.0003508309,0.00008793972,0.000028939374,0.00002326246,0.00024098516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825746,0.00011384778,0.00065102323,0.00027747694,0.0003704232,0.00032974564],"domain_scores_gemma":[0.99714816,0.00075084873,0.00037513924,0.000087391905,0.0014995964,0.00013888224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032134305,0.00017843257,0.0005699327,0.0002584786,0.000043015767,0.000026310228,0.00018473704,0.00016924896,0.000792387],"category_scores_gemma":[0.0017190868,0.000125551,0.00014356355,0.00025359011,0.0001047242,0.00011580216,0.000038090573,0.00036752227,0.0000036101264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03675387,0.005943663,0.80294704,0.00007151515,0.0010695979,0.0027456854,0.00081141136,0.0006961757,0.0033819622,0.000184394,0.005291653,0.14010306],"study_design_scores_gemma":[0.041088916,0.014234833,0.8949032,0.00034722144,0.00018529913,0.0005736993,0.0005095763,0.00048301142,0.0023771308,0.0002718511,0.044689212,0.000336091],"about_ca_topic_score_codex":0.00011604869,"about_ca_topic_score_gemma":0.00094585936,"teacher_disagreement_score":0.13976696,"about_ca_system_score_codex":0.0009283984,"about_ca_system_score_gemma":0.0014139776,"threshold_uncertainty_score":0.8676082},"labels":[],"label_agreement":null},{"id":"W3210670478","doi":"10.1136/ijgc-2021-igcs.3","title":"O003/#149 Antitumor activity of dostarlimab in patients with advanced or recurrent mismatch repair–deficient or proficient–cancer by prior therapy: results from the garnet study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Discontinuation; Medicine; Microsatellite instability; Internal medicine; Oncology; DNA mismatch repair; Regimen; Cancer; Population; Combination therapy; Endometrial cancer; Colorectal cancer","score_opus":0.03355676559790811,"score_gpt":0.33707618439258963,"score_spread":0.30351941879468153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210670478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291426,0.001516973,0.0000137677225,0.0022933234,0.0016035476,0.0010274233,0.00054187217,0.0000137625975,0.000075075965],"genre_scores_gemma":[0.99713606,0.0011763972,0.000503549,0.00068215426,0.00014484876,0.00009512341,0.000024154442,0.000021079644,0.00021660935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965374,0.0002535136,0.0009216232,0.00045977187,0.0015410215,0.00028670082],"domain_scores_gemma":[0.99610096,0.00086498423,0.0009098729,0.00028625285,0.0017233007,0.00011463184],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000484507,0.00025543064,0.0006298441,0.000087245986,0.000051604966,0.00003182569,0.00042657365,0.000099434554,0.0015199288],"category_scores_gemma":[0.0013698117,0.00012338115,0.00016060329,0.0004031408,0.00014722576,0.000112582944,0.00014174616,0.0005538217,0.0000012883193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12209614,0.010195121,0.7733852,0.000024794672,0.0009701726,0.00041572764,0.0016442663,0.0008860007,0.00360541,0.0000017213199,0.0046241577,0.08215125],"study_design_scores_gemma":[0.019024469,0.008187521,0.9582347,0.00043793087,0.00011061772,0.000013699627,0.0006278086,0.000083533174,0.0076825824,0.000010029429,0.0053943004,0.00019278216],"about_ca_topic_score_codex":0.00023960721,"about_ca_topic_score_gemma":0.0011937823,"teacher_disagreement_score":0.18484949,"about_ca_system_score_codex":0.00084335863,"about_ca_system_score_gemma":0.001138579,"threshold_uncertainty_score":0.9993928},"labels":[],"label_agreement":null},{"id":"W3210733329","doi":"10.1136/ijgc-2021-igcs.264","title":"EPV193/#344 Systematic review and meta-analysis of the survival impact of secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Oncology; Hazard ratio; Internal medicine; Serous fluid; Progression-free survival; Serous carcinoma; Randomized controlled trial; Overall survival; Ovarian cancer; Cancer; Confidence interval","score_opus":0.08448108011781826,"score_gpt":0.37965533611517965,"score_spread":0.2951742559973614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210733329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76110333,0.21758012,0.00009820428,0.017224254,0.0011696178,0.0012317032,0.0014814857,0.0000044385447,0.000106838714],"genre_scores_gemma":[0.9943809,0.004679314,0.00012900308,0.00055487244,0.00008113769,0.000092398084,0.000016631186,0.0000083287005,0.000057412188],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99786323,0.00025532985,0.0010501243,0.00018679879,0.00051752327,0.00012701782],"domain_scores_gemma":[0.9955327,0.0013164197,0.001256539,0.00019197432,0.0016033227,0.00009906152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006749105,0.00016373003,0.0023441764,0.00014242658,0.000025592242,0.000014562194,0.0001656627,0.000063314605,0.0015505734],"category_scores_gemma":[0.0009807694,0.00008095015,0.002680878,0.00031872926,0.00008093469,0.00006681537,0.0000550834,0.00016365055,2.0591926e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088073564,0.002501447,0.12973368,0.027500238,0.83340716,0.00034081715,0.0003322769,0.00032785904,0.0002465085,0.0006179243,0.0029403383,0.0011710105],"study_design_scores_gemma":[0.0011474933,0.00055563805,0.58711237,0.0019194733,0.40768299,0.0001768785,0.000079963924,0.000037867256,0.00094068726,0.00018340917,0.000046087407,0.00011714396],"about_ca_topic_score_codex":0.00007522659,"about_ca_topic_score_gemma":0.000096257754,"teacher_disagreement_score":0.4573787,"about_ca_system_score_codex":0.00045908685,"about_ca_system_score_gemma":0.0007921078,"threshold_uncertainty_score":0.9993622},"labels":[],"label_agreement":null},{"id":"W3210792150","doi":"10.1136/ijgc-2021-igcs.167","title":"EPV097/#140 Application of a machine learning algorithm to identify predictors of recurrence and recurrence free survival in high grade endometrial cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Sinai Health System; Trillium Health Centre; Juravinski Cancer Centre; Hôtel-Dieu de Québec; McGill University; Centre Hospitalier de l’Université de Montréal; University of Toronto","funders":"","keywords":"Random forest; Receiver operating characteristic; Test set; Algorithm; Proportional hazards model; Stage (stratigraphy); Endometrial cancer; Artificial intelligence; Lasso (programming language); Statistics; Concordance; Mathematics; Machine learning; Cancer; Medicine; Computer science; Internal medicine","score_opus":0.0348305006583805,"score_gpt":0.362894680689458,"score_spread":0.3280641800310775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210792150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870119,0.0060849204,0.0014539761,0.0023355545,0.002379155,0.00028170925,0.000333086,0.000007040808,0.00011261841],"genre_scores_gemma":[0.9920112,0.0053384113,0.0018752633,0.00012692744,0.00051956077,0.000048995615,0.00002249423,0.000009244562,0.00004790929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760926,0.00015480471,0.00087027816,0.0002614036,0.00092620763,0.0001780224],"domain_scores_gemma":[0.9972198,0.00085496117,0.0006154749,0.00011585948,0.0010171036,0.00017679094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005291397,0.00014979014,0.0006427557,0.00038547683,0.000021424186,0.00001533347,0.00029845163,0.000109590015,0.00055969355],"category_scores_gemma":[0.003213877,0.000115729104,0.00014760742,0.0008003985,0.000090037356,0.00011437128,0.00016954838,0.00040110789,9.395728e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001737748,0.00072209566,0.7453164,0.000059447677,0.0004543767,0.00014018262,0.00014744562,0.0003689324,0.0050053895,0.00017505171,0.000075800715,0.24579714],"study_design_scores_gemma":[0.011115915,0.0014922981,0.97029203,0.0004951536,0.00019534466,0.000054517317,0.00008198165,0.0003695481,0.012092921,0.0012006173,0.002450834,0.00015885127],"about_ca_topic_score_codex":0.0012554935,"about_ca_topic_score_gemma":0.00054489484,"teacher_disagreement_score":0.24563828,"about_ca_system_score_codex":0.0003876752,"about_ca_system_score_gemma":0.00028486992,"threshold_uncertainty_score":0.6128252},"labels":[],"label_agreement":null},{"id":"W3211070760","doi":"10.1136/ijgc-2021-igcs.37","title":"OP020/#524 Heath care resource and cost implications of integration of molecular classification in the management of endometrial cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; University of Manitoba; Health Sciences Centre; McGill University; Sunnybrook Health Science Centre; Jewish General Hospital; Centre for Advancing Health Outcomes; Université de Montréal; University of Saskatchewan; Dalhousie University; Vancouver General Hospital; Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Cohort; Retrospective cohort study; Internal medicine; Incidence (geometry); Cancer; Stage (stratigraphy); Oncology; Biology","score_opus":0.06081086107269008,"score_gpt":0.3840277693280877,"score_spread":0.3232169082553976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211070760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834948,0.0072117364,0.000455866,0.0052180085,0.00027253487,0.00036704153,0.00012359978,0.0000022229253,0.0028541775],"genre_scores_gemma":[0.99537647,0.0034495187,0.0006805897,0.00028168215,0.00009389351,0.00005725411,0.000026600736,0.0000047255776,0.000029272165],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985251,0.00009318865,0.000647882,0.00012987008,0.00051862147,0.00008534302],"domain_scores_gemma":[0.9980838,0.00032713497,0.00048764175,0.000114401664,0.0009402927,0.00004673904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002526443,0.000086401444,0.00033117124,0.00019244915,0.000014560182,0.000008546451,0.00019006844,0.00006570914,0.00029129634],"category_scores_gemma":[0.0002490399,0.00005421554,0.00014116762,0.0004794698,0.0000873839,0.000050530252,0.000046642395,0.00015615424,1.5261747e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048674666,0.002149317,0.19836608,0.00036492277,0.0021222087,0.00025099973,0.0016803764,0.0005855148,0.101349026,0.016235938,0.00040099578,0.67162716],"study_design_scores_gemma":[0.008149744,0.00081627956,0.9358335,0.0005780893,0.0004710542,0.00004975047,0.0028253896,0.000027376724,0.04636092,0.0010423195,0.0037571213,0.000088430286],"about_ca_topic_score_codex":0.00010911745,"about_ca_topic_score_gemma":0.000083061794,"teacher_disagreement_score":0.73746747,"about_ca_system_score_codex":0.00028869227,"about_ca_system_score_gemma":0.00014865828,"threshold_uncertainty_score":0.31894904},"labels":[],"label_agreement":null},{"id":"W3211093299","doi":"10.1136/ijgc-2021-002571","title":"Gallstone mimicking metastatic cervical cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Cervical cancer; Cervix; Positron emission tomography; Radiology; Stage (stratigraphy); Laparoscopic cholecystectomy; General surgery; Computed tomography; Cervical carcinoma; Cancer; Gynecology; Internal medicine","score_opus":0.04022523056414111,"score_gpt":0.3650701926784585,"score_spread":0.3248449621143174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211093299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553064,0.005437578,0.00034956427,0.033923827,0.0024674253,0.00009277823,0.000022815442,0.000015937992,0.002383676],"genre_scores_gemma":[0.98852164,0.002231075,0.0012543291,0.0066552954,0.000646625,0.000013769809,0.0000075254156,0.000012123993,0.0006576201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839795,0.000060241644,0.00047916244,0.00016766653,0.00069729437,0.000197681],"domain_scores_gemma":[0.99796706,0.0001769962,0.00023046002,0.00008156273,0.0013799669,0.0001639514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018190841,0.0001243741,0.00035970483,0.0000980546,0.000031090218,0.000038393104,0.00020883135,0.00006858994,0.015057186],"category_scores_gemma":[0.0004931359,0.0000881656,0.00026587548,0.0001426732,0.00007422778,0.000110130364,0.00006791506,0.00036520895,0.000014477741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026421098,0.004255719,0.61148447,0.00020497598,0.006830554,0.016953139,0.0009603596,0.0019254748,0.09736135,0.0017961222,0.03422974,0.22135599],"study_design_scores_gemma":[0.0075863693,0.0007257686,0.86280656,0.00048086824,0.0008340207,0.0030923954,0.00093376386,0.0004107484,0.015654955,0.0024250292,0.104643635,0.00040591124],"about_ca_topic_score_codex":0.000052748313,"about_ca_topic_score_gemma":0.00016542019,"teacher_disagreement_score":0.25132206,"about_ca_system_score_codex":0.00029696664,"about_ca_system_score_gemma":0.0006232815,"threshold_uncertainty_score":0.9858432},"labels":[],"label_agreement":null},{"id":"W3211113743","doi":"10.1136/ijgc-2021-003144","title":"ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Serous carcinoma; Serous fluid; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Carcinoma; Carcinosarcoma; Gynecology; Phases of clinical research; Clinical trial; Cancer; Ovarian cancer","score_opus":0.04614336769951693,"score_gpt":0.3626149689393576,"score_spread":0.31647160123984064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211113743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928317,0.0004886382,0.0000047159483,0.00422927,0.0018261601,0.0002905601,0.00004392108,0.0000047891895,0.000280254],"genre_scores_gemma":[0.9979044,0.00021623432,0.00009275155,0.0007807619,0.00045394961,0.00006123622,0.000003687832,0.000010565157,0.0004763732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774086,0.00011184738,0.0006849535,0.00021904848,0.0010490279,0.00019427913],"domain_scores_gemma":[0.9980987,0.00017839653,0.00042171974,0.00013412857,0.0010215825,0.0001454921],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019858804,0.00016149366,0.00045140935,0.00015644406,0.000028207527,0.000025524361,0.00035755677,0.000060523456,0.0030586654],"category_scores_gemma":[0.00041071328,0.00008102772,0.00016692844,0.0003662476,0.00006297312,0.00010297486,0.00016863659,0.00034091287,0.0000013949534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13046785,0.034940045,0.63005155,0.00009668932,0.004818338,0.009297194,0.004496956,0.00068895693,0.0048797666,0.00003735498,0.0007409211,0.17948437],"study_design_scores_gemma":[0.0676293,0.022865804,0.8894022,0.00052104576,0.00027724935,0.00091277395,0.0052271043,0.00011068546,0.0024889968,0.000056112687,0.0102843065,0.0002244214],"about_ca_topic_score_codex":0.000117441785,"about_ca_topic_score_gemma":0.0006726041,"teacher_disagreement_score":0.25935063,"about_ca_system_score_codex":0.0013187893,"about_ca_system_score_gemma":0.00053137064,"threshold_uncertainty_score":0.9978527},"labels":[],"label_agreement":null},{"id":"W3211250876","doi":"10.1136/ijgc-2021-igcs.216","title":"EPV146/#133 Acceptability of bariatric surgery in young women with endometrial cancer and atypical endometrial hyperplasia: a qualitative study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Weight loss; Obesity; Population; Fertility; Comorbidity; Hysterectomy; Qualitative research; Gynecology; Cancer; Surgery; Internal medicine","score_opus":0.04393443208651908,"score_gpt":0.37150286930932164,"score_spread":0.32756843722280254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211250876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948005,0.001127097,0.000031753807,0.0013213736,0.002255231,0.00028009873,0.00004042372,0.0000069905645,0.00013654926],"genre_scores_gemma":[0.9978163,0.00079784513,0.0002798714,0.00015655551,0.00082301,0.000059310038,0.0000025734828,0.000011573841,0.000052917647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671596,0.0004753524,0.0012165683,0.00030549,0.0009993376,0.00028729098],"domain_scores_gemma":[0.9895893,0.00832041,0.00065581215,0.00011586154,0.0011161967,0.00020245688],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024885153,0.00019673002,0.0012129092,0.0007205766,0.000032099004,0.000033442273,0.00016992359,0.00014860248,0.0040946384],"category_scores_gemma":[0.009951593,0.00013113864,0.00022167052,0.0011084684,0.00014724834,0.00021116702,0.00010904063,0.0005384174,9.224915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023087757,0.0014657995,0.9526522,0.00002357913,0.00096196344,0.000877625,0.0032426403,0.000027955428,0.00014522581,0.000054074724,0.00007497407,0.0173862],"study_design_scores_gemma":[0.010222096,0.0009901855,0.97983843,0.000040470757,0.0001801483,0.00025973472,0.007710076,0.000005746778,0.0002558177,0.00017268423,0.00019194462,0.00013266502],"about_ca_topic_score_codex":0.00021400639,"about_ca_topic_score_gemma":0.00053888833,"teacher_disagreement_score":0.027186226,"about_ca_system_score_codex":0.00075621525,"about_ca_system_score_gemma":0.001194372,"threshold_uncertainty_score":0.998388},"labels":[],"label_agreement":null},{"id":"W3211274193","doi":"10.1136/ijgc-2021-igcs.186","title":"EPV116/#34 High grade endometrial carcinoma limited to the endometrium or a polyp. Is adjuvant treatment necessary?","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Carcinoma; Hysterectomy; Endometrium; Stage (stratigraphy); Adenocarcinoma; Endometrial cancer; Adjuvant therapy; Endometrial Polyp; Surgery; Internal medicine; Oncology; Cancer","score_opus":0.06675058701079117,"score_gpt":0.356138139646656,"score_spread":0.28938755263586485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211274193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92426646,0.006987706,0.00014483782,0.060989935,0.0058968207,0.0005457278,0.0003172059,0.00002546155,0.0008258482],"genre_scores_gemma":[0.9797482,0.0029056654,0.0007289948,0.010440705,0.0034111934,0.000097903154,0.000027576521,0.000024171522,0.0026156171],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967507,0.00017880228,0.0008991104,0.00038665257,0.001372192,0.00041253632],"domain_scores_gemma":[0.9956778,0.0018417622,0.00043132357,0.000261443,0.0013105326,0.0004771359],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002972235,0.0003134383,0.00086188,0.0005536914,0.00010169504,0.00010170776,0.0004917547,0.0001560013,0.012034988],"category_scores_gemma":[0.003033022,0.00015263709,0.00060893095,0.0015398475,0.00007575755,0.00013172341,0.00016287649,0.00036768985,0.00006740197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06022737,0.010812824,0.17699234,0.00006655554,0.012050604,0.028626855,0.0012149973,0.00036797186,0.015846634,0.0009098973,0.03496922,0.6579147],"study_design_scores_gemma":[0.05292978,0.014116664,0.54414564,0.00019765226,0.0014715573,0.0021576087,0.00053277466,0.000044283508,0.06323084,0.0004921479,0.3201937,0.0004873059],"about_ca_topic_score_codex":0.0005532935,"about_ca_topic_score_gemma":0.00026163182,"teacher_disagreement_score":0.65742743,"about_ca_system_score_codex":0.0018490694,"about_ca_system_score_gemma":0.00086203765,"threshold_uncertainty_score":0.9888681},"labels":[],"label_agreement":null},{"id":"W3211312367","doi":"10.1136/ijgc-2021-igcs.169","title":"EPV099/#179 Robotic-assisted surgery for endometrial cancer in morbidly and extremely morbidly obese patients","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Endometrial cancer; Morbidly obese; Exact test; Surgery; Cancer; Laparotomy; Single Center; Internal medicine; Weight loss; Obesity","score_opus":0.06766384275218977,"score_gpt":0.3606213424797206,"score_spread":0.2929574997275308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211312367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98396564,0.0069565717,0.00013200015,0.0043395464,0.0038783234,0.00031863432,0.000114238086,0.000010696848,0.0002843571],"genre_scores_gemma":[0.9918946,0.0046423255,0.0006791553,0.0012754083,0.0010483854,0.000097221266,0.000028859826,0.000019445524,0.00031458391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764746,0.00009772062,0.0008824502,0.00030384533,0.000761238,0.00030731072],"domain_scores_gemma":[0.99599564,0.0017229768,0.00044109384,0.00009382788,0.0014951521,0.0002513062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035964363,0.00020516728,0.00078150426,0.00042732182,0.000039955255,0.000054591255,0.00016398037,0.00015610378,0.0021162545],"category_scores_gemma":[0.0035867414,0.00015003316,0.00036344508,0.0004857888,0.00007045062,0.00017756224,0.00008143596,0.0002869842,0.0000026837797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052705533,0.0014877946,0.7647453,0.000059246962,0.00078079896,0.00080301723,0.000046499896,0.00018180854,0.0010493107,0.00007237985,0.001135188,0.22436808],"study_design_scores_gemma":[0.015340832,0.000632943,0.97624516,0.00032619527,0.00022950277,0.000079584934,0.00003634754,0.00008233279,0.0013566414,0.0005936312,0.004900427,0.0001763882],"about_ca_topic_score_codex":0.00017944779,"about_ca_topic_score_gemma":0.00051817385,"teacher_disagreement_score":0.2241917,"about_ca_system_score_codex":0.00086475705,"about_ca_system_score_gemma":0.0005647091,"threshold_uncertainty_score":0.9987959},"labels":[],"label_agreement":null},{"id":"W3213113842","doi":"10.1136/ijgc-2021-003017","title":"Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; Merck Sharp and Dohme","keywords":"Medicine; Lenvatinib; Pembrolizumab; Internal medicine; Oncology; Endometrial cancer; Carboplatin; Chemotherapy; Cancer; Immunotherapy; Thyroid cancer","score_opus":0.15653561812722921,"score_gpt":0.46595637251184885,"score_spread":0.30942075438461963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213113842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98307806,0.0065060174,0.00014039097,0.0024835165,0.0043972526,0.0026858533,0.00044783394,0.000010393969,0.00025066626],"genre_scores_gemma":[0.9740123,0.022049949,0.0010836304,0.00025397024,0.0011585655,0.0008157473,0.000055761822,0.000028388133,0.00054169993],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99660546,0.00018741393,0.0016276232,0.00037267365,0.000927534,0.00027932783],"domain_scores_gemma":[0.9921055,0.003844619,0.0014624279,0.00020137092,0.0021710584,0.00021504065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044545223,0.00032072968,0.0021298036,0.00028730623,0.0000617503,0.000034025044,0.00046065816,0.00012968469,0.0036340577],"category_scores_gemma":[0.0027681724,0.00019261314,0.00046707364,0.0005008182,0.00012114007,0.00015815282,0.000096761745,0.00018383341,0.0000011692747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66326445,0.032106176,0.00026479497,0.000044759254,0.0043421756,0.00017259523,0.00027307137,0.0002162395,0.00052111485,0.00005843296,0.00016074227,0.29857543],"study_design_scores_gemma":[0.9204202,0.057124674,0.00032414898,0.00020253894,0.0011541777,0.0000308043,0.00026597935,0.00017330985,0.008460093,0.00012427333,0.011549955,0.0001698235],"about_ca_topic_score_codex":0.00028710204,"about_ca_topic_score_gemma":0.00069812685,"teacher_disagreement_score":0.29840562,"about_ca_system_score_codex":0.0015314409,"about_ca_system_score_gemma":0.0010476344,"threshold_uncertainty_score":0.9972768},"labels":[],"label_agreement":null},{"id":"W3213540592","doi":"10.1136/ijgc-2021-002968","title":"Implementation of a restrictive opioid prescription protocol after minimally invasive gynecologic oncology surgery","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Calgary; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Opioid; Medical prescription; Morphine; Cohort; Gynecologic oncology; Retrospective cohort study; Anesthesia; Surgery; Internal medicine; Pharmacology","score_opus":0.032865950344668625,"score_gpt":0.3889824430951238,"score_spread":0.3561164927504552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213540592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899573,0.00030969482,0.000060171056,0.0033812276,0.000730915,0.005857374,0.000050472805,0.0000108346685,0.00060359365],"genre_scores_gemma":[0.98566985,0.00053952885,0.0014259814,0.0010980669,0.00030052755,0.0107892305,0.000024953604,0.000013241141,0.00013861469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977546,0.00020005999,0.0009767498,0.00023052216,0.000633558,0.00020455198],"domain_scores_gemma":[0.99563825,0.00089208415,0.00092342607,0.00011189018,0.0023129089,0.00012143644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029724612,0.00016584888,0.0005443905,0.00023489672,0.000024280795,0.000020893533,0.00015211108,0.00016274526,0.0055864532],"category_scores_gemma":[0.0011125943,0.00012447916,0.00034565228,0.00018539533,0.00008760586,0.00018802946,0.0000970819,0.00025300795,0.000008713468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056570764,0.002809565,0.9188361,0.00014890781,0.0013591391,0.0036303462,0.00090018637,0.00005753236,0.010999657,0.000089603374,0.00479855,0.050713334],"study_design_scores_gemma":[0.0038313863,0.0021848103,0.9508539,0.00015540706,0.00019794093,0.00022869528,0.001214448,0.000005543618,0.028763872,0.0005452197,0.011904917,0.00011388734],"about_ca_topic_score_codex":0.00008998253,"about_ca_topic_score_gemma":0.0003686442,"teacher_disagreement_score":0.05059945,"about_ca_system_score_codex":0.0011909327,"about_ca_system_score_gemma":0.0030151503,"threshold_uncertainty_score":0.9953226},"labels":[],"label_agreement":null},{"id":"W3216314699","doi":"10.1136/ijgc-2021-003153","title":"Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case–control study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Serous fluid; Ovarian cancer; Gynecology; Serous carcinoma; Tamoxifen; Malignancy; Prophylactic Surgery; Fallopian tube; Lynch syndrome; Germline mutation; Internal medicine; Oncology; Cancer; Gastroenterology; Mutation; Breast cancer; DNA mismatch repair; Colorectal cancer","score_opus":0.023951621384007683,"score_gpt":0.32952558191545545,"score_spread":0.30557396053144775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216314699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917119,0.0016277325,0.00011417418,0.0043272353,0.0013373622,0.00031489957,0.000027560247,0.00001373242,0.00052536547],"genre_scores_gemma":[0.997651,0.00021385278,0.00036999708,0.001125646,0.00043411445,0.000077508805,0.0000030889973,0.000012153203,0.000112654416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980194,0.0002525443,0.000671634,0.00026855417,0.0005639615,0.00022392518],"domain_scores_gemma":[0.99806595,0.0006069289,0.0003295946,0.00010366398,0.0007490823,0.000144784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045471604,0.00017002622,0.00048261433,0.00018306538,0.00005358843,0.00006295052,0.00012000269,0.00010319639,0.0015972941],"category_scores_gemma":[0.0010623187,0.00012414492,0.00019499157,0.0001821298,0.00006837821,0.000160077,0.000043091957,0.0003872009,0.000004415424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013362159,0.002514289,0.6567305,0.00003426621,0.00081411016,0.30401328,0.0012849773,0.0011816337,0.00025829682,0.00026217554,0.00012629484,0.031443983],"study_design_scores_gemma":[0.011376578,0.0026946599,0.9625092,0.00013724537,0.0003611927,0.018856851,0.0026779345,0.00013823046,0.00029407558,0.00037627466,0.00041319226,0.00016457908],"about_ca_topic_score_codex":0.00015287545,"about_ca_topic_score_gemma":0.0010777657,"teacher_disagreement_score":0.3057787,"about_ca_system_score_codex":0.0019813946,"about_ca_system_score_gemma":0.00093703106,"threshold_uncertainty_score":0.9993154},"labels":[],"label_agreement":null},{"id":"W3217694962","doi":"10.1136/ijgc-2021-003103","title":"Gynecologic pathology services in low- and middle-income countries","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Subspecialty; Medicine; Family medicine; Health care; Middle income country; Pathology; Socioeconomics; Economic growth","score_opus":0.014357251697202967,"score_gpt":0.36313446543516015,"score_spread":0.34877721373795717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217694962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97826487,0.008824201,0.00009429063,0.00993805,0.0020845267,0.00007032699,0.000008304634,0.000008503057,0.00070695265],"genre_scores_gemma":[0.974604,0.014251386,0.0023099168,0.00795564,0.00054672203,0.000010293707,0.0000025352606,0.000006871368,0.00031261833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887294,0.00009149176,0.00045749455,0.00016719158,0.00024045013,0.0001704079],"domain_scores_gemma":[0.9983924,0.00067829195,0.0002625751,0.000066754525,0.0005171983,0.00008275675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002889028,0.00010895959,0.00039310582,0.0001199163,0.00003186098,0.000016544469,0.00016532213,0.000195404,0.0021713756],"category_scores_gemma":[0.00033391046,0.0000764446,0.00007930463,0.00009223981,0.00020792613,0.00013361481,0.00006326556,0.00036816197,0.0000054076972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014100976,0.00042211887,0.9697427,0.00013941378,0.00027228618,0.017258646,0.00033505022,0.00023420661,0.00058112363,0.0015116726,0.000060719292,0.008031947],"study_design_scores_gemma":[0.003878872,0.00086635473,0.96967375,0.0005707877,0.0000415258,0.0039597745,0.00022621673,0.00009401112,0.0007142775,0.003475626,0.01637809,0.000120726596],"about_ca_topic_score_codex":0.0000038333274,"about_ca_topic_score_gemma":0.00016246595,"teacher_disagreement_score":0.016317371,"about_ca_system_score_codex":0.00033430787,"about_ca_system_score_gemma":0.00026035155,"threshold_uncertainty_score":0.9987408},"labels":[],"label_agreement":null},{"id":"W4200555614","doi":"10.1136/ijgc-2021-003112","title":"The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Hazard ratio; Lymphadenectomy; Internal medicine; Endometrial cancer; Chemotherapy; Ovarian cancer; Proportional hazards model; Carcinoma; Cancer; Survival analysis; Surgery; Gastroenterology; Oncology; Confidence interval","score_opus":0.024353530339287895,"score_gpt":0.3303531971240088,"score_spread":0.3059996667847209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200555614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845551,0.0047427486,0.0000073523047,0.009766443,0.0004648786,0.0001300772,0.00002878185,0.0000022553972,0.000302318],"genre_scores_gemma":[0.9945198,0.004885263,0.00007073166,0.00022330137,0.00020309498,0.000011322275,0.0000027530048,0.0000069473413,0.00007673485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877244,0.0001512523,0.0003675635,0.00015223099,0.0004208667,0.00013566474],"domain_scores_gemma":[0.9973245,0.0021384384,0.00020260045,0.00007249656,0.0001690689,0.00009286424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004933062,0.00011279801,0.00041384043,0.00009997826,0.000033967845,0.00003251521,0.000086902895,0.00004922664,0.00024744717],"category_scores_gemma":[0.00028039695,0.0000622226,0.00009721652,0.00011004112,0.00010210152,0.00003768061,0.000043187596,0.00023032619,3.1453695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017331346,0.00016250022,0.92750067,0.000018515395,0.00032118236,0.002015158,0.00006807846,0.00003143626,0.00047906517,0.00080579583,0.000053167398,0.06681133],"study_design_scores_gemma":[0.01087118,0.0017562129,0.97183233,0.00012218673,0.000047084653,0.00017597593,0.000057118745,0.00007498851,0.0040322156,0.00008050326,0.010889777,0.00006043506],"about_ca_topic_score_codex":0.00007738837,"about_ca_topic_score_gemma":0.00007139303,"teacher_disagreement_score":0.06675089,"about_ca_system_score_codex":0.00023309774,"about_ca_system_score_gemma":0.00010451695,"threshold_uncertainty_score":0.2709373},"labels":[],"label_agreement":null},{"id":"W4205357699","doi":"10.1136/ijgc-2021-003082","title":"Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Health Sciences Centre; Mount Sinai Hospital; Toronto Metropolitan University; University of Toronto; University Health Network; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society","keywords":"Lynch syndrome; Family history; Microsatellite instability; Medicine; MLH1; Ovarian cancer; Oncology; Gynecology; Internal medicine; Serous fluid; Cancer; Colorectal cancer; Microsatellite; DNA mismatch repair; Genetics","score_opus":0.01790649610960995,"score_gpt":0.2794641179026553,"score_spread":0.26155762179304537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205357699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894259,0.00076261954,0.0014336403,0.004145782,0.002809982,0.0008321661,0.00007770289,0.000017481525,0.0004947181],"genre_scores_gemma":[0.9862202,0.00011503748,0.0025712065,0.009294176,0.00037783536,0.0009371791,0.0000071174563,0.000037963266,0.00043931592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974292,0.00007123669,0.0006414656,0.00036468124,0.0010599057,0.00043349087],"domain_scores_gemma":[0.99815166,0.00025966167,0.00039149763,0.00016158719,0.0007083717,0.00032719498],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005675211,0.00023314105,0.0005600058,0.00038941822,0.00007518563,0.000022094046,0.00057136733,0.0001031754,0.0018145262],"category_scores_gemma":[0.00035071865,0.00019331981,0.0001258979,0.00025860916,0.00009367167,0.000107780135,0.00014370981,0.00058772735,0.0000033406868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07304034,0.0028438144,0.41015637,0.00021223145,0.002623237,0.014232496,0.008897902,0.2087738,0.014675284,0.00024374673,0.09651431,0.16778648],"study_design_scores_gemma":[0.008222379,0.00983727,0.9314578,0.00025541475,0.00006179948,0.0005970223,0.00046403296,0.00039433438,0.00008068612,0.00011531511,0.048219394,0.00029455844],"about_ca_topic_score_codex":0.0017634614,"about_ca_topic_score_gemma":0.0010898825,"teacher_disagreement_score":0.52130145,"about_ca_system_score_codex":0.017265992,"about_ca_system_score_gemma":0.0025090077,"threshold_uncertainty_score":0.99909794},"labels":[],"label_agreement":null},{"id":"W4205847468","doi":"10.1136/ijgc-2021-003065","title":"Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Gynecologic oncology; Perioperative; Quality management; Complication; Gynecologic surgical procedures; Intervention (counseling)","score_opus":0.03507781830629262,"score_gpt":0.3540534622366569,"score_spread":0.31897564393036426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205847468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97748727,0.0004687823,0.00062998536,0.009095408,0.010276012,0.000919496,0.00028629677,0.000041495456,0.0007952673],"genre_scores_gemma":[0.97594357,0.00059708755,0.0009872462,0.018125366,0.0011029314,0.0014447403,0.000029662157,0.00003886666,0.0017305044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99477386,0.0006421197,0.0018563579,0.00064130576,0.0014637946,0.0006225662],"domain_scores_gemma":[0.9924536,0.0042854585,0.0014417421,0.0002992689,0.0011744578,0.00034549172],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00276232,0.0003781905,0.001240128,0.0006762594,0.00012240042,0.00006315498,0.00062052585,0.00020672893,0.0077656587],"category_scores_gemma":[0.0056617577,0.0002970523,0.0008509686,0.0004235286,0.00011766918,0.0003454216,0.00070216437,0.001084613,0.00003320197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042320713,0.005217936,0.06374203,0.0001864586,0.003104477,0.0052444227,0.0014716786,0.0010343735,0.43489954,0.000049961287,0.029022848,0.41370556],"study_design_scores_gemma":[0.009617794,0.03620635,0.61674494,0.0005682307,0.00065539696,0.0009749213,0.0027733403,0.00004196344,0.14991981,0.0017936192,0.17852,0.002183619],"about_ca_topic_score_codex":0.000111344925,"about_ca_topic_score_gemma":0.0003047667,"teacher_disagreement_score":0.55300295,"about_ca_system_score_codex":0.004290381,"about_ca_system_score_gemma":0.00307812,"threshold_uncertainty_score":0.99994814},"labels":[],"label_agreement":null},{"id":"W4205938445","doi":"10.1136/ijgc-2020-igcs.364","title":"419 Survival after minimally invasive surgery in early cervical cancer: is the uterine manipulator to blame?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Hysterectomy; Radical Hysterectomy; Cervical cancer; Retrospective cohort study; Surgery; Robotic surgery; Cancer; Internal medicine","score_opus":0.06018139843836679,"score_gpt":0.342088620379198,"score_spread":0.28190722194083123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205938445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8941238,0.0009731363,0.000017274795,0.10293848,0.0013787949,0.0002426361,0.000080987054,0.000010531133,0.00023436661],"genre_scores_gemma":[0.96410125,0.0010404454,0.0001555466,0.03268903,0.0017504389,0.000096283344,0.000002788795,0.000018050529,0.00014614494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976242,0.00009680969,0.000767213,0.00027944538,0.000938147,0.00029416435],"domain_scores_gemma":[0.997786,0.0008948031,0.0002656017,0.00010468137,0.00054238643,0.00040656253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025598783,0.00021009281,0.0006209684,0.00016814527,0.000025975738,0.00005423316,0.0004109942,0.000116074654,0.007637875],"category_scores_gemma":[0.00087421824,0.00012369978,0.00036035603,0.0004409896,0.00006778739,0.00012624466,0.00017398428,0.00042839837,0.000054774067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009197968,0.00032224055,0.96917826,0.000039542072,0.0006194389,0.0021176378,0.0006017024,0.000084487016,0.00063845894,0.000031857944,0.002342431,0.014825996],"study_design_scores_gemma":[0.0025586726,0.0008829091,0.970714,0.00016120763,0.00009293898,0.00003669092,0.000070759816,0.00001622454,0.0012402498,0.00010194601,0.023973718,0.0001507051],"about_ca_topic_score_codex":0.00044305823,"about_ca_topic_score_gemma":0.00064005464,"teacher_disagreement_score":0.07024945,"about_ca_system_score_codex":0.00057065545,"about_ca_system_score_gemma":0.00040794385,"threshold_uncertainty_score":0.99326926},"labels":[],"label_agreement":null},{"id":"W4207027567","doi":"10.1136/ijgc-2021-003087","title":"Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer treated with curative intent surgery: impact on recurrence and survival","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbotsford Veterinary Clinic; BC Cancer Agency","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Proportional hazards model; Radiation therapy; Stage (stratigraphy); Survival analysis; Oncology; Chemotherapy; Cancer; Survival rate; Surgery","score_opus":0.025050157986746154,"score_gpt":0.32449004540942344,"score_spread":0.2994398874226773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207027567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955966,0.0008430116,0.000064836364,0.0012790225,0.0006626822,0.00055953563,0.00096580735,0.000007979901,0.000020546913],"genre_scores_gemma":[0.9962759,0.0026556246,0.00010187493,0.00038785717,0.0002733682,0.00017450591,0.00006119658,0.000015455107,0.00005422275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983722,0.00012103693,0.0003527491,0.0002385591,0.0007354824,0.00017995895],"domain_scores_gemma":[0.9971687,0.0013803791,0.0006155271,0.00005641289,0.0006140854,0.00016488147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030148277,0.00019277968,0.0005384089,0.00027330537,0.000102201135,0.000033057204,0.000092522976,0.00004226627,0.0010032601],"category_scores_gemma":[0.00041167517,0.000101441794,0.000112303285,0.00027377182,0.000079620826,0.00011958879,0.00003074638,0.00027488777,1.9055932e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049072642,0.00060490135,0.8070392,0.000007867152,0.0010883403,0.00003565719,0.00007557756,0.0002709663,0.000014553663,0.000028338723,0.00019410618,0.14156783],"study_design_scores_gemma":[0.02342868,0.015580367,0.95814776,0.00007754873,0.00020457455,0.000012724584,0.00007597713,0.000055460612,0.0002482946,0.00006138449,0.0019665172,0.00014070213],"about_ca_topic_score_codex":0.00054572796,"about_ca_topic_score_gemma":0.000060983457,"teacher_disagreement_score":0.15110855,"about_ca_system_score_codex":0.0009666202,"about_ca_system_score_gemma":0.00023795018,"threshold_uncertainty_score":0.99990994},"labels":[],"label_agreement":null},{"id":"W4210316197","doi":"10.1136/ijgc-2021-003142","title":"Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"UCLH Biomedical Research Centre; National Health and Medical Research Council; University College London Hospitals NHS Foundation Trust; Cancer Australia; Cancer Research UK; Target Ovarian Cancer; National Institute for Health and Care Research; Australian Government","keywords":"Medicine; Quality of life (healthcare); Ovarian cancer; Internal medicine; Chemotherapy; Cancer; Physical therapy","score_opus":0.046994248915324804,"score_gpt":0.36479880366788614,"score_spread":0.3178045547525613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210316197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515904,0.0052065197,0.000056383742,0.040254,0.0014490775,0.0010708182,0.00027354984,0.000011277008,0.000087932334],"genre_scores_gemma":[0.99198055,0.0031203527,0.00018492214,0.0023563174,0.0008227378,0.0013470314,0.0000073820206,0.00002169465,0.00015898835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758387,0.00014517929,0.0008324886,0.00032949977,0.0008675054,0.00024145261],"domain_scores_gemma":[0.9969538,0.0008848586,0.0010128134,0.00017486924,0.0008139433,0.00015971306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076726207,0.00023225263,0.00070543605,0.00012229664,0.00016340503,0.000040807896,0.00044301397,0.00006159611,0.003516366],"category_scores_gemma":[0.00018594439,0.00013075219,0.00022570153,0.00017022475,0.00013386561,0.00008356995,0.00015437933,0.00037887297,3.2627503e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010008599,0.0020713157,0.833404,0.000048435944,0.004461893,0.000047066915,0.0015441081,0.0021183465,0.00015365171,0.00093668123,0.0012684669,0.14393741],"study_design_scores_gemma":[0.013507121,0.008780019,0.95539856,0.00012085744,0.0004660051,0.00003113257,0.0015227222,0.00015178439,0.00012101402,0.0003211635,0.019386074,0.00019352426],"about_ca_topic_score_codex":0.0012740974,"about_ca_topic_score_gemma":0.0015749505,"teacher_disagreement_score":0.14374389,"about_ca_system_score_codex":0.0012013093,"about_ca_system_score_gemma":0.0005946244,"threshold_uncertainty_score":0.99739456},"labels":[],"label_agreement":null},{"id":"W4211133976","doi":"10.1136/ijgc-2021-003322","title":"Tubo-ovarian Ewing sarcoma with pseudovascular pattern and hemoperitoneum","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hemoperitoneum; Abdominal hysterectomy; Gross hematuria; Shock (circulatory); Radiology; Surgery; Hysterectomy","score_opus":0.01939464919719642,"score_gpt":0.2887177409697988,"score_spread":0.2693230917726024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211133976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843285,0.0025128874,0.00011048535,0.012136359,0.00048424027,0.00011213702,0.00001520438,0.000008331937,0.00029185013],"genre_scores_gemma":[0.99589807,0.000325042,0.0005397692,0.0028625417,0.00025759562,0.000046813235,0.0000044401822,0.000010625981,0.000055115524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987803,0.000054683107,0.0002586103,0.00014425196,0.000631499,0.00013066897],"domain_scores_gemma":[0.99932224,0.00012797466,0.00015842002,0.00007216101,0.00020856335,0.00011065828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019374443,0.00010312991,0.00025376427,0.0000978698,0.000082967774,0.000030667594,0.0001469056,0.000027432641,0.0027371936],"category_scores_gemma":[0.000048851536,0.00006616067,0.000114373484,0.00006722482,0.000047926707,0.00006887925,0.000112556416,0.00026769226,0.000001934061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005014679,0.00080889865,0.84157294,0.000007128647,0.0009679194,0.0061284914,0.00014242939,0.00019177847,0.00048628627,0.00013407385,0.0006749709,0.14838359],"study_design_scores_gemma":[0.0045343786,0.0015677437,0.9610386,0.000063164465,0.00020155954,0.005567478,0.00026069095,0.00016178773,0.00061625714,0.00013478924,0.02573087,0.00012268069],"about_ca_topic_score_codex":0.00007847278,"about_ca_topic_score_gemma":0.00001842598,"teacher_disagreement_score":0.1482609,"about_ca_system_score_codex":0.0003435757,"about_ca_system_score_gemma":0.000105183,"threshold_uncertainty_score":0.9981744},"labels":[],"label_agreement":null},{"id":"W4220699614","doi":"10.1136/ijgc-2022-003449","title":"Building opportunities to improve quality of life for women with ovarian cancer in low- and middle-income countries: the Every Woman Study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"World Health Organization","keywords":"Medicine; Middle income country; International agency; Falling (accident); Agency (philosophy); Ovarian cancer; Low and middle income countries; Incidence (geometry); Gynecology; Demography; Developing country; Cancer; Economic growth; Socioeconomics; Environmental health; Internal medicine; Social science; Economics","score_opus":0.11925881783200129,"score_gpt":0.39466562484367007,"score_spread":0.27540680701166875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220699614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903917,0.00047721295,0.000118114855,0.007860551,0.00045696483,0.000494802,0.00012800902,0.000004238806,0.000068431],"genre_scores_gemma":[0.9947458,0.00010025233,0.00022317059,0.004216216,0.00022257036,0.0003591048,5.141875e-7,0.000007965721,0.00012443657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980874,0.000107705295,0.00062701607,0.00015940404,0.0008128229,0.00020564899],"domain_scores_gemma":[0.9981838,0.00049677346,0.00047003262,0.00008673147,0.000617146,0.00014552122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015186105,0.000111174544,0.000403676,0.00013907271,0.00008632015,0.000030033174,0.0003167998,0.000030125768,0.00063984055],"category_scores_gemma":[0.00046300265,0.00006891154,0.000055196735,0.00011217592,0.00008581105,0.0001240009,0.00015013975,0.00026976375,8.77954e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025774928,0.00044014477,0.95488614,0.0001735529,0.00092867104,0.00026193575,0.0051235324,0.0053939978,0.00046929918,0.000991803,0.00020201858,0.0053539923],"study_design_scores_gemma":[0.0044331495,0.004354124,0.9719453,0.0003482939,0.000048969316,0.000037448895,0.015794784,0.000094730305,0.000072960574,0.00037576316,0.0023625193,0.00013199578],"about_ca_topic_score_codex":0.0008141946,"about_ca_topic_score_gemma":0.0007774597,"teacher_disagreement_score":0.021341778,"about_ca_system_score_codex":0.0010998269,"about_ca_system_score_gemma":0.000765308,"threshold_uncertainty_score":0.70058054},"labels":[],"label_agreement":null},{"id":"W4220795525","doi":"10.1136/ijgc-2021-002471","title":"The role of oophoropexy in patients with gynecological cancer who need radiation therapy","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Medicine; Radiation therapy; Gynecologic cancer; Gynecology; Cancer; Oncology; Internal medicine; Ovarian cancer","score_opus":0.0370411667879426,"score_gpt":0.3528297125455417,"score_spread":0.31578854575759907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220795525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021220522,0.9752431,8.547684e-7,0.0004123847,0.001360307,0.0008797586,0.00012875853,0.000007554379,0.0007467471],"genre_scores_gemma":[0.017202647,0.9814159,0.000023372646,0.0003148605,0.0004988787,0.00032523007,0.000045285182,0.000029996227,0.00014380299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646735,0.00032052907,0.0012796149,0.00028584144,0.0013503571,0.0002963262],"domain_scores_gemma":[0.9957878,0.0017023103,0.0016142749,0.00016525868,0.00058286666,0.00014748197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004726433,0.00034598404,0.001644208,0.00033355545,0.000079616344,0.00003621961,0.0006854777,0.00023968,0.0057056476],"category_scores_gemma":[0.00061548204,0.00016062296,0.00058762013,0.00059609435,0.00013827736,0.00009798408,0.00012302301,0.0008976914,0.0000033557412],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00240411,0.0007576736,0.050973374,0.00009026017,0.0012190377,0.000061197024,0.00002642334,0.00002257144,3.8009776e-7,0.00005883557,0.00015909348,0.94422704],"study_design_scores_gemma":[0.0056655174,0.0026410052,0.09158412,0.00088020414,0.0003879801,0.000013415817,0.000026628612,0.0000025732397,0.000005155612,0.000120418415,0.8985056,0.00016735707],"about_ca_topic_score_codex":0.00015916284,"about_ca_topic_score_gemma":0.00007527012,"teacher_disagreement_score":0.94405967,"about_ca_system_score_codex":0.0021061487,"about_ca_system_score_gemma":0.000951889,"threshold_uncertainty_score":0.99520326},"labels":[],"label_agreement":null},{"id":"W4220964506","doi":"10.1136/ijgc-2021-003324","title":"Four protective maneuvers in minimal invasive surgery of endometrial cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Israel Cancer Research Fund","keywords":"Medicine; Endometrial cancer; Uterine cancer; Retrospective cohort study; Gynecology; Cancer; Surgery; Internal medicine","score_opus":0.07069780089969711,"score_gpt":0.34267446460976103,"score_spread":0.2719766637100639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220964506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919691,0.001432776,0.000011559906,0.002970343,0.0026116874,0.00035314917,0.00012554284,0.0000058506616,0.00051997876],"genre_scores_gemma":[0.997295,0.00092124054,0.0001017361,0.00073242025,0.0006006733,0.00021420335,0.0000051676584,0.000011089714,0.00011847255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753517,0.00017932296,0.0007806873,0.0001880401,0.0011094282,0.0002073798],"domain_scores_gemma":[0.9968771,0.0016840693,0.00070694834,0.00006863925,0.0005438872,0.00011935356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005745632,0.0001380379,0.00063966657,0.0007484293,0.000037552767,0.000009255194,0.00027353098,0.000067783905,0.008742521],"category_scores_gemma":[0.0020619384,0.000103745886,0.00038224974,0.0006564567,0.00007887561,0.000102597056,0.00014210153,0.00049094623,0.0000018762138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031159818,0.0021048628,0.8741764,0.000064975444,0.0019135893,0.0039044514,0.0004081499,0.0018563016,0.0067411335,0.00012468558,0.0022905706,0.075255066],"study_design_scores_gemma":[0.020622574,0.0042604166,0.9502798,0.0002601505,0.0002769859,0.000424147,0.0005943908,0.000025077965,0.012912503,0.0012278808,0.008840731,0.0002753513],"about_ca_topic_score_codex":0.0006540178,"about_ca_topic_score_gemma":0.0002282897,"teacher_disagreement_score":0.0761034,"about_ca_system_score_codex":0.001746628,"about_ca_system_score_gemma":0.000916719,"threshold_uncertainty_score":0.9921636},"labels":[],"label_agreement":null},{"id":"W4220968566","doi":"10.1136/ijgc-2021-003296","title":"Gender imbalance in gynecologic oncology authorship and impact of COVID-19 pandemic","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Gynecologic oncology; Medicine; Pandemic; Editorial board; Coronavirus disease 2019 (COVID-19); Institutional review board; Family medicine; MEDLINE; Oncology; Gynecology; Internal medicine; Library science; Surgery","score_opus":0.1539230942884508,"score_gpt":0.46457435014074727,"score_spread":0.31065125585229647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220968566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894431,0.00089482,0.00004158979,0.0047649457,0.0011895398,0.00009136918,0.000033539483,0.00000748848,0.0035335564],"genre_scores_gemma":[0.99635005,0.0012260878,0.000069012516,0.0020235314,0.00017870638,0.000009118998,0.0000018233949,0.0000023666487,0.00013930355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785763,0.00061815185,0.0003483222,0.00012205845,0.00085900415,0.00019483604],"domain_scores_gemma":[0.99794817,0.0011479066,0.00041272273,0.00003908572,0.00024484535,0.00020729231],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003554884,0.00007119181,0.0002669767,0.00019489239,0.0001388259,0.000017559376,0.00070825545,0.00010424441,0.008231977],"category_scores_gemma":[0.0026029083,0.000056415585,0.00011703848,0.00019756237,0.00036420487,0.000110572284,0.00020667523,0.0004891648,9.4234485e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037020622,0.0001865206,0.97857916,0.000004192613,0.00009439087,0.00032731632,0.0069541344,0.0021723171,0.000107618354,0.002460919,0.0024070968,0.0063361493],"study_design_scores_gemma":[0.0021344873,0.0012891289,0.90273285,0.000008554528,0.000033483757,0.000098169556,0.01192983,0.000043319218,0.000002795596,0.023068633,0.058538675,0.00012007159],"about_ca_topic_score_codex":0.0013694296,"about_ca_topic_score_gemma":0.0014417284,"teacher_disagreement_score":0.075846285,"about_ca_system_score_codex":0.0029038421,"about_ca_system_score_gemma":0.0016270292,"threshold_uncertainty_score":0.99267465},"labels":[],"label_agreement":null},{"id":"W4221054879","doi":"10.1136/ijgc-2021-002463","title":"Postoperative management of vulvar cancer","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vulvar cancer; Sentinel node; Radiation therapy; Groin; Vulva; Lymphadenectomy; Wide local excision; Sentinel lymph node; Vulvar Carcinoma; Lymphovascular invasion; Surgery; Biopsy; Metastasis; Cancer; Radiology; Breast cancer; Internal medicine","score_opus":0.11846308338141805,"score_gpt":0.44408004551151825,"score_spread":0.3256169621301002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221054879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029891028,0.9920278,0.0000091432985,0.0005612475,0.002988871,0.0004863253,0.0002626604,0.000007933221,0.0033570689],"genre_scores_gemma":[0.00058698165,0.99651116,0.0002876891,0.00048476708,0.00056109636,0.00022990436,0.00003721737,0.000026334463,0.0012748612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708694,0.00014365965,0.0011658522,0.00025242925,0.0011548267,0.00019629297],"domain_scores_gemma":[0.9975313,0.0004340318,0.001253492,0.00013237489,0.0004919735,0.00015685009],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028222532,0.0002967662,0.0017685768,0.00033921687,0.0000382402,0.000016302683,0.0005685299,0.00015880012,0.03370678],"category_scores_gemma":[0.00012575451,0.00018083396,0.0009823464,0.0003980111,0.0000796785,0.0000688759,0.00023264057,0.0006256727,0.000010225381],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004725994,0.0005160502,0.00021880907,0.0014080991,0.0055697635,0.0012549589,0.000023990558,0.000012847959,7.88525e-7,0.00028304957,0.00086261734,0.9893764],"study_design_scores_gemma":[0.002067529,0.0010280008,0.0006065019,0.00455576,0.0025506255,0.0001892038,0.00003919882,5.935323e-7,0.000006978126,0.00006891865,0.9887338,0.00015288034],"about_ca_topic_score_codex":0.00006860877,"about_ca_topic_score_gemma":0.000009466816,"teacher_disagreement_score":0.98922354,"about_ca_system_score_codex":0.0018661334,"about_ca_system_score_gemma":0.0006125268,"threshold_uncertainty_score":0.96717656},"labels":[],"label_agreement":null},{"id":"W4225108580","doi":"10.1136/ijgc-2021-003325","title":"Placenta accreta spectrum: a non-oncologic challenge for gynecologic oncologists","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Placenta accreta; Medicine; Obstetrics; Hysterectomy; Context (archaeology); General surgery; Gynecology; Pregnancy; Surgery; Placenta","score_opus":0.19056755011938184,"score_gpt":0.4837177912394369,"score_spread":0.29315024112005506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225108580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004460976,0.9813906,0.000057411424,0.0040233587,0.007924181,0.0020835425,0.00042224975,0.000044967917,0.0036075888],"genre_scores_gemma":[0.0019004714,0.99047595,0.0004935691,0.0015846556,0.0028656768,0.00078025035,0.00013711455,0.00006268773,0.0016996157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535716,0.00027870192,0.0020254108,0.00059495616,0.001114335,0.0006294685],"domain_scores_gemma":[0.9938984,0.002323517,0.002555689,0.0002610041,0.00054447004,0.00041694325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011313075,0.0006217484,0.0032173546,0.0004958046,0.00015536362,0.000060017624,0.001409744,0.0007529707,0.016792031],"category_scores_gemma":[0.0011772471,0.00039533616,0.001960315,0.0002448618,0.00016293858,0.00012376095,0.0004657388,0.0018198446,0.00004436943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00125264,0.0010626437,0.000254429,0.004823471,0.0013596221,0.0030724502,0.000046076108,0.000008745504,8.1953243e-7,0.00027048643,0.0055448683,0.98230374],"study_design_scores_gemma":[0.0022048126,0.0066029043,0.00056976936,0.0021730964,0.0010925723,0.0017881293,0.000058607868,0.000020148318,0.0000014018184,0.00071747357,0.9843968,0.00037426577],"about_ca_topic_score_codex":0.000037793616,"about_ca_topic_score_gemma":0.00007734333,"teacher_disagreement_score":0.9819295,"about_ca_system_score_codex":0.0044543203,"about_ca_system_score_gemma":0.0023373927,"threshold_uncertainty_score":0.99984986},"labels":[],"label_agreement":null},{"id":"W4225551590","doi":"10.1136/ijgc-2021-003319","title":"Interobserver and intraobserver variability of RECIST assessment in ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; Memorial University of Newfoundland; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Radiology; Nuclear medicine; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.03491300503856809,"score_gpt":0.3637118285953803,"score_spread":0.3287988235568122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225551590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826642,0.0007471655,0.000060764836,0.01400948,0.0014363405,0.00020678958,0.00010257135,0.0000036151657,0.00076905126],"genre_scores_gemma":[0.9964831,0.0009985868,0.0011116688,0.0010165452,0.00017716344,0.00011239634,0.000006443974,0.000008541609,0.00008555049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982438,0.00016791328,0.0006688938,0.00020472071,0.0005743329,0.00014033714],"domain_scores_gemma":[0.9987032,0.00030259838,0.00042059008,0.00010614833,0.00036981713,0.00009768415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008299474,0.00011804084,0.00042320887,0.0001417321,0.000032528158,0.000015584881,0.00021535903,0.00005262196,0.0068704556],"category_scores_gemma":[0.00016312471,0.00008968549,0.00013636064,0.00014816425,0.00007675791,0.00009806376,0.00018467828,0.0004568259,2.724293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080239924,0.0010486452,0.96985906,0.0000241601,0.0004631088,0.00031412276,0.00016931178,0.00072219624,0.00054623204,0.0014617715,0.0007004754,0.023888536],"study_design_scores_gemma":[0.0037130176,0.00083882204,0.9847884,0.00010480528,0.000096192445,0.0000794778,0.00009678408,0.00013854596,0.00025703857,0.0009616807,0.0088426825,0.00008250947],"about_ca_topic_score_codex":0.00068552664,"about_ca_topic_score_gemma":0.0002760722,"teacher_disagreement_score":0.023806026,"about_ca_system_score_codex":0.0016390418,"about_ca_system_score_gemma":0.0004865374,"threshold_uncertainty_score":0.9940374},"labels":[],"label_agreement":null},{"id":"W4229779432","doi":"10.1136/ijgc-00009577-200201000-00014","title":"Use of CA-125 and ultrasound in high-risk women","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ultrasound; Ovarian cancer; Gynecology; BRCA mutation; Population; Retrospective cohort study; Obstetrics; Cancer; Radiology; Internal medicine","score_opus":0.03750988866655887,"score_gpt":0.2948254529117063,"score_spread":0.25731556424514745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229779432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563146,0.0011687559,0.000010136119,0.0024807432,0.00039527603,0.000078285964,0.00004672043,0.0000023958605,0.00018624838],"genre_scores_gemma":[0.98764783,0.010990808,0.0004353096,0.0005547485,0.00016552504,0.000014994416,0.0000012450265,0.0000050873987,0.00018442818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990642,0.00003746219,0.00037498595,0.0001041589,0.00030038194,0.000118813776],"domain_scores_gemma":[0.9987088,0.0006210045,0.00027860375,0.000055848992,0.00023616172,0.00009959763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014458432,0.00008084947,0.00028351697,0.00012130103,0.000011552378,0.000018299388,0.00007684249,0.000060242844,0.0049425387],"category_scores_gemma":[0.0005316702,0.000054658816,0.00006251247,0.00007779308,0.00006626517,0.000112430804,0.00002180493,0.00017414872,0.0000037738798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002100862,0.0006521214,0.94317687,0.0000074349928,0.00036010362,0.0003396046,0.0002606395,0.00017611585,0.00021254308,0.00016663794,0.0015054147,0.052932423],"study_design_scores_gemma":[0.00277762,0.0008069492,0.9860401,0.000088840185,0.00005513168,0.00011213106,0.000046522066,0.000058694124,0.00026770317,0.00035030986,0.009341686,0.00005432006],"about_ca_topic_score_codex":0.00032068777,"about_ca_topic_score_gemma":0.00014812849,"teacher_disagreement_score":0.052878104,"about_ca_system_score_codex":0.0005135603,"about_ca_system_score_gemma":0.00004487914,"threshold_uncertainty_score":0.9959671},"labels":[],"label_agreement":null},{"id":"W4232026268","doi":"10.1136/ijgc-00009577-200602001-00046","title":"Immunohistochemical characterization of endocervical papillary serous carcinoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pathology; Carcinoembryonic antigen; Serous fluid; Adenosquamous carcinoma; Immunostaining; Immunohistochemistry; Malignancy; Adenocarcinoma; Clear cell; Cervix; Clear cell carcinoma; Immunophenotyping; Carcinoma; Cancer; Internal medicine; Antigen","score_opus":0.014717601376427887,"score_gpt":0.29386459573895596,"score_spread":0.27914699436252804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232026268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942733,0.0009435406,0.00013513427,0.0019503135,0.00095068716,0.00012097074,0.000041061074,0.00001050601,0.001574464],"genre_scores_gemma":[0.9975106,0.00030353223,0.00028555488,0.0005860368,0.0010103362,0.000011292529,0.0000467742,0.0000105310555,0.00023530818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99831724,0.000038301157,0.0007000622,0.0001349005,0.0006562326,0.00015328573],"domain_scores_gemma":[0.9983738,0.00014962755,0.00046342012,0.000082420716,0.00083352276,0.00009720936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012166057,0.00012805994,0.00041919455,0.00014980507,0.000020239879,0.000012142411,0.00021439837,0.000120515266,0.0021511307],"category_scores_gemma":[0.00015862203,0.00008886099,0.00026163866,0.00017211284,0.00008723983,0.00009737146,0.000052908556,0.00021587509,0.0000065728705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043496625,0.0015511309,0.3984042,0.00005434764,0.00050348905,0.00074028684,0.00004258026,0.000024358038,0.56121594,0.0006996232,0.00050134136,0.031913016],"study_design_scores_gemma":[0.0046936367,0.00092904863,0.92525405,0.000076874036,0.00015607967,0.00032637612,0.000010575316,0.000027161477,0.062128235,0.00055861386,0.005732585,0.000106745974],"about_ca_topic_score_codex":0.000115934774,"about_ca_topic_score_gemma":0.000005330418,"teacher_disagreement_score":0.52684987,"about_ca_system_score_codex":0.00044818534,"about_ca_system_score_gemma":0.00017118343,"threshold_uncertainty_score":0.99876106},"labels":[],"label_agreement":null},{"id":"W4233344854","doi":"10.1136/ijgc-00009577-200501000-00006","title":"Pseudomyxoma peritonei: a case series and review of the literature","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Pseudomyxoma peritonei; Gynecologic oncology; Medical record; Appendix; General surgery; Surgery","score_opus":0.012180033099236352,"score_gpt":0.3091534647900782,"score_spread":0.29697343169084184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233344854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9144803,0.048458252,0.000001932352,0.035636764,0.0004917493,0.00011435723,0.00002582493,0.000003807111,0.00078701356],"genre_scores_gemma":[0.9686253,0.025042599,0.00049550465,0.0048363153,0.00057732564,0.000005687852,0.0000010887414,0.000004201963,0.00041195407],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99909765,0.00004661477,0.000370011,0.000075689175,0.00032181304,0.000088251756],"domain_scores_gemma":[0.9989253,0.00008579807,0.0002440784,0.00006011568,0.0006206924,0.00006400574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021862487,0.00008388969,0.00025782373,0.000035368965,0.00003492833,0.000016753957,0.00013729668,0.000057355523,0.00076616445],"category_scores_gemma":[0.0002793288,0.000041716718,0.00014771575,0.000084899904,0.00014347394,0.00013460459,0.00005748975,0.00023724379,0.0000011479775],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011665684,0.0036326787,0.14985348,0.019550938,0.0041205394,0.08347608,0.0054079453,0.00008713782,0.13749509,0.04158811,0.07515692,0.4679654],"study_design_scores_gemma":[0.0038193627,0.0025107355,0.116528265,0.045417797,0.0005499746,0.46131083,0.00046112086,0.000039321232,0.023234857,0.0011207947,0.34462234,0.00038459],"about_ca_topic_score_codex":0.000007807703,"about_ca_topic_score_gemma":0.000015667141,"teacher_disagreement_score":0.46758083,"about_ca_system_score_codex":0.00007846327,"about_ca_system_score_gemma":0.000103066486,"threshold_uncertainty_score":0.83889633},"labels":[],"label_agreement":null},{"id":"W4234586607","doi":"10.1136/ijgc-00009577-200311001-00003","title":"Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Paclitaxel; Cisplatin; Oncology; Regimen; Cyclophosphamide; Internal medicine; Chemotherapy; Ovarian cancer; Randomized controlled trial; Cancer","score_opus":0.02135910307198088,"score_gpt":0.3313539977105257,"score_spread":0.30999489463854485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234586607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843428,0.0021078603,0.00006955963,0.0073206984,0.0038106688,0.0005739836,0.000057597423,0.0000067629558,0.0017100846],"genre_scores_gemma":[0.99629074,0.0017342047,0.00013128994,0.0009749547,0.00016465508,0.000106555075,0.0000058291293,0.000019501176,0.0005722723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974118,0.00023210712,0.0008837221,0.0002536048,0.00095083995,0.0002679219],"domain_scores_gemma":[0.99739116,0.0007243287,0.00093532016,0.00023957939,0.00060446747,0.00010512054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068251777,0.00022925282,0.00053175393,0.000112391645,0.00006993782,0.00003468343,0.0004080574,0.0001348169,0.002549846],"category_scores_gemma":[0.0006836372,0.00012293865,0.0003198565,0.00028466934,0.000162448,0.00017096897,0.000068707515,0.00046409905,0.0000028446414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010742234,0.0006508138,0.97275215,0.00002200601,0.0005288443,0.00017971858,0.00028075578,0.00034809826,0.000635377,0.0056733503,0.0003595349,0.017495152],"study_design_scores_gemma":[0.01084804,0.00044325396,0.9820131,0.00045711471,0.00016979732,0.000053248248,0.00013290827,0.000037048543,0.0024478363,0.001005499,0.0022612175,0.0001309544],"about_ca_topic_score_codex":0.00023270323,"about_ca_topic_score_gemma":0.0010944527,"teacher_disagreement_score":0.017364196,"about_ca_system_score_codex":0.0009606223,"about_ca_system_score_gemma":0.0005019562,"threshold_uncertainty_score":0.99836195},"labels":[],"label_agreement":null},{"id":"W4235227157","doi":"10.1136/ijgc-2019-igcs.310","title":"310 Chemotherapy reduces PAR glycohydrolase (PARG) expression in high-grade serous ovarian cancer patients","year":2019,"lang":"fr","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Immunohistochemistry; Ovarian cancer; Chemotherapy; Serous fluid; Cancer; Cancer research; Medicine; Internal medicine; Oncology; Pathology; Biology","score_opus":0.018739081395368617,"score_gpt":0.3266469672862661,"score_spread":0.30790788589089746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235227157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93325543,0.013212155,0.0000596331,0.025619535,0.026460292,0.0005795594,0.00023840218,0.000020582835,0.00055438525],"genre_scores_gemma":[0.9699704,0.017287042,0.00070090126,0.0057106325,0.004248018,0.000095567695,0.000026114833,0.000057791956,0.0019035545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954248,0.00032837235,0.0015152723,0.00052113767,0.0015354406,0.00067495304],"domain_scores_gemma":[0.99642384,0.0005054151,0.0013531005,0.00022511634,0.0011070349,0.0003854956],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006343994,0.00044517269,0.00093132776,0.00042141433,0.000059273054,0.000087500506,0.00077177444,0.00051827525,0.030040497],"category_scores_gemma":[0.0002487764,0.00036456567,0.0003474402,0.00035770645,0.00024181374,0.00060550217,0.000103383274,0.0011673267,0.00014003254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010496219,0.005810914,0.72860515,0.00015296873,0.0014223885,0.0010157061,0.0013504021,0.008480298,0.12037917,0.00036214085,0.025646545,0.09627807],"study_design_scores_gemma":[0.03995538,0.0028421672,0.6967141,0.005436735,0.00016959528,0.00013558056,0.00016921764,0.0005666652,0.13686742,0.0021787302,0.11416332,0.0008010834],"about_ca_topic_score_codex":0.00052807713,"about_ca_topic_score_gemma":0.00012644609,"teacher_disagreement_score":0.095476985,"about_ca_system_score_codex":0.0034479299,"about_ca_system_score_gemma":0.0008495085,"threshold_uncertainty_score":0.9998806},"labels":[],"label_agreement":null},{"id":"W4238100782","doi":"10.1097/igc.0000000000000134","title":"Risk Factors for Ovarian Cancers With and Without Microsatellite Instability","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Women's College Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Microsatellite instability; Ovarian cancer; Tubal ligation; Body mass index; Oncology; Population; Internal medicine; Gynecology; Cancer; Microsatellite; Genetics; Family planning; Biology; Gene","score_opus":0.022629015554519207,"score_gpt":0.31516892783707556,"score_spread":0.2925399122825564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238100782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425805,0.00040860067,0.0013144434,0.002829886,0.00054666563,0.00024936386,0.000072942385,0.000008405928,0.00031165124],"genre_scores_gemma":[0.99469537,0.0008631193,0.0033463566,0.00064644904,0.00034130577,0.00003465896,0.0000054845304,0.000010823895,0.000056461722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990444,0.000040200546,0.00030531496,0.00018599721,0.00027768582,0.0001463547],"domain_scores_gemma":[0.99851424,0.00036998338,0.00034082902,0.000080378726,0.0005356592,0.00015893395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027267289,0.0001320817,0.00033164016,0.00006542497,0.000050480932,0.000037335274,0.00010264858,0.000068452835,0.0002628256],"category_scores_gemma":[0.00033535218,0.00007510572,0.00010883106,0.000045634795,0.000114974704,0.00008791064,0.000020454965,0.00016539892,6.372619e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013548932,0.00015853903,0.9624984,0.000013443676,0.0005845092,0.000009047235,0.00013817052,0.00013225572,0.0001315253,0.00028612412,0.00014974934,0.034543324],"study_design_scores_gemma":[0.0046875775,0.0017882098,0.95958436,0.00008468015,0.00025925224,0.0000482622,0.000056831163,0.000120496676,0.0010469621,0.0005127523,0.031713538,0.00009709216],"about_ca_topic_score_codex":0.00028925532,"about_ca_topic_score_gemma":0.00034191273,"teacher_disagreement_score":0.034446232,"about_ca_system_score_codex":0.0005720169,"about_ca_system_score_gemma":0.0002278915,"threshold_uncertainty_score":0.30627224},"labels":[],"label_agreement":null},{"id":"W4238371081","doi":"10.1136/ijgc-00009577-200605000-00067","title":"Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Microsatellite instability; Adenomyosis; Carcinoma; Pathology; Metaplasia; Microsatellite; Endometriosis; Allele; Gene; Biology","score_opus":0.024765188868998683,"score_gpt":0.3132980803192351,"score_spread":0.2885328914502364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238371081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920592,0.0017202277,0.0006568264,0.0012356637,0.0014322266,0.0003770264,0.000045452984,0.000018098885,0.0024552848],"genre_scores_gemma":[0.9943769,0.00072397833,0.003310407,0.00048580134,0.0008879265,0.00003132644,0.000026428312,0.000013826931,0.00014339911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694633,0.00017916111,0.0013740463,0.00032120993,0.00088184216,0.00029742692],"domain_scores_gemma":[0.9960661,0.0020079867,0.00074464973,0.00013458509,0.0009050241,0.00014166883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010539868,0.00021755644,0.00071450294,0.0006237159,0.00003663428,0.000044661803,0.00027437467,0.00021335769,0.0011039948],"category_scores_gemma":[0.0025016682,0.00013268099,0.00026293556,0.0008813583,0.0001634826,0.0001843118,0.000064785556,0.0005703709,0.000010218981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014422821,0.0014900028,0.9603078,0.000015488762,0.00014380385,0.0018740043,0.000027391725,0.000568694,0.0017546212,0.00026024238,0.00006977715,0.019065367],"study_design_scores_gemma":[0.022017393,0.00415486,0.9667014,0.00010450724,0.00015041478,0.0003493151,0.000033512446,0.000051955132,0.00094872696,0.001985027,0.0033311353,0.00017174408],"about_ca_topic_score_codex":0.00039387576,"about_ca_topic_score_gemma":0.00012765381,"teacher_disagreement_score":0.018893624,"about_ca_system_score_codex":0.0010791621,"about_ca_system_score_gemma":0.00039457946,"threshold_uncertainty_score":0.99980915},"labels":[],"label_agreement":null},{"id":"W4239651622","doi":"10.1136/ijgc-00009577-200505001-00007","title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Gemcitabine; Ovarian cancer; Internal medicine; Oncology; Hazard ratio; Regimen; Chemotherapy; Cancer; Surgery; Confidence interval; Cisplatin","score_opus":0.03470059525404154,"score_gpt":0.38610234289378614,"score_spread":0.35140174763974463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239651622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95325667,0.0059448536,0.000029875631,0.039508935,0.0003277768,0.00021459462,0.000008912321,0.000007234981,0.0007011356],"genre_scores_gemma":[0.98728716,0.0105223665,0.00047169102,0.0009799363,0.00048114377,0.00005233452,0.0000018302584,0.00000840073,0.00019515521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871045,0.00004537679,0.00032462904,0.00013972221,0.0006156418,0.00016418166],"domain_scores_gemma":[0.99885994,0.00015368697,0.00019223038,0.000050058155,0.00064765423,0.000096415955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028651624,0.00010835982,0.00026904678,0.00018342517,0.00002575226,0.000024969335,0.0001267105,0.000051764415,0.0007335642],"category_scores_gemma":[0.00018207834,0.00006597956,0.000044222863,0.00012522597,0.00010060624,0.00015395609,0.00004170982,0.00034050352,0.0000012328469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004736369,0.00074356905,0.54945964,0.00002138278,0.0005964424,0.00029602,0.00064911763,0.00040397,0.0016819198,0.0006165488,0.0014578267,0.4393372],"study_design_scores_gemma":[0.008204634,0.0013992941,0.9706469,0.00024471225,0.00002600793,0.00008784031,0.00006375743,0.00040081821,0.0007176824,0.00020024346,0.017909024,0.000099067365],"about_ca_topic_score_codex":0.00016571658,"about_ca_topic_score_gemma":0.0010555786,"teacher_disagreement_score":0.4392381,"about_ca_system_score_codex":0.0008523168,"about_ca_system_score_gemma":0.00025304765,"threshold_uncertainty_score":0.8032014},"labels":[],"label_agreement":null},{"id":"W4239793083","doi":"10.1097/00009577-201505001-00054","title":"UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Endometrial cancer; Cancer; Gynecology; Oncology; Internal medicine","score_opus":0.07350475750504878,"score_gpt":0.38407118295865306,"score_spread":0.31056642545360424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239793083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615186,0.0005166376,0.00008207957,0.00082646747,0.002014607,0.00019544661,0.000055860593,0.000015711299,0.00014131184],"genre_scores_gemma":[0.9979438,0.0003411611,0.00032020282,0.0002271822,0.00082913716,0.000060973467,0.00002270052,0.000012499357,0.00024235032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984771,0.00005635674,0.0003528593,0.00016356375,0.0007781146,0.00017199678],"domain_scores_gemma":[0.99795085,0.00006519648,0.000552168,0.00008767132,0.0009866897,0.0003574444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000089100184,0.00016060416,0.00038602087,0.0001813268,0.000026878794,0.000050614657,0.00021476364,0.00007673343,0.0017174273],"category_scores_gemma":[0.00019338625,0.00008775122,0.0001276849,0.00010135172,0.00006910388,0.00015999717,0.00005793268,0.00022546912,0.0000044507037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067693777,0.0034818805,0.9518957,0.0000070168453,0.0013686322,0.005183394,0.00011594687,0.00003333451,0.0007676012,0.000081030375,0.00047209178,0.029824005],"study_design_scores_gemma":[0.016348345,0.005753877,0.9725849,0.00013810958,0.00071721745,0.00076390663,0.000052514166,0.000049189915,0.0015900893,0.00013005492,0.0017285619,0.00014322608],"about_ca_topic_score_codex":0.00022060167,"about_ca_topic_score_gemma":0.00031594574,"teacher_disagreement_score":0.02968078,"about_ca_system_score_codex":0.00065817544,"about_ca_system_score_gemma":0.0002699256,"threshold_uncertainty_score":0.99919516},"labels":[],"label_agreement":null},{"id":"W4241872224","doi":"10.1136/ijgc-2020-igcs.89","title":"98 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Women's Health Research Institute","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Grading (engineering); Oncology; Lymph node; Multivariate analysis; Proportional hazards model; Retrospective cohort study; Adjuvant therapy; Lymph node metastasis; Infiltration (HVAC); Breast cancer; Adjuvant; Cancer; Metastasis; Gastroenterology","score_opus":0.0441598572596502,"score_gpt":0.3414817633456342,"score_spread":0.29732190608598397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241872224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892561,0.0040569007,0.000030581457,0.005297828,0.00068683777,0.00022838416,0.00015462528,0.0000066222738,0.00028213626],"genre_scores_gemma":[0.99617916,0.0018861834,0.000012244835,0.0010270416,0.00085997453,0.000016734106,0.000004069281,0.000007873464,0.0000067359556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868286,0.00007329048,0.00042980438,0.00015163097,0.0005122326,0.00015019692],"domain_scores_gemma":[0.9975159,0.0014102993,0.00041585683,0.000059275786,0.0003940388,0.00020458759],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015059877,0.00017099708,0.00046837627,0.00010368446,0.000030205549,0.000023317625,0.00026837483,0.000067732806,0.0018284188],"category_scores_gemma":[0.00148555,0.00006830992,0.00027488853,0.00024469112,0.00009985456,0.00006674899,0.00006255992,0.00032737674,0.0000024325273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025189638,0.0002233764,0.78724456,0.000010057705,0.0007562661,0.000030343845,0.00029268148,0.000060348106,0.00097336364,0.000027564194,0.0001397076,0.20772278],"study_design_scores_gemma":[0.004827234,0.005338732,0.9744715,0.00017933568,0.0001859545,0.000026547326,0.00023201034,0.00013817586,0.010407994,0.00045112224,0.0036282726,0.000113098606],"about_ca_topic_score_codex":0.0002470349,"about_ca_topic_score_gemma":0.000019570369,"teacher_disagreement_score":0.20760968,"about_ca_system_score_codex":0.00022567816,"about_ca_system_score_gemma":0.00018469346,"threshold_uncertainty_score":0.99908406},"labels":[],"label_agreement":null},{"id":"W4243329694","doi":"10.1136/ijgc-00009577-200311001-00016","title":"Translational research in ovarian cancer: a must","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Ovarian cancer; Disease; Medicine; Cancer; Translational research; Stage (stratigraphy); Bioinformatics; Epithelial ovarian cancer; Oncology; Internal medicine; Pathology; Biology","score_opus":0.13220467592093235,"score_gpt":0.45401756965117324,"score_spread":0.3218128937302409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243329694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9009684,0.006832042,0.00016300035,0.07140905,0.0028845407,0.00044408688,0.000052801955,0.000010206502,0.017235924],"genre_scores_gemma":[0.99480945,0.0025430168,0.0008967792,0.00092272775,0.00051195506,0.000079786194,0.00000280073,0.000010169457,0.00022330307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801856,0.00014932046,0.0004896441,0.0001855782,0.0009122834,0.0002446407],"domain_scores_gemma":[0.9983694,0.00040643362,0.00014899865,0.00007830806,0.0008444931,0.00015237341],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008226136,0.00010693862,0.0002872296,0.0003409177,0.000038374084,0.0000320211,0.00017750998,0.00010679959,0.0069778566],"category_scores_gemma":[0.00024926002,0.000077136276,0.00014924278,0.00028334046,0.00008837326,0.000112735,0.000016144724,0.0004903673,0.000012274552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010951762,0.0018658827,0.907485,0.000021858037,0.00066074834,0.0022430099,0.00031150482,0.0009940014,0.0007961221,0.017546738,0.003955411,0.06302452],"study_design_scores_gemma":[0.0071905153,0.0005989729,0.8749802,0.00033510476,0.00006252154,0.00025363103,0.00010935989,0.000049224767,0.0014330809,0.0050193914,0.10984476,0.00012319567],"about_ca_topic_score_codex":0.00020784713,"about_ca_topic_score_gemma":0.00034491412,"teacher_disagreement_score":0.10588935,"about_ca_system_score_codex":0.00092900835,"about_ca_system_score_gemma":0.0009166053,"threshold_uncertainty_score":0.9939299},"labels":[],"label_agreement":null},{"id":"W4243816917","doi":"10.1136/ijgc-00009577-200211000-00002","title":"Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian cancer; Carcinogenesis; Malignancy; Epithelial ovarian cancer; Bioinformatics; Oncology; Pathology; Cancer; Internal medicine; Biology","score_opus":0.07699829495805706,"score_gpt":0.3103954422065072,"score_spread":0.23339714724845018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243816917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880008,0.006733388,0.0000044298517,0.004330536,0.00036054803,0.0002595466,0.0000065148934,0.0000034233763,0.00030080014],"genre_scores_gemma":[0.9984403,0.0006976855,0.00024872398,0.0002134547,0.00023080701,0.00011571546,0.0000011754896,0.000008534331,0.00004356424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886066,0.00005046506,0.00040422252,0.00017182455,0.00035213443,0.00016066806],"domain_scores_gemma":[0.99955004,0.000057082394,0.00016284175,0.000051510404,0.00008185041,0.00009664589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017210943,0.000114817776,0.0002760918,0.00017651531,0.000013666069,0.00001577251,0.00011608173,0.00007811861,0.0005760609],"category_scores_gemma":[0.000035630008,0.00008132642,0.00007333964,0.00009082773,0.00005671772,0.00011426731,0.000040561466,0.0001747845,0.0000032108778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021787248,0.0014651109,0.979819,0.000009018883,0.00012986694,0.00037776944,0.00058470055,0.000073494455,0.0002871767,0.00012732793,0.000027720607,0.016880957],"study_design_scores_gemma":[0.0052091833,0.00072689203,0.9918907,0.00019284461,0.000024998304,0.00011334632,0.00007592318,0.00014922158,0.0010924686,0.00014845934,0.0002964317,0.00007947588],"about_ca_topic_score_codex":0.00014203214,"about_ca_topic_score_gemma":0.000103049846,"teacher_disagreement_score":0.016801482,"about_ca_system_score_codex":0.0005257832,"about_ca_system_score_gemma":0.000047679805,"threshold_uncertainty_score":0.6307463},"labels":[],"label_agreement":null},{"id":"W4243900892","doi":"10.1136/ijgc-00009577-200311000-00022","title":"Méthylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Placenta; Choriocarcinoma; Cadherin; Trophoblast; Cytotrophoblast; Syncytiotrophoblast; Gestational trophoblastic disease; Andrology; Medicine; Immunohistochemistry; Methylation; Decidua; Biology; Fetus; Internal medicine; Pregnancy; Gestation; Gene; Cell; Genetics","score_opus":0.017078053307122823,"score_gpt":0.3090786127829281,"score_spread":0.2920005594758053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243900892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996866,0.0018487205,0.00022921673,0.0004580134,0.00027849877,0.000111128364,0.00005355969,0.0000041508697,0.00015074237],"genre_scores_gemma":[0.99687624,0.0011945579,0.001666229,0.00011196931,0.000067671586,0.000013840122,0.000005130344,0.000007707246,0.000056652712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986814,0.000070219205,0.00046780249,0.00014370083,0.00050201424,0.00013481142],"domain_scores_gemma":[0.998387,0.00061461853,0.0002862865,0.00003812865,0.0005180676,0.00015589327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011579056,0.00011334108,0.00027771803,0.0001752527,0.00002346039,0.000013960962,0.000052354397,0.000048817226,0.00048811748],"category_scores_gemma":[0.0016679591,0.00008554757,0.00005352609,0.00008211156,0.00016046129,0.00012666191,0.000033429504,0.00012436678,8.175137e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007162719,0.00034468132,0.98455656,0.000055733086,0.000088047615,0.00013584663,0.00017696127,0.00082018634,0.008941769,0.0022183266,0.00008543388,0.0018602135],"study_design_scores_gemma":[0.0026091884,0.0003737119,0.9928861,0.00017496242,0.000059741513,0.000047078276,0.0003024778,0.00009115697,0.0006502165,0.0021164087,0.0006125379,0.000076369324],"about_ca_topic_score_codex":0.000025405432,"about_ca_topic_score_gemma":0.000030963365,"teacher_disagreement_score":0.0083296215,"about_ca_system_score_codex":0.00016151462,"about_ca_system_score_gemma":0.0002295934,"threshold_uncertainty_score":0.5344544},"labels":[],"label_agreement":null},{"id":"W4244887864","doi":"10.1046/j.1525-1438.2001.01008.x","title":"Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?","year":2001,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Cervix; Regimen; Cervical cancer; Randomized controlled trial; Chemotherapy; Cancer; Oncology; Modality (human–computer interaction); Intensive care medicine; Clinical trial; Internal medicine","score_opus":0.026882159760617922,"score_gpt":0.3754371144199064,"score_spread":0.3485549546592885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244887864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8284839,0.07717156,0.0053594094,0.08482177,0.002537327,0.0009746681,0.00023727365,0.000016345983,0.00039775137],"genre_scores_gemma":[0.96056634,0.031375255,0.0010625983,0.005661441,0.0010366039,0.000040999137,0.000004000589,0.000014701261,0.00023806618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986183,0.000026916283,0.0004713566,0.00016102186,0.0005540741,0.00016832529],"domain_scores_gemma":[0.9981204,0.00035816577,0.00034791513,0.000077940815,0.0009237971,0.00017173153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012556578,0.00014599538,0.00050179736,0.00007453202,0.00004067442,0.00002005748,0.0002332921,0.0000875167,0.002355004],"category_scores_gemma":[0.00012650329,0.000079580204,0.0002505135,0.00013458633,0.000113264316,0.000067841574,0.000024699368,0.00017938258,3.8549746e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015612063,0.0001710405,0.043241132,0.000046784673,0.0009255908,0.000032753815,0.0005678997,0.000094673815,0.00087294244,0.00029539553,0.0022094257,0.9359303],"study_design_scores_gemma":[0.053126603,0.013286015,0.18043576,0.0006430819,0.00045263304,0.00018898008,0.00059387466,0.00017736605,0.012265698,0.0017640421,0.7367518,0.00031413615],"about_ca_topic_score_codex":0.00008246203,"about_ca_topic_score_gemma":0.00012379175,"teacher_disagreement_score":0.93561614,"about_ca_system_score_codex":0.00050738023,"about_ca_system_score_gemma":0.0004363693,"threshold_uncertainty_score":0.998557},"labels":[],"label_agreement":null},{"id":"W4245260553","doi":"10.1136/ijgc-00009577-200407000-00013","title":"The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers — a study of the National Cancer Institute of Canada Clinical Trials Group","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; McGill University; Queen's University; University Health Network","funders":"","keywords":"Letrozole; Medicine; PTEN; Internal medicine; Oncology; Endometrial cancer; Cancer; Clinical trial; Breast cancer; Gynecology; Tamoxifen; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.03652983652612425,"score_gpt":0.36008780735944074,"score_spread":0.3235579708333165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245260553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975591,0.0005825077,0.000028655546,0.00027376448,0.0010392846,0.0004418772,0.00005617188,6.24938e-7,0.00001803081],"genre_scores_gemma":[0.99872786,0.001018091,0.000047868532,0.0000407283,0.000115987175,0.00003321401,0.000002942921,0.0000043897817,0.000008949034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981648,0.00031472815,0.00069683394,0.00015103474,0.0005626738,0.00010995066],"domain_scores_gemma":[0.9976202,0.00044301624,0.0012055924,0.00006057569,0.00062321266,0.000047400197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010201711,0.00011098681,0.00036400728,0.00004798202,0.00004273181,0.0000062100694,0.00024416432,0.00010499164,0.000015973901],"category_scores_gemma":[0.0017349401,0.000046156063,0.00008355859,0.00015898634,0.00023153004,0.000015995476,0.00006977907,0.00025258577,1.0948328e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0440391,0.0013290611,0.9068054,0.0000088776915,0.0010893117,0.0000063628095,0.00003933034,0.016344143,0.003097988,0.000045725476,0.00009202816,0.027102662],"study_design_scores_gemma":[0.013695107,0.0059753233,0.97722375,0.00012826083,0.000065951775,0.0000037373363,0.000054208922,0.000030372872,0.0023076048,0.000021946515,0.00040749455,0.00008624169],"about_ca_topic_score_codex":0.0035086279,"about_ca_topic_score_gemma":0.059409715,"teacher_disagreement_score":0.07041834,"about_ca_system_score_codex":0.00021201477,"about_ca_system_score_gemma":0.0010708456,"threshold_uncertainty_score":0.9577536},"labels":[],"label_agreement":null},{"id":"W4247081332","doi":"10.1136/ijgc-00009577-200602001-00045","title":"Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Carboplatin; Radiation therapy; Chemotherapy; Internal medicine; Retrospective cohort study; Oncology; Paclitaxel; Stage (stratigraphy); Radiology; Adjuvant; Urology; Cisplatin","score_opus":0.03562922212631931,"score_gpt":0.35521290532392763,"score_spread":0.3195836831976083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247081332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992381,0.004325458,0.00012017604,0.002197369,0.0002471351,0.00029610045,0.000023766506,0.0000058947644,0.0004031342],"genre_scores_gemma":[0.99575335,0.0018060813,0.0014442911,0.00037999603,0.00046317902,0.000027231838,0.0000075973485,0.000009998024,0.00010830134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985232,0.00007369758,0.000411836,0.00014904844,0.00072666554,0.00011560092],"domain_scores_gemma":[0.99849755,0.00014157173,0.00034679484,0.00007830104,0.0008549518,0.00008085056],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027719777,0.00014206374,0.00041283626,0.000109769244,0.0000205873,0.000013033217,0.00008461875,0.00006717223,0.0011546854],"category_scores_gemma":[0.0000349194,0.00007970179,0.00011526149,0.00010399352,0.000088045614,0.00007635304,0.0000112950465,0.00008042745,4.941907e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007314412,0.00141759,0.6667567,0.000023923343,0.0009971347,0.00017077292,0.00009818095,0.00034143298,0.006452228,0.000049468414,0.00007927018,0.3162989],"study_design_scores_gemma":[0.024714433,0.004240112,0.96201086,0.000047030386,0.00027423425,0.00021623763,0.000022274875,0.0004496983,0.005326103,0.00027184418,0.0023375917,0.000089608264],"about_ca_topic_score_codex":0.00065043493,"about_ca_topic_score_gemma":0.000112481306,"teacher_disagreement_score":0.31620932,"about_ca_system_score_codex":0.0009191205,"about_ca_system_score_gemma":0.00021895682,"threshold_uncertainty_score":0.9997584},"labels":[],"label_agreement":null},{"id":"W4252577980","doi":"10.1136/ijgc-00009577-200605000-00022","title":"Psychologic morbidities prior to loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Colposcopy; Cervical intraepithelial neoplasia; Anxiety; Depression (economics); Psychosocial; Hospital Anxiety and Depression Scale; Distress; Cervical cancer; Obstetrics; Gynecology; Cancer; Internal medicine; Clinical psychology; Psychiatry","score_opus":0.03233978136452263,"score_gpt":0.3864086841429708,"score_spread":0.35406890277844816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252577980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800025,0.0009889518,0.00007331472,0.015133936,0.00039510374,0.00036294566,0.00001830483,0.0000071507884,0.0030177613],"genre_scores_gemma":[0.99588126,0.0010801951,0.0002037777,0.0012560132,0.0012775209,0.000057307112,0.000005561558,0.000008666241,0.00022966907],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99772894,0.00010363496,0.00066614244,0.00019746626,0.0010293351,0.00027450174],"domain_scores_gemma":[0.99850464,0.0004520359,0.0001778803,0.000112301284,0.0006374281,0.00011573816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036649875,0.0001515005,0.00042999955,0.00021996906,0.00003196302,0.000033991837,0.00039569868,0.00013678205,0.0040105926],"category_scores_gemma":[0.0002293276,0.00007779462,0.00024009706,0.00027779484,0.00011641344,0.00006059521,0.000029754106,0.000333596,0.000011382208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03420281,0.013750274,0.40593997,0.000104414285,0.00047250217,0.0033011443,0.0014562116,0.0013630472,0.010158521,0.0038876012,0.013306033,0.5120575],"study_design_scores_gemma":[0.0038194293,0.005970804,0.963427,0.000037483143,0.00004135138,0.00031556515,0.00012373118,0.00006940658,0.0019030145,0.0015377088,0.022661684,0.00009283522],"about_ca_topic_score_codex":0.00015847529,"about_ca_topic_score_gemma":0.00041002067,"teacher_disagreement_score":0.557487,"about_ca_system_score_codex":0.00056063116,"about_ca_system_score_gemma":0.0002703314,"threshold_uncertainty_score":0.9968999},"labels":[],"label_agreement":null},{"id":"W4253179252","doi":"10.1136/ijgc-00009577-200602001-00008","title":"A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Debulking; Carboplatin; Chemotherapy; Ovarian cancer; Surgery; Stage (stratigraphy); Retrospective cohort study; Internal medicine; Oncology; Subgroup analysis; Cancer; Confidence interval; Cisplatin","score_opus":0.02393308602563269,"score_gpt":0.33291612833109313,"score_spread":0.3089830423054604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253179252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893527,0.0013751542,0.00020691204,0.006288112,0.0017511131,0.00018524424,0.000118653596,0.0000092490245,0.0007128723],"genre_scores_gemma":[0.9973993,0.00084499735,0.00066529773,0.0005628223,0.00033385036,0.00006058176,0.000022740043,0.000013358624,0.000097108124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797356,0.00005103076,0.0008300071,0.00024348895,0.00068998145,0.00021193927],"domain_scores_gemma":[0.9978065,0.00047819392,0.0007580497,0.00012522556,0.0007446673,0.00008737522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028011546,0.00017885983,0.00088065385,0.0005942615,0.00001964479,0.00001716122,0.00015978001,0.00011189691,0.0041958624],"category_scores_gemma":[0.0001936049,0.00013190559,0.0005348457,0.00047028836,0.00007374401,0.00009474648,0.000018125693,0.00022556144,0.0000014529257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005323487,0.0009618891,0.94256556,0.0000092900345,0.0030236004,0.0003314993,0.00007337581,0.014879247,0.00055554433,0.00018812681,0.0009143463,0.031174056],"study_design_scores_gemma":[0.009369658,0.00048206572,0.9846714,0.0001787295,0.00068386726,0.0000045867423,0.000035605495,0.0009192468,0.0019394231,0.00011417467,0.0014806696,0.000120586155],"about_ca_topic_score_codex":0.001179893,"about_ca_topic_score_gemma":0.0029694345,"teacher_disagreement_score":0.04210585,"about_ca_system_score_codex":0.0020358488,"about_ca_system_score_gemma":0.00056717696,"threshold_uncertainty_score":0.9967144},"labels":[],"label_agreement":null},{"id":"W4253365483","doi":"10.1136/ijgc-2020-igcs.106","title":"124 Simple vaginal trachelectomy in women with early-stage low risk cervical cancer who wish to preserve fertility: the new standard of care ?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Trachelectomy; Medicine; Stage (stratigraphy); Cervical cancer; Obstetrics; Pregnancy; Gynecology; Fertility preservation; Lymph node; Cancer; Fertility; Internal medicine; Population","score_opus":0.02253275353878509,"score_gpt":0.3230382971184928,"score_spread":0.3005055435797077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253365483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790145,0.0014936416,0.00022443512,0.018066239,0.00019846346,0.00040963836,0.00026584795,0.000010424971,0.00031679845],"genre_scores_gemma":[0.99548113,0.0003886963,0.00021790362,0.0031921214,0.0005342197,0.000066860055,0.0000034334887,0.000016833217,0.00009882383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975416,0.000119770666,0.0006250173,0.00026839372,0.0011211112,0.0003241157],"domain_scores_gemma":[0.99779713,0.00034337505,0.00036552592,0.0001216332,0.00087836693,0.0004939909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022585203,0.0002000687,0.00067492865,0.000116187584,0.00003550927,0.00004313853,0.00048792615,0.00009851939,0.004082131],"category_scores_gemma":[0.000641523,0.00010982252,0.00012116355,0.0005157728,0.00009288226,0.00014846666,0.0001072646,0.000600437,0.0000031658976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07924352,0.00035925466,0.82193035,0.0001221164,0.0011466958,0.0004698942,0.00440392,0.0031255677,0.00047989417,0.000039002123,0.0011386655,0.08754115],"study_design_scores_gemma":[0.009118511,0.009977516,0.96070856,0.00022176838,0.00015227523,0.000008519719,0.000565515,0.00004090619,0.0029199293,0.00025701086,0.01587772,0.00015176501],"about_ca_topic_score_codex":0.0016638659,"about_ca_topic_score_gemma":0.0022538782,"teacher_disagreement_score":0.13877824,"about_ca_system_score_codex":0.0011512031,"about_ca_system_score_gemma":0.00076354283,"threshold_uncertainty_score":0.99682826},"labels":[],"label_agreement":null},{"id":"W4253546705","doi":"10.1136/ijgc-00009577-200605000-00005","title":"Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Hazard ratio; Chemotherapy; Neoadjuvant therapy; Oncology; Internal medicine; Proportional hazards model; Stage (stratigraphy); Surgery; Cancer; Confidence interval; Breast cancer","score_opus":0.01255594879096513,"score_gpt":0.28171305097797655,"score_spread":0.26915710218701144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253546705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957059,0.00079531345,0.000021725054,0.0026398532,0.00021432224,0.00033395353,0.00003922865,0.0000064451924,0.0002432722],"genre_scores_gemma":[0.9983171,0.00054852036,0.00043455002,0.0003213364,0.0002184873,0.000082292485,0.00000738579,0.00001584623,0.000054445067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842954,0.00004658425,0.00061795977,0.0002306053,0.00047652543,0.00019877],"domain_scores_gemma":[0.9985416,0.00024181207,0.00048197436,0.00006667674,0.00057060306,0.000097346456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014672769,0.00017775994,0.0005117711,0.00015840503,0.000020487392,0.00002730057,0.00013157823,0.00006892382,0.00055223366],"category_scores_gemma":[0.000059921673,0.0001118291,0.00010641409,0.00016319808,0.00012438188,0.00010426955,0.000026998372,0.00019974713,5.458016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021957888,0.0013936838,0.97948784,0.00002175963,0.00027381277,0.00067391427,0.00005823036,0.000140342,0.0004596901,0.00008250698,0.00013077733,0.015081647],"study_design_scores_gemma":[0.009650681,0.0015929856,0.98304015,0.000627174,0.000119138764,0.000087132394,0.00001542714,0.00007986286,0.0036872155,0.00009539834,0.0008888836,0.000115940515],"about_ca_topic_score_codex":0.0014211348,"about_ca_topic_score_gemma":0.0005113457,"teacher_disagreement_score":0.0149657065,"about_ca_system_score_codex":0.0005358619,"about_ca_system_score_gemma":0.00021011173,"threshold_uncertainty_score":0.6046571},"labels":[],"label_agreement":null},{"id":"W4254120630","doi":"10.1136/ijgc-00009577-200201000-00019","title":"Postoperative chemotherapy in advanced ovarian granulosa cell tumors","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Univariate analysis; Chemotherapy; Stage (stratigraphy); Hysterectomy; Radiation therapy; Surgery; Retrospective cohort study; Population; Internal medicine; Gynecology; Multivariate analysis","score_opus":0.020721134848475244,"score_gpt":0.3043143164714355,"score_spread":0.2835931816229602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254120630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579582,0.0020962448,0.000036903013,0.033891007,0.0007702827,0.00020251842,0.000013522262,0.000008805012,0.005022488],"genre_scores_gemma":[0.9912415,0.002377668,0.00091042224,0.0047066887,0.00026754264,0.000029482202,0.0000019566858,0.000010956073,0.00045376417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998793,0.000037819565,0.00044013813,0.00016419114,0.0003977115,0.00016712546],"domain_scores_gemma":[0.9991248,0.00010312904,0.00023006264,0.00007568,0.00034841217,0.0001179146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001215285,0.0001332642,0.00033355813,0.00014881756,0.000021470667,0.000023299652,0.0001670081,0.00007156761,0.0069835573],"category_scores_gemma":[0.000082780716,0.0000917591,0.00015511212,0.00012128722,0.00004656638,0.00012742075,0.000019633582,0.00026341726,0.000022422406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028197228,0.00633656,0.66251135,0.000026378426,0.00073124067,0.006601582,0.0015535756,0.0011360548,0.005021937,0.0010917372,0.007919707,0.30425018],"study_design_scores_gemma":[0.015606657,0.0021732207,0.9458051,0.0002943772,0.000055461234,0.0002710041,0.00014397434,0.00027671302,0.006680863,0.00041524845,0.028081207,0.00019617836],"about_ca_topic_score_codex":0.000036546873,"about_ca_topic_score_gemma":0.00004179497,"teacher_disagreement_score":0.304054,"about_ca_system_score_codex":0.0006677096,"about_ca_system_score_gemma":0.00008739284,"threshold_uncertainty_score":0.9939242},"labels":[],"label_agreement":null},{"id":"W4281905911","doi":"10.1136/ijgc-2022-003431","title":"Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Lymphadenectomy; Endometrial cancer; Sentinel lymph node; Sampling (signal processing); Lymph node; Surgery; Carcinoma; Interquartile range; Cancer; Internal medicine; Breast cancer","score_opus":0.025183274683217394,"score_gpt":0.31729578817052534,"score_spread":0.29211251348730793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281905911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970166,0.0002633914,0.00003162802,0.0012399688,0.00095233903,0.00025945454,0.00013188747,0.000006930578,0.00009776554],"genre_scores_gemma":[0.99843454,0.00012286987,0.00049504085,0.0005770175,0.00024756606,0.000056138215,0.000014646576,0.000011497563,0.000040677383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751526,0.00016094107,0.0007757966,0.00024829456,0.0010629435,0.00023673406],"domain_scores_gemma":[0.99754703,0.0012037348,0.0005123962,0.00008226816,0.000432032,0.00022251715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043501757,0.0001764519,0.0007470195,0.00052728975,0.00004997106,0.000017726006,0.00026652357,0.00007299011,0.0014474178],"category_scores_gemma":[0.0009930523,0.00010862085,0.00017230521,0.00043938667,0.00008416458,0.00007488548,0.000257221,0.0004154275,0.0000014071057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010668892,0.0011419032,0.9661716,0.000008243292,0.00032660237,0.00046057114,0.000056298275,0.0003869066,0.0000269158,0.00005043671,0.000018805024,0.020682795],"study_design_scores_gemma":[0.02632169,0.0028145537,0.96972525,0.00003605799,0.00012487728,0.00004800034,0.00006590791,0.000011943053,0.00003569515,0.00012728624,0.00057942903,0.00010928654],"about_ca_topic_score_codex":0.00031591003,"about_ca_topic_score_gemma":0.000021846125,"teacher_disagreement_score":0.020573508,"about_ca_system_score_codex":0.00079376093,"about_ca_system_score_gemma":0.00017613648,"threshold_uncertainty_score":0.9994654},"labels":[],"label_agreement":null},{"id":"W4283372181","doi":"10.1136/ijgc-2022-003562","title":"The Canadian Gynecologic Oncology Peri-operative Management Survey: re-examining Enhanced Recovery After Surgery (ERAS) recommendations","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Dalhousie University; Public Works and Government Services Canada; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Gynecologic oncology; Foley catheter; General surgery; Surgery; Catheter","score_opus":0.05832575115339612,"score_gpt":0.3590314620529554,"score_spread":0.3007057108995593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283372181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468899,0.0014232701,0.00034426994,0.02591555,0.015648564,0.0005311331,0.00023021863,0.000031245378,0.008985863],"genre_scores_gemma":[0.98415834,0.0030876065,0.0006509958,0.008235225,0.00043367237,0.0005098211,0.00006644767,0.000026570053,0.0028313224],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99616534,0.0010129451,0.0010940876,0.00035397292,0.0008542698,0.0005193921],"domain_scores_gemma":[0.99274,0.0050362637,0.00072400476,0.00022490734,0.0009673224,0.00030751165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034629607,0.00024323307,0.00059209124,0.00050504715,0.00064726744,0.0001245871,0.00054162013,0.0001427233,0.014588112],"category_scores_gemma":[0.0018108127,0.00017403088,0.0003276816,0.0003939359,0.00016627433,0.00024761105,0.00028945087,0.0010638951,0.000023171962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0136595275,0.0015599077,0.2831425,0.00003666211,0.0052296566,0.008801978,0.001225526,0.003521337,0.00095643336,0.00026994335,0.09814279,0.5834537],"study_design_scores_gemma":[0.0011329339,0.0013868768,0.694069,0.00008541078,0.00011299925,0.0003021066,0.0010168528,0.00005603191,0.00024276454,0.0003294118,0.30096006,0.00030550244],"about_ca_topic_score_codex":0.0020984907,"about_ca_topic_score_gemma":0.11810094,"teacher_disagreement_score":0.58314824,"about_ca_system_score_codex":0.005936063,"about_ca_system_score_gemma":0.0019481358,"threshold_uncertainty_score":0.99788},"labels":[],"label_agreement":null},{"id":"W4283389001","doi":"10.1136/ijgc-2021-003210","title":"A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Brachytherapy; Vaginal vault; External beam radiotherapy; Radiation therapy; Endometrial cancer; Stage (stratigraphy); Proportional hazards model; Retrospective cohort study; Surgery; Radiology; Hysterectomy; Cancer; Internal medicine","score_opus":0.04960488829420832,"score_gpt":0.377848205535662,"score_spread":0.32824331724145367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283389001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955128,0.00054738397,0.000066949346,0.0014371385,0.0015096808,0.00073215686,0.00015388131,0.0000052395408,0.000034789304],"genre_scores_gemma":[0.99832845,0.00002222666,0.00036720256,0.0006274965,0.00025164956,0.00019976981,0.000014332465,0.000010982307,0.00017790412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793434,0.000115890776,0.00076860446,0.00015758214,0.0008771536,0.00014642812],"domain_scores_gemma":[0.99803245,0.0009573114,0.0005272012,0.00008292598,0.0003214611,0.00007864621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045643921,0.00011943881,0.00065056334,0.0005684925,0.00006069128,0.000007739302,0.00025539674,0.000039343326,0.0031070886],"category_scores_gemma":[0.0007143356,0.00008289751,0.00027773497,0.00033635914,0.000015592936,0.000052301653,0.00005877161,0.0002192484,1.363403e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009920885,0.004166619,0.97288585,0.000009635057,0.00044875886,0.00013864896,0.00016048533,0.003667857,0.00021335666,0.00004527312,0.0000389414,0.008303717],"study_design_scores_gemma":[0.04245876,0.01261402,0.94255435,0.000012806308,0.00009302604,0.0000075005632,0.00028223818,0.00019267818,0.00015751009,0.00009763858,0.001449449,0.0000800221],"about_ca_topic_score_codex":0.0006480373,"about_ca_topic_score_gemma":0.00019868146,"teacher_disagreement_score":0.032537878,"about_ca_system_score_codex":0.0012503762,"about_ca_system_score_gemma":0.00023650673,"threshold_uncertainty_score":0.9978042},"labels":[],"label_agreement":null},{"id":"W4283694626","doi":"10.1136/ijgc-2022-003560","title":"Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Fertility; Stage (stratigraphy); Retrospective cohort study; Exact test; Fertility preservation; Cancer; Cohort; Gynecology; Surgery; Internal medicine; Population","score_opus":0.052920230981355634,"score_gpt":0.35536453279962466,"score_spread":0.30244430181826903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283694626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719787,0.010092663,0.00013167909,0.014085688,0.0027025514,0.00052945403,0.00032489403,0.000017467193,0.00013687034],"genre_scores_gemma":[0.99359596,0.0018090442,0.00052987796,0.0023721128,0.00021282422,0.0008527148,0.000009622134,0.000018149853,0.0005997099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998055,0.00008660406,0.00064194936,0.0002921942,0.00064379367,0.00028048502],"domain_scores_gemma":[0.9974263,0.001424456,0.00046579086,0.0001129155,0.00039044753,0.00018009683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044146992,0.00019346784,0.00062988687,0.00028753557,0.00011527118,0.00005219515,0.00019452603,0.00007424517,0.0054075],"category_scores_gemma":[0.0005756865,0.00013690529,0.00037660435,0.00015862443,0.00007391671,0.00014199394,0.000160041,0.00033702084,0.0000010596057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012519556,0.0009880528,0.94394326,0.000052698084,0.00091983867,0.00067894644,0.00010562265,0.00024062423,0.00007393256,0.00013672859,0.0005582664,0.051050074],"study_design_scores_gemma":[0.00436637,0.0006699828,0.97531974,0.00020056359,0.00020957761,0.000040574145,0.000079651196,0.00006284365,0.00026112882,0.0003084275,0.018334838,0.00014629008],"about_ca_topic_score_codex":0.00013025002,"about_ca_topic_score_gemma":0.00010905641,"teacher_disagreement_score":0.050903782,"about_ca_system_score_codex":0.0014633705,"about_ca_system_score_gemma":0.00048235772,"threshold_uncertainty_score":0.9955017},"labels":[],"label_agreement":null},{"id":"W4283720278","doi":"10.1136/ijgc-2021-003251","title":"Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Vulvar Carcinoma; Medicine; Immunohistochemistry; Vulvar cancer; Clinical significance; Oncology; Carcinoma; Pathology; Internal medicine; Vulva","score_opus":0.03628701774650333,"score_gpt":0.3185789654541984,"score_spread":0.28229194770769506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283720278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951925,0.0017774386,0.0005422932,0.001164069,0.0002959026,0.00048721876,0.00008383889,0.0000065288496,0.000450195],"genre_scores_gemma":[0.99851894,0.00007009884,0.0010209747,0.00010127388,0.000100247824,0.00012853727,0.000007997194,0.00000887128,0.000043067008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791783,0.00012607122,0.00073046255,0.00033460258,0.00076627394,0.00012475664],"domain_scores_gemma":[0.99771017,0.00053933455,0.00069100433,0.00020932718,0.0007471482,0.00010303692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093212345,0.00011464747,0.0004298441,0.00016434886,0.000031205273,0.0000053994368,0.00023033895,0.00006341017,0.00059716037],"category_scores_gemma":[0.0011077427,0.000086056716,0.00017429698,0.00028368217,0.00014559191,0.000049560465,0.00012233699,0.00030437263,1.9241307e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064922622,0.0061479597,0.6488379,0.00022196448,0.00022367742,0.0007056742,0.00015435669,0.00075403805,0.32839867,0.0007273178,0.00008615416,0.0072500254],"study_design_scores_gemma":[0.012381075,0.0070396895,0.6967542,0.000058729853,0.0003842718,0.0006859084,0.00017632545,0.00016596873,0.2795909,0.0007610097,0.0017892771,0.00021264429],"about_ca_topic_score_codex":0.000118474556,"about_ca_topic_score_gemma":0.000003604238,"teacher_disagreement_score":0.04880778,"about_ca_system_score_codex":0.0003796102,"about_ca_system_score_gemma":0.0003014185,"threshold_uncertainty_score":0.65384877},"labels":[],"label_agreement":null},{"id":"W4283740161","doi":"10.1136/ijgc-2022-003597","title":"A step-by-step demonstration of laparoscopic sentinel lymph node mapping according to current guidelines","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Sentinel lymph node; Lymph; Lymphatic system; Adjuvant therapy; Lymph node; Sentinel node; General surgery; Oncology; Radiology; Cancer; Internal medicine; Pathology; Breast cancer","score_opus":0.07626305840280509,"score_gpt":0.38869987946855983,"score_spread":0.31243682106575477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283740161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817595,0.002737282,0.00389382,0.008145656,0.0026288202,0.00019129472,0.00007070388,0.000012643708,0.00056029233],"genre_scores_gemma":[0.9946013,0.00043756515,0.0020206717,0.0021055823,0.000601231,0.000053401203,0.00001685325,0.000009675069,0.00015372458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978261,0.00006934787,0.00082507153,0.0001695779,0.0009420851,0.00016779666],"domain_scores_gemma":[0.99819666,0.00019519062,0.00050547597,0.00007501998,0.00087979744,0.00014785133],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034942187,0.00012605231,0.0004014477,0.00024262605,0.0000638302,0.000019274286,0.0002786277,0.00003858026,0.0016154553],"category_scores_gemma":[0.00052393496,0.00009479139,0.00020339711,0.00031853432,0.000028194832,0.0000830009,0.00015978664,0.00022261954,0.000004157029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017765702,0.00096372707,0.82249606,0.000045268294,0.000620855,0.00011442514,0.000054692984,0.0011517239,0.014923422,0.00017018306,0.013243889,0.14443922],"study_design_scores_gemma":[0.030107595,0.002089434,0.71569103,0.0010566645,0.0006507349,0.00047578433,0.0017446636,0.0020284243,0.009317976,0.0003698974,0.2358145,0.0006532846],"about_ca_topic_score_codex":0.00007310733,"about_ca_topic_score_gemma":0.000004098099,"teacher_disagreement_score":0.22257061,"about_ca_system_score_codex":0.0007441538,"about_ca_system_score_gemma":0.00025132028,"threshold_uncertainty_score":0.9992972},"labels":[],"label_agreement":null},{"id":"W4283793801","doi":"10.1136/ijgc-2022-003569","title":"The pregnancy that wasn’t: challenges of gestational trophoblastic neoplasia management in low- and middle-income countries","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitochondrial DNA; Mitochondrion; Homologous recombination; Nuclear gene; Chimeric gene; Gene; Genome; Genetics; Biology; Homologous chromosome; Egg donation; Gene expression","score_opus":0.02617924558558677,"score_gpt":0.29583873314330195,"score_spread":0.2696594875577152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283793801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671205,0.015712054,0.000035343175,0.015048122,0.0009351146,0.00027037624,0.000074676485,0.000006049087,0.00079774193],"genre_scores_gemma":[0.9861057,0.013076251,0.00030434012,0.00017326424,0.00006970444,0.000099115074,0.0000024491446,0.000008021296,0.00016120344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981143,0.000079426216,0.00047499329,0.00014172896,0.0010324557,0.00015712078],"domain_scores_gemma":[0.99807334,0.0010468956,0.00037041935,0.000063110834,0.00037808114,0.00006818179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024472113,0.00011326469,0.00024559844,0.00016512873,0.00009370002,0.000016957594,0.00022843349,0.000023013654,0.0004709327],"category_scores_gemma":[0.00026142815,0.00007550051,0.000083537336,0.000080203994,0.00020579463,0.00007277885,0.00018153516,0.00022328238,0.0000015931929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020107446,0.0035400838,0.6945113,0.0025406578,0.0070814816,0.008982136,0.006375905,0.024728691,0.0001634518,0.17881119,0.00092699577,0.05223065],"study_design_scores_gemma":[0.0024261416,0.0005712358,0.98865557,0.00080445287,0.00008389168,0.00013503742,0.0018832367,0.00016194959,0.000019604726,0.003911161,0.001270285,0.00007745539],"about_ca_topic_score_codex":0.00000569202,"about_ca_topic_score_gemma":0.000030362344,"teacher_disagreement_score":0.29414424,"about_ca_system_score_codex":0.00035082057,"about_ca_system_score_gemma":0.00016604192,"threshold_uncertainty_score":0.5156383},"labels":[],"label_agreement":null},{"id":"W4283803674","doi":"10.1136/ijgc-2022-003500","title":"Vulvar squamous cell carcinoma metastasizes to lung pleura","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Occupational Health and Performance","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre; St. John’s Health Sciences Centre; Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psychological intervention; Intervention (counseling); Randomized controlled trial; Health promotion; Inclusion (mineral); Mindfulness; Physical therapy; Family medicine; Gerontology; Clinical psychology; Public health; Psychiatry; Internal medicine; Nursing; Psychology","score_opus":0.06358505919864618,"score_gpt":0.44585241817984805,"score_spread":0.3822673589812019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283803674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97994125,0.0007904087,0.00018057408,0.007837049,0.006846773,0.0003324602,0.00025746223,0.000016251099,0.003797801],"genre_scores_gemma":[0.982628,0.00005073956,0.0005546079,0.013810183,0.0012236242,0.00018058284,0.000013509037,0.000013702515,0.0015250908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971984,0.00040505917,0.00085974176,0.00017265258,0.0009785836,0.00038556283],"domain_scores_gemma":[0.9970277,0.0011353169,0.0006263033,0.000099624354,0.00082951406,0.00028155014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001015483,0.00012991687,0.00027520992,0.00023073543,0.00058766454,0.000011536533,0.000687841,0.00006744293,0.024679454],"category_scores_gemma":[0.0003957869,0.00010236782,0.00012292004,0.00021418172,0.000025707917,0.0001505167,0.00030987535,0.0010155307,0.00008933764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024015054,0.0003550615,0.85738033,0.00007701831,0.000050634975,0.00022938808,0.0015890938,0.0066422927,0.00042113222,0.0011630855,0.12410515,0.0055853343],"study_design_scores_gemma":[0.002235623,0.00095717417,0.6645167,0.00001830057,0.000030879106,0.000033251556,0.0008944686,0.00044763752,0.00010927308,0.0003419946,0.33023298,0.0001817074],"about_ca_topic_score_codex":0.00018608215,"about_ca_topic_score_gemma":0.000097084994,"teacher_disagreement_score":0.20612785,"about_ca_system_score_codex":0.0013112433,"about_ca_system_score_gemma":0.0010121985,"threshold_uncertainty_score":0.97621214},"labels":[],"label_agreement":null},{"id":"W4295760323","doi":"10.1136/ijgc-2022-003763","title":"Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunohistochemistry; Medicine; Pathology; Vulvar Carcinoma; Vulvar intraepithelial neoplasia; Vulva; Lichen sclerosus; HPV infection; Vulvar Diseases; Stage (stratigraphy); Internal medicine; Cancer; Biology; Cervical cancer","score_opus":0.027904451646808662,"score_gpt":0.3160905826524951,"score_spread":0.28818613100568646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295760323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970112,0.00069831504,0.000024745535,0.00034997816,0.00048136976,0.00035751288,0.00017903195,0.0000057702096,0.0008920774],"genre_scores_gemma":[0.9986546,0.000219808,0.000032545355,0.0000924435,0.00017824346,0.00004902586,0.000010541086,0.00001596905,0.00074682053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682117,0.0002755797,0.00085395516,0.00028002475,0.0014922603,0.00027703468],"domain_scores_gemma":[0.9980386,0.0004307761,0.0005601237,0.00014118645,0.00065450155,0.00017480692],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062595855,0.00016379707,0.0005190594,0.0003462096,0.00008486088,0.000018782679,0.00041869373,0.00010399114,0.010781237],"category_scores_gemma":[0.00026635456,0.00013410475,0.00014899918,0.0002477165,0.00020017858,0.00011113903,0.0003671095,0.00079355325,0.0000013543489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010108386,0.0010341805,0.819673,0.00017631051,0.00010284568,0.0006027613,0.00067782577,0.00073721696,0.16336223,0.00019662398,0.00022949073,0.0030991056],"study_design_scores_gemma":[0.0051303515,0.0034716122,0.9523497,0.000024615894,0.000041582676,0.00005419609,0.00022160355,0.00019871829,0.037690036,0.00019835743,0.0005032749,0.00011595033],"about_ca_topic_score_codex":0.0020768195,"about_ca_topic_score_gemma":0.0015990465,"teacher_disagreement_score":0.13267669,"about_ca_system_score_codex":0.0009828317,"about_ca_system_score_gemma":0.0002773498,"threshold_uncertainty_score":0.99012303},"labels":[],"label_agreement":null},{"id":"W4304974372","doi":"10.1136/ijgc-2022-004024","title":"In memorium: C Paul Morrow (1935–2022)","year":2022,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Texas MD Anderson Cancer Center; USC Norris Comprehensive Cancer Center; University of Southern California","keywords":"Navy; Medicine; Officer; Duty; Obstetrics and gynaecology; Library science; Family medicine; Medical education; Theology; Law; Philosophy; Pregnancy; Political science","score_opus":0.03868159240318904,"score_gpt":0.355309282045751,"score_spread":0.316627689642562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304974372","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029336657,0.005330132,0.0000068851837,0.9363153,0.019883886,0.00018663018,0.00013699276,0.000016198886,0.00878733],"genre_scores_gemma":[0.11301663,0.007701733,0.00016667554,0.8506162,0.01931604,0.00011276085,0.00009288561,0.000054831915,0.008922214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694127,0.00010630393,0.0008845815,0.00027828797,0.0014680312,0.0003215077],"domain_scores_gemma":[0.99825704,0.00029807814,0.00054371497,0.00013159409,0.00069292256,0.00007664808],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030949753,0.00026943415,0.0007626324,0.00045045826,0.000044830897,0.000019200168,0.0005708302,0.00036569138,0.04044534],"category_scores_gemma":[0.0004597726,0.00019989254,0.00048716489,0.00019506997,0.00008913621,0.000109256995,0.00019301327,0.0032014318,0.00002206084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034937885,0.00012770809,0.006085643,0.000037278358,0.0005882592,0.0211411,0.00010937062,0.00004289906,0.00006161031,0.000015821894,0.96787745,0.003563493],"study_design_scores_gemma":[0.0012844987,0.00063072523,0.018418008,0.00009998967,0.00014721014,0.00067428243,0.000090646936,0.000006418853,0.00003256417,0.00053397054,0.97788763,0.00019408258],"about_ca_topic_score_codex":0.00010766552,"about_ca_topic_score_gemma":0.00009031609,"teacher_disagreement_score":0.08569905,"about_ca_system_score_codex":0.001330938,"about_ca_system_score_gemma":0.00039477216,"threshold_uncertainty_score":0.99909824},"labels":[],"label_agreement":null},{"id":"W4307362938","doi":"10.1136/ijgc-2022-esgo.1011","title":"2022-LBA-1703-ESGO Survival outcomes in minimally invasive surgery versus abdominal surgery for cervical cancer-retrospective cohort from a high-volume Canadian center (2006–2017)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Laparotomy; Cervical cancer; Retrospective cohort study; Surgery; Adenocarcinoma; Adenosquamous carcinoma; Cohort; Cancer; Log-rank test; Survival analysis; Internal medicine","score_opus":0.04208907408910827,"score_gpt":0.3198543030401709,"score_spread":0.2777652289510626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307362938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96491545,0.0009545307,0.000015962032,0.016221818,0.012979007,0.0005419417,0.00400766,0.000015663985,0.00034793286],"genre_scores_gemma":[0.9936832,0.00078501663,0.00017433804,0.0025405127,0.0014812563,0.0005503298,0.00028064995,0.00003652347,0.0004681541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585634,0.00024312771,0.0011816331,0.0005257207,0.0015303371,0.0006628284],"domain_scores_gemma":[0.9932608,0.0043232823,0.00069443637,0.00017326075,0.0009817677,0.0005664788],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008940004,0.0003532746,0.0015217329,0.00081244117,0.0001544941,0.000058565543,0.0004957802,0.00017954949,0.01651843],"category_scores_gemma":[0.0025035674,0.00028741767,0.00081475184,0.00046059358,0.00011982003,0.00019620346,0.00016137112,0.00074574526,0.000012218822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015037624,0.00077841815,0.96655846,0.000013481417,0.0018638391,0.0016518093,0.000053551168,0.000105701736,0.000075582095,0.000034843764,0.00917747,0.004649194],"study_design_scores_gemma":[0.009014769,0.0008241158,0.97875434,0.00007457376,0.00028843232,0.000046582223,0.0001408778,0.000033943517,0.00007179824,0.00034110463,0.010127995,0.00028149525],"about_ca_topic_score_codex":0.09261624,"about_ca_topic_score_gemma":0.21527977,"teacher_disagreement_score":0.12266353,"about_ca_system_score_codex":0.0083105145,"about_ca_system_score_gemma":0.0031083147,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W4307450084","doi":"10.1136/ijgc-2022-esgo.1018","title":"2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Oncology; Internal medicine; Germline; Ovarian cancer; Medicine; Frameshift mutation; Germline mutation; Missense mutation; BRCA mutation; Cancer; Genetics; Cancer research; Biology; Mutation; Gene","score_opus":0.030882319487714607,"score_gpt":0.32630780080521254,"score_spread":0.29542548131749796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307450084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98905575,0.0009778411,0.00080885825,0.005951704,0.00096721906,0.0009438939,0.0010855615,0.00004566128,0.00016349295],"genre_scores_gemma":[0.992408,0.00040831266,0.00025696386,0.0050075757,0.0005875889,0.000907963,0.00014341575,0.000053936816,0.00022624832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952015,0.00053368806,0.0009932675,0.0006003209,0.0022284742,0.00044272168],"domain_scores_gemma":[0.99556226,0.000794936,0.0012830805,0.00043016425,0.0016311391,0.0002984045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067061436,0.00043242594,0.00089087966,0.00038821364,0.00033091943,0.00010094995,0.0008551419,0.00009630112,0.014483385],"category_scores_gemma":[0.00018795201,0.0002428776,0.00036302526,0.0012241596,0.0002652279,0.0003069473,0.00016363077,0.0009228247,0.0000072494436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019376265,0.004835766,0.93812835,0.000003710432,0.011201948,0.0012180718,0.0013843972,0.003508326,0.00045166747,0.000033613593,0.008781497,0.011076401],"study_design_scores_gemma":[0.04343637,0.0049140383,0.9245771,0.00012789134,0.0023452311,0.00003305292,0.0022447642,0.0004996625,0.00019675212,0.00009186626,0.02109688,0.00043638994],"about_ca_topic_score_codex":0.0011895585,"about_ca_topic_score_gemma":0.0015073632,"teacher_disagreement_score":0.024060108,"about_ca_system_score_codex":0.0021423835,"about_ca_system_score_gemma":0.0007333882,"threshold_uncertainty_score":0.9904261},"labels":[],"label_agreement":null},{"id":"W4307450117","doi":"10.1136/ijgc-2022-esgo.1019","title":"2022-LBA-414-ESGO Preliminary clinical outcome of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Medicine; Leukapheresis; Internal medicine; Oncology; CD8; Cancer; Population; Immunotherapy; Chemotherapy; Immunology; Antigen; Gastroenterology; Biology; Stem cell","score_opus":0.0713958216413929,"score_gpt":0.3759185532703714,"score_spread":0.30452273162897847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307450117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924234,0.0011861842,0.00004316825,0.0024875505,0.0024865537,0.0007631335,0.00015765279,0.000013973329,0.00043838302],"genre_scores_gemma":[0.99362147,0.0017836996,0.0008440756,0.0012701548,0.0006940468,0.0001790381,0.00005240103,0.00003944869,0.0015156677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955574,0.00050980266,0.0014641124,0.00040228278,0.0017044696,0.00036192843],"domain_scores_gemma":[0.99691534,0.0005064528,0.0010263956,0.00022156825,0.0011266207,0.00020363079],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011652937,0.000252846,0.0007665096,0.0003636597,0.00008342232,0.000028697741,0.00062718586,0.00017267436,0.022206932],"category_scores_gemma":[0.00029091703,0.00018461756,0.00032506837,0.00033050688,0.00017621074,0.00020706117,0.00020415855,0.0012930732,0.000005894316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032017324,0.0045422413,0.7517883,0.000025472526,0.00037277667,0.00022510167,0.0002615663,0.0036801663,0.058477845,0.00001770921,0.0017893054,0.14680216],"study_design_scores_gemma":[0.036976364,0.027309148,0.8977777,0.000106479936,0.00011527654,0.000049114282,0.0002427575,0.0010289856,0.00913057,0.000068710724,0.02675944,0.00043549124],"about_ca_topic_score_codex":0.00016915356,"about_ca_topic_score_gemma":0.000099919656,"teacher_disagreement_score":0.14636666,"about_ca_system_score_codex":0.0012064336,"about_ca_system_score_gemma":0.00081013126,"threshold_uncertainty_score":0.9786869},"labels":[],"label_agreement":null},{"id":"W4307509126","doi":"10.1136/ijgc-2022-004025","title":"The early history of the International Gynecologic Cancer Society (IGCS)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gynecologic cancer; Sadness; Cancer; General surgery; Gynecology; Family medicine; Ovarian cancer; Internal medicine; Psychiatry","score_opus":0.025515542893296196,"score_gpt":0.36187632882472665,"score_spread":0.33636078593143043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307509126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86723846,0.017126365,0.00018431174,0.064283974,0.045840915,0.00033036567,0.000059067657,0.000018170482,0.0049183583],"genre_scores_gemma":[0.968885,0.006462157,0.0004256348,0.0114891585,0.0014554784,0.00010066526,0.0000015842627,0.0000135052505,0.011166792],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980396,0.00013185223,0.0005523386,0.00014640254,0.0009535657,0.00017626051],"domain_scores_gemma":[0.9973823,0.0009262459,0.00087131717,0.00014099953,0.00062169705,0.000057464775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000680932,0.00011734228,0.00026668952,0.00004695978,0.00018834125,0.000010082619,0.0012093319,0.000087440756,0.0069110156],"category_scores_gemma":[0.00044237636,0.000060262148,0.00047185976,0.000097508724,0.00051147316,0.000088036366,0.00027007423,0.00082424894,0.0000015107762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028965771,0.0012774213,0.49859962,0.000014842211,0.0036366205,0.00022101274,0.0019070382,0.006496738,0.008907417,0.0041061193,0.36915687,0.10277975],"study_design_scores_gemma":[0.0015826422,0.00052235235,0.19750236,0.00001905451,0.00006776784,0.00016990636,0.00021349562,0.00021049705,0.00020991937,0.0010161025,0.7984115,0.00007442223],"about_ca_topic_score_codex":0.000038084432,"about_ca_topic_score_gemma":0.000042307358,"teacher_disagreement_score":0.42925462,"about_ca_system_score_codex":0.0044925977,"about_ca_system_score_gemma":0.0012052257,"threshold_uncertainty_score":0.999329},"labels":[],"label_agreement":null},{"id":"W4307580725","doi":"10.1136/ijgc-2022-004066","title":"Correspondence on “The increasing incidence of stage IV cervical cancer in the USA: what factors are related?” by Francoeur et al","year":2022,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cervical cancer; Incidence (geometry); Stage (stratigraphy); Cervical cancer screening; Gynecology; Cancer; Cancer incidence; Oncology; Obstetrics; Internal medicine","score_opus":0.06101509580864532,"score_gpt":0.3880919556532156,"score_spread":0.32707685984457024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307580725","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40773693,0.0029582311,0.0000051256557,0.58587474,0.0019947418,0.0003521614,0.00031781668,0.000005672908,0.0007546024],"genre_scores_gemma":[0.51955914,0.0062823165,0.0000066209773,0.47261128,0.00048598772,0.00008093674,0.00003147544,0.00002738298,0.00091486936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928282,0.0012539246,0.0011155418,0.0004228477,0.003930962,0.00044851797],"domain_scores_gemma":[0.9909969,0.00649964,0.001136047,0.0003115157,0.000935074,0.00012081179],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023391552,0.00035668752,0.00081822753,0.00033879298,0.00011174584,0.00015557391,0.0018306165,0.00042554236,0.09623312],"category_scores_gemma":[0.0024269552,0.00018949315,0.00043974115,0.00047511913,0.0003686043,0.00029539608,0.0003265084,0.0075034695,0.000012147927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042168903,0.0004276014,0.20690683,0.00009300561,0.00048266977,0.0038022923,0.0007799096,0.00056043844,0.0001618267,0.00010112526,0.77655804,0.00590937],"study_design_scores_gemma":[0.0011853394,0.00085077976,0.46634394,0.0004953501,0.00006634669,0.00013052036,0.0006463445,0.000094437266,0.0000616663,0.00014763053,0.52977663,0.00020101252],"about_ca_topic_score_codex":0.0022805927,"about_ca_topic_score_gemma":0.0013924864,"teacher_disagreement_score":0.25943708,"about_ca_system_score_codex":0.0016171554,"about_ca_system_score_gemma":0.00092137436,"threshold_uncertainty_score":0.99478626},"labels":[],"label_agreement":null},{"id":"W4308196586","doi":"10.1136/ijgc-2022-003836","title":"Inguinofemoral sentinel lymph node biopsy by scar injection in vulvar cancer: an assessment of feasibility and long-term outcomes","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Vulvar cancer; Sentinel lymph node; Groin; Biopsy; Sentinel node; Surgery; Lymph node; Proportional hazards model; Retrospective cohort study; Lymphadenectomy; Radiology; Cancer; Vulva; Breast cancer; Internal medicine","score_opus":0.05881593667747437,"score_gpt":0.41988305490514516,"score_spread":0.3610671182276708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308196586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587554,0.0012157395,0.000026848486,0.0014243008,0.0010528481,0.00016924037,0.0001212973,0.000008409304,0.000105749874],"genre_scores_gemma":[0.9982807,0.00046097513,0.00018247354,0.00074621383,0.00017062957,0.00004998197,0.000023074494,0.000009511189,0.00007642699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980179,0.00015046218,0.0006408845,0.00022794968,0.00079369365,0.00016911476],"domain_scores_gemma":[0.99877954,0.00016473017,0.0004728541,0.00009173338,0.00035149453,0.00013967168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044129713,0.000143433,0.0004901559,0.00023798199,0.00005207701,0.000019138588,0.00021023191,0.00006327284,0.0019389304],"category_scores_gemma":[0.00016435294,0.000105367806,0.00014075208,0.00024943444,0.00008041366,0.00013733692,0.00013833994,0.0003124005,2.450391e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097500766,0.0012627079,0.9872818,0.000023529063,0.00025450528,0.00016379551,0.00004584596,0.00038422068,0.001639175,0.000020514699,0.000041059313,0.007907865],"study_design_scores_gemma":[0.007031652,0.00053627876,0.9915388,0.000043005068,0.00009276029,0.0001292278,0.00007205299,0.00014204852,0.00016625682,0.00011504577,0.000040475374,0.00009240282],"about_ca_topic_score_codex":0.0006892594,"about_ca_topic_score_gemma":0.000079277954,"teacher_disagreement_score":0.007815462,"about_ca_system_score_codex":0.0017853188,"about_ca_system_score_gemma":0.00028879414,"threshold_uncertainty_score":0.9989734},"labels":[],"label_agreement":null},{"id":"W4308994718","doi":"10.1136/ijgc-2022-003866","title":"Endometrial cancer after endometrial ablation: a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Endometrial ablation; Gynecology; Stage (stratigraphy); Incidence (geometry); Cancer; Cochrane Library; Endometrium; Carcinoma; Ablation; Obstetrics; Internal medicine; Meta-analysis","score_opus":0.09734651202429966,"score_gpt":0.42063660377421985,"score_spread":0.3232900917499202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308994718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018102397,0.9847268,0.00001181664,0.0006783134,0.01056198,0.0028367583,0.00047713614,0.000028109052,0.0006610032],"genre_scores_gemma":[0.00014244375,0.988744,0.00009491721,0.0021300802,0.0047821663,0.0029826462,0.00008832888,0.0000659592,0.000969462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99213296,0.00074960105,0.0033879515,0.0005156255,0.0027901907,0.0004236812],"domain_scores_gemma":[0.9909768,0.0039977403,0.003354253,0.00033851326,0.00092653657,0.00040611989],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014637834,0.0006628949,0.0062084645,0.0014064835,0.00007722771,0.00008537159,0.0010097333,0.00032005218,0.059602015],"category_scores_gemma":[0.008708493,0.00039804727,0.0033355306,0.0018715373,0.00009316532,0.0001874952,0.0003025696,0.001381153,0.00006641536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021296171,0.0008159254,0.00010748088,0.3577354,0.010302033,0.0028192855,0.000017163324,0.0000028051327,2.591287e-7,0.000035461995,0.0024288776,0.62360567],"study_design_scores_gemma":[0.0044147545,0.0009543386,0.00003895249,0.2143558,0.014960492,0.00072890497,0.0000045880593,4.674273e-7,6.979132e-7,0.000032239313,0.7641998,0.00030897206],"about_ca_topic_score_codex":0.00005193728,"about_ca_topic_score_gemma":0.000012966851,"teacher_disagreement_score":0.7617709,"about_ca_system_score_codex":0.0041452106,"about_ca_system_score_gemma":0.0017559013,"threshold_uncertainty_score":0.9998471},"labels":[],"label_agreement":null},{"id":"W4312139173","doi":"10.1136/ijgc-2022-igcs.495","title":"EP406/#808 The efficacy of second curettage in the treatment of low-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Chemotherapy; Internal medicine; Curettage; Relative risk; Confounding; Oncology; Surgery; Confidence interval","score_opus":0.07808897522943682,"score_gpt":0.3878957923626345,"score_spread":0.3098068171331977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013161692,0.9949246,0.00001964505,0.0007751459,0.00014562333,0.0016880094,0.0010873296,0.0000023809125,0.000041101655],"genre_scores_gemma":[0.007827653,0.9908222,0.00009778231,0.00034523776,0.000065216016,0.0006100514,0.000050869137,0.00001574084,0.00016525897],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950835,0.0010779967,0.0020576543,0.00026316015,0.0013586876,0.00015899636],"domain_scores_gemma":[0.98108274,0.014715805,0.0032834602,0.00025210125,0.00059162476,0.00007429865],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008649328,0.00037334303,0.0049162046,0.00041411567,0.000058468646,0.000026618096,0.00050476403,0.000081444414,0.0044083735],"category_scores_gemma":[0.0034006513,0.00015313183,0.0028279088,0.00062650105,0.00024381244,0.00006322095,0.00006600643,0.00044296953,0.0000018446208],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050422363,0.00412061,0.0006068139,0.29254502,0.6900727,0.0011312591,0.00105385,0.0010350322,5.4737205e-7,0.00069226767,0.0009803055,0.0072573517],"study_design_scores_gemma":[0.0012435664,0.0013037191,0.009881253,0.008984886,0.9453499,0.0002801791,0.00019431023,0.000016055672,1.7903857e-7,0.00008321909,0.032476425,0.00018632879],"about_ca_topic_score_codex":0.000020930347,"about_ca_topic_score_gemma":0.0000682404,"teacher_disagreement_score":0.28356013,"about_ca_system_score_codex":0.0004479956,"about_ca_system_score_gemma":0.0005434572,"threshold_uncertainty_score":0.99650174},"labels":[],"label_agreement":null},{"id":"W4312139189","doi":"10.1136/ijgc-2022-igcs.482","title":"EP393/#809 Validation of a frailty index in gynaecologic oncology","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Frailty Index; Malignancy; Psychological intervention; Population; Emergency medicine; Disease; Internal medicine; Surgery","score_opus":0.04997616358399587,"score_gpt":0.3797183913186457,"score_spread":0.32974222773464984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815646,0.00027768133,0.00015097631,0.011208761,0.0023065512,0.00022220192,0.000034875826,0.000010531345,0.004223813],"genre_scores_gemma":[0.9968743,0.00016809803,0.0005420405,0.0017153204,0.0002257025,0.000055795597,0.000011383283,0.000009670801,0.00039770993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763644,0.0002185445,0.0008803452,0.00017206767,0.00089927815,0.00019334296],"domain_scores_gemma":[0.9977097,0.00070063776,0.00075942,0.0001013082,0.0006339042,0.00009502135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007712033,0.00011953083,0.00047192743,0.00041177156,0.000034773875,0.000008403778,0.00045430826,0.00012622464,0.0156227015],"category_scores_gemma":[0.0013988034,0.000097208846,0.0001900437,0.00026524067,0.00012271895,0.00011531363,0.00021413623,0.0007701109,0.0000054746447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035014201,0.0037753386,0.8345918,0.000035576722,0.00053896144,0.0027962297,0.0009609794,0.021133892,0.0054598055,0.00062689977,0.008849931,0.117729165],"study_design_scores_gemma":[0.0066034785,0.003545987,0.94406724,0.000051511168,0.00006209059,0.0007526641,0.00052460656,0.00056814845,0.0018691248,0.002349211,0.039461493,0.00014442923],"about_ca_topic_score_codex":0.000096667885,"about_ca_topic_score_gemma":0.0000978197,"teacher_disagreement_score":0.117584735,"about_ca_system_score_codex":0.0020293787,"about_ca_system_score_gemma":0.0006613909,"threshold_uncertainty_score":0.9852772},"labels":[],"label_agreement":null},{"id":"W4312139195","doi":"10.1136/ijgc-2022-igcs.479","title":"EP390/#568 Apixaban for postoperative thromboprophylaxis as standard of care for gynecologic oncology patients: a real-world data study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Gynecologic oncology; Apixaban; Cohort; Thrombosis; Venous thrombosis; Internal medicine; Emergency medicine; Rivaroxaban; Atrial fibrillation; Warfarin","score_opus":0.05785531463027614,"score_gpt":0.4213188877240995,"score_spread":0.3634635730938233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866219,0.00031900147,0.000121063604,0.005116662,0.002289038,0.0027938215,0.0015862386,0.000013371087,0.001138876],"genre_scores_gemma":[0.9948641,0.00032628613,0.0015731904,0.0019350251,0.00029674955,0.00060257124,0.00021117332,0.000022300215,0.00016861156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746114,0.00016414592,0.0008789401,0.0003757162,0.0008626224,0.00025744064],"domain_scores_gemma":[0.9953569,0.0009188816,0.0009470557,0.0002669455,0.0023978285,0.00011235935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082481554,0.00018818823,0.0010464042,0.00028144178,0.00018561709,0.000024766456,0.00087381655,0.000051496027,0.0018240149],"category_scores_gemma":[0.0011902029,0.00013984709,0.00025024518,0.00017926971,0.000117693184,0.00013818733,0.00060604594,0.0002935405,0.0000012978259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043881334,0.03508073,0.45040172,0.00037459447,0.010074376,0.00066650944,0.010886528,0.0029485533,0.00059596635,0.008679326,0.09514512,0.34126523],"study_design_scores_gemma":[0.016675346,0.15306011,0.5532833,0.00006471031,0.0009468082,0.000017746035,0.014169178,0.00008194961,0.00031381738,0.0013810674,0.25969478,0.00031119707],"about_ca_topic_score_codex":0.00026857428,"about_ca_topic_score_gemma":0.0023159997,"teacher_disagreement_score":0.34095404,"about_ca_system_score_codex":0.001847722,"about_ca_system_score_gemma":0.0007029381,"threshold_uncertainty_score":0.99908847},"labels":[],"label_agreement":null},{"id":"W4312139225","doi":"10.1136/ijgc-2022-igcs.582","title":"SF022/#737 Hudson posterior exenteration, with the use of ICG fluorescence to assess colorectal anastomosis and ureteral integrity","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ureteral procedures and complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Anastomosis; Surgery; Dissection (medical); Ureterolysis; Colorectal surgery; Rectum; Abdominal surgery; Urinary system; Anatomy","score_opus":0.09178944750220515,"score_gpt":0.34037531607729243,"score_spread":0.2485858685750873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745674,0.00009535882,0.0004978303,0.02425636,0.00026060347,0.00022413903,0.000059856047,0.0000061943206,0.00003226901],"genre_scores_gemma":[0.9941611,0.000025977648,0.002189314,0.003319096,0.0001318501,0.000060344682,0.0000063736497,0.0000069820235,0.0000989625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879915,0.00008064693,0.00032431947,0.0001429662,0.0005410639,0.00011188627],"domain_scores_gemma":[0.998618,0.0002056154,0.00027313404,0.00008262083,0.00072087575,0.0000997564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001760398,0.000098647935,0.00021201333,0.0000943058,0.000112129266,0.000058948648,0.0002698787,0.000031170955,0.00061012805],"category_scores_gemma":[0.00016477608,0.00005713559,0.00007893975,0.00013503566,0.000093539165,0.00014436422,0.00016059053,0.00040303657,5.456635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015020133,0.001828418,0.77106494,0.0000697722,0.0013126635,0.00035560815,0.0034392038,0.00430175,0.12414748,0.0018269706,0.02659283,0.050040223],"study_design_scores_gemma":[0.001402854,0.0044530123,0.9726865,0.00009504049,0.00013588715,0.0013504913,0.00037556404,0.001202599,0.002407791,0.00009706337,0.015642632,0.00015052424],"about_ca_topic_score_codex":0.000066841276,"about_ca_topic_score_gemma":0.00009027187,"teacher_disagreement_score":0.20162159,"about_ca_system_score_codex":0.00019705723,"about_ca_system_score_gemma":0.00015743265,"threshold_uncertainty_score":0.6680474},"labels":[],"label_agreement":null},{"id":"W4312139226","doi":"10.1136/ijgc-2022-igcs.530","title":"TP021/#1521 FLORA-5/GOG3035: chemo-immunotherapy (paclitaxel and carboplatin ± oregovomab) as front-line treatment for patients with ovarian cancer. A phase III double blind placebo controlled, global multicenter study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Carboplatin; Medicine; Internal medicine; Cohort; Chemotherapy; Oncology; Ovarian cancer; Paclitaxel; Gastroenterology; Cancer; Surgery; Urology; Cisplatin","score_opus":0.046282078756144686,"score_gpt":0.40440084489158007,"score_spread":0.35811876613543536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98938704,0.0015531452,0.00006779723,0.0046533793,0.00081665703,0.0026223673,0.0005446285,0.000011437146,0.00034354196],"genre_scores_gemma":[0.99477273,0.00043664686,0.00039725786,0.0008776175,0.00057037896,0.0009410571,0.0000637873,0.000021291546,0.0019192086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972996,0.000115913375,0.0007178936,0.00034183013,0.0011713835,0.00035334483],"domain_scores_gemma":[0.9978132,0.00036873558,0.00050623337,0.00012164272,0.0009368412,0.00025331575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037931761,0.00029315162,0.00081189687,0.00012878794,0.00023034782,0.000069914604,0.00029494622,0.0000695004,0.0040893573],"category_scores_gemma":[0.00009973463,0.00017791234,0.00025085232,0.00010861962,0.000117795586,0.00011893454,0.0001222555,0.00032539957,0.0000023943528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7282617,0.009609684,0.22189568,0.00001561483,0.004514334,0.00043984415,0.0007153676,0.00040773235,0.0002445343,0.000082106984,0.00060849503,0.033204902],"study_design_scores_gemma":[0.8369016,0.044052556,0.084474094,0.00009409226,0.00065895123,0.00013076114,0.00097073114,0.001868098,0.00022163102,0.00014112116,0.030089725,0.00039663262],"about_ca_topic_score_codex":0.0016272959,"about_ca_topic_score_gemma":0.00073831505,"teacher_disagreement_score":0.13742158,"about_ca_system_score_codex":0.0013991497,"about_ca_system_score_gemma":0.0005540643,"threshold_uncertainty_score":0.99682105},"labels":[],"label_agreement":null},{"id":"W4312139245","doi":"10.1136/ijgc-2022-igcs.525","title":"TP016/#1442 Keynote-C93/GOG-3064/ENGOT-EN15: phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Pembrolizumab; Medicine; Endometrial cancer; Chemotherapy; Internal medicine; Oncology; Paclitaxel; Clinical endpoint; Randomization; Cancer; Randomized controlled trial; Cisplatin; Immunotherapy","score_opus":0.10652013931723535,"score_gpt":0.41839107092867556,"score_spread":0.3118709316114402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881115,0.0023903828,0.000040954277,0.0018248528,0.0042394316,0.0025575405,0.0001636524,0.000023603397,0.0006480608],"genre_scores_gemma":[0.99624956,0.001278804,0.0005070178,0.0004519866,0.0005320196,0.0006512676,0.000033762,0.000033449218,0.00026214882],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946356,0.00050639757,0.002038432,0.00051904836,0.0018898317,0.00041071497],"domain_scores_gemma":[0.9943035,0.0029811992,0.001381186,0.00027394472,0.0008022351,0.00025792114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016387197,0.0003726839,0.0018439079,0.0007166867,0.00013857422,0.00004837328,0.0009598875,0.00011082583,0.0076484927],"category_scores_gemma":[0.0028521717,0.0002499863,0.0004510618,0.0010807125,0.00011739011,0.00020204247,0.0004719035,0.0008014519,0.0000037209409],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91783726,0.025989877,0.0066870507,0.00003332668,0.0014701446,0.0011931784,0.000746927,0.0012571178,0.00014675448,0.000054606153,0.00044186082,0.04414189],"study_design_scores_gemma":[0.9509543,0.035488673,0.00353194,0.000112231675,0.00043204238,0.00012159706,0.0009645811,0.00079908525,0.00041874265,0.00012363093,0.0067803157,0.00027285874],"about_ca_topic_score_codex":0.00061554526,"about_ca_topic_score_gemma":0.0005203815,"teacher_disagreement_score":0.04386903,"about_ca_system_score_codex":0.0022705386,"about_ca_system_score_gemma":0.0005679972,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W4312139260","doi":"10.1136/ijgc-2022-igcs.507","title":"EP418/#181 Outcomes of positive groin sentinel lymph node biopsies in vulvar squamous cell carcinoma and HPV status: a population based study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Groin; Radiation therapy; Sentinel lymph node; Population; Sentinel node; Surgery; Adjuvant therapy; Radiology; Retrospective cohort study; Oncology; Internal medicine; Cancer; Chemotherapy; Breast cancer","score_opus":0.028019879002781266,"score_gpt":0.3474666582949818,"score_spread":0.31944677929220056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655646,0.0005354194,0.00001589671,0.0016857791,0.00027367182,0.0002573026,0.00008883318,0.0000051863376,0.0005814334],"genre_scores_gemma":[0.9989617,0.000028466144,0.000090482456,0.00068535516,0.00009142528,0.000035781995,0.00001800585,0.000011181038,0.00007763148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978425,0.00019508041,0.0006041218,0.00019489735,0.00094504736,0.0002183469],"domain_scores_gemma":[0.99840194,0.00054366636,0.00030165317,0.00008231661,0.0005390406,0.00013136848],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047326917,0.00012859763,0.0004350712,0.0003812706,0.0000556708,0.000020587822,0.0001944503,0.000046719648,0.00525229],"category_scores_gemma":[0.00037231925,0.000097971264,0.00012591378,0.00021335176,0.00004985846,0.00008367094,0.00017623235,0.00037706774,7.681131e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001947896,0.0014323568,0.99180526,0.000028070226,0.00006552054,0.00039435452,0.0003481211,0.0008098275,0.00035919657,0.000021534886,0.000036247115,0.0027516065],"study_design_scores_gemma":[0.007196748,0.000863256,0.98975223,0.000006829901,0.00005951029,0.00003460019,0.0009630017,0.00073326245,0.00016555112,0.00010008111,0.000034553723,0.00009036137],"about_ca_topic_score_codex":0.0016962715,"about_ca_topic_score_gemma":0.00019132528,"teacher_disagreement_score":0.005251522,"about_ca_system_score_codex":0.0008973319,"about_ca_system_score_gemma":0.00027440238,"threshold_uncertainty_score":0.995657},"labels":[],"label_agreement":null},{"id":"W4312139266","doi":"10.1136/ijgc-2022-igcs.510","title":"TP001/#1553 GOG-3043 (NCT04831580): a randomized non-inferiority trial of robotic versus open radical hysterectomy for early stage cervical cancer (ROCC)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Cervical cancer; Radical Hysterectomy; Randomized controlled trial; Perioperative; Stage (stratigraphy); Cervix; Laparoscopy; Surgery; Cancer; Interim analysis; Internal medicine","score_opus":0.07357854072544867,"score_gpt":0.40518634524170083,"score_spread":0.33160780451625216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97597593,0.0010488766,0.0008047329,0.005854577,0.010516744,0.0034830628,0.00040471664,0.000020732992,0.0018906423],"genre_scores_gemma":[0.9935854,0.00052105665,0.0009618332,0.0010381782,0.001555254,0.0013222906,0.00002865987,0.00003154116,0.00095579535],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957692,0.00038759108,0.0015071401,0.00039591588,0.0015383188,0.00040185434],"domain_scores_gemma":[0.9946762,0.0027336525,0.0011179919,0.0001969661,0.0009208732,0.0003543656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014586303,0.00030453815,0.001875395,0.00027903912,0.00014245666,0.00007984362,0.0010957867,0.00016344662,0.013607103],"category_scores_gemma":[0.0017399428,0.00021283411,0.0010289786,0.0003596261,0.00024008017,0.00021487789,0.00052363804,0.0006965851,0.000004339267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97557586,0.0020058476,0.0069982708,0.00005188981,0.0027210824,0.00022571134,0.00013840101,0.0006213448,0.0002574888,0.0006945264,0.00080222206,0.009907361],"study_design_scores_gemma":[0.95241535,0.010737141,0.0149665,0.00011801226,0.0010751636,0.00004060529,0.000105093095,0.00039099524,0.0005295913,0.00069985894,0.018640224,0.00028148913],"about_ca_topic_score_codex":0.0014176168,"about_ca_topic_score_gemma":0.00017319393,"teacher_disagreement_score":0.023160527,"about_ca_system_score_codex":0.0016519586,"about_ca_system_score_gemma":0.0011711451,"threshold_uncertainty_score":0.9872946},"labels":[],"label_agreement":null},{"id":"W4312139269","doi":"10.1136/ijgc-2022-igcs.480","title":"EP391/#571 Utilization of indocyanine green fluorescence angiography for anastomotic perfusion assessment following bowel resection for gynecologic malignancies: a pan-Canadian survey","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Impact; Juravinski Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Indocyanine green; Medicine; Anastomosis; Perfusion; Bowel resection; Modalities; Radiology; General surgery; Medical physics; Surgery","score_opus":0.06616787558676558,"score_gpt":0.37164104915184226,"score_spread":0.3054731735650767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921251,0.000791544,0.00123602,0.0015252855,0.002388398,0.0012326966,0.0005063033,0.0000151272025,0.000179544],"genre_scores_gemma":[0.9967438,0.00017644263,0.0017010578,0.00042755847,0.0001975206,0.00043606758,0.00015147353,0.000022133274,0.00014395465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745953,0.00021540262,0.00078686187,0.00031203503,0.0008788506,0.00034732005],"domain_scores_gemma":[0.9964892,0.0011661119,0.00064020354,0.0001221182,0.0013659549,0.0002163893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013868157,0.0001980165,0.0005299765,0.0006209324,0.00022215952,0.000026569025,0.00036803287,0.00011545555,0.0010723098],"category_scores_gemma":[0.0011434071,0.00016190806,0.0007801691,0.0005317781,0.00006997271,0.0001503469,0.000105867795,0.0002701381,5.214987e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078948615,0.0011210433,0.9383029,0.000073628464,0.001251608,0.00025209063,0.000177932,0.0011005332,0.0033740597,0.0002076726,0.001605501,0.044638168],"study_design_scores_gemma":[0.005005579,0.008766631,0.97835267,0.000095173586,0.00025353188,0.00006719879,0.00016387973,0.0019418265,0.0006054459,0.0005078628,0.004072914,0.00016731862],"about_ca_topic_score_codex":0.00437909,"about_ca_topic_score_gemma":0.014260641,"teacher_disagreement_score":0.04447085,"about_ca_system_score_codex":0.00242981,"about_ca_system_score_gemma":0.0010008602,"threshold_uncertainty_score":0.99984086},"labels":[],"label_agreement":null},{"id":"W4312139301","doi":"10.1136/ijgc-2022-igcs.514","title":"TP005/#272 Contessa/neocon-F trial: neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Clinical trial; Trachelectomy; Oncology; Lymph node; Chemotherapy; Cancer; Surgery; Gynecology; Internal medicine","score_opus":0.05198478110866677,"score_gpt":0.3538379198385505,"score_spread":0.30185313872988373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97184753,0.005400494,0.00003585957,0.01668953,0.0044403477,0.00060091034,0.00025306724,0.00002828289,0.00070398784],"genre_scores_gemma":[0.98866487,0.0016336147,0.00005437293,0.0070878365,0.0006846493,0.0003765006,0.00003702998,0.00003158954,0.0014295356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962218,0.0002614982,0.0012562881,0.000395975,0.0014162945,0.00044816005],"domain_scores_gemma":[0.99723375,0.0012386356,0.0006846888,0.00016736078,0.00037993985,0.0002956323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009571956,0.00028699555,0.001037394,0.00034862553,0.000100582256,0.000051933028,0.000486656,0.00018524918,0.025627468],"category_scores_gemma":[0.0006587582,0.000216239,0.0005577163,0.00044772367,0.00009248646,0.00017961353,0.0001765127,0.0010824244,0.0000071975132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.206489,0.0054681445,0.6517441,0.00006846008,0.0019315168,0.0021232972,0.0002936306,0.00092883303,0.0031919167,0.00008223063,0.03996729,0.08771158],"study_design_scores_gemma":[0.17792402,0.0045050313,0.5436031,0.00033660125,0.0002931947,0.00012059024,0.00039110304,0.00039240278,0.0035427667,0.0005745967,0.26757696,0.00073960616],"about_ca_topic_score_codex":0.0014170298,"about_ca_topic_score_gemma":0.00038748008,"teacher_disagreement_score":0.22760966,"about_ca_system_score_codex":0.0026053232,"about_ca_system_score_gemma":0.0006763743,"threshold_uncertainty_score":0.97526324},"labels":[],"label_agreement":null},{"id":"W4312139306","doi":"10.1136/ijgc-2022-igcs.534","title":"TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Clinical endpoint; Internal medicine; Oncology; Tolerability; Carboplatin; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Gastroenterology; Clinical trial; Immunotherapy; Cisplatin; Adverse effect","score_opus":0.02582260374654257,"score_gpt":0.33403609801599854,"score_spread":0.308213494269456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494106,0.00022828917,0.000011254805,0.0018013859,0.0015809587,0.0008198372,0.00042900254,0.000009198595,0.00017904666],"genre_scores_gemma":[0.99792707,0.00017818558,0.00027677172,0.0007981924,0.0003439362,0.0002713861,0.00003596513,0.000028982551,0.00013950057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996983,0.00013517197,0.000886465,0.0003416521,0.001367302,0.00028644069],"domain_scores_gemma":[0.9981813,0.00026772302,0.0006836503,0.00017464411,0.00053428364,0.00015844352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021371536,0.00025856597,0.0006904748,0.0002164207,0.000081629354,0.000030533272,0.0003625096,0.000070002825,0.006194993],"category_scores_gemma":[0.000089913745,0.00017247774,0.00013523489,0.0002162877,0.00008237497,0.00013724617,0.00012240476,0.00047844514,0.0000010990334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29313055,0.02061616,0.64669794,0.00004197189,0.002446391,0.001931976,0.0014411347,0.003678844,0.00034289339,0.000032315864,0.0007105944,0.02892926],"study_design_scores_gemma":[0.14383453,0.017514229,0.83287865,0.00013282611,0.00024210833,0.000017380811,0.0004584396,0.00016619112,0.00015514258,0.0000059306867,0.004414982,0.0001795594],"about_ca_topic_score_codex":0.00082459766,"about_ca_topic_score_gemma":0.0011531652,"teacher_disagreement_score":0.18618074,"about_ca_system_score_codex":0.0032980002,"about_ca_system_score_gemma":0.000982088,"threshold_uncertainty_score":0.9947135},"labels":[],"label_agreement":null},{"id":"W4312139307","doi":"10.1136/ijgc-2022-igcs.465","title":"EP376/#727 The effect of transversus abdominis plane block on postoperative opioid use in gynecologic oncology patients undergoing laparotomy with enhanced recovery after surgery (ERAS)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Laparotomy; Opioid; Gynecologic oncology; Anesthesia; Retrospective cohort study; Visual analogue scale; Morphine; Surgery; Internal medicine","score_opus":0.015103531742996605,"score_gpt":0.27812180921187646,"score_spread":0.26301827746887985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526244,0.00007526103,0.000020409692,0.0030847644,0.0005439787,0.000638991,0.000014745469,0.0000061167275,0.0003533146],"genre_scores_gemma":[0.9942254,0.00021790162,0.0000680068,0.004994335,0.000082376624,0.00024207188,0.000011208696,0.000012146307,0.00014656656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976139,0.00068905053,0.00058312627,0.00020283805,0.00069852563,0.00021253421],"domain_scores_gemma":[0.99215025,0.0069760517,0.00048171758,0.00010470246,0.00022044002,0.00006684505],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009132304,0.00018216496,0.00057164166,0.00024315204,0.0000658631,0.000017930237,0.00024834072,0.00008097938,0.0015866406],"category_scores_gemma":[0.0005785337,0.00010130175,0.00020350593,0.00016507962,0.00010800227,0.00010233008,0.00005198904,0.0005334231,0.0000032731941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052128967,0.00088225154,0.9243215,0.000033847475,0.0006407469,0.0017624777,0.00040262137,0.008890167,0.00015639795,0.00003378716,0.0013398167,0.009407458],"study_design_scores_gemma":[0.007117594,0.023360299,0.9568751,0.000169348,0.00014428214,0.00008876715,0.00025622532,0.00003228909,0.0009558962,0.00003370479,0.010809459,0.00015706032],"about_ca_topic_score_codex":0.00003930489,"about_ca_topic_score_gemma":0.00024665744,"teacher_disagreement_score":0.045011375,"about_ca_system_score_codex":0.00092355156,"about_ca_system_score_gemma":0.0002871658,"threshold_uncertainty_score":0.99932605},"labels":[],"label_agreement":null},{"id":"W4312139324","doi":"10.1136/ijgc-2022-igcs.473","title":"EP384/#926 Cost-analysis of an enhanced recovery program after minimally invasive gynecologic oncology surgery","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Perioperative; Gynecologic oncology; Emergency medicine; Cost effectiveness; Emergency department; Hysterectomy; Surgery; Cost analysis; Cohort; Retrospective cohort study; General surgery; Internal medicine; Nursing","score_opus":0.03341307314532476,"score_gpt":0.3552597118375247,"score_spread":0.3218466386921999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930275,0.0005741307,0.00018605504,0.0016503234,0.0029189175,0.0005227998,0.00018013996,0.000037289137,0.0009028426],"genre_scores_gemma":[0.99228346,0.00085338036,0.0017456448,0.003466412,0.00039116404,0.00071571016,0.0000831175,0.000026633095,0.00043445622],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9955351,0.0005948219,0.0016968681,0.00044963058,0.0012926026,0.00043099152],"domain_scores_gemma":[0.9920154,0.004048924,0.0018372936,0.0002737896,0.001529855,0.0002947052],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015935386,0.00028659703,0.0015722726,0.0013576216,0.00007588727,0.000034053326,0.00058593444,0.00022675462,0.016987806],"category_scores_gemma":[0.0025646526,0.00023317833,0.0013713974,0.0009808458,0.00021524949,0.0003645568,0.0002994238,0.0008362449,0.000007508809],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03444498,0.01280463,0.35908413,0.00010583731,0.024535296,0.011352215,0.00080388016,0.016921023,0.024748024,0.0000469763,0.0050668633,0.5100862],"study_design_scores_gemma":[0.0030464868,0.011712203,0.9328286,0.0001362401,0.003950009,0.00063044153,0.00067568664,0.00045035742,0.016885204,0.00070181536,0.028329104,0.0006538762],"about_ca_topic_score_codex":0.0000405422,"about_ca_topic_score_gemma":0.0003833392,"teacher_disagreement_score":0.5737445,"about_ca_system_score_codex":0.0019920552,"about_ca_system_score_gemma":0.0017613946,"threshold_uncertainty_score":0.9839108},"labels":[],"label_agreement":null},{"id":"W4312139331","doi":"10.1136/ijgc-2022-igcs.552","title":"TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vulvar cancer; Sentinel node; Sentinel lymph node; Groin; Clinical endpoint; Surgery; Stage (stratigraphy); Lymph node; Lymphadenectomy; Radiation therapy; Vulvar Carcinoma; Cancer; Primary tumor; Cosmesis; Radiology; Breast cancer; Vulva; Metastasis; Internal medicine; Randomized controlled trial","score_opus":0.01788006768954299,"score_gpt":0.32008649775098547,"score_spread":0.3022064300614425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952829,0.00024978525,0.000018445067,0.001965085,0.001258698,0.0009101771,0.00024498472,0.000010650258,0.000059288832],"genre_scores_gemma":[0.99794227,0.0003270775,0.00007415209,0.0007298384,0.0003466565,0.00042051848,0.00007339889,0.00002937997,0.00005670358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963804,0.00022867377,0.0010915746,0.0004852843,0.0014843009,0.0003297888],"domain_scores_gemma":[0.99800694,0.00029254972,0.0009540871,0.00014116568,0.00048019504,0.00012508668],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005687923,0.0003283483,0.00086226553,0.0009719319,0.000068884205,0.000037906222,0.00027020558,0.00009851679,0.0012121227],"category_scores_gemma":[0.00025244427,0.00025897732,0.00012254487,0.000786666,0.00008912876,0.0003290039,0.00021803993,0.0005212234,8.5206545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1401506,0.010630367,0.8319166,0.000025673651,0.00057636644,0.00042486796,0.00051833974,0.0032545421,0.00071045134,0.000011962058,0.000021209558,0.01175901],"study_design_scores_gemma":[0.18417001,0.0016102039,0.8125514,0.00018971015,0.00016297055,0.000016083488,0.0001389051,0.0005974868,0.0002907658,0.00004348509,0.000031085383,0.00019793444],"about_ca_topic_score_codex":0.004111156,"about_ca_topic_score_gemma":0.0005313487,"teacher_disagreement_score":0.044019386,"about_ca_system_score_codex":0.0024527598,"about_ca_system_score_gemma":0.00036605418,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W4312139354","doi":"10.1136/ijgc-2022-igcs.475","title":"EP386/#184 Mobile app post-operative home monitoring after gynecologic oncology and breast reconstruction surgery associated with improved quality of recovery: results of a randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Gynecologic oncology; Randomized controlled trial; Patient satisfaction; Adverse effect; Quality of life (healthcare); Clinical trial; Oncoplastic Surgery; Smartphone app; Breast cancer; Breast surgery; Surgery; Internal medicine; Cancer; Nursing","score_opus":0.045090474075622354,"score_gpt":0.38581956492227387,"score_spread":0.34072909084665154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178547,0.000824833,0.000030342704,0.0010417381,0.005034364,0.00067808153,0.00045944587,0.000011537627,0.00013417045],"genre_scores_gemma":[0.99771184,0.0010013994,0.00014407444,0.00021863641,0.00051256537,0.00028441,0.00002403035,0.0000120212735,0.000091010246],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946429,0.0019360132,0.002238972,0.00028339922,0.00070928223,0.00018941233],"domain_scores_gemma":[0.9859992,0.009001464,0.0027067885,0.00011432029,0.0020453788,0.00013283115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067448798,0.00017824028,0.0018022779,0.00023310607,0.000054194043,0.000016189071,0.00017430096,0.00020343791,0.0009022913],"category_scores_gemma":[0.005736103,0.000121625555,0.0006278875,0.00019659293,0.00042110714,0.00014625328,0.00012506837,0.0006956733,2.95249e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8495812,0.00095049804,0.06276011,0.000017449192,0.0016622507,0.00010542495,0.00036644208,0.0000855841,0.00056530884,0.000007819028,0.00005148532,0.083846435],"study_design_scores_gemma":[0.5123217,0.013711584,0.46822724,0.00031819005,0.0007034339,0.0005512016,0.0026023577,0.00009366841,0.0003971356,0.00027486548,0.00046755958,0.00033106594],"about_ca_topic_score_codex":0.00041191862,"about_ca_topic_score_gemma":0.00052995246,"teacher_disagreement_score":0.40546712,"about_ca_system_score_codex":0.00084131135,"about_ca_system_score_gemma":0.0010396218,"threshold_uncertainty_score":0.9879457},"labels":[],"label_agreement":null},{"id":"W4312139355","doi":"10.1136/ijgc-2022-igcs.463","title":"EP374/#164 A double-blind randomized trial comparing surgeon-administered transversus abdominis plane (TAP) block with placebo after midline laparotomy in gynecologic oncology","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Placebo; Anesthesia; Bupivacaine; Surgery; Nausea; Postoperative nausea and vomiting; Randomized controlled trial; Laparotomy; Vomiting; Ileus","score_opus":0.05695764832027593,"score_gpt":0.3491827728390451,"score_spread":0.29222512451876914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854614,0.0003117366,0.00005499571,0.008085359,0.0010704969,0.002685669,0.0000081893695,0.00002128265,0.002300842],"genre_scores_gemma":[0.99339193,0.00018223996,0.0005041508,0.0028485544,0.00045773608,0.001977438,0.000022139639,0.00002119532,0.0005946001],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99627715,0.00069577404,0.0012856708,0.000336936,0.0010224953,0.00038197343],"domain_scores_gemma":[0.99637455,0.0021932097,0.0008077227,0.00014318086,0.00028307998,0.0001982408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025479784,0.00028621213,0.0014740553,0.00046429277,0.00008348586,0.000041101102,0.00047029104,0.00015160088,0.006407285],"category_scores_gemma":[0.00022774395,0.00019711029,0.00040656445,0.00023337896,0.00022699153,0.000093056224,0.00010499422,0.000877835,0.000008040717],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9484515,0.0017355965,0.034298275,0.000020300178,0.0008428274,0.009803642,0.00032019935,0.0028765718,0.00001796564,0.00014957368,0.00061375723,0.0008697811],"study_design_scores_gemma":[0.9263042,0.005577148,0.019922452,0.000060783797,0.00045329198,0.0008875278,0.00039287301,0.00052729505,0.000026703603,0.000057116456,0.045547113,0.00024345379],"about_ca_topic_score_codex":0.000092607355,"about_ca_topic_score_gemma":0.00040494028,"teacher_disagreement_score":0.044933356,"about_ca_system_score_codex":0.0010507548,"about_ca_system_score_gemma":0.00055665005,"threshold_uncertainty_score":0.994501},"labels":[],"label_agreement":null},{"id":"W4312139357","doi":"10.1136/ijgc-2022-igcs.508","title":"EP419/#488 Groin node management in surgically unresectable, locally advanced vulva cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; University of Toronto","funders":"","keywords":"Groin; Medicine; Vulva; Radiation therapy; Surgery; Retrospective cohort study; Lymph node; Internal medicine","score_opus":0.02558568463868266,"score_gpt":0.3473633704325114,"score_spread":0.32177768579382876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661587,0.0069697364,0.0002115536,0.013847152,0.0035879984,0.0005620959,0.00010388877,0.000029313767,0.008529567],"genre_scores_gemma":[0.9877211,0.004698737,0.0009860343,0.004359465,0.00043900838,0.0003080449,0.00001466037,0.000021875108,0.0014510832],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968651,0.00014266529,0.00082926935,0.00031516072,0.0014703958,0.0003774255],"domain_scores_gemma":[0.99849474,0.00032136263,0.0003999146,0.00013061607,0.00043087744,0.00022246437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005056271,0.00021222941,0.00055746606,0.0004337726,0.000096651886,0.000039272443,0.00054614805,0.000072843606,0.019180767],"category_scores_gemma":[0.00018001319,0.000158879,0.00027327953,0.00061081315,0.00007959251,0.0001485053,0.0003123776,0.0006680277,0.000009250667],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03766882,0.006089198,0.30708563,0.00013014767,0.0037034666,0.022986645,0.0003007722,0.054900583,0.0020177842,0.003260189,0.007798307,0.55405843],"study_design_scores_gemma":[0.045736413,0.0040255245,0.6764601,0.0004134756,0.00041107234,0.00083134655,0.0005047396,0.0007620226,0.00074037537,0.0025829913,0.26690263,0.0006293169],"about_ca_topic_score_codex":0.0003542335,"about_ca_topic_score_gemma":0.00024429246,"teacher_disagreement_score":0.5534291,"about_ca_system_score_codex":0.0024677727,"about_ca_system_score_gemma":0.00038248487,"threshold_uncertainty_score":0.98171586},"labels":[],"label_agreement":null},{"id":"W4312139360","doi":"10.1136/ijgc-2022-igcs.469","title":"EP380/#421 Perioperative glycemic management program (PGMP) pilot in a Canadian tertiary centre","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Glycemic; Perioperative; Diabetes mellitus; Cohort; Emergency medicine; Internal medicine; Surgery; Insulin","score_opus":0.015278190000716868,"score_gpt":0.32634797696376916,"score_spread":0.3110697869630523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746216,0.0005761932,0.0000066053926,0.014945216,0.0015019665,0.0005029828,0.000056207544,0.000014204549,0.0077750348],"genre_scores_gemma":[0.99335605,0.00024191139,0.00038385327,0.004807347,0.00020933013,0.0001419163,0.000021619024,0.000011451868,0.00082650833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981622,0.00008224523,0.00053179584,0.000202516,0.000642163,0.00037906153],"domain_scores_gemma":[0.9990318,0.00007945956,0.00012582446,0.00008458572,0.00034705864,0.00033129484],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021746113,0.00014440641,0.0003077502,0.00030489275,0.00009620553,0.000034275843,0.00032923702,0.00005121904,0.006792045],"category_scores_gemma":[0.00012622547,0.00011355612,0.00014889044,0.00015640324,0.000068530986,0.00008795619,0.00011655192,0.00055183965,0.00000968016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013532092,0.0039813444,0.78814346,0.000051165945,0.0011145486,0.017113123,0.0012777072,0.00093865435,0.0005634556,0.00340288,0.0042152535,0.16566631],"study_design_scores_gemma":[0.024076654,0.00935647,0.49061635,0.00028046625,0.00025751453,0.0009669894,0.0019418207,0.001651613,0.000053249805,0.00070045865,0.46960592,0.0004925087],"about_ca_topic_score_codex":0.007770233,"about_ca_topic_score_gemma":0.013083504,"teacher_disagreement_score":0.46539065,"about_ca_system_score_codex":0.0016500624,"about_ca_system_score_gemma":0.00048391838,"threshold_uncertainty_score":0.9988371},"labels":[],"label_agreement":null},{"id":"W4312139361","doi":"10.1136/ijgc-2022-igcs.455","title":"EP366/#354 The IGCS virtual tumor board in Vietnam: an impact assessment of the last 5 years","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Institutional review board; Gynecologic oncology; Retrospective cohort study; Malignancy; Internal medicine; Surgery","score_opus":0.06820097914382857,"score_gpt":0.42234544302699084,"score_spread":0.3541444638831623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406815,0.00023303811,0.00003771996,0.003788067,0.0010477642,0.00014053544,0.000032827233,0.0000034600118,0.000648436],"genre_scores_gemma":[0.9966293,0.00005029538,0.00013506632,0.0028179411,0.00028285396,0.000021138501,0.000001934891,0.0000065496256,0.000054917604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978698,0.00019142406,0.00047731117,0.00011593925,0.0011831224,0.00016238968],"domain_scores_gemma":[0.9988752,0.00018374386,0.00044495685,0.00012873638,0.00029037835,0.00007696576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082473597,0.0000930779,0.00025365016,0.00008489321,0.00006621092,0.000022343314,0.00067693496,0.00003083397,0.0027401126],"category_scores_gemma":[0.00025244974,0.000048623322,0.00024162476,0.00021337188,0.000105775456,0.000118917946,0.00021510407,0.0006687436,9.85078e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079045276,0.00036156486,0.9601517,0.000002924192,0.0002067487,0.0004811902,0.00034444663,0.0211479,0.0014222754,0.0008057826,0.0028934206,0.01139161],"study_design_scores_gemma":[0.0011438646,0.0014252634,0.9906161,0.00004960058,0.000036853635,0.00027791713,0.0009064133,0.000579212,0.000056155714,0.00025064818,0.00460171,0.000056273235],"about_ca_topic_score_codex":0.00025739445,"about_ca_topic_score_gemma":0.00034602924,"teacher_disagreement_score":0.030464403,"about_ca_system_score_codex":0.0010943594,"about_ca_system_score_gemma":0.0007068348,"threshold_uncertainty_score":0.9981715},"labels":[],"label_agreement":null},{"id":"W4312139397","doi":"10.1136/ijgc-2022-igcs.65","title":"21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Grading (engineering); Cohort; Stage (stratigraphy); Internal medicine; Oncology","score_opus":0.09239304784717996,"score_gpt":0.38491782724280377,"score_spread":0.2925247793956238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97626245,0.0015171303,0.00005292758,0.006955919,0.0051309885,0.00038425878,0.0020021596,0.000028191545,0.0076659494],"genre_scores_gemma":[0.99451476,0.000666774,0.00018738562,0.0013247487,0.0030472155,0.000039236267,0.00012612445,0.000019372263,0.00007436513],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964677,0.00079485564,0.000776044,0.00041433083,0.0013303241,0.00021674634],"domain_scores_gemma":[0.99598724,0.0014952898,0.0009916818,0.00017915275,0.0010559463,0.00029069895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006502065,0.00020666006,0.00042956474,0.0003769917,0.00016936412,0.000045931727,0.00046971982,0.000049276186,0.004130666],"category_scores_gemma":[0.0034208577,0.00014962442,0.00031864076,0.00038839,0.00008178957,0.00014904569,0.00015203132,0.000982739,0.000032187858],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17887011,0.015618665,0.29564488,0.000012212011,0.004297301,0.004642848,0.008811313,0.0019071543,0.0008459723,0.002173722,0.00737129,0.47980455],"study_design_scores_gemma":[0.036314625,0.00657454,0.9209928,0.000054735432,0.00039793865,0.000050892042,0.003051086,0.00028213783,0.00027760898,0.0009895856,0.030786995,0.00022707209],"about_ca_topic_score_codex":0.00032838163,"about_ca_topic_score_gemma":0.000050606046,"teacher_disagreement_score":0.6253479,"about_ca_system_score_codex":0.0028555987,"about_ca_system_score_gemma":0.0003343874,"threshold_uncertainty_score":0.9967797},"labels":[],"label_agreement":null},{"id":"W4312139409","doi":"10.1136/ijgc-2022-igcs.412","title":"EP322/#302 Information needs of lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing surgery: a qualitative study of the decision making process","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Juravinski Hospital; McMaster University","funders":"","keywords":"Thematic analysis; Information needs; Context (archaeology); Feeling; Qualitative research; Medicine; Family medicine; Psychology; Computer science; Social psychology","score_opus":0.07132874860448687,"score_gpt":0.4396355229393806,"score_spread":0.36830677433489367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963941,0.00016330177,0.00095850165,0.00067919673,0.0014445847,0.00019435208,0.00006340723,0.0000040850236,0.00009847285],"genre_scores_gemma":[0.99962664,0.000020388045,0.000107949796,0.00017451565,0.00003566726,0.000019235302,9.4348275e-7,0.0000041933527,0.000010489901],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9946845,0.0008090009,0.0015763919,0.00011875867,0.00268276,0.00012857647],"domain_scores_gemma":[0.98692656,0.0076754396,0.0035616348,0.00012001465,0.0016596222,0.000056745415],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008071028,0.00010542968,0.0004093211,0.0006486262,0.0002294853,0.00021171542,0.0012559945,0.000059900376,0.000425204],"category_scores_gemma":[0.022695463,0.0000653785,0.00012712379,0.0008970201,0.00012768913,0.0017731233,0.00046595992,0.0005470364,4.171276e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009294242,0.00030576476,0.4522249,0.000017198161,0.0004332608,0.000039335442,0.24956803,0.12303609,0.000048120437,0.00028059524,0.0020621507,0.17105512],"study_design_scores_gemma":[0.0015345782,0.000555606,0.37099892,0.00020681208,0.000083241786,0.0003762189,0.6011511,0.0031192221,0.00015787949,0.021184742,0.00044050315,0.00019120572],"about_ca_topic_score_codex":0.00022095177,"about_ca_topic_score_gemma":0.000042555304,"teacher_disagreement_score":0.35158306,"about_ca_system_score_codex":0.00027010808,"about_ca_system_score_gemma":0.0004104271,"threshold_uncertainty_score":0.9855368},"labels":[],"label_agreement":null},{"id":"W4312139428","doi":"10.1136/ijgc-2022-igcs.16","title":"O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Clinical endpoint; Oncology; Phases of clinical research; Adverse effect; Cancer; Clinical trial; Immunotherapy","score_opus":0.04543722970944045,"score_gpt":0.3907274243883293,"score_spread":0.34529019467888883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337494,0.0007659682,0.000001276997,0.0034870158,0.0013891713,0.0005857499,0.00007320848,0.0000018931802,0.00032078646],"genre_scores_gemma":[0.9990491,0.0002708971,0.000055215743,0.00031184364,0.00019638006,0.00007077798,0.0000031549996,0.000007727688,0.000034872835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980813,0.00030077194,0.0006818587,0.00017015744,0.0006404778,0.00012539767],"domain_scores_gemma":[0.99866164,0.00022480881,0.0006468386,0.0001175258,0.0002629652,0.000086218046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054055086,0.00010901229,0.00046813203,0.00015170596,0.00005596227,0.0000055771397,0.00026686137,0.00005064819,0.001215126],"category_scores_gemma":[0.00011882725,0.00006904946,0.00014532635,0.00013598194,0.00008747297,0.000058558355,0.00021949135,0.00040137445,1.8627279e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28407508,0.08713402,0.46212617,0.000041184085,0.0007925787,0.0014793419,0.004484127,0.0005704428,0.0011423139,0.00042189905,0.0019930096,0.15573981],"study_design_scores_gemma":[0.23822057,0.14737734,0.6003667,0.000052679454,0.00035374358,0.00016070215,0.0019171849,0.0001822834,0.001109276,0.00030371945,0.009830028,0.00012575538],"about_ca_topic_score_codex":0.00018193031,"about_ca_topic_score_gemma":0.00014015294,"teacher_disagreement_score":0.15561406,"about_ca_system_score_codex":0.000855185,"about_ca_system_score_gemma":0.0005423262,"threshold_uncertainty_score":0.9996979},"labels":[],"label_agreement":null},{"id":"W4312139441","doi":"10.1136/ijgc-2022-igcs.206","title":"EP115/#640 Are all stage IA p53abn endometrial cancers the same? Seeking clarity in the management of stage IA p53abn and/or non-endometrioid endometrial cancers without myometrial invasion","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Medicine; Endometrial cancer; Oncology; Internal medicine; Chemotherapy; Adjuvant therapy; Retrospective cohort study; Adjuvant; Cancer; Gynecology; Gastroenterology; Biology","score_opus":0.0831108309517018,"score_gpt":0.39807388206524663,"score_spread":0.31496305111354483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981877,0.0054719723,0.00009329832,0.0054824413,0.0039487816,0.0018450727,0.0004881209,0.000014207319,0.0007790971],"genre_scores_gemma":[0.98313385,0.012874953,0.0003020943,0.0011880378,0.0010925733,0.00028494396,0.00002864536,0.00002896448,0.0010659195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939077,0.00063406443,0.0012476364,0.0004713804,0.0031410665,0.000598136],"domain_scores_gemma":[0.994641,0.0030023442,0.0013030593,0.00030013014,0.00053887785,0.00021458403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041169827,0.0003486628,0.0009435318,0.001585431,0.00028773886,0.00012875267,0.0012131603,0.00014483258,0.0033459435],"category_scores_gemma":[0.001653472,0.00018784424,0.00041898587,0.002319726,0.00035332062,0.00024230633,0.0006108561,0.0016070523,0.000002072552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19753945,0.0031096714,0.6328888,0.0007889458,0.012392019,0.011880071,0.005133958,0.014362393,0.006689026,0.0006589643,0.006457252,0.108099476],"study_design_scores_gemma":[0.17017446,0.017643135,0.6167216,0.0014462463,0.0018060666,0.00061704236,0.025504852,0.0013052771,0.0033015986,0.000648072,0.1596349,0.0011968045],"about_ca_topic_score_codex":0.002329784,"about_ca_topic_score_gemma":0.0013142561,"teacher_disagreement_score":0.15317765,"about_ca_system_score_codex":0.0050195507,"about_ca_system_score_gemma":0.0012377057,"threshold_uncertainty_score":0.9988},"labels":[],"label_agreement":null},{"id":"W4312139442","doi":"10.1136/ijgc-2022-igcs.316","title":"EP225/#402 Factors contributing to surgeon’s decision for diverting ileostomy at the time of cytoreductive surgery in patients with advanced ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Anastomosis; Surgery; Univariate analysis; Retrospective cohort study; Carcinosis; Multivariate analysis; Cancer; Colorectal cancer; Internal medicine; Peritoneal carcinomatosis","score_opus":0.016849349443202433,"score_gpt":0.3056247584167668,"score_spread":0.28877540897356435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567467,0.0002852726,0.000059304537,0.0017160595,0.0011046934,0.0007028902,0.00039342907,0.000006724484,0.000056928082],"genre_scores_gemma":[0.9989739,0.000031684544,0.00015706678,0.00038258513,0.00010599103,0.00021088752,0.000030255429,0.000016501224,0.00009109809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759024,0.000109630746,0.00070542126,0.00024389256,0.0010165274,0.00033430665],"domain_scores_gemma":[0.99507785,0.0029111952,0.00071156013,0.00009603944,0.0010701162,0.00013326542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006718601,0.00017246197,0.00059831055,0.0002081611,0.00016531798,0.00001243513,0.00025715053,0.000049487127,0.0030363044],"category_scores_gemma":[0.0015347418,0.00010108639,0.00025095596,0.0003097804,0.00006618353,0.000109982444,0.00029180688,0.00026722695,0.0000014340611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017473558,0.00040206884,0.94874287,0.0000054565203,0.00036050504,0.000054734937,0.0002371947,0.003946094,0.00019877734,0.000007424523,0.00036261036,0.02820869],"study_design_scores_gemma":[0.00463038,0.001293654,0.98968565,0.00015747856,0.0000764947,0.000010707065,0.00014010089,0.000046089364,0.0009707098,0.000054173946,0.0028172531,0.00011729992],"about_ca_topic_score_codex":0.00020352934,"about_ca_topic_score_gemma":0.00016971541,"teacher_disagreement_score":0.040942773,"about_ca_system_score_codex":0.0032034528,"about_ca_system_score_gemma":0.0003522644,"threshold_uncertainty_score":0.99787503},"labels":[],"label_agreement":null},{"id":"W4312139445","doi":"10.1136/ijgc-2022-igcs.45","title":"1/#337 Molecular classification of endometrial cancers using an integrative DNA sequencing panel","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sinai Health System; Sunnybrook Health Science Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Microsatellite instability; MLH1; Biology; Endometrial cancer; DNA methylation; Methylation; DNA sequencing; Genetics; Somatic cell; Epigenetics; Loss of heterozygosity; Gene; Cancer research; Computational biology; DNA mismatch repair; Cancer; Microsatellite; Gene expression; DNA repair","score_opus":0.12498973418658871,"score_gpt":0.3841221950334288,"score_spread":0.2591324608468401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949142,0.00082945765,0.00074325816,0.0006449772,0.001868943,0.0002145404,0.00009512008,0.000009857853,0.000679668],"genre_scores_gemma":[0.99762213,0.00017468474,0.0010051143,0.0006119325,0.00047167743,0.0000342522,0.000019224957,0.000013596891,0.000047407662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757606,0.00020369506,0.00070829614,0.00020444141,0.0011315544,0.00017596789],"domain_scores_gemma":[0.9978057,0.0003088737,0.00080252695,0.00010798874,0.0008125467,0.00016232795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046347448,0.000150026,0.0004942901,0.00043677824,0.000072146904,0.000017715334,0.0002985359,0.0000666721,0.0031562608],"category_scores_gemma":[0.00071202597,0.000108610315,0.00028466462,0.0005226672,0.00009774416,0.0001677914,0.00009379197,0.0004174731,8.3681977e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017600613,0.0023486302,0.058468048,0.00006289844,0.0038401026,0.0023409,0.0014018932,0.025359266,0.79372627,0.0028899733,0.0002526859,0.09170871],"study_design_scores_gemma":[0.10684254,0.052770264,0.3470118,0.0013101196,0.0049182125,0.005050885,0.021545282,0.024287853,0.40194798,0.012933135,0.019062903,0.002319048],"about_ca_topic_score_codex":0.0004774834,"about_ca_topic_score_gemma":0.000035853263,"teacher_disagreement_score":0.39177832,"about_ca_system_score_codex":0.0042816694,"about_ca_system_score_gemma":0.0010475359,"threshold_uncertainty_score":0.99954075},"labels":[],"label_agreement":null},{"id":"W4312139452","doi":"10.1136/ijgc-2022-igcs.406","title":"EP316/#1111 Malignant bowel obstruction pathway to improve serious illness conversation and standardize management","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nausea; Vomiting; Medicine; Documentation; Conversation; Chart; Palliative care; Intensive care medicine; General surgery; Internal medicine; Psychology; Nursing","score_opus":0.012524066929264853,"score_gpt":0.28809051175313066,"score_spread":0.27556644482386583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857558,0.00015552886,0.00040562224,0.009570891,0.002888007,0.00027296875,0.00010369094,0.000014528381,0.00083294447],"genre_scores_gemma":[0.9950418,0.00015150214,0.001195408,0.002174828,0.00034924355,0.00006490588,0.0000074012664,0.000008567234,0.0010063348],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862593,0.00005237724,0.0003655695,0.00016949502,0.0006422343,0.00014441674],"domain_scores_gemma":[0.9990374,0.00008242566,0.00021547609,0.000060672173,0.00045883426,0.00014523194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026954105,0.000105256084,0.00020649824,0.00014222489,0.00012909816,0.000027574699,0.00014967856,0.000035915273,0.0021121243],"category_scores_gemma":[0.00012635722,0.0000785788,0.00009354625,0.00009438212,0.000045964967,0.00008009217,0.00017060859,0.00026530132,0.0000050159883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017151514,0.0013465611,0.064260006,0.0001947661,0.0017345888,0.009067811,0.0035257838,0.0037116185,0.097046144,0.011049885,0.008995447,0.7819159],"study_design_scores_gemma":[0.007783947,0.008379897,0.52135265,0.00025897936,0.00033609537,0.005204661,0.0054967185,0.0006894654,0.01570105,0.0044982764,0.4296922,0.00060602615],"about_ca_topic_score_codex":0.00004910109,"about_ca_topic_score_gemma":0.000010180396,"teacher_disagreement_score":0.78130984,"about_ca_system_score_codex":0.00063330703,"about_ca_system_score_gemma":0.000105600404,"threshold_uncertainty_score":0.9988001},"labels":[],"label_agreement":null},{"id":"W4312139456","doi":"10.1136/ijgc-2022-igcs.220","title":"EP129/#635 Does order of adjuvant treatment matter? Retrospective review of high-risk endometrial cancer patients treated with adjuvant chemotherapy followed by radiation","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Endometrial cancer; Serous fluid; Chemotherapy; Internal medicine; Stage (stratigraphy); Oncology; Radiation therapy; Cancer; Retrospective cohort study; Adjuvant","score_opus":0.009007393291748315,"score_gpt":0.291643497615729,"score_spread":0.2826361043239807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97650313,0.016949486,0.000029582416,0.0025946463,0.0011502453,0.0008409238,0.0017360213,0.00000997253,0.00018598838],"genre_scores_gemma":[0.9460548,0.051839463,0.0001546165,0.0010380055,0.00026445044,0.00021549848,0.000129568,0.000024369225,0.00027922433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968568,0.00020839652,0.0010337176,0.00029281777,0.0013916041,0.00021665075],"domain_scores_gemma":[0.99614966,0.0003476124,0.0018511191,0.00014226658,0.0013644674,0.00014489713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028324287,0.0002666307,0.0012059553,0.00028979665,0.00006203885,0.000009174917,0.00026493927,0.00007236658,0.014516905],"category_scores_gemma":[0.00035983327,0.00014390677,0.00036184557,0.0006940061,0.00009102655,0.00010691389,0.00005274124,0.0002664035,0.000001972707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012280596,0.003080483,0.90859395,0.00012481652,0.0030312352,0.000053658878,0.00008869309,0.00008992311,0.0005897227,0.000012272843,0.0032985578,0.068756066],"study_design_scores_gemma":[0.053189997,0.018922582,0.90075916,0.0010737489,0.0015895884,0.00002421857,0.000050051665,0.000013024162,0.013619944,0.00010799713,0.010370537,0.00027916298],"about_ca_topic_score_codex":0.0018262784,"about_ca_topic_score_gemma":0.00006582656,"teacher_disagreement_score":0.0684769,"about_ca_system_score_codex":0.0025470706,"about_ca_system_score_gemma":0.0003319623,"threshold_uncertainty_score":0.986384},"labels":[],"label_agreement":null},{"id":"W4312139465","doi":"10.1136/ijgc-2022-igcs.104","title":"EP013/#933 Testing for mismatch repair protein deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Microsatellite instability; Endometrial cancer; Serous fluid; Lynch syndrome; Ovarian cancer; MLH1; Oncology; Medicine; Internal medicine; Cancer; Meta-analysis; DNA mismatch repair; Biology; Microsatellite; Colorectal cancer; Genetics; Allele","score_opus":0.15429690628857506,"score_gpt":0.40042607266881425,"score_spread":0.24612916638023918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001984308,0.99159193,0.000020665922,0.0009491099,0.00025328048,0.00479577,0.00034490353,0.000016027312,0.00004399186],"genre_scores_gemma":[0.004015485,0.9888603,0.0022918577,0.00071448105,0.000053719148,0.003808212,0.000018855266,0.000039533188,0.00019755917],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949615,0.000557394,0.0025867044,0.00065940147,0.00088935945,0.0003456502],"domain_scores_gemma":[0.9944371,0.0021963886,0.0021378228,0.00028842167,0.0007397998,0.0002004583],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026367244,0.0005155869,0.006920932,0.0005872185,0.00007606821,0.00006535719,0.00053145987,0.0002598657,0.0018429791],"category_scores_gemma":[0.0038683657,0.000328805,0.0019490662,0.00093017844,0.00014730194,0.00008884121,0.00029518513,0.000827507,7.831627e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013423426,0.00045657338,0.0012868496,0.87873405,0.099362925,0.0007621469,0.00012470678,0.000039485036,0.000013569194,0.00004863571,0.000109790824,0.018927049],"study_design_scores_gemma":[0.0012727446,0.0018000149,0.0014077272,0.060918294,0.8717154,0.003622725,0.000045637353,0.000054813183,0.000003895568,0.00028385705,0.058040965,0.000833914],"about_ca_topic_score_codex":0.00014085679,"about_ca_topic_score_gemma":0.00022515055,"teacher_disagreement_score":0.8178157,"about_ca_system_score_codex":0.0015897247,"about_ca_system_score_gemma":0.0010042292,"threshold_uncertainty_score":0.9999164},"labels":[],"label_agreement":null},{"id":"W4312139480","doi":"10.1136/ijgc-2022-igcs.335","title":"EP244/#718 Poly-(ADP-ribose)-glycohydrolase localizes to the cytoplasm following neoadjuvant chemotherapy in ovarian serous carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Cancer research; Ovarian cancer; Biology; Tissue microarray; Cytoplasm; Cancer; Serous fluid; Molecular biology; Pathology; Immunohistochemistry; Medicine; Immunology; Cell biology","score_opus":0.01747602531681466,"score_gpt":0.3127252415776656,"score_spread":0.295249216260851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88607377,0.0020728784,0.0001635162,0.10721459,0.0035208494,0.0003766687,0.00006435004,0.000011504441,0.00050186075],"genre_scores_gemma":[0.98737633,0.00020609265,0.00035878213,0.010612901,0.0009806086,0.00017168875,0.000007086256,0.000021670987,0.00026482213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777097,0.00013040997,0.0005836131,0.00026444037,0.0009542652,0.00029630217],"domain_scores_gemma":[0.99894696,0.00028385356,0.00026142295,0.00017283286,0.00014401051,0.00019088824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000531493,0.00019129491,0.0004311524,0.00023219777,0.00012518532,0.00005054016,0.00048054822,0.00006321118,0.00441157],"category_scores_gemma":[0.00012357035,0.00012358543,0.0003331088,0.0002460189,0.000035695164,0.000088244975,0.00016047616,0.00047619172,0.000017141565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006446302,0.0026090813,0.796755,0.000014267938,0.001953727,0.01578037,0.0019231036,0.019125622,0.0015746555,0.001134499,0.022718474,0.12996486],"study_design_scores_gemma":[0.013579603,0.0033104464,0.70579845,0.00013447068,0.00021073013,0.0011251374,0.00048787077,0.0007843725,0.002278938,0.0005757544,0.271398,0.00031623009],"about_ca_topic_score_codex":0.0006765462,"about_ca_topic_score_gemma":0.00034389866,"teacher_disagreement_score":0.24867952,"about_ca_system_score_codex":0.0022485852,"about_ca_system_score_gemma":0.00047729825,"threshold_uncertainty_score":0.9964985},"labels":[],"label_agreement":null},{"id":"W4312139481","doi":"10.1136/ijgc-2022-igcs.437","title":"EP348/#107 Role of HPV in prediction of recurrence/persistence after treatment for cervical precancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa","funders":"","keywords":"Colposcopy; Persistence (discontinuity); Medicine; Ascus (bryozoa); Retrospective cohort study; Univariate analysis; Internal medicine; Proportional hazards model; Multivariate analysis; Cervical cancer; Univariate; Multivariate statistics; Oncology; Gynecology; Cancer; Biology; Statistics","score_opus":0.06861397794421543,"score_gpt":0.36968517815752916,"score_spread":0.30107120021331374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867699,0.0050651263,0.00010882219,0.0024556308,0.0010507889,0.00057555194,0.0006043301,0.0000057009106,0.0033641087],"genre_scores_gemma":[0.99785346,0.0009187265,0.00026437492,0.00018797502,0.000294373,0.000299832,0.000011990738,0.000007994054,0.00016127984],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99807835,0.00007252562,0.0006638653,0.00017329228,0.0008287477,0.00018325249],"domain_scores_gemma":[0.99834013,0.0003020159,0.00030355438,0.0000898489,0.0008592198,0.00010525582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037830698,0.00010345363,0.00042144384,0.00022630152,0.000026088032,0.0000062537515,0.00023982812,0.000065759574,0.020426182],"category_scores_gemma":[0.00022394233,0.00007660131,0.0002870769,0.00019194245,0.00010331807,0.00007755676,0.00009387678,0.0002771028,6.496218e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022033464,0.0023209136,0.45025152,0.00011698852,0.00048362068,0.000075919015,0.00086833414,0.0015369516,0.0019852812,0.0002576505,0.00038760283,0.51968175],"study_design_scores_gemma":[0.005273231,0.0059554134,0.96036404,0.000050500334,0.00009528562,0.00004991711,0.00048534814,0.0011298673,0.0033434455,0.0010453912,0.022127079,0.00008050184],"about_ca_topic_score_codex":0.00012402597,"about_ca_topic_score_gemma":0.0001488472,"teacher_disagreement_score":0.5196013,"about_ca_system_score_codex":0.001316487,"about_ca_system_score_gemma":0.00051555224,"threshold_uncertainty_score":0.9804693},"labels":[],"label_agreement":null},{"id":"W4312139491","doi":"10.1136/ijgc-2022-igcs.158","title":"EP067/#802 A comparison of adverse outcomes with the use of bevacizumab with cisplatin/paclitaxel or carboplatin/paclitaxel in recurrent, persistent or metastatic cervical cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Carboplatin; Bevacizumab; Common Terminology Criteria for Adverse Events; Paclitaxel; Internal medicine; Adverse effect; Chemotherapy; Oncology; Cervical cancer; Cisplatin; Response Evaluation Criteria in Solid Tumors; Nedaplatin; Cancer; Surgery; Progressive disease; Gastroenterology","score_opus":0.15177764845947542,"score_gpt":0.39896816123539525,"score_spread":0.24719051277591983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864764,0.0011781496,0.00003174497,0.008805474,0.00038214924,0.0005500535,0.00033647698,0.000005380307,0.00006293336],"genre_scores_gemma":[0.9973392,0.00033422236,0.0010191335,0.00068791053,0.00006243681,0.0002702966,0.000010858516,0.000018599,0.0002573519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698853,0.00018343322,0.00095174747,0.00024460966,0.0013910128,0.00024068846],"domain_scores_gemma":[0.99646163,0.0013984878,0.0011586371,0.00017907388,0.00067299913,0.00012916913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029104535,0.00023956616,0.0009482511,0.00022086516,0.00006715641,0.000013466591,0.0003179374,0.000044538938,0.0045043407],"category_scores_gemma":[0.00027280248,0.00010645637,0.00031241463,0.00035052464,0.00020758527,0.00013174763,0.00012500763,0.00052059314,5.7724696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026381,0.0032584316,0.92875755,0.00008435842,0.0030711486,0.00071281596,0.0018015659,0.024026008,0.000046065292,0.000112215166,0.0012724984,0.01047635],"study_design_scores_gemma":[0.01575566,0.01516219,0.9514454,0.0006274247,0.0015190735,0.0003666641,0.0049369475,0.0017646981,0.00019127369,0.000019884686,0.007957018,0.00025379012],"about_ca_topic_score_codex":0.0014019848,"about_ca_topic_score_gemma":0.009931586,"teacher_disagreement_score":0.022687832,"about_ca_system_score_codex":0.0013329278,"about_ca_system_score_gemma":0.0008897328,"threshold_uncertainty_score":0.99640566},"labels":[],"label_agreement":null},{"id":"W4312139508","doi":"10.1136/ijgc-2022-igcs.165","title":"EP074/#619 Single molecule array (SIMOA) for the detection of cervical dysplasia and cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Colposcopy; Dysplasia; Cervical cancer; Oncology; Cervical intraepithelial neoplasia; Cancer; Internal medicine; Gastroenterology","score_opus":0.044906151756102554,"score_gpt":0.36232068577837145,"score_spread":0.3174145340222689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92543066,0.017361991,0.007343969,0.041593686,0.0036949862,0.00096927054,0.00027831105,0.000021376172,0.0033057514],"genre_scores_gemma":[0.996635,0.00094401796,0.00011078102,0.0013374356,0.0005932525,0.0001414363,0.0000025558074,0.000011272798,0.00022423966],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984272,0.00006288497,0.00038722376,0.0001460504,0.0008021492,0.00017448253],"domain_scores_gemma":[0.99808156,0.0006534441,0.00024322557,0.0000766203,0.00083476823,0.000110401044],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042477096,0.000093129136,0.00026106255,0.00010551373,0.0001212716,0.000022433098,0.0002786479,0.000053932883,0.006023986],"category_scores_gemma":[0.00037410052,0.00005886722,0.00017741793,0.00014012083,0.00013058163,0.000056524645,0.00011524319,0.00043316957,5.674758e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014116575,0.0012655901,0.037498485,0.00015617287,0.0015086752,0.00012455705,0.00046050773,0.0016888365,0.19836761,0.00076093466,0.0035089487,0.7405431],"study_design_scores_gemma":[0.010097193,0.007859704,0.61455,0.00006385511,0.0005248989,0.0004711716,0.0009592209,0.0026632268,0.0881025,0.0022772215,0.27211332,0.0003176497],"about_ca_topic_score_codex":0.00012079508,"about_ca_topic_score_gemma":0.0001819176,"teacher_disagreement_score":0.74022543,"about_ca_system_score_codex":0.0005247896,"about_ca_system_score_gemma":0.00023469681,"threshold_uncertainty_score":0.99488467},"labels":[],"label_agreement":null},{"id":"W4312139511","doi":"10.1136/ijgc-2022-igcs.13","title":"O011/#496 Mirvetuximab soravtansine and bevacizumab in folate receptor αlpha-positive ovarian cancer: efficacy in patients with and without prior bevacizumab","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Nausea; Bevacizumab; Adverse effect; Ovarian cancer; Clinical endpoint; Oncology; Gastroenterology; Cancer; Clinical trial; Chemotherapy","score_opus":0.011953853926783935,"score_gpt":0.2915304767041746,"score_spread":0.27957662277739065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898121,0.001857453,0.0000075371413,0.0070079453,0.000485209,0.00053913856,0.00017220348,0.0000074812892,0.00011094511],"genre_scores_gemma":[0.99723893,0.0008702957,0.0005361464,0.0010192567,0.00013087387,0.00011295486,0.000020719655,0.000020937401,0.000049867067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980635,0.0001202372,0.0005522396,0.00033967616,0.0006714332,0.0002528886],"domain_scores_gemma":[0.99883765,0.00018577954,0.00037657763,0.00008914186,0.00034716993,0.00016369847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027583382,0.00021615833,0.00054813176,0.00029532818,0.00007798023,0.00004270371,0.00015580162,0.000075333315,0.0011924967],"category_scores_gemma":[0.000104354134,0.00015758978,0.00006775466,0.00020971523,0.00009371637,0.00017035166,0.00013144901,0.0005287275,9.836892e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008932625,0.0019519839,0.9101563,0.000012423781,0.00045678424,0.00031227825,0.0004908543,0.00019086171,0.00004232235,0.000112868154,0.00014364932,0.07719703],"study_design_scores_gemma":[0.031209048,0.003405827,0.96245456,0.00026398269,0.00012609358,0.00008183755,0.00007784943,0.00006295494,0.00007938626,0.000087432345,0.0019819376,0.00016911096],"about_ca_topic_score_codex":0.00047347337,"about_ca_topic_score_gemma":0.00061671535,"teacher_disagreement_score":0.07702792,"about_ca_system_score_codex":0.0017783883,"about_ca_system_score_gemma":0.00036533544,"threshold_uncertainty_score":0.9997206},"labels":[],"label_agreement":null},{"id":"W4312139517","doi":"10.1136/ijgc-2022-igcs.407","title":"EP317/#1119 Serious illness conversations in patients with malignant bowel obstruction","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Distress; Concordance; Palliative care; Family medicine; Bowel obstruction; Patient satisfaction; Nursing; Internal medicine; Clinical psychology; Surgery","score_opus":0.04022961320872642,"score_gpt":0.36095524706259774,"score_spread":0.3207256338538713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640447,0.00030035764,0.00007808654,0.0015861219,0.0011285652,0.0001263999,0.00007180553,0.0000051209063,0.00029904654],"genre_scores_gemma":[0.99864316,0.00018988109,0.00038215567,0.0005269887,0.00010832596,0.000020390842,0.000021167447,0.0000064569567,0.00010148079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873877,0.000058021204,0.00037409918,0.00010387982,0.00061831396,0.000106919295],"domain_scores_gemma":[0.9987814,0.00012983757,0.00035654652,0.00005280284,0.000622765,0.000056647576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001508603,0.00008059122,0.00023297235,0.00017297184,0.000039246803,0.000006851541,0.0001564711,0.000036321573,0.001963953],"category_scores_gemma":[0.00019761513,0.00005721847,0.00007657188,0.00013642639,0.00006480622,0.00009955961,0.000052940377,0.00025182604,0.0000012247618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015407366,0.00034246055,0.9876658,0.0000083495015,0.00018484336,0.00015974163,0.00062104623,0.001688183,0.00010778496,0.0001794601,0.0003887273,0.007112901],"study_design_scores_gemma":[0.0040835557,0.0010950477,0.9754484,0.00011827977,0.00004748089,0.00003710358,0.0008348338,0.00006263154,0.0003451317,0.00019426702,0.017646696,0.00008653592],"about_ca_topic_score_codex":0.000079038124,"about_ca_topic_score_gemma":0.000038706126,"teacher_disagreement_score":0.01725797,"about_ca_system_score_codex":0.0006319548,"about_ca_system_score_gemma":0.00017419684,"threshold_uncertainty_score":0.9989484},"labels":[],"label_agreement":null},{"id":"W4312139524","doi":"10.1136/ijgc-2022-igcs.49","title":"5/#274 Is reflex MLH1 promoter hypermethylation testing following MLH1 loss by immunohistochemistry in endometrial carcinoma best practice?","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"MLH1; Lynch syndrome; PMS2; MSH6; MSH2; Medicine; Internal medicine; Oncology; Endometrial cancer; Cancer; Gynecology; DNA mismatch repair; Colorectal cancer","score_opus":0.026623100176642316,"score_gpt":0.36059344369884583,"score_spread":0.3339703435222035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891721,0.0040576262,0.0016469151,0.0020799467,0.001436233,0.0002381319,0.00006799453,0.0000062285285,0.001294827],"genre_scores_gemma":[0.996521,0.00020086707,0.0014504099,0.00077990885,0.0004429157,0.00008643307,0.000051609164,0.000024048157,0.00044280285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974877,0.00024037724,0.0006079294,0.00035311363,0.0010125457,0.00029833952],"domain_scores_gemma":[0.99840885,0.00021302165,0.0005032256,0.00018079973,0.0005955622,0.00009853055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096092594,0.000174234,0.00025219348,0.0001971999,0.000113897084,0.00006893322,0.00077121664,0.00017416029,0.0004295589],"category_scores_gemma":[0.0025060654,0.00017247455,0.000226274,0.0003243676,0.000047657126,0.000036468333,0.00047489806,0.00072440284,0.000002725293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008074539,0.00036917714,0.0011917757,0.0000064357637,0.0002342358,0.0005631577,0.000062711275,0.00053495733,0.9782979,0.000009583763,0.0013527045,0.016569922],"study_design_scores_gemma":[0.012763572,0.0056052436,0.0028019783,0.00010728376,0.00015983846,0.0017993052,0.00048094481,0.0005633579,0.84245926,0.00057471264,0.13175982,0.000924651],"about_ca_topic_score_codex":0.00010763822,"about_ca_topic_score_gemma":0.0000037900322,"teacher_disagreement_score":0.1358386,"about_ca_system_score_codex":0.0010137247,"about_ca_system_score_gemma":0.0005623239,"threshold_uncertainty_score":0.70333076},"labels":[],"label_agreement":null},{"id":"W4312139536","doi":"10.1136/ijgc-2022-igcs.289","title":"EP198/#938 Access to treatment for endometrial cancer patients during the COVID-19 pandemic in Ontario, Canada","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Endometrial cancer; Medicine; Pandemic; Hysterectomy; Cancer; Coronavirus disease 2019 (COVID-19); Cancer registry; General surgery; Gynecology; Internal medicine; Surgery; Disease","score_opus":0.16733271293377114,"score_gpt":0.4544225052823736,"score_spread":0.28708979234860244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585589,0.00028064512,0.000021504657,0.037179593,0.0029073087,0.00076709694,0.00022949331,0.000005414323,0.000050039773],"genre_scores_gemma":[0.9712199,0.00020917381,0.000017516024,0.027226124,0.00047722348,0.00040621258,0.000011188992,0.000009283647,0.00042339496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808675,0.00008565144,0.0005558673,0.00017988699,0.00081548165,0.0002763861],"domain_scores_gemma":[0.99770683,0.0011650973,0.0003210516,0.00007840084,0.0003675102,0.0003611051],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038070267,0.00012859942,0.0003352549,0.00024824776,0.00015821401,0.000033002245,0.00042102358,0.00004198334,0.0041472474],"category_scores_gemma":[0.0015182844,0.00008063413,0.0001357454,0.00020058412,0.000020614018,0.00009373708,0.00014169356,0.00037362846,2.9252652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0054498813,0.0002670423,0.9726449,0.000014482907,0.00017646392,0.00018264622,0.00046043718,0.009375406,0.000045871377,0.000013667376,0.0045338906,0.006835287],"study_design_scores_gemma":[0.007566903,0.0011192358,0.7539281,0.000021051539,0.00003634842,0.000044712688,0.00007389737,0.000017028513,0.000028733562,0.00010275181,0.2369841,0.00007710229],"about_ca_topic_score_codex":0.91868013,"about_ca_topic_score_gemma":0.9919754,"teacher_disagreement_score":0.23245022,"about_ca_system_score_codex":0.037745133,"about_ca_system_score_gemma":0.011237717,"threshold_uncertainty_score":0.9967631},"labels":[],"label_agreement":null},{"id":"W4312139539","doi":"10.1136/ijgc-2022-igcs.83","title":"39/#452 Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the garnet study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"","keywords":"Endometrial cancer; Medicine; Internal medicine; Discontinuation; Clinical endpoint; Microsatellite instability; Oncology; Cancer; Cohort; Surrogate endpoint; Tolerability; Response Evaluation Criteria in Solid Tumors; Population; Chemotherapy; Clinical trial; Progressive disease; Adverse effect","score_opus":0.02093814535172436,"score_gpt":0.31391583836022013,"score_spread":0.2929776930084958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954986,0.000637247,0.0000019032034,0.000939072,0.001234049,0.0013734723,0.00009119251,0.000009709533,0.00021475578],"genre_scores_gemma":[0.9986396,0.000166618,0.00008249706,0.0004146435,0.000102814076,0.00046944202,0.000021390046,0.000022887825,0.00008010586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625295,0.00040172125,0.0009079864,0.00031988765,0.0017960557,0.0003214068],"domain_scores_gemma":[0.99795836,0.00059403136,0.0006489718,0.0001669786,0.0005454797,0.000086160435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072947785,0.00024993747,0.00057685765,0.00048120224,0.00006691104,0.00003077356,0.00060486945,0.00006596826,0.0058272113],"category_scores_gemma":[0.00048222355,0.00012610071,0.000103907776,0.00092590315,0.00009890347,0.000114007606,0.00013586413,0.0010947286,0.0000013063038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060971204,0.0036887503,0.90249467,0.000006302235,0.00046110767,0.0009512894,0.0010722177,0.0052935597,0.000096710195,0.0000036316492,0.0001265861,0.02483398],"study_design_scores_gemma":[0.032638054,0.020515058,0.94380534,0.000121797304,0.0001147146,0.00007445916,0.001112818,0.000035764453,0.000100707926,0.00001852818,0.0012887039,0.00017402864],"about_ca_topic_score_codex":0.00032313206,"about_ca_topic_score_gemma":0.0016741519,"teacher_disagreement_score":0.0413107,"about_ca_system_score_codex":0.0022401628,"about_ca_system_score_gemma":0.00059274584,"threshold_uncertainty_score":0.9950816},"labels":[],"label_agreement":null},{"id":"W4312139567","doi":"10.1136/ijgc-2022-igcs.297","title":"EP206/#804 Rates of genetic testing in high grade serous ovarian cancer patients in the era of parp inhibitor therapy: a population-based study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Population; Cancer; Genetic testing; Internal medicine; Cohort; Cancer registry; Ovarian cancer; Oncology; Pediatrics","score_opus":0.028786081328560774,"score_gpt":0.3240015327073445,"score_spread":0.29521545137878374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753076,0.0006685568,0.000022347996,0.0007229614,0.0006479518,0.0003158584,0.00008097658,0.0000013203993,0.000009253868],"genre_scores_gemma":[0.99861217,0.00007704383,0.00045230315,0.00047785207,0.00017371506,0.00017190514,0.000019755598,0.000010946384,0.0000043309783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812376,0.00032526487,0.00069997413,0.00017838737,0.00054100394,0.00013158782],"domain_scores_gemma":[0.9985818,0.00021214799,0.0006274366,0.00011256801,0.0004427629,0.000023240002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044834366,0.00011436078,0.00021433832,0.0001221914,0.000042853986,0.000012846914,0.0005205849,0.000055189255,0.00020614237],"category_scores_gemma":[0.0003119178,0.00008520304,0.00007655655,0.00028482947,0.000040668343,0.0000086024,0.000089245244,0.00027979354,9.803389e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000315157,0.0010295409,0.9031448,0.0000038814524,0.00008008459,0.000014367261,0.0002598462,0.085222654,0.0037275238,0.000005674094,0.00006542329,0.006131076],"study_design_scores_gemma":[0.0027733098,0.0011680974,0.992488,0.000023721004,0.000013711706,0.000003510039,0.00026523173,0.00019892963,0.002651507,0.00017954782,0.00014523121,0.00008919312],"about_ca_topic_score_codex":0.0018512002,"about_ca_topic_score_gemma":0.0016169696,"teacher_disagreement_score":0.08934324,"about_ca_system_score_codex":0.00035592722,"about_ca_system_score_gemma":0.0004236947,"threshold_uncertainty_score":0.34744793},"labels":[],"label_agreement":null},{"id":"W4312139568","doi":"10.1136/ijgc-2022-igcs.50","title":"6/#455 Management of immune-related adverse events in patients with solid tumors treated with dostarlimab in the garnet study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discontinuation; Medicine; Adverse effect; Internal medicine; Interim analysis; Lung cancer; Thyroid cancer; Interim; Cancer; Oncology; Surgery; Clinical trial","score_opus":0.010203547223004383,"score_gpt":0.2824847885999458,"score_spread":0.27228124137694143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824077,0.0001556589,0.0000014750998,0.00050095597,0.00014929942,0.0006218666,0.000016495844,0.0000031525174,0.0003103153],"genre_scores_gemma":[0.9994691,0.000058921523,0.000028315766,0.0002623854,0.000012276418,0.00006698987,0.000013119943,0.000008262083,0.00008060962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979771,0.00015729979,0.00067363464,0.00013090743,0.00092009705,0.00014096386],"domain_scores_gemma":[0.9991097,0.0000701279,0.00050676527,0.000099011915,0.00018833014,0.000026092226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056342967,0.000116458956,0.00029689164,0.0002112243,0.00003101055,0.000003335755,0.00033196466,0.00002390368,0.0010679407],"category_scores_gemma":[0.000013155611,0.000061708284,0.00008800887,0.00035754553,0.00005499724,0.000069636284,0.000060240283,0.00033455717,4.901129e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024993883,0.0035387166,0.9642539,0.000007263787,0.00090958254,0.0008234545,0.0006982135,0.0019057507,0.000034742985,0.000009258674,0.000027123153,0.0027980884],"study_design_scores_gemma":[0.020487236,0.005990238,0.9702137,0.00015691975,0.000086592576,0.000038978924,0.0027345896,0.000020720388,0.000021169757,0.000014836667,0.00016133192,0.00007368856],"about_ca_topic_score_codex":0.00022708949,"about_ca_topic_score_gemma":0.00012882841,"teacher_disagreement_score":0.005959777,"about_ca_system_score_codex":0.0006450865,"about_ca_system_score_gemma":0.00009877615,"threshold_uncertainty_score":0.9998452},"labels":[],"label_agreement":null},{"id":"W4312139596","doi":"10.1136/ijgc-2022-igcs.70","title":"26/#534 The impact of utilization indocyanine green for anastomotic perfusion assessment on the rate of diverting ileostomy in patients with advanced ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Ileostomy; Indocyanine green; Bowel resection; Anastomosis; Cohort; Surgery; Retrospective cohort study; Bowel obstruction; Internal medicine","score_opus":0.03744260218365659,"score_gpt":0.36831049145088796,"score_spread":0.3308678892672314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684143,0.00010349425,0.00013029766,0.0019398856,0.0003158832,0.0004921413,0.00011624369,0.000003072561,0.000057539866],"genre_scores_gemma":[0.99929357,0.00011505112,0.000048278176,0.0003554015,0.000081473154,0.000065862645,0.00000916353,0.00001096634,0.000020253792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986606,0.0001079989,0.00046230984,0.0001121775,0.0005320829,0.00012479365],"domain_scores_gemma":[0.99805766,0.00041490697,0.0007622921,0.000084127176,0.00064221973,0.00003880412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047703984,0.00010474759,0.00027240912,0.00012248658,0.00007467385,0.000007769578,0.0002425532,0.000027856735,0.0013812629],"category_scores_gemma":[0.0001808183,0.00004812904,0.00014738593,0.00019449636,0.000061794206,0.00006891246,0.00007714494,0.0003008792,8.5935035e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004705555,0.00045968458,0.9254715,0.000008826525,0.00019868999,0.0000061030796,0.000337575,0.027750812,0.00064254174,0.00009694034,0.00013779217,0.040184017],"study_design_scores_gemma":[0.004148053,0.0033998527,0.9897966,0.00012382756,0.00005282806,0.0000029612752,0.00020023002,0.0016699063,0.0002052131,0.0000854748,0.00026101744,0.00005405994],"about_ca_topic_score_codex":0.00090355007,"about_ca_topic_score_gemma":0.00023071782,"teacher_disagreement_score":0.06432512,"about_ca_system_score_codex":0.0009339802,"about_ca_system_score_gemma":0.00035101877,"threshold_uncertainty_score":0.9995316},"labels":[],"label_agreement":null},{"id":"W4312139604","doi":"10.1136/ijgc-2022-igcs.275","title":"EP184/#40 Defining the longitudinal risk of CIN3+ in patients with less than CIN2 colposcopy following index high grade cytology","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Colposcopy; Medicine; Biopsy; Cytology; Gynecology; Adenocarcinoma; Cancer; Cervical cancer; Population; Cytopathology; Internal medicine; Pathology","score_opus":0.025128751596957127,"score_gpt":0.3359702349828593,"score_spread":0.3108414833859021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533224,0.0005911403,0.00011249322,0.0024455863,0.00078377227,0.00021719556,0.000044109736,0.0000049348077,0.00046850857],"genre_scores_gemma":[0.9990531,0.000118438045,0.000105630344,0.00048136784,0.00014214213,0.00004552946,0.000010461383,0.000012608209,0.000030689836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973014,0.00023810103,0.0005656179,0.00019273574,0.0014361234,0.00026601728],"domain_scores_gemma":[0.9980819,0.0006885174,0.00046067883,0.00011703494,0.00054697465,0.00010487794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073153834,0.00013161272,0.00046075886,0.00023943358,0.00011457465,0.000018340585,0.0005088092,0.00006639172,0.0031269314],"category_scores_gemma":[0.00040849939,0.00007757912,0.00019479214,0.00032134086,0.00013815887,0.000084991894,0.00023707135,0.0010754102,0.0000011512644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056821955,0.0005123389,0.98164886,0.000009885971,0.00043279232,0.00024165814,0.00013147756,0.0022896652,0.0000127314015,0.0003394623,0.00016541505,0.00853354],"study_design_scores_gemma":[0.0065036826,0.0021518639,0.9896704,0.00003499059,0.00009625673,0.000035510297,0.0003526538,0.00012879045,0.000069735506,0.00053250307,0.00034021636,0.000083425766],"about_ca_topic_score_codex":0.0008723699,"about_ca_topic_score_gemma":0.00087467744,"teacher_disagreement_score":0.008450115,"about_ca_system_score_codex":0.0007081607,"about_ca_system_score_gemma":0.0003942924,"threshold_uncertainty_score":0.9977843},"labels":[],"label_agreement":null},{"id":"W4312139625","doi":"10.1136/ijgc-2022-igcs.32","title":"O030/#339 Primary cytoreductive surgery leads to improved survival in patients with advanced ovarian cancer with brca germline or somatic mutation","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Germline; BRCA mutation; Oncology; Cohort; Internal medicine; Ovarian cancer; Germline mutation; Retrospective cohort study; Cancer; Somatic cell; Population; Chemotherapy; Surgery; Mutation; Genetics; Biology","score_opus":0.016571957150046463,"score_gpt":0.2942076407295227,"score_spread":0.27763568357947627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899617,0.0002038301,0.000109385306,0.007599966,0.0012459911,0.00062987674,0.00013296871,0.000013351134,0.00010296093],"genre_scores_gemma":[0.99572307,0.000104964456,0.0013347096,0.0018332903,0.0003002678,0.00048414464,0.00005141195,0.000028568133,0.00013957046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766976,0.000107711276,0.00062675605,0.00031511427,0.0010121508,0.00026853074],"domain_scores_gemma":[0.9979227,0.00041297052,0.000569672,0.00012073328,0.0007948478,0.00017907267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003112051,0.0002175699,0.0006185997,0.00032558202,0.00007273979,0.00003048586,0.00019314089,0.000048772446,0.0023097203],"category_scores_gemma":[0.00016724116,0.00013279999,0.00011371896,0.0003750556,0.00005406081,0.00021586813,0.00007523643,0.00035758232,0.0000018120714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024859121,0.0024261924,0.9040172,0.000036245736,0.0008793486,0.0011367776,0.00035131906,0.009245594,0.00021922619,0.000029444236,0.00038057365,0.056418937],"study_design_scores_gemma":[0.009418361,0.003928991,0.98456365,0.00024210544,0.00015239572,0.000077744524,0.00014520726,0.000050181214,0.0002045281,0.000029097808,0.0009993674,0.0001883745],"about_ca_topic_score_codex":0.00018475212,"about_ca_topic_score_gemma":0.00050477555,"teacher_disagreement_score":0.080546424,"about_ca_system_score_codex":0.0032200248,"about_ca_system_score_gemma":0.0012792944,"threshold_uncertainty_score":0.99860233},"labels":[],"label_agreement":null},{"id":"W4312139630","doi":"10.1136/ijgc-2022-igcs.7","title":"O005/#638 ProMisE-2: a one step DNA-based endometrial cancer molecular classifier","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Concordance; Microsatellite instability; Endometrial cancer; DNA sequencing; Oncology; Molecular diagnostics; Internal medicine; Computational biology; Medicine; Biopsy; Biology; Bioinformatics; Cancer; Pathology; DNA; Microsatellite; Genetics; Gene","score_opus":0.024476995115870495,"score_gpt":0.30279965986556,"score_spread":0.27832266474968953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435396,0.0037206796,0.0023583272,0.004454341,0.003863012,0.00025126303,0.0003931401,0.0000070663878,0.00059822924],"genre_scores_gemma":[0.9926593,0.00076222216,0.0008210273,0.0038894215,0.0013959386,0.00016804467,0.000039889117,0.000023809698,0.00024039789],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819,0.00011693009,0.00049303006,0.00027067852,0.0006849598,0.0002444195],"domain_scores_gemma":[0.9985662,0.00013991116,0.00047887315,0.00014785137,0.0005247059,0.00014247136],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037190906,0.00016337838,0.00026385408,0.00015408624,0.000092576614,0.000053840642,0.00068058766,0.00010385608,0.0031064532],"category_scores_gemma":[0.0005733239,0.00015081718,0.00028840432,0.00014207065,0.000080572456,0.000006824209,0.00028250462,0.00031771456,0.0000027656786],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008225277,0.0020195113,0.031480867,0.000023913175,0.0020301493,0.00067611336,0.00006333346,0.06114135,0.7880402,0.0012482695,0.054715864,0.050335135],"study_design_scores_gemma":[0.010841357,0.0031960446,0.01629931,0.000041079584,0.00020682963,0.000080492355,0.00009042108,0.0007061032,0.1311844,0.0005532968,0.83618885,0.00061181467],"about_ca_topic_score_codex":0.000058938178,"about_ca_topic_score_gemma":0.00009291204,"teacher_disagreement_score":0.781473,"about_ca_system_score_codex":0.00047741763,"about_ca_system_score_gemma":0.0008523551,"threshold_uncertainty_score":0.9978048},"labels":[],"label_agreement":null},{"id":"W4312139650","doi":"10.1136/ijgc-2022-igcs.46","title":"2/#338 Are mismatch repair deficient endometrial cancer recurrences more salvageable than intact cohort?","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sinai Health System; Juravinski Cancer Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Endometrial cancer; Cancer; Internal medicine; Oncology","score_opus":0.041350106945711174,"score_gpt":0.3554929466635537,"score_spread":0.3141428397178425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737727,0.0077802073,0.000025450341,0.008832732,0.007743782,0.00041895456,0.00028397958,0.00007152471,0.0010706366],"genre_scores_gemma":[0.99257743,0.0023722071,0.00027423917,0.002380127,0.0015299522,0.00024615417,0.000021317917,0.000024449164,0.00057410216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962993,0.00017667186,0.0008514235,0.00036260905,0.0019583819,0.0003516014],"domain_scores_gemma":[0.9972529,0.0006240342,0.0008917666,0.00015812475,0.0007960228,0.00027719833],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007238636,0.00023880844,0.0007038833,0.0004501024,0.00017869615,0.000046900557,0.0005341775,0.00009512911,0.0124239875],"category_scores_gemma":[0.0010825564,0.0001668536,0.00061973475,0.00073109096,0.00010543447,0.00014518101,0.00025644587,0.00073725363,0.00001215746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066658994,0.0016414323,0.9470252,0.00003163718,0.0021273652,0.0014973634,0.00021169346,0.0019273435,0.00030516702,0.00013343098,0.0126234135,0.025810104],"study_design_scores_gemma":[0.014044581,0.0038639659,0.8059299,0.00023698919,0.0007856269,0.000520149,0.0009942856,0.00016319465,0.0012171168,0.00068120385,0.17114313,0.00041986108],"about_ca_topic_score_codex":0.00071433577,"about_ca_topic_score_gemma":0.00011465762,"teacher_disagreement_score":0.15851973,"about_ca_system_score_codex":0.0021695676,"about_ca_system_score_gemma":0.00053041434,"threshold_uncertainty_score":0.9884788},"labels":[],"label_agreement":null},{"id":"W4312139659","doi":"10.1136/ijgc-2022-igcs.284","title":"EP193/#340 Remote gynecologic oncology perioperative care through mobile application: a prospective cohort study to assess feasibility and patient engagement","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Perioperative; Medicine; Prospective cohort study; Gynecologic oncology; Cohort; Hysterectomy; Mobile apps; Emergency medicine; Internal medicine; Surgery; World Wide Web; Computer science","score_opus":0.07084996983184369,"score_gpt":0.4376027942559588,"score_spread":0.36675282442411516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930305,0.0014749218,0.00024539288,0.0016646894,0.00061678176,0.0045291996,0.00006272062,0.000016032116,0.0020871852],"genre_scores_gemma":[0.9943882,0.00038108215,0.001603982,0.0016248069,0.0001184196,0.0017814325,0.000009364723,0.000010770318,0.00008191261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702567,0.0005688517,0.00055811595,0.00042628418,0.0011824871,0.0002385849],"domain_scores_gemma":[0.9967869,0.0010300364,0.00030522962,0.0001654102,0.0014927653,0.00021965078],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074256375,0.0001771513,0.0005325166,0.00017622327,0.0002591613,0.000040509967,0.0002715639,0.000045270997,0.0021475048],"category_scores_gemma":[0.0015457425,0.0001231196,0.00013484406,0.00029481557,0.0000893878,0.00009807582,0.00051535096,0.00064059405,0.000006472186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027826373,0.0057188184,0.89919645,0.0000116302135,0.0012165535,0.001200311,0.008798534,0.0013154442,0.00026309816,0.000098844546,0.00038000304,0.079017706],"study_design_scores_gemma":[0.0054879775,0.037650164,0.86528337,0.000011939574,0.00015307806,0.00021071252,0.028175738,0.000048419133,0.00038485182,0.0001352476,0.062302694,0.0001558235],"about_ca_topic_score_codex":0.00011837166,"about_ca_topic_score_gemma":0.00016250399,"teacher_disagreement_score":0.078861885,"about_ca_system_score_codex":0.00633591,"about_ca_system_score_gemma":0.000558275,"threshold_uncertainty_score":0.9987647},"labels":[],"label_agreement":null},{"id":"W4312139660","doi":"10.1136/ijgc-2022-igcs.428","title":"EP338/#105 Epidemiological profile and clinico-pathological features of pediatric gynecological cancers at moi teaching & referral hospital, Kenya","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Germ cell tumors; Chemotherapy; Internal medicine; Gynecologic oncology; Stage (stratigraphy); Referral; Oncology; Gynecology","score_opus":0.05279364372803519,"score_gpt":0.3754760172361449,"score_spread":0.3226823735081097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781019,0.00436611,0.000029031355,0.01282927,0.0021874085,0.0004637841,0.00019862647,0.00003171531,0.0017921259],"genre_scores_gemma":[0.9876635,0.004387634,0.0032490562,0.0025770841,0.0011582664,0.00020982951,0.00004182211,0.000020468191,0.00069230946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961154,0.00056519185,0.0012802327,0.00055680895,0.0010397972,0.0004425544],"domain_scores_gemma":[0.9958718,0.0019300893,0.0012127183,0.00020542924,0.00044111555,0.00033887313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016025858,0.00033710862,0.0011084337,0.00022321446,0.00025766046,0.000028000393,0.00050900853,0.0002681054,0.00863611],"category_scores_gemma":[0.0028512306,0.00021721341,0.0005240464,0.00016634438,0.00029499247,0.000117139294,0.0006452147,0.0014078065,0.000008019927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022924938,0.0020248538,0.93076307,0.00002975819,0.00062380434,0.0011700396,0.00022005709,0.0005592599,0.00026078132,0.0012966787,0.038405724,0.022353498],"study_design_scores_gemma":[0.0036462804,0.007006782,0.9581398,0.00003515677,0.0003644703,0.0006521503,0.00015756323,0.00003485736,0.00006783989,0.00084471906,0.028792938,0.00025744762],"about_ca_topic_score_codex":0.0000854817,"about_ca_topic_score_gemma":0.000049913095,"teacher_disagreement_score":0.027376745,"about_ca_system_score_codex":0.0021469018,"about_ca_system_score_gemma":0.0004171821,"threshold_uncertainty_score":0.9922701},"labels":[],"label_agreement":null},{"id":"W4312139665","doi":"10.1136/ijgc-2022-igcs.337","title":"EP246/#636 The efficacy of mek inhibitors (MEKI) in the treatment of low-grade serous ovarian cancer (LGSC): a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sinai Health System; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; MEDLINE; Oncology; Clinical trial; Retrospective cohort study","score_opus":0.0808161628935687,"score_gpt":0.4060114342737805,"score_spread":0.3251952713802118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000587357,0.98961484,0.0000019433794,0.004732969,0.0014607045,0.0032217924,0.00023246475,0.0000048321417,0.00014311883],"genre_scores_gemma":[0.0045841313,0.9919971,0.000033809065,0.0008683543,0.0005543218,0.0018193632,0.00002814455,0.00003138723,0.000083341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99443734,0.0008972712,0.0026733042,0.0003123751,0.0014240904,0.00025559808],"domain_scores_gemma":[0.9922504,0.003519408,0.003339341,0.0004323076,0.00035970213,0.0000988575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011307183,0.00045917538,0.0036041937,0.00025654002,0.000053685904,0.000026131189,0.0009240296,0.00016679766,0.0023777874],"category_scores_gemma":[0.000649605,0.0001909252,0.0017581838,0.0005244565,0.00014251492,0.00005461899,0.00007529137,0.00056359294,0.0000033516103],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050697604,0.011430748,0.0010585353,0.33372486,0.015078685,0.0023893341,0.0012254196,0.00012627072,0.0000015272543,0.0006744668,0.004113116,0.6296701],"study_design_scores_gemma":[0.0043131458,0.0026544603,0.001821205,0.38906604,0.013968976,0.0006826287,0.00014950178,0.000004115313,0.0000086580285,0.000052205207,0.5870023,0.0002767932],"about_ca_topic_score_codex":0.0003461365,"about_ca_topic_score_gemma":0.00015303119,"teacher_disagreement_score":0.6293933,"about_ca_system_score_codex":0.0026737123,"about_ca_system_score_gemma":0.001282394,"threshold_uncertainty_score":0.9985342},"labels":[],"label_agreement":null},{"id":"W4312139668","doi":"10.1136/ijgc-2022-igcs.108","title":"EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Concordance; Immunohistochemistry; Medicine; Biopsy; Pathology; Biomarker; Oncology; Internal medicine; Biology","score_opus":0.07215531685176914,"score_gpt":0.41495175829142544,"score_spread":0.3427964414396563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985028,0.00015835559,0.0004538526,0.00007190389,0.00018933343,0.00024503967,0.0003299765,0.0000020153884,0.000046738543],"genre_scores_gemma":[0.9972252,0.000047388934,0.0024377878,0.000035183002,0.00009092528,0.000055505214,0.00009589801,0.0000072556318,0.0000048356287],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99774164,0.0003839451,0.0012662599,0.00022325762,0.0002675368,0.000117376],"domain_scores_gemma":[0.9983173,0.00023444732,0.0010553643,0.0001372316,0.00021690191,0.000038741186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057754386,0.000106448904,0.0004257446,0.00010583415,0.000021151867,0.0000050804506,0.0004685093,0.00010625924,0.00035041888],"category_scores_gemma":[0.0003989241,0.00009101158,0.000089368405,0.0000983047,0.00010418073,0.000005111547,0.000319512,0.00024607003,8.2655774e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007524054,0.0017591417,0.3703959,0.0000053014487,0.0000669489,0.00002762194,0.00012225713,0.0015009257,0.6182298,0.00002931982,0.00022006885,0.006890309],"study_design_scores_gemma":[0.002751642,0.005981061,0.6945306,0.00008716103,0.000034526547,0.000018539882,0.0016659941,0.00020860281,0.29245833,0.0013004029,0.00078894506,0.00017421419],"about_ca_topic_score_codex":0.0005929293,"about_ca_topic_score_gemma":0.00055890763,"teacher_disagreement_score":0.32577148,"about_ca_system_score_codex":0.0000429004,"about_ca_system_score_gemma":0.00016263455,"threshold_uncertainty_score":0.3836841},"labels":[],"label_agreement":null},{"id":"W4312139697","doi":"10.1136/ijgc-2022-igcs.99","title":"EP008/#378 Comparative genomic analysis of ovarian clear cell carcinoma patients with and without a second primary malignancy","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Sinai Health System; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Exome sequencing; Germline mutation; Germline; Exome; Somatic cell; Mutation; Malignancy; Clear cell carcinoma; Biology; Cancer research; Genetics; Oncology; Medicine; Cancer; Gene","score_opus":0.01899243943221456,"score_gpt":0.27941193840184797,"score_spread":0.2604194989696334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967769,0.0008546763,0.000021653954,0.00050938036,0.00022581803,0.00020434149,0.00024401482,0.000003174351,0.0011600418],"genre_scores_gemma":[0.9982989,0.00007368712,0.0006096435,0.00073094585,0.00006663268,0.000034434044,0.000035207548,0.000008637719,0.00014195367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986121,0.00007448082,0.00043777842,0.0001921259,0.0005576917,0.00012579998],"domain_scores_gemma":[0.99865186,0.00011455102,0.0005798635,0.000090447946,0.000452812,0.00011049028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014302945,0.0001291343,0.0005760871,0.00027553982,0.000056636152,0.000015722342,0.00015452244,0.00003389123,0.0049394914],"category_scores_gemma":[0.000010488074,0.00008903217,0.00016460649,0.00021378305,0.00007689923,0.00007094638,0.000099582605,0.00021617598,8.811374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024314632,0.0010202667,0.9908799,0.000014204475,0.0027499634,0.00010499432,0.00040534482,0.00064634584,0.00020424814,0.00007225019,0.0003073134,0.0011637113],"study_design_scores_gemma":[0.005469063,0.002640924,0.988087,0.000019153897,0.0013249079,0.00002498457,0.00012742379,0.000086723325,0.00023805832,0.000024656842,0.0018676252,0.00008946157],"about_ca_topic_score_codex":0.00006035666,"about_ca_topic_score_gemma":0.000056708082,"teacher_disagreement_score":0.0049386104,"about_ca_system_score_codex":0.00067009416,"about_ca_system_score_gemma":0.0002510144,"threshold_uncertainty_score":0.99597013},"labels":[],"label_agreement":null},{"id":"W4312139712","doi":"10.1136/ijgc-2022-igcs.341","title":"EP250/#199 Intraoperative predictors of appendiceal abnormalities in mucinous ovarian neoplasms","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre","funders":"","keywords":"Appendix; Medicine; Mucinous cystadenoma; Frozen section procedure; Mucinous Tumor; Pathological; Malignancy; Adenocarcinoma; Ovarian tumor; Surgical pathology; Radiology; Mucinous cystadenocarcinoma; Adnexal mass; Pathology; Ovary; Internal medicine; Ovarian cancer; Cancer","score_opus":0.013774682696939584,"score_gpt":0.2889047287264949,"score_spread":0.2751300460295553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905311,0.00050373026,0.00002095725,0.0032872811,0.0020427592,0.00017245079,0.00011201975,0.000010022559,0.003319711],"genre_scores_gemma":[0.9974827,0.0002109771,0.00024416787,0.0011571813,0.0004914245,0.000033349745,0.000013768404,0.000010216666,0.00035621252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977987,0.00012979248,0.0007956941,0.00015414442,0.00088590727,0.00023576431],"domain_scores_gemma":[0.9987583,0.000234871,0.00044360862,0.00007094353,0.0003821284,0.00011011258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049745385,0.00014321384,0.000456733,0.00027553661,0.00006935216,0.000017109514,0.0003621158,0.00007057124,0.006578465],"category_scores_gemma":[0.0001714205,0.000107546955,0.00017574201,0.00018952807,0.00016138455,0.00015332214,0.00015276695,0.0006074475,0.000003368082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010503541,0.0034348464,0.89252293,0.00013482357,0.0017800522,0.009159628,0.009518286,0.00905426,0.016962485,0.023399245,0.004126452,0.019403463],"study_design_scores_gemma":[0.008194078,0.0072517823,0.92020494,0.00029641954,0.00018344607,0.0038040073,0.007138391,0.00051393,0.010528227,0.0015646215,0.039914712,0.00040543158],"about_ca_topic_score_codex":0.0003089944,"about_ca_topic_score_gemma":0.00010788698,"teacher_disagreement_score":0.03578826,"about_ca_system_score_codex":0.0005045084,"about_ca_system_score_gemma":0.00042961983,"threshold_uncertainty_score":0.99432963},"labels":[],"label_agreement":null},{"id":"W4312139713","doi":"10.1136/ijgc-2022-igcs.205","title":"EP114/#506 Molecular classification of endometrial carcinosarcoma shows uniformly P53ABN subtype and provide opportunities for diagnostic improvement","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Carcinosarcoma; Spindle cell carcinoma; Pathology; Medicine; Carcinoma; Stromal cell; Population; Molecular pathology; Oncology; Biology","score_opus":0.07413221766127297,"score_gpt":0.3328791397358116,"score_spread":0.25874692207453864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324596,0.0006387267,0.00025423622,0.0043106335,0.0007030033,0.0004227148,0.00018416933,0.000005224504,0.00023535949],"genre_scores_gemma":[0.99817216,0.0002837837,0.00046748773,0.0004953584,0.00017276255,0.00015432156,0.000034088494,0.000009373585,0.00021067169],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881977,0.000038791037,0.00046401715,0.00012371525,0.0004335831,0.00012013787],"domain_scores_gemma":[0.99835384,0.00052946026,0.0004642951,0.00006824427,0.0004938941,0.000090294714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002672693,0.000099411875,0.00027114718,0.0001845236,0.00004837901,0.000015632071,0.00014796162,0.000034236156,0.000389566],"category_scores_gemma":[0.000723184,0.00007409241,0.00012414438,0.00006793463,0.000056792578,0.000072628056,0.00009623056,0.00013226167,1.7553543e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011200407,0.004931389,0.39877757,0.0002132621,0.0034899935,0.0021509603,0.0003341461,0.00028732375,0.10760589,0.014458626,0.0027355885,0.45381483],"study_design_scores_gemma":[0.03697075,0.026181525,0.807017,0.00013946371,0.0010794058,0.0008116451,0.0013695178,0.00088401296,0.018672785,0.0037388173,0.10271961,0.00041545686],"about_ca_topic_score_codex":0.000046514142,"about_ca_topic_score_gemma":0.0000139261865,"teacher_disagreement_score":0.4533994,"about_ca_system_score_codex":0.00034373414,"about_ca_system_score_gemma":0.0002871231,"threshold_uncertainty_score":0.42654744},"labels":[],"label_agreement":null},{"id":"W4312139724","doi":"10.1136/ijgc-2022-igcs.5","title":"O003/#557 Overall survival results from ARIEL3: a phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Placebo; Clinical endpoint; Oncology; Population; Discontinuation; Randomized controlled trial","score_opus":0.07927624418906286,"score_gpt":0.40390224494664057,"score_spread":0.3246260007575777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97864944,0.00023260507,0.0019070092,0.011621929,0.0040308046,0.0026506723,0.00075152126,0.000020074138,0.00013595364],"genre_scores_gemma":[0.9939981,0.00001605175,0.0016058531,0.0025139218,0.0007326587,0.000821178,0.000079527876,0.000034632663,0.0001980762],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99526656,0.0007276462,0.0016835559,0.0004319923,0.001601275,0.0002889555],"domain_scores_gemma":[0.992931,0.004477536,0.0012454609,0.00025452967,0.0008478074,0.00024364215],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036719183,0.0002795612,0.0011960757,0.00041719284,0.00014012416,0.000048155973,0.00053686334,0.00010443114,0.0017347194],"category_scores_gemma":[0.001543758,0.00022817863,0.0006614626,0.0002381625,0.00007389417,0.00009230619,0.000092177244,0.00055929105,0.0000013815076],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9768022,0.0033973062,0.0020658358,0.000005903937,0.0012276114,0.00023798943,0.002033949,0.004423882,0.005397394,0.000056910598,0.0016634332,0.0026876307],"study_design_scores_gemma":[0.9662048,0.012179393,0.0061246357,0.00012163341,0.0003055056,0.000022940487,0.0006332494,0.0011694584,0.0032128277,0.00036058066,0.009405423,0.00025953804],"about_ca_topic_score_codex":0.00032763655,"about_ca_topic_score_gemma":0.00010342078,"teacher_disagreement_score":0.015348669,"about_ca_system_score_codex":0.0013953567,"about_ca_system_score_gemma":0.0010129324,"threshold_uncertainty_score":0.9991778},"labels":[],"label_agreement":null},{"id":"W4312139731","doi":"10.1136/ijgc-2022-igcs.78","title":"34/#806 Patterns of palliative care utilization by women with gynecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Palliative care; Retrospective cohort study; Population; Gynecologic cancer; Cohort; Logistic regression; Cancer; Malignancy; End-of-life care; Uterine cancer; Comorbidity; Health care; Emergency medicine; Internal medicine; Ovarian cancer; Nursing","score_opus":0.0542230057266596,"score_gpt":0.34951810085004936,"score_spread":0.29529509512338975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979001,0.00045138664,0.000255941,0.0004249239,0.00022167634,0.00016211382,0.000389877,0.0000041682783,0.00018980089],"genre_scores_gemma":[0.99891686,0.00010001075,0.00021071952,0.00044160776,0.000031488922,0.00005454043,0.00013814495,0.000008006832,0.00009861871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979086,0.00010808381,0.00060835446,0.00018982291,0.0010034645,0.0001816849],"domain_scores_gemma":[0.99753207,0.0003175436,0.00081126735,0.00008547943,0.0011739647,0.00007966931],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019970266,0.00014215006,0.0006165274,0.00030981473,0.000040351377,0.0000073202445,0.00022397994,0.0000579757,0.004889003],"category_scores_gemma":[0.00034899852,0.00010763822,0.00012504689,0.0004306795,0.000041848856,0.000061794235,0.000048776023,0.0003336403,1.12330405e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000936615,0.00019312867,0.98407155,0.000018082517,0.00080658094,0.000121323916,0.0014770051,0.011845861,0.000080110985,0.000044988723,0.00015592469,0.00024884604],"study_design_scores_gemma":[0.0018899211,0.0012356517,0.99004495,0.00011149318,0.00019174333,0.0000014754457,0.0048881085,0.000118826814,0.0004135944,0.00005216909,0.0009462472,0.00010582424],"about_ca_topic_score_codex":0.5549873,"about_ca_topic_score_gemma":0.9190657,"teacher_disagreement_score":0.36407843,"about_ca_system_score_codex":0.008809414,"about_ca_system_score_gemma":0.0015108163,"threshold_uncertainty_score":0.9960207},"labels":[],"label_agreement":null},{"id":"W4312139732","doi":"10.1136/ijgc-2022-igcs.208","title":"EP117/#763 Application of shallow whole genome sequencing to identify therapeutic opportunities in p53abn endometrial cancers","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Immunohistochemistry; Ovarian cancer; Serous fluid; DNA sequencing; Cancer research; Biology; Gene; Medicine; Computational biology; Internal medicine; Cancer; Genetics","score_opus":0.05400606972188343,"score_gpt":0.3417697228001382,"score_spread":0.28776365307825474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349403,0.0019192246,0.0015776037,0.001226507,0.0011058978,0.00017306664,0.00023121394,0.0000020481082,0.00027041172],"genre_scores_gemma":[0.99681675,0.00090570515,0.0001880757,0.0014114187,0.0004613137,0.000083768304,0.000039360548,0.000010898504,0.0000827201],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987583,0.00006559512,0.00048321832,0.0001683298,0.000375592,0.00014893369],"domain_scores_gemma":[0.9990442,0.000107488675,0.00036707422,0.000100462246,0.00030662798,0.00007414951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044814378,0.00009693409,0.00020079527,0.00021527034,0.00004033193,0.000021237793,0.0005094952,0.000054156728,0.0003509885],"category_scores_gemma":[0.0002128513,0.000093534116,0.00012194906,0.0001389395,0.000043475804,0.000008394014,0.00021436256,0.00016201938,0.0000011314083],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011184481,0.0001525164,0.022552207,0.000009269939,0.00026877783,0.000071239854,0.00025006963,0.13429408,0.8105014,0.00044547862,0.0005140103,0.029822508],"study_design_scores_gemma":[0.008622826,0.005366103,0.2603837,0.00006691011,0.00015854198,0.00021789492,0.003677361,0.000953843,0.04227611,0.004195258,0.6731088,0.0009726278],"about_ca_topic_score_codex":0.00027374597,"about_ca_topic_score_gemma":0.0004515844,"teacher_disagreement_score":0.7682253,"about_ca_system_score_codex":0.0008536857,"about_ca_system_score_gemma":0.00058807654,"threshold_uncertainty_score":0.3843078},"labels":[],"label_agreement":null},{"id":"W4312139759","doi":"10.1136/ijgc-2022-igcs.9","title":"O007/#456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hamilton Health Sciences; Juravinski Cancer Centre; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"PMS2; MSH2; MSH6; MLH1; Medicine; Cancer research; Mutation; Oncology; DNA mismatch repair; Internal medicine; Endometrial cancer; Cancer; Genetics; Biology; Gene","score_opus":0.009203471795560211,"score_gpt":0.27710181128738326,"score_spread":0.26789833949182307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598867,0.0007785101,0.000035166533,0.00076861685,0.00042368312,0.0010684711,0.00085235474,0.000034919685,0.000049601902],"genre_scores_gemma":[0.99803954,0.00008049731,0.0007149575,0.00042794226,0.000056117162,0.00034352098,0.00011213457,0.000033654513,0.00019160459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99521744,0.0008318466,0.0010827122,0.00049350865,0.001958855,0.00041560899],"domain_scores_gemma":[0.9947801,0.0010030243,0.0012360049,0.00021647816,0.0025677707,0.00019660026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012568686,0.00031354523,0.000901009,0.0011511632,0.00009073854,0.00002361946,0.0002899555,0.00012048075,0.0029038875],"category_scores_gemma":[0.0011731536,0.00021649568,0.00039316682,0.0019456204,0.00019775113,0.00014292875,0.00011531539,0.00062845834,9.696995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2597336,0.0016790335,0.70328593,0.000021668293,0.0045619714,0.00040764036,0.0008619874,0.02276099,0.0051862,0.000003804133,0.0003714561,0.0011257617],"study_design_scores_gemma":[0.016228193,0.01826518,0.95749813,0.00012704163,0.0012602491,0.000025806456,0.00064451154,0.00054759276,0.004102313,0.000010945931,0.0009990387,0.00029101022],"about_ca_topic_score_codex":0.001479074,"about_ca_topic_score_gemma":0.00079639035,"teacher_disagreement_score":0.2542122,"about_ca_system_score_codex":0.0040574577,"about_ca_system_score_gemma":0.0012245885,"threshold_uncertainty_score":0.9997658},"labels":[],"label_agreement":null},{"id":"W4312139790","doi":"10.1136/ijgc-2022-igcs.354","title":"EP263/#849 Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: characterization of long-term/short-term treatment duration in light","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Manitoba; CancerCare Manitoba; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Olaparib; Medicine; Ovarian cancer; Oncology; Internal medicine; BRCA mutation; Chemotherapy; Paclitaxel; Cancer; Biology","score_opus":0.014314468246697822,"score_gpt":0.29310357414764676,"score_spread":0.27878910590094896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966475,0.0002249569,0.00016069038,0.0013266862,0.00053787115,0.0007393412,0.00027591892,0.000009081507,0.000077956814],"genre_scores_gemma":[0.9978495,0.0010102727,0.00008371181,0.0001724227,0.00006372886,0.00026869445,0.00046171734,0.000016922952,0.000073001516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978806,0.00020249917,0.0008286454,0.00027832264,0.00060511066,0.00020483711],"domain_scores_gemma":[0.99841756,0.00013372926,0.0007688439,0.0000831298,0.00051437336,0.000082340965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020353094,0.00019993438,0.0004241095,0.00040124214,0.00006693209,0.000023576711,0.00008436752,0.00009180736,0.0005111646],"category_scores_gemma":[0.000051581388,0.00015491605,0.00006794035,0.00026024348,0.00006693533,0.00028427973,0.000024517443,0.00021272371,4.4232678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047817435,0.0023577316,0.9197463,0.00001318774,0.00019118059,0.00026395413,0.0017981795,0.0005085537,0.0140411705,0.000035427085,0.000013716629,0.056248873],"study_design_scores_gemma":[0.012721741,0.0052698255,0.97339743,0.00013936928,0.0000712761,0.0000708604,0.000103457875,0.00013458615,0.007819147,0.00003664123,0.00009274046,0.0001429018],"about_ca_topic_score_codex":0.00022443001,"about_ca_topic_score_gemma":0.00044403897,"teacher_disagreement_score":0.05610597,"about_ca_system_score_codex":0.0047661085,"about_ca_system_score_gemma":0.00038121274,"threshold_uncertainty_score":0.99905443},"labels":[],"label_agreement":null},{"id":"W4312139815","doi":"10.1136/ijgc-2022-igcs.283","title":"EP192/#270 Enhanced recovery after surgery for gynecologic oncology patients undergoing laparotomy during the COVID-19 pandemic","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Laparotomy; Gynecologic oncology; Comorbidity; Coronavirus disease 2019 (COVID-19); Pandemic; Emergency medicine; Internal medicine; General surgery; Surgery; Disease","score_opus":0.043283087436037614,"score_gpt":0.3447656084093469,"score_spread":0.3014825209733093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845634,0.000622179,0.0009578451,0.0057652537,0.006906126,0.0007336158,0.0001247739,0.000042432323,0.0002843362],"genre_scores_gemma":[0.98046976,0.0009976504,0.0002757109,0.015386829,0.00081632927,0.00118438,0.000026233376,0.0000305282,0.00081259373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967059,0.00042821447,0.001129281,0.00037213217,0.00089760113,0.00046687786],"domain_scores_gemma":[0.988533,0.009175473,0.0011312239,0.00019121676,0.00069414324,0.00027492386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016106918,0.00025337003,0.0007187457,0.00035617047,0.0002947372,0.000043549848,0.0005091433,0.00017265546,0.0056386227],"category_scores_gemma":[0.006156141,0.0001742323,0.0007142026,0.00023793099,0.00014598544,0.00024156032,0.00032353064,0.0008303564,0.000008418994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019696444,0.0011820509,0.93497676,0.00012734832,0.0011138795,0.0008449271,0.00028303603,0.006350607,0.0017181811,0.000021976211,0.010473303,0.02321148],"study_design_scores_gemma":[0.009488911,0.0040853797,0.74604475,0.00013255724,0.00029597472,0.0013267272,0.00037118112,0.00006928004,0.0011486132,0.0022752592,0.23416242,0.0005989471],"about_ca_topic_score_codex":0.0000142364215,"about_ca_topic_score_gemma":0.00013372254,"teacher_disagreement_score":0.22368912,"about_ca_system_score_codex":0.0053114463,"about_ca_system_score_gemma":0.001833737,"threshold_uncertainty_score":0.99850696},"labels":[],"label_agreement":null},{"id":"W4312139817","doi":"10.1136/ijgc-2022-igcs.385","title":"EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; Discontinuation; Adverse effect; Cancer; Oncology; Endometrial cancer; Cervical cancer; Gastroenterology","score_opus":0.008890800626564428,"score_gpt":0.2760678294530735,"score_spread":0.26717702882650907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765354,0.0007254376,0.00003383955,0.0005190581,0.0007275278,0.00020276578,0.000038718073,0.0000138826435,0.0000852442],"genre_scores_gemma":[0.9978462,0.00017585214,0.0008647934,0.0007479852,0.000088996094,0.000068713554,0.000022165728,0.000023244229,0.00016205767],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99801,0.0004752625,0.0004275614,0.00035955245,0.0004500723,0.0002775736],"domain_scores_gemma":[0.99896413,0.00015550572,0.00036286862,0.00015411341,0.00022186474,0.00014149155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081518525,0.00019545894,0.00027340636,0.00017354239,0.00009059799,0.000032070435,0.000490339,0.00013018845,0.00044815041],"category_scores_gemma":[0.000529642,0.00015597984,0.00008764815,0.00016814093,0.00010544128,0.000034346274,0.00027274952,0.00040333258,8.098277e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02074196,0.0006102275,0.073128775,0.000009663183,0.00039302488,0.0019629318,0.0003074227,0.017003616,0.87399125,0.00021451132,0.00087168283,0.010764902],"study_design_scores_gemma":[0.01979379,0.032564938,0.7445548,0.00012215212,0.00015144992,0.001660904,0.002052758,0.00093584467,0.15120628,0.0026238556,0.042931966,0.0014012265],"about_ca_topic_score_codex":0.000040796844,"about_ca_topic_score_gemma":0.0006536628,"teacher_disagreement_score":0.722785,"about_ca_system_score_codex":0.0005842557,"about_ca_system_score_gemma":0.0005129641,"threshold_uncertainty_score":0.63606733},"labels":[],"label_agreement":null},{"id":"W4312139819","doi":"10.1136/ijgc-2022-igcs.369","title":"EP278/#101 Applications of machine learning in ovarian cancer: a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Machine learning; Artificial intelligence; Support vector machine; Logistic regression; Computer science; Ovarian cancer; Medicine; Artificial neural network; Internal medicine; Oncology; Cancer","score_opus":0.06121618485942105,"score_gpt":0.40301123788233745,"score_spread":0.3417950530229164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033937915,0.99511975,0.000031521904,0.0016169203,0.0005977288,0.0019624487,0.00018859336,0.000008584141,0.0004710787],"genre_scores_gemma":[0.00021136057,0.9951278,0.000143049,0.00064124505,0.00031652354,0.0031150207,0.000068507696,0.000032022315,0.00034445184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604934,0.00036624793,0.0021845961,0.0002914478,0.0009100395,0.00019832818],"domain_scores_gemma":[0.9954682,0.00096069847,0.0028118521,0.00021461018,0.0004108708,0.00013376516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087355555,0.00032015896,0.0034720611,0.0004325346,0.00003896936,0.000017967599,0.0005896571,0.00015619639,0.009381119],"category_scores_gemma":[0.00068167795,0.00020790685,0.0009718549,0.00049396657,0.0000510732,0.000060263137,0.00014289602,0.0010058444,0.00000862393],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006307403,0.001021953,0.0012524942,0.43141827,0.0034036525,0.00063168065,0.000035579378,0.00004575657,3.1300027e-7,0.00031806354,0.0005947776,0.5612144],"study_design_scores_gemma":[0.0008681063,0.00031089725,0.00014118366,0.28810027,0.0044274875,0.00033982145,0.000010127587,0.000006083231,5.4655385e-7,0.000034711105,0.7056138,0.00014700499],"about_ca_topic_score_codex":0.00022730484,"about_ca_topic_score_gemma":0.00009096329,"teacher_disagreement_score":0.705019,"about_ca_system_score_codex":0.0024313284,"about_ca_system_score_gemma":0.001319764,"threshold_uncertainty_score":0.99152446},"labels":[],"label_agreement":null},{"id":"W4312139826","doi":"10.1136/ijgc-2022-igcs.207","title":"EP116/#725 Low-grade p53abn endometrial carcinomas exist and are associated with a high risk of recurrence, even in low-stage disease","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Internal medicine; Serous fluid; Adjuvant therapy; Retrospective cohort study; Disease; Gastroenterology; Cancer; Oncology","score_opus":0.021401458180357498,"score_gpt":0.2848225849616474,"score_spread":0.2634211267812899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485743,0.0018613914,0.000037785354,0.0011110975,0.0009806952,0.00031828057,0.00069581385,0.000009667792,0.00012782853],"genre_scores_gemma":[0.9986727,0.0005385792,0.00007939614,0.00026928922,0.00019860922,0.000054099888,0.00003121447,0.000017697681,0.00013839538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974603,0.00027431914,0.00065772736,0.00025417592,0.0011279109,0.00022555696],"domain_scores_gemma":[0.99748033,0.00057719724,0.0011119496,0.00011768847,0.0004881757,0.00022465354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005925621,0.00017270904,0.0005311062,0.00046759757,0.00006020818,0.000018444807,0.00027908827,0.00008149038,0.0010410412],"category_scores_gemma":[0.0026006594,0.0001345576,0.00017651712,0.00047580161,0.00014786649,0.000085354855,0.00015024772,0.0008708715,7.328513e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010242401,0.0016776032,0.9668007,0.000051247305,0.0009903901,0.0049321386,0.00022877625,0.010052443,0.0010361149,0.00019591479,0.0005265562,0.0032657052],"study_design_scores_gemma":[0.011971459,0.0015315557,0.983441,0.00046028505,0.00023655791,0.00007630338,0.00014783566,0.00027384836,0.0003971401,0.00041986743,0.00087476464,0.00016937013],"about_ca_topic_score_codex":0.00025978574,"about_ca_topic_score_gemma":0.00033506608,"teacher_disagreement_score":0.016640302,"about_ca_system_score_codex":0.0012979843,"about_ca_system_score_gemma":0.00065461715,"threshold_uncertainty_score":0.99987215},"labels":[],"label_agreement":null},{"id":"W4312139847","doi":"10.1136/ijgc-2022-igcs.236","title":"EP145/#106 Application of machine learning in endometrial cancer: a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Endometrial cancer; Machine learning; Mean absolute error; Medicine; Artificial intelligence; Biomarker; Cancer; Systematic review; Algorithm; Internal medicine; Computer science; Mean squared error; MEDLINE; Statistics; Mathematics","score_opus":0.07398715233753653,"score_gpt":0.4159809458887163,"score_spread":0.34199379355117976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028718921,0.9959367,0.000026855281,0.00045638718,0.0012195475,0.0018758009,0.00015069918,0.000012154013,0.00029311818],"genre_scores_gemma":[0.0007312246,0.9967344,0.0000652744,0.0004314311,0.00054190174,0.0011834543,0.00008603412,0.00003230453,0.00019397303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947611,0.0005641215,0.002723074,0.00031213084,0.0014095869,0.00022997783],"domain_scores_gemma":[0.993414,0.0022372329,0.0035446612,0.00018069718,0.0004721009,0.00015132813],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013192364,0.0003584719,0.0045600343,0.0008829988,0.000032756936,0.000014817833,0.00068394403,0.0002009549,0.0053068865],"category_scores_gemma":[0.0045674527,0.00022401178,0.0012864146,0.0012214076,0.000055712615,0.000076731885,0.00017368952,0.0011867563,0.000008587279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043992707,0.00060891756,0.0007489148,0.30415958,0.0022419463,0.00030959264,0.00001605671,0.000026468206,0.0000014241933,0.000055214343,0.00009931543,0.69129264],"study_design_scores_gemma":[0.004069459,0.0011327931,0.00008984756,0.26574978,0.0064804675,0.0003311841,0.000011234612,0.000019888017,0.0000026449718,0.000050149498,0.7218078,0.00025477033],"about_ca_topic_score_codex":0.00031872222,"about_ca_topic_score_gemma":0.00006129194,"teacher_disagreement_score":0.7217085,"about_ca_system_score_codex":0.0025512357,"about_ca_system_score_gemma":0.0008420744,"threshold_uncertainty_score":0.99560237},"labels":[],"label_agreement":null},{"id":"W4312294925","doi":"10.1136/ijgc-2022-esgo.394","title":"2022-RA-165-ESGO Surgeon-administered transversus abdominis plane (TAP) block versus placebo after midline laparotomy in gynecologic oncology: a double-blind randomized trial","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Placebo; Anesthesia; Surgery; Nausea; Bupivacaine; Laparotomy; Randomized controlled trial; Postoperative nausea and vomiting; Vomiting; Placebo-controlled study; Double blind","score_opus":0.05881158276733157,"score_gpt":0.3657621266228672,"score_spread":0.30695054385553566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312294925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729576,0.0006706803,0.000024919935,0.015691936,0.004139575,0.0032691504,0.000026646589,0.000027755985,0.0031917414],"genre_scores_gemma":[0.99031293,0.0005773991,0.00029039773,0.0040009744,0.0008879405,0.002611922,0.00004270239,0.000026375488,0.0012493491],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952477,0.00094540825,0.0016028965,0.00042345308,0.0013131272,0.0004673735],"domain_scores_gemma":[0.9943455,0.0039607054,0.0009137807,0.00019543742,0.00032838847,0.00025620588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035671443,0.00034651888,0.0014935839,0.0005717378,0.00010427818,0.000048032423,0.0006394761,0.0002477235,0.017603595],"category_scores_gemma":[0.0006987945,0.00026415594,0.00071674975,0.0003058407,0.00024965193,0.00011693669,0.00015569411,0.0011136541,0.000020815729],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9763372,0.0020512734,0.004556368,0.0000192658,0.0010812464,0.009767289,0.00029730206,0.0006403996,0.00003715078,0.0001508758,0.0027566936,0.0023049654],"study_design_scores_gemma":[0.85747707,0.0056191813,0.004180508,0.000035871755,0.00051720627,0.0003186241,0.00040998735,0.0002070535,0.00003507546,0.00009851517,0.13084215,0.00025876783],"about_ca_topic_score_codex":0.0000669861,"about_ca_topic_score_gemma":0.0002702472,"teacher_disagreement_score":0.12808546,"about_ca_system_score_codex":0.0015533649,"about_ca_system_score_gemma":0.0007663273,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W4312327267","doi":"10.1136/ijgc-2022-esgo.214","title":"2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Occupational Cancer Research Centre","funders":"","keywords":"Grading (engineering); Endometrial cancer; Medicine; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Cohort; Prospective cohort study; Gastroenterology; Cancer; Confidence interval; Biology","score_opus":0.0415855608351319,"score_gpt":0.34509499324475335,"score_spread":0.30350943240962147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312327267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98104304,0.0029609334,0.00013710833,0.008838231,0.0049677417,0.00053421175,0.00030350944,0.0000195738,0.0011956586],"genre_scores_gemma":[0.99216974,0.0009542025,0.00088295905,0.0041160956,0.0010483754,0.00013568078,0.000014705319,0.000020391499,0.0006578481],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967149,0.000116553645,0.0009051449,0.00029343495,0.0016623421,0.0003076225],"domain_scores_gemma":[0.99667823,0.00135648,0.00066844514,0.0001420821,0.00085673435,0.00029800745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048598903,0.00019872117,0.0006587669,0.000640534,0.00009403632,0.000022482434,0.0005413335,0.00007488349,0.012393505],"category_scores_gemma":[0.0035459627,0.00015151536,0.000395003,0.0011203192,0.0000708247,0.000110000066,0.00022833365,0.00054701365,0.000010057058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045279805,0.0037022596,0.48944566,0.00016206928,0.0060783923,0.003035913,0.0014295896,0.00926575,0.024257768,0.0009007892,0.04501213,0.3714299],"study_design_scores_gemma":[0.0566198,0.033069845,0.41162905,0.00088784314,0.0017051114,0.0011100443,0.0010523709,0.0006565679,0.028502285,0.0037521205,0.45983374,0.0011812124],"about_ca_topic_score_codex":0.0002106173,"about_ca_topic_score_gemma":0.000038734503,"teacher_disagreement_score":0.41482162,"about_ca_system_score_codex":0.002242956,"about_ca_system_score_gemma":0.0005719863,"threshold_uncertainty_score":0.9885093},"labels":[],"label_agreement":null},{"id":"W4312387531","doi":"10.1136/ijgc-2022-esgo.956","title":"2022-RA-1165-ESGO Feasibility and safety of inguinofemoral sentinel lymph node biopsy for previously excised vulvar cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vulvar cancer; Sentinel lymph node; Groin; Biopsy; Surgery; Sentinel node; Proportional hazards model; Retrospective cohort study; Lymph node; Cancer; Vulva; Urology; Radiology; Breast cancer; Internal medicine","score_opus":0.05064725621194882,"score_gpt":0.36095758938559713,"score_spread":0.3103103331736483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312387531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878248,0.0053879055,0.00015718344,0.003784969,0.0016686402,0.00045124607,0.00037171395,0.000012229508,0.00034131613],"genre_scores_gemma":[0.9952215,0.0015117578,0.0006609812,0.0014375944,0.0006335131,0.00014584801,0.00002490425,0.000016117518,0.00034779529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770886,0.000107112726,0.0008210123,0.00027998575,0.0008300907,0.00025295987],"domain_scores_gemma":[0.99769485,0.00047375658,0.0006675863,0.00012262672,0.00084381003,0.00019739971],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061514054,0.00018023551,0.0006185179,0.00018249355,0.00010518051,0.00001773413,0.00030617387,0.00007852322,0.004578751],"category_scores_gemma":[0.00072934414,0.00013151484,0.00031534236,0.00025256546,0.00012212088,0.00008980495,0.00019725974,0.0002739143,7.475329e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014324316,0.0010835454,0.95498896,0.00011113015,0.0009330622,0.00016199528,0.00013915985,0.00030198437,0.0033065449,0.00020049706,0.0005898766,0.02385891],"study_design_scores_gemma":[0.019401936,0.0007856965,0.97064376,0.00012178921,0.00038765973,0.0002354231,0.00014846321,0.00020415474,0.0007887309,0.0010545207,0.00604043,0.00018744169],"about_ca_topic_score_codex":0.00019440256,"about_ca_topic_score_gemma":0.000017734093,"teacher_disagreement_score":0.023671469,"about_ca_system_score_codex":0.0012826846,"about_ca_system_score_gemma":0.00045797956,"threshold_uncertainty_score":0.9963312},"labels":[],"label_agreement":null},{"id":"W4312391275","doi":"10.1136/ijgc-2022-esgo.169","title":"2022-RA-1161-ESGO The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"CHEK2; Medicine; Breast cancer; Internal medicine; Tamoxifen; Oophorectomy; Cancer; Oncology; Gynecology; Mutation; Surgery; Hysterectomy; Biology; Germline mutation; Gene","score_opus":0.009432999278752265,"score_gpt":0.30131398882167176,"score_spread":0.2918809895429195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312391275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953628,0.000358238,0.000031866915,0.001129403,0.00097184815,0.00014097197,0.0018083315,0.0000019198874,0.00019457654],"genre_scores_gemma":[0.9989903,0.00013398877,0.000056077897,0.00026363292,0.00032339134,0.000080940554,0.00008641798,0.000014092961,0.00005115194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855757,0.00015135919,0.00036742442,0.00019096745,0.00058603927,0.00014662989],"domain_scores_gemma":[0.99868053,0.00012898061,0.00043387298,0.0001360371,0.00057285506,0.000047732352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022143057,0.00013064168,0.00018780821,0.000098515055,0.00006820695,0.000017932882,0.00055908115,0.000056961824,0.003440841],"category_scores_gemma":[0.00009077874,0.00008109374,0.00015071241,0.0001839226,0.0001075773,0.000010740053,0.00013301132,0.00031027678,9.933648e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029750282,0.0006701256,0.8249942,0.0000015423249,0.00085947284,0.000015863421,0.00019733325,0.1511858,0.0068001393,0.000030447709,0.0025666687,0.009703365],"study_design_scores_gemma":[0.0020545078,0.0008097337,0.99421275,0.000015658281,0.00002726006,0.000007990459,0.00013441121,0.000081726495,0.0010823408,0.00015303232,0.001308489,0.00011210055],"about_ca_topic_score_codex":0.000562282,"about_ca_topic_score_gemma":0.00049348024,"teacher_disagreement_score":0.16921854,"about_ca_system_score_codex":0.0008020942,"about_ca_system_score_gemma":0.0006513893,"threshold_uncertainty_score":0.99747014},"labels":[],"label_agreement":null},{"id":"W4312441204","doi":"10.1136/ijgc-2022-esgo.437","title":"2022-RA-1144-ESGO Management of immune-related adverse events in patients with solid tumours treated with dostarlimab in the GARNET study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Internal medicine; Interim analysis; Thyroid cancer; Surgery; Cancer; Oncology; Clinical trial","score_opus":0.009573825460149116,"score_gpt":0.2815752089474993,"score_spread":0.2720013834873502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312441204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770766,0.00025028456,0.0000019786476,0.00071646523,0.0002550024,0.0006983314,0.000025546398,0.0000037858929,0.00034096514],"genre_scores_gemma":[0.99927694,0.00012054085,0.000029197137,0.00029822873,0.000016931353,0.000080076854,0.000020903864,0.00001041488,0.00014674259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768007,0.00019898749,0.0007066047,0.00016078947,0.0010831686,0.00017038114],"domain_scores_gemma":[0.99899197,0.00007708444,0.00055718847,0.00012042045,0.00022048793,0.000032851378],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006780009,0.00013867595,0.00032512896,0.0002445356,0.000039163428,0.0000044310095,0.00039953695,0.00003112189,0.0014640996],"category_scores_gemma":[0.0000164402,0.00007591051,0.00010317552,0.0004224032,0.00006411405,0.00008413423,0.000075477845,0.00041504417,6.452474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02551404,0.003918191,0.9637702,0.000008459121,0.0010089756,0.00079056073,0.0006456414,0.0015280722,0.000057150035,0.00001011398,0.00007285654,0.0026757084],"study_design_scores_gemma":[0.021818403,0.0058988663,0.9682587,0.00014915016,0.0001194463,0.000040972358,0.0033065744,0.000024832922,0.000027190681,0.000016817181,0.00024917192,0.0000898835],"about_ca_topic_score_codex":0.00024850614,"about_ca_topic_score_gemma":0.00021619715,"teacher_disagreement_score":0.0044884584,"about_ca_system_score_codex":0.0007539717,"about_ca_system_score_gemma":0.00011655984,"threshold_uncertainty_score":0.9994487},"labels":[],"label_agreement":null},{"id":"W4312452303","doi":"10.1136/ijgc-2022-esgo.221","title":"2022-RA-648-ESGO Interpretable deep learning provides clues for prognostic refinement of the molecular endometrial cancer classification","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Receiver operating characteristic; Artificial intelligence; Cancer; Endometrial cancer; Computational biology; Biology; Oncology; Computer science; Internal medicine; Medicine","score_opus":0.021602683434326423,"score_gpt":0.34456503909149955,"score_spread":0.32296235565717313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312452303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96517867,0.0033756415,0.007387836,0.019687455,0.0032971376,0.0006329499,0.000024764695,0.000014274503,0.00040125515],"genre_scores_gemma":[0.99614054,0.00039586524,0.0011500447,0.0012343841,0.00046084344,0.00023963368,0.00000954847,0.000015736612,0.0003533834],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979591,0.00018094805,0.0006211063,0.00017425275,0.0008865181,0.00017807953],"domain_scores_gemma":[0.9977775,0.00063956156,0.0008055063,0.000092079455,0.0006066893,0.00007866582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094910763,0.00011244997,0.00032550225,0.0001734549,0.00012880395,0.000026578504,0.00045748285,0.00004565452,0.0013714904],"category_scores_gemma":[0.005000238,0.000072659896,0.0002773821,0.0002071541,0.00012517633,0.00006506238,0.00018091127,0.0007319521,3.80634e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004395782,0.0011966571,0.4229191,0.00017307291,0.0019339817,0.00008905146,0.0009205669,0.051738974,0.15786555,0.0038890077,0.0043793176,0.35049894],"study_design_scores_gemma":[0.019238323,0.0068092924,0.30533966,0.0009946455,0.0015772902,0.0004135481,0.0022810127,0.18800586,0.01126587,0.0037754758,0.45964634,0.0006526641],"about_ca_topic_score_codex":0.00005584777,"about_ca_topic_score_gemma":0.000010646708,"teacher_disagreement_score":0.45526704,"about_ca_system_score_codex":0.0005933385,"about_ca_system_score_gemma":0.0003280085,"threshold_uncertainty_score":0.9995414},"labels":[],"label_agreement":null},{"id":"W4312462526","doi":"10.1136/ijgc-2022-esgo.538","title":"2022-RA-657-ESGO ENGOT-ov65/KEYNOTE-B96: phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bevacizumab; Pembrolizumab; Clinical endpoint; Ovarian cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Placebo; Oncology; Progression-free survival; Paclitaxel; Phases of clinical research; Cancer; Surgery; Clinical trial; Chemotherapy; Pathology; Immunotherapy","score_opus":0.07586500025897046,"score_gpt":0.39868658035641974,"score_spread":0.32282158009744927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312462526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814531,0.0029444755,0.0005273296,0.006117123,0.0036237722,0.0038737087,0.0009807044,0.000020384334,0.00045936505],"genre_scores_gemma":[0.9933491,0.0006437053,0.0008113366,0.00029493342,0.0009614417,0.0035501083,0.00009432361,0.000040140847,0.0002549221],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954395,0.00028331627,0.0013940441,0.00051271793,0.0019826314,0.0003877814],"domain_scores_gemma":[0.995003,0.0017225697,0.0014893094,0.00024084985,0.001271002,0.00027328383],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010887627,0.00038680754,0.0013520656,0.0003667439,0.00023018717,0.000059436647,0.0004977332,0.00010759677,0.0068084016],"category_scores_gemma":[0.0003286525,0.00026739112,0.00048288394,0.00026770897,0.00016477602,0.00017276325,0.00017158865,0.0006479648,0.0000018167257],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9605726,0.006712001,0.0011845361,0.000047962985,0.006014692,0.00045339594,0.0007703722,0.010368254,0.00010779998,0.001379264,0.0018687999,0.0105203185],"study_design_scores_gemma":[0.9637077,0.020120911,0.003473811,0.00020366334,0.0019716995,0.00012430218,0.0011752407,0.001104498,0.00018009718,0.00018739422,0.0074326615,0.0003180225],"about_ca_topic_score_codex":0.0003737828,"about_ca_topic_score_gemma":0.00062534853,"teacher_disagreement_score":0.0134089105,"about_ca_system_score_codex":0.0033452068,"about_ca_system_score_gemma":0.0015801688,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W4312462741","doi":"10.1136/ijgc-2022-esgo.685","title":"2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Barts Health NHS Trust; Cancer Research UK; London School of Hygiene and Tropical Medicine; University of Washington; Queen Mary University of London; Univerzitetni Klinični Center Maribor","keywords":"Medicine; Genetic testing; Germline mutation; Germline; Oncology; PARP inhibitor; Breast cancer; Population; Ovarian cancer; BRCA mutation; Internal medicine; Cancer; Gynecology; Cost effectiveness; Genetics; Biology; Mutation","score_opus":0.030854852112699144,"score_gpt":0.34022892624514034,"score_spread":0.3093740741324412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312462741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98645806,0.0031979955,0.0077687628,0.00049987866,0.0010723077,0.00046976315,0.00050661154,0.000004999579,0.000021637596],"genre_scores_gemma":[0.9933415,0.00031931305,0.004769917,0.00041677317,0.0006254998,0.00042067817,0.000040867475,0.000021774506,0.000043694756],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998508,0.0002032844,0.0005070416,0.00025368703,0.00034339854,0.000184635],"domain_scores_gemma":[0.99770474,0.00040320703,0.0005440101,0.00009255157,0.0011735986,0.00008186862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049621443,0.00014340415,0.00026759302,0.00008671909,0.00011284255,0.000019092737,0.00039462373,0.000086095904,0.00039426828],"category_scores_gemma":[0.00096171536,0.00012957508,0.0001074786,0.00015907073,0.00009682147,0.000008934562,0.0001696948,0.00017987659,2.1057821e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012909754,0.00017882076,0.024296159,0.000058526606,0.00044247045,0.000015319336,0.000088746056,0.05193946,0.88339037,0.000024674931,0.00041262477,0.037861854],"study_design_scores_gemma":[0.0119914105,0.0048616417,0.5374531,0.00016753002,0.00036495915,0.00030920588,0.00026136063,0.011947794,0.4054959,0.0012280573,0.025183894,0.0007351414],"about_ca_topic_score_codex":0.00005961124,"about_ca_topic_score_gemma":0.000055967572,"teacher_disagreement_score":0.51315695,"about_ca_system_score_codex":0.00030491894,"about_ca_system_score_gemma":0.00066500885,"threshold_uncertainty_score":0.52839184},"labels":[],"label_agreement":null},{"id":"W4312465454","doi":"10.1136/ijgc-2022-esgo.905","title":"2022-RA-745-ESGO The efficacy of second curettage in the treatment of low-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Chemotherapy; Internal medicine; Relative risk; Confounding; Curettage; Oncology; Surgery; Confidence interval","score_opus":0.069461810607754,"score_gpt":0.38281502387659383,"score_spread":0.3133532132688398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312465454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013197074,0.99455464,0.000020641017,0.0007881152,0.00017270575,0.0017841306,0.0013133351,0.0000025940788,0.000044112665],"genre_scores_gemma":[0.0065752775,0.9919177,0.00009148402,0.0003707058,0.00007589136,0.0006726948,0.00006627092,0.000017430526,0.00021252305],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99451214,0.0011713282,0.0023427904,0.00029535074,0.0015043016,0.00017409037],"domain_scores_gemma":[0.9809027,0.0146514885,0.0034119866,0.00028195395,0.00066992344,0.00008195867],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009749249,0.00040223228,0.0050403657,0.00044861817,0.000065752385,0.000029515204,0.00055574655,0.00008846862,0.005834694],"category_scores_gemma":[0.0037371619,0.00016848391,0.002847479,0.0007097908,0.00025062932,0.00007007507,0.000076527635,0.00050329324,0.0000023206776],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057973823,0.0046765143,0.00074304536,0.28498545,0.6958668,0.0012537234,0.0011101991,0.000980465,9.0547996e-7,0.0007380316,0.001383672,0.007681417],"study_design_scores_gemma":[0.0013862392,0.0014118571,0.010453597,0.00917187,0.9403622,0.00033240631,0.00023414181,0.000018380742,2.6003553e-7,0.0001023921,0.036312245,0.00021437134],"about_ca_topic_score_codex":0.000027089342,"about_ca_topic_score_gemma":0.000094421826,"teacher_disagreement_score":0.27581358,"about_ca_system_score_codex":0.0004946332,"about_ca_system_score_gemma":0.0005942082,"threshold_uncertainty_score":0.9950741},"labels":[],"label_agreement":null},{"id":"W4312515827","doi":"10.1136/ijgc-2022-esgo.1007","title":"2022-RA-1699-ESGO ERAS pathway for gynecological oncology – a pre-post implementation cohort with 1211 patients","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Retrospective cohort study; Cohort; Intensive care unit; General surgery; Emergency medicine; Internal medicine","score_opus":0.01487144885955462,"score_gpt":0.34344021050948886,"score_spread":0.32856876164993426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312515827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892727,0.00015867679,0.0009815724,0.0041075116,0.0035528957,0.0009896357,0.0003513428,0.000026582768,0.0005590418],"genre_scores_gemma":[0.9903306,0.00013921558,0.0017907987,0.0056025703,0.00060260034,0.00079723535,0.00020907505,0.000027988273,0.000499952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969623,0.00022029689,0.0009248634,0.0003635445,0.0011484261,0.0003805539],"domain_scores_gemma":[0.995849,0.0012341943,0.00094594347,0.00013443605,0.0016273675,0.00020904765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086998777,0.00022908591,0.0006157904,0.0002604012,0.00016926271,0.000034140998,0.0004108114,0.0001320293,0.010425414],"category_scores_gemma":[0.0007240106,0.00016190587,0.00031461156,0.00018407678,0.0001025462,0.00023605784,0.00020349347,0.0006573449,0.0000052873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011423729,0.0024425422,0.84642357,0.00002712662,0.0013220101,0.0007198998,0.00027814484,0.0006897482,0.0032643988,0.00016323758,0.012140108,0.12110546],"study_design_scores_gemma":[0.007065784,0.013491671,0.86107767,0.000034060366,0.00019176546,0.00033826253,0.00032261343,0.00006708689,0.0018674406,0.00029201267,0.11500422,0.00024740733],"about_ca_topic_score_codex":0.000035050143,"about_ca_topic_score_gemma":0.000203244,"teacher_disagreement_score":0.12085805,"about_ca_system_score_codex":0.0023128968,"about_ca_system_score_gemma":0.0010046795,"threshold_uncertainty_score":0.9904792},"labels":[],"label_agreement":null},{"id":"W4312529229","doi":"10.1136/ijgc-2022-esgo.302","title":"2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Microsatellite instability; Endometrial cancer; Cohort; Discontinuation; Subgroup analysis; Oncology; Population; Cancer; Pembrolizumab; Clinical trial; Confidence interval; Immunotherapy","score_opus":0.0138661576199066,"score_gpt":0.29580592083675544,"score_spread":0.2819397632168488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312529229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952325,0.000515377,0.000018124498,0.001526274,0.0015529232,0.00070489704,0.00042045544,0.0000036036995,0.000025819128],"genre_scores_gemma":[0.99777776,0.00042301876,0.00006785897,0.0012525251,0.00015088645,0.00024057782,0.00004303102,0.00001624031,0.000028100521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956695,0.0011417851,0.0011482419,0.00026664298,0.0015156998,0.00025813314],"domain_scores_gemma":[0.9959885,0.0021276716,0.0011138888,0.00016609069,0.00052869436,0.00007515293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022506705,0.00019485383,0.0007619956,0.00088700425,0.000045795285,0.000029173607,0.00051000476,0.00008351421,0.004025628],"category_scores_gemma":[0.0016614451,0.00012508951,0.00023582348,0.0013670457,0.0000954187,0.00007902496,0.000098479715,0.0007136101,3.1909408e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38991976,0.001429417,0.5945606,0.000004690566,0.0010158664,0.00009923721,0.0009716104,0.0019756486,0.0012761432,0.0000024959627,0.0005618424,0.008182656],"study_design_scores_gemma":[0.0437219,0.007871668,0.9443153,0.000046731882,0.0003090359,0.0000048198217,0.0002447782,0.00021102719,0.00023349919,0.00001472289,0.0028827568,0.00014377035],"about_ca_topic_score_codex":0.00034333617,"about_ca_topic_score_gemma":0.00044879163,"teacher_disagreement_score":0.34975466,"about_ca_system_score_codex":0.0017429516,"about_ca_system_score_gemma":0.0004925102,"threshold_uncertainty_score":0.9968848},"labels":[],"label_agreement":null},{"id":"W4312533640","doi":"10.1136/ijgc-2022-esgo.585","title":"2022-RA-893-ESGO Is ethnicity a risk factor for differential outcomes in mucinous ovarian cancer? experience from a UK gynaecological oncology centre","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Ulm; Leids Universitair Medisch Centrum; Rijksuniversiteit Groningen; Barts Health NHS Trust; Universitätsklinikum Heidelberg; Universiteit Leiden; McGill University; Jewish General Hospital; University of Ottawa; Université Laval","keywords":"Ethnic group; Ovarian cancer; Medicine; Stage (stratigraphy); Population; Cancer; Gynecology; Internal medicine; Oncology; Biology","score_opus":0.04532582613489729,"score_gpt":0.37525337181455215,"score_spread":0.3299275456796549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312533640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97222316,0.0009646285,0.00019159858,0.018272236,0.0046838066,0.00063095795,0.0028897633,0.000016097198,0.00012774924],"genre_scores_gemma":[0.99238396,0.0014607895,0.000806058,0.0038463657,0.00062435825,0.0005965461,0.000024995834,0.000018864304,0.000238062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707144,0.00024163359,0.00091075286,0.0004918673,0.0008675032,0.00041679776],"domain_scores_gemma":[0.9970595,0.0013122295,0.00080171996,0.00016881691,0.00040992038,0.00024781094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023254698,0.0002813567,0.00091567467,0.00019743263,0.00015288636,0.00003855095,0.0005410012,0.0001967107,0.07895712],"category_scores_gemma":[0.0005719516,0.00019930076,0.00048978574,0.00015728043,0.00010685085,0.0000894714,0.0002654422,0.00083358225,0.000004301227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026932412,0.0028637706,0.8868903,0.0000063193747,0.0011150136,0.0009935026,0.00218584,0.00027068157,0.00037876295,0.00011785131,0.0016013669,0.100883335],"study_design_scores_gemma":[0.009947749,0.0020265405,0.9697722,0.000030113331,0.00022535607,0.000036574336,0.0006192214,0.00041827784,0.0004267511,0.0006011993,0.015686931,0.00020903746],"about_ca_topic_score_codex":0.0019004513,"about_ca_topic_score_gemma":0.0018959468,"teacher_disagreement_score":0.100674294,"about_ca_system_score_codex":0.004182177,"about_ca_system_score_gemma":0.0007095324,"threshold_uncertainty_score":0.9996406},"labels":[],"label_agreement":null},{"id":"W4312537268","doi":"10.1136/ijgc-2022-esgo.780","title":"2022-RA-747-ESGO Quality of end-of-life care and patterns of palliative care use by women with gynaecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; McMaster University; Queen's University; University of Toronto; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Palliative care; Retrospective cohort study; End-of-life care; Intensive care unit; Emergency department; Logistic regression; Population; Cancer; Emergency medicine; Internal medicine; Nursing","score_opus":0.05705649422280812,"score_gpt":0.3565112348128402,"score_spread":0.2994547405900321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312537268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668175,0.0012110258,0.000054635802,0.00016920375,0.00015942518,0.00017666847,0.0014740112,0.00000233588,0.000070937625],"genre_scores_gemma":[0.9990965,0.00017521299,0.00030232838,0.00021791038,0.00002039343,0.000033966186,0.00011370336,0.0000074245886,0.000032553144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997402,0.00019601175,0.00092489796,0.00021166407,0.0010952095,0.00017021128],"domain_scores_gemma":[0.99600875,0.0007615749,0.0013737835,0.000111940906,0.0016398905,0.00010408482],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028090202,0.00015885259,0.0009761628,0.00028591283,0.000031702486,0.0000058344394,0.00021853288,0.00006970502,0.0028122822],"category_scores_gemma":[0.0008271057,0.00012055291,0.00015372524,0.00033507467,0.000103732724,0.000076027514,0.00007753216,0.00034560362,2.5689602e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015084026,0.00017303311,0.9890381,0.00008855945,0.0011575901,0.000054299686,0.003887441,0.0035164922,0.00022762959,0.000048705253,0.000051490762,0.00024822718],"study_design_scores_gemma":[0.002331958,0.001487832,0.9819048,0.0001340112,0.00019773432,6.7092293e-7,0.013059699,0.000021698039,0.00053606665,0.000027543221,0.00018764897,0.000110355744],"about_ca_topic_score_codex":0.70490456,"about_ca_topic_score_gemma":0.93213904,"teacher_disagreement_score":0.22723448,"about_ca_system_score_codex":0.0042449143,"about_ca_system_score_gemma":0.0018760917,"threshold_uncertainty_score":0.99957764},"labels":[],"label_agreement":null},{"id":"W4312562578","doi":"10.1136/ijgc-2022-esgo.272","title":"2022-RA-995-ESGO Independent prognostic significance of substantial lymphovascular space invasion (LVSI) in a consecutive series of primary LVSI-positive endometrial carcinoma (EC)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Univariate analysis; Oncology; Multivariate analysis","score_opus":0.026690615501646402,"score_gpt":0.281416564406527,"score_spread":0.2547259489048806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312562578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125206,0.004156564,0.000081447164,0.001038202,0.0016755168,0.00072851666,0.00035806326,0.0000070293318,0.0007025846],"genre_scores_gemma":[0.9979544,0.0009075864,0.000287571,0.00026731624,0.0003311336,0.00010388827,0.000038527804,0.00001720642,0.000092348964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598473,0.00039122914,0.0011346552,0.000323541,0.0018897784,0.0002760479],"domain_scores_gemma":[0.9962447,0.0013681967,0.0010875093,0.00014116584,0.0010017751,0.000156606],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081292575,0.00023053367,0.0009970253,0.00068396406,0.000056657893,0.0000142998215,0.00042643657,0.00011903346,0.0024688053],"category_scores_gemma":[0.0016508444,0.00018096135,0.0004143086,0.0008935789,0.00024860102,0.00017369931,0.00026593474,0.00054058246,0.0000013442523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051082075,0.0037671777,0.88316417,0.00014939022,0.0020986025,0.004003189,0.0010260817,0.0008007573,0.040509768,0.00080336805,0.00024789598,0.012347512],"study_design_scores_gemma":[0.025867315,0.007853077,0.9120628,0.00026610773,0.00042302074,0.00049189996,0.0010605279,0.000019910258,0.050193556,0.000761283,0.0007498574,0.0002506292],"about_ca_topic_score_codex":0.00057638506,"about_ca_topic_score_gemma":0.00016479939,"teacher_disagreement_score":0.028898634,"about_ca_system_score_codex":0.0021073418,"about_ca_system_score_gemma":0.0013255673,"threshold_uncertainty_score":0.99844307},"labels":[],"label_agreement":null},{"id":"W4312610418","doi":"10.1136/ijgc-2022-esgo.925","title":"2022-RA-690-ESGO Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Groin; Surgery; Sentinel node; Vulvar cancer; Stage (stratigraphy); Metastasis; Sentinel lymph node; Radiation therapy; Lymph node; Lymphadenectomy; Radiology; Cancer; Vulva; Breast cancer; Internal medicine","score_opus":0.018829365366987493,"score_gpt":0.2992526011319527,"score_spread":0.2804232357649652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312610418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953864,0.0003924949,0.000012006411,0.0019590068,0.00042813702,0.00026062704,0.00011300744,0.000009493283,0.0014388218],"genre_scores_gemma":[0.9952156,0.000045347013,0.00016443443,0.0031432153,0.00017236071,0.000041510088,0.000031549233,0.000027766071,0.0011582213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968413,0.00019008177,0.0006617917,0.0003455533,0.0015264165,0.00043482997],"domain_scores_gemma":[0.99831855,0.00019884229,0.00032458553,0.00014223871,0.0007277612,0.00028802402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003984063,0.00024103014,0.0005309534,0.0004133199,0.00011169185,0.00007669944,0.00040023058,0.00006633205,0.013538242],"category_scores_gemma":[0.00010378861,0.00017768072,0.00013996729,0.00033140605,0.00013219572,0.00019379202,0.00034521727,0.00064136,0.000004934636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004637247,0.00074609293,0.9899419,0.00004957543,0.00010913974,0.0013923274,0.00039189422,0.00035625766,0.000117572316,0.000038633032,0.00026599024,0.001953367],"study_design_scores_gemma":[0.0151236085,0.000965551,0.9806572,0.000017404638,0.00007639457,0.0000952958,0.00012214702,0.00053414574,0.00015275393,0.000082620114,0.0019739168,0.00019892988],"about_ca_topic_score_codex":0.00055857317,"about_ca_topic_score_gemma":0.000045862987,"teacher_disagreement_score":0.013533307,"about_ca_system_score_codex":0.0012253767,"about_ca_system_score_gemma":0.0004823723,"threshold_uncertainty_score":0.9873635},"labels":[],"label_agreement":null},{"id":"W4312636240","doi":"10.1136/ijgc-2022-esgo.885","title":"2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Microsatellite instability; Internal medicine; Oncology; Endometrial cancer; Medicine; Biomarker; Population; Cancer; Immunohistochemistry; Cohort; Discontinuation; Companion diagnostic; Biology; Microsatellite; Genetics; Gene","score_opus":0.01881900531286725,"score_gpt":0.3396093660512748,"score_spread":0.32079036073840755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312636240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907396,0.0047393744,0.000007832329,0.0020942248,0.0011978004,0.0004606955,0.00057031534,0.000003753826,0.00018642262],"genre_scores_gemma":[0.99837595,0.0005368508,0.000025199424,0.0006926903,0.00013520475,0.00007412119,0.000025969035,0.00001153023,0.0001224765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964938,0.00033794987,0.0010168365,0.00024161201,0.0017031704,0.00020663922],"domain_scores_gemma":[0.9972661,0.0008171933,0.0009548586,0.00018409727,0.00067347835,0.000104276005],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066110434,0.00016915641,0.0008638311,0.00080415054,0.00004301826,0.000011765873,0.00064553943,0.000064082626,0.008881702],"category_scores_gemma":[0.001112371,0.000106129984,0.00062812574,0.0024149888,0.00009669267,0.00005862065,0.00027175425,0.0004999145,6.111856e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026531467,0.008800595,0.9032527,0.000020077985,0.012134236,0.00048290167,0.0005704275,0.00731035,0.017775506,0.00008101046,0.000769231,0.022271454],"study_design_scores_gemma":[0.02918692,0.006814325,0.95361394,0.000053458494,0.0031111066,0.000021375541,0.00063641643,0.000097546734,0.0030471059,0.000074321775,0.0031695736,0.00017388543],"about_ca_topic_score_codex":0.0015626693,"about_ca_topic_score_gemma":0.00063108606,"teacher_disagreement_score":0.05036122,"about_ca_system_score_codex":0.0010263108,"about_ca_system_score_gemma":0.00043249046,"threshold_uncertainty_score":0.9920243},"labels":[],"label_agreement":null},{"id":"W4312654940","doi":"10.1136/ijgc-2022-esgo.546","title":"2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Internal medicine; Oncology; Chemotherapy; Tolerability; Fallopian tube; Carboplatin; Cancer; Bevacizumab; Gastroenterology; Immunotherapy; Cisplatin; Gynecology; Adverse effect","score_opus":0.02393015304150537,"score_gpt":0.32948489967474714,"score_spread":0.3055547466332418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312654940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403745,0.00035430098,0.000016233766,0.0019485801,0.0018116147,0.0010040455,0.00062293635,0.000012135367,0.00019267494],"genre_scores_gemma":[0.9973714,0.00031831127,0.0002902162,0.00090616464,0.00048163504,0.00036450234,0.000057065747,0.000038687915,0.00017202483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962633,0.00018564037,0.0010703232,0.0004406773,0.0016778595,0.00036216463],"domain_scores_gemma":[0.9978407,0.00030260443,0.0008215219,0.00022968653,0.0006029016,0.00020258641],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002889009,0.00032968944,0.0008343617,0.00026283562,0.00010829141,0.0000402744,0.0004561094,0.000093174145,0.008382718],"category_scores_gemma":[0.00011205842,0.00022568888,0.00016924221,0.00027493175,0.0001006893,0.0001719391,0.00016070301,0.00064000185,0.0000016473157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28044236,0.02379455,0.6477968,0.000063971245,0.0033421495,0.002135772,0.001960216,0.0044251163,0.00072337623,0.000050413044,0.0011797716,0.034085512],"study_design_scores_gemma":[0.15458627,0.017962204,0.8194781,0.00016501153,0.00032502177,0.00002493089,0.0006330714,0.0002570909,0.0002600109,0.00000782883,0.006043255,0.0002571972],"about_ca_topic_score_codex":0.0010188055,"about_ca_topic_score_gemma":0.0017555427,"teacher_disagreement_score":0.1716813,"about_ca_system_score_codex":0.003715269,"about_ca_system_score_gemma":0.0011208236,"threshold_uncertainty_score":0.9925237},"labels":[],"label_agreement":null},{"id":"W4312695801","doi":"10.1136/ijgc-2022-esgo.236","title":"2022-RA-768-ESGO Free cancer cells in fallopian tubes (floaters) as artifacts of uterine manipulator use in minimally invasive surgery (MIS) for endometrial cancer: Does it matter? A retrospective cohort study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; The Society of Gynecologic Oncology of Canada","funders":"","keywords":"Endometrial cancer; Medicine; Hysterectomy; Retrospective cohort study; Uterine cancer; Univariate analysis; Stage (stratigraphy); Cancer; Surgery; Gynecology; Multivariate analysis; Internal medicine; Biology","score_opus":0.04048040783630756,"score_gpt":0.33814827557647525,"score_spread":0.2976678677401677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312695801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896206,0.0004937459,0.000003863948,0.0031346988,0.0040375153,0.0015256231,0.0010821793,0.000008992398,0.000092738555],"genre_scores_gemma":[0.9945436,0.0014767812,0.00010264026,0.0014948595,0.0006611077,0.0011513738,0.000022173108,0.00003313959,0.00051430304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578565,0.000255536,0.0015387755,0.000515854,0.0014756504,0.00042850288],"domain_scores_gemma":[0.996066,0.001992168,0.0007538002,0.0002172659,0.00076153834,0.0002092349],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009419979,0.0003225252,0.0013685843,0.0010680392,0.000062086365,0.000050542985,0.0005732328,0.00011491385,0.014008284],"category_scores_gemma":[0.0018324645,0.00023305799,0.00043175713,0.00076201634,0.0000893551,0.00028948713,0.0002806141,0.0005642151,0.0000033488404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013943155,0.0023046103,0.9728807,0.00006935547,0.0012915765,0.0010637837,0.00037001199,0.00069631706,0.005038159,0.000012232652,0.001174317,0.0011557554],"study_design_scores_gemma":[0.0146483,0.002550431,0.97182775,0.00021477266,0.00021530868,0.00003048144,0.00062540325,0.00002388408,0.0077061313,0.00023322765,0.0016768025,0.0002475197],"about_ca_topic_score_codex":0.009706672,"about_ca_topic_score_gemma":0.021315293,"teacher_disagreement_score":0.0140049355,"about_ca_system_score_codex":0.0038804414,"about_ca_system_score_gemma":0.0008638769,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W4312741811","doi":"10.1136/ijgc-2022-esgo.976","title":"2022-RA-1696-ESGO Impact of ERAS implementation for vulvar cancer surgery","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Vulvar cancer; Vulvar Carcinoma; Lichen sclerosus; Retrospective cohort study; Cancer; Cohort; Vulvar neoplasm; Carcinoma; Gynecology; General surgery; Oncology; Internal medicine; Dermatology","score_opus":0.042714185726742765,"score_gpt":0.4175017347640622,"score_spread":0.3747875490373195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312741811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915318,0.0013033573,0.0008174956,0.0021827351,0.0032674817,0.00028550683,0.0005224429,0.000010532868,0.00007863938],"genre_scores_gemma":[0.99621093,0.00090230757,0.00042383405,0.0010135549,0.00082161126,0.00021162402,0.00006234673,0.000020584253,0.00033322256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771297,0.00010745257,0.0009059003,0.00018709758,0.00083614537,0.0002504578],"domain_scores_gemma":[0.996666,0.0011486037,0.0009904692,0.0001011617,0.0009665745,0.00012720324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008470981,0.00015377713,0.00054867484,0.000345848,0.00006885938,0.000016614858,0.0002515266,0.00006088799,0.016394679],"category_scores_gemma":[0.0004386433,0.00011814546,0.00075947173,0.00020659274,0.00005128285,0.00019802236,0.00009863665,0.00033985515,0.0000016908895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004534069,0.0006087165,0.8177947,0.000049032024,0.0019810935,0.00021608274,0.00018890711,0.004950923,0.033074625,0.000062309125,0.07637805,0.06016151],"study_design_scores_gemma":[0.0036808616,0.0019159652,0.94993025,0.00014113498,0.00028205937,0.00036150214,0.00031354302,0.0002876156,0.011382367,0.0007700213,0.030634426,0.00030025543],"about_ca_topic_score_codex":0.00021884884,"about_ca_topic_score_gemma":0.0001074776,"teacher_disagreement_score":0.13213557,"about_ca_system_score_codex":0.001629545,"about_ca_system_score_gemma":0.0011889104,"threshold_uncertainty_score":0.98450446},"labels":[],"label_agreement":null},{"id":"W4312743757","doi":"10.1136/ijgc-2022-esgo.999","title":"2022-RA-1432-ESGO Economical impact of ERAS implementation in a high-volume gynecologic oncology surgery division in Canada","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Gynecologic oncology; General surgery; Emergency medicine; Surgery; Internal medicine","score_opus":0.01916558858123564,"score_gpt":0.34463389506243336,"score_spread":0.32546830648119773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312743757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993852,0.00035968891,0.000036595877,0.0025143898,0.0027864352,0.00022021905,0.00013093888,0.000004389032,0.00009533482],"genre_scores_gemma":[0.9981936,0.00039025178,0.00011762491,0.00095539173,0.0001610339,0.000073505296,0.000052003197,0.000013729748,0.00004283994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968656,0.00038503332,0.0014968694,0.00025632032,0.0006492357,0.000346962],"domain_scores_gemma":[0.996596,0.0018860942,0.0009904383,0.00011161586,0.00027312196,0.00014277328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012421188,0.00017740166,0.000874618,0.00062739506,0.00003162,0.000010397794,0.00031437396,0.000084317,0.015867416],"category_scores_gemma":[0.00063143973,0.00014723223,0.00031945578,0.00030780304,0.000051997522,0.00019751771,0.00020830896,0.00075742893,0.0000028116544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012937791,0.00047506543,0.9440372,0.000009957022,0.0001956774,0.0014743548,0.000058490685,0.022912942,0.0011887823,0.000011608601,0.0047872206,0.023554914],"study_design_scores_gemma":[0.002189113,0.0010042357,0.99352413,0.000043286604,0.00002187421,0.0001612466,0.00025951312,0.0004911701,0.00029465798,0.00025373464,0.0016206852,0.00013633311],"about_ca_topic_score_codex":0.24135457,"about_ca_topic_score_gemma":0.52381235,"teacher_disagreement_score":0.2824578,"about_ca_system_score_codex":0.015863786,"about_ca_system_score_gemma":0.006863848,"threshold_uncertainty_score":0.9987663},"labels":[],"label_agreement":null},{"id":"W4312767254","doi":"10.1136/ijgc-2022-esgo.927","title":"2022-RA-725-ESGO Treatment patterns & outcomes of patients with locally advanced vulvar or vaginal cancer in British Columbia","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbotsford Veterinary Clinic; University of the Fraser Valley; University of Toronto; University of British Columbia","funders":"","keywords":"Vulvar cancer; Medicine; Vaginal cancer; Hazard ratio; Chemotherapy; Cancer; Vulva; Radiation therapy; Cervical cancer; Chemoradiotherapy; Internal medicine; Oncology; Surgery; Confidence interval","score_opus":0.02036711858831985,"score_gpt":0.31714047447735605,"score_spread":0.2967733558890362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312767254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956895,0.0006524695,0.000037612244,0.0009797657,0.0011252479,0.0004583807,0.00094183866,0.000009801193,0.00010538409],"genre_scores_gemma":[0.9955109,0.001166465,0.00027923335,0.00096646574,0.00015233061,0.00025755283,0.000051502928,0.00002106031,0.0015945391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973065,0.00010154404,0.00077053736,0.00028067562,0.001261691,0.00027905474],"domain_scores_gemma":[0.9981447,0.0002965725,0.0005917174,0.0001212405,0.0006683212,0.00017748619],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016152524,0.0001760854,0.00074329466,0.00016551583,0.000067340254,0.00004181767,0.00032725735,0.00006329638,0.028665686],"category_scores_gemma":[0.00018112696,0.00014260385,0.00020432683,0.000340638,0.00007395003,0.0001357107,0.00011288662,0.000341472,0.000001897998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045712376,0.0024732982,0.90309155,0.000016242626,0.0008107988,0.0006370703,0.00006312474,0.00078922557,0.000025748363,0.0000022435597,0.0002095277,0.08730991],"study_design_scores_gemma":[0.019786188,0.0050394363,0.96675277,0.00014056146,0.00017436767,0.000057339214,0.00009474208,0.000006770277,0.000030766496,0.000048962134,0.007717191,0.00015088423],"about_ca_topic_score_codex":0.013376189,"about_ca_topic_score_gemma":0.12823424,"teacher_disagreement_score":0.114858046,"about_ca_system_score_codex":0.002338462,"about_ca_system_score_gemma":0.0005834433,"threshold_uncertainty_score":0.9931938},"labels":[],"label_agreement":null},{"id":"W4312793672","doi":"10.1136/ijgc-2022-esgo.258","title":"2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Endometrial cancer; Interquartile range; Internal medicine; Oncology; Adjuvant therapy; Proportional hazards model; Clinical trial; Adjuvant; Guideline; Cohort; Stage (stratigraphy); Gynecology; Cancer; Pathology","score_opus":0.06675258038874639,"score_gpt":0.40044965976143804,"score_spread":0.33369707937269166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312793672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128896,0.0013497958,0.00008829144,0.00020933362,0.0005408563,0.002125075,0.0043692617,0.0000029103735,0.000025538082],"genre_scores_gemma":[0.9971673,0.0005112186,0.00041330376,0.00019050356,0.00014382192,0.001080639,0.00043330074,0.000009963702,0.000049933074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955201,0.00034832963,0.0018959332,0.0003973704,0.0016291273,0.00020909955],"domain_scores_gemma":[0.9946968,0.0029383947,0.00145608,0.00022218058,0.0005870503,0.00009948727],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029746087,0.00020690846,0.0016440409,0.000639988,0.00007719918,0.000020149224,0.0005810442,0.00006068957,0.0046557537],"category_scores_gemma":[0.0019936096,0.00011693131,0.00025226595,0.00083649467,0.000051340558,0.00012715907,0.0002927903,0.00018931861,2.6359191e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020674676,0.0067174947,0.87090445,0.000005246908,0.014432897,0.000041013947,0.0020676153,0.000071089504,0.00030962977,0.0000022425072,0.00032117544,0.0844525],"study_design_scores_gemma":[0.033184092,0.0063736313,0.9532916,0.000024505765,0.0036901608,0.0000021627168,0.0008405346,0.00006093614,0.00045753113,0.00014311243,0.0018153009,0.00011645684],"about_ca_topic_score_codex":0.0007012813,"about_ca_topic_score_gemma":0.00067741243,"teacher_disagreement_score":0.08433604,"about_ca_system_score_codex":0.0027286294,"about_ca_system_score_gemma":0.00075883744,"threshold_uncertainty_score":0.99625415},"labels":[],"label_agreement":null},{"id":"W4312812087","doi":"10.1136/ijgc-2022-esgo.887","title":"2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Hamilton Health Sciences; Juravinski Cancer Centre; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"PMS2; MSH2; MSH6; MLH1; Medicine; Internal medicine; Oncology; Mutation; DNA mismatch repair; Cancer research; Cancer; Genetics; Biology; Gene","score_opus":0.008507642097674963,"score_gpt":0.27324294834027346,"score_spread":0.2647353062425985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312812087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954991,0.0009614521,0.0000351835,0.0007555488,0.00047217187,0.0011111379,0.0010753528,0.000033937416,0.00005611449],"genre_scores_gemma":[0.9980171,0.0001122191,0.0005950476,0.00042175764,0.00006305603,0.00036564178,0.00014644943,0.000035969657,0.00024280805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949367,0.0008869838,0.0011215619,0.00053327356,0.0020850967,0.00043640527],"domain_scores_gemma":[0.9947301,0.001046298,0.0012995808,0.00023673986,0.0024800946,0.00020717143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013302144,0.00033185523,0.00094263407,0.001205541,0.00010510883,0.000025994903,0.00031592103,0.00012703564,0.0035637126],"category_scores_gemma":[0.0012672348,0.00023178087,0.0003993434,0.0021372135,0.00021972995,0.00015369598,0.00012927923,0.0006880857,0.0000011094029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23780581,0.001786903,0.7266571,0.000023732267,0.0047167293,0.0004507844,0.00083240273,0.019098178,0.0069934535,0.0000044151143,0.0005507993,0.0010796774],"study_design_scores_gemma":[0.016438054,0.016779648,0.9580724,0.00013744763,0.0013037099,0.000028089215,0.00069727656,0.00057354756,0.004362725,0.000011470606,0.0012786636,0.0003169211],"about_ca_topic_score_codex":0.0016214371,"about_ca_topic_score_gemma":0.001055675,"teacher_disagreement_score":0.23141535,"about_ca_system_score_codex":0.0042405156,"about_ca_system_score_gemma":0.0012964046,"threshold_uncertainty_score":0.99958205},"labels":[],"label_agreement":null},{"id":"W4312818504","doi":"10.1136/ijgc-2022-esgo.405","title":"2022-RA-744-ESGO Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer centre: a quality improvement initiative","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hepatitis B virus; Oncology; Chemotherapy; Psychological intervention; Hepatitis B; Cancer; Risk factor; Immunology; Virus","score_opus":0.04407608550875307,"score_gpt":0.3634230772257654,"score_spread":0.3193469917170123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312818504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97563845,0.00035339082,0.00007367826,0.021738954,0.0010672387,0.00067124295,0.00020418072,0.000010302033,0.00024254636],"genre_scores_gemma":[0.9865548,0.002555618,0.00048916833,0.009616018,0.0002972968,0.00030369268,0.00002312724,0.000017962218,0.00014228627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996339,0.0005892305,0.0011996934,0.00032794697,0.0012239413,0.00032014423],"domain_scores_gemma":[0.9955908,0.001477605,0.0016209356,0.00014506697,0.0010510597,0.00011454915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014121386,0.00021182308,0.0005993977,0.00025896588,0.00020638641,0.000013213345,0.00042502076,0.000100878045,0.0023618473],"category_scores_gemma":[0.0023166847,0.00015042815,0.00022856054,0.00030981164,0.00014278061,0.00015850518,0.0004312233,0.000791066,0.0000020470648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002654995,0.00095706247,0.8732534,0.000009949464,0.00058287417,0.000058885787,0.0019391798,0.00070169714,0.004805297,0.000029669603,0.0044629737,0.11054399],"study_design_scores_gemma":[0.0040571243,0.0017738774,0.98059434,0.000104769104,0.000068482506,0.000013166506,0.00039981658,0.00013866076,0.001894656,0.00023408572,0.010569128,0.00015188695],"about_ca_topic_score_codex":0.0047306824,"about_ca_topic_score_gemma":0.011191932,"teacher_disagreement_score":0.1103921,"about_ca_system_score_codex":0.004867083,"about_ca_system_score_gemma":0.00046822504,"threshold_uncertainty_score":0.99895304},"labels":[],"label_agreement":null},{"id":"W4312842410","doi":"10.1136/ijgc-2022-esgo.645","title":"2022-RA-1127-ESGO The efficacy of MEK inhibitors in the treatment of low-grade serous ovarian cancers: a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Trametinib; Randomized controlled trial; Selumetinib; Internal medicine; MEDLINE; Oncology; Meta-analysis; Cancer; Kinase; MAPK/ERK pathway; KRAS","score_opus":0.07253093457225157,"score_gpt":0.3944759572621893,"score_spread":0.32194502268993774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312842410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036460534,0.99161375,0.0000017976203,0.0031092695,0.0013941714,0.0031177318,0.00020174115,0.0000042660618,0.00019265516],"genre_scores_gemma":[0.0035447408,0.99365723,0.000030906755,0.00079400145,0.0005191697,0.0013213434,0.0000349304,0.000027980195,0.00006972141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945871,0.0008836488,0.0025486525,0.00030242043,0.0014361918,0.00024196],"domain_scores_gemma":[0.99257463,0.0033641248,0.0031895458,0.00045075134,0.0003275505,0.0000934029],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011754634,0.00043007144,0.003409294,0.0002568626,0.000046423622,0.000025283869,0.0009394366,0.00015245301,0.001964907],"category_scores_gemma":[0.0007173805,0.00018117859,0.0016373568,0.0005510772,0.00013838329,0.0000555153,0.000072410985,0.00055326417,0.0000031911015],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004981332,0.0095474785,0.00067989994,0.3725769,0.015531224,0.0029585408,0.0014320358,0.00012893307,0.0000014010175,0.0005831004,0.005898199,0.5901642],"study_design_scores_gemma":[0.003607177,0.003206462,0.0007855508,0.36854056,0.011824959,0.0008043171,0.00023516415,0.0000042409442,0.000006981461,0.00004712429,0.6106839,0.0002535334],"about_ca_topic_score_codex":0.00033296,"about_ca_topic_score_gemma":0.00017827073,"teacher_disagreement_score":0.60478574,"about_ca_system_score_codex":0.003815005,"about_ca_system_score_gemma":0.0015839463,"threshold_uncertainty_score":0.99894744},"labels":[],"label_agreement":null},{"id":"W4312886117","doi":"10.1136/ijgc-2022-esgo.278","title":"2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Endometrial cancer; Discontinuation; Clinical endpoint; Oncology; Microsatellite instability; Cancer; Cohort; Surrogate endpoint; Population; Tolerability; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Clinical trial; Phases of clinical research; Adverse effect","score_opus":0.018415909106584444,"score_gpt":0.31028415400367676,"score_spread":0.2918682448970923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312886117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947893,0.00091388094,0.0000024009255,0.0010167153,0.0014417206,0.001483217,0.00010172383,0.000010475962,0.00024057907],"genre_scores_gemma":[0.9983751,0.0002765348,0.00008207806,0.00046808587,0.00012166345,0.0005119444,0.000027838012,0.00002602326,0.000110701745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958895,0.00044909437,0.0009836399,0.00036297188,0.001959389,0.000355407],"domain_scores_gemma":[0.9977901,0.0006247111,0.0007132627,0.0001919921,0.0005836363,0.00009630863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081284565,0.00027732347,0.0006283818,0.0005341572,0.00007759023,0.00003415944,0.0006722191,0.00007395477,0.007705294],"category_scores_gemma":[0.000511635,0.00014303497,0.00011379547,0.0010772871,0.000107418644,0.0001279853,0.00016220288,0.0012187653,0.0000017998283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061599646,0.0039615133,0.90222585,0.0000072945068,0.00052035536,0.0010677186,0.0010970791,0.0056919637,0.0001471711,0.00000448472,0.00022126462,0.023455627],"study_design_scores_gemma":[0.03410835,0.02103344,0.94121873,0.00013531387,0.0001338771,0.00008344879,0.0012777821,0.00005682999,0.00011429909,0.000020611267,0.0016118492,0.00020547895],"about_ca_topic_score_codex":0.0003097284,"about_ca_topic_score_gemma":0.0019955733,"teacher_disagreement_score":0.03899284,"about_ca_system_score_codex":0.0024383783,"about_ca_system_score_gemma":0.0006642209,"threshold_uncertainty_score":0.9932018},"labels":[],"label_agreement":null},{"id":"W4312887979","doi":"10.1136/ijgc-2022-esgo.624","title":"2022-RA-1068-ESGO Canadian practice patterns of primary treatment in advanced (stage III-IV) low grade serous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Dalhousie University; University of Toronto; Centre Hospitalier de l’Université de Montréal; McGill University; Impact; University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Regimen; Internal medicine; Oncology; Chemotherapy; Serous fluid; Ovarian carcinoma; Stage (stratigraphy); Ovarian cancer; Gynecology; Family medicine; Cancer","score_opus":0.023235797728728524,"score_gpt":0.3125554198190113,"score_spread":0.2893196220902828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312887979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97699594,0.0017110412,0.000021377225,0.017022459,0.0015466097,0.0004933279,0.00044656667,0.0000071847385,0.0017554604],"genre_scores_gemma":[0.9937387,0.0013185855,0.0004320082,0.0032906898,0.00028052076,0.00019838457,0.000055786393,0.00002051947,0.00066477514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765193,0.00016725824,0.00074806326,0.00028763153,0.0008242796,0.00032080428],"domain_scores_gemma":[0.9980669,0.00041374576,0.0006347442,0.00018090593,0.0004067597,0.00029691574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034985365,0.00021257656,0.0005779865,0.00038866722,0.00007661388,0.000022095457,0.00031279252,0.000078745004,0.005120445],"category_scores_gemma":[0.00015969899,0.0001686712,0.00023128376,0.00021049427,0.00003957691,0.00018942024,0.000086411485,0.00042272577,0.000002696034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032899843,0.0043568783,0.9134234,0.0000433088,0.0012750407,0.014805734,0.0009769929,0.004661754,0.0007267585,0.00066083035,0.000959639,0.05481966],"study_design_scores_gemma":[0.011443579,0.0033931863,0.9174624,0.00010655617,0.00021799715,0.00056730304,0.0008734316,0.00008191729,0.00074217253,0.0000654085,0.064856894,0.00018913283],"about_ca_topic_score_codex":0.056688357,"about_ca_topic_score_gemma":0.04367622,"teacher_disagreement_score":0.06389725,"about_ca_system_score_codex":0.008271382,"about_ca_system_score_gemma":0.0022313239,"threshold_uncertainty_score":0.995789},"labels":[],"label_agreement":null},{"id":"W4312929213","doi":"10.1136/ijgc-2022-esgo.420","title":"2022-RA-933-ESGO Risk of venous thromboembolism and major bleeding in gynaecological cancer surgery: series of systematic reviews and meta-analyses","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"","keywords":"Medicine; Observational study; Venous thromboembolism; Meta-analysis; MEDLINE; Randomized controlled trial; Incidence (geometry); Absolute risk reduction; Relative risk; Risk assessment; Intensive care medicine; Surgery; Confidence interval; Internal medicine; Thrombosis","score_opus":0.15937704380658205,"score_gpt":0.3933041456550083,"score_spread":0.23392710184842627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312929213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382657,0.057785586,0.000016739423,0.0022431586,0.0007029999,0.00072280486,0.0000955972,0.000005178225,0.00016223194],"genre_scores_gemma":[0.95568174,0.042981412,0.00024520993,0.0006225579,0.00009412681,0.00029456825,0.0000029003013,0.00001091209,0.0000665922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967804,0.0005069543,0.0015389463,0.00022848324,0.00074878836,0.00019641005],"domain_scores_gemma":[0.9963688,0.0012040981,0.001833851,0.00012281013,0.00036973282,0.00010070321],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00240715,0.00019943954,0.0029201738,0.0003605064,0.00007000032,0.000020693507,0.0002449554,0.00007138904,0.0042888694],"category_scores_gemma":[0.0017922638,0.00012329174,0.00044880054,0.0002381036,0.00015880457,0.00014267859,0.00026570712,0.00037433702,4.4996656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002929657,0.013221289,0.7688177,0.029731255,0.102185965,0.0027136456,0.0060059396,0.0063124923,0.011326187,0.0069622733,0.023677502,0.02611607],"study_design_scores_gemma":[0.0018698663,0.0018248215,0.964544,0.0009277052,0.023283413,0.00027125396,0.0015597938,0.00013661296,0.0007438358,0.0016037461,0.002925036,0.00030992844],"about_ca_topic_score_codex":0.00046909778,"about_ca_topic_score_gemma":0.00026106444,"teacher_disagreement_score":0.19572626,"about_ca_system_score_codex":0.00030301735,"about_ca_system_score_gemma":0.00014174881,"threshold_uncertainty_score":0.9966214},"labels":[],"label_agreement":null},{"id":"W4312965440","doi":"10.1136/ijgc-2022-esgo.423","title":"2022-RA-993-ESGO Comparing thoracic epidural analgesia to surgeon-administered continuous transversus abdominus plane blocks in gynaecologic oncology patients: a retrospective cohort study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Retrospective cohort study; Anesthesia; Surgery; Body mass index; Abdominal surgery; Internal medicine","score_opus":0.027392517850480132,"score_gpt":0.34068784133440466,"score_spread":0.3132953234839245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312965440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906124,0.00010747612,0.000048607286,0.004324782,0.0012648595,0.0013134659,0.00001827016,0.000020197524,0.0022899497],"genre_scores_gemma":[0.9958708,0.000052644165,0.00013508729,0.002934531,0.00018843447,0.00025198958,0.00002372775,0.000016754793,0.00052597286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638444,0.00057564053,0.0010369475,0.0004020678,0.0012151339,0.00038576173],"domain_scores_gemma":[0.99785125,0.0006410684,0.0006139569,0.00015506757,0.0005164815,0.00022215272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018515029,0.00024548313,0.0010501393,0.00050673675,0.000120441975,0.000033456356,0.00055558083,0.00009727093,0.0066573634],"category_scores_gemma":[0.00048104202,0.00020174409,0.00023195604,0.0003576491,0.00008070992,0.00008328372,0.00017062775,0.00080478366,0.000008493661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006511835,0.0030032818,0.97272575,0.0000069622256,0.0006376558,0.005855821,0.00068526214,0.0009856988,0.00002174714,0.00004074146,0.0029429628,0.0065823],"study_design_scores_gemma":[0.005438582,0.009240751,0.9705913,0.00002493554,0.00020576501,0.00015768301,0.0021174122,0.00014218422,0.000008252399,0.00005350143,0.011821053,0.0001985466],"about_ca_topic_score_codex":0.00020237896,"about_ca_topic_score_gemma":0.00071979244,"teacher_disagreement_score":0.00887809,"about_ca_system_score_codex":0.0034912075,"about_ca_system_score_gemma":0.00025503163,"threshold_uncertainty_score":0.9942507},"labels":[],"label_agreement":null},{"id":"W4313005602","doi":"10.1136/ijgc-2022-esgo.812","title":"2022-RA-1020-ESGO Family history in BRCA mutation carriers affected by breast and ovarian cancer and its role in identifying subjects at high risk","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Family history; Medicine; Ovarian cancer; Breast cancer; BRCA mutation; Oncology; Internal medicine; Cancer; Genetic counseling; Genetic testing; Prostate cancer; Pancreatic cancer; Gynecology; Genetics","score_opus":0.010076300872394745,"score_gpt":0.26493490227503835,"score_spread":0.2548586014026436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313005602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97373086,0.02379038,0.000029588682,0.00070541713,0.0012333174,0.00014086273,0.0002981224,0.0000035850437,0.00006788336],"genre_scores_gemma":[0.995582,0.0032071618,0.0000726232,0.0005845169,0.00016911639,0.00011084263,0.000049887793,0.000015527366,0.00020834689],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985848,0.00020219956,0.00037167832,0.00030071227,0.00035860259,0.00018200737],"domain_scores_gemma":[0.9992305,0.000066579574,0.00036133835,0.000067102745,0.00019493952,0.00007955584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040676206,0.00013638758,0.00019109556,0.00017885683,0.00007873763,0.000022178274,0.00023510303,0.000106662876,0.000557951],"category_scores_gemma":[0.00015573013,0.00013749872,0.00004931406,0.00011847924,0.000071002636,0.000025863808,0.0002266713,0.00034126986,4.5335858e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017586601,0.00031146538,0.25452456,0.000027537117,0.000487386,0.0003129802,0.001384755,0.015459075,0.67476696,0.00008728385,0.01201278,0.038866572],"study_design_scores_gemma":[0.0043316116,0.0003730146,0.9650418,0.000039630835,0.000053413452,0.0002845655,0.00066481804,0.0009112259,0.008733452,0.0003019182,0.018936971,0.00032755345],"about_ca_topic_score_codex":0.0010799473,"about_ca_topic_score_gemma":0.0032431437,"teacher_disagreement_score":0.7105173,"about_ca_system_score_codex":0.0024050085,"about_ca_system_score_gemma":0.0003707915,"threshold_uncertainty_score":0.62890136},"labels":[],"label_agreement":null},{"id":"W4313011202","doi":"10.1136/ijgc-2022-esgo.274","title":"2022-RA-998-ESGO Intermediate-risk endometrial cancer: isolated tumor cells (ITC) versus node-negative in sentinel lymph node mapping. An international multi-institutional comparative study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Lymph node; Sentinel lymph node; Sentinel node; Internal medicine; Oncology; Biopsy; Urology; Cancer; Breast cancer","score_opus":0.07066396365413957,"score_gpt":0.36970942138731244,"score_spread":0.29904545773317287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313011202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983384,0.0005064871,0.00018656046,0.00086822675,0.012844197,0.00071504014,0.00095364853,0.000035200086,0.00050665234],"genre_scores_gemma":[0.9957721,0.00061334646,0.0004610846,0.00087392883,0.0016053757,0.00036730003,0.000108149354,0.000026495893,0.00017220425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948536,0.0005698158,0.0014458158,0.0006237345,0.0020507756,0.0004562414],"domain_scores_gemma":[0.99586034,0.001197492,0.0012560514,0.00019556245,0.0011367943,0.0003537392],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089997734,0.00043848663,0.0010369401,0.0011907658,0.0002348454,0.00009235296,0.0010131281,0.00010882414,0.009644671],"category_scores_gemma":[0.0011426891,0.00033834664,0.00043010962,0.0010340073,0.00021475047,0.00048093408,0.0004712176,0.0012322227,0.000023264707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045785476,0.011040844,0.9075098,0.000014406522,0.0041867923,0.0030456611,0.0018364484,0.016166883,0.0022293883,0.00004443745,0.0003909906,0.0077488413],"study_design_scores_gemma":[0.091284916,0.0030717922,0.888471,0.000118893055,0.00041254648,0.00013654005,0.0034752067,0.009017746,0.00076448405,0.0000913527,0.002659988,0.0004955057],"about_ca_topic_score_codex":0.0013885718,"about_ca_topic_score_gemma":0.00043409583,"teacher_disagreement_score":0.045499437,"about_ca_system_score_codex":0.0046176515,"about_ca_system_score_gemma":0.00096279953,"threshold_uncertainty_score":0.99990684},"labels":[],"label_agreement":null},{"id":"W4313022548","doi":"10.1136/ijgc-2022-esgo.586","title":"2022-RA-894-ESGO Endometrioid ovarian carcinoma – real world evidence from a large transatlantic team initiative: First results of the LEOPARD study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Ontario Institute for Cancer Research; Jewish General Hospital; University of Ottawa; Université Laval","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian carcinoma; Cohort; Lymph node; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.05574767353281292,"score_gpt":0.3420120527129563,"score_spread":0.2862643791801434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313022548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795374,0.0014667718,0.000025548125,0.01433981,0.0021033697,0.0006079182,0.0006950782,0.0000091401635,0.0012149386],"genre_scores_gemma":[0.9972955,0.0008390577,0.00011141894,0.0007737767,0.0005781124,0.0001371435,0.000012601148,0.000013886372,0.00023852629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966816,0.0003416485,0.0009449401,0.00031331182,0.0014861489,0.00023235523],"domain_scores_gemma":[0.9963931,0.0018866351,0.00083845475,0.000251275,0.0005031211,0.0001274525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008849151,0.00018885564,0.0005602322,0.00028024346,0.00016843405,0.000030631385,0.0006651569,0.00004550038,0.004227513],"category_scores_gemma":[0.0008679853,0.000118554104,0.00035618793,0.00055285665,0.00007812217,0.00013202283,0.00022764973,0.00062012346,0.0000031808754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004335602,0.0035217393,0.97995806,0.000009888946,0.0011579054,0.00084235996,0.0015891225,0.00030765895,0.00017475786,0.00007714218,0.005635437,0.0023903418],"study_design_scores_gemma":[0.010523499,0.0025314225,0.97229147,0.00019174787,0.00042750695,0.000052198873,0.00068080786,0.000063214175,0.0005488042,0.00010056515,0.012477895,0.00011087378],"about_ca_topic_score_codex":0.0020662386,"about_ca_topic_score_gemma":0.003764277,"teacher_disagreement_score":0.017758051,"about_ca_system_score_codex":0.0013289854,"about_ca_system_score_gemma":0.0006384065,"threshold_uncertainty_score":0.99668276},"labels":[],"label_agreement":null},{"id":"W4313038059","doi":"10.1136/ijgc-2022-esgo.539","title":"2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Interquartile range; Adverse effect; Ovarian cancer; Gastroenterology; Population; Phases of clinical research; Progression-free survival; Cancer; Oncology; Clinical trial; Surgery; Chemotherapy","score_opus":0.09066084088177515,"score_gpt":0.3777070812159118,"score_spread":0.2870462403341366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313038059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915622,0.0009970298,0.00026907932,0.0019156557,0.0010304801,0.0008922881,0.003293733,0.000012636639,0.000026920166],"genre_scores_gemma":[0.99567443,0.00185637,0.0006555634,0.00031375367,0.00044651967,0.00021023762,0.00075775455,0.00003133254,0.00005404562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967507,0.00034993616,0.0013331416,0.00045701134,0.00088498736,0.00022418944],"domain_scores_gemma":[0.99610764,0.0006843459,0.0018720167,0.00015373505,0.0009425236,0.00023972655],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059687934,0.00031559923,0.0011534226,0.00018146644,0.00010386251,0.000045544148,0.00016234026,0.00009769414,0.0039428123],"category_scores_gemma":[0.00016228341,0.00019212611,0.00020866755,0.00018665433,0.00011119687,0.0001674326,0.000070062044,0.00029912018,8.466661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030081145,0.010255758,0.4860829,0.000007682639,0.0055287024,0.00026997647,0.00021873474,0.000044922737,0.0038477844,0.000028278586,0.000060545884,0.46357355],"study_design_scores_gemma":[0.04115526,0.03405109,0.9181394,0.00039925735,0.0017678554,0.000024964771,0.000060347455,0.00018751263,0.0024964698,0.000038723818,0.0014601131,0.00021901038],"about_ca_topic_score_codex":0.00031468534,"about_ca_topic_score_gemma":0.0003263977,"teacher_disagreement_score":0.46335456,"about_ca_system_score_codex":0.0017081592,"about_ca_system_score_gemma":0.0003621472,"threshold_uncertainty_score":0.99696773},"labels":[],"label_agreement":null},{"id":"W4313055427","doi":"10.1136/ijgc-2022-esgo.284","title":"2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Adjuvant; Adjuvant therapy; Lymph node; Univariate analysis; Oncology; Biopsy; Gastroenterology; Cancer; Urology; Multivariate analysis","score_opus":0.048631668453438325,"score_gpt":0.3705715555682476,"score_spread":0.3219398871148093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313055427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938345,0.0007470648,0.000024597395,0.00029920324,0.0023448989,0.0008662235,0.001657172,0.000018854265,0.00020748694],"genre_scores_gemma":[0.9970976,0.00080136064,0.00023418601,0.00029661963,0.0010554682,0.00030017903,0.000117666124,0.000020609961,0.00007631238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961335,0.0006455107,0.00094369455,0.0006841276,0.0012474327,0.00034569847],"domain_scores_gemma":[0.9966865,0.0013730465,0.00078609854,0.00015351748,0.00061261264,0.0003882042],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007397412,0.00045243115,0.0010738628,0.00067929126,0.0002444425,0.000108814806,0.0004059182,0.000103578146,0.00180571],"category_scores_gemma":[0.00057767605,0.00030696456,0.00020634905,0.00043775045,0.00021081824,0.00039941823,0.00020443651,0.00070768775,0.000007028206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015923277,0.004721003,0.95091593,0.000011465129,0.0016264977,0.000863975,0.0007617364,0.0013197463,0.00091204984,0.00001278636,0.000021649605,0.02290986],"study_design_scores_gemma":[0.046960548,0.008212718,0.93916154,0.00015076944,0.00041708484,0.00012347916,0.0004987214,0.0029240923,0.0008608836,0.00005755693,0.0003079908,0.00032458975],"about_ca_topic_score_codex":0.0017014915,"about_ca_topic_score_gemma":0.00018990444,"teacher_disagreement_score":0.031037271,"about_ca_system_score_codex":0.0024355196,"about_ca_system_score_gemma":0.00037296073,"threshold_uncertainty_score":0.99993825},"labels":[],"label_agreement":null},{"id":"W4313117166","doi":"10.1136/ijgc-2022-esgo.45","title":"2022-RA-678-ESGO CONTESSA/NEOCON-F trial: Assessing the effectiveness and safety of neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Clinical trial; Trachelectomy; Lymph node; Cancer; Surgery; Chemotherapy; Fertility; Oncology; Internal medicine; Population","score_opus":0.035724913251834356,"score_gpt":0.35890476414787753,"score_spread":0.3231798508960432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313117166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857277,0.006286749,0.00007818098,0.0048621767,0.0019895236,0.0006291991,0.00014881206,0.00000954957,0.00026808842],"genre_scores_gemma":[0.9963159,0.0016659847,0.000025872363,0.0013650795,0.0002550781,0.00021031105,0.000013311583,0.000018807894,0.00012968275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968368,0.00064789644,0.0009687133,0.00029111365,0.0009820352,0.0002734401],"domain_scores_gemma":[0.99465007,0.004099949,0.000655581,0.00013367904,0.00032169992,0.00013904509],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021296933,0.00021238347,0.0008962643,0.00019374737,0.000114519455,0.000043739015,0.00032621514,0.00010108201,0.003880215],"category_scores_gemma":[0.00089335174,0.00013415451,0.00031700858,0.00036343402,0.00014556233,0.00016841287,0.00017130365,0.00064834097,4.772107e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12596625,0.0017273915,0.78952706,0.000102253325,0.0012122053,0.00031747317,0.00016364531,0.00053929124,0.00571032,0.00006810574,0.0012075345,0.07345847],"study_design_scores_gemma":[0.050286733,0.0011381117,0.93567115,0.00027098518,0.00013280266,0.000034736036,0.00021920807,0.00015922956,0.0025565925,0.00024970982,0.0090992935,0.00018144808],"about_ca_topic_score_codex":0.0009949319,"about_ca_topic_score_gemma":0.00018057082,"teacher_disagreement_score":0.14614409,"about_ca_system_score_codex":0.0012901436,"about_ca_system_score_gemma":0.00046784268,"threshold_uncertainty_score":0.9970304},"labels":[],"label_agreement":null},{"id":"W4313117506","doi":"10.1136/ijgc-2022-esgo.223","title":"2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Pembrolizumab; Endometrial cancer; Oncology; Lenvatinib; Regimen; Progression-free survival; Cancer; Chemotherapy; Immunotherapy","score_opus":0.026942669316189268,"score_gpt":0.3565096313593196,"score_spread":0.32956696204313035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313117506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959665,0.001756684,0.0000037179757,0.00050749595,0.0005278017,0.0007477582,0.0004157193,0.0000046215096,0.000069732305],"genre_scores_gemma":[0.99858445,0.00087586045,0.000035890935,0.00022954363,0.00006583938,0.00013877264,0.00002030255,0.000013553737,0.000035785462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969223,0.0003033971,0.0009239721,0.0002731891,0.0013184845,0.00025864108],"domain_scores_gemma":[0.99658984,0.0013849004,0.0011546956,0.00017563613,0.00057477714,0.000120153774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046045837,0.00023129296,0.0011867711,0.0009795226,0.00006942509,0.000011948028,0.00036149545,0.000057689642,0.002671661],"category_scores_gemma":[0.00062227825,0.000117299234,0.00040713904,0.0012086289,0.00014774669,0.00009280111,0.00012592849,0.0004835393,1.8604125e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045582436,0.0042059775,0.9015036,0.000004951989,0.00637845,0.000052191495,0.00036451628,0.0034220426,0.000075622826,0.000017302671,0.00002452991,0.038368333],"study_design_scores_gemma":[0.038224638,0.019144654,0.94134635,0.00002192149,0.00065704284,0.0000034556795,0.00024421138,0.000036143843,0.00004589848,0.00003735498,0.00013605965,0.00010229263],"about_ca_topic_score_codex":0.0021659883,"about_ca_topic_score_gemma":0.00070717075,"teacher_disagreement_score":0.03984268,"about_ca_system_score_codex":0.0015221729,"about_ca_system_score_gemma":0.00038946327,"threshold_uncertainty_score":0.99824005},"labels":[],"label_agreement":null},{"id":"W4313117816","doi":"10.1136/ijgc-2022-esgo.246","title":"2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cancer; Oncology; Gynecology; Confidence interval","score_opus":0.041139498914907785,"score_gpt":0.3683494407713364,"score_spread":0.3272099418564286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313117816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435186,0.0014746449,0.000004008926,0.0023709235,0.00045618022,0.00088744715,0.00025711392,0.0000027949168,0.00019501612],"genre_scores_gemma":[0.9978873,0.0009611523,0.0000151915765,0.0004016608,0.00019363883,0.00044975738,0.000004578998,0.000008441131,0.00007826266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674296,0.0005884811,0.0010942444,0.00018304611,0.0011951855,0.00019608701],"domain_scores_gemma":[0.9955099,0.0024521768,0.0014590628,0.00012694749,0.00034785486,0.00010402739],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021870178,0.00016581287,0.0013148922,0.0006828939,0.000057596182,0.000017054246,0.00040171432,0.000054806806,0.0048048897],"category_scores_gemma":[0.0022064627,0.00006760823,0.0006718414,0.0018180609,0.00014738877,0.000047788493,0.00011459046,0.0004188492,1.0624726e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27569175,0.0026055533,0.6022936,0.000021522104,0.035853263,0.0003435863,0.0010153959,0.011401963,0.004001833,0.0000609235,0.0004131369,0.06629747],"study_design_scores_gemma":[0.062993005,0.0053430125,0.9268065,0.00008071145,0.0027736055,0.00002809227,0.00027448442,0.00009087655,0.0009774473,0.0001766728,0.0003614501,0.000094112875],"about_ca_topic_score_codex":0.0007971276,"about_ca_topic_score_gemma":0.00019053502,"teacher_disagreement_score":0.32451293,"about_ca_system_score_codex":0.001193362,"about_ca_system_score_gemma":0.00047231768,"threshold_uncertainty_score":0.99610484},"labels":[],"label_agreement":null},{"id":"W4313127679","doi":"10.1136/ijgc-2022-esgo.878","title":"2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; Kelowna General Hospital","funders":"","keywords":"Medicine; Discontinuation; Oncology; Internal medicine; Cancer; Chemotherapy; DNA mismatch repair","score_opus":0.011142410108652419,"score_gpt":0.2752725663059558,"score_spread":0.2641301561973034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313127679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957864,0.0005774506,0.0000124615735,0.0022507661,0.00049405487,0.0007257713,0.00006527734,0.000004676789,0.00008308992],"genre_scores_gemma":[0.99935085,0.000084240295,0.0001225215,0.00025739995,0.000069498965,0.000074123396,0.000009958349,0.000009313051,0.000022091144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976995,0.00023988537,0.0004927776,0.00023379405,0.0011492699,0.0001847796],"domain_scores_gemma":[0.99877477,0.00030912043,0.00047474314,0.00008205467,0.0002953001,0.00006403421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008635358,0.00014024794,0.00034289196,0.00020216269,0.00005112413,0.000021447588,0.00020853916,0.000052584695,0.0002588989],"category_scores_gemma":[0.00034443504,0.00008997284,0.00006721051,0.00022648033,0.00012731765,0.00007885665,0.00011686954,0.0005130347,1.7995143e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071777955,0.0024818212,0.90969115,0.00005189044,0.00014222976,0.0003222328,0.0022074173,0.003396999,0.004100018,0.00003861252,0.0014411503,0.0043485],"study_design_scores_gemma":[0.023322793,0.006015177,0.9679151,0.000066069566,0.00005541525,0.00009530978,0.00085966603,0.00047237633,0.0006896987,0.00006749862,0.00032757953,0.00011330842],"about_ca_topic_score_codex":0.000241682,"about_ca_topic_score_gemma":0.00014882721,"teacher_disagreement_score":0.058223937,"about_ca_system_score_codex":0.00056226016,"about_ca_system_score_gemma":0.00024719795,"threshold_uncertainty_score":0.3668986},"labels":[],"label_agreement":null},{"id":"W4313140213","doi":"10.1136/ijgc-2022-esgo.518","title":"2022-RA-588-ESGO Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients with advanced solid tumours: ARTISTRY-1","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; Alberta Health Services; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Response Evaluation Criteria in Solid Tumors; Internal medicine; Combination therapy; CD8; Renal cell carcinoma; Cytokine; Immunotherapy; Gastroenterology; Nivolumab; Oncology; Pharmacology; Phases of clinical research; Cancer research; Immunology; Chemotherapy; Cancer; Immune system","score_opus":0.007700267472341213,"score_gpt":0.2772337533473079,"score_spread":0.26953348587496667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313140213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956915,0.0007694836,0.000040131756,0.0027178542,0.00031912312,0.00028689462,0.000026720776,0.0000061037053,0.00014222738],"genre_scores_gemma":[0.99784297,0.00048742283,0.00021072394,0.0012177499,0.000058400306,0.000062551524,0.00001881621,0.000014196482,0.00008717855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984315,0.000080567486,0.00043121705,0.00018819253,0.00069044525,0.00017807544],"domain_scores_gemma":[0.99915767,0.00009584562,0.00035893664,0.00007428424,0.0002494692,0.000063820895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000260757,0.00013659382,0.0003051558,0.0002612197,0.000044327317,0.00002387984,0.00018035386,0.000044606157,0.0011276643],"category_scores_gemma":[0.000041010047,0.00009585246,0.000048971448,0.0002292348,0.00008776348,0.00018053854,0.000041215946,0.00040616823,3.6882102e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05767189,0.0012594415,0.89259315,0.000009391047,0.0001979969,0.0003529951,0.00023581726,0.0014607051,0.0011341998,0.000034083805,0.00023863529,0.044811677],"study_design_scores_gemma":[0.027375728,0.0043479954,0.9648982,0.00012059954,0.000019309562,0.000113040776,0.00017586644,0.0001327331,0.00024080655,0.000113926944,0.002332166,0.00012962817],"about_ca_topic_score_codex":0.00006765335,"about_ca_topic_score_gemma":0.00029990668,"teacher_disagreement_score":0.07230503,"about_ca_system_score_codex":0.0010021742,"about_ca_system_score_gemma":0.00023772728,"threshold_uncertainty_score":0.9997854},"labels":[],"label_agreement":null},{"id":"W4313147584","doi":"10.1136/ijgc-2022-esgo.488","title":"2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Placebo; Oncology; Regimen; Population; Chemotherapy regimen; Chemotherapy; Clinical trial","score_opus":0.07666200252183013,"score_gpt":0.3994733332075067,"score_spread":0.3228113306856766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313147584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803863,0.00022120151,0.0014902633,0.010107909,0.0042451,0.0024265163,0.0009733214,0.000020262813,0.00012912341],"genre_scores_gemma":[0.9945088,0.000019834317,0.001114909,0.0023890322,0.0008398087,0.00073846465,0.00010216091,0.00003809339,0.00024888953],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99539125,0.00053092936,0.0015903467,0.00047565778,0.0016941291,0.00031769247],"domain_scores_gemma":[0.99429977,0.0031747606,0.0011596396,0.0002869412,0.0008046631,0.00027424656],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027922536,0.00029222385,0.0009351047,0.0004235514,0.00016191408,0.00005012625,0.00059657084,0.00011163123,0.00234019],"category_scores_gemma":[0.0011027787,0.00024978825,0.0005611453,0.00027091024,0.000052786338,0.000101447455,0.000100422156,0.0006244863,0.0000015862147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9620987,0.0038616934,0.0032992223,0.000007398974,0.0012041002,0.0003141668,0.0018569824,0.0042938143,0.015337437,0.000021622287,0.0033681854,0.0043366533],"study_design_scores_gemma":[0.92818755,0.021568432,0.01735991,0.00015683775,0.0003193593,0.000034012246,0.001032107,0.0011986801,0.00775807,0.0002772315,0.021734519,0.00037327866],"about_ca_topic_score_codex":0.0002524199,"about_ca_topic_score_gemma":0.00014467414,"teacher_disagreement_score":0.03391116,"about_ca_system_score_codex":0.001559697,"about_ca_system_score_gemma":0.0011181871,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W4313150678","doi":"10.1136/ijgc-2022-esgo.1008","title":"2022-RA-1702-ESGO Opioid prescription adequacy in endometrial cancer patients undergoing hysterectomy under ERAS protocol","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Endometrial cancer; Medical prescription; Hysterectomy; Opioid; Laparotomy; Retrospective cohort study; Cancer; Internal medicine; Anesthesia; Surgery; Pharmacology","score_opus":0.029951654744140643,"score_gpt":0.3443371810089583,"score_spread":0.3143855262648177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313150678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98102003,0.00028960055,0.0002417781,0.0018190586,0.0069512413,0.008842681,0.00006762846,0.000024159615,0.0007437976],"genre_scores_gemma":[0.97945046,0.00017859029,0.00019200938,0.0017861759,0.0010640188,0.01668157,0.000017738446,0.000028020348,0.00060138595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965382,0.00029644975,0.0010590338,0.00031937406,0.001452227,0.00033468354],"domain_scores_gemma":[0.9975655,0.0007496916,0.00081483385,0.00012353422,0.00059342437,0.00015303302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006521484,0.00021706703,0.00051868416,0.0006803294,0.00009258161,0.00005463397,0.00041422815,0.00011029117,0.009562312],"category_scores_gemma":[0.0009310814,0.00017775017,0.00028036506,0.00045205225,0.00005442635,0.00040889476,0.00025557162,0.0009499236,0.0000074903114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011976907,0.002811086,0.9238544,0.00009712814,0.00073620985,0.00057764025,0.00027536953,0.007653369,0.006847517,0.00014824337,0.0075774873,0.03744463],"study_design_scores_gemma":[0.026871165,0.0033621204,0.8867848,0.0006067573,0.00009258825,0.00014685302,0.0002465007,0.00029044904,0.0036815566,0.0014893395,0.07594501,0.00048284518],"about_ca_topic_score_codex":0.00010900924,"about_ca_topic_score_gemma":0.00027305348,"teacher_disagreement_score":0.068367526,"about_ca_system_score_codex":0.0032711125,"about_ca_system_score_gemma":0.0008695284,"threshold_uncertainty_score":0.9913431},"labels":[],"label_agreement":null},{"id":"W4313175178","doi":"10.1136/ijgc-2022-esgo.197","title":"2022-RA-168-ESGO Does order of adjuvant treatment for high risk endometrial cancer matter? A retrospective review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Endometrial cancer; Serous fluid; Stage (stratigraphy); Chemotherapy; Internal medicine; Radiation therapy; Oncology; Cancer; Retrospective cohort study","score_opus":0.06828965632778176,"score_gpt":0.4153883779547741,"score_spread":0.34709872162699235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313175178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026195584,0.9838617,0.000035084955,0.0013823723,0.006804931,0.0024199025,0.004931056,0.000014007356,0.00028903008],"genre_scores_gemma":[0.00047689286,0.99228674,0.0003945085,0.0007395019,0.0027587991,0.0019814314,0.00022432316,0.00006627827,0.0010715477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947911,0.00038483524,0.0023125277,0.0005970102,0.0015121098,0.00040242268],"domain_scores_gemma":[0.9917228,0.0024029997,0.0039064595,0.0002960982,0.0014011251,0.00027048512],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007556872,0.0006417912,0.004764499,0.0006678945,0.00009290745,0.000028595712,0.0007010705,0.00029362773,0.05424219],"category_scores_gemma":[0.0026600084,0.00033329692,0.0023114984,0.0009577621,0.00012467746,0.00010779198,0.00018276498,0.0007980267,0.000014139495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020608497,0.0011860346,0.0024422,0.0044195494,0.008507203,0.00021909483,0.000018899233,0.000004475786,0.0000016448178,0.00006059307,0.0043549044,0.97672457],"study_design_scores_gemma":[0.009475534,0.0046636155,0.0015861988,0.011972025,0.010612774,0.00012060506,0.0000122334095,8.1985013e-7,0.000020311814,0.00036599493,0.96083915,0.00033074088],"about_ca_topic_score_codex":0.0007751617,"about_ca_topic_score_gemma":0.00015856227,"teacher_disagreement_score":0.9763938,"about_ca_system_score_codex":0.0059935665,"about_ca_system_score_gemma":0.0016551358,"threshold_uncertainty_score":0.9999119},"labels":[],"label_agreement":null},{"id":"W4313340213","doi":"10.1136/ijgc-2022-004073","title":"Endometrial carcinosarcoma","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eisai; Ministero della Salute; National Cancer Institute; National Institutes of Health; Incyte; Genentech; PharmaMar; Mersana Therapeutics; AstraZeneca; Novartis; Pfizer","keywords":"Medicine; Carcinosarcoma; Gynecology; Pathology; Carcinoma","score_opus":0.14342821852239143,"score_gpt":0.43775995785975536,"score_spread":0.2943317393373639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313340213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003205919,0.99214494,0.000004766602,0.0003583073,0.005029791,0.00028654266,0.00011102009,0.000010550234,0.0017334633],"genre_scores_gemma":[0.00065904367,0.995954,0.00021531052,0.00024262899,0.0020413492,0.00007069969,0.000052028783,0.0000254637,0.00073952304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772185,0.00011833722,0.0008904565,0.00019461184,0.00089683285,0.00017790623],"domain_scores_gemma":[0.997902,0.0006510896,0.0009278938,0.00011928901,0.00024059115,0.00015915626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024251326,0.00025043046,0.0015291477,0.00047902064,0.000037138612,0.000031852134,0.0004745546,0.00015116444,0.02112835],"category_scores_gemma":[0.00058029464,0.00015223629,0.0011939873,0.00021017279,0.0000434097,0.000056802473,0.00021293362,0.0007007133,0.000024143994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019912129,0.00036554816,0.0005234308,0.00028390577,0.002092151,0.0047993385,0.000006745732,6.5183144e-7,3.185643e-7,0.00007200929,0.0018129477,0.98984385],"study_design_scores_gemma":[0.0019433129,0.0010104644,0.0004950174,0.0008773727,0.0012998063,0.0025473745,0.0000040222426,5.386844e-7,8.0127865e-7,0.00003365461,0.99167037,0.00011723549],"about_ca_topic_score_codex":0.000019217961,"about_ca_topic_score_gemma":0.000002624813,"teacher_disagreement_score":0.98985744,"about_ca_system_score_codex":0.0013064604,"about_ca_system_score_gemma":0.00074425637,"threshold_uncertainty_score":0.9797665},"labels":[],"label_agreement":null},{"id":"W4313447346","doi":"10.1136/ijgc-2022-004039","title":"Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Leids Universitair Medisch Centrum; Canadian Institutes of Health Research; Institut Gustave-Roussy; KWF Kankerbestrijding; National Institute for Health and Care Research; Universiteit Leiden; Cancer Research UK; Wellcome Trust; Academy of Medical Sciences; AstraZeneca","keywords":"Medicine; Endometrial cancer; Oncology; Clinical trial; Internal medicine; Adjuvant; Randomized controlled trial; Radiation therapy; Cancer; Stage (stratigraphy); Gynecology","score_opus":0.0925120558051597,"score_gpt":0.4522445388100751,"score_spread":0.3597324830049154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313447346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96589,0.0028866134,0.000014304327,0.020443855,0.007663088,0.0012332977,0.00010444757,0.00002751498,0.0017368984],"genre_scores_gemma":[0.9901777,0.0005572453,0.00028098878,0.005552266,0.0018874995,0.0011666381,0.000018482891,0.00001933437,0.0003398446],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963267,0.0005672817,0.0010388199,0.0003205075,0.001444114,0.0003025622],"domain_scores_gemma":[0.9967384,0.0020219076,0.00059963774,0.0001730291,0.0002818468,0.0001852187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012123911,0.00022628478,0.00071265054,0.00039387555,0.000104903025,0.00004355686,0.0004675093,0.000111121786,0.0038832608],"category_scores_gemma":[0.001759768,0.00012211101,0.00070509413,0.00059456914,0.00010409169,0.00004711002,0.000100428944,0.0008836912,0.0000034277502],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23325956,0.007060691,0.044107296,0.0000054163393,0.0009805552,0.0024646341,0.00006885914,0.0056866994,0.000093631075,0.00013334578,0.0009051838,0.7052341],"study_design_scores_gemma":[0.46696475,0.07486713,0.20144542,0.0001887153,0.00072353776,0.00014914309,0.00020290182,0.00058015826,0.00053720054,0.00035859083,0.25357276,0.00040967207],"about_ca_topic_score_codex":0.00037648634,"about_ca_topic_score_gemma":0.00016484947,"teacher_disagreement_score":0.70482445,"about_ca_system_score_codex":0.0024055322,"about_ca_system_score_gemma":0.0009451672,"threshold_uncertainty_score":0.99702734},"labels":[],"label_agreement":null},{"id":"W4315754398","doi":"10.1136/ijgc-2022-004114","title":"Impact of podcasting on novel and conventional measures of academic impact","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Citation; Randomized controlled trial; Odds ratio; Bibliometrics; Impact factor; Cervical cancer; Internal medicine; Cancer; Library science","score_opus":0.3207639779919976,"score_gpt":0.5416743800611883,"score_spread":0.22091040206919071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315754398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941191,0.00022443123,0.000038824077,0.0023983223,0.0027293507,0.00014394964,0.000044844357,0.00000769608,0.00029346076],"genre_scores_gemma":[0.99811655,0.00074533105,0.00008755758,0.00005392587,0.00095998595,0.000014756881,0.0000020479322,0.0000047091066,0.000015146363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824697,0.00012347294,0.0005045138,0.000085048705,0.000871826,0.00016818172],"domain_scores_gemma":[0.99485797,0.003231285,0.0007590769,0.000030411265,0.0009884072,0.0001328505],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013822326,0.00007021878,0.00021830329,0.00022721395,0.00006443688,0.000011670595,0.0002690558,0.00012792632,0.0006146643],"category_scores_gemma":[0.010714476,0.00005216922,0.00017492234,0.00026595482,0.0002440836,0.00014137871,0.00002863859,0.0002762794,0.0000024811877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002987298,0.00015386546,0.9494437,0.000010302968,0.00022893924,0.0000049173377,0.0031758659,0.0009974603,0.0034261977,0.0026328492,0.00087918306,0.038747992],"study_design_scores_gemma":[0.00045029182,0.00035683508,0.9965121,0.00009943744,0.000013697664,0.0000036159388,0.00041691176,0.000051881554,0.00010426974,0.0013973631,0.0005465752,0.000046991223],"about_ca_topic_score_codex":0.0014290307,"about_ca_topic_score_gemma":0.00008334571,"teacher_disagreement_score":0.047068432,"about_ca_system_score_codex":0.00062789855,"about_ca_system_score_gemma":0.0010711228,"threshold_uncertainty_score":0.9976187},"labels":[],"label_agreement":null},{"id":"W4315874294","doi":"10.1136/ijgc-2022-004113","title":"Black and hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in gynecologic malignancy","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prospective cohort study; Logistic regression; Malignancy; Cancer; Gynecologic oncology; Quality of life (healthcare); Internal medicine","score_opus":0.05353187284664565,"score_gpt":0.3658735555993947,"score_spread":0.3123416827527491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315874294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512887,0.0004222797,5.635731e-7,0.002463116,0.00077399396,0.0007903598,0.000119708566,0.00003415809,0.00026696452],"genre_scores_gemma":[0.99604636,0.0026198057,0.000031038217,0.00022298546,0.00017282776,0.0005617814,0.000030432302,0.0000136632425,0.00030108553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978762,0.00009217888,0.0007424167,0.00036360815,0.00065152405,0.00027403331],"domain_scores_gemma":[0.99829376,0.00027581363,0.00053869653,0.00010370321,0.00063152367,0.00015650979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041050534,0.0001927013,0.0004865853,0.00023841466,0.000040900795,0.000046813642,0.00009203719,0.00013149157,0.0004962648],"category_scores_gemma":[0.0006716983,0.00013326884,0.00009563859,0.00017921363,0.000103178834,0.00013799517,0.00007704051,0.00021638567,0.0000019005174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018648882,0.00031454425,0.8786266,0.000011650809,0.00047604812,0.00082269596,0.0050197016,0.00012852065,0.00027423125,0.000006327629,0.000049908875,0.11240489],"study_design_scores_gemma":[0.007307792,0.0016661176,0.98658663,0.00013485391,0.00012290302,0.000040334628,0.002335076,0.0002684155,0.00028486244,0.0004577313,0.0006581315,0.0001371658],"about_ca_topic_score_codex":0.0013401532,"about_ca_topic_score_gemma":0.0070165456,"teacher_disagreement_score":0.112267725,"about_ca_system_score_codex":0.0024099692,"about_ca_system_score_gemma":0.00035756305,"threshold_uncertainty_score":0.6301986},"labels":[],"label_agreement":null},{"id":"W4317234272","doi":"10.1136/ijgc-2022-004122","title":"Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Universitair Medisch Centrum Groningen; National Cancer Institute; KWF Kankerbestrijding","keywords":"Medicine; Vulvar cancer; Sentinel node; Sentinel lymph node; Biopsy; Radiation therapy; Oncology; Radiology; Cancer; Internal medicine; Breast cancer","score_opus":0.021592600312094253,"score_gpt":0.33271573863922865,"score_spread":0.3111231383271344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317234272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560034,0.00014783726,0.000015688414,0.0020405143,0.0011503105,0.00081656594,0.000161729,0.000016650569,0.00005035871],"genre_scores_gemma":[0.9980612,0.00060469424,0.000058688172,0.00046123224,0.00039722823,0.0002513032,0.000072326344,0.000029221528,0.00006410173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678594,0.0001499683,0.0010419982,0.0004577138,0.0012216592,0.00034274353],"domain_scores_gemma":[0.9980666,0.0003318904,0.00078934385,0.00013246441,0.0005510763,0.00012859941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005219193,0.0003206385,0.0008442253,0.001131196,0.000040807918,0.000040637893,0.00022277435,0.00013545742,0.00044606248],"category_scores_gemma":[0.00036096675,0.00024198156,0.000112494,0.0010042011,0.00009333269,0.00035183708,0.00013951513,0.00038002123,0.0000025878985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.106509365,0.00796812,0.86645436,0.00003423558,0.00056344015,0.00045486982,0.00044483982,0.0016147132,0.0008926196,0.000009709531,0.00002735822,0.015026356],"study_design_scores_gemma":[0.1854707,0.0011963042,0.81130487,0.00035901248,0.00014023279,0.000007721449,0.00009034082,0.00075495086,0.0004363459,0.00004572301,0.0000146372095,0.0001791393],"about_ca_topic_score_codex":0.003173514,"about_ca_topic_score_gemma":0.00065814686,"teacher_disagreement_score":0.078961335,"about_ca_system_score_codex":0.0014798755,"about_ca_system_score_gemma":0.00029231436,"threshold_uncertainty_score":0.9867722},"labels":[],"label_agreement":null},{"id":"W4320914255","doi":"10.1136/ijgc-2022-004228","title":"Adverse postoperative outcomes associated with perioperative blood transfusion in gynecologic oncology surgery","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Blood transfusion and management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Perioperative; Gynecologic oncology; Blood transfusion; Incidence (geometry); Odds ratio; Laparotomy; Surgery; Internal medicine","score_opus":0.03843193249496432,"score_gpt":0.34071514351853116,"score_spread":0.3022832110235668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320914255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972015,0.00007470568,0.000038070735,0.024622696,0.000732994,0.00035906272,0.000016218768,0.000039317416,0.0021018959],"genre_scores_gemma":[0.99244076,0.0017815239,0.000104917475,0.0044050985,0.000070881964,0.00005968996,0.000018664032,0.000012992742,0.0011054957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981137,0.00018655704,0.00062200386,0.00021762321,0.0006011948,0.0002589215],"domain_scores_gemma":[0.9977633,0.0011270158,0.00024450113,0.00006835749,0.0006672366,0.00012960819],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073252036,0.00017855261,0.0006507343,0.00048350872,0.000053051128,0.000016037797,0.0001791139,0.00016541341,0.002486138],"category_scores_gemma":[0.0009677752,0.00010790216,0.0002359606,0.0004213518,0.00011566725,0.00014816406,0.000043164306,0.0004677505,0.000017804832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021525037,0.0027760286,0.957031,0.000013408313,0.0018397379,0.012036763,0.0015097316,0.0014298778,0.0022282198,0.00032550213,0.0018415609,0.016815651],"study_design_scores_gemma":[0.0067985575,0.0019272572,0.98374397,0.00016139119,0.00019339763,0.00010594374,0.00097184634,0.00008322421,0.00045174194,0.000044470973,0.005372384,0.00014584135],"about_ca_topic_score_codex":0.00006767318,"about_ca_topic_score_gemma":0.0017553424,"teacher_disagreement_score":0.02671293,"about_ca_system_score_codex":0.00048521566,"about_ca_system_score_gemma":0.0004789773,"threshold_uncertainty_score":0.9984257},"labels":[],"label_agreement":null},{"id":"W4323347677","doi":"10.1136/ijgc-2022-003698","title":"Overcoming PARP inhibitor resistance in ovarian cancer","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; DNA repair; Ovarian cancer; Synthetic lethality; Homologous recombination; Chemotherapy; Drug resistance; Epigenetics; Cancer research; Dosing; Cancer; Bioinformatics; Pharmacology; Internal medicine; DNA; Genetics; Biology; Gene","score_opus":0.13180094881557272,"score_gpt":0.4535494446225136,"score_spread":0.32174849580694087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323347677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032525058,0.9892797,0.000032182965,0.0026365211,0.005853209,0.00052359834,0.00021290797,0.00003251775,0.0011041423],"genre_scores_gemma":[0.0004158822,0.99206805,0.0004051465,0.00095423864,0.0038655465,0.0003148239,0.000021406626,0.00007650578,0.0018783684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958621,0.00021053075,0.0019611502,0.00041851684,0.0011550772,0.00039257438],"domain_scores_gemma":[0.9963068,0.00089616945,0.0016527445,0.00020716862,0.00071917794,0.00021797296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007779558,0.0004250746,0.0021147316,0.00075789355,0.000040280698,0.00006212613,0.000644328,0.0005127099,0.002864888],"category_scores_gemma":[0.00068139,0.00031301152,0.0008471337,0.0005915805,0.00012889685,0.00017548831,0.0001198839,0.0014440587,0.00005701094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001775856,0.0007145509,0.0024550837,0.006609161,0.0037409489,0.007574594,0.00026480923,0.00008008997,0.000063652384,0.0012641035,0.045508627,0.9299485],"study_design_scores_gemma":[0.0021914057,0.00011848104,0.001171639,0.037878472,0.00035451562,0.00014573101,0.000014095957,0.0000023558835,0.000015652864,0.00064553914,0.9571738,0.00028827752],"about_ca_topic_score_codex":0.00007266191,"about_ca_topic_score_gemma":0.00054182636,"teacher_disagreement_score":0.92966026,"about_ca_system_score_codex":0.0040612966,"about_ca_system_score_gemma":0.0020327696,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W4324098920","doi":"10.1136/ijgc-2023-004327","title":"Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Oncology; Ovary; Mucinous Tumor; Gynecology; Internal medicine; General surgery; Cancer","score_opus":0.0299935915704022,"score_gpt":0.37075725853071123,"score_spread":0.340763666960309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324098920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954044,0.00031428583,0.0000054943634,0.0025304966,0.00074653595,0.00018679487,0.000106193474,0.000009562654,0.00069623225],"genre_scores_gemma":[0.99797493,0.0010663511,0.00007439716,0.00040205396,0.0003133838,0.000027352991,0.000005813409,0.000012296307,0.00012338984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986055,0.000067812325,0.00044486768,0.00019382393,0.00048620056,0.00020178076],"domain_scores_gemma":[0.9987863,0.00034983302,0.00028202528,0.00008021018,0.00035475788,0.00014693277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002547194,0.00016008716,0.0004672085,0.00029135603,0.000022278571,0.000025598942,0.0001425555,0.00008066454,0.0009998152],"category_scores_gemma":[0.0002414813,0.000102326194,0.00017925858,0.00024137918,0.00008198918,0.00009502184,0.000040380815,0.00024282212,0.0000055093765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017799297,0.00041324907,0.9798663,0.000013708974,0.0008590859,0.0024383985,0.00058784924,0.0032849533,0.0004922229,0.00048719975,0.0005283071,0.009248749],"study_design_scores_gemma":[0.004738113,0.00232556,0.9910929,0.00020097088,0.000048571856,0.000060473107,0.00010769393,0.00014889333,0.0005285011,0.00010759959,0.0005500759,0.00009060261],"about_ca_topic_score_codex":0.0015174452,"about_ca_topic_score_gemma":0.00041357556,"teacher_disagreement_score":0.011226598,"about_ca_system_score_codex":0.0015629455,"about_ca_system_score_gemma":0.00063323934,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4362458627","doi":"10.1136/ijgc-2023-004380","title":"Association of literature metrics in gynecologic oncology with country classification by income level","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Gynecologic oncology; Citation; Gross national income; Middle income country; Publishing; Demography; High income countries; Developing country; China; Family medicine; Gynecology; Internal medicine; Socioeconomics; Library science; Economic growth; Political science","score_opus":0.6804300321512953,"score_gpt":0.6334504089332188,"score_spread":0.04697962321807647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362458627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018282877,0.99081105,0.0002760335,0.0012959021,0.0032219498,0.00047849052,0.0012092687,0.000011440443,0.0008675682],"genre_scores_gemma":[0.0034886755,0.9935884,0.000349338,0.00010497793,0.0002637066,0.00005290866,0.000053554886,0.000021429569,0.002077001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9846336,0.0011026282,0.003139433,0.0005897709,0.010056199,0.0004783566],"domain_scores_gemma":[0.9512793,0.03103554,0.006428694,0.00028226533,0.010739908,0.0002343042],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.02327456,0.00032190356,0.002168811,0.03724602,0.000054446416,0.00073666713,0.0041856267,0.0010869626,0.00075761875],"category_scores_gemma":[0.09133675,0.000177626,0.0005004061,0.07980809,0.00014506365,0.00051325484,0.00048795383,0.0016705159,0.000051028506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008172004,0.0004574058,0.027573545,0.00021052564,0.00047774805,0.0002447199,0.000036336478,0.00004152255,0.000004090724,0.00023893276,0.023916584,0.94671685],"study_design_scores_gemma":[0.00084461586,0.00077018933,0.026312064,0.0012378079,0.00012222119,0.000041821895,0.00006549284,0.00011026292,0.0000021301985,0.0011381152,0.9691242,0.00023109543],"about_ca_topic_score_codex":0.000042270673,"about_ca_topic_score_gemma":0.0002289102,"teacher_disagreement_score":0.94648576,"about_ca_system_score_codex":0.005520735,"about_ca_system_score_gemma":0.00213964,"threshold_uncertainty_score":0.9982969},"labels":[],"label_agreement":null},{"id":"W4362522297","doi":"10.1136/ijgc-2022-004050","title":"Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"","keywords":"Medicine; Cervix; Gestation; Cervical cancer; Papanicolaou stain; Obstetrics; Gynecology; Nivolumab; Cancer; Radiology; Pregnancy; Internal medicine","score_opus":0.030345255472182458,"score_gpt":0.37110844499037704,"score_spread":0.34076318951819456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362522297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786929,0.00043473678,0.0000017605417,0.01975302,0.00040319562,0.0002034212,0.00002674212,0.0000027743758,0.00048145646],"genre_scores_gemma":[0.99430513,0.0047034295,0.00004216172,0.0002909985,0.00006795236,0.000018903598,7.939502e-7,0.000005138642,0.0005654878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816686,0.000116250674,0.000499326,0.000090759706,0.0009811736,0.00014564079],"domain_scores_gemma":[0.9984336,0.0004266362,0.0005774154,0.000093417606,0.00043814725,0.0000307743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032284667,0.00006954553,0.0002504367,0.00014049179,0.00001481753,0.0000060612733,0.0003830934,0.000007916861,0.00023308251],"category_scores_gemma":[0.00040932538,0.000037205755,0.000107941545,0.00034388242,0.00009627378,0.000067137036,0.00014906413,0.00024925265,5.1884064e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092883286,0.00042571337,0.9676546,0.00025497665,0.000653233,0.0012495611,0.00015486412,0.0010911073,0.005265425,0.00088434445,0.004505275,0.01693208],"study_design_scores_gemma":[0.001892458,0.00035455928,0.98693806,0.0002105243,0.00007265068,0.00010630407,0.0002341227,0.0000955327,0.005071491,0.00068675913,0.0043048356,0.00003270531],"about_ca_topic_score_codex":0.00012543352,"about_ca_topic_score_gemma":0.00020521342,"teacher_disagreement_score":0.019462023,"about_ca_system_score_codex":0.00015842258,"about_ca_system_score_gemma":0.000076678654,"threshold_uncertainty_score":0.255209},"labels":[],"label_agreement":null},{"id":"W4362550449","doi":"10.1136/ijgc-2022-004202","title":"Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Stage (stratigraphy); Ovarian cancer; Chemotherapy; Internal medicine; Oncology; Surgery; Cytoreductive surgery; Neoadjuvant therapy; Cancer; Breast cancer","score_opus":0.05024807923466793,"score_gpt":0.3719066315430669,"score_spread":0.32165855230839896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362550449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835725,0.00018131957,0.002932505,0.005415377,0.0022756322,0.00042494733,0.00035172512,0.000009958873,0.000051303407],"genre_scores_gemma":[0.9961915,0.0006316342,0.0025146783,0.00012288602,0.00021850034,0.00013618253,0.000021755643,0.000009429889,0.00015343771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986181,0.000034085617,0.0006943799,0.00012686219,0.00041673586,0.000109784196],"domain_scores_gemma":[0.99829316,0.00013769309,0.0005703867,0.00008001634,0.00087835174,0.000040385446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031104565,0.00009402011,0.0003064156,0.00019518679,0.000019641542,0.0000063774055,0.00015161674,0.0000865607,0.0001541101],"category_scores_gemma":[0.0002564287,0.000057495836,0.00019971085,0.00028723135,0.000053152966,0.000115914154,0.000027829154,0.00015124306,4.2371505e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001296745,0.0009016376,0.5454694,0.00006679743,0.0007679365,0.000018295777,0.0003511567,0.15319912,0.0148095125,0.00049415295,0.0012925229,0.28133273],"study_design_scores_gemma":[0.006574879,0.00066703995,0.8920142,0.00047268876,0.0002347506,0.00001761289,0.00017562679,0.061130602,0.036395926,0.0013450885,0.0008827007,0.00008887471],"about_ca_topic_score_codex":0.00012298701,"about_ca_topic_score_gemma":0.000050344748,"teacher_disagreement_score":0.3465448,"about_ca_system_score_codex":0.00070597196,"about_ca_system_score_gemma":0.0002996805,"threshold_uncertainty_score":0.23446122},"labels":[],"label_agreement":null},{"id":"W4377825501","doi":"10.1136/ijgc-2023-004460","title":"Evaluating open access publication and research impact in gynecologic oncology","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Gynecologic oncology; Gynecologic cancer; Odds ratio; Internal medicine; Oncology; Impact factor; Citation; Gynecology; Cancer; Library science; Ovarian cancer","score_opus":0.9559723428180329,"score_gpt":0.8286021912471291,"score_spread":0.1273701515709038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377825501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96848714,0.00035363657,0.0000460011,0.02472294,0.0010870899,0.0002919914,0.000019330033,0.0000072026205,0.004984665],"genre_scores_gemma":[0.9966768,0.0015035814,0.00036603375,0.00042789878,0.00019705977,0.000052217165,0.0000031340553,0.000005623843,0.00076762174],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9883739,0.0013212807,0.0012159406,0.00048020354,0.008060468,0.00054824166],"domain_scores_gemma":[0.9571442,0.025827967,0.0007588042,0.00023142438,0.015683495,0.00035411192],"candidate_categories":["metaresearch","bibliometrics","scholarly_communication","open_science","insufficient_payload"],"consensus_categories":["metaresearch","bibliometrics"],"category_scores_codex":[0.089982666,0.00010237777,0.0003933907,0.03639208,0.00015111554,0.0061254995,0.008504366,0.00017659817,0.005882241],"category_scores_gemma":[0.23237438,0.00006041716,0.00010851107,0.061438072,0.00023200877,0.002389666,0.0053714896,0.00077651284,0.0001265961],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017397178,0.00017988287,0.41920432,9.78672e-7,0.000031649117,0.00014426226,0.000091520036,0.0009007057,0.00060988776,0.0005125798,0.03140881,0.5467414],"study_design_scores_gemma":[0.0010451732,0.00093971886,0.93069166,0.0000107264805,0.0000021542367,0.000027167798,0.0002259181,0.0073382515,0.000081492515,0.039838377,0.019723268,0.00007609778],"about_ca_topic_score_codex":0.00036496145,"about_ca_topic_score_gemma":0.00025705918,"teacher_disagreement_score":0.5466653,"about_ca_system_score_codex":0.0015020232,"about_ca_system_score_gemma":0.0014906725,"threshold_uncertainty_score":0.9968601},"labels":[],"label_agreement":null},{"id":"W4382396967","doi":"10.1136/ijgc-2023-004491","title":"A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"MorphoSys; Eisai; National Cancer Institute; Novocure; Regeneron Pharmaceuticals; Seagen; Gilead Sciences; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Cervical cancer; Endometrial cancer; Toxicity; Clinical endpoint; Internal medicine; External beam radiotherapy; Urology; Mucositis; Wee1; Cisplatin; Oncology; Radiation therapy; Clinical trial; Surgery; Cancer; Brachytherapy; Chemotherapy","score_opus":0.028719404599842617,"score_gpt":0.3524805468404295,"score_spread":0.3237611422405869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382396967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402416,0.00014352814,0.000004595116,0.005067828,0.0003886521,0.00031742384,0.0000064888727,0.000004813781,0.00004251157],"genre_scores_gemma":[0.9994507,0.00012665105,0.00002385436,0.00021230443,0.00010649158,0.000028641758,0.0000026245023,0.000004373131,0.00004435667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891937,0.0001055835,0.00039954946,0.00016631937,0.00030521082,0.000103995386],"domain_scores_gemma":[0.99918336,0.000115534654,0.00023738186,0.00008766317,0.0003338281,0.00004224619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043656255,0.00008463377,0.0002531211,0.00017809597,0.000019804163,0.000007095092,0.000127417,0.000061754996,0.00011187256],"category_scores_gemma":[0.00037665703,0.000048419522,0.00003552832,0.00031375617,0.00011180679,0.00010552129,0.00005286211,0.0002677204,5.823753e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007932842,0.0021767358,0.9754846,0.000020122026,0.000088892164,0.0001370282,0.00068856153,0.00023096256,0.0042203804,0.00001896879,0.00008812465,0.008912747],"study_design_scores_gemma":[0.010368765,0.002792218,0.98387504,0.00008374464,0.000021979986,0.000023426872,0.0004601427,0.0003197759,0.0014879437,0.0001669194,0.00035100826,0.000049051378],"about_ca_topic_score_codex":0.0002447472,"about_ca_topic_score_gemma":0.0005937208,"teacher_disagreement_score":0.008863696,"about_ca_system_score_codex":0.00038512333,"about_ca_system_score_gemma":0.00017005808,"threshold_uncertainty_score":0.19744909},"labels":[],"label_agreement":null},{"id":"W4384342608","doi":"10.1136/ijgc-2023-004355","title":"Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University Health Centre; McGill University","keywords":"Medicine; Norwegian; Prospective cohort study; Ovarian cancer; Cohort; Cancer; Oncology; Cohort study; General surgery; Gynecology; Internal medicine","score_opus":0.020453087972659306,"score_gpt":0.31570718245029966,"score_spread":0.29525409447764034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384342608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705833,0.00012949796,0.00007315028,0.00024074684,0.0014313142,0.00071336963,0.00014250728,0.000018750889,0.00019230577],"genre_scores_gemma":[0.99845165,0.0003570429,0.0003321112,0.00016135206,0.00019888529,0.00031495883,0.000044750188,0.000027618958,0.000111610985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633706,0.00023628269,0.0011284241,0.00033268557,0.0016870835,0.00027848512],"domain_scores_gemma":[0.9938749,0.00076263206,0.0010879466,0.00018205548,0.003961774,0.00013067723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012623826,0.00021936788,0.0008237436,0.0006958731,0.00001805599,0.000014281385,0.00020116032,0.0001556624,0.0023773934],"category_scores_gemma":[0.0017682579,0.00014798401,0.00020101052,0.0007979808,0.00011410679,0.0005172208,0.000051615185,0.00033944295,0.0000026121468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026401306,0.00089550193,0.89477444,0.000052169114,0.0006118918,0.00021095786,0.00023737203,0.0032974794,0.004163111,0.0000037846967,0.000053261672,0.06929872],"study_design_scores_gemma":[0.004375421,0.0010958794,0.9726346,0.00079183665,0.00011212175,0.000009854887,0.00007073298,0.00012604718,0.02037906,0.00018607451,0.000050280963,0.0001680854],"about_ca_topic_score_codex":0.00007439147,"about_ca_topic_score_gemma":0.0011592781,"teacher_disagreement_score":0.07786016,"about_ca_system_score_codex":0.0011796687,"about_ca_system_score_gemma":0.0015218009,"threshold_uncertainty_score":0.99853456},"labels":[],"label_agreement":null},{"id":"W4384342640","doi":"10.1136/ijgc-2023-004356","title":"Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patients","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University Health Centre; McGill University","keywords":"Medicine; Protocol (science); Nausea; Oncology; General surgery; Surgery; Pathology; Alternative medicine","score_opus":0.0378627544721345,"score_gpt":0.40123550757031323,"score_spread":0.36337275309817874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384342640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826156,0.000013673489,0.00027782557,0.00044548104,0.0024595675,0.013954515,0.00011873888,0.00003021056,0.000084382955],"genre_scores_gemma":[0.934152,0.00003715065,0.00076981203,0.0009594232,0.00044276533,0.06346491,0.00006301655,0.000030101195,0.00008083455],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99685633,0.00013471342,0.0015854134,0.00029289717,0.0007987112,0.00033192686],"domain_scores_gemma":[0.99507076,0.0009937831,0.0014260217,0.00015966616,0.002166995,0.00018280295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064579735,0.00020863094,0.00064332044,0.0005183256,0.00002701167,0.000024106064,0.00015545094,0.00019888944,0.0026106152],"category_scores_gemma":[0.00092728273,0.00016036881,0.0004702351,0.00026573736,0.00007793556,0.0004837056,0.000079046054,0.00023073296,0.000008474716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032257322,0.0015263291,0.4172956,0.00018546828,0.0010339164,0.0007305897,0.00037476222,0.00012603344,0.005820172,0.0000030212611,0.0051180017,0.5355288],"study_design_scores_gemma":[0.0049272273,0.004237887,0.937059,0.00026327837,0.00010915531,0.000043186916,0.00014472568,0.000024427218,0.039350692,0.0003355401,0.013281705,0.00022318018],"about_ca_topic_score_codex":0.000018485669,"about_ca_topic_score_gemma":0.00008379534,"teacher_disagreement_score":0.5353056,"about_ca_system_score_codex":0.000637033,"about_ca_system_score_gemma":0.000702673,"threshold_uncertainty_score":0.99830115},"labels":[],"label_agreement":null},{"id":"W4385410408","doi":"10.1136/ijgc-2023-004528","title":"Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgery","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto; University of Calgary; Impact","funders":"","keywords":"Medicine; Gynecologic oncology; Psychological intervention; Pharmacy; Emergency medicine; Cost analysis; Cost effectiveness; Surgery; Total cost; Hysterectomy; Cohort; Internal medicine; Nursing","score_opus":0.05331649526399561,"score_gpt":0.3845841403479,"score_spread":0.3312676450839044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385410408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939643,0.00048272472,0.00032486673,0.0016096316,0.0024073978,0.0002273708,0.00015662472,0.000035966572,0.0007911105],"genre_scores_gemma":[0.99278927,0.004273452,0.0003215152,0.0015126552,0.00042762017,0.00009432489,0.00005763279,0.000021523778,0.00050198525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661726,0.00023785733,0.0014959598,0.00033626918,0.00087896764,0.00043371043],"domain_scores_gemma":[0.98888695,0.0074925763,0.0014004197,0.00020990807,0.0017437574,0.00026638375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012736963,0.0002695073,0.0015674299,0.0020049494,0.000028862782,0.000027991322,0.0003677131,0.0003360663,0.00812136],"category_scores_gemma":[0.0054557044,0.00019233148,0.0018167974,0.001607615,0.0001950538,0.00029361752,0.00015294157,0.00048246342,0.000053156167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015803523,0.0012676673,0.7925146,0.000074257514,0.020615432,0.0060993345,0.000359684,0.013200899,0.03989977,0.00000642595,0.015985657,0.09417274],"study_design_scores_gemma":[0.0009898877,0.0015257668,0.98068124,0.00018015246,0.0012619796,0.000092191454,0.00011296481,0.00012406685,0.012385777,0.00017299944,0.0022562267,0.00021673394],"about_ca_topic_score_codex":0.000040556562,"about_ca_topic_score_gemma":0.00032722333,"teacher_disagreement_score":0.18816665,"about_ca_system_score_codex":0.0014280195,"about_ca_system_score_gemma":0.0015863593,"threshold_uncertainty_score":0.99278533},"labels":[],"label_agreement":null},{"id":"W4385607045","doi":"10.1136/ijgc-2023-004373","title":"Moderately differentiated Sertoli–Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Sertoli cell; Leydig cell; Stromal cell; Hormone; Neoplasm; Internal medicine; Oncology; Pathology; Luteinizing hormone; Spermatogenesis","score_opus":0.026765430232276895,"score_gpt":0.294180692498527,"score_spread":0.2674152622662501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385607045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242675,0.0005054187,0.000056923564,0.0050657117,0.00066469004,0.00019555904,0.00006674896,0.000065755135,0.0009524138],"genre_scores_gemma":[0.9972206,0.0010350181,0.000107248525,0.00065926387,0.00019426069,0.000047510268,0.0000616534,0.000028434251,0.00064601435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798596,0.00006647051,0.0005293444,0.00024519162,0.00084727607,0.00032574122],"domain_scores_gemma":[0.99804634,0.00040000447,0.0005146973,0.00008923755,0.00072083913,0.00022886251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023435861,0.00021776726,0.0005073251,0.0002279368,0.00007649914,0.000082575956,0.0002315258,0.00013417729,0.0008274703],"category_scores_gemma":[0.00023748272,0.00013926277,0.00020476062,0.00031204292,0.000059316797,0.00013912577,0.00006934925,0.00038608242,0.000039938568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007809788,0.006200864,0.84154296,0.000110991605,0.011120978,0.060610723,0.0012685424,0.009123835,0.013526458,0.00031590767,0.030233813,0.01813515],"study_design_scores_gemma":[0.006119618,0.001603392,0.9871285,0.00035452723,0.00031782754,0.00047603666,0.000093603834,0.0014470726,0.0011888728,0.00018858329,0.0008987303,0.00018321104],"about_ca_topic_score_codex":0.00005543436,"about_ca_topic_score_gemma":0.00005489993,"teacher_disagreement_score":0.14558558,"about_ca_system_score_codex":0.00075227255,"about_ca_system_score_gemma":0.00031641335,"threshold_uncertainty_score":0.90602195},"labels":[],"label_agreement":null},{"id":"W4385778900","doi":"10.1136/ijgc-2023-004627","title":"Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Lymph node; Stage (stratigraphy); Ovary; Proportional hazards model; Oncology; Adenocarcinoma; Carcinoma; Cohort; Internal medicine; Endometrial cancer; Gynecology; Cancer; Gastroenterology","score_opus":0.03490518763349605,"score_gpt":0.30928954666474623,"score_spread":0.2743843590312502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385778900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946426,0.0014917975,0.000046714264,0.002797547,0.00052371016,0.00013732674,0.000114701754,0.0000024209849,0.00024315299],"genre_scores_gemma":[0.9968003,0.0024535388,0.00029060667,0.00022120606,0.00014084305,0.000011742884,0.0000037865464,0.0000051674383,0.00007280242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988799,0.00003857326,0.00049217115,0.00008503721,0.000427332,0.00007695821],"domain_scores_gemma":[0.99855155,0.00042295427,0.00044713085,0.00009118795,0.00043908565,0.0000480989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012320728,0.000070191076,0.0003033603,0.00016628277,0.000014133933,0.000004549376,0.00014756441,0.000042725136,0.00037662752],"category_scores_gemma":[0.0001998624,0.000041070125,0.0001571717,0.00016270053,0.000069466674,0.00003699664,0.000075893164,0.00009980189,5.5203697e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001578547,0.00027844397,0.97506106,0.000055768563,0.0004394375,0.00007824366,0.000114749055,0.00019949545,0.0062758685,0.00017617822,0.00040291352,0.016759964],"study_design_scores_gemma":[0.0016176387,0.000519229,0.9844283,0.00018432483,0.00013671692,0.000065923545,0.000028976805,0.000027748343,0.012239245,0.00017078311,0.00055010314,0.000031032105],"about_ca_topic_score_codex":0.00010133486,"about_ca_topic_score_gemma":0.000031877367,"teacher_disagreement_score":0.01672893,"about_ca_system_score_codex":0.00013656101,"about_ca_system_score_gemma":0.00020430108,"threshold_uncertainty_score":0.41238073},"labels":[],"label_agreement":null},{"id":"W4385949246","doi":"10.1136/ijgc-2023-004610","title":"Low-grade serous ovarian cancer: expert consensus report on the state of the science","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"National Cancer Institute; Cancer Research UK; Verastem Oncology","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Disease; Ovarian cancer; Intensive care medicine; Consensus conference; Clinical trial; Translational research; Internal medicine; Oncology; Gynecology; Cancer; Pathology","score_opus":0.05335657227922008,"score_gpt":0.3657755046738609,"score_spread":0.3124189323946408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385949246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9004229,0.00031906224,0.0000042612633,0.09554114,0.0028035138,0.00021238027,0.000038321647,0.000011121502,0.0006473316],"genre_scores_gemma":[0.9947893,0.0012658435,0.000052995478,0.002928215,0.0003796736,0.000050816958,9.1309147e-7,0.000008669764,0.00052359886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789834,0.0000555527,0.0005093611,0.00019068003,0.0011397693,0.00020629384],"domain_scores_gemma":[0.99778605,0.00052192813,0.00056205405,0.00021525969,0.00081257964,0.0001021335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006755515,0.00011689644,0.00025444446,0.000118104705,0.00010467744,0.00003345174,0.000473649,0.000038607774,0.0006435476],"category_scores_gemma":[0.0007833724,0.000052334904,0.0001948092,0.00041969673,0.00041886882,0.000041565443,0.00010525323,0.00025984508,0.0000073787523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041096946,0.0045949924,0.4466495,0.00007953106,0.0051956507,0.01879942,0.003349452,0.021534642,0.047154695,0.008512559,0.1315786,0.30844128],"study_design_scores_gemma":[0.0020807208,0.0005718254,0.93157345,0.00047844966,0.00008642721,0.00058110006,0.00012579428,0.00025091175,0.048000734,0.001359546,0.014778691,0.00011237624],"about_ca_topic_score_codex":0.00028929775,"about_ca_topic_score_gemma":0.000086503074,"teacher_disagreement_score":0.48492393,"about_ca_system_score_codex":0.00071225455,"about_ca_system_score_gemma":0.0010432109,"threshold_uncertainty_score":0.70463955},"labels":[],"label_agreement":null},{"id":"W4386332493","doi":"10.1136/ijgc-2023-004621","title":"Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Gynecologic oncology; Laparotomy; Analgesic; Prospective cohort study; Malignancy; Surgery; Cohort; Demographics; Anesthesia; Internal medicine","score_opus":0.03253657911603578,"score_gpt":0.407486619345892,"score_spread":0.3749500402298562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386332493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928669,0.00013782737,0.00002575651,0.0009036309,0.0023705964,0.001451045,0.000015543133,0.0000744392,0.002154268],"genre_scores_gemma":[0.9968684,0.00064393115,0.00062980666,0.00042223727,0.000454252,0.00050591945,0.000016554488,0.000022663346,0.0004362508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647194,0.00041548628,0.0013216845,0.00042947306,0.0009615977,0.0003997989],"domain_scores_gemma":[0.9964916,0.0010304351,0.0009624081,0.00020624379,0.0011041048,0.00020521307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018919137,0.00024870795,0.0010320882,0.00068237947,0.000036732115,0.000030169613,0.0004374726,0.00025194915,0.0014106043],"category_scores_gemma":[0.0024694332,0.00018474604,0.00031015318,0.00080002926,0.00016626428,0.00040266683,0.00013197027,0.0007251888,0.000034412413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004312584,0.0043768403,0.8447966,0.000021602309,0.0008247598,0.003165163,0.00032170725,0.00073440606,0.0021396219,0.00001544255,0.00033964452,0.13895161],"study_design_scores_gemma":[0.0021323645,0.010664319,0.9797403,0.00016913743,0.00013138779,0.00013258857,0.0006050905,0.0001125415,0.004343651,0.0010446907,0.00074219814,0.0001817323],"about_ca_topic_score_codex":0.000062762665,"about_ca_topic_score_gemma":0.0004954225,"teacher_disagreement_score":0.1387699,"about_ca_system_score_codex":0.0013477736,"about_ca_system_score_gemma":0.00077185204,"threshold_uncertainty_score":0.99950224},"labels":[],"label_agreement":null},{"id":"W4386421537","doi":"10.1136/ijgc-2023-004622","title":"Evaluating the use of machine learning in endometrial cancer: a systematic review","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Machine learning; Medicine; Artificial intelligence; Endometrial cancer; Logistic regression; Support vector machine; Cancer; Algorithm; Computer science; Internal medicine","score_opus":0.4035949846497122,"score_gpt":0.5166116364541455,"score_spread":0.11301665180443332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386421537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014471539,0.9954175,0.000004609007,0.00079750625,0.0016171804,0.0018649752,0.000113239104,0.000013767572,0.000026524758],"genre_scores_gemma":[0.00014401211,0.9974673,0.000096810814,0.00052086014,0.00065917993,0.00051081716,0.000025303727,0.000036048583,0.00053971243],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9940879,0.0009693566,0.002856984,0.00025634954,0.0015822917,0.00024716734],"domain_scores_gemma":[0.98773223,0.007735398,0.0033365933,0.00018311433,0.0008942397,0.00011839512],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022303849,0.000341732,0.004175141,0.0006652232,0.000035078257,0.000037886064,0.00063013507,0.00020553313,0.0011673232],"category_scores_gemma":[0.02340324,0.00016062534,0.001327307,0.0013505237,0.00007618046,0.00009888103,0.00017295922,0.0011550551,0.000015046951],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005823723,0.0003024545,0.0005149622,0.4004911,0.004570052,0.00049096637,0.000027819817,0.00019167493,0.000001489451,0.000027009808,0.00023122056,0.5925689],"study_design_scores_gemma":[0.0035651312,0.0016125684,0.00013347594,0.8582931,0.010070132,0.0002524955,0.000008078532,0.00010462221,0.0000012973387,0.00003459131,0.12570603,0.00021846473],"about_ca_topic_score_codex":0.00036847152,"about_ca_topic_score_gemma":0.00010908227,"teacher_disagreement_score":0.5923504,"about_ca_system_score_codex":0.0013834079,"about_ca_system_score_gemma":0.0009945435,"threshold_uncertainty_score":0.9997457},"labels":[],"label_agreement":null},{"id":"W4386843755","doi":"10.1136/ijgc-2023-004526","title":"Gestational trophoblastic neoplasia: does centralization of care impact clinical management?","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Gestational trophoblastic neoplasia; Obstetrics; Chemotherapy; Human chorionic gonadotropin; Gynecology; Referral; Retrospective cohort study; Chemotherapy regimen; Choriocarcinoma; Gestational age; Pregnancy; Internal medicine; Family medicine","score_opus":0.024586807690110807,"score_gpt":0.412889556750872,"score_spread":0.38830274906076123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386843755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939886,0.00026769258,0.0005205268,0.0017492736,0.0022013956,0.00020145295,0.00018417362,0.00002769425,0.00085923815],"genre_scores_gemma":[0.9957098,0.0021260132,0.0011238153,0.00019910502,0.0004831004,0.000014826958,0.000085453605,0.000013893294,0.0002440413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976806,0.00007156251,0.0008728819,0.00017712732,0.0010022754,0.0001955471],"domain_scores_gemma":[0.9967103,0.00071817194,0.0005310101,0.000077463534,0.0017962208,0.00016684206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001882773,0.00014513925,0.00040435515,0.00030911394,0.00003758012,0.000018828943,0.00021236934,0.00007628972,0.0012240479],"category_scores_gemma":[0.0010273927,0.00009023146,0.00037820905,0.00028701642,0.00016579697,0.000111869005,0.000078902645,0.000187302,0.00002572812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004405428,0.00077327853,0.93885785,0.00025480118,0.003371663,0.0017835958,0.00043794193,0.013917462,0.00043322597,0.002932706,0.011527799,0.02130422],"study_design_scores_gemma":[0.002671551,0.00078886986,0.99206364,0.00020235167,0.00027241083,0.00003964655,0.0006884199,0.00029707325,0.000069831585,0.0011129761,0.0017057939,0.000087440574],"about_ca_topic_score_codex":0.000006286048,"about_ca_topic_score_gemma":0.000008229296,"teacher_disagreement_score":0.05320576,"about_ca_system_score_codex":0.00031388216,"about_ca_system_score_gemma":0.00030982547,"threshold_uncertainty_score":0.999689},"labels":[],"label_agreement":null},{"id":"W4387134875","doi":"10.1136/ijgc-2023-esgo.11","title":"#73 Non-steroidal anti-inflammatory medication use and survival following an endometrial cancer diagnosis: a population-based norwegian cohort study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Oklahoma Health Sciences Center; INCLIVA Instituto de Investigación Sanitaria; Stephenson Cancer Center; London Health Sciences Centre; Centro de Investigación Biomédica en Red de Cáncer; Ostravská Univerzita v Ostravě; Tel Aviv University; University of Oklahoma","keywords":"Medicine; Aspirin; Internal medicine; Endometrial cancer; Proportional hazards model; Retrospective cohort study; Cancer registry; Population; Hazard ratio; Medical prescription; Cancer; Norwegian; Cohort; Cohort study; Incidence (geometry); Pharmacology; Confidence interval","score_opus":0.0178890441719206,"score_gpt":0.32117839291319994,"score_spread":0.30328934874127933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387134875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598646,0.00029596567,0.000060567247,0.0003480643,0.002952502,0.00030448008,0.000028169608,0.000013763996,0.000010028632],"genre_scores_gemma":[0.99786663,0.00076827046,0.000050547613,0.00015943298,0.0008941025,0.00014918891,0.0000707154,0.000016954267,0.000024139763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983993,0.00018356592,0.00042573406,0.00026045187,0.0005488588,0.00018207317],"domain_scores_gemma":[0.99893785,0.0002235124,0.000310854,0.000109896464,0.000265902,0.00015198521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070466613,0.00015049987,0.00025599648,0.000193452,0.00008214324,0.00008260263,0.000271885,0.00017885969,0.00007310097],"category_scores_gemma":[0.00060371804,0.000117627875,0.0001465832,0.00014364395,0.00004047106,0.00003962302,0.00007497128,0.00020276972,0.0000025107045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002431351,0.00018550914,0.98441917,0.000003480445,0.0005293785,0.00012789363,0.000037072317,0.0013170945,0.010236911,0.0000028332408,0.00023190143,0.0026656494],"study_design_scores_gemma":[0.0025894793,0.0006632271,0.99351066,0.000033448505,0.000107920634,0.000005219327,0.00005605462,0.00034169396,0.002054721,0.000008925192,0.00048725714,0.00014141592],"about_ca_topic_score_codex":0.00018824305,"about_ca_topic_score_gemma":0.0001918509,"teacher_disagreement_score":0.009091496,"about_ca_system_score_codex":0.000107047454,"about_ca_system_score_gemma":0.00015882912,"threshold_uncertainty_score":0.47967255},"labels":[],"label_agreement":null},{"id":"W4387134912","doi":"10.1136/ijgc-2023-esgo.157","title":"#543 Gastric-type well differentiated adenocarcinoma of the endocervix: overcoming resistant behaviour with surgical aggressiveness","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cervix; Stage (stratigraphy); Cervical cancer; Adenocarcinoma; Disease; Internal medicine; Oncology; Biopsy; Cancer; Retrospective cohort study; Surgery","score_opus":0.027070501008984813,"score_gpt":0.30827547501289565,"score_spread":0.2812049740039108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387134912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942089,0.0004882994,0.000019069943,0.0033597068,0.0012813548,0.00016009451,0.00001411331,0.000017069024,0.00045144893],"genre_scores_gemma":[0.9978395,0.0004922175,0.00006378846,0.00019837881,0.00028874225,0.000006942894,0.0000064647934,0.000012511893,0.0010914244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981626,0.00006812124,0.00049072405,0.00015245129,0.0009143958,0.00021168988],"domain_scores_gemma":[0.99829215,0.00025725982,0.00057977217,0.0001295134,0.0006493251,0.00009196077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021904355,0.00013989008,0.00036457356,0.00020116055,0.000046888363,0.000025355635,0.000423556,0.000065824606,0.0014573947],"category_scores_gemma":[0.0001659351,0.000073671756,0.00022037773,0.00045411428,0.000103823804,0.000074139185,0.00017154623,0.00029700118,0.0000057042553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023904238,0.00014404595,0.99054104,0.000024825777,0.0003746473,0.0014381252,0.000042680946,0.00019838438,0.0005991735,0.00013143609,0.0019864195,0.0021288],"study_design_scores_gemma":[0.003240978,0.00056806125,0.99129224,0.00026973512,0.00023863556,0.00021097041,0.000105558276,0.00005746554,0.00084032526,0.00006940543,0.0030298482,0.000076768985],"about_ca_topic_score_codex":0.00006120597,"about_ca_topic_score_gemma":0.000048909253,"teacher_disagreement_score":0.0036306859,"about_ca_system_score_codex":0.00026351897,"about_ca_system_score_gemma":0.0001988913,"threshold_uncertainty_score":0.9994554},"labels":[],"label_agreement":null},{"id":"W4387134922","doi":"10.1136/ijgc-2023-esgo.144","title":"#438 Molecular alterations predictive of outcome in early staged cervical cancer : a translational investigation from the SENTICOL III trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cervical cancer; Oncology; Stage (stratigraphy); Medicine; Internal medicine; Clinical trial; Sentinel node; Cancer; Biopsy; Biology; Breast cancer","score_opus":0.061798374608982826,"score_gpt":0.36744920589065644,"score_spread":0.3056508312816736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387134922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978852,0.00039205598,0.00022069963,0.018332088,0.0012806099,0.0005576277,0.0002591319,0.0000145514205,0.00009123673],"genre_scores_gemma":[0.99724364,0.00024262215,0.00014201226,0.0013827259,0.0007365616,0.00011684481,0.00005105131,0.000010963928,0.000073571195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974684,0.00017198313,0.0009616153,0.00019021612,0.0010324415,0.00017533584],"domain_scores_gemma":[0.99775004,0.0010204086,0.00042236267,0.00009425146,0.0005866951,0.00012621994],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040412904,0.0001425229,0.00043121557,0.00022789201,0.000038225855,0.0000288659,0.0002666115,0.00012345634,0.0015096052],"category_scores_gemma":[0.0005742368,0.000088809,0.00027134453,0.000558962,0.00012312058,0.00015019717,0.000045604535,0.00039502874,0.000007001636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031393282,0.00056189037,0.9523259,0.000015175628,0.0011820607,0.00026821956,0.0012025528,0.0031304338,0.0038479266,0.00055216555,0.00043813753,0.0050822822],"study_design_scores_gemma":[0.041716874,0.0007976432,0.95164204,0.00014647482,0.00022126184,0.0000049242194,0.00009786258,0.0005418139,0.0013673364,0.003036716,0.0003369671,0.00009008164],"about_ca_topic_score_codex":0.0011064415,"about_ca_topic_score_gemma":0.00050616986,"teacher_disagreement_score":0.018391648,"about_ca_system_score_codex":0.00034272744,"about_ca_system_score_gemma":0.0003603068,"threshold_uncertainty_score":0.9994032},"labels":[],"label_agreement":null},{"id":"W4387134990","doi":"10.1136/ijgc-2023-esgo.13","title":"#267 Quality-adjusted time without symptoms of disease or toxicity in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel in the ENGOT-EN6/GOG-3031/RUBY trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); McGill University Health Centre","funders":"National Cancer Institute; Daiichi Sankyo Europe; MSD Italia; Genentech; National Institutes of Health; PharmaMar; Eisai; Seagen; Silverback Therapeutics; Puma Biotechnology; Deciphera Pharmaceuticals; Clovis Oncology; Novocure; Amgen; Relay Therapeutics; Mersana Therapeutics; Karyopharm Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Carboplatin; Toxicity; Endometrial cancer; Internal medicine; Population; Paclitaxel; Placebo; Cancer; Adverse effect; Gastroenterology; Oncology; Surgery; Chemotherapy; Urology; Cisplatin; Pathology","score_opus":0.053971030871499744,"score_gpt":0.361832289369025,"score_spread":0.30786125849752527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387134990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942913,0.0005013846,0.000004734393,0.0009963599,0.0012084374,0.0020511083,0.0006036094,0.000034507564,0.00030855107],"genre_scores_gemma":[0.9976455,0.00045426554,0.00014582409,0.0003638349,0.00057142955,0.00038702373,0.00015822113,0.00003965122,0.00023425059],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9943678,0.0005483028,0.0016021293,0.0005288079,0.0023926878,0.00056032185],"domain_scores_gemma":[0.9938293,0.0033310645,0.0012465989,0.0002942266,0.00096029835,0.00033849097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087402057,0.0004777704,0.0014493227,0.00080098247,0.0000643892,0.000047621343,0.00056562724,0.00018984731,0.0010748811],"category_scores_gemma":[0.0030768344,0.00023050555,0.0002874524,0.0021386002,0.00022177718,0.00029226957,0.00011260558,0.0007433864,0.000005581319],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7809439,0.0021455318,0.19032101,0.00008350669,0.00097261,0.0005239038,0.0004087238,0.00076919975,0.000088662455,0.000018697423,0.000066961504,0.0236573],"study_design_scores_gemma":[0.3160436,0.020648148,0.66101307,0.0006927828,0.00048726596,0.000007263841,0.0002617778,0.00011424765,0.00011496316,0.000029887955,0.0002592296,0.00032780293],"about_ca_topic_score_codex":0.00082187797,"about_ca_topic_score_gemma":0.0019469898,"teacher_disagreement_score":0.47069204,"about_ca_system_score_codex":0.002599474,"about_ca_system_score_gemma":0.0015333699,"threshold_uncertainty_score":0.9998383},"labels":[],"label_agreement":null},{"id":"W4387135053","doi":"10.1136/ijgc-2023-esgo.50","title":"#248 How long do we need to monitor HCG after evacuation of a complete hydatidiform mole?","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Genentech; BeiGene; AstraZeneca","keywords":"Medicine; Normalization (sociology); Pregnancy; Gynecology; Gestation; Gestational age; Internal medicine; Obstetrics; Biology","score_opus":0.03879929907570517,"score_gpt":0.3475106312802284,"score_spread":0.30871133220452324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95162255,0.00050379033,0.00055569934,0.04510474,0.001550907,0.00023791756,0.00012832746,0.000020185471,0.00027587477],"genre_scores_gemma":[0.99704,0.0004511276,0.0007850683,0.0005355962,0.00065350306,0.00006266914,0.00001244214,0.000013214046,0.0004464035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802446,0.00003877862,0.0004808419,0.00015719932,0.0011103984,0.00018832898],"domain_scores_gemma":[0.99718976,0.00050509314,0.0003298673,0.00008484233,0.0017034628,0.00018696226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022491587,0.00014076532,0.00035222777,0.000356022,0.000029462164,0.000031796182,0.00021341293,0.000057186524,0.00088861195],"category_scores_gemma":[0.0013857328,0.000102124395,0.00018976006,0.00029161904,0.00008037469,0.00012853747,0.00010972456,0.00016865683,0.00006337205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027704593,0.0023144092,0.6310477,0.00056619756,0.006692319,0.005418481,0.0032459202,0.016196359,0.038017597,0.002093663,0.11211635,0.15458637],"study_design_scores_gemma":[0.0016358639,0.00066955626,0.9897979,0.00038128177,0.00012573521,0.0000385048,0.00035625196,0.00041949103,0.00043308354,0.0012890281,0.004744561,0.00010877305],"about_ca_topic_score_codex":0.000010229113,"about_ca_topic_score_gemma":0.0000133673975,"teacher_disagreement_score":0.35875013,"about_ca_system_score_codex":0.0003201973,"about_ca_system_score_gemma":0.00014870914,"threshold_uncertainty_score":0.97296774},"labels":[],"label_agreement":null},{"id":"W4387135356","doi":"10.1136/ijgc-2023-esgo.883","title":"#142 An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Canadian Cancer Society; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Randomized controlled trial; Clinical endpoint; Stage (stratigraphy); Surgery; Hysterectomy; Dissection (medical); Lymph node; Cervical cancer; Radical Hysterectomy; Urology; Cancer; Internal medicine","score_opus":0.02311838625115397,"score_gpt":0.33958572564572104,"score_spread":0.31646733939456706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952719,0.00017372299,0.00018263473,0.0007770524,0.0021431113,0.0010689328,0.0001392859,0.000056426223,0.00018691343],"genre_scores_gemma":[0.99735427,0.0007507508,0.00009506591,0.00028464213,0.0010239836,0.00020326195,0.00013858189,0.00003808651,0.000111372115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623936,0.0003812322,0.0011819822,0.00056131714,0.0012200471,0.00041604694],"domain_scores_gemma":[0.99724305,0.00086259656,0.00074973464,0.00014962607,0.0005776017,0.00041739136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007551679,0.00038347478,0.0012410833,0.0006544217,0.00012818347,0.00017102722,0.0002988184,0.00021587391,0.0010918331],"category_scores_gemma":[0.00067074376,0.00025836308,0.00025087007,0.00047285322,0.00024507463,0.00060139515,0.00014428906,0.0007540999,0.0000056984136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4370418,0.0012381672,0.55111986,0.000038968108,0.00074442464,0.00020521127,0.0002656916,0.0002599333,0.00006936109,0.000022869906,0.000029814732,0.008963903],"study_design_scores_gemma":[0.42388922,0.0017576984,0.5707333,0.00022277559,0.00024976407,0.000033133336,0.000076539705,0.0024414829,0.00008428765,0.00009141145,0.00022020533,0.00020020669],"about_ca_topic_score_codex":0.0018480697,"about_ca_topic_score_gemma":0.0015888566,"teacher_disagreement_score":0.019613428,"about_ca_system_score_codex":0.0008486941,"about_ca_system_score_gemma":0.00015937032,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W4387135371","doi":"10.1136/ijgc-2023-esgo.374","title":"#775 Retrospective analysis on the prognostic value of pretreatment platelet count & C-reactive protein level in endometrial cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute; McGill University Health Centre","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Retrospective cohort study; Gastroenterology; Thrombocytosis; Univariate analysis; Proportional hazards model; C-reactive protein; Platelet; Cancer; Multivariate analysis; Adjuvant therapy; Stage (stratigraphy); Survival analysis; Inflammation","score_opus":0.05939114032625982,"score_gpt":0.3603391543295122,"score_spread":0.3009480140032524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395114,0.0002098233,0.000045420802,0.0036667243,0.0006212461,0.0008625316,0.00027082762,0.000015538055,0.0003567249],"genre_scores_gemma":[0.9985112,0.00018390185,0.0001758819,0.00024534055,0.00031037504,0.00040050884,0.000015574384,0.000013461879,0.00014376132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972585,0.00019809812,0.0007338225,0.00025089725,0.0013180642,0.00024064306],"domain_scores_gemma":[0.9967768,0.0011858108,0.0007447918,0.00015091646,0.0010388935,0.00010277828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095296814,0.00019038354,0.0005845926,0.0008504763,0.00004120719,0.000025647749,0.0003441965,0.00012803308,0.0015469807],"category_scores_gemma":[0.003762135,0.000112124275,0.0004206621,0.001301206,0.00016647788,0.00008588109,0.000081131715,0.0004018804,0.000012411648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046477197,0.00071826123,0.97932094,0.00002014067,0.006662206,0.00051406387,0.00025581862,0.0015476351,0.0024672549,0.0007001433,0.000627202,0.0025186255],"study_design_scores_gemma":[0.0027890021,0.0005694769,0.9868885,0.00029732063,0.0006103431,0.000010067411,0.00008722394,0.00033345213,0.0071727727,0.0006876638,0.00044578308,0.000108349945],"about_ca_topic_score_codex":0.00017796444,"about_ca_topic_score_gemma":0.00025109883,"teacher_disagreement_score":0.0075676152,"about_ca_system_score_codex":0.002009959,"about_ca_system_score_gemma":0.00045734117,"threshold_uncertainty_score":0.99936575},"labels":[],"label_agreement":null},{"id":"W4387135422","doi":"10.1136/ijgc-2023-esgo.44","title":"#1015 Mirvetuximab soravtansine demonstrates longer overall survival and progression-free survival by prior lines of therapy vs chemotherapy in platinum-resistant ovarian cancer and high folate receptor alpha expression in the MIRASOL trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Progression-free survival; Hazard ratio; Medicine; Internal medicine; Clinical endpoint; Oncology; Topotecan; Population; Ovarian cancer; Adverse effect; Paclitaxel; Confidence interval; Chemotherapy; Cancer; Randomized controlled trial","score_opus":0.03363870962360981,"score_gpt":0.34231345501011756,"score_spread":0.30867474538650774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717878,0.005030516,0.000008088039,0.02143392,0.0008797452,0.0006670815,0.00014989663,0.000009812454,0.000033122036],"genre_scores_gemma":[0.9788376,0.019670915,0.00044816337,0.0003985082,0.00042708998,0.00012487888,0.000020032332,0.000019572726,0.00005321932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977719,0.00018657176,0.0007625061,0.0002808221,0.0007610768,0.00023708843],"domain_scores_gemma":[0.99812245,0.0008853404,0.0004771781,0.00013375882,0.00028414058,0.00009710307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084842095,0.0002267048,0.0006183758,0.00017677726,0.00004189242,0.000056335928,0.00027026408,0.00016230704,0.0004427579],"category_scores_gemma":[0.00026366435,0.0001272515,0.000096882184,0.00021661664,0.00013566253,0.00013992909,0.00006128058,0.00031700812,5.069254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19411898,0.004292681,0.48126855,0.00009127293,0.0011771512,0.000720721,0.0015646138,0.00006501468,0.05449816,0.00036610957,0.008097455,0.2537393],"study_design_scores_gemma":[0.10503162,0.0036618987,0.88013947,0.000835109,0.00005805477,0.000018482508,0.00019444726,0.000115671886,0.005665933,0.0009098366,0.0031572105,0.00021226027],"about_ca_topic_score_codex":0.00038636336,"about_ca_topic_score_gemma":0.00050428166,"teacher_disagreement_score":0.39887092,"about_ca_system_score_codex":0.00019362112,"about_ca_system_score_gemma":0.00022891942,"threshold_uncertainty_score":0.51891655},"labels":[],"label_agreement":null},{"id":"W4387135433","doi":"10.1136/ijgc-2023-esgo.866","title":"#24 A phase 2 study (GOG-3084) OF ADP-A2M4CD8 TCR T-cell therapy, alone or in combination with nivolumab, in patients with recurrent ovarian cancers","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Oncology; Ovarian cancer; Nivolumab; Medicine; Internal medicine; Population; Ovarian carcinoma; Debulking; CD8; Immunotherapy; Cancer; Immunology; Antigen","score_opus":0.04904749363744676,"score_gpt":0.37701556038881845,"score_spread":0.3279680667513717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997032,0.00014446788,0.000016015943,0.0011190601,0.00042665217,0.00095192104,0.00002391618,0.000011221384,0.00027477948],"genre_scores_gemma":[0.998402,0.00048606793,0.00009706708,0.00017426311,0.00009855221,0.00008428175,0.000018740291,0.000022656868,0.0006163639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970501,0.00018072056,0.00071161444,0.00024690913,0.0015344826,0.00027615548],"domain_scores_gemma":[0.9979585,0.00032633738,0.000452036,0.00013316142,0.0010064746,0.00012349502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000736269,0.00017686833,0.000523987,0.00067179336,0.000023119472,0.000024408931,0.00032246095,0.000080860395,0.0031056823],"category_scores_gemma":[0.00019062131,0.00010665649,0.00007321184,0.00079996104,0.00010799516,0.00015154641,0.000054402994,0.00054512644,0.000003619979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06641149,0.009584048,0.8449677,0.000026299404,0.00043543478,0.00094691786,0.0012656912,0.00073747686,0.0011834078,0.0000090311405,0.0005073132,0.07392518],"study_design_scores_gemma":[0.073777,0.027650386,0.895285,0.00031092585,0.000033994213,0.000014838845,0.000726532,0.00032247687,0.00055626413,0.000045519802,0.0011243257,0.0001527219],"about_ca_topic_score_codex":0.00053731573,"about_ca_topic_score_gemma":0.0023393102,"teacher_disagreement_score":0.07377246,"about_ca_system_score_codex":0.0014581389,"about_ca_system_score_gemma":0.00079919887,"threshold_uncertainty_score":0.9978056},"labels":[],"label_agreement":null},{"id":"W4387135441","doi":"10.1136/ijgc-2023-esgo.45","title":"#1056 Mirvetuximab soravtansine demonstrates efficacy over investigator’s choice chemotherapy regardless of prior PARPi exposure in phase III MIRASOL trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Confidence interval; Oncology; Progression-free survival; Clinical endpoint; Chemotherapy; Metastatic breast cancer; Topotecan; Clinical trial; Cancer; Breast cancer","score_opus":0.06036787237546302,"score_gpt":0.4109277313982548,"score_spread":0.35055985902279174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800045,0.000964596,0.000058849997,0.008428284,0.0016328917,0.0005605466,0.00006184904,0.00003726933,0.0002552423],"genre_scores_gemma":[0.99417865,0.0015602601,0.00036531393,0.0023865937,0.0011860337,0.000053335265,0.00002039183,0.000029249833,0.00022017886],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968965,0.00014357793,0.0013715384,0.0002814151,0.0010018144,0.00030517636],"domain_scores_gemma":[0.9969938,0.0008761343,0.0009236055,0.0001722686,0.0007639895,0.00027025028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074035686,0.00024285083,0.00081001216,0.0004476084,0.00003494374,0.0000326451,0.0004071839,0.00023871726,0.0021164373],"category_scores_gemma":[0.0013905403,0.00018889084,0.0003288787,0.00052124157,0.0002800056,0.00020068177,0.000043449065,0.0005702955,0.00000873688],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33216223,0.011853945,0.15337531,0.00018341199,0.0032568,0.0025458988,0.0020310867,0.0014667753,0.2920455,0.00067598105,0.04918109,0.15122196],"study_design_scores_gemma":[0.6096227,0.006700262,0.29394057,0.0013820061,0.00018332039,0.00018642595,0.00019850113,0.00060139014,0.05268399,0.0013477745,0.03260569,0.00054737844],"about_ca_topic_score_codex":0.00006881122,"about_ca_topic_score_gemma":0.0000714749,"teacher_disagreement_score":0.27746046,"about_ca_system_score_codex":0.0004963525,"about_ca_system_score_gemma":0.00085745845,"threshold_uncertainty_score":0.99879575},"labels":[],"label_agreement":null},{"id":"W4387135460","doi":"10.1136/ijgc-2023-esgo.49","title":"#71 Integrated multi-omic and clinicopathological analysis of high-grade serous ovarian cancer in BRCA1/2 mutated patients with poor survival: identification of predictive biomarkers for personalized treatment","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Oncology; Ovarian cancer; Serous fluid; Medicine; Internal medicine; Cancer; Germline; Cancer research; BRCA mutation; Serous carcinoma; Survival analysis; Biology; Gene; Genetics","score_opus":0.04083059711996549,"score_gpt":0.3617334189412684,"score_spread":0.3209028218213029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943578,0.00032110812,0.00049761287,0.0022474322,0.00044371185,0.0006203357,0.0014949507,0.000012653472,0.000004387483],"genre_scores_gemma":[0.9972447,0.0016242373,0.00052105845,0.0000807021,0.000045397555,0.00019343062,0.00021403222,0.000013659195,0.00006277834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979986,0.00012565462,0.0009564638,0.0003027114,0.00044151768,0.00017503196],"domain_scores_gemma":[0.99725735,0.00052812084,0.00092326454,0.000092629685,0.001096616,0.00010200532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041618958,0.0001868533,0.0008489029,0.00061361725,0.000024882762,0.00001529542,0.00013309343,0.00012878672,0.0002325857],"category_scores_gemma":[0.00031204338,0.00011463682,0.0002522093,0.0007208064,0.00018340896,0.000082214174,0.000026271478,0.00011262585,4.1110994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006533748,0.0020726505,0.96615905,0.000023580833,0.0059432723,0.00008694814,0.0003225967,0.002669296,0.00070437655,0.00006313233,0.000054811662,0.015366547],"study_design_scores_gemma":[0.015901769,0.0023310203,0.9738594,0.00014863769,0.0021541698,0.0000038071873,0.00022369227,0.0041420325,0.0010111138,0.00004240936,0.00008605158,0.000095897645],"about_ca_topic_score_codex":0.0009078903,"about_ca_topic_score_gemma":0.0009380087,"teacher_disagreement_score":0.015270649,"about_ca_system_score_codex":0.000835773,"about_ca_system_score_gemma":0.0002731188,"threshold_uncertainty_score":0.46747538},"labels":[],"label_agreement":null},{"id":"W4387135564","doi":"10.1136/ijgc-2023-esgo.23","title":"#236 Laparoscopic cytoreduction after neoadjuvant chemotherapy (LANCE): feasibility phase of a randomized trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Surgery; Laparotomy; Laparoscopic surgery; Stage (stratigraphy); Neoadjuvant therapy; Chemotherapy; Laparoscopy; Cancer; Internal medicine; Breast cancer","score_opus":0.04837968530107541,"score_gpt":0.40947463827845,"score_spread":0.3610949529773746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98592037,0.0007805904,0.000051895764,0.009246699,0.0030467836,0.00071073667,0.000043090862,0.000018384137,0.00018145844],"genre_scores_gemma":[0.9950543,0.002476763,0.0002569007,0.0005881165,0.0012119364,0.00018294368,0.000010465184,0.000010514846,0.0002080409],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981134,0.00011153335,0.0008210234,0.00018279605,0.0006157848,0.00015549712],"domain_scores_gemma":[0.9982853,0.00031929577,0.0005657542,0.00011540224,0.0006031225,0.00011115931],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072063674,0.00013608155,0.0008784864,0.00016824125,0.000018738661,0.000019312365,0.00014092987,0.000095280564,0.0028024865],"category_scores_gemma":[0.0005480602,0.000085624364,0.0005204173,0.00016298336,0.00015094875,0.00009242937,0.000026071164,0.00017860079,0.000010404016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9505258,0.0022975085,0.015376309,0.000023663802,0.0013462261,0.0003013331,0.00020448398,0.000055662364,0.0013673464,0.00011537139,0.002277142,0.026109142],"study_design_scores_gemma":[0.90709054,0.0023336157,0.08282234,0.00018302324,0.00029082788,0.000042353935,0.000037587644,0.00010674082,0.0034441717,0.0009664277,0.0025917962,0.00009054581],"about_ca_topic_score_codex":0.000032684144,"about_ca_topic_score_gemma":0.0000100041625,"teacher_disagreement_score":0.06744603,"about_ca_system_score_codex":0.0004758322,"about_ca_system_score_gemma":0.0002871965,"threshold_uncertainty_score":0.9981091},"labels":[],"label_agreement":null},{"id":"W4387135575","doi":"10.1136/ijgc-2023-esgo.899","title":"#1120 Durvalumab with paclitaxel/carboplatin + bevacizumab then maintenance durvalumab, bevacizumab + olaparib in patients with newly diagnosed advanced ovarian cancer without a tumour BRCA1/2 mutation: results from the DUO-O/ENGOT-Ov46/AGO-OVAR 23/GOG-3025 trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Shota Rustaveli National Science Foundation; National Science Foundation","keywords":"Bevacizumab; Medicine; Carboplatin; Oncology; Internal medicine; Olaparib; Progression-free survival; Clinical endpoint; Urology; Ovarian cancer; Surgery; Cancer; Chemotherapy; Randomized controlled trial; Cisplatin","score_opus":0.024671418381854684,"score_gpt":0.31675219718426856,"score_spread":0.2920807788024139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977193,0.00041062533,0.00035447627,0.016018322,0.0022780213,0.001950536,0.0012623288,0.000109381836,0.0004233133],"genre_scores_gemma":[0.99262,0.00061261916,0.0013550932,0.0026152127,0.0014440374,0.0006434803,0.00028130418,0.0000950046,0.00033325847],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9931215,0.00059879443,0.001939127,0.00089503714,0.00265147,0.0007940459],"domain_scores_gemma":[0.99228704,0.002728293,0.0019344284,0.00053753133,0.0021670738,0.00034566273],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013685728,0.0006445002,0.0012125539,0.0003217095,0.00024752162,0.0001671975,0.0009718823,0.0002995055,0.0012728304],"category_scores_gemma":[0.0025249694,0.00038812152,0.00032384915,0.00097183796,0.00040642917,0.00059458276,0.00014146669,0.0016503629,0.000043062744],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7439813,0.0023752127,0.14299937,0.00005350298,0.003554271,0.0038377962,0.0063539734,0.025520748,0.00054148707,0.00060520926,0.009077073,0.061100062],"study_design_scores_gemma":[0.29034626,0.00389903,0.69755167,0.0017093759,0.00025777443,0.00008744286,0.00081321,0.000804735,0.00026279202,0.0012604897,0.002449588,0.00055764726],"about_ca_topic_score_codex":0.0013049778,"about_ca_topic_score_gemma":0.0031837916,"teacher_disagreement_score":0.55455226,"about_ca_system_score_codex":0.00244836,"about_ca_system_score_gemma":0.0015490535,"threshold_uncertainty_score":0.99985707},"labels":[],"label_agreement":null},{"id":"W4387135672","doi":"10.1136/ijgc-2023-esgo.16","title":"#540 Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Discontinuation; Medicine; Placebo; Paclitaxel; Adverse effect; Internal medicine; Chemotherapy; Tolerability; Surgery; Oncology; Cisplatin","score_opus":0.018217437013317538,"score_gpt":0.33396324274095357,"score_spread":0.31574580572763605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174577,0.0005071255,0.000039301467,0.0018343981,0.0012492094,0.0042862543,0.00008392931,0.000014593335,0.00023942275],"genre_scores_gemma":[0.9951718,0.0030153247,0.00022316803,0.00033119132,0.0002651579,0.00082455826,0.00005216181,0.000025333384,0.0000913137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99579084,0.00036803132,0.0017438129,0.00033988483,0.0013986226,0.000358829],"domain_scores_gemma":[0.9953013,0.0025490406,0.0011694479,0.00011667648,0.00072342064,0.00014009843],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013918724,0.00030725356,0.0020263104,0.0013932303,0.000022974096,0.000021163703,0.0002806835,0.00015704671,0.0012242601],"category_scores_gemma":[0.0019535795,0.00016797947,0.00028195672,0.0015576859,0.00014017754,0.0002553291,0.00004625176,0.0005396976,0.0000017766787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87270814,0.0049147583,0.037799295,0.000033096294,0.00066480145,0.00022596591,0.0002034011,0.0007089357,0.00004295951,0.000023846575,0.000020129042,0.08265469],"study_design_scores_gemma":[0.87906253,0.010000802,0.10941224,0.00060672837,0.00014199679,0.0000044674844,0.000049529775,0.00013929396,0.00012546538,0.00011902955,0.00017169998,0.00016620998],"about_ca_topic_score_codex":0.00021777836,"about_ca_topic_score_gemma":0.0009257254,"teacher_disagreement_score":0.08248848,"about_ca_system_score_codex":0.0020706907,"about_ca_system_score_gemma":0.0007788322,"threshold_uncertainty_score":0.99968874},"labels":[],"label_agreement":null},{"id":"W4387135688","doi":"10.1136/ijgc-2023-esgo.1","title":"#67 Pembrolizumab + chemotherapy for first-line treatment of patients with persistent, recurrent, or metastatic cervical cancer: bevacizumab subgroup analysis based on protocol-specified final overall survival results of KEYNOTE-826","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Bevacizumab; Internal medicine; Oncology; Cervical cancer; Hazard ratio; Cancer; Gemcitabine; Progression-free survival; Chemotherapy; Cisplatin; Immunotherapy; Confidence interval","score_opus":0.08366524295195818,"score_gpt":0.3744814509143597,"score_spread":0.2908162079624015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98389244,0.00009064293,0.0003373717,0.0049717217,0.00051120046,0.008519015,0.0015510631,0.000020159547,0.00010638497],"genre_scores_gemma":[0.99462825,0.00058423483,0.0004167484,0.00031809873,0.00023612576,0.0033129528,0.00015909676,0.000026046459,0.00031845656],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99708724,0.00009905996,0.0011210149,0.00033318048,0.0010859518,0.0002735528],"domain_scores_gemma":[0.9964515,0.0008933885,0.0011977659,0.00019606255,0.0011328153,0.00012847042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031232846,0.00028327448,0.00093771744,0.0005019453,0.000053018026,0.00002012807,0.0002861998,0.000102958,0.0015287763],"category_scores_gemma":[0.00021718057,0.00016250071,0.0009069493,0.0005864105,0.00013696439,0.00007516304,0.000018634375,0.00014372137,8.4672223e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8551702,0.0060719075,0.059661835,0.00022673956,0.009611673,0.000100816505,0.0003027678,0.010142999,0.00030671115,0.000031007025,0.00096592854,0.057407416],"study_design_scores_gemma":[0.15917113,0.049498223,0.75529116,0.00055413175,0.0019914326,0.000009531055,0.00007585469,0.008390871,0.0036530779,0.000058121295,0.020932738,0.00037369248],"about_ca_topic_score_codex":0.00015623446,"about_ca_topic_score_gemma":0.00065124186,"teacher_disagreement_score":0.6959991,"about_ca_system_score_codex":0.0010970547,"about_ca_system_score_gemma":0.00051137846,"threshold_uncertainty_score":0.999384},"labels":[],"label_agreement":null},{"id":"W4387135691","doi":"10.1136/ijgc-2023-esgo.879","title":"#487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hamilton Health Sciences","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Oncology; Internal medicine; Tolerability; Fallopian tube; Carboplatin; Chemotherapy; Bevacizumab; Phases of clinical research; Cancer; Immunotherapy; Cisplatin; Surgery; Adverse effect","score_opus":0.026223513900528708,"score_gpt":0.3356447379003544,"score_spread":0.3094212239998257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632484,0.000070589194,0.000012577622,0.0018358285,0.0005823234,0.00091118884,0.00014097978,0.000013847999,0.00010779951],"genre_scores_gemma":[0.9986599,0.00027443565,0.00023680177,0.00030073244,0.00018029225,0.00020719407,0.000043008557,0.000028546556,0.00006905593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739,0.000100618076,0.00081203453,0.00032980737,0.0010732189,0.00029432256],"domain_scores_gemma":[0.9982778,0.0002975448,0.0005413041,0.00014667322,0.0006079222,0.00012875903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023316973,0.0002552862,0.00063886575,0.00036409253,0.000035546615,0.000034952143,0.0002354503,0.000104231156,0.0008325203],"category_scores_gemma":[0.00010300451,0.00015867258,0.00007661713,0.00041789413,0.000085194224,0.00019314063,0.000048425667,0.00035445095,0.0000020978546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12663622,0.012233863,0.8353639,0.000044088792,0.00096181827,0.0013034015,0.0011137257,0.0013317516,0.00022148601,0.000031654836,0.00014499958,0.020613076],"study_design_scores_gemma":[0.14024286,0.012931121,0.8448494,0.00040451394,0.00012545113,0.000006942639,0.0003116875,0.00028211376,0.00021472652,0.00000840384,0.0004707594,0.00015199154],"about_ca_topic_score_codex":0.0009712123,"about_ca_topic_score_gemma":0.0047754035,"teacher_disagreement_score":0.020461084,"about_ca_system_score_codex":0.0016194114,"about_ca_system_score_gemma":0.00058003236,"threshold_uncertainty_score":0.91155136},"labels":[],"label_agreement":null},{"id":"W4387135770","doi":"10.1136/ijgc-2023-esgo.301","title":"#277 Systemic therapy and outcomes in metastatic/recurrent endometrial cancer – real world population study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of the Fraser Valley; Western University; Spinal Cord Injury BC; University of British Columbia","funders":"Intuitive Surgical","keywords":"Medicine; Endometrial cancer; Systemic therapy; Internal medicine; Metastatic breast cancer; Oncology; Population; Salvage therapy; Cancer; Progression-free survival; Surgery; Chemotherapy; Breast cancer","score_opus":0.10250009516698239,"score_gpt":0.4249493516807434,"score_spread":0.322449256513761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932076,0.0015079146,0.0000029821936,0.0018167937,0.002699963,0.0005670846,0.000041906816,0.000022521543,0.0001332317],"genre_scores_gemma":[0.99217236,0.0065502506,0.000053386666,0.00025543943,0.00051327486,0.00013150893,0.000010272866,0.000012595899,0.0003009269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977994,0.00015195312,0.00077475555,0.00021542147,0.0008485918,0.00020988222],"domain_scores_gemma":[0.998268,0.0008147396,0.0003812117,0.00007326195,0.00032278037,0.00013998557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005881018,0.00017155247,0.00067134394,0.00093698804,0.0000317019,0.000039075876,0.0001710473,0.000047899353,0.0008390633],"category_scores_gemma":[0.0005433889,0.00010546276,0.00016561808,0.0008105307,0.00003193498,0.00013033349,0.000060624472,0.00026185883,0.0000064535575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027153564,0.0006978404,0.8962056,0.0000105879335,0.0006990165,0.00038592107,0.00014444593,0.00010951305,0.0000932295,0.000058703536,0.000085121275,0.09879467],"study_design_scores_gemma":[0.014402957,0.00128686,0.98301667,0.00010176415,0.00011356387,0.000021502445,0.00018225244,0.00004988039,0.00003771318,0.00027313107,0.0004172502,0.000096452604],"about_ca_topic_score_codex":0.0015954317,"about_ca_topic_score_gemma":0.0017197191,"teacher_disagreement_score":0.09869821,"about_ca_system_score_codex":0.00076504285,"about_ca_system_score_gemma":0.00012055511,"threshold_uncertainty_score":0.9187155},"labels":[],"label_agreement":null},{"id":"W4387135776","doi":"10.1136/ijgc-2023-esgo.46","title":"#461 Patient reported outcomes from CCTG CX.5 (SHAPE): randomized trial comparing radical hysterectomy (RH) and pelvic node dissection (PND) vs simple hysterectomy (SH) and PND in women with low-risk early-stage","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; Queen's University; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Sexual function; Randomized controlled trial; Distress; Clinical endpoint; Hysterectomy; Cervical cancer; Cancer; Gynecology; Internal medicine; Surgery; Clinical psychology","score_opus":0.027036975049091073,"score_gpt":0.31432638956476605,"score_spread":0.28728941451567497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684435,0.00028737567,0.00003980859,0.00085215416,0.00090627023,0.00082373165,0.000050564635,0.00003870588,0.00015704308],"genre_scores_gemma":[0.9982781,0.0006087294,0.00012055448,0.00036593768,0.00033337536,0.00017107493,0.00002379585,0.000022369028,0.00007606483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969826,0.0002996291,0.0011420831,0.00038693653,0.000851301,0.00033750007],"domain_scores_gemma":[0.9966296,0.0018742188,0.0008185103,0.00012026081,0.0002537901,0.00030360362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006996111,0.0002783044,0.0013534963,0.0003845933,0.000070439986,0.000097195625,0.00014650018,0.00014640238,0.00085774506],"category_scores_gemma":[0.001328393,0.00016695898,0.00018038349,0.00033250055,0.00017817953,0.00019798047,0.00011568804,0.0005107183,0.000004475023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48373666,0.00037837646,0.5004494,0.000022209626,0.0011521587,0.0008428259,0.00050077745,0.00007410978,0.00008665568,0.000005717241,0.000033400764,0.012717696],"study_design_scores_gemma":[0.38256747,0.0014531373,0.6142417,0.00015994678,0.00017731199,0.000044803895,0.00016970024,0.0004492079,0.00007951761,0.00026257336,0.00025478037,0.000139876],"about_ca_topic_score_codex":0.0013602427,"about_ca_topic_score_gemma":0.0003544756,"teacher_disagreement_score":0.113792285,"about_ca_system_score_codex":0.0006302259,"about_ca_system_score_gemma":0.00012414186,"threshold_uncertainty_score":0.93917066},"labels":[],"label_agreement":null},{"id":"W4387135840","doi":"10.1136/ijgc-2023-esgo.886","title":"#1121 KEYNOTE-826: final overall survival results from a randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy for first-line treatment of persistent, recurrent, or metastatic cervical cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Medicine; Carboplatin; Chemotherapy; Cervical cancer; Placebo; Internal medicine; Oncology; Interim analysis; Gemcitabine; Cancer; Cisplatin; Randomized controlled trial; Immunotherapy","score_opus":0.14921725532726443,"score_gpt":0.42177302605141054,"score_spread":0.2725557707241461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842828,0.0015161893,0.00017330261,0.008866597,0.0017426631,0.0023533849,0.0009890421,0.000023038741,0.000052962747],"genre_scores_gemma":[0.9845917,0.012569301,0.0002533538,0.00047638573,0.0007773296,0.00042867372,0.0001227365,0.00003953702,0.0007409484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961708,0.00018917712,0.0018620578,0.00041726144,0.0010290263,0.00033166888],"domain_scores_gemma":[0.9946751,0.002296945,0.0015394547,0.00023135648,0.0010917642,0.00016540287],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087403733,0.0003790225,0.0017981083,0.0003392506,0.00006508811,0.000033043085,0.00041662174,0.00014567513,0.0024968274],"category_scores_gemma":[0.0003406777,0.0002316671,0.0013706463,0.00031481683,0.00020995078,0.000115843075,0.00003618187,0.00021388558,0.0000018582475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94287676,0.0071550105,0.0012043271,0.000055540302,0.010452519,0.00011036495,0.0018623839,0.0008922483,0.0006882177,0.000009297316,0.0010268759,0.03366647],"study_design_scores_gemma":[0.9595467,0.021036433,0.004643279,0.00032790916,0.0012749379,0.000034014567,0.00057946204,0.002977244,0.0019223962,0.00009590856,0.007312203,0.0002495351],"about_ca_topic_score_codex":0.0012794968,"about_ca_topic_score_gemma":0.001165617,"teacher_disagreement_score":0.033416934,"about_ca_system_score_codex":0.00084662676,"about_ca_system_score_gemma":0.0005985423,"threshold_uncertainty_score":0.99841505},"labels":[],"label_agreement":null},{"id":"W4387135996","doi":"10.1136/ijgc-2023-esgo.22","title":"#161 Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase 3 trial of niraparib in patients with recurrent ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Hazard ratio; Medicine; Internal medicine; Cohort; Ovarian cancer; Oncology; Progression-free survival; Proportional hazards model; Cancer; Chemotherapy; Confidence interval","score_opus":0.07927103726113195,"score_gpt":0.40133592823622494,"score_spread":0.322064890975093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225587,0.0002569165,0.000042581953,0.004933425,0.001665723,0.00048326593,0.00009578617,0.00000676014,0.00025966184],"genre_scores_gemma":[0.9973996,0.0013469493,0.000043930533,0.0005684242,0.0005125448,0.00005185925,0.000026336264,0.000010815552,0.000039520968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976737,0.00017705595,0.000790048,0.00019707065,0.000945024,0.00021712818],"domain_scores_gemma":[0.99840057,0.00046040968,0.00048899354,0.000104328814,0.00046714064,0.00007855112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083103677,0.00015703384,0.0004424432,0.0002956186,0.000024958208,0.000023035527,0.00026852894,0.00009737898,0.0011137502],"category_scores_gemma":[0.00022926035,0.000095100695,0.000102562546,0.00031547924,0.00013756489,0.00013976365,0.00004330267,0.00050081,0.0000017232261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17046499,0.002090179,0.7758058,0.000028264298,0.00029645488,0.00031535045,0.0005181757,0.00027504424,0.00016160366,0.0003382249,0.0006796755,0.04902629],"study_design_scores_gemma":[0.12488157,0.0026877308,0.87062407,0.00036479175,0.000035424473,0.000014469764,0.000037065634,0.00004140194,0.000055131997,0.00016064367,0.0010012296,0.000096497424],"about_ca_topic_score_codex":0.000109892746,"about_ca_topic_score_gemma":0.0007141637,"teacher_disagreement_score":0.094818294,"about_ca_system_score_codex":0.0005305745,"about_ca_system_score_gemma":0.00033633749,"threshold_uncertainty_score":0.9997994},"labels":[],"label_agreement":null},{"id":"W4387136040","doi":"10.1136/ijgc-2023-esgo.521","title":"#136 The role of edmonton frail scale assessment in pre-operative counselling for ovarian cancer cytoreductive surgery","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytoreductive surgery; Univariate analysis; Retrospective cohort study; Frailty Index; Demographics; Surgery; Ovarian cancer; Cancer; Internal medicine; Multivariate analysis","score_opus":0.032928854829373785,"score_gpt":0.38109318650000534,"score_spread":0.34816433167063154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387136040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98105496,0.00090490835,0.00048821204,0.0152701875,0.0013923665,0.000434538,0.00011235266,0.000012472942,0.00033002268],"genre_scores_gemma":[0.99559087,0.0020276024,0.00046334535,0.0004782419,0.00078028045,0.00018226777,0.0000120111845,0.000014505409,0.0004508917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981686,0.00008929989,0.0006716368,0.00017560004,0.0006752743,0.0002195722],"domain_scores_gemma":[0.99665004,0.0014909931,0.00044728923,0.00009071382,0.0012438531,0.000077123594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008323191,0.00013248573,0.0004404043,0.0001997415,0.000043899152,0.000024715206,0.00027145498,0.00010343413,0.0006239473],"category_scores_gemma":[0.00048400552,0.00008280717,0.00022794199,0.0002290544,0.00013543677,0.0001515026,0.000032720116,0.000400766,0.000002010887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004600263,0.0011883788,0.7633178,0.00009164713,0.0020218028,0.00019544754,0.008821676,0.019572562,0.031516157,0.0012874447,0.016867105,0.15051967],"study_design_scores_gemma":[0.0021027618,0.0004608511,0.9629095,0.00055868557,0.00010215024,0.00004438164,0.0013058096,0.0054575326,0.008270785,0.0035504948,0.015090573,0.00014645787],"about_ca_topic_score_codex":0.0004713473,"about_ca_topic_score_gemma":0.00094504416,"teacher_disagreement_score":0.19959167,"about_ca_system_score_codex":0.00069116964,"about_ca_system_score_gemma":0.0007222659,"threshold_uncertainty_score":0.68317854},"labels":[],"label_agreement":null},{"id":"W4387136062","doi":"10.1136/ijgc-2023-esgo.524","title":"#141 Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Olaparib; Chemotherapy; Oncology; Progression-free survival; Population; Retrospective cohort study; Cancer; Poly ADP ribose polymerase; Biology","score_opus":0.033715588662758846,"score_gpt":0.3599319659043354,"score_spread":0.32621637724157654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387136062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88633144,0.00032525155,0.000037505615,0.11009557,0.0025519012,0.00036353045,0.00018428633,0.000025284344,0.00008524187],"genre_scores_gemma":[0.9903168,0.0007287308,0.00050970813,0.006957685,0.001046366,0.00020104273,0.00001511092,0.000024077019,0.00020046828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978047,0.00012774677,0.0006862813,0.00028476145,0.00078156573,0.00031496337],"domain_scores_gemma":[0.9981218,0.0005209289,0.00029278462,0.00012866576,0.0006692936,0.00026650357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007007337,0.00020407999,0.00044336347,0.0004759187,0.00003518724,0.000044015764,0.00025523957,0.00012395132,0.0030901073],"category_scores_gemma":[0.0005844303,0.00014715064,0.0002330268,0.00040669402,0.000049865586,0.000081451326,0.000048064892,0.00032762034,0.000054785203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079269834,0.0030586838,0.43784732,0.000057502166,0.0013989989,0.0075518466,0.001454224,0.008272737,0.04433384,0.0002756747,0.024049515,0.39242983],"study_design_scores_gemma":[0.00968265,0.0022172164,0.9331019,0.0005784121,0.0000544922,0.000035398672,0.000069657166,0.00020431883,0.0076230676,0.00013026664,0.046120845,0.00018179254],"about_ca_topic_score_codex":0.00027933053,"about_ca_topic_score_gemma":0.00054638344,"teacher_disagreement_score":0.49525458,"about_ca_system_score_codex":0.0021006924,"about_ca_system_score_gemma":0.0010789166,"threshold_uncertainty_score":0.9978212},"labels":[],"label_agreement":null},{"id":"W4387142310","doi":"10.1136/ijgc-2023-esgo.507","title":"#66 Survival of PARP inhibitor (PARPi) naïve ovarian cancer patients with a BRCA-mutation receiving maintenance olaparib after chemotherapy for first recurrence. An exploratory analysis of the solo2/engot-ov21 trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Medicine; PARP inhibitor; Internal medicine; Oncology; BRCA mutation; Placebo; Ovarian cancer; Chemotherapy; Maintenance therapy; Cancer; Poly ADP ribose polymerase; Biology; Pathology","score_opus":0.036841560699802454,"score_gpt":0.3359133151894682,"score_spread":0.2990717544896658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387142310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173146,0.00015612015,0.0006101782,0.0033356377,0.002770331,0.00077425234,0.00056831626,0.00001812857,0.00003557248],"genre_scores_gemma":[0.99718225,0.00053774804,0.00031443397,0.00065681315,0.00076521793,0.00040562532,0.000050564176,0.00002791059,0.000059452697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696773,0.00017207378,0.0011006299,0.00032105506,0.0011530633,0.00028541894],"domain_scores_gemma":[0.9949149,0.0006078473,0.0015372558,0.00022438818,0.002583437,0.00013219009],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080622104,0.0002305578,0.00077509996,0.00041615978,0.00007559672,0.00002755385,0.00041946166,0.00016443749,0.0009460143],"category_scores_gemma":[0.0005732912,0.00014545982,0.00046513035,0.0009937356,0.00024646855,0.0002987617,0.000048394395,0.00031603026,0.0000010432918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22610348,0.0026667884,0.6996346,0.00016291,0.009899362,0.00005671026,0.004982326,0.008443004,0.0022018328,0.0002977915,0.00433402,0.041217133],"study_design_scores_gemma":[0.054583117,0.0029111824,0.931755,0.0007880657,0.0009201042,0.0000046777536,0.00036169207,0.0010433361,0.004007485,0.00046113582,0.002883034,0.00028117653],"about_ca_topic_score_codex":0.000061132916,"about_ca_topic_score_gemma":0.0010603179,"teacher_disagreement_score":0.23212036,"about_ca_system_score_codex":0.00066722883,"about_ca_system_score_gemma":0.0005844728,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W4387142402","doi":"10.1136/ijgc-2023-esgo.781","title":"#535 Diagnostic accuracy of human and human papillomavirus DNA methylation testing in cervical cancer: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Meta-analysis; Oncology; Confidence interval; Internal medicine; Cervical intraepithelial neoplasia; DNA methylation; Cervical cancer; Colposcopy; Cancer; Biology; Genetics; Gene","score_opus":0.32021568028211544,"score_gpt":0.5188574383273882,"score_spread":0.19864175804527273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387142402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005048508,0.99696976,0.000005461393,0.00074261276,0.00007600493,0.0014073331,0.00014242459,0.000011691563,0.00013983788],"genre_scores_gemma":[0.014041429,0.9846596,0.00004257621,0.00037811295,0.00017208909,0.000529654,0.000030429312,0.000031538515,0.00011457416],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99490565,0.0005914409,0.0026792104,0.00040959922,0.0011414079,0.00027269917],"domain_scores_gemma":[0.9887523,0.007368362,0.0021095627,0.00021499401,0.0013089802,0.00024579532],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019124873,0.00038359826,0.007266015,0.0008707433,0.00006027516,0.000059092683,0.00045683706,0.00026637348,0.003341376],"category_scores_gemma":[0.009455904,0.00023023417,0.0013872114,0.0011378088,0.00016037973,0.00011982272,0.00026392136,0.00091908115,0.0000029504465],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004728262,0.0003378666,0.0030068737,0.7950836,0.13332902,0.0006510185,0.00006445924,0.000013850466,0.0000088451325,0.00027187384,0.00012017822,0.06706516],"study_design_scores_gemma":[0.0012617345,0.00081117335,0.028438143,0.06831605,0.89634,0.00016797363,0.00002759405,0.000020314983,0.0000039761194,0.0005496378,0.0035700877,0.0004933152],"about_ca_topic_score_codex":0.00081264594,"about_ca_topic_score_gemma":0.0013307896,"teacher_disagreement_score":0.763011,"about_ca_system_score_codex":0.0006003206,"about_ca_system_score_gemma":0.00038048415,"threshold_uncertainty_score":0.9988879},"labels":[],"label_agreement":null},{"id":"W4387142412","doi":"10.1136/ijgc-2023-esgo.788","title":"#1051 Liquid biopsy based detection of human papillomavirus in cervical cancer and cervical dysplasia patients","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Liquid biopsy; Medicine; Cervical cancer; Concordance; Dysplasia; Biopsy; Internal medicine; Cancer; Liquid-based cytology; Oncology; Gastroenterology","score_opus":0.03987939219497718,"score_gpt":0.3769267269850271,"score_spread":0.33704733479004995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387142412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529266,0.00038487994,0.00002402897,0.0028040821,0.0006064513,0.0001913234,0.00004701963,0.000017746326,0.00063181494],"genre_scores_gemma":[0.9982687,0.0005814609,0.00003455273,0.00060020044,0.00037189634,0.000042349937,0.00001179048,0.000016291931,0.000072743576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765706,0.00008383916,0.0007195773,0.000235515,0.0010163495,0.0002876853],"domain_scores_gemma":[0.9980387,0.00030773497,0.00025587867,0.00009346768,0.0010682251,0.00023596449],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004103514,0.00015399138,0.0004643619,0.00048477293,0.000043850294,0.000022604587,0.00025495546,0.00019145681,0.0042542717],"category_scores_gemma":[0.000413486,0.000114786366,0.00016503107,0.00045061283,0.00017046413,0.000108539934,0.00012710373,0.0005409441,0.000008658882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008452692,0.0009554285,0.8639294,0.00019164816,0.0002596991,0.0004603321,0.00015806829,0.00019182323,0.031193443,0.00014052974,0.00031197508,0.09375498],"study_design_scores_gemma":[0.0048477473,0.0018282697,0.9840015,0.000113281654,0.000043831646,0.000017437203,0.000043131357,0.00056587777,0.0071451953,0.00020085221,0.0010813632,0.000111468646],"about_ca_topic_score_codex":0.0004702938,"about_ca_topic_score_gemma":0.0008672857,"teacher_disagreement_score":0.12007216,"about_ca_system_score_codex":0.0005534031,"about_ca_system_score_gemma":0.00023201108,"threshold_uncertainty_score":0.996656},"labels":[],"label_agreement":null},{"id":"W4387934508","doi":"10.1136/ijgc-2023-004745","title":"Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Cytoreductive surgery; Stage (stratigraphy); Adjuvant; Chemotherapy; Adjuvant chemotherapy; Ovarian carcinoma; Oncology; Overall survival; Serous carcinoma; Surgery; Internal medicine; Ovarian cancer; Cancer","score_opus":0.026704651296443983,"score_gpt":0.3154612162167232,"score_spread":0.2887565649202792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387934508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964735,0.0001724637,0.000010678809,0.0019630194,0.0007339796,0.0002776311,0.00016938857,0.000008511114,0.00019082565],"genre_scores_gemma":[0.9989158,0.00034693794,0.000072641735,0.0003363941,0.00019805743,0.000024055036,0.000027987802,0.00001988953,0.000058228055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814206,0.00007456433,0.0005175683,0.00017804008,0.0008890397,0.0001987206],"domain_scores_gemma":[0.9975817,0.0009249195,0.00065398024,0.00014305103,0.00060022646,0.00009612349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029440434,0.0001801055,0.00060371513,0.00016849028,0.000030494495,0.0000126704535,0.00019271401,0.00006570713,0.00052827434],"category_scores_gemma":[0.00018942765,0.0000917234,0.00052933046,0.00019736122,0.00008757158,0.00011774282,0.000033819768,0.00020898684,0.0000017051618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003655181,0.0012063642,0.9827187,0.000020260399,0.001902969,0.0002518403,0.00017454698,0.001135584,0.00041152685,0.000119575765,0.000728424,0.007675046],"study_design_scores_gemma":[0.004145623,0.0019376824,0.99218625,0.00026210476,0.000094511095,0.000005481988,0.00004801658,0.000016669192,0.0009639355,0.00008059654,0.00017098118,0.00008817295],"about_ca_topic_score_codex":0.00010894676,"about_ca_topic_score_gemma":0.0000114145205,"teacher_disagreement_score":0.009467543,"about_ca_system_score_codex":0.00088505005,"about_ca_system_score_gemma":0.0005286289,"threshold_uncertainty_score":0.5784233},"labels":[],"label_agreement":null},{"id":"W4388294328","doi":"10.1136/ijgc-2023-004774","title":"Low-grade serous ovarian carcinoma: a brief overview of the histopathologic features and differential diagnosis","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Differential diagnosis; Carcinoma; Ovarian carcinomas; Ovarian cancer; Ovary; Oncology; Gynecology; Pathology; Internal medicine; Cancer","score_opus":0.04661172194320745,"score_gpt":0.331772037629931,"score_spread":0.28516031568672356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388294328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97567147,0.0039542257,0.000006900377,0.018371161,0.0015750725,0.00018201095,0.00005662815,0.0000116088095,0.00017090938],"genre_scores_gemma":[0.99238515,0.0057521323,0.000067857996,0.001137891,0.00038785225,0.000051646122,0.0000039506135,0.000009437554,0.00020407766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987044,0.00007568149,0.00039050865,0.00016960167,0.00050350657,0.00015632658],"domain_scores_gemma":[0.9988647,0.0002879389,0.00035203394,0.00011974442,0.00027890064,0.00009669153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001566131,0.00013443248,0.0003751771,0.00010521353,0.000048073824,0.000023810502,0.00023706169,0.00009800205,0.0007038824],"category_scores_gemma":[0.0002617111,0.00007326918,0.00025440985,0.000170077,0.00013011588,0.000053817817,0.00013607545,0.00023913202,0.000002317993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031435167,0.00074147404,0.9563559,0.00006903167,0.0004102857,0.00092445896,0.0002170697,0.000044837077,0.00084650225,0.0012539469,0.009083742,0.029738361],"study_design_scores_gemma":[0.0022529908,0.00044378458,0.9903256,0.00021821767,0.00021011915,0.00032211147,0.000028146771,0.0000148954705,0.0019922338,0.0005643955,0.003558428,0.0000690279],"about_ca_topic_score_codex":0.00011435698,"about_ca_topic_score_gemma":0.00007150237,"teacher_disagreement_score":0.033969708,"about_ca_system_score_codex":0.0003019348,"about_ca_system_score_gemma":0.00014678082,"threshold_uncertainty_score":0.77070194},"labels":[],"label_agreement":null},{"id":"W4388465546","doi":"10.1136/ijgc-2023-004981","title":"FIGO 2023 endometrial cancer staging: too much, too soon?","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Gynecologic oncology; Endometrial cancer; Radiation oncology; Obstetrics and gynaecology; Oncology; Internal medicine; Gynecology; Cancer; Medical physics; Radiation therapy; General surgery","score_opus":0.19645484530107457,"score_gpt":0.47565875084028747,"score_spread":0.2792039055392129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388465546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039535743,0.98022836,0.000019341485,0.0021728766,0.013655644,0.00085449265,0.00083074695,0.0000638781,0.0017792704],"genre_scores_gemma":[0.00026632115,0.9819245,0.00013778744,0.0010855388,0.008040224,0.00033191624,0.000106934334,0.00008587057,0.008020904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99448085,0.00022705822,0.002113661,0.000568586,0.0020275211,0.0005823341],"domain_scores_gemma":[0.9937181,0.0023925204,0.0018435788,0.00025555072,0.0012742828,0.0005159933],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007079919,0.0006469189,0.0032474373,0.0012488086,0.000080164995,0.00012752727,0.0010175132,0.00059179746,0.0115586715],"category_scores_gemma":[0.003019149,0.00040599017,0.0020860296,0.0013567623,0.00013872857,0.00018528913,0.00031015894,0.0013893476,0.00028427388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091995765,0.0004665124,0.0006063822,0.0013782609,0.0058217035,0.0022099619,0.00001835446,0.000011019639,0.0000027566512,0.00010812664,0.029920721,0.95853627],"study_design_scores_gemma":[0.005404683,0.00095896056,0.00058496004,0.0056864745,0.0026804216,0.00018500908,0.000020814045,0.0000027831782,0.000010320256,0.00023523025,0.98385084,0.00037947763],"about_ca_topic_score_codex":0.00027792333,"about_ca_topic_score_gemma":0.000057055484,"teacher_disagreement_score":0.95815676,"about_ca_system_score_codex":0.0031013654,"about_ca_system_score_gemma":0.0021106577,"threshold_uncertainty_score":0.9998392},"labels":[],"label_agreement":null},{"id":"W4388488788","doi":"10.1136/ijgc-2023-004815","title":"Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panel","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Cancer Society","keywords":"Medicine; Lynch syndrome; Oncology; Ovarian cancer; DNA mismatch repair; Internal medicine; Gynecology; Cancer","score_opus":0.21018061425284432,"score_gpt":0.3982070345294928,"score_spread":0.18802642027664848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388488788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608624,0.0004569946,0.00057661126,0.00063695206,0.0016666125,0.00022099617,0.000019356421,0.000024378996,0.00031186757],"genre_scores_gemma":[0.9951836,0.00027492057,0.0037364135,0.00055120373,0.00018150242,0.000015952815,0.000013117061,0.000015954161,0.000027363674],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976193,0.00014415635,0.000814074,0.00022071556,0.0009507273,0.0002510375],"domain_scores_gemma":[0.99771327,0.0002402869,0.0005861267,0.00010382926,0.0012605077,0.000095990865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050212664,0.0001530006,0.0004537868,0.00034100775,0.000033602722,0.000021979442,0.00022448607,0.00015894801,0.00045138816],"category_scores_gemma":[0.00052579923,0.00012962877,0.00021253282,0.000500659,0.000085598345,0.000105237654,0.00007888453,0.00036955535,0.000001394365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018278683,0.00016182539,0.15178399,0.000056414214,0.0003891078,0.0011647163,0.00039925103,0.17731573,0.6654514,0.00009348596,0.00039015015,0.002611175],"study_design_scores_gemma":[0.0033404648,0.0010470307,0.75442404,0.00051029405,0.00016855267,0.00021226295,0.0006469756,0.22198245,0.016703244,0.00042872515,0.00025811337,0.0002778411],"about_ca_topic_score_codex":0.0006095208,"about_ca_topic_score_gemma":0.00023430916,"teacher_disagreement_score":0.64874816,"about_ca_system_score_codex":0.00441282,"about_ca_system_score_gemma":0.001564547,"threshold_uncertainty_score":0.9994091},"labels":[],"label_agreement":null},{"id":"W4388494902","doi":"10.1136/ijgc-2023-igcs.66","title":"PR024/#394  Molecular profiling of P53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; Vancouver General Hospital","funders":"","keywords":"PTEN; Carcinosarcoma; Cohort; Oncology; Internal medicine; Medicine; Cancer; Endometrial cancer; Retrospective cohort study; Cancer research; Biology; Genetics; Carcinoma","score_opus":0.20088842192002793,"score_gpt":0.37146117385750205,"score_spread":0.17057275193747412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987363,0.0031238175,0.0011925726,0.0052833343,0.0012212225,0.00080998277,0.0002628374,0.000032157906,0.000711068],"genre_scores_gemma":[0.99595,0.0012110143,0.0008420926,0.0004730231,0.0007064795,0.0002926869,0.000036270678,0.000026976815,0.00046149286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753344,0.00008895578,0.00069703156,0.00023152992,0.0011662522,0.00028278283],"domain_scores_gemma":[0.996936,0.0009396637,0.0006452693,0.00009614822,0.0012099961,0.00017290414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006975203,0.0002120966,0.0007135233,0.00038658155,0.000047308877,0.00002882668,0.00027778963,0.000109506385,0.0008705158],"category_scores_gemma":[0.0008285115,0.0001260877,0.00038091608,0.00046232,0.00019027673,0.00010173654,0.000049917326,0.0002175271,0.0000013180733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11842991,0.0040385416,0.38066474,0.0013579807,0.023579355,0.0047119833,0.0011716873,0.0018094833,0.08215286,0.029329818,0.0014250492,0.35132858],"study_design_scores_gemma":[0.21569073,0.04237431,0.4054886,0.0045118877,0.010557733,0.0014036051,0.007933582,0.0025331476,0.21384257,0.032791052,0.060025226,0.0028475355],"about_ca_topic_score_codex":0.000043650303,"about_ca_topic_score_gemma":0.000019040319,"teacher_disagreement_score":0.34848106,"about_ca_system_score_codex":0.000506144,"about_ca_system_score_gemma":0.000527542,"threshold_uncertainty_score":0.9531537},"labels":[],"label_agreement":null},{"id":"W4388494940","doi":"10.1136/ijgc-2023-igcs.286","title":"EP204/#941  Correlation between HER2 testing by immunohistochemistry-ish and ERBB2 determined by next generation sequencing","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Immunohistochemistry; Fluorescence in situ hybridization; DNA sequencing; Fish <Actinopterygii>; Biology; Pathology; Gene duplication; Internal medicine; Oncology; Medicine; Bioinformatics; Gene; Genetics","score_opus":0.04999640671163099,"score_gpt":0.3080430180494672,"score_spread":0.25804661133783624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954829,0.0016694586,0.0013447515,0.0005283184,0.0006144952,0.00006940759,0.00012151514,0.000008310047,0.00016081019],"genre_scores_gemma":[0.99655277,0.0011103258,0.00043253164,0.0003757767,0.0009748729,0.00001269423,0.00023422751,0.000013326873,0.00029345634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990423,0.00002810712,0.00037431656,0.00018861087,0.00021507328,0.000151607],"domain_scores_gemma":[0.9989862,0.0001710382,0.00032058806,0.00007095858,0.00036681615,0.000084442814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306475,0.000117409705,0.00015025515,0.00004002774,0.00006978859,0.000082136095,0.0001757452,0.00014324712,0.00005271933],"category_scores_gemma":[0.00087344856,0.00010929689,0.00006095046,0.00007547522,0.00005733087,0.000016684966,0.000096781274,0.0001426783,0.0000027932406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037178397,0.000014909918,0.017123668,0.000003892031,0.00007690609,0.000015610069,0.000020859079,0.00065452297,0.9382241,0.000003711327,0.023703927,0.020120725],"study_design_scores_gemma":[0.0059375023,0.0024302916,0.071508676,0.00020875348,0.00027888612,0.00036900336,0.00030092502,0.020230666,0.7661383,0.00090167415,0.13029136,0.0014039747],"about_ca_topic_score_codex":0.00006852927,"about_ca_topic_score_gemma":0.000015589956,"teacher_disagreement_score":0.17208579,"about_ca_system_score_codex":0.00021851246,"about_ca_system_score_gemma":0.00015030193,"threshold_uncertainty_score":0.44569978},"labels":[],"label_agreement":null},{"id":"W4388494944","doi":"10.1136/ijgc-2023-igcs.20","title":"SO006/#55  Regular dilation and/or sexual activity show less risk for vaginal stenosis in cervical cancer patients","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Stenosis; Cervical cancer; Cervical dilation; Brachytherapy; Gynecology; Vagina; Longitudinal study; Vaginal bleeding; Internal medicine; Radiology; Urology; Surgery; Cancer; Radiation therapy; Pregnancy; Pathology","score_opus":0.06099923077263945,"score_gpt":0.3643680441906399,"score_spread":0.3033688134180004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928244,0.00024780395,0.000118736265,0.004977749,0.0011489263,0.00037674778,0.00022452454,0.000020208912,0.00006092001],"genre_scores_gemma":[0.9968538,0.0012581998,0.00018612792,0.00048097392,0.0007095398,0.00014458816,0.00002408879,0.000016369137,0.0003262683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820626,0.00008820364,0.0004758079,0.0002658039,0.00069484295,0.00026910787],"domain_scores_gemma":[0.9980144,0.0007333504,0.00037429426,0.00006990856,0.0006253478,0.0001827219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037238147,0.00017328524,0.00045970213,0.00031075213,0.00006052998,0.000036603735,0.00017878157,0.00015433891,0.00062995404],"category_scores_gemma":[0.0007681789,0.000112373215,0.00013568916,0.00037228852,0.000070943446,0.00020073175,0.00008286944,0.00032003186,0.000004709176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00802421,0.00060539006,0.7870865,0.000041647665,0.00034590665,0.00008751322,0.00009061313,0.00020573108,0.0002181453,0.000032203676,0.00075044314,0.2025117],"study_design_scores_gemma":[0.009514107,0.001790678,0.98472804,0.00010070049,0.00017523638,0.000008856369,0.00008187819,0.00066858716,0.0004296195,0.0005237679,0.0018498856,0.00012862042],"about_ca_topic_score_codex":0.0003845305,"about_ca_topic_score_gemma":0.00078798167,"teacher_disagreement_score":0.20238307,"about_ca_system_score_codex":0.00076122105,"about_ca_system_score_gemma":0.00020369678,"threshold_uncertainty_score":0.6897555},"labels":[],"label_agreement":null},{"id":"W4388494972","doi":"10.1136/ijgc-2023-igcs.80","title":"PR038/#248  Management of immune-related adverse events in patients with primary advanced or recurrent endometrial cancer: dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Medicine; Paclitaxel; Placebo; Internal medicine; Chemotherapy; Adverse effect; Endometrial cancer; Oncology; Urology; Surgery; Cancer; Cisplatin; Pathology","score_opus":0.022118742384950128,"score_gpt":0.31551453856649325,"score_spread":0.2933957961815431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930894,0.00074553693,0.0000145056365,0.0025617527,0.001266554,0.0020975263,0.0000556069,0.000018827714,0.00015032261],"genre_scores_gemma":[0.99228483,0.0060386853,0.00027581403,0.0007627075,0.00016941866,0.00023356154,0.000060463874,0.000031249983,0.00014329073],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99628913,0.00017952063,0.0013678847,0.00031932167,0.0014758776,0.00036824268],"domain_scores_gemma":[0.9977646,0.00038244645,0.001133945,0.00021225012,0.000430066,0.000076683886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009536147,0.00030767004,0.0008593413,0.0005299433,0.000042956995,0.000012529865,0.0005946643,0.00013004855,0.0008791675],"category_scores_gemma":[0.000070494614,0.00016524503,0.0002596252,0.0012150713,0.00015521905,0.00019416849,0.000051442155,0.00051394646,0.0000020979378],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80962783,0.0023915032,0.10125649,0.00008343394,0.002241264,0.00029808847,0.0011370229,0.0011404688,0.00033816183,0.000010863506,0.00024739822,0.08122748],"study_design_scores_gemma":[0.2851219,0.0050369655,0.7059153,0.00093590684,0.00009528941,0.000014577736,0.00039492248,0.000056670317,0.00018457978,0.000025738467,0.0020227393,0.00019546546],"about_ca_topic_score_codex":0.0001826648,"about_ca_topic_score_gemma":0.00026255535,"teacher_disagreement_score":0.6046588,"about_ca_system_score_codex":0.0016382077,"about_ca_system_score_gemma":0.0004972509,"threshold_uncertainty_score":0.9626268},"labels":[],"label_agreement":null},{"id":"W4388494977","doi":"10.1136/ijgc-2023-igcs.334","title":"EP262/#530  Is there a role for intraperitoneal chemotherapy in early stage pelvic high-grade serous carcinoma?","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Serous fluid; Stage (stratigraphy); Proportional hazards model; Serous carcinoma; Retrospective cohort study; Population; Cancer; Ovarian cancer","score_opus":0.030596037256476177,"score_gpt":0.33838296012120417,"score_spread":0.307786922864728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861974,0.00078815984,0.000036435624,0.0112164505,0.0009283685,0.000352972,0.00014540814,0.000025755213,0.00030900925],"genre_scores_gemma":[0.9941106,0.0008958465,0.00029015666,0.002599404,0.00079543685,0.000094350406,0.000012230246,0.000027252021,0.0011747347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851036,0.000034861016,0.00045155728,0.0002126847,0.00050427223,0.00028627564],"domain_scores_gemma":[0.9990503,0.0001787873,0.00020664411,0.00009691569,0.00033411937,0.00013320967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019101564,0.00017166967,0.00039164085,0.00021032245,0.000035298643,0.000037889873,0.00026996358,0.00013739585,0.0016030385],"category_scores_gemma":[0.0000654702,0.00012385452,0.00022140294,0.00019660976,0.00005721721,0.000118448785,0.00003323975,0.00027972477,0.000020395843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057894965,0.0011169454,0.9182728,0.00006141938,0.0011415218,0.0015310546,0.0027499646,0.00021000156,0.007343472,0.00045202594,0.004694753,0.056636535],"study_design_scores_gemma":[0.008704209,0.0015638059,0.9663321,0.00007313137,0.00005933566,0.000056719928,0.00021087295,0.0002186936,0.0047617285,0.0018577849,0.016023017,0.00013861357],"about_ca_topic_score_codex":0.00062968594,"about_ca_topic_score_gemma":0.00018299822,"teacher_disagreement_score":0.05649792,"about_ca_system_score_codex":0.00050930306,"about_ca_system_score_gemma":0.00028805173,"threshold_uncertainty_score":0.99930966},"labels":[],"label_agreement":null},{"id":"W4388494993","doi":"10.1136/ijgc-2023-igcs.318","title":"EP244/#277  Examining real-world treatment benefits of first-line maintenance niraparib in non-BRCA mutant high grade serous ovarian cancers","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oncology; Internal medicine; Ovarian cancer; BRCA mutation; Chemotherapy; Progression-free survival; Population; Bevacizumab; Maintenance therapy; Cancer","score_opus":0.07316367645092837,"score_gpt":0.35850553879708075,"score_spread":0.2853418623461524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860842,0.00029211986,0.00009422261,0.009403886,0.0024891899,0.0003284955,0.00020318,0.00003486802,0.0010698015],"genre_scores_gemma":[0.98771334,0.009300195,0.00045445558,0.0007326997,0.0009511518,0.00010949541,0.000027383232,0.000030421957,0.0006808519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722993,0.00006774614,0.0011390032,0.00032274929,0.00083599193,0.00040455762],"domain_scores_gemma":[0.9977257,0.00055203296,0.0007997526,0.0001882928,0.00054286345,0.00019134487],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048525035,0.00026597845,0.00074764906,0.0006519385,0.000049219263,0.000021873708,0.00035333034,0.00014270181,0.0013449787],"category_scores_gemma":[0.00017601108,0.0001995205,0.00021009211,0.0006037099,0.00014923637,0.00014892466,0.00006180824,0.00036188186,0.000014539928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007984794,0.0014669043,0.6998069,0.000111093206,0.002199301,0.00443994,0.0019330533,0.18357415,0.008979742,0.0028258408,0.006743895,0.07993435],"study_design_scores_gemma":[0.012755057,0.0025163877,0.961066,0.0012358489,0.00011229476,0.0001763751,0.00019471254,0.0017147203,0.010553164,0.0011029585,0.0082827965,0.00028969688],"about_ca_topic_score_codex":0.004285396,"about_ca_topic_score_gemma":0.011151923,"teacher_disagreement_score":0.26125905,"about_ca_system_score_codex":0.004665629,"about_ca_system_score_gemma":0.0005827862,"threshold_uncertainty_score":0.9995679},"labels":[],"label_agreement":null},{"id":"W4388494995","doi":"10.1136/ijgc-2023-igcs.360","title":"EP293/#283  Post-operative cognitive decline in patients undergoing major gynecologic oncology surgery: a preliminary prospective study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Delirium; Gynecologic oncology; Cognitive decline; Quality of life (healthcare); Incidence (geometry); Endometrial cancer; Surgery; Cancer; Internal medicine; Dementia; Disease; Psychiatry; Nursing","score_opus":0.032036762260780886,"score_gpt":0.3600969361092777,"score_spread":0.3280601738484968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871094,0.00008271271,0.000020570391,0.008231741,0.00089907733,0.000990885,0.000048464208,0.000038329636,0.000977293],"genre_scores_gemma":[0.99715656,0.00016660507,0.000084720334,0.0016921953,0.0002857164,0.00024279626,0.000057714897,0.000014298745,0.0002993938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777627,0.00022267432,0.00077805633,0.00030337155,0.00062726624,0.00029235636],"domain_scores_gemma":[0.9944612,0.0026942717,0.00044639478,0.00007913588,0.0021934567,0.00012556557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050139136,0.00020656823,0.00058179256,0.00046640163,0.00009674685,0.000032861753,0.0002278148,0.00014997205,0.0010219939],"category_scores_gemma":[0.0025933932,0.00014650961,0.00020540113,0.0004355758,0.00010474418,0.00018627747,0.0001627416,0.00048295746,0.00008728453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005608493,0.0054967473,0.9693821,0.0000069911357,0.0005788255,0.002049125,0.0007573026,0.00007265,0.000057509398,0.00009627475,0.00042707496,0.0154668735],"study_design_scores_gemma":[0.007107563,0.011834254,0.97812915,0.00009524354,0.00017588468,0.000086113345,0.0014373615,0.00006808923,0.00007183291,0.00067799335,0.00017835078,0.00013813842],"about_ca_topic_score_codex":0.00008098779,"about_ca_topic_score_gemma":0.0007987803,"teacher_disagreement_score":0.015328735,"about_ca_system_score_codex":0.0010704014,"about_ca_system_score_gemma":0.0007035693,"threshold_uncertainty_score":0.9998912},"labels":[],"label_agreement":null},{"id":"W4388494998","doi":"10.1136/ijgc-2023-igcs.345","title":"EP274/#837  Characterization of a three-dimensional culture system representative of disease progression in high-grade serous ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Cell culture; In vivo; Ovarian cancer; Cell growth; Biology; Serous fluid; Cell; Cancer cell; Pathology; Apoptosis; Cancer; Cancer research; Cell biology; Chemistry; Medicine; Biochemistry; Genetics","score_opus":0.02483250963084361,"score_gpt":0.3201350258185463,"score_spread":0.2953025161877027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959979,0.00018584677,0.00008133612,0.0014734613,0.0016372596,0.00024069524,0.00035007202,0.000024731957,0.000008695694],"genre_scores_gemma":[0.99913305,0.00008574764,0.00032605376,0.000091571,0.00023058131,0.00005902073,0.000023903622,0.000011117913,0.000038940143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975072,0.00019934261,0.0008510966,0.00023488775,0.0010005691,0.0002069081],"domain_scores_gemma":[0.9976003,0.00021759675,0.001038292,0.000114517694,0.0009049169,0.00012436218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055583846,0.00014043113,0.0003735577,0.00022431559,0.00003439138,0.000026477948,0.0004270115,0.00008912668,0.00055793894],"category_scores_gemma":[0.0002825617,0.00009941411,0.00011327327,0.00037852104,0.0001352596,0.00032863286,0.00014837035,0.00016574531,0.000011230089],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001802869,0.00038288173,0.08064263,0.00007291152,0.00007512957,0.00036151794,0.00030781337,0.010125207,0.9042853,0.00047288847,0.00026050958,0.0012103088],"study_design_scores_gemma":[0.0024751464,0.000332328,0.7180335,0.0010579033,0.00006523632,0.000014805655,0.00013975939,0.0035684821,0.27361923,0.00044526267,0.0000719694,0.00017636958],"about_ca_topic_score_codex":0.0002564756,"about_ca_topic_score_gemma":0.00012183995,"teacher_disagreement_score":0.63739085,"about_ca_system_score_codex":0.00039599568,"about_ca_system_score_gemma":0.0003119978,"threshold_uncertainty_score":0.61090404},"labels":[],"label_agreement":null},{"id":"W4388495034","doi":"10.1136/ijgc-2023-igcs.354","title":"EP286/#514  Real world management of endometriosis: how can we prevent endometriosis associated ovarian cancer?","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; B.C. Women's Hospital & Health Centre; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Endometriosis; Medicine; Malignancy; Asymptomatic; Estrogen; Cancer; Hormonal therapy; Internal medicine; Gynecology; Malignant transformation; Hormone; Hormone therapy; Oncology; Gastroenterology; Breast cancer; Pathology","score_opus":0.057265034890711275,"score_gpt":0.37893623421289757,"score_spread":0.3216711993221863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9251954,0.0061070714,0.00006708094,0.056829527,0.0028391841,0.0013648384,0.0005855698,0.00010749183,0.0069038244],"genre_scores_gemma":[0.9016462,0.0909747,0.00039735777,0.00023658764,0.00032077899,0.00020468612,0.000028467513,0.000024970775,0.006166271],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99587196,0.00019241805,0.00086185744,0.00031539417,0.002228327,0.0005300472],"domain_scores_gemma":[0.99377537,0.0035017845,0.0008542221,0.00019201261,0.0012776294,0.00039899955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001011233,0.00026262517,0.0008324763,0.0026233012,0.000077847886,0.00007535824,0.00056860695,0.00012288577,0.00218525],"category_scores_gemma":[0.00468999,0.00018710236,0.0005637159,0.0037940412,0.00010904221,0.0001356383,0.00023336575,0.00046665297,0.000011818258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038992239,0.005708883,0.27273196,0.00038327524,0.029484801,0.00876164,0.00033587942,0.0005838733,0.0038339163,0.0015357706,0.031996194,0.64074457],"study_design_scores_gemma":[0.028299091,0.0044151633,0.85520804,0.002723733,0.0015658117,0.00010179955,0.00067991344,0.00019954333,0.021857264,0.0013428454,0.083026625,0.0005801667],"about_ca_topic_score_codex":0.00047825355,"about_ca_topic_score_gemma":0.00071558624,"teacher_disagreement_score":0.64016443,"about_ca_system_score_codex":0.00238282,"about_ca_system_score_gemma":0.0003735634,"threshold_uncertainty_score":0.9987269},"labels":[],"label_agreement":null},{"id":"W4388495075","doi":"10.1136/ijgc-2023-igcs.121","title":"PR085/#158  Predictors of lifetime cervical cancer screening and association with social determinants of health: cross-sectional evidence from the Canadian longitudinal study on aging","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Impact; University of Toronto; McMaster University","funders":"","keywords":"Cervical cancer; Medicine; Cross-sectional study; Demography; Cancer; Population; Cancer screening; Gerontology; Internal medicine; Environmental health","score_opus":0.19182369338563734,"score_gpt":0.4723316360099713,"score_spread":0.280507942624334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990158,0.00049304566,0.000015945605,0.008351637,0.00048684102,0.00026706746,0.00014816482,0.000007621727,0.00007164663],"genre_scores_gemma":[0.9982558,0.00026913735,0.00002956817,0.0004184668,0.00091796886,0.000021805807,0.0000055538726,0.000011056907,0.0000706758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996829,0.00018689752,0.0006942769,0.00021750575,0.0017916885,0.00028065903],"domain_scores_gemma":[0.9962377,0.0013642621,0.0006557338,0.000073786265,0.0014761235,0.00019236947],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015445086,0.00012526516,0.00043314067,0.00019752157,0.0001859767,0.000058302387,0.00029538193,0.0001133445,0.0013408619],"category_scores_gemma":[0.00103617,0.000077355275,0.00011710424,0.00029732726,0.000167019,0.00013098076,0.00008758179,0.0005491275,0.0000019119987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011563102,0.000115683164,0.98756546,0.000021306887,0.00045072663,0.000055551624,0.00056232663,0.00021043298,0.000024620173,0.0000061052388,0.00042252455,0.009408979],"study_design_scores_gemma":[0.0016990481,0.0012397029,0.99606216,0.0002007146,0.000061185136,0.000009774426,0.00018786413,0.00019883354,0.0000853536,0.000036990397,0.00015164856,0.00006675293],"about_ca_topic_score_codex":0.06536602,"about_ca_topic_score_gemma":0.15355195,"teacher_disagreement_score":0.08818592,"about_ca_system_score_codex":0.0012133826,"about_ca_system_score_gemma":0.0013235962,"threshold_uncertainty_score":0.99957204},"labels":[],"label_agreement":null},{"id":"W4388495132","doi":"10.1136/ijgc-2023-igcs.103","title":"PR063/#79  Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Serous carcinoma; Population; Cohort; Serous fluid; Retrospective cohort study; BRCA mutation; Gynecology; Internal medicine; Ovarian cancer; Oncology; Cancer","score_opus":0.030236286863281663,"score_gpt":0.3562752845719344,"score_spread":0.32603899770865274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929297,0.000114807866,0.00003623615,0.004601928,0.0018851946,0.00019006614,0.00009401692,0.000023096925,0.00012494261],"genre_scores_gemma":[0.99771905,0.00049144967,0.00026185546,0.0006091592,0.00070941175,0.000032677795,0.0000354827,0.000014345106,0.00012658486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983324,0.00009374782,0.0005663822,0.00020260217,0.00058876595,0.00021610309],"domain_scores_gemma":[0.99882454,0.00027683369,0.00032135416,0.00010319452,0.00031782014,0.00015627818],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034102617,0.0001489137,0.00039657604,0.00027916674,0.000037509533,0.00004262529,0.00019190444,0.00011117758,0.0010748749],"category_scores_gemma":[0.00039442707,0.00010265119,0.00017037739,0.00017894538,0.000033386357,0.00018920471,0.000046638932,0.00032113705,0.00002941075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044242706,0.000516165,0.9579789,0.0000057114885,0.00018776326,0.0012969378,0.00014949904,0.002050347,0.000067961475,0.00012696769,0.00029460518,0.03688271],"study_design_scores_gemma":[0.0034561178,0.0009892893,0.9928374,0.00005236516,0.00008582698,0.00006503484,0.000048563707,0.0008725967,0.00012031201,0.0008024586,0.00057078846,0.000099213015],"about_ca_topic_score_codex":0.00063678995,"about_ca_topic_score_gemma":0.00077669654,"teacher_disagreement_score":0.036783494,"about_ca_system_score_codex":0.0008826253,"about_ca_system_score_gemma":0.00016455282,"threshold_uncertainty_score":0.9998383},"labels":[],"label_agreement":null},{"id":"W4388495144","doi":"10.1136/ijgc-2023-igcs.58","title":"PR016/#541  Detection of human papillomvirus circulating tumor DNA (CTDNA) as a novel approach to cervical cancer screening and monitoring","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada; McGill University Health Centre","funders":"","keywords":"Cervical cancer; Liquid biopsy; Medicine; Cancer; Internal medicine; Biopsy; Oncology; Cytology; Cancer screening; Dysplasia; Urine; Gastroenterology; Pathology","score_opus":0.10514173979579139,"score_gpt":0.4149997240209168,"score_spread":0.3098579842251254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460125,0.0004137716,0.0006593412,0.0013596645,0.00053020124,0.00024308154,0.000018769611,0.00002914153,0.0021447507],"genre_scores_gemma":[0.99737597,0.00017946916,0.00052185653,0.00036998148,0.0013239039,0.00006520199,0.0000027884366,0.000021348513,0.00013947891],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976606,0.000044521817,0.000593175,0.00026603488,0.0011299007,0.0003057705],"domain_scores_gemma":[0.9980585,0.0002542581,0.0002726965,0.00009265616,0.0010046277,0.00031727768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000541375,0.00015457983,0.0004292557,0.0003608802,0.00009885421,0.000049645434,0.0002610695,0.00010562427,0.0008035297],"category_scores_gemma":[0.0006754624,0.00012020821,0.00017292678,0.00042022736,0.00009183052,0.00013015376,0.00020286127,0.00051236304,0.000005246641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021424894,0.000498292,0.16047613,0.00025171705,0.00079139223,0.0002822186,0.00074032653,0.0021669716,0.55175203,0.00031731636,0.00014441567,0.28043666],"study_design_scores_gemma":[0.0026565052,0.0008274844,0.96343976,0.00021465289,0.000084840765,0.00016884149,0.00042990336,0.001402161,0.029540434,0.00021920193,0.000851849,0.00016439152],"about_ca_topic_score_codex":0.0005551638,"about_ca_topic_score_gemma":0.00006137236,"teacher_disagreement_score":0.8029636,"about_ca_system_score_codex":0.00042891758,"about_ca_system_score_gemma":0.00016132102,"threshold_uncertainty_score":0.87980866},"labels":[],"label_agreement":null},{"id":"W4388495146","doi":"10.1136/ijgc-2023-igcs.473","title":"TP011/#1536  A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Carboplatin; Medicine; Chemotherapy; Paclitaxel; Internal medicine; Placebo; Cohort; Ovarian cancer; Gastroenterology; Oncology; Cancer; Urology; Cisplatin; Pathology","score_opus":0.03222303950896773,"score_gpt":0.36840030227341597,"score_spread":0.33617726276444826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847525,0.00075687293,0.000078289384,0.0074504977,0.0017540281,0.0039666677,0.00022199193,0.00007964258,0.0009395191],"genre_scores_gemma":[0.9913354,0.0015762906,0.0004983178,0.0015374729,0.0012399508,0.00092867773,0.00009794438,0.00010840802,0.0026775482],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928837,0.00035299064,0.0019848093,0.00083795376,0.0028811311,0.0010594077],"domain_scores_gemma":[0.9945298,0.0016712846,0.0012174797,0.00041245253,0.0016332017,0.0005358258],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015422616,0.0007833417,0.0020091964,0.0009439069,0.00022018598,0.0001779824,0.0009919909,0.00035092587,0.004825281],"category_scores_gemma":[0.00054139685,0.0005289987,0.00060140196,0.0009848746,0.0003147281,0.0004836638,0.00019893878,0.0015103188,0.000048425856],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7955918,0.005863665,0.13049285,0.000051526516,0.0038760605,0.0018629832,0.001576886,0.001914761,0.0022107852,0.00020019217,0.0012014217,0.05515709],"study_design_scores_gemma":[0.7052175,0.009583334,0.2745804,0.0005342087,0.00024721873,0.00005373065,0.0005831165,0.0013240499,0.0008015736,0.00040680743,0.0058864686,0.0007816442],"about_ca_topic_score_codex":0.0009990197,"about_ca_topic_score_gemma":0.0010363337,"teacher_disagreement_score":0.14408754,"about_ca_system_score_codex":0.0011932777,"about_ca_system_score_gemma":0.0010044585,"threshold_uncertainty_score":0.99971616},"labels":[],"label_agreement":null},{"id":"W4388495151","doi":"10.1136/ijgc-2023-igcs.349","title":"EP280/#231  Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Olaparib; Progression-free survival; Cancer; Retrospective cohort study; Poly ADP ribose polymerase; Biology","score_opus":0.03373060143368868,"score_gpt":0.3597673841096987,"score_spread":0.32603678267601005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88749415,0.00034422748,0.00003631134,0.10872152,0.0026876826,0.00039852195,0.00019971258,0.000027046115,0.00009081945],"genre_scores_gemma":[0.99008703,0.0007731859,0.000572526,0.0069485954,0.0011369002,0.0002258143,0.000017210676,0.000026357944,0.00021239724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976548,0.00013985456,0.0007308096,0.00030699378,0.00082748395,0.00034004328],"domain_scores_gemma":[0.998003,0.0005724745,0.00031643827,0.00013971639,0.0006795551,0.00028879897],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074279425,0.00022032676,0.00047483484,0.00049945404,0.00003866212,0.000047601672,0.0002725595,0.00013458345,0.0033290123],"category_scores_gemma":[0.000608365,0.00015983988,0.00024652178,0.00042873304,0.00005434526,0.000086803826,0.00005196606,0.00034941908,0.000060133094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08054865,0.0032694729,0.4210136,0.000061986015,0.0015703099,0.008026858,0.001546617,0.009294522,0.04505659,0.00031397777,0.024331579,0.40496585],"study_design_scores_gemma":[0.0102294395,0.0022853194,0.9291148,0.00058514305,0.00006149375,0.00003831408,0.000067759065,0.00021178115,0.008156683,0.00015677039,0.048891913,0.00020054427],"about_ca_topic_score_codex":0.00030838215,"about_ca_topic_score_gemma":0.00056741823,"teacher_disagreement_score":0.5081013,"about_ca_system_score_codex":0.0021846134,"about_ca_system_score_gemma":0.0011588268,"threshold_uncertainty_score":0.9975821},"labels":[],"label_agreement":null},{"id":"W4388495164","doi":"10.1136/ijgc-2023-igcs.90","title":"PR049/#741  Improved risk prediction in HPV-associated endocervical adenocarcinoma through assessment of binary silva pattern-based classification: international multicenter retrospective study of the international society of gynecological pathologists","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Toronto General Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; Internal medicine; Retrospective cohort study; Lymph node; Gynecology; Pathology; Biology","score_opus":0.050691104222757646,"score_gpt":0.36254711898793385,"score_spread":0.3118560147651762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915597,0.00009241318,0.00014472051,0.003392192,0.0029779372,0.0007941794,0.0005269219,0.000025606238,0.00048635635],"genre_scores_gemma":[0.9981922,0.0003993157,0.0004003408,0.0003994802,0.00031455743,0.00012294734,0.000074609336,0.000017936376,0.000078600795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954135,0.00032967777,0.0017820128,0.0004280658,0.0017760856,0.00027066463],"domain_scores_gemma":[0.9946139,0.000925562,0.0022026459,0.00024093207,0.0019232761,0.000093696464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009867864,0.0002682008,0.0007970489,0.0002970871,0.000056127763,0.000022014496,0.000918418,0.0002732332,0.0014681163],"category_scores_gemma":[0.0017288201,0.00017321446,0.0006264818,0.0007345514,0.00027943245,0.00019067182,0.00032142858,0.00078841706,0.0000020460545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014784024,0.0059483643,0.98164123,0.00002716679,0.0013361117,0.000081957696,0.00047442922,0.001107658,0.0045124693,0.000025877427,0.00043046958,0.0029358657],"study_design_scores_gemma":[0.01369778,0.0030417514,0.966372,0.00015754264,0.00024478606,0.000010799517,0.0009540164,0.014231956,0.0009238634,0.0001684016,0.000079019206,0.000118055505],"about_ca_topic_score_codex":0.0003435691,"about_ca_topic_score_gemma":0.00019838446,"teacher_disagreement_score":0.015269199,"about_ca_system_score_codex":0.0020712116,"about_ca_system_score_gemma":0.0004458819,"threshold_uncertainty_score":0.99944466},"labels":[],"label_agreement":null},{"id":"W4388495210","doi":"10.1136/ijgc-2023-igcs.288","title":"EP206/#943  The spectrum of HER2 expression in endometrial carcinoma","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Immunohistochemistry; Medicine; Internal medicine; Oncology; Serous carcinoma; Serous fluid; Endometrial cancer; Trastuzumab; Carcinoma; Cancer; Breast cancer; Ovarian cancer","score_opus":0.08222163464780835,"score_gpt":0.4235963263892816,"score_spread":0.3413746917414732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793894,0.00069576025,0.00003300101,0.016031373,0.0019649405,0.000223464,0.000020125211,0.000010131952,0.0016317645],"genre_scores_gemma":[0.9969488,0.0009891695,0.00010277178,0.00036911978,0.0011360068,0.0000245829,0.000002722507,0.0000115468,0.00041532423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975221,0.00014957417,0.0006511036,0.0001462954,0.0012758289,0.00025510218],"domain_scores_gemma":[0.99790037,0.0011306984,0.0003058277,0.00013297371,0.00042075137,0.00010939353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012306559,0.000101689024,0.0003493639,0.00050039456,0.000026131464,0.000020159452,0.00054572365,0.000102640915,0.003461961],"category_scores_gemma":[0.0022890836,0.000057460984,0.00019853593,0.00061509176,0.00014493159,0.00007656994,0.00016349243,0.0005948849,0.000026323465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004545313,0.0005260396,0.8857705,0.00005962554,0.0002577788,0.0026469808,0.0005541666,0.00091193203,0.03842904,0.0004636897,0.026253704,0.03958124],"study_design_scores_gemma":[0.004490337,0.0010327619,0.9407371,0.0002609705,0.000023822604,0.00012900177,0.0002382023,0.00024972446,0.02759463,0.0014043271,0.023750266,0.00008881269],"about_ca_topic_score_codex":0.00016048731,"about_ca_topic_score_gemma":0.00011115134,"teacher_disagreement_score":0.054966655,"about_ca_system_score_codex":0.00057162275,"about_ca_system_score_gemma":0.00047142938,"threshold_uncertainty_score":0.997449},"labels":[],"label_agreement":null},{"id":"W4388495240","doi":"10.1136/ijgc-2023-igcs.6","title":"PO006LBA/#1520  Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Placebo; Endometrial cancer; Internal medicine; Medicine; Nausea; Vomiting; Adverse effect; Neutropenia; Tolerability; Oncology; Cancer; Chemotherapy; Pathology","score_opus":0.04446913692738484,"score_gpt":0.3860501588021604,"score_spread":0.34158102187477557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945883,0.0007244593,0.000077901255,0.0011804254,0.0013670535,0.0014963639,0.0005351236,0.00001036612,0.000019974177],"genre_scores_gemma":[0.9957616,0.0030950245,0.00011280372,0.00007207675,0.00021655533,0.00014369455,0.000045945257,0.000017058417,0.00053528865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724954,0.00011431917,0.00087400584,0.000301896,0.0011514024,0.00030882936],"domain_scores_gemma":[0.99544317,0.0013703887,0.00085822714,0.0001800091,0.0019971335,0.0001510714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005477533,0.00021004927,0.0008455449,0.0005428906,0.0000787264,0.000020830896,0.00041972272,0.000076532866,0.00035327635],"category_scores_gemma":[0.001476194,0.00010026176,0.0003554058,0.0012746662,0.00019108824,0.00011869316,0.00014293443,0.00027750796,4.6035447e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056424778,0.001488653,0.8710563,0.000060928625,0.005923471,0.00006391596,0.00038922223,0.00047617796,0.00036973777,0.000016371801,0.00024462424,0.06348581],"study_design_scores_gemma":[0.037172865,0.005218555,0.9542973,0.00030230597,0.0015087979,0.0000049719515,0.00017238913,0.0001374059,0.00051400386,0.000012560462,0.00054483983,0.00011397837],"about_ca_topic_score_codex":0.00005826132,"about_ca_topic_score_gemma":0.0005667025,"teacher_disagreement_score":0.08324102,"about_ca_system_score_codex":0.00054297596,"about_ca_system_score_gemma":0.00043456012,"threshold_uncertainty_score":0.4088556},"labels":[],"label_agreement":null},{"id":"W4388495249","doi":"10.1136/ijgc-2023-igcs.22","title":"SO008/#160  Mental health among women with a history of gynecologic cancers: a cross-sectional analysis of the Canadian longitudinal study on aging","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Health and Wellbeing Research","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Impact; McMaster University","funders":"","keywords":"Psychosocial; Cross-sectional study; Mental health; Medicine; Depression (economics); Distress; Clinical psychology; Psychiatry; Demography","score_opus":0.1579545140940277,"score_gpt":0.5009348256672803,"score_spread":0.3429803115732526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929247,0.0001153971,0.00000616976,0.0029037308,0.0021359124,0.00054961344,0.0001371557,0.000012021891,0.0012152854],"genre_scores_gemma":[0.9968726,0.00009405818,0.000012886731,0.001251611,0.00023274601,0.00012444834,0.000007474542,0.000010964777,0.0013932106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995714,0.0007060249,0.001157324,0.0002602099,0.0014799197,0.0006825286],"domain_scores_gemma":[0.9956316,0.00120943,0.0013162431,0.00017883952,0.0012216342,0.0004422557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033064033,0.00015485554,0.00057899696,0.0009971812,0.0004465993,0.0000145552785,0.000729615,0.0001405324,0.0039329412],"category_scores_gemma":[0.000813223,0.00009404167,0.00018786319,0.00095253513,0.00032974948,0.00011018588,0.00013174722,0.0010408851,0.000008942185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00051572925,0.00017069206,0.98596275,0.000034973793,0.0011032696,0.00004216622,0.0037169827,0.00418499,0.000010699683,0.00007391248,0.0037166832,0.000467154],"study_design_scores_gemma":[0.0012733677,0.0012096162,0.99324113,0.000093907416,0.000040297753,0.0000020243638,0.0014612639,0.0003098339,0.0000013116083,0.000056164714,0.002230551,0.00008054203],"about_ca_topic_score_codex":0.092221625,"about_ca_topic_score_gemma":0.49537483,"teacher_disagreement_score":0.4031532,"about_ca_system_score_codex":0.018930428,"about_ca_system_score_gemma":0.01075944,"threshold_uncertainty_score":0.9969776},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4388495254","doi":"10.1136/ijgc-2023-igcs.255","title":"EP164/#666  Does perinephric fat predict surgical complications and survival in individuals with endometrial cancer?","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System; Princess Margaret Cancer Centre; Lakeridge Health; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Proportional hazards model; Hazard ratio; Retrospective cohort study; Internal medicine; Adipose capsule of kidney; Overall survival; Cancer; Lymph node; Survival analysis; Cohort; Gastroenterology; Surgery; Urology; Confidence interval","score_opus":0.040204844998033826,"score_gpt":0.3570129076384629,"score_spread":0.31680806264042904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857272,0.0010510292,0.000022975504,0.010219077,0.0012329336,0.00030425342,0.00017836964,0.000033985783,0.0012301839],"genre_scores_gemma":[0.9937288,0.0043516993,0.00018879812,0.00037328893,0.0009748015,0.0001198995,0.000024317173,0.0000147944465,0.00022358254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784416,0.00009403704,0.0005965784,0.00025887872,0.0009297649,0.00027660443],"domain_scores_gemma":[0.99780583,0.0011385963,0.00029232434,0.00009116472,0.00043270877,0.00023938373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039378475,0.00018239365,0.00054206373,0.0006239872,0.000050515962,0.00004944464,0.000251893,0.00011324884,0.0011979126],"category_scores_gemma":[0.0004885454,0.00009990385,0.00013461798,0.0008933141,0.00015227265,0.00014159981,0.00010981756,0.0003679663,0.000008658151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016059224,0.00033178768,0.96107566,0.000016922135,0.0005671026,0.0006921314,0.000080514896,0.00017712687,0.00015542653,0.00033761002,0.00028063726,0.034679156],"study_design_scores_gemma":[0.013959198,0.0009418999,0.96055716,0.00014912974,0.00011275756,0.00015027299,0.000110875335,0.000056028624,0.00017269378,0.0004656222,0.023194272,0.00013009812],"about_ca_topic_score_codex":0.00024683433,"about_ca_topic_score_gemma":0.00024597446,"teacher_disagreement_score":0.034549057,"about_ca_system_score_codex":0.00043715906,"about_ca_system_score_gemma":0.00020808382,"threshold_uncertainty_score":0.99971515},"labels":[],"label_agreement":null},{"id":"W4388495257","doi":"10.1136/ijgc-2023-igcs.300","title":"EP222/#246  Quantifying platinum sensitivity as a marker for response to PARP inhibition in patients with advanced ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Debulking; Ovarian cancer; PARP inhibitor; Proportional hazards model; Progression-free survival; Chemotherapy; Cancer; Multivariate analysis; Log-rank test; Retrospective cohort study; Cohort; Poly ADP ribose polymerase; Biology","score_opus":0.04336273576673604,"score_gpt":0.3839761170429713,"score_spread":0.34061338127623525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826017,0.00005081349,0.00075849757,0.014467445,0.0011156955,0.000686557,0.0001709966,0.000035143643,0.00011313133],"genre_scores_gemma":[0.9943952,0.00010108723,0.0013476356,0.0033016065,0.00034831683,0.00024235649,0.000027207494,0.000028888739,0.00020770867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781436,0.00017108528,0.00060382584,0.00028870575,0.00080285233,0.00031919457],"domain_scores_gemma":[0.9971112,0.00095706456,0.00039868333,0.000108617285,0.0012378963,0.0001865487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010826373,0.00018783608,0.00041364116,0.00046780985,0.00005805049,0.00003520118,0.000093767856,0.00012286984,0.0007022738],"category_scores_gemma":[0.0012160966,0.00014366805,0.00013670282,0.0004452762,0.000060647442,0.000235406,0.00004734413,0.00031661725,0.00001907806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1882619,0.00085606956,0.68553275,0.00005987728,0.0006096765,0.0013971962,0.0008188584,0.015204695,0.046767432,0.00020383633,0.004069694,0.056218006],"study_design_scores_gemma":[0.012888755,0.0017469132,0.9716569,0.00076588185,0.00003531258,0.000046068864,0.00009661889,0.0002863525,0.0039681527,0.0003126101,0.007997994,0.00019843246],"about_ca_topic_score_codex":0.00005962158,"about_ca_topic_score_gemma":0.00026141878,"teacher_disagreement_score":0.28612414,"about_ca_system_score_codex":0.0012340916,"about_ca_system_score_gemma":0.00045355764,"threshold_uncertainty_score":0.76894057},"labels":[],"label_agreement":null},{"id":"W4388495266","doi":"10.1136/ijgc-2023-igcs.128","title":"PR092/#646  Avoiding the needle: apixaban for extended venous thromboembolism prophylaxis after major gynecologic cancer surgery","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Apixaban; Audit; Psychological intervention; Internal medicine; Atrial fibrillation; Nursing","score_opus":0.04219937662066002,"score_gpt":0.3537819327811592,"score_spread":0.3115825561604992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694032,0.0023375002,0.00014051418,0.021422671,0.0051482343,0.0010026803,0.00008456269,0.000076136384,0.00038448587],"genre_scores_gemma":[0.98615897,0.004348473,0.00015852234,0.005284295,0.0021779526,0.0010131611,0.000015144825,0.000041014915,0.0008024445],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9972124,0.00013918536,0.00085860543,0.00034299635,0.000887986,0.00055878906],"domain_scores_gemma":[0.9961314,0.0018933992,0.0006067851,0.00020787894,0.0009744579,0.00018606358],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001408526,0.0002817543,0.0009321668,0.00036521885,0.00022553751,0.00011155211,0.0005270316,0.0001949109,0.0027889267],"category_scores_gemma":[0.0016939729,0.00016735173,0.0006333532,0.00039335492,0.000172477,0.0001872779,0.00019502339,0.00055585743,0.000045712564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046392614,0.0066248886,0.13148157,0.0007182727,0.010049636,0.003960893,0.0036104107,0.0028279407,0.0051133656,0.003168152,0.45444608,0.37335953],"study_design_scores_gemma":[0.0016327993,0.0011733939,0.9292909,0.00028616964,0.0005198715,0.000090090034,0.0005530011,0.0001789766,0.0007268451,0.0031238939,0.062129866,0.0002942094],"about_ca_topic_score_codex":0.000099526966,"about_ca_topic_score_gemma":0.00012946849,"teacher_disagreement_score":0.7978093,"about_ca_system_score_codex":0.000655567,"about_ca_system_score_gemma":0.00045481924,"threshold_uncertainty_score":0.99812263},"labels":[],"label_agreement":null},{"id":"W4388495351","doi":"10.1136/ijgc-2023-igcs.127","title":"PR091/#367  Improving the rate of same day discharge in gynecologic oncology patients undergoing minimally invasive surgery – an enhanced recovery after surgery quality improvement initiative","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Psychological intervention; Audit; Demographics; Quality management; Gynecologic oncology; Surgery; Emergency medicine; Nursing","score_opus":0.04711562668024958,"score_gpt":0.3414381621372648,"score_spread":0.2943225354570152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269515,0.00015399585,0.000028278224,0.0044642333,0.0018587742,0.00039067183,0.000048121492,0.000018240466,0.00034253878],"genre_scores_gemma":[0.9942306,0.0014458313,0.000058751662,0.003657726,0.0002948355,0.00012004952,0.00003759244,0.000018512523,0.0001360761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958631,0.0010393028,0.0016573047,0.00032699568,0.00070204184,0.00041126754],"domain_scores_gemma":[0.9689098,0.028483856,0.0013310638,0.00016705733,0.00094104547,0.00016720103],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004186928,0.00024770966,0.001326246,0.00042984952,0.0000515727,0.000037170714,0.00028220366,0.00019471654,0.0006236167],"category_scores_gemma":[0.013637433,0.0001520481,0.0007970258,0.0003688777,0.00019236228,0.00036162906,0.00015190791,0.00047648232,0.000010496291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059132357,0.0013190482,0.91399413,0.00011085804,0.00073073583,0.0012458345,0.00073477475,0.00016469564,0.00524989,0.00012369659,0.00038715574,0.070025936],"study_design_scores_gemma":[0.0019404127,0.0015728768,0.9914737,0.00018656503,0.00008264817,0.000015397254,0.0007189929,0.000016400578,0.0027945528,0.000345406,0.00066480885,0.0001882671],"about_ca_topic_score_codex":0.000094030824,"about_ca_topic_score_gemma":0.00078951573,"teacher_disagreement_score":0.077479534,"about_ca_system_score_codex":0.00094978744,"about_ca_system_score_gemma":0.0014049632,"threshold_uncertainty_score":0.9946711},"labels":[],"label_agreement":null},{"id":"W4388495380","doi":"10.1136/ijgc-2023-igcs.418","title":"EP363/#213  The role of surgeon specialty in management and survival of malignant ovarian germ cell tumors: a population-based study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Specialty; Internal medicine; Retrospective cohort study; Stage (stratigraphy); Logistic regression; Chemotherapy; Population; Proportional hazards model; Cohort; Surgery; Oncology; Gynecology; Gastroenterology; Pathology","score_opus":0.018288731561434273,"score_gpt":0.3078220713244816,"score_spread":0.2895333397630473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851406,0.00027565158,0.000007072033,0.00048506467,0.00021120303,0.00025365595,0.000027352058,0.000004036295,0.00022188594],"genre_scores_gemma":[0.9996767,0.00007833219,0.00005968779,0.000040795243,0.00006700435,0.000013338373,0.000007990114,0.0000052287046,0.000050919298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878997,0.00007576472,0.00044264694,0.00010013303,0.00049687695,0.00009462815],"domain_scores_gemma":[0.99906564,0.00026915318,0.00035045555,0.00007237631,0.00018768384,0.000054705848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003330443,0.00007718383,0.00025040918,0.00015236769,0.000015966423,0.000008766711,0.000115188566,0.000024893481,0.00031138418],"category_scores_gemma":[0.0001312607,0.000045171517,0.000097531476,0.00015026573,0.0000262559,0.0000289163,0.0000471819,0.00007840482,0.0000012727891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039629327,0.0009415954,0.9918817,0.000020452972,0.00018905908,0.0005292228,0.00006321081,0.00057278207,0.000059482394,0.00019985276,0.00001665498,0.005129652],"study_design_scores_gemma":[0.0022770911,0.00037663232,0.9955713,0.00009697411,0.0001099663,0.0000050340795,0.00041320833,0.00025678918,0.00011688247,0.0006527901,0.000085288215,0.00003802145],"about_ca_topic_score_codex":0.0004317837,"about_ca_topic_score_gemma":0.00024160722,"teacher_disagreement_score":0.0050916304,"about_ca_system_score_codex":0.00011958251,"about_ca_system_score_gemma":0.00008104296,"threshold_uncertainty_score":0.34094384},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4388495382","doi":"10.1136/ijgc-2023-igcs.409","title":"EP354/#665  Histopathologic and oncological characteristics of ovarian borderline tumours with positive peritoneal cytology: a case series","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Serous fluid; Cytology; Retrospective cohort study; Adjuvant therapy; Stage (stratigraphy); Biopsy; Cohort; Internal medicine; Radiology; Gastroenterology; Pathology; Cancer","score_opus":0.020949409875915457,"score_gpt":0.3236738171394997,"score_spread":0.30272440726358424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810315,0.00041779238,0.000056513007,0.017260117,0.0005861747,0.000198657,0.0001546943,0.000021889875,0.00027265496],"genre_scores_gemma":[0.99570847,0.0013315075,0.001628366,0.0007239209,0.0003590159,0.000037732298,0.00002152697,0.000012091543,0.00017739799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858123,0.000082855666,0.0005376717,0.0002242367,0.00036581693,0.00020821622],"domain_scores_gemma":[0.9981619,0.00034384246,0.00048861123,0.000084319596,0.00075862615,0.00016270057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028661845,0.00017797737,0.0006153889,0.00017647311,0.000060066726,0.000022357179,0.00012131212,0.00014169162,0.0005006667],"category_scores_gemma":[0.00031354447,0.00010975606,0.00011904648,0.00016569268,0.00034428324,0.00010314359,0.000079078774,0.00029870533,0.0000034579718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058526723,0.0012091803,0.77435976,0.000046724497,0.00077206234,0.17082034,0.0005350785,0.000045097353,0.0010364633,0.0015993038,0.0007388307,0.042984515],"study_design_scores_gemma":[0.0031547875,0.0059435596,0.9468024,0.00015005833,0.00029588887,0.04063405,0.0003051445,0.00004708542,0.00037855894,0.00023221504,0.0019289139,0.0001273878],"about_ca_topic_score_codex":0.000051343093,"about_ca_topic_score_gemma":0.00008184866,"teacher_disagreement_score":0.17244262,"about_ca_system_score_codex":0.00036191262,"about_ca_system_score_gemma":0.00029258363,"threshold_uncertainty_score":0.54819494},"labels":[],"label_agreement":null},{"id":"W4388495401","doi":"10.1136/ijgc-2023-igcs.444","title":"EP398/#161  Air travel and thromboembolism among postoperative gynecologic cancer patients: ten-year single-centre experience prior to the era of postoperative extended thromboprophylaxis","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Debulking; Surgery; Laparotomy; Pulmonary embolism; Deep vein; Retrospective cohort study; Incidence (geometry); Context (archaeology); Medical record; Ovarian cancer; Thrombosis; Cancer; Internal medicine","score_opus":0.019832585955438298,"score_gpt":0.30460420731501087,"score_spread":0.28477162135957257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691103,0.00028664383,0.000023907927,0.027463239,0.0015395352,0.00096001563,0.00009479969,0.000023597338,0.00049795373],"genre_scores_gemma":[0.9911788,0.001149105,0.00027135614,0.0067558023,0.00023874886,0.00013520905,0.00001019705,0.000023730947,0.0002370479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973806,0.00013603152,0.0007815045,0.00039015716,0.00093275774,0.0003789301],"domain_scores_gemma":[0.99701166,0.00036934356,0.00049246266,0.0001738253,0.0017272023,0.0002254872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003376675,0.0002847354,0.00082737906,0.00019921882,0.00016738244,0.00006001298,0.0004916553,0.00013945565,0.001610307],"category_scores_gemma":[0.00089220365,0.00016759412,0.00020395168,0.00041008095,0.0003508416,0.00026304746,0.0003003598,0.00045699888,0.000018083256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00254451,0.010124329,0.674056,0.00014326027,0.004616797,0.00083301443,0.059933517,0.0036429565,0.027405268,0.0042174356,0.048346665,0.16413628],"study_design_scores_gemma":[0.0019173885,0.0023913702,0.9855822,0.00024040454,0.000121626275,0.000008356378,0.0035745439,0.0000687737,0.0034975081,0.00013089582,0.0022697418,0.00019724002],"about_ca_topic_score_codex":0.00020524897,"about_ca_topic_score_gemma":0.00040792965,"teacher_disagreement_score":0.31152618,"about_ca_system_score_codex":0.0004993314,"about_ca_system_score_gemma":0.00020735676,"threshold_uncertainty_score":0.9993023},"labels":[],"label_agreement":null},{"id":"W4388495416","doi":"10.1136/ijgc-2023-igcs.15","title":"SO001/#159  Exploring the association between frailty and gynecologic cancer survivorship: a cross-sectional analysis of the Canadian longitudinal study on aging","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Impact; McMaster University","funders":"","keywords":"Medicine; Psychosocial; Gerontology; Gynecologic cancer; Cohort study; Cohort; Affect (linguistics); Longitudinal study; Cross-sectional study; Multivariate analysis; Cancer survivor; Survivorship curve; Prospective cohort study; Population; Cancer; Demography; Internal medicine; Psychology; Environmental health; Ovarian cancer; Psychiatry","score_opus":0.2166015044025165,"score_gpt":0.4239168731376841,"score_spread":0.20731536873516762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768616,0.00008832317,0.0000073839365,0.009480168,0.0020911507,0.00027929628,0.00013771308,0.00001665129,0.0002131577],"genre_scores_gemma":[0.9980342,0.00013450794,0.000009706111,0.0005186786,0.00064846914,0.00007113917,0.000009120229,0.00001162479,0.0005625728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708396,0.00023207121,0.0006964882,0.00025744835,0.0014126246,0.00031740195],"domain_scores_gemma":[0.9956551,0.0021927988,0.00068856974,0.00016359285,0.0011335717,0.00016634092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017149296,0.0001693442,0.00046370787,0.00054472446,0.0002777269,0.00010984447,0.0005059402,0.00013210325,0.00063456135],"category_scores_gemma":[0.002668558,0.00009570964,0.00032639314,0.0010384364,0.00013867299,0.00015221846,0.00013380482,0.0007188021,0.0000054649704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076552395,0.00009319313,0.98980606,0.0000052446157,0.0037666736,0.000051011146,0.0004468664,0.0032857794,0.000032550262,0.000044340195,0.00025638996,0.0021353704],"study_design_scores_gemma":[0.0009546345,0.00025919435,0.9967223,0.000045981647,0.0007574781,0.000006990072,0.00021284063,0.00022224132,0.0000688409,0.00013842883,0.00051706267,0.000094044975],"about_ca_topic_score_codex":0.034037452,"about_ca_topic_score_gemma":0.38903877,"teacher_disagreement_score":0.3550013,"about_ca_system_score_codex":0.0023880615,"about_ca_system_score_gemma":0.00051053724,"threshold_uncertainty_score":0.972395},"labels":[],"label_agreement":null},{"id":"W4388495440","doi":"10.1136/ijgc-2023-igcs.2","title":"PO002/#156  Efficacy and safety results from skyscraper-04: an open-label randomized phase 2 trial of tiragolumab plus atezolizumab for PD-L1-positive recurrent cervical cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Atezolizumab; Medicine; Oncology; Internal medicine; Clinical endpoint; TIGIT; Randomized controlled trial; Regimen; Progression-free survival; Cancer; Chemotherapy; Immunotherapy; Pembrolizumab","score_opus":0.08152142274293853,"score_gpt":0.4260592654103299,"score_spread":0.3445378426673914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980174,0.0017591408,0.00018530474,0.010188715,0.0032744843,0.0020528184,0.0020295815,0.000024039746,0.00031192458],"genre_scores_gemma":[0.9890064,0.007106608,0.00059870444,0.0010815884,0.0013593619,0.00020625546,0.00027950495,0.000027924165,0.00033363764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99677986,0.000284477,0.0015289625,0.0003979746,0.0007238392,0.00028489172],"domain_scores_gemma":[0.9951166,0.0024770303,0.0010370308,0.0001668061,0.000978491,0.00022403055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001422668,0.00025157485,0.0012181707,0.00020540963,0.00009405122,0.00008260708,0.0005575067,0.00020994313,0.00088458596],"category_scores_gemma":[0.001396948,0.00017350964,0.0002883407,0.00022035603,0.00030457322,0.00023881182,0.00015983194,0.0003438594,0.000002368652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8412591,0.0015058867,0.000032210042,0.000013540698,0.0016257575,0.00007800988,0.00044115377,0.000036452344,0.0025467225,0.00007767018,0.0017172868,0.15066619],"study_design_scores_gemma":[0.9695373,0.008525235,0.008921268,0.00047653113,0.00049012207,0.000031079056,0.00011871257,0.0020605484,0.0008966985,0.00044185275,0.008279353,0.00022125723],"about_ca_topic_score_codex":0.000899107,"about_ca_topic_score_gemma":0.00034379907,"teacher_disagreement_score":0.15044492,"about_ca_system_score_codex":0.0007225041,"about_ca_system_score_gemma":0.000734614,"threshold_uncertainty_score":0.96855956},"labels":[],"label_agreement":null},{"id":"W4388495443","doi":"10.1136/ijgc-2023-igcs.199","title":"EP095/#141  IGCS-MD anderson project echo gynecologic cancers in Latin America: transfering knowledge, building confidence and increasing collaboration in Latin America through a telementoring model","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Latin Americans; Mentorship; Curriculum; Medicine; Echo (communications protocol); Medical education; Gynecologic oncology; Family medicine; Psychology; Oncology; Computer science; Political science; Pedagogy","score_opus":0.16698346474259856,"score_gpt":0.4880682159463365,"score_spread":0.3210847512037379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878038,0.00093548116,0.0021892604,0.0072966013,0.00037351745,0.000564692,0.000018640034,0.000029911067,0.00078806205],"genre_scores_gemma":[0.98380387,0.010570067,0.0034260948,0.0017986868,0.00023718693,0.00008788759,0.000006776366,0.000015732785,0.000053689662],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99712205,0.00023603294,0.00082701957,0.00030159982,0.00081286795,0.0007004151],"domain_scores_gemma":[0.99721664,0.0014302144,0.0002726236,0.000076115284,0.00044858086,0.0005558222],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0015726433,0.00018964913,0.00054784026,0.0005540692,0.00006888967,0.000060843504,0.00020943963,0.00015042738,0.00015411878],"category_scores_gemma":[0.016288316,0.00015099435,0.00006742253,0.0010965948,0.00016414048,0.00036339718,0.00007684055,0.00079056615,0.000002790668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064103985,0.0009803555,0.38116243,0.0006704879,0.00039508106,0.0031605922,0.02097951,0.044590697,0.046223756,0.00053120055,0.00583995,0.4890555],"study_design_scores_gemma":[0.022334365,0.0058280877,0.5422568,0.005532203,0.0001388552,0.00019801552,0.016115885,0.3689941,0.0033056645,0.0030840952,0.031139279,0.0010726976],"about_ca_topic_score_codex":0.0017125114,"about_ca_topic_score_gemma":0.0016257064,"teacher_disagreement_score":0.4879828,"about_ca_system_score_codex":0.0027719268,"about_ca_system_score_gemma":0.004393459,"threshold_uncertainty_score":0.9919979},"labels":[],"label_agreement":null},{"id":"W4388495465","doi":"10.1136/ijgc-2023-igcs.14","title":"PO014/#364  Laparoscopic cytoreduction after neoadjuvant chemotherapy (LANCE): feasibility phase of a randomized trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Surgery; Laparotomy; Stage (stratigraphy); Laparoscopic surgery; Neoadjuvant therapy; Laparoscopy; Cancer; Internal medicine; Breast cancer","score_opus":0.04728695400374413,"score_gpt":0.4086763127666668,"score_spread":0.3613893587629227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843342,0.0008466101,0.00005299979,0.010616573,0.0031317566,0.0007511198,0.00004869524,0.000019998228,0.00019804954],"genre_scores_gemma":[0.99486065,0.0025237286,0.00026827247,0.00063694915,0.0012623613,0.00018775064,0.000011989509,0.000011747401,0.00023652773],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979837,0.00012187048,0.000870085,0.00019910885,0.00065547694,0.00016973914],"domain_scores_gemma":[0.9981709,0.00033877784,0.00060358667,0.00012512688,0.0006402894,0.00012132826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075875974,0.00014876778,0.00093191187,0.00018204552,0.000020824464,0.000021469765,0.00015252986,0.00010327789,0.0025589392],"category_scores_gemma":[0.00057434815,0.000094311334,0.00055322546,0.0001738834,0.00015880122,0.000098861805,0.000028827935,0.00019401753,0.000011760715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9461084,0.0024767576,0.019822773,0.000025817299,0.0014776238,0.0003401583,0.00020537933,0.00005958217,0.001299624,0.00012711994,0.002563048,0.025493717],"study_design_scores_gemma":[0.8976821,0.0024404123,0.09225177,0.00019352564,0.0003170843,0.000048426176,0.000038505623,0.00010765876,0.0031224876,0.0010381893,0.0026601972,0.00009968524],"about_ca_topic_score_codex":0.00004366772,"about_ca_topic_score_gemma":0.000013872603,"teacher_disagreement_score":0.072429,"about_ca_system_score_codex":0.0005106233,"about_ca_system_score_gemma":0.000305641,"threshold_uncertainty_score":0.9983529},"labels":[],"label_agreement":null},{"id":"W4388495918","doi":"10.1136/ijgc-2023-igcs.437","title":"EP390/#403  Baseline compliance with enhanced recovery after surgery (ERAS) in gynaecologic oncology in low middle income countries (LMIC), the South African experience","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Perioperative; Psychological intervention; Informed consent; Emergency medicine; Surgery; Nursing; Alternative medicine","score_opus":0.043209958838388754,"score_gpt":0.3228101802592061,"score_spread":0.27960022142081736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990055,0.00050803524,0.00025951216,0.0053687925,0.0028652784,0.00032171735,0.000039204522,0.000034902278,0.00054753467],"genre_scores_gemma":[0.994067,0.0016101347,0.00025331514,0.002786573,0.00039896043,0.00032827185,0.000008313995,0.000024692057,0.00052271824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656034,0.0003510582,0.0012954014,0.00040937585,0.00082100113,0.0005628219],"domain_scores_gemma":[0.9934692,0.004718098,0.00077059364,0.0002255791,0.0006637598,0.00015276873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017294282,0.00029003096,0.00089695805,0.0006771277,0.000050322757,0.000045498375,0.0004905898,0.00022224241,0.0023688786],"category_scores_gemma":[0.002208931,0.00017783913,0.00024484418,0.00090351765,0.00040419857,0.0003552558,0.00015248895,0.00084183464,0.000051976232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013999067,0.0006291347,0.95739114,0.00012706545,0.00026468365,0.007021434,0.002362464,0.006174121,0.00070113584,0.00001785772,0.0006765383,0.010635383],"study_design_scores_gemma":[0.0018096548,0.00068229245,0.9902867,0.0012562003,0.000025704103,0.00016001349,0.00070991874,0.0002744625,0.0011691153,0.00017984267,0.0031793409,0.00026673646],"about_ca_topic_score_codex":0.00005305587,"about_ca_topic_score_gemma":0.0012274245,"teacher_disagreement_score":0.032895602,"about_ca_system_score_codex":0.0015426385,"about_ca_system_score_gemma":0.0008876823,"threshold_uncertainty_score":0.9985431},"labels":[],"label_agreement":null},{"id":"W4388498274","doi":"10.1136/ijgc-2023-igcs.413","title":"EP358/#615  Methylation profiling identifies two distinct clusters of small cell carcinoma of the ovary hypercalcemic type (SCCOHT)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Alberta; McGill University Health Centre","funders":"Ajou University","keywords":"Biology; Malignancy; DNA methylation; Ovarian carcinoma; Oncology; Breakpoint; Internal medicine; Ovarian cancer; Medicine; Cancer; Genetics; Chromosomal translocation; Gene","score_opus":0.030803691309683884,"score_gpt":0.311248810703695,"score_spread":0.28044511939401107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388498274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968927,0.00078911165,0.00034857346,0.0002434167,0.0013060085,0.00007644622,0.000025216457,0.0000034784578,0.00031504125],"genre_scores_gemma":[0.9987944,0.00022458688,0.0003213941,0.00009208379,0.00028205808,0.0000042471015,0.000015192489,0.000008765472,0.00025726663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896574,0.00007315537,0.00043992343,0.00012435872,0.000290565,0.00010625898],"domain_scores_gemma":[0.99871886,0.000084737934,0.00045099398,0.000110100205,0.0006038572,0.000031432424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032560236,0.0000879836,0.000161958,0.000056617726,0.000028956309,0.000010097983,0.0003875048,0.000081568935,0.00006647361],"category_scores_gemma":[0.00029620406,0.000058196954,0.00017858211,0.00012429341,0.0000845688,0.0000064977103,0.00014662088,0.00012600534,0.0000014822367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034950417,0.00007035173,0.06531392,0.000039086884,0.00013922634,0.0000075413504,0.000089421104,0.017248554,0.9124382,0.00002410738,0.0007359959,0.0035440472],"study_design_scores_gemma":[0.0013317234,0.0003639238,0.14845115,0.00008089164,0.000085469976,0.000025210495,0.00019325431,0.0037561972,0.8442734,0.0005553835,0.00073340966,0.00014997649],"about_ca_topic_score_codex":0.00005634096,"about_ca_topic_score_gemma":0.000053642692,"teacher_disagreement_score":0.08313722,"about_ca_system_score_codex":0.000062805084,"about_ca_system_score_gemma":0.00019215066,"threshold_uncertainty_score":0.23732029},"labels":[],"label_agreement":null},{"id":"W4389058158","doi":"10.1136/ijgc-2023-004788","title":"Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; St. John’s Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; Memorial University of Newfoundland","funders":"","keywords":"Hyperthermic intraperitoneal chemotherapy; Medicine; Cytoreductive surgery; Gynecologic oncology; Ovarian cancer; Intensive care medicine; Cancer; General surgery; Oncology; Internal medicine","score_opus":0.18243995402321764,"score_gpt":0.48576634239077343,"score_spread":0.30332638836755577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389058158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011469287,0.97229046,0.000011394645,0.0066460073,0.005948851,0.0016601398,0.00009951967,0.00015117395,0.0017231767],"genre_scores_gemma":[0.001942887,0.9902639,0.0016361135,0.0031216647,0.0019427536,0.00053697673,0.00004193341,0.00007597481,0.00043781963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961931,0.00017516846,0.0016284578,0.00047322008,0.0007751405,0.00075490604],"domain_scores_gemma":[0.99665546,0.0006296711,0.0011149168,0.00017751147,0.0008769111,0.0005455414],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047783167,0.0005624575,0.0024229302,0.00068401475,0.00013331493,0.00010496382,0.0010573757,0.0008588969,0.0023003442],"category_scores_gemma":[0.00058127654,0.00036976094,0.0009162467,0.00053521275,0.00034495498,0.0001342657,0.00012480018,0.0012390813,0.00013649678],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001241144,0.0002374833,0.00011298216,0.00079285837,0.0009580482,0.005671653,0.00021687179,0.0000014133973,0.00001039096,0.0003512098,0.0008596376,0.99066335],"study_design_scores_gemma":[0.00081734953,0.0012868971,0.00069999177,0.004969204,0.0003708322,0.0033365777,0.00018061731,0.000008145753,0.000011826808,0.0001253404,0.98779553,0.0003976795],"about_ca_topic_score_codex":0.0022613825,"about_ca_topic_score_gemma":0.0064464654,"teacher_disagreement_score":0.99026567,"about_ca_system_score_codex":0.00432227,"about_ca_system_score_gemma":0.0074565806,"threshold_uncertainty_score":0.9998754},"labels":[],"label_agreement":null},{"id":"W4389485521","doi":"10.1136/ijgc-2023-005032","title":"Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Lymph; Oncology; Value (mathematics); Internal medicine; Cancer; Gynecology; Pathology; Statistics","score_opus":0.04151529652794401,"score_gpt":0.36340712051137025,"score_spread":0.32189182398342625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389485521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379027,0.00023603383,0.000057582212,0.0007020805,0.0034701612,0.00047035905,0.0011477249,0.00002450105,0.00010130294],"genre_scores_gemma":[0.9971663,0.0011500265,0.00030512703,0.00022560298,0.00089332554,0.000078838486,0.000114616734,0.000016536853,0.000049621543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996256,0.0002582116,0.0015449179,0.0004123678,0.0012349444,0.0002935891],"domain_scores_gemma":[0.99661857,0.0014141343,0.0008814922,0.00013766308,0.0007622243,0.00018593464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008983514,0.00024833914,0.0007270721,0.0011494937,0.000036654328,0.000038748232,0.00054852426,0.00012748594,0.0007497126],"category_scores_gemma":[0.0036896744,0.00017710401,0.00024034349,0.0010989561,0.00010940451,0.0002959784,0.00014199666,0.00046833995,0.000015054192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011591102,0.0043183994,0.95666915,0.000010734539,0.0007285904,0.0017886757,0.0002879326,0.015904086,0.0014710614,0.000019979563,0.000020713767,0.0071895844],"study_design_scores_gemma":[0.03997891,0.00057955575,0.9475663,0.00034175816,0.00014090522,0.000017048646,0.00020021369,0.01002619,0.0007560661,0.00016468718,0.000080181984,0.00014820973],"about_ca_topic_score_codex":0.0051412927,"about_ca_topic_score_gemma":0.00067679014,"teacher_disagreement_score":0.02838781,"about_ca_system_score_codex":0.0011486193,"about_ca_system_score_gemma":0.00057017064,"threshold_uncertainty_score":0.82088274},"labels":[],"label_agreement":null},{"id":"W4389730142","doi":"10.1136/ijgc-2023-004970","title":"Predictors and outcomes of same day discharge after minimally invasive hysterectomy in gynecologic oncology within the National Surgical Quality Improvement Program database","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Gynecologic oncology; Hysterectomy; General surgery; Oncology; Surgery","score_opus":0.047436673744768704,"score_gpt":0.3996173185232197,"score_spread":0.352180644778451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389730142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990274,0.00012850393,0.0000015379601,0.008033721,0.0006461231,0.0004838373,0.0001781035,0.000015908528,0.00023826801],"genre_scores_gemma":[0.997895,0.00034266707,0.00035485852,0.00079235696,0.00015713314,0.00022791566,0.000032345324,0.0000085557385,0.00018918164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977458,0.00018264895,0.00090178894,0.0002171023,0.000754231,0.00019841021],"domain_scores_gemma":[0.99724185,0.0014995021,0.0005729517,0.00008103467,0.00049025606,0.00011441856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001149454,0.00016450472,0.0005134156,0.00019550584,0.000027093667,0.000022523756,0.00023123669,0.00010658213,0.00048313453],"category_scores_gemma":[0.0010766739,0.00008586774,0.0001559986,0.00017125225,0.00020164005,0.00013590876,0.00018485736,0.00029886575,0.0000047312483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010483168,0.001174839,0.9862464,0.000028581106,0.0007170223,0.00076168793,0.00036719153,0.000019741541,0.0008749007,0.00024506787,0.00020840926,0.00830785],"study_design_scores_gemma":[0.0042033214,0.0019805422,0.99019396,0.00006605705,0.00006758203,0.0000789772,0.00016086505,0.000060168095,0.00035380342,0.0002654623,0.0024853537,0.0000838854],"about_ca_topic_score_codex":0.00006868114,"about_ca_topic_score_gemma":0.0005241331,"teacher_disagreement_score":0.008223965,"about_ca_system_score_codex":0.00044207607,"about_ca_system_score_gemma":0.00036002637,"threshold_uncertainty_score":0.52899843},"labels":[],"label_agreement":null},{"id":"W4389954605","doi":"10.1136/ijgc-2023-005109","title":"Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilation","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Gynecologic oncology; Oncology; Internal medicine; Family medicine","score_opus":0.06874968603770203,"score_gpt":0.385044084649317,"score_spread":0.31629439861161496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389954605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509721,0.00018657862,0.000010915985,0.03701351,0.004772629,0.0002462469,0.000092393784,0.000033558514,0.0066720652],"genre_scores_gemma":[0.99341977,0.0011023661,0.0001337831,0.0037174993,0.001172321,0.00003109979,0.00007048522,0.000014888478,0.0003378038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979164,0.0003880208,0.0006374228,0.00026673885,0.0005677755,0.0002236566],"domain_scores_gemma":[0.9976272,0.0013286788,0.0003975675,0.0001475139,0.0003494171,0.00014960793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006597111,0.00016565148,0.0003954013,0.0001452176,0.0000642271,0.000042588075,0.00039775806,0.00012662531,0.0038687554],"category_scores_gemma":[0.00037795695,0.00009068524,0.00016099989,0.00019038533,0.00012596736,0.000106677784,0.00007756811,0.00043823145,0.00011970243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005209342,0.0052841324,0.7593012,0.000009654792,0.0013461593,0.013466017,0.0015215636,0.003985672,0.00113352,0.006922333,0.06062387,0.14119655],"study_design_scores_gemma":[0.003529264,0.0020827132,0.8828381,0.00006988983,0.00006443413,0.000027337292,0.00015569337,0.00026730436,0.00022564396,0.0006950308,0.10995251,0.000092099915],"about_ca_topic_score_codex":0.00009177934,"about_ca_topic_score_gemma":0.0005716629,"teacher_disagreement_score":0.14110446,"about_ca_system_score_codex":0.0011350355,"about_ca_system_score_gemma":0.0002051052,"threshold_uncertainty_score":0.9970418},"labels":[],"label_agreement":null},{"id":"W4390101910","doi":"10.1136/ijgc-2023-004864","title":"Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review","year":2023,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health","funders":"","keywords":"Medicine; Classifier (UML); Oncology; Cohort; Cohort study; Gynecology; Endometrial cancer; Internal medicine; Artificial intelligence; Cancer","score_opus":0.15018937893617215,"score_gpt":0.44985663913035717,"score_spread":0.299667260194185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390101910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020017712,0.99081,0.000006337516,0.00012710255,0.0026012945,0.0040489403,0.0002984284,0.000021628848,0.0000845177],"genre_scores_gemma":[0.0049144295,0.992806,0.000054483775,0.00031082728,0.0010053354,0.00061009714,0.00003770083,0.000040279447,0.00022082769],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99341524,0.00064776605,0.00377242,0.0004411113,0.0014566106,0.00026688463],"domain_scores_gemma":[0.9894854,0.0049158228,0.0038888683,0.00026337994,0.0011660977,0.00028045793],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021514695,0.00047336033,0.007204504,0.0005984331,0.000033660097,0.000035781577,0.00056929595,0.0003556086,0.00070451375],"category_scores_gemma":[0.017804785,0.00025996138,0.0012523101,0.0007205597,0.00015949743,0.0000743674,0.00023779026,0.0008348095,0.000021892047],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012895552,0.002199441,0.05174231,0.6027262,0.011848028,0.0038945312,0.00004049388,2.6125505e-7,7.302722e-7,0.000018285707,0.00042523237,0.32581493],"study_design_scores_gemma":[0.010529312,0.0077752746,0.03599373,0.8565435,0.04575194,0.0011533508,0.00007518766,0.0000051574348,7.724547e-7,0.000042704174,0.04148513,0.0006439857],"about_ca_topic_score_codex":0.00004194207,"about_ca_topic_score_gemma":0.000016521122,"teacher_disagreement_score":0.32517093,"about_ca_system_score_codex":0.0011222984,"about_ca_system_score_gemma":0.00080884545,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W4392015605","doi":"10.1136/ijgc-2023-005151","title":"Consensus on surgical technique for sentinel lymph node dissection in cervical cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Cervical cancer; Dissection (medical); Sentinel lymph node; General surgery; Lymph node; Surgery; Cancer; Internal medicine; Breast cancer","score_opus":0.03883426355820433,"score_gpt":0.38353823982780266,"score_spread":0.3447039762695983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392015605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606697,0.003330882,0.00040913833,0.028230393,0.0041718385,0.0005252523,0.00011689823,0.00004644465,0.002499476],"genre_scores_gemma":[0.9953144,0.0008863272,0.00030160227,0.0010535654,0.00166302,0.00027516478,0.000010335189,0.0000188379,0.0004767042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834687,0.000052893163,0.00058354874,0.000251421,0.00053980347,0.00022548698],"domain_scores_gemma":[0.99831265,0.00093379745,0.00013506204,0.00006466604,0.00040181004,0.00015200464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033024285,0.00016623945,0.00040034333,0.00034852934,0.000026344142,0.00004250661,0.00015598071,0.0001773683,0.0018901727],"category_scores_gemma":[0.00034226725,0.00010746236,0.00033133358,0.00029758463,0.00006253909,0.0000546531,0.000032767948,0.0003576166,0.000009346539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04113893,0.0046731215,0.7094572,0.00062027364,0.0031718055,0.017216545,0.00017902916,0.001985469,0.017843165,0.0077956333,0.007232083,0.18868673],"study_design_scores_gemma":[0.026034942,0.0021091013,0.84624857,0.0031590506,0.00057629985,0.0027112393,0.000093174625,0.0020302022,0.018073905,0.006300082,0.092030235,0.0006332334],"about_ca_topic_score_codex":0.00010855439,"about_ca_topic_score_gemma":0.00003034061,"teacher_disagreement_score":0.18805349,"about_ca_system_score_codex":0.0012312098,"about_ca_system_score_gemma":0.0003161867,"threshold_uncertainty_score":0.99902225},"labels":[],"label_agreement":null},{"id":"W4392031017","doi":"10.1136/ijgc-2024-005400","title":"Mirvetuximab soravtansine: an oasis in the desert?","year":2024,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Medicine; Desert (philosophy); Ovarian cancer; Oncology; Internal medicine; Gynecology; Traditional medicine; Cancer; Epistemology","score_opus":0.028342962206979457,"score_gpt":0.3995215446298507,"score_spread":0.3711785824228712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392031017","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019023743,0.00809323,0.00001160085,0.025279542,0.9451665,0.0003476184,0.0003304961,0.000018552762,0.0017287085],"genre_scores_gemma":[0.16775046,0.008764856,0.0003849466,0.0020188545,0.82015944,0.00011252264,0.00014227173,0.00004859759,0.0006180396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969312,0.00013400437,0.00072228425,0.00030322117,0.0016853695,0.0002239242],"domain_scores_gemma":[0.99721307,0.0011072973,0.00037558685,0.00019117727,0.0009880536,0.00012483308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007288134,0.00026631085,0.000607997,0.00027720258,0.000026151585,0.00015293594,0.00067890825,0.0004995314,0.0012842017],"category_scores_gemma":[0.00091307494,0.00014154223,0.00037353334,0.00018377892,0.000079974576,0.00013276942,0.00006366642,0.0014852001,0.000027698616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006260259,0.001054545,0.0013945963,0.000038305952,0.0007686681,0.005410205,0.00019158174,0.000021531621,0.00000810839,0.00013423472,0.9634511,0.026901098],"study_design_scores_gemma":[0.002546698,0.0014672494,0.017004702,0.000672511,0.000511185,0.00014976313,0.00008145694,0.00002081449,0.000022246086,0.0010112302,0.9763553,0.00015684612],"about_ca_topic_score_codex":0.00028907813,"about_ca_topic_score_gemma":0.00070578454,"teacher_disagreement_score":0.14872672,"about_ca_system_score_codex":0.0013999799,"about_ca_system_score_gemma":0.001225752,"threshold_uncertainty_score":0.9996288},"labels":[],"label_agreement":null},{"id":"W4392031846","doi":"10.1136/ijgc-2023-005149","title":"Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Vancouver Coastal Health Research Institute","keywords":"Medicine; Stage (stratigraphy); Endometrial cancer; Gynecology; Oncology; Cancer; Internal medicine; Urology","score_opus":0.05262037003215478,"score_gpt":0.3867086721685902,"score_spread":0.33408830213643537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392031846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98310137,0.013338195,0.000093837865,0.0013511793,0.0015955999,0.00025961842,0.0001321795,0.0000074257678,0.00012058223],"genre_scores_gemma":[0.9805313,0.01834709,0.00026568366,0.00015849715,0.0005414579,0.000031463307,0.0000050047242,0.000010530126,0.00010898402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982006,0.00008129012,0.00059579767,0.00027184922,0.0006708335,0.00017960618],"domain_scores_gemma":[0.99822545,0.0008746903,0.00029094433,0.00006276292,0.0003857838,0.0001603896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004725035,0.0001731012,0.0005435438,0.0006601085,0.000020077092,0.00005724306,0.0001528123,0.00010074455,0.0009731726],"category_scores_gemma":[0.000967508,0.000103286744,0.000087069355,0.00057704136,0.00012485904,0.00022174304,0.0000785794,0.0003956099,9.0006336e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005559702,0.0001905409,0.86315274,0.00013133198,0.0003500161,0.00023898891,0.00012895429,0.000023316969,0.0006207968,0.00012599652,0.0000366136,0.12944098],"study_design_scores_gemma":[0.014749954,0.003859964,0.9696985,0.0028533097,0.00022879189,0.00016075534,0.00011877019,0.00011716148,0.004271985,0.0003830979,0.0033477645,0.00020997474],"about_ca_topic_score_codex":0.0004969146,"about_ca_topic_score_gemma":0.0004266533,"teacher_disagreement_score":0.129231,"about_ca_system_score_codex":0.0003149196,"about_ca_system_score_gemma":0.00032197754,"threshold_uncertainty_score":0.9999401},"labels":[],"label_agreement":null},{"id":"W4392345767","doi":"10.1136/ijgc-2023-005166","title":"Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Meta-analysis; Chemotherapy; Incidence (geometry); Ovarian cancer; Oncology; Venous thromboembolism; Internal medicine; Cancer; Gynecology; Thrombosis","score_opus":0.04430907294159164,"score_gpt":0.3730797009938521,"score_spread":0.3287706280522605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392345767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000384078,0.99617535,0.000014695279,0.0012769707,0.0002756809,0.0017004161,0.000099213095,0.000007657792,0.000065961125],"genre_scores_gemma":[0.0062901247,0.99152005,0.00015384165,0.0014804278,0.0000834094,0.0003335674,0.000013663963,0.000034978297,0.00008993653],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962988,0.00021509193,0.0019181729,0.0003719098,0.000978608,0.00021742858],"domain_scores_gemma":[0.9964888,0.000289314,0.0020818892,0.00024521849,0.0007744549,0.00012030777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008799893,0.00042166255,0.009833871,0.00064564316,0.000020088406,0.00004663349,0.0004676877,0.00017598945,0.0014928725],"category_scores_gemma":[0.0002818381,0.00021319691,0.0014795555,0.0006633977,0.00008413375,0.0001134669,0.00013808625,0.00055494125,0.0000034215195],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052897973,0.0013058742,0.0006828348,0.50584,0.46231374,0.00032286465,0.00018908957,0.000035234076,8.287446e-8,0.00016339115,0.0006825715,0.028411398],"study_design_scores_gemma":[0.000544505,0.00048393366,0.010612501,0.12127005,0.8603901,0.00003241427,0.000010716524,0.0000030593553,2.1529101e-7,0.00005047094,0.006358667,0.00024335999],"about_ca_topic_score_codex":0.00019134174,"about_ca_topic_score_gemma":0.00018219737,"teacher_disagreement_score":0.39807636,"about_ca_system_score_codex":0.0006388308,"about_ca_system_score_gemma":0.00039075036,"threshold_uncertainty_score":0.9994199},"labels":[],"label_agreement":null},{"id":"W4392361970","doi":"10.1136/ijgc-2023-004593","title":"De-escalation of surgical radicality for non-fertility preserving management in patients with early-stage cervical cancer: a systematic review","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); General surgery; Gynecology; Fertility preservation; Fertility; Cancer; Internal medicine; Population","score_opus":0.04276829984920728,"score_gpt":0.39399386274232684,"score_spread":0.35122556289311957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392361970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025881792,0.9918625,0.000060969967,0.00050547963,0.00057454,0.0038508028,0.0003125505,0.000011509675,0.00023348426],"genre_scores_gemma":[0.008612953,0.9894084,0.00024646326,0.00019636168,0.00021267202,0.0009765475,0.00005874621,0.000034115463,0.0002537569],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955865,0.0002665166,0.0022222737,0.0003876664,0.001229083,0.00030796396],"domain_scores_gemma":[0.99666893,0.00077207177,0.0013262043,0.00022511235,0.00077894324,0.00022872012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010561575,0.0003873375,0.0032862462,0.00035359574,0.0000214296,0.000037379607,0.0005433214,0.00027796728,0.00076391245],"category_scores_gemma":[0.0004173269,0.00020887444,0.0010008091,0.0005364796,0.000078234545,0.000105680054,0.00015720609,0.00060780434,0.0000035982562],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023029998,0.0013440651,0.012602402,0.86801577,0.0050712023,0.00042113053,0.000025394058,0.000009979437,3.4955946e-8,0.00009469826,0.00024218747,0.109870136],"study_design_scores_gemma":[0.008763946,0.0018505297,0.049959872,0.85576314,0.01866437,0.00003706357,0.000008333605,0.0000585665,0.0000011306264,0.00016931267,0.064312294,0.0004114627],"about_ca_topic_score_codex":0.00010681489,"about_ca_topic_score_gemma":0.000033713928,"teacher_disagreement_score":0.10945868,"about_ca_system_score_codex":0.0022045306,"about_ca_system_score_gemma":0.00050098146,"threshold_uncertainty_score":0.8517652},"labels":[],"label_agreement":null},{"id":"W4392631648","doi":"10.1136/ijgc-2024-esgo.1115","title":"#88 Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: primary results of the phase 3 ENGOT-en9/LEAP-001 study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Lenvatinib; Pembrolizumab; Oncology; Endometrial cancer; Medicine; Internal medicine; Chemotherapy; Cancer; Immunotherapy","score_opus":0.08773621335716103,"score_gpt":0.43360179732535287,"score_spread":0.34586558396819184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664204,0.009708024,0.00004685531,0.009535316,0.011042681,0.0019743033,0.00063377514,0.000033809767,0.00060485344],"genre_scores_gemma":[0.9791918,0.015766213,0.00016381472,0.0009178687,0.002704993,0.00035727015,0.000031154046,0.000034016466,0.00083288987],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967607,0.00011040708,0.0011989406,0.00038867383,0.0012431745,0.0002980993],"domain_scores_gemma":[0.995107,0.0028319987,0.00069119147,0.0002065436,0.0009910725,0.00017217007],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005690008,0.0003016595,0.0008167697,0.00030032755,0.00008589248,0.000054094224,0.0005782004,0.00013732037,0.00217456],"category_scores_gemma":[0.0020036404,0.00015379647,0.00055496744,0.00065050024,0.00011651334,0.00016243142,0.00008187548,0.00047315483,0.0000039700635],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40041274,0.0042827865,0.00088278623,0.00006835154,0.0027688134,0.00016004068,0.0003534341,0.0002676909,0.00078463176,0.000050964383,0.0020199216,0.58794785],"study_design_scores_gemma":[0.57838076,0.07116122,0.017006591,0.0009211187,0.00085777254,0.000098176686,0.00024663642,0.00024008354,0.00882075,0.000462299,0.32136053,0.00044408988],"about_ca_topic_score_codex":0.00015878501,"about_ca_topic_score_gemma":0.00021820539,"teacher_disagreement_score":0.58750373,"about_ca_system_score_codex":0.0016663884,"about_ca_system_score_gemma":0.0011952642,"threshold_uncertainty_score":0.9987376},"labels":[],"label_agreement":null},{"id":"W4392631745","doi":"10.1136/ijgc-2024-esgo.875","title":"126 Select and treat at guy’s and St. Thomas’ hospital colposcopy unit","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Colposcopy; Medicine; Referral; Cytology; Cancer; Internal medicine; Cervical cancer; Pathology; Family medicine","score_opus":0.028814175360155014,"score_gpt":0.38776598602591933,"score_spread":0.3589518106657643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97070116,0.011175907,0.000034524823,0.010226007,0.00076191255,0.00013827936,0.00003607998,0.00001892605,0.006907191],"genre_scores_gemma":[0.9912319,0.004744354,0.00012000716,0.0006697607,0.0007386196,0.000017666132,0.0000054259754,0.000011878232,0.002460387],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987564,0.00003734799,0.00027727362,0.00018898059,0.0005575347,0.0001824643],"domain_scores_gemma":[0.9987826,0.00039418548,0.00006068785,0.000049461174,0.000473574,0.00023953336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023813435,0.00011691079,0.00025954537,0.00014406786,0.000047573434,0.000097977296,0.0001238472,0.00009621299,0.0088615585],"category_scores_gemma":[0.00024302852,0.0000753897,0.00009252926,0.00011430925,0.00015398256,0.00011621923,0.00012360203,0.00038163154,0.000009116214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006364713,0.00070780347,0.37238458,0.00043652594,0.0019816894,0.0065593715,0.0019752125,0.00001882007,0.0029708697,0.0030604126,0.08599037,0.51754963],"study_design_scores_gemma":[0.0038571903,0.0043247184,0.7872394,0.00020039032,0.00023533282,0.0011877806,0.0002974073,0.0007144805,0.0018229509,0.0017378001,0.19814429,0.00023828374],"about_ca_topic_score_codex":0.000031809122,"about_ca_topic_score_gemma":0.00007415692,"teacher_disagreement_score":0.51731133,"about_ca_system_score_codex":0.0004006322,"about_ca_system_score_gemma":0.00022394315,"threshold_uncertainty_score":0.99204445},"labels":[],"label_agreement":null},{"id":"W4392631795","doi":"10.1136/ijgc-2024-esgo.870","title":"4 Is the most common gynecological cancer has an awareness blind spot? An israeli preliminary study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Cervical cancer; Population; Family medicine; Gynecology; Endometrial cancer; Cancer; Demography; Environmental health; Internal medicine","score_opus":0.20753877667313175,"score_gpt":0.47840964001667474,"score_spread":0.270870863343543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95101166,0.0070472737,0.000036337235,0.035953965,0.005005439,0.0005697801,0.00009327044,0.00005488245,0.00022741513],"genre_scores_gemma":[0.9865997,0.0008273886,0.00009668357,0.009373652,0.0026283169,0.00012690332,0.000019521587,0.000028386994,0.00029945932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676996,0.00035316256,0.000859505,0.0004888375,0.001173882,0.0003546477],"domain_scores_gemma":[0.9970338,0.0010080748,0.00025519892,0.00030800223,0.00104103,0.00035393747],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010886914,0.00027178507,0.0005129825,0.00020227832,0.00023290346,0.00024098628,0.0008201206,0.00025064114,0.005196021],"category_scores_gemma":[0.0003494978,0.00015073743,0.00022991437,0.00029157184,0.00022838675,0.0003474841,0.00015312867,0.0010835204,0.000019833666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004201175,0.0028870497,0.66658086,0.000071741604,0.0011500992,0.0040746685,0.00451733,0.0007510394,0.00016450889,0.00024329998,0.008025336,0.30733293],"study_design_scores_gemma":[0.0023821644,0.010032138,0.9276135,0.00021007768,0.00033192735,0.0004912984,0.0048621045,0.002712737,0.0002364741,0.0011183135,0.04975643,0.0002528342],"about_ca_topic_score_codex":0.00089736946,"about_ca_topic_score_gemma":0.0015747534,"teacher_disagreement_score":0.3070801,"about_ca_system_score_codex":0.0006653594,"about_ca_system_score_gemma":0.0011069784,"threshold_uncertainty_score":0.99571335},"labels":[],"label_agreement":null},{"id":"W4392631817","doi":"10.1136/ijgc-2024-esgo.25","title":"462 Progression-free survival 2-progression-free survival 1 in patients with primary advanced/recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Chemotherapy; Endometrial cancer; Oncology; Progression-free survival; Medicine; Internal medicine; Overall survival; Cancer","score_opus":0.025821576770782763,"score_gpt":0.33671398861533974,"score_spread":0.31089241184455696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833255,0.0039280504,0.000053374028,0.007289179,0.0021001282,0.0024782221,0.00024929145,0.000054113436,0.0005221853],"genre_scores_gemma":[0.99402577,0.0018381397,0.00087888737,0.00094973826,0.0014200498,0.00062790513,0.0001159144,0.00007403802,0.000069549315],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9936744,0.00036031808,0.0011657985,0.00068566075,0.0034710194,0.00064279017],"domain_scores_gemma":[0.9961439,0.001584128,0.00069606,0.00043124694,0.0008692929,0.0002753894],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009465977,0.0006169513,0.0014198927,0.00068792613,0.000087760374,0.00017493768,0.0011272973,0.00022352244,0.0011759272],"category_scores_gemma":[0.0004255019,0.00028652776,0.00027590684,0.0016341304,0.00029734275,0.00039515775,0.00012416804,0.0011407471,0.000003020929],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.509709,0.0042427224,0.33909318,0.00008210897,0.0015666496,0.0011072451,0.00049091614,0.00027392904,0.000049327176,0.000042433207,0.00043533067,0.14290717],"study_design_scores_gemma":[0.4102153,0.01766676,0.5636642,0.0020656055,0.0003075202,0.00005044213,0.00019273997,0.00008620087,0.00024157469,0.00016802106,0.004829125,0.00051252526],"about_ca_topic_score_codex":0.00031514728,"about_ca_topic_score_gemma":0.0013485143,"teacher_disagreement_score":0.22457102,"about_ca_system_score_codex":0.002433743,"about_ca_system_score_gemma":0.0011191824,"threshold_uncertainty_score":0.9999587},"labels":[],"label_agreement":null},{"id":"W4392631875","doi":"10.1136/ijgc-2024-esgo.651","title":"486 Platelet count as a prognostic marker in advanced stage and relapsed ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Platelet; Surgery; Stage (stratigraphy); Cancer; Internal medicine; Gastroenterology; Urology","score_opus":0.015518224082253017,"score_gpt":0.33400611378864953,"score_spread":0.3184878897063965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815938,0.0076947357,0.000030723004,0.0069045397,0.0019977046,0.00035021704,0.000059887647,0.00003144748,0.0013369644],"genre_scores_gemma":[0.9944592,0.0024838585,0.0005661117,0.0013724797,0.00035351794,0.00011982479,0.000005346043,0.000021627935,0.00061800703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819833,0.000068703135,0.00059178215,0.00026089378,0.00064535445,0.00023491429],"domain_scores_gemma":[0.9986992,0.0004298027,0.00019071315,0.00007827646,0.00041386235,0.00018817162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004819546,0.00017547091,0.00032599666,0.0002905933,0.000027412343,0.000085690015,0.00019417418,0.00014587078,0.0044258987],"category_scores_gemma":[0.0007991435,0.0001284052,0.00013145864,0.00018077831,0.00012260048,0.0002364971,0.00007868563,0.0004734749,0.000013935202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00669724,0.00041252084,0.83089966,0.00028986204,0.001409068,0.01811494,0.00035714536,0.00020393769,0.0035762554,0.0014664723,0.0030107624,0.13356212],"study_design_scores_gemma":[0.003919479,0.00049243594,0.9246977,0.0015990486,0.00015343205,0.00047246614,0.00012788625,0.0013247292,0.00066679704,0.0009722605,0.06534781,0.0002259778],"about_ca_topic_score_codex":0.00004757842,"about_ca_topic_score_gemma":0.00007577664,"teacher_disagreement_score":0.13333614,"about_ca_system_score_codex":0.0008018974,"about_ca_system_score_gemma":0.00065262837,"threshold_uncertainty_score":0.9964842},"labels":[],"label_agreement":null},{"id":"W4392631890","doi":"10.1136/ijgc-2024-esgo.584","title":"176 Rucaparib maintenance treatment in patients (Pts) with newly diagnosed ovarian cancer (OC): defining benefit according to disease risk subgroups within the phase 3 ATHENA-MONO study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Population; Placebo; Stage (stratigraphy); Chemotherapy; Ovarian cancer; Cancer; Surgery; Gynecology; Pathology","score_opus":0.02559736903672858,"score_gpt":0.3509724077453201,"score_spread":0.3253750387085915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854315,0.0012866323,0.00050713983,0.00621681,0.0020013351,0.0010303727,0.0002596865,0.00003433444,0.0001205287],"genre_scores_gemma":[0.995711,0.00068211765,0.00035104182,0.0018179824,0.00062265975,0.0006260117,0.000010766366,0.000039541705,0.00013885616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729204,0.00013987589,0.0008297257,0.00044374098,0.00094985,0.0003447582],"domain_scores_gemma":[0.99777126,0.00063344603,0.00046186993,0.00021534877,0.0005830934,0.00033497697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057205075,0.00031467873,0.00050042046,0.00030009728,0.00010837765,0.00015837348,0.00039613398,0.000070736336,0.00064384466],"category_scores_gemma":[0.00037676914,0.00017131554,0.00019947477,0.00040552067,0.000090831716,0.00026253937,0.000066773646,0.0005483154,0.000016696711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010097576,0.002652376,0.91021216,0.00001223818,0.0010097977,0.001582668,0.002532731,0.011170974,0.000058509097,0.0005598569,0.0004275779,0.05968352],"study_design_scores_gemma":[0.030120557,0.006756726,0.95187616,0.0013275318,0.0004952333,0.00003948314,0.0013814906,0.0014521236,0.000113053306,0.0007639481,0.0053202296,0.00035347656],"about_ca_topic_score_codex":0.0012737011,"about_ca_topic_score_gemma":0.0020098216,"teacher_disagreement_score":0.059330042,"about_ca_system_score_codex":0.0030687721,"about_ca_system_score_gemma":0.00069455843,"threshold_uncertainty_score":0.80247325},"labels":[],"label_agreement":null},{"id":"W4392631905","doi":"10.1136/ijgc-2024-esgo.637","title":"380 Real world clinical outcomes of niraparib first line maintenance therapy in patients with BRCA wildtype advanced ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Oncology; Internal medicine; Ovarian cancer; Single Center; Progression-free survival; Proportional hazards model; Chemotherapy; Retrospective cohort study; Cancer; Stage (stratigraphy); Cohort; Maintenance therapy; Biology","score_opus":0.04213907978529078,"score_gpt":0.3982500482550754,"score_spread":0.3561109684697846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982593,0.0013375342,0.00017972356,0.01119184,0.0032770932,0.00037047672,0.00010166534,0.000028258684,0.00092039787],"genre_scores_gemma":[0.9858838,0.0095074065,0.0007739793,0.0024168016,0.00059643434,0.00005854883,0.000011406698,0.00003100002,0.00072067033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971576,0.00008520638,0.0012729476,0.0003198724,0.00089285587,0.00027153126],"domain_scores_gemma":[0.99732715,0.0006584021,0.0005864594,0.000162825,0.0011090006,0.00015617997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051399076,0.00023443105,0.0007546406,0.00036556533,0.000026728334,0.000030863277,0.00034618014,0.00014001012,0.0023481313],"category_scores_gemma":[0.00022720991,0.00014488502,0.00029974463,0.00040832837,0.00022930559,0.00024482506,0.000042328906,0.00070172996,0.0000056916724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00703145,0.00075828953,0.9206885,0.00002217484,0.0008423535,0.00019102759,0.000089078094,0.0007801329,0.000054305423,0.00037804813,0.0014993744,0.067665234],"study_design_scores_gemma":[0.01121177,0.0019327049,0.96161747,0.00096921565,0.000054105403,0.000010125201,0.000014005888,0.00008378545,0.0001911254,0.00041905724,0.023334302,0.00016232037],"about_ca_topic_score_codex":0.00022892973,"about_ca_topic_score_gemma":0.0014645975,"teacher_disagreement_score":0.067502916,"about_ca_system_score_codex":0.00085610955,"about_ca_system_score_gemma":0.0006200287,"threshold_uncertainty_score":0.9985639},"labels":[],"label_agreement":null},{"id":"W4392631936","doi":"10.1136/ijgc-2024-esgo.1033","title":"122 CO2 laser therapy versus topical imiquimod for the treatment of vulvar high-grade intraepithelial lesions (HSIL), A retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Imiquimod; Vulvar intraepithelial neoplasia; Retrospective cohort study; Vulva; Vulvar cancer; Cohort; Dermatology; Surgery; Internal medicine","score_opus":0.07429996959295505,"score_gpt":0.4195441358284959,"score_spread":0.3452441662355409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827134,0.0035040327,0.0002711581,0.009067933,0.0029941024,0.0010229329,0.000108243585,0.000015581656,0.0003026288],"genre_scores_gemma":[0.9911546,0.0060127187,0.00009347534,0.0001999376,0.0020221886,0.00021263446,0.000005298546,0.00001377675,0.00028537467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822795,0.000072096955,0.00044628733,0.00021541529,0.00084551447,0.00019270302],"domain_scores_gemma":[0.9972984,0.0014761563,0.00011208585,0.00012566557,0.0008683189,0.00011933705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003592877,0.00014235031,0.00042882623,0.00011092019,0.0000638829,0.000047691294,0.00027349478,0.0000896256,0.004737208],"category_scores_gemma":[0.00030018206,0.00007083605,0.0003439332,0.00013994721,0.0001485262,0.000060523245,0.000033798362,0.00030102456,0.000004371317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04374558,0.013459143,0.48348546,0.000043328357,0.010995999,0.0008570718,0.0015554501,0.0003098433,0.0007119972,0.0043590534,0.0050091594,0.4354679],"study_design_scores_gemma":[0.01162754,0.015785415,0.95410854,0.000022869097,0.00029937614,0.000021423737,0.00019731154,0.00027434996,0.0014527265,0.0007007299,0.015426628,0.000083101986],"about_ca_topic_score_codex":0.00027378433,"about_ca_topic_score_gemma":0.00030562107,"teacher_disagreement_score":0.47062308,"about_ca_system_score_codex":0.0010922313,"about_ca_system_score_gemma":0.0003646392,"threshold_uncertainty_score":0.9961726},"labels":[],"label_agreement":null},{"id":"W4392631937","doi":"10.1136/ijgc-2024-esgo.368","title":"680 Is there a way to optimize the performance of preoperative diagnosis of patients with endometrial cancer on imaging? The artificial intelligence response","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Endometrial cancer; Sørensen–Dice coefficient; Segmentation; Artificial intelligence; Computer science; Pipeline (software); Cervical cancer; Stage (stratigraphy); Medicine; Radiology; Cancer; Image segmentation; Internal medicine","score_opus":0.02113890227282735,"score_gpt":0.3416441317647595,"score_spread":0.32050522949193216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96554935,0.00096573454,0.000696501,0.031300794,0.0010754116,0.00027650272,0.000038715905,0.0000050650133,0.00009190528],"genre_scores_gemma":[0.99624515,0.00073009165,0.00035229526,0.0021403125,0.00039583657,0.000054794175,9.734376e-7,0.000011479831,0.000069060545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825853,0.00014197605,0.00049899734,0.00014835323,0.0008175592,0.0001345914],"domain_scores_gemma":[0.996743,0.0020815816,0.00026069113,0.0001048462,0.00073509576,0.00007477597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008503003,0.000120228106,0.00027310284,0.00016480742,0.00004982451,0.000043033044,0.00039415748,0.000035064237,0.0013758152],"category_scores_gemma":[0.001741386,0.0000497874,0.00013761081,0.00028084387,0.00023825139,0.00007925888,0.00006225476,0.0005186207,0.000003216732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029250082,0.00071373954,0.5184125,0.00005703553,0.0012524733,0.00012179185,0.0038219828,0.03186228,0.000575809,0.0006234134,0.002869905,0.410439],"study_design_scores_gemma":[0.0017166731,0.0050750254,0.930163,0.0018239109,0.00034031278,0.000035666573,0.0004566191,0.03239944,0.015803866,0.0002311238,0.011745643,0.00020867321],"about_ca_topic_score_codex":0.000047204507,"about_ca_topic_score_gemma":0.000006442188,"teacher_disagreement_score":0.41175058,"about_ca_system_score_codex":0.00021150452,"about_ca_system_score_gemma":0.00021447266,"threshold_uncertainty_score":0.99953705},"labels":[],"label_agreement":null},{"id":"W4392631941","doi":"10.1136/ijgc-2024-esgo.130","title":"85 Lymphovascular invasion in cervical squamous cell carcinoma is associated with mitogen-activated protein kinase (MAP kinase) pathway alterations","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Lymphovascular invasion; Medicine; Pathology; MAPK/ERK pathway; Protein kinase A; Internal medicine; Oncology; Cancer; Cancer research; Kinase; Metastasis; Biology; Genetics","score_opus":0.03779154242643258,"score_gpt":0.325780249370875,"score_spread":0.28798870694444245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854148,0.0028303748,0.00013290883,0.009356676,0.0010133064,0.0005695125,0.00008242183,0.000037710306,0.0005622575],"genre_scores_gemma":[0.9969756,0.000097589334,0.0001992383,0.0009998253,0.00052793766,0.0001315668,0.000034583834,0.000040428313,0.0009932162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966437,0.00023754929,0.00072792184,0.0004025851,0.0015852305,0.00040296733],"domain_scores_gemma":[0.99780285,0.00040090698,0.00021163211,0.00018043297,0.0011106269,0.00029357467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066613057,0.00024936296,0.0004682132,0.00046493477,0.000061665065,0.00014362717,0.00039662496,0.0002512678,0.0040893424],"category_scores_gemma":[0.00069573725,0.00017287166,0.0002591482,0.00052154774,0.00015109088,0.00023275072,0.00010753319,0.00093762006,0.000040055435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008970362,0.0063566887,0.20744282,0.0010380305,0.0018526978,0.07179301,0.0036353713,0.001891184,0.62103707,0.0009173895,0.022190837,0.05287457],"study_design_scores_gemma":[0.021893252,0.0075450093,0.28577468,0.004175258,0.0003296165,0.00084305555,0.00043733575,0.00611613,0.59788567,0.0012021789,0.072724305,0.0010735386],"about_ca_topic_score_codex":0.00037688419,"about_ca_topic_score_gemma":0.000393583,"teacher_disagreement_score":0.078331865,"about_ca_system_score_codex":0.002934279,"about_ca_system_score_gemma":0.0019406085,"threshold_uncertainty_score":0.99682105},"labels":[],"label_agreement":null},{"id":"W4392631993","doi":"10.1136/ijgc-2024-esgo.34","title":"639 Management of immune-related adverse events in patients with primary advanced or recurrent endometrial cancer: dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Chemotherapy; Oncology; Medicine; Endometrial cancer; Adverse effect; Internal medicine; Cancer; Immune system; Immunology","score_opus":0.018033520643407783,"score_gpt":0.3126615419709289,"score_spread":0.2946280213275211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392631993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035627,0.0031850163,0.00003684134,0.0025785044,0.0017670459,0.0018077232,0.000055553184,0.000015715435,0.00019730862],"genre_scores_gemma":[0.99154496,0.0067689354,0.00038096946,0.00073521107,0.00020697164,0.00017529332,0.000036888956,0.00003058218,0.00012015867],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99659336,0.00015359781,0.0012969908,0.00032481938,0.0013245014,0.00030672754],"domain_scores_gemma":[0.99832153,0.00037283121,0.00071085076,0.00018285311,0.00034290206,0.00006904423],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008046577,0.00030184496,0.00078056735,0.00046493483,0.00003206552,0.000019787498,0.00051421585,0.00012434549,0.00124107],"category_scores_gemma":[0.000043836862,0.00015611779,0.0002760384,0.0008547921,0.00014874383,0.00022146721,0.000039087772,0.00058177335,0.0000013700763],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8073884,0.0024633312,0.041921142,0.00014293886,0.0031091063,0.00044521995,0.0012421786,0.000678674,0.00033851317,0.000025077738,0.0001989654,0.14204645],"study_design_scores_gemma":[0.32079923,0.007526664,0.6623093,0.0025414608,0.00019432207,0.0000389351,0.0004016024,0.00011203317,0.0002769209,0.000047313635,0.005469777,0.0002824703],"about_ca_topic_score_codex":0.00016728797,"about_ca_topic_score_gemma":0.00021681089,"teacher_disagreement_score":0.62038815,"about_ca_system_score_codex":0.0019403938,"about_ca_system_score_gemma":0.0005811341,"threshold_uncertainty_score":0.99967194},"labels":[],"label_agreement":null},{"id":"W4392632002","doi":"10.1136/ijgc-2024-esgo.654","title":"489 Lymphocyte to monocyte ratio as a prognostic factor in ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Perioperative; Lymphocyte; Stage (stratigraphy); Lymph node; Internal medicine; Monocyte; Immune system; Gastroenterology; Oncology; Cancer; Surgery; Immunology; Biology","score_opus":0.02901840494340804,"score_gpt":0.3672461501868094,"score_spread":0.3382277452434014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781861,0.0042098784,0.00031726153,0.012282846,0.0035001172,0.0004599732,0.000057736048,0.000037709615,0.0009484078],"genre_scores_gemma":[0.99418676,0.0007238588,0.0006742845,0.0028521367,0.00093933055,0.00019158547,0.0000036555682,0.000023276221,0.00040510978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799037,0.00006794281,0.0006622846,0.00026916477,0.0007441584,0.00026607435],"domain_scores_gemma":[0.9985673,0.00031709185,0.00015531128,0.00009544382,0.00057200855,0.00029284562],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028217095,0.00018739815,0.00033708935,0.00046282416,0.000026377847,0.000116796575,0.00033603254,0.00013511728,0.0056781378],"category_scores_gemma":[0.00094682747,0.00013818039,0.00022056521,0.00031026674,0.00005828059,0.00021277765,0.00009771122,0.0003206379,0.00009423112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005331976,0.000606878,0.7660164,0.00018432163,0.0020474198,0.013813337,0.0009829227,0.00081990083,0.017892586,0.0012920998,0.0073176306,0.1836945],"study_design_scores_gemma":[0.0026472425,0.0005840556,0.94041586,0.0014537912,0.0001865493,0.0003612777,0.0000783934,0.0012229919,0.0067231115,0.0007216177,0.04532813,0.00027697696],"about_ca_topic_score_codex":0.00009924997,"about_ca_topic_score_gemma":0.00010553261,"teacher_disagreement_score":0.18341751,"about_ca_system_score_codex":0.0020971328,"about_ca_system_score_gemma":0.0014186085,"threshold_uncertainty_score":0.9952308},"labels":[],"label_agreement":null},{"id":"W4392632047","doi":"10.1136/ijgc-2024-esgo.793","title":"1131 Leveraging electronic medical records and machine learning for early detection of ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Ovarian cancer; Medicine; Cohort; Complete blood count; Cancer; Population; Cancer registry; Internal medicine; Retrospective cohort study; Absolute neutrophil count; Oncology; Neutropenia","score_opus":0.02203414509357845,"score_gpt":0.32452478452648276,"score_spread":0.30249063943290433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809683,0.0086926585,0.0041862866,0.0041679107,0.0016433088,0.00016843798,0.000014198931,0.000024843424,0.0001340856],"genre_scores_gemma":[0.9961991,0.0023369994,0.00024645298,0.0002963467,0.00071756373,0.000047497957,0.0000026923185,0.000015403179,0.0001379651],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99858135,0.00005516298,0.0004562261,0.000160139,0.00056499237,0.0001821367],"domain_scores_gemma":[0.9987595,0.00038449367,0.00020407174,0.00003844967,0.00047912882,0.00013432272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006755856,0.000106935026,0.0002476031,0.00019603685,0.000040496616,0.00003555076,0.00014154516,0.00012542999,0.0012906556],"category_scores_gemma":[0.000861876,0.00007927477,0.00017285868,0.000099882185,0.0000853768,0.00012048025,0.00004617283,0.00046536475,9.609978e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035165076,0.0001462161,0.35881487,0.00025570882,0.002096469,0.00039152268,0.00025062717,0.0000776245,0.010800587,0.00044187604,0.00032536284,0.62288266],"study_design_scores_gemma":[0.0068893987,0.0029156362,0.8496875,0.0022536856,0.0009563936,0.00096932467,0.00010832885,0.035115924,0.021297332,0.0036057585,0.0757774,0.00042330453],"about_ca_topic_score_codex":0.00008826096,"about_ca_topic_score_gemma":0.00008561412,"teacher_disagreement_score":0.62245935,"about_ca_system_score_codex":0.00046945526,"about_ca_system_score_gemma":0.00052763254,"threshold_uncertainty_score":0.9996223},"labels":[],"label_agreement":null},{"id":"W4392632410","doi":"10.1136/ijgc-2024-esgo.9","title":"256 Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer from the CCTG CX.5 ‘SHAPE’ phase III clinical trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre; Health Sciences Centre; Provincial Health Services Authority; Princess Margaret Cancer Centre; The Society of Gynecologic Oncology of Canada; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Hysterectomy; Radical Hysterectomy; Medicine; Cervical cancer; Quality of life (healthcare); Quality-adjusted life year; Cost effectiveness; Gynecology; Obstetrics; Cancer; Surgery; Internal medicine","score_opus":0.156874152536921,"score_gpt":0.491822741104774,"score_spread":0.334948588567853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98276895,0.001849928,0.002714934,0.0048373537,0.0046257228,0.0018114427,0.0012702078,0.000029891853,0.0000915557],"genre_scores_gemma":[0.9944075,0.00025401975,0.00022370597,0.0015064353,0.0028352104,0.00057462463,0.000102109545,0.0000265652,0.00006986303],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9958807,0.00043717123,0.0017091675,0.0005052092,0.001118048,0.0003496529],"domain_scores_gemma":[0.9893663,0.008447423,0.0005243337,0.00021903598,0.0010195358,0.00042340354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012286027,0.0003003456,0.0016379462,0.0004003944,0.00006786081,0.000111007736,0.0006457307,0.00023960075,0.0048720096],"category_scores_gemma":[0.0013001708,0.00017073311,0.0015723057,0.0010231141,0.0001944433,0.00014493614,0.00013561733,0.0005727165,0.0000106503985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42121407,0.0047895904,0.1796824,0.000107440595,0.042117093,0.00047330986,0.00041859352,0.000645482,0.0011915653,0.000285071,0.0040993486,0.34497604],"study_design_scores_gemma":[0.24984713,0.010401685,0.6275905,0.0008138245,0.013031371,0.000023679626,0.00011148559,0.0065565417,0.0015023862,0.0007993387,0.088835485,0.0004866054],"about_ca_topic_score_codex":0.0011515339,"about_ca_topic_score_gemma":0.00044513997,"teacher_disagreement_score":0.44790807,"about_ca_system_score_codex":0.0008360478,"about_ca_system_score_gemma":0.00055908586,"threshold_uncertainty_score":0.99603766},"labels":[],"label_agreement":null},{"id":"W4392632417","doi":"10.1136/ijgc-2024-esgo.460","title":"1345 Impact of obesity on sentinel lymph node mapping in patients with endometrial intraepithelial neoplasia undergoing robotic surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Sentinel lymph node; Medicine; Mann–Whitney U test; Body mass index; Endometrial cancer; Hysterectomy; Lymph node; Retrospective cohort study; Gynecology; Surgery; Internal medicine; Cancer; Breast cancer","score_opus":0.026555066773972985,"score_gpt":0.3109539662551475,"score_spread":0.28439889948117447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969513,0.00040448364,0.00014482466,0.0005678176,0.0014433527,0.00014865474,0.00002807755,0.0000132355835,0.0002982542],"genre_scores_gemma":[0.99859095,0.00029785887,0.00014349275,0.00021319967,0.0006743397,0.0000073186397,0.000012436579,0.000015570122,0.000044848173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978677,0.00008189444,0.0007173307,0.00020812674,0.0008895609,0.00023538746],"domain_scores_gemma":[0.996908,0.0021278,0.00032731547,0.00007557514,0.0004171341,0.00014414],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003493014,0.00018796175,0.00063208234,0.000853509,0.000019819867,0.00004001626,0.00015710706,0.00010344183,0.0010625095],"category_scores_gemma":[0.0012105071,0.000109943096,0.0004427677,0.0006357429,0.000059680686,0.00015083778,0.000041529114,0.0003153396,0.000008932968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049764374,0.0009557638,0.9739296,0.000054266304,0.0010512098,0.0004516254,0.000040275005,0.0016755962,0.00013588964,0.000040142164,0.00009154928,0.016597686],"study_design_scores_gemma":[0.0076579116,0.00071691617,0.9899389,0.0009513366,0.000112817856,0.000034263718,0.00000969807,0.00013130034,0.00014109655,0.00016438648,0.000038431117,0.00010290013],"about_ca_topic_score_codex":0.00013252615,"about_ca_topic_score_gemma":0.000010572088,"teacher_disagreement_score":0.016494786,"about_ca_system_score_codex":0.0015149176,"about_ca_system_score_gemma":0.0007161832,"threshold_uncertainty_score":0.99985063},"labels":[],"label_agreement":null},{"id":"W4392632523","doi":"10.1136/ijgc-2024-esgo.652","title":"487 Is there a correlation between systemic inflammatory index and extent of peritoneal carcinomatosis in advanced stage ovarian cancer?","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Conventional PCI; Debulking; Ascites; Ovarian cancer; Stage (stratigraphy); Peritoneal carcinomatosis; Cancer; Internal medicine; Gastroenterology; Surgery; Oncology; Myocardial infarction; Colorectal cancer","score_opus":0.018393487679715263,"score_gpt":0.3178191260110951,"score_spread":0.2994256383313798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98548853,0.011374964,0.00017098845,0.0013540414,0.001007178,0.00030224142,0.00011293297,0.000018838715,0.00017030688],"genre_scores_gemma":[0.99777466,0.0014478453,0.0001383487,0.0001499359,0.00032317347,0.000060842256,0.0000044589515,0.000018340308,0.000082404906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804604,0.00008474643,0.0008430499,0.00022114342,0.00063195446,0.00017304554],"domain_scores_gemma":[0.99865085,0.0002651284,0.00039257164,0.000092636576,0.00045888676,0.0001399125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039664924,0.0001657633,0.00042632414,0.0003515197,0.00002444183,0.000038027298,0.00016929285,0.00017277492,0.0007997861],"category_scores_gemma":[0.00014846903,0.00012816186,0.00016535445,0.00016318957,0.0001229264,0.00022331107,0.00008007382,0.0003694557,0.0000022692373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007812013,0.00006177752,0.9714028,0.0003640626,0.00053180207,0.00067740807,0.00049032905,0.00028643795,0.0017882696,0.00015022953,0.000114222275,0.023351464],"study_design_scores_gemma":[0.0017659483,0.00018100302,0.9908868,0.0019141806,0.00015280677,0.00011426073,0.00031245325,0.0024832368,0.0009919883,0.00013195322,0.0009400091,0.00012535254],"about_ca_topic_score_codex":0.00008222278,"about_ca_topic_score_gemma":0.000038888436,"teacher_disagreement_score":0.023226112,"about_ca_system_score_codex":0.0008091782,"about_ca_system_score_gemma":0.00050994713,"threshold_uncertainty_score":0.8757097},"labels":[],"label_agreement":null},{"id":"W4392632527","doi":"10.1136/ijgc-2024-esgo.19","title":"738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer – analysis of the international CCTG CX.5/SHAPE phase III trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada; Université de Sherbrooke; Princess Margaret Cancer Centre; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Surgery; Hysterectomy; Cervical cancer; Radical surgery; Cancer; Internal medicine","score_opus":0.03904529868681127,"score_gpt":0.36491386545129784,"score_spread":0.32586856676448656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212,0.0039382353,0.00011615508,0.0015432541,0.0012273298,0.0003367364,0.0004692433,0.0000058418386,0.00024318723],"genre_scores_gemma":[0.99418956,0.0049647894,0.00011475376,0.00012780388,0.00044109413,0.000052442876,0.000018353865,0.000008798306,0.00008239928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975568,0.00014920608,0.00095191284,0.00032356216,0.0008485727,0.0001699108],"domain_scores_gemma":[0.9980702,0.00073056336,0.0004679056,0.00009997378,0.00048826114,0.0001430923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050186476,0.00019377384,0.00076482206,0.0004771171,0.00002918178,0.00004498217,0.0003238944,0.00013943967,0.001840037],"category_scores_gemma":[0.0003889244,0.00010930896,0.00035357953,0.0006080259,0.00015858954,0.00015374443,0.00017017205,0.0004839229,3.466688e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038672175,0.0024238236,0.88989305,0.00011615435,0.0074754087,0.0003544798,0.0006963634,0.0004817022,0.00034394613,0.0008136314,0.000040270854,0.058688987],"study_design_scores_gemma":[0.07899236,0.001971395,0.8974051,0.0008686782,0.002713735,0.00016203715,0.0002202831,0.015399598,0.0010726756,0.00032901467,0.0006229862,0.00024214547],"about_ca_topic_score_codex":0.00072768633,"about_ca_topic_score_gemma":0.0002528062,"teacher_disagreement_score":0.058446843,"about_ca_system_score_codex":0.00034876287,"about_ca_system_score_gemma":0.00026179588,"threshold_uncertainty_score":0.99907243},"labels":[],"label_agreement":null},{"id":"W4392632806","doi":"10.1136/ijgc-2024-esgo.66","title":"406 Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Computer science","score_opus":0.03372868583268057,"score_gpt":0.3387590040337425,"score_spread":0.3050303182010619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392632806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774059,0.0015051363,0.00003893788,0.019485654,0.0012384168,0.000075983335,0.000005793645,0.000009780264,0.00023437191],"genre_scores_gemma":[0.9984105,0.0001288893,0.00030249587,0.00092321145,0.00020533937,0.0000049646374,0.0000061371697,0.000004417866,0.000014004937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926966,0.00003294536,0.00029851132,0.00011171094,0.00020608574,0.00008106958],"domain_scores_gemma":[0.99941105,0.00025921655,0.00009010092,0.000036705376,0.00015056411,0.000052348136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033851303,0.000060149792,0.00013589501,0.00014857748,0.000017031145,0.000017182296,0.000080180755,0.00031478755,0.0007039824],"category_scores_gemma":[0.00032665956,0.00004384678,0.000026909023,0.00006248728,0.000023911203,0.00008739972,0.000012403391,0.0007656663,0.0000014840019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017513146,0.00006047844,0.7416236,0.000018370789,0.00017807106,0.00055472716,0.0000372484,0.0123256715,0.0005281112,0.00086584233,0.000447562,0.24318522],"study_design_scores_gemma":[0.0007340878,0.00014410599,0.91510147,0.00016032982,0.00005061374,0.00016408137,0.000032823256,0.08180253,0.0001613108,0.0006715248,0.00092211727,0.00005501218],"about_ca_topic_score_codex":0.10261526,"about_ca_topic_score_gemma":0.25814107,"teacher_disagreement_score":0.2431302,"about_ca_system_score_codex":0.0018936386,"about_ca_system_score_gemma":0.0020322357,"threshold_uncertainty_score":0.9033605},"labels":[],"label_agreement":null},{"id":"W4392634093","doi":"10.1136/ijgc-2024-esgo.461","title":"1346 Impact of obesity on sentinel lymph node mapping in patients with endometrial intraepithelial neoplasia undergoing robotic surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Sentinel lymph node; Body mass index; Mann–Whitney U test; Endometrial cancer; Lymph node; Hysterectomy; Retrospective cohort study; Gynecology; Internal medicine; Surgery; Cancer; Breast cancer","score_opus":0.026679834577243686,"score_gpt":0.31109826217151915,"score_spread":0.28441842759427544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969483,0.000402861,0.00014491576,0.0005687227,0.0014459231,0.00014879687,0.00002795331,0.000013236972,0.00029929494],"genre_scores_gemma":[0.99858665,0.0003014813,0.00014330196,0.00021441221,0.00067441753,0.0000073261353,0.000012389326,0.000015570919,0.000044441167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978679,0.00008187691,0.000717241,0.00020811483,0.0008895089,0.00023539459],"domain_scores_gemma":[0.9969088,0.0021270257,0.00032738733,0.00007557628,0.0004170956,0.0001441426],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003462583,0.00018797113,0.00063136575,0.0008537333,0.00001981384,0.00004001424,0.00015714658,0.00010344517,0.0010579325],"category_scores_gemma":[0.001208069,0.0001099461,0.00044277782,0.0006344423,0.00005967965,0.00015094866,0.00004153562,0.00031533465,0.000008927563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00493741,0.0009551876,0.9741964,0.000054202603,0.001050285,0.00044703766,0.000040231946,0.0016713375,0.00013614714,0.00004064001,0.000092372844,0.016378772],"study_design_scores_gemma":[0.0076466817,0.00071814534,0.9899512,0.00095019257,0.000112741225,0.00003359973,0.000009698769,0.00013037177,0.00014088264,0.00016546615,0.000038152146,0.00010288287],"about_ca_topic_score_codex":0.00013346455,"about_ca_topic_score_gemma":0.000010639042,"teacher_disagreement_score":0.016275888,"about_ca_system_score_codex":0.001514968,"about_ca_system_score_gemma":0.0007159738,"threshold_uncertainty_score":0.9998552},"labels":[],"label_agreement":null},{"id":"W4392634149","doi":"10.1136/ijgc-2024-esgo.795","title":"1150 Does route of chemotherapy administration affect recurrence site or timing in advanced ovarian cancer?","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Chemotherapy; Serous fluid; Internal medicine; Oncology; Cohort; Proportional hazards model; Surgery; Adjuvant; Paclitaxel; Stage (stratigraphy); Cancer","score_opus":0.03576939653080135,"score_gpt":0.39389878387233557,"score_spread":0.3581293873415342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977424,0.0031990085,0.00019218597,0.01600049,0.0024517917,0.0002577198,0.0000958183,0.000014756198,0.00036418866],"genre_scores_gemma":[0.9906291,0.0068076686,0.0011763709,0.0005450117,0.00050752703,0.00006397153,0.0000078614175,0.000012254918,0.00025028156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859804,0.000041614847,0.00055500976,0.0002130151,0.00044053534,0.00015181421],"domain_scores_gemma":[0.99889994,0.00035886434,0.00027552733,0.000078765974,0.00029935298,0.00008756424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025560262,0.00014336547,0.00037091406,0.00018532327,0.00001594959,0.000040730705,0.00015159145,0.000088479945,0.0025674836],"category_scores_gemma":[0.00016771065,0.00008118911,0.00016332537,0.00020464965,0.000050347557,0.00019470125,0.000021992606,0.00025461632,0.0000033338188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052011576,0.0009486478,0.3120643,0.00018019625,0.0009481477,0.0023350818,0.00061992306,0.00065156986,0.0049407114,0.0007530812,0.00090664456,0.67045057],"study_design_scores_gemma":[0.0065088044,0.003513908,0.93777114,0.003951948,0.00023272992,0.00023263325,0.000111019974,0.001052696,0.020900805,0.0006287603,0.024845028,0.0002505197],"about_ca_topic_score_codex":0.00013119979,"about_ca_topic_score_gemma":0.00080182886,"teacher_disagreement_score":0.67020005,"about_ca_system_score_codex":0.000867356,"about_ca_system_score_gemma":0.0007544863,"threshold_uncertainty_score":0.9983443},"labels":[],"label_agreement":null},{"id":"W4392634152","doi":"10.1136/ijgc-2024-esgo.806","title":"1217 The ultrasound features of papillary projections in benign, borderline and malignant ovarian tumours","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Histopathology; Radiology; Ultrasound; Retrospective cohort study; Pathology","score_opus":0.017731592397199358,"score_gpt":0.331546813620879,"score_spread":0.31381522122367966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311987,0.019628813,0.000053719574,0.045759875,0.0015622712,0.0002758522,0.000059974718,0.000010513519,0.0014502723],"genre_scores_gemma":[0.9918977,0.0065816147,0.0002764099,0.00059751683,0.00041602773,0.000027312879,0.000003751376,0.0000074921295,0.00019217332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990299,0.00004279934,0.0003600691,0.0001341808,0.00032598423,0.00010709021],"domain_scores_gemma":[0.999025,0.00049261836,0.00012747986,0.00006313952,0.00023589974,0.000055875193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028055033,0.00009544378,0.00022430929,0.00014528622,0.000026191903,0.000043364897,0.000112871894,0.00006121166,0.0004902964],"category_scores_gemma":[0.00021164805,0.000049495942,0.00011268729,0.00014381974,0.00009329907,0.00007381383,0.000028023118,0.00026945127,9.555228e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014605656,0.0018370916,0.7884981,0.00016847505,0.002756196,0.004320281,0.0017502127,0.00054812245,0.0050741313,0.020746196,0.018396392,0.15444423],"study_design_scores_gemma":[0.0011164603,0.000615827,0.97985256,0.00043288711,0.00015565331,0.00096904114,0.0002073259,0.0000394613,0.0009311979,0.0013299251,0.014287056,0.000062626],"about_ca_topic_score_codex":0.0002179124,"about_ca_topic_score_gemma":0.00034937952,"teacher_disagreement_score":0.19135444,"about_ca_system_score_codex":0.00024269309,"about_ca_system_score_gemma":0.00028284255,"threshold_uncertainty_score":0.53684014},"labels":[],"label_agreement":null},{"id":"W4392634220","doi":"10.1136/ijgc-2024-esgo.7","title":"237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Open label; Medicine; Chemotherapy; Oncology; Internal medicine; Phases of clinical research; Randomized controlled trial","score_opus":0.19083547522675567,"score_gpt":0.5127291952406223,"score_spread":0.3218937200138666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537624,0.003915505,0.000046085563,0.00599374,0.0023485085,0.001732954,0.00013515685,0.000016254817,0.00043556778],"genre_scores_gemma":[0.9939144,0.0032188962,0.00058165827,0.0008992688,0.0005113494,0.000283518,0.000009169816,0.000036738922,0.00054496253],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99509543,0.00054747803,0.0018857231,0.0004314682,0.0016674546,0.00037246433],"domain_scores_gemma":[0.99475604,0.0026125535,0.0007218218,0.000231611,0.001363114,0.00031483645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001944308,0.00032478856,0.0016314867,0.00044722072,0.000030157256,0.000101557634,0.0010441126,0.00014024758,0.020142004],"category_scores_gemma":[0.003992249,0.00019611766,0.0002156643,0.0011932014,0.0003602617,0.00026077332,0.0002683312,0.00087155896,0.0000059214353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7358775,0.013869187,0.0067766546,0.00035703753,0.006588321,0.0020981482,0.0012143545,0.0001309089,0.008027918,0.0005067148,0.00586203,0.2186912],"study_design_scores_gemma":[0.92291445,0.025708979,0.011915011,0.0023731836,0.0009165326,0.00022132587,0.0010158028,0.0031303642,0.004041248,0.00083734083,0.026394114,0.00053164875],"about_ca_topic_score_codex":0.001522627,"about_ca_topic_score_gemma":0.0024323524,"teacher_disagreement_score":0.21815956,"about_ca_system_score_codex":0.0016739835,"about_ca_system_score_gemma":0.0030236843,"threshold_uncertainty_score":0.9807537},"labels":[],"label_agreement":null},{"id":"W4392634223","doi":"10.1136/ijgc-2024-esgo.218","title":"945 Performance of HPV self-sampling for cervical cancer screening in urban, semi urban, rural, tribal and difficult to reach women in India","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University","funders":"","keywords":"Medicine; Cluster sampling; Slum; Cervical cancer; Nonprobability sampling; Family medicine; Sampling (signal processing); Rural area; Environmental health; Cancer; Population; Internal medicine; Telecommunications; Pathology","score_opus":0.036021460608233115,"score_gpt":0.37394337046967163,"score_spread":0.3379219098614385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918788,0.003649131,0.00013180045,0.0028902453,0.00048289468,0.00037677423,0.000061704035,0.000014358336,0.00051427865],"genre_scores_gemma":[0.99579626,0.0018850778,0.00054943876,0.00063385797,0.00077312207,0.00017200346,0.0000066591374,0.000017607,0.00016595889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783856,0.000045366094,0.0007450326,0.00024386,0.00069101574,0.00043614552],"domain_scores_gemma":[0.9981928,0.0006509953,0.00012595316,0.0000707502,0.0006761942,0.00028332678],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008540631,0.00016213086,0.00052908284,0.0004843367,0.000026852762,0.00005392231,0.00027066478,0.00015467276,0.0020557554],"category_scores_gemma":[0.0005087679,0.00011800185,0.00011410578,0.00047376266,0.00006419133,0.00017364773,0.00012334638,0.0006396733,0.0000015115598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070243226,0.00048250056,0.7581513,0.00055818586,0.00042885155,0.00020076628,0.0027072586,0.0012836743,0.0013861186,0.00027882875,0.0019973072,0.22550093],"study_design_scores_gemma":[0.002991973,0.0011119186,0.9793665,0.00038395642,0.000033354183,0.000040350806,0.00028655486,0.004478607,0.00034479357,0.00008666017,0.010735004,0.00014037415],"about_ca_topic_score_codex":0.00015247607,"about_ca_topic_score_gemma":0.00014168717,"teacher_disagreement_score":0.22536054,"about_ca_system_score_codex":0.0012312634,"about_ca_system_score_gemma":0.00046834227,"threshold_uncertainty_score":0.9988565},"labels":[],"label_agreement":null},{"id":"W4392634300","doi":"10.1136/ijgc-2024-esgo.650","title":"484 Should patients with advanced stage ovarian cancer and preoperative hyponatremia be excluded from primary debulking surgery?","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Debulking; Hyponatremia; Serous cystadenocarcinoma; Surgery; Stage (stratigraphy); Ascites; Ovarian cancer; Cancer; Internal medicine","score_opus":0.03804027396947504,"score_gpt":0.3253447822723904,"score_spread":0.2873045083029153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97755855,0.007829207,0.000101368474,0.01190582,0.0013446672,0.00028733822,0.00036189237,0.000026759637,0.00058440125],"genre_scores_gemma":[0.9910996,0.0038041428,0.0011414394,0.0029238472,0.0005468337,0.000088955676,0.000052402196,0.000026080863,0.00031673026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821097,0.00004495882,0.00046448558,0.00033177866,0.0007451493,0.00020268357],"domain_scores_gemma":[0.9981093,0.0007936477,0.00023162329,0.00009095999,0.0005894116,0.00018505052],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015549787,0.00022050606,0.00048121496,0.00015358294,0.000050579052,0.00011410315,0.00012924102,0.00010597103,0.002625865],"category_scores_gemma":[0.00012852786,0.00013435245,0.00014823659,0.0001243713,0.000086558895,0.0003209453,0.00006245219,0.00036211414,0.000002279106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021412051,0.0005095722,0.79011273,0.000049414644,0.0022581215,0.001173485,0.0003447269,0.0002258194,0.0002802635,0.00020013006,0.0029960661,0.19970845],"study_design_scores_gemma":[0.0031538748,0.0005397757,0.965228,0.0008701473,0.00030777184,0.000022377404,0.00004302784,0.00007768796,0.0006405203,0.00011755563,0.028824124,0.00017510756],"about_ca_topic_score_codex":0.00024510044,"about_ca_topic_score_gemma":0.00023885736,"teacher_disagreement_score":0.19953334,"about_ca_system_score_codex":0.0011327165,"about_ca_system_score_gemma":0.00065669004,"threshold_uncertainty_score":0.9982859},"labels":[],"label_agreement":null},{"id":"W4392634316","doi":"10.1136/ijgc-2024-esgo.477","title":"1065 Fertility-sparing treatment for endometrial hyperplasia with and without atypia, and early endometrial cancer: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Endometrial hyperplasia; Meta-analysis; Endometrial cancer; Atypia; Gynecology; Hysterectomy; Odds ratio; Obstetrics; Oncology; Internal medicine; Cancer; Endometrium; Surgery; Pathology","score_opus":0.15983667447760933,"score_gpt":0.43596078665217186,"score_spread":0.27612411217456256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634316","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033747752,0.9920412,0.000034728524,0.0005333586,0.00024195519,0.0031733625,0.0005528614,0.00001481021,0.000033002903],"genre_scores_gemma":[0.027787521,0.9688965,0.00044342078,0.00017154995,0.00012764258,0.0019787566,0.000027217297,0.000028299966,0.0005390573],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997035,0.00022779235,0.0014219609,0.0005440937,0.00052161026,0.0002494881],"domain_scores_gemma":[0.9959113,0.0019528152,0.0011471083,0.00016362577,0.00053476525,0.00029036036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006258131,0.0005561123,0.0076411813,0.0008310226,0.00008205407,0.00016566466,0.00017536273,0.00024043075,0.00049421715],"category_scores_gemma":[0.0012250787,0.00024742444,0.0017971761,0.0005465376,0.00014487295,0.000111201465,0.000092213224,0.0003582222,0.0000021463732],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007075484,0.00053812313,0.004959435,0.15548827,0.802554,0.00044219565,0.000037495338,0.0000020625423,3.6865467e-7,0.00012308772,0.00004801042,0.03509943],"study_design_scores_gemma":[0.0032697837,0.002751113,0.0012499007,0.012600566,0.9678818,0.00036835732,0.0000069770467,0.0000044901903,5.4972423e-7,0.0000632813,0.011559125,0.00024407372],"about_ca_topic_score_codex":0.000083561965,"about_ca_topic_score_gemma":0.000117423086,"teacher_disagreement_score":0.1653278,"about_ca_system_score_codex":0.00066951616,"about_ca_system_score_gemma":0.00031257485,"threshold_uncertainty_score":0.9999978},"labels":[],"label_agreement":null},{"id":"W4392634340","doi":"10.1136/ijgc-2024-esgo.657","title":"494 Prognostic role of C reactive protein to albumin ratio in advanced stage ovarian cancer patients","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Debulking; Ovarian cancer; Medicine; Internal medicine; C-reactive protein; Albumin; Chemotherapy; Stage (stratigraphy); Gastroenterology; Oncology; Receiver operating characteristic; Cancer; Cutoff; Surgery; Inflammation; Biology","score_opus":0.007907008836525349,"score_gpt":0.2951806565855154,"score_spread":0.28727364774899006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904212,0.0026567522,0.00022421703,0.00060568674,0.005261497,0.00035318927,0.00014811054,0.0000042198435,0.00032517413],"genre_scores_gemma":[0.99556434,0.00037311722,0.00033678228,0.0002560253,0.0027551937,0.0001422396,0.00001504269,0.000013993833,0.0005432674],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875647,0.000055379845,0.00045350933,0.00022715786,0.0003373765,0.00017010461],"domain_scores_gemma":[0.9990395,0.000045922086,0.00020827756,0.000076066586,0.00053983746,0.00009043472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001884157,0.00012933361,0.00022233474,0.00013899157,0.000014360438,0.000028115195,0.00028547726,0.000104402716,0.00029052154],"category_scores_gemma":[0.00045598284,0.00010294519,0.0001159441,0.00012583872,0.000043037937,0.000023428933,0.000084426305,0.0001820519,0.000002549291],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014833376,0.00043823622,0.05659194,0.000035456324,0.0003209868,0.0000067502524,0.0003840591,0.0023044911,0.8681289,0.0006264479,0.0024748284,0.06720459],"study_design_scores_gemma":[0.0021945988,0.0012571493,0.3175137,0.00041252983,0.00004652869,0.0000067776027,0.00019459655,0.000120815836,0.15025769,0.00042594215,0.5272632,0.00030643956],"about_ca_topic_score_codex":0.00016790967,"about_ca_topic_score_gemma":0.000648443,"teacher_disagreement_score":0.7178712,"about_ca_system_score_codex":0.00019313558,"about_ca_system_score_gemma":0.00040478728,"threshold_uncertainty_score":0.4197983},"labels":[],"label_agreement":null},{"id":"W4392634389","doi":"10.1136/ijgc-2024-esgo.32","title":"625 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: analysis of progression-free survival and overall survival outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Oncology; Endometrial cancer; Chemotherapy; Overall survival; Internal medicine; Medicine; Progression-free survival; Primary (astronomy); Primary treatment; Cancer","score_opus":0.06179492529121656,"score_gpt":0.40617375460581095,"score_spread":0.3443788293145944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602593,0.020005416,0.00032836254,0.014394913,0.0026481228,0.0016008908,0.0006425126,0.0000099224435,0.00011054227],"genre_scores_gemma":[0.9732475,0.02509768,0.00029565362,0.00034323844,0.00041816552,0.00044604213,0.00005836379,0.000016020938,0.00007729235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99716216,0.00019626654,0.0009998995,0.00028461637,0.0011511876,0.00020584544],"domain_scores_gemma":[0.99389946,0.0047723884,0.0006040587,0.00020465665,0.00043835267,0.00008109589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008052555,0.00023404213,0.0010115129,0.00041203568,0.000039814408,0.000046046498,0.00042029345,0.00011761092,0.00040045156],"category_scores_gemma":[0.0008989249,0.00010117372,0.00065048697,0.0007781319,0.00013776742,0.000101357444,0.000036251276,0.00020190685,1.7213893e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19052544,0.004208014,0.038885202,0.00009765442,0.0126052825,0.00008271502,0.0006862837,0.00016573495,0.0034095861,0.00074728625,0.0004334498,0.7481533],"study_design_scores_gemma":[0.3373436,0.031282347,0.5517233,0.0005238447,0.008935165,0.000019594703,0.0007972631,0.0015458543,0.0048297388,0.0014422055,0.06102226,0.00053484447],"about_ca_topic_score_codex":0.00021083745,"about_ca_topic_score_gemma":0.0002610452,"teacher_disagreement_score":0.7476185,"about_ca_system_score_codex":0.00083103485,"about_ca_system_score_gemma":0.0003595282,"threshold_uncertainty_score":0.43846637},"labels":[],"label_agreement":null},{"id":"W4392634404","doi":"10.1136/ijgc-2024-esgo.1121","title":"#1350 Tumor treating fields (TTFields) therapy in platinum-resistant ovarian cancer: results from the ENGOT-ov50/GOG-3029/INNOVATE-3 phase 3 study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Paclitaxel; Oncology; Ovarian cancer; Population; Cancer; Chemotherapy; Mesothelioma; Pathology","score_opus":0.05021908909820553,"score_gpt":0.3849673919569026,"score_spread":0.33474830285869706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95580894,0.0046146647,0.00004923042,0.035426874,0.0023815925,0.00050660194,0.0003182047,0.000026075846,0.0008678362],"genre_scores_gemma":[0.9930154,0.0019721088,0.00015216155,0.0026586705,0.0018292491,0.00015193192,0.000018097931,0.000020536505,0.00018182279],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975112,0.00013266371,0.0010189418,0.00037489808,0.0007089214,0.00025337085],"domain_scores_gemma":[0.9973385,0.001611939,0.00035767397,0.00019491701,0.0003888514,0.00010811902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059855037,0.00024282013,0.00048215763,0.00016263733,0.000069992595,0.00015492103,0.0003771476,0.00011290598,0.002813203],"category_scores_gemma":[0.00046014503,0.00013400285,0.00019312275,0.00030320103,0.000056152046,0.0001451491,0.000063407104,0.0007195508,0.000007979251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018781416,0.0067304694,0.22705069,0.000024116787,0.005404931,0.016438145,0.006946855,0.00095741765,0.0023056653,0.0010584784,0.014515413,0.6997864],"study_design_scores_gemma":[0.05315812,0.011093834,0.87429655,0.0019526904,0.0005267372,0.00015098142,0.0023053424,0.0014211074,0.0027652227,0.0019072593,0.049903437,0.0005187449],"about_ca_topic_score_codex":0.0045440407,"about_ca_topic_score_gemma":0.0026478763,"teacher_disagreement_score":0.6992677,"about_ca_system_score_codex":0.00080526754,"about_ca_system_score_gemma":0.0005575004,"threshold_uncertainty_score":0.9980984},"labels":[],"label_agreement":null},{"id":"W4392634417","doi":"10.1136/ijgc-2024-esgo.494","title":"200 Effectiveness of a thromboprophylaxis protocol in a high volume gynaecological oncological Canadian center","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Endometrial cancer; Pulmonary embolism; Retrospective cohort study; Ovarian cancer; Cancer; Low molecular weight heparin; Stage (stratigraphy); Surgery; Thrombosis; Gynecology; Internal medicine","score_opus":0.017222420892983318,"score_gpt":0.35270536334803804,"score_spread":0.3354829424550547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793154,0.00019208124,0.000076797056,0.0037129957,0.0020213157,0.01041594,0.000058792557,0.000022042028,0.0041846186],"genre_scores_gemma":[0.9931371,0.00011079399,0.00037106668,0.00066385337,0.00032181875,0.00527875,0.000007570136,0.0000142124145,0.00009479805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978407,0.0002019416,0.00074619066,0.00027875486,0.0006029121,0.0003294869],"domain_scores_gemma":[0.99853164,0.00043369047,0.00018843444,0.00010087017,0.0005029481,0.00024241809],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009406,0.00018681002,0.00075516995,0.0004873387,0.000025185627,0.000048892147,0.00035306255,0.00022309716,0.0089989435],"category_scores_gemma":[0.00050616375,0.00012069933,0.00027968874,0.00028257965,0.0001489636,0.00013609782,0.0001000001,0.00051848247,0.000039858653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003520493,0.00782472,0.8552378,0.0011162289,0.0021915273,0.018619888,0.0002838189,0.0012441698,0.0023489154,0.010801733,0.012505762,0.08430494],"study_design_scores_gemma":[0.0025315187,0.0029676454,0.95910597,0.0005727056,0.00006116012,0.00011724477,0.00003128161,0.0001444878,0.0002102246,0.0012140541,0.032916617,0.00012706938],"about_ca_topic_score_codex":0.0047164825,"about_ca_topic_score_gemma":0.0048847343,"teacher_disagreement_score":0.103868194,"about_ca_system_score_codex":0.0018899586,"about_ca_system_score_gemma":0.00082756847,"threshold_uncertainty_score":0.99190694},"labels":[],"label_agreement":null},{"id":"W4392634440","doi":"10.1136/ijgc-2024-esgo.895","title":"583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Worry; Salpingectomy; Thematic analysis; Gynecology; Obstetrics; Qualitative research; Pregnancy; Anxiety","score_opus":0.034612812250605494,"score_gpt":0.3842941385633512,"score_spread":0.34968132631274573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926539,0.0031957794,0.000016204542,0.0018363838,0.0012686421,0.00090621726,0.000013208192,0.000015450922,0.00009421955],"genre_scores_gemma":[0.9981224,0.00052934815,0.00013384316,0.00015670934,0.00037196363,0.00064383884,4.865208e-7,0.000015035935,0.00002635682],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9980355,0.00029295954,0.00055815774,0.00028288751,0.0006240997,0.00020641423],"domain_scores_gemma":[0.9971748,0.0020297344,0.00034335107,0.000091374524,0.00022314207,0.00013762823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013589412,0.00017991157,0.0004748996,0.00018571493,0.00008058183,0.00011172903,0.00015573154,0.000063759355,0.0003564759],"category_scores_gemma":[0.000985034,0.000096369935,0.00016713515,0.00018824777,0.00012695913,0.00012068993,0.00006486825,0.00036315646,0.0000013958316],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03372805,0.0030540412,0.03644549,0.00009376617,0.011630876,0.0017938178,0.84062636,0.00004433166,0.0008243005,0.00072890334,0.00067628105,0.07035381],"study_design_scores_gemma":[0.09088406,0.07273203,0.3126966,0.0038016173,0.0019304429,0.0003314697,0.5014728,0.00048439426,0.006557992,0.0031604304,0.004993732,0.00095442974],"about_ca_topic_score_codex":0.00030848305,"about_ca_topic_score_gemma":0.000019710877,"teacher_disagreement_score":0.33915356,"about_ca_system_score_codex":0.0005911021,"about_ca_system_score_gemma":0.0002442524,"threshold_uncertainty_score":0.39298517},"labels":[],"label_agreement":null},{"id":"W4392634492","doi":"10.1136/ijgc-2024-esgo.33","title":"633 Time to deterioration of patient-reported outcomes in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Chemotherapy; Medicine; Endometrial cancer; Oncology; Cancer; Gynecologic cancer; Internal medicine; Ovarian cancer","score_opus":0.022162498306942342,"score_gpt":0.3225435495479979,"score_spread":0.3003810512410556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944706,0.000378854,0.000029335682,0.002419922,0.00045528763,0.00201706,0.00008290086,0.000018889787,0.00012712905],"genre_scores_gemma":[0.9973029,0.00028045368,0.00048213062,0.0012315476,0.00022318885,0.00031209417,0.000048843896,0.00003171273,0.000087126406],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9967259,0.00014296333,0.0010470736,0.0003627442,0.0014324776,0.00028882615],"domain_scores_gemma":[0.9977115,0.0006873604,0.00062709587,0.00016127301,0.0006803191,0.00013245968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003073342,0.0003304416,0.0009910639,0.00059529516,0.00002838865,0.00006209802,0.0002878259,0.00010557499,0.0013799127],"category_scores_gemma":[0.00022339732,0.00014501635,0.00015273358,0.0011812097,0.00008991908,0.00023922764,0.000026229194,0.00038525157,0.0000029054029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6348323,0.0025996622,0.2524444,0.000038264174,0.0014453495,0.00043997998,0.0008154687,0.0004943399,0.00029931302,0.0000032595262,0.00010337981,0.10648424],"study_design_scores_gemma":[0.24268529,0.029920416,0.72268736,0.0009292355,0.00023436212,0.000034149663,0.000117412885,0.000055367826,0.0006626181,0.000017270002,0.0023662748,0.00029022622],"about_ca_topic_score_codex":0.0002212697,"about_ca_topic_score_gemma":0.00046199042,"teacher_disagreement_score":0.47024298,"about_ca_system_score_codex":0.0016961568,"about_ca_system_score_gemma":0.00071332185,"threshold_uncertainty_score":0.99953294},"labels":[],"label_agreement":null},{"id":"W4392634569","doi":"10.1136/ijgc-2024-esgo.653","title":"488 Hemoglobin levels correlate with systemic inflammatory index in advanced stage ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Internal medicine; Gastroenterology; Receiver operating characteristic; Anemia; Cancer; Hemoglobin; Retrospective cohort study; Surgery","score_opus":0.01772282580912298,"score_gpt":0.3201021865518996,"score_spread":0.3023793607427766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879912,0.0052009244,0.00031497396,0.0022551296,0.0028357536,0.00038983562,0.000095695534,0.000054659125,0.00086179277],"genre_scores_gemma":[0.9971434,0.000618503,0.00033606606,0.0006933315,0.00046425138,0.00012288785,0.0000044165527,0.000032079457,0.0005850943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760294,0.000090839894,0.0008217305,0.0002952121,0.00089131464,0.00029795212],"domain_scores_gemma":[0.9984098,0.0002478059,0.0003546477,0.00012939857,0.00064865337,0.0002096605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005080175,0.00023616383,0.00043928876,0.00043049132,0.00003093979,0.00007933193,0.00035299858,0.00019126631,0.003246268],"category_scores_gemma":[0.00021959687,0.00016267072,0.00018363414,0.00028302168,0.00013688976,0.0003445317,0.00008185738,0.0006743476,0.000017384857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054866024,0.00024788058,0.9121652,0.00042286626,0.0016253082,0.017154677,0.00035876915,0.0053348783,0.0042039426,0.000890512,0.0010391352,0.05107022],"study_design_scores_gemma":[0.005096423,0.0003605078,0.9737898,0.004433491,0.00018134092,0.0009383189,0.0002409767,0.0024788827,0.0008666738,0.00023661536,0.011059733,0.0003172094],"about_ca_topic_score_codex":0.00003792315,"about_ca_topic_score_gemma":0.00012531757,"teacher_disagreement_score":0.06162462,"about_ca_system_score_codex":0.0018477853,"about_ca_system_score_gemma":0.0012417522,"threshold_uncertainty_score":0.9976649},"labels":[],"label_agreement":null},{"id":"W4392634581","doi":"10.1136/ijgc-2024-esgo.53","title":"285 Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Medicine; Placebo; Population; Internal medicine; Quality of life (healthcare); Clinical endpoint; Tolerability; Randomized controlled trial; Physical therapy; Adverse effect; Cancer","score_opus":0.02594423331852203,"score_gpt":0.3469784173388849,"score_spread":0.3210341840203629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869835,0.0041547213,0.00016819728,0.0021053774,0.0028277163,0.0034659458,0.00018875164,0.000029118144,0.0000767074],"genre_scores_gemma":[0.9966959,0.0011809501,0.000089473964,0.0007209294,0.00045696492,0.0007273072,0.000040512707,0.000038379378,0.000049617865],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949268,0.00039554868,0.0019669568,0.00048738776,0.0018760032,0.00034731242],"domain_scores_gemma":[0.99414796,0.0029195081,0.0012968194,0.00023680922,0.0011647992,0.00023409915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060317555,0.0004479037,0.0022688722,0.00030764684,0.00006105943,0.00008065288,0.00047269274,0.00016815522,0.0026028887],"category_scores_gemma":[0.00071618543,0.00021263535,0.0005718994,0.00046430077,0.00020373409,0.00021351058,0.000085837986,0.0008285123,0.0000036505144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78157353,0.004366641,0.13448504,0.000018149012,0.007310298,0.000348624,0.0007292,0.0018502311,0.000017393995,0.00003320028,0.00006709566,0.06920061],"study_design_scores_gemma":[0.88267326,0.005018635,0.10898667,0.00035573577,0.0015515441,0.000008440596,0.00021377135,0.0004358289,0.00013744405,0.000102369035,0.00029519334,0.0002211086],"about_ca_topic_score_codex":0.002452159,"about_ca_topic_score_gemma":0.0010112032,"teacher_disagreement_score":0.101099744,"about_ca_system_score_codex":0.0013967346,"about_ca_system_score_gemma":0.0007021391,"threshold_uncertainty_score":0.99830884},"labels":[],"label_agreement":null},{"id":"W4393188573","doi":"10.1136/ijgc-2024-005342","title":"Sustainability of an enhanced recovery pathway after minimally invasive gynecologic oncology surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Gynecologic oncology; Invasive surgery; Oncology; Gynecologic cancer; General surgery; Internal medicine; Surgery; Cancer; Ovarian cancer","score_opus":0.020231148678362572,"score_gpt":0.3311993775534297,"score_spread":0.31096822887506714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393188573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98732764,0.0023059384,0.0006467445,0.0033106336,0.004883586,0.00027396448,0.00006107427,0.000043561104,0.0011468752],"genre_scores_gemma":[0.99461085,0.0014943361,0.0007824082,0.0014269185,0.00089808245,0.000095386764,0.000013718046,0.000026799235,0.0006514942],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967256,0.00032253278,0.0014154235,0.0004160666,0.0007506607,0.00036972106],"domain_scores_gemma":[0.99107385,0.0054588905,0.00063844805,0.0002143755,0.0023539625,0.00026050422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014575421,0.0002647106,0.0009772168,0.00056955614,0.000025313591,0.00005244687,0.0003482335,0.00037048274,0.0040465025],"category_scores_gemma":[0.005952434,0.00019206437,0.0007709576,0.00030430764,0.00027560393,0.0006167875,0.0001295658,0.0006714244,0.000015709322],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024224974,0.0045361915,0.07842757,0.0011414011,0.003477829,0.030570941,0.0010161446,0.0014645613,0.0763692,0.0001953817,0.0063235164,0.77225226],"study_design_scores_gemma":[0.003296566,0.01347691,0.6470145,0.0024217535,0.00065946626,0.0022989016,0.00097241096,0.00022933648,0.23732047,0.015347336,0.07584594,0.001116382],"about_ca_topic_score_codex":0.000025934063,"about_ca_topic_score_gemma":0.00017289298,"teacher_disagreement_score":0.7711359,"about_ca_system_score_codex":0.0021592767,"about_ca_system_score_gemma":0.0043842117,"threshold_uncertainty_score":0.99686396},"labels":[],"label_agreement":null},{"id":"W4393279102","doi":"10.1136/ijgc-2023-005065","title":"Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; Serous ovarian cancer; Oncology; Serous fluid; BRCA mutation; Chemotherapy; Internal medicine; Cancer","score_opus":0.013951653045734846,"score_gpt":0.28712731150373744,"score_spread":0.27317565845800257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393279102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915833,0.0008721072,0.00008932726,0.005830004,0.0010039498,0.00029789275,0.00015931364,0.000027109983,0.00013702392],"genre_scores_gemma":[0.99734473,0.00083627366,0.0006665027,0.00048413486,0.000330278,0.00007205788,0.00011087778,0.000029138384,0.00012597955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978602,0.00007400776,0.00054503453,0.0003750903,0.0008852344,0.0002604244],"domain_scores_gemma":[0.99830955,0.00033770266,0.00032566563,0.00012732469,0.00073865143,0.00016112512],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019996107,0.00024766003,0.00083514693,0.00046805892,0.000029676326,0.000067052235,0.00016726494,0.000086856504,0.0022796134],"category_scores_gemma":[0.000034980916,0.00014975478,0.0002245648,0.000728237,0.00010084711,0.00021045677,0.000024089393,0.00032392237,0.0000042279835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009080816,0.001411115,0.94574076,0.000028336119,0.008148549,0.0013275184,0.0001881548,0.005699553,0.00003418413,0.000060544342,0.0006146909,0.027665786],"study_design_scores_gemma":[0.007604304,0.0009498673,0.9881371,0.00042505687,0.0007758019,0.000019610774,0.000054918644,0.000095920885,0.00019638512,0.000045925397,0.0015102903,0.00018482252],"about_ca_topic_score_codex":0.0005396078,"about_ca_topic_score_gemma":0.00057329255,"teacher_disagreement_score":0.042396344,"about_ca_system_score_codex":0.001975671,"about_ca_system_score_gemma":0.00075247855,"threshold_uncertainty_score":0.99863243},"labels":[],"label_agreement":null},{"id":"W4394842371","doi":"10.1136/ijgc-2023-005162","title":"Association of reviewer experience with discriminating human-written versus ChatGPT-written abstracts","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Association (psychology); Psychotherapist","score_opus":0.15765764986991018,"score_gpt":0.4781672253580695,"score_spread":0.3205095754881593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394842371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98215324,0.0017299828,0.00010654597,0.010898357,0.0034825765,0.00013709225,0.000006118609,0.0000148345025,0.0014712333],"genre_scores_gemma":[0.9964019,0.000991405,0.00032737528,0.00038284078,0.0013326904,0.000020899379,0.000005569436,0.000009644178,0.0005276889],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982009,0.000041378073,0.00074619596,0.00014309469,0.0007127468,0.0001557154],"domain_scores_gemma":[0.99693036,0.0005754249,0.0004858177,0.00006991784,0.0018437369,0.000094727584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057125906,0.000097655786,0.00025885476,0.00013261652,0.000042004343,0.00004436706,0.00016713717,0.00010066681,0.0011107393],"category_scores_gemma":[0.0017748112,0.00006451478,0.0001207874,0.00014489134,0.00006164484,0.00024147952,0.000022649065,0.00034172882,0.000011245092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026185825,0.0010817777,0.37630698,0.0006900505,0.0017410473,0.00078308297,0.010586778,0.00048825057,0.012400668,0.0024913766,0.016503599,0.5743078],"study_design_scores_gemma":[0.001461249,0.0065852855,0.8171539,0.007626108,0.0010006558,0.0002916435,0.008139743,0.00056422764,0.04773069,0.003030341,0.10576742,0.0006487793],"about_ca_topic_score_codex":0.00017277789,"about_ca_topic_score_gemma":0.00012599333,"teacher_disagreement_score":0.573659,"about_ca_system_score_codex":0.0007138445,"about_ca_system_score_gemma":0.00027873323,"threshold_uncertainty_score":0.99980235},"labels":[],"label_agreement":null},{"id":"W4395117164","doi":"10.1136/ijgc-2023-005220","title":"Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Leiomyoma; Uterine leiomyoma; Radiology; Diagnostic accuracy; Magnetic resonance imaging; Gynecology","score_opus":0.04019542168873805,"score_gpt":0.37112813733326083,"score_spread":0.33093271564452276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395117164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98715293,0.0006192158,0.008176066,0.0019287064,0.0015202642,0.0002872244,0.00012447665,0.000030526546,0.00016059141],"genre_scores_gemma":[0.9947017,0.000036745274,0.0040297154,0.00012209568,0.0009342855,0.000053479685,0.000032430227,0.000020315432,0.000069259266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985121,0.000056175937,0.0006345395,0.00018860622,0.00045150865,0.00015708436],"domain_scores_gemma":[0.99589634,0.003094296,0.00039698064,0.00012404556,0.00039525802,0.000093091825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002676204,0.00015415766,0.00034720395,0.000114743765,0.000058662026,0.000092603346,0.0002896415,0.000059519556,0.0003514632],"category_scores_gemma":[0.0007379171,0.000087703826,0.0002601668,0.00007426263,0.000048514918,0.00017173,0.00006748961,0.00018709546,0.000002028174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039674523,0.0025056512,0.4210118,0.0019647137,0.010387652,0.00718451,0.0012718845,0.0058313985,0.11857144,0.012734686,0.0005860111,0.4139828],"study_design_scores_gemma":[0.014284714,0.0061277663,0.77384025,0.009031176,0.0022742893,0.0008794967,0.00057140324,0.06566482,0.1073784,0.0028045462,0.01646164,0.0006814834],"about_ca_topic_score_codex":0.00008343622,"about_ca_topic_score_gemma":0.000021837956,"teacher_disagreement_score":0.41330132,"about_ca_system_score_codex":0.00038038683,"about_ca_system_score_gemma":0.00022844487,"threshold_uncertainty_score":0.38482755},"labels":[],"label_agreement":null},{"id":"W4399153876","doi":"10.1136/ijgc-00009577-200603000-00045","title":"Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Biopsy; Erythropoietin; Immunohistochemistry; Radioresistance; Pathology; Cervix; Receptor; Hypoxia (environmental); Oncology; Internal medicine; Radiation therapy; Cancer","score_opus":0.009761644269694957,"score_gpt":0.26605904651118495,"score_spread":0.25629740224149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399153876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404716,0.00041967927,0.00004239766,0.0029516642,0.0007733321,0.000157895,0.000079134334,0.000011221089,0.0015175111],"genre_scores_gemma":[0.9936254,0.00007406358,0.0046684477,0.0002911911,0.0007283545,0.000011473986,0.0000711518,0.000016780621,0.00051316025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998403,0.000046887453,0.0005168005,0.00021635977,0.00061726564,0.00019967645],"domain_scores_gemma":[0.9988628,0.00015214368,0.0003562008,0.000101891266,0.0004170786,0.00010990613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007815742,0.00018036377,0.00033304983,0.00012688944,0.000027928647,0.000023762392,0.00017971794,0.00010818107,0.0077213557],"category_scores_gemma":[0.00004403731,0.000110924106,0.00011478623,0.00008950703,0.000084337174,0.00009131206,0.00005969215,0.0002774767,0.000024428033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016188442,0.0021416873,0.9745081,0.000011570317,0.000030493458,0.00080430263,0.00007081092,0.00008609936,0.014443201,0.000010851331,0.0049842065,0.0012898255],"study_design_scores_gemma":[0.008744766,0.001159421,0.9621037,0.0001190893,0.000034082073,0.000030500298,0.000076281285,0.000008316405,0.018710693,0.00008305355,0.008795404,0.0001346568],"about_ca_topic_score_codex":0.00038025703,"about_ca_topic_score_gemma":0.00009331169,"teacher_disagreement_score":0.012404371,"about_ca_system_score_codex":0.0006357974,"about_ca_system_score_gemma":0.00010358848,"threshold_uncertainty_score":0.9931857},"labels":[],"label_agreement":null},{"id":"W4399166567","doi":"10.1136/ijgc-00009577-200609000-00006","title":"Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Intraperitoneal chemotherapy; Epithelial ovarian cancer; Catheter; Cancer; Oncology; Intensive care medicine; Internal medicine; Surgery","score_opus":0.014201608342584682,"score_gpt":0.3331052177308427,"score_spread":0.318903609388258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399166567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8244774,0.0040787263,0.00046073398,0.16114548,0.0044173994,0.00084977667,0.0005734638,0.000026468919,0.003970598],"genre_scores_gemma":[0.9889052,0.0013013126,0.0025105905,0.003911632,0.0028478052,0.00019011048,0.000012045678,0.000021233314,0.00030005784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868727,0.000020852682,0.0004182414,0.0002213236,0.00036611967,0.00028621772],"domain_scores_gemma":[0.9979914,0.0001457106,0.00027081362,0.000080362675,0.0012806862,0.00023105119],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014000312,0.0001683006,0.0003755172,0.00018116669,0.00006940044,0.000043728232,0.00020351009,0.00011748214,0.0022457303],"category_scores_gemma":[0.00010053854,0.0001243591,0.00028351115,0.00009888007,0.000074662705,0.000108532964,0.000012073791,0.00019717599,0.0000037528885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014678345,0.004108523,0.29278743,0.00005933604,0.006484381,0.0024914534,0.001178425,0.0035153273,0.015387046,0.053587724,0.04579594,0.55992603],"study_design_scores_gemma":[0.022155777,0.0023742602,0.66266423,0.00025861055,0.00038300062,0.0002879394,0.000331446,0.00021006711,0.009666924,0.008909079,0.29236472,0.0003939334],"about_ca_topic_score_codex":0.044059835,"about_ca_topic_score_gemma":0.050112307,"teacher_disagreement_score":0.5595321,"about_ca_system_score_codex":0.0031515951,"about_ca_system_score_gemma":0.0013587371,"threshold_uncertainty_score":0.99866635},"labels":[],"label_agreement":null},{"id":"W4399167420","doi":"10.1136/ijgc-00009577-200511001-00013","title":"Trial design for testing new therapies in ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.1429027847521492,"score_gpt":0.40107506838636586,"score_spread":0.2581722836342166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399167420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912441,0.011126011,0.011940299,0.17622185,0.0058635767,0.002183391,0.000048594302,0.000033153174,0.0013390154],"genre_scores_gemma":[0.9630576,0.0009867277,0.028285043,0.002755726,0.0042935316,0.0001843751,0.0000016441367,0.0000141512755,0.00042122064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987818,0.000038343136,0.00050727883,0.00015287621,0.00033781712,0.00018190262],"domain_scores_gemma":[0.99832606,0.00075434806,0.00030467476,0.000057992962,0.00043381003,0.00012308174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003421051,0.00012228452,0.00032880544,0.00013254308,0.000025335245,0.000035299505,0.00017013303,0.00008543142,0.0017064103],"category_scores_gemma":[0.00056216185,0.00008254789,0.00015422238,0.00010277585,0.000027780054,0.00012390988,0.000018480832,0.00017477733,0.0000033685722],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05773429,0.0016750594,0.10982251,0.000013138976,0.0012289281,0.0002531189,0.0004015304,0.008284495,0.0011891257,0.0007092385,0.01512961,0.80355895],"study_design_scores_gemma":[0.25770617,0.00924149,0.54581076,0.00082513766,0.00048393867,0.00017403274,0.00010048872,0.0015489944,0.004938511,0.004699815,0.17403144,0.00043923617],"about_ca_topic_score_codex":0.00019258195,"about_ca_topic_score_gemma":0.0002139432,"teacher_disagreement_score":0.8031197,"about_ca_system_score_codex":0.0009393092,"about_ca_system_score_gemma":0.00081524247,"threshold_uncertainty_score":0.9992062},"labels":[],"label_agreement":null},{"id":"W4399167576","doi":"10.1136/ijgc-00009577-200601000-00018","title":"Primary malignant mesodermal ovarian sarcomas","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Stage (stratigraphy); Adjuvant chemotherapy; Disease; Surgery; Adjuvant; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.01619722178816822,"score_gpt":0.29752697941472117,"score_spread":0.28132975762655293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399167576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92215294,0.005311691,0.0005599008,0.04241262,0.0031027836,0.00027102797,0.00005288464,0.00003258233,0.026103599],"genre_scores_gemma":[0.9920082,0.00053284207,0.0020461492,0.0030178695,0.0015841444,0.000020225536,0.000013136738,0.000011813073,0.00076558394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985039,0.000034150275,0.000504426,0.00015628102,0.00061603193,0.00018516507],"domain_scores_gemma":[0.9988587,0.00013635526,0.0003038835,0.000088651774,0.0004977969,0.000114628776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018038998,0.0001317661,0.00032855073,0.00011747353,0.000033073055,0.000037667112,0.00019186022,0.00008784434,0.0030690124],"category_scores_gemma":[0.000053919623,0.000086440654,0.00024294121,0.00007442542,0.00006117057,0.000110599234,0.00004776379,0.00019941057,0.000020010753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017259457,0.0031754947,0.81062984,0.000032735185,0.001460933,0.0082273055,0.00005954437,0.0005012925,0.0049311253,0.010134121,0.045239884,0.113881774],"study_design_scores_gemma":[0.003463373,0.00049136375,0.9049864,0.000100982936,0.00015057718,0.00063683203,0.000009458923,0.000024852206,0.0018316454,0.0013384233,0.08686634,0.00009976],"about_ca_topic_score_codex":0.00012553895,"about_ca_topic_score_gemma":0.000036035,"teacher_disagreement_score":0.11378202,"about_ca_system_score_codex":0.00075137324,"about_ca_system_score_gemma":0.00031141998,"threshold_uncertainty_score":0.9978423},"labels":[],"label_agreement":null},{"id":"W4399167922","doi":"10.1136/ijgc-00009577-200511000-00012","title":"Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"MLH1; DNA methylation; Methylation; CpG site; Microsatellite instability; Bisulfite sequencing; Cancer research; DNA mismatch repair; Promoter; Biology; Molecular biology; Gene; Genetics; Gene expression; DNA repair; Microsatellite","score_opus":0.02272117602898052,"score_gpt":0.30813341697297747,"score_spread":0.285412240943997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399167922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924001,0.0023560063,0.0035636888,0.00030531627,0.0007742785,0.00013045632,0.000026271262,0.000004016873,0.00043987622],"genre_scores_gemma":[0.9935188,0.0008007816,0.0044958713,0.000101432,0.0009445133,0.000008934145,0.000020401398,0.00001134359,0.00009786417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839157,0.0001353143,0.0007084103,0.00019149385,0.00040724428,0.00016597442],"domain_scores_gemma":[0.99849415,0.00019348827,0.0005445955,0.00011009512,0.0005956094,0.00006206912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008874435,0.00012063602,0.00025432912,0.0003010784,0.000018694755,0.000020164083,0.00028159618,0.0001727904,0.0003937262],"category_scores_gemma":[0.0012890378,0.00010096468,0.000174714,0.0002029591,0.000034116343,0.000020187936,0.00008351915,0.00016849874,0.0000015069595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065249717,0.00031985872,0.3513596,0.000015971858,0.00021588392,0.000018941186,0.00009292736,0.0047836206,0.6219011,0.0001742229,0.00009825715,0.020367099],"study_design_scores_gemma":[0.004107767,0.0011124735,0.2625677,0.00006984753,0.000051212442,0.000017319182,0.000042728254,0.0005045186,0.70389265,0.0007434407,0.026646635,0.0002436908],"about_ca_topic_score_codex":0.00007635462,"about_ca_topic_score_gemma":0.00015820058,"teacher_disagreement_score":0.08879191,"about_ca_system_score_codex":0.00014746537,"about_ca_system_score_gemma":0.00015124875,"threshold_uncertainty_score":0.43110257},"labels":[],"label_agreement":null},{"id":"W4399170608","doi":"10.1136/ijgc-00009577-200509000-00016","title":"Quality of life assessments in epithelial ovarian cancer patients during and after chemotherapy","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Quality of life (healthcare); Ovarian cancer; Internal medicine; Disease; Oncology; Epithelial ovarian cancer; Cancer; Progressive disease; Physical therapy","score_opus":0.024166087515949567,"score_gpt":0.3670684280130039,"score_spread":0.3429023404970543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399170608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995302,0.0006542876,0.000020866932,0.0028179504,0.00076120585,0.00010064564,0.00005160866,0.000003544852,0.00028784497],"genre_scores_gemma":[0.99621516,0.0010972187,0.0001592745,0.0018379255,0.0005604244,0.000021456615,0.0000017462365,0.000008223683,0.000098565055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856216,0.000056990983,0.00059316825,0.00012877783,0.0005295048,0.00012939463],"domain_scores_gemma":[0.99890935,0.00008820025,0.0003511962,0.000054878266,0.00048046254,0.00011591907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002467751,0.00010096903,0.00033821384,0.0001210392,0.000011452135,0.000013199265,0.0001240324,0.000086134365,0.0022133824],"category_scores_gemma":[0.00013641732,0.000075696815,0.00010598953,0.00007313851,0.000055819553,0.00013607617,0.00003988828,0.00022425395,8.758671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003286159,0.00035804132,0.95888287,0.000026288488,0.00015679766,0.000017109016,0.00026587714,0.000038268132,0.0013397456,0.00002195283,0.000036368976,0.035570513],"study_design_scores_gemma":[0.00508538,0.0001906015,0.9913333,0.00011213414,0.000015658246,0.000004070425,0.00004826814,0.00001812065,0.0009732353,0.000055303186,0.0020877603,0.0000761705],"about_ca_topic_score_codex":0.0004921731,"about_ca_topic_score_gemma":0.0027547183,"teacher_disagreement_score":0.035494342,"about_ca_system_score_codex":0.00044189856,"about_ca_system_score_gemma":0.00019032444,"threshold_uncertainty_score":0.9986987},"labels":[],"label_agreement":null},{"id":"W4399182680","doi":"10.1136/ijgc-00009577-200103000-00001","title":"Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?","year":2001,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Cervical cancer; Regimen; Cervix; Randomized controlled trial; Modality (human–computer interaction); Chemotherapy; Oncology; Cancer; Intensive care medicine; Malignancy; Clinical trial; Medical physics; Internal medicine","score_opus":0.026882159760617922,"score_gpt":0.3754371144199064,"score_spread":0.3485549546592885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399182680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8284839,0.07717156,0.0053594094,0.08482177,0.002537327,0.0009746681,0.00023727365,0.000016345983,0.00039775137],"genre_scores_gemma":[0.96056634,0.031375255,0.0010625983,0.005661441,0.0010366039,0.000040999137,0.000004000589,0.000014701261,0.00023806618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986183,0.000026916283,0.0004713566,0.00016102186,0.0005540741,0.00016832529],"domain_scores_gemma":[0.9981204,0.00035816577,0.00034791513,0.000077940815,0.0009237971,0.00017173153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012556578,0.00014599538,0.00050179736,0.00007453202,0.00004067442,0.00002005748,0.0002332921,0.0000875167,0.002355004],"category_scores_gemma":[0.00012650329,0.000079580204,0.0002505135,0.00013458633,0.000113264316,0.000067841574,0.000024699368,0.00017938258,3.8549746e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015612063,0.0001710405,0.043241132,0.000046784673,0.0009255908,0.000032753815,0.0005678997,0.000094673815,0.00087294244,0.00029539553,0.0022094257,0.9359303],"study_design_scores_gemma":[0.053126603,0.013286015,0.18043576,0.0006430819,0.00045263304,0.00018898008,0.00059387466,0.00017736605,0.012265698,0.0017640421,0.7367518,0.00031413615],"about_ca_topic_score_codex":0.00008246203,"about_ca_topic_score_gemma":0.00012379175,"teacher_disagreement_score":0.93561614,"about_ca_system_score_codex":0.00050738023,"about_ca_system_score_gemma":0.0004363693,"threshold_uncertainty_score":0.998557},"labels":[],"label_agreement":null},{"id":"W4399202965","doi":"10.1136/ijgc-2024-005490","title":"Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Conquer Cancer Foundation","keywords":"Medicine; Bowel obstruction; Smartphone application; Oncology; Internal medicine; General surgery; Gynecology; Radiology","score_opus":0.011806832853119231,"score_gpt":0.3036788920926892,"score_spread":0.29187205923957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399202965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992211,0.00084534223,0.0017384588,0.0020759774,0.002514357,0.00037381504,0.000036550115,0.00003986981,0.00016462906],"genre_scores_gemma":[0.9964743,0.00040415418,0.0011261064,0.00022875726,0.0012698747,0.0001562006,0.000020900281,0.000017477863,0.00030219703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986649,0.000019476623,0.00039490726,0.00021330391,0.0004529865,0.00025438695],"domain_scores_gemma":[0.99824625,0.00033779212,0.0002016448,0.00006505594,0.0010388381,0.00011039837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016920475,0.00014680265,0.00023548865,0.00014277193,0.00006804355,0.000043444907,0.00016943667,0.00009738914,0.00030276948],"category_scores_gemma":[0.00020828562,0.000090879425,0.00015705307,0.00013892046,0.00006134073,0.00015563879,0.000023323179,0.00032592996,0.000009298502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005022097,0.00072560296,0.78091514,0.00019259595,0.0013465695,0.00022344144,0.00023328503,0.0015233713,0.012724363,0.002770544,0.0017092315,0.19261374],"study_design_scores_gemma":[0.0026271364,0.005102676,0.9431451,0.00061403844,0.00033013817,0.00027994197,0.00009166801,0.0012243999,0.0038582804,0.0021114673,0.040350344,0.0002648117],"about_ca_topic_score_codex":0.000052039264,"about_ca_topic_score_gemma":0.000029517541,"teacher_disagreement_score":0.19234891,"about_ca_system_score_codex":0.0016077817,"about_ca_system_score_gemma":0.0005499062,"threshold_uncertainty_score":0.42042935},"labels":[],"label_agreement":null},{"id":"W4399517501","doi":"10.1136/ijgc-2024-005588","title":"A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Oncology; Cervical cancer; Internal medicine; Cancer; Urology; Immunotherapy; Nivolumab","score_opus":0.07864419944511089,"score_gpt":0.4285225515594585,"score_spread":0.3498783521143476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399517501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217035,0.0090957275,0.0010397614,0.005703059,0.006739017,0.003678724,0.0005440949,0.00004635908,0.0009828757],"genre_scores_gemma":[0.9910004,0.003296025,0.00071868487,0.00042857215,0.0023334671,0.0012303271,0.00006176172,0.000033532357,0.0008972042],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99611723,0.00015124246,0.0016279066,0.00046969613,0.0011825562,0.00045137006],"domain_scores_gemma":[0.99550325,0.0017428485,0.0007079604,0.00014054787,0.0015466274,0.0003587785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006486006,0.00040977457,0.0019591523,0.00040463428,0.000104079656,0.00009172546,0.00042028798,0.00025411916,0.0021457085],"category_scores_gemma":[0.00070851453,0.0002351387,0.001206669,0.00045488655,0.00027304186,0.00022260338,0.00012477447,0.0005374535,0.000007044305],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85471356,0.0033014682,0.000088856825,0.00016048212,0.004210532,0.00045656424,0.0006139561,0.000054973658,0.00032398445,0.00041822853,0.0012184255,0.13443895],"study_design_scores_gemma":[0.9396681,0.029996313,0.00060896465,0.0013808308,0.0021687774,0.00021897456,0.00012745245,0.0028270106,0.0054701148,0.0010351131,0.016135111,0.0003631895],"about_ca_topic_score_codex":0.00026154402,"about_ca_topic_score_gemma":0.00017199815,"teacher_disagreement_score":0.13407576,"about_ca_system_score_codex":0.0016536324,"about_ca_system_score_gemma":0.0016094631,"threshold_uncertainty_score":0.9987665},"labels":[],"label_agreement":null},{"id":"W4399665924","doi":"10.1136/ijgc-2024-005727","title":"Operative performance indicators: benchmarking gynecological robotic surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Credentialing; Benchmarking; Robotic surgery; Gynecological surgery; Medical physics; General surgery; Process management; Operations management; Surgery; Medical education; Management; Engineering","score_opus":0.04560271936236473,"score_gpt":0.3695530632430817,"score_spread":0.323950343880717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399665924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856262,0.0013886867,0.0005262269,0.0036420054,0.003212021,0.000110627596,0.0000042928195,0.000052618507,0.005437323],"genre_scores_gemma":[0.9952208,0.0008844377,0.0003951659,0.0016658057,0.0014520278,0.000012699828,0.000008497005,0.000012439992,0.00034811808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981367,0.00007575702,0.0006589517,0.00021246393,0.0006896422,0.00022649743],"domain_scores_gemma":[0.9972456,0.00193386,0.00018428062,0.00006006841,0.00037441877,0.00020176373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006690029,0.0001538499,0.00042180394,0.00039539777,0.000058340236,0.0001046099,0.00018478761,0.00015255863,0.0098802475],"category_scores_gemma":[0.0008378926,0.00009746433,0.00033054786,0.00032786187,0.000119048535,0.0002576549,0.000058216534,0.000579649,0.000044005617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070445094,0.00040059088,0.33163583,0.00005689113,0.0010219641,0.0033885941,0.00027142145,0.006462737,0.00017107927,0.0015123312,0.0031623119,0.6512118],"study_design_scores_gemma":[0.0016988043,0.0008472407,0.86454386,0.0008107196,0.00017128838,0.0006432576,0.00010109228,0.015594537,0.0004076889,0.00027217026,0.11463749,0.00027188766],"about_ca_topic_score_codex":0.000002796759,"about_ca_topic_score_gemma":0.0000021904932,"teacher_disagreement_score":0.6509399,"about_ca_system_score_codex":0.00042892076,"about_ca_system_score_gemma":0.00039405233,"threshold_uncertainty_score":0.99102485},"labels":[],"label_agreement":null},{"id":"W4400262625","doi":"10.1136/ijgc-2024-005573","title":"Use of social media for academic and professional purposes by gynecologic oncologists","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Social media; Gynecology; Medical physics; Family medicine; World Wide Web","score_opus":0.2407661417355005,"score_gpt":0.510911527091751,"score_spread":0.27014538535625054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400262625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93004525,0.003140512,0.00008499988,0.03979235,0.02604458,0.0005796675,0.00013984679,0.000027484512,0.00014532452],"genre_scores_gemma":[0.992231,0.0030801708,0.0006431745,0.0006131629,0.003012779,0.0002824347,0.0000090421445,0.000009360669,0.00011887954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998052,0.00025478855,0.0006053825,0.00016488599,0.0006835425,0.00023942548],"domain_scores_gemma":[0.9812507,0.017464725,0.0004561145,0.000026275462,0.0006656271,0.00013654302],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011076756,0.00010008204,0.0002742958,0.00014410948,0.00016815774,0.00006481714,0.00036182278,0.00035395302,0.0006555994],"category_scores_gemma":[0.019208783,0.00007734023,0.00011894117,0.0001670606,0.0005294947,0.0004014685,0.000052147698,0.00043333668,0.0000017369161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007785635,0.0005810163,0.061440766,0.00016967572,0.00044021575,0.00005738456,0.038555767,0.000019411547,0.004181605,0.07421179,0.14887843,0.67068535],"study_design_scores_gemma":[0.00068159995,0.00037013745,0.18306835,0.00018050494,0.00009444777,0.00001042649,0.002916759,0.000055958724,0.0004503616,0.013118635,0.7988367,0.00021611639],"about_ca_topic_score_codex":0.00012617705,"about_ca_topic_score_gemma":0.00030074,"teacher_disagreement_score":0.6704693,"about_ca_system_score_codex":0.0005933609,"about_ca_system_score_gemma":0.0012900926,"threshold_uncertainty_score":0.98905283},"labels":[],"label_agreement":null},{"id":"W4401431893","doi":"10.1136/ijgc-2024-005691","title":"Navigating the complexities of artificial intelligence in scientific writing: a dual perspective","year":2024,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Perspective (graphical); Dual (grammatical number); Artificial intelligence","score_opus":0.1628731875091407,"score_gpt":0.5059870404789913,"score_spread":0.34311385296985064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401431893","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11965378,0.0048560076,0.00015384537,0.017847884,0.85648674,0.00035066344,0.00013893966,0.000014784815,0.0004973565],"genre_scores_gemma":[0.66053736,0.00047568436,0.00024399102,0.00013198011,0.3384326,0.000026638209,0.000025894353,0.000018338853,0.000107487984],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.996105,0.00013474775,0.0016337277,0.00030479016,0.001566524,0.00025519397],"domain_scores_gemma":[0.9909378,0.0031356702,0.00088366034,0.00014509437,0.0048053768,0.0000923503],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017776655,0.000200091,0.00053974055,0.00023854266,0.00008942953,0.00017314624,0.000489313,0.00038164697,0.00068600365],"category_scores_gemma":[0.0066867834,0.00013043129,0.00029664297,0.0003930939,0.00067662605,0.00011919694,0.000118883014,0.0028168198,0.000020018719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027454395,0.0015648055,0.0022982946,0.0006261327,0.0011144179,0.0012955832,0.026731176,0.0011736482,0.00086351804,0.03222453,0.5532562,0.37610623],"study_design_scores_gemma":[0.00039156203,0.0047444426,0.0027977359,0.021757111,0.0009614088,0.00050129154,0.14787038,0.0059075477,0.010340286,0.4260019,0.37750208,0.0012242381],"about_ca_topic_score_codex":0.0013848585,"about_ca_topic_score_gemma":0.0010518696,"teacher_disagreement_score":0.5408836,"about_ca_system_score_codex":0.001428125,"about_ca_system_score_gemma":0.0031140528,"threshold_uncertainty_score":0.9994837},"labels":[],"label_agreement":null},{"id":"W4401789342","doi":"10.1136/ijgc-2024-005936","title":"Enhancing patient care in low-volume practice settings: the crucial role of overseas sub-specialty training","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Specialty; Gynecologic cancer; Patient care; Medical education; Medical physics; Cancer; Nursing; Family medicine; Internal medicine; Ovarian cancer","score_opus":0.010556737827124388,"score_gpt":0.36859023641632327,"score_spread":0.35803349858919886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401789342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580867,0.022336584,0.00050148886,0.008102992,0.005311201,0.00023269313,0.000021627822,0.000014489423,0.0053922166],"genre_scores_gemma":[0.99297935,0.0018716258,0.0010318105,0.0022287131,0.0018290218,0.000011148796,0.0000016433601,0.00000923057,0.000037444013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862283,0.000105647974,0.00053048856,0.00013098803,0.0004642304,0.00014578432],"domain_scores_gemma":[0.9980235,0.0010462386,0.00032656637,0.00005645786,0.00049419043,0.000053028056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042813167,0.00009399556,0.00026467853,0.000113809874,0.000036329802,0.00001834095,0.00018560131,0.00010977059,0.0008069479],"category_scores_gemma":[0.0013615945,0.000057177665,0.0001507706,0.00012606477,0.00013630826,0.00019699645,0.000034131106,0.0005671673,0.0000027262518],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005287595,0.00055575423,0.016662052,0.000108731176,0.0009628474,0.0028731728,0.029806506,0.003991173,0.011449068,0.0024790112,0.0018683961,0.9239557],"study_design_scores_gemma":[0.0039891996,0.004896737,0.063519776,0.0025387271,0.00027433882,0.0016001312,0.033793386,0.0012036016,0.0124741625,0.0024420635,0.87294036,0.0003275001],"about_ca_topic_score_codex":0.000014333344,"about_ca_topic_score_gemma":0.00014868731,"teacher_disagreement_score":0.9236282,"about_ca_system_score_codex":0.0008069677,"about_ca_system_score_gemma":0.0006242187,"threshold_uncertainty_score":0.88355136},"labels":[],"label_agreement":null},{"id":"W4401847181","doi":"10.1136/ijgc-2024-005704","title":"Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Gynecologic oncology; Medicine; Novelty; Relevance (law); Oncology; Family medicine; Internal medicine; Gynecology; Political science","score_opus":0.05096300176144875,"score_gpt":0.37081358492742783,"score_spread":0.3198505831659791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401847181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7494859,0.0076717706,0.000029807878,0.20916684,0.014959156,0.0004431278,0.00007073294,0.000030773463,0.018141892],"genre_scores_gemma":[0.9832268,0.0046555907,0.000080322294,0.009434645,0.0018275821,0.000058566922,0.000009998507,0.000016615873,0.0006899214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977074,0.0005042794,0.000720837,0.0002941468,0.0005461554,0.00022716544],"domain_scores_gemma":[0.9970712,0.0021470962,0.00025387926,0.00017323226,0.00024174184,0.00011282519],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089083,0.00020246179,0.00041923442,0.00009938554,0.00006152695,0.00009597213,0.00064226397,0.00011906173,0.00814989],"category_scores_gemma":[0.00041625754,0.000081952414,0.00032548787,0.00014848555,0.00020565878,0.00008076379,0.00014478248,0.0008141129,0.00014831852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002951044,0.0038669677,0.09931245,0.000030018178,0.0038816652,0.025910025,0.002392886,0.0006301588,0.00045583927,0.021145329,0.24435757,0.5950661],"study_design_scores_gemma":[0.0016110329,0.0013411418,0.46366355,0.00026162894,0.00012848654,0.000101817226,0.00011624183,0.00016633945,0.000178189,0.00071140786,0.5316361,0.00008406352],"about_ca_topic_score_codex":0.0001221512,"about_ca_topic_score_gemma":0.0006598554,"teacher_disagreement_score":0.59498197,"about_ca_system_score_codex":0.0012948377,"about_ca_system_score_gemma":0.00029909465,"threshold_uncertainty_score":0.9927568},"labels":[],"label_agreement":null},{"id":"W4402016419","doi":"10.1136/ijgc-2024-005941","title":"Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Radical Hysterectomy; Hysterectomy; Clinical trial; Invasive surgery; Cancer; Randomized controlled trial; Gynecology; Surgery; General surgery; Internal medicine","score_opus":0.14496160099861677,"score_gpt":0.4707801343949147,"score_spread":0.3258185333962979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402016419","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072982665,0.97866374,0.000028492377,0.0015259479,0.00962945,0.0019323579,0.000746623,0.000019303714,0.00015582248],"genre_scores_gemma":[0.013810455,0.9787112,0.00008930749,0.0006241287,0.0053178533,0.0009978383,0.00006957681,0.000056819375,0.00032284408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606484,0.00029584253,0.0017729189,0.00046770135,0.0009908965,0.00040779624],"domain_scores_gemma":[0.9916027,0.0058854604,0.0014085599,0.00017962237,0.00070869125,0.00021493668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088924024,0.00049441477,0.0022409176,0.00045223915,0.000074243624,0.000257612,0.0007967582,0.00046043747,0.0017195162],"category_scores_gemma":[0.0024616828,0.00024465713,0.0016839185,0.000533274,0.00011542393,0.00018785222,0.0001979116,0.001417217,0.000023922701],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009940551,0.00033810583,0.0007861597,0.0029169465,0.0039369874,0.0005512661,0.000079223406,0.000027589593,7.7375626e-7,0.000029020204,0.0034737077,0.9779197],"study_design_scores_gemma":[0.03775259,0.0019223862,0.0011545331,0.01473386,0.0072372644,0.00016029365,0.000114697046,0.000047387275,0.000008344199,0.0006411721,0.9358506,0.00037682094],"about_ca_topic_score_codex":0.00029278782,"about_ca_topic_score_gemma":0.0009234108,"teacher_disagreement_score":0.9775429,"about_ca_system_score_codex":0.00245949,"about_ca_system_score_gemma":0.0026545348,"threshold_uncertainty_score":0.9991931},"labels":[],"label_agreement":null},{"id":"W4402283491","doi":"10.1136/ijgc-2024-005753","title":"Anastomotic diversion rates following integration of indocyanine green fluorescence angiography in cytoreductive surgery for ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University","funders":"","keywords":"Medicine; Indocyanine green; Anastomosis; Ovarian cancer; Cytoreductive surgery; Angiography; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.037786488762256994,"score_gpt":0.35242529460028776,"score_spread":0.3146388058380308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402283491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145765,0.006545703,0.0005400371,0.0079665715,0.003026497,0.00030640877,0.00008853749,0.000011144352,0.000057452933],"genre_scores_gemma":[0.99705,0.0013526258,0.0008140995,0.00016479428,0.00048257556,0.000068234614,0.000015322961,0.000011070084,0.000041265255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870694,0.0000404828,0.0005169648,0.00019353803,0.00039191663,0.00015014842],"domain_scores_gemma":[0.998572,0.0006111458,0.00022628927,0.000055983888,0.00045785782,0.00007674297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033578405,0.00013058186,0.00039861113,0.0005462774,0.000022309981,0.000029425135,0.00012572449,0.00008282189,0.00034097812],"category_scores_gemma":[0.00021168042,0.000090271125,0.0006037234,0.0003496944,0.00005553812,0.00022630801,0.000028488266,0.00017261866,8.86811e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016809345,0.00071170187,0.75171506,0.00011442228,0.0025260784,0.00090593105,0.00065100536,0.00025966117,0.006879826,0.0006512173,0.0027132493,0.23119092],"study_design_scores_gemma":[0.002349429,0.0007817859,0.98049915,0.0024025273,0.00050407933,0.000042589723,0.00021930246,0.0009916861,0.00980767,0.0010135669,0.001240347,0.00014784028],"about_ca_topic_score_codex":0.0006330348,"about_ca_topic_score_gemma":0.00020728231,"teacher_disagreement_score":0.23104309,"about_ca_system_score_codex":0.00067263417,"about_ca_system_score_gemma":0.00036496154,"threshold_uncertainty_score":0.37334713},"labels":[],"label_agreement":null},{"id":"W4402896741","doi":"10.1136/ijgc-2024-005823","title":"ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Bayer Vital; Chugai Pharmaceutical; Genentech; PharmaMar; Eisai; European Network for Rare Adult Solid Cancers; BeiGene; Arog Pharmaceuticals; Novocure; Sanofi-Aventis Deutschland; Pfizer; Intuitive Surgical; Karyopharm Therapeutics; Gilead Sciences; Symphogen; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Foghorn Therapeutics; Daiichi Sankyo Europe; Iterion Therapeutics; Sanofi; Amgen","keywords":"Medicine; General surgery; Gynecology","score_opus":0.05870867190981867,"score_gpt":0.40260802432545467,"score_spread":0.343899352415636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402896741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684125,0.002696227,0.0026748725,0.022961063,0.002013638,0.00047567248,0.000129006,0.000015189738,0.0006217912],"genre_scores_gemma":[0.99172366,0.00075551367,0.0052238996,0.00068269146,0.00036556297,0.000038639384,0.000010350486,0.000010988042,0.0011886737],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989845,0.000007931243,0.0003843194,0.0001013934,0.00042490926,0.00009691716],"domain_scores_gemma":[0.9985852,0.00014356051,0.00015696422,0.00007029636,0.0009970784,0.000046853907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012227471,0.0000951968,0.00018461708,0.000064743705,0.000020218777,0.000023875316,0.00017746419,0.000026966329,0.00065469055],"category_scores_gemma":[0.00003829347,0.0000422141,0.00013940224,0.0000649685,0.000043935546,0.00006785943,0.00005514985,0.00008490944,0.0000021603012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055564395,0.0013429091,0.20042661,0.00041380443,0.013080038,0.0015607119,0.00010761908,0.0005209525,0.00016557856,0.0046816966,0.02094384,0.7511998],"study_design_scores_gemma":[0.0034855844,0.0015735882,0.6470453,0.0004153531,0.0004487715,0.000065383116,0.000031594725,0.00042657586,0.00021350302,0.00032932783,0.3458908,0.00007425071],"about_ca_topic_score_codex":0.0000095722635,"about_ca_topic_score_gemma":0.000007585777,"teacher_disagreement_score":0.7511256,"about_ca_system_score_codex":0.00012900661,"about_ca_system_score_gemma":0.00005173236,"threshold_uncertainty_score":0.71684027},"labels":[],"label_agreement":null},{"id":"W4402896743","doi":"10.1136/ijgc-2024-005484","title":"Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Genentech; PharmaMar; Eisai; Natera; Seagen; MacroGenics; Tarveda Therapeutics; Mersana Therapeutics; Clovis Oncology; Novocure; Pfizer; Intuitive Surgical; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Carboplatin; Medicine; Endometrial cancer; Placebo; Clinical endpoint; Internal medicine; Quality of life (healthcare); Population; Oncology; Paclitaxel; Chemotherapy; Microsatellite instability; Cancer; Randomized controlled trial; Surgery; Urology; Pathology","score_opus":0.02813212996517463,"score_gpt":0.32254755394392143,"score_spread":0.2944154239787468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402896743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993216,0.0011472647,0.000027879347,0.002234322,0.00063829945,0.0024995378,0.00014140649,0.00002676384,0.000068536014],"genre_scores_gemma":[0.9972739,0.00070106937,0.00034169824,0.0009960714,0.00018959725,0.00030157831,0.00014177745,0.000030470012,0.000023829778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99576324,0.0003068602,0.0013306971,0.0004417779,0.0018197083,0.00033774378],"domain_scores_gemma":[0.99681646,0.0012207893,0.000837051,0.0002637124,0.00077322754,0.000088779096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067016354,0.00037887867,0.0010365554,0.00045625033,0.000056214176,0.00007401269,0.0003610282,0.00012845662,0.0004014929],"category_scores_gemma":[0.0002504685,0.00014965897,0.0002458552,0.0014641358,0.00019325111,0.00024852218,0.000026652155,0.00057336007,6.303066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36782134,0.003521028,0.5910414,0.00006652718,0.0011184586,0.00034803344,0.001520321,0.00055922684,0.00008506588,0.00001432783,0.00003167724,0.033872604],"study_design_scores_gemma":[0.15299201,0.010554351,0.8331565,0.00061264256,0.0002860176,0.000041418192,0.00034297307,0.0000453586,0.0003051263,0.00003647939,0.0014089345,0.00021819554],"about_ca_topic_score_codex":0.001120781,"about_ca_topic_score_gemma":0.0016615462,"teacher_disagreement_score":0.2421151,"about_ca_system_score_codex":0.0015268574,"about_ca_system_score_gemma":0.00062122574,"threshold_uncertainty_score":0.61029154},"labels":[],"label_agreement":null},{"id":"W4403239841","doi":"10.1136/ijgc-2024-005919","title":"GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Verastem Oncology; GOG Foundation; Australia New Zealand Gynaecological Oncology Group; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Ovarian cancer; Serous fluid; Regimen; Oncology; Internal medicine; Discontinuation; KRAS; Tolerability; Clinical trial; Clinical endpoint; Progression-free survival; Adverse effect; Cancer; Chemotherapy; Colorectal cancer","score_opus":0.07159507315498903,"score_gpt":0.40996909379088864,"score_spread":0.3383740206358996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403239841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971975,0.0023251204,0.00006108808,0.0033032645,0.0019969526,0.0022616775,0.00017662307,0.00002547552,0.0001300255],"genre_scores_gemma":[0.996146,0.0007214915,0.0010700679,0.00040982498,0.0006837534,0.00081780454,0.000054506487,0.0000369316,0.000059590606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962154,0.0003443641,0.0013238399,0.00047219085,0.001289384,0.0003548214],"domain_scores_gemma":[0.99598855,0.0015843615,0.00094861945,0.00017938095,0.0009271101,0.00037199364],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070673926,0.00041518293,0.0015147617,0.0003993467,0.000048868766,0.00009279328,0.00024566884,0.00013731243,0.0013813358],"category_scores_gemma":[0.00080806477,0.00023253779,0.00036706525,0.00039853094,0.00022431284,0.00018063557,0.000041847055,0.00046716005,0.0000032361615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82182103,0.0055377614,0.099198274,0.00012323743,0.005641603,0.0005053148,0.0010577618,0.004102197,0.000070461014,0.00013544384,0.00041141527,0.06139552],"study_design_scores_gemma":[0.9137107,0.017249594,0.059902824,0.0025347811,0.0015590248,0.000031648655,0.000072364266,0.0025961015,0.0003975327,0.000094252326,0.0015472568,0.00030388063],"about_ca_topic_score_codex":0.0010283443,"about_ca_topic_score_gemma":0.00081592164,"teacher_disagreement_score":0.091889724,"about_ca_system_score_codex":0.0038604909,"about_ca_system_score_gemma":0.0029332028,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W4403276721","doi":"10.1136/ijgc-2024-005883","title":"Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Observational study; Checklist; Interquartile range; Systematic review; MEDLINE; Ovarian cancer; Meta-analysis; Internal medicine; Cancer","score_opus":0.17106095717308906,"score_gpt":0.5313054002840988,"score_spread":0.3602444431110097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403276721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038928553,0.98971695,0.0000023678306,0.0044028964,0.0018798595,0.0034889956,0.000101496655,0.0000040537593,0.000014109121],"genre_scores_gemma":[0.001829273,0.9933685,0.00023128983,0.0004072856,0.00022155982,0.0038495392,0.000007875373,0.000020725369,0.00006394928],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965564,0.0001815833,0.0022599387,0.0003299827,0.0005134591,0.00015864168],"domain_scores_gemma":[0.995866,0.000820614,0.0021002723,0.00012471412,0.0010228957,0.00006549294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007077756,0.00034235386,0.0043635587,0.00037516677,0.000014885427,0.0000150101205,0.00012852841,0.00016625751,0.000035372646],"category_scores_gemma":[0.00096466346,0.00017596793,0.00055351044,0.00022699701,0.000055636738,0.00007884771,0.000079791054,0.0004717038,2.4638484e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011117913,0.0010035504,0.0033304202,0.8422372,0.03378906,0.00096086896,0.00048322734,0.000007921675,2.6737018e-7,0.00018951195,0.0010741863,0.11681262],"study_design_scores_gemma":[0.0025127262,0.0013940149,0.0058216485,0.9249117,0.032502312,0.00029830285,0.0008535124,0.000005348717,0.000001619092,0.00018865257,0.031213215,0.00029697115],"about_ca_topic_score_codex":0.000044785575,"about_ca_topic_score_gemma":0.00034558194,"teacher_disagreement_score":0.116515644,"about_ca_system_score_codex":0.004355283,"about_ca_system_score_gemma":0.00090863043,"threshold_uncertainty_score":0.99946684},"labels":[],"label_agreement":null},{"id":"W4403533274","doi":"10.1136/ijgc-2024-igcs.50","title":"PR008/#179  Predictors of specialist palliative care access and impact on aggressiveness of end-of-life care: a population-based study of gynecologic cancer decedents in Ontario, Canada from 2006–2018","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gynecologic cancer; Palliative care; End-of-life care; Medicine; Population; Cancer; Gerontology; Nursing; Environmental health; Ovarian cancer; Internal medicine","score_opus":0.0881640913171135,"score_gpt":0.43549598989701815,"score_spread":0.34733189857990465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403533274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902684,0.0065634944,0.000009056446,0.00013581628,0.0014130487,0.00036331982,0.0011429306,0.0000031134525,0.000100822544],"genre_scores_gemma":[0.9991101,0.00047479328,0.000057847694,0.00007278673,0.00018161666,0.000023855202,0.000057741992,0.000012061999,0.000009179526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973093,0.00012869826,0.0011279277,0.00023362471,0.0010416895,0.00015871131],"domain_scores_gemma":[0.9958618,0.0012874703,0.0012317637,0.00011214658,0.0013839211,0.00012287311],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013002778,0.00021418538,0.00094683265,0.0003081497,0.000016863716,0.000011904102,0.00035302932,0.00012452336,0.0012374897],"category_scores_gemma":[0.0008181256,0.00014702606,0.00018124844,0.00022415396,0.00011407444,0.000111511494,0.000074138086,0.0003065099,8.529053e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023074062,0.00041543302,0.98456466,0.00017145013,0.0009875164,0.0001443942,0.0029803347,0.006228839,0.00017372116,0.000009935539,0.00017374622,0.0018425802],"study_design_scores_gemma":[0.002900227,0.0016427996,0.98755735,0.0025906456,0.00022872043,6.1329774e-7,0.0022730078,0.000052536456,0.0024223048,0.000045808207,0.00017813075,0.00010784293],"about_ca_topic_score_codex":0.8032853,"about_ca_topic_score_gemma":0.939899,"teacher_disagreement_score":0.13661373,"about_ca_system_score_codex":0.0026274712,"about_ca_system_score_gemma":0.0036424608,"threshold_uncertainty_score":0.9996755},"labels":[],"label_agreement":null},{"id":"W4403533428","doi":"10.1136/ijgc-2024-igcs.82","title":"PR040/#437  Impact of hormone therapy use on survival outcomes of ovarian cancer in British Columbia","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Hormone therapy; Oncology; Ovarian cancer; Medicine; Overall survival; Internal medicine; Computer science; Breast cancer","score_opus":0.04559295242723059,"score_gpt":0.3772053781750264,"score_spread":0.3316124257477958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403533428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075526,0.0047142105,0.000009548874,0.0024298197,0.0013076004,0.00021187562,0.00035686942,0.000007884473,0.00020693814],"genre_scores_gemma":[0.9867949,0.012240571,0.00010380676,0.00025097278,0.00026297278,0.00003388317,0.0000049708015,0.000016168162,0.00029175475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982655,0.00006065544,0.00068146014,0.00018612843,0.0006398802,0.00016637858],"domain_scores_gemma":[0.9984483,0.00055488886,0.0003057087,0.00009446203,0.0004935615,0.0001030436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027103454,0.00012194849,0.00061724824,0.00015028284,0.000012983305,0.00009344307,0.00018018215,0.00010580517,0.004186867],"category_scores_gemma":[0.00020371862,0.00010291625,0.00043235486,0.00018348265,0.00007985427,0.0001526466,0.000028427079,0.00027600618,0.0000018623194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006355986,0.001074882,0.93551064,0.000011832052,0.0016811967,0.0008746244,0.000076793534,0.00041874504,0.000500911,0.00007286721,0.0032534676,0.055888455],"study_design_scores_gemma":[0.003832601,0.001958563,0.9917279,0.00042770352,0.00008259535,0.000047590976,0.000018604027,0.000060112347,0.00015821897,0.00020465777,0.0013957378,0.000085722204],"about_ca_topic_score_codex":0.03486857,"about_ca_topic_score_gemma":0.019468807,"teacher_disagreement_score":0.056217268,"about_ca_system_score_codex":0.0010160111,"about_ca_system_score_gemma":0.0006187996,"threshold_uncertainty_score":0.99842334},"labels":[],"label_agreement":null},{"id":"W4403533849","doi":"10.1136/ijgc-2024-igcs.22","title":"PO009/#913  Implementation of a virtual provincial gynecologic cancer prevention and survivorship clinic (GCPSC) in Canada","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gynecologic cancer; Survivorship curve; Cancer survivorship; Cancer; Medicine; Internal medicine; Ovarian cancer","score_opus":0.027159695856889172,"score_gpt":0.37246807996834314,"score_spread":0.345308384111454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403533849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899394,0.0033662363,0.00005119426,0.0031094651,0.0038889938,0.00024723687,0.000100651356,0.000008602063,0.00023367333],"genre_scores_gemma":[0.9966725,0.0019103329,0.00003380284,0.0005597497,0.0004979552,0.00004892509,0.000010321318,0.000011880646,0.0002545141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979995,0.0001166538,0.0008166429,0.00021520266,0.00065425364,0.00019774117],"domain_scores_gemma":[0.99860394,0.00044792236,0.0003323319,0.000060651964,0.00044218515,0.000112969756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055157417,0.00014352014,0.00039545426,0.00021504967,0.000018826406,0.000029521969,0.00017125075,0.00010066463,0.0043441793],"category_scores_gemma":[0.00019811785,0.00011011429,0.00014057614,0.00020361264,0.000060926046,0.00017194815,0.000060543494,0.00037582082,0.0000015344281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007919543,0.00012874733,0.72554594,0.00012589827,0.00037737243,0.00047960054,0.0005902036,0.000073928786,0.0007655681,0.00034279772,0.0012161807,0.2695618],"study_design_scores_gemma":[0.0018530237,0.0011846072,0.98694724,0.00044715786,0.00015006101,0.00007906089,0.0021763581,0.00014316617,0.00088405923,0.0005496832,0.005425852,0.00015971455],"about_ca_topic_score_codex":0.5614643,"about_ca_topic_score_gemma":0.9819537,"teacher_disagreement_score":0.42048937,"about_ca_system_score_codex":0.001910749,"about_ca_system_score_gemma":0.00458669,"threshold_uncertainty_score":0.996566},"labels":[],"label_agreement":null},{"id":"W4403533907","doi":"10.1136/ijgc-2024-igcs.205","title":"EV086/#1279  Oncologic outcomes following open versus minimally invasive radical surgery for early cervical cancer in Nova Scotia – a retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Retrospective cohort study; Nova scotia; Cohort; Cervical cancer; Surgery; Cancer; Internal medicine","score_opus":0.07720427711670995,"score_gpt":0.4154742630225502,"score_spread":0.33826998590584023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403533907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799691,0.0015027162,0.000021879154,0.0065086978,0.009333939,0.001678658,0.00010916517,0.000027853739,0.0008479781],"genre_scores_gemma":[0.99698925,0.00026462722,0.0003181823,0.0009225407,0.00084204273,0.00034176433,0.000011756539,0.00003209122,0.00027777062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652195,0.00016408021,0.0011250187,0.0005553083,0.0012124612,0.00042115754],"domain_scores_gemma":[0.99438447,0.0042209807,0.0003373808,0.00013660938,0.0006465121,0.00027407322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012642153,0.00031607645,0.0013712472,0.0004996072,0.000050742678,0.00021115712,0.00064815744,0.00022414199,0.0037191461],"category_scores_gemma":[0.0033593297,0.0002082679,0.00077799597,0.000602179,0.000101354424,0.00038870028,0.00025364404,0.0006384429,0.00002093972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072839446,0.0015567722,0.9744575,0.000030070605,0.0038157532,0.0030083794,0.00015954832,0.00002762975,0.000070618895,0.00007875532,0.00090632687,0.008604705],"study_design_scores_gemma":[0.012573194,0.0038323433,0.9807734,0.00039315858,0.00067216525,0.000023142227,0.00014610347,0.000023058175,0.000089243964,0.00043775293,0.0008198324,0.0002166156],"about_ca_topic_score_codex":0.0026118567,"about_ca_topic_score_gemma":0.008334052,"teacher_disagreement_score":0.017020112,"about_ca_system_score_codex":0.0039051177,"about_ca_system_score_gemma":0.0015100223,"threshold_uncertainty_score":0.9999187},"labels":[],"label_agreement":null},{"id":"W4403637538","doi":"10.1136/ijgc-2024-005976","title":"How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Duration (music); Ovarian cancer; Term (time); Oncology; Cancer; Internal medicine; Intensive care medicine","score_opus":0.09070783638145405,"score_gpt":0.36343949108522,"score_spread":0.2727316547037659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403637538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95298743,0.00023217,0.0011008637,0.043233752,0.0016650233,0.0004961915,0.00018639883,0.000015980724,0.000082164624],"genre_scores_gemma":[0.99561274,0.0017281644,0.0003205968,0.0017043031,0.0003652481,0.00011806776,0.000050997474,0.000026875137,0.000072977986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975558,0.0002721059,0.0006251741,0.00033447225,0.0010098756,0.00020259751],"domain_scores_gemma":[0.9959757,0.0013167462,0.0007256085,0.00014350955,0.0017360842,0.000102350205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081725663,0.00024312378,0.0003731584,0.0002814762,0.000064003725,0.00017467789,0.0002119082,0.00009051706,0.00026756583],"category_scores_gemma":[0.00053163804,0.00013642311,0.0000809314,0.00026741435,0.00012076656,0.0011039403,0.000036020796,0.00058556313,8.0675676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007320169,0.00069200865,0.95114887,0.000015674872,0.001145911,0.00017789182,0.0013429003,0.00017966397,0.00007725831,0.00044469084,0.00019582821,0.03725912],"study_design_scores_gemma":[0.004352866,0.0015480275,0.9909251,0.0010661726,0.00005811108,0.000047782967,0.00017450111,0.00017031256,0.0009902258,0.000052422332,0.00044817818,0.00016633078],"about_ca_topic_score_codex":0.0001246434,"about_ca_topic_score_gemma":0.0008350941,"teacher_disagreement_score":0.04262531,"about_ca_system_score_codex":0.0009134162,"about_ca_system_score_gemma":0.00032014487,"threshold_uncertainty_score":0.5563173},"labels":[],"label_agreement":null},{"id":"W4403782309","doi":"10.1136/ijgc-2024-005916","title":"Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of British Columbia Hospital","funders":"Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"Medicine; Endometrial cancer; Classifier (UML); Oncology; Internal medicine; Gynecology; Cancer; Artificial intelligence","score_opus":0.0625426196462945,"score_gpt":0.3867021664053225,"score_spread":0.324159546759028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403782309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898548,0.0033817294,0.00021450272,0.0031890904,0.002448678,0.00016452711,0.00005324466,0.0000152030925,0.00067820726],"genre_scores_gemma":[0.99557906,0.0021132375,0.0005127043,0.00064636057,0.0009693961,0.000018271287,0.000006353833,0.000012831198,0.00014179663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981084,0.00006791489,0.00078245695,0.000203676,0.00069145975,0.00014608032],"domain_scores_gemma":[0.99745804,0.001404139,0.0003001028,0.000071540184,0.0006061898,0.00015999224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047102972,0.00013554907,0.00044117772,0.00032020043,0.00001889646,0.000041176485,0.00015240035,0.00013713431,0.001821578],"category_scores_gemma":[0.0014884856,0.00008896715,0.00029177568,0.00034781097,0.00013399578,0.00014141951,0.000043651035,0.0002947484,0.0000041343737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054499093,0.0017890326,0.5562743,0.00019224959,0.0018297083,0.0005824362,0.000035979116,0.00020879,0.04660978,0.00018225031,0.00078676286,0.3860588],"study_design_scores_gemma":[0.02588706,0.017091136,0.7215535,0.0021030477,0.0019864663,0.00026274275,0.000037369122,0.0044060224,0.19848786,0.00062865793,0.027078688,0.0004774705],"about_ca_topic_score_codex":0.000029466635,"about_ca_topic_score_gemma":0.0000067277483,"teacher_disagreement_score":0.38558134,"about_ca_system_score_codex":0.00038046335,"about_ca_system_score_gemma":0.00039198177,"threshold_uncertainty_score":0.9990909},"labels":[],"label_agreement":null},{"id":"W4404038575","doi":"10.1136/ijgc-2024-005982","title":"How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Western University; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Cancer Care South East","funders":"Anhui University of Science and Technology; Cancer Research UK; National Cancer Institute; National Cancer Research Institute","keywords":"Medicine; Clinical trial; Inclusion (mineral); Ethnic group; Health equity; Population; Gynecologic cancer; Family medicine; MEDLINE; Diversity (politics); Gerontology; Cancer; Nursing; Internal medicine; Environmental health; Ovarian cancer; Public health","score_opus":0.7574953304185128,"score_gpt":0.6849006878381808,"score_spread":0.07259464258033199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404038575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82372785,0.004653439,0.000284573,0.16697836,0.0034745277,0.0004315963,0.00009269799,0.000014311934,0.0003426305],"genre_scores_gemma":[0.9707496,0.019055096,0.001478104,0.0065275165,0.0014557503,0.00004056495,0.0000033805456,0.000012585622,0.0006773645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946371,0.0013584577,0.001442374,0.0004259868,0.0018379336,0.00029820247],"domain_scores_gemma":[0.9379522,0.059695594,0.00045467858,0.00016276831,0.001373073,0.00036167252],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02668562,0.00016609504,0.0007438769,0.0001536902,0.00009929147,0.0002315006,0.0007205106,0.000322728,0.0022533564],"category_scores_gemma":[0.10711132,0.00009014174,0.00032863015,0.0002057093,0.00028233856,0.00021196912,0.0010413324,0.002465627,0.0000122992005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036717816,0.00043069507,0.76729965,0.00005121938,0.0018865498,0.0017019458,0.0007270113,0.00094734016,0.00040666029,0.00084793393,0.009052057,0.21297713],"study_design_scores_gemma":[0.0055460883,0.0014667751,0.9324449,0.0016413021,0.00041207328,0.000022237586,0.00068832294,0.003456893,0.0001036716,0.03232548,0.021655424,0.00023685295],"about_ca_topic_score_codex":0.0005564285,"about_ca_topic_score_gemma":0.0018694636,"teacher_disagreement_score":0.21274027,"about_ca_system_score_codex":0.00079033006,"about_ca_system_score_gemma":0.00086874387,"threshold_uncertainty_score":0.9998357},"labels":[],"label_agreement":null},{"id":"W4405446733","doi":"10.1136/ijgc-2024-igcs.367","title":"EV248/#846  Canadian survey of surgeons’ knowledge and attitudes towards opportunistic salpingectomy during non-gynecologic surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Salpingectomy; Medicine; Surgery; Pregnancy","score_opus":0.08724833695448767,"score_gpt":0.3995602692417485,"score_spread":0.31231193228726084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405446733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879664,0.007937883,0.000014181211,0.0016793098,0.0009626741,0.0001776703,0.00015027497,0.000012682249,0.0010988829],"genre_scores_gemma":[0.99011254,0.009163002,0.00006626147,0.00010322063,0.00016160418,0.000022079983,0.000024886493,0.0000139873055,0.00033243868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982032,0.00014087238,0.00060466933,0.00020966819,0.0005257663,0.00031581946],"domain_scores_gemma":[0.99363905,0.0044486616,0.00016713292,0.00008538986,0.0011384023,0.00052133965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012875398,0.00016010845,0.000567445,0.0009206837,0.000049927025,0.00006144318,0.00017718677,0.000114180984,0.0019428862],"category_scores_gemma":[0.0069826855,0.000108036795,0.00021997788,0.0003699873,0.00014447006,0.000117303825,0.000076190314,0.0003453008,0.0000123228665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034576765,0.00032664303,0.9565173,0.00018951307,0.0012523085,0.003866585,0.000048645376,0.00000932169,0.000443914,0.00004749098,0.0029152844,0.034037217],"study_design_scores_gemma":[0.0007306891,0.00036256434,0.99313444,0.0003846237,0.000071542774,0.0003254232,0.000011031615,0.00006492063,0.0004577765,0.000045759487,0.0043156426,0.00009558736],"about_ca_topic_score_codex":0.017190661,"about_ca_topic_score_gemma":0.048774857,"teacher_disagreement_score":0.03661713,"about_ca_system_score_codex":0.0010152551,"about_ca_system_score_gemma":0.0028266306,"threshold_uncertainty_score":0.9989695},"labels":[],"label_agreement":null},{"id":"W4405948797","doi":"10.1016/j.ijgc.2024.100033","title":"Laparoscopic bariatric surgery with hysterectomy for endometrial cancer to improve long-term outcomes: A review article","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Endometrial cancer; Hysterectomy; General surgery; Term (time); Gynecology; Cancer; Surgery; Internal medicine","score_opus":0.10128892619362521,"score_gpt":0.43135596698779505,"score_spread":0.3300670407941698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405948797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003110467,0.9804671,0.00009764639,0.0032066798,0.010984491,0.0018504799,0.00021548267,0.000031901443,0.000035751986],"genre_scores_gemma":[0.0012400268,0.99089247,0.0001692279,0.0027258953,0.0032497717,0.0008817967,0.00002451721,0.00006394984,0.00075232075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960843,0.00015441688,0.0019409865,0.0004787912,0.00091221934,0.0004293326],"domain_scores_gemma":[0.99352396,0.0037127773,0.0012298331,0.00022708905,0.0009359494,0.0003703912],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001141424,0.0005279374,0.0041601188,0.00085977983,0.000039988874,0.00010013256,0.00046978577,0.00029865096,0.0015279824],"category_scores_gemma":[0.002777544,0.00027361346,0.0021068759,0.00085392257,0.00004644204,0.00013839363,0.00012026152,0.0007470843,0.000048471997],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057323114,0.00027352455,0.037194967,0.024679609,0.0051308707,0.00095927174,0.000012438333,0.0000013477514,0.0000013634478,0.000023839482,0.013281674,0.91786784],"study_design_scores_gemma":[0.00281768,0.0008251367,0.0084080035,0.07470419,0.015625691,0.0005659418,0.0000038392136,0.0000012594918,0.000010315288,0.00002002074,0.8964519,0.000566046],"about_ca_topic_score_codex":0.000031306725,"about_ca_topic_score_gemma":0.000043271913,"teacher_disagreement_score":0.91730183,"about_ca_system_score_codex":0.0011724213,"about_ca_system_score_gemma":0.0022598724,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W4405948803","doi":"10.1016/j.ijgc.2024.100030","title":"Prognostic significance and accuracy of oncologists’ estimates of survival time in recurrent ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.03854051515351675,"score_gpt":0.37859451134333816,"score_spread":0.3400539961898214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405948803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97269404,0.015390092,0.000098396566,0.009064841,0.0016818212,0.00034621838,0.00011915123,0.000011148942,0.0005942905],"genre_scores_gemma":[0.99314785,0.005412456,0.0009682853,0.000103013,0.00024255499,0.00005895482,0.0000044453564,0.000009907145,0.0000525101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984928,0.000051216328,0.0006763209,0.00019293277,0.0004424878,0.00014425171],"domain_scores_gemma":[0.9975438,0.001473494,0.0003711446,0.000067004476,0.00045517605,0.00008938711],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035436,0.00013547212,0.0005181951,0.00018881733,0.00001040999,0.000022323957,0.00015667047,0.00008684808,0.0014881436],"category_scores_gemma":[0.00085968815,0.000091179616,0.00012852965,0.00017254088,0.00014961208,0.00010701811,0.000052138512,0.00023595466,0.000002427004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014053928,0.00141162,0.7492343,0.00032764516,0.001196287,0.0010765512,0.00035262833,0.0004492686,0.005046385,0.0012529878,0.0011301577,0.23711674],"study_design_scores_gemma":[0.002236335,0.0016056402,0.9846708,0.0020741671,0.00028835706,0.00007371338,0.00004505226,0.0010202541,0.0035874506,0.0012618459,0.0030175005,0.00011887557],"about_ca_topic_score_codex":0.00023490057,"about_ca_topic_score_gemma":0.00012593817,"teacher_disagreement_score":0.23699786,"about_ca_system_score_codex":0.0005155987,"about_ca_system_score_gemma":0.0006561954,"threshold_uncertainty_score":0.99942464},"labels":[],"label_agreement":null},{"id":"W4405949197","doi":"10.1016/j.ijgc.2024.100017","title":"Artificial intelligence-enhanced magnetic resonance imaging-based pre-operative staging in patients with endometrial cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Agence Nationale de la Recherche; Fondation de l'Avenir pour la Recherche Médicale Appliquée","keywords":"Medicine; Endometrial cancer; Radiology; Oncology; General surgery; Cancer; Internal medicine","score_opus":0.023036007020801726,"score_gpt":0.34529169189778014,"score_spread":0.3222556848769784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405949197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97708195,0.011964068,0.0020663415,0.004325495,0.0033082187,0.0005751932,0.00014584952,0.00003608239,0.000496772],"genre_scores_gemma":[0.9971103,0.000416065,0.00050075946,0.00087674725,0.00084792,0.00009935064,0.000013127837,0.000022500748,0.00011322266],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745816,0.00008465115,0.00076729694,0.00034013137,0.0010465635,0.0003032139],"domain_scores_gemma":[0.9981456,0.00059326563,0.00019513702,0.00009265413,0.00081054145,0.00016283884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028157205,0.00023190674,0.00047850338,0.00060789404,0.00003604054,0.00010858332,0.00026473572,0.00008014417,0.004230084],"category_scores_gemma":[0.000498286,0.00014535278,0.00017931683,0.0007961081,0.00013506912,0.00024385698,0.000044257147,0.00051144965,0.000011182409],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011558952,0.0007926956,0.31199917,0.000026983884,0.00017740413,0.000515757,0.00019845398,0.001418842,0.00017698588,0.00018096811,0.000112101305,0.67284167],"study_design_scores_gemma":[0.008125373,0.0044894717,0.9692133,0.0016249717,0.0002646043,0.000013358324,0.00009845443,0.0020142666,0.008102447,0.0012373163,0.004423028,0.00039339048],"about_ca_topic_score_codex":0.00017819088,"about_ca_topic_score_gemma":0.00017629782,"teacher_disagreement_score":0.6724483,"about_ca_system_score_codex":0.0013228133,"about_ca_system_score_gemma":0.00064317154,"threshold_uncertainty_score":0.9966802},"labels":[],"label_agreement":null},{"id":"W4405949675","doi":"10.1016/j.ijgc.2024.100001","title":"Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of British Columbia; Queen's University; Centre Hospitalier Universitaire de Sherbrooke; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Hysterectomy; Cervical cancer; Exploratory analysis; Invasive surgery; Oncology; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.0704194863402348,"score_gpt":0.36560962539060404,"score_spread":0.2951901390503692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405949675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832127,0.003607554,0.000025420912,0.0050254394,0.0047404263,0.001628501,0.0016736786,0.000029888322,0.000056369205],"genre_scores_gemma":[0.9896995,0.0011809414,0.00013047106,0.005578879,0.0019392958,0.0011665671,0.00022055596,0.000050262403,0.00003357356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941917,0.0010820163,0.0019011756,0.0008191786,0.0013597198,0.0006462066],"domain_scores_gemma":[0.992292,0.004876453,0.0008744543,0.00031038202,0.0008417891,0.0008049581],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019136429,0.00051323,0.002252402,0.0010026902,0.00014381233,0.00047815067,0.001283885,0.00026396586,0.010665125],"category_scores_gemma":[0.0020766219,0.00028690134,0.0009773835,0.0018837386,0.000107083426,0.00069443625,0.0002785278,0.0008296432,0.000014360705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050118376,0.0008021342,0.88534176,0.000021188538,0.009796594,0.0006529173,0.0006524487,0.0009638025,0.000073276424,0.0000073034166,0.0015899953,0.0499802],"study_design_scores_gemma":[0.03331339,0.0018225715,0.95586956,0.0009872044,0.003441522,0.0000019362496,0.00038420002,0.0002843679,0.00012424607,0.0002082801,0.0031025994,0.00046015173],"about_ca_topic_score_codex":0.12901999,"about_ca_topic_score_gemma":0.62455976,"teacher_disagreement_score":0.49553975,"about_ca_system_score_codex":0.0039952355,"about_ca_system_score_gemma":0.0028734761,"threshold_uncertainty_score":0.99995834},"labels":[],"label_agreement":null},{"id":"W4405962925","doi":"10.1016/j.ijgc.2024.100009","title":"Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.11711469803318757,"score_gpt":0.45289664239862987,"score_spread":0.3357819443654423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405962925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057581372,0.98365295,0.000007774717,0.009949865,0.002257623,0.0022834737,0.0016394523,0.000011698335,0.00013959825],"genre_scores_gemma":[0.0012790522,0.9953456,0.00015441132,0.0007279844,0.0011090135,0.00095429324,0.00009088533,0.000049685954,0.0002890823],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99182504,0.0008908066,0.005307542,0.00045752892,0.0012424256,0.00027666296],"domain_scores_gemma":[0.9915461,0.0025506443,0.004682964,0.00029116898,0.0007015635,0.00022757203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002363889,0.0005585364,0.0088115,0.0005411136,0.000020724869,0.000065324784,0.00059534906,0.00036172243,0.0057937778],"category_scores_gemma":[0.0030188928,0.00030481175,0.0019653994,0.00040883216,0.00007688799,0.00007570801,0.00011257549,0.00095002074,0.00001614151],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068304816,0.0012458417,0.000029240608,0.6721714,0.014634517,0.0037553315,0.00013761042,0.000004397765,0.000006071886,0.0003830294,0.006810238,0.30013928],"study_design_scores_gemma":[0.004110223,0.0005351895,0.000018291465,0.7451826,0.017925212,0.00009350276,0.0000232107,0.000004102093,0.000003824339,0.00020797979,0.23169062,0.00020525284],"about_ca_topic_score_codex":0.0011043902,"about_ca_topic_score_gemma":0.0007942652,"teacher_disagreement_score":0.299934,"about_ca_system_score_codex":0.0029351013,"about_ca_system_score_gemma":0.0027091356,"threshold_uncertainty_score":0.9999404},"labels":[],"label_agreement":null},{"id":"W4406063341","doi":"10.1016/j.ijgc.2024.101625","title":"Perspectives on inclusion, diversity, equity, and access in clinical trials: findings from a 6-continent survey","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Equity (law); Inclusion (mineral); Diversity (politics); Gender equity; Family medicine; Clinical trial; Demographic economics; Internal medicine; Gender studies; Anthropology","score_opus":0.7356856616081492,"score_gpt":0.7092116227082033,"score_spread":0.02647403889994593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406063341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9356778,0.0008874394,0.00012476995,0.05981985,0.0013730929,0.0001877451,0.000043072807,0.0000057757343,0.0018804325],"genre_scores_gemma":[0.9845166,0.009424752,0.00014106827,0.005241507,0.00037217958,0.000004848963,0.0000037085363,0.00000459472,0.00029071458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534625,0.0011213248,0.0014261211,0.00032425375,0.0016075681,0.00017448161],"domain_scores_gemma":[0.9233452,0.07348528,0.0005470179,0.0001517403,0.0022494784,0.00022128096],"candidate_categories":["metaresearch","open_science","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.030872079,0.00011481111,0.0007487673,0.00033459006,0.00011109322,0.00010820889,0.0011061307,0.00036865592,0.0010865116],"category_scores_gemma":[0.2005245,0.00007779184,0.00024947946,0.00019785631,0.00031718073,0.00013022278,0.01427543,0.0021783058,0.0000032052615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005265832,0.0008482066,0.9636123,0.00001101931,0.00038191862,0.00024466653,0.0003050411,0.000010921648,0.00005069528,0.0028753174,0.0018109562,0.024583116],"study_design_scores_gemma":[0.004016322,0.00052749953,0.9129538,0.00046697858,0.000045516223,0.0000026847656,0.00015979135,0.00005846614,0.000053173986,0.08123411,0.00042141532,0.000060226223],"about_ca_topic_score_codex":0.0010237497,"about_ca_topic_score_gemma":0.0031580091,"teacher_disagreement_score":0.16965242,"about_ca_system_score_codex":0.00064122677,"about_ca_system_score_gemma":0.0006774348,"threshold_uncertainty_score":0.9998266},"labels":[],"label_agreement":null},{"id":"W4406320384","doi":"10.1016/j.ijgc.2025.101635","title":"Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Janet D. Cottrelle Foundation; BC Cancer Foundation; Victoria General Hospital Foundation; University of British Columbia; VGH and UBC Hospital Foundation","keywords":"Medicine; Fallopian tube; Gynecology; Reduction (mathematics); Obstetrics; Tube (container)","score_opus":0.022909444462998283,"score_gpt":0.33842010651214793,"score_spread":0.3155106620491496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406320384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821616,0.0002683156,0.000019122788,0.016440876,0.0003414065,0.00019943787,0.000029662855,0.0000036420763,0.0005359467],"genre_scores_gemma":[0.9972893,0.00018477948,0.000113227215,0.0020219223,0.00014840547,0.000027495746,0.0000028108518,0.0000040041846,0.00020803102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895346,0.000091123264,0.0002911346,0.00011764471,0.0004397727,0.00010687072],"domain_scores_gemma":[0.998188,0.00082880486,0.00025988862,0.00006274282,0.000627224,0.00003329834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019100233,0.00009877299,0.00032099674,0.00008320497,0.000019734873,0.000025478383,0.00015118529,0.000073856616,0.00028396246],"category_scores_gemma":[0.00058422924,0.00005053289,0.00013616448,0.00018373872,0.00010180477,0.00010418952,0.000017003618,0.00030424996,4.71556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011343679,0.011928018,0.8708887,0.000037433714,0.008553362,0.0019348754,0.0048749135,0.002329258,0.0049407324,0.010255159,0.022018123,0.05089575],"study_design_scores_gemma":[0.004381772,0.0011466121,0.98944384,0.00036288748,0.00024170996,0.000029441864,0.0002772894,0.00008304049,0.0014356895,0.00077455153,0.0017665431,0.000056643217],"about_ca_topic_score_codex":0.00012447279,"about_ca_topic_score_gemma":0.00017707082,"teacher_disagreement_score":0.11855513,"about_ca_system_score_codex":0.00048115317,"about_ca_system_score_gemma":0.00025176705,"threshold_uncertainty_score":0.310919},"labels":[],"label_agreement":null},{"id":"W4406405159","doi":"10.1016/j.ijgc.2025.101640","title":"Factors influencing surgeons’ decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; General surgery; Ileostomy; Surgery; Cancer; Internal medicine","score_opus":0.05877032026354865,"score_gpt":0.3753638135145411,"score_spread":0.31659349325099245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406405159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003977,0.001141689,0.00036429663,0.007075471,0.00090674456,0.00025523233,0.00008248951,0.0000071088443,0.00012717808],"genre_scores_gemma":[0.9978181,0.00082046667,0.0002534065,0.00085606484,0.00008847567,0.000105737454,0.000010950807,0.0000067251053,0.000040076615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987975,0.000039533534,0.00055539765,0.00018601958,0.00025587407,0.00016572067],"domain_scores_gemma":[0.9962966,0.0024429644,0.00035503707,0.000058233658,0.00076357345,0.0000835864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033781966,0.00012369694,0.0004132002,0.00031517196,0.000068973466,0.000035188226,0.00010433644,0.00009577244,0.00017124524],"category_scores_gemma":[0.0016010691,0.00008854107,0.00016950881,0.0001939881,0.000054421565,0.00012113719,0.000049019538,0.00017692296,2.8101192e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028004733,0.0002829429,0.97184694,0.000009514956,0.00049781747,0.000024104127,0.0001428359,0.00016145213,0.00021269872,0.00028956044,0.0012628207,0.024989262],"study_design_scores_gemma":[0.0017742852,0.000078435325,0.99382436,0.00066830846,0.00011937642,0.000004903338,0.00015038702,0.000083205916,0.000522548,0.000980526,0.0017192086,0.00007445684],"about_ca_topic_score_codex":0.0005017222,"about_ca_topic_score_gemma":0.0005969147,"teacher_disagreement_score":0.024914805,"about_ca_system_score_codex":0.0013637568,"about_ca_system_score_gemma":0.00051529304,"threshold_uncertainty_score":0.36106},"labels":[],"label_agreement":null},{"id":"W4406512317","doi":"10.1016/j.ijgc.2025.101642","title":"Frailty and gynecologic cancer: a cross-sectional analysis of the Canadian Longitudinal Study on Aging","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University Medical Centre; Ontario Clinical Oncology Group; McMaster University; University of Alberta","funders":"McMaster Institute for Research on Aging, McMaster University; Canadian Institutes of Health Research; McMaster University; Hamilton Health Sciences Foundation; Government of Canada; Canada Foundation for Innovation","keywords":"Medicine; Gynecologic cancer; Cross-sectional study; Gerontology; Cancer; Gynecology; Oncology; Internal medicine; Ovarian cancer; Pathology","score_opus":0.08595260657837586,"score_gpt":0.43128475903113134,"score_spread":0.3453321524527555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406512317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778594,0.00041294895,0.000025041303,0.008288788,0.0018550003,0.00024671564,0.00007572743,0.0000067546844,0.0013031069],"genre_scores_gemma":[0.99689186,0.00010571132,0.000050755378,0.001917013,0.00017861785,0.000027195367,0.0000026294538,0.00000540191,0.00082083436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806523,0.000093523464,0.0006414184,0.0002444556,0.00074875494,0.00020663366],"domain_scores_gemma":[0.9975148,0.00057603564,0.00041138276,0.0001537555,0.0011953093,0.00014872004],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004890459,0.00015015336,0.0004583869,0.00066974194,0.00014947726,0.00006748945,0.0004321336,0.00013072953,0.0015952676],"category_scores_gemma":[0.0012181624,0.0000929958,0.00030342667,0.00065549643,0.0002330685,0.00007810665,0.00010777718,0.0005273951,0.0000011713565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022472875,0.0003096882,0.98941654,0.000007417693,0.0034738441,0.00009586876,0.00009951456,0.0024118738,0.00007359035,0.0002436534,0.00042484308,0.0032184597],"study_design_scores_gemma":[0.0016021268,0.00040374114,0.99519503,0.00007675179,0.00072009914,0.000022758615,0.00006992634,0.0002629065,0.00011433456,0.00021338636,0.0012432663,0.0000756612],"about_ca_topic_score_codex":0.019266302,"about_ca_topic_score_gemma":0.27721685,"teacher_disagreement_score":0.25795057,"about_ca_system_score_codex":0.0014624043,"about_ca_system_score_gemma":0.0010052021,"threshold_uncertainty_score":0.9993174},"labels":[],"label_agreement":null},{"id":"W4406771807","doi":"10.1016/j.ijgc.2025.101662","title":"High-grade serous ovarian cancer—bridging the gap between epidemiology and prevention with biology","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bridging (networking); Serous ovarian cancer; Ovarian cancer; Epidemiology; Serous fluid; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.04748571791150178,"score_gpt":0.39473500308847126,"score_spread":0.34724928517696946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406771807","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0409461,0.02220536,0.0021690233,0.12650587,0.80531365,0.0010825187,0.0013641566,0.000043960317,0.00036934984],"genre_scores_gemma":[0.21327603,0.031765703,0.0020010218,0.002161284,0.7488651,0.00033482202,0.00031505025,0.000044032495,0.0012369158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974703,0.0003519458,0.00091164495,0.0004262293,0.0005096046,0.00033023144],"domain_scores_gemma":[0.9933172,0.0041260486,0.0012536005,0.00017772666,0.0009667546,0.00015865605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092388416,0.0003349546,0.0011959058,0.00020714095,0.0000999334,0.000039657014,0.00041440842,0.0006287235,0.0004878049],"category_scores_gemma":[0.0015004392,0.00017685797,0.0002504115,0.00012635296,0.0002573632,0.0000734149,0.00013525398,0.0012269247,0.0000017615279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012477906,0.00029200115,0.13389187,0.00010214986,0.007225264,0.0003339598,0.00005635598,0.00015561309,0.0000137099405,0.0014450592,0.7293136,0.1259226],"study_design_scores_gemma":[0.007247542,0.002860867,0.17571525,0.001856975,0.0027072027,0.00008904431,0.000025784224,0.000016653168,0.0000697097,0.0067813583,0.8023193,0.00031031633],"about_ca_topic_score_codex":0.001342437,"about_ca_topic_score_gemma":0.00048216386,"teacher_disagreement_score":0.17232992,"about_ca_system_score_codex":0.0011534579,"about_ca_system_score_gemma":0.0015059226,"threshold_uncertainty_score":0.72120583},"labels":[],"label_agreement":null},{"id":"W4406893812","doi":"10.1016/j.ijgc.2025.101664","title":"Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Cytoreductive surgery; Ovarian cancer; Oncology; Interval (graph theory); Gynecology; Internal medicine; Cancer","score_opus":0.04534175409149385,"score_gpt":0.36289113864890743,"score_spread":0.31754938455741355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406893812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013453155,0.96229124,0.000025259054,0.0019654515,0.017234014,0.0019290022,0.0021047494,0.000025361165,0.0009717439],"genre_scores_gemma":[0.0051868604,0.9908178,0.00026582746,0.0004920029,0.0021567966,0.0004201445,0.00015872282,0.000048995473,0.00045284056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964777,0.00017701059,0.0014048599,0.00052130927,0.0010330983,0.00038599415],"domain_scores_gemma":[0.99560535,0.001558121,0.001322164,0.00021040314,0.0010851942,0.00021878837],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031778746,0.0005682673,0.0027895654,0.0007101242,0.000043672066,0.000065332635,0.0004936395,0.00040118862,0.0025632363],"category_scores_gemma":[0.00048434848,0.0003171309,0.00089912553,0.00041859018,0.0001355384,0.00019956038,0.000160337,0.000922456,0.000010369019],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.013603956,0.0016560272,0.019983452,0.0017248521,0.004503112,0.0016351915,0.000055255005,0.000017339438,1.6721052e-7,0.000016966205,0.0025888463,0.9542148],"study_design_scores_gemma":[0.01987628,0.0031522748,0.21104988,0.06166149,0.004277155,0.00009182974,0.000032492248,0.0000016770839,0.000008730615,0.000022584652,0.6991166,0.0007090279],"about_ca_topic_score_codex":0.00018647901,"about_ca_topic_score_gemma":0.00024180069,"teacher_disagreement_score":0.9535058,"about_ca_system_score_codex":0.005359381,"about_ca_system_score_gemma":0.0061369156,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null},{"id":"W4406934729","doi":"10.1016/j.ijgc.2025.101665","title":"Raising the bar: enhancing the quality and impact of surgical video publications in gynecological oncology","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Raising (metalworking); Gynecologic oncology; Quality (philosophy); Bar (unit); Oncology; Gynecology; General surgery; Oceanography","score_opus":0.0754722699177046,"score_gpt":0.4757258665896179,"score_spread":0.4002535966719133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406934729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55692583,0.004323092,0.00027634535,0.058273967,0.3627817,0.0011147673,0.00024907565,0.00004724438,0.016007988],"genre_scores_gemma":[0.9235287,0.0023089484,0.00006529709,0.0005192179,0.07318721,0.00003765526,0.000033998982,0.000011951576,0.0003070436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956533,0.0007118384,0.0018144285,0.0003019295,0.0012243165,0.00029423228],"domain_scores_gemma":[0.96493506,0.031369276,0.0013650665,0.0002026664,0.0019655866,0.00016236225],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038632413,0.000269189,0.0010705893,0.00029375302,0.000104224084,0.000080733626,0.0006429048,0.0007710994,0.0024090817],"category_scores_gemma":[0.016734239,0.00012246503,0.0006185652,0.00035772088,0.0004599988,0.00011734463,0.00023729778,0.0021804445,0.0000020568734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0100905085,0.0033281012,0.17953527,0.00020816816,0.00571289,0.0011255795,0.0013823594,0.0043473034,0.0002895289,0.0068964898,0.49714103,0.28994277],"study_design_scores_gemma":[0.005774405,0.00077145995,0.25768006,0.0003059053,0.00019119585,0.00007704296,0.00014875272,0.00015644511,0.000017846365,0.0011061877,0.7336092,0.00016153915],"about_ca_topic_score_codex":0.00021658294,"about_ca_topic_score_gemma":0.00030761168,"teacher_disagreement_score":0.36660287,"about_ca_system_score_codex":0.001286597,"about_ca_system_score_gemma":0.0023872985,"threshold_uncertainty_score":0.99850285},"labels":[],"label_agreement":null},{"id":"W4407058915","doi":"10.1016/j.ijgc.2025.101676","title":"Modified radical hysterectomy for stage IB1 (≤2 cm) cervical cancer: assessment of temporal trends and oncologic outcomes in the United States","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Cervical cancer; Radical Hysterectomy; Stage (stratigraphy); Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.058629605858344945,"score_gpt":0.428195420033728,"score_spread":0.3695658141753831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407058915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676273,0.0007290427,0.00038118474,0.029209707,0.00073784933,0.00034095478,0.00018511605,0.000007951528,0.00078090077],"genre_scores_gemma":[0.9940579,0.0009345055,0.00063138007,0.0035858299,0.00013871233,0.0001423535,0.00004141989,0.0000063648868,0.00046154213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812233,0.00015538438,0.00076799403,0.00018833159,0.0005626993,0.00020324634],"domain_scores_gemma":[0.9973264,0.0016708309,0.00038480837,0.00008987406,0.00043559022,0.000092507194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005612184,0.00016827957,0.0006617772,0.0005147189,0.000037851478,0.00003018265,0.00033288304,0.00013070604,0.0005072751],"category_scores_gemma":[0.00034525813,0.000087735534,0.00022865142,0.0004748155,0.00015699163,0.00006851145,0.00006829187,0.00034390666,1.4917494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030061116,0.0015378387,0.94864935,0.000092285794,0.0010187619,0.00015096966,0.00013398075,0.00090968,0.0001409725,0.002488646,0.0006401879,0.041231245],"study_design_scores_gemma":[0.013138878,0.0018162146,0.9685594,0.000135606,0.00022897459,0.000013535063,0.00022610404,0.0014417046,0.00014080697,0.001289386,0.012911187,0.000098229306],"about_ca_topic_score_codex":0.00077421457,"about_ca_topic_score_gemma":0.00038153364,"teacher_disagreement_score":0.041133013,"about_ca_system_score_codex":0.0006327665,"about_ca_system_score_gemma":0.00032948857,"threshold_uncertainty_score":0.5554307},"labels":[],"label_agreement":null},{"id":"W4407619754","doi":"10.1016/j.ijgc.2024.100795","title":"The Pattern Of Lymph Node Involvement In Patients Treated Surgically For Endometrioid Adenocarcinoma Of The Uterus Between 2000 To 2023: A Retrospective Cohort Study In King Abdulaziz University Hospital, Jeddah, Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Retrospective cohort study; Uterus; Lymph node; General surgery; University hospital; Cohort; Gynecology; Adenocarcinoma; Internal medicine; Cancer","score_opus":0.017031394471116755,"score_gpt":0.29298549813406116,"score_spread":0.2759541036629444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407619754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961858,0.00029734996,0.000039380913,0.0013510335,0.00057907536,0.0012546289,0.00013584539,0.0000026462528,0.00015425646],"genre_scores_gemma":[0.99941546,0.00015461529,0.000025217238,0.00016125983,0.000058197063,0.000034069668,0.0000060541697,0.0000058621426,0.00013928035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998015,0.00014629588,0.0007605662,0.00021991278,0.00066011585,0.0001981178],"domain_scores_gemma":[0.99744344,0.0009499903,0.00049004966,0.00014068461,0.0009124633,0.00006335115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055116724,0.00014373478,0.00059879565,0.00041036014,0.000045401874,0.000012891322,0.00048353279,0.00007884479,0.00009481311],"category_scores_gemma":[0.00085872924,0.00008283883,0.00023492707,0.00093241065,0.000077807315,0.000057639925,0.00016886105,0.0002047574,5.198978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002080904,0.001358473,0.9865751,0.000013199558,0.0007279775,0.000026861417,0.00015011865,0.00005706057,0.000022120996,0.000012907256,0.00005394089,0.008921313],"study_design_scores_gemma":[0.013008019,0.0016211015,0.98411304,0.0002255406,0.00017228264,4.4970298e-7,0.00018024993,0.000006278082,0.00033262526,0.000076078235,0.00019681673,0.000067536486],"about_ca_topic_score_codex":0.0020371194,"about_ca_topic_score_gemma":0.00090970244,"teacher_disagreement_score":0.010927116,"about_ca_system_score_codex":0.0026647584,"about_ca_system_score_gemma":0.0002569965,"threshold_uncertainty_score":0.696825},"labels":[],"label_agreement":null},{"id":"W4407620181","doi":"10.1016/j.ijgc.2024.100651","title":"Risk Factors For Endometrial Cancer Among Women With A BRCA1 Or BRCA2 Mutation","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Gynecology; Mutation; Internal medicine; Obstetrics; Cancer; Genetics; Gene","score_opus":0.026821197326251402,"score_gpt":0.3517105001342434,"score_spread":0.324889302807992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407620181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160683,0.00052779843,0.0011731217,0.0037423957,0.0019733035,0.00047469375,0.00015469236,0.000013750971,0.000333426],"genre_scores_gemma":[0.9954575,0.0012278404,0.00064548204,0.0007320387,0.00063936354,0.00037662318,0.0000073888364,0.0000117772415,0.00090200105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863464,0.00004087589,0.0004599145,0.00020313887,0.0004467025,0.00021470968],"domain_scores_gemma":[0.9972753,0.0011319815,0.00050255813,0.00007642299,0.00087783346,0.00013593624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024568464,0.0001588317,0.00042915283,0.00028762844,0.000062294646,0.000053876327,0.00017453595,0.00009815704,0.0024326998],"category_scores_gemma":[0.0009915914,0.00008558584,0.0001569841,0.00024314999,0.0000801996,0.00013577583,0.000026169888,0.00020961073,0.0000011125279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01473131,0.00079009356,0.8792166,0.000032918655,0.0045115785,0.00030462915,0.00048498355,0.0012050907,0.00007025383,0.00019931879,0.0033178357,0.09513535],"study_design_scores_gemma":[0.014659925,0.003070721,0.9586764,0.00026714822,0.00052693253,0.000025139841,0.00029179198,0.000101398,0.0013593079,0.0003877952,0.020509962,0.00012349665],"about_ca_topic_score_codex":0.00030052132,"about_ca_topic_score_gemma":0.00044976873,"teacher_disagreement_score":0.09501185,"about_ca_system_score_codex":0.0018376829,"about_ca_system_score_gemma":0.000760479,"threshold_uncertainty_score":0.9984792},"labels":[],"label_agreement":null},{"id":"W4407620903","doi":"10.1016/j.ijgc.2024.100580","title":"Temporal Trends And Outcomes Of Sentinel Lymph Node Biopsy For Cervical Cancer In The United States","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Cervical cancer; Sentinel lymph node; Biopsy; General surgery; Oncology; Cancer; Obstetrics; Gynecology; Radiology; Internal medicine; Breast cancer","score_opus":0.043755530076794356,"score_gpt":0.41592244992269084,"score_spread":0.3721669198458965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407620903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336343,0.001008015,0.00017444031,0.06339231,0.00038811425,0.0001141851,0.00009324888,0.0000045113984,0.0011908899],"genre_scores_gemma":[0.9942825,0.00084682397,0.00013397385,0.0041074846,0.00015640774,0.000044265602,0.00001696357,0.000005367674,0.00040623907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986546,0.000059714388,0.0005039477,0.00012850892,0.00047978168,0.00017345205],"domain_scores_gemma":[0.9981205,0.00076348876,0.00016849148,0.00007238566,0.00080690964,0.000068240224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044841276,0.00010435522,0.00036205832,0.00043351893,0.000028207298,0.000026876993,0.00028806808,0.00008453275,0.0018548378],"category_scores_gemma":[0.0003587568,0.000056783047,0.00015692429,0.00037706277,0.00014389365,0.0000492596,0.00006867132,0.00023980832,2.823022e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013801038,0.00027970996,0.95811176,0.00005859542,0.00028787772,0.000043548393,0.00010010935,0.00015837702,0.000102158905,0.0006806284,0.0007881003,0.03800902],"study_design_scores_gemma":[0.003747193,0.000079634934,0.98885673,0.000055410917,0.000072118,0.000017923629,0.00017996617,0.0013001891,0.00008100826,0.00095457234,0.0046018315,0.000053424475],"about_ca_topic_score_codex":0.0007432931,"about_ca_topic_score_gemma":0.00014570622,"teacher_disagreement_score":0.060648188,"about_ca_system_score_codex":0.00022398138,"about_ca_system_score_gemma":0.00022761711,"threshold_uncertainty_score":0.9990576},"labels":[],"label_agreement":null},{"id":"W4407621014","doi":"10.1016/j.ijgc.2025.101722","title":"Time Course Of Adverse Events In Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Chemotherapy In The ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Endometrial cancer; Adverse effect; Oncology; Chemotherapy; Internal medicine; Gynecology; Cancer","score_opus":0.021795219485234888,"score_gpt":0.35484716623193185,"score_spread":0.33305194674669697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908423,0.0015662226,0.000015385838,0.0044913283,0.0011541877,0.0011828571,0.000082414284,0.000009176472,0.0006561458],"genre_scores_gemma":[0.9938702,0.0033393896,0.00015541314,0.0015138699,0.00047152748,0.00021618848,0.00002148512,0.000013935082,0.0003980072],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99720067,0.0002860896,0.0010315769,0.00027827008,0.0009130221,0.00029036758],"domain_scores_gemma":[0.9970151,0.0016616923,0.0006229729,0.0001505716,0.00045702123,0.00009262962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007241146,0.0002647604,0.0009388853,0.0005519097,0.000026859228,0.000006409412,0.0004948536,0.0001669816,0.0017821807],"category_scores_gemma":[0.000741832,0.00013218146,0.0002673355,0.0011127322,0.00012495782,0.00015336038,0.000053826872,0.00056088064,0.0000026593589],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75739145,0.0049276175,0.09275759,0.00006505978,0.0015482939,0.0005898883,0.00052577554,0.0008227118,0.00074998266,0.000039970953,0.00031251498,0.14026913],"study_design_scores_gemma":[0.43814567,0.00978575,0.5429143,0.0012005031,0.0004004314,0.000055223107,0.00039050705,0.000108757406,0.0014554344,0.00019527283,0.005084807,0.00026336446],"about_ca_topic_score_codex":0.00023484908,"about_ca_topic_score_gemma":0.00044407183,"teacher_disagreement_score":0.4501567,"about_ca_system_score_codex":0.0022011334,"about_ca_system_score_gemma":0.001290305,"threshold_uncertainty_score":0.9991303},"labels":[],"label_agreement":null},{"id":"W4407621048","doi":"10.1016/j.ijgc.2025.101684","title":"Co-Amplification Of CCNE1 And AKT2 As Prognostic Biomarker And Therapeutic Target In Tubo-Ovarian High-Grade Serous Carcinoma","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Serous fluid; Oncology; Biomarker; Internal medicine; Ovarian carcinoma; Ovarian cancer; Cancer","score_opus":0.02302481567659131,"score_gpt":0.35242598286241417,"score_spread":0.32940116718582285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952475,0.0018506794,0.00036412987,0.0019860838,0.00019455008,0.00014064886,0.000026780852,0.0000016726466,0.00018794391],"genre_scores_gemma":[0.9987744,0.00046362003,0.00027722336,0.00027792132,0.00006042789,0.000013999392,0.0000142787885,0.0000057343937,0.00011239966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904156,0.00010329873,0.0003230551,0.00017283105,0.00022713275,0.00013215166],"domain_scores_gemma":[0.9992541,0.0001369472,0.00015761326,0.00007551935,0.00031986262,0.00005593865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002702282,0.0000945287,0.00016720213,0.00015221674,0.000021990534,0.000027547805,0.00022472712,0.00012859912,0.00011564217],"category_scores_gemma":[0.00040195373,0.0000737481,0.000041855725,0.000085315645,0.00014122635,0.000008060276,0.00006956101,0.00014758196,6.8662723e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043079123,0.00015620189,0.6811096,0.000017411725,0.00016258586,0.000026173433,0.000031823056,0.00003248298,0.3093376,0.00048912346,0.00018186867,0.008024341],"study_design_scores_gemma":[0.0011506168,0.00029472448,0.95417464,0.000033952812,0.000013548416,0.00003532148,0.000045845012,0.00008536903,0.04085,0.0015201613,0.0017244888,0.00007130656],"about_ca_topic_score_codex":0.00014543514,"about_ca_topic_score_gemma":0.00007339099,"teacher_disagreement_score":0.27306506,"about_ca_system_score_codex":0.000077814206,"about_ca_system_score_gemma":0.00020960273,"threshold_uncertainty_score":0.30073604},"labels":[],"label_agreement":null},{"id":"W4407621052","doi":"10.1016/j.ijgc.2025.101653","title":"PITMEX Study: Prophylactic IntraThecal Methotrexate For Patients With Stage III Gestational Trophoblastic Neoplasia, A Retrospective Multicentric Comparative Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Francophone University Association","funders":"","keywords":"Medicine; Gestational trophoblastic neoplasia; Methotrexate; Stage (stratigraphy); Retrospective cohort study; Obstetrics; Gestational trophoblastic disease; Gynecology; Choriocarcinoma; Pregnancy; Internal medicine; Gestation","score_opus":0.02250199812910365,"score_gpt":0.3635233951326701,"score_spread":0.3410213970035665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925086,0.000096872864,0.0029578446,0.0005543994,0.0009014626,0.0025715383,0.00014396009,0.000019198264,0.00024613543],"genre_scores_gemma":[0.99603105,0.000013196434,0.0026790884,0.00021746958,0.0001873146,0.0003661397,0.000015018453,0.000015782814,0.00047495525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711686,0.00018100141,0.00079691084,0.00038602442,0.0012519655,0.0002672088],"domain_scores_gemma":[0.99252206,0.0016347,0.00066020264,0.00011153562,0.004914133,0.00015739584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029370218,0.00028749573,0.00072966027,0.00039123208,0.00013924493,0.00006725366,0.00026599862,0.000054747492,0.00031668338],"category_scores_gemma":[0.0017692255,0.00018842929,0.0001635541,0.00036846125,0.00016651003,0.00018169564,0.000080973536,0.00037645863,0.000005525007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0250852,0.0205335,0.94178414,0.0000447319,0.004885992,0.00039536075,0.0021112899,0.0023406928,0.000055697907,0.000453086,0.00034227,0.0019680355],"study_design_scores_gemma":[0.02262887,0.011183109,0.9606755,0.00008520981,0.0009328258,0.0000064457167,0.0033248675,0.00053770555,0.000017877934,0.0002718839,0.00017306252,0.00016268152],"about_ca_topic_score_codex":0.00002678683,"about_ca_topic_score_gemma":0.000086445914,"teacher_disagreement_score":0.018891316,"about_ca_system_score_codex":0.0010834822,"about_ca_system_score_gemma":0.00077054347,"threshold_uncertainty_score":0.7683923},"labels":[],"label_agreement":null},{"id":"W4407621174","doi":"10.1016/j.ijgc.2024.101613","title":"Minimally Invasive Simple Hysterectomy In Low-Risk Cervical Cancer: A Single-Arm Trial With Stopping Rules (LAcc &amp; SHape – LASH Trial).","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Hysterectomy; Cervical cancer; Surgery; Cancer; Internal medicine","score_opus":0.04121214438464685,"score_gpt":0.34563846558780614,"score_spread":0.30442632120315927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887983,0.0015187693,0.000048672595,0.0045099505,0.0021301964,0.00095556985,0.0000895683,0.00002554986,0.001923408],"genre_scores_gemma":[0.99400187,0.001184085,0.0005244666,0.002267013,0.0013249487,0.0002394194,0.000022375638,0.000021184982,0.00041466535],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99681145,0.00022449855,0.0011848209,0.00040935818,0.0009702834,0.00039958887],"domain_scores_gemma":[0.99619657,0.0017314713,0.0007817047,0.00015947472,0.0008962815,0.00023452936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047806243,0.00031654624,0.000993129,0.00055367465,0.000067428104,0.000095619944,0.00048541502,0.00023146307,0.004010714],"category_scores_gemma":[0.001984333,0.00020683659,0.0003725024,0.0005587732,0.00013242215,0.00019957685,0.00014086372,0.0007004579,0.00001463103],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7705608,0.0058973017,0.128234,0.00011652955,0.0021637469,0.00080899295,0.00019830924,0.00032268625,0.0006982485,0.00012210973,0.00084284745,0.0900344],"study_design_scores_gemma":[0.78514135,0.016699174,0.16787902,0.002213973,0.00095350656,0.000071749026,0.00022265287,0.00010317648,0.0016546187,0.0021040537,0.022416966,0.00053978816],"about_ca_topic_score_codex":0.00063089497,"about_ca_topic_score_gemma":0.0052351966,"teacher_disagreement_score":0.089494616,"about_ca_system_score_codex":0.0018558861,"about_ca_system_score_gemma":0.0012632873,"threshold_uncertainty_score":0.9968998},"labels":[],"label_agreement":null},{"id":"W4407621178","doi":"10.1016/j.ijgc.2024.101566","title":"Increasing Diversity In Gynaecological Cancer Trials: The GCIG Statement From The Barcelona Meeting","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care South East; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Statement (logic); Diversity (politics); Gynecology; Family medicine","score_opus":0.11496339712258943,"score_gpt":0.35006091975453496,"score_spread":0.23509752263194553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384928,0.013325416,0.00063437945,0.03512055,0.0045771776,0.0002413734,0.00024289699,0.000007974667,0.007357456],"genre_scores_gemma":[0.98801816,0.0046974644,0.00015154672,0.0062614894,0.00064514513,0.0000335855,0.0000025906447,0.000006155954,0.00018384303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759376,0.00022834093,0.001531418,0.00024580135,0.0001326631,0.00026803665],"domain_scores_gemma":[0.9950166,0.0032515228,0.0013327225,0.0001337749,0.00020636452,0.00005904525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004970449,0.00015826593,0.00064443436,0.00013305162,0.00022428238,0.00014004699,0.0011555548,0.00013352012,0.003630474],"category_scores_gemma":[0.0048560007,0.0000949649,0.00028301968,0.00016904208,0.00016558255,0.00026291003,0.00046366794,0.00050759973,0.000017080729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000484384,0.0001231121,0.9346826,0.0000027938258,0.00043553393,0.00002790072,0.00045395095,0.0020493385,0.000018235414,0.01977828,0.007208036,0.03473583],"study_design_scores_gemma":[0.0014079389,0.000054671524,0.86574286,0.00006564554,0.000029824478,0.000001850639,0.0002432412,0.0004005557,0.00003198376,0.05420439,0.07769118,0.00012584559],"about_ca_topic_score_codex":0.0063288943,"about_ca_topic_score_gemma":0.0027191176,"teacher_disagreement_score":0.07048315,"about_ca_system_score_codex":0.0013445709,"about_ca_system_score_gemma":0.00020404355,"threshold_uncertainty_score":0.99728036},"labels":[],"label_agreement":null},{"id":"W4407621231","doi":"10.1016/j.ijgc.2024.101565","title":"Minimal Required Data Set For Gynecological Cancer Trials: The GCIG Statement From The Barcelona Meeting","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East","funders":"","keywords":"Medicine; Statement (logic); Gynecology; Set (abstract data type); Data set; Artificial intelligence; Programming language","score_opus":0.7236042655967159,"score_gpt":0.578048515603214,"score_spread":0.14555574999350185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621231","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29139087,0.021587906,0.008725822,0.65556246,0.011522879,0.0016422458,0.008196214,0.000027854761,0.0013437726],"genre_scores_gemma":[0.9163077,0.003679894,0.0035126524,0.070523895,0.004316003,0.00060085976,0.00017401014,0.000027021322,0.00085795403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918083,0.0010847381,0.005898875,0.0005163106,0.00031239408,0.00037937236],"domain_scores_gemma":[0.96634805,0.027413825,0.005112695,0.0004851972,0.00052928546,0.000110938],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038140457,0.00022065584,0.0011751712,0.00013301236,0.0003176501,0.00024784703,0.0025637394,0.000183489,0.0034824102],"category_scores_gemma":[0.04638624,0.00013834565,0.00033441672,0.0001444903,0.00018446754,0.00042706256,0.00041709084,0.0004013736,0.00004830682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008817921,0.00028690667,0.08387734,0.000052414583,0.0025486513,0.00001061443,0.0010888675,0.0023621768,0.000043310363,0.03374744,0.8624475,0.012653005],"study_design_scores_gemma":[0.0029226786,0.00018762739,0.09419076,0.0001958665,0.00011436417,0.0000033004162,0.0015525125,0.007890365,0.000026642167,0.040421877,0.8522401,0.00025390997],"about_ca_topic_score_codex":0.0011492061,"about_ca_topic_score_gemma":0.0014633579,"teacher_disagreement_score":0.62491685,"about_ca_system_score_codex":0.0013675877,"about_ca_system_score_gemma":0.00074333645,"threshold_uncertainty_score":0.99742854},"labels":[],"label_agreement":null},{"id":"W4407621538","doi":"10.1016/j.ijgc.2024.100073","title":"Patterns, Risk Factors And The Impact Of Concomitant Cisplatin On Distant Metastasis In Locally Advanced Cervical Cancer – An EMBRACE I Analysis","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cervical cancer; Concomitant; Cisplatin; Oncology; Distant metastasis; Internal medicine; Metastasis; Cancer; Chemotherapy","score_opus":0.020967585639656963,"score_gpt":0.3756296494641938,"score_spread":0.35466206382453686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995232,0.0017255046,0.00030076504,0.0016916441,0.00033830013,0.00023728337,0.00027746515,0.00000491997,0.00019212624],"genre_scores_gemma":[0.99627876,0.0031482652,0.00007644524,0.0003455425,0.00007235276,0.000028314178,0.000010701829,0.0000068348904,0.00003279575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798155,0.0002528988,0.0007865287,0.00023274135,0.00056111807,0.00018519419],"domain_scores_gemma":[0.9972138,0.0014590978,0.0005877838,0.00014025015,0.00045331268,0.00014575922],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004259918,0.00020405833,0.0009121427,0.00042511115,0.000037261114,0.00002862513,0.00027924802,0.00009489644,0.0014105189],"category_scores_gemma":[0.00076978706,0.00009360189,0.0005396974,0.00063661265,0.00013659388,0.00010624202,0.00006555838,0.00041212473,4.047747e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012504622,0.00057340524,0.94311756,0.000013102866,0.0048313253,0.00008724816,0.00012548915,0.0059607057,0.000120296805,0.00028741467,0.00001860244,0.032360252],"study_design_scores_gemma":[0.011175739,0.0012285883,0.9835067,0.0001512605,0.0012252531,0.000004800435,0.00018854169,0.0011488119,0.00058020983,0.00065293774,0.000050322702,0.00008685592],"about_ca_topic_score_codex":0.004230746,"about_ca_topic_score_gemma":0.0020964884,"teacher_disagreement_score":0.040389143,"about_ca_system_score_codex":0.0007918491,"about_ca_system_score_gemma":0.0002547264,"threshold_uncertainty_score":0.9995023},"labels":[],"label_agreement":null},{"id":"W4407621635","doi":"10.1016/j.ijgc.2024.100432","title":"Randomized Study Evaluating Optimal Dose, Efficacy And Safety Of E7386 + Lenvatinib Versus Treatment Of Physicians’ Choice In Advanced/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Eisai","keywords":"Medicine; Lenvatinib; Immunotherapy; Oncology; Internal medicine; Randomized controlled trial; Gynecology; Sorafenib; Cancer; Hepatocellular carcinoma","score_opus":0.046844560633795926,"score_gpt":0.3959338950705721,"score_spread":0.34908933443677614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902464,0.006995762,0.000044384316,0.00035545928,0.00063337694,0.0015449321,0.000018182991,0.000005620904,0.0001558375],"genre_scores_gemma":[0.99562025,0.003578359,0.00049360155,0.000054589393,0.0001169063,0.00007751136,0.000005893802,0.000010195187,0.00004269999],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976199,0.00029784848,0.0011506971,0.00022259404,0.0005349801,0.00017397646],"domain_scores_gemma":[0.995973,0.0023389373,0.0009349119,0.0001201618,0.00059753994,0.000035475678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072579726,0.00021572734,0.0012287957,0.00037835047,0.000030071578,0.000014158746,0.00017599661,0.00006954855,0.00016477058],"category_scores_gemma":[0.00058824266,0.00013374686,0.00026366004,0.0003972242,0.00021185551,0.000093393544,0.00002526997,0.00016014506,1.00105254e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6555302,0.0024591035,0.12716964,0.000020709045,0.0025119677,0.000033342585,0.00052796333,0.0004754915,0.006276023,0.000009483447,0.000004873638,0.20498118],"study_design_scores_gemma":[0.5119477,0.015300698,0.46873555,0.00040863748,0.00034741955,0.000007650499,0.0002283149,0.0001467472,0.0026085242,0.000003395486,0.00017662495,0.00008872301],"about_ca_topic_score_codex":0.00034987842,"about_ca_topic_score_gemma":0.00011775363,"teacher_disagreement_score":0.3415659,"about_ca_system_score_codex":0.00063117774,"about_ca_system_score_gemma":0.00035939872,"threshold_uncertainty_score":0.54540384},"labels":[],"label_agreement":null},{"id":"W4407621799","doi":"10.1016/j.ijgc.2024.100497","title":"TroFuse-020/GOG-3101/ENGOT-Cx20: A Phase 3, Randomised, Active-Controlled, Open-Label, Multicentre Study Comparing Sacituzumab Tirumotecan Monotherapy Vs Treatment Of Physician’s Choice As Second-Line Treatment For Recurrent Or Metastatic Cervical Cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Open label; Second line treatment; Surgery; Randomized controlled trial; Overall survival","score_opus":0.10189097653742804,"score_gpt":0.4888273389316147,"score_spread":0.3869363623941866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98379636,0.0025211195,0.00052188744,0.0039629512,0.0013656436,0.006874861,0.0004805764,0.000021378584,0.0004552338],"genre_scores_gemma":[0.99091405,0.0014838638,0.0008084716,0.00097250775,0.00046096425,0.002814406,0.00004745916,0.00003252311,0.002465737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972238,0.00019457637,0.0012754624,0.00044899064,0.0005076094,0.00034954245],"domain_scores_gemma":[0.9961181,0.0014123471,0.0010241899,0.00022046625,0.0010014476,0.00022342501],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018993675,0.00044738484,0.0019113503,0.0002814158,0.00014032588,0.00009085212,0.0004179686,0.00008450554,0.0021846853],"category_scores_gemma":[0.00023761558,0.0002594362,0.00047629976,0.0002136893,0.000079985155,0.00020965048,0.0000523709,0.00017496709,0.0000037021148],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4785421,0.052420966,0.0042031906,0.00007250157,0.028761815,0.00024885195,0.0021308518,0.0007823716,0.0015087632,0.00013366448,0.0004971169,0.43069783],"study_design_scores_gemma":[0.90060383,0.048998337,0.008032453,0.0004894707,0.0074877604,0.000028183198,0.0013270015,0.0047388813,0.0060174423,0.00023139072,0.021698143,0.00034709644],"about_ca_topic_score_codex":0.0010191917,"about_ca_topic_score_gemma":0.0050041485,"teacher_disagreement_score":0.43035072,"about_ca_system_score_codex":0.0042416607,"about_ca_system_score_gemma":0.0016171698,"threshold_uncertainty_score":0.9999858},"labels":[],"label_agreement":null},{"id":"W4407621808","doi":"10.1016/j.ijgc.2024.100379","title":"Bilateral Oophorectomy And The Probability Of Amnestic Mild Cognitive Impairment Among Carriers Of A Pathogenic Variant In BRCA1 Or BRCA2","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Fractal and DNA sequence analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Mount Sinai Hospital; McGill University; Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Medicine; Cognitive impairment; Oophorectomy; Cognition; Oncology; Psychiatry; Hysterectomy; Surgery","score_opus":0.010776275410833319,"score_gpt":0.2910423270101659,"score_spread":0.2802660515993326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801636,0.0008626252,0.00014483424,0.0005743014,0.000146551,0.00014000364,0.00002939245,6.632487e-7,0.00008527217],"genre_scores_gemma":[0.99896765,0.0005828862,0.00009816803,0.00022911311,0.000038073704,0.00001857465,0.000003615679,0.0000021513968,0.00005975289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905926,0.000114952825,0.00044040062,0.0001286785,0.00016742822,0.00008929671],"domain_scores_gemma":[0.9990319,0.00018010198,0.0002926827,0.00005808888,0.00040470593,0.000032535714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004193162,0.00008023847,0.00024161932,0.000073079325,0.000015252549,0.000009331635,0.00019726843,0.00007625922,0.000109683766],"category_scores_gemma":[0.0006589142,0.00004249401,0.00014024533,0.0001192272,0.0003785934,0.000007868237,0.0000878988,0.00010918468,8.038135e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015885957,0.00080647966,0.9042356,0.00009626141,0.0021668528,0.00026823557,0.00055634644,0.0017605497,0.060360104,0.0004649185,0.00017931846,0.013219347],"study_design_scores_gemma":[0.0050425506,0.0008539049,0.9696391,0.0002334035,0.00019612284,0.000050888684,0.00033666004,0.0004122203,0.019548416,0.0034457291,0.00012187309,0.00011911769],"about_ca_topic_score_codex":0.0002562679,"about_ca_topic_score_gemma":0.00055672886,"teacher_disagreement_score":0.065403484,"about_ca_system_score_codex":0.000049476086,"about_ca_system_score_gemma":0.0002237215,"threshold_uncertainty_score":0.17328554},"labels":[],"label_agreement":null},{"id":"W4407621972","doi":"10.1016/j.ijgc.2024.100427","title":"Mapping The Global Landscape Of Inclusion, Diversity, Equity, And Access In Clinical Trials: Perspectives From Gynaecologic Research Groups","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care South East","funders":"","keywords":"Medicine; Equity (law); Inclusion (mineral); Diversity (politics); Gender equity; Clinical trial; Socioeconomics; Internal medicine; Demographic economics; Gender studies; Anthropology","score_opus":0.7838983817897663,"score_gpt":0.6428289164861376,"score_spread":0.14106946530362874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407621972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88471967,0.00943964,0.0005630854,0.09808673,0.0022834952,0.00031180755,0.00017827387,0.000004550755,0.004412742],"genre_scores_gemma":[0.99194914,0.002878047,0.00020380724,0.004417694,0.000498103,0.000015561838,0.000002441131,0.000003102645,0.00003207396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99253994,0.0022815056,0.004275154,0.000312489,0.00037157052,0.00021933652],"domain_scores_gemma":[0.9805798,0.015807861,0.0027449925,0.00015102822,0.0006268866,0.000089443],"candidate_categories":["metaresearch","open_science","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07805743,0.00010379725,0.0010245879,0.00040455183,0.0002583887,0.00013332762,0.0016664441,0.00019655314,0.0012951643],"category_scores_gemma":[0.047619797,0.00008055914,0.00020486985,0.0003520907,0.00029841738,0.00035727347,0.008176501,0.00052610616,0.00000974516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016594311,0.00023665934,0.9319011,0.000021569518,0.0002656367,0.0000097815,0.0015027183,0.00014066401,8.0524256e-7,0.054276023,0.0055233203,0.0059557976],"study_design_scores_gemma":[0.0010984838,0.000076773686,0.67083037,0.00006391335,0.000005909768,0.0000010935373,0.0024245712,0.0004412098,6.0734203e-7,0.32323575,0.0017682902,0.000053037144],"about_ca_topic_score_codex":0.0015169039,"about_ca_topic_score_gemma":0.0014814367,"teacher_disagreement_score":0.26895973,"about_ca_system_score_codex":0.0013136292,"about_ca_system_score_gemma":0.00036158448,"threshold_uncertainty_score":0.9998452},"labels":[],"label_agreement":null},{"id":"W4407622117","doi":"10.1016/j.ijgc.2024.100355","title":"The Association Between Endometriosis And Ovarian Cancer Risk In Women With A Pathogenic Variant In BRCA1 Or BRCA2: A Case-Control Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto; McGill University; Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Cancer Society","keywords":"Medicine; Endometriosis; Ovarian cancer; Oncology; Gynecology; Case-control study; Internal medicine; Obstetrics; Cancer","score_opus":0.008230848716415764,"score_gpt":0.2842446451867266,"score_spread":0.2760137964703108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955629,0.0024108174,0.00016655738,0.001148093,0.00024951552,0.00026529506,0.00016082701,0.0000017305248,0.0000342333],"genre_scores_gemma":[0.9951365,0.003923556,0.000050340732,0.0004121413,0.00024233077,0.00013021383,0.000001343791,0.0000055187347,0.000098082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987149,0.00027274166,0.0003996207,0.0001864123,0.00023460244,0.00019171162],"domain_scores_gemma":[0.9985581,0.0006672482,0.00030360033,0.000077672674,0.00032246253,0.00007093788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009014736,0.000105690124,0.00020526191,0.00014443671,0.00006514236,0.00006490954,0.00020287618,0.00009760826,0.00006232025],"category_scores_gemma":[0.0017352395,0.0000647628,0.000043999025,0.00018520048,0.000037764657,0.000009290767,0.00005526634,0.0001850792,1.7246701e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003391829,0.00032116997,0.9642075,0.0000041209864,0.000757251,0.00065075187,0.00014620626,0.00024908292,0.00045589491,0.000009176265,0.00011253423,0.029694518],"study_design_scores_gemma":[0.008079499,0.0007761486,0.9879283,0.00003130443,0.00010455826,0.000047811394,0.0004713367,0.000024514926,0.00007980507,0.0002827981,0.0020831393,0.00009080905],"about_ca_topic_score_codex":0.00025603932,"about_ca_topic_score_gemma":0.00700279,"teacher_disagreement_score":0.02960371,"about_ca_system_score_codex":0.00046383374,"about_ca_system_score_gemma":0.0003455404,"threshold_uncertainty_score":0.39077213},"labels":[],"label_agreement":null},{"id":"W4407622128","doi":"10.1016/j.ijgc.2024.100319","title":"ATHENA-MONO Post-Progression Survival Data Update In Patients With Newly Diagnosed Advanced Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.01982819557555372,"score_gpt":0.35010076076022595,"score_spread":0.33027256518467224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974197,0.0016846466,0.00016036232,0.020438178,0.0023260943,0.00042748917,0.0002541688,0.00001432216,0.00049775746],"genre_scores_gemma":[0.993578,0.0016604101,0.001466895,0.0027816908,0.0002157452,0.000071756025,0.000112996466,0.000015161369,0.00009730707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998061,0.000070113005,0.00057417125,0.00035635184,0.00069054664,0.00024783038],"domain_scores_gemma":[0.9978978,0.0003177757,0.0003967618,0.00028053104,0.00097094604,0.00013617618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002515081,0.00020342242,0.00047685477,0.00022743802,0.00004169832,0.000048322196,0.00054754416,0.00010655437,0.0015391428],"category_scores_gemma":[0.00037157166,0.00012607746,0.000091814945,0.00023347935,0.0000727209,0.00030617314,0.0001993842,0.00033850098,0.000005189126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004805075,0.0014386298,0.80409217,0.000015091292,0.00064405455,0.00043023267,0.000036120706,0.0004544369,0.000021654992,0.0004806389,0.001459361,0.18612255],"study_design_scores_gemma":[0.021105573,0.00079068425,0.9656333,0.0007783868,0.00017176304,0.000004405439,0.000030302013,0.00008826867,0.0000762679,0.00027754714,0.010913464,0.00013005773],"about_ca_topic_score_codex":0.00023549535,"about_ca_topic_score_gemma":0.000855616,"teacher_disagreement_score":0.1859925,"about_ca_system_score_codex":0.0009049409,"about_ca_system_score_gemma":0.0006964326,"threshold_uncertainty_score":0.9993736},"labels":[],"label_agreement":null},{"id":"W4407622230","doi":"10.1016/j.ijgc.2024.100356","title":"Perioperative Outcomes Of Heated Intraperitoneal Chemotherapy For Patients Enrolled In The Feasibility Phase Of A Randomized Controlled Trial: Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Perioperative; Intraperitoneal chemotherapy; Chemotherapy; Randomized controlled trial; Surgery; Oncology; Internal medicine; Cancer; Ovarian cancer","score_opus":0.019881335835593775,"score_gpt":0.3795334288721695,"score_spread":0.35965209303657575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870348,0.00040311244,0.000071211194,0.0070452234,0.001203227,0.0040784455,0.000035119945,0.000004718421,0.00012411945],"genre_scores_gemma":[0.9966794,0.00039688963,0.0002578359,0.001721808,0.00016201973,0.000659266,0.000007467936,0.000007140963,0.00010817237],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99735767,0.00029292097,0.0015378194,0.00016221954,0.00049241475,0.00015694994],"domain_scores_gemma":[0.9969143,0.0009837339,0.0007478492,0.000097643046,0.0012175279,0.000038909355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011828078,0.00018529857,0.0020092388,0.00018814635,0.000029446763,0.000019653593,0.00023492321,0.00012127036,0.0003893365],"category_scores_gemma":[0.0012221303,0.00009132759,0.0007631855,0.00014714384,0.00029773693,0.00008549287,0.000014605844,0.00020795022,1.6244172e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9673857,0.0039459867,0.01607212,0.000036104564,0.0011656138,0.0000091382535,0.00089813874,0.000013554375,0.0077237412,0.00028581297,0.000059241065,0.0024048167],"study_design_scores_gemma":[0.9250931,0.0032988542,0.063889965,0.00017839503,0.00021703032,0.0000044196236,0.00024521598,0.00011993292,0.006358611,0.00036870188,0.00015040465,0.00007533493],"about_ca_topic_score_codex":0.000043996715,"about_ca_topic_score_gemma":0.000016291333,"teacher_disagreement_score":0.04781785,"about_ca_system_score_codex":0.0002040759,"about_ca_system_score_gemma":0.00029409066,"threshold_uncertainty_score":0.42629614},"labels":[],"label_agreement":null},{"id":"W4407622270","doi":"10.1016/j.ijgc.2024.100411","title":"Does The Molecular Profile Of Ovarian Tumors Influence The Response To Radiotherapy? An In Vitro Study On Behalf Of Multicenter Italian Trials In Ovarian Cancer (MITO) Group","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Radiation therapy; In vitro; Multicenter study; Gynecology; Cancer; Randomized controlled trial; Genetics","score_opus":0.026010581732868906,"score_gpt":0.38487876437098323,"score_spread":0.3588681826381143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96488684,0.00037591447,0.00004236963,0.03249176,0.00075504824,0.0013192608,0.000076840464,0.0000028660102,0.000049108843],"genre_scores_gemma":[0.9958423,0.000121360994,0.00030214482,0.0031834773,0.00013144115,0.00036614743,0.0000016720143,0.000010509105,0.000040993975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966585,0.0010717236,0.0012305377,0.00024070915,0.0006154683,0.00018307868],"domain_scores_gemma":[0.996977,0.0016171557,0.00061597704,0.0002463632,0.00046785266,0.00007567878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028335599,0.00017389221,0.000727568,0.0003534194,0.000028106428,0.000030009292,0.0005057519,0.00007485012,0.00039120964],"category_scores_gemma":[0.0018222911,0.00007441504,0.0002072943,0.000355215,0.000100985555,0.00009139429,0.00005994962,0.0003197799,5.077449e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0647513,0.007638772,0.71142334,0.000032827975,0.0017937698,0.0008612516,0.0039051895,0.003576894,0.17474854,0.0006055717,0.00019677379,0.030465776],"study_design_scores_gemma":[0.00740617,0.001896331,0.96018255,0.00049973076,0.00012684341,0.000004719255,0.00084585766,0.000064506865,0.028216539,0.000117790085,0.0005618409,0.00007715238],"about_ca_topic_score_codex":0.0015989289,"about_ca_topic_score_gemma":0.0010331081,"teacher_disagreement_score":0.24875918,"about_ca_system_score_codex":0.000818196,"about_ca_system_score_gemma":0.00039018632,"threshold_uncertainty_score":0.42834714},"labels":[],"label_agreement":null},{"id":"W4407622371","doi":"10.1016/j.ijgc.2024.100272","title":"Long-Term Prognostic Impact Of LVSI In Apparent Early-Stage Endometrioid Endometrial Cancer: The SLYM-EC II Retrospective International Collaborative Study.","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pomorski Uniwersytet Medyczny W Szczecinie; University of Toronto; Vanderbilt University Medical Center; Università degli Studi di Milano; McGill University; David Geffen School of Medicine, University of California, Los Angeles; Ohio State University; University of California, Los Angeles; Vanderbilt-Ingram Cancer Center; Vanderbilt University","keywords":"Medicine; Endometrial cancer; Oncology; Stage (stratigraphy); Internal medicine; Term (time); Retrospective cohort study; Gynecology; Cancer","score_opus":0.02626674573851565,"score_gpt":0.3964953813911719,"score_spread":0.37022863565265623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884708,0.0028911931,0.000055494274,0.0019385038,0.0037130937,0.001275929,0.00028650975,0.000012455915,0.0013560251],"genre_scores_gemma":[0.9959002,0.0022355556,0.000047987978,0.00021341644,0.00074573926,0.00023347189,0.000012826199,0.000014137192,0.00059667794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996414,0.00022666558,0.0012448884,0.0003572637,0.0014386505,0.0003185547],"domain_scores_gemma":[0.9948815,0.0014996027,0.00097117014,0.00017923382,0.0023177352,0.00015072631],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007361342,0.00030167628,0.00093750394,0.0012595707,0.00008454249,0.00006788266,0.0007820019,0.00013973223,0.0029458902],"category_scores_gemma":[0.004333465,0.00017296331,0.0005201497,0.0021585596,0.00019738622,0.00021102188,0.00028911908,0.0006610777,0.0000028321942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008975737,0.0029388934,0.9651799,0.000013891648,0.0037381658,0.00037209358,0.000459186,0.00036622348,0.00036085653,0.00014613199,0.00017433736,0.01727459],"study_design_scores_gemma":[0.018673955,0.005066629,0.9739901,0.0002617583,0.000313091,0.0000168589,0.00022315586,0.000021052361,0.0007492063,0.00017386748,0.0003792098,0.0001311048],"about_ca_topic_score_codex":0.0012610977,"about_ca_topic_score_gemma":0.0008902729,"teacher_disagreement_score":0.017143486,"about_ca_system_score_codex":0.0039311135,"about_ca_system_score_gemma":0.0011891269,"threshold_uncertainty_score":0.9998926},"labels":[],"label_agreement":null},{"id":"W4407622456","doi":"10.1016/j.ijgc.2024.100344","title":"Integrated Gene Expression Meta-Analysis And Risk Stratification In High-Grade Serous Ovarian Cancer: Identifying Functional Genes And Survival Predictors","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ovarian cancer; Serous ovarian cancer; Serous fluid; Meta-analysis; Oncology; Risk stratification; Gene; Internal medicine; Bioinformatics; Cancer; Genetics; Biology","score_opus":0.06573290604936621,"score_gpt":0.34312447972683385,"score_spread":0.27739157367746764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97772056,0.011764049,0.003992959,0.005203918,0.0009233537,0.00019681705,0.00014656849,0.000011020131,0.000040735085],"genre_scores_gemma":[0.9844233,0.013216921,0.0017273529,0.00019547748,0.0001699702,0.0000992314,0.00003354798,0.000006828518,0.00012741493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831533,0.00015869775,0.00062123657,0.000307303,0.00046030714,0.00013711836],"domain_scores_gemma":[0.9985531,0.00034124026,0.0004236091,0.00009814845,0.00047676841,0.000107113134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043429717,0.00017407163,0.0006835857,0.00047294333,0.00006671957,0.00008273025,0.000111312256,0.00012095817,0.0010450939],"category_scores_gemma":[0.00014446383,0.00011401266,0.00026957784,0.00037733596,0.00007594954,0.00016201593,0.000052871685,0.00028601772,4.2450694e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004633983,0.00034607283,0.9389147,0.000014501755,0.041877687,0.0000897599,0.00006671378,0.001555587,0.0033643187,0.00034026787,0.00013733565,0.012829653],"study_design_scores_gemma":[0.0021696081,0.00010595944,0.9654,0.00004235305,0.02521484,0.0000144532905,0.000083020794,0.0003016872,0.0056212475,0.00063120615,0.00032617923,0.000089444904],"about_ca_topic_score_codex":0.0018674905,"about_ca_topic_score_gemma":0.0025398154,"teacher_disagreement_score":0.026485298,"about_ca_system_score_codex":0.00045471848,"about_ca_system_score_gemma":0.00024393032,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W4407622484","doi":"10.1016/j.ijgc.2024.100273","title":"Treatment Of Infertility And Risk Of Breast Cancer Among Women With A BRCA Mutation: A Matched Case-Control Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Women's College Hospital; CReATe Fertility Centre","funders":"","keywords":"Medicine; BRCA mutation; Infertility; Gynecology; Breast cancer; Obstetrics; Oncology; Case-control study; Cancer; Internal medicine; Pregnancy; Genetics","score_opus":0.00811479988027624,"score_gpt":0.2989182845831972,"score_spread":0.29080348470292094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972724,0.0010082755,0.00053539494,0.00033230407,0.00022983472,0.00024741635,0.00031226774,0.000002109351,0.000060013368],"genre_scores_gemma":[0.9989186,0.00055723154,0.00018424145,0.00005613224,0.0000979439,0.000121164005,0.0000014397397,0.000005907891,0.000057341953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989618,0.00011471296,0.00043866073,0.00017279941,0.00020452283,0.00010746943],"domain_scores_gemma":[0.9983453,0.00010937213,0.00050354237,0.00010932283,0.00088133523,0.00005110128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019344236,0.00011999105,0.00029021548,0.000087488566,0.000031405256,0.000013832933,0.00014464794,0.000076449556,0.0002283961],"category_scores_gemma":[0.00009128399,0.000081396975,0.0000657396,0.0000964816,0.00017036688,0.000011536023,0.00003674876,0.00007360898,8.059341e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002369255,0.0005944462,0.96081793,0.000011142489,0.0025476497,0.00014034948,0.00069949543,0.002717014,0.0024156487,0.0000060401503,0.000025520067,0.027655492],"study_design_scores_gemma":[0.0043924134,0.0017723541,0.98914593,0.000024224022,0.0002339062,0.00021840332,0.0008876915,0.000091704416,0.0029690948,0.00008129043,0.00010821751,0.000074737225],"about_ca_topic_score_codex":0.0005156952,"about_ca_topic_score_gemma":0.0014552927,"teacher_disagreement_score":0.028328016,"about_ca_system_score_codex":0.00037709266,"about_ca_system_score_gemma":0.0004334745,"threshold_uncertainty_score":0.3319272},"labels":[],"label_agreement":null},{"id":"W4407622522","doi":"10.1016/j.ijgc.2024.100243","title":"Patient-Reported Outcomes In Patients With Primary Advanced Or Recurrent Endometrial Cancer Treated With Chemotherapy Plus Dostarlimab Or Placebo In The ENGOT-EN6-NSGO/GOG3031/RUBY Trial Over 3 Years Of Follow-Up","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Placebo; Endometrial cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Alternative medicine","score_opus":0.02350707287604202,"score_gpt":0.33280676243101737,"score_spread":0.30929968955497533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950959,0.00039124148,0.000010047112,0.0009871656,0.0013823734,0.0017688932,0.000087735025,0.000009931391,0.00026671417],"genre_scores_gemma":[0.99701995,0.00070142455,0.00018485628,0.0013375381,0.00015390228,0.0002822484,0.000027503625,0.000018536583,0.00027404987],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9966731,0.00017583762,0.0011792694,0.00031863325,0.0013493436,0.00030379518],"domain_scores_gemma":[0.9967023,0.0014999324,0.0008988527,0.00017825977,0.0006237363,0.00009690038],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003490105,0.000286855,0.0010556325,0.0006360654,0.000027545717,0.000029499126,0.0003408034,0.0001442435,0.0011287081],"category_scores_gemma":[0.0011328316,0.00013074918,0.00021903815,0.0011632256,0.00011271174,0.00017634268,0.000051438543,0.00046479295,5.889977e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.522621,0.0018470298,0.39077267,0.000019478104,0.0010115289,0.00027943894,0.0001886264,0.0000985247,0.000024263549,0.0000063957764,0.000100374586,0.0830307],"study_design_scores_gemma":[0.3190139,0.008962338,0.6696459,0.0003829303,0.00020841205,0.000006821179,0.00009497514,0.0000052324153,0.00015127682,0.000017079317,0.0013828066,0.00012835291],"about_ca_topic_score_codex":0.00055572466,"about_ca_topic_score_gemma":0.0013914224,"teacher_disagreement_score":0.2788732,"about_ca_system_score_codex":0.0018046221,"about_ca_system_score_gemma":0.0011062725,"threshold_uncertainty_score":0.9997844},"labels":[],"label_agreement":null},{"id":"W4407645596","doi":"10.1016/j.ijgc.2024.100194","title":"Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; Sunnybrook Health Science Centre; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; Université Laval; University of Alberta; McGill University; University of Calgary; Hôpital Maisonneuve-Rosemont; University of Toronto; McMaster University; University of Manitoba; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Cervical cancer; Adjuvant; Surgery; Radiology; Cancer; Nuclear medicine; Oncology; Internal medicine","score_opus":0.016710440019288057,"score_gpt":0.33191735482011353,"score_spread":0.31520691480082547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407645596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651307,0.0009374431,0.000010726694,0.0008712205,0.00028802987,0.0008557488,0.000060110622,0.000012151886,0.00045150635],"genre_scores_gemma":[0.9987562,0.00032679582,0.000054075048,0.00035239436,0.000074675256,0.00014015616,0.000027737933,0.000014522909,0.00025345277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759156,0.00018350584,0.00075675215,0.00033370635,0.0008675272,0.00026696626],"domain_scores_gemma":[0.9977578,0.0004200293,0.00051665114,0.00010789565,0.0010330842,0.00016451748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018861066,0.00029361926,0.0008938508,0.00043742894,0.000051415118,0.00003370602,0.00021874628,0.00012927511,0.0008930996],"category_scores_gemma":[0.00011889289,0.00015136763,0.0002033457,0.0008789791,0.00010127589,0.0001139528,0.000050937906,0.00028824157,3.5159312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023322497,0.008882677,0.9468682,0.000008876072,0.0026805403,0.00035515625,0.0003158642,0.00011514654,0.00009515141,0.000007252695,0.000033357777,0.017315315],"study_design_scores_gemma":[0.02702355,0.013911779,0.95614076,0.0010916975,0.0005342009,0.000004255615,0.00011811095,0.000042219886,0.0008027182,0.000027517846,0.00016098477,0.00014222904],"about_ca_topic_score_codex":0.0012725184,"about_ca_topic_score_gemma":0.0025446056,"teacher_disagreement_score":0.017173087,"about_ca_system_score_codex":0.0017321596,"about_ca_system_score_gemma":0.0003578786,"threshold_uncertainty_score":0.97788143},"labels":[],"label_agreement":null},{"id":"W4407645648","doi":"10.1016/j.ijgc.2024.100131","title":"ULTRASOUND ASSESSMENT OF LYMPH NODES FOR STAGING OF GYNECOLOGICAL CANCER: CONSENSUS OPINION ON TERMINOLOGY AND EXAMINATION TECHNIQUE","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Terminology; Ultrasound; Lymph; Radiology; Medical physics; Gynecology; General surgery; Pathology; Linguistics","score_opus":0.020891834555635026,"score_gpt":0.3453812145160894,"score_spread":0.32448937996045435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407645648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757035,0.0007886453,0.020078067,0.0008713691,0.00084444066,0.00031355754,0.00016126427,0.00002520993,0.0012139833],"genre_scores_gemma":[0.9940676,0.001882269,0.003612343,0.00014109889,0.000089996545,0.00015983981,0.0000073206197,0.000007669446,0.00003184898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898565,0.00004804685,0.00053490314,0.00012430223,0.00018452122,0.00012258458],"domain_scores_gemma":[0.9972417,0.0019488853,0.00027517744,0.00006760454,0.00043205725,0.00003457813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003147612,0.000115855,0.00030628807,0.0001925072,0.000035484478,0.000014883228,0.00022503197,0.00013613021,0.00012635588],"category_scores_gemma":[0.00031750047,0.00009223838,0.00008581287,0.000087086024,0.00013712124,0.000045474622,0.000024673656,0.0001533984,1.2250398e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002950267,0.00087604445,0.26220456,0.0003487465,0.0012917431,0.00001307946,0.00021618609,0.033016767,0.45453012,0.05187165,0.001285766,0.19405031],"study_design_scores_gemma":[0.0015784217,0.00032162116,0.95515823,0.00026523662,0.00006629829,0.000037205606,0.00014681215,0.0032428687,0.02966889,0.0043966956,0.004938297,0.00017943354],"about_ca_topic_score_codex":0.000016502687,"about_ca_topic_score_gemma":0.000011725601,"teacher_disagreement_score":0.69295365,"about_ca_system_score_codex":0.00030885715,"about_ca_system_score_gemma":0.0001351702,"threshold_uncertainty_score":0.37613717},"labels":[],"label_agreement":null},{"id":"W4407645862","doi":"10.1016/j.ijgc.2024.100081","title":"Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Term (time); Rescue therapy; Internal medicine; Cancer; Gynecology","score_opus":0.024261746771147695,"score_gpt":0.35163362055384045,"score_spread":0.3273718737826928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407645862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931141,0.0018374455,0.00024114225,0.0007990207,0.0020848778,0.00150829,0.00034616634,0.0000069181433,0.000062023006],"genre_scores_gemma":[0.99551564,0.003312158,0.00022801488,0.00031295518,0.00020155289,0.00012286563,0.000016363674,0.000012361601,0.00027805983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972996,0.00013288273,0.0011172601,0.00032326818,0.00088889524,0.00023808837],"domain_scores_gemma":[0.994653,0.0019946937,0.0010909479,0.00020080774,0.0019436463,0.00011693404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043002988,0.0002455817,0.0011272313,0.0005346102,0.00006865289,0.000019273211,0.0004459592,0.000090015375,0.00044415766],"category_scores_gemma":[0.0018654026,0.0001163936,0.0005238947,0.0014171096,0.00015334449,0.000102232276,0.000100013545,0.00025067612,1.303894e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11074091,0.0030938156,0.6602338,0.00003623829,0.008901561,0.00001274951,0.0002510553,0.00022063148,0.00015536223,0.00005778911,0.000067942834,0.21622814],"study_design_scores_gemma":[0.06943508,0.0070257005,0.91827226,0.0002959647,0.002391158,0.0000021928217,0.00014710003,0.000037985217,0.00058323954,0.000034816017,0.0016523345,0.00012216109],"about_ca_topic_score_codex":0.000079957084,"about_ca_topic_score_gemma":0.0005040215,"teacher_disagreement_score":0.25803846,"about_ca_system_score_codex":0.0005467133,"about_ca_system_score_gemma":0.00038392114,"threshold_uncertainty_score":0.48632148},"labels":[],"label_agreement":null},{"id":"W4407645875","doi":"10.1016/j.ijgc.2024.100092","title":"Effect Of Crossover-Surgery At The Subsequent Relapse On The Survival Of Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Prespecified And Post-Hoc Analyses Of The SOC-1 Randomized Phase 3 Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Post-hoc analysis; Ovarian cancer; Randomized controlled trial; Post hoc; Oncology; Internal medicine; Crossover study; Surgery; Cancer; Alternative medicine; Placebo","score_opus":0.031121597202661264,"score_gpt":0.3583909555542078,"score_spread":0.3272693583515465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407645875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922753,0.00079049764,0.0000113601045,0.006867493,0.001310563,0.0012000211,0.0002603129,0.000002477794,0.00032971526],"genre_scores_gemma":[0.99844754,0.00072241237,0.000010584842,0.00042075245,0.00013349867,0.00009279313,0.000007777595,0.0000082430815,0.00015640155],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971619,0.0007892029,0.0008860876,0.00017711076,0.0008548987,0.00013076172],"domain_scores_gemma":[0.98633397,0.0109493695,0.0014212439,0.00019505585,0.0010521957,0.000048148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013501907,0.00018602762,0.0009943434,0.00009701692,0.00008222955,0.000017576736,0.00021094446,0.000087653,0.00048836175],"category_scores_gemma":[0.0021840753,0.00006685832,0.0005331327,0.00018213215,0.0005693949,0.000047409292,0.00008517093,0.00026481913,2.3047922e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9438081,0.0009933003,0.042323533,0.00003527668,0.00448103,0.0000269969,0.00018829387,0.00027154712,0.00069643377,0.00066531944,0.00082353636,0.0056866407],"study_design_scores_gemma":[0.60957175,0.006145688,0.33071333,0.0010324722,0.002310736,0.000006806701,0.000074112,0.00004731405,0.049469687,0.00015984956,0.00035062074,0.0001176133],"about_ca_topic_score_codex":0.00024490163,"about_ca_topic_score_gemma":0.00012241001,"teacher_disagreement_score":0.33423632,"about_ca_system_score_codex":0.00042639006,"about_ca_system_score_gemma":0.00043203705,"threshold_uncertainty_score":0.5347219},"labels":[],"label_agreement":null},{"id":"W4407646030","doi":"10.1016/j.ijgc.2024.100219","title":"Development Of A Multiplex Immunofluorescence Assay For The Assessment Of Homologous Recombination Repair Capacity In Patient-Derived 3D Models Of High Grade Serous Ovarian Cancer.","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Serous ovarian cancer; Homologous recombination; Multiplex; Serous fluid; Homologous chromosome; Ovarian cancer; Immunofluorescence; Cancer research; Oncology; Pathology; Cancer; Internal medicine; Bioinformatics; Immunology; Antibody; Genetics; Gene; Biology","score_opus":0.03357078404284908,"score_gpt":0.3122956321266351,"score_spread":0.278724848083786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407646030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969371,0.00037113985,0.028768213,0.00030043136,0.00076762383,0.00031652415,0.000065006796,0.0000031185264,0.000036951536],"genre_scores_gemma":[0.9582624,0.00034566046,0.0411349,0.000091914706,0.000025096753,0.00010480684,0.000009951229,0.0000059430868,0.000019339373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984829,0.00009759587,0.0008136735,0.00016792407,0.00030991444,0.00012801476],"domain_scores_gemma":[0.99787015,0.00020519643,0.000803606,0.00012766304,0.0009695559,0.000023856843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063327537,0.00011252718,0.00028128127,0.00010155721,0.000030657393,0.0000053360404,0.00042336786,0.00013373372,0.00003360838],"category_scores_gemma":[0.0003634598,0.00008149734,0.00015929072,0.000092990434,0.000090266985,0.000013145679,0.00012977204,0.00013494158,2.5845504e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005807558,0.0006987483,0.0053072986,0.00005418994,0.00074874243,0.000005403478,0.00029139663,0.018106665,0.93583196,0.001913695,0.00010333027,0.03635779],"study_design_scores_gemma":[0.002545088,0.00069493125,0.09724794,0.00021340109,0.0000602751,0.000008920878,0.0001915234,0.009644341,0.88573825,0.0031631454,0.00035318895,0.00013899487],"about_ca_topic_score_codex":0.00025992206,"about_ca_topic_score_gemma":0.00048787834,"teacher_disagreement_score":0.09194065,"about_ca_system_score_codex":0.00028580424,"about_ca_system_score_gemma":0.00055692287,"threshold_uncertainty_score":0.33233652},"labels":[],"label_agreement":null},{"id":"W4407647179","doi":"10.1016/j.ijgc.2024.100197","title":"Chemoradiotherapy And Image Guided Adaptive Brachytherapy For Locally Advanced Cervical Cancer Results In Stable Outcome Beyond 5 Years","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Brachytherapy; Cervical cancer; Chemoradiotherapy; Outcome (game theory); Oncology; Radiology; Radiation therapy; Internal medicine; Cancer","score_opus":0.03645161676209611,"score_gpt":0.39016070588210555,"score_spread":0.3537090891200094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407647179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96030885,0.007606911,0.0018401222,0.025296913,0.0019373328,0.0008537656,0.00024997184,0.000021505173,0.0018846013],"genre_scores_gemma":[0.9821473,0.0037484218,0.005627543,0.006847973,0.00040715554,0.0001417784,0.000009618181,0.000016720875,0.0010534832],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99823,0.000045240657,0.0008195146,0.00027325997,0.00038275385,0.00024922067],"domain_scores_gemma":[0.9982216,0.00056007144,0.00031535834,0.00009175808,0.0006770827,0.00013414126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036281714,0.00017549681,0.00063191453,0.00027298598,0.000029422134,0.00003557723,0.00022180464,0.00013703974,0.00050765375],"category_scores_gemma":[0.00048582343,0.00012786321,0.00018441737,0.00028791858,0.000100234385,0.0001635283,0.00004390886,0.00028561818,0.00000110008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072116636,0.0017150997,0.26442042,0.000120661134,0.0020875647,0.00072598306,0.00034928348,0.0008668699,0.008437321,0.002264025,0.0041355826,0.6427605],"study_design_scores_gemma":[0.072025806,0.0029402352,0.8830651,0.00051417144,0.00020082857,0.000058396046,0.00015412588,0.00060048595,0.0040948787,0.0077346317,0.028275196,0.00033614357],"about_ca_topic_score_codex":0.00021116943,"about_ca_topic_score_gemma":0.00029770576,"teacher_disagreement_score":0.6424244,"about_ca_system_score_codex":0.00094230135,"about_ca_system_score_gemma":0.00035800273,"threshold_uncertainty_score":0.55584526},"labels":[],"label_agreement":null},{"id":"W4407647325","doi":"10.1016/j.ijgc.2024.100084","title":"Prognostic Significance Of Isolated Tumor Cells In Sentinel Lymph Nodes In Low- And Intermediate-Risk Endometrial Cancer Patients: Updated Results From An International Multi-Institutional Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Lymph; Oncology; Internal medicine; Cancer; Gynecology; Pathology","score_opus":0.02039911930973257,"score_gpt":0.32939286087280345,"score_spread":0.30899374156307086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407647325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475753,0.00032600845,0.000079513076,0.00037756976,0.002742302,0.0006106952,0.0010033653,0.000011459634,0.00009152407],"genre_scores_gemma":[0.99815035,0.00070811674,0.00023531346,0.00035685633,0.0002933175,0.00008463595,0.00012504653,0.00001070805,0.00003568052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968239,0.00022855216,0.0015397478,0.0004305165,0.0007439229,0.00023335479],"domain_scores_gemma":[0.9969141,0.0009534887,0.0008344943,0.00011609303,0.0010399228,0.00014189207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050503283,0.00025215588,0.00070448004,0.0009388128,0.000032203752,0.000043860626,0.00043015272,0.0001239302,0.00043956505],"category_scores_gemma":[0.0028061015,0.00018095809,0.00013735713,0.00068556867,0.0001643947,0.0003194588,0.00014726471,0.0004337214,0.000001904105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015099056,0.006206201,0.9677849,0.00001640815,0.000682141,0.00031326435,0.00021135673,0.0009906243,0.0008682876,0.000009358335,0.000016783852,0.007801648],"study_design_scores_gemma":[0.045649666,0.0005838674,0.94981575,0.00052834576,0.00016245477,0.0000029151201,0.00015662976,0.0018595748,0.0009560198,0.000085689935,0.000063118656,0.00013598247],"about_ca_topic_score_codex":0.0029040587,"about_ca_topic_score_gemma":0.0008049245,"teacher_disagreement_score":0.03055061,"about_ca_system_score_codex":0.0009976225,"about_ca_system_score_gemma":0.0005135631,"threshold_uncertainty_score":0.73792565},"labels":[],"label_agreement":null},{"id":"W4407649481","doi":"10.1016/j.ijgc.2024.101420","title":"Classification And Management Of Ovarian Neuroectodermal-Type Tumors: A Scoping Review And Case Report","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pathology","score_opus":0.10484425452093571,"score_gpt":0.44799666585608483,"score_spread":0.3431524113351491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407649481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041476087,0.9967461,0.0000067331557,0.0012714455,0.00032659285,0.00084974064,0.000013968756,0.0000044898293,0.00036612127],"genre_scores_gemma":[0.0012461637,0.9975819,0.0004308141,0.00045814013,0.00008261652,0.000085542255,0.000013649125,0.0000086194605,0.000092580594],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99826866,0.00008197801,0.0010669765,0.00022254343,0.0002690822,0.0000907362],"domain_scores_gemma":[0.99790543,0.00035626136,0.0011000973,0.00012469948,0.00042693058,0.0000865691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029239117,0.00018109038,0.0012594068,0.000163664,0.000023236382,0.000019608404,0.000102273065,0.00007345367,0.0001968585],"category_scores_gemma":[0.00030283834,0.00011663729,0.00021396046,0.00013057937,0.000054933753,0.000047452442,0.00010098437,0.00020245215,6.784279e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003468929,0.00026543645,0.0015215151,0.073428504,0.0013269515,0.12325872,0.0000041158182,2.5591942e-7,1.5338566e-7,0.00023539172,0.0004291183,0.79949516],"study_design_scores_gemma":[0.0010777531,0.00036767547,0.010055046,0.6942898,0.008948778,0.18346348,0.000012875024,0.0000029171144,0.0000011112078,0.000044326687,0.101551324,0.00018492981],"about_ca_topic_score_codex":0.000012011115,"about_ca_topic_score_gemma":0.0000065545055,"teacher_disagreement_score":0.7993102,"about_ca_system_score_codex":0.00018369405,"about_ca_system_score_gemma":0.00032469342,"threshold_uncertainty_score":0.47563305},"labels":[],"label_agreement":null},{"id":"W4407650966","doi":"10.1016/j.ijgc.2024.101073","title":"Real-World Experience Of Treating Ovarian Cancer With PARP Inhibitors","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.028574344574752466,"score_gpt":0.3878671504596491,"score_spread":0.35929280588489665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407650966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97636384,0.00070408336,0.0004801473,0.008097897,0.0015784614,0.00017781933,0.000024674178,0.000018822797,0.012554263],"genre_scores_gemma":[0.99359167,0.0012512893,0.0014445445,0.0015848163,0.00056063704,0.00007062063,0.0000021535277,0.000010700159,0.0014835673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824107,0.000051165505,0.00071136653,0.00018387365,0.00063666835,0.00017585033],"domain_scores_gemma":[0.99775785,0.00028013007,0.0006346923,0.000114450166,0.001110752,0.00010211236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002098669,0.00014881957,0.00042666143,0.00031498543,0.00004195255,0.000021042104,0.00025798523,0.00007829309,0.0025032577],"category_scores_gemma":[0.00015797671,0.00009969339,0.00015174817,0.00037595743,0.00020992456,0.00014945392,0.000040689352,0.0002950843,0.0000012579194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044947146,0.0005087872,0.90921926,0.000054626562,0.0010759886,0.0003123076,0.0008505836,0.0011753286,0.028028049,0.0031551374,0.0045398846,0.046585355],"study_design_scores_gemma":[0.010531135,0.0011924774,0.8097953,0.003162463,0.00026425006,0.00011606457,0.0006939005,0.00020103634,0.13692874,0.0013050644,0.03549649,0.00031308722],"about_ca_topic_score_codex":0.00059730205,"about_ca_topic_score_gemma":0.00043942084,"teacher_disagreement_score":0.108900696,"about_ca_system_score_codex":0.00084076065,"about_ca_system_score_gemma":0.00070745894,"threshold_uncertainty_score":0.9984086},"labels":[],"label_agreement":null},{"id":"W4407762879","doi":"10.1016/j.ijgc.2025.101703","title":"Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Durvalumab; Medicine; Olaparib; Paclitaxel; Carboplatin; Endometrial cancer; Biomarker; Oncology; Cancer; Internal medicine; Cisplatin; Chemotherapy; Immunotherapy; Nivolumab","score_opus":0.07644395857801443,"score_gpt":0.4110237908825988,"score_spread":0.3345798323045844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98762524,0.008224461,0.000052361007,0.002449554,0.0007701127,0.000622107,0.000050493156,0.0000116039355,0.00019408161],"genre_scores_gemma":[0.9981835,0.0008643931,0.00016900201,0.000487718,0.00010019634,0.00012643353,0.000016742948,0.000009816352,0.00004221076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971805,0.00039620002,0.0010587123,0.00031987406,0.0008018986,0.0002427707],"domain_scores_gemma":[0.99771446,0.00095801346,0.0006171235,0.00015704575,0.00046330073,0.00009004127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094218086,0.00022383084,0.00082909886,0.00064375007,0.0000452404,0.000022991286,0.00027492276,0.00016688011,0.000116166724],"category_scores_gemma":[0.001234333,0.0001310674,0.00024194246,0.0009118935,0.00020391388,0.00012504564,0.0000680841,0.00036303105,4.210812e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012557965,0.0012919164,0.97251505,0.00005891462,0.00091881794,0.00020368736,0.00027436425,0.00046280972,0.004530258,0.000050733346,0.0004302094,0.006705251],"study_design_scores_gemma":[0.027656773,0.0011100043,0.9660703,0.00032876263,0.00040657478,0.00004244535,0.0002521315,0.00042222207,0.002780974,0.000081919454,0.00070138625,0.00014652088],"about_ca_topic_score_codex":0.001972566,"about_ca_topic_score_gemma":0.0027807218,"teacher_disagreement_score":0.015098809,"about_ca_system_score_codex":0.0013541238,"about_ca_system_score_gemma":0.0004807143,"threshold_uncertainty_score":0.5344773},"labels":[],"label_agreement":null},{"id":"W4407762903","doi":"10.1016/j.ijgc.2025.101710","title":"Challenges in Surgical Randomized Controlled Trials (RCTS) in Gynaecologic Oncology: Insights from a European Network of Young Gynae Oncologists (ENYGO) Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada","funders":"","keywords":"Medicine; Randomized controlled trial; Gynecology; Internal medicine","score_opus":0.0863220818077003,"score_gpt":0.4116204164029794,"score_spread":0.3252983345952791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9279546,0.026919642,0.000013804259,0.008440966,0.0040365215,0.0023880226,0.000012087824,0.000014057483,0.030220298],"genre_scores_gemma":[0.9804492,0.017733095,0.00025309096,0.00046120986,0.00058887445,0.00038900884,0.0000059996037,0.000011823095,0.00010772772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99003065,0.0051050754,0.0035157425,0.00041006194,0.00065304997,0.00028539638],"domain_scores_gemma":[0.9777408,0.019321442,0.0019474812,0.00017427892,0.0006977395,0.000118254706],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008507405,0.00030858495,0.005535332,0.000474918,0.000027901779,0.000028121372,0.0004424615,0.00025190666,0.0013511727],"category_scores_gemma":[0.010315873,0.00017293991,0.0009913313,0.00029110129,0.00020757597,0.00009285312,0.00015399422,0.00062894117,0.0000044438257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34685865,0.014713793,0.43594718,0.000026103073,0.0089267595,0.01826683,0.0010873814,0.0024654001,0.000038065482,0.003042048,0.00058143085,0.16804633],"study_design_scores_gemma":[0.37763798,0.0016222331,0.6152703,0.00030949918,0.00072352035,0.000022067905,0.00042626748,0.00009645946,0.000015789286,0.0021494594,0.0016196248,0.00010678165],"about_ca_topic_score_codex":0.00033002056,"about_ca_topic_score_gemma":0.003639293,"teacher_disagreement_score":0.17932314,"about_ca_system_score_codex":0.002085056,"about_ca_system_score_gemma":0.00085978606,"threshold_uncertainty_score":0.9995617},"labels":[],"label_agreement":null},{"id":"W4407762907","doi":"10.1016/j.ijgc.2025.101701","title":"Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab As First-Line Treatment For Endometrial Cancer: Patient-Reported Outcomes In The DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat And Mismatch Repair Deficient Populations","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Medicine; Durvalumab; Carboplatin; Paclitaxel; Endometrial cancer; Oncology; Internal medicine; Urology; Gynecology; Cancer; Chemotherapy; Cisplatin; Nivolumab; Immunotherapy","score_opus":0.0606368878569673,"score_gpt":0.3927037686228137,"score_spread":0.3320668807658464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675849,0.0036130904,0.00019911666,0.023377072,0.002313721,0.0018386997,0.00034609222,0.000033873075,0.0006934551],"genre_scores_gemma":[0.9933417,0.0015839179,0.0005479921,0.0024103364,0.00029027043,0.00056529755,0.00005974604,0.000020450625,0.0011803234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666315,0.0001542659,0.0013845545,0.0004570125,0.0009402437,0.0004007803],"domain_scores_gemma":[0.9963362,0.0018065843,0.00058476586,0.0002360058,0.0008023949,0.00023400753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005035798,0.00036927298,0.0009877826,0.00057739555,0.00017670896,0.000077100325,0.00030469891,0.00018561253,0.00036646173],"category_scores_gemma":[0.0030929781,0.00021486329,0.00061406934,0.000686504,0.00008523377,0.00012173187,0.0000803493,0.0002888645,0.000003087595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029168976,0.0062417104,0.82776535,0.00012399185,0.0045912974,0.00086906797,0.0021609892,0.002194626,0.0009750539,0.0011711902,0.010071649,0.114666104],"study_design_scores_gemma":[0.16398229,0.023882082,0.69892806,0.0011574234,0.004733638,0.00041623428,0.002361204,0.0013051974,0.0031405808,0.0042793755,0.09465313,0.0011608031],"about_ca_topic_score_codex":0.0040488224,"about_ca_topic_score_gemma":0.0027380432,"teacher_disagreement_score":0.13481331,"about_ca_system_score_codex":0.002896789,"about_ca_system_score_gemma":0.00054944283,"threshold_uncertainty_score":0.8761871},"labels":[],"label_agreement":null},{"id":"W4407762960","doi":"10.1016/j.ijgc.2025.101697","title":"Patient-Reported Outcomes With Pembrolizumab Plus Chemoradiotherapy For High-Risk, Locally Advanced Cervical Cancer: Interim Analysis 2 Results From The Randomised, Double-Blind, Phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Interim; Pembrolizumab; Interim analysis; Cervical cancer; Chemoradiotherapy; Oncology; Internal medicine; Gynecology; Clinical trial; Cancer; Immunotherapy","score_opus":0.03861104697851629,"score_gpt":0.3862248945327503,"score_spread":0.34761384755423397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815864,0.0012691033,0.0031327556,0.009232035,0.001718397,0.0023053465,0.00056214724,0.000038139573,0.0001556764],"genre_scores_gemma":[0.9938663,0.0009542074,0.00066558353,0.002781606,0.00058909826,0.00071956485,0.00011747415,0.000028266153,0.00027786096],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957912,0.00020964172,0.0017755453,0.00062259793,0.001217514,0.00038351488],"domain_scores_gemma":[0.99325204,0.0027446807,0.001564364,0.0003992754,0.0017846198,0.00025504315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059027696,0.00044504125,0.0016642655,0.00040401256,0.00017114723,0.0001167367,0.00065048767,0.00018229734,0.0012821549],"category_scores_gemma":[0.0011441476,0.00022907788,0.00079705886,0.00094114436,0.00015934963,0.00017359016,0.00010494515,0.0006349971,0.000001949318],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73917323,0.003358871,0.13146342,0.000011834145,0.029087432,0.00033031855,0.00054697035,0.0035697666,0.00011421171,0.000032145654,0.00038739233,0.0919244],"study_design_scores_gemma":[0.768579,0.0071687866,0.2099368,0.00018935022,0.0081246495,0.000016421578,0.0006266221,0.00040888044,0.0014482402,0.00024238153,0.0029222309,0.00033662218],"about_ca_topic_score_codex":0.0032778664,"about_ca_topic_score_gemma":0.0029144897,"teacher_disagreement_score":0.09158778,"about_ca_system_score_codex":0.0015111285,"about_ca_system_score_gemma":0.0008196726,"threshold_uncertainty_score":0.9996308},"labels":[],"label_agreement":null},{"id":"W4407762963","doi":"10.1016/j.ijgc.2025.101700","title":"Pembrolizumab Or Placebo Plus Adjuvant Chemotherapy With Or Without Radiotherapy In Patients With Newly Diagnosed, High-Risk Endometrial Cancer: Exploratory Analysis Of Disease-Specific Survival From The Phase 3 ENGOT-En11/GOG-3053/KEYNOTE-B21 Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh; University of Texas MD Anderson Cancer Center; University of California, San Diego; National and Kapodistrian University of Athens; McGovern Medical School","keywords":"Medicine; Endometrial cancer; Pembrolizumab; Oncology; Placebo; Internal medicine; Radiation therapy; Adjuvant; Chemotherapy; Disease; Cancer; Immunotherapy; Alternative medicine; Pathology","score_opus":0.031928649341981336,"score_gpt":0.3391723876426938,"score_spread":0.3072437383007125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234426,0.0025829505,0.000694996,0.0010901393,0.0011521996,0.0014247707,0.00067228253,0.00001740244,0.00002101891],"genre_scores_gemma":[0.9922428,0.0056212232,0.00025443797,0.0007468753,0.0006786705,0.0002773942,0.000050169412,0.000031667398,0.00009676919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959523,0.00044601396,0.0010949585,0.00049880636,0.0016788336,0.0003290724],"domain_scores_gemma":[0.9944566,0.0029518816,0.0010127906,0.00033258315,0.0009872186,0.0002589209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048791396,0.00040717743,0.0016424896,0.00082225486,0.00008602524,0.000066591776,0.0006401473,0.00011397728,0.0041016825],"category_scores_gemma":[0.00059125444,0.00018299965,0.00032561264,0.0021789838,0.00020773013,0.00019962557,0.00006269546,0.00054729165,9.872991e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3161307,0.0036352254,0.63318866,0.000006877274,0.009015919,0.00026172874,0.00046715426,0.002274723,0.000013382778,0.00000665755,0.00012531702,0.034873627],"study_design_scores_gemma":[0.20383245,0.007791941,0.7835041,0.00021600223,0.0024989066,9.554782e-7,0.000547398,0.000121364894,0.00008086835,0.0000184752,0.0011873177,0.00020019694],"about_ca_topic_score_codex":0.0023846952,"about_ca_topic_score_gemma":0.0065634144,"teacher_disagreement_score":0.15031543,"about_ca_system_score_codex":0.0017865698,"about_ca_system_score_gemma":0.0012734311,"threshold_uncertainty_score":0.9968087},"labels":[],"label_agreement":null},{"id":"W4408059154","doi":"10.1016/j.ijgc.2025.101760","title":"ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; GOG Foundation; National Institutes of Health; Intuitive Surgical","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Randomized controlled trial; Open surgery; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.06652822512324104,"score_gpt":0.4088668284931574,"score_spread":0.3423386033699164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408059154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9406091,0.0046065575,0.0019259319,0.017483378,0.020750733,0.007559954,0.00012911185,0.000025257033,0.0069099995],"genre_scores_gemma":[0.99133676,0.0018946362,0.00042616,0.0012364688,0.0010118263,0.0012999311,0.000009968817,0.000014975193,0.002769271],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996728,0.00026287793,0.0017074014,0.00025973833,0.000767039,0.0002749257],"domain_scores_gemma":[0.98784655,0.009222972,0.0010822085,0.00013469755,0.0015334197,0.00018017367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015242982,0.00023756556,0.0029012752,0.00038028447,0.000051439514,0.00006877159,0.00057305687,0.0001943919,0.0038141103],"category_scores_gemma":[0.0065547447,0.0001421045,0.0015606255,0.00030600122,0.00015994097,0.0001569324,0.00015602646,0.00028767885,0.0000023760874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9777091,0.0010628108,0.0044955052,0.000050021303,0.005373697,0.00006171345,0.000024603223,0.00026606396,0.000056594577,0.0011179653,0.0010775939,0.008704312],"study_design_scores_gemma":[0.9849916,0.0015381775,0.006665492,0.00030702283,0.0015600016,0.0000038962276,0.000026697606,0.00020766375,0.00040011405,0.0010371408,0.0031339517,0.00012824846],"about_ca_topic_score_codex":0.0005583542,"about_ca_topic_score_gemma":0.00014987073,"teacher_disagreement_score":0.050727684,"about_ca_system_score_codex":0.00067503034,"about_ca_system_score_gemma":0.0012157483,"threshold_uncertainty_score":0.99709654},"labels":[],"label_agreement":null},{"id":"W4408073032","doi":"10.1016/j.ijgc.2025.101755","title":"Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Cervical cancer; Human papillomavirus; Biomarker; DNA sequencing; Oncology; DNA; Computational biology; Cancer research; Cancer; Virology; Internal medicine; Genetics; Biology","score_opus":0.06217829594589125,"score_gpt":0.4492171011232463,"score_spread":0.38703880517735506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408073032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842652,0.0018279578,0.00005461508,0.005234394,0.0005791249,0.00020474648,0.0000160618,0.000010387927,0.007807495],"genre_scores_gemma":[0.9971985,0.00040934476,0.00016372443,0.0016228204,0.00016706539,0.00004030865,0.0000023764399,0.000011477104,0.00038437318],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997493,0.00018869973,0.00093141134,0.00023629407,0.00086393754,0.000286599],"domain_scores_gemma":[0.99740773,0.00072138465,0.00032957026,0.00012992078,0.001260137,0.00015123695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094977993,0.00015345482,0.00056118844,0.00051713147,0.000046160232,0.000024366886,0.00037793376,0.00016167336,0.009854671],"category_scores_gemma":[0.0017168294,0.00011748909,0.0002467365,0.00046265422,0.00015664872,0.00012881545,0.00014692821,0.00056374393,0.0000034295365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032014485,0.0006630833,0.31859294,0.00021698228,0.00084972655,0.00244733,0.0003981459,0.000973873,0.41933477,0.0013718252,0.00053110195,0.22260574],"study_design_scores_gemma":[0.0047577014,0.00063150324,0.97875696,0.00049620634,0.000059195452,0.000074860545,0.00021993613,0.00038310804,0.0104369605,0.0018523824,0.0022097074,0.00012144599],"about_ca_topic_score_codex":0.00059549464,"about_ca_topic_score_gemma":0.00041827466,"teacher_disagreement_score":0.66016406,"about_ca_system_score_codex":0.0019568615,"about_ca_system_score_gemma":0.0012714943,"threshold_uncertainty_score":0.9910505},"labels":[],"label_agreement":null},{"id":"W4408173499","doi":"10.1016/j.ijgc.2025.101764","title":"Outcomes of low-risk endometrial cancer with isolated tumor cells in the sentinel lymph nodes: a prospective, multi-center, single-arm, observational study (ENDO-ITC study)","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute","keywords":"Medicine; Observational study; Endometrial cancer; Multicenter study; Oncology; Lymph; Prospective cohort study; Internal medicine; Gynecology; Cancer; Pathology; Randomized controlled trial","score_opus":0.06868543557021173,"score_gpt":0.37207158404270396,"score_spread":0.30338614847249223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408173499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954562,0.00039140327,0.00014355399,0.0010295184,0.0013284398,0.0013200486,0.00013735627,0.000013074826,0.00018038118],"genre_scores_gemma":[0.9979144,0.00014018248,0.00027425453,0.000998072,0.0002444774,0.000246576,0.000005864211,0.000014670946,0.00016151016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658394,0.00031267767,0.0011824853,0.000344169,0.001305918,0.0002707952],"domain_scores_gemma":[0.9961299,0.0013832122,0.0008910261,0.00017429516,0.001330814,0.0000907707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068802846,0.00028879495,0.0008908081,0.00058722676,0.000065940454,0.000053998967,0.00056379347,0.00007332793,0.0005336826],"category_scores_gemma":[0.0011730011,0.00015142717,0.00027750985,0.001151191,0.00011115962,0.00015708763,0.00011212809,0.0004703045,0.0000021902083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009210524,0.035503298,0.9489693,0.000021697924,0.0024926928,0.00046241714,0.000355598,0.0003407157,0.00031064858,0.00002091266,0.0000410187,0.002271164],"study_design_scores_gemma":[0.06200968,0.002421352,0.9333387,0.00018584184,0.00045815075,0.000018122202,0.000828945,0.0001174208,0.0003511781,0.00006264578,0.00008358893,0.00012434994],"about_ca_topic_score_codex":0.001026514,"about_ca_topic_score_gemma":0.0005204262,"teacher_disagreement_score":0.052799158,"about_ca_system_score_codex":0.0009696813,"about_ca_system_score_gemma":0.00047851354,"threshold_uncertainty_score":0.61750203},"labels":[],"label_agreement":null},{"id":"W4408473389","doi":"10.1016/j.ijgc.2025.101770","title":"Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or because we must?","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Oncology; Chemotherapy; Internal medicine; Cancer","score_opus":0.03542894649066185,"score_gpt":0.3897565134562985,"score_spread":0.35432756696563666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408473389","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025293995,0.012700478,0.00005281121,0.13440977,0.8211284,0.0015906822,0.0036281985,0.0000790795,0.001116585],"genre_scores_gemma":[0.04292693,0.14317918,0.0009175461,0.014195347,0.75769037,0.0007956429,0.00029603913,0.000185759,0.039813194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993683,0.00019043537,0.0018296269,0.0007855304,0.0027835758,0.000727877],"domain_scores_gemma":[0.9935958,0.002417287,0.0009706674,0.00034255823,0.0019506268,0.00072307396],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005505193,0.00073263753,0.0020283898,0.001124698,0.00006837797,0.00012892942,0.0012563333,0.0011658245,0.014815571],"category_scores_gemma":[0.002951004,0.0004807276,0.00065639376,0.00094591844,0.0001228429,0.0001520773,0.00031815207,0.0023125447,0.000025306845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021005157,0.0017057111,0.0047710272,0.00030704009,0.0024462785,0.0046007065,0.0003747985,0.00029430873,0.000117021154,0.000039246475,0.83518404,0.12915468],"study_design_scores_gemma":[0.015437194,0.002435965,0.0076129544,0.0026853918,0.0004259691,0.000024340183,0.00010275881,0.000015707516,0.00033502677,0.00018812012,0.97025603,0.00048056882],"about_ca_topic_score_codex":0.0032915366,"about_ca_topic_score_gemma":0.013365581,"teacher_disagreement_score":0.13507198,"about_ca_system_score_codex":0.006261889,"about_ca_system_score_gemma":0.0045548948,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W4408711760","doi":"10.1016/j.ijgc.2025.101788","title":"Clinician perceptions of asynchronous care for patients with ovarian cancer on PARP inhibitor therapy","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Conquer Cancer Foundation","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Oncology; Cancer therapy; Asynchronous communication; Internal medicine; Cancer; Poly ADP ribose polymerase; DNA","score_opus":0.022921903966865494,"score_gpt":0.30572157543885836,"score_spread":0.28279967147199286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408711760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829589,0.0028467567,0.0023622254,0.00222213,0.0034617726,0.00035850843,0.0007217349,0.0000073696,0.005060586],"genre_scores_gemma":[0.99518853,0.0018955049,0.0005218454,0.0016299591,0.00052900927,0.000068282956,0.000010410778,0.000013019249,0.0001434539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868804,0.000012122892,0.0008276347,0.00020983501,0.00007940532,0.00018295753],"domain_scores_gemma":[0.99800444,0.00019424346,0.0009043199,0.0001077202,0.0007250845,0.00006421176],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018331998,0.00014300931,0.00048720985,0.0002375914,0.00006585869,0.000038649145,0.00037515175,0.00013227122,0.000991378],"category_scores_gemma":[0.00021626306,0.00011606181,0.0002257674,0.00009339804,0.00009785646,0.00018766888,0.000027234057,0.0001855935,0.000006972553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016757547,0.00051395176,0.8818761,0.000020002093,0.00047455952,0.0000022145728,0.0003422024,0.0014389326,0.000008506547,0.022438973,0.0015083811,0.08970042],"study_design_scores_gemma":[0.0043973285,0.0013886418,0.9280559,0.00012277969,0.000018948896,3.7474155e-7,0.0001272603,0.00005571381,0.00008079729,0.0051899063,0.06039343,0.00016893461],"about_ca_topic_score_codex":0.00013062637,"about_ca_topic_score_gemma":0.00028293353,"teacher_disagreement_score":0.08953149,"about_ca_system_score_codex":0.00064290967,"about_ca_system_score_gemma":0.0002206116,"threshold_uncertainty_score":0.99992186},"labels":[],"label_agreement":null},{"id":"W4409099263","doi":"10.1016/j.ijgc.2025.101804","title":"Response to “Correspondence on “Laparoscopic bariatric surgery with hysterectomy for endometrial cancer to improve long-term outcomes: a review article” by Mezzapesa et al.”","year":2025,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Endometrial cancer; Hysterectomy; Laparoscopy; General surgery; Laparoscopic surgery; Surgery; Gynecologic cancer; Cancer; Gynecology; Ovarian cancer; Internal medicine","score_opus":0.0523685840373516,"score_gpt":0.41818190938442207,"score_spread":0.36581332534707045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409099263","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14488985,0.0060859863,0.000311853,0.8423866,0.0026999353,0.0028072712,0.0007563961,0.000020078744,0.000041997493],"genre_scores_gemma":[0.034687772,0.013906651,0.00032659277,0.94371045,0.0010853404,0.0023182803,0.00006575994,0.000049077455,0.0038501055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477834,0.00056672894,0.0011838664,0.0006390835,0.00220836,0.00062361604],"domain_scores_gemma":[0.976188,0.020563684,0.00070414366,0.00032119837,0.0017774374,0.00044554163],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001900124,0.0004918699,0.0018219115,0.0017069532,0.000056177887,0.00012207421,0.0006483384,0.00027067921,0.0014770351],"category_scores_gemma":[0.02567198,0.00029316795,0.0007127987,0.00096762506,0.000050737497,0.00012003255,0.00013904936,0.0013580803,0.000033185657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024498885,0.00044067547,0.033765994,0.00037043993,0.0020167597,0.0021241568,0.000012578394,0.000011052681,0.0005244996,0.0000014285048,0.9186165,0.01761708],"study_design_scores_gemma":[0.009580436,0.007099287,0.04165553,0.008688501,0.0006562232,0.00008432055,0.000003268167,0.0000017883814,0.0018369404,0.000006935767,0.9299896,0.00039720006],"about_ca_topic_score_codex":0.000104240695,"about_ca_topic_score_gemma":0.00007809862,"teacher_disagreement_score":0.110202074,"about_ca_system_score_codex":0.002584077,"about_ca_system_score_gemma":0.0021613352,"threshold_uncertainty_score":0.999952},"labels":[],"label_agreement":null},{"id":"W4409203300","doi":"10.1016/j.ijgc.2025.101818","title":"Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm trial with stopping rules (ENGOT-cx23/MITO/LASH trial)","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Hysterectomy; Surgery; Gynecology; Cancer; Internal medicine","score_opus":0.031163555015335544,"score_gpt":0.3338226025107174,"score_spread":0.30265904749538186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409203300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877576,0.0015955997,0.000056629447,0.0045794235,0.0026877811,0.0010464826,0.00009236882,0.000026922244,0.0021571894],"genre_scores_gemma":[0.9939206,0.0013012443,0.00041931824,0.0021160417,0.001622634,0.00026778542,0.000016659946,0.000022203063,0.00031349587],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966188,0.00024585164,0.0012562432,0.0004293735,0.0010255395,0.0004241669],"domain_scores_gemma":[0.9960411,0.0018046872,0.0008195268,0.00016789227,0.00091550354,0.00025124662],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004833109,0.00033582855,0.0010498267,0.000592747,0.00007436922,0.0000948779,0.0005096887,0.00024746862,0.0020331563],"category_scores_gemma":[0.001927168,0.00021977825,0.00040134354,0.0005931663,0.00014488518,0.00020835949,0.0001405251,0.00076132466,0.0000095618025],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7834319,0.0064532077,0.11755767,0.00012737387,0.002494162,0.0013364098,0.00023405824,0.0004662802,0.0008060935,0.00016899766,0.00075714965,0.08616668],"study_design_scores_gemma":[0.80046743,0.022250183,0.15476441,0.0022740606,0.0009714968,0.00007349832,0.00035441434,0.00009890775,0.0038383116,0.0021683825,0.012200817,0.00053805707],"about_ca_topic_score_codex":0.0008300721,"about_ca_topic_score_gemma":0.0033352075,"teacher_disagreement_score":0.08562863,"about_ca_system_score_codex":0.0021103118,"about_ca_system_score_gemma":0.0013787852,"threshold_uncertainty_score":0.99887913},"labels":[],"label_agreement":null},{"id":"W4409203336","doi":"10.1016/j.ijgc.2025.101812","title":"Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician’s choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitors","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Eisai Incorporated; Eisai Canada; AbbVie","keywords":"Medicine; Lenvatinib; Oncology; Chemotherapy; Internal medicine; Randomized controlled trial; Sorafenib","score_opus":0.04268350615576826,"score_gpt":0.3771761306306152,"score_spread":0.33449262447484696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409203336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292517,0.0042454763,0.000032974378,0.0003606359,0.00039357707,0.0018375507,0.000021008447,0.0000065590916,0.0001770533],"genre_scores_gemma":[0.998178,0.0007461076,0.0007132218,0.000045087487,0.00014577982,0.00012831728,0.000009221066,0.000011605217,0.000022667322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997388,0.00024389182,0.0012917228,0.00027513402,0.0006136075,0.0001876625],"domain_scores_gemma":[0.9950814,0.0032264618,0.0009600981,0.00010603262,0.0005356071,0.00009035985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006058199,0.00026272054,0.0015019269,0.000431488,0.000031415697,0.000014585405,0.00012241805,0.000080973805,0.00009787162],"category_scores_gemma":[0.0011663449,0.00015808326,0.00023423553,0.00047442887,0.00019340469,0.00007890297,0.000038333794,0.00018051657,1.07302085e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.729712,0.0032432245,0.10976269,0.00005654582,0.0018340275,0.000051007875,0.00041230445,0.0013260548,0.0018715019,0.000012964895,0.0000011022274,0.15171653],"study_design_scores_gemma":[0.6656903,0.021048972,0.30235812,0.00046447047,0.0006098552,0.0000041788676,0.0001795246,0.00052159233,0.008979878,0.000010793619,0.000025128711,0.0001071902],"about_ca_topic_score_codex":0.00045251774,"about_ca_topic_score_gemma":0.00011129481,"teacher_disagreement_score":0.1925954,"about_ca_system_score_codex":0.00091510883,"about_ca_system_score_gemma":0.00042345605,"threshold_uncertainty_score":0.64464486},"labels":[],"label_agreement":null},{"id":"W4409671039","doi":"10.1016/j.ijgc.2025.101911","title":"Is modified radical hysterectomy the answer?","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Radical Hysterectomy; Hysterectomy; Gynecology; General surgery; Internal medicine; Surgery; Cervical cancer; Cancer","score_opus":0.0314130996891792,"score_gpt":0.37275906404910436,"score_spread":0.34134596435992515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409671039","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035398784,0.0058369874,0.0001044374,0.01995798,0.96205467,0.0003736644,0.00042555766,0.000023359984,0.007683478],"genre_scores_gemma":[0.058593914,0.0074222903,0.00016971254,0.0063376226,0.9170497,0.00008874173,0.000087736655,0.00003188438,0.010218373],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99603176,0.00013508664,0.0009527228,0.0003218439,0.0022739836,0.00028462062],"domain_scores_gemma":[0.99406,0.0028454484,0.0007372935,0.00022041942,0.0019323286,0.00020455012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004686219,0.00032737356,0.0009227666,0.00027811347,0.0000704203,0.00009087257,0.0009729299,0.0007341053,0.0040629925],"category_scores_gemma":[0.0030764232,0.00016855514,0.00078568637,0.0002819808,0.00019170385,0.0000813051,0.0001760728,0.0017340442,0.000022857314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027074902,0.00035867264,0.0006705183,0.000049787202,0.002188412,0.0004856163,0.000040338196,0.00001098738,0.000017286467,0.000063628024,0.9655423,0.027864933],"study_design_scores_gemma":[0.006049061,0.0008062728,0.00224388,0.00048750636,0.0007100658,0.000036894264,0.000015754718,0.000014415325,0.00015587854,0.0006961855,0.9886286,0.00015548134],"about_ca_topic_score_codex":0.00012872249,"about_ca_topic_score_gemma":0.000027453098,"teacher_disagreement_score":0.055054035,"about_ca_system_score_codex":0.001281302,"about_ca_system_score_gemma":0.0016445728,"threshold_uncertainty_score":0.99684745},"labels":[],"label_agreement":null},{"id":"W4409816394","doi":"10.1016/j.ijgc.2025.101900","title":"Providing tertiary gynecologic oncology care for Quebec’s indigenous population in Montreal","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Interpreting and Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gynecologic oncology; Indigenous; Tertiary care; Oncology; Gynecology; Family medicine; Internal medicine","score_opus":0.03465604103287889,"score_gpt":0.47447433846861015,"score_spread":0.43981829743573125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409816394","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04174329,0.0046734167,0.0001394403,0.0039830795,0.94370836,0.0020361184,0.00052839826,0.000054184984,0.0031337186],"genre_scores_gemma":[0.4696068,0.004763162,0.0011569663,0.0029677066,0.5119173,0.0027849716,0.001079294,0.0000719526,0.0056518447],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944258,0.001456783,0.002346836,0.0004005652,0.0007831719,0.0005868696],"domain_scores_gemma":[0.9772271,0.015201485,0.0026400175,0.00026775367,0.0045404206,0.00012320392],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016734661,0.0003385519,0.0010255656,0.0006372884,0.00042336198,0.00003773063,0.0015960316,0.0023435645,0.0004518081],"category_scores_gemma":[0.010740894,0.00027608205,0.00034701984,0.00015595458,0.000066101515,0.00016187942,0.0003564075,0.0036974829,0.000008968648],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0019062465,0.00030930698,0.10572367,0.0009421261,0.0003212567,0.00010766472,0.00994718,0.00043615646,0.0000071315453,0.00017909319,0.73802716,0.14209303],"study_design_scores_gemma":[0.0028433925,0.0007947736,0.07186076,0.00274358,0.00011655513,0.0000026465789,0.0046133036,0.00007791203,0.0000038567564,0.0017850118,0.91481096,0.0003472365],"about_ca_topic_score_codex":0.028880911,"about_ca_topic_score_gemma":0.19479929,"teacher_disagreement_score":0.43179104,"about_ca_system_score_codex":0.011576604,"about_ca_system_score_gemma":0.0061602807,"threshold_uncertainty_score":0.9999691},"labels":[],"label_agreement":null},{"id":"W4409885354","doi":"10.1016/j.ijgc.2025.101906","title":"Prognostic value of isolated tumor cells in sentinel lymph nodes in intermediate-risk endometrial cancer: results from an international, multi-institutional study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Lymph; Oncology; Value (mathematics); Internal medicine; Cancer; Gynecology; Pathology; Statistics","score_opus":0.03121137380681613,"score_gpt":0.36332973285455766,"score_spread":0.33211835904774156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409885354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923736,0.0006342123,0.00015467592,0.0007679202,0.0045953896,0.0005205014,0.0007132828,0.000014343249,0.00022610299],"genre_scores_gemma":[0.9970743,0.0012866796,0.00039395562,0.00045190236,0.0005732361,0.00008373675,0.000064154374,0.000011848714,0.00006020481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964006,0.0002724541,0.0017420725,0.0004238235,0.00090358534,0.0002574792],"domain_scores_gemma":[0.99651885,0.0014126186,0.0008924808,0.00015489807,0.000874785,0.00014638266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073983916,0.0002641148,0.0008154046,0.001230401,0.000033023785,0.000043910662,0.0006422051,0.00013907507,0.00058472966],"category_scores_gemma":[0.004071329,0.00018804667,0.0002443245,0.0008274171,0.0001377636,0.0002956667,0.00016742658,0.0005227448,0.0000041451176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015355781,0.0058156797,0.959778,0.000012806406,0.000995884,0.00085688115,0.0002396942,0.0036959925,0.0013089974,0.0000463208,0.00002275404,0.011871184],"study_design_scores_gemma":[0.044330046,0.00058578415,0.94904613,0.0005200642,0.00022806737,0.00000962698,0.00022912493,0.0034637456,0.0010605615,0.00023414828,0.00015400053,0.00013867984],"about_ca_topic_score_codex":0.0054681445,"about_ca_topic_score_gemma":0.0010124856,"teacher_disagreement_score":0.028974263,"about_ca_system_score_codex":0.0014662487,"about_ca_system_score_gemma":0.00080253294,"threshold_uncertainty_score":0.8266235},"labels":[],"label_agreement":null},{"id":"W4409886967","doi":"10.1016/j.ijgc.2025.101912","title":"The role of molecular classification in endometrial cancer: a focus on patients with low-volume metastasis—a retrospective multi-center study and literature review","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Retrospective cohort study; Multicenter study; Endometrial cancer; Metastasis; Focus (optics); Oncology; Gynecology; Cancer; Internal medicine; Randomized controlled trial","score_opus":0.012250506667706704,"score_gpt":0.32526772907318047,"score_spread":0.31301722240547375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409886967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957525,0.037412718,0.00001857821,0.0032505402,0.0004823223,0.0009125769,0.00008161706,0.0000040363107,0.0003126186],"genre_scores_gemma":[0.9810477,0.018158149,0.00006564364,0.00049366755,0.000070396185,0.000105096304,0.0000053686267,0.0000061939595,0.000047795656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983495,0.00014616425,0.00055057515,0.00019480074,0.0006313097,0.00012767245],"domain_scores_gemma":[0.99812573,0.00026847975,0.00042820265,0.00010349986,0.0010103091,0.00006377545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032150437,0.00013870187,0.00047043466,0.0002574646,0.000031775056,0.000028209664,0.00019154033,0.000057076748,0.00008696365],"category_scores_gemma":[0.0009076795,0.000070315946,0.00012099501,0.0005893171,0.000065076914,0.000073467076,0.000047673537,0.0003237742,5.3289915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054733045,0.0029687567,0.8815525,0.00004735595,0.0009455295,0.00008470584,0.000059301132,0.000005639471,0.0001036784,0.0001945575,0.000059456022,0.10850521],"study_design_scores_gemma":[0.019210316,0.002340087,0.97422034,0.002194703,0.00026128127,0.000004728178,0.00007000181,0.000015425443,0.00037146034,0.0002606052,0.0009817577,0.00006928128],"about_ca_topic_score_codex":0.0000552294,"about_ca_topic_score_gemma":0.00012121991,"teacher_disagreement_score":0.10843593,"about_ca_system_score_codex":0.000598989,"about_ca_system_score_gemma":0.00012909154,"threshold_uncertainty_score":0.2867401},"labels":[],"label_agreement":null},{"id":"W4410252512","doi":"10.1016/j.ijgc.2025.101926","title":"Leading causes of death after a diagnosis of endometrial cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Endometrial cancer; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.13401554703386181,"score_gpt":0.44508440168289065,"score_spread":0.31106885464902884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410252512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008300185,0.9967781,0.0000150495935,0.00045703482,0.0003798841,0.0013270198,0.000854923,0.000004764006,0.000100222314],"genre_scores_gemma":[0.00411285,0.99328196,0.00012765925,0.0005763949,0.00016020043,0.0013250316,0.000013643182,0.000015217914,0.00038707108],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952937,0.0003969649,0.0027804258,0.00031614015,0.0010221807,0.00019061106],"domain_scores_gemma":[0.9910252,0.004034549,0.0032372915,0.0002186759,0.0013187693,0.00016553144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076896616,0.000417452,0.012277598,0.0013811906,0.000017335155,0.000020051777,0.00044091794,0.00023557003,0.0049347463],"category_scores_gemma":[0.004115118,0.0002182385,0.0051269545,0.0014972371,0.00009386661,0.00008162607,0.00014927579,0.00038121486,0.0000015043045],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027169756,0.0003953469,0.0016275931,0.5132725,0.46890527,0.0001940177,0.00001360978,0.000003192715,1.783107e-7,0.000041855314,0.00010984378,0.015164847],"study_design_scores_gemma":[0.001079361,0.00044354095,0.0001595037,0.082222946,0.90675634,0.0000407388,0.0000037707737,2.2445457e-7,0.0000103588545,0.00002840732,0.009102457,0.00015233546],"about_ca_topic_score_codex":0.00017545304,"about_ca_topic_score_gemma":0.00007657023,"teacher_disagreement_score":0.43785107,"about_ca_system_score_codex":0.0006090611,"about_ca_system_score_gemma":0.0006329252,"threshold_uncertainty_score":0.9959749},"labels":[],"label_agreement":null},{"id":"W4410258382","doi":"10.1016/j.ijgc.2025.101929","title":"Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Mount Sinai Hospital; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Women's College Hospital","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canada Research Chairs; Women's College Hospital; Canadian Cancer Society","keywords":"Medicine; Oophorectomy; Cognitive impairment; Oncology; Gynecology; Cognition; Psychiatry; Hysterectomy; Surgery","score_opus":0.019504363677306513,"score_gpt":0.32451517684137404,"score_spread":0.30501081316406753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410258382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939494,0.0012104032,0.00009298035,0.0030556573,0.0005669558,0.0007656115,0.000057405217,0.0000044713433,0.00029711187],"genre_scores_gemma":[0.9982295,0.0008994366,0.0001080587,0.0004990609,0.00006969187,0.000079234385,0.0000017459377,0.0000056163726,0.00010766118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981742,0.00018203763,0.0008542834,0.00018457754,0.00043620478,0.00016871103],"domain_scores_gemma":[0.996856,0.001346325,0.00053031376,0.00006960477,0.0011319983,0.00006575561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077128655,0.00015046042,0.00061175186,0.00022952986,0.000030181734,0.000010365809,0.00016237049,0.00009211169,0.00039635075],"category_scores_gemma":[0.0020570257,0.000080498176,0.00019179698,0.00028818505,0.00082257733,0.00007140833,0.00012557155,0.00035244456,2.6133134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033311017,0.0010322669,0.9489293,0.0001988411,0.0027356215,0.0005453234,0.0016929539,0.00019967828,0.0005075393,0.00030915806,0.00030015674,0.010238154],"study_design_scores_gemma":[0.013558527,0.0011139143,0.9803336,0.0012483168,0.0004158776,0.00011571689,0.0005949159,0.000212095,0.00058829406,0.0016922043,0.00004784854,0.00007868508],"about_ca_topic_score_codex":0.00027316026,"about_ca_topic_score_gemma":0.0004315001,"teacher_disagreement_score":0.031404313,"about_ca_system_score_codex":0.00042824552,"about_ca_system_score_gemma":0.0005432449,"threshold_uncertainty_score":0.43397626},"labels":[],"label_agreement":null},{"id":"W4410384399","doi":"10.1016/j.ijgc.2025.101939","title":"The benefit of sentinel lymph node evaluation in pre-operative grade 1 endometrial cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Jewish General Hospital","funders":"Israel Cancer Research Fund","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Oncology; General surgery; Internal medicine; Cancer; Breast cancer","score_opus":0.04456731607401624,"score_gpt":0.4073958920086412,"score_spread":0.3628285759346249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410384399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784529,0.006810697,0.000052891275,0.009930192,0.0025729064,0.00032494168,0.000029391767,0.000004708894,0.0018213453],"genre_scores_gemma":[0.99412984,0.0037731684,0.000085825086,0.00085583277,0.0004906552,0.000116045645,0.000005112633,0.000005754261,0.0005377821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977706,0.00012053421,0.0007951685,0.00016043577,0.0009774402,0.000175835],"domain_scores_gemma":[0.9968637,0.001157738,0.00043207008,0.00009233279,0.0013857045,0.00006842887],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078906846,0.00013063614,0.00041419893,0.0003495266,0.000048293412,0.00002898487,0.00029988593,0.00009790668,0.0011794786],"category_scores_gemma":[0.0020168046,0.0000732183,0.00022763888,0.0005856313,0.00010241306,0.000096904165,0.00007092657,0.0002411624,0.0000015308644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006819627,0.0008443581,0.82505995,0.000023547042,0.0014098418,0.000051974464,0.00013852597,0.0026922943,0.002416182,0.0013701065,0.00035225737,0.15882133],"study_design_scores_gemma":[0.01441114,0.00016070879,0.9762979,0.0002698992,0.00026454782,0.000010474209,0.00006062909,0.00060763065,0.0035915019,0.0023364872,0.0019180167,0.00007103418],"about_ca_topic_score_codex":0.00046479987,"about_ca_topic_score_gemma":0.00017352673,"teacher_disagreement_score":0.1587503,"about_ca_system_score_codex":0.0012426878,"about_ca_system_score_gemma":0.00064039475,"threshold_uncertainty_score":0.99973357},"labels":[],"label_agreement":null},{"id":"W4410415534","doi":"10.1016/j.ijgc.2025.101943","title":"Correspondence on “the prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma” by Pradhan et al","year":2025,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Internal medicine; Value (mathematics); Carcinoma; Oncology; Tertiary care; Statistics; Mathematics","score_opus":0.02022323389263021,"score_gpt":0.3228061939882528,"score_spread":0.3025829600956226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410415534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61269844,0.0029833957,0.00007955624,0.37973484,0.0028149919,0.00068539416,0.00043965413,0.000006563091,0.00055717106],"genre_scores_gemma":[0.72758514,0.0004645341,0.000115576964,0.27103359,0.00048521956,0.00004547932,0.000056624376,0.000016202612,0.00019766201],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9960843,0.00043686654,0.0011833052,0.00030820668,0.0017255668,0.0002618044],"domain_scores_gemma":[0.9936595,0.00423556,0.0011488925,0.00019302878,0.0006864331,0.000076599674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005596981,0.00031253308,0.0009560003,0.000750192,0.000017295873,0.00002130731,0.00075297256,0.00038156335,0.0013437081],"category_scores_gemma":[0.00427021,0.00018345445,0.0004867119,0.0005004282,0.00019501998,0.000060031452,0.00012681696,0.0013921398,0.0000015636634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012877782,0.0013674507,0.25244185,0.00025857656,0.0026548512,0.005598226,0.000103010876,0.00025197546,0.008164253,0.00083266187,0.7075501,0.00789929],"study_design_scores_gemma":[0.043469653,0.013607781,0.52966356,0.0046363254,0.0019320393,0.0007737119,0.00009083087,0.00012004098,0.06517172,0.0065582423,0.33296075,0.0010153444],"about_ca_topic_score_codex":0.0003045337,"about_ca_topic_score_gemma":0.000012407903,"teacher_disagreement_score":0.37458932,"about_ca_system_score_codex":0.00079566985,"about_ca_system_score_gemma":0.0008354172,"threshold_uncertainty_score":0.9995692},"labels":[],"label_agreement":null},{"id":"W4410578058","doi":"10.1016/j.ijgc.2025.101935","title":"Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; GlaxoSmithKline (Canada); McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Carboplatin; Paclitaxel; Oncology; Toxicity; Endometrial cancer; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.0344239302774716,"score_gpt":0.36865564480969265,"score_spread":0.33423171453222106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410578058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514234,0.0012340118,0.000017694405,0.00036909626,0.00069672544,0.0014867987,0.00054631697,0.000019310313,0.00048771827],"genre_scores_gemma":[0.99784935,0.0004906906,0.00067709124,0.000115725285,0.00014695447,0.00021904739,0.00009459537,0.000024573543,0.00038195614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962468,0.00023847647,0.0013907755,0.0004346339,0.0013328919,0.00035637908],"domain_scores_gemma":[0.9953221,0.0013357302,0.0013667187,0.00023082105,0.0014463454,0.0002982929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002669747,0.00042178138,0.0015031992,0.00063320977,0.000042505413,0.000018945484,0.00028785496,0.00015361933,0.00081814156],"category_scores_gemma":[0.0010464597,0.00020842545,0.0002595211,0.0010681676,0.00022023723,0.00019713532,0.00008366468,0.00030757446,8.1724187e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43217516,0.0029249152,0.47650176,0.0001457376,0.0017898447,0.00012275596,0.00008832894,0.00047019587,0.00035996322,0.00001672051,0.000013233975,0.08539137],"study_design_scores_gemma":[0.13822444,0.035146594,0.8204384,0.0022281157,0.0010048713,0.000004035357,0.000079371406,0.00009050942,0.0022603944,0.000019724946,0.00022009047,0.00028346374],"about_ca_topic_score_codex":0.0005331188,"about_ca_topic_score_gemma":0.0007848752,"teacher_disagreement_score":0.34393665,"about_ca_system_score_codex":0.004373851,"about_ca_system_score_gemma":0.0023957752,"threshold_uncertainty_score":0.9994482},"labels":[],"label_agreement":null},{"id":"W4410641165","doi":"10.1016/j.ijgc.2025.101949","title":"Simple perinephric adipose tissue measurement for prediction of failed sentinel lymph node mapping in endometrial cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Lakeridge Health; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Adipose capsule of kidney; Adipose tissue; Endometrial cancer; Sentinel lymph node; Lymph node; Lymph; Oncology; Internal medicine; Radiology; Cancer; Pathology; Breast cancer","score_opus":0.061188164879051335,"score_gpt":0.3554144626550139,"score_spread":0.2942262977759626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410641165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838971,0.004854554,0.0025219792,0.003718228,0.0032016416,0.00062171335,0.00021935842,0.000015158199,0.00095029164],"genre_scores_gemma":[0.9967633,0.0010234414,0.000435231,0.0006555141,0.0007589592,0.00016078711,0.000014116414,0.000008988308,0.00017967576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787414,0.000054352084,0.0009016817,0.00019385845,0.0007714048,0.00020457426],"domain_scores_gemma":[0.9976299,0.0003935967,0.00042820862,0.00008002626,0.0013758122,0.00009245459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005430497,0.00014856448,0.0005543059,0.0006619019,0.000028322629,0.00001755224,0.00021253334,0.000113239155,0.0010861958],"category_scores_gemma":[0.0017283246,0.00010805441,0.00024380487,0.00055604574,0.000046460136,0.00009541544,0.000056283494,0.00016496136,0.0000010519756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005361179,0.0009224827,0.8920902,0.00015598244,0.0014611244,0.0000634334,0.000062318744,0.00070681586,0.022919405,0.0001531419,0.00077576184,0.07532816],"study_design_scores_gemma":[0.022103846,0.00030750447,0.9533701,0.0004391332,0.00026101284,0.000009071124,0.000058172234,0.00030789964,0.0077977246,0.0005764481,0.014681714,0.00008735247],"about_ca_topic_score_codex":0.00024225058,"about_ca_topic_score_gemma":0.000049471404,"teacher_disagreement_score":0.075240806,"about_ca_system_score_codex":0.0015912412,"about_ca_system_score_gemma":0.0005011004,"threshold_uncertainty_score":0.99982697},"labels":[],"label_agreement":null},{"id":"W4410816600","doi":"10.1016/j.ijgc.2025.101957","title":"Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Vancouver Coastal Health Research Institute","keywords":"Medicine; Pathological; Carcinoma; Oncology; Gynecology; Ovarian carcinoma; Internal medicine; Ovarian cancer; Cancer","score_opus":0.015502008662485722,"score_gpt":0.3271406186816569,"score_spread":0.31163861001917115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410816600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848501,0.0075244666,0.00027132034,0.003930666,0.0010758622,0.00020391856,0.00006493492,0.000011432957,0.0020672816],"genre_scores_gemma":[0.9945647,0.002490631,0.00070176594,0.0016788964,0.00034137024,0.000016785712,0.0000077096565,0.000005712983,0.00019242315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853665,0.00012005277,0.00044709406,0.00023895713,0.000477902,0.00017935378],"domain_scores_gemma":[0.9985321,0.00054868794,0.00026385265,0.00007967796,0.00038918332,0.00018650103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037137602,0.0001632761,0.0004803848,0.00029949273,0.00006280868,0.000059616,0.00015376077,0.00020593706,0.0005210242],"category_scores_gemma":[0.0019070271,0.00010352401,0.00019052689,0.00021901607,0.00016574521,0.00006962115,0.00008894974,0.0005434328,0.0000018460762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056938943,0.0007343779,0.89669603,0.000043014494,0.0009888529,0.0020281216,0.000040670086,0.000012485786,0.0032365613,0.0027047524,0.0008142449,0.08700697],"study_design_scores_gemma":[0.011903631,0.0012084432,0.9768606,0.00007498044,0.00035819598,0.0002996578,0.000029425508,0.000009176799,0.0030659672,0.0029162758,0.0031695657,0.00010410384],"about_ca_topic_score_codex":0.00011796207,"about_ca_topic_score_gemma":0.00002300529,"teacher_disagreement_score":0.086902864,"about_ca_system_score_codex":0.00028144656,"about_ca_system_score_gemma":0.00013148485,"threshold_uncertainty_score":0.570485},"labels":[],"label_agreement":null},{"id":"W4410871503","doi":"10.1016/j.ijgc.2025.101963","title":"Correspondence on “the effect of prior adjuvant radiotherapy on immunotherapy outcomes in recurrent endometrial cancer” by Guo et al","year":2025,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Adjuvant; Oncology; Internal medicine; Radiation therapy; Immunotherapy; Adjuvant radiotherapy; Gynecology; Cancer","score_opus":0.026064572769152836,"score_gpt":0.3812286727117147,"score_spread":0.3551640999425618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410871503","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19292201,0.009262277,0.00002074333,0.78549653,0.010024421,0.0011657702,0.0006425502,0.000013374998,0.00045231348],"genre_scores_gemma":[0.092671074,0.02583593,0.000053346866,0.8759023,0.0021282502,0.00042004493,0.00006683541,0.00005327782,0.0028689727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99532825,0.000723371,0.0012233972,0.00041090383,0.001965592,0.00034850306],"domain_scores_gemma":[0.98728913,0.010783761,0.0011921418,0.0002514073,0.00039956483,0.00008397279],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010330621,0.00049037,0.0016871621,0.00083234475,0.000037543407,0.000043020766,0.000875312,0.00042789223,0.0048984215],"category_scores_gemma":[0.0026313155,0.00024920193,0.0008183367,0.00048410334,0.0001470171,0.00006355766,0.000058291327,0.0025414568,0.000006741483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042945072,0.0007472412,0.02432098,0.00005650394,0.0028335871,0.0008584154,0.000050856124,0.00007877492,0.0005696129,0.000023313447,0.78601253,0.14150313],"study_design_scores_gemma":[0.02863345,0.017914448,0.025993705,0.002095075,0.0002309842,0.000028995364,0.0000065171266,0.000015344996,0.0034146323,0.00007356712,0.9212796,0.00031365114],"about_ca_topic_score_codex":0.0002772888,"about_ca_topic_score_gemma":0.00003409853,"teacher_disagreement_score":0.14118949,"about_ca_system_score_codex":0.002349295,"about_ca_system_score_gemma":0.00054907,"threshold_uncertainty_score":0.999996},"labels":[],"label_agreement":null},{"id":"W4410912460","doi":"10.1016/j.ijgc.2025.101952","title":"Erratum to ‘Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101664]","year":2025,"lang":"en","type":"erratum","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Cytoreductive surgery; Ovarian cancer; Cancer; Interval (graph theory); Gynecology; Oncology; General surgery; Internal medicine","score_opus":0.022011221980292556,"score_gpt":0.3203235331637252,"score_spread":0.29831231118343265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410912460","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42222682,0.007219292,0.00025250507,0.07047944,0.4798053,0.0030719596,0.008030337,0.00007181881,0.008842551],"genre_scores_gemma":[0.7685013,0.038406827,0.0030396853,0.01714837,0.07194408,0.0013569181,0.0012327891,0.00039788286,0.09797217],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9918842,0.00031625517,0.0027728698,0.00093595026,0.0032363182,0.00085444207],"domain_scores_gemma":[0.9884181,0.0011396911,0.003028707,0.00035909918,0.0063845734,0.0006698465],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084297714,0.0009930963,0.0029146103,0.0016535426,0.00010808735,0.00023183507,0.0017309521,0.0010300914,0.0154699925],"category_scores_gemma":[0.0018661054,0.00065630506,0.0011187453,0.00066437724,0.00031565758,0.00050772954,0.000498566,0.0028279747,0.000026957678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.05994023,0.0034972257,0.13899262,0.00014255382,0.008281054,0.0049621416,0.00036393505,0.0007162178,0.000027345368,0.0000131624765,0.7141596,0.068903916],"study_design_scores_gemma":[0.018342137,0.0050971773,0.6337252,0.0051076286,0.0012211376,0.00009564747,0.00015634984,0.000028243256,0.00011331683,0.00005094083,0.33537266,0.000689558],"about_ca_topic_score_codex":0.0011109154,"about_ca_topic_score_gemma":0.0017695173,"teacher_disagreement_score":0.4947326,"about_ca_system_score_codex":0.011232323,"about_ca_system_score_gemma":0.011378527,"threshold_uncertainty_score":0.99958885},"labels":[],"label_agreement":null},{"id":"W4411223168","doi":"10.1016/j.ijgc.2025.101959","title":"Erratum to ‘Factors influencing surgeons’ decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101640]","year":2025,"lang":"en","type":"erratum","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; General surgery; Cytoreductive surgery; Ovarian cancer; Gynecology; Cancer; Internal medicine","score_opus":0.03772306682926509,"score_gpt":0.36327811029964974,"score_spread":0.32555504347038466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411223168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7310294,0.017516041,0.0011042475,0.09400099,0.14731593,0.0027538617,0.004153845,0.000055297398,0.0020703794],"genre_scores_gemma":[0.9559955,0.022752587,0.0012454472,0.004514131,0.005484723,0.0006359247,0.00028508616,0.00008905334,0.008997523],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99438745,0.00021728541,0.0024858075,0.00067511824,0.001629472,0.0006048858],"domain_scores_gemma":[0.987414,0.003172381,0.002860554,0.00020991484,0.005869847,0.00047328157],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012003821,0.00060960144,0.001989081,0.001440245,0.00016482442,0.0002032705,0.0008882111,0.0007995006,0.002577148],"category_scores_gemma":[0.006640906,0.0004674391,0.00082729576,0.0005358953,0.00017413795,0.00039167213,0.00033313988,0.0015606512,0.0000033108718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015147672,0.0010127901,0.4582284,0.000056652458,0.0034486207,0.0003616211,0.00043783063,0.0009874984,0.00007808675,0.000044510696,0.5028542,0.030974954],"study_design_scores_gemma":[0.0034276473,0.00056821224,0.8275738,0.0041309455,0.00070655526,0.00005497839,0.00025616869,0.00011115963,0.000102966835,0.00054786383,0.16212937,0.00039037137],"about_ca_topic_score_codex":0.0020204762,"about_ca_topic_score_gemma":0.002954492,"teacher_disagreement_score":0.36934534,"about_ca_system_score_codex":0.0069995006,"about_ca_system_score_gemma":0.0045112018,"threshold_uncertainty_score":0.99977773},"labels":[],"label_agreement":null},{"id":"W4411968242","doi":"10.1016/j.ijgc.2025.101992","title":"Uterine leiomyosarcoma","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Leiomyosarcoma; Gynecology; Radiology","score_opus":0.06295853412099622,"score_gpt":0.4545167713177445,"score_spread":0.39155823719674826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411968242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011091739,0.9928642,0.000035002155,0.0010601538,0.002832885,0.0002452349,0.000089925765,0.000013293454,0.0027484167],"genre_scores_gemma":[0.00020956024,0.9922964,0.0006087089,0.0004322688,0.0010157966,0.000042431737,0.000031947617,0.000015684693,0.005347197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982727,0.000056115867,0.00085066515,0.00018803177,0.00046819242,0.0001642872],"domain_scores_gemma":[0.99829245,0.00028257375,0.000663347,0.00013034223,0.00050060026,0.00013070296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012539933,0.00026988497,0.0015123371,0.0003501681,0.000020403188,0.000035672547,0.00041935296,0.00021449114,0.0031852517],"category_scores_gemma":[0.00023979087,0.00015763528,0.0009162568,0.00014296848,0.000046488924,0.00006087972,0.00017127892,0.00043825246,0.000028731472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082049824,0.0002974455,0.00026491904,0.0016158122,0.0019308551,0.0030331237,0.000002988862,3.674554e-7,4.73538e-7,0.0001340434,0.003001085,0.98963684],"study_design_scores_gemma":[0.0009597683,0.0004191962,0.0007105882,0.009138418,0.001019984,0.0013707755,0.0000012082828,7.67154e-7,0.0000016997282,0.000063047344,0.98620343,0.0001111088],"about_ca_topic_score_codex":0.000008997027,"about_ca_topic_score_gemma":0.0000038670028,"teacher_disagreement_score":0.98952574,"about_ca_system_score_codex":0.00062982494,"about_ca_system_score_gemma":0.00078675966,"threshold_uncertainty_score":0.99772596},"labels":[],"label_agreement":null},{"id":"W4412444425","doi":"10.1016/j.ijgc.2025.102010","title":"Comprehensive genomic profiling and clinico-pathologic characterization of primary ovarian leiomyosarcoma","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Leiomyosarcoma; Medicine; PTEN; PDGFRA; Microsatellite instability; Comparative genomic hybridization; Cancer research; Ovarian cancer; Pathology; Oncology; Internal medicine; Cancer; Stromal cell; Biology; Gene; GiST; Microsatellite; Genome; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.03398084008052272,"score_gpt":0.341240859330969,"score_spread":0.30726001925044627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954189,0.0003978045,0.00034384534,0.0023567996,0.00069642527,0.00015639166,0.000025214742,0.0000066333264,0.0005979691],"genre_scores_gemma":[0.9955036,0.00085970486,0.002033865,0.0012445776,0.00014365614,0.000007649541,0.000021711947,0.000004544721,0.00018066746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909484,0.000039845527,0.0004783835,0.00011783097,0.00018287549,0.00008624268],"domain_scores_gemma":[0.99891615,0.00012070131,0.00035597818,0.000057981735,0.0005017736,0.000047398382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011239943,0.00009065395,0.00034311967,0.00014759025,0.00002185051,0.000013795434,0.00011029665,0.00007490334,0.00015194232],"category_scores_gemma":[0.00007858534,0.000062928586,0.0000952811,0.000067105335,0.00007624189,0.00007197426,0.00008617293,0.00014478972,0.0000010261092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010970327,0.00040075465,0.65258795,0.00006216938,0.0005440791,0.00049489195,0.000040583494,0.000006075719,0.29169264,0.00065463537,0.000030189538,0.052388977],"study_design_scores_gemma":[0.0023588897,0.000591182,0.98923177,0.00011026957,0.0001001554,0.0001941565,0.000014482006,0.000058574133,0.004092335,0.000328311,0.0028733897,0.00004647038],"about_ca_topic_score_codex":0.0000064991773,"about_ca_topic_score_gemma":9.895781e-7,"teacher_disagreement_score":0.33664384,"about_ca_system_score_codex":0.00016920606,"about_ca_system_score_gemma":0.0001608861,"threshold_uncertainty_score":0.25661534},"labels":[],"label_agreement":null},{"id":"W4412444529","doi":"10.1016/j.ijgc.2025.102009","title":"Management of intravenous leiomyomatosis: a comprehensive review of surgical and perioperative considerations","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Perioperative; Intensive care medicine; General surgery; Surgery","score_opus":0.05036821727721715,"score_gpt":0.40880392355485906,"score_spread":0.35843570627764193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034727989,0.99645776,0.000007749638,0.0010506711,0.00034646192,0.0005785374,0.00012919903,0.0000033574347,0.0010790128],"genre_scores_gemma":[0.0010470117,0.997464,0.0009061938,0.0001847685,0.000080047146,0.00005988269,0.000021734993,0.000008198364,0.00022817256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980061,0.00011767385,0.0012043363,0.00016881371,0.00040414472,0.000098896984],"domain_scores_gemma":[0.9973536,0.00047513258,0.00093435316,0.00010269418,0.0010547887,0.000079394194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012850502,0.00022089922,0.001962534,0.00018542288,0.000021775208,0.000011443712,0.00013830072,0.000112925365,0.0010095994],"category_scores_gemma":[0.00007877655,0.00013571032,0.0004825304,0.00011957922,0.00013910112,0.000041275875,0.00013324583,0.00023367339,0.0000011933594],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012779298,0.0007715576,0.00012696913,0.10699939,0.008656667,0.004468795,0.000047796406,0.0000013549358,0.0000012455729,0.005076774,0.0008480412,0.8728736],"study_design_scores_gemma":[0.0015165895,0.0006369967,0.0005828203,0.2170569,0.0033151417,0.001950986,0.000028070552,9.0114986e-7,0.0000052619143,0.000061481456,0.774733,0.000111872956],"about_ca_topic_score_codex":0.000008263006,"about_ca_topic_score_gemma":0.0000012757996,"teacher_disagreement_score":0.8727617,"about_ca_system_score_codex":0.00019030416,"about_ca_system_score_gemma":0.00044645145,"threshold_uncertainty_score":0.9999036},"labels":[],"label_agreement":null},{"id":"W4413099211","doi":"10.1016/j.ijgc.2025.102022","title":"Indocyanine green fluorescence angiography for bowel anastomosis assessment in ovarian cancer surgery","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Indocyanine green; Anastomosis; Ovarian cancer; Angiography; Radiology; Surgery; Cancer; Internal medicine","score_opus":0.0637561363470203,"score_gpt":0.4236527311634819,"score_spread":0.3598965948164616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413099211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046586985,0.9924626,0.00011613038,0.0017943261,0.002874205,0.0012977704,0.0005054351,0.000018568455,0.00046511885],"genre_scores_gemma":[0.002931448,0.99288607,0.0010092431,0.00050027546,0.00095593015,0.0011525184,0.00008226611,0.000037002268,0.0004452476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99615204,0.00019963305,0.0017648385,0.00051072054,0.00092785736,0.00044489568],"domain_scores_gemma":[0.9945184,0.0027393098,0.0012838616,0.00019343956,0.001014493,0.0002504725],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006711947,0.0005129151,0.0027621991,0.0014258614,0.00004468053,0.00005408803,0.00060244853,0.00044854905,0.0013788758],"category_scores_gemma":[0.0005296395,0.00035562538,0.0028909908,0.0009284849,0.000110654924,0.00014370812,0.00016539234,0.00088766386,0.0000023105722],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074921764,0.0006595506,0.045229178,0.0026521147,0.0030534463,0.0009870111,0.000012635695,0.000013947028,0.0000013562333,0.00006381822,0.0031402146,0.9434375],"study_design_scores_gemma":[0.003448777,0.0006607294,0.07960883,0.034537464,0.002978057,0.00019303361,0.000011874958,0.000032053482,0.0000068084696,0.00021898022,0.8777747,0.000528668],"about_ca_topic_score_codex":0.00047655572,"about_ca_topic_score_gemma":0.00040844755,"teacher_disagreement_score":0.9429088,"about_ca_system_score_codex":0.0031710935,"about_ca_system_score_gemma":0.0034021575,"threshold_uncertainty_score":0.99988955},"labels":[],"label_agreement":null},{"id":"W4413372506","doi":"10.1016/j.ijgc.2025.102117","title":"Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Instituto de Salud Carlos III; Eisai; Seagen; Gilead Sciences; AstraZeneca; GlaxoSmithKline; Amgen","keywords":"Medicine; Antibody-drug conjugate; Gynecologic cancer; Drug; Antibody; Gynecology; Oncology; Pharmacology; Monoclonal antibody; Internal medicine; Ovarian cancer; Immunology; Cancer","score_opus":0.21986321063698808,"score_gpt":0.5025747878709089,"score_spread":0.2827115772339208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413372506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041923532,0.99454045,0.000044685436,0.0010936386,0.0015377655,0.0011875809,0.00008599277,0.0000086602795,0.0010819773],"genre_scores_gemma":[0.0027381903,0.9959036,0.00038976507,0.00012634172,0.0003192946,0.00017805037,0.00001735336,0.000018652481,0.0003087625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99590206,0.00039225706,0.0017829473,0.000464914,0.0010990639,0.00035872712],"domain_scores_gemma":[0.9955152,0.00235072,0.001117686,0.00021792566,0.0006207401,0.00017770262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015277187,0.00037802637,0.0021728163,0.00084209215,0.00003088649,0.000042241412,0.00086895324,0.00024135057,0.0008021581],"category_scores_gemma":[0.0015468723,0.00025510383,0.00048650606,0.00048470142,0.00032785974,0.00015085508,0.00048026314,0.0011991232,0.000004189962],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033132522,0.00029648343,0.0038316639,0.024499219,0.00066369877,0.0006007151,0.0000440488,0.00003783862,0.0000013285226,0.0004152227,0.0013598239,0.96791863],"study_design_scores_gemma":[0.0015127909,0.00046344497,0.0070379237,0.14080483,0.00087789854,0.00016511044,0.00007828875,0.000040002757,0.00001057275,0.00023464867,0.8484836,0.00029089343],"about_ca_topic_score_codex":0.00007930349,"about_ca_topic_score_gemma":0.00017669197,"teacher_disagreement_score":0.96762776,"about_ca_system_score_codex":0.0030443869,"about_ca_system_score_gemma":0.002025593,"threshold_uncertainty_score":0.9999901},"labels":[],"label_agreement":null},{"id":"W4413821122","doi":"10.1016/j.ijgc.2025.102133","title":"The missing link in SHAPE: standardizing magnetic resonance imaging assessment of stromal invasion for cervical cancer","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cervical cancer; Stromal cell; Oncology; Cancer; Internal medicine","score_opus":0.02453024317890071,"score_gpt":0.3904645004455004,"score_spread":0.36593425726659967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413821122","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009814883,0.11145015,0.0006915044,0.055189528,0.81779563,0.0015023528,0.001684703,0.00002579027,0.0018454537],"genre_scores_gemma":[0.2890074,0.071093686,0.007410382,0.0035481814,0.6260889,0.00074401905,0.00021027586,0.00012593936,0.0017712057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607563,0.00017747692,0.0013252902,0.00034038152,0.0017418277,0.00033936749],"domain_scores_gemma":[0.99103963,0.005495153,0.00091462984,0.00015180286,0.0022677665,0.00013100656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012784307,0.00029080518,0.0009310718,0.00030445735,0.000085524,0.00009329101,0.0006039684,0.00034341632,0.00051138684],"category_scores_gemma":[0.003736688,0.00017942568,0.00046481198,0.00027174404,0.00013810459,0.000113373695,0.00018049189,0.0011956652,2.5045495e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006336226,0.00042918455,0.045783058,0.00027116074,0.00045187646,0.00027793055,0.00004568365,0.00013618359,0.0003051387,0.00027059205,0.11531887,0.8303741],"study_design_scores_gemma":[0.012264779,0.001462034,0.12841426,0.0041321917,0.00046086722,0.000011477937,0.000047837566,0.0008489714,0.00017586986,0.0014229246,0.85051584,0.0002429337],"about_ca_topic_score_codex":0.00024106557,"about_ca_topic_score_gemma":0.00037977402,"teacher_disagreement_score":0.8301312,"about_ca_system_score_codex":0.0024634895,"about_ca_system_score_gemma":0.0035374782,"threshold_uncertainty_score":0.7316767},"labels":[],"label_agreement":null},{"id":"W4414043887","doi":"10.1016/j.ijgc.2025.102654","title":"A randomized, phase III study of sacituzumab govitecan versus treatment of the physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Gilead UK and Ireland Corporate Contributions; Gilead Sciences","keywords":"Endometrial cancer; Chemotherapy; Phases of clinical research; Cancer; MEDLINE","score_opus":0.021133839750503276,"score_gpt":0.3474064422235527,"score_spread":0.32627260247304946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414043887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931423,0.0016339419,0.000016050215,0.0010130546,0.0010777939,0.0029185454,0.00006734187,0.000005653303,0.00012531002],"genre_scores_gemma":[0.99831253,0.00034796097,0.00001787224,0.00054531265,0.00022895249,0.00046148762,0.0000030143729,0.000016097665,0.00006675609],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99704593,0.0003895562,0.0010072519,0.0002784831,0.0010619408,0.00021683914],"domain_scores_gemma":[0.9962085,0.0020176827,0.0009024202,0.00023821056,0.00056354515,0.000069664275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039894084,0.00029948933,0.0012280517,0.0003296398,0.0000620573,0.000028741919,0.00034976835,0.00007980502,0.0004250315],"category_scores_gemma":[0.00032905518,0.00013399949,0.00033591452,0.0006962693,0.00023473022,0.00008721909,0.0000501354,0.00026880726,1.973132e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5284975,0.014932717,0.38866132,0.00001149116,0.0040361504,0.000020182912,0.00084473524,0.00015086208,0.00006488326,0.000007887461,0.000012016832,0.062760234],"study_design_scores_gemma":[0.5639551,0.009448413,0.42472777,0.00013137593,0.0006013955,4.872107e-7,0.000369485,0.000024920504,0.00038803043,0.00001687509,0.00025454018,0.00008160545],"about_ca_topic_score_codex":0.0019611933,"about_ca_topic_score_gemma":0.0015270626,"teacher_disagreement_score":0.062678635,"about_ca_system_score_codex":0.0010889785,"about_ca_system_score_gemma":0.00039135828,"threshold_uncertainty_score":0.5464341},"labels":[],"label_agreement":null},{"id":"W4414903375","doi":"10.1016/j.ijgc.2025.102096","title":"Cancer in pregnancy","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Obstetricians and Gynaecologists of Canada","funders":"","keywords":"","score_opus":0.025821416585355587,"score_gpt":0.3936028015383389,"score_spread":0.3677813849529833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414903375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688775,0.00948092,0.00015744366,0.011633692,0.0036362833,0.00014862839,0.000021949294,0.00001121786,0.00603236],"genre_scores_gemma":[0.9901352,0.006367673,0.00009234365,0.0016291118,0.00026165403,0.000024589079,8.1238795e-7,0.0000044837666,0.0014841444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990436,0.000019275714,0.00040133164,0.000109054985,0.0002978678,0.00012888073],"domain_scores_gemma":[0.99922204,0.000105514104,0.00016624988,0.000055545588,0.00039017745,0.00006045258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000106344596,0.00008273384,0.00025786876,0.00022766185,0.000012679766,0.000016385022,0.00019144198,0.00008125393,0.0031764344],"category_scores_gemma":[0.00019178908,0.0000573951,0.00013244255,0.00016382936,0.00004759861,0.0000810154,0.00004192293,0.00029962545,0.0000028343143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043920314,0.00018693555,0.7971175,0.000013003323,0.00018473665,0.00025247398,0.000054504275,0.00024792532,0.0007090399,0.00043032592,0.0020135855,0.19835079],"study_design_scores_gemma":[0.0021903438,0.00014141998,0.955033,0.00084950076,0.000044655237,0.000024213043,0.000036470265,0.00006351444,0.0005080677,0.00075466733,0.04029205,0.000062083236],"about_ca_topic_score_codex":0.0002527664,"about_ca_topic_score_gemma":0.0006871329,"teacher_disagreement_score":0.19828871,"about_ca_system_score_codex":0.00075051555,"about_ca_system_score_gemma":0.00046369917,"threshold_uncertainty_score":0.9977348},"labels":[],"label_agreement":null},{"id":"W4415000166","doi":"10.1016/j.ijgc.2025.102709","title":"Bridging historical evidence and contemporary strategies in the adjuvant treatment of early-stage epithelial ovarian cancer","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Epithelial ovarian cancer; Adjuvant; Adjuvant therapy; Disease; Ovarian cancer; Epithelial ovarian carcinoma; Stage (stratigraphy)","score_opus":0.15135005815310243,"score_gpt":0.4292500234011852,"score_spread":0.27789996524808275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415000166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028466724,0.9907413,0.000025646887,0.0039498815,0.0013143105,0.00063959614,0.00015190142,0.000004749649,0.0003259088],"genre_scores_gemma":[0.08564735,0.91288453,0.00007213967,0.00018614622,0.00064135884,0.00023164146,0.000005874163,0.000011573382,0.00031936998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975938,0.0002402137,0.0011171985,0.00028694724,0.00058422127,0.00017761935],"domain_scores_gemma":[0.9971079,0.0013473738,0.00097435893,0.00015891211,0.00032044356,0.00009101406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036443103,0.0003175104,0.0017309809,0.00029224646,0.000031354743,0.000057872512,0.0003362559,0.00019691973,0.00029874605],"category_scores_gemma":[0.00020818549,0.00016341177,0.0005378525,0.00018789875,0.000095969335,0.00014994566,0.000052527725,0.00035596098,8.924799e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003955211,0.00082950335,0.011954225,0.0013734279,0.0012140932,0.0016463592,0.00027837342,0.000014816028,0.0000013474455,0.00040605266,0.0005985833,0.9812877],"study_design_scores_gemma":[0.0034364813,0.002797257,0.059503093,0.034413315,0.0018992728,0.00019497666,0.00010307634,0.000008975553,0.000007542359,0.00011537782,0.89726424,0.00025637238],"about_ca_topic_score_codex":0.002530101,"about_ca_topic_score_gemma":0.00028951175,"teacher_disagreement_score":0.9810313,"about_ca_system_score_codex":0.003204464,"about_ca_system_score_gemma":0.002958974,"threshold_uncertainty_score":0.8379562},"labels":[],"label_agreement":null},{"id":"W4415078132","doi":"10.1016/j.ijgc.2025.102721","title":"Association of sentinel lymph node biopsy and isolated tumor cells in cervical cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Sentinel lymph node; Biopsy; Lymphadenectomy; Lymph; Cervical cancer; Lymph node; Metastasis","score_opus":0.015293268455578731,"score_gpt":0.32075404368699933,"score_spread":0.3054607752314206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415078132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731863,0.0014279778,0.000045848916,0.0088842325,0.0011329692,0.000095134776,0.000046617773,0.0000064706956,0.0010421003],"genre_scores_gemma":[0.9957915,0.0012581778,0.00016264924,0.0018955467,0.00020087273,0.000015857351,0.0000033332828,0.0000055907813,0.0006664977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985599,0.00005839812,0.0006224264,0.00014834538,0.00045002846,0.00016091969],"domain_scores_gemma":[0.9983978,0.00039286833,0.0004288624,0.000050926268,0.0006439378,0.00008557209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026018615,0.00011440366,0.00043818515,0.00029319996,0.000016338141,0.000016245685,0.0001431807,0.00011806951,0.0012475968],"category_scores_gemma":[0.00041281065,0.00008111042,0.00013454382,0.00035453992,0.000043277316,0.00007325948,0.00006404761,0.0002212939,0.0000021068197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015529613,0.0004448617,0.982782,0.000044345794,0.0005761777,0.00015020154,0.000026390444,0.00008132542,0.007397641,0.000077950106,0.00030082144,0.006565332],"study_design_scores_gemma":[0.006793724,0.00008141022,0.9878375,0.00028924856,0.00017785956,0.000021219616,0.00002895122,0.00029233983,0.0029854109,0.0003918519,0.001031031,0.00006946674],"about_ca_topic_score_codex":0.00037204727,"about_ca_topic_score_gemma":0.00003996976,"teacher_disagreement_score":0.008472826,"about_ca_system_score_codex":0.00096954964,"about_ca_system_score_gemma":0.00025765467,"threshold_uncertainty_score":0.9996654},"labels":[],"label_agreement":null},{"id":"W4415099668","doi":"10.1016/j.ijgc.2025.102719","title":"Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Université Claude Bernard Lyon 1; Hospices Civils de Lyon","keywords":"Ovarian cancer; Adjuvant; Gynecologic cancer; Stage (stratigraphy); Cancer; Epithelial ovarian cancer; Adjuvant therapy","score_opus":0.139126315380412,"score_gpt":0.3962642136323559,"score_spread":0.2571378982519439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415099668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96035475,0.0066722417,0.001517057,0.026715584,0.0025877396,0.0008098459,0.0012291305,0.00001798785,0.00009569565],"genre_scores_gemma":[0.98965937,0.0032553244,0.0012385367,0.0049179844,0.00024482777,0.00035663144,0.00004373739,0.000019620033,0.0002639513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960304,0.00046213847,0.0014157322,0.00066605996,0.0009953253,0.0004303252],"domain_scores_gemma":[0.9960849,0.0009496837,0.0012082993,0.00048891024,0.0010778704,0.00019031475],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015146884,0.00037211616,0.0012615378,0.00094260194,0.00023534529,0.00020289115,0.00091025216,0.00020076743,0.0039910143],"category_scores_gemma":[0.0010051822,0.00022610903,0.00069755956,0.001317337,0.0001473624,0.00039052696,0.0007636558,0.00075804745,0.0000034802376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023205802,0.0019617095,0.6841423,0.000049725862,0.21477894,0.0016413976,0.002233119,0.04554886,0.00048965425,0.002529524,0.0031729273,0.04113125],"study_design_scores_gemma":[0.0040394845,0.00080868957,0.8986634,0.00025375068,0.08852484,0.00002056785,0.00050776737,0.0016848856,0.00082100503,0.00066537113,0.0036651175,0.00034511852],"about_ca_topic_score_codex":0.0117981415,"about_ca_topic_score_gemma":0.020491922,"teacher_disagreement_score":0.2145211,"about_ca_system_score_codex":0.0021685977,"about_ca_system_score_gemma":0.0009192709,"threshold_uncertainty_score":0.99738157},"labels":[],"label_agreement":null},{"id":"W4415727035","doi":"10.1016/j.ijgc.2025.102771","title":"Improving ovarian cancer risk assessment using a machine learning model developed on data from the Prostate Lung Colorectal Ovarian Cancer Screening Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute; National Institutes of Health; University of Texas MD Anderson Cancer Center; Duncan Family Institute for Cancer Prevention and Risk Assessment","keywords":"Ovarian cancer; Risk assessment; Incidence (geometry); Colorectal cancer; Prostate cancer; Epithelial ovarian cancer","score_opus":0.07505002470963278,"score_gpt":0.4011571425097286,"score_spread":0.3261071178000958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415727035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94890994,0.0035161907,0.017906975,0.02254553,0.0040295264,0.0012321778,0.0014313995,0.00003998588,0.00038827574],"genre_scores_gemma":[0.9804821,0.0031300844,0.011853727,0.002529748,0.0014274522,0.00021057314,0.00009853693,0.000032654145,0.00023513801],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969747,0.00026547594,0.00091112877,0.0005545762,0.0009282852,0.0003657997],"domain_scores_gemma":[0.9968094,0.0009246327,0.0010655153,0.00028954912,0.0007532458,0.00015762424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096458587,0.00032631055,0.00062530325,0.00017200438,0.00033361965,0.00021629763,0.00077571615,0.00016396926,0.0012649411],"category_scores_gemma":[0.0008318915,0.00020176973,0.00021864595,0.0002564095,0.00009214518,0.00029739787,0.00042368146,0.0011970208,0.0000012714884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04156009,0.0010210456,0.68976307,0.000026854237,0.0066677295,0.00039529055,0.00032376853,0.0921587,0.0012145058,0.00032333197,0.0020846867,0.16446093],"study_design_scores_gemma":[0.048339892,0.00066004216,0.32974598,0.0010432581,0.0016978012,0.00001720814,0.0000976669,0.6132948,0.00037100218,0.000285145,0.0041461764,0.0003010674],"about_ca_topic_score_codex":0.010948019,"about_ca_topic_score_gemma":0.002992719,"teacher_disagreement_score":0.52113605,"about_ca_system_score_codex":0.002319341,"about_ca_system_score_gemma":0.002788341,"threshold_uncertainty_score":0.99964803},"labels":[],"label_agreement":null},{"id":"W4416018865","doi":"10.1016/j.ijgc.2025.102265","title":"ASSOCIATION OF KELIM INDEX WITH PERITONEAL CANCER INDEX AND CHEMOTHERAPY RESPONSE SCORE IN OVARIAN CANCER PATIENTS UNDERGOING INTERVAL CYTOREDUCTIVE SURGERY- FROM INDEX TO IMPACT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Ovarian cancer; Index (typography); Chemotherapy; Interval (graph theory); Epithelial ovarian cancer","score_opus":0.015026622035676843,"score_gpt":0.32853083127767924,"score_spread":0.3135042092420024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813703,0.00058913865,0.00012426576,0.0164144,0.0009390114,0.00032867922,0.0001820873,0.0000057509906,0.000046389265],"genre_scores_gemma":[0.99671185,0.0010842297,0.000077851364,0.0016139344,0.0002807014,0.000101170364,0.000007899427,0.000016929762,0.00010541697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797875,0.00014200523,0.0006618913,0.00029356487,0.00068164343,0.00024213167],"domain_scores_gemma":[0.997052,0.0010220071,0.00065103365,0.00009336234,0.0010278678,0.00015373666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038953673,0.00022202599,0.000671293,0.00047191835,0.000033616892,0.000046881934,0.00016206138,0.00017810226,0.0009176615],"category_scores_gemma":[0.00050571637,0.00015591586,0.00016613548,0.00034051164,0.000065982305,0.00018199114,0.00006270449,0.00035133926,4.593605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022173503,0.0006912194,0.95492715,0.000016244801,0.001997334,0.00006439537,0.00051956414,0.0012101625,0.00020597252,0.000007120619,0.0011508312,0.017036494],"study_design_scores_gemma":[0.007161473,0.00084050413,0.98884743,0.0013343194,0.00012650652,0.0000043237587,0.00013948574,0.000114065515,0.0007625128,0.00012913863,0.0004052128,0.00013500736],"about_ca_topic_score_codex":0.0051970296,"about_ca_topic_score_gemma":0.0057256934,"teacher_disagreement_score":0.03392029,"about_ca_system_score_codex":0.0048751617,"about_ca_system_score_gemma":0.0016707814,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W4416018889","doi":"10.1016/j.ijgc.2025.102251","title":"SURVIVAL AND SAFETY OUTCOMES IN PART 1 OF THE ENGOT-EN6-NSGO/GOG-3031/RUBY TRIAL OF DOSTARLIMAB PLUS CARBOPLATIN-PACLITAXEL IN THE PRESENCE OF COMMON COMORBIDITIES","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"MEDLINE; Comorbidity; Clinical trial; Randomized controlled trial","score_opus":0.03308950848791858,"score_gpt":0.34881642831054593,"score_spread":0.31572691982262735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188584,0.0006633994,0.0000042591764,0.0046343924,0.00072797335,0.0003293864,0.0000858961,0.0000011870975,0.001667674],"genre_scores_gemma":[0.9988249,0.0008018268,0.000026939611,0.00020166152,0.000034144654,0.000012533016,0.000002901041,0.0000028655463,0.00009220866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983284,0.0001980337,0.0007642948,0.00009051502,0.00051109405,0.00010767163],"domain_scores_gemma":[0.9974851,0.0016988114,0.0004753559,0.00010876864,0.00020984678,0.000022110567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005765153,0.0001011921,0.0005846566,0.00011181619,0.000018628072,0.000006872938,0.00030092028,0.000074142015,0.00008784643],"category_scores_gemma":[0.0008598751,0.00005088891,0.00014320895,0.00013401225,0.00021282656,0.00006003525,0.00008552313,0.00027247166,8.675174e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018469222,0.0015575375,0.9699514,0.000058235568,0.00056421186,0.00015988118,0.001130518,0.00035100235,0.00021259501,0.0025579196,0.0002610597,0.0047264174],"study_design_scores_gemma":[0.03142577,0.00066629733,0.9633033,0.00030165043,0.00008008741,0.000016758742,0.0010362033,0.00010627651,0.00042960115,0.002061739,0.00052266906,0.000049596474],"about_ca_topic_score_codex":0.0008909332,"about_ca_topic_score_gemma":0.0020614122,"teacher_disagreement_score":0.0129565485,"about_ca_system_score_codex":0.00014840152,"about_ca_system_score_gemma":0.00022942654,"threshold_uncertainty_score":0.20751895},"labels":[],"label_agreement":null},{"id":"W4416018903","doi":"10.1016/j.ijgc.2025.102165","title":"VARIATIONS IN EMOTIONAL SUPPORT NEEDS AND PROVISION OF CARE FOR WOMEN WITH OVARIAN CANCER IN THE EVERY WOMAN STUDY LOW- AND MIDDLE-INCOME COHORT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Emotional support; Ovarian cancer; Cohort; Social support; Cohort study; MEDLINE","score_opus":0.01621430692929048,"score_gpt":0.32676799700539677,"score_spread":0.3105536900761063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955871,0.00032476216,0.00007477415,0.002959334,0.00021376289,0.00063506496,0.000028595474,0.0000017143373,0.00017490963],"genre_scores_gemma":[0.99918276,0.00009465381,0.000096181066,0.00033181804,0.00007920943,0.0001399855,0.000002943374,0.0000023969756,0.00007006919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991089,0.00008635145,0.00035901336,0.00014623717,0.00020131873,0.00009818385],"domain_scores_gemma":[0.99897414,0.0002784684,0.00015709522,0.000066470995,0.0004939137,0.00002988311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006971698,0.00007569552,0.00026212537,0.00019858817,0.000030916864,0.000009612761,0.000111449124,0.00006325899,0.00010548296],"category_scores_gemma":[0.0003252641,0.000042253145,0.000026035848,0.00014972985,0.00010685474,0.000076176984,0.000034984954,0.0001907546,4.6988294e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005898576,0.00043045476,0.9880457,0.00006716501,0.00020217006,0.000023774284,0.0024500268,0.0000394417,0.0000859016,0.00021814568,0.000010273924,0.0025283631],"study_design_scores_gemma":[0.002674418,0.0013964907,0.99242043,0.00020236192,0.000041363906,0.000020164165,0.0023743277,0.000028139817,0.000029668878,0.00063052983,0.00014302913,0.000039082628],"about_ca_topic_score_codex":0.000086182794,"about_ca_topic_score_gemma":0.00058480044,"teacher_disagreement_score":0.0043747164,"about_ca_system_score_codex":0.00030286866,"about_ca_system_score_gemma":0.00031318652,"threshold_uncertainty_score":0.17230332},"labels":[],"label_agreement":null},{"id":"W4416018911","doi":"10.1016/j.ijgc.2025.102622","title":"ROBOTIC RESECTION OF A SOLITARY DIAPHRAGMATIC RECURRENCE OF ENDOMETRIAL CANCER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Endometrial cancer; Resection; Diaphragmatic breathing; Uterine cancer; Diaphragm (acoustics); Carcinoma","score_opus":0.03799848528195204,"score_gpt":0.38511895483505476,"score_spread":0.3471204695531027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97879326,0.009824526,0.0006467438,0.002934072,0.0052379183,0.00030055878,0.00005387737,0.00000747973,0.0022015884],"genre_scores_gemma":[0.9944055,0.004148429,0.00048214258,0.00030418934,0.000424194,0.000019570236,0.0000038691937,0.000004493174,0.00020762712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980555,0.00008629608,0.00089323556,0.00013981546,0.0006801138,0.00014504489],"domain_scores_gemma":[0.9970516,0.0009206899,0.00064194173,0.00009449408,0.0012023636,0.00008890775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003399503,0.00012062989,0.0006204845,0.00057418615,0.000019418872,0.000007473448,0.000264173,0.00010469956,0.0022690294],"category_scores_gemma":[0.0021732587,0.00008188234,0.0003221409,0.0006580784,0.0001214208,0.000098620396,0.000052238374,0.00025673435,0.000001383388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023385188,0.0025124508,0.64962524,0.00062766817,0.0054251193,0.00021556317,0.00018519002,0.003039444,0.012077282,0.001651972,0.0022142853,0.29904062],"study_design_scores_gemma":[0.019275522,0.0047753113,0.92582893,0.002483497,0.0011056634,0.000060756913,0.00012903435,0.0003035108,0.03715666,0.00700977,0.0016737779,0.00019758075],"about_ca_topic_score_codex":0.00043613146,"about_ca_topic_score_gemma":0.000112797075,"teacher_disagreement_score":0.29884303,"about_ca_system_score_codex":0.0004309067,"about_ca_system_score_gemma":0.00048513204,"threshold_uncertainty_score":0.99864304},"labels":[],"label_agreement":null},{"id":"W4416018921","doi":"10.1016/j.ijgc.2025.102743","title":"VIBOSTOLIMAB AND PEMBROLIZUMAB COFORMULATION COMBINED WITH LENVATINIB FOR MISMATCH REPAIR-PROFICIENT ADVANCED ENDOMETRIAL CANCER: RESULTS FROM COHORT B2 OF THE PHASE 2 KEYVIBE-005 STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Pembrolizumab; Lenvatinib; Endometrial cancer; Cohort; Phases of clinical research; Immunotherapy; Clinical trial","score_opus":0.026014243984070727,"score_gpt":0.3690824225653903,"score_spread":0.3430681785813196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992029,0.00076959317,0.00019469926,0.0029680906,0.0015633898,0.0016354559,0.0004892708,0.000015981295,0.00033451442],"genre_scores_gemma":[0.99779314,0.00043989567,0.00059676723,0.00048377906,0.00027490896,0.00018005425,0.00003053084,0.000010718599,0.00019020837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976584,0.00008863839,0.00096850947,0.00029527358,0.0008048738,0.00018431373],"domain_scores_gemma":[0.9964615,0.0013628744,0.00083280564,0.00017060546,0.0010752033,0.000097029704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004177908,0.000190618,0.0006578308,0.00023604509,0.00008798036,0.000022580325,0.00025628725,0.00009266096,0.00016642074],"category_scores_gemma":[0.0015753735,0.00010385386,0.00024067974,0.00046160657,0.00011489366,0.00010399231,0.000086109794,0.00023554059,2.566226e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2728147,0.0054043466,0.6165663,0.00006624638,0.004880272,0.00007497803,0.00044580168,0.0009993265,0.0026700601,0.00031279947,0.0004878223,0.09527735],"study_design_scores_gemma":[0.19045149,0.011683618,0.78365195,0.0004605017,0.0013763225,0.000015129858,0.00034176017,0.00064557616,0.0070582135,0.000541295,0.003596969,0.000177153],"about_ca_topic_score_codex":0.00047660523,"about_ca_topic_score_gemma":0.00028214135,"teacher_disagreement_score":0.16708566,"about_ca_system_score_codex":0.00058678095,"about_ca_system_score_gemma":0.0004334027,"threshold_uncertainty_score":0.42350376},"labels":[],"label_agreement":null},{"id":"W4416018926","doi":"10.1016/j.ijgc.2025.102217","title":"PRIORITIES OF WOMEN WITH OVARIAN CANCER: THE EVERY WOMAN STUDY LOW- AND MIDDLE-INCOME EDITION COHORT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"National Cancer Institute; Chittaranjan National Cancer Institute; James Cook University; Mansoura University; Universidad Nacional de Colombia; Instituto Nacional de Cancerología","keywords":"Cohort; Cohort study; MEDLINE; Ovarian cancer","score_opus":0.014888510347374314,"score_gpt":0.3118197924135143,"score_spread":0.29693128206614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507385,0.0007181018,0.000045254073,0.0024239025,0.0010710377,0.0002964162,0.000025448297,0.0000072392136,0.00033874728],"genre_scores_gemma":[0.99735546,0.0010727885,0.000035800538,0.0007692036,0.00042204402,0.000068139205,8.7496016e-7,0.0000057192956,0.00026996803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987712,0.000046068744,0.00040319117,0.00012621794,0.0005031286,0.00015022013],"domain_scores_gemma":[0.99871933,0.00022848918,0.00030465485,0.00008378652,0.0005843963,0.00007932859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003893172,0.00010751722,0.0003456699,0.00013013097,0.000049555438,0.000030253877,0.00018282514,0.000053144784,0.0005283866],"category_scores_gemma":[0.00012401052,0.00005770109,0.000057558667,0.00012605712,0.00016434329,0.00010483125,0.000057263966,0.00026396237,2.9090077e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019507104,0.00025142016,0.989989,0.00004433973,0.0009876832,0.00007155797,0.0006956033,0.000047613463,0.00009754648,0.00016477786,0.00019137582,0.0055084187],"study_design_scores_gemma":[0.002234077,0.0010706855,0.99258876,0.000479271,0.00014477533,0.00003753742,0.0011602695,0.000014522645,0.00009914203,0.00023287087,0.001877184,0.000060917264],"about_ca_topic_score_codex":0.0006414421,"about_ca_topic_score_gemma":0.0005772105,"teacher_disagreement_score":0.0054475013,"about_ca_system_score_codex":0.0008958912,"about_ca_system_score_gemma":0.00045504165,"threshold_uncertainty_score":0.5785463},"labels":[],"label_agreement":null},{"id":"W4416018930","doi":"10.1016/j.ijgc.2025.102499","title":"THE IMPACT OF PATHOGENIC VARIANTS OF BRCA1, BRCA2 AND OTHER DNA-REPAIR GENES ON THE SURVIVAL BENEFITS CONFERRED BY PARP INHIBITORS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Gene; Poly ADP ribose polymerase; Mutation; PARP inhibitor; Survival analysis","score_opus":0.018716775951991994,"score_gpt":0.32194161487988227,"score_spread":0.30322483892789026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905311,0.0060040653,0.00007724596,0.0016327467,0.0008179617,0.00010805637,0.00019266453,0.000002210581,0.00063397683],"genre_scores_gemma":[0.99762607,0.0016446874,0.000040373663,0.00033059908,0.00018115698,0.000013241231,0.0000037831617,0.0000074379204,0.00015266179],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99891955,0.0001270273,0.000430337,0.00014151933,0.00026250066,0.00011909289],"domain_scores_gemma":[0.998577,0.0003184728,0.0004012608,0.0001403035,0.0005280399,0.00003492453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047427075,0.000115317045,0.00017625454,0.000042870095,0.000058006877,0.000021261449,0.000398376,0.000107669875,0.00012977238],"category_scores_gemma":[0.00038381576,0.000060468938,0.00022432828,0.000075089076,0.000261299,0.0000054158972,0.00010268675,0.000116730305,3.9351005e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023122055,0.00056735805,0.16544841,0.00001787974,0.00489277,0.00000902771,0.00015800318,0.006603606,0.69669175,0.00597703,0.040473346,0.076848626],"study_design_scores_gemma":[0.002878229,0.0018763723,0.67113376,0.0001714757,0.00015205861,0.000036592206,0.00032838646,0.0003774223,0.27685085,0.002181662,0.0437052,0.00030803258],"about_ca_topic_score_codex":0.00006314073,"about_ca_topic_score_gemma":0.00008948099,"teacher_disagreement_score":0.5056853,"about_ca_system_score_codex":0.000114512644,"about_ca_system_score_gemma":0.00037852046,"threshold_uncertainty_score":0.24658518},"labels":[],"label_agreement":null},{"id":"W4416018937","doi":"10.1016/j.ijgc.2025.102140","title":"LONG-TERM FOLLOW-UP OF SELINEXOR MAINTENANCE TREATMENT IN PATIENTS WITH TP53 WILD TYPE ADVANCED/RECURRENT ENDOMETRIAL CANCER: INTERMEDIATE ENDPOINTS BY MISMATCH REPAIR STATUS IN THE ENGOT-EN5/GOG-3055/SIENDO STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA mismatch repair; Wild type; Endometrial cancer; MEDLINE; Complete response","score_opus":0.019060225440390485,"score_gpt":0.3352039784227874,"score_spread":0.3161437529823969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910812,0.003128153,0.00001986036,0.0008225282,0.0030882324,0.001415976,0.00018825934,0.0000141283035,0.00024170215],"genre_scores_gemma":[0.99473274,0.003875179,0.0000769815,0.00052253105,0.00021311187,0.00024735555,0.000040259947,0.000017066906,0.00027480428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652416,0.0002666876,0.0012583309,0.00041137738,0.0010899648,0.00044950764],"domain_scores_gemma":[0.99705976,0.0009302137,0.0006931952,0.00022798496,0.00093290495,0.00015593288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048678558,0.0003440113,0.00095433125,0.00057837926,0.000036464604,0.000029185789,0.00048861245,0.0001119978,0.000432604],"category_scores_gemma":[0.0008991042,0.00018581058,0.00028775175,0.0010207307,0.000117407566,0.00019865423,0.000093619004,0.00047563735,0.0000021777091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02866654,0.0058339243,0.8815908,0.000033536067,0.0009953143,0.00027224614,0.0005698726,0.00011611961,0.00003452133,0.000018402387,0.00040967352,0.081459075],"study_design_scores_gemma":[0.06482795,0.010276937,0.9210445,0.00061374105,0.00032076825,0.00000681698,0.000415756,0.0000189058,0.00023554382,0.00007856777,0.0019886193,0.00017186579],"about_ca_topic_score_codex":0.00067296997,"about_ca_topic_score_gemma":0.002672236,"teacher_disagreement_score":0.08128721,"about_ca_system_score_codex":0.0023531294,"about_ca_system_score_gemma":0.0005799671,"threshold_uncertainty_score":0.75771356},"labels":[],"label_agreement":null},{"id":"W4416018954","doi":"10.1016/j.ijgc.2025.102488","title":"REAL-WORLD TREATMENT PATTERNS OF PATIENTS WITH ADVANCED PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN CANCER WITHIN THE UNITED STATES: AN ANALYSIS OF SECONDARY DATA","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; MEDLINE; Epithelial ovarian cancer; Cancer; Ovary","score_opus":0.02697586960240581,"score_gpt":0.3421523388154213,"score_spread":0.31517646921301545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946924,0.0001670676,0.0001323325,0.0018459853,0.00024917707,0.00031553465,0.0024217453,0.0000052760106,0.00017051988],"genre_scores_gemma":[0.99697536,0.001277273,0.00050134485,0.0005360182,0.000054054326,0.000030134765,0.00053685164,0.000009725203,0.00007924433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982482,0.00010533416,0.00073598145,0.00027899435,0.00049653393,0.00013493284],"domain_scores_gemma":[0.99703544,0.00057589635,0.0009368272,0.0002980325,0.0010569346,0.000096861186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021691999,0.00019206092,0.00065916264,0.00046154935,0.00004839511,0.00002300935,0.00026599184,0.00005537016,0.0004958539],"category_scores_gemma":[0.000075476484,0.00010092927,0.000097728014,0.00048215035,0.00013460766,0.00014983746,0.00008786228,0.00017401461,9.30319e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048407447,0.0010646703,0.9504981,0.000024498117,0.011275621,0.000102715734,0.00065115513,0.008571427,0.000061901424,0.0004984223,0.00006317951,0.02234755],"study_design_scores_gemma":[0.0054563265,0.0018219425,0.9853756,0.00032653369,0.002914773,0.0000019134698,0.0005412598,0.002158539,0.0006931828,0.000053071355,0.00056584604,0.00009103111],"about_ca_topic_score_codex":0.0065935287,"about_ca_topic_score_gemma":0.021885866,"teacher_disagreement_score":0.034877468,"about_ca_system_score_codex":0.0006423175,"about_ca_system_score_gemma":0.00048374967,"threshold_uncertainty_score":0.9967487},"labels":[],"label_agreement":null},{"id":"W4416018957","doi":"10.1016/j.ijgc.2025.102260","title":"FAPIROC: SEQUENTIAL LU-177 FAPI THERAPY AND CHEMOTHERAPY IN PLATINUM-RESISTANT RECURRENT OVARIAN CANCER – AN INITIAL CLINICAL EXPERIENCE","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Chemotherapy; Ovarian cancer; MEDLINE; Complete response; Cancer","score_opus":0.09106998827535076,"score_gpt":0.46262595309245647,"score_spread":0.37155596481710573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883665,0.00069087517,0.00025120933,0.009237068,0.0007103772,0.0001367832,0.000028681308,0.000012309339,0.00056619465],"genre_scores_gemma":[0.9878409,0.0033266533,0.00036768094,0.0075701987,0.00069158996,0.000032071377,0.000008122629,0.000007916323,0.00015484652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99803334,0.00015005184,0.0008964388,0.0002679347,0.00046665984,0.00018555454],"domain_scores_gemma":[0.9987555,0.00019022312,0.0003409836,0.0000952169,0.00044936748,0.00016867626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044766066,0.00015938158,0.00045634666,0.00026680052,0.000046380675,0.000060685255,0.00022335182,0.00015987469,0.003109651],"category_scores_gemma":[0.00024441388,0.000115315524,0.00018098843,0.00019325875,0.00019366722,0.00018816153,0.00004477321,0.00047246242,0.0000012786776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012101069,0.002367292,0.3932522,0.000024088853,0.0009470837,0.00097601884,0.0011287207,0.0000898591,0.017711466,0.0013697569,0.0017438313,0.5682886],"study_design_scores_gemma":[0.01189075,0.0012681197,0.9662957,0.00078134146,0.00005935463,0.000056918554,0.0005442818,0.0009555593,0.0028248937,0.0009446945,0.014147797,0.00023057724],"about_ca_topic_score_codex":0.00015049984,"about_ca_topic_score_gemma":0.0004321913,"teacher_disagreement_score":0.5730435,"about_ca_system_score_codex":0.00032974832,"about_ca_system_score_gemma":0.00039834922,"threshold_uncertainty_score":0.99780166},"labels":[],"label_agreement":null},{"id":"W4416018967","doi":"10.1016/j.ijgc.2025.102609","title":"TROFUSE-020/GOG-3101/ENGOT-CX20: A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, OPEN-LABEL, MULTICENTER STUDY COMPARING SACITUZUMAB TIRUMOTECAN MONOTHERAPY VS TREATMENT OF PHYSICIAN’S CHOICE AS SECOND-LINE TREATMENT FOR RECURRENT/METASTATIC CERVICAL CANCER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Multicenter study; Cervical cancer; Phases of clinical research; MEDLINE; Phase (matter)","score_opus":0.0994556808411903,"score_gpt":0.4577780152489046,"score_spread":0.3583223344077143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98221594,0.0038195457,0.00044594132,0.0038409499,0.0020645643,0.006469642,0.0003891378,0.000023084358,0.00073119556],"genre_scores_gemma":[0.9907276,0.002168959,0.0005692953,0.0016032573,0.0007636271,0.002684115,0.000040263014,0.00003592337,0.0014069682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961803,0.0003972028,0.0017405662,0.00054386066,0.0007067912,0.00043131266],"domain_scores_gemma":[0.99444807,0.0026428767,0.0012778303,0.00025247462,0.0011049537,0.00027377284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000409553,0.0005518618,0.0032638945,0.00044031203,0.00011798159,0.00010029388,0.0005837546,0.0001186429,0.0026603227],"category_scores_gemma":[0.00052067346,0.00033183082,0.0008713418,0.00033631484,0.00015005658,0.00022749847,0.00008986513,0.00025061655,0.0000066009393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6985497,0.036325905,0.0042598867,0.000053752454,0.016428554,0.00011762674,0.00047387474,0.00014781683,0.0008571512,0.00015845595,0.00016267505,0.2424646],"study_design_scores_gemma":[0.9391745,0.034096897,0.004446781,0.00036834835,0.0038260105,0.0000105735735,0.00027736486,0.0022675246,0.0055311383,0.0005183393,0.009199612,0.0002829412],"about_ca_topic_score_codex":0.0012452197,"about_ca_topic_score_gemma":0.001793256,"teacher_disagreement_score":0.24218166,"about_ca_system_score_codex":0.0035532217,"about_ca_system_score_gemma":0.0007812498,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4416018970","doi":"10.1016/j.ijgc.2025.102509","title":"EVALUATING THE IMPACT OF SURGICAL COMPLEXITY ON OUTCOMES IN SECONDARY CYTOREDUCTIVE SURGERY FOR RECURRENT OVARIAN CANCER: INSIGHTS FROM A TERTIARY CARE CENTER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Tertiary care; Cytoreductive surgery; Center (category theory); Tertiary level; MEDLINE","score_opus":0.08600791248976548,"score_gpt":0.4471920142018166,"score_spread":0.3611841017120511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985584,0.004179852,0.000014243303,0.007420919,0.0014277614,0.0004742889,0.00068728114,0.0000042868573,0.00020737135],"genre_scores_gemma":[0.9976956,0.0011330942,0.00011478513,0.0005250142,0.00027461973,0.00018225289,0.000051896437,0.0000072853836,0.000015434236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842125,0.00015614797,0.0006702425,0.00020298413,0.0003884981,0.00016089738],"domain_scores_gemma":[0.99657154,0.0020766181,0.0004317897,0.0001021961,0.000747264,0.00007059066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024378415,0.00016708666,0.00058135507,0.00018195985,0.000042066127,0.000019060224,0.00019057665,0.00007712154,0.00058603496],"category_scores_gemma":[0.00025687725,0.000085575244,0.00053169555,0.000096899246,0.0001319969,0.00007532327,0.00005538479,0.00031028898,4.4367036e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005373488,0.0011087399,0.8642849,0.000028053848,0.0016949166,0.00012155521,0.0006044204,0.00050415954,0.00008587834,0.00018985964,0.0012781131,0.12472597],"study_design_scores_gemma":[0.004798227,0.0011337439,0.98966014,0.00073108904,0.00010899854,0.0000079447545,0.0002083208,0.00021785368,0.00078058906,0.0016916033,0.00058424816,0.000077252924],"about_ca_topic_score_codex":0.000868288,"about_ca_topic_score_gemma":0.00040187847,"teacher_disagreement_score":0.12537529,"about_ca_system_score_codex":0.0020398763,"about_ca_system_score_gemma":0.0010261041,"threshold_uncertainty_score":0.6416672},"labels":[],"label_agreement":null},{"id":"W4416018981","doi":"10.1016/j.ijgc.2025.102157","title":"PEMBROLIZUMAB PLUS CONCURRENT CHEMORADIOTHERAPY FOR HIGH-RISK LOCALLY ADVANCED CERVICAL CANCER: POST HOC SUBGROUP ANALYSES FROM THE PHASE 3 ENGOT-CX11/GOG-3047/KEYNOTE-A18 STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Post-hoc analysis; Interim analysis; Chemoradiotherapy; Subgroup analysis; Placebo; Post hoc","score_opus":0.045552829597350956,"score_gpt":0.43115121432870035,"score_spread":0.3855983847313494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663422,0.012961584,0.0028442896,0.011598541,0.0040436117,0.0012089384,0.0008592519,0.000034604276,0.000106960426],"genre_scores_gemma":[0.9867597,0.005282544,0.00044040126,0.0049778176,0.0018669558,0.00034366996,0.00006982183,0.0000267556,0.00023233205],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99677104,0.0002122149,0.0011054749,0.00048190774,0.0010399491,0.00038939057],"domain_scores_gemma":[0.99475056,0.002261525,0.00077329954,0.0002534258,0.0017075478,0.00025365964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039127824,0.00038430083,0.0011150205,0.00021551551,0.0001759426,0.000102357066,0.0008138274,0.00017475129,0.002866323],"category_scores_gemma":[0.0010253628,0.00021997036,0.00058004906,0.00044916957,0.00017117613,0.00016335136,0.00011670756,0.00063660205,0.000005633686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07576625,0.0065508243,0.09679787,0.00004879597,0.010334386,0.00038456693,0.0006101829,0.0014943479,0.003017768,0.00046697774,0.0031407187,0.8013873],"study_design_scores_gemma":[0.27082822,0.024757335,0.64213836,0.00072630664,0.004923336,0.000047539335,0.001581677,0.0012440612,0.007092318,0.0025073742,0.04332558,0.00082791445],"about_ca_topic_score_codex":0.0022187894,"about_ca_topic_score_gemma":0.0015919841,"teacher_disagreement_score":0.8005594,"about_ca_system_score_codex":0.0019402183,"about_ca_system_score_gemma":0.00095722865,"threshold_uncertainty_score":0.9980452},"labels":[],"label_agreement":null},{"id":"W4416018985","doi":"10.1016/j.ijgc.2025.102411","title":"THE FEASIBILITY AND ACCEPTABILITY OF ENDOMETRIAL CANCER SCREENING TO IDENTIFY HIGH-RISK POSTMENOPAUSAL POPULATION","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Women's cancer prevention and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of British Columbia","funders":"","keywords":"Endometrial cancer; Population; Postmenopausal women; MEDLINE; Cancer screening","score_opus":0.036936389124155714,"score_gpt":0.4151217009288021,"score_spread":0.3781853118046464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707545,0.0011294478,0.0018664715,0.0070248866,0.0022144096,0.0004121299,0.000037448444,0.0000081540065,0.00023161825],"genre_scores_gemma":[0.99667937,0.0011660642,0.0008498518,0.00072727405,0.00027157489,0.000033474982,0.0000030136512,0.000004251313,0.00026511357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983706,0.00014170195,0.00065540604,0.00017489771,0.0005248924,0.00013248883],"domain_scores_gemma":[0.99822384,0.0004647683,0.000459664,0.000116958065,0.0006403999,0.00009435693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011046671,0.00009846294,0.00029858018,0.0001995247,0.0000815041,0.000046711473,0.00023325144,0.000057129066,0.0011974039],"category_scores_gemma":[0.0015766089,0.00006270925,0.0001229564,0.00023924696,0.000079431156,0.00011177911,0.00016936434,0.00022134795,6.716871e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028988088,0.00018057773,0.6726116,0.000024327957,0.0006208576,0.00000822957,0.000045026343,0.00031353277,0.00073383225,0.001309276,0.00076979486,0.32048413],"study_design_scores_gemma":[0.0028063278,0.000438264,0.9883598,0.000059589616,0.00016000771,0.0000032556688,0.00009500473,0.000030508905,0.00039116063,0.0022881855,0.005316657,0.000051220926],"about_ca_topic_score_codex":0.0007440111,"about_ca_topic_score_gemma":0.0004427716,"teacher_disagreement_score":0.3204329,"about_ca_system_score_codex":0.0005672207,"about_ca_system_score_gemma":0.00011950896,"threshold_uncertainty_score":0.9997156},"labels":[],"label_agreement":null},{"id":"W4416018986","doi":"10.1016/j.ijgc.2025.102459","title":"RACIAL SUBGROUP ANALYSES OF TUMOR RESPONSE AND SAFETY IN PATIENTS WITH MISMATCH REPAIR-DEFICIENT/MICROSATELLITE INSTABILITY-HIGH ADVANCED/RECURRENT ENDOMETRIAL CANCER RECEIVING DOSTARLIMAB MONOTHERAPY IN THE GARNET TRIAL","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; University of British Columbia; McMaster University Medical Centre; Spinal Cord Injury BC; McMaster University; Kelowna General Hospital; BC Cancer Agency","funders":"","keywords":"Endometrial cancer; Subgroup analysis; Complete response; Clinical trial; MEDLINE","score_opus":0.030970265410018478,"score_gpt":0.3835874890435213,"score_spread":0.35261722363350284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243385,0.0039647515,0.00001566785,0.0018187356,0.00071391766,0.0009121158,0.00009378567,0.0000054002576,0.00004177634],"genre_scores_gemma":[0.996544,0.0027288434,0.0002082782,0.00028390007,0.000108543405,0.00007365431,0.000015641184,0.000007703891,0.000029427054],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99736917,0.00046650067,0.0008859687,0.00026596533,0.0007684764,0.00024389163],"domain_scores_gemma":[0.9973712,0.0014009504,0.00041391904,0.0001269802,0.0006257074,0.0000612401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014820237,0.00017311252,0.0005632802,0.00057142664,0.00004671106,0.000033016582,0.00025181702,0.00007717594,0.0001905466],"category_scores_gemma":[0.0010247154,0.000094849995,0.00015333637,0.00066489534,0.00021073417,0.000145247,0.00005746836,0.00045594748,1.9262794e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5357162,0.0012677003,0.43672404,0.000027003289,0.00026669924,0.00008984201,0.0005587729,0.0002363866,0.0007700951,0.000022722888,0.000026601638,0.024293942],"study_design_scores_gemma":[0.100672916,0.003749247,0.8923036,0.0005196584,0.00007213185,0.000004053663,0.0002080123,0.000029661034,0.0010897345,0.00009886715,0.0011586836,0.00009342984],"about_ca_topic_score_codex":0.0003640156,"about_ca_topic_score_gemma":0.00061645394,"teacher_disagreement_score":0.45557958,"about_ca_system_score_codex":0.0010347104,"about_ca_system_score_gemma":0.0006459474,"threshold_uncertainty_score":0.38678706},"labels":[],"label_agreement":null},{"id":"W4416018995","doi":"10.1016/j.ijgc.2025.102238","title":"FIRST-LINE LENVATINIB + PEMBROLIZUMAB VERSUS CHEMOTHERAPY FOR ADVANCED OR RECURRENT ENDOMETRIAL CANCER: ADDITIONAL 1-YEAR FOLLOW-UP RESULTS FROM ENGOT-EN9/LEAP-001","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Lenvatinib; Chemotherapy; MEDLINE; Compassionate Use","score_opus":0.09522776136698008,"score_gpt":0.43349187069703443,"score_spread":0.33826410933005435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7666931,0.006430365,0.0020582618,0.11053871,0.05857279,0.004094021,0.044857305,0.00017945218,0.006575965],"genre_scores_gemma":[0.9465943,0.02041749,0.0068197506,0.00399713,0.011283743,0.0012839237,0.0014262936,0.00008570198,0.008091648],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613553,0.00010296635,0.0012863103,0.00051820575,0.0014749855,0.00048199712],"domain_scores_gemma":[0.98993236,0.006385176,0.00070912123,0.00023838032,0.0024580467,0.00027693235],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062634534,0.000313415,0.0007758587,0.0004773409,0.00013281773,0.00008126762,0.00075556966,0.00027242038,0.031451195],"category_scores_gemma":[0.01129396,0.0002293077,0.00047252217,0.0004692434,0.00017255603,0.00019061477,0.00012312262,0.00081156247,0.000020149984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.399313,0.001092492,0.0009254939,0.00006772104,0.0020729823,0.00017212969,0.00013293597,0.00065910217,0.00065301853,0.00042373216,0.27596912,0.31851828],"study_design_scores_gemma":[0.13755137,0.004436755,0.008116511,0.00094295,0.00015776594,0.00001652014,0.000081749204,0.0005312068,0.0020957068,0.0009720534,0.84481996,0.00027744164],"about_ca_topic_score_codex":0.00022000632,"about_ca_topic_score_gemma":0.0011267415,"teacher_disagreement_score":0.5688509,"about_ca_system_score_codex":0.0025149593,"about_ca_system_score_gemma":0.00220716,"threshold_uncertainty_score":0.9970343},"labels":[],"label_agreement":null},{"id":"W4416019007","doi":"10.1016/j.ijgc.2025.102606","title":"NON-INVASIVE STRATEGIES FOR EARLY ENDOMETRIAL CANCER DETECTION IN PATIENTS WITH ABNORMAL UTERINE BLEEDING","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Uterine bleeding; Endometrial cancer; Uterine cancer; Cancer; MEDLINE","score_opus":0.01892904922677148,"score_gpt":0.330675117940712,"score_spread":0.31174606871394056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946676,0.0002401635,0.0009616856,0.0007607511,0.0022792914,0.0004639464,0.000045777266,0.000008461457,0.00057236344],"genre_scores_gemma":[0.9980074,0.00025793933,0.00028864178,0.0004912726,0.00064852857,0.00014039563,0.0000055943447,0.0000087526,0.00015148647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986345,0.000019544274,0.00049558136,0.00017577808,0.00046534376,0.00020922498],"domain_scores_gemma":[0.9981455,0.00040691538,0.00029804063,0.000052087365,0.0010114025,0.000086057786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016812669,0.00014912167,0.0004069218,0.00052280084,0.00003804717,0.00005449306,0.00017600502,0.000099925055,0.00042058376],"category_scores_gemma":[0.00032934244,0.00009589527,0.00015532895,0.00042902934,0.000050412717,0.00027074575,0.000039458453,0.00023714096,9.813098e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025384765,0.000630091,0.90183705,0.00005918886,0.0010031112,0.000074327305,0.00007137046,0.0004092156,0.00083676213,0.00010973166,0.00008167288,0.069502726],"study_design_scores_gemma":[0.026949527,0.003329327,0.96351707,0.00029337927,0.00015455854,0.0000045991524,0.00006375815,0.000027245462,0.0039996724,0.0004541642,0.0011035276,0.000103149025],"about_ca_topic_score_codex":0.0002976147,"about_ca_topic_score_gemma":0.00047877897,"teacher_disagreement_score":0.06939958,"about_ca_system_score_codex":0.0009044878,"about_ca_system_score_gemma":0.00045325924,"threshold_uncertainty_score":0.46050972},"labels":[],"label_agreement":null},{"id":"W4416019011","doi":"10.1016/j.ijgc.2025.102583","title":"CASE REPORT: HIGH-GRADE ENDOMETRIAL STROMAL SARCOMA WITH NTRK FUSION AND RESPONSE TO LAROTRECTINIB","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Endometrial stromal sarcoma; Sarcoma; Stromal cell; Fusion gene; Soft tissue sarcoma","score_opus":0.024851785799234555,"score_gpt":0.34890820225737446,"score_spread":0.3240564164581399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864862,0.00017638566,0.00018573407,0.011653809,0.0010157644,0.0002058546,0.000021333759,0.000010885106,0.00024402858],"genre_scores_gemma":[0.995232,0.000047882342,0.0027885775,0.0007408237,0.00032821053,0.000017319493,0.0000029357873,0.000006514025,0.00083572435],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99885374,0.0000750093,0.00038969837,0.00017416177,0.00037268916,0.00013469184],"domain_scores_gemma":[0.9986447,0.0005030179,0.00021373577,0.00008623851,0.0003943606,0.00015791121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003310046,0.00011797174,0.00030287288,0.0003233771,0.00004996091,0.000039131613,0.00009019207,0.00006409872,0.0004283707],"category_scores_gemma":[0.0009870841,0.000071700575,0.00007691527,0.00018626597,0.000044796176,0.000066530796,0.00008771387,0.00019023547,0.0000018773385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051982615,0.0010080041,0.22898173,0.000013145575,0.0014571999,0.660518,0.000117702315,0.00005266088,0.008325025,0.00028434972,0.0016199632,0.045639623],"study_design_scores_gemma":[0.017468603,0.006401498,0.7940408,0.00023457182,0.00029951028,0.15368353,0.000094557334,0.000018242028,0.003524535,0.00020812136,0.023878684,0.00014732416],"about_ca_topic_score_codex":0.00013460197,"about_ca_topic_score_gemma":0.00009334846,"teacher_disagreement_score":0.56505907,"about_ca_system_score_codex":0.0003215976,"about_ca_system_score_gemma":0.00022348482,"threshold_uncertainty_score":0.46903586},"labels":[],"label_agreement":null},{"id":"W4416019012","doi":"10.1016/j.ijgc.2025.102486","title":"HEALTHCARE UTILIZATION AND TOXICITY BURDEN AMONG PATIENTS RECEIVING PARP INHIBITORS: A RETROSPECTIVE SINGLE-CENTER REVIEW","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Retrospective cohort study; Toxicity; Health care; MEDLINE","score_opus":0.033947565944713175,"score_gpt":0.3509759070526609,"score_spread":0.31702834110794775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98040056,0.0077875587,0.000050248498,0.0089683775,0.001067667,0.00026861476,0.000018358443,0.000014629879,0.0014239609],"genre_scores_gemma":[0.987141,0.009283174,0.00011624747,0.0029665707,0.00021498644,0.000012249175,0.000011942895,0.000005870877,0.0002479712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987942,0.00007272797,0.00044682564,0.00016283774,0.0003932876,0.00013015064],"domain_scores_gemma":[0.9984794,0.0001036523,0.0003359028,0.00006118821,0.00092111045,0.00009874453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018876365,0.000113745264,0.00032736937,0.0001077242,0.000045900884,0.000026050926,0.00009658385,0.00008500522,0.00015730012],"category_scores_gemma":[0.0011795327,0.00008065769,0.00010057029,0.00012902002,0.000058309484,0.00013899566,0.000060256214,0.00022228765,0.0000013558063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018734997,0.00032254407,0.94464916,0.00009856635,0.00021213827,0.00003953092,0.00006598423,0.000001852977,0.000067034845,0.000036116333,0.0029559247,0.05136382],"study_design_scores_gemma":[0.0022548188,0.00061523746,0.9859354,0.006161934,0.00010089909,0.00002175375,0.000020059946,0.00002726728,0.00032662178,0.00020170056,0.0042649293,0.000069413654],"about_ca_topic_score_codex":0.0000481654,"about_ca_topic_score_gemma":0.000049895316,"teacher_disagreement_score":0.051294405,"about_ca_system_score_codex":0.000987042,"about_ca_system_score_gemma":0.00010700114,"threshold_uncertainty_score":0.32891253},"labels":[],"label_agreement":null},{"id":"W4416019028","doi":"10.1016/j.ijgc.2025.102420","title":"RACIAL DISPARITIES IN HISTOLOGIC SUBTYPES AND STAGE AT PRESENTATION OF ENDOMETRIAL CANCER: A CANADIAN TERTIARY CENTER STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Presentation (obstetrics); Stage (stratigraphy); Center (category theory); Endometrial cancer; Neoplasm staging; Race (biology); Cancer","score_opus":0.026008559114937328,"score_gpt":0.35991283781469735,"score_spread":0.33390427869976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088115,0.0030174272,0.0000055415985,0.0033507622,0.0015177625,0.0003659545,0.00010195564,0.0000039455645,0.00075552525],"genre_scores_gemma":[0.996962,0.0013829672,0.000036025296,0.00070633687,0.00019883293,0.00004953465,0.0000074699706,0.0000046320233,0.0006522132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985961,0.00009781961,0.0005764652,0.00016416758,0.00039194364,0.00017351555],"domain_scores_gemma":[0.9988279,0.0003896445,0.00026527623,0.0000578462,0.00033099827,0.00012837235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023811027,0.00011762057,0.00042956413,0.00067389436,0.000034996992,0.000016988384,0.00015994928,0.0000860085,0.0012694703],"category_scores_gemma":[0.0006722577,0.000082608334,0.00010433067,0.0002776041,0.00009429248,0.00009931284,0.00007447678,0.00019663696,7.688817e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034436027,0.00058093236,0.9795539,0.000025424513,0.00038911295,0.00027911342,0.00014938963,0.00003407874,0.00019361424,0.00008963447,0.00024986334,0.01501136],"study_design_scores_gemma":[0.010366059,0.0008002985,0.98490936,0.00009463167,0.00011160969,0.000013027376,0.00012733245,0.000015464593,0.0004375493,0.00017153383,0.0028891398,0.000063973064],"about_ca_topic_score_codex":0.048789646,"about_ca_topic_score_gemma":0.16723871,"teacher_disagreement_score":0.11844906,"about_ca_system_score_codex":0.0014678274,"about_ca_system_score_gemma":0.00042818682,"threshold_uncertainty_score":0.9996435},"labels":[],"label_agreement":null},{"id":"W4416019029","doi":"10.1016/j.ijgc.2025.102231","title":"PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 ENGOT-CX12/GOG-3057/INNOVATV 301 TRIAL OF TISOTUMAB VEDOTIN AS SECOND/THIRD-LINE TREATMENT FOR RECURRENT OR METASTATIC CERVICAL CANCER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cervical cancer; Phases of clinical research; Clinical trial; MEDLINE; Cancer","score_opus":0.09977714570942955,"score_gpt":0.43717366595983953,"score_spread":0.33739652025041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97408044,0.0028528306,0.00021315602,0.014233642,0.005733712,0.0015319264,0.0008864906,0.000019280966,0.00044849093],"genre_scores_gemma":[0.99195284,0.0013059812,0.0006336808,0.0035181579,0.00087331806,0.00054362166,0.00008382788,0.000020002333,0.001068549],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965906,0.00015064151,0.0017318627,0.00034884317,0.0008758013,0.00030221083],"domain_scores_gemma":[0.9942431,0.0028262937,0.0011921166,0.00022640741,0.0013359765,0.00017613916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035202559,0.0003329001,0.0011451829,0.00022316397,0.00007917418,0.00004110384,0.00037244766,0.00013812057,0.009011872],"category_scores_gemma":[0.0023202861,0.00016186801,0.0006830093,0.00040992355,0.00012531117,0.000100423116,0.00008758466,0.00033536708,0.0000047439335],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35943207,0.009924808,0.017125065,0.00006492038,0.012459461,0.00045902608,0.00032370302,0.00005957822,0.00078165706,0.00043463765,0.0042121997,0.59472287],"study_design_scores_gemma":[0.6538136,0.059747063,0.07653036,0.00097174844,0.0058553247,0.00010139696,0.0005770252,0.00023049627,0.020740947,0.0054647466,0.17537117,0.00059613277],"about_ca_topic_score_codex":0.00063366716,"about_ca_topic_score_gemma":0.0007118385,"teacher_disagreement_score":0.59412676,"about_ca_system_score_codex":0.0011965785,"about_ca_system_score_gemma":0.0013235003,"threshold_uncertainty_score":0.991894},"labels":[],"label_agreement":null},{"id":"W4416019030","doi":"10.1016/j.ijgc.2025.102460","title":"A DECADE OF CHANGE - ENDOMETRIAL CARCINOMA (EC) RISK CLASSIFICATION BEFORE, AFTER AND BEYOND TCGA","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Carcinoma; MEDLINE; Neoplasm staging","score_opus":0.05118506969521696,"score_gpt":0.35404888281667746,"score_spread":0.3028638131214605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367934,0.0012212485,0.00013737318,0.00248129,0.0008875558,0.00024306052,0.00010817925,0.000006661767,0.0012352989],"genre_scores_gemma":[0.9976712,0.0005289011,0.00053870317,0.00078239175,0.00018695944,0.000083626066,0.000010446647,0.000004910431,0.00019289953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987845,0.00006650084,0.0005175209,0.0001598984,0.00034026522,0.00013130314],"domain_scores_gemma":[0.9983042,0.00044290238,0.00041762454,0.00008215407,0.0006516076,0.00010152126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023193409,0.00011722705,0.00035269893,0.00037141604,0.000036854533,0.000019085484,0.00013978752,0.0001414832,0.0011532027],"category_scores_gemma":[0.0009940328,0.000076770295,0.00017363574,0.00020852304,0.00013671393,0.00012162848,0.00006786039,0.00024968365,0.000003026985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071714225,0.000442156,0.9258715,0.000010804278,0.0004199819,0.00013464778,0.000069659494,0.0000014893096,0.00020064344,0.0013377862,0.00015852861,0.07063568],"study_design_scores_gemma":[0.0038733636,0.0013278299,0.99001884,0.00005565209,0.00028149592,0.000019676685,0.00006117535,0.00004446829,0.00032721902,0.002572719,0.0013648315,0.000052699444],"about_ca_topic_score_codex":0.000042011634,"about_ca_topic_score_gemma":0.00004120215,"teacher_disagreement_score":0.07058298,"about_ca_system_score_codex":0.00025157354,"about_ca_system_score_gemma":0.00012354652,"threshold_uncertainty_score":0.99975985},"labels":[],"label_agreement":null},{"id":"W4416019031","doi":"10.1016/j.ijgc.2025.102146","title":"OVARIAN CANCER TREATMENT IN LOW AND MIDDLE INCOME COUNTRIES:HOW THE EVERY WOMAN STUDY REFLECTS THE LANDSCAPE","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Ovarian cancer; Cancer treatment; Low and middle income countries; Middle income country; Low income; MEDLINE","score_opus":0.03163820194983179,"score_gpt":0.35131592036382203,"score_spread":0.31967771841399023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623486,0.002508701,0.0000071898403,0.03323748,0.0010925158,0.00035949153,0.000016601834,0.0000058504106,0.00042358908],"genre_scores_gemma":[0.99300605,0.0029759884,0.000008693596,0.002519917,0.0003536707,0.000085695516,7.6355667e-7,0.0000054649427,0.0010437499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989563,0.000080973725,0.00030757618,0.00014138567,0.00036239054,0.00015136118],"domain_scores_gemma":[0.99896353,0.0004287355,0.00018984868,0.00010616543,0.00025684154,0.00005488711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031918907,0.00012539292,0.00028069667,0.00012081906,0.000075177595,0.000077561344,0.00022848751,0.000059758466,0.00049441075],"category_scores_gemma":[0.00013949916,0.000054867553,0.000086201166,0.00016028137,0.000094453135,0.000075169264,0.00006263845,0.00027855305,8.922608e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097040716,0.00028693434,0.9902916,0.000012806249,0.0004996037,0.00017861712,0.0008769501,0.000113057235,0.000019841587,0.00010412731,0.0006110843,0.0060349596],"study_design_scores_gemma":[0.003171146,0.0007371985,0.980443,0.00026100973,0.000109498345,0.000033308977,0.0008147716,0.00008181364,0.000042034044,0.00015945121,0.01408794,0.00005882823],"about_ca_topic_score_codex":0.0010106884,"about_ca_topic_score_gemma":0.008441624,"teacher_disagreement_score":0.030717563,"about_ca_system_score_codex":0.0008298378,"about_ca_system_score_gemma":0.00043833625,"threshold_uncertainty_score":0.5413451},"labels":[],"label_agreement":null},{"id":"W4416019033","doi":"10.1016/j.ijgc.2025.102190","title":"MULTICOHORT DEVELOPMENT AND VALIDATION OF A REPRODUCIBLE VAGINAL MICROBIOME MODEL FOR ENDOMETRIAL CANCER DETECTION","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Microbiome; Vaginal cancer; Vagina; MEDLINE","score_opus":0.04019977965437519,"score_gpt":0.3443785331204776,"score_spread":0.3041787534661024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019033","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38094956,0.00045339996,0.6148187,0.0010322535,0.0025100664,0.00018166975,0.000007943879,0.000012698647,0.00003372124],"genre_scores_gemma":[0.95744973,0.00021992363,0.04170507,0.00017075008,0.00020293974,0.000089532725,8.378602e-7,0.000004495554,0.0001567274],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986114,0.000038374223,0.0005968583,0.00028667197,0.00033151158,0.00013521491],"domain_scores_gemma":[0.9979382,0.0002733241,0.00052016875,0.00011685802,0.0011085754,0.000042860644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072879146,0.00010723609,0.00023058112,0.00044205552,0.000065602064,0.00006488359,0.00048708802,0.00008517512,0.000020034999],"category_scores_gemma":[0.00047132012,0.000090602305,0.0000877784,0.0002959649,0.00005152249,0.00036525854,0.00013284256,0.00013746847,3.031429e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001211464,0.00028460438,0.008382551,0.000077482386,0.0007223913,0.000006887778,0.000653579,0.041438296,0.1512404,0.0014224303,0.00054513686,0.79401475],"study_design_scores_gemma":[0.0034259963,0.00032433972,0.013622341,0.00015238767,0.00007106957,0.000028919214,0.000020644313,0.12347181,0.8469931,0.004247413,0.007436994,0.00020501614],"about_ca_topic_score_codex":0.000037655915,"about_ca_topic_score_gemma":0.000055182638,"teacher_disagreement_score":0.7938098,"about_ca_system_score_codex":0.0006882521,"about_ca_system_score_gemma":0.0004777062,"threshold_uncertainty_score":0.3694655},"labels":[],"label_agreement":null},{"id":"W4416019034","doi":"10.1016/j.ijgc.2025.102498","title":"REVISITING INTRAPERITONEAL CHEMOTHERAPY IN ADVANCED HIGH-GRADE SEROUS OVARIAN CANCER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); McGill University Health Centre","funders":"","keywords":"Serous ovarian cancer; Intraperitoneal chemotherapy; Ovarian cancer; Chemotherapy; Serous fluid; MEDLINE","score_opus":0.016372235080735133,"score_gpt":0.35169512344338855,"score_spread":0.3353228883626534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9146388,0.0039623585,0.00012664108,0.07794395,0.002159836,0.00023214731,0.000019738764,0.000015041694,0.00090145797],"genre_scores_gemma":[0.98340917,0.0070369346,0.0016663036,0.0066902093,0.00083477807,0.000084013445,0.0000042108,0.000011937301,0.00026243564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99848926,0.00004867721,0.00061881234,0.00022640635,0.00039395332,0.0002228865],"domain_scores_gemma":[0.9988756,0.00021532526,0.00029660223,0.00010053656,0.0004150812,0.00009683171],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022304851,0.00016472282,0.00047723047,0.00022948728,0.000033065615,0.000039383744,0.00023372044,0.000117253054,0.0018833635],"category_scores_gemma":[0.00014952788,0.0001219172,0.00016652943,0.00024419412,0.000053768686,0.00012361747,0.000040375257,0.0003676848,0.0000028295467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016300525,0.00078131014,0.4332016,0.000040531333,0.0009332603,0.0009419874,0.00012253018,0.0009913845,0.0023063836,0.0023139743,0.0011352965,0.55560166],"study_design_scores_gemma":[0.008971695,0.00030792062,0.9594345,0.00091864215,0.000103620616,0.000058612513,0.0000665062,0.00009807335,0.0033634014,0.0008695402,0.025678342,0.00012913681],"about_ca_topic_score_codex":0.00034076982,"about_ca_topic_score_gemma":0.00016142223,"teacher_disagreement_score":0.55547255,"about_ca_system_score_codex":0.0014104857,"about_ca_system_score_gemma":0.00046081436,"threshold_uncertainty_score":0.99902904},"labels":[],"label_agreement":null},{"id":"W4416019040","doi":"10.1016/j.ijgc.2025.102150","title":"COMMUNITY-BASED SCREENING OF CERVICAL HIGH-RISK HUMAN PAPILLOMAVIRUS IN WESTERN UGANDA: A DOOR-TO-DOOR APPROACH WITH CHALLENGING OUTCOMES IN FOLLOW-UP","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"","keywords":"Human papillomavirus; Cervical cancer; MEDLINE; Cervical screening","score_opus":0.0566139821943034,"score_gpt":0.3834573114936558,"score_spread":0.3268433292993524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083024,0.0002360697,0.0024006073,0.0047756047,0.00020301127,0.0003059339,0.000025778778,0.000010671227,0.001212067],"genre_scores_gemma":[0.99677145,0.0000896038,0.0011257015,0.0016628669,0.000092466165,0.000052618718,0.000009966525,0.000014321541,0.00018101351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751306,0.0002907506,0.0008061269,0.00020132502,0.0008815246,0.0003071944],"domain_scores_gemma":[0.99806446,0.0006655173,0.00025733834,0.00017745979,0.00067060953,0.00016459316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010659022,0.00018798455,0.0007904402,0.0007576939,0.000070879316,0.00003231112,0.0005687105,0.0001439401,0.0005876581],"category_scores_gemma":[0.000443364,0.00012742351,0.00017960108,0.00044677843,0.00012589664,0.000093092865,0.00018388205,0.0014348322,0.0000014210253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004145964,0.0009710588,0.9738338,0.00011017909,0.00029258238,0.00016748521,0.0003139171,0.0031074625,0.00019880667,0.00025668458,0.00005187474,0.016550206],"study_design_scores_gemma":[0.011458271,0.0011228647,0.9851704,0.00035123562,0.0000585204,0.000009035479,0.00031032533,0.00032232984,0.0003626159,0.00026774575,0.00044610942,0.00012051383],"about_ca_topic_score_codex":0.0026009837,"about_ca_topic_score_gemma":0.005784889,"teacher_disagreement_score":0.01642969,"about_ca_system_score_codex":0.0006039182,"about_ca_system_score_gemma":0.00029391164,"threshold_uncertainty_score":0.6434444},"labels":[],"label_agreement":null},{"id":"W4416019048","doi":"10.1016/j.ijgc.2025.102553","title":"OPTIMIZING RADIATION THERAPY DELIVERY IN POST-HYSTERECTOMY PROLAPSE: A CASE FOR VAGINAL PESSARY USE","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pessary; Radiation therapy; MEDLINE; Vagina; Complication","score_opus":0.03712577140005839,"score_gpt":0.35819122687421484,"score_spread":0.32106545547415644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857385,0.004691539,0.00033738944,0.0075718686,0.0009797137,0.00051886076,0.000051530817,0.00000843009,0.00010214074],"genre_scores_gemma":[0.9911218,0.0036022773,0.0015672455,0.0031776624,0.0002156894,0.0001862249,0.000013713047,0.000007580098,0.00010777839],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990181,0.000042738007,0.00042453132,0.00015434177,0.00020977893,0.00015055509],"domain_scores_gemma":[0.99833393,0.00049492053,0.0002221625,0.00006045818,0.00082392356,0.00006459254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021030477,0.000116228526,0.00027672286,0.00025455045,0.000032921635,0.00005582407,0.00010640641,0.00007535496,0.00019853667],"category_scores_gemma":[0.00023125736,0.000081962986,0.0001565374,0.00010538797,0.000030156254,0.00025410144,0.000024821788,0.0001803185,7.3511086e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010288593,0.0019044899,0.4483681,0.000064010535,0.0016796448,0.009416061,0.0005336756,0.0011984771,0.0022071144,0.00045494217,0.003233385,0.5206515],"study_design_scores_gemma":[0.030971639,0.004335089,0.9078701,0.0008954818,0.00029425233,0.0021109807,0.00029077812,0.0014984419,0.007639498,0.0006848789,0.043107413,0.00030143277],"about_ca_topic_score_codex":0.00012635745,"about_ca_topic_score_gemma":0.00010774428,"teacher_disagreement_score":0.5203501,"about_ca_system_score_codex":0.00091742125,"about_ca_system_score_gemma":0.00043920727,"threshold_uncertainty_score":0.33423534},"labels":[],"label_agreement":null},{"id":"W4416019055","doi":"10.1016/j.ijgc.2025.102577","title":"BIOLOGICAL BEHAVIOR RATHER THAN HISTOLOGY OR MOLECULAR PATHOLOGY INFLUENCES TREATMENT IN STUMP","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Immunotoxicology and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Histology; Molecular pathology; Immunohistochemistry; Human Pathology; Histopathology; Anatomical pathology","score_opus":0.02894472580060884,"score_gpt":0.3565541693943548,"score_spread":0.32760944359374594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826429,0.010701814,0.00008129725,0.0020543255,0.0038035263,0.00024484028,0.000017805087,0.000017575616,0.00043592195],"genre_scores_gemma":[0.99454975,0.0017938524,0.000106403415,0.001248529,0.0000346368,0.0001616755,0.000008711364,0.000006447012,0.0020900047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780494,0.00074999116,0.0007773173,0.00026107294,0.000063766194,0.00034292214],"domain_scores_gemma":[0.9983263,0.0008724687,0.00036579513,0.00013504869,0.00027908088,0.000021289303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040720074,0.00022506996,0.0005885045,0.0004273814,0.00007116945,0.000014750499,0.0006790355,0.0005567276,0.0031766538],"category_scores_gemma":[0.0007976464,0.00013568102,0.00022091159,0.00017179587,0.00057379,0.000093012466,0.0001315075,0.0004770768,0.00004495475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009581208,0.002407071,0.41975117,0.000004276222,0.0010963463,0.004266232,0.00031462798,0.000075864045,0.5018294,0.0032442478,0.00066171784,0.056767862],"study_design_scores_gemma":[0.0055564744,0.0031028858,0.86592567,0.00006166835,0.00011488712,0.0010287296,0.0002895199,0.0000012715353,0.055709153,0.00090229174,0.06707056,0.00023689125],"about_ca_topic_score_codex":0.00008114766,"about_ca_topic_score_gemma":0.00019345827,"teacher_disagreement_score":0.4461745,"about_ca_system_score_codex":0.00053943234,"about_ca_system_score_gemma":0.0005070999,"threshold_uncertainty_score":0.9977346},"labels":[],"label_agreement":null},{"id":"W4416019057","doi":"10.1016/j.ijgc.2025.102226","title":"UPDATES ON THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (IGCS) GLOBAL FELLOWSHIP PROGRAM","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Gynecologic cancer; Cancer; MEDLINE; Gynecologic oncology; Gynecologic surgical procedures","score_opus":0.028394288496270837,"score_gpt":0.4525217221145811,"score_spread":0.42412743361831023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7111727,0.0039299447,0.0008329344,0.24323212,0.01776045,0.00068643707,0.000072728435,0.000085718515,0.022226965],"genre_scores_gemma":[0.92916834,0.007443042,0.0028375518,0.055724002,0.0020899253,0.00018610246,0.00000823899,0.00001066356,0.002532121],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825686,0.0000790792,0.00054357026,0.000245776,0.00061829126,0.00025639264],"domain_scores_gemma":[0.99750346,0.0010231453,0.00041805088,0.00013714976,0.0008291074,0.000089066685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005013125,0.00019929517,0.00036724133,0.00007044429,0.00012527003,0.000058139078,0.0008916993,0.00023968657,0.005019396],"category_scores_gemma":[0.0008271949,0.00010847398,0.00043028287,0.00021865271,0.0003887404,0.000116987954,0.00011079381,0.00066312583,0.000014502305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002353557,0.0022647905,0.37809658,0.000019738405,0.004236664,0.00036226827,0.000116527655,0.0014154321,0.0006864503,0.019773932,0.22778717,0.36288688],"study_design_scores_gemma":[0.003486032,0.0012645881,0.28603482,0.00023387875,0.00018179948,0.00013378583,0.00022289799,0.00082392513,0.00090889697,0.009951608,0.6965645,0.00019326874],"about_ca_topic_score_codex":0.000015523092,"about_ca_topic_score_gemma":0.000052934993,"teacher_disagreement_score":0.4687773,"about_ca_system_score_codex":0.001836872,"about_ca_system_score_gemma":0.0006215222,"threshold_uncertainty_score":0.99589014},"labels":[],"label_agreement":null},{"id":"W4416019059","doi":"10.1016/j.ijgc.2025.102545","title":"HPV STATUS, MIXED HISTOLOGIES, AND THE RISK OF VULVAR CANCER RECURRENCE","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Vulvar cancer; Vulvar Carcinoma; Vulvar neoplasm; Vulva; Human papillomavirus; Cancer recurrence","score_opus":0.02864261768387123,"score_gpt":0.38220549862070197,"score_spread":0.35356288093683075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8788227,0.064941555,0.0006566417,0.033227704,0.003765146,0.0004916897,0.00017015079,0.000016511607,0.017907936],"genre_scores_gemma":[0.9540145,0.043979216,0.00020799623,0.0010369689,0.00021199851,0.000030950494,0.0000017157744,0.0000041345006,0.0005125406],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99840516,0.0001642697,0.0005076097,0.00014652306,0.00058305607,0.0001933817],"domain_scores_gemma":[0.9967926,0.0012849875,0.00035417534,0.00010577426,0.001360267,0.000102194324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007015775,0.00010416233,0.00041988594,0.00013878074,0.000053231546,0.00002200406,0.00033447522,0.00008954032,0.004770335],"category_scores_gemma":[0.0028279473,0.000054742213,0.00016354675,0.00018298968,0.0005690503,0.00006310916,0.00015370766,0.0005730794,0.0000012676376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074142893,0.00019815943,0.40454614,0.00007088615,0.0009309944,0.00005262496,0.00015398732,0.000109281485,0.00012284708,0.004954865,0.0130379,0.568408],"study_design_scores_gemma":[0.0051964615,0.0002900371,0.94331473,0.000077384364,0.00020668068,0.000022718003,0.00011395715,0.00021126983,0.00048449935,0.004096139,0.04592312,0.000062977124],"about_ca_topic_score_codex":0.0010106773,"about_ca_topic_score_gemma":0.000630889,"teacher_disagreement_score":0.56834507,"about_ca_system_score_codex":0.00044653736,"about_ca_system_score_gemma":0.00068202906,"threshold_uncertainty_score":0.99613947},"labels":[],"label_agreement":null},{"id":"W4416019104","doi":"10.1016/j.ijgc.2025.102218","title":"PATIENT PREFERENCES FOR OVARIAN CANCER MAINTENANCE THERAPY: A DISCRETE CHOICE EXPERIMENT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada; GlaxoSmithKline (Canada); Sunnybrook Hospital","funders":"","keywords":"Ovarian cancer; Discrete choice; Patient choice; MEDLINE; Epithelial ovarian cancer","score_opus":0.044580721777271765,"score_gpt":0.3832983742858993,"score_spread":0.3387176525086275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711328,0.005746117,0.0011922579,0.017072387,0.00310571,0.00043515168,0.0000384746,0.000010650097,0.001266422],"genre_scores_gemma":[0.99414116,0.0012330642,0.00052733766,0.0027771797,0.00048015645,0.00020817155,0.0000034127277,0.000004048485,0.0006254834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989536,0.000053617212,0.00040354833,0.0002196345,0.00021572072,0.00015389989],"domain_scores_gemma":[0.99837977,0.00024403167,0.0002599704,0.000099171964,0.0009555847,0.00006145692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022812489,0.00011215255,0.00028106658,0.00007107815,0.000046489527,0.000015801581,0.00020066442,0.00009472404,0.0008172733],"category_scores_gemma":[0.000699071,0.00006507353,0.00017455278,0.00006464542,0.00012529422,0.000074602416,0.00004359052,0.00019561498,8.9285373e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03650204,0.0012888578,0.5159852,0.000042122323,0.0026752183,0.0000513279,0.0005718806,0.00014813621,0.027356321,0.0016571635,0.0145529555,0.39916876],"study_design_scores_gemma":[0.0022869154,0.00091544894,0.86233234,0.0001455645,0.00004370304,0.000009911239,0.0000930435,0.000035273504,0.01366343,0.002488364,0.11790675,0.000079245],"about_ca_topic_score_codex":0.000072277035,"about_ca_topic_score_gemma":0.000033597567,"teacher_disagreement_score":0.39908952,"about_ca_system_score_codex":0.00034878394,"about_ca_system_score_gemma":0.0003077713,"threshold_uncertainty_score":0.8948569},"labels":[],"label_agreement":null},{"id":"W4416019119","doi":"10.1016/j.ijgc.2025.102383","title":"EXTENDED POSTOPERATIVE THROMBOPROPHYLAXIS IN GYNECOLOGIC ONCOLOGY PATIENTS UNDERGOING LAPAROTOMY: A QUALITY IMPROVEMENT ASSESSMENT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Thyroid and Parathyroid Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research; Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Gynecologic oncology; Quality management; Gynecologic surgical procedures; Quality (philosophy); MEDLINE; Clinical Oncology","score_opus":0.02576068069926714,"score_gpt":0.4105979437410858,"score_spread":0.3848372630418187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815112,0.0003885948,0.00017528377,0.0064606215,0.0024834976,0.00046191493,0.000018275428,0.000014191756,0.008486447],"genre_scores_gemma":[0.99199325,0.00057273643,0.0007749237,0.0059848917,0.00014744219,0.000079279576,0.0000110183455,0.000007496595,0.00042893822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751616,0.00025692437,0.0011012122,0.00027321413,0.00057316636,0.0002793035],"domain_scores_gemma":[0.9969779,0.0011515083,0.0005420429,0.000119343524,0.0010923493,0.00011684897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084835815,0.00019320105,0.00069579756,0.00035157285,0.000052727824,0.000036347978,0.00028220064,0.00019830173,0.00088557764],"category_scores_gemma":[0.0012695196,0.00013662475,0.00023879665,0.00024202366,0.00010784105,0.00015668996,0.00013688776,0.000629891,0.0000068361437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021220772,0.0041097486,0.89321184,0.000033435543,0.0007390178,0.00055151555,0.00023953232,0.00019103235,0.012607197,0.0025784194,0.0030574903,0.08055871],"study_design_scores_gemma":[0.0059238053,0.00313782,0.98165035,0.00010809646,0.000039103517,0.000011772865,0.0003175735,0.000044766555,0.0010952773,0.0013794889,0.0061572893,0.00013464189],"about_ca_topic_score_codex":0.000056238026,"about_ca_topic_score_gemma":0.00028291505,"teacher_disagreement_score":0.08843854,"about_ca_system_score_codex":0.002842485,"about_ca_system_score_gemma":0.0017345326,"threshold_uncertainty_score":0.96964544},"labels":[],"label_agreement":null},{"id":"W4416019133","doi":"10.1016/j.ijgc.2025.102480","title":"PREVENTION OF BRCA/HRD-ASSOCIATED SECONDARY MALIGNANCIES WITH PARP INHIBITORS: A RETROSPECTIVE STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Retrospective cohort study; Poly ADP ribose polymerase; PARP inhibitor; MEDLINE; Cancer","score_opus":0.01085122666833703,"score_gpt":0.3122476998155697,"score_spread":0.30139647314723267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959759,0.0007707157,0.00058111426,0.0005611016,0.00086170516,0.00019119652,0.000034562574,0.000004296299,0.0010194012],"genre_scores_gemma":[0.9983522,0.00013818723,0.0003103643,0.00021199118,0.00020208585,0.00003635369,0.000009768717,0.0000074687587,0.00073152763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882,0.000098248245,0.0004445422,0.00018174219,0.00034424066,0.000111219604],"domain_scores_gemma":[0.9979873,0.000037163583,0.0005146196,0.000099177254,0.0013315361,0.000030243524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032809481,0.00011072991,0.00022124493,0.000111779096,0.000036089412,0.000022090542,0.00030423573,0.00010502309,0.00022195975],"category_scores_gemma":[0.00036989042,0.00008375395,0.00011847825,0.00015755712,0.00010434426,0.000013894469,0.00009394885,0.00016880734,5.8392925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018606794,0.0022644482,0.87030584,0.00002099104,0.003646951,0.000072930285,0.0004568265,0.0017732765,0.09107117,0.0003500421,0.012180459,0.015996365],"study_design_scores_gemma":[0.0037039826,0.0033434825,0.92276424,0.00017710275,0.00014820928,0.000019160805,0.00083480903,0.00001201375,0.062495753,0.0013967132,0.0049307747,0.00017373555],"about_ca_topic_score_codex":0.000022771346,"about_ca_topic_score_gemma":0.00044557473,"teacher_disagreement_score":0.052458405,"about_ca_system_score_codex":0.00040694795,"about_ca_system_score_gemma":0.0007320508,"threshold_uncertainty_score":0.3415387},"labels":[],"label_agreement":null},{"id":"W4416019143","doi":"10.1016/j.ijgc.2025.102360","title":"EXPLORING THE PREDICTORS AND IMPACT OF INPATIENT CHEMOTHERAPY IN GYNECOLOGIC ONCOLOGY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Gynecologic oncology; Gynecologic cancer; Chemotherapy; MEDLINE; Gynecologic surgical procedures","score_opus":0.057852689570578326,"score_gpt":0.38034710436866914,"score_spread":0.3224944147980908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908331,0.00087444455,0.000032785683,0.0053512626,0.0015235178,0.00013723604,0.000008348527,0.000004195928,0.0012351156],"genre_scores_gemma":[0.9949197,0.0037951635,0.000035604382,0.0010169727,0.00013395284,0.000030228799,0.0000010294959,0.0000038462076,0.00006348191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990065,0.00007149192,0.00044528593,0.000100346806,0.00025642532,0.000119914046],"domain_scores_gemma":[0.9987076,0.00055669126,0.00024160165,0.00006617813,0.00037598025,0.000051975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036489073,0.00009057293,0.00031895144,0.00020219563,0.000016805154,0.000009459373,0.00019225356,0.00006839122,0.0004245269],"category_scores_gemma":[0.0002784385,0.000048924594,0.00016149976,0.00018435944,0.00012249566,0.00008567621,0.00004561367,0.00030158818,3.087773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001723807,0.00034184166,0.83722126,0.000016944035,0.00044510185,0.000099846984,0.0010862958,0.00029805358,0.0007057421,0.00022726344,0.00046055575,0.15737331],"study_design_scores_gemma":[0.0018244733,0.00136322,0.987466,0.000111439644,0.00003700597,0.000033008862,0.00037252266,0.00005448395,0.00047281716,0.00032592693,0.007896886,0.00004221973],"about_ca_topic_score_codex":0.0002781151,"about_ca_topic_score_gemma":0.00070517854,"teacher_disagreement_score":0.15733108,"about_ca_system_score_codex":0.00083507935,"about_ca_system_score_gemma":0.00038782778,"threshold_uncertainty_score":0.46482718},"labels":[],"label_agreement":null},{"id":"W4416019152","doi":"10.1016/j.ijgc.2025.102227","title":"INVESTIGATING ACCEPTABILITY AND EXPERIENCES OF WOMEN FOR HPV SELF SAMPLING IN A MULTI-CENTRIC STUDY IN INDIA","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Cervical cancer; Sampling (signal processing); MEDLINE; Self-disclosure; Human papillomavirus","score_opus":0.08169633544833843,"score_gpt":0.4515768572464905,"score_spread":0.36988052179815206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821085,0.00049323693,0.00010053273,0.00036462303,0.00022343965,0.00040998362,0.0000032344005,0.000003043917,0.00019103884],"genre_scores_gemma":[0.99827856,0.00010174753,0.0011293292,0.00026679016,0.000054079082,0.00015661058,4.576727e-7,0.0000027877966,0.000009662936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870247,0.00006888959,0.0005657125,0.00014769835,0.00032460154,0.0001906364],"domain_scores_gemma":[0.9985537,0.00072176126,0.00015024196,0.0000456604,0.00043556126,0.00009307835],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010381114,0.00007137046,0.00034221256,0.00031942697,0.00001792736,0.000018648861,0.00018348837,0.000057761714,0.0009808299],"category_scores_gemma":[0.0025976908,0.000052011153,0.00005105058,0.00029358699,0.000083758925,0.00008226409,0.00009637685,0.00026677633,8.963303e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051409495,0.00095629983,0.93466,0.000061018225,0.00007153147,0.000015182916,0.013265249,0.000049766248,0.00005516996,0.000043041608,0.000005368341,0.050303273],"study_design_scores_gemma":[0.004934225,0.0005607322,0.9759023,0.000034377652,0.000009925806,0.0000026030648,0.017421635,0.00055603776,0.000117371135,0.0003300027,0.00008995801,0.000040805095],"about_ca_topic_score_codex":0.00009348461,"about_ca_topic_score_gemma":0.00018697226,"teacher_disagreement_score":0.05026247,"about_ca_system_score_codex":0.00096695835,"about_ca_system_score_gemma":0.00042829048,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W4416019155","doi":"10.1016/j.ijgc.2025.102631","title":"LAPAROSCOPIC RADICAL HYSTERECTOMY WITH INTERNAL ILIAC VESSEL RESECTION AND URETERAL REIMPLANTATION FOR LOW-GRADE ENDOMETRIAL STROMAL SARCOMA","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Endometrial stromal sarcoma; Resection; Sarcoma; Stromal cell; Hysterectomy; Radical Hysterectomy","score_opus":0.02178290360562904,"score_gpt":0.3500813908083031,"score_spread":0.32829848720267407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933993,0.000277873,0.0014645675,0.002714487,0.0015660768,0.00029670174,0.000037754864,0.000011335356,0.0002318924],"genre_scores_gemma":[0.9964711,0.00015872864,0.0019055604,0.0004164641,0.00063096406,0.000043914348,0.000017412605,0.00000813403,0.00034769948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886304,0.000046590747,0.00040610347,0.00017864924,0.00034711184,0.00015849477],"domain_scores_gemma":[0.9989048,0.00035651535,0.00023937158,0.00005595738,0.000344442,0.000098895434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015682438,0.00013320688,0.0003440954,0.00027130774,0.0000483277,0.000060849034,0.00012406729,0.00007395162,0.00013007925],"category_scores_gemma":[0.00024487704,0.00008611801,0.00011016847,0.00010409603,0.000086061606,0.00014332282,0.000039345057,0.0002220565,7.2593696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05091968,0.0012978417,0.87550825,0.00020348428,0.0036487295,0.0010926594,0.00016838197,0.00005628198,0.018262131,0.0017084015,0.0033522653,0.043781865],"study_design_scores_gemma":[0.04186654,0.008069312,0.91912264,0.0009004614,0.0004749771,0.0014158775,0.00006327818,0.00045262303,0.014101947,0.0009286455,0.012412101,0.00019162332],"about_ca_topic_score_codex":0.0000422921,"about_ca_topic_score_gemma":0.000042956603,"teacher_disagreement_score":0.043614335,"about_ca_system_score_codex":0.00029896345,"about_ca_system_score_gemma":0.00015428929,"threshold_uncertainty_score":0.35117906},"labels":[],"label_agreement":null},{"id":"W4416019168","doi":"10.1016/j.ijgc.2025.102495","title":"GA-68 FAPI PET/CT VS. FDG PET/CT IN STAGING AND RESTAGING OF OVARIAN CANCER: A COMPARATIVE ANALYSIS OF 38 PATIENTS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Ovarian cancer; Ovary; Neoplasm staging; MEDLINE; Ovarian tumor","score_opus":0.025012087386285693,"score_gpt":0.3697848996254092,"score_spread":0.34477281223912354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955424,0.000346643,0.00011073425,0.002166405,0.00015452177,0.00009580894,0.000094644165,0.000004628382,0.0014841966],"genre_scores_gemma":[0.99827486,0.0005447755,0.0002692289,0.00065086246,0.00004673756,0.0000093700655,0.000018683662,0.0000037853383,0.00018168201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807405,0.0001103772,0.0009096806,0.0001928587,0.0005609411,0.00015211134],"domain_scores_gemma":[0.99781686,0.00033194385,0.00070428196,0.0000871814,0.00096750766,0.00009221946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034924637,0.00013783712,0.00080949056,0.001127444,0.00003143702,0.000023172362,0.00017673502,0.000007775796,0.0015992936],"category_scores_gemma":[0.00031186314,0.000106392006,0.00029358736,0.0007843846,0.00014617828,0.0001482413,0.00007550252,0.00029293002,5.440817e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006679638,0.0005207719,0.9881395,0.00004519034,0.0029282426,0.0010888341,0.00018188304,0.0026481675,0.0009408719,0.0004292839,0.0004161417,0.001993156],"study_design_scores_gemma":[0.0033458038,0.0002032028,0.98609006,0.0010268948,0.00086453767,0.00004899464,0.00067212473,0.004704785,0.001806544,0.00014224212,0.0009827855,0.000112035785],"about_ca_topic_score_codex":0.0007843605,"about_ca_topic_score_gemma":0.00074373756,"teacher_disagreement_score":0.0027324567,"about_ca_system_score_codex":0.00036416942,"about_ca_system_score_gemma":0.00025613935,"threshold_uncertainty_score":0.99931335},"labels":[],"label_agreement":null},{"id":"W4416019187","doi":"10.1016/j.ijgc.2025.102731","title":"PHASE 3 ROSELLA (GOG-3073, ENGOT-OV72) TRIAL OF RELACORILANT + NAB-PACLITAXEL VS NAB-PACLITAXEL IN PLATINUM-RESISTANT OVARIAN CANCER: PRIMARY RESULTS AND OUTCOMES IN OLDER PATIENTS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Phase (matter); Phases of clinical research; Clinical trial; MEDLINE","score_opus":0.022602088258806528,"score_gpt":0.39534424490579323,"score_spread":0.3727421566469867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834457,0.002410132,0.000011137205,0.00925275,0.0017929474,0.00096202525,0.00040508935,0.000011036009,0.0017092051],"genre_scores_gemma":[0.99314195,0.0043734387,0.00027041038,0.0008875552,0.00029988308,0.00012453215,0.000018491712,0.00001612689,0.00086762774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586976,0.00022942535,0.0017688118,0.0004081543,0.0013009321,0.00042290823],"domain_scores_gemma":[0.9964376,0.0014641517,0.0007331616,0.00018956547,0.0010024162,0.0001731018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001238363,0.00028466494,0.0011256449,0.0006888421,0.000051943785,0.00003787233,0.00039957973,0.00020767549,0.00017101159],"category_scores_gemma":[0.004285829,0.0002017391,0.00019378534,0.00037895073,0.00024391571,0.00020090956,0.0002543268,0.0008206483,0.0000011222739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23019834,0.005909383,0.7197424,0.00026731592,0.0012509424,0.0006764972,0.0011928679,0.000085974294,0.0016446277,0.000436106,0.005767409,0.032828115],"study_design_scores_gemma":[0.1732936,0.0036012507,0.8156157,0.00102074,0.00009105988,0.000005419697,0.00015666497,0.000051456107,0.0002852546,0.00047878415,0.005232097,0.00016793665],"about_ca_topic_score_codex":0.0010559944,"about_ca_topic_score_gemma":0.001338351,"teacher_disagreement_score":0.09587332,"about_ca_system_score_codex":0.0023089908,"about_ca_system_score_gemma":0.0010379967,"threshold_uncertainty_score":0.82266814},"labels":[],"label_agreement":null},{"id":"W4416019189","doi":"10.1016/j.ijgc.2025.102240","title":"LOW NEUTROPHIL-TO-LYMPHOCYTE RATIO IS ASSOCIATED WITH IMPROVED PROGRESSION FREE SURVIVAL IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER: AN ANCILLARY ANALYSIS OF NRG-GY018","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Sunnybrook Hospital","funders":"","keywords":"Endometrial cancer; Progression-free survival; Overall survival; MEDLINE; Survival analysis","score_opus":0.018766221891567222,"score_gpt":0.3400307760058051,"score_spread":0.3212645541142379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959356,0.00059189205,0.00012417114,0.0010426153,0.0011005037,0.0006820473,0.00042040148,0.000013010469,0.000089757894],"genre_scores_gemma":[0.9976772,0.0005655667,0.00048334742,0.00083124544,0.00017321568,0.000100247824,0.00007888045,0.000014800428,0.0000754637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969894,0.0001457973,0.0009045213,0.0003664619,0.0013010027,0.00029280258],"domain_scores_gemma":[0.9961117,0.000540645,0.00082196965,0.00020360334,0.002091072,0.00023101483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000365358,0.00026033158,0.0010974171,0.0011758547,0.000041883315,0.000031430365,0.00042769875,0.00014130957,0.00079147425],"category_scores_gemma":[0.0013934887,0.00014327746,0.00022414069,0.002836099,0.000085085325,0.00020958565,0.00009863479,0.0002937961,3.8587132e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10546589,0.003256052,0.7433703,0.000027824162,0.0059686694,0.00014259986,0.00010320625,0.0017004412,0.00047673212,0.00001621923,0.00008543444,0.13938665],"study_design_scores_gemma":[0.042137317,0.011654064,0.9409307,0.0007230309,0.001383772,0.0000015103772,0.000037999627,0.00032938982,0.0022785764,0.000027504913,0.00031188436,0.00018425217],"about_ca_topic_score_codex":0.00019665655,"about_ca_topic_score_gemma":0.0022418587,"teacher_disagreement_score":0.19756041,"about_ca_system_score_codex":0.002013677,"about_ca_system_score_gemma":0.0009658523,"threshold_uncertainty_score":0.8666088},"labels":[],"label_agreement":null},{"id":"W4416019191","doi":"10.1016/j.ijgc.2025.102617","title":"REJOICE-OVARIAN02: A PHASE 1B/2 STUDY OF RALUDOTATUG DERUXTECAN WITH OTHER ANTICANCER AGENTS IN PARTICIPANTS WITH RELAPSED OVARIAN CANCER AFTER PLATINUM-BASED CHEMOTHERAPY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Carboplatin; Ovarian cancer; Bevacizumab; Paclitaxel; Chemotherapy; Phases of clinical research; Topoisomerase","score_opus":0.02738652279505877,"score_gpt":0.3559953659501616,"score_spread":0.32860884315510286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622136,0.0005239952,0.0013260468,0.0009441479,0.00041703836,0.0003473336,0.000028303233,0.0000053518092,0.00018641964],"genre_scores_gemma":[0.99622697,0.00015351514,0.0011200436,0.001759258,0.0001616348,0.00021506134,0.0000050122294,0.000022756045,0.00033574604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981386,0.000112147456,0.00062269764,0.00032895576,0.0005059198,0.00029165333],"domain_scores_gemma":[0.99863553,0.00006285235,0.00047631087,0.00016268522,0.0005819822,0.00008066162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003557403,0.00023006147,0.00038709666,0.00017960313,0.00003354531,0.000033752425,0.00042055506,0.00012980394,0.00089076126],"category_scores_gemma":[0.00007034308,0.00015527062,0.00007926974,0.00026914064,0.00013000311,0.000018722729,0.0000484399,0.00022356353,6.272945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027900826,0.0040204357,0.9173843,0.000032960987,0.0019114251,0.00019174753,0.0005962571,0.0070218355,0.02455977,0.000020654024,0.00084967253,0.015510102],"study_design_scores_gemma":[0.06937642,0.0056552906,0.8342056,0.0010288664,0.0003152566,0.000015376687,0.0005382255,0.00041509874,0.069469474,0.00013548492,0.018158464,0.0006864175],"about_ca_topic_score_codex":0.0002248403,"about_ca_topic_score_gemma":0.0019259381,"teacher_disagreement_score":0.08317869,"about_ca_system_score_codex":0.00020422431,"about_ca_system_score_gemma":0.00078090216,"threshold_uncertainty_score":0.9753211},"labels":[],"label_agreement":null},{"id":"W4416019196","doi":"10.1016/j.ijgc.2025.102333","title":"OPTIMIZING LENGTH OF STAY IN PATIENTS UNDERGOING CYTOREDUCTIVE SURGERY WITH HIPEC IN GYNECOLOGY ONCOLOGY: A QUALITY IMPROVEMENT ASSESSMENT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research; Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Quality management; Cytoreductive surgery; Gynecologic surgical procedures; Quality assessment; MEDLINE","score_opus":0.02797066931660318,"score_gpt":0.3795986928303437,"score_spread":0.3516280235137405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933764,0.00023160606,0.00029425736,0.002684754,0.0016175014,0.0002461345,0.000014862479,0.0000047752965,0.0015297119],"genre_scores_gemma":[0.9979648,0.00035667082,0.00064284465,0.00084661995,0.00007969141,0.000043140684,0.0000068151344,0.0000070355295,0.000052372794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978781,0.0001990373,0.000978605,0.00021018191,0.00051643903,0.00021764816],"domain_scores_gemma":[0.9965825,0.001741501,0.0006571217,0.00009128948,0.0008598497,0.000067758476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009276846,0.00014009007,0.0006985863,0.0004882462,0.000016945749,0.000011793585,0.00018266664,0.0001379095,0.00028821343],"category_scores_gemma":[0.00069448986,0.00010354061,0.00014359968,0.00027069348,0.00011009811,0.00013595835,0.00008269433,0.00048412304,2.419557e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002896649,0.0012838171,0.93867105,0.000052307412,0.00039027625,0.00013030403,0.00046110357,0.0006652797,0.00022251488,0.00043802118,0.00008091288,0.054707754],"study_design_scores_gemma":[0.0049409377,0.0017236165,0.98947257,0.00038964816,0.00005141001,0.000004508973,0.0016375141,0.00003226799,0.0005399714,0.00034752506,0.00075945084,0.00010056833],"about_ca_topic_score_codex":0.00064572744,"about_ca_topic_score_gemma":0.011280346,"teacher_disagreement_score":0.054607186,"about_ca_system_score_codex":0.0038772128,"about_ca_system_score_gemma":0.002038647,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W4416019198","doi":"10.1016/j.ijgc.2025.102156","title":"PEMBROLIZUMAB PLUS CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN PARTICIPANTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER: 5-YEAR FOLLOW-UP RESULTS FROM KEYNOTE-826","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Bevacizumab; Pembrolizumab; Chemotherapy; Cervical cancer; Monoclonal","score_opus":0.103389803524005,"score_gpt":0.4244518838935613,"score_spread":0.3210620803695563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787752,0.00090000645,0.00019837588,0.017083857,0.0010815752,0.00071770675,0.0002494856,0.000028149532,0.0009656571],"genre_scores_gemma":[0.9904196,0.0021707807,0.0014974693,0.0022454206,0.00039618558,0.00018904814,0.000020640007,0.000038794406,0.0030220384],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99584967,0.0002232375,0.001076734,0.0005564888,0.0016553692,0.000638481],"domain_scores_gemma":[0.99668306,0.00088429725,0.00053097383,0.00028766607,0.0012460264,0.0003679496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060687325,0.00035154977,0.0010429928,0.00040110637,0.00006960949,0.000102804326,0.00070576504,0.00016239715,0.004733267],"category_scores_gemma":[0.0010785011,0.00018813815,0.00022066475,0.0006283039,0.00027703933,0.00019980228,0.00011118131,0.0010263904,0.000011548891],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6718808,0.0015112947,0.25038728,0.00018053388,0.004620073,0.004022446,0.0023250445,0.001818398,0.00032446318,0.00007112592,0.0077510276,0.05510756],"study_design_scores_gemma":[0.35516128,0.02862641,0.5100581,0.012681489,0.0025470408,0.0009296689,0.0071267113,0.012284227,0.0037334638,0.0005326358,0.06467613,0.0016428694],"about_ca_topic_score_codex":0.0022672394,"about_ca_topic_score_gemma":0.018686933,"teacher_disagreement_score":0.31671947,"about_ca_system_score_codex":0.0030730923,"about_ca_system_score_gemma":0.004561636,"threshold_uncertainty_score":0.9992195},"labels":[],"label_agreement":null},{"id":"W4416019219","doi":"10.1016/j.ijgc.2025.102634","title":"ROBOTIC SECONDARY CYTOREDUCTION IN THE DIAPHRAGMATIC AREA - SURGICAL APPROACH, TIPS AND TRIKS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Advanced Computational Techniques in Science and Engineering","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Diaphragmatic breathing; Diaphragm (acoustics); Laparoscopy; MEDLINE; Laparoscopes","score_opus":0.017930372262424978,"score_gpt":0.3139470853649892,"score_spread":0.2960167131025642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019219","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.101915896,0.00094328326,0.88811654,0.004746651,0.0012174736,0.000105988394,7.993494e-7,0.000024927269,0.0029284335],"genre_scores_gemma":[0.9749136,0.0002636826,0.024141008,0.0005263679,0.00009762994,0.000018621831,5.0269665e-7,0.0000015891155,0.000037018686],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99901736,0.00005951552,0.0003200885,0.00014012866,0.00034732898,0.00011556123],"domain_scores_gemma":[0.999166,0.00046046698,0.00012084974,0.00008094894,0.00014186357,0.000029877401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005516885,0.00007816624,0.00014214627,0.00019726287,0.000041851585,0.000103953906,0.0009096406,0.000047684392,0.0000151820195],"category_scores_gemma":[0.00014973215,0.000048880607,0.00005510837,0.00030877432,0.00007398746,0.00044601772,0.00011717836,0.00030014024,3.9252484e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077645724,0.00036360268,0.0035612357,0.000025513104,0.0001089326,0.00045641992,0.0009358295,0.2497121,0.00023643536,0.26638013,0.0018309848,0.47631118],"study_design_scores_gemma":[0.0028880253,0.00047666233,0.15518709,0.00034411848,0.000035049026,0.0028957035,0.0005828092,0.4616564,0.00050179934,0.34907055,0.025815384,0.00054641],"about_ca_topic_score_codex":0.0000033240249,"about_ca_topic_score_gemma":0.0000016418303,"teacher_disagreement_score":0.8729977,"about_ca_system_score_codex":0.00014510972,"about_ca_system_score_gemma":0.00009641521,"threshold_uncertainty_score":0.19932933},"labels":[],"label_agreement":null},{"id":"W4416019222","doi":"10.1016/j.ijgc.2025.102160","title":"POST-(NEO)ADJUVANT THERAPY OUTCOMES WITH LENVATINIB PLUS PEMBROLIZUMAB IN PARTICIPANTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER: RESULTS FROM STUDY 309/KEYNOTE-775 AND ENGOT-EN9/LEAP-001","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Lenvatinib; MEDLINE; Compassionate Use; Nivolumab","score_opus":0.09727618982288361,"score_gpt":0.4481342611936658,"score_spread":0.3508580713707822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856094,0.0027757015,0.000033284126,0.008500459,0.0012378865,0.0012620649,0.00031200954,0.000022787224,0.0002464174],"genre_scores_gemma":[0.9918088,0.0054194834,0.00037095396,0.0012089633,0.0003829791,0.0003066005,0.000016806853,0.00002752944,0.0004579366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957876,0.00029678663,0.0011964227,0.0005630462,0.0016125564,0.000543573],"domain_scores_gemma":[0.995071,0.0023782044,0.000605539,0.00025744157,0.0014038614,0.00028393333],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088932907,0.0003527572,0.0011057317,0.00057599467,0.00007699537,0.00009965628,0.0005398018,0.0001426193,0.0011204885],"category_scores_gemma":[0.002717108,0.00018994017,0.00010290017,0.00054853474,0.00022271862,0.00022601045,0.00014763299,0.0010236641,0.0000029923697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22921132,0.0024696141,0.5006339,0.000028900738,0.0018358924,0.0022097505,0.0014216012,0.0009220767,0.0006145561,0.00002898674,0.00038468846,0.2602387],"study_design_scores_gemma":[0.10326541,0.012747465,0.87515247,0.0009523283,0.00016236486,0.0000465088,0.0011449829,0.0001998884,0.0007759811,0.000079886115,0.005185182,0.00028753854],"about_ca_topic_score_codex":0.0023900012,"about_ca_topic_score_gemma":0.010322475,"teacher_disagreement_score":0.37451854,"about_ca_system_score_codex":0.0016425271,"about_ca_system_score_gemma":0.0022528348,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W4416019250","doi":"10.1016/j.ijgc.2025.102732","title":"PEMBROLIZUMAB VS PLACEBO PLUS PACLITAXEL ± BEVACIZUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: RESULTS FROM THE PHASE 3 ENGOT-OV65/KEYNOTE-B96 STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pembrolizumab; Bevacizumab; Placebo; Paclitaxel; Phases of clinical research; Monoclonal; Ovarian cancer","score_opus":0.07765121716790024,"score_gpt":0.45433611366968646,"score_spread":0.3766848965017862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92416877,0.0041251197,0.0015020819,0.056229137,0.0059017627,0.0030512111,0.003040356,0.000050297833,0.0019312402],"genre_scores_gemma":[0.9922591,0.001123427,0.00057755015,0.0020521358,0.0021884274,0.000594394,0.00005799578,0.00003130023,0.0011156602],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952257,0.0003829714,0.0015571621,0.00057394436,0.0017197981,0.00054040545],"domain_scores_gemma":[0.99225754,0.00437604,0.00076867506,0.0004208206,0.001892678,0.00028423517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017819934,0.00034694347,0.0008248902,0.0002600296,0.00023394614,0.00016910251,0.0012250489,0.00021899771,0.0017502836],"category_scores_gemma":[0.0059735905,0.00021840777,0.00037102238,0.00033782478,0.00020340564,0.00014834989,0.0002710777,0.0011931276,0.000008879609],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4734591,0.0050774403,0.021805385,0.0001306371,0.0060338005,0.0013200291,0.0038752826,0.0018091861,0.0023742171,0.0018187054,0.135121,0.3471752],"study_design_scores_gemma":[0.24184631,0.018218668,0.2591689,0.0026958538,0.0015030903,0.00008783098,0.0032607527,0.0058738505,0.0016780337,0.0049490593,0.4598638,0.00085385994],"about_ca_topic_score_codex":0.0016227617,"about_ca_topic_score_gemma":0.00244228,"teacher_disagreement_score":0.34632134,"about_ca_system_score_codex":0.0037566056,"about_ca_system_score_gemma":0.002767087,"threshold_uncertainty_score":0.99916226},"labels":[],"label_agreement":null},{"id":"W4416019264","doi":"10.1016/j.ijgc.2025.102481","title":"VENOUS THROMBOEMBOLISM AMONG PATIENTS WITH OVARIAN CANCER: TOWARD SAFE AND EFFECTIVE THROMBOPHYLAXIS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Venous thromboembolism; Ovarian cancer; MEDLINE; Pulmonary embolism","score_opus":0.007135059177926467,"score_gpt":0.288723566292316,"score_spread":0.28158850711438954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830324,0.0009786882,0.00022418943,0.0044866316,0.0017068925,0.0005689415,0.000026234942,0.000016383121,0.0036887983],"genre_scores_gemma":[0.99501336,0.0016996608,0.00031722203,0.0024538846,0.00029304717,0.000084997904,0.000005318109,0.000013025318,0.00011951082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985142,0.000054946915,0.00040607716,0.0002456118,0.0005546337,0.000224532],"domain_scores_gemma":[0.9983641,0.00020160191,0.0003219653,0.0001026805,0.00087378494,0.00013585156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001951038,0.0001926581,0.0007123557,0.0002215161,0.00007250972,0.000057992213,0.00023394359,0.00011091266,0.000826881],"category_scores_gemma":[0.00017893022,0.00012643673,0.0001227706,0.00016571858,0.00018458978,0.00016976062,0.00012776247,0.00032202416,0.0000028510283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008442031,0.001988788,0.85458213,0.00008877151,0.0031999282,0.00018571239,0.00042522143,0.00018168607,0.00009879798,0.0020083908,0.0040703868,0.13232599],"study_design_scores_gemma":[0.0035619321,0.001464343,0.9864427,0.00042080265,0.0003915815,0.0000070605665,0.00006982251,0.000018199054,0.00020381532,0.00074120384,0.0065521915,0.0001263349],"about_ca_topic_score_codex":0.00035306576,"about_ca_topic_score_gemma":0.00012548736,"teacher_disagreement_score":0.13219966,"about_ca_system_score_codex":0.0005274473,"about_ca_system_score_gemma":0.00019547754,"threshold_uncertainty_score":0.9053767},"labels":[],"label_agreement":null},{"id":"W4416019271","doi":"10.1016/j.ijgc.2025.102244","title":"THE SAFETY AND FEASIBILITY OF LAPAROSCOPIC BARIATRIC SURGERY WITH HYSTERECTOMY FOR ENDOMETRIAL CANCER: A PROSPECTIVE COHORT STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Hysterectomy; Prospective cohort study; Cohort study; Laparoscopy; MEDLINE; Laparoscopic surgery","score_opus":0.03374369190268864,"score_gpt":0.3677072147379502,"score_spread":0.33396352283526154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918352,0.0027447522,0.0001361125,0.001664213,0.0015180042,0.0016241544,0.000052271356,0.0000066286657,0.00041867522],"genre_scores_gemma":[0.9974262,0.0015979167,0.00007481927,0.00014409561,0.0003234344,0.00021970326,0.0000019396384,0.000005886676,0.00020599937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983394,0.00010276674,0.0006725611,0.00020858344,0.0005209768,0.00015567805],"domain_scores_gemma":[0.9950006,0.0031491301,0.00047196308,0.00009917175,0.0011994261,0.000079703546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086591864,0.00013295408,0.0007052715,0.00021472402,0.00008591112,0.000030419491,0.00016893553,0.000059457678,0.00013021957],"category_scores_gemma":[0.0017776957,0.000065709326,0.00018231699,0.0004517611,0.00012825253,0.00006723729,0.00005304016,0.00018265378,1.6842101e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019955333,0.000614121,0.96232337,0.00002957928,0.0018466216,0.000017806444,0.000030185633,0.00001241822,0.000021936441,0.00013173567,0.00008503726,0.0149318725],"study_design_scores_gemma":[0.014839408,0.0020381466,0.9805467,0.000107481974,0.00057181856,0.00001034914,0.00010645323,0.000008851219,0.0002646402,0.00032881595,0.0011174894,0.00005983334],"about_ca_topic_score_codex":0.00026390573,"about_ca_topic_score_gemma":0.00044559545,"teacher_disagreement_score":0.01822336,"about_ca_system_score_codex":0.00073176087,"about_ca_system_score_gemma":0.00060632423,"threshold_uncertainty_score":0.26795486},"labels":[],"label_agreement":null},{"id":"W4416019286","doi":"10.1016/j.ijgc.2025.102342","title":"RELEVANCE AND IMPACT OF CONCURRENT HYSTERECTOMY AT THE TIME OF SURGERY FOR BENIGN ADNEXAL MASSES: DOES THE LEVEL OF PREOPERATIVE SUSPICION OF MALIGNANCY MATTER?","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Abdominal Surgery and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Malignancy; Hysterectomy; Adnexal Diseases; Relevance (law); Clinical significance","score_opus":0.06975165137661458,"score_gpt":0.3853418299149163,"score_spread":0.3155901785383017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940572,0.0012466258,0.0007134307,0.003040005,0.000250005,0.00026769264,0.00026150406,0.0000011326258,0.000162411],"genre_scores_gemma":[0.9988987,0.00032846243,0.00008649884,0.00013507737,0.000049501086,0.000028131255,0.0000049918453,0.0000036506567,0.00046498407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987758,0.00009293438,0.0007065489,0.000091939066,0.0002492098,0.000083597675],"domain_scores_gemma":[0.9947433,0.0032192855,0.00083738606,0.000097933196,0.001074338,0.000027747685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041989438,0.00008932829,0.00043947203,0.00007863805,0.000032389336,0.0000045194943,0.0001815471,0.000046936453,0.0005821787],"category_scores_gemma":[0.00058393006,0.000039000606,0.00029678651,0.000094667026,0.00025218743,0.00005958815,0.00006431897,0.0001049548,4.0629254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034692618,0.0005766662,0.89568055,0.00024092666,0.001580364,0.0000057201087,0.00044075577,0.00028621705,0.07485091,0.0015749341,0.006686338,0.014607363],"study_design_scores_gemma":[0.000628102,0.0004488382,0.94271886,0.0007182331,0.00017663527,0.000030006198,0.00014163555,0.00012638555,0.053689726,0.0008405241,0.00042887876,0.00005214979],"about_ca_topic_score_codex":0.000046968158,"about_ca_topic_score_gemma":0.000022480763,"teacher_disagreement_score":0.047038343,"about_ca_system_score_codex":0.0001237632,"about_ca_system_score_gemma":0.00026988974,"threshold_uncertainty_score":0.63744485},"labels":[],"label_agreement":null},{"id":"W4416019293","doi":"10.1016/j.ijgc.2025.102245","title":"PEMBROLIZUMAB PLUS ADJUVANT CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY FOR NEWLY DIAGNOSED HIGH-RISK ENDOMETRIAL CANCER: HEALTH-RELATED QUALITY OF LIFE (HRQOL) FROM THE PHASE 3 ENGOT-EN11/GOG-3053/KEYNOTE-B21 STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Radiation therapy; Quality of life (healthcare); Chemotherapy; Adjuvant; Phases of clinical research","score_opus":0.08763137003118326,"score_gpt":0.4690589906847477,"score_spread":0.38142762065356445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95937353,0.00895113,0.0031875547,0.022667157,0.002195339,0.0028644707,0.000688818,0.00003210759,0.000039901242],"genre_scores_gemma":[0.98266757,0.009511478,0.0012798076,0.0041262126,0.0015567747,0.00047709848,0.000021593947,0.000047481928,0.00031197016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99417967,0.0008728012,0.0020876424,0.00050980673,0.001850018,0.0005000749],"domain_scores_gemma":[0.9889971,0.006494685,0.0019180259,0.00039985863,0.0018354892,0.00035485966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025811114,0.00037495414,0.0018497024,0.00035913297,0.00017339583,0.00008170111,0.0010449565,0.0002164803,0.003628125],"category_scores_gemma":[0.004467435,0.00020185387,0.00040259867,0.00066089473,0.00034236046,0.00013868266,0.00008295926,0.0010834549,0.00000148445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25310713,0.0044885348,0.44568598,0.00010323874,0.009384474,0.0001638958,0.0030726565,0.0017399007,0.0011980971,0.00014282322,0.011202806,0.26971045],"study_design_scores_gemma":[0.3598111,0.026710432,0.58004886,0.00105414,0.00062756403,0.000033008746,0.0020835928,0.0015314668,0.0016339988,0.0005677187,0.025357632,0.0005404836],"about_ca_topic_score_codex":0.02238369,"about_ca_topic_score_gemma":0.0063471757,"teacher_disagreement_score":0.26917,"about_ca_system_score_codex":0.0027544387,"about_ca_system_score_gemma":0.0062574814,"threshold_uncertainty_score":0.9993761},"labels":[],"label_agreement":null},{"id":"W4416019328","doi":"10.1016/j.ijgc.2025.102535","title":"IS A SENTINEL LYMPH NODE BIOPSY OF BENEFIT IN VULVAR TUMORS ≥4CM?","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Sentinel lymph node; Biopsy; Vulvar cancer; Lymph node; Vulvar neoplasm","score_opus":0.019968942683277945,"score_gpt":0.33649508752268864,"score_spread":0.3165261448394107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98316514,0.0008029142,0.000021870766,0.011933732,0.0004777429,0.00007145564,0.000020241636,0.000004474731,0.0035024195],"genre_scores_gemma":[0.99587286,0.00048371442,0.00033949543,0.0027655016,0.000109594475,0.000015736785,0.0000027990284,0.00000442591,0.00040590682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987606,0.000016959826,0.0005797193,0.00012931996,0.00038284523,0.0001305715],"domain_scores_gemma":[0.9988934,0.00019160472,0.0002882493,0.0000776169,0.00048412036,0.000065018554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013801883,0.00010619991,0.00036267706,0.0002531594,0.000013397626,0.000012360097,0.00018458246,0.00007563968,0.0010234301],"category_scores_gemma":[0.0001846032,0.0000719938,0.00019775613,0.00020940605,0.00005786317,0.000055678884,0.000056807636,0.00010080064,0.000006077168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043090718,0.00093919825,0.9863449,0.00001870055,0.00039112664,0.00067444117,0.000058667763,0.000104561645,0.00083260896,0.0011834587,0.00065205724,0.008369413],"study_design_scores_gemma":[0.004330641,0.000074084135,0.98985666,0.00043883294,0.00007766159,0.00012059807,0.000050192237,0.00010437202,0.0029408415,0.0010534953,0.0008983127,0.000054322336],"about_ca_topic_score_codex":0.0003144079,"about_ca_topic_score_gemma":0.000017470275,"teacher_disagreement_score":0.012707677,"about_ca_system_score_codex":0.0006038893,"about_ca_system_score_gemma":0.00028303877,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W4416019335","doi":"10.1016/j.ijgc.2025.102345","title":"PREGNANCY OUTCOMES AMONG WOMEN WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS WHO UNDERWENT EXCISIONAL TREATMENT FOR HIGH-GRADE CERVICAL INTRAEPITHELIAL LESIONS: A RETROSPECTIVE COHORT STUDY IN LOW-RESOURCE SETTINGS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Retrospective cohort study; Pregnancy; Human immunodeficiency virus (HIV); Cohort study; Cervical intraepithelial neoplasia; Human papillomavirus","score_opus":0.02419474200028925,"score_gpt":0.372177487445357,"score_spread":0.34798274544506774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943655,0.00025945637,0.00034417445,0.002319307,0.00033248359,0.0014325074,0.00005955893,0.00002076669,0.0008662207],"genre_scores_gemma":[0.99778813,0.00020848397,0.00007085575,0.00044373504,0.00015873772,0.0006221114,0.000009387906,0.000017072256,0.0006814779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972242,0.00012451256,0.0008148567,0.00039775486,0.0010370252,0.00040162526],"domain_scores_gemma":[0.99779356,0.00064089475,0.000289705,0.00017231898,0.0009351677,0.00016837855],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005221958,0.00024928703,0.0007749678,0.00048039525,0.00018677536,0.000078960846,0.00035186775,0.00013538548,0.0020159693],"category_scores_gemma":[0.0004675056,0.00015487708,0.00019676621,0.00037007435,0.0002041655,0.00013701679,0.00012638696,0.00055489334,0.000001798528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021873482,0.005230772,0.9788829,0.000023357266,0.00093181507,0.00015497002,0.00049245544,0.0003297976,0.00009639385,0.00070880406,0.00009983937,0.010861567],"study_design_scores_gemma":[0.00994674,0.007124397,0.97962433,0.00032198752,0.00012446956,0.000011177335,0.0005561501,0.000069509435,0.00012979857,0.0016032684,0.00034369805,0.00014447876],"about_ca_topic_score_codex":0.00073894014,"about_ca_topic_score_gemma":0.0021065096,"teacher_disagreement_score":0.010717088,"about_ca_system_score_codex":0.004952645,"about_ca_system_score_gemma":0.00056439114,"threshold_uncertainty_score":0.9988963},"labels":[],"label_agreement":null},{"id":"W4416019357","doi":"10.1016/j.ijgc.2025.102225","title":"DIAGNOSTIC ACCURACY OF THE PROGESTERONE CHALLENGE TEST TO GUIDE PREVENTION IN ENDOMETRIAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; University of Waterloo","funders":"","keywords":"Diagnostic accuracy; Test (biology); Diagnostic test; MEDLINE","score_opus":0.12122039656267498,"score_gpt":0.45739382948099766,"score_spread":0.3361734329183227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031365103,0.99115366,0.000011794016,0.0040797894,0.00041604062,0.003917967,0.00027378718,0.000004267588,0.00011130506],"genre_scores_gemma":[0.0012518981,0.9950979,0.00007553289,0.0008325732,0.00016056423,0.0018143975,0.000009888521,0.000012564799,0.0007447333],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954492,0.00051711843,0.0025790283,0.00032881074,0.000933527,0.00019234176],"domain_scores_gemma":[0.98684543,0.009513905,0.002433268,0.00027096775,0.0007923826,0.00014404833],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010498981,0.0003597972,0.0070177033,0.0008881578,0.000022985536,0.000027210825,0.0006612607,0.00018799581,0.0011727996],"category_scores_gemma":[0.030762758,0.00016733432,0.002816132,0.0019513688,0.000052723273,0.000077922996,0.00024308026,0.00044761683,0.000002237767],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017879753,0.0016701516,0.0010382733,0.6122975,0.26649737,0.00020460728,0.000041075877,0.000018372808,4.6227862e-7,0.000056505207,0.00040489747,0.11759203],"study_design_scores_gemma":[0.001702915,0.00074887497,0.0006193852,0.13543095,0.83764577,0.000051847597,0.0000063105776,4.6178397e-7,0.0000024832743,0.000054360673,0.023560237,0.00017638938],"about_ca_topic_score_codex":0.00012726685,"about_ca_topic_score_gemma":0.00035804728,"teacher_disagreement_score":0.5711484,"about_ca_system_score_codex":0.0010346937,"about_ca_system_score_gemma":0.00085681834,"threshold_uncertainty_score":0.99974024},"labels":[],"label_agreement":null},{"id":"W4416019364","doi":"10.1016/j.ijgc.2025.102464","title":"RADICAL HYSTERECTOMY FOR STAGE II ENDOMETRIAL CANCER IN THE POST-LACC ERA: SURGICAL TRENDS AND ONCOLOGIC OUTCOMES","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Endometrial cancer; Hysterectomy; Stage (stratigraphy); Radical Hysterectomy; MEDLINE","score_opus":0.03627687985924257,"score_gpt":0.4012886199373294,"score_spread":0.36501174007808684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93219906,0.0036732045,0.00003293888,0.058333367,0.0025433807,0.0004463582,0.00016878985,0.000012489895,0.0025903876],"genre_scores_gemma":[0.99102104,0.0013121181,0.00021920208,0.004511285,0.0007468833,0.00019864202,0.000010444292,0.000008002527,0.001972396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792016,0.00015469558,0.0007529996,0.00025184557,0.0006395499,0.00028075228],"domain_scores_gemma":[0.99609673,0.0029242826,0.00030102907,0.00009464396,0.00045998662,0.00012332472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074163935,0.00020535565,0.00072455825,0.00061978545,0.00008996905,0.000052462117,0.00039494736,0.00018248556,0.0021399138],"category_scores_gemma":[0.0014766258,0.000104440274,0.00037898115,0.000564297,0.00015293022,0.00011106077,0.000111892,0.0004872676,9.279109e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015854606,0.0019121952,0.5539883,0.00005001678,0.0015153615,0.0010263178,0.00019723951,0.00005789437,0.00024005535,0.002825409,0.0018886873,0.42044395],"study_design_scores_gemma":[0.03485004,0.0030906214,0.8413824,0.00012451719,0.00030775144,0.000101297956,0.00011746566,0.00004046758,0.00016456794,0.00064500654,0.11902856,0.00014734315],"about_ca_topic_score_codex":0.00020560702,"about_ca_topic_score_gemma":0.00033877473,"teacher_disagreement_score":0.4202966,"about_ca_system_score_codex":0.00071996026,"about_ca_system_score_gemma":0.0003723215,"threshold_uncertainty_score":0.99877226},"labels":[],"label_agreement":null},{"id":"W4416019380","doi":"10.1016/j.ijgc.2025.102201","title":"COMPARATIVE EVALUATION OF GA 68 FAPI-PET SCAN OVER CONVENTIONAL IMAGING FOR PERITONEAL CARCINOMATOSIS DETECTION IN OVARIAN CARCINOMA: A PROSPECTIVE MULTIMODAL IMAGING STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Peritoneal carcinomatosis; Ovarian cancer; Multimodal therapy; Prospective cohort study; Computed tomography; Ultrasound imaging","score_opus":0.0355565687670968,"score_gpt":0.3973486590170488,"score_spread":0.361792090249952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362415,0.0008622368,0.0006362971,0.0015415534,0.0014302724,0.0013868547,0.000062499785,0.0000061854716,0.00044997447],"genre_scores_gemma":[0.998592,0.00001885127,0.0004347059,0.00015806961,0.00027507584,0.00048017153,0.000010473872,0.000008729156,0.000021919193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786776,0.00015592271,0.0007307799,0.00028595654,0.0007831831,0.00017637163],"domain_scores_gemma":[0.99691623,0.00029953363,0.00047295628,0.00008969756,0.0021554087,0.00006618442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008101154,0.00017185738,0.0005188575,0.00041654982,0.00006045347,0.000036061938,0.00014780804,0.000036713875,0.0004840188],"category_scores_gemma":[0.00024527038,0.00013993189,0.00023561415,0.0002038024,0.00008960858,0.0001878031,0.000048923812,0.00021440285,7.0901604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018233998,0.002012376,0.9837618,0.00002153746,0.0006490312,0.00007430059,0.00057265046,0.0005635695,0.0013875705,0.00017518771,0.00016060115,0.008798015],"study_design_scores_gemma":[0.01718134,0.0005244883,0.9600327,0.0001791212,0.0005335341,0.000054054355,0.0013102408,0.01569749,0.0038445098,0.0004653326,0.000077381505,0.00009982339],"about_ca_topic_score_codex":0.0007714204,"about_ca_topic_score_gemma":0.000669261,"teacher_disagreement_score":0.023729078,"about_ca_system_score_codex":0.002653123,"about_ca_system_score_gemma":0.00076119177,"threshold_uncertainty_score":0.69378245},"labels":[],"label_agreement":null},{"id":"W4416528167","doi":"10.1016/j.ijgc.2025.102829","title":"Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"AstraZeneca","keywords":"Overall survival; Carcinoma; Endometrial cancer; Clinical trial; Phases of clinical research; Risk stratification","score_opus":0.031379944470373816,"score_gpt":0.33253354896648935,"score_spread":0.3011536044961155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416528167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942692,0.00028829006,0.000043701726,0.0032492937,0.0010770239,0.00050073414,0.00013760802,0.0000034463978,0.0004307323],"genre_scores_gemma":[0.9992028,0.000079995705,0.00012343092,0.00023079012,0.00019629244,0.000016992975,0.000023824865,0.000005390284,0.00012052448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785167,0.0001824693,0.0007745216,0.00016594527,0.0008861087,0.0001392743],"domain_scores_gemma":[0.99740046,0.0008992692,0.0007732295,0.00009252002,0.0007685971,0.00006589458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006189812,0.0001236587,0.00049240736,0.0002910414,0.00003492979,0.000016710492,0.00018002224,0.000089126384,0.000062763014],"category_scores_gemma":[0.003024122,0.00007032484,0.00014618805,0.00044095813,0.00005082766,0.00009658701,0.00007063165,0.0002671414,2.2659395e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.091271706,0.001577385,0.8916029,0.000017597069,0.0011028335,0.000023985163,0.00003834515,0.000029519837,0.00024632318,0.0001693893,0.00015816046,0.013761859],"study_design_scores_gemma":[0.20585428,0.0031263463,0.78904325,0.00007795646,0.00037818312,8.649068e-7,0.000010729418,0.0000147584715,0.00051355903,0.00025048634,0.00067642983,0.00005318184],"about_ca_topic_score_codex":0.00009094609,"about_ca_topic_score_gemma":0.000036113575,"teacher_disagreement_score":0.11458257,"about_ca_system_score_codex":0.0008748947,"about_ca_system_score_gemma":0.00030263804,"threshold_uncertainty_score":0.36203748},"labels":[],"label_agreement":null},{"id":"W4416528213","doi":"10.1016/j.ijgc.2025.102812","title":"The International Gynecologic Cancer Society Early Career Network: empowering the next generation of gynecologic oncologists","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Gynecologic cancer; Cancer; MEDLINE; Gynecologic oncology","score_opus":0.09376013115662489,"score_gpt":0.38362866272163026,"score_spread":0.28986853156500536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416528213","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022611896,0.0072449706,0.00010295507,0.02505111,0.9366927,0.0004914999,0.00022830028,0.000034714936,0.0075418125],"genre_scores_gemma":[0.15639555,0.08262747,0.00025403965,0.0036689385,0.747535,0.00017288743,0.000074433665,0.000026865175,0.009244804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930042,0.0005976755,0.0011904504,0.00040427837,0.004188101,0.0006153028],"domain_scores_gemma":[0.9833409,0.008888826,0.002089953,0.00024209291,0.0052889064,0.00014928881],"candidate_categories":["metaresearch","open_science","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005910649,0.0003511624,0.00068902277,0.00010761469,0.0010081461,0.000599768,0.0056102974,0.0011202325,0.0022530074],"category_scores_gemma":[0.009828356,0.0002055282,0.00077847304,0.00035028576,0.001401432,0.00036649837,0.00084300817,0.0019721508,0.0000061527753],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014612394,0.00010327666,0.0042933105,0.000011599404,0.0012200277,0.000050945084,0.0011624367,0.001753179,0.00003726766,0.00096747646,0.9714892,0.018765142],"study_design_scores_gemma":[0.0008202184,0.00030095573,0.004145466,0.00016200435,0.00027931572,0.0000013903933,0.0026877588,0.00010175228,0.000018015917,0.00086521317,0.99039584,0.00022207129],"about_ca_topic_score_codex":0.0019680122,"about_ca_topic_score_gemma":0.009287443,"teacher_disagreement_score":0.18915772,"about_ca_system_score_codex":0.0030160905,"about_ca_system_score_gemma":0.0039215176,"threshold_uncertainty_score":0.9997698},"labels":[],"label_agreement":null},{"id":"W4416536795","doi":"10.1016/j.ijgc.2025.102795","title":"First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer: 1-Year follow-up after final analysis of the ENGOT-en9/LEAP-001 phase 3 trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Eisai Canada","keywords":"Pembrolizumab; Lenvatinib; Chemotherapy; Phases of clinical research; Clinical trial","score_opus":0.0560075135470095,"score_gpt":0.40081940651819326,"score_spread":0.34481189297118375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416536795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792216,0.001987627,0.00055244524,0.006274742,0.009848769,0.0010742348,0.00050680403,0.000014253072,0.00051956397],"genre_scores_gemma":[0.99323684,0.002087432,0.00032285333,0.0011737411,0.0014914117,0.00039383376,0.000029955798,0.000016491918,0.0012474597],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722326,0.0000862549,0.001126217,0.0003183882,0.0009422031,0.0003036562],"domain_scores_gemma":[0.99563694,0.0018774064,0.0008437496,0.00021599485,0.0012855919,0.00014031363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038916757,0.00026668215,0.0011148512,0.0006790647,0.00008205618,0.000034252687,0.0005473816,0.0001907335,0.0043684677],"category_scores_gemma":[0.0024138305,0.0001621653,0.0013422344,0.0014094779,0.00013895007,0.00011999469,0.000088599314,0.00035796306,0.0000015324555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8811638,0.0016812983,0.0061720978,0.000042780513,0.011448423,0.000030417696,0.000081150865,0.001281658,0.00030546062,0.00023280852,0.00080820767,0.0967519],"study_design_scores_gemma":[0.9099761,0.007846267,0.02704786,0.0002327739,0.0057105385,0.0000044785843,0.000054573375,0.00058750226,0.0030333444,0.0004044616,0.044862974,0.0002390759],"about_ca_topic_score_codex":0.00016758686,"about_ca_topic_score_gemma":0.00065157766,"teacher_disagreement_score":0.096512824,"about_ca_system_score_codex":0.0012926913,"about_ca_system_score_gemma":0.0007533433,"threshold_uncertainty_score":0.9965417},"labels":[],"label_agreement":null},{"id":"W7117112880","doi":"10.1016/j.ijgc.2025.104447","title":"Correspondence on “Multicenter validated machine learning model for cervical cancer based on HPV genotyping results” by Ziren Chen et al","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Cervical cancer; Chen; Genotyping; Human papillomavirus; MEDLINE","score_opus":0.05619395559220882,"score_gpt":0.4237325587662452,"score_spread":0.3675386031740364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117112880","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23805737,0.004290433,0.09914881,0.61071813,0.0063317358,0.0028228275,0.0028245002,0.00020808633,0.03559809],"genre_scores_gemma":[0.9416335,0.0005866522,0.00063201017,0.053101353,0.00021598113,0.0000962517,0.00008348171,0.00002155824,0.0036291925],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974518,0.00014506732,0.00066078664,0.0003667041,0.0010319431,0.00034371243],"domain_scores_gemma":[0.996639,0.0014000984,0.00027988636,0.00013362271,0.0013359819,0.00021139761],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086113333,0.00021388773,0.00043059947,0.0002801275,0.00009688863,0.000075514494,0.00045838373,0.00015244192,0.0046327966],"category_scores_gemma":[0.0021062056,0.00015255003,0.0002683788,0.00018283314,0.000087054534,0.00009226339,0.00009323333,0.0010787315,0.00000975858],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1848151,0.0028952353,0.034683123,0.00016806378,0.0013755063,0.000246349,0.00031652997,0.32717487,0.010427526,0.00089206547,0.21548782,0.22151782],"study_design_scores_gemma":[0.013622541,0.0016658999,0.046387073,0.00031228497,0.000116656556,0.0000053922463,0.000020992544,0.80673176,0.00348063,0.00022659935,0.127205,0.00022519342],"about_ca_topic_score_codex":0.0001369014,"about_ca_topic_score_gemma":0.00013057789,"teacher_disagreement_score":0.70357615,"about_ca_system_score_codex":0.0010983276,"about_ca_system_score_gemma":0.00071107416,"threshold_uncertainty_score":0.9962771},"labels":[],"label_agreement":null}]}